Citrus Sinensis ID: 017232

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-----
Protein Sequence
MGIMAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEMMTQSPDSVTLSWTSTKTTPTSSS
Secondary Structure (PSIPRED)
ccHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccEEEEcHHHHHHHHcccccccccccccccEEEEEEEccccEEEEEEcccccHHHHHHHHHHHHHHHHccccccccEEccccccccEEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHcccccccccccccccccccccccEEcccccccccccccccEEEcccccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHHHHHHHHHcccccccccccccccccHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHccccccHHHHHHHcccccccEEccccccccccccc
Secondary Structure Prediction (SSPRO)
cHHHHHHHHHHHHHHHcccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHcccccccccEEEEcEcccccEEEEEEEcccccccHHHHHHHHHHHHHHHcHcHHHEEEEEEcccccEEEEEEEcccccHHHHHcccccccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcHHHcEEEccccccccccccccEEEEEEEcccccccHHHHHcccccccHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHcccHHHHccccHccccccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHccccccccccccccccccccccccccccccccccccccc
Coil and Loop (DISEMBL)
MGIMAAIFLIYLRRKKNKHSASTLLfrntssepsskvdlekggnyhgvqvfsygeleeatnyfdsarelgdggfgtVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSlygctsrhsRELLLVYEFISNgtvadhlhgerakpgalpwptRLKIAIETASALTYLhasdiihrdvktnnilldnnfcvkvadfglsrlfpnhvthvstapqgtpgyvdpeyhqcyqltdksdvFSFGVVLIELIssmpavditrhrheinLSNLAINKIQNKALHELVDqtlgyesdnkVRRTINAVAELAFQCLqsekdlrpYMVDVLDALRDIesdgyddkktheemmtqspdsvtlswtstkttptsss
Flexible Loop (DISEMBL)
MGIMAAIFLIYLRRKKNkhsastllfrntssepsskvdlekggnYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGtvadhlhgerakpgalpwpTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQClqsekdlrPYMVDVLDALRDIESDGYDDKKTHeemmtqspdsvtlswtstkttptsss
Low Complexity Region (SEG)
MGIMAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEMMTQSPDsvtlswtstkttptsss
Disordered region (IsUnstruct)
**IMAAIFLIYLRR****************************GNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL****************************************
Disordered Region (DISOPRED)
MGIMAAIFLIYLR************************************VFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN***RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAV******H**NLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR***************************************
Disordered Region (DISEMBL)
MGIMAAIFLIYLRRKKNKHSASTLLFR**********DLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKK****************************
Disordered Region (DISPRO)
MGIMAAIFLIYLRRKKN****************************HGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI*************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MGIMAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEMMTQSPDSVTLSWTSTKTTPTSSS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	375	2.2.26 [Sep-21-2011]
P0C5E2	654	Probable serine/threonine	yes	no	0.970	0.556	0.652	1e-138
Q8RY67	708	Wall-associated receptor	no	no	0.818	0.433	0.469	2e-78
Q8GYF5	622	Wall-associated receptor	no	no	0.84	0.506	0.439	2e-73
Q9LX66	830	Receptor-like protein kin	no	no	0.853	0.385	0.405	4e-62
Q9LZM4	657	Wall-associated receptor	no	no	0.76	0.433	0.445	1e-60
Q9LMP1	732	Wall-associated receptor	no	no	0.829	0.424	0.425	2e-60
Q9LMN7	733	Wall-associated receptor	no	no	0.829	0.424	0.419	4e-60
Q9T020	878	Probable receptor-like pr	no	no	0.813	0.347	0.431	1e-59
Q9FLW0	824	Probable receptor-like pr	no	no	0.842	0.383	0.417	2e-59
Q9M342	639	Wall-associated receptor	no	no	0.744	0.436	0.449	2e-59

>sp|P0C5E2|Y1839_ARATH Probable serine/threonine-protein kinase At1g18390 OS=Arabidopsis thaliana GN=At1g18390 PE=1 SV=2

 Score =  493 bits (1268), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 244/374 (65%), Positives = 299/374 (79%), Gaps = 10/374 (2%)

Query: 3   IMAAIFL-IYLRRK-KNKHSASTLLFRNTSSEPSSK-VDLEKGGNYH-GVQVFSYGELEE 58
           I A+IF  +Y RRK K+  ++S LL RN SS+PS+K  D+EK      GV +FSY ELEE
Sbjct: 280 IAASIFWYVYHRRKTKSYRNSSALLPRNISSDPSAKSFDIEKAEELLVGVHIFSYEELEE 339

Query: 59  ATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
           ATN FD ++ELGDGGFGTVYYG+L+DGR+VAVKRLY+NN+KR EQF NEV+IL  LRH N
Sbjct: 340 ATNNFDPSKELGDGGFGTVYYGKLKDGRSVAVKRLYDNNFKRAEQFRNEVEILTGLRHPN 399

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           LV+L+GC+S+ SR+LLLVYE+++NGT+ADHLHG +A P +LPW  RLKIA+ETASAL YL
Sbjct: 400 LVALFGCSSKQSRDLLLVYEYVANGTLADHLHGPQANPSSLPWSIRLKIAVETASALKYL 459

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           HAS IIHRDVK+NNILLD NF VKVADFGLSRLFP   THVSTAPQGTPGYVDP+YH CY
Sbjct: 460 HASKIIHRDVKSNNILLDQNFNVKVADFGLSRLFPMDKTHVSTAPQGTPGYVDPDYHLCY 519

Query: 239 QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           QL++KSDV+SF VVL+ELISS+PAVDITR R EINLSN+A+ KIQN  L ++VD +LG++
Sbjct: 520 QLSNKSDVYSFAVVLMELISSLPAVDITRPRQEINLSNMAVVKIQNHELRDMVDPSLGFD 579

Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYD------DKKTHEEM 352
           +D +VR+T+ AVAELAFQCLQS+KDLRP M  V D L  I+++G+       D      +
Sbjct: 580 TDTRVRQTVIAVAELAFQCLQSDKDLRPCMSHVQDTLTRIQNNGFGSEMDVVDVNKSGPL 639

Query: 353 MTQSPDSVTLSWTS 366
           + QSPDSV + W S
Sbjct: 640 VAQSPDSVIVKWDS 653

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q8RY67|WAKLO_ARATH Wall-associated receptor kinase-like 14 OS=Arabidopsis thaliana GN=WAKL14 PE=2 SV=2

 Score =  293 bits (749), Expect = 2e-78,   Method: Compositional matrix adjust.
 Identities = 147/313 (46%), Positives = 205/313 (65%), Gaps = 6/313 (1%)

Query: 34  SSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRL 93
           S+K  L +      V  F Y E+E+AT+ F   ++LG G +GTVY G+LQ+   VA+KRL
Sbjct: 319 SAKRLLSEAAGNSSVAFFPYKEIEKATDGFSEKQKLGIGAYGTVYRGKLQNDEWVAIKRL 378

Query: 94  YENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER 153
              + + ++Q MNE+ +L+ + H NLV L GC      + +LVYE++ NGT+++HL  +R
Sbjct: 379 RHRDSESLDQVMNEIKLLSSVSHPNLVRLLGCCIEQG-DPVLVYEYMPNGTLSEHLQRDR 437

Query: 154 AKPGALPWPTRLKIAIETASALTYLHAS---DIIHRDVKTNNILLDNNFCVKVADFGLSR 210
                LPW  RL +A +TA A+ YLH+S    I HRD+K+ NILLD +F  KVADFGLSR
Sbjct: 438 GS--GLPWTLRLTVATQTAKAIAYLHSSMNPPIYHRDIKSTNILLDYDFNSKVADFGLSR 495

Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
           L     +H+STAPQGTPGY+DP+YHQC+ L+DKSDV+SFGVVL E+I+ +  VD TR   
Sbjct: 496 LGMTESSHISTAPQGTPGYLDPQYHQCFHLSDKSDVYSFGVVLAEIITGLKVVDFTRPHT 555

Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
           EINL+ LA++KI +  + E++D  L  + D     +I+ VAELAF+CL    D+RP M +
Sbjct: 556 EINLAALAVDKIGSGCIDEIIDPILDLDLDAWTLSSIHTVAELAFRCLAFHSDMRPTMTE 615

Query: 331 VLDALRDIESDGY 343
           V D L  I   G+
Sbjct: 616 VADELEQIRLSGW 628

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GYF5|WAKLR_ARATH Wall-associated receptor kinase-like 21 OS=Arabidopsis thaliana GN=WAKL21 PE=2 SV=2

 Score =  276 bits (705), Expect = 2e-73,   Method: Compositional matrix adjust.
 Identities = 145/330 (43%), Positives = 212/330 (64%), Gaps = 15/330 (4%)

Query: 22  STLLFRNTSSEPSSKVDL------EKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFG 75
           +T  FRN  S  S +  +      E  GN   V  ++Y E+E+AT+ F     LG G +G
Sbjct: 268 ATYFFRNKQSASSERASIANRLLCELAGN-SSVPFYTYKEIEKATDSFSDKNMLGTGAYG 326

Query: 76  TVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL 135
           TVY GE  +   VA+KRL   +   ++Q +NE+ +L+ + H NLV L GC      E  L
Sbjct: 327 TVYAGEFPNSSCVAIKRLKHKDTTSIDQVVNEIKLLSSVSHPNLVRLLGCCFADG-EPFL 385

Query: 136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---DIIHRDVKTNN 192
           VYEF+ NGT+  HL  ER +P  L W  RL IA +TA+A+ +LH+S    I HRD+K++N
Sbjct: 386 VYEFMPNGTLYQHLQHERGQP-PLSWQLRLAIACQTANAIAHLHSSVNPPIYHRDIKSSN 444

Query: 193 ILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSF 249
           ILLD+ F  K++DFGLSRL  +     +H+STAPQGTPGY+DP+YHQ +QL+DKSDV+SF
Sbjct: 445 ILLDHEFNSKISDFGLSRLGMSTDFEASHISTAPQGTPGYLDPQYHQDFQLSDKSDVYSF 504

Query: 250 GVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINA 309
           GVVL+E+IS    +D TR   E+NL++LA+++I    + +++D  L  E + K+  +I+ 
Sbjct: 505 GVVLVEIISGFKVIDFTRPYSEVNLASLAVDRIGRGRVVDIIDPCLNKEINPKMFASIHN 564

Query: 310 VAELAFQCLQSEKDLRPYMVDVLDALRDIE 339
           +AELAF+CL   +++RP MV++ + L  I+
Sbjct: 565 LAELAFRCLSFHRNMRPTMVEITEDLHRIK 594

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LX66|HERK_ARATH Receptor-like protein kinase HERK 1 OS=Arabidopsis thaliana GN=HERK1 PE=1 SV=1

 Score =  238 bits (608), Expect = 4e-62,   Method: Compositional matrix adjust.
 Identities = 139/343 (40%), Positives = 200/343 (58%), Gaps = 23/343 (6%)

Query: 3   IMAAIFLIYLRRKKNK--HSASTLLFRNTSSEPSSK-------VDLEKGGNYHGVQVFSY 53
            + + F++Y +RK+ +  HS + + F    +   SK         +    NY       +
Sbjct: 420 FLGSCFVLYKKRKRGQDGHSKTWMPFSINGTSMGSKYSNGTTLTSITTNANYR----IPF 475

Query: 54  GELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
             +++ATN FD +R +G GGFG VY GEL DG  VAVKR    + + + +F  E+++L++
Sbjct: 476 AAVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQ 535

Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
            RH++LVSL G    ++ E++L+YE++ NGTV  HL+G      +L W  RL+I I  A 
Sbjct: 536 FRHRHLVSLIGYCDENN-EMILIYEYMENGTVKSHLYGSGLP--SLTWKQRLEICIGAAR 592

Query: 174 ALTYLHASD---IIHRDVKTNNILLDNNFCVKVADFGLSRLFPN-HVTHVSTAPQGTPGY 229
            L YLH  D   +IHRDVK+ NILLD NF  KVADFGLS+  P    THVSTA +G+ GY
Sbjct: 593 GLHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGY 652

Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE 289
           +DPEY +  QLTDKSDV+SFGVVL E++ + P +D T  R  +NL+  A+   +   L +
Sbjct: 653 LDPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAMKWQKKGQLDQ 712

Query: 290 LVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
           ++DQ+L     N    ++   AE   +CL      RP M DVL
Sbjct: 713 IIDQSL---RGNIRPDSLRKFAETGEKCLADYGVDRPSMGDVL 752

Receptor-like protein kinase required for cell elongation during vegetative growth, mostly in a brassinosteroid-(BR-) independent manner.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LZM4|WAKLQ_ARATH Wall-associated receptor kinase-like 20 OS=Arabidopsis thaliana GN=WAKL20 PE=2 SV=1

 Score =  233 bits (595), Expect = 1e-60,   Method: Compositional matrix adjust.
 Identities = 135/303 (44%), Positives = 187/303 (61%), Gaps = 18/303 (5%)

Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEV 108
           ++F+  E+ +ATN F     +G GGFG V+   L+DG   A+KR   NN K  +Q +NEV
Sbjct: 349 RIFTGREITKATNNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNNTKGTDQILNEV 408

Query: 109 DILARLRHKNLVSLYGCTSRHSREL-LLVYEFISNGTVADHLHGER---AKPGALPWPTR 164
            IL ++ H++LV L GC      EL LL+YEFI NGT+ +HLHG      KP  L W  R
Sbjct: 409 RILCQVNHRSLVRLLGCCV--DLELPLLIYEFIPNGTLFEHLHGSSDRTWKP--LTWRRR 464

Query: 165 LKIAIETASALTYLHAS---DIIHRDVKTNNILLDNNFCVKVADFGLSRLF-----PNHV 216
           L+IA +TA  L YLH++    I HRDVK++NILLD     KV+DFGLSRL       N+ 
Sbjct: 465 LQIAYQTAEGLAYLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDLTETANNE 524

Query: 217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
           +H+ T  QGT GY+DPEY++ +QLTDKSDV+SFGVVL+E+++S  A+D TR   ++NL  
Sbjct: 525 SHIFTGAQGTLGYLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREEEDVNLV- 583

Query: 277 LAINKIQNKA-LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
           + INK+ ++  L E +D  L   ++    +TI  +  LA  CL   +  RP M +V D +
Sbjct: 584 MYINKMMDQERLTECIDPLLKKTANKIDMQTIQQLGNLASACLNERRQNRPSMKEVADEI 643

Query: 336 RDI 338
             I
Sbjct: 644 EYI 646

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMP1|WAK2_ARATH Wall-associated receptor kinase 2 OS=Arabidopsis thaliana GN=WAK2 PE=1 SV=1

 Score =  233 bits (593), Expect = 2e-60,   Method: Compositional matrix adjust.
 Identities = 141/331 (42%), Positives = 195/331 (58%), Gaps = 20/331 (6%)

Query: 12  LRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGD 71
           LR+K  + +   +L +  S    S VD         V++F+   ++EATN +  +R LG 
Sbjct: 362 LRQKFFEQNGGGMLIQRVSGAGPSNVD---------VKIFTEKGMKEATNGYHESRILGQ 412

Query: 72  GGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR 131
           GG GTVY G L D   VA+K+    N  +VEQF+NEV +L+++ H+N+V + GC    + 
Sbjct: 413 GGQGTVYKGILPDNSIVAIKKARLGNRSQVEQFINEVLVLSQINHRNVVKVLGC-CLETE 471

Query: 132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---DIIHRDV 188
             LLVYEFI++GT+ DHLHG      +L W  RL+IA E A +L YLH+S    IIHRD+
Sbjct: 472 VPLLVYEFINSGTLFDHLHGSLYDS-SLTWEHRLRIATEVAGSLAYLHSSASIPIIHRDI 530

Query: 189 KTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
           KT NILLD N   KVADFG SRL P     ++T  QGT GY+DPEY+    L +KSDV+S
Sbjct: 531 KTANILLDKNLTAKVADFGASRLIPMDKEQLTTIVQGTLGYLDPEYYNTGLLNEKSDVYS 590

Query: 249 FGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTIN 308
           FGVVL+EL+S   A+   R     NL +   +  +N   HE++D  +  E DN+  R I 
Sbjct: 591 FGVVLMELLSGQKALCFERPHCPKNLVSCFASATKNNRFHEIIDGQVMNE-DNQ--REIQ 647

Query: 309 AVAELAFQCLQSEKDLRPYMVDV---LDALR 336
             A +A +C +   + RP M +V   L+ALR
Sbjct: 648 EAARIAAECTRLMGEERPRMKEVAAELEALR 678

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LMN7|WAK5_ARATH Wall-associated receptor kinase 5 OS=Arabidopsis thaliana GN=WAK5 PE=2 SV=1

 Score =  232 bits (591), Expect = 4e-60,   Method: Compositional matrix adjust.
 Identities = 139/331 (41%), Positives = 198/331 (59%), Gaps = 20/331 (6%)

Query: 12  LRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGD 71
           LR++  + +   +L +  S    S VD         V++F+   ++EAT+ ++ +R LG 
Sbjct: 366 LRQQFFEQNGGGMLIQRLSGAGPSNVD---------VKIFTEEGMKEATDGYNESRILGQ 416

Query: 72  GGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR 131
           GG GTVY G LQD   VA+K+    +  +VEQF+NEV +L+++ H+N+V L GC    + 
Sbjct: 417 GGQGTVYKGILQDNSIVAIKKARLGDRSQVEQFINEVLVLSQINHRNVVKLLGC-CLETE 475

Query: 132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---DIIHRDV 188
             LLVYEFIS+GT+ DHLHG      +L W  RL+IAIE A  L YLH+     IIHRDV
Sbjct: 476 VPLLVYEFISSGTLFDHLHGSMFD-SSLTWEHRLRIAIEVAGTLAYLHSYASIPIIHRDV 534

Query: 189 KTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
           KT NILLD N   KVADFG SRL P     ++T  QGT GY+DPEY+    L +KSDV+S
Sbjct: 535 KTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLDPEYYNTGLLNEKSDVYS 594

Query: 249 FGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTIN 308
           FGVVL+EL+S   A+   R +   +L +  ++ ++   LHE++D  +  E +   +R I 
Sbjct: 595 FGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMKENRLHEIIDGQVMNEYN---QREIQ 651

Query: 309 AVAELAFQCLQSEKDLRPYMVDV---LDALR 336
             A +A +C +   + RP M +V   L+ALR
Sbjct: 652 ESARIAVECTRIMGEERPSMKEVAAELEALR 682

Serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component. Binding to pectin may have significance in the control of cell expansion, morphogenesis and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9T020|Y4391_ARATH Probable receptor-like protein kinase At4g39110 OS=Arabidopsis thaliana GN=At4g39110 PE=1 SV=1

 Score =  231 bits (588), Expect = 1e-59,   Method: Compositional matrix adjust.
 Identities = 136/315 (43%), Positives = 189/315 (60%), Gaps = 10/315 (3%)

Query: 51  FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDI 110
           FS  EL+EAT  F++++ +G GGFG VY G L DG  VAVKR    + + + +F  E+ +
Sbjct: 514 FSLSELQEATKNFEASQIIGVGGFGNVYIGTLDDGTKVAVKRGNPQSEQGITEFQTEIQM 573

Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           L++LRH++LVSL G    +S E++LVYEF+SNG   DHL+G+   P  L W  RL+I I 
Sbjct: 574 LSKLRHRHLVSLIGYCDENS-EMILVYEFMSNGPFRDHLYGKNLAP--LTWKQRLEICIG 630

Query: 171 TASALTYLH---ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           +A  L YLH   A  IIHRDVK+ NILLD     KVADFGLS+       HVSTA +G+ 
Sbjct: 631 SARGLHYLHTGTAQGIIHRDVKSTNILLDEALVAKVADFGLSKDVAFGQNHVSTAVKGSF 690

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL 287
           GY+DPEY +  QLTDKSDV+SFGVVL+E + + PA++    R ++NL+  A+   +   L
Sbjct: 691 GYLDPEYFRRQQLTDKSDVYSFGVVLLEALCARPAINPQLPREQVNLAEWAMQWKRKGLL 750

Query: 288 HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR-DIESDGYDDK 346
            +++D  L    + +   ++   AE A +CL+     RP M DVL  L   ++      +
Sbjct: 751 EKIIDPHLAGTINPE---SMKKFAEAAEKCLEDYGVDRPTMGDVLWNLEYALQLQEAFTQ 807

Query: 347 KTHEEMMTQSPDSVT 361
              EE     PD VT
Sbjct: 808 GKAEETENAKPDVVT 822

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9FLW0|Y5241_ARATH Probable receptor-like protein kinase At5g24010 OS=Arabidopsis thaliana GN=At5g24010 PE=1 SV=1

 Score =  229 bits (585), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 140/335 (41%), Positives = 200/335 (59%), Gaps = 19/335 (5%)

Query: 9   LIYLRRKKNKHSAS-----TLL--FRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATN 61
           L   RRK NK  +S     T L  FR +S+  +++  +   G YH +++ S+ EL+  TN
Sbjct: 430 LCLCRRKNNKTRSSESTGWTPLRRFRGSSNSRTTERTVSSSG-YHTLRI-SFAELQSGTN 487

Query: 62  YFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
            FD +  +G GGFG V+ G L+D   VAVKR    + + + +F++E+ IL+++RH++LVS
Sbjct: 488 NFDRSLVIGVGGFGMVFRGSLKDNTKVAVKRGSPGSRQGLPEFLSEITILSKIRHRHLVS 547

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH-- 179
           L G     S E++LVYE++  G +  HL+G    P  L W  RL++ I  A  L YLH  
Sbjct: 548 LVGYCEEQS-EMILVYEYMDKGPLKSHLYGSTNPP--LSWKQRLEVCIGAARGLHYLHTG 604

Query: 180 -ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN-HVTHVSTAPQGTPGYVDPEYHQC 237
            +  IIHRD+K+ NILLDNN+  KVADFGLSR  P    THVST  +G+ GY+DPEY + 
Sbjct: 605 SSQGIIHRDIKSTNILLDNNYVAKVADFGLSRSGPCIDETHVSTGVKGSFGYLDPEYFRR 664

Query: 238 YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY 297
            QLTDKSDV+SFGVVL E++ + PAVD    R ++NL+  AI   +   L ++VD  +  
Sbjct: 665 QQLTDKSDVYSFGVVLFEVLCARPAVDPLLVREQVNLAEWAIEWQRKGMLDQIVDPNI-- 722

Query: 298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
            +D     ++   AE A +C       RP + DVL
Sbjct: 723 -ADEIKPCSLKKFAETAEKCCADYGVDRPTIGDVL 756

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9M342|WAKLP_ARATH Wall-associated receptor kinase-like 15 OS=Arabidopsis thaliana GN=WAKL15 PE=2 SV=2

 Score =  229 bits (584), Expect = 2e-59,   Method: Compositional matrix adjust.
 Identities = 129/287 (44%), Positives = 176/287 (61%), Gaps = 8/287 (2%)

Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEV 108
           ++F+  E+ +AT+ F  +  LG GGFG V+ G L DG  VAVKR    N K + Q +NEV
Sbjct: 340 RIFTGKEIVKATDNFAKSNLLGFGGFGEVFKGNLDDGTTVAVKRAKLGNEKSIYQIVNEV 399

Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL----PWPTR 164
            IL ++ HKNLV L GC       +L VYEF+ NGT+ +H++G     G L    P   R
Sbjct: 400 QILCQVSHKNLVKLLGCCIELEMPVL-VYEFVPNGTLFEHIYGGGGGGGGLYDHLPLRRR 458

Query: 165 LKIAIETASALTYLHASD---IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST 221
           L IA +TA  L YLH+S    I HRDVK++NILLD N  VKVADFGLSRL  + V+HV+T
Sbjct: 459 LMIAHQTAQGLDYLHSSSSPPIYHRDVKSSNILLDENLDVKVADFGLSRLGVSDVSHVTT 518

Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK 281
             QGT GY+DPEY+  +QLTDKSDV+SFGVVL EL++   A+D  R   ++NL       
Sbjct: 519 CAQGTLGYLDPEYYLNFQLTDKSDVYSFGVVLFELLTCKKAIDFNREEEDVNLVVFVRKA 578

Query: 282 IQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYM 328
           ++   L +++D  +G  +  K   ++ A+  LA  C++  +  RP M
Sbjct: 579 LKEGRLMDVIDPVIGIGATEKEIESMKALGVLAELCVKETRQCRPTM 625

Putative serine/threonine-protein kinase that may function as a signaling receptor of extracellular matrix component.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	375
255567852	694	wall-associated kinase, putative [Ricinu	0.992	0.536	0.740	1e-169
297734240	973	unnamed protein product [Vitis vinifera]	0.992	0.382	0.722	1e-159
359472668	666	PREDICTED: probable serine/threonine-pro	0.994	0.560	0.651	1e-149
147811712	691	hypothetical protein VITISV_005934 [Viti	0.997	0.541	0.652	1e-148
359472670	750	PREDICTED: probable serine/threonine-pro	0.992	0.496	0.655	1e-148
297737780	1368	unnamed protein product [Vitis vinifera]	0.989	0.271	0.655	1e-148
297737779	656	unnamed protein product [Vitis vinifera]	0.914	0.522	0.728	1e-147
224121266	369	predicted protein [Populus trichocarpa]	0.949	0.964	0.718	1e-147
147772916	534	hypothetical protein VITISV_041559 [Viti	0.997	0.700	0.630	1e-146
356528194	698	PREDICTED: probable serine/threonine-pro	0.96	0.515	0.706	1e-145

>gi|255567852|ref|XP_002524904.1| wall-associated kinase, putative [Ricinus communis] gi|223535867|gb|EEF37528.1| wall-associated kinase, putative [Ricinus communis]

 Score =  599 bits (1545), Expect = e-169,   Method: Compositional matrix adjust.
 Identities = 286/386 (74%), Positives = 330/386 (85%), Gaps = 14/386 (3%)

Query: 3   IMAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNY 62
           IM  IF  YLRRKKN +  S+ + ++T+S+ SS+ D+E+GG + G+ +F+Y ELE+ATN 
Sbjct: 308 IMCIIFFFYLRRKKNPYVPSSYISQSTTSDFSSRSDIERGGTHFGIHLFTYAELEQATNN 367

Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           FDSA+ELG+GGFGTVYYG+L+DGR VAVKRLYENN+KRVEQFMNEVDIL RLRH+NLVSL
Sbjct: 368 FDSAKELGEGGFGTVYYGKLRDGRTVAVKRLYENNFKRVEQFMNEVDILTRLRHQNLVSL 427

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           YGCTSRHSRELLLVYE+ISNGTVADHLHGE+AKPGALPWP R+KIA ETA+ALTYLHASD
Sbjct: 428 YGCTSRHSRELLLVYEYISNGTVADHLHGEKAKPGALPWPIRMKIAAETANALTYLHASD 487

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           IIHRDVKTNNILLD+NFCVKVADFGLSRLFP HVTHVSTAPQGTPGYVDPEYH+CYQLTD
Sbjct: 488 IIHRDVKTNNILLDSNFCVKVADFGLSRLFPLHVTHVSTAPQGTPGYVDPEYHECYQLTD 547

Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNK 302
           KSDV+SFGVVLIELISSMPAVDITRHRHEINLSN+AINKIQ+ ALHELVD+ LGYESD  
Sbjct: 548 KSDVYSFGVVLIELISSMPAVDITRHRHEINLSNMAINKIQSGALHELVDRNLGYESDYA 607

Query: 303 VRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEM---------- 352
           VR+ INAVAELAFQCLQS K+LRP M +VL+AL++I++  Y  +K  EEM          
Sbjct: 608 VRKMINAVAELAFQCLQSAKELRPSMGEVLEALKEIQTKDYTLQKAEEEMDGRSDGVGLL 667

Query: 353 ----MTQSPDSVTLSWTSTKTTPTSS 374
               +  SPD+V + W ST TTP +S
Sbjct: 668 KSDPVPPSPDTVMIKWISTSTTPNTS 693

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297734240|emb|CBI15487.3| unnamed protein product [Vitis vinifera]

 Score =  566 bits (1459), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 279/386 (72%), Positives = 318/386 (82%), Gaps = 14/386 (3%)

Query: 3   IMAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNY 62
           I +  FL+YLRR K ++    L  RN SS+PSSK   E  G+ HGV +F+Y ELEEATN 
Sbjct: 589 ISSIFFLMYLRRYKKRYPPP-LFSRNISSDPSSKTIFESQGSLHGVHIFTYEELEEATNN 647

Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           FDS++ELGDGGFGTVY+G+L+DGR VAVKRLYENNYKRVEQFMNEV+IL  LRH+NLVSL
Sbjct: 648 FDSSKELGDGGFGTVYHGKLRDGRVVAVKRLYENNYKRVEQFMNEVEILQLLRHRNLVSL 707

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           YGCTSRHSRELLLVYE++ NGTVADHLHGE+AKPG+L WPTR+KIAIETASAL YLHASD
Sbjct: 708 YGCTSRHSRELLLVYEYVPNGTVADHLHGEQAKPGSLTWPTRMKIAIETASALKYLHASD 767

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           IIHRDVKTNNILLD+NF VKVADFGLSRLFP  VTHVSTAPQGTPGYVDP+YHQCYQLT 
Sbjct: 768 IIHRDVKTNNILLDSNFSVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPDYHQCYQLTS 827

Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNK 302
           KSDV+SFGVVLIELISSMPAVDITRHRHEINLSN+AINKIQN ALHELVD++LG++SD  
Sbjct: 828 KSDVYSFGVVLIELISSMPAVDITRHRHEINLSNMAINKIQNHALHELVDRSLGFDSDQN 887

Query: 303 VRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHE------------ 350
           +RR I AVAELAFQCLQ+EK++RP M +VL+ L  IES+G +  KT E            
Sbjct: 888 IRRMIMAVAELAFQCLQNEKEMRPAMDEVLEVLMGIESEGCNIVKTEEVEIPADSVGLLK 947

Query: 351 -EMMTQSPDSVTLSWTSTKTTPTSSS 375
            +    SPDSVT +WTS  +T   SS
Sbjct: 948 SKQPPASPDSVTTNWTSWPSTTNGSS 973

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359472668|ref|XP_002279774.2| PREDICTED: probable serine/threonine-protein kinase At1g18390-like [Vitis vinifera]

 Score =  534 bits (1376), Expect = e-149,   Method: Compositional matrix adjust.
 Identities = 265/407 (65%), Positives = 309/407 (75%), Gaps = 34/407 (8%)

Query: 2   GIMAAI------FLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGE 55
           GI+ +I      F I  +R+K K+ AST L RNTSS+PSS+  LE  G Y G+ +F Y E
Sbjct: 261 GIVGSIPFLIICFFIIRQRRKGKY-ASTFLSRNTSSDPSSQPGLETAGAYFGIAIFPYTE 319

Query: 56  LEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR 115
           LEEATNYFD  RE+GDGGFG+VY+G+L+DGR VAVKRLYENNY+RVEQFMNEV IL RLR
Sbjct: 320 LEEATNYFDPDREIGDGGFGSVYHGQLRDGREVAVKRLYENNYRRVEQFMNEVQILTRLR 379

Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           H+NLVSLYGCTSRHSRELLLVYEFI NGTVADHLHG+RA  G L WP RL IAIETA+AL
Sbjct: 380 HRNLVSLYGCTSRHSRELLLVYEFIPNGTVADHLHGDRADSGLLTWPIRLSIAIETATAL 439

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            YLHASD++HRDVKT+NILLDN+FCVKVADFGLSRLFP  VTHVSTAPQGTPGYVDPEYH
Sbjct: 440 CYLHASDVVHRDVKTSNILLDNSFCVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPEYH 499

Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
           QCYQLTDKSDV+SFGVVLIELISS+PAVDI+RHRHEINLSN AINKIQ  A HEL+D  L
Sbjct: 500 QCYQLTDKSDVYSFGVVLIELISSLPAVDISRHRHEINLSNYAINKIQKCAFHELMDPHL 559

Query: 296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKT------- 348
           G++SD  V R    VAELAF+CLQ +K++RP M +VL+ L++IESD ++ +         
Sbjct: 560 GFDSDLAVNRMTTLVAELAFRCLQPDKEMRPSMDEVLEILKEIESDKHELENMDTAADSV 619

Query: 349 --------------------HEEMMTQSPDSVTLSWTSTKTTPTSSS 375
                                   +  SPD+V   W S  TTP++S+
Sbjct: 620 GSSMRKPPSPSPDCDEVGLLKSAPLMPSPDTVIARWPSMSTTPSASA 666

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147811712|emb|CAN65965.1| hypothetical protein VITISV_005934 [Vitis vinifera]

 Score =  531 bits (1368), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 263/403 (65%), Positives = 305/403 (75%), Gaps = 29/403 (7%)

Query: 1   MGIMAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEAT 60
           + I+   F I  +  K K+ A T L RNT S+PSSK +LE  G Y G+ +F Y ELEEAT
Sbjct: 290 ITILIICFFIIWQSHKRKY-APTFLSRNTCSDPSSKSELEITGAYFGIPIFPYTELEEAT 348

Query: 61  NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
           NYFD  RE+GDGGFGTVY+G+L+DGR VAVKRLYENN++RVEQFMNEV IL RLRH+NLV
Sbjct: 349 NYFDPDREIGDGGFGTVYHGQLRDGREVAVKRLYENNHRRVEQFMNEVQILTRLRHRNLV 408

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
           SLYGCTSRHSRELLLVYEFI NGTVADHLHG+RA  G L WP RL IAIETA+AL YLHA
Sbjct: 409 SLYGCTSRHSRELLLVYEFIPNGTVADHLHGDRADSGLLTWPIRLSIAIETATALCYLHA 468

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
           SD++HRDVKT NILLD++FCVKVADFGLSRLFP  VTHVSTAPQGTPGYVDPEYHQCYQL
Sbjct: 469 SDVVHRDVKTKNILLDDSFCVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPEYHQCYQL 528

Query: 241 TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD 300
           TDKSDV+SFGVVLIELISS+PAVDI RHRHEINLSN AINKIQ  A HEL+D  LG++SD
Sbjct: 529 TDKSDVYSFGVVLIELISSLPAVDINRHRHEINLSNYAINKIQKCAFHELIDPRLGFDSD 588

Query: 301 NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDK-----------KTH 349
             V R    VAELAF+CLQ +K++RP M +VL+ L++IESD ++ +             H
Sbjct: 589 LAVNRMTTLVAELAFRCLQPDKEMRPSMDEVLEILKEIESDKHESENMDIATDSVGSSMH 648

Query: 350 EEMMTQSP-----------------DSVTLSWTSTKTTPTSSS 375
           E  +  SP                 D+VT  W S  TTP++S+
Sbjct: 649 EPPLPPSPDCDEVGLLKSVQLMPSLDTVTAQWPSRSTTPSASA 691

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359472670|ref|XP_002279726.2| PREDICTED: probable serine/threonine-protein kinase At1g18390 [Vitis vinifera]

 Score =  530 bits (1366), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 263/401 (65%), Positives = 304/401 (75%), Gaps = 29/401 (7%)

Query: 3   IMAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNY 62
           I+   F I  +  K K+ A T L RNT S+PSSK +LE  G Y G+ +F Y ELEEATNY
Sbjct: 351 ILIICFFIIWQSHKRKY-APTFLSRNTCSDPSSKSELEITGAYFGIPIFPYTELEEATNY 409

Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           FD  RE+GDGGFGTVY+G+L+DGR VAVKRLYENN++RVEQFMNEV IL RLRH+NLVSL
Sbjct: 410 FDPDREIGDGGFGTVYHGQLRDGREVAVKRLYENNHRRVEQFMNEVQILTRLRHRNLVSL 469

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           YGCTSRHSRELLLVYEFI NGTVADHLHG+RA  G L WP RL IAIETA+AL YLHASD
Sbjct: 470 YGCTSRHSRELLLVYEFIPNGTVADHLHGDRADSGLLTWPIRLSIAIETATALCYLHASD 529

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           ++HRDVKT NILLD++FCVKVADFGLSRLFP  VTHVSTAPQGTPGYVDPEYHQCYQLTD
Sbjct: 530 VVHRDVKTKNILLDDSFCVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPEYHQCYQLTD 589

Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNK 302
           KSDV+SFGVVLIELISS+PAVDI RHRHEINLSN AINKIQ  A HEL+D  LG++SD  
Sbjct: 590 KSDVYSFGVVLIELISSLPAVDINRHRHEINLSNYAINKIQKCAFHELIDPRLGFDSDLA 649

Query: 303 VRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKK-----------THEE 351
           V R    VAELAF+CLQ +K++RP M +VL+ L++IESD ++ +             HE 
Sbjct: 650 VNRMTTLVAELAFRCLQPDKEMRPSMDEVLEILKEIESDKHESENMDIATDSVGSSMHEP 709

Query: 352 MMTQSP-----------------DSVTLSWTSTKTTPTSSS 375
            +  SP                 D+VT  W S  TTP++S+
Sbjct: 710 PLPPSPDCDEVGLLKSVQLMPSLDTVTAQWPSRSTTPSASA 750

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297737780|emb|CBI26981.3| unnamed protein product [Vitis vinifera]

 Score =  529 bits (1362), Expect = e-148,   Method: Compositional matrix adjust.
 Identities = 262/400 (65%), Positives = 303/400 (75%), Gaps = 29/400 (7%)

Query: 3   IMAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNY 62
           I+   F I  +  K K+ A T L RNT S+PSSK +LE  G Y G+ +F Y ELEEATNY
Sbjct: 277 ILIICFFIIWQSHKRKY-APTFLSRNTCSDPSSKSELEITGAYFGIPIFPYTELEEATNY 335

Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           FD  RE+GDGGFGTVY+G+L+DGR VAVKRLYENN++RVEQFMNEV IL RLRH+NLVSL
Sbjct: 336 FDPDREIGDGGFGTVYHGQLRDGREVAVKRLYENNHRRVEQFMNEVQILTRLRHRNLVSL 395

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           YGCTSRHSRELLLVYEFI NGTVADHLHG+RA  G L WP RL IAIETA+AL YLHASD
Sbjct: 396 YGCTSRHSRELLLVYEFIPNGTVADHLHGDRADSGLLTWPIRLSIAIETATALCYLHASD 455

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           ++HRDVKT NILLD++FCVKVADFGLSRLFP  VTHVSTAPQGTPGYVDPEYHQCYQLTD
Sbjct: 456 VVHRDVKTKNILLDDSFCVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPEYHQCYQLTD 515

Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNK 302
           KSDV+SFGVVLIELISS+PAVDI RHRHEINLSN AINKIQ  A HEL+D  LG++SD  
Sbjct: 516 KSDVYSFGVVLIELISSLPAVDINRHRHEINLSNYAINKIQKCAFHELIDPRLGFDSDLA 575

Query: 303 VRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKK-----------THEE 351
           V R    VAELAF+CLQ +K++RP M +VL+ L++IESD ++ +             HE 
Sbjct: 576 VNRMTTLVAELAFRCLQPDKEMRPSMDEVLEILKEIESDKHESENMDIATDSVGSSMHEP 635

Query: 352 MMTQSP-----------------DSVTLSWTSTKTTPTSS 374
            +  SP                 D+VT  W S  TTP+++
Sbjct: 636 PLPPSPDCDEVGLLKSVQLMPSLDTVTAQWPSRSTTPSAT 675

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297737779|emb|CBI26980.3| unnamed protein product [Vitis vinifera]

 Score =  529 bits (1362), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 255/350 (72%), Positives = 294/350 (84%), Gaps = 7/350 (2%)

Query: 1   MGIMAAI------FLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYG 54
           +GI+ +I      F I  +R+K K+ AST L RNTSS+PSS+  LE  G Y G+ +F Y 
Sbjct: 232 LGIVGSIPFLIICFFIIRQRRKGKY-ASTFLSRNTSSDPSSQPGLETAGAYFGIAIFPYT 290

Query: 55  ELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL 114
           ELEEATNYFD  RE+GDGGFG+VY+G+L+DGR VAVKRLYENNY+RVEQFMNEV IL RL
Sbjct: 291 ELEEATNYFDPDREIGDGGFGSVYHGQLRDGREVAVKRLYENNYRRVEQFMNEVQILTRL 350

Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
           RH+NLVSLYGCTSRHSRELLLVYEFI NGTVADHLHG+RA  G L WP RL IAIETA+A
Sbjct: 351 RHRNLVSLYGCTSRHSRELLLVYEFIPNGTVADHLHGDRADSGLLTWPIRLSIAIETATA 410

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
           L YLHASD++HRDVKT+NILLDN+FCVKVADFGLSRLFP  VTHVSTAPQGTPGYVDPEY
Sbjct: 411 LCYLHASDVVHRDVKTSNILLDNSFCVKVADFGLSRLFPTDVTHVSTAPQGTPGYVDPEY 470

Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT 294
           HQCYQLTDKSDV+SFGVVLIELISS+PAVDI+RHRHEINLSN AINKIQ  A HEL+D  
Sbjct: 471 HQCYQLTDKSDVYSFGVVLIELISSLPAVDISRHRHEINLSNYAINKIQKCAFHELMDPH 530

Query: 295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYD 344
           LG++SD  V R    VAELAF+CLQ +K++RP M +VL+ L++IESD ++
Sbjct: 531 LGFDSDLAVNRMTTLVAELAFRCLQPDKEMRPSMDEVLEILKEIESDKHE 580

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224121266|ref|XP_002318540.1| predicted protein [Populus trichocarpa] gi|222859213|gb|EEE96760.1| predicted protein [Populus trichocarpa]

 Score =  526 bits (1354), Expect = e-147,   Method: Compositional matrix adjust.
 Identities = 258/359 (71%), Positives = 298/359 (83%), Gaps = 3/359 (0%)

Query: 4   MAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYF 63
           M+  F  + R KK ++   + + R+  S PSSK  +EK G+Y+GV +FSY ELEEATN F
Sbjct: 1   MSIAFFFWYRHKKRQYV--SFVSRSIKSVPSSKAYMEKRGSYNGVHLFSYDELEEATNNF 58

Query: 64  DSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLY 123
           D  RELGDGGFGTVYYG+L DG  VAVKRLYENNYKR+EQF+NEVDIL RLRHKNLV LY
Sbjct: 59  DETRELGDGGFGTVYYGKLPDGSEVAVKRLYENNYKRLEQFLNEVDILTRLRHKNLVLLY 118

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           GCTSRHSRELLLVYE+I NGT+ADHLHG+RAKPGAL   TR+ IA+ETASAL YLHASDI
Sbjct: 119 GCTSRHSRELLLVYEYIPNGTLADHLHGQRAKPGALTCRTRMNIAVETASALAYLHASDI 178

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           +HRDVKT NILL N+FCVKVADFGLSRLFP  VTHVSTAPQGTPGYVDP+YHQCYQLTDK
Sbjct: 179 VHRDVKTTNILLGNDFCVKVADFGLSRLFPLDVTHVSTAPQGTPGYVDPDYHQCYQLTDK 238

Query: 244 SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKV 303
           SDV+SFGVVLIELISSMPAVDI+RHRHEINLSN+AINKIQ+ AL+ELVD +LG+ESD   
Sbjct: 239 SDVYSFGVVLIELISSMPAVDISRHRHEINLSNMAINKIQSNALNELVDPSLGFESDYAA 298

Query: 304 RRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEMMTQSPDSVTL 362
           R+ I+AVAELAFQCLQS ++LRP M  V++ L+DI+S  Y  ++  EE+   S D V L
Sbjct: 299 RKMISAVAELAFQCLQSARELRPSMEKVVEILKDIQSRDYTAERA-EEIDIPSDDVVLL 356

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|147772916|emb|CAN62706.1| hypothetical protein VITISV_041559 [Vitis vinifera]

 Score =  523 bits (1346), Expect = e-146,   Method: Compositional matrix adjust.
 Identities = 264/419 (63%), Positives = 309/419 (73%), Gaps = 45/419 (10%)

Query: 1   MGIMAAI------FLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYG 54
           +GI+ +I      F I  +R+K K+ AST L RNTSS+PSS+  LE  G Y G+ +F Y 
Sbjct: 117 LGIVGSIPFLIICFFIIRQRRKGKY-ASTFLSRNTSSDPSSQPGLETAGAYFGIAIFPYT 175

Query: 55  ELEEATNYFDSARELGDGGFGTVYYG-----------ELQDGRAVAVKRLYENNYKRVEQ 103
           ELEEATNYFD  RE+GDGGFG+VY+G           +L+DGR VAVKRLYENNY+RVEQ
Sbjct: 176 ELEEATNYFDPDREIGDGGFGSVYHGKRLFFDLCQIGQLRDGREVAVKRLYENNYRRVEQ 235

Query: 104 FMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPT 163
           FMNEV IL RLRH+NLVSLYGCTSRHSRELLLVYEFI NGTVADHLHG+RA  G L W  
Sbjct: 236 FMNEVQILTRLRHRNLVSLYGCTSRHSRELLLVYEFIPNGTVADHLHGDRADSGLLTWXI 295

Query: 164 RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
           RL IAIETA+AL YLHASD++HRDVKT+NILLDN+FCVKVADFGLSRLFP  VTHVSTAP
Sbjct: 296 RLSIAIETATALCYLHASDVVHRDVKTSNILLDNSFCVKVADFGLSRLFPTDVTHVSTAP 355

Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ 283
           QGTPGYVDPEYHQCYQLTDKSDV+SFGVVLIELISS+PAVDI+RHRHEINLSN AINKIQ
Sbjct: 356 QGTPGYVDPEYHQCYQLTDKSDVYSFGVVLIELISSLPAVDISRHRHEINLSNYAINKIQ 415

Query: 284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY 343
             A HEL+D  LG++SD  V R    VAELAF+CLQ +K++RP M +VL+ L++IESD +
Sbjct: 416 KCAFHELMDPHLGFDSDLAVNRMTTLVAELAFRCLQPDKEMRPSMDEVLEILKEIESDKH 475

Query: 344 DDKKT---------------------------HEEMMTQSPDSVTLSWTSTKTTPTSSS 375
           + +                                 +  SPD+V   W S  TTP++S+
Sbjct: 476 ELENMDTAADSVGSSMRKPPSPSPDCDEVGLLKSAPLMPSPDTVIARWPSMSTTPSASA 534

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356528194|ref|XP_003532690.1| PREDICTED: probable serine/threonine-protein kinase At1g18390-like [Glycine max]

 Score =  521 bits (1341), Expect = e-145,   Method: Compositional matrix adjust.
 Identities = 255/361 (70%), Positives = 293/361 (81%), Gaps = 1/361 (0%)

Query: 13  RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDG 72
           ++KKN H+ S+ +    +S  SS  D EKG  Y GV  F+Y ELEEATN+FD ARELGDG
Sbjct: 324 KKKKNLHAVSSSVQSKETSYSSSIEDTEKGCTYFGVHFFTYSELEEATNFFDPARELGDG 383

Query: 73  GFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE 132
           GFGTVY+G+L DGR VAVKR+YEN+Y+RVEQF+NEV+IL  L H+NLVSLYGCTSRHSRE
Sbjct: 384 GFGTVYFGKLHDGRVVAVKRMYENSYRRVEQFVNEVEILTGLHHQNLVSLYGCTSRHSRE 443

Query: 133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNN 192
           LLLVYE+I NGTVADHLHG+RAKPG L W TR+ IAIETASAL YLHAS+IIHRDVKTNN
Sbjct: 444 LLLVYEYIPNGTVADHLHGQRAKPGTLAWHTRMNIAIETASALVYLHASEIIHRDVKTNN 503

Query: 193 ILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVV 252
           ILLDN+F VKVADFGLSRL P H THVSTAPQGTPGYVDPEY++ YQLTDKSDV+SFGVV
Sbjct: 504 ILLDNHFSVKVADFGLSRLLPTHATHVSTAPQGTPGYVDPEYNEYYQLTDKSDVYSFGVV 563

Query: 253 LIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAE 312
           LIELISSMPAVDI+R RHEINLSN+AI KIQ+ ALHE+VD TLG+E+D KVR+ I+AVAE
Sbjct: 564 LIELISSMPAVDISRRRHEINLSNMAIKKIQSGALHEIVDTTLGFETDFKVRKMISAVAE 623

Query: 313 LAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEMMTQSPDSVTLSWTSTKTTPT 372
           LAFQCLQS KD+RP M +VLD L DI SDG   +  HE +     D+  L       +P 
Sbjct: 624 LAFQCLQSSKDVRPSMAEVLDRLEDIRSDG-SHRSKHEVLDISEDDAALLKNVPPPPSPD 682

Query: 373 S 373
           S
Sbjct: 683 S 683

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	375
TAIR|locus:2014154	654	AT1G18390 [Arabidopsis thalian	0.954	0.547	0.653	1.5e-122
TAIR|locus:2204465	1296	AT1G66880 [Arabidopsis thalian	0.904	0.261	0.657	7.6e-118
TAIR|locus:2176667	686	AT5G38210 [Arabidopsis thalian	0.874	0.478	0.664	6.4e-115
TAIR|locus:2031230	629	AT1G25390 [Arabidopsis thalian	0.885	0.527	0.658	1.1e-112
TAIR|locus:2046728	708	AT2G23450 [Arabidopsis thalian	0.877	0.464	0.449	3.2e-72
TAIR|locus:2174994	622	AT5G66790 [Arabidopsis thalian	0.882	0.532	0.426	1e-68
TAIR|locus:2185118	657	AT5G02070 [Arabidopsis thalian	0.88	0.502	0.411	8.1e-60
TAIR|locus:2075346	830	HERK1 "hercules receptor kinas	0.845	0.381	0.418	2.5e-58
TAIR|locus:2084425	639	AT3G53840 [Arabidopsis thalian	0.768	0.450	0.444	2.2e-57
TAIR|locus:2014962	733	WAK5 "wall associated kinase 5	0.882	0.451	0.407	4.6e-57

TAIR|locus:2014154 AT1G18390 [Arabidopsis thaliana (taxid:3702)]

 Score = 1205 (429.2 bits), Expect = 1.5e-122, P = 1.5e-122
 Identities = 241/369 (65%), Positives = 297/369 (80%)

Query:     1 MGIMAA-IF-LIYLRRK-KNKHSASTLLFRNTSSEPSSK-VDLEKGGNYH-GVQVFSYGE 55
             +G++AA IF  +Y RRK K+  ++S LL RN SS+PS+K  D+EK      GV +FSY E
Sbjct:   277 VGLIAASIFWYVYHRRKTKSYRNSSALLPRNISSDPSAKSFDIEKAEELLVGVHIFSYEE 336

Query:    56 LEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR 115
             LEEATN FD ++ELGDGGFGTVYYG+L+DGR+VAVKRLY+NN+KR EQF NEV+IL  LR
Sbjct:   337 LEEATNNFDPSKELGDGGFGTVYYGKLKDGRSVAVKRLYDNNFKRAEQFRNEVEILTGLR 396

Query:   116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
             H NLV+L+GC+S+ SR+LLLVYE+++NGT+ADHLHG +A P +LPW  RLKIA+ETASAL
Sbjct:   397 HPNLVALFGCSSKQSRDLLLVYEYVANGTLADHLHGPQANPSSLPWSIRLKIAVETASAL 456

Query:   176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
              YLHAS IIHRDVK+NNILLD NF VKVADFGLSRLFP   THVSTAPQGTPGYVDP+YH
Sbjct:   457 KYLHASKIIHRDVKSNNILLDQNFNVKVADFGLSRLFPMDKTHVSTAPQGTPGYVDPDYH 516

Query:   236 QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
              CYQL++KSDV+SF VVL+ELISS+PAVDITR R EINLSN+A+ KIQN  L ++VD +L
Sbjct:   517 LCYQLSNKSDVYSFAVVLMELISSLPAVDITRPRQEINLSNMAVVKIQNHELRDMVDPSL 576

Query:   296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYD------DKKTH 349
             G+++D +VR+T+ AVAELAFQCLQS+KDLRP M  V D L  I+++G+       D    
Sbjct:   577 GFDTDTRVRQTVIAVAELAFQCLQSDKDLRPCMSHVQDTLTRIQNNGFGSEMDVVDVNKS 636

Query:   350 EEMMTQSPD 358
               ++ QSPD
Sbjct:   637 GPLVAQSPD 645

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006984 "ER-nucleus signaling pathway" evidence=RCA

GO:0009407 "toxin catabolic process" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010583 "response to cyclopentenone" evidence=RCA

GO:0034976 "response to endoplasmic reticulum stress" evidence=RCA

TAIR|locus:2204465 AT1G66880 [Arabidopsis thaliana (taxid:3702)]

 Score = 1142 (407.1 bits), Expect = 7.6e-118, Sum P(2) = 7.6e-118
 Identities = 230/350 (65%), Positives = 278/350 (79%)

Query:    11 YLRRKKNKHSASTLLFR--NTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARE 68
             Y  R  +++  ST +    N S  PS   +L    +Y GVQVFSY ELEEAT  F  +RE
Sbjct:   916 YSSRDTSRNPTSTTISSSSNHSLLPSIS-NLANRSDYCGVQVFSYEELEEATENF--SRE 972

Query:    69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
             LGDGGFGTVYYG L+DGRAVAVKRLYE + KRVEQF NE++IL  L+H NLV LYGCTSR
Sbjct:   973 LGDGGFGTVYYGVLKDGRAVAVKRLYERSLKRVEQFKNEIEILKSLKHPNLVILYGCTSR 1032

Query:   129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDV 188
             HSRELLLVYE+ISNGT+A+HLHG RA+   L W TRL IAIETASAL++LH   IIHRD+
Sbjct:  1033 HSRELLLVYEYISNGTLAEHLHGNRAEARPLCWSTRLNIAIETASALSFLHIKGIIHRDI 1092

Query:   189 KTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
             KT NILLD+N+ VKVADFGLSRLFP   TH+STAPQGTPGYVDPEY+QCYQL +KSDV+S
Sbjct:  1093 KTTNILLDDNYQVKVADFGLSRLFPMDQTHISTAPQGTPGYVDPEYYQCYQLNEKSDVYS 1152

Query:   249 FGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTIN 308
             FGVVL ELISS  AVDITRHRH+INL+N+A++KIQN ALHELVD +LGY++D +VRR + 
Sbjct:  1153 FGVVLTELISSKEAVDITRHRHDINLANMAVSKIQNNALHELVDSSLGYDNDPEVRRKMM 1212

Query:   309 AVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEMMTQSPD 358
             AVAELAF+CLQ E+D+RP M ++++ LR I+    DD+K  + ++ +SPD
Sbjct:  1213 AVAELAFRCLQQERDVRPAMDEIVEILRGIK----DDEK--KRVLVKSPD 1256

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009625 "response to insect" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009963 "positive regulation of flavonoid biosynthetic process" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2176667 AT5G38210 [Arabidopsis thaliana (taxid:3702)]

 Score = 1133 (403.9 bits), Expect = 6.4e-115, P = 6.4e-115
 Identities = 220/331 (66%), Positives = 269/331 (81%)

Query:    17 NKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGT 76
             N  +++T+   N S  PS   +L  G  Y G+QVFSY ELEEAT  F  ++ELGDGGFGT
Sbjct:   315 NTPTSTTISGSNHSLVPSIS-NLGNGSVYSGIQVFSYEELEEATENF--SKELGDGGFGT 371

Query:    77 VYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV 136
             VYYG L+DGRAVAVKRL+E + KRVEQF NE+DIL  L+H NLV LYGCT+RHSRELLLV
Sbjct:   372 VYYGTLKDGRAVAVKRLFERSLKRVEQFKNEIDILKSLKHPNLVILYGCTTRHSRELLLV 431

Query:   137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD 196
             YE+ISNGT+A+HLHG +A+   + WP RL+IAIETASAL+YLHAS IIHRDVKT NILLD
Sbjct:   432 YEYISNGTLAEHLHGNQAQSRPICWPARLQIAIETASALSYLHASGIIHRDVKTTNILLD 491

Query:   197 NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
             +N+ VKVADFGLSRLFP   TH+STAPQGTPGYVDPEY+QCY+L +KSDV+SFGVVL EL
Sbjct:   492 SNYQVKVADFGLSRLFPMDQTHISTAPQGTPGYVDPEYYQCYRLNEKSDVYSFGVVLSEL 551

Query:   257 ISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQ 316
             ISS  AVDITRHRH+INL+N+AI+KIQN A+HEL D +LG+  D  V++ +++VAELAF+
Sbjct:   552 ISSKEAVDITRHRHDINLANMAISKIQNDAVHELADLSLGFARDPSVKKMMSSVAELAFR 611

Query:   317 CLQSEKDLRPYMVDVLDALRDIESDGYDDKK 347
             CLQ E+D+RP M ++++ LR I+ DG  D K
Sbjct:   612 CLQQERDVRPSMDEIVEVLRVIQKDGISDSK 642

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009617 "response to bacterium" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

TAIR|locus:2031230 AT1G25390 [Arabidopsis thaliana (taxid:3702)]

 Score = 1112 (396.5 bits), Expect = 1.1e-112, P = 1.1e-112
 Identities = 224/340 (65%), Positives = 262/340 (77%)

Query:     3 IMAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNY 62
             I+ A+F +  R  + K   S L      S  +SK D+E    +  + +FSY EL+ AT+ 
Sbjct:   238 ILVALFAVIHRNYRRK-DGSEL------SRDNSKSDVEFSQVFFKIPIFSYKELQAATDN 290

Query:    63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
             F   R LGDGGFGTVYYG+++DGR VAVKRLYE+NY+R+EQFMNE++IL RL HKNLVSL
Sbjct:   291 FSKDRLLGDGGFGTVYYGKVRDGREVAVKRLYEHNYRRLEQFMNEIEILTRLHHKNLVSL 350

Query:   123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAK-PGALPWPTRLKIAIETASALTYLHAS 181
             YGCTSR SRELLLVYEFI NGTVADHL+GE     G L W  RL IAIETASAL YLHAS
Sbjct:   351 YGCTSRRSRELLLVYEFIPNGTVADHLYGENTPHQGFLTWSMRLSIAIETASALAYLHAS 410

Query:   182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
             DIIHRDVKT NILLD NF VKVADFGLSRL P+ VTHVSTAPQGTPGYVDPEYH+CY LT
Sbjct:   411 DIIHRDVKTTNILLDRNFGVKVADFGLSRLLPSDVTHVSTAPQGTPGYVDPEYHRCYHLT 470

Query:   242 DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN 301
             DKSDV+SFGVVL+ELISS PAVDI+R + EINLS+LAINKIQN A HEL+DQ LGY ++ 
Sbjct:   471 DKSDVYSFGVVLVELISSKPAVDISRCKSEINLSSLAINKIQNHATHELIDQNLGYATNE 530

Query:   302 KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
              VR+    VAELAFQCLQ +  +RP M  V+  L+ I+++
Sbjct:   531 GVRKMTTMVAELAFQCLQQDNTMRPTMEQVVHELKGIQNE 570

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006865 "amino acid transport" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

TAIR|locus:2046728 AT2G23450 [Arabidopsis thaliana (taxid:3702)]

 Score = 730 (262.0 bits), Expect = 3.2e-72, P = 3.2e-72
 Identities = 155/345 (44%), Positives = 223/345 (64%)

Query:     3 IMAAI-FLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATN 61
             ++AA+ F  + +R++     ST L  + S++   ++  E  GN   V  F Y E+E+AT+
Sbjct:   296 LLAALAFFFFCKRRR-----STPLRSHLSAK---RLLSEAAGN-SSVAFFPYKEIEKATD 346

Query:    62 YFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
              F   ++LG G +GTVY G+LQ+   VA+KRL   + + ++Q MNE+ +L+ + H NLV 
Sbjct:   347 GFSEKQKLGIGAYGTVYRGKLQNDEWVAIKRLRHRDSESLDQVMNEIKLLSSVSHPNLVR 406

Query:   122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
             L GC      + +LVYE++ NGT+++HL  +R     LPW  RL +A +TA A+ YLH+S
Sbjct:   407 LLGCCIEQG-DPVLVYEYMPNGTLSEHLQRDRGS--GLPWTLRLTVATQTAKAIAYLHSS 463

Query:   182 ---DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
                 I HRD+K+ NILLD +F  KVADFGLSRL     +H+STAPQGTPGY+DP+YHQC+
Sbjct:   464 MNPPIYHRDIKSTNILLDYDFNSKVADFGLSRLGMTESSHISTAPQGTPGYLDPQYHQCF 523

Query:   239 QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
              L+DKSDV+SFGVVL E+I+ +  VD TR   EINL+ LA++KI +  + E++D  L  +
Sbjct:   524 HLSDKSDVYSFGVVLAEIITGLKVVDFTRPHTEINLAALAVDKIGSGCIDEIIDPILDLD 583

Query:   299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY 343
              D     +I+ VAELAF+CL    D+RP M +V D L  I   G+
Sbjct:   584 LDAWTLSSIHTVAELAFRCLAFHSDMRPTMTEVADELEQIRLSGW 628

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2174994 AT5G66790 [Arabidopsis thaliana (taxid:3702)]

 Score = 697 (250.4 bits), Expect = 1.0e-68, P = 1.0e-68
 Identities = 147/345 (42%), Positives = 222/345 (64%)

Query:     1 MGIMAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEAT 60
             +G++  + LI     +NK SAS+       +  ++++  E  GN   V  ++Y E+E+AT
Sbjct:   258 VGVLVIVVLIATYFFRNKQSASS-----ERASIANRLLCELAGN-SSVPFYTYKEIEKAT 311

Query:    61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
             + F     LG G +GTVY GE  +   VA+KRL   +   ++Q +NE+ +L+ + H NLV
Sbjct:   312 DSFSDKNMLGTGAYGTVYAGEFPNSSCVAIKRLKHKDTTSIDQVVNEIKLLSSVSHPNLV 371

Query:   121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
              L GC      E  LVYEF+ NGT+  HL  ER +P  L W  RL IA +TA+A+ +LH+
Sbjct:   372 RLLGCCFADG-EPFLVYEFMPNGTLYQHLQHERGQP-PLSWQLRLAIACQTANAIAHLHS 429

Query:   181 S---DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEY 234
             S    I HRD+K++NILLD+ F  K++DFGLSRL  +     +H+STAPQGTPGY+DP+Y
Sbjct:   430 SVNPPIYHRDIKSSNILLDHEFNSKISDFGLSRLGMSTDFEASHISTAPQGTPGYLDPQY 489

Query:   235 HQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT 294
             HQ +QL+DKSDV+SFGVVL+E+IS    +D TR   E+NL++LA+++I    + +++D  
Sbjct:   490 HQDFQLSDKSDVYSFGVVLVEIISGFKVIDFTRPYSEVNLASLAVDRIGRGRVVDIIDPC 549

Query:   295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE 339
             L  E + K+  +I+ +AELAF+CL   +++RP MV++ + L  I+
Sbjct:   550 LNKEINPKMFASIHNLAELAFRCLSFHRNMRPTMVEITEDLHRIK 594

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2185118 AT5G02070 [Arabidopsis thaliana (taxid:3702)]

 Score = 613 (220.8 bits), Expect = 8.1e-60, P = 8.1e-60
 Identities = 145/352 (41%), Positives = 207/352 (58%)

Query:     1 MGIMAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEAT 60
             +G+  AI +  +  K +       + +N   E    +     G     ++F+  E+ +AT
Sbjct:   303 VGVTLAIAVAVIGTKHSHQKVKKDIHKNIVKEREEMLSANSTGK--SSRIFTGREITKAT 360

Query:    61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
             N F     +G GGFG V+   L+DG   A+KR   NN K  +Q +NEV IL ++ H++LV
Sbjct:   361 NNFSKDNLIGTGGFGEVFKAVLEDGTITAIKRAKLNNTKGTDQILNEVRILCQVNHRSLV 420

Query:   121 SLYGCTSRHSREL-LLVYEFISNGTVADHLHG--ERA-KPGALPWPTRLKIAIETASALT 176
              L GC      EL LL+YEFI NGT+ +HLHG  +R  KP  L W  RL+IA +TA  L 
Sbjct:   421 RLLGCCV--DLELPLLIYEFIPNGTLFEHLHGSSDRTWKP--LTWRRRLQIAYQTAEGLA 476

Query:   177 YLHAS---DIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-----NHVTHVSTAPQGTPG 228
             YLH++    I HRDVK++NILLD     KV+DFGLSRL       N+ +H+ T  QGT G
Sbjct:   477 YLHSAAQPPIYHRDVKSSNILLDEKLNAKVSDFGLSRLVDLTETANNESHIFTGAQGTLG 536

Query:   229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA-L 287
             Y+DPEY++ +QLTDKSDV+SFGVVL+E+++S  A+D TR   ++NL  + INK+ ++  L
Sbjct:   537 YLDPEYYRNFQLTDKSDVYSFGVVLLEMVTSKKAIDFTREEEDVNLV-MYINKMMDQERL 595

Query:   288 HELVDQTLGYESDNKV-RRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
              E +D  L  ++ NK+  +TI  +  LA  CL   +  RP M +V D +  I
Sbjct:   596 TECIDPLLK-KTANKIDMQTIQQLGNLASACLNERRQNRPSMKEVADEIEYI 646

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2075346 HERK1 "hercules receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 599 (215.9 bits), Expect = 2.5e-58, P = 2.5e-58
 Identities = 144/344 (41%), Positives = 205/344 (59%)

Query:     4 MAAIFLIYLRRKKNK--HSASTLLFRNTSSEPSSK-------VDLEKGGNYHGVQVFSYG 54
             + + F++Y +RK+ +  HS + + F    +   SK         +    NY       + 
Sbjct:   421 LGSCFVLYKKRKRGQDGHSKTWMPFSINGTSMGSKYSNGTTLTSITTNANYR----IPFA 476

Query:    55 ELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL 114
              +++ATN FD +R +G GGFG VY GEL DG  VAVKR    + + + +F  E+++L++ 
Sbjct:   477 AVKDATNNFDESRNIGVGGFGKVYKGELNDGTKVAVKRGNPKSQQGLAEFRTEIEMLSQF 536

Query:   115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
             RH++LVSL G    ++ E++L+YE++ NGTV  HL+G    P +L W  RL+I I  A  
Sbjct:   537 RHRHLVSLIGYCDENN-EMILIYEYMENGTVKSHLYGS-GLP-SLTWKQRLEICIGAARG 593

Query:   175 LTYLHASD---IIHRDVKTNNILLDNNFCVKVADFGLSRLFPN-HVTHVSTAPQGTPGYV 230
             L YLH  D   +IHRDVK+ NILLD NF  KVADFGLS+  P    THVSTA +G+ GY+
Sbjct:   594 LHYLHTGDSKPVIHRDVKSANILLDENFMAKVADFGLSKTGPELDQTHVSTAVKGSFGYL 653

Query:   231 DPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA-LHE 289
             DPEY +  QLTDKSDV+SFGVVL E++ + P +D T  R  +NL+  A+ K Q K  L +
Sbjct:   654 DPEYFRRQQLTDKSDVYSFGVVLFEVLCARPVIDPTLPREMVNLAEWAM-KWQKKGQLDQ 712

Query:   290 LVDQTL-GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
             ++DQ+L G    + +R+     AE   +CL      RP M DVL
Sbjct:   713 IIDQSLRGNIRPDSLRK----FAETGEKCLADYGVDRPSMGDVL 752

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IGI

GO:0009791 "post-embryonic development" evidence=IGI

GO:0051510 "regulation of unidimensional cell growth" evidence=IGI;RCA

GO:0009741 "response to brassinosteroid stimulus" evidence=IGI

GO:0009826 "unidimensional cell growth" evidence=IGI

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2084425 AT3G53840 [Arabidopsis thaliana (taxid:3702)]

 Score = 590 (212.7 bits), Expect = 2.2e-57, P = 2.2e-57
 Identities = 133/299 (44%), Positives = 183/299 (61%)

Query:    49 QVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEV 108
             ++F+  E+ +AT+ F  +  LG GGFG V+ G L DG  VAVKR    N K + Q +NEV
Sbjct:   340 RIFTGKEIVKATDNFAKSNLLGFGGFGEVFKGNLDDGTTVAVKRAKLGNEKSIYQIVNEV 399

Query:   109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL----PWPTR 164
              IL ++ HKNLV L GC       +L VYEF+ NGT+ +H++G     G L    P   R
Sbjct:   400 QILCQVSHKNLVKLLGCCIELEMPVL-VYEFVPNGTLFEHIYGGGGGGGGLYDHLPLRRR 458

Query:   165 LKIAIETASALTYLHASD---IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST 221
             L IA +TA  L YLH+S    I HRDVK++NILLD N  VKVADFGLSRL  + V+HV+T
Sbjct:   459 LMIAHQTAQGLDYLHSSSSPPIYHRDVKSSNILLDENLDVKVADFGLSRLGVSDVSHVTT 518

Query:   222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK 281
               QGT GY+DPEY+  +QLTDKSDV+SFGVVL EL++   A+D  R   ++NL       
Sbjct:   519 CAQGTLGYLDPEYYLNFQLTDKSDVYSFGVVLFELLTCKKAIDFNREEEDVNLVVFVRKA 578

Query:   282 IQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
             ++   L +++D  +G  +  K   ++ A+  LA  C++  +  RP M  V  A ++IE+
Sbjct:   579 LKEGRLMDVIDPVIGIGATEKEIESMKALGVLAELCVKETRQCRPTM-QV--AAKEIEN 634

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2014962 WAK5 "wall associated kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 587 (211.7 bits), Expect = 4.6e-57, P = 4.6e-57
 Identities = 141/346 (40%), Positives = 206/346 (59%)

Query:     1 MGIMAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEK----GGNYHGVQVFSYGEL 56
             +G +  +  I   ++K +H  +T L +    +    + +++    G +   V++F+   +
Sbjct:   342 IGFLIILLTISYIQQKMRHRKNTELRQQFFEQNGGGMLIQRLSGAGPSNVDVKIFTEEGM 401

Query:    57 EEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRH 116
             +EAT+ ++ +R LG GG GTVY G LQD   VA+K+    +  +VEQF+NEV +L+++ H
Sbjct:   402 KEATDGYNESRILGQGGQGTVYKGILQDNSIVAIKKARLGDRSQVEQFINEVLVLSQINH 461

Query:   117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
             +N+V L GC    +   LLVYEFIS+GT+ DHLHG      +L W  RL+IAIE A  L 
Sbjct:   462 RNVVKLLGCCLE-TEVPLLVYEFISSGTLFDHLHGSMFD-SSLTWEHRLRIAIEVAGTLA 519

Query:   177 YLH--AS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
             YLH  AS  IIHRDVKT NILLD N   KVADFG SRL P     ++T  QGT GY+DPE
Sbjct:   520 YLHSYASIPIIHRDVKTANILLDENLTAKVADFGASRLIPMDQEQLTTMVQGTLGYLDPE 579

Query:   234 YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ 293
             Y+    L +KSDV+SFGVVL+EL+S   A+   R +   +L +  ++ ++   LHE++D 
Sbjct:   580 YYNTGLLNEKSDVYSFGVVLMELLSGEKALCFERPQSSKHLVSYFVSAMKENRLHEIID- 638

Query:   294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDV---LDALR 336
               G   +   +R I   A +A +C +   + RP M +V   L+ALR
Sbjct:   639 --GQVMNEYNQREIQESARIAVECTRIMGEERPSMKEVAAELEALR 682

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.766

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00017721001 SubName- Full=Chromosome chr17 scaffold_16, whole genome shotgun sequence; (378 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	375
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-53
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	3e-49
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-48
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	6e-46
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-44
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	9e-44
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-43
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-42
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	1e-41
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-37
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	4e-34
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	7e-34
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	5e-33
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	6e-33
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-32
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-31
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	1e-31
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-31
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-31
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-31
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-30
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-30
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-30
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	6e-30
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-29
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-29
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-29
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-29
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	9e-29
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-29
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-28
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-28
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-27
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-27
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	3e-27
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-27
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-26
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-26
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-25
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-25
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-25
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-25
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-25
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-25
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-25
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	1e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-24
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-24
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-24
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	4e-24
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	7e-24
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	8e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-24
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	9e-24
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-23
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	4e-23
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	6e-23
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-23
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	7e-23
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-22
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-22
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-22
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	1e-22
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	2e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-22
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-22
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-22
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-22
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-22
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-21
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-21
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-21
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	2e-21
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-21
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-21
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	4e-21
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	4e-21
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-21
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	5e-21
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	6e-21
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	1e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-20
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-20
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-20
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-20
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-20
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-20
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	7e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	8e-20
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-20
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	9e-20
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-19
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-19
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-19
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	2e-19
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-19
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-19
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-19
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	3e-19
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-19
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	4e-19
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	5e-19
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-19
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-19
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-19
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-19
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-18
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-18
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-18
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	1e-18
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	1e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-18
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-18
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-18
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	2e-18
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-18
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	3e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-18
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-18
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	4e-18
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-18
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	4e-18
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-18
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-18
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	7e-18
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	9e-18
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-17
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-17
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-17
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	1e-17
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-17
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-17
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-17
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-17
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	4e-17
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	5e-17
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-17
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-16
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-16
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	1e-16
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-16
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-16
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	2e-16
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-16
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-16
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-16
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	3e-16
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-16
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-16
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	4e-16
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	5e-16
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	5e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	5e-16
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	9e-16
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	1e-15
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-15
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-15
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-15
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-15
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-15
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-15
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	8e-15
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-14
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-14
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-14
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-14
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-14
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	2e-14
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-14
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-14
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-14
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-14
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	5e-14
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	6e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	6e-14
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-14
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	9e-14
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-14
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	9e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-13
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-13
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	1e-13
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-13
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-13
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-13
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-13
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	3e-13
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-13
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	3e-13
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	3e-13
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	4e-13
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-13
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	6e-13
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	7e-13
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-13
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	9e-13
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-12
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-12
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-12
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	2e-12
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	3e-12
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-12
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	7e-12
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	9e-12
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	9e-12
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-12
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-11
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-11
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-11
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-11
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	2e-11
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-11
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	3e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	4e-11
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	4e-11
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	1e-10
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	1e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-10
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	2e-10
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-10
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	4e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	4e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	5e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	6e-10
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	7e-10
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	7e-10
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	9e-10
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	2e-09
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-09
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-09
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	3e-09
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-09
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	4e-09
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	5e-09
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	6e-09
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	7e-09
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	7e-09
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	1e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-08
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	1e-08
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	1e-08
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	2e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	4e-08
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	7e-08
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-07
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	1e-07
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-07
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	2e-07
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	5e-07
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	6e-07
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-07
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	4e-06
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	5e-06
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	5e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-05
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-05
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-05
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	5e-05
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	1e-04
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-04
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-04
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	0.004

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  174 bits (443), Expect = 7e-53
 Identities = 77/192 (40%), Positives = 113/192 (58%), Gaps = 9/192 (4%)

Query: 69  LGDGGFGTVYYGE-LQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           LG+GGFGTVY     + G+ VA+K +  E++   +E+ + E++IL +L H N+V LYG  
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGV- 59

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
                 L LV E+   G++ D L   +   G L     L+I ++    L YLH++ IIHR
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLL---KENEGKLSEDEILRILLQILEGLEYLHSNGIIHR 116

Query: 187 DVKTNNILLDN-NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ-LTDKS 244
           D+K  NILLD+ N  VK+ADFGLS+L  +  + + T   GTP Y+ PE        ++KS
Sbjct: 117 DLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI-VGTPAYMAPEVLLGKGYYSEKS 175

Query: 245 DVFSFGVVLIEL 256
           D++S GV+L EL
Sbjct: 176 DIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  166 bits (422), Expect = 3e-49
 Identities = 70/197 (35%), Positives = 101/197 (51%), Gaps = 9/197 (4%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
            +LG+G FG VY   + + G+ VA+K +  +   K  E+ + E+ IL +L+H N+V LY 
Sbjct: 5   EKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYD 64

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
                  +L LV E+   G + D L     K G L          +  SAL YLH+  I+
Sbjct: 65  VF-EDEDKLYLVMEYCEGGDLFDLLK----KRGRLSEDEARFYLRQILSALEYLHSKGIV 119

Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 244
           HRD+K  NILLD +  VK+ADFGL+R         +    GTP Y+ PE           
Sbjct: 120 HRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFV--GTPEYMAPEVLLGKGYGKAV 177

Query: 245 DVFSFGVVLIELISSMP 261
           D++S GV+L EL++  P
Sbjct: 178 DIWSLGVILYELLTGKP 194

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  162 bits (413), Expect = 6e-48
 Identities = 68/204 (33%), Positives = 102/204 (50%), Gaps = 21/204 (10%)

Query: 67  RELGDGGFGTVYYGEL-----QDGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKNLV 120
           ++LG+G FG VY G L          VAVK L E   +   E+F+ E  I+ +L H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
            L G CT      L +V E++  G + D L   R     L     L++A++ A  + YL 
Sbjct: 65  RLLGVCT--QGEPLYIVTEYMPGGDLLDFL---RKHGEKLTLKDLLQMALQIAKGMEYLE 119

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD-----PEY 234
           + + +HRD+   N L+  N  VK++DFGLSR     +       +   G +      PE 
Sbjct: 120 SKNFVHRDLAARNCLVTENLVVKISDFGLSRD----IYEDDYYRKRGGGKLPIKWMAPES 175

Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
            +  + T KSDV+SFGV+L E+ +
Sbjct: 176 LKDGKFTSKSDVWSFGVLLWEIFT 199

Length = 258

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  157 bits (400), Expect = 6e-46
 Identities = 64/197 (32%), Positives = 105/197 (53%), Gaps = 9/197 (4%)

Query: 67  RELGDGGFGTVYYGELQD-GRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNLVSLY 123
             LG G FG+VY    +D G  +AVK   L  ++ + +E    E+ IL+ L+H N+V  Y
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65

Query: 124 GC-TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           G         L +  E++S G+++  L     K G LP P   K   +    L YLH++ 
Sbjct: 66  GSERDEEKNTLNIFLEYVSGGSLSSLLK----KFGKLPEPVIRKYTRQILEGLAYLHSNG 121

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           I+HRD+K  NIL+D++  VK+ADFG ++ L        + + +GTP ++ PE  +  +  
Sbjct: 122 IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYG 181

Query: 242 DKSDVFSFGVVLIELIS 258
             +D++S G  +IE+ +
Sbjct: 182 RAADIWSLGCTVIEMAT 198

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  154 bits (391), Expect = 1e-44
 Identities = 76/196 (38%), Positives = 101/196 (51%), Gaps = 10/196 (5%)

Query: 67  RELGDGGFGTVYYGELQ-DGRAVAVKRLY--ENNYKRVEQFMNEVDILARLRHKNLVSLY 123
           R+LG G FGTVY  + +  G+ VAVK L       K+ +    E+ IL RL H N+V L 
Sbjct: 5   RKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLI 64

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
                    L LV E+   G + D+L       G L      KIA++    L YLH++ I
Sbjct: 65  D-AFEDKDHLYLVMEYCEGGDLFDYLSRG----GPLSEDEAKKIALQILRGLEYLHSNGI 119

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL-TD 242
           IHRD+K  NILLD N  VK+ADFGL++      +   T   GTP Y+ PE          
Sbjct: 120 IHRDLKPENILLDENGVVKIADFGLAKKL-LKSSSSLTTFVGTPWYMAPEVLLGGNGYGP 178

Query: 243 KSDVFSFGVVLIELIS 258
           K DV+S GV+L EL++
Sbjct: 179 KVDVWSLGVILYELLT 194

Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  151 bits (385), Expect = 9e-44
 Identities = 77/294 (26%), Positives = 127/294 (43%), Gaps = 66/294 (22%)

Query: 67  RELGDGGFGTVYYGELQD-----GRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLV 120
           ++LG+G FG VY G+L+         VAVK L E+ + +++E+F+ E  I+ +L H N+V
Sbjct: 5   KKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVV 64

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G        L +V E++  G +  +L   R     L     L  A++ A  + YL +
Sbjct: 65  KLLGV-CTEEEPLYIVMEYMEGGDLLSYL---RKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS---------TAPQGTPGYVD 231
            + IHRD+   N L+  N  VK++DFGLSR   +   +            AP        
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAP-------- 172

Query: 232 PEYHQCYQL---TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKA 286
               +  +    T KSDV+SFGV+L E+ +    P   ++                 N+ 
Sbjct: 173 ----ESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMS-----------------NEE 211

Query: 287 LHELVDQTLGYESDNKVRRTI-----NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
           + E +    GY      R          + +L  QC   + + RP   ++++ L
Sbjct: 212 VLEYLKN--GY------RLPQPPNCPPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  150 bits (381), Expect = 4e-43
 Identities = 75/286 (26%), Positives = 127/286 (44%), Gaps = 40/286 (13%)

Query: 67  RELGDGGFGTVYYGELQDG----RAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG+G FG VY G+L+        VAVK L E+ + +  + F+ E  ++ +L H N+V 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERA-----KPGALPWPTRLKIAIETASALT 176
           L G        L LV E++  G + D+L   R      +   L     L  AI+ A  + 
Sbjct: 61  LLGV-CTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYH 235
           YL +   +HRD+   N L+  +  VK++DFGLSR   +   +        P  ++ PE  
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179

Query: 236 QCYQLTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ 293
           +    T KSDV+SFGV+L E+ +  + P                    + N+ + E +  
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPG-----------------LSNEEVLEYL-- 220

Query: 294 TLGYESDNKVRRTINA---VAELAFQCLQSEKDLRPYMVDVLDALR 336
                   ++ +       + EL   C Q + + RP   ++++ L 
Sbjct: 221 ----RKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  148 bits (375), Expect = 2e-42
 Identities = 66/210 (31%), Positives = 105/210 (50%), Gaps = 33/210 (15%)

Query: 67  RELGDGGFGTVYYGELQDG-----RAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLV 120
           ++LG+G FG VY G L+         VAVK L E+ + +++E+F+ E  I+ +L H N+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIV 64

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G        L++V E++  G + D+L   + +P  L     L  A++ A  + YL +
Sbjct: 65  KLLGV-CTEEEPLMIVMEYMPGGDLLDYLR--KNRPKELSLSDLLSFALQIARGMEYLES 121

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS---------TAPQGTPGYVD 231
            + IHRD+   N L+  N  VK++DFGLSR   +   +            AP        
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP-------- 173

Query: 232 PEYHQCYQL---TDKSDVFSFGVVLIELIS 258
               +  +    T KSDV+SFGV+L E+ +
Sbjct: 174 ----ESLKEGKFTSKSDVWSFGVLLWEIFT 199

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  145 bits (369), Expect = 1e-41
 Identities = 68/206 (33%), Positives = 104/206 (50%), Gaps = 17/206 (8%)

Query: 62  YFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
            F+   ++G GGFG VY     + G+ VA+K +   + ++ E+ +NE+ IL + +H N+V
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIV 60

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             YG   +   EL +V EF S G++ D L   ++    L       +  E    L YLH+
Sbjct: 61  KYYGSYLKKD-ELWIVMEFCSGGSLKDLL---KSTNQTLTESQIAYVCKELLKGLEYLHS 116

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-----GTPGYVDPEYH 235
           + IIHRD+K  NILL ++  VK+ DFGLS         +S         GTP ++ PE  
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLS-------AQLSDTKARNTMVGTPYWMAPEVI 169

Query: 236 QCYQLTDKSDVFSFGVVLIELISSMP 261
                  K+D++S G+  IEL    P
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKP 195

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  135 bits (342), Expect = 2e-37
 Identities = 78/263 (29%), Positives = 119/263 (45%), Gaps = 25/263 (9%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLY 123
           +++G G FG VY      DG+   +K +  +N   K  E  +NEV IL +L H N++  Y
Sbjct: 6   KQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYY 65

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
                   +L +V E+   G ++  +  ++ +    P    L   ++   AL YLH+  I
Sbjct: 66  ESFE-EKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKI 124

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           +HRD+K  NI L +N  VK+ DFG+S++  + V    T   GTP Y+ PE  Q      K
Sbjct: 125 LHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTV-VGTPYYLSPELCQNKPYNYK 183

Query: 244 SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN-----------KALHELVD 292
           SD++S G VL EL +     +        NL  L   KI               L  LV 
Sbjct: 184 SDIWSLGCVLYELCTLKHPFEGE------NLLEL-ALKILKGQYPPIPSQYSSELRNLVS 236

Query: 293 QTLGYESDNKVRRTINAVAELAF 315
             L  + D + R +I  + +  F
Sbjct: 237 SLL--QKDPEERPSIAQILQSPF 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  129 bits (325), Expect = 4e-34
 Identities = 92/317 (29%), Positives = 139/317 (43%), Gaps = 27/317 (8%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVSLY 123
           R+LG+G FG VY    +D + VA+K L    E+  K VE+F+ E+ ILA L H   +   
Sbjct: 6   RKLGEGSFGEVYLA--RDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKL 63

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
               +    L LV E++  G++ D L  +  + G L     L I  +  SAL YLH+  I
Sbjct: 64  YDFFQDEGSLYLVMEYVDGGSLEDLLK-KIGRKGPLSESEALFILAQILSALEYLHSKGI 122

Query: 184 IHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQ-----GTPGYVDPEYHQ- 236
           IHRD+K  NILLD +   VK+ DFGL++L P+  +  S         GTPGY+ PE    
Sbjct: 123 IHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLG 182

Query: 237 --CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT 294
                 +  SD++S G+ L EL++            E   ++ A ++     L       
Sbjct: 183 LSLAYASSSSDIWSLGITLYELLTG-------LPPFEGEKNSSATSQTLKIILELPTPSL 235

Query: 295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMV-----DVLDALRDIESDGYDDKKTH 349
               S +       A ++L  + L  +   R         D+L  L+  ESD  D  K  
Sbjct: 236 ASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPD 295

Query: 350 EEMMTQSPDSVTLSWTS 366
           +    +     +L    
Sbjct: 296 DSAPLRLSLPPSLEALI 312

Length = 384

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  125 bits (317), Expect = 7e-34
 Identities = 71/196 (36%), Positives = 102/196 (52%), Gaps = 12/196 (6%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           R+LG G FG V+ G       VAVK L        E F+ E  I+ +LRH  LV LY   
Sbjct: 12  RKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS-PEAFLQEAQIMKKLRHDKLVQLYAVC 70

Query: 127 SRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           S    E + +V E++S G++ D L     K   L  P  + +A + A  + YL + + IH
Sbjct: 71  SE--EEPIYIVTEYMSKGSLLDFLKSGEGK--KLRLPQLVDMAAQIAEGMAYLESRNYIH 126

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGT--P-GYVDPEYHQCYQLTD 242
           RD+   NIL+  N   K+ADFGL+RL  +      TA +G   P  +  PE     + T 
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEY---TAREGAKFPIKWTAPEAANYGRFTI 183

Query: 243 KSDVFSFGVVLIELIS 258
           KSDV+SFG++L E+++
Sbjct: 184 KSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  125 bits (317), Expect = 1e-33
 Identities = 64/201 (31%), Positives = 103/201 (51%), Gaps = 12/201 (5%)

Query: 67  RELGDGGFGTVY---YGELQD--GRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           ++LG+G FG V    Y  L D  G  VAVK L +    +    F  E++IL  L H+N+V
Sbjct: 10  KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
              G C     R L L+ E++ +G++ D+L   R +         L  + +    + YL 
Sbjct: 70  KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL---KRLLLFSSQICKGMDYLG 126

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPG-YVDPEYHQC 237
           +   IHRD+   NIL+++   VK++DFGL+++ P +   +    P  +P  +  PE  + 
Sbjct: 127 SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT 186

Query: 238 YQLTDKSDVFSFGVVLIELIS 258
            + +  SDV+SFGV L EL +
Sbjct: 187 SKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  123 bits (311), Expect = 5e-33
 Identities = 64/198 (32%), Positives = 100/198 (50%), Gaps = 11/198 (5%)

Query: 68  ELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKR--VEQFMNEVDILARLRHKNLVSLYG 124
            +G G FG VY G  L+ G  VA+K++     K   ++  M E+D+L  L+H N+V   G
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
                S  L ++ E+  NG++   +     K G  P         +    L YLH   +I
Sbjct: 67  SI-ETSDSLYIILEYAENGSLRQIIK----KFGPFPESLVAVYVYQVLQGLAYLHEQGVI 121

Query: 185 HRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           HRD+K  NIL   +  VK+ADFG++ +L  N V+    +  GTP ++ PE  +    +  
Sbjct: 122 HRDIKAANILTTKDGVVKLADFGVATKL--NDVSKDDASVVGTPYWMAPEVIEMSGASTA 179

Query: 244 SDVFSFGVVLIELISSMP 261
           SD++S G  +IEL++  P
Sbjct: 180 SDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  123 bits (310), Expect = 6e-33
 Identities = 64/193 (33%), Positives = 100/193 (51%), Gaps = 6/193 (3%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-C 125
           R+LG G FG V+ G   +   VAVK L        + F+ E  I+ +LRH  L+ LY  C
Sbjct: 12  RKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAVC 70

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           T      + +V E +  G++ ++L G      AL  P  + +A + AS + YL A + IH
Sbjct: 71  TLEEP--IYIVTELMKYGSLLEYLQGG--AGRALKLPQLIDMAAQVASGMAYLEAQNYIH 126

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N+L+  N   KVADFGL+R+    +       +    +  PE     + + KSD
Sbjct: 127 RDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSD 186

Query: 246 VFSFGVVLIELIS 258
           V+SFG++L E+++
Sbjct: 187 VWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  122 bits (308), Expect = 1e-32
 Identities = 80/275 (29%), Positives = 131/275 (47%), Gaps = 35/275 (12%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +ELG G FG V+ G+ +    VA+K + E      + F+ E  ++ +L H NLV LYG  
Sbjct: 10  KELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSE-DDFIEEAKVMMKLSHPNLVQLYGVC 68

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++  R + +V E+++NG + ++L   R + G L     L +  +   A+ YL ++  IHR
Sbjct: 69  TKQ-RPIFIVTEYMANGCLLNYL---RERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPEYHQCYQLTDK 243
           D+   N L+  +  VKV+DFGL+R     +    T+ QGT     +  PE     + + K
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYV---LDDQYTSSQGTKFPVKWAPPEVFDYSRFSSK 181

Query: 244 SDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL-GYESD 300
           SDV+SFGV++ E+ S   MP        +E   SN            E+V+    GY   
Sbjct: 182 SDVWSFGVLMWEVFSEGKMP--------YE-RFSNS-----------EVVESVSAGYRLY 221

Query: 301 NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
            + +     V  + + C   + + RP    +L  L
Sbjct: 222 -RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  119 bits (301), Expect = 1e-31
 Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 30/214 (14%)

Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V  G+ + G+ VAVK L +++    + F+ E  ++  LRH NLV L G   +
Sbjct: 14  IGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ 71

Query: 129 HSRELLLVYEFISNGTVADHLHG-ERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
            +  L +V E+++ G++ D+L    RA    +    +L  A++    + YL   + +HRD
Sbjct: 72  GN-PLYIVTEYMAKGSLVDYLRSRGRA---VITLAQQLGFALDVCEGMEYLEEKNFVHRD 127

Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG------YVDPEYHQCYQLT 241
           +   N+L+  +   KV+DFGL++           A QG         +  PE  +  + +
Sbjct: 128 LAARNVLVSEDLVAKVSDFGLAK----------EASQGQDSGKLPVKWTAPEALREKKFS 177

Query: 242 DKSDVFSFGVVLIELIS-------SMPAVDITRH 268
            KSDV+SFG++L E+ S        +P  D+  H
Sbjct: 178 TKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPH 211

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  120 bits (302), Expect = 1e-31
 Identities = 64/200 (32%), Positives = 103/200 (51%), Gaps = 12/200 (6%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           F   R+LG G FG V+ G  ++   VA+K L  ++  + + F  EV  L RLRHK+L+SL
Sbjct: 8   FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           +   S     + ++ E +  G++   L     +   LP  + + +A + A  + YL   +
Sbjct: 68  FAVCSV-GEPVYIITELMEKGSLLAFLRSPEGQ--VLPVASLIDMACQVAEGMAYLEEQN 124

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHVTHVSTAPQGTPGYVDPEY--HQCY 238
            IHRD+   NIL+  +   KVADFGL+RL     +++     P     +  PE   H  +
Sbjct: 125 SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPY---KWTAPEAASHGTF 181

Query: 239 QLTDKSDVFSFGVVLIELIS 258
               KSDV+SFG++L E+ +
Sbjct: 182 ST--KSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  119 bits (300), Expect = 1e-31
 Identities = 68/192 (35%), Positives = 106/192 (55%), Gaps = 7/192 (3%)

Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-CT 126
           E+G G FG V+ G   + R VA+K + E      E F+ E  ++ +L H  LV LYG CT
Sbjct: 11  EIGSGQFGLVWLGYWLEKRKVAIKTIREGAMSE-EDFIEEAQVMMKLSHPKLVQLYGVCT 69

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
            R    + LV+EF+ +G ++D+L   RA+ G     T L + ++    + YL +S++IHR
Sbjct: 70  ERSP--ICLVFEFMEHGCLSDYL---RAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHR 124

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D+   N L+  N  VKV+DFG++R   +     ST  +    +  PE     + + KSDV
Sbjct: 125 DLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDV 184

Query: 247 FSFGVVLIELIS 258
           +SFGV++ E+ S
Sbjct: 185 WSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  119 bits (299), Expect = 3e-31
 Identities = 71/208 (34%), Positives = 106/208 (50%), Gaps = 17/208 (8%)

Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-C 125
           +LG G +G VY G  +     VAVK L E+    VE+F+ E  ++  ++H NLV L G C
Sbjct: 13  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVC 71

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           T        ++ EF++ G + D+L         +     L +A + +SA+ YL   + IH
Sbjct: 72  T--REPPFYIITEFMTYGNLLDYL--RECNRQEVNAVVLLYMATQISSAMEYLEKKNFIH 127

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPEYHQCYQLTD 242
           RD+   N L+  N  VKVADFGLSRL         TA  G      +  PE     + + 
Sbjct: 128 RDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNKFSI 184

Query: 243 KSDVFSFGVVLIEL----ISSMPAVDIT 266
           KSDV++FGV+L E+    +S  P +D++
Sbjct: 185 KSDVWAFGVLLWEIATYGMSPYPGIDLS 212

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  119 bits (299), Expect = 4e-31
 Identities = 69/211 (32%), Positives = 105/211 (49%), Gaps = 21/211 (9%)

Query: 67  RELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQ-FMNEVDILARLRHKNL 119
           RELG+G FG V+ GE        D   VAVK L E       + F  E ++L   +H+N+
Sbjct: 11  RELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENI 70

Query: 120 VSLYG-CTSRHSRELLLVYEFISNGTVADHL--HG--------ERAKPGALPWPTRLKIA 168
           V  YG CT       ++V+E++ +G +   L  HG          +  G L     L+IA
Sbjct: 71  VKFYGVCT--EGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIA 128

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTP 227
           ++ AS + YL +   +HRD+ T N L+  +  VK+ DFG+SR ++      V        
Sbjct: 129 VQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPI 188

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
            ++ PE     + T +SDV+SFGVVL E+ +
Sbjct: 189 RWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  116 bits (293), Expect = 2e-30
 Identities = 81/273 (29%), Positives = 122/273 (44%), Gaps = 26/273 (9%)

Query: 67  RELGDGGFG-TVYYGELQDGRAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNLVSLY 123
           R LG G FG    Y   +D   V  K   L   + K     +NE+ IL+ L+H N+++ Y
Sbjct: 6   RVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYY 65

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
                    LL+  E+ + GT+ D +   R K         L    +  SA++Y+H + I
Sbjct: 66  N-HFMDDNTLLIEMEYANGGTLYDKI--VRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGI 122

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           +HRD+KT NI L     +K+ DFG+S++  +  +   T   GTP Y+ PE  Q  +   K
Sbjct: 123 LHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV-VGTPYYMSPELCQGVKYNFK 181

Query: 244 SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKV 303
           SD+++ G VL EL++     D T      N  NL + KI     +  V     Y S    
Sbjct: 182 SDIWALGCVLYELLTLKRTFDAT------NPLNL-VVKIVQGN-YTPVVS--VYSS---- 227

Query: 304 RRTINAVAELAFQCLQSEKDLRPYMVDVLDALR 336
                 +  L    LQ + + RP   +VLD   
Sbjct: 228 -----ELISLVHSLLQQDPEKRPTADEVLDQPL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  116 bits (294), Expect = 2e-30
 Identities = 62/225 (27%), Positives = 100/225 (44%), Gaps = 39/225 (17%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL---YENNYKRVEQFMNEVDILARL-RHK 117
           F   + +G+G F TV    E +  +  A+K L        K+V+    E ++L RL  H 
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
            ++ LY  T +    L  V E+  NG +  ++     K G+L        A E   AL Y
Sbjct: 63  GIIKLY-YTFQDEENLYFVLEYAPNGELLQYIR----KYGSLDEKCTRFYAAEILLALEY 117

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ------------- 224
           LH+  IIHRD+K  NILLD +  +K+ DFG +++   + +  S                 
Sbjct: 118 LHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR 177

Query: 225 ------GTPGYVDPEYHQCYQLTDK-----SDVFSFGVVLIELIS 258
                 GT  YV PE      L +K     SD+++ G ++ ++++
Sbjct: 178 RFASFVGTAEYVSPEL-----LNEKPAGKSSDLWALGCIIYQMLT 217

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  116 bits (293), Expect = 2e-30
 Identities = 63/199 (31%), Positives = 103/199 (51%), Gaps = 14/199 (7%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           +G G FG VY    L  G  +AVK  R+ +N+ K +++  +E+ +L  L+H NLV  YG 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYG- 66

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
              H  ++ +  E+ S GT+ + L   R     +    R+   ++    L YLH+  I+H
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV---IRV-YTLQLLEGLAYLHSHGIVH 122

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEYHQCYQLTD 242
           RD+K  NI LD+N  +K+ DFG +    N+ T +    Q   GTP Y+ PE     +   
Sbjct: 123 RDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKG 182

Query: 243 K---SDVFSFGVVLIELIS 258
               +D++S G V++E+ +
Sbjct: 183 HGRAADIWSLGCVVLEMAT 201

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  115 bits (290), Expect = 5e-30
 Identities = 68/202 (33%), Positives = 97/202 (48%), Gaps = 20/202 (9%)

Query: 69  LGDGGFGTVYY-GELQDGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           LG G FG V    +   G+  A+K L        K VE  + E +IL+R+ H  +V L+ 
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 125 C--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
              T      L LV E+   G +  HL  E    G          A E   AL YLH+  
Sbjct: 61  AFQTEEK---LYLVLEYAPGGELFSHLSKE----GRFSEERARFYAAEIVLALEYLHSLG 113

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ--CYQL 240
           II+RD+K  NILLD +  +K+ DFGL++   +  +  +T   GTP Y+ PE      Y  
Sbjct: 114 IIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT-FCGTPEYLAPEVLLGKGY-- 170

Query: 241 TDKS-DVFSFGVVLIELISSMP 261
             K+ D +S GV+L E+++  P
Sbjct: 171 -GKAVDWWSLGVLLYEMLTGKP 191

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  115 bits (289), Expect = 6e-30
 Identities = 68/195 (34%), Positives = 105/195 (53%), Gaps = 11/195 (5%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ++LG+G FG V+ G       VAVK L        E F+ E  I+ +LRH  LV LY   
Sbjct: 12  KKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMSP-ESFLEEAQIMKKLRHDKLVQLYAVV 70

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           S     + +V E++S G++ D L     +  AL  P  + +A + A+ + Y+   + IHR
Sbjct: 71  SE--EPIYIVTEYMSKGSLLDFLKDGEGR--ALKLPNLVDMAAQVAAGMAYIERMNYIHR 126

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPEYHQCYQLTDK 243
           D+++ NIL+ +    K+ADFGL+RL  ++     TA QG      +  PE     + T K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIK 183

Query: 244 SDVFSFGVVLIELIS 258
           SDV+SFG++L EL++
Sbjct: 184 SDVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  114 bits (286), Expect = 2e-29
 Identities = 66/198 (33%), Positives = 95/198 (47%), Gaps = 11/198 (5%)

Query: 68  ELGDGGFGTVYYGE----LQDGRAVAVKRLY-ENNYKRVEQFMNEVDILARLRHKNLVSL 122
           +LGDG FG V  GE          VAVK L  +     ++ F+ E  I+  L H+NL+ L
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           YG    H   L++V E    G++ D L  +    G     T    A++ A+ + YL +  
Sbjct: 62  YGVVLTHP--LMMVTELAPLGSLLDRLRKD--ALGHFLISTLCDYAVQIANGMRYLESKR 117

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTP-GYVDPEYHQCYQL 240
            IHRD+   NILL ++  VK+ DFGL R  P N   +V       P  +  PE  +    
Sbjct: 118 FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTF 177

Query: 241 TDKSDVFSFGVVLIELIS 258
           +  SDV+ FGV L E+ +
Sbjct: 178 SHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  113 bits (283), Expect = 4e-29
 Identities = 68/195 (34%), Positives = 110/195 (56%), Gaps = 11/195 (5%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-C 125
           +ELG G FG V YG+ +    VA+K + E +    ++F+ E  ++ +L H+ LV LYG C
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMKLSHEKLVQLYGVC 68

Query: 126 TSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           T +  R + +V E++SNG + ++L  HG+R +P  L     L++  +    + YL +   
Sbjct: 69  TKQ--RPIYIVTEYMSNGCLLNYLREHGKRFQPSQL-----LEMCKDVCEGMAYLESKQF 121

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           IHRD+   N L+D+  CVKV+DFGLSR   +     S   +    +  PE     + + K
Sbjct: 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK 181

Query: 244 SDVFSFGVVLIELIS 258
           SDV++FGV++ E+ S
Sbjct: 182 SDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  113 bits (284), Expect = 7e-29
 Identities = 70/198 (35%), Positives = 105/198 (53%), Gaps = 11/198 (5%)

Query: 69  LGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLY 123
           LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V   
Sbjct: 12  LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71

Query: 124 G-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           G C S   R L LV E++  G++ D+L   R +   L     L  A +    + YL +  
Sbjct: 72  GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYLGSKR 128

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGY-VDPEYHQCYQL 240
            +HRD+ T NIL+++   VK+ DFGL+++ P +   +    P  +P +   PE     + 
Sbjct: 129 YVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKF 188

Query: 241 TDKSDVFSFGVVLIELIS 258
           +  SDV+SFGVVL EL +
Sbjct: 189 SVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  112 bits (283), Expect = 7e-29
 Identities = 71/215 (33%), Positives = 111/215 (51%), Gaps = 29/215 (13%)

Query: 68  ELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQ-FMNEVDILARLRHKNLV 120
           ELG+G FG VY GEL          +VA+K L EN   +V+Q F  E ++++ L+H N+V
Sbjct: 12  ELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIV 71

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGA----------LPWPTRLKI 167
            L G CT    +   +++E++++G + + L  +   +  GA          L     L I
Sbjct: 72  CLLGVCTK--EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH----VTHVSTAP 223
           AI+ A+ + YL +   +HRD+   N L+     VK++DFGLSR   +     V   S  P
Sbjct: 130 AIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
                ++ PE     + T +SD++SFGVVL E+ S
Sbjct: 190 V---RWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 9e-29
 Identities = 70/220 (31%), Positives = 101/220 (45%), Gaps = 18/220 (8%)

Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL 114
           L + T  F+    +G+G +G VY     + G+ VA+K + +      E+   E +IL + 
Sbjct: 1   LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKY 59

Query: 115 -RHKNLVSLYGC-----TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
             H N+ + YG         +  +L LV E    G+V D + G R K   L       I 
Sbjct: 60  SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYIL 119

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHVTHVSTAPQGT 226
            ET   L YLH + +IHRD+K  NILL  N  VK+ DFG+S          +      GT
Sbjct: 120 RETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI---GT 176

Query: 227 PGYVDPEYHQCYQLTD-----KSDVFSFGVVLIELISSMP 261
           P ++ PE   C +  D     +SDV+S G+  IEL    P
Sbjct: 177 PYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  112 bits (281), Expect = 9e-29
 Identities = 80/271 (29%), Positives = 122/271 (45%), Gaps = 44/271 (16%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKR--LYENNYKR---VEQFMNEVDILARLRHKNLVSL 122
           LG G FG+VY G  L DG   AVK   L ++       V+Q   E+ +L++L+H N+V  
Sbjct: 8   LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
            G T R    L +  E +  G++A  L     K G+ P P       +    L YLH  +
Sbjct: 68  LG-TEREEDNLYIFLELVPGGSLAKLL----KKYGSFPEPVIRLYTRQILLGLEYLHDRN 122

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP--QGTPGYVDPEY-HQCYQ 239
            +HRD+K  NIL+D N  VK+ADFG+++     V   S A   +G+P ++ PE   Q   
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAK----QVVEFSFAKSFKGSPYWMAPEVIAQQGG 178

Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL----AINKIQNKALHELVDQTL 295
               +D++S G  ++E+ +  P             S L    A+ KI        +   L
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPP-----------WSQLEGVAAVFKIGRSKELPPIPDHL 227

Query: 296 GYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
             E+ + +            +CLQ +  LRP
Sbjct: 228 SDEAKDFIL-----------KCLQRDPSLRP 247

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  112 bits (282), Expect = 2e-28
 Identities = 58/207 (28%), Positives = 101/207 (48%), Gaps = 15/207 (7%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
              + +  ++G+G  G VY   +   G+ VA+K++     +  E  +NE+ I+   +H N
Sbjct: 18  RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPN 76

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +V  Y        EL +V E++  G++ D +         +  P    +  E    L YL
Sbjct: 77  IVDYYDSY-LVGDELWVVMEYMDGGSLTDII---TQNFVRMNEPQIAYVCREVLQGLEYL 132

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDPEY 234
           H+ ++IHRD+K++NILL  +  VK+ADFG    L++      + V     GTP ++ PE 
Sbjct: 133 HSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVV-----GTPYWMAPEV 187

Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMP 261
            +      K D++S G++ IE+    P
Sbjct: 188 IKRKDYGPKVDIWSLGIMCIEMAEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  111 bits (279), Expect = 2e-28
 Identities = 70/194 (36%), Positives = 103/194 (53%), Gaps = 11/194 (5%)

Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 13  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 71

Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 72  EEP--IYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 127

Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPEYHQCYQLTDKS 244
           ++  NIL+  N   KVADFGL+RL  ++     TA QG      +  PE     + T KS
Sbjct: 128 LRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 245 DVFSFGVVLIELIS 258
           DV+SFG++L EL +
Sbjct: 185 DVWSFGILLTELTT 198

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 4e-28
 Identities = 69/200 (34%), Positives = 103/200 (51%), Gaps = 11/200 (5%)

Query: 68  ELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ELGDG FG VY  +  + G   A K +   + + +E FM E+DIL+  +H N+V LY   
Sbjct: 12  ELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYE-A 70

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
             +  +L ++ EF   G + D +  E  +   L  P    +  +   AL +LH+  +IHR
Sbjct: 71  YFYENKLWILIEFCDGGAL-DSIMLELERG--LTEPQIRYVCRQMLEALNFLHSHKVIHR 127

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD---- 242
           D+K  NILL  +  VK+ADFG+S    + +    T   GTP ++ PE   C    D    
Sbjct: 128 DLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTF-IGTPYWMAPEVVACETFKDNPYD 186

Query: 243 -KSDVFSFGVVLIELISSMP 261
            K+D++S G+ LIEL    P
Sbjct: 187 YKADIWSLGITLIELAQMEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  109 bits (273), Expect = 1e-27
 Identities = 60/195 (30%), Positives = 99/195 (50%), Gaps = 8/195 (4%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLVSLYG- 124
            ++G G FG VY G L+    VAVK         +  +F+ E +IL +  H N+V L G 
Sbjct: 1   EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGV 60

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
           C  +    + +V E +  G++   L   R K   L     L+++++ A+ + YL + + I
Sbjct: 61  CVQKQP--IYIVMELVPGGSLLTFL---RKKKNRLTVKKLLQMSLDAAAGMEYLESKNCI 115

Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDK 243
           HRD+   N L+  N  +K++DFG+SR     +  VS   +  P  +  PE     + T +
Sbjct: 116 HRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSE 175

Query: 244 SDVFSFGVVLIELIS 258
           SDV+S+G++L E  S
Sbjct: 176 SDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score =  109 bits (273), Expect = 2e-27
 Identities = 73/210 (34%), Positives = 107/210 (50%), Gaps = 21/210 (10%)

Query: 68  ELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ELG+G FG V+  E       QD   VAVK L E +    + F  E ++L  L+H+++V 
Sbjct: 12  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR 71

Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAK---------PGALPWPTRLKIAI 169
            YG CT    R LL+V+E++ +G +   L  HG  AK         PG L     L IA 
Sbjct: 72  FYGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129

Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPG 228
           + AS + YL +   +HRD+ T N L+     VK+ DFG+SR ++      V         
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
           ++ PE     + T +SD++SFGVVL E+ +
Sbjct: 190 WMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  108 bits (270), Expect = 3e-27
 Identities = 59/195 (30%), Positives = 102/195 (52%), Gaps = 11/195 (5%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ++LG G FG V+ G       VA+K L + +    E F+ E +++ +L+H  LV LY   
Sbjct: 12  KKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS-PEAFLAEANLMKQLQHPRLVRLYAVV 70

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++    + ++ E++ NG++ D L         L     + +A + A  + ++   + IHR
Sbjct: 71  TQEP--IYIITEYMENGSLVDFLKTPEGI--KLTINKLIDMAAQIAEGMAFIERKNYIHR 126

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPEYHQCYQLTDK 243
           D++  NIL+    C K+ADFGL+RL  ++     TA +G      +  PE       T K
Sbjct: 127 DLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 244 SDVFSFGVVLIELIS 258
           SDV+SFG++L E+++
Sbjct: 184 SDVWSFGILLTEIVT 198

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  106 bits (266), Expect = 9e-27
 Identities = 75/267 (28%), Positives = 125/267 (46%), Gaps = 26/267 (9%)

Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQ--FMNEVDILARLRHKNL 119
           F+   ++G G FG V+    + D R  A+K++  +   R E+   ++E  +LA+L    +
Sbjct: 2   FEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYI 61

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           +  Y       + L +V E+  NG +   L  +R +P  LP     +  I+    L +LH
Sbjct: 62  IRYYESFLDKGK-LNIVMEYAENGDLHKLLKMQRGRP--LPEDQVWRFFIQILLGLAHLH 118

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
           +  I+HRD+K+ N+ LD    VK+ D G+++L  +  T+ +    GTP Y+ PE  +   
Sbjct: 119 SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLL-SDNTNFANTIVGTPYYLSPELCEDKP 177

Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
             +KSDV++ GVVL E  +        +H  + N     I KI  + +   V Q   Y  
Sbjct: 178 YNEKSDVWALGVVLYECCTG-------KHPFDANNQGALILKII-RGVFPPVSQ--MYSQ 227

Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP 326
                     +A+L  QCL  +   RP
Sbjct: 228 Q---------LAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  105 bits (263), Expect = 2e-26
 Identities = 68/194 (35%), Positives = 100/194 (51%), Gaps = 11/194 (5%)

Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  I+ +LRH  LV LY   S
Sbjct: 13  KLGQGCFGEVWMGTWNGTTKVAIKTLKPGTMMP-EAFLQEAQIMKKLRHDKLVPLYAVVS 71

Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V EF+  G++ D L     K   L  P  + +A + A  + Y+   + IHRD
Sbjct: 72  EEP--IYIVTEFMGKGSLLDFLKEGDGK--YLKLPQLVDMAAQIADGMAYIERMNYIHRD 127

Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPEYHQCYQLTDKS 244
           ++  NIL+ +N   K+ADFGL+RL  ++     TA QG      +  PE     + T KS
Sbjct: 128 LRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 245 DVFSFGVVLIELIS 258
           DV+SFG++L EL++
Sbjct: 185 DVWSFGILLTELVT 198

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  105 bits (264), Expect = 3e-26
 Identities = 65/209 (31%), Positives = 103/209 (49%), Gaps = 22/209 (10%)

Query: 68  ELGDGGFGTVY-YGELQDGRAVAVKRL-YEN-NYKRVEQFMNEVDILARLRHKNLVSLYG 124
            +G G FGTV       DG+ +  K + Y N   K  +Q ++EV+IL  L+H N+V  Y 
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 125 -CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH---- 179
               R ++ L +V E+   G +A  +   + +   +      +I  +   AL   H    
Sbjct: 67  RIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSD 126

Query: 180 -ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV----THVSTAPQGTPGYVDPEY 234
             + ++HRD+K  NI LD N  VK+ DFGL+++  +      T+V     GTP Y+ PE 
Sbjct: 127 PGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYV-----GTPYYMSPEQ 181

Query: 235 --HQCYQLTDKSDVFSFGVVLIELISSMP 261
             H  Y   +KSD++S G ++ EL +  P
Sbjct: 182 LNHMSY--DEKSDIWSLGCLIYELCALSP 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  103 bits (259), Expect = 1e-25
 Identities = 66/204 (32%), Positives = 103/204 (50%), Gaps = 16/204 (7%)

Query: 69  LGDGGFGTVYYGELQDGRAVAVKR--LYENNY----KRVEQFMNEVDILARLRHKNLVSL 122
           LG G +GTVY G    G+ +AVK+  L  +N     K  E+   EVD+L  L+H N+V  
Sbjct: 8   LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
            G T      + +  EF+  G+++  L+    + G LP P   K   +    + YLH + 
Sbjct: 68  LG-TCLDDNTISIFMEFVPGGSISSILN----RFGPLPEPVFCKYTKQILDGVAYLHNNC 122

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSR---LFPNHVTH--VSTAPQGTPGYVDPEYHQC 237
           ++HRD+K NN++L  N  +K+ DFG +R       H TH  +  +  GTP ++ PE    
Sbjct: 123 VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINE 182

Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                KSD++S G  + E+ +  P
Sbjct: 183 SGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  103 bits (258), Expect = 2e-25
 Identities = 64/198 (32%), Positives = 103/198 (52%), Gaps = 9/198 (4%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-C 125
           +ELG G FG V+ G+ +    VA+K + E      E F+ E  ++ +L H  LV LYG C
Sbjct: 10  KELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVC 68

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           T +  + L +V EF+ NG + ++L   R + G L     L +  +    + YL  +  IH
Sbjct: 69  TQQ--KPLYIVTEFMENGCLLNYL---RQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIH 123

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+ +   VKV+DFG++R   +     S+  +    +  PE     + + KSD
Sbjct: 124 RDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSD 183

Query: 246 VFSFGVVLIELISS--MP 261
           V+SFGV++ E+ +   MP
Sbjct: 184 VWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  103 bits (259), Expect = 2e-25
 Identities = 71/253 (28%), Positives = 120/253 (47%), Gaps = 31/253 (12%)

Query: 72  GGFGTVYYGE-LQDGRAVAVKRLYENNYKR---VEQFMNEVDILARLRHKNLVSLYGCTS 127
           G +G V+  +    G   A+K + + +  R   V+Q + E DIL++ +   +V LY  + 
Sbjct: 4   GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-YSF 62

Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
           +  + L LV E++  G +A  L       G+L          E   AL YLH++ IIHRD
Sbjct: 63  QGKKNLYLVMEYLPGGDLASLLENV----GSLDEDVARIYIAEIVLALEYLHSNGIIHRD 118

Query: 188 VKTNNILLDNNFCVKVADFGLSRL-FPNHVTHVSTAPQ------GTPGYVDPEYHQCYQL 240
           +K +NIL+D+N  +K+ DFGLS++       +++   +      GTP Y+ PE       
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178

Query: 241 TDKSDVFSFGVVLIELISSMPAV----------DITRHRHE----INLSNLAINKIQNKA 286
           +   D +S G +L E +  +P            +I   + E    + +S+ AI+ I  K 
Sbjct: 179 SKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDVEVSDEAIDLIS-KL 237

Query: 287 LHELVDQTLGYES 299
           L    ++ LG +S
Sbjct: 238 LVPDPEKRLGAKS 250

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  103 bits (258), Expect = 2e-25
 Identities = 60/192 (31%), Positives = 98/192 (51%), Gaps = 9/192 (4%)

Query: 68  ELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYGC 125
            LG G  G VY    +  G+  A+K+++ +  +    Q + E+  L       +V  YG 
Sbjct: 8   VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDII 184
                 E+ +V E++  G++AD L     K G +P P    IA +    L YLH    II
Sbjct: 68  FY-KEGEISIVLEYMDGGSLADLL----KKVGKIPEPVLAYIARQILKGLDYLHTKRHII 122

Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 244
           HRD+K +N+L+++   VK+ADFG+S++  N +   +T   GT  Y+ PE  Q    +  +
Sbjct: 123 HRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTF-VGTVTYMSPERIQGESYSYAA 181

Query: 245 DVFSFGVVLIEL 256
           D++S G+ L+E 
Sbjct: 182 DIWSLGLTLLEC 193

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  102 bits (255), Expect = 3e-25
 Identities = 64/192 (33%), Positives = 102/192 (53%), Gaps = 7/192 (3%)

Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYG-CT 126
           LG G FG V+ G L+D   VAVK   E+  + ++ +F++E  IL +  H N+V L G CT
Sbjct: 3   LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
            R  + + +V E +  G   D L   R K   L     +K A++ A+ + YL + + IHR
Sbjct: 63  QR--QPIYIVMELVPGG---DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D+   N L+  N  +K++DFG+SR   + +   S   Q    +  PE     + + +SDV
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177

Query: 247 FSFGVVLIELIS 258
           +S+G++L E  S
Sbjct: 178 WSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 5e-25
 Identities = 64/202 (31%), Positives = 99/202 (49%), Gaps = 15/202 (7%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENN-----YKRVEQFMNEVDILARLRHKNLVSL 122
           LG G FG VY   ++  GR +AVK++  +       K V     E+ +L  L+H+ +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           YGC  R    L +  E++  G+V D L       GAL      K   +    + YLH++ 
Sbjct: 70  YGCL-RDDETLSIFMEYMPGGSVKDQL----KAYGALTETVTRKYTRQILEGVEYLHSNM 124

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQ 239
           I+HRD+K  NIL D+   VK+ DFG S+         T + +   GTP ++ PE      
Sbjct: 125 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSV-TGTPYWMSPEVISGEG 183

Query: 240 LTDKSDVFSFGVVLIELISSMP 261
              K+DV+S G  ++E+++  P
Sbjct: 184 YGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score =  102 bits (256), Expect = 5e-25
 Identities = 68/211 (32%), Positives = 105/211 (49%), Gaps = 20/211 (9%)

Query: 67  RELGDGGFGTVYYGE------LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
           RELG+G FG V+  E       +D   VAVK L +      + F  E ++L  L+H+++V
Sbjct: 11  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 70

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHL--HGERA------KP----GALPWPTRLKIA 168
             YG        L++V+E++ +G +   L  HG  A      +P    G L     L IA
Sbjct: 71  KFYGVCG-DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTP 227
            + AS + YL +   +HRD+ T N L+  N  VK+ DFG+SR ++      V        
Sbjct: 130 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 189

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
            ++ PE     + T +SDV+SFGV+L E+ +
Sbjct: 190 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  101 bits (252), Expect = 1e-24
 Identities = 54/192 (28%), Positives = 100/192 (52%), Gaps = 4/192 (2%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ++LG G FG V+ G   +   VAVK L       V+ F+ E +++  L+H  LV LY   
Sbjct: 12  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 70

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++    + ++ E+++ G++ D L  +    G +  P  +  + + A  + Y+   + IHR
Sbjct: 71  TK-EEPIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKNYIHR 127

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D++  N+L+  +   K+ADFGL+R+  ++        +    +  PE       T KSDV
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 187

Query: 247 FSFGVVLIELIS 258
           +SFG++L E+++
Sbjct: 188 WSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  100 bits (252), Expect = 1e-24
 Identities = 63/202 (31%), Positives = 103/202 (50%), Gaps = 7/202 (3%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNL 119
           F   ++LG G +G+VY  + L D +  A+K   L   + K  E  +NE+ ILA + H N+
Sbjct: 2   FKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNI 61

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           +S Y        +L +V E+   G ++  +   + K   +P     +I I+    L  LH
Sbjct: 62  IS-YKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH 120

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              I+HRD+K+ NILL  N  VK+ D G+S++   ++        GTP Y+ PE  +   
Sbjct: 121 EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI---GTPHYMAPEVWKGRP 177

Query: 240 LTDKSDVFSFGVVLIELISSMP 261
            + KSD++S G +L E+ +  P
Sbjct: 178 YSYKSDIWSLGCLLYEMATFAP 199

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  101 bits (253), Expect = 1e-24
 Identities = 68/206 (33%), Positives = 101/206 (49%), Gaps = 14/206 (6%)

Query: 62  YFDSARELGDGGFGTVY---YGELQD--GRAVAVKRL-YENNYKRVEQFMNEVDILARLR 115
           Y    R LG+G FG V    Y    D  G  VAVK L  E   +    +  E++IL  L 
Sbjct: 5   YLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64

Query: 116 HKNLVSLYGCTSRH-SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
           H+N+V   GC S    + L L+ E++  G++ D+L   +     L     L  A +    
Sbjct: 65  HENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQL-----LLFAQQICEG 119

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-TPGY-VDP 232
           + YLH+   IHRD+   N+LLDN+  VK+ DFGL++  P    +      G +P +    
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179

Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS 258
           E  +  + +  SDV+SFGV L EL++
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELLT 205

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  100 bits (251), Expect = 2e-24
 Identities = 65/207 (31%), Positives = 97/207 (46%), Gaps = 17/207 (8%)

Query: 67  RELGDGGFGTVYYGELQD------GRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKN 118
           RELG G FG VY G  +          VA+K + EN    +R+E F+NE  ++      +
Sbjct: 12  RELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIE-FLNEASVMKEFNCHH 70

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK---PGALPWPTRLKI---AIETA 172
           +V L G  S     L+ V E ++ G +  +L   R +      L  PT  K    A E A
Sbjct: 71  VVRLLGVVSTGQPTLV-VMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIA 129

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVD 231
             + YL A   +HRD+   N ++  +  VK+ DFG++R       +        P  ++ 
Sbjct: 130 DGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMA 189

Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELIS 258
           PE  +    T KSDV+SFGVVL E+ +
Sbjct: 190 PESLKDGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 99.7 bits (249), Expect = 4e-24
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 14/200 (7%)

Query: 67  RELGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNL 119
           + +G G FG V  G L+        VA+K L     +  +    F+ E  I+ +  H N+
Sbjct: 10  KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRL--DFLTEASIMGQFDHPNI 67

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           + L G  ++ SR ++++ E++ NG++   L   R   G       + +    AS + YL 
Sbjct: 68  IRLEGVVTK-SRPVMIITEYMENGSLDKFL---RENDGKFTVGQLVGMLRGIASGMKYLS 123

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCY 238
             + +HRD+   NIL+++N   KV+DFGLSR   +     +T     P  +  PE     
Sbjct: 124 EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYR 183

Query: 239 QLTDKSDVFSFGVVLIELIS 258
           + T  SDV+SFG+V+ E++S
Sbjct: 184 KFTSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 99.3 bits (247), Expect = 7e-24
 Identities = 76/274 (27%), Positives = 133/274 (48%), Gaps = 29/274 (10%)

Query: 69  LGDGGFGTVYYGELQ-DGR---AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG V+ G L+  GR   AVA+K L      K+ + F++E  I+ +  H N++ L 
Sbjct: 13  IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G  ++  +  +++ E++ NG +  +L   R   G       + +    A+ + YL   + 
Sbjct: 73  GVVTKF-KPAMIITEYMENGALDKYL---RDHDGEFSSYQLVGMLRGIAAGMKYLSDMNY 128

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           +HRD+   NIL+++N   KV+DFGLSR+  +    T+ ++  +    +  PE     + T
Sbjct: 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188

Query: 242 DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN 301
             SDV+SFG+V+ E++S          R   ++SN  + K  N      +   +   S  
Sbjct: 189 SASDVWSFGIVMWEVMS-------FGERPYWDMSNHEVMKAINDGFR--LPAPMDCPS-- 237

Query: 302 KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
                  AV +L  QC Q ++  RP  VD+++ L
Sbjct: 238 -------AVYQLMLQCWQQDRARRPRFVDIVNLL 264

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 99.2 bits (248), Expect = 8e-24
 Identities = 66/204 (32%), Positives = 104/204 (50%), Gaps = 15/204 (7%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     +  G+  A+K L +      K+VE  +NE  IL  +RH  
Sbjct: 3   FEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPF 62

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           LV+LYG   +    L LV E++  G +  HL     K G  P P     A +   AL YL
Sbjct: 63  LVNLYGSF-QDDSNLYLVMEYVPGGELFSHLR----KSGRFPEPVARFYAAQVVLALEYL 117

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+ DI++RD+K  N+LLD++  +K+ DFG ++        +     GTP Y+ PE     
Sbjct: 118 HSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC----GTPEYLAPEIILS- 172

Query: 239 QLTDKS-DVFSFGVVLIELISSMP 261
           +   K+ D ++ G+++ E+++  P
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 98.5 bits (246), Expect = 9e-24
 Identities = 77/276 (27%), Positives = 127/276 (46%), Gaps = 33/276 (11%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           FD   +LG+G +G+VY     + G+ VA+K +       +++ + E+ IL +     +V 
Sbjct: 5   FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEE--DLQEIIKEISILKQCDSPYIVK 62

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA---LTYL 178
            YG   +++ +L +V E+   G+V+D +   +     L   T  +IA         L YL
Sbjct: 63  YYGSYFKNT-DLWIVMEYCGAGSVSDIM---KITNKTL---TEEEIAAILYQTLKGLEYL 115

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H++  IHRD+K  NILL+     K+ADFG+S    + +   +T   GTP ++ PE  Q  
Sbjct: 116 HSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTV-IGTPFWMAPEVIQEI 174

Query: 239 QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
              +K+D++S G+  IE+    P         +I+    AI  I NK    L D      
Sbjct: 175 GYNNKADIWSLGITAIEMAEGKPP------YSDIHPMR-AIFMIPNKPPPTLSDPE---- 223

Query: 299 SDNKVRRTINA-VAELAFQCLQSEKDLRPYMVDVLD 333
              K     N  V     +CL  + + RP  + +L 
Sbjct: 224 ---KWSPEFNDFVK----KCLVKDPEERPSAIQLLQ 252

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 99.3 bits (247), Expect = 9e-24
 Identities = 73/218 (33%), Positives = 109/218 (50%), Gaps = 29/218 (13%)

Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ELGDG FG VY  + ++  A+A  ++ E  + + +E +M E++ILA   H  +V L G  
Sbjct: 19  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLG-A 77

Query: 127 SRHSRELLLVYEFISNGTV-ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
                +L ++ EF   G V A  L  +R     L  P    I  +   AL YLH+  IIH
Sbjct: 78  FYWDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVICRQMLEALQYLHSMKIIH 133

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-----GTPGYVDPEYHQCYQL 240
           RD+K  N+LL  +  +K+ADFG+S        +V T  +     GTP ++ PE   C  +
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVS------AKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187

Query: 241 TD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
            D     K+D++S G+ LIE+    P        HE+N
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPP------HHELN 219

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 98.6 bits (245), Expect = 2e-23
 Identities = 73/224 (32%), Positives = 110/224 (49%), Gaps = 27/224 (12%)

Query: 61  NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNL 119
            +++   ELGDG FG VY  + ++   +A  ++ +  + + +E +M E+DILA   H N+
Sbjct: 5   EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 64

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV-ADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           V L      +   L ++ EF + G V A  L  ER     L  P    +  +T  AL YL
Sbjct: 65  VKLLD-AFYYENNLWILIEFCAGGAVDAVMLELERP----LTEPQIRVVCKQTLEALNYL 119

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLS----RLFPNHVTHVSTAPQGTPGYVDPEY 234
           H + IIHRD+K  NIL   +  +K+ADFG+S    R      + +     GTP ++ PE 
Sbjct: 120 HENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFI-----GTPYWMAPEV 174

Query: 235 HQCYQLTD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
             C    D     K+DV+S G+ LIE+    P        HE+N
Sbjct: 175 VMCETSKDRPYDYKADVWSLGITLIEMAQIEPP------HHELN 212

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 97.4 bits (242), Expect = 4e-23
 Identities = 67/208 (32%), Positives = 104/208 (50%), Gaps = 17/208 (8%)

Query: 67  RELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
           RELG+G FG V+  E       QD   VAVK L + +    + F  E ++L  L+H+++V
Sbjct: 11  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 70

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHL--HGERA-------KPGALPWPTRLKIAIET 171
             YG        L++V+E++ +G +   L  HG  A       +P  L     L IA + 
Sbjct: 71  KFYGVCVE-GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQI 129

Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYV 230
           A+ + YL +   +HRD+ T N L+  N  VK+ DFG+SR ++      V         ++
Sbjct: 130 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 189

Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELIS 258
            PE     + T +SDV+S GVVL E+ +
Sbjct: 190 PPESIMYRKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 96.2 bits (239), Expect = 6e-23
 Identities = 53/192 (27%), Positives = 99/192 (51%), Gaps = 5/192 (2%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ++LG G FG V+         VAVK +   +   VE F+ E +++  L+H  LV L+   
Sbjct: 12  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 70

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++    + ++ EF++ G++ D L  +       P P  +  + + A  + ++   + IHR
Sbjct: 71  TKEP--IYIITEFMAKGSLLDFLKSDEGS--KQPLPKLIDFSAQIAEGMAFIEQRNYIHR 126

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D++  NIL+  +   K+ADFGL+R+  ++        +    +  PE       T KSDV
Sbjct: 127 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 186

Query: 247 FSFGVVLIELIS 258
           +SFG++L+E+++
Sbjct: 187 WSFGILLMEIVT 198

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 96.5 bits (241), Expect = 7e-23
 Identities = 63/201 (31%), Positives = 91/201 (45%), Gaps = 17/201 (8%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
             +G G FG VY   + +  + VA+K +  E     +E    E+  L++ R   +   YG
Sbjct: 7   ECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYG 66

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
              + S+ L ++ E+   G+  D L     KPG L       I  E    L YLH    I
Sbjct: 67  SFLKGSK-LWIIMEYCGGGSCLDLL-----KPGKLDETYIAFILREVLLGLEYLHEEGKI 120

Query: 185 HRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
           HRD+K  NILL     VK+ADFG    L+       T V     GTP ++ PE  +    
Sbjct: 121 HRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFV-----GTPFWMAPEVIKQSGY 175

Query: 241 TDKSDVFSFGVVLIELISSMP 261
            +K+D++S G+  IEL    P
Sbjct: 176 DEKADIWSLGITAIELAKGEP 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 96.3 bits (240), Expect = 7e-23
 Identities = 60/215 (27%), Positives = 103/215 (47%), Gaps = 21/215 (9%)

Query: 69  LGDGGFGTVYYGE-LQDGR----AVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSL 122
           LG G FGTVY G  + +G      VA+K L E    K  ++ ++E  ++A + H ++V L
Sbjct: 15  LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74

Query: 123 YG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
            G C S    ++ L+ + +  G + D++   +   G+      L   ++ A  ++YL   
Sbjct: 75  LGICLSS---QVQLITQLMPLGCLLDYVRNHKDNIGSQ---YLLNWCVQIAKGMSYLEEK 128

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQL 240
            ++HRD+   N+L+     VK+ DFGL++L               P  ++  E       
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIY 188

Query: 241 TDKSDVFSFGVVLIELIS-------SMPAVDITRH 268
           T KSDV+S+GV + EL++        +PAV+I   
Sbjct: 189 THKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDL 223

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 95.4 bits (237), Expect = 1e-22
 Identities = 59/190 (31%), Positives = 100/190 (52%), Gaps = 9/190 (4%)

Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V  G+ + G  VAVK +   N    + F+ E  ++ +LRH NLV L G    
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70

Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDV 188
               L +V E+++ G++ D+L   R +   L     LK +++   A+ YL A++ +HRD+
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLR-SRGR-SVLGGDCLLKFSLDVCEAMEYLEANNFVHRDL 128

Query: 189 KTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
              N+L+  +   KV+DFGL++      +      +    +  PE  +  + + KSDV+S
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 184

Query: 249 FGVVLIELIS 258
           FG++L E+ S
Sbjct: 185 FGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 62/198 (31%), Positives = 90/198 (45%), Gaps = 17/198 (8%)

Query: 67  RELGDGGFGTVYYGELQDGRAV-AVKRLYENNYK-----RVEQFMNEVDILARLRHKNLV 120
           R +G G FG V   + +D + + A+K  Y N  K      V   +NE  IL  L H  LV
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMK--YMNKQKCVEKGSVRNVLNERRILQELNHPFLV 63

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLH 179
           +L+  + +    + LV + +  G +  HL    +          +  I  E   AL YLH
Sbjct: 64  NLWY-SFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQ----VKFWIC-EIVLALEYLH 117

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
           +  IIHRD+K +NILLD    V + DF ++          ST+  GTPGY+ PE      
Sbjct: 118 SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS--GTPGYMAPEVLCRQG 175

Query: 240 LTDKSDVFSFGVVLIELI 257
            +   D +S GV   E +
Sbjct: 176 YSVAVDWWSLGVTAYECL 193

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 95.7 bits (238), Expect = 1e-22
 Identities = 77/280 (27%), Positives = 127/280 (45%), Gaps = 39/280 (13%)

Query: 69  LGDGGFGTVYYGEL-QDGRA---VAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L   G+    VA+K L   Y    +R   F++E  I+ +  H N++ 
Sbjct: 12  IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRR--DFLSEASIMGQFDHPNIIH 69

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ SR ++++ EF+ NG +   L   R   G       + +    A+ + YL   
Sbjct: 70  LEGVVTK-SRPVMIITEFMENGALDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLSEM 125

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV---THVSTAPQGTP-GYVDPEYHQC 237
           + +HRD+   NIL+++N   KV+DFGLSR   +     T+ S+     P  +  PE    
Sbjct: 126 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY 185

Query: 238 YQLTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
            + T  SDV+S+G+V+ E++S    P  D++            IN I+        D  L
Sbjct: 186 RKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD--------VINAIEQ-------DYRL 230

Query: 296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
               D        A+ +L   C Q +++ RP    ++  L
Sbjct: 231 PPPMDCPT-----ALHQLMLDCWQKDRNARPKFGQIVSTL 265

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 95.8 bits (239), Expect = 1e-22
 Identities = 58/199 (29%), Positives = 94/199 (47%), Gaps = 11/199 (5%)

Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVSLY 123
            +G+G +G V     +  G  VA+K+     ++   + +  + EV +L +LRH+N+V+L 
Sbjct: 8   VVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK-KTALREVKVLRQLRHENIVNLK 66

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
               R    L LV+E++   T+ + L    A PG LP         +   A+ Y H+ +I
Sbjct: 67  E-AFRRKGRLYLVFEYVER-TLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           IHRD+K  NIL+  +  +K+ DFG +R          T    T  Y  PE         K
Sbjct: 122 IHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGK 181

Query: 244 S-DVFSFGVVLIELISSMP 261
             DV++ G ++ EL+   P
Sbjct: 182 PVDVWAIGCIMAELLDGEP 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 95.5 bits (238), Expect = 1e-22
 Identities = 61/196 (31%), Positives = 93/196 (47%), Gaps = 8/196 (4%)

Query: 68  ELGDGGFGTVYYGE-LQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            +G G    VY    L +   VA+KR+  E     V++   EV  +++  H N+V  Y  
Sbjct: 8   VIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYY-T 66

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +     EL LV  ++S G++ D +       G L       +  E    L YLH++  IH
Sbjct: 67  SFVVGDELWLVMPYLSGGSLLD-IMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIH 125

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPE-YHQCYQLT 241
           RD+K  NILL  +  VK+ADFG+S    +         +   GTP ++ PE   Q +   
Sbjct: 126 RDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYD 185

Query: 242 DKSDVFSFGVVLIELI 257
            K+D++SFG+  IEL 
Sbjct: 186 FKADIWSFGITAIELA 201

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 94.6 bits (235), Expect = 2e-22
 Identities = 62/193 (32%), Positives = 100/193 (51%), Gaps = 17/193 (8%)

Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYK---RVEQFMNEVDILARLRHKNLVSLYGC 125
           +G+G FG V  GE   G+ VAVK     N K     + F+ E  ++ +L HKNLV L G 
Sbjct: 14  IGEGEFGAVLQGEYT-GQKVAVK-----NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGV 67

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
              +   L +V E +S G + + L   R +   +     L+ +++ A  + YL +  ++H
Sbjct: 68  ILHNG--LYIVMELMSKGNLVNFLR-TRGR-ALVSVIQLLQFSLDVAEGMEYLESKKLVH 123

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   NIL+  +   KV+DFGL+R+    V +     + T     PE  +  + + KSD
Sbjct: 124 RDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTA----PEALKHKKFSSKSD 179

Query: 246 VFSFGVVLIELIS 258
           V+S+GV+L E+ S
Sbjct: 180 VWSYGVLLWEVFS 192

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 3e-22
 Identities = 61/202 (30%), Positives = 95/202 (47%), Gaps = 17/202 (8%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++  + +G G +G VY   ++  G  VA+K +        E    E+ +L   RH N+V+
Sbjct: 5   YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64

Query: 122 LYGCTSRHSR-ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            +G  S   R +L +V E+   G++ D     R   G L       +  ET   L YLH 
Sbjct: 65  YFG--SYLRRDKLWIVMEYCGGGSLQDIYQVTR---GPLSELQIAYVCRETLKGLAYLHE 119

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEYHQC 237
           +  IHRD+K  NILL  +  VK+ADFG+S      +T      +   GTP ++ PE    
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADFGVSAQ----LTATIAKRKSFIGTPYWMAPEVAAV 175

Query: 238 YQLTD---KSDVFSFGVVLIEL 256
            +      K D+++ G+  IEL
Sbjct: 176 ERKGGYDGKCDIWALGITAIEL 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 30/209 (14%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN--EVDILARLRHKNLVSLY 123
            ++G+G +G VY   +   G  VA+K++               E+ +L  L H N++ L 
Sbjct: 5   GKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLL 64

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
               RH  +L LV+EF+      D     + +   LP         +    L + H+  I
Sbjct: 65  DVF-RHKGDLYLVFEFMD----TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLF---PNHVTH-VST----APQ---GTPGYVDP 232
           +HRD+K  N+L++    +K+ADFGL+R F       TH V T    AP+   G  GY   
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGY--- 176

Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMP 261
                   +   D++S G +  EL+S  P
Sbjct: 177 --------STPVDIWSVGCIFAELLSRRP 197

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 93.8 bits (233), Expect = 5e-22
 Identities = 58/206 (28%), Positives = 101/206 (49%), Gaps = 20/206 (9%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLY-----ENNYKR----VEQFMNEVDILARLRHKN 118
           +G G FG+VY G     G  +AVK++       ++  R    ++    E+ +L  L+H+N
Sbjct: 8   IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +V   G +   +  L +  E++  G+VA  L+      GA           +    L YL
Sbjct: 68  IVQYLGSSL-DADHLNIFLEYVPGGSVAALLN----NYGAFEETLVRNFVRQILKGLNYL 122

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-----QGTPGYVDPE 233
           H   IIHRD+K  NIL+DN   +K++DFG+S+    +     T       QG+  ++ PE
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
             +    T K+D++S G +++E+++ 
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTG 208

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 94.1 bits (235), Expect = 6e-22
 Identities = 51/158 (32%), Positives = 88/158 (55%), Gaps = 16/158 (10%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF----MNEVDILARLRHK 117
           ++   ++G+G +G VY     + G  VA+K++   N K  E F    + E+ +L +LRH 
Sbjct: 1   YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHP 58

Query: 118 NLVSLYG-CTSRHSRELLLVYEFISNGTVADH-LHGERAKPGALPWPTRLK-IAIETASA 174
           N+V L    TS+    + +V+E++      DH L G    P      +++K    +    
Sbjct: 59  NIVRLKEIVTSKGKGSIYMVFEYM------DHDLTGLLDSPEVKFTESQIKCYMKQLLEG 112

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF 212
           L YLH++ I+HRD+K +NIL++N+  +K+ADFGL+R +
Sbjct: 113 LQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPY 150

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 93.6 bits (232), Expect = 6e-22
 Identities = 61/202 (30%), Positives = 99/202 (49%), Gaps = 13/202 (6%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLY-----ENNYKRVEQFMNEVDILARLRHKNLVSL 122
           LG G FG VY   ++  GR +A K++          K V     E+ +L  L+H+ +V  
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69

Query: 123 YGCTSRHSRELLLVY-EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           YGC    + + L ++ E++  G+V D L       GAL      K   +    ++YLH++
Sbjct: 70  YGCLRDRAEKTLTIFMEYMPGGSVKDQLKAY----GALTESVTRKYTRQILEGMSYLHSN 125

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS--TAPQGTPGYVDPEYHQCYQ 239
            I+HRD+K  NIL D+   VK+ DFG S+         +   +  GTP ++ PE      
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEG 185

Query: 240 LTDKSDVFSFGVVLIELISSMP 261
              K+DV+S G  ++E+++  P
Sbjct: 186 YGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 93.0 bits (232), Expect = 1e-21
 Identities = 60/207 (28%), Positives = 96/207 (46%), Gaps = 26/207 (12%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN--EVDILARL-RHKNLVSL 122
           ++LGDG FG+VY     + G  VA+K++ +  +   E+ MN  EV  L +L  H N+V L
Sbjct: 5   KQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHG--ERAKPGALPWPTRLKIAIETASALTYLHA 180
                R + EL  V+E++       +L+   +  K           I  +    L ++H 
Sbjct: 64  KE-VFRENDELYFVFEYMEG-----NLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHK 117

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLF---PNHVTHVSTAPQGTPGYVDPE---Y 234
               HRD+K  N+L+     VK+ADFGL+R     P +  +VST       Y  PE    
Sbjct: 118 HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTR-----WYRAPEILLR 172

Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMP 261
              Y  +   D+++ G ++ EL +  P
Sbjct: 173 STSY--SSPVDIWALGCIMAELYTLRP 197

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 92.9 bits (232), Expect = 2e-21
 Identities = 63/212 (29%), Positives = 97/212 (45%), Gaps = 40/212 (18%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVK--RLYENNYKRVEQF----MNEVDILARLRHKNLVS 121
           LG+G +G VY   + + G  VA+K  RL        E      + E+ +L  L+H N+V 
Sbjct: 7   LGEGTYGVVYKARDKKTGEIVALKKIRLDNEE----EGIPSTALREISLLKELKHPNIVK 62

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L        R+L LV+E+     +  +L     +PG L       I  +    L Y H+ 
Sbjct: 63  LL-DVIHTERKLYLVFEYCDM-DLKKYLD---KRPGPLSPNLIKSIMYQLLRGLAYCHSH 117

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLF---PNHVTH-VST----APQ---GTPGYV 230
            I+HRD+K  NIL++ +  +K+ADFGL+R F       TH V T    AP+   G+  Y 
Sbjct: 118 RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHY- 176

Query: 231 DPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
                        + D++S G +  E+I+  P
Sbjct: 177 -----------STAVDIWSVGCIFAEMITGKP 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 92.4 bits (230), Expect = 2e-21
 Identities = 64/193 (33%), Positives = 97/193 (50%), Gaps = 10/193 (5%)

Query: 67  RELGDGGFGTVYYGELQ-DGRAVAVKRLY-ENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
            ELG G  G V     +  G+ +AVK +  E N    +Q + E+DIL +     +V  YG
Sbjct: 7   GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DI 183
               +  ++ +  E++  G++   L   +   G +P     KIA+     LTYLH    I
Sbjct: 67  AFYNNG-DISICMEYMDGGSLDKIL---KEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           IHRDVK +NIL+++   +K+ DFG+S    N +        GT  Y+ PE  Q    + K
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFV---GTSSYMAPERIQGNDYSVK 179

Query: 244 SDVFSFGVVLIEL 256
           SD++S G+ LIEL
Sbjct: 180 SDIWSLGLSLIEL 192

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 92.9 bits (231), Expect = 2e-21
 Identities = 69/210 (32%), Positives = 102/210 (48%), Gaps = 25/210 (11%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF---MNEVDILARLRHKN 118
           F   RE+G G FG VY+  +++    VA+K++  +  +  E++   + EV  L +LRH N
Sbjct: 17  FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76

Query: 119 LVSLYGCTSR-HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA---SA 174
            +   GC  R H+  L++ Y     G+ +D L   + KP        ++IA         
Sbjct: 77  TIEYKGCYLREHTAWLVMEYCL---GSASDILEVHK-KP-----LQEVEIAAICHGALQG 127

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
           L YLH+ + IHRD+K  NILL     VK+ADFG + L     + V     GTP ++ PE 
Sbjct: 128 LAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSFV-----GTPYWMAPEV 182

Query: 235 HQCY---QLTDKSDVFSFGVVLIELISSMP 261
                  Q   K DV+S G+  IEL    P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 92.8 bits (231), Expect = 2e-21
 Identities = 64/206 (31%), Positives = 98/206 (47%), Gaps = 15/206 (7%)

Query: 67  RELGDGGFGTVYYGELQD-GRAVAVKRLYE---NNYKRVEQFMNEVDILARL-RHKNLVS 121
           + LG G FG V   EL+      AVK L +        VE  M E  +LA   +H  L  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L+ C     R L  V E+++ G +  H+     + G    P     A E    L +LH  
Sbjct: 61  LHSCFQTKDR-LFFVMEYVNGGDLMFHIQ----RSGRFDEPRARFYAAEIVLGLQFLHER 115

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPEYHQCYQL 240
            II+RD+K +N+LLD+   +K+ADFG+ +     +  V+T+   GTP Y+ PE    YQ 
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKIADFGMCK--EGILGGVTTSTFCGTPDYIAPEILS-YQP 172

Query: 241 TDKS-DVFSFGVVLIELISSMPAVDI 265
              + D ++ GV+L E+++     + 
Sbjct: 173 YGPAVDWWALGVLLYEMLAGQSPFEG 198

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 91.8 bits (228), Expect = 3e-21
 Identities = 66/200 (33%), Positives = 103/200 (51%), Gaps = 11/200 (5%)

Query: 67  RELGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVS 121
           R +G G FG VY+G L   DG+ +  AVK L    + + VEQF+ E  I+    H N++S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G         L+V  ++ +G + + +  E   P        +   ++ A  + YL + 
Sbjct: 61  LLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV---KDLIGFGLQVAKGMEYLASK 117

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCY 238
             +HRD+   N +LD +F VKVADFGL+R   +   +  H  T  +    ++  E  Q  
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ 177

Query: 239 QLTDKSDVFSFGVVLIELIS 258
           + T KSDV+SFGV+L EL++
Sbjct: 178 KFTTKSDVWSFGVLLWELMT 197

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 91.5 bits (227), Expect = 3e-21
 Identities = 71/275 (25%), Positives = 125/275 (45%), Gaps = 31/275 (11%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKR-----VEQFMNEVDILARLRHKNLVS 121
           LG G F + Y   +++ G  +AVK++ Y  N        VE    E+ ++ARL H +++ 
Sbjct: 8   LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           + G T        L  E+++ G+V+  L     K GA      +    +    L+YLH +
Sbjct: 68  MLGAT-CEDSHFNLFVEWMAGGSVSHLLS----KYGAFKEAVIINYTEQLLRGLSYLHEN 122

Query: 182 DIIHRDVKTNNILLDNN-FCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEYHQC 237
            IIHRDVK  N+L+D+    +++ADFG +       T          GT  ++ PE  + 
Sbjct: 123 QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG 182

Query: 238 YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY 297
            Q     DV+S G V+IE+ ++ P  +  +H + + L    I KI +      + + L  
Sbjct: 183 EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLAL----IFKIASATTAPSIPEHLS- 237

Query: 298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
                       + ++  +CL+ + + RP   ++L
Sbjct: 238 ----------PGLRDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 91.1 bits (226), Expect = 4e-21
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 9/200 (4%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF--MNEVDILARLRHKNL 119
           ++  R +G G FG V+      D + V +K++      + E+    NE  +L  L H N+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           +  Y       + L++V E+   GT+A+++         L   T L   ++   AL ++H
Sbjct: 62  IEYYE-NFLEDKALMIVMEYAPGGTLAEYIQKRCNS--LLDEDTILHFFVQILLALHHVH 118

Query: 180 ASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
              I+HRD+KT NILLD +   VK+ DFG+S++  +     +    GTP Y+ PE  +  
Sbjct: 119 TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVV--GTPCYISPELCEGK 176

Query: 239 QLTDKSDVFSFGVVLIELIS 258
               KSD+++ G VL EL S
Sbjct: 177 PYNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 91.3 bits (227), Expect = 4e-21
 Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 10/203 (4%)

Query: 60  TNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKR--LYE-NNYKRVEQFMNEVDILARLR 115
              F   +++G G F  VY    L DGR VA+K+  ++E  + K  +  + E+D+L +L 
Sbjct: 1   LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60

Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           H N++     +   + EL +V E    G ++  +   + +   +P  T  K  ++  SAL
Sbjct: 61  HPNVIKYLA-SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSAL 119

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-- 233
            ++H+  I+HRD+K  N+ +     VK+ D GL R F +  T   +   GTP Y+ PE  
Sbjct: 120 EHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERI 178

Query: 234 YHQCYQLTDKSDVFSFGVVLIEL 256
           +   Y    KSD++S G +L E+
Sbjct: 179 HENGYNF--KSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 91.3 bits (227), Expect = 4e-21
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 13/199 (6%)

Query: 67  RELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVEQ-FMNEVDILARLRHKNLVS 121
           +ELG G FG+V  G      G+   VAVK L + +    ++ F+ E  ++A+L H  +V 
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G        L+LV E    G +  +L   R  P +       ++A + A  + YL + 
Sbjct: 61  LIGVCK--GEPLMLVMELAPLGPLLKYLKKRREIPVS----DLKELAHQVAMGMAYLESK 114

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRL--FPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
             +HRD+   N+LL N    K++DFG+SR     +     +TA +    +  PE     +
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 240 LTDKSDVFSFGVVLIELIS 258
            + KSDV+S+GV L E  S
Sbjct: 175 FSSKSDVWSYGVTLWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 91.2 bits (226), Expect = 5e-21
 Identities = 61/203 (30%), Positives = 98/203 (48%), Gaps = 15/203 (7%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRL-----YENNYKRVEQFMNEVDILARLRHKNLVSL 122
           LG G FG VY   +   GR +AVK++      +   K V     E+ +L  LRH  +V  
Sbjct: 10  LGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQY 69

Query: 123 YGCTSRHS-RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           YGC      ++L +  E++  G++ D L       GAL      +   +    ++YLH++
Sbjct: 70  YGCLRDPEEKKLSIFVEYMPGGSIKDQLKAY----GALTENVTRRYTRQILQGVSYLHSN 125

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCY 238
            I+HRD+K  NIL D+   VK+ DFG S+         T + +   GTP ++ PE     
Sbjct: 126 MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSV-TGTPYWMSPEVISGE 184

Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
               K+DV+S    ++E+++  P
Sbjct: 185 GYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 91.4 bits (227), Expect = 6e-21
 Identities = 62/205 (30%), Positives = 106/205 (51%), Gaps = 16/205 (7%)

Query: 62  YFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
           Y D+  ++G+G  G V    +   GR VAVK++     +R E   NEV I+   +H N+V
Sbjct: 20  YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIV 79

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            +Y  +     EL +V EF+  G + D +   R     +       + +    AL++LHA
Sbjct: 80  EMYS-SYLVGDELWVVMEFLEGGALTDIVTHTR-----MNEEQIATVCLAVLKALSFLHA 133

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
             +IHRD+K+++ILL ++  VK++DFG    +S+  P   + V     GTP ++ PE   
Sbjct: 134 QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV-----GTPYWMAPEVIS 188

Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                 + D++S G+++IE++   P
Sbjct: 189 RLPYGTEVDIWSLGIMVIEMVDGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 90.0 bits (223), Expect = 1e-20
 Identities = 58/202 (28%), Positives = 103/202 (50%), Gaps = 16/202 (7%)

Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNL 119
           ++  +++G+G FG +Y  + + D     +K   L +   K  E    EV +LA+++H N+
Sbjct: 2   YEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNI 61

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIETASAL 175
           V+ +     + R L +V E+   G +   ++ +R    ++   L W       ++ +  L
Sbjct: 62  VTFFASFQENGR-LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSW------FVQISLGL 114

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
            ++H   I+HRD+K+ NI L  N  V K+ DFG++R   N    ++    GTP Y+ PE 
Sbjct: 115 KHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPEI 173

Query: 235 HQCYQLTDKSDVFSFGVVLIEL 256
            Q     +K+D++S G VL EL
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYEL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 90.5 bits (224), Expect = 1e-20
 Identities = 73/290 (25%), Positives = 136/290 (46%), Gaps = 41/290 (14%)

Query: 66  ARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKN 118
           +RELG G FG VY G      + +    VA+K + E    R   +F+NE  ++      +
Sbjct: 11  SRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 70

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGALPWPTR--LKIAIETA 172
           +V L G  S+  +  L++ E ++ G +  +L   R +    P   P   +  +++A E A
Sbjct: 71  VVRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIA 129

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG---- 228
             + YL+A+  +HRD+   N ++  +F VK+ DFG++R     +       +G  G    
Sbjct: 130 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185

Query: 229 -YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL 287
            ++ PE  +    T  SDV+SFGVVL E+ +      +    ++  +SN        + L
Sbjct: 186 RWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQ-GMSN-------EQVL 231

Query: 288 HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD 337
             +++  L  + DN      + + EL   C Q    +RP  ++++ ++++
Sbjct: 232 RFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 89.7 bits (222), Expect = 2e-20
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 16/205 (7%)

Query: 62  YFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
           Y DS  ++G+G  G V    E   G+ VAVK++     +R E   NEV I+    H+N+V
Sbjct: 23  YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVV 82

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            +Y  +     EL +V EF+  G + D +   R     +       + +    AL+YLH 
Sbjct: 83  DMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVCLSVLRALSYLHN 136

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
             +IHRD+K+++ILL ++  +K++DFG    +S+  P   + V     GTP ++ PE   
Sbjct: 137 QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLV-----GTPYWMAPEVIS 191

Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                 + D++S G+++IE+I   P
Sbjct: 192 RLPYGTEVDIWSLGIMVIEMIDGEP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 89.2 bits (221), Expect = 2e-20
 Identities = 62/201 (30%), Positives = 103/201 (51%), Gaps = 15/201 (7%)

Query: 67  RELGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRVEQFMNEVDILARLRHKNL 119
           + +G G FG V  G L+  G+    VA+K L   Y    +R   F++E  I+ +  H N+
Sbjct: 10  KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRR--DFLSEASIMGQFDHPNI 67

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           + L G  ++ S+ +++V E++ NG++   L   R   G       + +    AS + YL 
Sbjct: 68  IHLEGVVTK-SKPVMIVTEYMENGSLDAFL---RKHDGQFTVIQLVGMLRGIASGMKYLS 123

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGT-P-GYVDPEYHQC 237
               +HRD+   NIL+++N   KV+DFGLSR+  +      T   G  P  +  PE    
Sbjct: 124 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAY 183

Query: 238 YQLTDKSDVFSFGVVLIELIS 258
            + T  SDV+S+G+V+ E++S
Sbjct: 184 RKFTSASDVWSYGIVMWEVMS 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 89.7 bits (222), Expect = 2e-20
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 8/202 (3%)

Query: 61  NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
            Y D+  ++G+G  G V    ++  G+ VAVK++     +R E   NEV I+   +H+N+
Sbjct: 20  TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V +Y  +     EL +V EF+  G + D +   R     +       + +    AL+ LH
Sbjct: 80  VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----AVCLAVLKALSVLH 133

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
           A  +IHRD+K+++ILL ++  VK++DFG        V    +   GTP ++ PE      
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSL-VGTPYWMAPELISRLP 192

Query: 240 LTDKSDVFSFGVVLIELISSMP 261
              + D++S G+++IE++   P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 89.4 bits (222), Expect = 3e-20
 Identities = 84/286 (29%), Positives = 140/286 (48%), Gaps = 35/286 (12%)

Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYEN-NYKRVEQF-MNEVDILARLRHKNLVSLYGC 125
           +G+G +G V   + ++ G+ VA+K+  E+ + K V++  M E+ +L +LRH+NLV+L   
Sbjct: 9   VGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV 68

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
             R  R L LV+EF+ + TV D L  E+  P  L      K   +    + + H+ +IIH
Sbjct: 69  FRRKKR-LYLVFEFVDH-TVLDDL--EKY-PNGLDESRVRKYLFQILRGIEFCHSHNIIH 123

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLF--PNHV--THVST----APQGTPGYVDPEYHQC 237
           RD+K  NIL+  +  VK+ DFG +R    P  V   +V+T    AP+   G  D +Y + 
Sbjct: 124 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVG--DTKYGRA 181

Query: 238 YQLTDKSDVFSFGVVLIELISSMPAV----DITRHRHEI----NLSNLAINKIQNKALHE 289
                  D+++ G ++ E+++  P      DI +  H I    NL        Q   L  
Sbjct: 182 V------DIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFA 235

Query: 290 LVDQTLGYESDNKVRR--TINAVA-ELAFQCLQSEKDLRPYMVDVL 332
            +      E +   +R   ++ +  +LA QCL+ + D RP    +L
Sbjct: 236 GMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLL 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 89.3 bits (221), Expect = 3e-20
 Identities = 87/291 (29%), Positives = 142/291 (48%), Gaps = 45/291 (15%)

Query: 67  RELGDGGFGTVYYGELQD---GRA---VAVKRLYENNY--KRVEQFMNEVDILARLRHKN 118
           RELG G FG VY G  +D   G A   VAVK + E+    +R+E F+NE  ++      +
Sbjct: 12  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIE-FLNEASVMKGFTCHH 70

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGALPWPT---RLKIAIET 171
           +V L G  S+  +  L+V E +++G +  +L   R +    PG  P PT    +++A E 
Sbjct: 71  VVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP-PTLQEMIQMAAEI 128

Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--- 228
           A  + YL+A   +HRD+   N ++ ++F VK+ DFG++R     +       +G  G   
Sbjct: 129 ADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184

Query: 229 --YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA 286
             ++ PE  +    T  SD++SFGVVL E I+S+        +    LSN        + 
Sbjct: 185 VRWMAPESLKDGVFTTSSDMWSFGVVLWE-ITSLA------EQPYQGLSN-------EQV 230

Query: 287 LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD 337
           L  ++D     + DN   R    V +L   C Q    +RP  +++++ L+D
Sbjct: 231 LKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPKMRPTFLEIVNLLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 89.2 bits (222), Expect = 3e-20
 Identities = 62/218 (28%), Positives = 98/218 (44%), Gaps = 49/218 (22%)

Query: 69  LGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMN-----EVDILARLRHKNLVSL 122
           LG+G +  VY     + GR VA+K++     K  +  +N     E+ +L  L+H N++ L
Sbjct: 8   LGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGL 67

Query: 123 YGCTSRHSRELLLVYEF--------ISNG----TVADHLHGERAKPGALPWPTRLK-IAI 169
                 H   + LV+EF        I +     T AD                 +K   +
Sbjct: 68  LDVFG-HKSNINLVFEFMETDLEKVIKDKSIVLTPAD-----------------IKSYML 109

Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTH--VSTAPQ 224
            T   L YLH++ I+HRD+K NN+L+ ++  +K+ADFGL+R F +    +TH  V     
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVV----- 164

Query: 225 GTPGYVDPE-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
            T  Y  PE            D++S G +  EL+  +P
Sbjct: 165 -TRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 89.0 bits (221), Expect = 4e-20
 Identities = 61/199 (30%), Positives = 97/199 (48%), Gaps = 13/199 (6%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRH---KNLVSLY 123
           +G G +G VY G  +  GR VA+K +  +     V     EV +L++LR     N+   Y
Sbjct: 9   IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   +  R L ++ E+   G+V   +     K G +       I  E   AL Y+H   +
Sbjct: 69  GSYLKGPR-LWIIMEYAEGGSVRTLM-----KAGPIAEKYISVIIREVLVALKYIHKVGV 122

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD- 242
           IHRD+K  NIL+ N   VK+ DFG++ L  N  +   +   GTP ++ PE     +  D 
Sbjct: 123 IHRDIKAANILVTNTGNVKLCDFGVAALL-NQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181

Query: 243 KSDVFSFGVVLIELISSMP 261
           K+D++S G+ + E+ +  P
Sbjct: 182 KADIWSLGITIYEMATGNP 200

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 87.7 bits (218), Expect = 7e-20
 Identities = 61/201 (30%), Positives = 92/201 (45%), Gaps = 19/201 (9%)

Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           LG GGFG V   +++   R  A+K +   +     + E   +E +IL    H  +V LY 
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP-WPTRLKIA--IETASALTYLHAS 181
            T +  + + ++ E+   G +   L       G    +  R  IA  +    A  YLH  
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILR----DRGLFDEYTARFYIACVVL---AFEYLHNR 112

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
            II+RD+K  N+LLD+N  VK+ DFG ++ L     T       GTP YV PE       
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFC---GTPEYVAPEIILNKGY 169

Query: 241 TDKSDVFSFGVVLIELISSMP 261
               D +S G++L EL++  P
Sbjct: 170 DFSVDYWSLGILLYELLTGRP 190

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 88.4 bits (219), Expect = 8e-20
 Identities = 57/196 (29%), Positives = 103/196 (52%), Gaps = 10/196 (5%)

Query: 68  ELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ++G G  GTVY   ++  G+ VA+K++      + E  +NE+ ++   +H N+V+ Y  +
Sbjct: 26  KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVN-YLDS 84

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
                EL +V E+++ G++ D +       G +    R     E   AL +LH++ +IHR
Sbjct: 85  YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR-----ECLQALEFLHSNQVIHR 139

Query: 187 DVKTNNILLDNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           D+K++NILL  +  VK+ DFG  +++ P      +    GTP ++ PE         K D
Sbjct: 140 DIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTPYWMAPEVVTRKAYGPKVD 197

Query: 246 VFSFGVVLIELISSMP 261
           ++S G++ IE++   P
Sbjct: 198 IWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 88.2 bits (218), Expect = 9e-20
 Identities = 63/208 (30%), Positives = 104/208 (50%), Gaps = 22/208 (10%)

Query: 62  YFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
             ++  ++G+G  G V    E   GR VAVK +     +R E   NEV I+   +H+N+V
Sbjct: 22  LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVV 81

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS---ALTY 177
            +Y  +     EL ++ EF+  G + D +   R            +IA    S   AL Y
Sbjct: 82  EMYK-SYLVGEELWVLMEFLQGGALTDIVSQTRL--------NEEQIATVCESVLQALCY 132

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDPE 233
           LH+  +IHRD+K+++ILL  +  VK++DFG    +S+  P   + V     GTP ++ PE
Sbjct: 133 LHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPYWMAPE 187

Query: 234 YHQCYQLTDKSDVFSFGVVLIELISSMP 261
                    + D++S G+++IE++   P
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGEP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 87.5 bits (217), Expect = 9e-20
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 23/206 (11%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVK------RLYENNYKR----VEQFMNEVDILARLRHK 117
           +G G +G VY    +  G  +AVK       +   +  R    V+   +E++ L  L H 
Sbjct: 9   IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68

Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           N+V   G        L +  E++  G++   L       G            +    L Y
Sbjct: 69  NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLR----TYGRFEEQLVRFFTEQVLEGLAY 123

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPE--- 233
           LH+  I+HRD+K +N+L+D +   K++DFG+S+   +   +      QG+  ++ PE   
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIH 183

Query: 234 -YHQCYQLTDKSDVFSFGVVLIELIS 258
            Y Q Y  + K D++S G V++E+ +
Sbjct: 184 SYSQGY--SAKVDIWSLGCVVLEMFA 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 87.5 bits (217), Expect = 1e-19
 Identities = 85/293 (29%), Positives = 123/293 (41%), Gaps = 49/293 (16%)

Query: 67  RELGDGGFGTVYYGEL--QDGRA----VAVKRLYENNYKRVEQ-FMNEVDILARLRHKNL 119
           R LG G FG VY G    +DG A    VAVK L E+  ++ E  F+ E  I+++  H+N+
Sbjct: 12  RALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNI 71

Query: 120 VSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR----LKIAIETASA 174
           V L G    R  R +LL  E ++ G +   L   R +P   P        L  A + A  
Sbjct: 72  VRLIGVSFERLPRFILL--ELMAGGDLKSFLRENRPRPER-PSSLTMKDLLFCARDVAKG 128

Query: 175 LTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--- 228
             YL  +  IHRD+   N LL         K+ADFG++R     +   S   +G      
Sbjct: 129 CKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLP 184

Query: 229 --YVDPEYHQCYQLTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQN 284
             ++ PE       T K+DV+SFGV+L E+ S   MP    T                 N
Sbjct: 185 IKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT-----------------N 227

Query: 285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD 337
           + + E V  T G   D   +     V  +   C Q   + RP    +L+ ++ 
Sbjct: 228 QEVMEFV--TGGGRLD-PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY 277

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 87.4 bits (217), Expect = 2e-19
 Identities = 62/206 (30%), Positives = 105/206 (50%), Gaps = 28/206 (13%)

Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYEN----NYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G+G +G V+    ++ G+ VA+K+  E+      K++   + E+ +L +L+H NLV+L 
Sbjct: 9   IGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIA--LREIRMLKQLKHPNLVNLI 66

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
               R  R+L LV+E+  + TV   L+     P  +P     KI  +T  A+ + H  + 
Sbjct: 67  E-VFRRKRKLHLVFEYCDH-TV---LNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNC 121

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLF----PNHVTHVST----APQGTPGYVDPEYH 235
           IHRDVK  NIL+     +K+ DFG +R+      ++  +V+T    AP+   G  D +Y 
Sbjct: 122 IHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVG--DTQYG 179

Query: 236 QCYQLTDKSDVFSFGVVLIELISSMP 261
                    DV++ G V  EL++  P
Sbjct: 180 P------PVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 87.0 bits (215), Expect = 2e-19
 Identities = 67/218 (30%), Positives = 106/218 (48%), Gaps = 16/218 (7%)

Query: 56  LEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARL 114
           L +    F+    +G+G +G VY G  ++ G+  A+K + +      E+   E+++L + 
Sbjct: 11  LRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTEDEEEEIKLEINMLKKY 69

Query: 115 -RHKNLVSLYGCTSR-----HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
             H+N+ + YG   +     H  +L LV EF   G+V D +  +  K  AL       I 
Sbjct: 70  SHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLV--KNTKGNALKEDWIAYIC 127

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            E    L +LHA  +IHRD+K  N+LL  N  VK+ DFG+S      V   +T   GTP 
Sbjct: 128 REILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 186

Query: 229 YVDPEYHQCYQLTD-----KSDVFSFGVVLIELISSMP 261
           ++ PE   C +  D     +SD++S G+  IE+    P
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 86.7 bits (215), Expect = 2e-19
 Identities = 55/197 (27%), Positives = 94/197 (47%), Gaps = 10/197 (5%)

Query: 67  RELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLVS 121
           R +G+G FG VY G          AVAVK         V E+F+ E  I+ +  H ++V 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  +     + +V E    G +  +L   +     L   + +  + + ++AL YL + 
Sbjct: 72  LIGVIT--ENPVWIVMELAPLGELRSYLQVNKYS---LDLASLILYSYQLSTALAYLESK 126

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
             +HRD+   N+L+ +  CVK+ DFGLSR   +   + ++  +    ++ PE     + T
Sbjct: 127 RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFT 186

Query: 242 DKSDVFSFGVVLIELIS 258
             SDV+ FGV + E++ 
Sbjct: 187 SASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 86.6 bits (214), Expect = 2e-19
 Identities = 60/193 (31%), Positives = 92/193 (47%), Gaps = 6/193 (3%)

Query: 67  RELGDGGFGTV-YYGELQDGRAVAVKRLYENNYKRVEQFM--NEVDILARLRHKNLVSLY 123
           R +G G +G V       DG+   +K+L   N  R E+     E  +L++L+H N+V+  
Sbjct: 6   RVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYR 65

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
                    L +V  F   G +   L  ++ K   LP    ++  ++ A AL YLH   I
Sbjct: 66  ESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGK--LLPENQVVEWFVQIAMALQYLHEKHI 123

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           +HRD+KT N+ L     +KV D G++R+  N     ST   GTP Y+ PE         K
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLI-GTPYYMSPELFSNKPYNYK 182

Query: 244 SDVFSFGVVLIEL 256
           SDV++ G  + E+
Sbjct: 183 SDVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 87.0 bits (216), Expect = 2e-19
 Identities = 52/200 (26%), Positives = 93/200 (46%), Gaps = 15/200 (7%)

Query: 69  LGDGGFGTVYY-GELQDGRAVAVKRLYENNYKRVE-----QFMNEVDILARLRHKNLVSL 122
           +G+G  G V+   + + G  VA+K++     +R+E     Q + E+  L   +H  +V L
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKV---ALRRLEGGIPNQALREIKALQACQHPYVVKL 64

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
                 H    +LV E++    +++ L  E      LP              + Y+HA+ 
Sbjct: 65  LD-VFPHGSGFVLVMEYMP-SDLSEVLRDEER---PLPEAQVKSYMRMLLKGVAYMHANG 119

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YHQCYQLT 241
           I+HRD+K  N+L+  +  +K+ADFGL+RLF      + +    T  Y  PE  +   +  
Sbjct: 120 IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYD 179

Query: 242 DKSDVFSFGVVLIELISSMP 261
              D+++ G +  EL++  P
Sbjct: 180 PGVDLWAVGCIFAELLNGSP 199

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 66/203 (32%), Positives = 92/203 (45%), Gaps = 13/203 (6%)

Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+    LG G FG V   + +  G   A+K L +      K+V+    E  IL  L H  
Sbjct: 20  FEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPF 79

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +V++  C+ +    +  + EF+  G +  HL     K G  P         E   A  YL
Sbjct: 80  IVNMM-CSFQDENRVYFLLEFVVGGELFTHLR----KAGRFPNDVAKFYHAELVLAFEYL 134

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+ DII+RD+K  N+LLDN   VKV DFG    F   V   +    GTP Y+ PE  Q  
Sbjct: 135 HSKDIIYRDLKPENLLLDNKGHVKVTDFG----FAKKVPDRTFTLCGTPEYLAPEVIQSK 190

Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
                 D ++ GV+L E I+  P
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYP 213

Length = 329

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 86.4 bits (214), Expect = 3e-19
 Identities = 71/278 (25%), Positives = 126/278 (45%), Gaps = 44/278 (15%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           LG G +G VY   +L     +A+K + E + + V+    E+ + + L+H+N+V   G  S
Sbjct: 16  LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75

Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPW--PTRLKIAIETASALTYLHASDIIH 185
            +     +  E +  G+++  L   R+K G L     T +    +    L YLH + I+H
Sbjct: 76  ENGF-FKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVH 131

Query: 186 RDVKTNNILLDN-NFCVKVADFGLSRLFP--NHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           RD+K +N+L++  +  VK++DFG S+     N  T   T   GT  Y+ PE      + D
Sbjct: 132 RDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFT---GTLQYMAPE------VID 182

Query: 243 K--------SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT 294
           K        +D++S G  ++E+ +  P         E+     A+ K+    +H  + ++
Sbjct: 183 KGPRGYGAPADIWSLGCTIVEMATGKPPF------IELGEPQAAMFKVGMFKIHPEIPES 236

Query: 295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
           L  E+ N + R           C + + D R    D+L
Sbjct: 237 LSAEAKNFILR-----------CFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 86.3 bits (213), Expect = 3e-19
 Identities = 64/218 (29%), Positives = 104/218 (47%), Gaps = 16/218 (7%)

Query: 56  LEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARL 114
           L +    F+    +G+G +G VY G  ++ G+  A+K + +      E+   E+++L + 
Sbjct: 1   LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKY 59

Query: 115 -RHKNLVSLYGCTSRHS-----RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
             H+N+ + YG   + +      +L LV EF   G+V D +   +       W     I 
Sbjct: 60  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--IC 117

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            E    L++LH   +IHRD+K  N+LL  N  VK+ DFG+S      V   +T   GTP 
Sbjct: 118 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFI-GTPY 176

Query: 229 YVDPEYHQCYQLTD-----KSDVFSFGVVLIELISSMP 261
           ++ PE   C +  D     KSD++S G+  IE+    P
Sbjct: 177 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 87.0 bits (216), Expect = 3e-19
 Identities = 62/218 (28%), Positives = 101/218 (46%), Gaps = 33/218 (15%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF----MNEVDILARLRHKNLVSL- 122
           LG+G FG VY   +++ GR VA+K++  +N K  + F    + E+ IL +L+H N+V L 
Sbjct: 16  LGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILKKLKHPNVVPLI 73

Query: 123 ---YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK-IAIETASALTYL 178
                   +  R+   VY  ++     D L G    P      +++K   ++    + YL
Sbjct: 74  DMAVERPDKSKRKRGSVY-MVTPYMDHD-LSGLLENPSVKLTESQIKCYMLQLLEGINYL 131

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC- 237
           H + I+HRD+K  NIL+DN   +K+ADFGL+R +          P+G  G    +Y    
Sbjct: 132 HENHILHRDIKAANILIDNQGILKIADFGLARPY----DGPPPNPKGGGGGGTRKYTNLV 187

Query: 238 ----Y----------QLTDKSDVFSFGVVLIELISSMP 261
               Y          + T   D++  G V  E+ +  P
Sbjct: 188 VTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRP 225

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 85.6 bits (212), Expect = 4e-19
 Identities = 73/277 (26%), Positives = 122/277 (44%), Gaps = 35/277 (12%)

Query: 69  LGDGGFGTVYYGELQDGRA--VAVKRLYENNY----------KRVEQFMNEVDIL-ARLR 115
           LG G FG VY    ++     +A+K +  +N           K +   ++EV I+  +LR
Sbjct: 8   LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67

Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           H N+V  Y     + R L +V + I    + +H +  + K           I ++   AL
Sbjct: 68  HPNIVRYYKTFLENDR-LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLAL 126

Query: 176 TYLHASD-IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
            YLH    I+HRD+  NNI+L  +  V + DFGL++         S    GT  Y  PE 
Sbjct: 127 RYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVV--GTILYSCPEI 184

Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT 294
            +     +K+DV++FG +L ++ +  P        +  N+ +LA  KI   A++E + + 
Sbjct: 185 VKNEPYGEKADVWAFGCILYQMCTLQPPF------YSTNMLSLAT-KIVE-AVYEPLPEG 236

Query: 295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDV 331
           +  E    V   I         CL  + + RP ++ V
Sbjct: 237 MYSE---DVTDVIT-------SCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 85.7 bits (212), Expect = 5e-19
 Identities = 70/235 (29%), Positives = 117/235 (49%), Gaps = 21/235 (8%)

Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQF---MNEVDILARLRHKNLVSLYG 124
           LG GGFG V   +++  G+  A K+L +   K+ + +   M E  ILA++  + +VSL  
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHG-ERAKPGALPWPTRLKIAIETASALTYLHASDI 183
              +   +L LV   ++ G +  H++  +   PG  P P       +  S L +LH   I
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPG-FPEPRACFYTAQIISGLEHLHQRRI 118

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           I+RD+K  N+LLDN+  V+++D GL+    +  +  +    GTPG++ PE  Q  +    
Sbjct: 119 IYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYAGTPGFMAPELLQGEEYDFS 177

Query: 244 SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL-HELVDQTLGY 297
            D F+ GV L E+I+   A    R R E         K++NK L   +++ ++ Y
Sbjct: 178 VDYFALGVTLYEMIA---ARGPFRARGE---------KVENKELKQRILNDSVTY 220

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 85.1 bits (210), Expect = 6e-19
 Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 13/202 (6%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYEN-----NYKRVEQFMNEVDILARLRHKNLVSL 122
           LG G FG VY   +   GR +AVK++  +       K V     E+ +L  L H+ +V  
Sbjct: 10  LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69

Query: 123 YGC-TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           YGC      R L +  E +  G++ D L       GAL      K   +    ++YLH++
Sbjct: 70  YGCLRDPMERTLSIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSN 125

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS--TAPQGTPGYVDPEYHQCYQ 239
            I+HRD+K  NIL D+   VK+ DFG S+         +   +  GTP ++ PE      
Sbjct: 126 MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEG 185

Query: 240 LTDKSDVFSFGVVLIELISSMP 261
              K+D++S G  ++E+++  P
Sbjct: 186 YGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 85.9 bits (212), Expect = 7e-19
 Identities = 70/210 (33%), Positives = 104/210 (49%), Gaps = 25/210 (11%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF---MNEVDILARLRHKN 118
           F   RE+G G FG VY+  ++++   VA+K++  +  +  E++   + EV  L +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 119 LVSLYGCTSR-HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL-- 175
            +   GC  R H+  L++ Y     G+ +D L   + KP        ++IA  T  AL  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL---GSASDLLEVHK-KP-----LQEVEIAAVTHGALQG 127

Query: 176 -TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
             YLH+ ++IHRDVK  NILL     VK+ DFG + +       V     GTP ++ PE 
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182

Query: 235 HQCY---QLTDKSDVFSFGVVLIELISSMP 261
                  Q   K DV+S G+  IEL    P
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 88.4 bits (219), Expect = 7e-19
 Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 16/193 (8%)

Query: 83  QDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF 139
             G  VA+K L  +      +  +F  E  + ARL H N+V+L          L  V+E+
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEY 60

Query: 140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL---D 196
           +   T+ + L    A  GALP     ++ ++   AL   H   I+HRD+K  NI++    
Sbjct: 61  VPGRTLREVL----AADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTG 116

Query: 197 NNFCVKVADFGLSRLFPN-HVTHVSTAPQ-----GTPGYVDPEYHQCYQLTDKSDVFSFG 250
                KV DFG+  L P      V+T  +     GTP Y  PE  +   +T  SD++++G
Sbjct: 117 VRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWG 176

Query: 251 VVLIELISSMPAV 263
           ++ +E ++    V
Sbjct: 177 LIFLECLTGQRVV 189

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 85.3 bits (211), Expect = 8e-19
 Identities = 63/212 (29%), Positives = 100/212 (47%), Gaps = 26/212 (12%)

Query: 67  RELGDGGFGTVYYGEL-QDGRA---VAVKRLYENN--YKRVEQFMNEVDILARLRHKNLV 120
           + LG+G FG+V  G+L QD  +   VAVK +  +   Y  +E+F++E   +    H N++
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVM 64

Query: 121 SLYG-CTSRHSREL----LLVYEFISNGTVADHLHGER--AKPGALPWPTRLKIAIETAS 173
            L G C    S +     +++  F+ +G +   L   R    P  LP  T LK  ++ A 
Sbjct: 65  KLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIAL 124

Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN----HVTHVSTAP---QGT 226
            + YL   + IHRD+   N +L  +  V VADFGLS+   +        ++  P      
Sbjct: 125 GMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAI 184

Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
               D  Y      T KSDV++FGV + E+ +
Sbjct: 185 ESLADRVY------TSKSDVWAFGVTMWEIAT 210

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 84.8 bits (210), Expect = 1e-18
 Identities = 73/274 (26%), Positives = 122/274 (44%), Gaps = 22/274 (8%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
             LG+G  G+V    L++   +   +    + N    +Q + E++I    +   +V  YG
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 125 -CTSRHSRELLLVYEFISNGTVADHLHGE-RAKPGALPWPTRLKIAIETASALTYLHASD 182
                 S  + +  E+   G++ D ++ + + + G +      KIA      L+YLH+  
Sbjct: 67  AFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK 125

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           IIHRD+K +NILL     VK+ DFG+S    N +    T   GT  Y+ PE  Q    + 
Sbjct: 126 IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT---GTSFYMAPERIQGKPYSI 182

Query: 243 KSDVFSFGVVLIELISS---MPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            SDV+S G+ L+E+  +    P  +       I L    ++ I N    EL D     E 
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPP-EGEPPLGPIEL----LSYIVNMPNPELKD-----EP 232

Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD 333
            N ++ +     +   QCL+ +   RP   D+L+
Sbjct: 233 GNGIKWS-EEFKDFIKQCLEKDPTRRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 25/216 (11%)

Query: 57  EEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF---MNEVDILA 112
           E+    F   RE+G G FG VY+  +++    VA+K++  +  +  E++   + EV  L 
Sbjct: 21  EDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ 80

Query: 113 RLRHKNLVSLYGCTSR-HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
           R++H N +   GC  R H+  L++ Y     G+ +D L   + KP        ++IA  T
Sbjct: 81  RIKHPNSIEYKGCYLREHTAWLVMEYCL---GSASDLLEVHK-KP-----LQEVEIAAIT 131

Query: 172 ASAL---TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
             AL    YLH+ ++IHRD+K  NILL     VK+ADFG + +     + V     GTP 
Sbjct: 132 HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSFV-----GTPY 186

Query: 229 YVDPEYHQCY---QLTDKSDVFSFGVVLIELISSMP 261
           ++ PE        Q   K DV+S G+  IEL    P
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 63/204 (30%), Positives = 102/204 (50%), Gaps = 18/204 (8%)

Query: 67  RELGDGGFGTVY----YGELQDGRA--VAVKRLYENNYK-RVEQFMNEVDILARL-RHKN 118
           + LG G FG V     YG  +      VAVK L    +    E  M+E+ I++ L  H+N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 119 LVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           +V+L G CT      +L++ E+   G + + L   R +   L     L  + + A  + +
Sbjct: 101 IVNLLGACT--IGGPILVITEYCCYGDLLNFLR--RKRESFLTLEDLLSFSYQVAKGMAF 156

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPE--Y 234
           L + + IHRD+   N+LL +   VK+ DFGL+R   N   +V       P  ++ PE  +
Sbjct: 157 LASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIF 216

Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
           +  Y  T +SDV+S+G++L E+ S
Sbjct: 217 NCVY--TFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 85.2 bits (211), Expect = 1e-18
 Identities = 70/201 (34%), Positives = 105/201 (52%), Gaps = 17/201 (8%)

Query: 69  LGDGGFGTVYYGE-LQDGRAVAVKRLYEN---NYKRVEQFMNEVDILAR-LRHKNLVSLY 123
           +G G FG V   +   DG+  AVK L +      K  +  M E ++L + ++H  LV L+
Sbjct: 3   IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
             + + + +L  V ++++ G +  HL  ER+     P P     A E ASAL YLH+ +I
Sbjct: 63  -YSFQTADKLYFVLDYVNGGELFFHLQRERS----FPEPRARFYAAEIASALGYLHSLNI 117

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE--YHQCYQLT 241
           I+RD+K  NILLD+   V + DFGL +    H    ST   GTP Y+ PE    Q Y   
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFC-GTPEYLAPEVLRKQPY--- 173

Query: 242 DKS-DVFSFGVVLIELISSMP 261
           D++ D +  G VL E++  +P
Sbjct: 174 DRTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 85.4 bits (211), Expect = 1e-18
 Identities = 68/209 (32%), Positives = 107/209 (51%), Gaps = 12/209 (5%)

Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILAR-LRHKNLVSLY 123
           +G G FG V   + + DG+  AVK L +    N K  +  M E ++L + ++H  LV L+
Sbjct: 3   IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
             + + + +L  V +F++ G +  HL  ER+     P P     A E ASAL YLH+ +I
Sbjct: 63  -YSFQTTEKLYFVLDFVNGGELFFHLQRERS----FPEPRARFYAAEIASALGYLHSINI 117

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           ++RD+K  NILLD+   V + DFGL +      +  +T   GTP Y+ PE  +     + 
Sbjct: 118 VYRDLKPENILLDSQGHVVLTDFGLCKEGIA-QSDTTTTFCGTPEYLAPEVIRKQPYDNT 176

Query: 244 SDVFSFGVVLIELISSMPAVDITRHRHEI 272
            D +  G VL E++  +P     R   E+
Sbjct: 177 VDWWCLGAVLYEMLYGLPPF-YCRDVAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 84.6 bits (210), Expect = 1e-18
 Identities = 48/159 (30%), Positives = 84/159 (52%), Gaps = 13/159 (8%)

Query: 68  ELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFM-NEVDILARLR---HKNLVS 121
           E+G+G +GTVY   +L  GR VA+K++    + + +      E+ +L +L    H N+V 
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVR 65

Query: 122 LY----GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           L     G  +    +L LV+E +    +A +L   +     LP  T   +  +    + +
Sbjct: 66  LLDVCHGPRTDRELKLTLVFEHVDQ-DLATYL--SKCPKPGLPPETIKDLMRQLLRGVDF 122

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV 216
           LH+  I+HRD+K  NIL+ ++  VK+ADFGL+R++   +
Sbjct: 123 LHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM 161

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 60/226 (26%), Positives = 106/226 (46%), Gaps = 28/226 (12%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQ--------FMNEVDILAR 113
           F+    +G+G +G VY   +   G  VA+K++      R++          + E+ +L  
Sbjct: 9   FEKLNRIGEGTYGIVYRARDTTSGEIVALKKV------RMDNERDGIPISSLREITLLLN 62

Query: 114 LRHKNLVSLYG-CTSRHSRELLLVYEFISN--GTVADHLHGERAKPGALPWPTRLKIAIE 170
           LRH N+V L      +H   + LV E+      ++ D++      P          + ++
Sbjct: 63  LRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLDNM------PTPFSESQVKCLMLQ 116

Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-GTPGY 229
               L YLH + IIHRD+K +N+LL +  C+K+ADFGL+R +      ++  P+  T  Y
Sbjct: 117 LLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMT--PKVVTLWY 174

Query: 230 VDPE-YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL 274
             PE    C   T   D+++ G +L EL++  P +       +++L
Sbjct: 175 RAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL 220

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 84.5 bits (209), Expect = 1e-18
 Identities = 59/200 (29%), Positives = 97/200 (48%), Gaps = 21/200 (10%)

Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQ------FMNEVDILARLRHKNLVS 121
           LG GGFG V   +++  G+  A K+L   + KR+++       +NE  IL ++  + +VS
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKL---DKKRLKKRKGEQMALNEKKILEKVSSRFIVS 57

Query: 122 L-YGCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
           L Y   ++   +L LV   ++ G +  H+   GE       P    +  A +    L +L
Sbjct: 58  LAYAFETK--DDLCLVMTLMNGGDLKYHIYNVGEPG----FPEARAIFYAAQIICGLEHL 111

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H   I++RD+K  N+LLD++  V+++D GL+               GTPGY+ PE  Q  
Sbjct: 112 HQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK--IKGRAGTPGYMAPEVLQGE 169

Query: 239 QLTDKSDVFSFGVVLIELIS 258
                 D F+ G  L E+I+
Sbjct: 170 VYDFSVDWFALGCTLYEMIA 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 84.8 bits (210), Expect = 2e-18
 Identities = 66/204 (32%), Positives = 100/204 (49%), Gaps = 17/204 (8%)

Query: 69  LGDGGFGTVYYGELQDGRAV-AVKRLYEN---NYKRVEQFMNEVDILARL-RHKNLVSLY 123
           LG G FG V   E +    + A+K L ++       VE  M E  +LA   +   L  L+
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLH 67

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
            C     R L  V E+++ G +  H+     + G    P  +  A E A  L +LH+  I
Sbjct: 68  SCFQTMDR-LYFVMEYVNGGDLMYHIQ----QVGKFKEPHAVFYAAEIAIGLFFLHSKGI 122

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           I+RD+K +N++LD    +K+ADFG+ +  +F    T       GTP Y+ PE    YQ  
Sbjct: 123 IYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFC---GTPDYIAPEI-IAYQPY 178

Query: 242 DKS-DVFSFGVVLIELISSMPAVD 264
            KS D ++FGV+L E+++  P  D
Sbjct: 179 GKSVDWWAFGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 83.9 bits (207), Expect = 2e-18
 Identities = 59/208 (28%), Positives = 101/208 (48%), Gaps = 11/208 (5%)

Query: 68  ELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYG- 124
            +G G FG V+ G L+ D   VAVK   E     ++ +F+ E  IL +  H N+V L G 
Sbjct: 2   RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
           CT +    + +V E +  G     L  E  +   L     +++    A+ + YL +   I
Sbjct: 62  CTQKQP--IYIVMELVQGGDFLTFLRTEGPR---LKVKELIQMVENAAAGMEYLESKHCI 116

Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDK 243
           HRD+   N L+     +K++DFG+SR   + V   +   +  P  +  PE     + + +
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSE 176

Query: 244 SDVFSFGVVLIELIS--SMPAVDITRHR 269
           SDV+SFG++L E  S  ++P  +++  +
Sbjct: 177 SDVWSFGILLWEAFSLGAVPYANLSNQQ 204

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 83.5 bits (206), Expect = 2e-18
 Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 14/196 (7%)

Query: 67  RELGDGGFGT--VYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           R +G+G FG   +      D +    +     +   VE    E  +LA+++H N+V+   
Sbjct: 6   RVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAF-- 63

Query: 125 CTSRHSRE----LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
              + S E    L +V E+   G +   +  +R K    P  T L+  ++    + ++H 
Sbjct: 64  ---KESFEADGHLYIVMEYCDGGDLMQKIKLQRGK--LFPEDTILQWFVQMCLGVQHIHE 118

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
             ++HRD+K+ NI L  N  VK+ DFG +RL  +   +  T   GTP YV PE  +    
Sbjct: 119 KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY-VGTPYYVPPEIWENMPY 177

Query: 241 TDKSDVFSFGVVLIEL 256
            +KSD++S G +L EL
Sbjct: 178 NNKSDIWSLGCILYEL 193

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 83.9 bits (207), Expect = 3e-18
 Identities = 60/216 (27%), Positives = 103/216 (47%), Gaps = 26/216 (12%)

Query: 68  ELGDGGFGTVYYGEL-------------QDGRA--VAVKRLYENNYKRVEQ-FMNEVDIL 111
           +LG+G FG V+  E               DG+   VAVK L  +  K     F+ E+ I+
Sbjct: 12  KLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIM 71

Query: 112 ARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHL-----HGERAKPGALPWPTR-- 164
           +RL++ N++ L G        L ++ E++ NG +   L              +P  +   
Sbjct: 72  SRLKNPNIIRLLGVCVS-DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIAN 130

Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTA 222
            L +A++ AS + YL + + +HRD+ T N L+ N++ +K+ADFG+SR L+      +   
Sbjct: 131 LLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190

Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
                 ++  E     + T  SDV++FGV L E+ +
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 83.6 bits (207), Expect = 3e-18
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 30/206 (14%)

Query: 68  ELGDGGFGTVY-YGELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRH-KNLVSLYG 124
           E+G G FGTV        G  +AVKR+    + K  ++ + ++D++ R      +V  YG
Sbjct: 11  EIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYG 70

Query: 125 ----------CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
                     C       L   Y+++       +   +      +P     KIA+ T  A
Sbjct: 71  ALFREGDCWICMELMDISLDKFYKYV-------YEVLKSV----IPEEILGKIAVATVKA 119

Query: 175 LTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA---PQGTPGYV 230
           L YL     IIHRDVK +NILLD N  +K+ DFG+S    + +     A   P   P  +
Sbjct: 120 LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERI 179

Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIEL 256
           DP     Y +  +SDV+S G+ L E+
Sbjct: 180 DPSARDGYDV--RSDVWSLGITLYEV 203

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 84.2 bits (208), Expect = 3e-18
 Identities = 69/199 (34%), Positives = 93/199 (46%), Gaps = 15/199 (7%)

Query: 67  RELGDGGFGTVYYGEL-QDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLR-HKNLVS 121
           R LG G FG V    L + GR  AVK L ++       VE  M E  IL+  R H  L  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           LY C     R L  V EF++ G +  H+   R              A E  SAL +LH  
Sbjct: 61  LYCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRR----FDEARARFYAAEITSALMFLHDK 115

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
            II+RD+K +N+LLD+    K+ADFG+ +  +F    T       GTP Y+ PE  Q   
Sbjct: 116 GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFC---GTPDYIAPEILQEML 172

Query: 240 LTDKSDVFSFGVVLIELIS 258
                D ++ GV+L E++ 
Sbjct: 173 YGPSVDWWAMGVLLYEMLC 191

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 83.3 bits (206), Expect = 3e-18
 Identities = 63/195 (32%), Positives = 97/195 (49%), Gaps = 15/195 (7%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLVSLYG 124
            +LG G  G+V   + +  G  +A K ++      V +Q + E+ I+   R   +VS YG
Sbjct: 11  SDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYG 70

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH-ASDI 183
               +   + +  EF+  G     L     K G +P     KIA+     LTYL+    I
Sbjct: 71  -AFLNENNICMCMEFMDCG----SLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRI 125

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV--THVSTAPQGTPGYVDPEYHQCYQLT 241
           +HRD+K +NIL+++   +K+ DFG+S    N +  T V     GT  Y+ PE  Q  + T
Sbjct: 126 MHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFV-----GTSTYMSPERIQGGKYT 180

Query: 242 DKSDVFSFGVVLIEL 256
            KSDV+S G+ +IEL
Sbjct: 181 VKSDVWSLGISIIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 83.5 bits (206), Expect = 3e-18
 Identities = 60/211 (28%), Positives = 104/211 (49%), Gaps = 21/211 (9%)

Query: 68  ELGDGGFGTVYYGEL-----QDGRAVAVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVS 121
           ELG+  FG +Y G L        + VA+K L + NN ++  +F  E  ++A L H N+V 
Sbjct: 12  ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHL-----HGERA--------KPGALPWPTRLKIA 168
           L G  ++  + + +++E+++ G + + L     H +             +L     L IA
Sbjct: 72  LLGVVTQE-QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIA 130

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTP 227
           I+ A+ + YL +   +H+D+   NIL+     VK++D GLSR ++      V        
Sbjct: 131 IQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPI 190

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
            ++ PE     + +  SD++SFGVVL E+ S
Sbjct: 191 RWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 83.0 bits (205), Expect = 3e-18
 Identities = 59/221 (26%), Positives = 111/221 (50%), Gaps = 15/221 (6%)

Query: 67  RELGDGGFG-TVYYGELQDGRAVAVKRL--YENNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +++G+G FG  +     +DG+   +K +   + + K  E+   EV +L+ ++H N+V  Y
Sbjct: 6   KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQ-Y 64

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
             +   +  L +V ++   G +   ++ +R      P    L   ++   AL ++H   I
Sbjct: 65  QESFEENGNLYIVMDYCEGGDLYKKINAQRGVL--FPEDQILDWFVQICLALKHVHDRKI 122

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           +HRD+K+ NI L  +  +K+ DFG++R+  + V    T   GTP Y+ PE  +     +K
Sbjct: 123 LHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCI-GTPYYLSPEICENRPYNNK 181

Query: 244 SDVFSFGVVLIELISSMPAVDITRHRHEI-NLSNLAINKIQ 283
           SD+++ G VL E+ +        +H  E  N+ NL +  I+
Sbjct: 182 SDIWALGCVLYEMCT-------LKHAFEAGNMKNLVLKIIR 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 83.6 bits (206), Expect = 4e-18
 Identities = 60/213 (28%), Positives = 109/213 (51%), Gaps = 11/213 (5%)

Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
           + S G+ ++    F+   ++G G  GTVY   ++  G+ VA+K++      + E  +NE+
Sbjct: 11  IVSVGDPKKKYTRFE---KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEI 67

Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
            ++   ++ N+V+ Y  +     EL +V E+++ G++ D +       G +    R    
Sbjct: 68  LVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 122

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            E   AL +LH++ +IHRD+K++NILL  +  VK+ DFG         +  ST   GTP 
Sbjct: 123 -ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY 180

Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           ++ PE         K D++S G++ IE++   P
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 83.1 bits (205), Expect = 4e-18
 Identities = 61/201 (30%), Positives = 101/201 (50%), Gaps = 12/201 (5%)

Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLY-ENNYKRVEQFMNEVDILARLRHKNLV 120
           R+LG+G FG V    Y    D  G  VAVK L  E+    +     E++IL  L H+N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
              G CT      + L+ EF+ +G++ ++L   + K   +    +LK A++    + YL 
Sbjct: 70  KYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNK---INLKQQLKYAVQICKGMDYLG 126

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-GTPGY-VDPEYHQC 237
           +   +HRD+   N+L+++   VK+ DFGL++       + +      +P +   PE    
Sbjct: 127 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQ 186

Query: 238 YQLTDKSDVFSFGVVLIELIS 258
            +    SDV+SFGV L EL++
Sbjct: 187 SKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 82.8 bits (204), Expect = 4e-18
 Identities = 58/198 (29%), Positives = 98/198 (49%), Gaps = 6/198 (3%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKN 118
           F   +++G G F  VY    L DG  VA+K++      + K     + E+D+L +L H N
Sbjct: 4   FRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 63

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++  Y  +     EL +V E    G ++  +   + +   +P  T  K  ++  SAL ++
Sbjct: 64  VIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  ++HRD+K  N+ +     VK+ D GL R F +  T  + +  GTP Y+ PE     
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHEN 181

Query: 239 QLTDKSDVFSFGVVLIEL 256
               KSD++S G +L E+
Sbjct: 182 GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 83.2 bits (206), Expect = 4e-18
 Identities = 72/225 (32%), Positives = 107/225 (47%), Gaps = 41/225 (18%)

Query: 67  RELGDGGFGTVYYGE---LQD--------------GRAVAVKRLYENNYKRV-EQFMNEV 108
            +LG+G FG V+  E   LQD                 VAVK L  +      E F+ EV
Sbjct: 11  EKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV 70

Query: 109 DILARLRHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------ALP 160
            IL+RL   N+  L G CT      L ++ E++ NG +   L    A+         +L 
Sbjct: 71  KILSRLSDPNIARLLGVCT--VDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128

Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHV 219
           + T L +A + AS + YL + + +HRD+ T N L+  N+ +K+ADFG+SR L+ +    V
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 220 STAPQGTPGYVDP------EYHQCYQLTDKSDVFSFGVVLIELIS 258
               QG      P      E     + T KSDV++FGV L E+++
Sbjct: 189 ----QGRA--PLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 82.7 bits (204), Expect = 6e-18
 Identities = 75/295 (25%), Positives = 122/295 (41%), Gaps = 42/295 (14%)

Query: 63  FDSARELGDGGFGTVYYGELQ----DGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRH 116
           F   R LG G FG+V   +L+      + VAVK L     +   +E+F+ E   +    H
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDH 60

Query: 117 KNLVSLYGCTSRHSREL------LLVYEFISNGTVADHLHGER--AKPGALPWPTRLKIA 168
            N++ L G  S  SR        +++  F+ +G +   L   R   +P  LP  T ++  
Sbjct: 61  PNVIKLIG-VSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
           I+ AS + YL + + IHRD+   N +L+ N  V VADFGLS+     +       QG   
Sbjct: 120 IDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK----KIYSGDYYRQGCAS 175

Query: 229 YVDPEYHQCYQLTD-----KSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ 283
            +  ++     L D      SDV++FGV + E+++                       ++
Sbjct: 176 KLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMT---------------RGQTPYAGVE 220

Query: 284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
           N  ++  +   +      +    +  V EL  QC   E   RP    + D L  I
Sbjct: 221 NSEIYNYL---IKGNRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 82.8 bits (205), Expect = 7e-18
 Identities = 60/217 (27%), Positives = 107/217 (49%), Gaps = 34/217 (15%)

Query: 69  LGDGGFGTVYYGEL-----QDGR-AVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLV 120
           LG+G FG V   E       +    VAVK L ++   K +   ++E++++  + +HKN++
Sbjct: 20  LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA----LPWPTRLKI--------A 168
           +L G  ++    L +V E+ ++G + D L   R          P P    +        A
Sbjct: 80  NLLGVCTQEG-PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            + A  + +L +   IHRD+   N+L+  +  +K+ADFGL+R     + H+    + T G
Sbjct: 139 YQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLAR----DIHHIDYYRKTTNG 194

Query: 229 -----YVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
                ++ PE  + + Y  T +SDV+SFGV+L E+ +
Sbjct: 195 RLPVKWMAPEALFDRVY--THQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 83.3 bits (206), Expect = 9e-18
 Identities = 70/240 (29%), Positives = 106/240 (44%), Gaps = 36/240 (15%)

Query: 28  NTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGR 86
            +SS  SS      G      +  S  ELE           +G G  GTVY       GR
Sbjct: 50  PSSSSSSSSSSSASGSAPSAAKSLS--ELERV-------NRIGSGAGGTVYKVIHRPTGR 100

Query: 87  AVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTV 145
             A+K +Y N+   V  Q   E++IL  + H N+V  +     H+ E+ ++ EF+  G+ 
Sbjct: 101 LYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHD-MFDHNGEIQVLLEFMDGGS- 158

Query: 146 ADHLHGER-AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVA 204
              L G   A    L       +A +  S + YLH   I+HRD+K +N+L+++   VK+A
Sbjct: 159 ---LEGTHIADEQFLA-----DVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIA 210

Query: 205 DFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD---------KSDVFSFGVVLIE 255
           DFG+SR+          +  GT  Y+ PE       TD           D++S GV ++E
Sbjct: 211 DFGVSRIL-AQTMDPCNSSVGTIAYMSPERIN----TDLNHGAYDGYAGDIWSLGVSILE 265

Length = 353

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 72/218 (33%), Positives = 101/218 (46%), Gaps = 15/218 (6%)

Query: 56  LEEATNYFDSARELGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRV-EQFMNEVDILAR 113
           L + T+ ++    +G G +G VY     +DG   AVK L  +    V E+   E +IL  
Sbjct: 17  LGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKIL--DPISDVDEEIEAEYNILQS 74

Query: 114 L-RHKNLVSLYGCTSRHSR----ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
           L  H N+V  YG   +  +    +L LV E  + G+V + + G       L       I 
Sbjct: 75  LPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYIL 134

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
                 L +LH + IIHRDVK NNILL     VK+ DFG+S    +     +T+  GTP 
Sbjct: 135 YGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS-VGTPF 193

Query: 229 YVDPEYHQCYQLTDKS-----DVFSFGVVLIELISSMP 261
           ++ PE   C Q  D S     DV+S G+  IEL    P
Sbjct: 194 WMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 82.1 bits (202), Expect = 1e-17
 Identities = 59/214 (27%), Positives = 111/214 (51%), Gaps = 13/214 (6%)

Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
           + S G+ ++    F+   ++G G  GTVY   ++  G+ VA++++      + E  +NE+
Sbjct: 12  IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68

Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
            ++   ++ N+V+ Y  +     EL +V E+++ G++ D +       G +    R    
Sbjct: 69  LVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 123

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTP 227
            E   AL +LH++ +IHRD+K++NILL  +  VK+ DFG  +++ P      +    GTP
Sbjct: 124 -ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV--GTP 180

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
            ++ PE         K D++S G++ IE+I   P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 64/203 (31%), Positives = 93/203 (45%), Gaps = 28/203 (13%)

Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYENNY---KRVEQFMNEVDIL---ARLRHKNLVS 121
           LG G FG V   E +  G   A+K L + +      VE  M E  I       RH  LV+
Sbjct: 7   LGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVN 66

Query: 122 LYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           L+ C  T  H   +  V E+ + G +  H+H +         P  +  A      L YLH
Sbjct: 67  LFACFQTEDH---VCFVMEYAAGGDLMMHIHTDV-----FSEPRAVFYAACVVLGLQYLH 118

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
            + I++RD+K +N+LLD    VK+ADFGL +         ST   GTP ++ PE      
Sbjct: 119 ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFC-GTPEFLAPEV----- 172

Query: 240 LTDKS-----DVFSFGVVLIELI 257
           LT+ S     D +  GV++ E++
Sbjct: 173 LTETSYTRAVDWWGLGVLIYEML 195

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 81.9 bits (202), Expect = 1e-17
 Identities = 65/226 (28%), Positives = 108/226 (47%), Gaps = 37/226 (16%)

Query: 68  ELGDGGFGTVYYGELQD---------------GRA--VAVKRLYENNYKRVEQ-FMNEVD 109
           +LG+G FG V+  E+ +               GR   VAVK L  +  K     F+ EV 
Sbjct: 12  KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71

Query: 110 ILARLRHKNLVSLYG-CTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGA------ 158
           IL+RL+  N++ L G C       L ++ E++ NG +    + H   ++ + G       
Sbjct: 72  ILSRLKDPNIIRLLGVCVD--EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPA 129

Query: 159 --LP---WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LF 212
             LP   + + L +A++ AS + YL + + +HRD+ T N L+  N  +K+ADFG+SR L+
Sbjct: 130 HCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLY 189

Query: 213 PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
                 +         ++  E     + T  SDV++FGV L E++ 
Sbjct: 190 AGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 81.2 bits (200), Expect = 1e-17
 Identities = 57/198 (28%), Positives = 101/198 (51%), Gaps = 6/198 (3%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKR--LYEN-NYKRVEQFMNEVDILARLRHKN 118
           F   +++G G F  VY    L D + VA+K+  ++E  + K  +  + E+D+L +L H N
Sbjct: 4   FQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPN 63

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++  Y  +     EL +V E    G ++  +   + +   +P  T  K  ++  SA+ ++
Sbjct: 64  VIK-YLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  ++HRD+K  N+ +     VK+ D GL R F +  T  + +  GTP Y+ PE     
Sbjct: 123 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT-AAHSLVGTPYYMSPERIHEN 181

Query: 239 QLTDKSDVFSFGVVLIEL 256
               KSD++S G +L E+
Sbjct: 182 GYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 81.7 bits (201), Expect = 2e-17
 Identities = 55/195 (28%), Positives = 100/195 (51%), Gaps = 8/195 (4%)

Query: 68  ELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ++G G  GTV+   ++  G+ VA+K++      + E  +NE+ ++  L++ N+V+    +
Sbjct: 26  KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLD-S 84

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
                EL +V E+++ G++ D +         +    R     E   AL +LHA+ +IHR
Sbjct: 85  FLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCR-----ECLQALEFLHANQVIHR 139

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D+K++N+LL  +  VK+ DFG         +  ST   GTP ++ PE         K D+
Sbjct: 140 DIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPKVDI 198

Query: 247 FSFGVVLIELISSMP 261
           +S G++ IE++   P
Sbjct: 199 WSLGIMAIEMVEGEP 213

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 80.9 bits (200), Expect = 2e-17
 Identities = 63/198 (31%), Positives = 97/198 (48%), Gaps = 12/198 (6%)

Query: 67  RELGDGGFGTVY-YGELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRH-KNLVSLY 123
            ELG G +G V     +  G  +AVKR+    N +  ++ + ++DI  R       V+ Y
Sbjct: 7   EELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFY 66

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIETASALTYLHAS- 181
           G   R   ++ +  E +   T  D  + +    G  +P     KIA+    AL YLH+  
Sbjct: 67  GALFREG-DVWICMEVMD--TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL 123

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA---PQGTPGYVDPEYHQCY 238
            +IHRDVK +N+L++ N  VK+ DFG+S    + V     A   P   P  ++PE +Q  
Sbjct: 124 SVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQ-K 182

Query: 239 QLTDKSDVFSFGVVLIEL 256
               KSDV+S G+ +IEL
Sbjct: 183 GYDVKSDVWSLGITMIEL 200

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 80.9 bits (199), Expect = 2e-17
 Identities = 60/201 (29%), Positives = 94/201 (46%), Gaps = 9/201 (4%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           F     +G G FG VY G + +    VA+K +  E     +E    E+ +L++     + 
Sbjct: 6   FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             YG   + ++ L ++ E++  G+  D L     KPG L       I  E    L YLH+
Sbjct: 66  RYYGSYLKGTK-LWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS 119

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              IHRD+K  N+LL     VK+ADFG++    +     +T   GTP ++ PE  +    
Sbjct: 120 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAY 178

Query: 241 TDKSDVFSFGVVLIELISSMP 261
             K+D++S G+  IEL    P
Sbjct: 179 DFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 65/199 (32%), Positives = 92/199 (46%), Gaps = 13/199 (6%)

Query: 69  LGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCT 126
           +G G +G V+     ++G   AVK L +  +   E+   E +IL  L  H N+V  YG  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 127 SRHSR----ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
            +       +L LV E  + G+V D + G   +   +  P    I  E    L +LH + 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
            IHRDVK NNILL     VK+ DFG+S    +          GTP ++ PE   C Q  D
Sbjct: 145 TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTS-TRLRRNTSVGTPFWMAPEVIACEQQLD 203

Query: 243 KS-----DVFSFGVVLIEL 256
            +     DV+S G+  IEL
Sbjct: 204 STYDARCDVWSLGITAIEL 222

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 80.9 bits (200), Expect = 3e-17
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 13/203 (6%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRA-VAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
            +  + +G G FG V+    +      A+K +        K+ +   NE  +L  + H  
Sbjct: 3   LERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPF 62

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ L+  T    R L ++ E++  G +  +L   R   G     T L  A E   AL YL
Sbjct: 63  IIRLF-WTEHDQRFLYMLMEYVPGGELFSYL---RNS-GRFSNSTGLFYASEIVCALEYL 117

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+ +I++RD+K  NILLD    +K+ DFG    F   +   +    GTP Y+ PE  Q  
Sbjct: 118 HSKEIVYRDLKPENILLDKEGHIKLTDFG----FAKKLRDRTWTLCGTPEYLAPEVIQSK 173

Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
                 D ++ G+++ E++   P
Sbjct: 174 GHNKAVDWWALGILIYEMLVGYP 196

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 80.4 bits (198), Expect = 3e-17
 Identities = 64/201 (31%), Positives = 96/201 (47%), Gaps = 19/201 (9%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLY--------ENNYKRVEQFMNEVDILARLRHKN 118
           + LG G FGTVY   ++D +AVA +RL         E N     Q   E  +L++L H  
Sbjct: 6   QRLGKGSFGTVYL--VKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPA 63

Query: 119 LVSLYGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           +V  +   S   R+   ++ E+     +   L   +     L      +  I+    + Y
Sbjct: 64  IVKFH--ASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHY 121

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY--H 235
           +H   I+HRD+K  NI L NN  +K+ DFG+SRL       ++T   GTP Y+ PE   H
Sbjct: 122 MHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCD-LATTFTGTPYYMSPEALKH 179

Query: 236 QCYQLTDKSDVFSFGVVLIEL 256
           Q Y    KSD++S G +L E+
Sbjct: 180 QGYD--SKSDIWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 80.3 bits (198), Expect = 4e-17
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 16/204 (7%)

Query: 67  RELGDGGFGTVYYGELQDGRAVA---VKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSL 122
            E+G+G FG V  GE   G + A   VK L  +        F+ EV     L H N++  
Sbjct: 1   DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60

Query: 123 YG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAIETASALTYLHA 180
            G C    S   LLV EF   G + ++L   R     +       ++A E AS L +LH 
Sbjct: 61  LGQCI--ESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ 118

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQ 239
           +D IH D+   N  L  +  VK+ D+GL+        +++      P  ++ PE  +   
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG 178

Query: 240 -------LTDKSDVFSFGVVLIEL 256
                   T KS+++S GV + EL
Sbjct: 179 QDLLPKDQTKKSNIWSLGVTMWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.9 bits (197), Expect = 5e-17
 Identities = 60/196 (30%), Positives = 95/196 (48%), Gaps = 18/196 (9%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYGCT 126
           LG G  GTVY    L   R +AVK +  +    ++ Q M+E++IL +     ++  YG  
Sbjct: 9   LGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAF 68

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
              +R + +  EF+  G++  +          +P     +IA+     LTYL +  I+HR
Sbjct: 69  FVENR-ISICTEFMDGGSLDVY--------RKIPEHVLGRIAVAVVKGLTYLWSLKILHR 119

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHV--THVSTAPQGTPGYVDPEYHQCYQLTDKS 244
           DVK +N+L++    VK+ DFG+S    N +  T+V     GT  Y+ PE     Q    S
Sbjct: 120 DVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYV-----GTNAYMAPERISGEQYGIHS 174

Query: 245 DVFSFGVVLIELISSM 260
           DV+S G+  +EL    
Sbjct: 175 DVWSLGISFMELALGR 190

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 79.9 bits (197), Expect = 6e-17
 Identities = 61/218 (27%), Positives = 101/218 (46%), Gaps = 27/218 (12%)

Query: 67  RELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R++G G FG V+          +    VAVK L E     ++  F  E  ++A   H N+
Sbjct: 11  RDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNI 70

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK------------------PGALPW 161
           V L G  +   + + L++E+++ G + + L     +                  P  L  
Sbjct: 71  VKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSC 129

Query: 162 PTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST 221
             +L IA + A+ + YL     +HRD+ T N L+  N  VK+ADFGLSR   +   + ++
Sbjct: 130 TEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189

Query: 222 APQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
                P  ++ PE     + T +SDV+++GVVL E+ S
Sbjct: 190 ENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 63/195 (32%), Positives = 95/195 (48%), Gaps = 13/195 (6%)

Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYG 124
           LG G FG V   EL+  G   AVK L ++       VE  M E  +LA       ++   
Sbjct: 3   LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
           CT +    L  V EF++ G +  H+  +    G          A E    L +LH+  II
Sbjct: 63  CTFQTKEHLFFVMEFLNGGDLMFHIQDK----GRFDLYRATFYAAEIVCGLQFLHSKGII 118

Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPEYHQCYQLTD 242
           +RD+K +N++LD +  +K+ADFG+ +    +V   + A    GTP Y+ PE  Q  + T 
Sbjct: 119 YRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGDNRASTFCGTPDYIAPEILQGLKYTF 175

Query: 243 KSDVFSFGVVLIELI 257
             D +SFGV+L E++
Sbjct: 176 SVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 67/200 (33%), Positives = 101/200 (50%), Gaps = 15/200 (7%)

Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQ--FMNEVDILAR-LRHKNLVSLY 123
           +G G FG V   + + DG   AVK L +    K+ EQ   M E ++L + L+H  LV L+
Sbjct: 3   IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
             + + + +L  V ++++ G +  HL  ER        P     A E ASA+ YLH+ +I
Sbjct: 63  -YSFQTAEKLYFVLDYVNGGELFFHLQRERC----FLEPRARFYAAEVASAIGYLHSLNI 117

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           I+RD+K  NILLD+   V + DFGL +  + P   T       GTP Y+ PE  +     
Sbjct: 118 IYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFC---GTPEYLAPEVLRKEPYD 174

Query: 242 DKSDVFSFGVVLIELISSMP 261
              D +  G VL E++  +P
Sbjct: 175 RTVDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 79.3 bits (195), Expect = 1e-16
 Identities = 61/200 (30%), Positives = 100/200 (50%), Gaps = 18/200 (9%)

Query: 69  LGDGGFGTVYYG-ELQDGRAV----AVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSL 122
           LG G FGTVY G  + +G  V    A+K L E    +   +FM+E  I+A + H +LV L
Sbjct: 15  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA---LPWPTRLKIAIETASALTYLH 179
            G     S  + LV + + +G + D++H  +   G+   L W       ++ A  + YL 
Sbjct: 75  LGVCL--SPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNW------CVQIAKGMMYLE 126

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCY 238
              ++HRD+   N+L+ +   VK+ DFGL+RL        +      P  ++  E     
Sbjct: 127 ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYR 186

Query: 239 QLTDKSDVFSFGVVLIELIS 258
           + T +SDV+S+GV + EL++
Sbjct: 187 KFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 79.0 bits (194), Expect = 1e-16
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 11/202 (5%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           F    ++G G FG V+ G + +  + VA+K +  E     +E    E+ +L++     + 
Sbjct: 6   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             YG   + ++ L ++ E++  G+  D L     +PG L       I  E    L YLH+
Sbjct: 66  KYYGSYLKDTK-LWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 119

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPEYHQCYQ 239
              IHRD+K  N+LL  +  VK+ADFG++    +  T +      GTP ++ PE  +   
Sbjct: 120 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD--TQIKRNTFVGTPFWMAPEVIKQSA 177

Query: 240 LTDKSDVFSFGVVLIELISSMP 261
              K+D++S G+  IEL    P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 78.6 bits (193), Expect = 1e-16
 Identities = 61/202 (30%), Positives = 96/202 (47%), Gaps = 11/202 (5%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           F     +G G FG V+ G + +  + VA+K +  E     +E    E+ +L++     + 
Sbjct: 6   FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP-GALPWPTRLKIAIETASALTYLH 179
             YG   + ++ L ++ E++  G+  D L   RA P       T LK   E    L YLH
Sbjct: 66  KYYGSYLKGTK-LWIIMEYLGGGSALDLL---RAGPFDEFQIATMLK---EILKGLDYLH 118

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
           +   IHRD+K  N+LL     VK+ADFG++    +     +T   GTP ++ PE  Q   
Sbjct: 119 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIQQSA 177

Query: 240 LTDKSDVFSFGVVLIELISSMP 261
              K+D++S G+  IEL    P
Sbjct: 178 YDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 79.3 bits (195), Expect = 2e-16
 Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 17/204 (8%)

Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKN--LVSL 122
           LG G FG V   E +      A+K L ++       VE  M E  +LA L+ K   L  L
Sbjct: 8   LGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LQDKPPFLTQL 66

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           + C     R L  V E+++ G +  H+     + G    P  +  A E +  L +LH   
Sbjct: 67  HSCFQTVDR-LYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISVGLFFLHRRG 121

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPEYHQCYQLT 241
           II+RD+K +N++LD+   +K+ADFG+ +   + V  V+T    GTP Y+ PE    YQ  
Sbjct: 122 IIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMVDGVTTRTFCGTPDYIAPEI-IAYQPY 178

Query: 242 DKS-DVFSFGVVLIELISSMPAVD 264
            KS D +++GV+L E+++  P  D
Sbjct: 179 GKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 63/209 (30%), Positives = 107/209 (51%), Gaps = 30/209 (14%)

Query: 68  ELGDGGFGTVYYGE-LQDGRAVAVKRL-YENNYKRV-EQFMNEVDILARLRHKNLVSLYG 124
           ++G+G +G VY G   + G+ VA+K++  E+  + V    + E+ +L  L+H N+V L  
Sbjct: 7   KIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQD 66

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHASDI 183
              + SR L L++EF+S   +  +L  +    G       +K  + +    + + H+  +
Sbjct: 67  VLMQESR-LYLIFEFLSM-DLKKYL--DSLPKGQYMDAELVKSYLYQILQGILFCHSRRV 122

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHV-TH-VST----APQ---GTPGYVDP 232
           +HRD+K  N+L+DN   +K+ADFGL+R F  P  V TH V T    AP+   G+P Y  P
Sbjct: 123 LHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTP 182

Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMP 261
                       D++S G +  E+ +  P
Sbjct: 183 -----------VDIWSIGTIFAEMATKKP 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 62/210 (29%), Positives = 102/210 (48%), Gaps = 17/210 (8%)

Query: 71  DGGFGTVYYGELQDG-----RAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYG 124
           +G FG ++YG L D        V VK + ++ +  +V   + E  +L  L H+N++ +  
Sbjct: 16  EGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILH 75

Query: 125 -CTSRHSRELLLVYEFISNGTVADHL----HGERAKPGALPWPTRLKIAIETASALTYLH 179
            C        +L Y +++ G +   L     GE   P AL     + +AI+ A  ++YLH
Sbjct: 76  VCIEDGEPPFVL-YPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLH 134

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTP-GYVDPEYHQC 237
              +IH+D+   N ++D    VK+ D  LSR LFP    H     +  P  ++  E    
Sbjct: 135 KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY-HCLGDNENRPVKWMALESLVN 193

Query: 238 YQLTDKSDVFSFGVVLIELIS--SMPAVDI 265
            + +  SDV+SFGV+L EL++    P V+I
Sbjct: 194 KEYSSASDVWSFGVLLWELMTLGQTPYVEI 223

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 78.7 bits (194), Expect = 3e-16
 Identities = 57/214 (26%), Positives = 104/214 (48%), Gaps = 16/214 (7%)

Query: 53  YGELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV--EQFMNEVD 109
           +G + E TN +   + +G G FG V     Q  G+ VA+K++ +     V  ++   E+ 
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           +L  LRH+N++SL         ++  V E +    +   L     +   + +        
Sbjct: 62  LLKHLRHENIISLSDIFISPLEDIYFVTELLGT-DLHRLLTSRPLEKQFIQY-----FLY 115

Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPG 228
           +    L Y+H++ ++HRD+K +NIL++ N  +K+ DFGL+R+    +T +VST       
Sbjct: 116 QILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170

Query: 229 YVDPEYHQCYQLTD-KSDVFSFGVVLIELISSMP 261
           Y  PE    +Q  D + D++S G +  E++   P
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 65/218 (29%), Positives = 106/218 (48%), Gaps = 33/218 (15%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRA-VAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F++ + + +G +G VY    ++ R   A+K++ + N     +++Q   E DIL    +  
Sbjct: 3   FETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPF 62

Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPT-RLKIAIETASAL 175
           +VS++    T RH   L +V E++  G  A  L       GALP    R+  A ET  AL
Sbjct: 63  VVSMFCSFETKRH---LCMVMEYVEGGDCATLLK----NIGALPVDMARMYFA-ETVLAL 114

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR---------LFPNHVTHVSTAPQ-- 224
            YLH   I+HRD+K +N+L+ +   +K+ DFGLS+         L+  H+   +      
Sbjct: 115 EYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDK 174

Query: 225 ---GTPGYVDPE--YHQCYQLTDKSDVFSFGVVLIELI 257
              GTP Y+ PE    Q Y      D ++ G++L E +
Sbjct: 175 QVCGTPEYIAPEVILRQGY--GKPVDWWAMGIILYEFL 210

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 78.3 bits (193), Expect = 3e-16
 Identities = 67/205 (32%), Positives = 96/205 (46%), Gaps = 24/205 (11%)

Query: 69  LGDGGFGTVYYGELQDGRAV-AVKRLYEN---NYKRVEQFMNEVDILA-RLRHKNLVSLY 123
           LG G FG V   EL+      A+K L ++       VE  M E  +LA    H  L  L+
Sbjct: 3   LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHG------ERAKPGALPWPTRLKIAIETASALTY 177
            CT +    L  V E+++ G +  H+         RA+            A E    L +
Sbjct: 63  -CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARAR----------FYAAEIICGLQF 111

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           LH   II+RD+K +N+LLD +  +K+ADFG+ +   N     ST   GTP Y+ PE  + 
Sbjct: 112 LHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFC-GTPDYIAPEILKG 170

Query: 238 YQLTDKSDVFSFGVVLIE-LISSMP 261
            +  +  D +SFGV+L E LI   P
Sbjct: 171 QKYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 77.7 bits (191), Expect = 3e-16
 Identities = 64/209 (30%), Positives = 97/209 (46%), Gaps = 15/209 (7%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLR---H 116
           ++   E+G G +GTVY   +   G  VA+K  R+  N        + EV +L RL    H
Sbjct: 2   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDH 61

Query: 117 KNLVSLYG--CTSRHSRE--LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
            N+V L     TSR  RE  + LV+E +         + ++  P  LP  T   +  +  
Sbjct: 62  PNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRT---YLDKVPPPGLPAETIKDLMRQFL 118

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
             L +LHA+ I+HRD+K  NIL+ +   VK+ADFGL+R++   +    T    T  Y  P
Sbjct: 119 RGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA--LTPVVVTLWYRAP 176

Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           E           D++S G +  E+    P
Sbjct: 177 EVLLQSTYATPVDMWSVGCIFAEMFRRKP 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 25/218 (11%)

Query: 57  EEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLY---ENNYKRVEQFMNEVDILA 112
           ++    F    E+G G FG VY+         VAVK++    +   ++ +  + EV  L 
Sbjct: 17  DDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ 76

Query: 113 RLRHKNLVSLYGC-TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
           +L+H N +   GC    H+  L++ Y     G+ +D L   + KP        ++IA  T
Sbjct: 77  QLKHPNTIEYKGCYLKEHTAWLVMEYCL---GSASDLLEVHK-KP-----LQEVEIAAIT 127

Query: 172 ASAL---TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
             AL    YLH+ ++IHRD+K  NILL     VK+ADFG +       +  + +  GTP 
Sbjct: 128 HGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSAS-----KSSPANSFVGTPY 182

Query: 229 YVDPEYHQCY---QLTDKSDVFSFGVVLIELISSMPAV 263
           ++ PE        Q   K DV+S G+  IEL    P +
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPL 220

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 63/200 (31%), Positives = 94/200 (47%), Gaps = 15/200 (7%)

Query: 69  LGDGGFGTVYYGELQDGRAV-AVKRLYENNYKR---VEQFMNEVDILARLR-HKNLVSLY 123
           LG G FG V   EL+    V A+K L ++   +   V+  M E  ILA    H  L +L+
Sbjct: 3   LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
            C     R L  V E+++ G +   +   R        P     A E   AL +LH   +
Sbjct: 63  CCFQTKDR-LFFVMEYVNGGDLMFQIQRSRK----FDEPRSRFYAAEVTLALMFLHRHGV 117

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           I+RD+K +NILLD     K+ADFG+ +  +     T   T   GTP Y+ PE  Q  +  
Sbjct: 118 IYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTT---TTFCGTPDYIAPEILQELEYG 174

Query: 242 DKSDVFSFGVVLIELISSMP 261
              D ++ GV++ E+++  P
Sbjct: 175 PSVDWWALGVLMYEMMAGQP 194

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 77.3 bits (190), Expect = 4e-16
 Identities = 65/204 (31%), Positives = 96/204 (47%), Gaps = 16/204 (7%)

Query: 67  RELGDGGFGTVYYGELQDG---RAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSL 122
           +E+G+G FG V  GE+  G     V VK L  + + +   +F+ E      L+H NL+  
Sbjct: 1   KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQC 60

Query: 123 YG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRL-KIAIETASALTYLHA 180
            G CT       LLV EF   G +  +L   R      P PT L ++A E A  L +LH 
Sbjct: 61  LGQCT--EVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK 118

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEY----H 235
           ++ IH D+   N LL  +  VK+ D+GLS        +V+      P  ++ PE     H
Sbjct: 119 NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH 178

Query: 236 QCYQLTDK---SDVFSFGVVLIEL 256
               + D+   S+V+S GV + EL
Sbjct: 179 GNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 20/207 (9%)

Query: 69  LGDGGFGTVYYGEL-QDGRAV--AVKRLYENNYKRVEQ-FMNEVDILARL-RHKNLVSLY 123
           +G+G FG V    + +DG  +  A+KR+ E   K   + F  E+++L +L  H N+++L 
Sbjct: 15  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 74

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGER------------AKPGALPWPTRLKIAIET 171
           G    H   L L  E+  +G + D L   R            +    L     L  A + 
Sbjct: 75  G-ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 133

Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
           A  + YL     IHRD+   NIL+  N+  K+ADFGLSR     V    T  +    ++ 
Sbjct: 134 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMA 191

Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELIS 258
            E       T  SDV+S+GV+L E++S
Sbjct: 192 IESLNYSVYTTNSDVWSYGVLLWEIVS 218

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 64/195 (32%), Positives = 97/195 (49%), Gaps = 13/195 (6%)

Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILA-RLRHKNLVSLY 123
           LG G FG V+  EL+   +  A+K L ++       VE  M E  +L+    H  L  LY
Sbjct: 3   LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
            CT +    L  V E+++ G +  H+  +      LP  T    A E    L +LH+  I
Sbjct: 63  -CTFQTKENLFFVMEYLNGGDLMFHI--QSCHKFDLPRATFY--AAEIICGLQFLHSKGI 117

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPEYHQCYQLTD 242
           ++RD+K +NILLD +  +K+ADFG+ +   N +    T    GTP Y+ PE     +   
Sbjct: 118 VYRDLKLDNILLDTDGHIKIADFGMCK--ENMLGDAKTCTFCGTPDYIAPEILLGQKYNT 175

Query: 243 KSDVFSFGVVLIELI 257
             D +SFGV+L E++
Sbjct: 176 SVDWWSFGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 77.4 bits (191), Expect = 5e-16
 Identities = 64/208 (30%), Positives = 100/208 (48%), Gaps = 37/208 (17%)

Query: 68  ELGDGGFGTVYYGE-LQDGRAVAVKRLY-----ENNYKRVEQFMNEVDILARLRH--KNL 119
           E+G G  G VY     + G  +AVK++      E N KR+   + ++D++    H    +
Sbjct: 22  EIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN-KRI---LMDLDVVL-KSHDCPYI 76

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRL--KIAIETASALTY 177
           V  YG     S ++ +  E +S  T  D L  +R +    P P  +  K+ +    AL Y
Sbjct: 77  VKCYGYFITDS-DVFICMELMS--TCLDKLL-KRIQG---PIPEDILGKMTVAIVKALHY 129

Query: 178 L---HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE- 233
           L   H   +IHRDVK +NILLD +  VK+ DFG+S    +      +A  G   Y+ PE 
Sbjct: 130 LKEKHG--VIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA--GCAAYMAPER 185

Query: 234 -----YHQCYQLTDKSDVFSFGVVLIEL 256
                 +  Y +  ++DV+S G+ L+EL
Sbjct: 186 IDPPDPNPKYDI--RADVWSLGISLVEL 211

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 77.0 bits (189), Expect = 9e-16
 Identities = 65/202 (32%), Positives = 99/202 (49%), Gaps = 19/202 (9%)

Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILAR-LRHKNLVSLY 123
           +G G FG V     + + +  AVK L +      K  +  M+E ++L + ++H  LV L+
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
                  + L  V ++I+ G +  HL  ER        P     A E ASAL YLH+ +I
Sbjct: 63  FSFQTADK-LYFVLDYINGGELFYHLQRERC----FLEPRARFYAAEIASALGYLHSLNI 117

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPE--YHQCYQ 239
           ++RD+K  NILLD+   + + DFGL +  +  N  T       GTP Y+ PE  + Q Y 
Sbjct: 118 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFC---GTPEYLAPEVLHKQPYD 174

Query: 240 LTDKSDVFSFGVVLIELISSMP 261
            T   D +  G VL E++  +P
Sbjct: 175 RT--VDWWCLGAVLYEMLYGLP 194

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 76.0 bits (187), Expect = 1e-15
 Identities = 59/239 (24%), Positives = 101/239 (42%), Gaps = 40/239 (16%)

Query: 51  FSYGELEEATNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVEQ- 103
           F    L+E T        LG G FG V+  + +          V VK L +   + ++  
Sbjct: 2   FPRSNLQEIT-------TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSE 54

Query: 104 FMNEVDILARLRHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHL-----HGERAKPG 157
           F  E+D+  +L HKN+V L G C  R +    ++ E+   G +   L       E+ KP 
Sbjct: 55  FRRELDMFRKLSHKNVVRLLGLC--REAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPP 112

Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR------- 210
            L    ++ +  + A  + +L  +  +HRD+   N L+ +   VKV+   LS+       
Sbjct: 113 PLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY 172

Query: 211 -LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS--MPAVDIT 266
               N +  +            PE  Q    + KSDV+SFGV++ E+ +   +P   ++
Sbjct: 173 YKLRNALIPLRWLA--------PEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 76.1 bits (187), Expect = 1e-15
 Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 29/218 (13%)

Query: 68  ELGDGGFGTVYYGELQ-----------------DGRAVAVKRLYENNYKRVEQ-FMNEVD 109
           +LG+G FG V+  E +                     VAVK L E+  K     F+ E+ 
Sbjct: 12  KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71

Query: 110 ILARLRHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHL-------HGERAKPGALPW 161
           I++RL+  N++ L   C +  S  L ++ E++ NG +   L         E+A    + +
Sbjct: 72  IMSRLKDPNIIRLLAVCIT--SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISY 129

Query: 162 PTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVS 220
            T + +A + AS + YL + + +HRD+ T N L+  N+ +K+ADFG+SR L+      + 
Sbjct: 130 STLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQ 189

Query: 221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
                   ++  E     + T  SDV++FGV L E+++
Sbjct: 190 GRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 75/289 (25%), Positives = 114/289 (39%), Gaps = 45/289 (15%)

Query: 67  RELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMN---EVDILARLRHK-NLVS 121
           + +  G FG+VY  + +  G   A+K L +++     Q  N   E  I+        +  
Sbjct: 2   KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAK 61

Query: 122 LYGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
           LY   S  S++ L LV E+++ G  A  +       G LP     +   E    +  LH 
Sbjct: 62  LY--YSFQSKDYLYLVMEYLNGGDCASLIK----TLGGLPEDWAKQYIAEVVLGVEDLHQ 115

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
             IIHRD+K  N+L+D    +K+ DFGLSR         +    GTP Y+ PE       
Sbjct: 116 RGIIHRDIKPENLLIDQTGHLKLTDFGLSR-----NGLENKKFVGTPDYLAPETILGVGD 170

Query: 241 TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD 300
              SD +S G V+ E +   P                           E  D       D
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHA-----------------------ETPDAVF----D 203

Query: 301 NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTH 349
           N + R IN   E+   C     DL   ++ +  A R + ++GY + K+H
Sbjct: 204 NILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKR-LGANGYQEIKSH 251

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 62/220 (28%), Positives = 104/220 (47%), Gaps = 33/220 (15%)

Query: 69  LGDGGFGTVYYG---ELQDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLV 120
           LG+G FG V       L+ GRA    VAVK L EN +   +   ++E ++L ++ H +++
Sbjct: 8   LGEGEFGKVVKATAFRLK-GRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVI 66

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGERA------------------KPG--AL 159
            LYG C+      LLL+ E+   G++   L   R                    P   AL
Sbjct: 67  KLYGACSQ--DGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124

Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV 219
                +  A + +  + YL    ++HRD+   N+L+     +K++DFGLSR      ++V
Sbjct: 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYV 184

Query: 220 STAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
             +    P  ++  E    +  T +SDV+SFGV+L E+++
Sbjct: 185 KRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 74.2 bits (182), Expect = 3e-15
 Identities = 54/197 (27%), Positives = 96/197 (48%), Gaps = 11/197 (5%)

Query: 68  ELGDGGFGTVYYGELQDGRA---VAVKRLYENNYKRV-EQFMNEVDILARLRHKNLVSLY 123
           ELG G FG V  G  +  +    VA+K L   N K V ++ M E +I+ +L +  +V + 
Sbjct: 2   ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G     +  L+LV E  S G +   L G++ +   +     +++  + +  + YL   + 
Sbjct: 62  GVCEAEA--LMLVMEMASGGPLNKFLSGKKDE---ITVSNVVELMHQVSMGMKYLEGKNF 116

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           +HRD+   N+LL N    K++DFGLS+     +      +A +    +  PE     + +
Sbjct: 117 VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFS 176

Query: 242 DKSDVFSFGVVLIELIS 258
            +SDV+S+G+ + E  S
Sbjct: 177 SRSDVWSYGITMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 74.3 bits (182), Expect = 5e-15
 Identities = 64/204 (31%), Positives = 95/204 (46%), Gaps = 13/204 (6%)

Query: 66  ARELGDGGFGTVYYGEL-QDGR--AVAVKRLYENNYKR--VEQFMNEVDILARLRHKNLV 120
            + LG+G FG+V  G+L QD     VAVK +      R  +E F++E   +    H N++
Sbjct: 4   GKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVM 63

Query: 121 SLYG-CTSRHSRE----LLLVYEFISNGTVADHLHGERA--KPGALPWPTRLKIAIETAS 173
            L G C      E     +++  F+ +G +   L   R    P  LP    +K   + AS
Sbjct: 64  RLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIAS 123

Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
            + YL +   IHRD+   N +L+ N  V VADFGLS+   N   +        P  ++  
Sbjct: 124 GMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 233 EYHQCYQLTDKSDVFSFGVVLIEL 256
           E       T KSDV+SFGV + E+
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 74.2 bits (183), Expect = 5e-15
 Identities = 55/214 (25%), Positives = 101/214 (47%), Gaps = 48/214 (22%)

Query: 72  GGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQF----MNEVDILARLRHKNLVSL--- 122
           G +G VY   + + G  VA+K+L  E   K  E F    + E++IL +L+H N+V++   
Sbjct: 16  GTYGVVYRARDKKTGEIVALKKLKME---KEKEGFPITSLREINILLKLQHPNIVTVKEV 72

Query: 123 -YGCTSRHSRELLLVYEFISNG--TVADHLHGERAKPGALPWPTRLK-IAIETASALTYL 178
             G        + +V E++ +   ++ + +             + +K + ++  S + +L
Sbjct: 73  VVGSNLDK---IYMVMEYVEHDLKSLMETMKQPFL-------QSEVKCLMLQLLSGVAHL 122

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF--------PNHVTHVSTAPQ---GTP 227
           H + I+HRD+KT+N+LL+N   +K+ DFGL+R +           VT    AP+   G  
Sbjct: 123 HDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAK 182

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
            Y           +   D++S G +  EL++  P
Sbjct: 183 EY-----------STAIDMWSVGCIFAELLTKKP 205

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 74.7 bits (183), Expect = 6e-15
 Identities = 67/210 (31%), Positives = 103/210 (49%), Gaps = 17/210 (8%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRAV-AVKRLYEN---NYKRVEQFMNEVDILARLRHKN 118
           F+    LG G FG V   E +    + A+K L ++       VE  M E  +LA L  K 
Sbjct: 2   FNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLA-LSGKP 60

Query: 119 --LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
             L  L+ C     R L  V E+++ G +   +     + G    P  +  A E A  L 
Sbjct: 61  PFLTQLHSCFQTMDR-LYFVMEYVNGGDLMYQIQ----QVGRFKEPHAVFYAAEIAIGLF 115

Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPEYH 235
           +LH+  II+RD+K +N++LD+   +K+ADFG+ +   N    V+T    GTP Y+ PE  
Sbjct: 116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDYIAPEII 173

Query: 236 QCYQLTDKS-DVFSFGVVLIELISSMPAVD 264
             YQ   KS D ++FGV+L E+++     +
Sbjct: 174 A-YQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 74.1 bits (182), Expect = 8e-15
 Identities = 61/197 (30%), Positives = 92/197 (46%), Gaps = 18/197 (9%)

Query: 69  LGDGGFGTVYY-GELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYG 124
           LG G FG V    E   G+  A+K L +        V   + E  +L   RH  L +L  
Sbjct: 3   LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGER--AKPGALPWPTRLKIAIETASALTYLHASD 182
               H R L  V E+ + G +  HL  ER  ++        R   A E  SAL YLH+ D
Sbjct: 63  SFQTHDR-LCFVMEYANGGELFFHLSRERVFSED-----RARFYGA-EIVSALGYLHSCD 115

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPEYHQCYQL 240
           +++RD+K  N++LD +  +K+ DFGL +     ++  +T     GTP Y+ PE  +    
Sbjct: 116 VVYRDLKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDY 172

Query: 241 TDKSDVFSFGVVLIELI 257
               D +  GVV+ E++
Sbjct: 173 GRAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 73.6 bits (181), Expect = 1e-14
 Identities = 53/176 (30%), Positives = 84/176 (47%), Gaps = 35/176 (19%)

Query: 57  EEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF----MNEVDIL 111
           +E + Y   A+ +G G FG V+     +  + VA+K++   N K  E F    + E+ IL
Sbjct: 9   DEVSKYEKLAK-IGQGTFGEVFKARHKKTKQIVALKKVLMENEK--EGFPITALREIKIL 65

Query: 112 ARLRHKNLVSLYG-C------TSRHSRELLLVYEF--------ISNGTVADHLHGERAKP 156
             L+H+N+V+L   C       +R+     LV+EF        +SN  V   L       
Sbjct: 66  QLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTL------- 118

Query: 157 GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF 212
                    K+     + L Y+H + I+HRD+K  NIL+  +  +K+ADFGL+R F
Sbjct: 119 -----SEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAF 169

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 60/203 (29%), Positives = 100/203 (49%), Gaps = 15/203 (7%)

Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKN 118
           F   R LG GGFG V   +++  G+  A K+L +   K+ +     +NE  IL ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF 61

Query: 119 LVSL-YGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASAL 175
           +VSL Y   ++ +  L LV   ++ G +  H++  GE            +  A E    L
Sbjct: 62  VVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHMGE----AGFEEGRAVFYAAEICCGL 115

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
             LH   I++RD+K  NILLD++  ++++D GL+   P   T       GT GY+ PE  
Sbjct: 116 EDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVV 173

Query: 236 QCYQLTDKSDVFSFGVVLIELIS 258
           +  + T   D ++ G +L E+I+
Sbjct: 174 KNERYTFSPDWWALGCLLYEMIA 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 60/222 (27%), Positives = 107/222 (48%), Gaps = 38/222 (17%)

Query: 67  RELGDGGFGTVY----YG---ELQDGRA-VAVKRLYENNY-KRVEQFMNEVDILARL-RH 116
           + LG+G FG V     YG      D    VAVK L +N   K +   ++E++++  + +H
Sbjct: 18  KPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 117 KNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGER------------AKPGALPWPT 163
           KN+++L G CT      L ++ E+ + G + + L   R                 L +  
Sbjct: 78  KNIINLLGVCT--QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKD 135

Query: 164 RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
            +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R     V  +    
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR----GVHDIDYYK 191

Query: 224 QGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
           + + G     ++ PE  + + Y  T +SDV+SFG+++ E+ +
Sbjct: 192 KTSNGRLPVKWMAPEALFDRVY--THQSDVWSFGILMWEIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 64/211 (30%), Positives = 99/211 (46%), Gaps = 28/211 (13%)

Query: 69  LGDGGFGTVYYGELQ-DGRAV--AVKRL----YENNYKRVEQFMNEVDILARL-RHKNLV 120
           +G+G FG V    ++ DG  +  A+K L     EN+++    F  E+++L +L  H N++
Sbjct: 10  IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHR---DFAGELEVLCKLGHHPNII 66

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGER------------AKPGALPWPTRLKI 167
           +L G C +R    L +  E+   G + D L   R                 L     L+ 
Sbjct: 67  NLLGACENRGY--LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQF 124

Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           A + A+ + YL     IHRD+   N+L+  N   K+ADFGLSR     V    T  +   
Sbjct: 125 ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYVKKTMGRLPV 182

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
            ++  E       T KSDV+SFGV+L E++S
Sbjct: 183 RWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 37/91 (40%), Positives = 58/91 (63%), Gaps = 1/91 (1%)

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT-HVSTAPQGTP 227
           I+   A+ ++H+  +IHRD+K+ NILL +N  VK+ DFG S+++   V+  V     GTP
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP 209

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
            YV PE  +    + K+D+FS GV+L EL++
Sbjct: 210 YYVAPEIWRRKPYSKKADMFSLGVLLYELLT 240

Length = 496

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 72.4 bits (177), Expect = 2e-14
 Identities = 60/217 (27%), Positives = 105/217 (48%), Gaps = 27/217 (12%)

Query: 67  RELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
           + LG G FGTVY G  + DG      VA+K L EN   +  ++ ++E  ++A +    + 
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGA---LPWPTRLKIAIETASALT 176
            L G C +     + LV + +  G + D++   + + G+   L W       ++ A  ++
Sbjct: 73  RLLGICLTS---TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNW------CVQIAKGMS 123

Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYH 235
           YL    ++HRD+   N+L+ +   VK+ DFGL+RL     T         P  ++  E  
Sbjct: 124 YLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESI 183

Query: 236 QCYQLTDKSDVFSFGVVLIELIS-------SMPAVDI 265
              + T +SDV+S+GV + EL++        +PA +I
Sbjct: 184 LHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 74.5 bits (183), Expect = 2e-14
 Identities = 71/272 (26%), Positives = 120/272 (44%), Gaps = 26/272 (9%)

Query: 69  LGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +  G  G  Y G+ +++G    VK +  N+   +    +E+  + +L+H N+V L G   
Sbjct: 698 ISRGKKGASYKGKSIKNGMQFVVKEI--NDVNSIPS--SEIADMGKLQHPNIVKLIG-LC 752

Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH---ASDII 184
           R  +   L++E+I    +++ L         L W  R KIAI  A AL +LH   +  ++
Sbjct: 753 RSEKGAYLIHEYIEGKNLSEVLRN-------LSWERRRKIAIGIAKALRFLHCRCSPAVV 805

Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 244
             ++    I++D        D    RL    +    T    +  YV PE  +   +T+KS
Sbjct: 806 VGNLSPEKIIID------GKDEPHLRLSLPGLLCTDTKCFISSAYVAPETRETKDITEKS 859

Query: 245 DVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL-GYESDNKV 303
           D++ FG++LIEL++     D     H  ++   A     +  L   +D ++ G  S N+ 
Sbjct: 860 DIYGFGLILIELLTGKSPADAEFGVHG-SIVEWARYCYSDCHLDMWIDPSIRGDVSVNQ- 917

Query: 304 RRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
              I  V  LA  C  ++   RP   DVL  L
Sbjct: 918 -NEIVEVMNLALHCTATDPTARPCANDVLKTL 948

Length = 968

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 32/220 (14%)

Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++   K +   ++E++++  + +
Sbjct: 20  GKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 79

Query: 116 HKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPW 161
           HKN+++L G CT      L ++ E+ S G + ++L   R  PG              + +
Sbjct: 80  HKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRP-PGMEYSYDIARVPDEQMTF 136

Query: 162 PTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST 221
              +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R   N   +  T
Sbjct: 137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKT 196

Query: 222 APQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
                P  ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 197 TNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 72.8 bits (178), Expect = 2e-14
 Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 15/206 (7%)

Query: 67  RELGDGGFGTVYYGELQDGRAV----AVKRLYENNYKRVEQFMNEVDILARL-RHKNLVS 121
           R +G G +  V    L+    +     VK+   N+ + ++    E  +  +   H  LV 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L+ C    SR L  V E+++ G +  H+  +R     LP       + E + AL YLH  
Sbjct: 61  LHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNYLHER 115

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
            II+RD+K +N+LLD+   +K+ D+G+ +  L P   T       GTP Y+ PE  +   
Sbjct: 116 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEILRGED 172

Query: 240 LTDKSDVFSFGVVLIELISSMPAVDI 265
                D ++ GV++ E+++     DI
Sbjct: 173 YGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 72.8 bits (179), Expect = 2e-14
 Identities = 60/213 (28%), Positives = 91/213 (42%), Gaps = 33/213 (15%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEV-------DILARL 114
           F    ++G GG+G V+  + +D G  VA+KR+     K +   +NEV       DIL   
Sbjct: 3   FQILTQVGQGGYGQVFLAKKKDTGEIVALKRMK----KSLLFKLNEVRHVLTERDILTTT 58

Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNG------TVADHLHGERAKPGALPWPTRLKIA 168
           + + LV L     +    L L  E++  G           L  + A         R  +A
Sbjct: 59  KSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHA---------RFYMA 108

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            E   A+  LH    IHRD+K  N L+D +  +K+ DFGLS+    +   V     G+P 
Sbjct: 109 -EMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSVV----GSPD 163

Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           Y+ PE  +        D +S G +L E +   P
Sbjct: 164 YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFP 196

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 72.8 bits (178), Expect = 3e-14
 Identities = 51/171 (29%), Positives = 83/171 (48%), Gaps = 10/171 (5%)

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           LV L+ C    SR L LV E+++ G +  H+  +R     LP       A E   AL +L
Sbjct: 58  LVGLHSCFQTTSR-LFLVIEYVNGGDLMFHMQRQRK----LPEEHARFYAAEICIALNFL 112

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           H   II+RD+K +N+LLD +  +K+ D+G+ +  L P   T       GTP Y+ PE  +
Sbjct: 113 HERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFC---GTPNYIAPEILR 169

Query: 237 CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL 287
             +     D ++ GV++ E+++     DI     ++N  +     I  K +
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPI 220

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 71.8 bits (176), Expect = 3e-14
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 17/204 (8%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY       G  VA+K  RL           + E+ +L  L H N+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 61

Query: 120 VSLYGCTSRHS-RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           V L      H+  +L LV+EF+           + +    +P P       +    L + 
Sbjct: 62  VKLLDVI--HTENKLYLVFEFLHQDLKK---FMDASPLSGIPLPLIKSYLFQLLQGLAFC 116

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV---THVSTAPQGTPGYVDPE-Y 234
           H+  ++HRD+K  N+L++    +K+ADFGL+R F   V   TH       T  Y  PE  
Sbjct: 117 HSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVV----TLWYRAPEIL 172

Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
             C   +   D++S G +  E+++
Sbjct: 173 LGCKYYSTAVDIWSLGCIFAEMVT 196

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 55/219 (25%), Positives = 104/219 (47%), Gaps = 37/219 (16%)

Query: 68  ELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
           ELG+  FG VY G L      +  +AVA+K L +     + E+F +E  + +RL+H N+V
Sbjct: 12  ELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIV 71

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHL------------HGERAKPGALPWPTRLKIA 168
            L G  ++  + L +++ + S+  + + L              ++     L     + I 
Sbjct: 72  CLLGVVTK-EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR---------LFPNHVTHV 219
            + A+ + +L +  ++H+D+ T N+L+ +   VK++D GL R         L  N +  +
Sbjct: 131 TQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI 190

Query: 220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
                    ++ PE     + +  SD++S+GVVL E+ S
Sbjct: 191 R--------WMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 71.6 bits (175), Expect = 6e-14
 Identities = 64/225 (28%), Positives = 112/225 (49%), Gaps = 42/225 (18%)

Query: 66  ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E       +  R   VAVK L  +   K +   ++E++++  + +
Sbjct: 23  GKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82

Query: 116 HKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPW---PTR------- 164
           HKN+++L G CT      L ++ E+ S G + ++L   R  P  + +   PT+       
Sbjct: 83  HKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARR--PPGMEYCYNPTQVPEEQLS 138

Query: 165 ----LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS 220
               +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R     + H+ 
Sbjct: 139 FKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHID 194

Query: 221 TAPQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
              + T G     ++ PE  + + Y  T +SDV+SFGV+L E+ +
Sbjct: 195 YYKKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 71.0 bits (174), Expect = 6e-14
 Identities = 59/199 (29%), Positives = 96/199 (48%), Gaps = 16/199 (8%)

Query: 68  ELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           ELG G +G+VY    +  G  +A+K  RL E +  +  Q + E+DIL +     +V  YG
Sbjct: 8   ELGKGNYGSVYKVLHRPTGVTMAMKEIRL-ELDESKFNQIIMELDILHKAVSPYIVDFYG 66

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DI 183
                   + +  E++  G++ D L+        +P     +I       L +L    +I
Sbjct: 67  AFFIEG-AVYMCMEYMDAGSL-DKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNI 124

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY------HQC 237
           IHRDVK  N+L++ N  VK+ DFG+S    N V  ++    G   Y+ PE       +Q 
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVS---GNLVASLAKTNIGCQSYMAPERIKSGGPNQN 181

Query: 238 YQLTDKSDVFSFGVVLIEL 256
              T +SDV+S G+ ++E+
Sbjct: 182 PTYTVQSDVWSLGLSILEM 200

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 70.9 bits (174), Expect = 7e-14
 Identities = 44/156 (28%), Positives = 85/156 (54%), Gaps = 14/156 (8%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRL-YENNYKRVEQF-MNEVDILARLRHKNL 119
           ++   ++G+G +GTV+  + ++    VA+KR+  +++ + V    + E+ +L  L+HKN+
Sbjct: 2   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 61

Query: 120 VSLYGCTSRHS-RELLLVYEFISNG--TVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           V LY     HS ++L LV+E+         D  +G+      +          +    L 
Sbjct: 62  VRLYDVL--HSDKKLTLVFEYCDQDLKKYFDSCNGD------IDPEIVKSFMFQLLKGLA 113

Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF 212
           + H+ +++HRD+K  N+L++ N  +K+ADFGL+R F
Sbjct: 114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 70.5 bits (172), Expect = 9e-14
 Identities = 62/211 (29%), Positives = 99/211 (46%), Gaps = 28/211 (13%)

Query: 69  LGDGGFGTVYYGELQ-DGRAV--AVKRL----YENNYKRVEQFMNEVDILARL-RHKNLV 120
           +G+G FG V    ++ DG  +  A+KR+     +++++    F  E+++L +L  H N++
Sbjct: 3   IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHR---DFAGELEVLCKLGHHPNII 59

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGER------------AKPGALPWPTRLKI 167
           +L G C  R    L L  E+  +G + D L   R            +    L     L  
Sbjct: 60  NLLGACEHRGY--LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHF 117

Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           A + A  + YL     IHRD+   NIL+  N+  K+ADFGLSR     V    T  +   
Sbjct: 118 AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPV 175

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
            ++  E       T  SDV+S+GV+L E++S
Sbjct: 176 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 56/204 (27%), Positives = 93/204 (45%), Gaps = 14/204 (6%)

Query: 63  FDSARELGDGGFGTVYYGELQDGR--AVAVKRLYENNY---KRVEQFMNEVDILARLRHK 117
           F+  R LG G FG V     ++     VA+KR  ++     K+V+   +E  IL  + H 
Sbjct: 32  FNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHP 91

Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
             V+LYG     S  L LV EF+  G     L   +  P  +      +I +       Y
Sbjct: 92  FCVNLYGSFKDESY-LYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVL----IFEY 146

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           L + +I++RD+K  N+LLD +  +K+ DFG +++       +     GTP Y+ PE    
Sbjct: 147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLC----GTPEYIAPEILLN 202

Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 +D ++ G+ + E++   P
Sbjct: 203 VGHGKAADWWTLGIFIYEILVGCP 226

Length = 340

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 9e-14
 Identities = 44/157 (28%), Positives = 76/157 (48%), Gaps = 27/157 (17%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQ--------FMNEVDILARLRHKNL 119
           +G+G +G VY   +   G  VA+K++      R+E          + E+ +L  L H N+
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKI------RLETEDEGVPSTAIREISLLKELNHPNI 60

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADH---LHGERAKPGALPWPTRLKIAI-ETASAL 175
           V L       ++ L LV+EF+      D     + + +    L  P  +K  + +    +
Sbjct: 61  VRLLDVVHSENK-LYLVFEFL------DLDLKKYMDSSPLTGLD-PPLIKSYLYQLLQGI 112

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF 212
            Y H+  ++HRD+K  N+L+D    +K+ADFGL+R F
Sbjct: 113 AYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAF 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 56/203 (27%), Positives = 92/203 (45%), Gaps = 10/203 (4%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           F+  + +G G +G VY    +  G   A+K +     +       E+ ++   +H N+V+
Sbjct: 11  FELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVA 70

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
            +G   R  + L +  EF   G++ D  H      G L       ++ ET   L YLH+ 
Sbjct: 71  YFGSYLRRDK-LWICMEFCGGGSLQDIYH----VTGPLSESQIAYVSRETLQGLYYLHSK 125

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ-- 239
             +HRD+K  NILL +N  VK+ADFG+S      +    +   GTP ++ PE     +  
Sbjct: 126 GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFI-GTPYWMAPEVAAVERKG 184

Query: 240 -LTDKSDVFSFGVVLIELISSMP 261
                 D+++ G+  IEL    P
Sbjct: 185 GYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 70.4 bits (173), Expect = 1e-13
 Identities = 61/215 (28%), Positives = 96/215 (44%), Gaps = 46/215 (21%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN--EVDILARLR-HKNLVSLYG 124
           +G+G F  V      + G+  A+K + + ++K +EQ  N  E+  L RL  H N++ L  
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 125 CT-SRHSRELLLV--------YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
               R +  L LV        YE I            R +P  LP         +   +L
Sbjct: 66  VLFDRKTGRLALVFELMDMNLYELIKG----------RKRP--LPEKRVKSYMYQLLKSL 113

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF---PNHVTHVST----APQG--T 226
            ++H + I HRD+K  NIL+ ++  +K+ADFG  R     P +  ++ST    AP+   T
Sbjct: 114 DHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLT 172

Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
            GY  P          K D+++ G V  E++S  P
Sbjct: 173 DGYYGP----------KMDIWAVGCVFFEILSLFP 197

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 22/213 (10%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDG-RAVAVKRLYENNYKRVEQFM-----NEVDILARLR 115
           ++   E+G+G +G V+   +L++G R VA+KR+     +  E+ M      EV +L  L 
Sbjct: 3   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRV---RVQTGEEGMPLSTIREVAVLRHLE 59

Query: 116 ---HKNLVSLYG-CT-SRHSRE--LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
              H N+V L+  CT SR  RE  L LV+E +         + ++     +P  T   + 
Sbjct: 60  TFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETIKDMM 116

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L +LH+  ++HRD+K  NIL+ ++  +K+ADFGL+R++   +    T+   T  
Sbjct: 117 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVVTLW 174

Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           Y  PE           D++S G +  E+    P
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 61/196 (31%), Positives = 90/196 (45%), Gaps = 16/196 (8%)

Query: 69  LGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYG 124
           LG G FG V    E   GR  A+K L +        V   + E  +L   RH  L +L  
Sbjct: 3   LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASALTYLHASDI 183
               H R L  V E+ + G +  HL  ER          R +    E  SAL YLH+ D+
Sbjct: 63  AFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSALEYLHSRDV 116

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPEYHQCYQLT 241
           ++RD+K  N++LD +  +K+ DFGL +     ++  +T     GTP Y+ PE  +     
Sbjct: 117 VYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPEVLEDNDYG 173

Query: 242 DKSDVFSFGVVLIELI 257
              D +  GVV+ E++
Sbjct: 174 RAVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 62/223 (27%), Positives = 108/223 (48%), Gaps = 30/223 (13%)

Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYENNY-KRVEQFMNEVDILARL-R 115
            + LG+G FG V   E              VAVK L ++   K +   ++E++++  + +
Sbjct: 17  GKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGK 76

Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
           HKN+++L G  ++     +LV E+ S G + ++L   R  PG              L + 
Sbjct: 77  HKNIINLLGACTQDGPLYVLV-EYASKGNLREYLRARRP-PGMDYSFDTCKLPEEQLTFK 134

Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R   N   +  T 
Sbjct: 135 DLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTT 194

Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELISSMPA 262
               P  ++ PE  + + Y  T +SDV+SFGV+L E+ +   +
Sbjct: 195 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLLWEIFTLGGS 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 64/233 (27%), Positives = 100/233 (42%), Gaps = 41/233 (17%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQ---FMNEVDILARLRHKN 118
           F+  + +G G FG V+   +   G+  A+K L +++  +  Q      E DILA      
Sbjct: 3   FEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPW 62

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP--WPTRLKIAIETASALT 176
           +V LY  + +    L LV E++  G + + L     +    P     R  IA E   AL 
Sbjct: 63  IVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL----IRKDVFPEET-ARFYIA-ELVLALD 115

Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLS------------------RLFPNHVTH 218
            +H    IHRD+K +NIL+D +  +K+ADFGL                    LF ++V  
Sbjct: 116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 219 VSTAPQ----------GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
                +          GTP Y+ PE  +      + D +S GV+L E++   P
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFP 228

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 63/213 (29%), Positives = 96/213 (45%), Gaps = 28/213 (13%)

Query: 63  FDSARELGDGGFGTVYY----GELQDGRAVAVKRLYE----NNYKRVEQFMNEVDILARL 114
           F+  R LG G +G V+     G    G+  A+K L +       K  E    E  +L  +
Sbjct: 2   FELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAV 61

Query: 115 RHKN-LVSLYGCTSRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETA 172
           R    LV+L+      ++ L L+ ++++ G +  HL   E      +    R+ IA E  
Sbjct: 62  RRCPFLVTLHYAFQTDTK-LHLILDYVNGGELFTHLYQREHFTESEV----RVYIA-EIV 115

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
            AL +LH   II+RD+K  NILLD+   V + DFGLS+ F       + +  GT  Y+ P
Sbjct: 116 LALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAP 175

Query: 233 EY-------HQCYQLTDKSDVFSFGVVLIELIS 258
           E        H         D +S GV+  EL++
Sbjct: 176 EVIRGGSGGH-----DKAVDWWSLGVLTFELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 50/144 (34%), Positives = 72/144 (50%), Gaps = 9/144 (6%)

Query: 72  GGFGTVYYG-ELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           G FG VY G +  + +  AVK + +    N   V Q   E D LA  +   +V LY  + 
Sbjct: 15  GAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLY-YSL 73

Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
           + +  + LV E++  G V   LH      G       +K   E A AL YLH   IIHRD
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLH----IYGYFDEEMAVKYISEVALALDYLHRHGIIHRD 129

Query: 188 VKTNNILLDNNFCVKVADFGLSRL 211
           +K +N+L+ N   +K+ DFGLS++
Sbjct: 130 LKPDNMLISNEGHIKLTDFGLSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 63/211 (29%), Positives = 105/211 (49%), Gaps = 25/211 (11%)

Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           ++   +LG+G + TVY G+ + +G+ VA+K  RL E         + E  +L  L+H N+
Sbjct: 7   YEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHANI 65

Query: 120 VSLYGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTY 177
           V L+     H++E L LV+E++      D        PG L  P  +K+ + +    L+Y
Sbjct: 66  VLLHDII--HTKETLTLVFEYVHT----DLCQYMDKHPGGLH-PENVKLFLFQLLRGLSY 118

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL--FPNHV--THVSTAPQGTPGYV--D 231
           +H   I+HRD+K  N+L+ +   +K+ADFGL+R    P+H     V T     P  +   
Sbjct: 119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGS 178

Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELISSMPA 262
            EY  C       D++  G + +E+I  + A
Sbjct: 179 TEYSTCL------DMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 68.8 bits (168), Expect = 3e-13
 Identities = 54/199 (27%), Positives = 95/199 (47%), Gaps = 13/199 (6%)

Query: 67  RELGDGGFGTVYYGELQ-DGR---AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS 121
           R LG G FG +  G L+   +    VA+  L    + K+   F+ E   L +  H N+V 
Sbjct: 11  RILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVR 70

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  +R +  +++V E++SNG +   L   R   G L     + +    AS + YL   
Sbjct: 71  LEGVITRGN-TMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYLSEM 126

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +H+ +  + +L++++   K++ F   RL  +    + T   G     +  PE  Q + 
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHH 184

Query: 240 LTDKSDVFSFGVVLIELIS 258
            +  SDV+SFG+V+ E++S
Sbjct: 185 FSSASDVWSFGIVMWEVMS 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 63/195 (32%), Positives = 90/195 (46%), Gaps = 14/195 (7%)

Query: 69  LGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYG 124
           LG G FG V    E   G+  A+K L +        V   + E  +L   RH  L SL  
Sbjct: 3   LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
                 R L  V E+++ G +  HL  ER         TR   A E  SAL YLH+  I+
Sbjct: 63  SFQTKDR-LCFVMEYVNGGELFFHLSRERVFSED---RTRFYGA-EIVSALDYLHSGKIV 117

Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPEYHQCYQLTD 242
           +RD+K  N++LD +  +K+ DFGL +     +T  +T     GTP Y+ PE  +      
Sbjct: 118 YRDLKLENLMLDKDGHIKITDFGLCK---EGITDAATMKTFCGTPEYLAPEVLEDNDYGR 174

Query: 243 KSDVFSFGVVLIELI 257
             D +  GVV+ E++
Sbjct: 175 AVDWWGLGVVMYEMM 189

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 58/228 (25%), Positives = 106/228 (46%), Gaps = 39/228 (17%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRVEQ-FMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  +  ++E  ++A + +
Sbjct: 9   FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68

Query: 117 KNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGA---LPWPTRLKIAIETA 172
            ++  L G C +     + L+ + +  G + D++   +   G+   L W       ++ A
Sbjct: 69  PHVCRLLGICLTS---TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIA 119

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
             + YL    ++HRD+   N+L+     VK+ DFGL++L    +           G V  
Sbjct: 120 KGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL----LGADEKEYHAEGGKVPI 175

Query: 233 EY-------HQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
           ++       H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 176 KWMALESILHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 221

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 69.5 bits (171), Expect = 4e-13
 Identities = 57/235 (24%), Positives = 99/235 (42%), Gaps = 49/235 (20%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNY-------KRVEQFMNEVDILARLRHKN 118
           + +G G +G V      + GR VA+K++  +N        KR+   + E+ +L  LRH+N
Sbjct: 6   KPIGSGAYGVVCSAVDKRTGRKVAIKKI--SNVFDDLIDAKRI---LREIKLLRHLRHEN 60

Query: 119 LVSLY---GCTSRHS-RELLLVYEF--------ISNGTVADHLHGERAKPGALPWPTRLK 166
           ++ L       S     ++ +V E         I +       H +              
Sbjct: 61  IIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQY------------- 107

Query: 167 IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGT 226
              +    L YLH++++IHRD+K +NIL+++N  +K+ DFGL+R     V          
Sbjct: 108 FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLAR----GVDPDEDEKGFL 163

Query: 227 PGYV------DPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
             YV       PE         K+ D++S G +  EL++  P      +  ++NL
Sbjct: 164 TEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNL 218

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 69.4 bits (170), Expect = 4e-13
 Identities = 55/229 (24%), Positives = 104/229 (45%), Gaps = 15/229 (6%)

Query: 67  RELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLY-- 123
           R LG G  G V+     D  + VAVK++   + + V+  + E+ I+ RL H N+V +Y  
Sbjct: 11  RPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEV 70

Query: 124 --GCTSRHSRELLLVYEFISNGTVADHLHGERAK---PGALPWPTRLKIAIETASALTYL 178
                S  + ++  + E  S   V +++  + A     G L          +    L Y+
Sbjct: 71  LGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYI 130

Query: 179 HASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQG--TPGYVDPE-Y 234
           H+++++HRD+K  N+ ++  +  +K+ DFGL+R+   H +H     +G  T  Y  P   
Sbjct: 131 HSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLL 190

Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ 283
                 T   D+++ G +  E+++  P   +    HE+    L +  + 
Sbjct: 191 LSPNNYTKAIDMWAAGCIFAEMLTGKP---LFAGAHELEQMQLILESVP 236

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 55/198 (27%), Positives = 91/198 (45%), Gaps = 13/198 (6%)

Query: 68  ELGDGGFGTV---YYGELQDGRAVAVKRLY--ENNYKRVEQFMNEVDILARLRHKNLVSL 122
           ELG G FGTV    Y   +  + VAVK L    N+    ++ + E +++ +L +  +V +
Sbjct: 2   ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
            G     S   +LV E    G     L+    K   +      ++  + +  + YL  ++
Sbjct: 62  IGICEAES--WMLVMELAELGP----LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN 115

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGT-P-GYVDPEYHQCYQL 240
            +HRD+   N+LL      K++DFGLS+       +      G  P  +  PE    Y+ 
Sbjct: 116 FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKF 175

Query: 241 TDKSDVFSFGVVLIELIS 258
           + KSDV+SFGV++ E  S
Sbjct: 176 SSKSDVWSFGVLMWEAFS 193

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 68.1 bits (166), Expect = 5e-13
 Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 18/207 (8%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++  + +G G +G VY    L  G   AVK +             E+ ++   +H N+V+
Sbjct: 11  YELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVA 70

Query: 122 LYGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI---ETASALTY 177
            +G  S  SRE L +  E+   G++ D  H      G L   + L+IA    ET   L Y
Sbjct: 71  YFG--SYLSREKLWICMEYCGGGSLQDIYH----VTGPL---SELQIAYVCRETLQGLAY 121

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           LH+   +HRD+K  NILL +N  VK+ADFG++      +    +   GTP ++ PE    
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFI-GTPYWMAPEVAAV 180

Query: 238 YQ---LTDKSDVFSFGVVLIELISSMP 261
            +        D+++ G+  IEL    P
Sbjct: 181 EKNGGYNQLCDIWAVGITAIELAELQP 207

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 68.5 bits (168), Expect = 6e-13
 Identities = 51/161 (31%), Positives = 70/161 (43%), Gaps = 27/161 (16%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRL------YENNYKRVEQFMNEVDILARLR 115
           F   + LG G  G V+   L+  G+  A+K L        N  KRV     E +ILA L 
Sbjct: 3   FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVL---TEQEILATLD 59

Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK-PGALPWPTRLKI------A 168
           H  L +LY  + +    L LV ++   G     L     + PG       L        A
Sbjct: 60  HPFLPTLY-ASFQTETYLCLVMDYCPGG----ELFRLLQRQPG-----KCLSEEVARFYA 109

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS 209
            E   AL YLH   I++RD+K  NILL  +  + ++DF LS
Sbjct: 110 AEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLS 150

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 68.3 bits (167), Expect = 7e-13
 Identities = 48/152 (31%), Positives = 75/152 (49%), Gaps = 10/152 (6%)

Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           H  LV L+ C    SR L  V EF+S G +  H+  +R     LP       + E + AL
Sbjct: 55  HPFLVGLHSCFQTESR-LFFVIEFVSGGDLMFHMQRQRK----LPEEHARFYSAEISLAL 109

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPE 233
            +LH   II+RD+K +N+LLD    +K+ D+G+ +  + P   T       GTP Y+ PE
Sbjct: 110 NFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFC---GTPNYIAPE 166

Query: 234 YHQCYQLTDKSDVFSFGVVLIELISSMPAVDI 265
             +        D ++ GV++ E+++     DI
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 67.9 bits (166), Expect = 7e-13
 Identities = 57/200 (28%), Positives = 95/200 (47%), Gaps = 11/200 (5%)

Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKN 118
           F   R LG GGFG V   +++  G+  A K+L +   K+ +     +NE  IL ++  + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF 61

Query: 119 LVSL-YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           +VSL Y   ++ +  L LV   ++ G +  H++              +  A E    L  
Sbjct: 62  VVSLAYAYETKDA--LCLVLTLMNGGDLKFHIY--NMGNPGFDEERAVFYAAEITCGLED 117

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           LH   I++RD+K  NILLD+   ++++D GL+   P   T       GT GY+ PE  + 
Sbjct: 118 LHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRV--GTVGYMAPEVVKN 175

Query: 238 YQLTDKSDVFSFGVVLIELI 257
            + T   D +  G ++ E+I
Sbjct: 176 ERYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 67.9 bits (166), Expect = 9e-13
 Identities = 67/230 (29%), Positives = 109/230 (47%), Gaps = 41/230 (17%)

Query: 57  EEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQF----MNEVDIL 111
           +   + FD   ++G+G +G VY    +D G  VA+K++  +N K  E F    + E+ IL
Sbjct: 3   KRCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKIL 60

Query: 112 ARLRHKNLVSLYGCTS---------RHSRELLLVYEF--------ISNGTVADHLHGERA 154
            +L H+N+V+L    +         +      LV+E+        + +G V  H   +  
Sbjct: 61  RQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLV--HFSEDHI 118

Query: 155 KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN 214
           K       + +K  +E    L Y H  + +HRD+K +NILL+N   +K+ADFGL+RL+ +
Sbjct: 119 K-------SFMKQLLE---GLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168

Query: 215 HVTHVSTAPQGTPGYVDPEY---HQCYQLTDKSDVFSFGVVLIELISSMP 261
             +   T    T  Y  PE     + Y      DV+S G +L EL +  P
Sbjct: 169 EESRPYTNKVITLWYRPPELLLGEERY--GPAIDVWSCGCILGELFTKKP 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 11/200 (5%)

Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKN 118
           F   R LG GGFG V   +++  G+  A KRL +   K+ +     +NE  IL ++  + 
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF 61

Query: 119 LVSL-YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           +V+L Y   ++ +  L LV   ++ G +  H++     PG       L  A E    L  
Sbjct: 62  VVNLAYAYETKDA--LCLVLTIMNGGDLKFHIY-NMGNPG-FEEERALFYAAEILCGLED 117

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           LH  + ++RD+K  NILLD+   ++++D GL+   P           GT GY+ PE    
Sbjct: 118 LHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE--GESIRGRVGTVGYMAPEVLNN 175

Query: 238 YQLTDKSDVFSFGVVLIELI 257
            + T   D +  G ++ E+I
Sbjct: 176 QRYTLSPDYWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 58/208 (27%), Positives = 95/208 (45%), Gaps = 20/208 (9%)

Query: 69  LGDGGFGTVYYGELQDGRA-------VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLV 120
           LG G FG VY G   D          VAVK L +    +  ++F+ E  +++   H N+V
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAK---PGALPWPTRLKIAIETASALT 176
            L G C     + +++  E +  G +  +L   R +   P  L     L I ++ A    
Sbjct: 63  KLLGVCLLNEPQYIIM--ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120

Query: 177 YLHASDIIHRDVKTNNILL-----DNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYV 230
           YL     IHRD+   N L+     D +  VK+ DFGL+R ++ +              ++
Sbjct: 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWM 180

Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELIS 258
            PE     + T +SDV+SFGV++ E+++
Sbjct: 181 APESLLDGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 67.8 bits (165), Expect = 1e-12
 Identities = 54/197 (27%), Positives = 92/197 (46%), Gaps = 11/197 (5%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARLRHKNLV 120
           F+   ELG G  G V+    +    +  ++L     K     Q + E+ +L       +V
Sbjct: 7   FEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             YG       E+ +  E +  G++   L     K G +P     K++I     LTYL  
Sbjct: 67  GFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE 121

Query: 181 S-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              I+HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ PE  Q   
Sbjct: 122 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTH 178

Query: 240 LTDKSDVFSFGVVLIEL 256
            + +SD++S G+ L+E+
Sbjct: 179 YSVQSDIWSMGLSLVEM 195

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (164), Expect = 2e-12
 Identities = 59/199 (29%), Positives = 94/199 (47%), Gaps = 14/199 (7%)

Query: 69  LGDGGFGTVYYGELQDGRAV----AVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           +G G FG V     +D + +     +++ +  +   V   + E  +LA++    +V L  
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 125 CTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHASD 182
             S  S E L LV  FI+ G +  HL  E    G     +R +    E   AL  LH  +
Sbjct: 60  -FSFQSPEKLYLVLAFINGGELFHHLQRE----GRFD-LSRARFYTAELLCALENLHKFN 113

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           +I+RD+K  NILLD    + + DFGL +L        +T   GTP Y+ PE    +  T 
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFC-GTPEYLAPELLLGHGYTK 172

Query: 243 KSDVFSFGVVLIELISSMP 261
             D ++ GV+L E+++ +P
Sbjct: 173 AVDWWTLGVLLYEMLTGLP 191

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 67.5 bits (165), Expect = 2e-12
 Identities = 63/204 (30%), Positives = 97/204 (47%), Gaps = 16/204 (7%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRAV-AVKRLYENNY-KRVEQ--FMNEVDILARLRHKN 118
           FD  + +G G FG V     +  + V A+K L +    KR +   F  E DI+A    + 
Sbjct: 45  FDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEW 104

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +V L+    +  + L +V E++  G + + L      P    W  R   A E   AL  +
Sbjct: 105 IVQLH-YAFQDDKYLYMVMEYMPGGDLVN-LMSNYDIPEK--W-ARFYTA-EVVLALDAI 158

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H+   IHRDVK +N+LLD +  +K+ADFG   ++  N +    TA  GTP Y+ PE  + 
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-VGTPDYISPEVLKS 217

Query: 238 Y----QLTDKSDVFSFGVVLIELI 257
                    + D +S GV L E++
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 26/217 (11%)

Query: 62  YFDSARELGDGGFGTV---YYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARLR- 115
            ++  +ELG G +G V      E  +   VA+K++     K++  ++ + E+ +L   R 
Sbjct: 1   RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60

Query: 116 HKNLVSLYG---CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ET 171
           HKN+  LY        +  EL L YE +    +   +   +    A       +  I + 
Sbjct: 61  HKNITCLYDMDIVFPGNFNELYL-YEELMEADLHQIIRSGQPLTDA-----HFQSFIYQI 114

Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
              L Y+H+++++HRD+K  N+L++ +  +K+ DFGL+R F         A   T  YV 
Sbjct: 115 LCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF--SENPGENAGFMT-EYVA 171

Query: 232 ------PEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
                 PE    +Q   K+ DV+S G +L EL+   P
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKP 208

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 66.5 bits (162), Expect = 3e-12
 Identities = 65/200 (32%), Positives = 93/200 (46%), Gaps = 22/200 (11%)

Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYG 124
           +G G FG VY    +D  R  A+K L +      K V   + E +IL R        + G
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 125 C--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHAS 181
              + +   +L LV +++S G +  HL     K G      R K  I E   AL +LH  
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQ----KEGRFS-EDRAKFYIAELVLALEHLHKY 115

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEY---HQ 236
           DI++RD+K  NILLD    + + DFGLS+  L  N  T+      GT  Y+ PE     +
Sbjct: 116 DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFC---GTTEYLAPEVLLDEK 172

Query: 237 CYQLTDKSDVFSFGVVLIEL 256
            Y  T   D +S GV++ E+
Sbjct: 173 GY--TKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 65.0 bits (158), Expect = 6e-12
 Identities = 66/224 (29%), Positives = 102/224 (45%), Gaps = 22/224 (9%)

Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT- 126
           +G GGFG VY     D G+  A+K L   + KR++    E   L      +LVS   C  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 127 ------SRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
                 + H+ + L  + + ++ G +  HL    ++ G          A E    L ++H
Sbjct: 59  IVCMTYAFHTPDKLCFILDLMNGGDLHYHL----SQHGVFSEKEMRFYATEIILGLEHMH 114

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              +++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ PE  Q   
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGT 171

Query: 240 LTDKS-DVFSFGVVLIELISSMPAV--DITRHRHEINLSNLAIN 280
             D S D FS G +L +L+          T+ +HEI+   L +N
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVN 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 65.0 bits (158), Expect = 7e-12
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 8/204 (3%)

Query: 61  NYFDSARELGDGGFGTVYYGELQDGRA-VAVKRL--YENNYKRVEQFMNEVDILARLRHK 117
           N F+    +G+G +G V     ++ +  VA+K+    E N +  E  + E+ +L  L+ +
Sbjct: 1   NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60

Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           N+V L     R  + L LV+E++    +      E    G  P   R  I  +   A+ +
Sbjct: 61  NIVELKEAFRRRGK-LYLVFEYVEKNMLELL---EEMPNGVPPEKVRSYI-YQLIKAIHW 115

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
            H +DI+HRD+K  N+L+ +N  +K+ DFG +R          T    T  Y  PE    
Sbjct: 116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLG 175

Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                  D++S G +L EL    P
Sbjct: 176 APYGKAVDMWSVGCILGELSDGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 65.5 bits (160), Expect = 9e-12
 Identities = 51/169 (30%), Positives = 79/169 (46%), Gaps = 23/169 (13%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN---EVDILARLRHKN 118
           F+S + +G G FG V   + +D G   A+K+L ++     EQ  +   E DILA   +  
Sbjct: 3   FESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPW 62

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVA------DHLHGERAKPGALPWPTRLKIAIETA 172
           +V LY  + +    L L+ E++  G +       D    E          TR  IA ET 
Sbjct: 63  VVKLY-YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEE---------TRFYIA-ETI 111

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST 221
            A+  +H    IHRD+K +N+LLD    +K++DFGL        +H + 
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGL--KKSHRTE 158

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 64.8 bits (158), Expect = 9e-12
 Identities = 57/207 (27%), Positives = 101/207 (48%), Gaps = 17/207 (8%)

Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
           F    +LG+G + TVY G  +  G  VA+K ++ +  +      + E+ ++  L+H+N+V
Sbjct: 2   FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIV 61

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVAD-----HLHGERAKPGALPWPTRLKIAIETASAL 175
            L+      ++ L+LV+E++      D       HG R   GAL   T      +    +
Sbjct: 62  RLHDVIHTENK-LMLVFEYMDK----DLKKYMDTHGVR---GALDPNTVKSFTYQLLKGI 113

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            + H + ++HRD+K  N+L++    +K+ADFGL+R F   V   S     T  Y  P+  
Sbjct: 114 AFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVV-TLWYRAPDVL 172

Query: 236 QCYQLTDKS-DVFSFGVVLIELISSMP 261
              +    S D++S G ++ E+I+  P
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRP 199

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 64.6 bits (157), Expect = 9e-12
 Identities = 57/199 (28%), Positives = 91/199 (45%), Gaps = 9/199 (4%)

Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKN 118
           F   R LG GGFG V   +++  G+  A K+L +   K+ +     +NE  IL ++  + 
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF 61

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +VSL          L LV   ++ G +  H++     PG       +  A E    L  L
Sbjct: 62  VVSL-AYAYETKDALCLVLTIMNGGDLKFHIY-NMGNPG-FDEQRAIFYAAELCCGLEDL 118

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
               I++RD+K  NILLD+   ++++D GL+   P   T       GT GY+ PE     
Sbjct: 119 QRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET--VRGRVGTVGYMAPEVINNE 176

Query: 239 QLTDKSDVFSFGVVLIELI 257
           + T   D +  G ++ E+I
Sbjct: 177 KYTFSPDWWGLGCLIYEMI 195

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 52/197 (26%), Positives = 90/197 (45%), Gaps = 11/197 (5%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARLRHKNLV 120
           F+   ELG G  G V   + +    +  ++L     K     Q + E+ +L       +V
Sbjct: 7   FERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 66

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             YG       E+ +  E +  G++   L   +     +P     K++I     L YL  
Sbjct: 67  GFYGAFYSDG-EISICMEHMDGGSLDQVLKEAKR----IPEEILGKVSIAVLRGLAYLRE 121

Query: 181 S-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              I+HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ PE  Q   
Sbjct: 122 KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTH 178

Query: 240 LTDKSDVFSFGVVLIEL 256
            + +SD++S G+ L+EL
Sbjct: 179 YSVQSDIWSMGLSLVEL 195

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 7/147 (4%)

Query: 67  RELGDGGFGTVYYGELQDGRAVA---VKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSL 122
           +E+G+G FG V   E+     VA   VK L  N + K   +F+ + D    L+H N++  
Sbjct: 1   QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQC 60

Query: 123 YG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
            G C    +   LLV+E+   G +  +L  E+            ++A E A+ +T++H  
Sbjct: 61  LGQCV--EAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH 118

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGL 208
           + +H D+   N  L ++  VKV D+G+
Sbjct: 119 NFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 50/230 (21%), Positives = 94/230 (40%), Gaps = 51/230 (22%)

Query: 69  LGDGGFGTVY-YGELQDGRAVAVKRL----YENNYKRVEQF----------MNEVDILAR 113
           LG+G +G V    +   G+ VA+K++      N+  +  Q           + E+ I+  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK------I 167
           ++H+N++ L         ++ +  +FI+   V D +  +  K   +    RL       I
Sbjct: 77  IKHENIMGL--------VDVYVEGDFIN--LVMDIMASDLKK--VVDRKIRLTESQVKCI 124

Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
            ++  + L  LH    +HRD+   NI +++    K+ADFGL+R +       + +   T 
Sbjct: 125 LLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 228 G-------------YVDPEY---HQCYQLTDKSDVFSFGVVLIELISSMP 261
                         Y  PE     + Y      D++S G +  EL++  P
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKY--HFAVDMWSVGCIFAELLTGKP 232

Length = 335

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 64/213 (30%), Positives = 107/213 (50%), Gaps = 22/213 (10%)

Query: 59  ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRH 116
           AT+Y +   +LG+G + TVY G  + +G+ VA+K +     + V    + E  +L  L+H
Sbjct: 4   ATSYLN-LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH 62

Query: 117 KNLVSLYGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGAL-PWPTRLKIAIETASA 174
            N+V L+     H++E L  V+E++    +A ++      PG L P+  RL    +    
Sbjct: 63  ANIVLLHDII--HTKETLTFVFEYMHT-DLAQYM---IQHPGGLHPYNVRL-FMFQLLRG 115

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL--FPNHVTHVSTAPQGTPGYVDP 232
           L Y+H   I+HRD+K  N+L+     +K+ADFGL+R    P   +   ++   T  Y  P
Sbjct: 116 LAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIP---SQTYSSEVVTLWYRPP 172

Query: 233 EYHQCYQLTDKS---DVFSFGVVLIELISSMPA 262
           +       TD S   D++  G + IE++   PA
Sbjct: 173 DV--LLGATDYSSALDIWGAGCIFIEMLQGQPA 203

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 63.7 bits (155), Expect = 2e-11
 Identities = 68/205 (33%), Positives = 100/205 (48%), Gaps = 23/205 (11%)

Query: 69  LGDGGFGTVY-----YGELQDGRAVAVKRLYENNYK---RVEQFMNEVDILARLRHKNLV 120
           LG G FG V+      G    G+  A+K L +   K   RV   M E DILA + H  +V
Sbjct: 4   LGQGSFGKVFLVRKITGP-DAGQLYAMKVLKKATLKVRDRVRTKM-ERDILAEVNHPFIV 61

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLH 179
            L+       + L L+ +F+  G +   L  E      +     +K  + E A AL +LH
Sbjct: 62  KLHYAFQTEGK-LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALALDHLH 115

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPEYHQC 237
           +  II+RD+K  NILLD    +K+ DFGLS+     + H   A    GT  Y+ PE    
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAPEVVNR 172

Query: 238 YQLTDKSDVFSFGVVLIELIS-SMP 261
              T  +D +SFGV++ E+++ S+P
Sbjct: 173 RGHTQSADWWSFGVLMFEMLTGSLP 197

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 41/168 (24%), Positives = 81/168 (48%), Gaps = 25/168 (14%)

Query: 63  FDSARELGDGGFGTVYYG---ELQDGRAVAVKRLYENNYKRVEQF----MNEVDILARLR 115
           ++    +G G +G VY       +DG+  A+K+ ++ + ++          E+ +L  L+
Sbjct: 2   YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKK-FKGDKEQYTGISQSACREIALLRELK 60

Query: 116 HKNLVSLYG-CTSRHSRELLLVYEFISNGTVADH------LHGERAKPGALPWPTRLKIA 168
           H+N+VSL         + + L++++      A+H          +AK  ++P      + 
Sbjct: 61  HENVVSLVEVFLEHADKSVYLLFDY------AEHDLWQIIKFHRQAKRVSIPPSMVKSLL 114

Query: 169 IETASALTYLHASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLF 212
            +  + + YLH++ ++HRD+K  NIL+         VK+ D GL+RLF
Sbjct: 115 WQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 53/197 (26%), Positives = 101/197 (51%), Gaps = 12/197 (6%)

Query: 69  LGDGGFGTVYYG-ELQDGRA----VAVKRLYENNYKRV-EQFMNEVDILARLRHKNLVSL 122
           LG G FGTV+ G  + +G +    VA+K + + + ++  ++  + +  +  L H  +V L
Sbjct: 15  LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
            G     S  L LV +    G++ DH+   R    +L     L   ++ A  + YL    
Sbjct: 75  LGICPGAS--LQLVTQLSPLGSLLDHV---RQHRDSLDPQRLLNWCVQIAKGMYYLEEHR 129

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           ++HR++   NILL ++  V++ADFG++  L+P+   +  +  +    ++  E     + T
Sbjct: 130 MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYT 189

Query: 242 DKSDVFSFGVVLIELIS 258
            +SDV+S+GV + E++S
Sbjct: 190 HQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 63.6 bits (155), Expect = 3e-11
 Identities = 49/157 (31%), Positives = 75/157 (47%), Gaps = 13/157 (8%)

Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP 162
           Q + E+ +L       +V  YG       E+ +  E +  G++   L     K G +P  
Sbjct: 45  QIIRELKVLHECNSPYIVGFYG-AFYSDGEISICMEHMDGGSLDQVLK----KAGRIPEN 99

Query: 163 TRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST 221
              KI+I     LTYL     I+HRDVK +NIL+++   +K+ DFG+S          S 
Sbjct: 100 ILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL-----IDSM 154

Query: 222 APQ--GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
           A    GT  Y+ PE  Q    T +SD++S G+ L+E+
Sbjct: 155 ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEM 191

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 57/202 (28%), Positives = 98/202 (48%), Gaps = 17/202 (8%)

Query: 67  RELGDGGFGTVY-YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKNLVS-- 121
           R +G G FG V+   + +DG+ VA+K++     N    ++   E+ +L   +H N++S  
Sbjct: 6   RPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSAL 65

Query: 122 --LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYL 178
             L         E+ +V E + +      LH     P  L     +K+ + +    L YL
Sbjct: 66  DILQPPHIDPFEEIYVVTELMQS-----DLHKIIVSPQPLS-SDHVKVFLYQILRGLKYL 119

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPE-YHQ 236
           H++ I+HRD+K  N+L+++N  +K+ DFGL+R+  P+   H+ T    T  Y  PE    
Sbjct: 120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHM-TQEVVTQYYRAPEILMG 178

Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
               T   D++S G +  EL+ 
Sbjct: 179 SRHYTSAVDIWSVGCIFAELLG 200

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 50/180 (27%), Positives = 92/180 (51%), Gaps = 18/180 (10%)

Query: 88  VAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTV-- 145
           V  K +  N+ ++     +E+  LA   H  +V  +    +   +LLL+ E+ S G +  
Sbjct: 96  VVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFD-DFKSDDKLLLIMEYGSGGDLNK 154

Query: 146 ------ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF 199
                  +HL  +  + G L +   L        AL  +H+  ++HRD+K+ NI L    
Sbjct: 155 QIKQRLKEHLPFQEYEVGLLFYQIVL--------ALDEVHSRKMMHRDLKSANIFLMPTG 206

Query: 200 CVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
            +K+ DFG S+ + + V+  V+++  GTP Y+ PE  +  + + K+D++S GV+L EL++
Sbjct: 207 IIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLT 266

Length = 478

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 63.5 bits (155), Expect = 4e-11
 Identities = 58/230 (25%), Positives = 103/230 (44%), Gaps = 45/230 (19%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQ-FMNEVDILARLRHKNLVSLYGCT 126
           +G+G +G V        G  VA+K++    ++   Q  + E+ IL R +H+N++ +    
Sbjct: 13  IGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDII 72

Query: 127 SRHS----RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS--------- 173
              S     ++ +V E +                      T L   I+T           
Sbjct: 73  RPPSFESFNDVYIVQELM---------------------ETDLYKLIKTQHLSNDHIQYF 111

Query: 174 ------ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV-THVSTAPQG 225
                  L Y+H+++++HRD+K +N+LL+ N  +K+ DFGL+R+  P H  T   T    
Sbjct: 112 LYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVA 171

Query: 226 TPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           T  Y  PE     +   K+ D++S G +L E++S+ P      + H++NL
Sbjct: 172 TRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNL 221

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 51/224 (22%), Positives = 96/224 (42%), Gaps = 37/224 (16%)

Query: 56  LEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLY-----ENNYKRVEQFMNEVD 109
           + E  + + +   +G G +G V        GR VA+K+L        + KR  +   E+ 
Sbjct: 10  VWEVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYR---ELR 66

Query: 110 ILARLRHKNLVSLYGC-----TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
           +L  + H+N++ L        +    +++ LV   +     AD  +  + +        +
Sbjct: 67  LLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLMG----ADLNNIVKCQ--------K 114

Query: 165 LK------IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH 218
           L       +  +    L Y+H++ IIHRD+K +NI ++ +  +K+ DFGL+R    H   
Sbjct: 115 LSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR----HTDD 170

Query: 219 VSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMP 261
             T    T  Y  PE    +       D++S G ++ EL++   
Sbjct: 171 EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKT 214

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.1 bits (148), Expect = 1e-10
 Identities = 65/224 (29%), Positives = 101/224 (45%), Gaps = 22/224 (9%)

Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT- 126
           +G GGFG VY     D G+  A+K L   + KR++    E   L      +LVS   C  
Sbjct: 2   IGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSLVSTGDCPF 58

Query: 127 ------SRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
                 + H+ + L  + + ++ G +  HL    ++ G          A E    L ++H
Sbjct: 59  IVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEAEMRFYAAEIILGLEHMH 114

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              +++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ PE  Q   
Sbjct: 115 NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMAPEVLQKGV 171

Query: 240 LTDKS-DVFSFGVVLIELISSMPAVD--ITRHRHEINLSNLAIN 280
             D S D FS G +L +L+          T+ +HEI+   L + 
Sbjct: 172 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA 215

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 61.6 bits (149), Expect = 1e-10
 Identities = 60/195 (30%), Positives = 88/195 (45%), Gaps = 13/195 (6%)

Query: 69  LGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYG 124
           LG G FG V    E   GR  A+K L +        V   + E  +L   RH  L +L  
Sbjct: 3   LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASALTYLHAS-D 182
               H R L  V E+ + G +  HL  ER          R +    E  SAL YLH+  +
Sbjct: 63  SFQTHDR-LCFVMEYANGGELFFHLSRERVFS-----EDRARFYGAEIVSALDYLHSEKN 116

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           +++RD+K  N++LD +  +K+ DFGL +        + T   GTP Y+ PE  +      
Sbjct: 117 VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEVLEDNDYGR 175

Query: 243 KSDVFSFGVVLIELI 257
             D +  GVV+ E++
Sbjct: 176 AVDWWGLGVVMYEMM 190

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 18/205 (8%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQ--FMNEVDILARLRHKN 118
           +D  + +G G FG V     +  + V   +L       KR +   F  E DI+A      
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +V L+ C  +  + L +V E++  G + + +           + T      E   AL  +
Sbjct: 105 VVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYT-----AEVVLALDAI 158

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H+  +IHRDVK +N+LLD +  +K+ADFG   ++    +    TA  GTP Y+ PE  + 
Sbjct: 159 HSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTA-VGTPDYISPEVLKS 217

Query: 238 YQLTD-----KSDVFSFGVVLIELI 257
            Q  D     + D +S GV L E++
Sbjct: 218 -QGGDGYYGRECDWWSVGVFLFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 60.7 bits (147), Expect = 2e-10
 Identities = 54/197 (27%), Positives = 99/197 (50%), Gaps = 15/197 (7%)

Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKNLVSL-Y 123
           LG GGFG V   ++++ G+  A K+L +   K+    +  + E +IL ++    +V+L Y
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAY 60

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALTYLHAS 181
              S+    L LV   ++ G +  H++  GER     L     +  + +    + +LH+ 
Sbjct: 61  AFESK--THLCLVMSLMNGGDLKYHIYNVGERG----LEMERVIHYSAQITCGILHLHSM 114

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           DI++RD+K  N+LLD+    +++D GL+    +  T   T   GT GY+ PE  +    +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRAGTNGYMAPEILKEEPYS 172

Query: 242 DKSDVFSFGVVLIELIS 258
              D F+ G  + E+++
Sbjct: 173 YPVDWFAMGCSIYEMVA 189

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 61.1 bits (149), Expect = 2e-10
 Identities = 46/163 (28%), Positives = 83/163 (50%), Gaps = 25/163 (15%)

Query: 62  YFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN---------EVDIL 111
            ++  ++LG G +G V+   + +    VA+K++++        F N         E+  L
Sbjct: 8   KYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFD-------AFRNATDAQRTFREIMFL 60

Query: 112 ARLR-HKNLVSLYGC-TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
             L  H N+V L     + + +++ LV+E++      D LH    +   L    +  I  
Sbjct: 61  QELGDHPNIVKLLNVIKAENDKDIYLVFEYME----TD-LH-AVIRANILEDVHKRYIMY 114

Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF 212
           +   AL Y+H+ ++IHRD+K +NILL+++  VK+ADFGL+R  
Sbjct: 115 QLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSL 157

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 60.6 bits (147), Expect = 3e-10
 Identities = 62/206 (30%), Positives = 93/206 (45%), Gaps = 20/206 (9%)

Query: 67  RELGDGGFGTVYYGELQDG----RAVAVKRLYE----NNYKRVEQFMNEVDILARLRHKN 118
           + LG GG+G V+      G    +  A+K L +     N K       E +IL  ++H  
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPF 61

Query: 119 LVSL-YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           +V L Y   +    +L L+ E++S G +  HL  E    G     T      E + AL +
Sbjct: 62  IVDLIYAFQT--GGKLYLILEYLSGGELFMHLERE----GIFMEDTACFYLSEISLALEH 115

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYH 235
           LH   II+RD+K  NILLD    VK+ DFGL +  +    VTH      GT  Y+ PE  
Sbjct: 116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFC---GTIEYMAPEIL 172

Query: 236 QCYQLTDKSDVFSFGVVLIELISSMP 261
                    D +S G ++ ++++  P
Sbjct: 173 MRSGHGKAVDWWSLGALMYDMLTGAP 198

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 58/228 (25%), Positives = 97/228 (42%), Gaps = 37/228 (16%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKN 118
           +D  R +G GG G VY   +    R VA+K++ E+   N    ++F+ E  I A L H  
Sbjct: 4   YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63

Query: 119 LVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALP--------WPTRLKI 167
           +V +Y   S        VY    +I   T+   L     K  +L             L I
Sbjct: 64  IVPVYSICSDGD----PVYYTMPYIEGYTLKSLLKSVWQKE-SLSKELAEKTSVGAFLSI 118

Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL--------------FP 213
             +  + + Y+H+  ++HRD+K +NILL     V + D+G +                  
Sbjct: 119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDER 178

Query: 214 NHVTHVSTAPQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
           N      T P    GTP Y+ PE       ++ +D+++ GV+L ++++
Sbjct: 179 NICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLT 226

Length = 932

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 61.3 bits (148), Expect = 4e-10
 Identities = 60/239 (25%), Positives = 108/239 (45%), Gaps = 38/239 (15%)

Query: 53  YGELEEATNYFDSARELGDGGFGTVYY------GELQDGRAVAVKRLYENNYKRVEQFMN 106
           Y + E   N ++  +++G+G FG V+        E    +A++ + L E   +   Q + 
Sbjct: 5   YDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKE---REKSQLVI 61

Query: 107 EVDILARLRHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRL 165
           EV+++  L+HKN+V       ++ +++L ++ EF   G ++ ++       G +     +
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIV 121

Query: 166 KIAIETASALTYLH-------ASDIIHRDVKTNNILLD-------------NNF----CV 201
            I  +   AL Y H          ++HRD+K  NI L              NN       
Sbjct: 122 DITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIA 181

Query: 202 KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY--HQCYQLTDKSDVFSFGVVLIELIS 258
           K+ DFGLS+     +  ++ +  GTP Y  PE   H+     DKSD+++ G ++ EL S
Sbjct: 182 KIGDFGLSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCS 238

Length = 1021

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 64/261 (24%), Positives = 101/261 (38%), Gaps = 71/261 (27%)

Query: 67  RELGDGGFGTVY----YGELQDGRA--VAVKRLYENNYKRVEQ-FMNEVDILARL-RHKN 118
           + LG G FG V     +G  +      VAVK L E       +  M+E+ IL  +  H N
Sbjct: 13  KVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLN 72

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH---------------------------- 150
           +V+L G  ++ +  L+++ EF   G +++ L                             
Sbjct: 73  VVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSR 132

Query: 151 ---------------------GERAKPGALP---WPTRLKI------AIETASALTYLHA 180
                                     P       W + L +      + + A  + +L +
Sbjct: 133 VDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLAS 192

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPE--YHQC 237
              IHRD+   NILL  N  VK+ DFGL+R       +V       P  ++ PE  + + 
Sbjct: 193 RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKV 252

Query: 238 YQLTDKSDVFSFGVVLIELIS 258
           Y  T +SDV+SFGV+L E+ S
Sbjct: 253 Y--TTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 59.4 bits (144), Expect = 6e-10
 Identities = 58/222 (26%), Positives = 105/222 (47%), Gaps = 46/222 (20%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQ--------FMNEVDILAR 113
           ++   ++G+G +G VY   +      +A+K++      R+EQ         + E+ +L  
Sbjct: 4   YEKVEKIGEGTYGVVYKARDRVTNETIALKKI------RLEQEDEGVPSTAIREISLLKE 57

Query: 114 LRHKNLVSLYGCTSRHS-RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ET 171
           ++H N+V L      HS + L LV+E++ +  +  H+    + P     P  +K  + + 
Sbjct: 58  MQHGNIVRLQDVV--HSEKRLYLVFEYL-DLDLKKHMD---SSPDFAKNPRLIKTYLYQI 111

Query: 172 ASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHV---TH-VST----A 222
              + Y H+  ++HRD+K  N+L+D     +K+ADFGL+R F   V   TH V T    A
Sbjct: 112 LRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRA 171

Query: 223 PQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           P+   G+  Y  P            D++S G +  E+++  P
Sbjct: 172 PEILLGSRHYSTP-----------VDIWSVGCIFAEMVNQKP 202

Length = 294

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 60.1 bits (145), Expect = 7e-10
 Identities = 57/273 (20%), Positives = 100/273 (36%), Gaps = 55/273 (20%)

Query: 18  KHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGD---GGF 74
              AS L F     + +  V L            +  +L+    +    R + D   G F
Sbjct: 114 DSDASHLDFDEAPPDAAGPVPL------------AQAKLKHDDEFLAHFRVIDDLPAGAF 161

Query: 75  GTV-------YYGELQDGRAVA------------VKRLYENNYKRVEQFMNEVDILARLR 115
           G +          E +  R V             + +  +   +   Q  NE+  L RL 
Sbjct: 162 GKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN 221

Query: 116 HKNLVSL----------YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRL 165
           H+N++ +          Y  T ++  +L   Y F+ +            K   L   TR 
Sbjct: 222 HENILKIEEILRSEANTYMITQKYDFDL---YSFMYDEAF-------DWKDRPLLKQTR- 270

Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG 225
            I  +   A+ Y+H   +IHRD+K  NI L+ +  + + DFG +  F            G
Sbjct: 271 AIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVG 330

Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
           T     PE        + +D++S G++L++++S
Sbjct: 331 TVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 59.7 bits (144), Expect = 7e-10
 Identities = 64/237 (27%), Positives = 100/237 (42%), Gaps = 43/237 (18%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN---EVDILARLRHKN 118
           F+S + +G G FG V   + +D G   A+K L + +    EQ  +   E DIL       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAW 62

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +V ++  + +  R L L+ EF+  G +   L     K       T+  IA ET  A+  +
Sbjct: 63  VVKMF-YSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIA-ETVLAIDAI 117

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGL--------SRLFPNHVTH------------ 218
           H    IHRD+K +N+LLD    VK++DFGL           F  ++TH            
Sbjct: 118 HQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 219 --------------VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
                         ++ +  GTP Y+ PE           D +S GV++ E++   P
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 58.6 bits (142), Expect = 9e-10
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 29/211 (13%)

Query: 67  RELGDGGFGTVYYGELQ---DGRAVA-------VKRLYENNYKRVEQFMNEVDILARLRH 116
             LG G F  +Y G L+   D   V        V ++  ++++    F     ++++L H
Sbjct: 1   EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSH 60

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           K+LV LYG   R   E ++V E++  G +   LH E+       W  +L +A + ASAL 
Sbjct: 61  KHLVKLYGVCVR--DENIMVEEYVKFGPLDVFLHREKNNVSLH-W--KLDVAKQLASALH 115

Query: 177 YLHASDIIHRDVKTNNILL-------DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           YL    ++H +V   NIL+            +K++D G+     +    V   P     +
Sbjct: 116 YLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSREERVERIP-----W 170

Query: 230 VDPEYHQCYQ--LTDKSDVFSFGVVLIELIS 258
           + PE  +  Q  LT  +D +SFG  L+E+ S
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICS 201

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 15/160 (9%)

Query: 104 FMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPT 163
           F     ++ ++ HK++V LYG   R   E ++V EF+  G +   +H  ++     PW  
Sbjct: 51  FFETASMMRQVSHKHIVLLYGVCVRD-VENIMVEEFVEFGPLDLFMH-RKSDVLTTPW-- 106

Query: 164 RLKIAIETASALTYLHASDIIHRDVKTNNILL-----DNNF--CVKVADFGLSRLFPNHV 216
           + K+A + ASAL+YL   D++H +V T NILL     D      +K++D G+     +  
Sbjct: 107 KFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ 166

Query: 217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
             V   P   P  V+        L+  +D +SFG  L E+
Sbjct: 167 ECVERIPWIAPECVE----DSKNLSIAADKWSFGTTLWEI 202

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 54/207 (26%), Positives = 92/207 (44%), Gaps = 19/207 (9%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQ--FMNEVDILARLRHKN 118
           F+  + +G G FG V   +L++   V   ++       KR E   F  E D+L    ++ 
Sbjct: 3   FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQW 62

Query: 119 LVSLYGCTSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           + +L+    +    L LV ++   G   T+         +  A  +   + IAI++   L
Sbjct: 63  ITTLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            Y      +HRD+K +NIL+D N  +++ADFG         T  S+   GTP Y+ PE  
Sbjct: 122 HY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 175

Query: 236 QCYQ-----LTDKSDVFSFGVVLIELI 257
           Q  +        + D +S GV + E++
Sbjct: 176 QAMEDGKGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 57.9 bits (140), Expect = 2e-09
 Identities = 50/168 (29%), Positives = 81/168 (48%), Gaps = 23/168 (13%)

Query: 63  FDSARELGDGGFGTV-YYGELQDGRAVAVKRLYENNYKRVEQFMN---EVDILARLRHKN 118
           F + + +G G FG V    +   G+  A+K L ++   + +Q  +   E D+LA      
Sbjct: 3   FHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPW 62

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP------TRLKIAIETA 172
           +VSLY  + + ++ L L+ EF+  G +   L         + +       TR  +A E  
Sbjct: 63  VVSLY-YSFQDAQYLYLIMEFLPGGDLMTML---------IKYDTFSEDVTRFYMA-ECV 111

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS 220
            A+  +H    IHRD+K +NIL+D    +K++DFGLS  F  H  H S
Sbjct: 112 LAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGF--HKQHDS 157

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 57.8 bits (139), Expect = 2e-09
 Identities = 58/220 (26%), Positives = 97/220 (44%), Gaps = 39/220 (17%)

Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVE------QFMNEVDILARLRHKNLVS 121
           ++G G +G VY  + +DG     K   E   K++E          E+ +L  L+H N+++
Sbjct: 8   KVGRGTYGHVYKAKRKDG-----KDEKEYALKQIEGTGISMSACREIALLRELKHPNVIA 62

Query: 122 LYGCTSRHS-RELLLVYEFISNGT--VADHLHGERA--KPGALPWPTRLKIAIETASALT 176
           L      HS R++ L++++  +    +       +A  KP  LP      +  +    + 
Sbjct: 63  LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122

Query: 177 YLHASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLF-----------PNHVTHVST 221
           YLHA+ ++HRD+K  NIL+         VK+AD G +RLF           P  VT    
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYR 182

Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           AP+   G            T   D+++ G +  EL++S P
Sbjct: 183 APELLLG--------ARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 57.5 bits (139), Expect = 2e-09
 Identities = 39/154 (25%), Positives = 70/154 (45%), Gaps = 11/154 (7%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKN----LVS 121
           +G+G +G VY   +   G+ VA+K  RL  +        + E+ +L  L        L+ 
Sbjct: 9   IGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLD 68

Query: 122 LYGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIETASALTYLH 179
           +     ++ +  L LV+E++ +  +   +      PG  LP  T      +    + + H
Sbjct: 69  VEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127

Query: 180 ASDIIHRDVKTNNILLDNN-FCVKVADFGLSRLF 212
              ++HRD+K  N+L+D     +K+AD GL R F
Sbjct: 128 KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 68/250 (27%), Positives = 96/250 (38%), Gaps = 57/250 (22%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRAV-AVKRLYEN---NYKRVEQFMNEVDILARLRHKN 118
           F   + LG G FG V      D  A+ A+K L +    N  +V     E DILA   ++ 
Sbjct: 3   FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62

Query: 119 LVSLYGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           +V LY   S   ++ L  V ++I  G +   L      P  L    R  IA E   A+  
Sbjct: 63  VVKLY--YSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVL---ARFYIA-ELTLAIES 116

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-----------NHVTHVSTAPQ-- 224
           +H    IHRD+K +NIL+D +  +K+ DFGL   F            +H+   S  P   
Sbjct: 117 VHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176

Query: 225 ---------------------------------GTPGYVDPEYHQCYQLTDKSDVFSFGV 251
                                            GTP Y+ PE       T   D +S GV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236

Query: 252 VLIELISSMP 261
           +L E++   P
Sbjct: 237 ILFEMLVGQP 246

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 57.4 bits (139), Expect = 3e-09
 Identities = 55/238 (23%), Positives = 98/238 (41%), Gaps = 62/238 (26%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRL---YEN--NYKRVEQFMNEVDILARLRHKNLVSL 122
           +G G +G V      +    VA+K++   ++N  + KR    + E+ +L  L H+N++++
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRT---LREIKLLRHLDHENVIAI 69

Query: 123 YGCTSRHSRE----LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT-- 176
                   RE    + +VYE +                      T L   I ++  L+  
Sbjct: 70  KDIMPPPHREAFNDVYIVYELMD---------------------TDLHQIIRSSQTLSDD 108

Query: 177 --------------YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
                         Y+H+++++HRD+K +N+LL+ N  +K+ DFGL+R      T     
Sbjct: 109 HCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR------TTSEKG 162

Query: 223 PQGTPGYVDPEYH------QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL 274
              T   V   Y        C + T   DV+S G +  EL+   P      + H++ L
Sbjct: 163 DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKL 220

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 56.9 bits (137), Expect = 3e-09
 Identities = 63/209 (30%), Positives = 100/209 (47%), Gaps = 20/209 (9%)

Query: 63  FDSARELGDGGFGTVYY----GELQDGRAVAVKRLYE----NNYKRVEQFMNEVDILARL 114
           F+  + LG G +G V+          G+  A+K L +       K  E    E  +L  +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 61

Query: 115 RHKN-LVSLYGCTSRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAI-ET 171
           R    LV+L+      ++ L L+ ++I+ G +  HL   ER K         ++I   E 
Sbjct: 62  RQSPFLVTLHYAFQTDTK-LHLILDYINGGELFTHLSQRERFKE------QEVQIYSGEI 114

Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
             AL +LH   II+RD+K  NILLD+N  V + DFGLS+ F       + +  GT  Y+ 
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMA 174

Query: 232 PEYHQCYQLT-DKS-DVFSFGVVLIELIS 258
           P+  +      DK+ D +S GV++ EL++
Sbjct: 175 PDIVRGGDGGHDKAVDWWSMGVLMYELLT 203

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 45/146 (30%), Positives = 75/146 (51%), Gaps = 9/146 (6%)

Query: 68  ELGDGGFGTVYYGELQ-DGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           +LG+G + TV+ G  +     VA+K +  E+        + EV +L  L+H N+V+L+  
Sbjct: 12  KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHASDII 184
                R L LV+E++ +      L       G L     +KI + +    L+Y H   I+
Sbjct: 72  I-HTERCLTLVFEYLDS-----DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125

Query: 185 HRDVKTNNILLDNNFCVKVADFGLSR 210
           HRD+K  N+L++    +K+ADFGL+R
Sbjct: 126 HRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 62/247 (25%), Positives = 93/247 (37%), Gaps = 55/247 (22%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRAV-AVKRLYENNYKRVEQFMN---EVDILARLRHKN 118
           F   + +G G FG V      D  A+ A+K L + +     Q  +   E DILA   ++ 
Sbjct: 3   FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62

Query: 119 LVSLYGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAIETASALT 176
           +V LY   S   ++ L  V ++I  G +   L     + G       R  IA E   A+ 
Sbjct: 63  VVKLY--YSFQDKDNLYFVMDYIPGGDMMSLL----IRLGIFEEDLARFYIA-ELTCAIE 115

Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGL----------------------SRLFPN 214
            +H    IHRD+K +NIL+D +  +K+ DFGL                      S     
Sbjct: 116 SVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSE 175

Query: 215 HVTHVSTAPQ--------------------GTPGYVDPEYHQCYQLTDKSDVFSFGVVLI 254
             + +                         GTP Y+ PE       T   D +S GV+L 
Sbjct: 176 EWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235

Query: 255 ELISSMP 261
           E++   P
Sbjct: 236 EMLVGQP 242

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 56.4 bits (136), Expect = 6e-09
 Identities = 38/104 (36%), Positives = 55/104 (52%), Gaps = 10/104 (9%)

Query: 160 PWPTRLKIAIETA--SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT 217
           P P    + IE      L YLHA  IIHRDVKT NI +++   V + D G ++ FP    
Sbjct: 153 PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQ-FPV--- 208

Query: 218 HVSTAPQGTPGYVD---PEYHQCYQLTDKSDVFSFGVVLIELIS 258
            V+ A  G  G V+   PE     +   K+D++S G+VL E+++
Sbjct: 209 -VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 56.2 bits (135), Expect = 7e-09
 Identities = 56/217 (25%), Positives = 97/217 (44%), Gaps = 33/217 (15%)

Query: 68  ELGDGGFGTVYYGELQDGRA---VAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           ++G G +G VY  + +DG+     A+K++             E+ +L  L+H N++SL  
Sbjct: 8   KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISM--SACREIALLRELKHPNVISLQK 65

Query: 125 CTSRHS-RELLLVYEFISNGT--VADHLHGERA--KPGALPWPTRLKIAIETASALTYLH 179
               H+ R++ L++++  +    +       +A  KP  LP      +  +    + YLH
Sbjct: 66  VFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 180 ASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLF-----------PNHVTHVSTAPQ 224
           A+ ++HRD+K  NIL+         VK+AD G +RLF           P  VT    AP+
Sbjct: 126 ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPE 185

Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
              G            T   D+++ G +  EL++S P
Sbjct: 186 LLLG--------ARHYTKAIDIWAIGCIFAELLTSEP 214

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 56.4 bits (136), Expect = 7e-09
 Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           + + A  + +L +   IHRD+   NILL  N  VK+ DFGL+R       +V       P
Sbjct: 179 SFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238

Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
             ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 239 LKWMAPESIFDKVY--TTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 62/237 (26%), Positives = 99/237 (41%), Gaps = 43/237 (18%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN---EVDILARLRHKN 118
           F+S + +G G FG V   + +D G   A+K L + +    EQ  +   E DIL       
Sbjct: 3   FESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLW 62

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +V ++  + +    L L+ EF+  G +   L     K       T+  IA ET  A+  +
Sbjct: 63  VVKMF-YSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIA-ETVLAIDSI 117

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFG----------------LSRLFPNHVT----- 217
           H    IHRD+K +N+LLD+   VK++DFG                L+   P+  T     
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 218 -------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
                         ++ +  GTP Y+ PE           D +S GV++ E++   P
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 58/206 (28%), Positives = 97/206 (47%), Gaps = 15/206 (7%)

Query: 63  FDSARELGDGGFGTVYY----GELQDGRAVAVKRLYE----NNYKRVEQFMNEVDILARL 114
           F+  + LG G +G V+          G+  A+K L +       K VE    E ++L  +
Sbjct: 2   FELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHV 61

Query: 115 RHKN-LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
           R    LV+L+      ++ L L+ +++S G +  HL+             R     E   
Sbjct: 62  RQSPFLVTLHYAFQTEAK-LHLILDYVSGGEMFTHLYQRDNFSED---EVRFYSG-EIIL 116

Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
           AL +LH   I++RD+K  NILLD+   V + DFGLS+ F +     + +  GT  Y+ PE
Sbjct: 117 ALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPE 176

Query: 234 YHQCYQLTDKS-DVFSFGVVLIELIS 258
             +      K+ D +S G+++ EL++
Sbjct: 177 IIRGKGGHGKAVDWWSLGILIFELLT 202

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 66/249 (26%), Positives = 97/249 (38%), Gaps = 55/249 (22%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRAV-AVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG G FG V      D +A+ A+K L + +     +V     E DILA   ++ 
Sbjct: 3   FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEW 62

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +V LY  + +    L  V ++I  G +   L      P  L    R  IA E   A+  +
Sbjct: 63  VVRLY-YSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDL---ARFYIA-ELTCAVESV 117

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGL------------------------------ 208
           H    IHRD+K +NIL+D +  +K+ DFGL                              
Sbjct: 118 HKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW 177

Query: 209 ---------SRLFP-------NHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVV 252
                     RL P        H   ++ +  GTP Y+ PE       T   D +S GV+
Sbjct: 178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVI 237

Query: 253 LIELISSMP 261
           L E++   P
Sbjct: 238 LYEMLVGQP 246

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 55.5 bits (134), Expect = 1e-08
 Identities = 44/157 (28%), Positives = 77/157 (49%), Gaps = 33/157 (21%)

Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQ-------FMNEVDILARLRHKNLV 120
           LG+G + TVY G  +  G+ VA+K +      R+E         + E  +L  L+H N+V
Sbjct: 13  LGEGSYATVYKGRSKLTGQLVALKEI------RLEHEEGAPFTAIREASLLKDLKHANIV 66

Query: 121 SLYGCTSRHSRELL-LVYEFISNGTVADHLHGERAK-----PGALPWPTRLKIAI-ETAS 173
           +L+     H+++ L LV+E+         L  +  +      G L     +++ + +   
Sbjct: 67  TLHDII--HTKKTLTLVFEY---------LDTDLKQYMDDCGGGLS-MHNVRLFLFQLLR 114

Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR 210
            L Y H   ++HRD+K  N+L+     +K+ADFGL+R
Sbjct: 115 GLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 55.6 bits (134), Expect = 1e-08
 Identities = 57/213 (26%), Positives = 86/213 (40%), Gaps = 30/213 (14%)

Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKN 118
           FD    +G G FG V    E   G   A+K + ++     + V  F  E DIL+      
Sbjct: 3   FDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPW 62

Query: 119 LVSL-YGCTSRHSRELLLVYEFISNGTV-------ADHLHGERAKPGALPWPTRLKIAIE 170
           +  L Y    + +  L LV E+   G +        D    + A         +  +A E
Sbjct: 63  IPQLQYAFQDKDN--LYLVMEYQPGGDLLSLLNRYEDQFDEDMA---------QFYLA-E 110

Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
              A+  +H    +HRD+K  N+L+D    +K+ADFG +     +    S  P GTP Y+
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYI 170

Query: 231 DPEYHQCYQLTDKS------DVFSFGVVLIELI 257
            PE         K       D +S GV+  E+I
Sbjct: 171 APEVLTTMNGDGKGTYGVECDWWSLGVIAYEMI 203

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 18/205 (8%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQ--FMNEVDILARLRHKN 118
           ++  + +G G FG V     +  R V   +L       KR +   F  E DI+A      
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +V L+    +  R L +V E++  G + + L      P    W  R   A E   AL  +
Sbjct: 105 VVQLF-YAFQDDRYLYMVMEYMPGGDLVN-LMSNYDVPEK--W-ARFYTA-EVVLALDAI 158

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H+   IHRDVK +N+LLD +  +K+ADFG   ++    +    TA  GTP Y+ PE  + 
Sbjct: 159 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKS 217

Query: 238 YQLTD-----KSDVFSFGVVLIELI 257
            Q  D     + D +S GV L E++
Sbjct: 218 -QGGDGYYGRECDWWSVGVFLYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 45/164 (27%), Positives = 63/164 (38%), Gaps = 38/164 (23%)

Query: 63  FDSARELGDGGFGTVYYGELQD-----GRAVAVKRLYENNYKRVEQFMNEVDILARLRH- 116
           F   ++LG+G FG VY   L +          +K+  E  Y  VE +MNE     R+R  
Sbjct: 134 FVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATE--YGAVEIWMNE-----RVRRA 186

Query: 117 ------KNLVSLYGCTSRHSR-ELLLVYEFISNGTVADHLHGER-----------AKPGA 158
                   +       S     E  LV+ +    T+AD L   +            K   
Sbjct: 187 CPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLAD-LMQSKEFPYNVEPYLLGKVQD 245

Query: 159 LP-WPTRLKIAIETA-----SALTYLHASDIIHRDVKTNNILLD 196
           LP    R    I+T       AL  LH++ I+HRDVK  NI+  
Sbjct: 246 LPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFS 289

Length = 566

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 31/210 (14%)

Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVSLYG-- 124
           +G+G FG VY     D    VA+K++ ++      Q+ N E+ I+  L H N++ L    
Sbjct: 74  IGNGSFGVVYEAICIDTSEKVAIKKVLQD-----PQYKNRELLIMKNLNHINIIFLKDYY 128

Query: 125 ---CTSRHSRELLL--VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
              C  ++ + + L  V EFI   TV  ++        ALP       + +   AL Y+H
Sbjct: 129 YTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIH 187

Query: 180 ASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           +  I HRD+K  N+L+D N   +K+ DFG ++           A Q +  Y+   +++  
Sbjct: 188 SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL--------LAGQRSVSYICSRFYRAP 239

Query: 239 QL-------TDKSDVFSFGVVLIELISSMP 261
           +L       T   D++S G ++ E+I   P
Sbjct: 240 ELMLGATNYTTHIDLWSLGCIIAEMILGYP 269

Length = 440

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 54.9 bits (132), Expect = 3e-08
 Identities = 32/97 (32%), Positives = 53/97 (54%), Gaps = 5/97 (5%)

Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
           L+ + + A  + +L + + IHRDV   N+LL +    K+ DFGL+R   N   +V     
Sbjct: 215 LRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274

Query: 225 GTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
             P  ++ PE  +   Y  T +SDV+S+G++L E+ S
Sbjct: 275 RLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 5/94 (5%)

Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           + + A  + +L +   IHRD+   NILL  N  VK+ DFGL+R       +V       P
Sbjct: 185 SFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244

Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
             ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 245 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 54.3 bits (131), Expect = 4e-08
 Identities = 26/93 (27%), Positives = 51/93 (54%), Gaps = 16/93 (17%)

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN-------HVT-HVSTAPQGT 226
           L Y+H++++IHRD+K +N+L++ +  +++ DFG++R   +        +T +V+T     
Sbjct: 120 LKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRA 179

Query: 227 PG--YVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           P      PEY      T   D++S G +  E++
Sbjct: 180 PELLLSLPEY------TTAIDMWSVGCIFAEML 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 53.8 bits (129), Expect = 4e-08
 Identities = 55/220 (25%), Positives = 99/220 (45%), Gaps = 33/220 (15%)

Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLY-----ENNYKRVEQFMNEVDIL 111
           E  + +   +++G G +GTV    + + G  VA+K+LY     E   KR  +   E+ +L
Sbjct: 12  EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYR---ELRLL 68

Query: 112 ARLRHKNLVSLYGCTSRHS-----RELLLVYEFISN--GTVADH--LHGERAKPGALPWP 162
             ++H+N++ L    +         +  LV  F+    G +  H  L  +R +       
Sbjct: 69  KHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQ------- 121

Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
               +  +    L Y+HA+ IIHRD+K  N+ ++ +  +K+ DFGL+R          T 
Sbjct: 122 ---FLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTG 174

Query: 223 PQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMP 261
              T  Y  PE    +   T   D++S G ++ E+++  P
Sbjct: 175 YVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 53.7 bits (129), Expect = 7e-08
 Identities = 50/164 (30%), Positives = 63/164 (38%), Gaps = 33/164 (20%)

Query: 107 EVDILARLRHK---NLVSLYGCTS------RHSRELLLVYEFISNGTVADHLHGERAKPG 157
           E+DIL  + H+   NL+  Y   S         +  L  Y   S               G
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKCDLFTYVDRS---------------G 180

Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT 217
            LP    + I      AL YLH   IIHRDVKT NI LD      + DFG +     H  
Sbjct: 181 PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP- 239

Query: 218 HVSTAPQ-----GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
                PQ     GT     PE         K+D++S G+VL E+
Sbjct: 240 ---DTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.5 bits (126), Expect = 7e-08
 Identities = 55/213 (25%), Positives = 93/213 (43%), Gaps = 30/213 (14%)

Query: 69  LGDGGFGTVYYG---ELQDGRA-----VAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
           LG G F  ++ G   E+ D        V +K L +++    E F     ++++L HK+LV
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
             YG C      E ++V E++  G++  +L   +       W  +L++A + A AL +L 
Sbjct: 63  LNYGVCVC--GDESIMVQEYVKFGSLDTYLKKNKNLINIS-W--KLEVAKQLAWALHFLE 117

Query: 180 ASDIIHRDVKTNNILL--------DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
              + H +V   N+LL         N   +K++D G+S         +   P     +V 
Sbjct: 118 DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEILLERIP-----WVP 172

Query: 232 PE-YHQCYQLTDKSDVFSFGVVLIELIS--SMP 261
           PE       L+  +D +SFG  L E+ S    P
Sbjct: 173 PECIENPQNLSLAADKWSFGTTLWEIFSGGDKP 205

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 56/227 (24%), Positives = 102/227 (44%), Gaps = 21/227 (9%)

Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
           E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L  +
Sbjct: 14  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73

Query: 115 RHKNLVSLYGCTS--RHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
           +H+N++ L    +  R   E   VY       +  HL G       K   L       + 
Sbjct: 74  KHENVIGLLDVFTPARSLEEFNDVY-------LVTHLMGADLNNIVKCQKLTDDHVQFLI 126

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 127 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 182

Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 183 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 229

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 32/97 (32%), Positives = 54/97 (55%), Gaps = 5/97 (5%)

Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
           L  + + A  +++L + + IHRD+   NILL +    K+ DFGL+R   N   +V     
Sbjct: 217 LSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 225 GTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
             P  ++ PE  ++  Y  T +SDV+S+G++L E+ S
Sbjct: 277 RLPVKWMAPESIFNCVY--TFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 52.5 bits (126), Expect = 1e-07
 Identities = 57/212 (26%), Positives = 99/212 (46%), Gaps = 29/212 (13%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYE-NNYKRVEQ--FMNEVDILARLRHKN 118
           F+  + +G G FG V   ++++ G+  A+K L +    KR E   F  E D+L     + 
Sbjct: 3   FEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRW 62

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTV-------ADHLHGERAKPGALPWPTRLKIAIET 171
           + +L+    +    L LV ++   G +        D L  + A+     +   + +AI++
Sbjct: 63  ITNLH-YAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARF----YLAEMVLAIDS 117

Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYV 230
              L Y      +HRD+K +N+LLD N  +++ADFG   RL  +     + A  GTP Y+
Sbjct: 118 VHQLGY------VHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVA-VGTPDYI 170

Query: 231 DPEYHQCYQ-----LTDKSDVFSFGVVLIELI 257
            PE  Q  +        + D +S GV + E++
Sbjct: 171 SPEILQAMEDGKGRYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 49/206 (23%), Positives = 83/206 (40%), Gaps = 26/206 (12%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           +   D     +   +      VAVK+  L   + + ++    E+    +L+H N++    
Sbjct: 8   KCFEDLMIVHLAKHK-PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVT 66

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI---ETASALTYLHAS 181
                S EL +V   ++ G+  D L  +   P  LP    L IA    +  +AL Y+H+ 
Sbjct: 67  SFIVDS-ELYVVSPLMAYGSCEDLL--KTHFPEGLP---ELAIAFILKDVLNALDYIHSK 120

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH-----------VTHVSTAPQGTPGYV 230
             IHR VK ++ILL  +  V ++    S     H            + V   P  +P  +
Sbjct: 121 GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVL 180

Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIEL 256
                  Y   +KSD++S G+   EL
Sbjct: 181 QQNLQG-Y--NEKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 51.8 bits (125), Expect = 1e-07
 Identities = 39/151 (25%), Positives = 63/151 (41%), Gaps = 25/151 (16%)

Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           + N + LY   +   +  +L+ ++I +G + D L  E     A     + KI  +   AL
Sbjct: 68  NPNFIKLYYSVTT-LKGHVLIMDYIKDGDLFDLLKKEGKLSEAE---VK-KIIRQLVEAL 122

Query: 176 TYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE- 233
             LH  +IIH D+K  N+L D     + + D+GL +     +    +   GT  Y  PE 
Sbjct: 123 NDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCK-----IIGTPSCYDGTLDYFSPEK 177

Query: 234 -YHQCYQLTDKSDVFSF-----GVVLIELIS 258
                Y         SF     GV+  EL++
Sbjct: 178 IKGHNYD-------VSFDWWAVGVLTYELLT 201

Length = 267

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 5/93 (5%)

Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           E   A+  +H    +HRD+K +N+LLD N  +++ADFG         T  S+   GTP Y
Sbjct: 110 EMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDY 169

Query: 230 VDPEYHQCYQ-----LTDKSDVFSFGVVLIELI 257
           + PE  Q  +        + D +S GV + E++
Sbjct: 170 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEML 202

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 51.9 bits (124), Expect = 2e-07
 Identities = 43/147 (29%), Positives = 75/147 (51%), Gaps = 11/147 (7%)

Query: 68  ELGDGGFGTVYYG--ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           +LG+G + TV+ G  +L +   VA+K +  E+        + EV +L  L+H N+V+L+ 
Sbjct: 13  KLGEGTYATVFKGRSKLTEN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHASDI 183
                 + L LV+E++        L       G +     +KI + +    L Y H   +
Sbjct: 72  IV-HTDKSLTLVFEYLDK-----DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKV 125

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR 210
           +HRD+K  N+L++    +K+ADFGL+R
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 51.7 bits (124), Expect = 2e-07
 Identities = 54/270 (20%), Positives = 108/270 (40%), Gaps = 40/270 (14%)

Query: 77  VYYGELQDGRAVAVKRL--YENNYKR-VEQFMNEVDILARLRHKNLVSLYGCTSRHSREL 133
           +Y G   + + V ++    +   +K  ++   NE+  L R+   N++ +YG       +L
Sbjct: 36  IYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDL 94

Query: 134 ---LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD-IIHRDVK 189
               L+ E+ + G + + L  E+     L + T+L +AI+    L  L+      ++++ 
Sbjct: 95  PRLSLILEYCTRGYLREVLDKEK----DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLT 150

Query: 190 TNNILLDNNFCVKVADFGLSRLFP----NHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           + + L+  N+ +K+   GL ++       +V  +          +  EY      T K D
Sbjct: 151 SVSFLVTENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEY------TIKDD 204

Query: 246 VFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRR 305
           ++S GVVL E+         T     I   NL   +I +  +++     L          
Sbjct: 205 IYSLGVVLWEI--------FTGK---IPFENLTTKEIYDLIINKNNSLKL----PLDCPL 249

Query: 306 TINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
            I  + E    C   +   RP + ++L  L
Sbjct: 250 EIKCIVE---ACTSHDSIKRPNIKEILYNL 276

Length = 283

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 51.5 bits (123), Expect = 2e-07
 Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 11/147 (7%)

Query: 68  ELGDGGFGTVYYG--ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           +LG+G + TVY G  +L D   VA+K +  E+        + EV +L  L+H N+V+L+ 
Sbjct: 13  KLGEGTYATVYKGRSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 71

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHASDI 183
                 + L LV+E++        L       G       +K+ + +    L Y H   +
Sbjct: 72  IIHTE-KSLTLVFEYLDK-----DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKV 125

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR 210
           +HRD+K  N+L++    +K+ADFGL+R
Sbjct: 126 LHRDLKPQNLLINERGELKLADFGLAR 152

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 50.8 bits (121), Expect = 5e-07
 Identities = 54/227 (23%), Positives = 99/227 (43%), Gaps = 33/227 (14%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKNL 119
           +   + +G G  G V    +   G  VAVK+L     N    ++   E+ +L  + HKN+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 120 VSLYGC-----TSRHSRELLLVYEFI-SNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
           +SL        +    +++ LV E + +N     H+  +  +   L +        +   
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLY--------QMLC 134

Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAPQGT 226
            + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP+  
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194

Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
            G             +  D++S G ++ EL+        T H  + N
Sbjct: 195 LG---------MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 50.5 bits (120), Expect = 6e-07
 Identities = 50/213 (23%), Positives = 98/213 (46%), Gaps = 37/213 (17%)

Query: 63  FDSARELGDGGFGTV--YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77

Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        +    +++ LV E +       +   L  ER             +  +
Sbjct: 78  IISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 127

Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R          T+   TP YV
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMMTP-YV 179

Query: 231 DPEYHQCYQL------TDKSDVFSFGVVLIELI 257
              Y++  ++       +  D++S G ++ E++
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.8 bits (121), Expect = 6e-07
 Identities = 31/97 (31%), Positives = 51/97 (52%), Gaps = 5/97 (5%)

Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
           L    + A  + +L + + +HRD+   N+LL     VK+ DFGL+R   +   +VS    
Sbjct: 240 LSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGST 299

Query: 225 GTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
             P  ++ PE  +   Y  T  SDV+S+G++L E+ S
Sbjct: 300 FLPVKWMAPESIFDNLY--TTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 50.5 bits (121), Expect = 6e-07
 Identities = 50/204 (24%), Positives = 95/204 (46%), Gaps = 16/204 (7%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKNLVS---- 121
           +G G +G V    +   G  VA+K++ +   +     + + E+ +L  LRH ++V     
Sbjct: 8   IGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHI 67

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           +   + R  +++ +V+E + +      LH        L          +   AL Y+H +
Sbjct: 68  MLPPSRREFKDIYVVFELMES-----DLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTA 122

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRL-FPNHVTHVS-TAPQGTPGYVDPEYHQCY- 238
           ++ HRD+K  NIL + +  +K+ DFGL+R+ F +  T +  T    T  Y  PE    + 
Sbjct: 123 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 182

Query: 239 -QLTDKSDVFSFGVVLIELISSMP 261
            + T   D++S G +  E+++  P
Sbjct: 183 SKYTPAIDIWSIGCIFAEVLTGKP 206

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 30/104 (28%), Positives = 56/104 (53%), Gaps = 5/104 (4%)

Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT 217
           AL +   +  + + A+ + +L + + +HRD+   N+L+     VK+ DFGL+R       
Sbjct: 235 ALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSN 294

Query: 218 HVSTAPQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
           ++S      P  ++ PE  ++  Y  T  SDV+SFG++L E+ +
Sbjct: 295 YISKGSTFLPLKWMAPESIFNNLY--TTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.4 bits (115), Expect = 4e-06
 Identities = 34/108 (31%), Positives = 52/108 (48%), Gaps = 7/108 (6%)

Query: 151 GERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR 210
           G R +P  L   T   +A +  SA+ Y+H   IIHRD+KT N+L++    + + DFG + 
Sbjct: 251 GARLRPLGLAQVT--AVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAAC 308

Query: 211 LFPNHVTHVSTAPQGTPGYVD---PEYHQCYQLTDKSDVFSFGVVLIE 255
                 +  +    G  G VD   PE       T   D++S G+V+ E
Sbjct: 309 FARG--SWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 44/164 (26%), Positives = 81/164 (49%), Gaps = 23/164 (14%)

Query: 104 FMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPT 163
           F     +++++ H +L  ++G   R S E ++V EF+ +G +   L  E+   G +P   
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCVRGS-ENIMVEEFVEHGPLDVCLRKEK---GRVPVAW 118

Query: 164 RLKIAIETASALTYLHASDIIHRDVKTNNILL------DNNF-CVKVADFGLSRLFPNHV 216
           ++ +A + ASAL+YL   +++H +V   NILL      +     +K++D G+S    +  
Sbjct: 119 KITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSRE 178

Query: 217 THVSTAPQGTPGYVDPEYHQCYQ----LTDKSDVFSFGVVLIEL 256
             V   P     ++ PE   C      L+  +D +SFG  L+E+
Sbjct: 179 ERVERIP-----WIAPE---CVPGGNSLSTAADKWSFGTTLLEI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 47.4 bits (113), Expect = 5e-06
 Identities = 27/90 (30%), Positives = 51/90 (56%), Gaps = 14/90 (15%)

Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
            + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R          T+   TP YV   
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------AGTSFMMTP-YVVTR 181

Query: 234 YHQCYQL------TDKSDVFSFGVVLIELI 257
           Y++  ++       +  D++S G ++ E+I
Sbjct: 182 YYRAPEVILGMGYKENVDIWSVGCIMGEMI 211

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 41/215 (19%)

Query: 63  FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
           + + + +G G  G V   Y   L+  R VA+K+L     N    ++   E+ ++  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83

Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAI 169
           N++ L    T + S E    + +V E +       +   L  ER             +  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS----------YLLY 133

Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
           +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193

Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           P+   G             +  D++S G ++ E+I
Sbjct: 194 PEVILG---------MGYKENVDIWSVGCIMGEMI 219

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 46.0 bits (109), Expect = 1e-05
 Identities = 46/208 (22%), Positives = 97/208 (46%), Gaps = 26/208 (12%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARLRHKNL 119
           + S +++G G +G+V    + + G  VA+K+L       +  ++   E+ +L  ++H+N+
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 120 VSLY----GCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ET 171
           + L        S    +   L++ Y       +  H   E           +++  + + 
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSED----------KVQYLVYQM 126

Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
              L Y+H++ IIHRD+K  N+ ++ +  +K+ DFGL+R    H     T    T  Y  
Sbjct: 127 LCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWYRA 182

Query: 232 PEYHQCYQLTDKS-DVFSFGVVLIELIS 258
           PE    +   +++ D++S G ++ E+++
Sbjct: 183 PEVILNWMHYNQTVDIWSVGCIMAEMLT 210

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 39/151 (25%), Positives = 66/151 (43%), Gaps = 8/151 (5%)

Query: 107 EVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK 166
           E  IL  + H +++ L G  + +    L++  + ++      L+   A    +     L 
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTD------LYCYLAAKRNIAICDILA 186

Query: 167 IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT-HVSTAPQG 225
           I      A+ YLH + IIHRD+K  NI +++   V + DFG +  FP  +  +      G
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWAG 245

Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
           T     PE           D++S G+VL E+
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEM 276

Length = 391

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 44.2 bits (104), Expect = 5e-05
 Identities = 48/213 (22%), Positives = 84/213 (39%), Gaps = 33/213 (15%)

Query: 69  LGDGGFGTVYYGE-----------------LQDGRAVAVKRLYENNYK--RVEQFMNEVD 109
           +G GGFG VY  +                 L++   V    +Y N Y   ++  + N  +
Sbjct: 20  IGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHN 79

Query: 110 ILARLRHKNLVSLYGCTS-RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
           I     H  +   YGC S +  R   + Y FI    + ++      +           I 
Sbjct: 80  I----DHLGIPKYYGCGSFKRCR---MYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIM 132

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---- 224
            +  + L Y+H   I H D+K  NI++D N    + D+G++  F  H  H+  + +    
Sbjct: 133 KDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDL 192

Query: 225 --GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIE 255
             GT  Y   + H    +T + D+ S G  +++
Sbjct: 193 HRGTLYYAGLDAHNGACVTRRGDLESLGYCMLK 225

Length = 294

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 42.0 bits (99), Expect = 1e-04
 Identities = 35/155 (22%), Positives = 56/155 (36%), Gaps = 20/155 (12%)

Query: 64  DSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS-- 121
            S + L  G    VY    +D   V +K     + ++      EV IL  L  K L    
Sbjct: 1   SSIKLLKGGLTNRVYLLGTKDEDYV-LKIN--PSREKGADREREVAILQLLARKGLPVPK 57

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           +   +        L+ E+I  G   D +  E           +  IA + A  L  LH  
Sbjct: 58  VL-ASGESDGWSYLLMEWIE-GETLDEVSEE----------EKEDIAEQLAELLAKLHQL 105

Query: 182 DI---IHRDVKTNNILLDNNFCVKVADFGLSRLFP 213
            +    H D+   NIL+D+   + + D+  +   P
Sbjct: 106 PLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGP 140

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 47/211 (22%), Positives = 94/211 (44%), Gaps = 23/211 (10%)

Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
           E    + +   +G G +G+V    + +  + VAVK+L     +     +   E+ +L  +
Sbjct: 12  EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHM 71

Query: 115 RHKNLVSLYGC-TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
           +H+N++ L    T   S E       ++N   AD       K   L       +  +   
Sbjct: 72  KHENVIGLLDVFTPATSIENFNEVYLVTNLMGADL--NNIVKCQKLSDEHVQFLIYQLLR 129

Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
            L Y+H++ IIHRD+K +N+ ++ +  +++ DFGL+R   + +T          GYV   
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT----------GYVATR 179

Query: 234 YHQCYQL-------TDKSDVFSFGVVLIELI 257
           +++  ++           D++S G ++ EL+
Sbjct: 180 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 210

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 40.6 bits (95), Expect = 6e-04
 Identities = 34/141 (24%), Positives = 54/141 (38%), Gaps = 25/141 (17%)

Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           A E   AL  LH   I+ RD+  NNILLD+   +++  F                     
Sbjct: 91  AAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS---------RWSEVEDSCDG 141

Query: 228 GYVD-----PEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD-----ITRHRHEINLSNL 277
             V+     PE     + T+  D +S G +L EL++    V+     I  H      + L
Sbjct: 142 EAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGINTH------TTL 195

Query: 278 AINKIQNKALHELVDQTLGYE 298
            I +  ++    L+ Q L + 
Sbjct: 196 NIPEWVSEEARSLLQQLLQFN 216

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 38.4 bits (89), Expect = 0.004
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 26/197 (13%)

Query: 87  AVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVA 146
            V +  L     + ++   NEV +    RH N+++ +   +  S  L ++  F++ G+ A
Sbjct: 29  TVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW-LWVISPFMAYGS-A 86

Query: 147 DHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADF 206
           + L  +   P  +       I       L YLH +  IHR++K ++IL+  +  V ++  
Sbjct: 87  NSLL-KTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS-- 143

Query: 207 GLSRL---------------FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGV 251
           GLS L               FP   T  S  P  +P  +  + +  Y +  KSD++S G+
Sbjct: 144 GLSHLYSLVRNGQKAKVVYDFPQFST--SVLPWLSPELLRQDLYG-YNV--KSDIYSVGI 198

Query: 252 VLIELISS-MPAVDITR 267
              EL +  +P  D+ R
Sbjct: 199 TACELATGRVPFQDMLR 215

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	375
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.98
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.92
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.92
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.91
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.9
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.9
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.89
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
PRK12274	218	serine/threonine protein kinase; Provisional	99.88
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
PRK10345	210	hypothetical protein; Provisional	99.86
smart00090	237	RIO RIO-like kinase.	99.83
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.82
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.82
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.8
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.77
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.77
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.73
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.72
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.68
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.67
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.62
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.54
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.53
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.52
KOG1243	690	consensus Protein kinase [General function predict	99.52
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.47
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.43
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.36
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.36
COG4248	637	Uncharacterized protein with protein kinase and he	99.35
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.31
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.3
KOG3087	229	consensus Serine/threonine protein kinase [General	99.3
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.25
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.2
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.19
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.15
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.97
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.93
PRK09902	216	hypothetical protein; Provisional	98.92
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.89
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.8
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.8
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.66
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.59
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.57
PF01636	239	APH: Phosphotransferase enzyme family This family	98.53
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.43
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.36
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.33
PRK05231	319	homoserine kinase; Provisional	98.3
PLN02876	822	acyl-CoA dehydrogenase	98.26
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.25
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.24
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.13
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	98.12
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.08
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.04
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.01
PRK10593	297	hypothetical protein; Provisional	97.98
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.96
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	97.85
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.8
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.72
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.63
KOG2270	520	consensus Serine/threonine protein kinase involved	97.5
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.47
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.45
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.36
PLN02236	344	choline kinase	97.31
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.3
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.25
PRK12396	409	5-methylribose kinase; Reviewed	97.06
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.97
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.93
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.91
COG2334	331	Putative homoserine kinase type II (protein kinase	96.86
PRK06148	1013	hypothetical protein; Provisional	96.81
PRK11768	325	serine/threonine protein kinase; Provisional	96.77
PLN02756	418	S-methyl-5-thioribose kinase	96.76
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.68
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.57
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.52
PTZ00384	383	choline kinase; Provisional	96.2
PF04655	253	APH_6_hur: Aminoglycoside/hydroxyurea antibiotic r	95.57
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.56

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-54  Score=390.71  Aligned_cols=289  Identities=47%  Similarity=0.765  Sum_probs=250.6

Q ss_pred             cccccchHHHHHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeee
Q 017232           47 GVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT  126 (375)
Q Consensus        47 ~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  126 (375)
                      ....|++.++..++++|...+.||+|+||.||+|...+|..||||++.........+|.+|+.++.+++|||+|+++|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            57789999999999999999999999999999999999999999988665433134599999999999999999999998


Q ss_pred             ecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC---ceeccCCCCCEEecCCCcEEE
Q 017232          127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD---IIHRDVKTNNILLDNNFCVKV  203 (375)
Q Consensus       127 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~---ivH~dlkp~Nill~~~~~~kl  203 (375)
                      .+.+.+.+||+||+++|+|.++++.....  .++|..+.+|+.++|.||+|||...   |+|||||++|||+|++..+||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKl  218 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKL  218 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEc
Confidence            87544689999999999999999765432  7899999999999999999999964   999999999999999999999


Q ss_pred             eeeccccccCC-CccccccCC-CCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHH
Q 017232          204 ADFGLSRLFPN-HVTHVSTAP-QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK  281 (375)
Q Consensus       204 ~Dfg~~~~~~~-~~~~~~~~~-~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  281 (375)
                      +|||++...+. ....  ... .||.+|+|||+...+..+.++||||||++|+||+||+++.+.........+..|....
T Consensus       219 sDFGLa~~~~~~~~~~--~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~  296 (361)
T KOG1187|consen  219 SDFGLAKLGPEGDTSV--STTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPL  296 (361)
T ss_pred             cCccCcccCCccccce--eeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHH
Confidence            99999976543 2211  111 6999999999999889999999999999999999999999876655666688999889


Q ss_pred             hhhhHHHHHHhhhcC-CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          282 IQNKALHELVDQTLG-YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~-~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      +.+..+.+++|+.+. ......  .....+..++.+|++.+|.+||+|.+|+++|+.+...
T Consensus       297 ~~~~~~~eiiD~~l~~~~~~~~--~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~~  355 (361)
T KOG1187|consen  297 LEEGKLREIVDPRLKEGEYPDE--KEVKKLAELALRCLRPDPKERPTMSQVVKELEGILSL  355 (361)
T ss_pred             HHCcchhheeCCCccCCCCChH--HHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhccc
Confidence            999899999999986 333322  4566799999999999999999999999999776654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-53  Score=363.22  Aligned_cols=262  Identities=27%  Similarity=0.408  Sum_probs=217.8

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      +.+.++.||+|..|+||++.++ +++.+|+|++... +....+++.+|+++++..+||+||.+||+|..+...++|+|||
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY  159 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY  159 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence            3455788999999999999776 6889999999554 4555688999999999999999999999888755469999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |++|+|.+++...    +.+++.....++.+|++||.|||. ++|+||||||+|||++..|.+||+|||.+..+.+.   
T Consensus       160 MDgGSLd~~~k~~----g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS---  232 (364)
T KOG0581|consen  160 MDGGSLDDILKRV----GRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS---  232 (364)
T ss_pred             cCCCCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh---
Confidence            9999999999543    569999999999999999999995 89999999999999999999999999999876544   


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      .....+||..|||||.+.+..|+.++||||||++++|+.+|+.|+.......              ....++++......
T Consensus       233 ~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~--------------~~~~~Ll~~Iv~~p  298 (364)
T KOG0581|consen  233 IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPY--------------LDIFELLCAIVDEP  298 (364)
T ss_pred             hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCC--------------CCHHHHHHHHhcCC
Confidence            4466789999999999999999999999999999999999999997652111              11233344444333


Q ss_pred             CChHHH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhhhcCCCC
Q 017232          299 SDNKVR-RTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDIESDGYD  344 (375)
Q Consensus       299 ~~~~~~-~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i~~~~~~  344 (375)
                      .+..+. .++.++++++..||++||.+|||+.|+++.  |.+......+
T Consensus       299 pP~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd  347 (364)
T KOG0581|consen  299 PPRLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVD  347 (364)
T ss_pred             CCCCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhccccccc
Confidence            333333 378899999999999999999999999975  5555554444

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-52  Score=377.78  Aligned_cols=271  Identities=27%  Similarity=0.423  Sum_probs=219.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .+|...+.||+|+|+.||.++. .+|+.||+|++.+.   .....+...+|+++.+.|+|||||+++++|++ ...+|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FED-s~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFED-SNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeec-CCceEEE
Confidence            4688999999999999999977 78999999999663   33455778899999999999999999998877 7889999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      .|+|..++|..++.    ..+.+++.++..++.||+.||.|||+++|+|||||..|+|++++.++||+|||+|..+..+.
T Consensus        97 LELC~~~sL~el~K----rrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~  172 (592)
T KOG0575|consen   97 LELCHRGSLMELLK----RRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG  172 (592)
T ss_pred             EEecCCccHHHHHH----hcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence            99999999999995    34679999999999999999999999999999999999999999999999999999887543


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .. ....+|||.|.|||++.....+..+||||+||+||.||.|+|||+...-.                   +.+.....
T Consensus       173 Er-k~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk-------------------ety~~Ik~  232 (592)
T KOG0575|consen  173 ER-KKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK-------------------ETYNKIKL  232 (592)
T ss_pred             cc-cceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH-------------------HHHHHHHh
Confidence            32 34568999999999999999999999999999999999999999865311                   11111110


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCCCCccccccccCCCCc
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEMMTQSPDS  359 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~~~~~~~~~~~~~~~~  359 (375)
                      .+. ..+..++.+..+||.++|+.+|.+|||+++|+..  ..-+....+...+..-.+.+|..
T Consensus       233 ~~Y-~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h--~Ff~~g~~p~~lp~~~l~~~p~~  292 (592)
T KOG0575|consen  233 NEY-SMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH--PFFKSGFTPARLPSSCLTMVPRF  292 (592)
T ss_pred             cCc-ccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC--HhhhCCCcCCCCCccccccCCcC
Confidence            011 1112456789999999999999999999999864  11244444444444333344443

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-53  Score=352.47  Aligned_cols=254  Identities=26%  Similarity=0.403  Sum_probs=214.6

Q ss_pred             CCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEee-eeecCCceeEEEE
Q 017232           62 YFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYG-CTSRHSRELLLVY  137 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~-~~~~~~~~~~lv~  137 (375)
                      +|+++++||+|.||.||++ ...+|..+|.|.+.-.  +.+..+++..|+.+|++|+|||||++++ .+.++...++|||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm   99 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM   99 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence            4788999999999999999 5568999999998644  5566778999999999999999999999 4555455699999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh--CC--ceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA--SD--IIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~--~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      |+|.+|+|...+...+.....+++..+|+++.|++.||.++|+  ..  |.||||||.||+++.+|.+||+|||+++.+.
T Consensus       100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~  179 (375)
T KOG0591|consen  100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS  179 (375)
T ss_pred             HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence            9999999999998888888899999999999999999999999  45  9999999999999999999999999999876


Q ss_pred             CCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          214 NHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       214 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      +... .....+|||.||+||.+.+.+|+.+|||||+||++|||+.-++||....                   +.++...
T Consensus       180 s~~t-fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n-------------------~~~L~~K  239 (375)
T KOG0591|consen  180 SKTT-FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN-------------------LLSLCKK  239 (375)
T ss_pred             chhH-HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc-------------------HHHHHHH
Confidence            5433 3456689999999999999999999999999999999999999997552                   1222222


Q ss_pred             hcCCCCChHH-HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017232          294 TLGYESDNKV-RRTINAVAELAFQCLQSEKDLRPYMVDVLDAL  335 (375)
Q Consensus       294 ~l~~~~~~~~-~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L  335 (375)
                      ...++.++.+ ..++.++..+|..|+.+||+.||+.-.++..+
T Consensus       240 I~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di  282 (375)
T KOG0591|consen  240 IEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDI  282 (375)
T ss_pred             HHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCCcchHHHHH
Confidence            2233444333 55778999999999999999999964444443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-51  Score=359.36  Aligned_cols=255  Identities=26%  Similarity=0.402  Sum_probs=204.9

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEecccch-------hhHHHHHHHHHHHHhcCCCCeEEEeeeeecC
Q 017232           58 EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-------KRVEQFMNEVDILARLRHKNLVSLYGCTSRH  129 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  129 (375)
                      ...+.|.+.+.||+|+||.|-+| ..++|+.||||++.+...       .......+|+++|++|+|||||++++++.. 
T Consensus       169 s~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~-  247 (475)
T KOG0615|consen  169 SFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEV-  247 (475)
T ss_pred             hhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeec-
Confidence            35667899999999999999999 666899999999965411       112335799999999999999999998776 


Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC---CcEEEeee
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN---FCVKVADF  206 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~---~~~kl~Df  206 (375)
                      ....|+||||++||.|.+.+...    +.+.+...+.++.|++.|+.|||+.||+||||||+|||+..+   ..+||+||
T Consensus       248 ~ds~YmVlE~v~GGeLfd~vv~n----k~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDF  323 (475)
T KOG0615|consen  248 PDSSYMVLEYVEGGELFDKVVAN----KYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDF  323 (475)
T ss_pred             CCceEEEEEEecCccHHHHHHhc----cccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEeccc
Confidence            56789999999999999999544    457888889999999999999999999999999999999766   77999999


Q ss_pred             ccccccCCCccccccCCCCCccccCcccccccC--CCC-chhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh
Q 017232          207 GLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ--LTD-KSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ  283 (375)
Q Consensus       207 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~-~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  283 (375)
                      |+|+..+.  .......||||.|.|||++.+..  +.+ +.|+||+||+||-+|+|.+||.....+...      .+.+.
T Consensus       324 GlAK~~g~--~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl------~eQI~  395 (475)
T KOG0615|consen  324 GLAKVSGE--GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSL------KEQIL  395 (475)
T ss_pred             chhhcccc--ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccH------HHHHh
Confidence            99998763  33456778999999999887644  333 789999999999999999999765432211      11111


Q ss_pred             hhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       284 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .+.        . ...+....+.+++..+||.+||..||++|||+.|+++.
T Consensus       396 ~G~--------y-~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  396 KGR--------Y-AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             cCc--------c-cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence            111        1 11223345667889999999999999999999999863

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4e-50  Score=363.30  Aligned_cols=261  Identities=32%  Similarity=0.505  Sum_probs=213.8

Q ss_pred             CCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ..+.+.||+|+||+||+|.+.+...||+|++.....  ...+.|.+|+.+|.+++|||||+++|++......+++||||+
T Consensus        43 l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~  122 (362)
T KOG0192|consen   43 LPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYM  122 (362)
T ss_pred             hhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeC
Confidence            344566999999999999998555599999976532  225689999999999999999999998887554799999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC-ceeccCCCCCEEecCCC-cEEEeeeccccccCCCccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD-IIHRDVKTNNILLDNNF-CVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~  218 (375)
                      ++|+|.++++..  ....+++..+..++.+|+.|+.|||+++ ||||||||+|||++.++ ++||+|||+++...... .
T Consensus       123 ~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~-~  199 (362)
T KOG0192|consen  123 PGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK-T  199 (362)
T ss_pred             CCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc-c
Confidence            999999999764  4567999999999999999999999999 99999999999999998 99999999998654321 2


Q ss_pred             cccCCCCCccccCccccc--ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          219 VSTAPQGTPGYVDPEYHQ--CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      ..+...||+.|||||++.  ...|+.++||||||+++|||+||+.||..... .     ..         ...+..... 
T Consensus       200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~-~-----~~---------~~~v~~~~~-  263 (362)
T KOG0192|consen  200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP-V-----QV---------ASAVVVGGL-  263 (362)
T ss_pred             cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH-H-----HH---------HHHHHhcCC-
Confidence            233357999999999999  56899999999999999999999999986542 1     01         111111111 


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYD  344 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~  344 (375)
                        .+..+..++..+..++.+||..+|..||++.+++..|+.+......
T Consensus       264 --Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  264 --RPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             --CCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence              1222223677899999999999999999999999999998875554

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-50  Score=350.16  Aligned_cols=202  Identities=34%  Similarity=0.597  Sum_probs=180.4

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..+|...+.||+|+||+||+|+++ ++..||||.+...  +.+..+.+..|+.+|+.++|||||.+++++.. ++.+|||
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~-~~~i~lV   87 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIED-DDFIYLV   87 (429)
T ss_pred             cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEec-CCeEEEE
Confidence            356888999999999999999665 6899999999766  66677788999999999999999999997776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC------CcEEEeeecccc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN------FCVKVADFGLSR  210 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~------~~~kl~Dfg~~~  210 (375)
                      ||||.||+|.++++..    +.+++..+..++.||+.||++||+++||||||||+|||++..      -.+||+|||+|+
T Consensus        88 MEyC~gGDLs~yi~~~----~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR  163 (429)
T KOG0595|consen   88 MEYCNGGDLSDYIRRR----GRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFAR  163 (429)
T ss_pred             EEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhh
Confidence            9999999999999644    469999999999999999999999999999999999999765      568999999999


Q ss_pred             ccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCcccccc
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRH  268 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~  268 (375)
                      .+...  ......+|++-|||||++..+.|+.|+|+||+|+|+|++++|++||+....
T Consensus       164 ~L~~~--~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  164 FLQPG--SMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             hCCch--hHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            87643  334566899999999999999999999999999999999999999986553

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-49  Score=342.21  Aligned_cols=242  Identities=26%  Similarity=0.379  Sum_probs=199.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .++|++++.||+|+||.||.++.+ +++.||+|++++..   ........+|..+|..++||+||+++..|+. ...+|+
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt-~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQT-EEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEeccc-CCeEEE
Confidence            356899999999999999999554 68999999997652   2345678899999999999999999987776 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      |+||+.||.|...|.    +.+.+++..+..++.+|+.||.|||++||+||||||+|||++.+|+++|+|||+++..-..
T Consensus       103 Vld~~~GGeLf~hL~----~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQ----REGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             EEeccCCccHHHHHH----hcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            999999999999995    3456999999999999999999999999999999999999999999999999999854333


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .. .....+||+.|||||++.+..|+.++|+||||+++|||++|.+||......                   .+++..+
T Consensus       179 ~~-~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~-------------------~~~~~I~  238 (357)
T KOG0598|consen  179 GD-ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK-------------------KMYDKIL  238 (357)
T ss_pred             CC-ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH-------------------HHHHHHh
Confidence            22 223468999999999999999999999999999999999999999765421                   1111111


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCC
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRP  326 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  326 (375)
                      .......+.-.+.+.++++.++|..+|++|.
T Consensus       239 ~~k~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  239 KGKLPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             cCcCCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence            1111111112456799999999999999996

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-49  Score=334.21  Aligned_cols=266  Identities=24%  Similarity=0.383  Sum_probs=213.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|+.+.++|+|+||+||+.+.+ +|+-||||++...  +....+-.++|+.+|++++|+|+|.++++|.. ...++||+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrr-krklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRR-KRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHh-cceeEEEe
Confidence            46888999999999999999776 6999999999654  34445667899999999999999999998877 67799999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      |||+..-|.+ +..   ....++...+..+++|++.|+.|+|+++++||||||+||||+.+|.+||||||+|+.+... .
T Consensus        81 E~~dhTvL~e-Le~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p-g  155 (396)
T KOG0593|consen   81 EYCDHTVLHE-LER---YPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP-G  155 (396)
T ss_pred             eecchHHHHH-HHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCC-c
Confidence            9997654444 432   3456899999999999999999999999999999999999999999999999999987642 2


Q ss_pred             ccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc-
Q 017232          218 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL-  295 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l-  295 (375)
                      ...+..+.|.+|+|||.+.| .+|....|||++||++.||++|.+.|......++.+......+.+...... ++...- 
T Consensus       156 d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~-iF~~N~~  234 (396)
T KOG0593|consen  156 DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQS-IFSSNPF  234 (396)
T ss_pred             chhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHH-HhccCCc
Confidence            33456678999999998877 789999999999999999999999999888777666655555444333222 111110 


Q ss_pred             -----------CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          296 -----------GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       296 -----------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                                 ........+..+..+.+++..||..||++|++-++++.
T Consensus       235 F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  235 FHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             eeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                       00111222345567899999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-49  Score=355.47  Aligned_cols=257  Identities=30%  Similarity=0.496  Sum_probs=219.3

Q ss_pred             CCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccC
Q 017232           63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISN  142 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  142 (375)
                      ++.++.||+|.||.||.|.+++...||+|.+...... .+.|.+|+.+|++|+|+|||++++++.. +..++|||||++.
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~-~~~f~~Ea~iMk~L~H~~lV~l~gV~~~-~~piyIVtE~m~~  285 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMS-PEAFLREAQIMKKLRHEKLVKLYGVCTK-QEPIYIVTEYMPK  285 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcCCCcccceEEeccccC-hhHHHHHHHHHHhCcccCeEEEEEEEec-CCceEEEEEeccc
Confidence            4557889999999999999998889999999776433 3678899999999999999999998877 4489999999999


Q ss_pred             CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccC
Q 017232          143 GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA  222 (375)
Q Consensus       143 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  222 (375)
                      |+|.++|..  ..+..+...+.+.++.||++|++||+++++|||||...||||++++.+||+|||+|+...++.......
T Consensus       286 GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~  363 (468)
T KOG0197|consen  286 GSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG  363 (468)
T ss_pred             CcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence            999999975  245678899999999999999999999999999999999999999999999999999666555555555


Q ss_pred             CCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       223 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ..-...|.|||.+....++.+|||||||++||||+| |+.|+.....                   .+++.....+..-+
T Consensus       364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn-------------------~ev~~~le~GyRlp  424 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSN-------------------EEVLELLERGYRLP  424 (468)
T ss_pred             CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCH-------------------HHHHHHHhccCcCC
Confidence            556779999999999999999999999999999998 8888764431                   22333333344445


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      .+..|+..+.+++..||..+|++|||++.+...|+++....
T Consensus       425 ~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~~  465 (468)
T KOG0197|consen  425 RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTST  465 (468)
T ss_pred             CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhcc
Confidence            55678999999999999999999999999999999876543

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-48  Score=347.49  Aligned_cols=270  Identities=24%  Similarity=0.337  Sum_probs=213.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-CceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-SRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~l  135 (375)
                      .+.|+.+++||+|.||.||+| +..+|+.||+|++..++  ........+||.+|++|+||||+++.+..... ...+||
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl  195 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL  195 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence            356888999999999999999 55689999999997665  33345567999999999999999999965554 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      |+|||+ -+|..++..   ..-.+++.+++.++.||+.||+|+|++||+|||||.+|||||++|.+||+|||+|+++...
T Consensus       196 VFeYMd-hDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  196 VFEYMD-HDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEeccc-chhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            999996 577777743   2346999999999999999999999999999999999999999999999999999988777


Q ss_pred             ccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH--HH--
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH--EL--  290 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~--~~--  290 (375)
                      .....+..+.|.+|+|||++.| ..|+.+.|+||.||||.||++|++.|......++........+...+..+.  .+  
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence            6666777889999999998776 579999999999999999999999999887665544333332222222111  00  


Q ss_pred             ---HhhhcC--CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          291 ---VDQTLG--YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       291 ---~~~~l~--~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                         +.+.-.  .........++....+|+..+|..||.+|.|+.++++
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence               000000  0001112234567889999999999999999998875

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-47  Score=337.05  Aligned_cols=261  Identities=26%  Similarity=0.430  Sum_probs=205.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc-eeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR-ELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~lv~e  138 (375)
                      .+|...+.||+|+||+||++... +|...|+|.+...+....+.+.+|+.+|++++|||||+++|....... .+++.||
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE   96 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME   96 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence            44677889999999999999665 489999999876644446789999999999999999999996444333 6899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC-CCcEEEeeeccccccCC--C
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-NFCVKVADFGLSRLFPN--H  215 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~--~  215 (375)
                      |+++|+|.+++....   +.+++..+..+..|+++||.|||++|++||||||+|||++. ++.+||+|||++.....  .
T Consensus        97 y~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~  173 (313)
T KOG0198|consen   97 YAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGT  173 (313)
T ss_pred             ccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccccccc
Confidence            999999999996542   26999999999999999999999999999999999999999 79999999999987653  2


Q ss_pred             ccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .........||+.|||||++.. .....++|||||||++.||+||++||.....     ...+....            .
T Consensus       174 ~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-----~~~~~~~i------------g  236 (313)
T KOG0198|consen  174 KSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-----EAEALLLI------------G  236 (313)
T ss_pred             cccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc-----hHHHHHHH------------h
Confidence            2222334679999999999885 3344599999999999999999999975300     00111100            0


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .....+..+..++....+++.+|+..+|++|||+.++++..--....
T Consensus       237 ~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  237 REDSLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ccCCCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence            01111222334667899999999999999999999999886554433

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=341.90  Aligned_cols=262  Identities=24%  Similarity=0.379  Sum_probs=211.5

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEE-eCCCCEEEEEEeccc---chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCc
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  131 (375)
                      ..-.++|.+.+.||.|+|++|++|+ ..+++.||||++.+.   .....+....|-++|.+| .||.|++++--|.+ ..
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD-~~  147 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQD-EE  147 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeec-cc
Confidence            3345789999999999999999994 447999999998654   222334567788899999 79999999986665 67


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      .+|.|+||+++|+|.++|...    +.+++.-+..++.+|+.||+|||++|||||||||+|||++++++++|+|||.|..
T Consensus       148 sLYFvLe~A~nGdll~~i~K~----Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~  223 (604)
T KOG0592|consen  148 SLYFVLEYAPNGDLLDLIKKY----GSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKI  223 (604)
T ss_pred             ceEEEEEecCCCcHHHHHHHh----CcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeecccccc
Confidence            899999999999999999644    5699999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccc----------c--ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHH
Q 017232          212 FPNHVTH----------V--STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAI  279 (375)
Q Consensus       212 ~~~~~~~----------~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  279 (375)
                      ++.....          .  ....+||..|.+||++.....++.+|+|+||||||+|+.|.+||....+..         
T Consensus       224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Neyl---------  294 (604)
T KOG0592|consen  224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYL---------  294 (604)
T ss_pred             CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHH---------
Confidence            7532111          1  134689999999999999999999999999999999999999998654211         


Q ss_pred             HHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhhhcCCC
Q 017232          280 NKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDIESDGY  343 (375)
Q Consensus       280 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i~~~~~  343 (375)
                            .+..+++-..  .++   ...++.+.+|+.+.|..||++|+|..+|.+.  ++++..+..
T Consensus       295 ------iFqkI~~l~y--~fp---~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nl  349 (604)
T KOG0592|consen  295 ------IFQKIQALDY--EFP---EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENL  349 (604)
T ss_pred             ------HHHHHHHhcc--cCC---CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhh
Confidence                  1122222222  122   1244678999999999999999999888775  555555543

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-48  Score=343.93  Aligned_cols=270  Identities=24%  Similarity=0.350  Sum_probs=216.2

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchh-hHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK-RVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~l  135 (375)
                      ..++|.+.++||.|.||.||+|+.+ +|..||||+++..-.. ....-.+|+..|++|+ ||||+++.+.+.+....+++
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4568999999999999999999554 7899999998765332 2223468999999998 99999999987776669999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      |||||+ .+|++++...   +..+++..+..|+.||++||+|+|.+|+.|||+||+|||+.....+||+|||+|+.+.+.
T Consensus        88 VfE~Md-~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk  163 (538)
T KOG0661|consen   88 VFEFMD-CNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK  163 (538)
T ss_pred             eHHhhh-hhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccC
Confidence            999995 7999999654   567999999999999999999999999999999999999999999999999999987665


Q ss_pred             ccccccCCCCCccccCcccc-cccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHH--HHh
Q 017232          216 VTHVSTAPQGTPGYVDPEYH-QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE--LVD  292 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~  292 (375)
                      .++  +..+.|.+|+|||++ ....|+.+.|+|++|||++|+.+-++.|.+..+.++.+....+.+........+  .+.
T Consensus       164 pPY--TeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  164 PPY--TEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             CCc--chhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence            543  455789999999965 567899999999999999999999999988776665544433333222221111  111


Q ss_pred             hhcCCCC--------ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          293 QTLGYES--------DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       293 ~~l~~~~--------~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ..+....        ......++.+..+++.+|+.+||++|||+.+.++.
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            2222211        22223567889999999999999999999999976

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.1e-46  Score=335.14  Aligned_cols=247  Identities=24%  Similarity=0.352  Sum_probs=199.6

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ..++|+++..||+|+||.||+|+.+ +|..+|+|++++...   ...+....|-.+|...++|+||+++..|++ ...+|
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD-~~~LY  217 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQD-KEYLY  217 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecC-CCeeE
Confidence            3578999999999999999999554 799999999987644   345567789999999999999999987776 78899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      |||||++||++..+|.    +.+.+++..+..++.+++.|++.+|+.|++||||||+|+|||..|++||+|||++.-+..
T Consensus       218 LiMEylPGGD~mTLL~----~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  218 LIMEYLPGGDMMTLLM----RKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             EEEEecCCccHHHHHH----hcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            9999999999999994    456799999999999999999999999999999999999999999999999999853211


Q ss_pred             -----------------------Ccc-----------------------ccccCCCCCccccCcccccccCCCCchhHHH
Q 017232          215 -----------------------HVT-----------------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS  248 (375)
Q Consensus       215 -----------------------~~~-----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws  248 (375)
                                             ...                       ......+|||.|+|||++.+..|+..+|+||
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWS  373 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWS  373 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHH
Confidence                                   000                       0011235999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 017232          249 FGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY  327 (375)
Q Consensus       249 lG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  327 (375)
                      ||||+||||.|.|||....+...       .+.        ++.-...... +....+..+..+||.+||. ||++|..
T Consensus       374 LG~ImyEmLvGyPPF~s~tp~~T-------~rk--------I~nwr~~l~f-P~~~~~s~eA~DLI~rll~-d~~~RLG  435 (550)
T KOG0605|consen  374 LGCIMYEMLVGYPPFCSETPQET-------YRK--------IVNWRETLKF-PEEVDLSDEAKDLITRLLC-DPENRLG  435 (550)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHH-------HHH--------HHHHhhhccC-CCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence            99999999999999987764321       111        1111111111 1112344789999999999 9999976

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.9e-46  Score=340.90  Aligned_cols=264  Identities=25%  Similarity=0.386  Sum_probs=206.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCc
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL------QDGRAVAVKRLYENN-YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  131 (375)
                      .++|++.+.||+|+||.||+|..      .++..||+|++.... ......+.+|+.++..+ +||||+++++++.....
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46799999999999999999963      235679999986543 33456788999999999 89999999998776666


Q ss_pred             eeEEEEecccCCChhHhhccCCCC--------------------------------------------------------
Q 017232          132 ELLLVYEFISNGTVADHLHGERAK--------------------------------------------------------  155 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------------------  155 (375)
                      .+++||||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            789999999999999998653210                                                        


Q ss_pred             --CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc-cccCCCCCccccCc
Q 017232          156 --PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTPGYVDP  232 (375)
Q Consensus       156 --~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP  232 (375)
                        ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++......... ......++..|+||
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  245 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP  245 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence              234778889999999999999999999999999999999999999999999999765332221 11223456789999


Q ss_pred             ccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHH
Q 017232          233 EYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVA  311 (375)
Q Consensus       233 E~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~  311 (375)
                      |++.+..++.++|||||||++|||++ |..||.......      .....+..        .    .....+..++..+.
T Consensus       246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~------~~~~~~~~--------~----~~~~~~~~~~~~l~  307 (338)
T cd05102         246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE------EFCQRLKD--------G----TRMRAPENATPEIY  307 (338)
T ss_pred             HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH------HHHHHHhc--------C----CCCCCCCCCCHHHH
Confidence            99988889999999999999999997 999997543211      00011110        0    00011123456789


Q ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          312 ELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       312 ~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      +++.+||+.+|++|||+.++++.|+++...
T Consensus       308 ~li~~cl~~dp~~RPs~~el~~~l~~~~~~  337 (338)
T cd05102         308 RIMLACWQGDPKERPTFSALVEILGDLLQE  337 (338)
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=1.5e-46  Score=310.04  Aligned_cols=268  Identities=24%  Similarity=0.338  Sum_probs=208.4

Q ss_pred             cCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEecccchhh--HHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .+|...++||+|.||+||+| +..+|+.||||++...+...  .....+|+..|+.++|+||+.+++++.. ...+.||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~-~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPH-KSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccC-CCceEEEE
Confidence            46788899999999999999 55689999999997664432  3457899999999999999999997776 66799999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||++ .+|...+.+   +...++..+++.++.+++.|++|||++.|+||||||.|+|++.+|.+||+|||+++.+.....
T Consensus        81 Efm~-tdLe~vIkd---~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~  156 (318)
T KOG0659|consen   81 EFMP-TDLEVVIKD---KNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR  156 (318)
T ss_pred             Eecc-ccHHHHhcc---cccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc
Confidence            9995 789998854   446789999999999999999999999999999999999999999999999999998876554


Q ss_pred             ccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH---HHHHhh
Q 017232          218 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL---HELVDQ  293 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  293 (375)
                      .... .+.|.+|+|||.+.| ..|+...|+||.|||+.||+-|.|.|....+-++....-.+.+.......   ..+.+.
T Consensus       157 ~~~~-~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY  235 (318)
T KOG0659|consen  157 IQTH-QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDY  235 (318)
T ss_pred             cccc-ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccH
Confidence            3322 368999999997765 57999999999999999999999999876644433222211111111111   111111


Q ss_pred             h-cCC----CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          294 T-LGY----ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       294 ~-l~~----~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      . +..    .........+.++.+|+.+|+..||.+|+|+.|++++
T Consensus       236 ~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  236 VKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence            0 000    0011223345678999999999999999999998864

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-46  Score=339.25  Aligned_cols=250  Identities=25%  Similarity=0.408  Sum_probs=209.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ...|....+||+|+.|.||.| +..+++.||||++........+-+.+|+.+|+..+|+|||.+++.|.. +..+|+|||
T Consensus       272 ~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv-~deLWVVME  350 (550)
T KOG0578|consen  272 RSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV-GDELWVVME  350 (550)
T ss_pred             hhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc-cceeEEEEe
Confidence            456888899999999999999 555788999999987766666788999999999999999999997766 477999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |++||+|.+.+..     ..+++.++..||.+++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+..... 
T Consensus       351 ym~ggsLTDvVt~-----~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-  424 (550)
T KOG0578|consen  351 YMEGGSLTDVVTK-----TRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-  424 (550)
T ss_pred             ecCCCchhhhhhc-----ccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC-
Confidence            9999999999943     3489999999999999999999999999999999999999999999999999987765444 


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh-hhcCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD-QTLGY  297 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~  297 (375)
                      .....+|||.|||||++....|+++.||||||++++||+-|++||=...+                  +..+.- ..-..
T Consensus       425 KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~P------------------lrAlyLIa~ng~  486 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENP------------------LRALYLIATNGT  486 (550)
T ss_pred             ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCCh------------------HHHHHHHhhcCC
Confidence            34566899999999999999999999999999999999999999843221                  111110 00001


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .........+..+.+++.+||..|+++|+++.|+|+.
T Consensus       487 P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  487 PKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             CCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence            1112234567789999999999999999999999974

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-46  Score=310.16  Aligned_cols=236  Identities=29%  Similarity=0.450  Sum_probs=200.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|+.++.||.|+||.|.+++.+ +|..||+|++.....   +..+...+|..+|+.+.||+++++++.+.. ...+++|
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d-~~~lymv  122 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKD-NSNLYMV  122 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeecc-CCeEEEE
Confidence            45888999999999999999766 688999999976643   445567789999999999999999996665 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||++||.|..+++    +.+++++..++.++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+.+... 
T Consensus       123 meyv~GGElFS~Lr----k~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-  197 (355)
T KOG0616|consen  123 MEYVPGGELFSYLR----KSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-  197 (355)
T ss_pred             EeccCCccHHHHHH----hcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence            99999999999995    3456999999999999999999999999999999999999999999999999999876543 


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                         ....||||.|+|||++...++..++|+|+||+++|||+.|.+||-...+.               .....++...+.
T Consensus       198 ---T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~---------------~iY~KI~~~~v~  259 (355)
T KOG0616|consen  198 ---TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI---------------QIYEKILEGKVK  259 (355)
T ss_pred             ---EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH---------------HHHHHHHhCccc
Confidence               34568999999999999999999999999999999999999999766531               112223333332


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCC
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLR  325 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~R  325 (375)
                      +.     .-...++.+|+...|+.|-.+|
T Consensus       260 fP-----~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  260 FP-----SYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             CC-----cccCHHHHHHHHHHHhhhhHhh
Confidence            21     2245679999999999999999

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=322.91  Aligned_cols=261  Identities=25%  Similarity=0.346  Sum_probs=207.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEE-eCCCCEEEEEEecccch-hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNY-KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +.|++.+.||.|..++||+|. ...++.||||++..... .....+.+|+..|+.++||||++++.+|.. +..+|+||.
T Consensus        26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv-~~~LWvVmp  104 (516)
T KOG0582|consen   26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVV-DSELWVVMP  104 (516)
T ss_pred             cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEe-cceeEEeeh
Confidence            568899999999999999995 45789999999976543 336889999999999999999999997776 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      ||.+|++.+.+......  .+++..+..|+++++.||.|||++|.+|||||+.||||+.+|.+||+|||.+..+......
T Consensus       105 fMa~GS~ldIik~~~~~--Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  105 FMAGGSLLDIIKTYYPD--GLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             hhcCCcHHHHHHHHccc--cccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence            99999999999776443  4999999999999999999999999999999999999999999999999987644332211


Q ss_pred             ---cccCCCCCccccCccccc--ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          219 ---VSTAPQGTPGYVDPEYHQ--CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       219 ---~~~~~~~~~~y~aPE~~~--~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                         .....+||++|||||++.  ...|+.|+||||||++..||.+|..||....+      .......+.+......   
T Consensus       183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pP------mkvLl~tLqn~pp~~~---  253 (516)
T KOG0582|consen  183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPP------MKVLLLTLQNDPPTLL---  253 (516)
T ss_pred             eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCCh------HHHHHHHhcCCCCCcc---
Confidence               114557999999999843  35799999999999999999999999975432      1112222222110000   


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       ...........+...+++++..||..||.+|||++++++.
T Consensus       254 -t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  254 -TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             -cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence             1111223334456689999999999999999999999863

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-45  Score=334.75  Aligned_cols=256  Identities=29%  Similarity=0.405  Sum_probs=206.5

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc----ch-hhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCC
Q 017232           58 EATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN----NY-KRVEQFMNEVDILARLR-HKNLVSLYGCTSRHS  130 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  130 (375)
                      ...++|.+.+.||+|+||.|+.|.. .++..||+|++...    .. ...+.+.+|+.+++.++ ||||+++++++.. .
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t-~   92 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFAT-P   92 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEec-C
Confidence            3456899999999999999999954 47899999976553    11 23456778999999999 9999999998777 4


Q ss_pred             ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC-CcEEEeeeccc
Q 017232          131 RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN-FCVKVADFGLS  209 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~  209 (375)
                      ..+++|||||.||+|.+++..    .+++.+.++..++.|++.|++|+|++||+||||||+|+|++.+ +++||+|||++
T Consensus        93 ~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s  168 (370)
T KOG0583|consen   93 TKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS  168 (370)
T ss_pred             CeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence            559999999999999999954    4568999999999999999999999999999999999999999 99999999999


Q ss_pred             cccCCCccccccCCCCCccccCcccccccC-CC-CchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ-LT-DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL  287 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~-~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (375)
                      .... .........+|++.|+|||++.+.. |+ .++||||+|++||.|++|+.||+.....      .. ...+.    
T Consensus       169 ~~~~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~------~l-~~ki~----  236 (370)
T KOG0583|consen  169 AISP-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVP------NL-YRKIR----  236 (370)
T ss_pred             cccC-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHH------HH-HHHHh----
Confidence            8764 2223345678999999999999877 76 6899999999999999999999863211      00 11111    


Q ss_pred             HHHHhhhcCCCCChHHHHH-HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          288 HELVDQTLGYESDNKVRRT-INAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       288 ~~~~~~~l~~~~~~~~~~~-~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                          ....  ..+   ..+ +.++..++.+||..+|.+|+|+.+++ .-.-++.
T Consensus       237 ----~~~~--~~p---~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~-~h~w~~~  280 (370)
T KOG0583|consen  237 ----KGEF--KIP---SYLLSPEARSLIEKMLVPDPSTRITLLEIL-EHPWFQK  280 (370)
T ss_pred             ----cCCc--cCC---CCcCCHHHHHHHHHHcCCCcccCCCHHHHh-hChhhcc
Confidence                1111  111   112 57789999999999999999999999 5444444

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=1.7e-45  Score=331.97  Aligned_cols=247  Identities=30%  Similarity=0.450  Sum_probs=208.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|.+.+.||+|.||+||+|+.+ +.+.||+|.+.+.  ..+..+.+.+|+++++.++||||+.+++.|+. ..++++|+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt-~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFET-SAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcc-cceEEEEe
Confidence            56888899999999999999655 6889999998654  44567889999999999999999999997776 78899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      |||.| +|..++.    ..+.++++.+..++.+++.||.|||+.+|.|||+||.|||++.+|.+|++|||+|+.... ..
T Consensus        81 e~a~g-~L~~il~----~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t  154 (808)
T KOG0597|consen   81 EYAVG-DLFTILE----QDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NT  154 (808)
T ss_pred             hhhhh-hHHHHHH----hccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhccc-Cc
Confidence            99976 9999994    446799999999999999999999999999999999999999999999999999987654 33


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                      ...+...|||-|||||++.+.+|+..+|+||+|||+||+++|+|||-...                   +..++...+. 
T Consensus       155 ~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s-------------------i~~Lv~~I~~-  214 (808)
T KOG0597|consen  155 SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS-------------------ITQLVKSILK-  214 (808)
T ss_pred             eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH-------------------HHHHHHHHhc-
Confidence            44456679999999999999999999999999999999999999996432                   1112222221 


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      +....+...+..+..++...|.+||..|.|-.+++..
T Consensus       215 d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  215 DPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             CCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence            1112223567789999999999999999999998754

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-45  Score=332.34  Aligned_cols=252  Identities=24%  Similarity=0.397  Sum_probs=214.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|..++++|+|+||.+++++.+ +++.|++|.+....  ........+|+.++++++|||||.+.+.|..++..++|||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm   83 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM   83 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence            56888999999999999999655 67899999986543  2334467899999999999999999999988666699999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      +||+||++.+.+...+  +..+++..++.|+.|++.|+.|||+++|+|||||+.|||++.++.++|+|||+|+..+....
T Consensus        84 ~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   84 EYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             eecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            9999999999997764  56799999999999999999999999999999999999999999999999999998876542


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                       ......||+.|++||++.+.+|..|+|||||||++|||++-+++|...+-                   ..++......
T Consensus       162 -~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m-------------------~~Li~ki~~~  221 (426)
T KOG0589|consen  162 -LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM-------------------SELILKINRG  221 (426)
T ss_pred             -hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch-------------------HHHHHHHhhc
Confidence             34556799999999999999999999999999999999999999986541                   1122222222


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ...+.+..++.++..++..||+.+|..||++.+++..
T Consensus       222 ~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  222 LYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             cCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence            2344445567889999999999999999999999987

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=317.26  Aligned_cols=274  Identities=22%  Similarity=0.352  Sum_probs=213.8

Q ss_pred             HHHHhcCCCCCCccCCCCcEEEEEEE-eCCCCEEEEEEecc--cchhhHHHHHHHHHHHHhcCCCCeEEEeeeeec----
Q 017232           56 LEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR----  128 (375)
Q Consensus        56 ~~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----  128 (375)
                      .......|...+.||+|+||.|+.|. ..+|+.||||++..  .+....+...+|+.+|+.++|+||+.+++++..    
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~   96 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRD   96 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccc
Confidence            33445667778999999999999994 45799999999973  355567788999999999999999999996654    


Q ss_pred             CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecc
Q 017232          129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL  208 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  208 (375)
                      .-+.+|+|+|++ +.+|...+.    .+..++..++..+++|++.||+|+|+.|++||||||.|++++.+..+||+|||+
T Consensus        97 ~f~DvYiV~elM-etDL~~iik----~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGL  171 (359)
T KOG0660|consen   97 KFNDVYLVFELM-ETDLHQIIK----SQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGL  171 (359)
T ss_pred             ccceeEEehhHH-hhHHHHHHH----cCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccc
Confidence            235689999999 578888884    334599999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCC-ccccccCCCCCccccCcccc-cccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHH--------H
Q 017232          209 SRLFPNH-VTHVSTAPQGTPGYVDPEYH-QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL--------A  278 (375)
Q Consensus       209 ~~~~~~~-~~~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~--------~  278 (375)
                      |+..... .....+..+.|.+|+|||++ ....|+.+.||||+|||+.||++|++.|.+.+..++..+...        .
T Consensus       172 AR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~  251 (359)
T KOG0660|consen  172 ARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEED  251 (359)
T ss_pred             eeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHH
Confidence            9976532 12233556789999999965 456899999999999999999999999987775554433322        2


Q ss_pred             HHHhhhhHHHHHHhhhcCC---CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          279 INKIQNKALHELVDQTLGY---ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       279 ~~~~~~~~~~~~~~~~l~~---~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ...+........+...-..   ..............+|+.+||..||.+|+|++|.++.
T Consensus       252 l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  252 LQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             HHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            2233333333322221111   1112223445688999999999999999999998865

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=5e-45  Score=331.96  Aligned_cols=266  Identities=28%  Similarity=0.449  Sum_probs=211.6

Q ss_pred             HHHHHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc
Q 017232           54 GELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        54 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  131 (375)
                      .+++...+.+.+...||+|.||+||+|.+.+  .||||++...  ..+..+.|.+|+.++++-+|.||+-+.|++.... 
T Consensus       385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~-  461 (678)
T KOG0193|consen  385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP-  461 (678)
T ss_pred             cccccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc-
Confidence            4455555667788999999999999999874  4999998654  4557788999999999999999999999887643 


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                       +.||+.+|+|.+|+.+++..+   ..+.....+.|+.|+++|+.|||.++|+|+|||..|||+.++++|||+|||++..
T Consensus       462 -~AIiTqwCeGsSLY~hlHv~e---tkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  462 -LAIITQWCEGSSLYTHLHVQE---TKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             -eeeeehhccCchhhhhccchh---hhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceee
Confidence             499999999999999997654   4589999999999999999999999999999999999999999999999999864


Q ss_pred             cCC-CccccccCCCCCccccCcccccc---cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH
Q 017232          212 FPN-HVTHVSTAPQGTPGYVDPEYHQC---YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL  287 (375)
Q Consensus       212 ~~~-~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (375)
                      -.. ..........|...|||||++..   .+|++++||||||+++|||+||..||..... +..-+... .+.      
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~-dqIifmVG-rG~------  609 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR-DQIIFMVG-RGY------  609 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh-hheEEEec-ccc------
Confidence            321 11111222347789999998754   5799999999999999999999999984332 21111000 000      


Q ss_pred             HHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          288 HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       288 ~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                             +.........+++.++.+|+..||..++++||.+.+|+..|+.+...
T Consensus       610 -------l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  610 -------LMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             -------cCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence                   01111222345777999999999999999999999999999988774

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=318.46  Aligned_cols=262  Identities=26%  Similarity=0.358  Sum_probs=204.0

Q ss_pred             HHHHHhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccch--------------hhHHHHHHHHHHHHhcCCCCe
Q 017232           55 ELEEATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNY--------------KRVEQFMNEVDILARLRHKNL  119 (375)
Q Consensus        55 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~--------------~~~~~~~~e~~~l~~l~h~ni  119 (375)
                      +.....++|++...||+|.||.|-+|.. .+++.||||++.+...              ...+...+|+.+|+++.||||
T Consensus        91 ~~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nV  170 (576)
T KOG0585|consen   91 QDRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNV  170 (576)
T ss_pred             ccceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCe
Confidence            3445678999999999999999999954 4789999999854322              123578899999999999999


Q ss_pred             EEEeeeeec-CCceeEEEEecccCCChhHhhccCCCCCCC-CChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          120 VSLYGCTSR-HSRELLLVYEFISNGTVADHLHGERAKPGA-LPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       120 v~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~-l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      |+++++..+ ....+|||+|||..|.+...=     ..++ +++.++++++.+++.||+|||.+||+||||||+|+|+++
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p-----~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-----PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSS  245 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCC-----CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcC
Confidence            999996543 346799999999988765432     2334 899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccccccCCC----ccccccCCCCCccccCcccccccC----CCCchhHHHHHHHHHHHHhCCCCccccccc
Q 017232          198 NFCVKVADFGLSRLFPNH----VTHVSTAPQGTPGYVDPEYHQCYQ----LTDKSDVFSFGVVLIELISSMPAVDITRHR  269 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~p~~~~~~~  269 (375)
                      +|++||+|||.+......    .........|||.|+|||.+.++.    .+.+.||||+||+||.|+.|+-||.....-
T Consensus       246 ~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~  325 (576)
T KOG0585|consen  246 DGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL  325 (576)
T ss_pred             CCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH
Confidence            999999999999866321    111223367999999999887632    355889999999999999999999754310


Q ss_pred             cccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          270 HEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                                     .....++...+.+...   .+..+.+.+||.+||.+||+.|.++.+|.....-..
T Consensus       326 ---------------~l~~KIvn~pL~fP~~---pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  326 ---------------ELFDKIVNDPLEFPEN---PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             ---------------HHHHHHhcCcccCCCc---ccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence                           1112222232322211   245678999999999999999999999987765433

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.8e-45  Score=344.77  Aligned_cols=261  Identities=28%  Similarity=0.415  Sum_probs=215.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCC------CCEEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           61 NYFDSARELGDGGFGTVYYGELQD------GRAVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      .+.+..+.||+|+||.||+|+..+      ...||||.++..... ..++|++|++++..++|||||+++|.|.. ++.+
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~-~~P~  564 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCRE-GDPL  564 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEcc-CCee
Confidence            445668899999999999996542      457999999877555 67899999999999999999999998887 7789


Q ss_pred             EEEEecccCCChhHhhccCCCC----------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEE
Q 017232          134 LLVYEFISNGTVADHLHGERAK----------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKV  203 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~----------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl  203 (375)
                      ++|+||+..|+|.++|......          +.+++..+.+.|+.||+.|++||.++.+|||||-..|+||.++..|||
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKI  644 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKI  644 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEe
Confidence            9999999999999999764321          233888999999999999999999999999999999999999999999


Q ss_pred             eeeccccccCCCcccc-ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHH
Q 017232          204 ADFGLSRLFPNHVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINK  281 (375)
Q Consensus       204 ~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  281 (375)
                      +|||+++..-....+. .....-..+|||||.+..+.++.+||||||||+|||+++ |+-|+......       .+.+.
T Consensus       645 sDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~-------EVIe~  717 (774)
T KOG1026|consen  645 SDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ-------EVIEC  717 (774)
T ss_pred             cccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH-------HHHHH
Confidence            9999998654333332 224456779999999999999999999999999999997 88777654321       12223


Q ss_pred             hhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          282 IQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ++.+.            .-+.+..|+.++..|+..||+.+|.+||+++||-..|......
T Consensus       718 i~~g~------------lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  718 IRAGQ------------LLSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             HHcCC------------cccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence            33222            2344566889999999999999999999999999999876554

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-45  Score=299.04  Aligned_cols=265  Identities=22%  Similarity=0.338  Sum_probs=214.2

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeec----CCcee
Q 017232           59 ATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR----HSREL  133 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----~~~~~  133 (375)
                      ..++|++.++||.|||+.||+++ ..++..||+|++.....+..+..++|++..++++|||+++++++...    .....
T Consensus        19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence            35689999999999999999995 55789999999988877888899999999999999999999884322    23468


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC--ceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--IIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ||+++|...|+|.+.+.....++..+++.+++.|+.+|.+||++||...  +.||||||.|||+.+.+.++|+|||.++.
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            9999999999999999988888889999999999999999999999998  99999999999999999999999999876


Q ss_pred             cCCCcccc--------ccCCCCCccccCccccc---ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHH
Q 017232          212 FPNHVTHV--------STAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       212 ~~~~~~~~--------~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      ..-.....        -.....|..|+|||.+.   +...++++|||||||+||+|+.|..||+..-. .+.++.-.   
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-~GgSlaLA---  254 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-QGGSLALA---  254 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-cCCeEEEe---
Confidence            53211110        01123688999999875   45678899999999999999999999975432 11111111   


Q ss_pred             HhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          281 KIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                               +....+......   .+++.+.+++..||++||.+||++.+++..++++.
T Consensus       255 ---------v~n~q~s~P~~~---~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  255 ---------VQNAQISIPNSS---RYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             ---------eeccccccCCCC---CccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                     111111111111   16678999999999999999999999999998764

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.2e-43  Score=321.28  Aligned_cols=264  Identities=25%  Similarity=0.362  Sum_probs=199.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCC-----------------CCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQD-----------------GRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSL  122 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~  122 (375)
                      ++|++.++||+|+||.||++...+                 +..||+|.+.... ......+.+|+.++..++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            568899999999999999996532                 3469999887643 3345678999999999999999999


Q ss_pred             eeeeecCCceeEEEEecccCCChhHhhccCCC---------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceecc
Q 017232          123 YGCTSRHSRELLLVYEFISNGTVADHLHGERA---------------KPGALPWPTRLKIAIETASALTYLHASDIIHRD  187 (375)
Q Consensus       123 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~d  187 (375)
                      ++++.. ....++||||+.+++|.+++.....               ....+++..++.++.|++.||.|||+.|++|||
T Consensus        85 ~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~d  163 (304)
T cd05096          85 LGVCVD-EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRD  163 (304)
T ss_pred             EEEEec-CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccC
Confidence            997776 5678999999999999998854321               123477888999999999999999999999999


Q ss_pred             CCCCCEEecCCCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh--CCCCcc
Q 017232          188 VKTNNILLDNNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS--SMPAVD  264 (375)
Q Consensus       188 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~p~~  264 (375)
                      |||+|||++.++.+||+|||++........ .......++..|+|||++.+..++.++||||||+++|+|++  +..||.
T Consensus       164 lkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~  243 (304)
T cd05096         164 LATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYG  243 (304)
T ss_pred             cchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCC
Confidence            999999999999999999999876533221 11223345778999999888889999999999999999987  456665


Q ss_pred             ccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          265 ITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                      ......   ....         ...................++..+.+++.+||+.+|++|||+.+|.+.|++
T Consensus       244 ~~~~~~---~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~  304 (304)
T cd05096         244 ELTDEQ---VIEN---------AGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE  304 (304)
T ss_pred             cCCHHH---HHHH---------HHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence            432111   0000         011111110000001112345679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.5e-43  Score=316.97  Aligned_cols=248  Identities=17%  Similarity=0.276  Sum_probs=199.4

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhh---HHHHHHHHHHHHhcCCCCeEEEeeeeec---CCceeEEEEec
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKR---VEQFMNEVDILARLRHKNLVSLYGCTSR---HSRELLLVYEF  139 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~e~  139 (375)
                      ...||+|++|.||+|.. +|+.||+|.+.......   .+.+.+|+.++++++||||+++++++..   ....+++||||
T Consensus        25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey  103 (283)
T PHA02988         25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY  103 (283)
T ss_pred             CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence            35799999999999987 58899999987553322   4678899999999999999999997654   23468999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      +++|+|.+++..    ...+++.....++.+++.||.|||+. +++||||||+||+++.++.+||+|||++.......  
T Consensus       104 ~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--  177 (283)
T PHA02988        104 CTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--  177 (283)
T ss_pred             CCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--
Confidence            999999999954    34588999999999999999999984 99999999999999999999999999987653321  


Q ss_pred             cccCCCCCccccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          219 VSTAPQGTPGYVDPEYHQC--YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                        ....++..|+|||++.+  ..++.++|||||||++|||++|..||+......      ..         ..+......
T Consensus       178 --~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~------~~---------~~i~~~~~~  240 (283)
T PHA02988        178 --FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKE------IY---------DLIINKNNS  240 (283)
T ss_pred             --ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHH------HH---------HHHHhcCCC
Confidence              23357889999999876  678999999999999999999999997543111      00         011111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      ...   +..++..+.+++.+||+.+|++|||+.++++.|+.++.
T Consensus       241 ~~~---~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        241 LKL---PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             CCC---CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence            111   11356679999999999999999999999999998764

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-45  Score=323.19  Aligned_cols=249  Identities=26%  Similarity=0.391  Sum_probs=206.7

Q ss_pred             cCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ..|+..++||+|.||.||+| +..+++.||+|++... .....+++.+|+.++.+++++||.++|+.+.. +..++++||
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~-g~~LwiiMe   91 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLK-GTKLWIIME   91 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheee-cccHHHHHH
Confidence            45777899999999999999 5557899999999665 34456788999999999999999999997766 667999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      ||.||++.+.+.    .+..+.+..+..++.+++.||.|||..+.+|||||+.|||+..+|.+||+|||++..+......
T Consensus        92 y~~gGsv~~lL~----~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r  167 (467)
T KOG0201|consen   92 YCGGGSVLDLLK----SGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR  167 (467)
T ss_pred             HhcCcchhhhhc----cCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence            999999999994    3344588888899999999999999999999999999999999999999999999877654443


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      . ...+||+.|||||++.+..|+.++||||||++.+||.+|.||+....+-.-..+.-                   ...
T Consensus       168 r-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIp-------------------k~~  227 (467)
T KOG0201|consen  168 R-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIP-------------------KSA  227 (467)
T ss_pred             c-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEecc-------------------CCC
Confidence            3 66789999999999999899999999999999999999999997554311110000                   001


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ++.....++..+.+++..||+.+|+.||++.++++.
T Consensus       228 PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  228 PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence            111122456779999999999999999999999864

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.5e-44  Score=321.36  Aligned_cols=268  Identities=21%  Similarity=0.303  Sum_probs=200.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|++.+.||+|+||.||++..+ +++.||+|++....  ....+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRR-RGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEec-CCEEEEEE
Confidence            46899999999999999999775 67889999986542  2334567889999999999999999997766 66899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||++++.+..+..    ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++........
T Consensus        80 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  155 (287)
T cd07848          80 EYVEKNMLELLEE----MPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN  155 (287)
T ss_pred             ecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence            9999876665442    234689999999999999999999999999999999999999999999999999987643332


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh-----
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD-----  292 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  292 (375)
                      .......+++.|+|||++.+..++.++|||||||++|+|++|++||..................+..........     
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07848         156 ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFH  235 (287)
T ss_pred             ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhc
Confidence            223344689999999999888899999999999999999999999975432211100000000000000000000     


Q ss_pred             ----hhcCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          293 ----QTLGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       293 ----~~l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                          +.......   .....++..+.+++.+||+.||++|||++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         236 GLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             ccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence                00000000   001124567999999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1e-43  Score=339.85  Aligned_cols=252  Identities=23%  Similarity=0.309  Sum_probs=204.8

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-C-CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-D-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .|.+.+.||+|++|.||+|... + +..||+|.+..........+.+|+.+++.++||||+++++++.. ...++|||||
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~-~~~~~lv~E~  146 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKS-DDKLLLIMEY  146 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEE-CCEEEEEEEC
Confidence            3888999999999999999544 4 67889998766665656678889999999999999999998776 5789999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc-c
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT-H  218 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~  218 (375)
                      +++|+|.+++........++++.++..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..+..... .
T Consensus       147 ~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~  226 (478)
T PTZ00267        147 GSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLD  226 (478)
T ss_pred             CCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccc
Confidence            999999998865444456789999999999999999999999999999999999999999999999999986643322 1


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......                   +++...+...
T Consensus       227 ~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~-------------------~~~~~~~~~~  287 (478)
T PTZ00267        227 VASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR-------------------EIMQQVLYGK  287 (478)
T ss_pred             cccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH-------------------HHHHHHHhCC
Confidence            223456899999999999889999999999999999999999999643311                   1111111111


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..+.+..++..+.+++.+||..+|++||++.+++.
T Consensus       288 ~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        288 YDPFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence            11112234567999999999999999999999875

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.9e-43  Score=312.83  Aligned_cols=255  Identities=23%  Similarity=0.471  Sum_probs=205.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ++|++.++||+|++|.||+|...++..|++|.+..... ..+.+.+|+.+++.++|+||+++++++.. ....+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   83 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM-SVQAFLEEANLMKTLQHDKLVRLYAVVTK-EEPIYIITEYM   83 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch-hHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCCcEEEEecC
Confidence            56889999999999999999888888999998765433 35678899999999999999999997665 56789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      ++++|.+++...  ....+++..+..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++...........
T Consensus        84 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  161 (261)
T cd05072          84 AKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAR  161 (261)
T ss_pred             CCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceecc
Confidence            999999998643  234688889999999999999999999999999999999999999999999999986544322222


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......       ....         +......  
T Consensus       162 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~-------~~~~---------~~~~~~~--  223 (261)
T cd05072         162 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD-------VMSA---------LQRGYRM--  223 (261)
T ss_pred             CCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH-------HHHH---------HHcCCCC--
Confidence            23345678999999988889999999999999999998 999996443111       0000         0000110  


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                       +....++..+.+++.+|+..+|++||+++++.+.|+++
T Consensus       224 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         224 -PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             -CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence             11122456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.2e-43  Score=318.11  Aligned_cols=250  Identities=24%  Similarity=0.317  Sum_probs=197.8

Q ss_pred             CCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           63 FDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      |+..+.||+|+||.||+|.. .+|+.||+|.+.....   .....+.+|+.+++.++|+|++++++++.. ....++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~-~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYET-KDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEcc-CCeEEEEEE
Confidence            67788999999999999965 5789999998865422   223457789999999999999999997766 567999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++|+|.+.+...  ....+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........ 
T Consensus        81 ~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05631          81 IMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET-  157 (285)
T ss_pred             ecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe-
Confidence            99999998887543  234589999999999999999999999999999999999999999999999999976543222 


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                       .....|+..|+|||++.+..++.++|||||||++|+|++|+.||.........   .....        .+....    
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~---~~~~~--------~~~~~~----  221 (285)
T cd05631         158 -VRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR---EEVDR--------RVKEDQ----  221 (285)
T ss_pred             -ecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH---HHHHH--------Hhhccc----
Confidence             23346899999999999999999999999999999999999999754321100   00000        000000    


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPY-----MVDVLD  333 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~evl~  333 (375)
                       .......+..+.+|+.+||+.+|.+||+     ++++++
T Consensus       222 -~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         222 -EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             -ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence             0111224567899999999999999997     777776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.1e-44  Score=329.66  Aligned_cols=248  Identities=25%  Similarity=0.361  Sum_probs=206.2

Q ss_pred             CCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           62 YFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      -|++.+.||.|+-|.|-+|++ .+|+.+|||++...   .......+.+|+-+|+.+.|||++++|+.++. ..++|+|.
T Consensus        13 pwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~-~~~lylvl   91 (786)
T KOG0588|consen   13 PWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWEN-KQHLYLVL   91 (786)
T ss_pred             ceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeecc-CceEEEEE
Confidence            477889999999999999954 58999999998654   11223457899999999999999999998777 77899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+++|.|.+++.    ..+++++.++..+++||+.|+.|+|..+|+|||+||+|+|++..+.+||+|||+|.+-..+. 
T Consensus        92 Eyv~gGELFdylv----~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-  166 (786)
T KOG0588|consen   92 EYVPGGELFDYLV----RKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-  166 (786)
T ss_pred             EecCCchhHHHHH----hhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc-
Confidence            9999999999994    55789999999999999999999999999999999999999999999999999998643332 


Q ss_pred             ccccCCCCCccccCcccccccCCCC-chhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTD-KSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                       .....||.|.|.|||++.|.+|.- ++||||.|||||.||||+.||+...                   +..++...-.
T Consensus       167 -lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN-------------------ir~LLlKV~~  226 (786)
T KOG0588|consen  167 -LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN-------------------IRVLLLKVQR  226 (786)
T ss_pred             -cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc-------------------HHHHHHHHHc
Confidence             234568999999999999998865 8999999999999999999998332                   1222222222


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                      +.+. .+.+.+.++++|+.+||.+||..|.|++||++.--
T Consensus       227 G~f~-MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~  265 (786)
T KOG0588|consen  227 GVFE-MPSNISSEAQDLLRRMLDVDPSTRITTEEILKHPF  265 (786)
T ss_pred             Cccc-CCCcCCHHHHHHHHHHhccCccccccHHHHhhCch
Confidence            2221 11346678999999999999999999999998743

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-43  Score=313.79  Aligned_cols=255  Identities=24%  Similarity=0.374  Sum_probs=202.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC----CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ----DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|++.+.||+|+||.||+|..+    .+..||+|.+.... ......+.+|+.+++.++||||+++++++.. +...++
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l   83 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITR-GNTMMI   83 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEec-CCCcEE
Confidence            56889999999999999999653    35689999987653 3334578899999999999999999997765 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++...   ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.++++|||.+......
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~  160 (266)
T cd05064          84 VTEYMSNGALDSFLRKH---EGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSE  160 (266)
T ss_pred             EEEeCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCccccccccc
Confidence            99999999999998543   346899999999999999999999999999999999999999999999999987653222


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .........++..|+|||.+.+..++.++|||||||++||+++ |..||.......      . ...         +...
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~------~-~~~---------~~~~  224 (266)
T cd05064         161 AIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD------V-IKA---------VEDG  224 (266)
T ss_pred             chhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------H-HHH---------HHCC
Confidence            1111112235678999999998899999999999999999875 999996543110      0 000         1110


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                      .   ..+....++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       225 ~---~~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         225 F---RLPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             C---CCCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            0   1111233566799999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.4e-45  Score=315.11  Aligned_cols=273  Identities=22%  Similarity=0.309  Sum_probs=208.1

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc----eeEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR----ELLLV  136 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----~~~lv  136 (375)
                      .|...+++|.|+||.||+|... ++..||||+.-.+...    -.+|+.+|+.++|||||++.-++.....    +..+|
T Consensus        25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence            4666889999999999999665 5789999998655432    2479999999999999999886644322    45789


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC-CcEEEeeeccccccCCC
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN-FCVKVADFGLSRLFPNH  215 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~  215 (375)
                      |||++ .+|...++.....+..++...++-+.+||++||.|||+.||+||||||.|+|+|.+ |.+||+|||.|+.+...
T Consensus       101 leymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  101 LEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             HHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            99996 78999997655556779999999999999999999999999999999999999976 99999999999987665


Q ss_pred             ccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh--
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD--  292 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  292 (375)
                      .+...  ...|..|+|||.+.| ..|+.+.||||.||++.||+-|++.|.+....++....-.+.+...+..+..+.-  
T Consensus       180 epniS--YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y  257 (364)
T KOG0658|consen  180 EPNIS--YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY  257 (364)
T ss_pred             CCcee--EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc
Confidence            55433  347889999997765 5799999999999999999999999987665444333322222222222222211  


Q ss_pred             -----hhcCCCCC--hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhhhcC
Q 017232          293 -----QTLGYESD--NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDIESD  341 (375)
Q Consensus       293 -----~~l~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i~~~  341 (375)
                           +.+.....  -.......+..+|+.++|..+|.+|.++.|++..  +++++..
T Consensus       258 ~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  258 TEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             ccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHhhCc
Confidence                 11111110  0112345689999999999999999999999864  6666554

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-44  Score=330.10  Aligned_cols=244  Identities=27%  Similarity=0.380  Sum_probs=203.4

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCce
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  132 (375)
                      ...++|.++++||+|+||+|+++..+ +++.||||++++..   .++.+..+.|-.|+.... ||.++.++.+++. ..+
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT-~~~  443 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQT-KEH  443 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccccc-CCe
Confidence            34567999999999999999999766 68899999998763   355678888999988885 9999999997776 789


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      +|.||||+.||++..+.     ....+++..+..++..|+.||.|||++||++||||.+|||+|.+|++||+|||+++..
T Consensus       444 l~fvmey~~Ggdm~~~~-----~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~  518 (694)
T KOG0694|consen  444 LFFVMEYVAGGDLMHHI-----HTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEG  518 (694)
T ss_pred             EEEEEEecCCCcEEEEE-----ecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEeccccccccc
Confidence            99999999999955444     3356999999999999999999999999999999999999999999999999999864


Q ss_pred             CCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ..... ..+..+|||.|+|||++.+..|+.+.|+|||||+|||||.|..||...+.+                   ++++
T Consensus       519 m~~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEe-------------------e~Fd  578 (694)
T KOG0694|consen  519 MGQGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEE-------------------EVFD  578 (694)
T ss_pred             CCCCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHH-------------------HHHH
Confidence            32222 345678999999999999999999999999999999999999999876532                   2222


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYM  328 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  328 (375)
                      ..+..+ ...+..++.+...++.++|..+|++|..+
T Consensus       579 sI~~d~-~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  579 SIVNDE-VRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHhcCC-CCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            222111 12224467789999999999999999877

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.4e-43  Score=313.80  Aligned_cols=257  Identities=27%  Similarity=0.460  Sum_probs=209.9

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ...+|++.+.||.|+||.||+|...++..+++|.+..........+.+|+.+++.++|+|++++++++.. ....++|||
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   82 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSV-GEPVYIITE   82 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEec-CCCeEEEEe
Confidence            4566889999999999999999888899999999987766566788999999999999999999997665 667899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++...  ....+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+.........
T Consensus        83 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~  160 (261)
T cd05148          83 LMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL  160 (261)
T ss_pred             ecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence            99999999999654  3356899999999999999999999999999999999999999999999999998765432221


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                       .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      .         .. .+..... 
T Consensus       161 -~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~------~---------~~-~~~~~~~-  222 (261)
T cd05148         161 -SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE------V---------YD-QITAGYR-  222 (261)
T ss_pred             -ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH------H---------HH-HHHhCCc-
Confidence             123345678999999988889999999999999999998 899996443110      0         00 1111111 


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                        .+....++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         223 --MPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             --CCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence              111123456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.3e-43  Score=309.74  Aligned_cols=252  Identities=27%  Similarity=0.464  Sum_probs=200.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ++|++.+.||+|+||.||++..+++..+|+|.+..... ....+.+|+.+++.++||||+++++++.. ....++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM-SEEDFIEEAKVMMKLSHPKLVQLYGVCTQ-QKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc-cHHHHHHHHHHHHHCCCCCceeEEEEEcc-CCCEEEEEEcC
Confidence            35788899999999999999888888999998764432 23578889999999999999999997766 56789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      ++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+...........
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05114          82 ENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSS  158 (256)
T ss_pred             CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceecc
Confidence            999999998543   23588999999999999999999999999999999999999999999999999876543322222


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.......      .. ..+..        . ..   
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~------~~-~~i~~--------~-~~---  219 (256)
T cd05114         159 SGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE------VV-EMISR--------G-FR---  219 (256)
T ss_pred             CCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH------HH-HHHHC--------C-CC---
Confidence            22335568999999988889999999999999999999 899986543111      00 00100        0 00   


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                      ...+...+..+.+++.+|++.+|++||++.++++.|.
T Consensus       220 ~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l~  256 (256)
T cd05114         220 LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAIT  256 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            0000112356899999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=3.1e-43  Score=326.98  Aligned_cols=260  Identities=24%  Similarity=0.354  Sum_probs=201.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe------CCCCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCc
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  131 (375)
                      .++|++.+.||+|+||.||+|..      .++..||+|++... .....+.+.+|+.++..+ +||||+++++++.. ..
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~-~~  112 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTV-GG  112 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeecc-CC
Confidence            45689999999999999999953      23568999998644 233456788999999999 89999999997766 56


Q ss_pred             eeEEEEecccCCChhHhhccCCC---------------------------------------------------------
Q 017232          132 ELLLVYEFISNGTVADHLHGERA---------------------------------------------------------  154 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  154 (375)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       113 ~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (375)
T cd05104         113 PTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSG  192 (375)
T ss_pred             cceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccc
Confidence            78999999999999999864321                                                         


Q ss_pred             --------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc-
Q 017232          155 --------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV-  219 (375)
Q Consensus       155 --------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-  219 (375)
                                    ....+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++.......... 
T Consensus       193 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  272 (375)
T cd05104         193 SYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVV  272 (375)
T ss_pred             eecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccc
Confidence                          11257888999999999999999999999999999999999999999999999987654332211 


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......      ..         ...+.......
T Consensus       273 ~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~------~~---------~~~~~~~~~~~  337 (375)
T cd05104         273 KGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS------KF---------YKMIKEGYRML  337 (375)
T ss_pred             cCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH------HH---------HHHHHhCccCC
Confidence            112234567999999999899999999999999999998 888886432111      00         01111111101


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                      .   +...+.++.+++.+||+.+|++|||+.+|++.|++.
T Consensus       338 ~---~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         338 S---PECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             C---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            0   011345789999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-44  Score=319.76  Aligned_cols=245  Identities=24%  Similarity=0.365  Sum_probs=198.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHD-QRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhcc-CCeEEEE
Confidence            36889999999999999999665 68999999986442   2334568889999999999999999986665 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++..    ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~  155 (291)
T cd05612          80 MEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT  155 (291)
T ss_pred             EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc
Confidence            999999999999853    3458999999999999999999999999999999999999999999999999987654321


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                          ....|++.|+|||++.+..++.++|||||||++|+|++|+.||.......      .         ...+......
T Consensus       156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~------~---------~~~i~~~~~~  216 (291)
T cd05612         156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG------I---------YEKILAGKLE  216 (291)
T ss_pred             ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H---------HHHHHhCCcC
Confidence                23458999999999998889999999999999999999999997543110      0         0111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPY-----MVDVLDA  334 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~evl~~  334 (375)
                      .     +......+.+++.+||+.||.+||+     ++++++.
T Consensus       217 ~-----~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         217 F-----PRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             C-----CccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence            1     1123457889999999999999995     7777654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=336.06  Aligned_cols=266  Identities=25%  Similarity=0.371  Sum_probs=215.2

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCC-CEEEEEEecccchhhHHHHHHHHHHHHhcC-CCCeEEEee-eee----cC-Cc
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDG-RAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYG-CTS----RH-SR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~-~~~----~~-~~  131 (375)
                      ..++++.+.|.+|||+.||+|....+ ..||+|++...+....+.+.+|+++|+.|+ |+|||.+++ ...    .. ..
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~  115 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVW  115 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCcee
Confidence            45678899999999999999977655 999999998888889999999999999997 999999999 221    11 35


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC--ceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--IIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      +++|.||||.||.|-++++....  ..|++.++++|+.++++|+.+||...  |+|||||-+||||..+|..||||||.+
T Consensus       116 EvllLmEyC~gg~Lvd~mn~Rlq--~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSa  193 (738)
T KOG1989|consen  116 EVLLLMEYCKGGSLVDFMNTRLQ--TRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSA  193 (738)
T ss_pred             EEEeehhhccCCcHHHHHHHHHh--ccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCccccc
Confidence            68999999999999999976533  34999999999999999999999997  999999999999999999999999998


Q ss_pred             cccCCCccc--c------ccCCCCCccccCcccc---cccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHH
Q 017232          210 RLFPNHVTH--V------STAPQGTPGYVDPEYH---QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA  278 (375)
Q Consensus       210 ~~~~~~~~~--~------~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~  278 (375)
                      +-.-.....  .      .-...-|+.|+|||++   .+.++++|+|||+|||+||-|+....||+..+.-.        
T Consensus       194 tt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la--------  265 (738)
T KOG1989|consen  194 TTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA--------  265 (738)
T ss_pred             ccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee--------
Confidence            643211100  0      0112368999999965   57889999999999999999999999998764221        


Q ss_pred             HHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCCCCccc
Q 017232          279 INKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTH  349 (375)
Q Consensus       279 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~~~~~~  349 (375)
                                 ++....  .++ ....++..+.+||..||+.+|++||++-+|+..+-.+......-...+
T Consensus       266 -----------Ilng~Y--~~P-~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~~~~~~  322 (738)
T KOG1989|consen  266 -----------ILNGNY--SFP-PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCPIPDIY  322 (738)
T ss_pred             -----------EEeccc--cCC-CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCCccccc
Confidence                       111111  111 114577889999999999999999999999999998887655444443

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-43  Score=324.29  Aligned_cols=253  Identities=23%  Similarity=0.344  Sum_probs=201.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.++..++||||+++++++.. ....++|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQD-DEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEc-CCEEEEE
Confidence            46889999999999999999765 58899999986542   2334567889999999999999999997766 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.....  
T Consensus        80 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--  153 (333)
T cd05600          80 MEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--  153 (333)
T ss_pred             EeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--
Confidence            999999999999953    34588999999999999999999999999999999999999999999999999876533  


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                        ......|++.|+|||++.+..++.++|||||||++|+|++|.+||........       ...+...  ...+.   .
T Consensus       154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~-------~~~i~~~--~~~~~---~  219 (333)
T cd05600         154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET-------WENLKYW--KETLQ---R  219 (333)
T ss_pred             --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH-------HHHHHhc--ccccc---C
Confidence              22344689999999999988999999999999999999999999975432110       0000000  00000   0


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .........++..+.+++.+||..+|.+||++.++++.
T Consensus       220 ~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         220 PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            00010012345678999999999999999999999965

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-43  Score=309.19  Aligned_cols=256  Identities=28%  Similarity=0.454  Sum_probs=205.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .++|++.+.||+|++|.||+|...++..||+|.+..... ..+.+.+|+.++++++|||++++++++.. .+..++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM-DPKDFLAEAQIMKKLRHPKLIQLYAVCTL-EEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc-cHHHHHHHHHHHHHCCCCCccceeEEEec-CCCeeeeeec
Confidence            456889999999999999999877788899999865442 34678899999999999999999997665 5678999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +.+++|.+++....  ...+++..+..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus        83 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  160 (261)
T cd05068          83 MKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEA  160 (261)
T ss_pred             ccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccc
Confidence            99999999985432  3468999999999999999999999999999999999999999999999999998765322221


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ......+..|+|||.+.+..++.++||||||+++|+|++ |+.||.......       ..         ..+.....  
T Consensus       161 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~---------~~~~~~~~--  222 (261)
T cd05068         161 REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE-------VL---------QQVDQGYR--  222 (261)
T ss_pred             cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH-------HH---------HHHHcCCC--
Confidence            122223457999999998899999999999999999999 999996443110       00         01111100  


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                       .+....++..+.+++.+|++.+|++||++.++++.|+++
T Consensus       223 -~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         223 -MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             -CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence             011123456799999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=2.8e-43  Score=321.26  Aligned_cols=241  Identities=24%  Similarity=0.328  Sum_probs=193.1

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccC
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISN  142 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  142 (375)
                      +.||+|+||.||++... +|+.||+|++....   ......+.+|+.+++.++||||+++++++.. ....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEc-CCEEEEEEeCCCC
Confidence            36999999999999654 78999999986542   2334567889999999999999999997766 6689999999999


Q ss_pred             CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccC
Q 017232          143 GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA  222 (375)
Q Consensus       143 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  222 (375)
                      ++|.+++..    ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++........ ....
T Consensus        80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~-~~~~  154 (323)
T cd05571          80 GELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGA-TMKT  154 (323)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCC-cccc
Confidence            999998853    34689999999999999999999999999999999999999999999999999875322111 1223


Q ss_pred             CCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChH
Q 017232          223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNK  302 (375)
Q Consensus       223 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  302 (375)
                      ..||+.|+|||++.+..++.++|||||||++|||++|..||.......      . ..        .+......     .
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~-~~--------~~~~~~~~-----~  214 (323)
T cd05571         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------L-FE--------LILMEEIR-----F  214 (323)
T ss_pred             eecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHH------H-HH--------HHHcCCCC-----C
Confidence            468999999999999899999999999999999999999996432110      0 00        01101010     1


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 017232          303 VRRTINAVAELAFQCLQSEKDLRP-----YMVDVLD  333 (375)
Q Consensus       303 ~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~  333 (375)
                      +...+..+.+++.+||..||++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence            122456789999999999999999     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=8.8e-43  Score=313.14  Aligned_cols=261  Identities=28%  Similarity=0.461  Sum_probs=207.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ++|.+.+.||+|+||.||++...      ++..+++|.+..........+.+|+.+++.++|||++++++++.. ....+
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccE
Confidence            46889999999999999999642      345689998876665566789999999999999999999997766 67789


Q ss_pred             EEEecccCCChhHhhccCC---------CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEee
Q 017232          135 LVYEFISNGTVADHLHGER---------AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD  205 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~D  205 (375)
                      +||||+++++|.+++....         .....+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~d  163 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD  163 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEecc
Confidence            9999999999999986432         1234589999999999999999999999999999999999999999999999


Q ss_pred             eccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhh
Q 017232          206 FGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQ  283 (375)
Q Consensus       206 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  283 (375)
                      ||++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |.+||.......       ....+.
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-------~~~~i~  236 (288)
T cd05093         164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIECIT  236 (288)
T ss_pred             CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHHHHH
Confidence            999875533221 11122335678999999998889999999999999999998 899986443211       001111


Q ss_pred             hhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       284 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .        ...    ......++..+.+++.+||+.+|.+|||+.++++.|+++...
T Consensus       237 ~--------~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         237 Q--------GRV----LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             c--------CCc----CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            1        000    000112345789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.9e-43  Score=326.03  Aligned_cols=261  Identities=24%  Similarity=0.355  Sum_probs=202.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCc
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  131 (375)
                      .++|++.+.||+|+||.||+|...      ++..||+|.+... .......+.+|+.+++.+ +|+||+++++++.. ..
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~-~~  115 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTH-GG  115 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecC-CC
Confidence            456899999999999999998642      2357999998654 334456788999999999 89999999997766 56


Q ss_pred             eeEEEEecccCCChhHhhccCCC---------------------------------------------------------
Q 017232          132 ELLLVYEFISNGTVADHLHGERA---------------------------------------------------------  154 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~---------------------------------------------------------  154 (375)
                      ..++||||+++|+|.+++.....                                                         
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            79999999999999998853210                                                         


Q ss_pred             ---------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc-cccCCC
Q 017232          155 ---------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQ  224 (375)
Q Consensus       155 ---------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~  224 (375)
                               ....+++..++.++.|++.||.|||++|++||||||+|||+++++.++|+|||++......... ......
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence                     1134788899999999999999999999999999999999999999999999998765432221 111223


Q ss_pred             CCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHH
Q 017232          225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKV  303 (375)
Q Consensus       225 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  303 (375)
                      ++..|+|||++.+..++.++|||||||++|+|++ |+.||.......               ...............   
T Consensus       276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~---------------~~~~~~~~~~~~~~~---  337 (374)
T cd05106         276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS---------------KFYKMVKRGYQMSRP---  337 (374)
T ss_pred             CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH---------------HHHHHHHcccCccCC---
Confidence            5568999999988899999999999999999997 999996432111               001111111111111   


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          304 RRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       304 ~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      ...+..+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus       338 ~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         338 DFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence            112467899999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=2.3e-43  Score=322.66  Aligned_cols=245  Identities=29%  Similarity=0.423  Sum_probs=198.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.+++.++||||+++++++.. ....++|
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv   96 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQD-ENRVYFL   96 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEc-CCEEEEE
Confidence            46888999999999999999765 68899999986542   2334568899999999999999999997776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+.+++|.+++..    ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        97 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  172 (329)
T PTZ00263         97 LEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT  172 (329)
T ss_pred             EcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc
Confidence            999999999999853    3468899999999999999999999999999999999999999999999999997654322


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                          ....|++.|+|||++.+..++.++|||||||++|+|++|..||.......       ...        .+....+.
T Consensus       173 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-------~~~--------~i~~~~~~  233 (329)
T PTZ00263        173 ----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR-------IYE--------KILAGRLK  233 (329)
T ss_pred             ----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH-------HHH--------HHhcCCcC
Confidence                23468999999999999889999999999999999999999996432110       001        11111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPY-----MVDVLDA  334 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~evl~~  334 (375)
                      .  +   ......+.+++.+||+.||.+||+     +++++..
T Consensus       234 ~--p---~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        234 F--P---NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             C--C---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            0  0   113456889999999999999997     5776644

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=7.6e-43  Score=309.40  Aligned_cols=255  Identities=30%  Similarity=0.459  Sum_probs=204.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .+|.+.+.||+|++|.||+|..+ .++.|++|.+.... .....+.+|+.+++.++|+|++++++++.. ....+++|||
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   83 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITEF   83 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCc-hHHHHHHHHHHHHHhCCCCChhheEEEEcC-CCCcEEEEEe
Confidence            34778899999999999999654 58889999886543 335678899999999999999999997766 5678999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++++|.+++...  ....+++..++.++.|++.||.|||++|++|+||||+||++++++.+||+|||++..........
T Consensus        84 ~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~  161 (263)
T cd05052          84 MTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  161 (263)
T ss_pred             CCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeec
Confidence            9999999998543  23458899999999999999999999999999999999999999999999999988665433222


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ......+..|+|||.+.+..++.++|||||||++|+|++ |..||.......      . .         ..+.......
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~------~-~---------~~~~~~~~~~  225 (263)
T cd05052         162 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------V-Y---------ELLEKGYRME  225 (263)
T ss_pred             cCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------H-H---------HHHHCCCCCC
Confidence            222334668999999998899999999999999999998 999986432110      0 0         0111111111


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                         ....++..+.+++.+||+.+|++||++.++++.|+.+
T Consensus       226 ---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         226 ---RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence               1122456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.2e-43  Score=336.64  Aligned_cols=258  Identities=26%  Similarity=0.344  Sum_probs=206.2

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----
Q 017232           58 EATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----  130 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  130 (375)
                      ...++|.+.+.||+|+||+||+|.. .+|+.||+|++...  .......+.+|+.++..++|+|++++++.+....    
T Consensus        29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence            3456899999999999999999964 47899999998654  3344566888999999999999999887543321    


Q ss_pred             ---ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeec
Q 017232          131 ---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFG  207 (375)
Q Consensus       131 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg  207 (375)
                         ..+++||||+++|+|.+++.........+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence               14689999999999999997655555679999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCc-cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH
Q 017232          208 LSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA  286 (375)
Q Consensus       208 ~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (375)
                      ++..+.... ........||+.|+|||++.+..++.++|||||||++|||++|+.||......                 
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~-----------------  251 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME-----------------  251 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH-----------------
Confidence            987654321 12223456899999999999989999999999999999999999999643211                 


Q ss_pred             HHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          287 LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       287 ~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                        +++...+.....+.+..++..+.+++.+||+.+|.+||++.++++.
T Consensus       252 --~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        252 --EVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             --HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence              1111111111112223355679999999999999999999999864

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.3e-43  Score=324.26  Aligned_cols=268  Identities=21%  Similarity=0.340  Sum_probs=198.0

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----ceeE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----RELL  134 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~  134 (375)
                      +|++.+.||+|+||.||+|... ++..||+|++...  .......+.+|+.+++.++||||+++++++....    ..++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            5888999999999999999654 6899999988643  2233456889999999999999999999764322    3589


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+. ++|.+++..    ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        81 lv~e~~~-~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          81 VVFELME-SDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEecCC-CCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999995 788888843    34589999999999999999999999999999999999999999999999999875432


Q ss_pred             Ccc--ccccCCCCCccccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchh--------HHHHHHh
Q 017232          215 HVT--HVSTAPQGTPGYVDPEYHQC--YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLS--------NLAINKI  282 (375)
Q Consensus       215 ~~~--~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~--------~~~~~~~  282 (375)
                      ...  .......+++.|+|||++.+  ..++.++|||||||++|+|++|++||............        ......+
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            211  11233468999999998865  57899999999999999999999999654321111000        0001111


Q ss_pred             hhhHHHHHHhhhcCCCCCh---HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          283 QNKALHELVDQTLGYESDN---KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       283 ~~~~~~~~~~~~l~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ........+..........   ........+.+++.+||+.+|++|||++|+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            1111111221111111111   111234568899999999999999999999965

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=325.21  Aligned_cols=247  Identities=26%  Similarity=0.363  Sum_probs=204.1

Q ss_pred             CCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCC
Q 017232           64 DSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG  143 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~  143 (375)
                      ..++.||.|+.|.||+|+.+ ++.||||+++.-.       ..+|..|++|+||||+.|.|+|.. ..++|||||||..|
T Consensus       127 sELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtq-sPcyCIiMEfCa~G  197 (904)
T KOG4721|consen  127 SELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQ-SPCYCIIMEFCAQG  197 (904)
T ss_pred             hhhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecC-CceeEEeeeccccc
Confidence            34678999999999999987 6889999874332       347888999999999999998877 67899999999999


Q ss_pred             ChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCC
Q 017232          144 TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP  223 (375)
Q Consensus       144 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  223 (375)
                      .|.+.|..    +.+++......|..+|+.|+.|||.+.|||||||.-||||..+..+||+|||.++......+.  ...
T Consensus       198 qL~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STk--MSF  271 (904)
T KOG4721|consen  198 QLYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTK--MSF  271 (904)
T ss_pred             cHHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhh--hhh
Confidence            99999954    356888889999999999999999999999999999999999999999999999876554332  345


Q ss_pred             CCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHH
Q 017232          224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKV  303 (375)
Q Consensus       224 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  303 (375)
                      .||..|||||++.+.+.++|.|||||||+|||||||..||...+....    -|       +.-...       ...+.+
T Consensus       272 aGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI----Iw-------GVGsNs-------L~LpvP  333 (904)
T KOG4721|consen  272 AGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI----IW-------GVGSNS-------LHLPVP  333 (904)
T ss_pred             hhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchhee----EE-------eccCCc-------ccccCc
Confidence            699999999999999999999999999999999999999964331110    00       000000       012333


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          304 RRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       304 ~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                      ..|++.+.-|+++||+..|..||++.+++..|+-...+.+
T Consensus       334 stcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell  373 (904)
T KOG4721|consen  334 STCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELL  373 (904)
T ss_pred             ccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHh
Confidence            4677889999999999999999999999999987665544

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.2e-42  Score=311.39  Aligned_cols=258  Identities=28%  Similarity=0.449  Sum_probs=204.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           61 NYFDSARELGDGGFGTVYYGELQD------GRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      ++|++.+.||+|+||.||+|....      ...|++|.+.... ......+.+|+.++..++||||+++++++.. ....
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTK-EQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcC-CCce
Confidence            458889999999999999996543      2579999886543 3345678899999999999999999997765 5678


Q ss_pred             EEEEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcE
Q 017232          134 LLVYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV  201 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~  201 (375)
                      +++|||+++++|.+++.....            ....+++..++.++.|++.||.|||+.|++|+||||+||++++++.+
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV  163 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence            999999999999999865421            11458889999999999999999999999999999999999999999


Q ss_pred             EEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHH
Q 017232          202 KVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAI  279 (375)
Q Consensus       202 kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  279 (375)
                      +|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.......         
T Consensus       164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~---------  234 (283)
T cd05048         164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE---------  234 (283)
T ss_pred             EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHH---------
Confidence            9999999875432221 12223346788999999888889999999999999999998 999986433110         


Q ss_pred             HHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          280 NKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       280 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                             ....+..   .........++..+.+|+.+||+.+|++||++.+|++.|+++
T Consensus       235 -------~~~~i~~---~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~  283 (283)
T cd05048         235 -------VIEMIRS---RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW  283 (283)
T ss_pred             -------HHHHHHc---CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence                   0011111   111112234667899999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.3e-44  Score=312.18  Aligned_cols=249  Identities=27%  Similarity=0.451  Sum_probs=208.5

Q ss_pred             HhcCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           59 ATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ...+|++.+.||+|.||.|-+| ....|+.||||.+.++..   ..+-.+.+|+++|..|+||||+.+|++|+. ...+.
T Consensus        51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFEN-kdKIv  129 (668)
T KOG0611|consen   51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFEN-KDKIV  129 (668)
T ss_pred             hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcC-CceEE
Confidence            3467999999999999999999 457899999999977643   345567899999999999999999998877 66799


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      |||||..+|.|++++..    .+.+++.++..+++||..|+.|+|.++++|||||.+|||+|.++++||+|||++.++..
T Consensus       130 ivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  130 IVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             EEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            99999999999999954    35699999999999999999999999999999999999999999999999999988765


Q ss_pred             CccccccCCCCCccccCcccccccCCC-CchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLT-DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ..  .....+|++-|.+||++.|.+|. +..|-||||++||.|+.|..||+..+...       ..+.+..+.+.     
T Consensus       206 ~k--fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~-------lvrQIs~GaYr-----  271 (668)
T KOG0611|consen  206 KK--FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKR-------LVRQISRGAYR-----  271 (668)
T ss_pred             cc--HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHH-------HHHHhhccccc-----
Confidence            43  34567899999999999999885 58999999999999999999998765311       11111111111     


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL  335 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L  335 (375)
                          ++     +.+....-||++||.++|++|.|+.+|...-
T Consensus       272 ----EP-----~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  272 ----EP-----ETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ----CC-----CCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                11     1235677899999999999999999998764

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=4.4e-44  Score=304.34  Aligned_cols=269  Identities=22%  Similarity=0.290  Sum_probs=203.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhh--HHHHHHHHHHHHhcCCCCeEEEeeeee-cCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKR--VEQFMNEVDILARLRHKNLVSLYGCTS-RHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~~lv  136 (375)
                      +.|+.++.|++|.||.||+|+. ++++.||+|+++....+.  --.-.+|+.+|.+++|||||.+-.+.. .+-+.+|+|
T Consensus        76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            4588899999999999999954 478999999997553221  123468999999999999999988543 334569999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||||+ -+|..++....   +++...+++.++.|++.|++|||.+.|+|||||++|+|++..|.+||+|||+|+.++++.
T Consensus       156 Me~~E-hDLksl~d~m~---q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  156 MEYVE-HDLKSLMETMK---QPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             HHHHH-hhHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            99996 57888887654   569999999999999999999999999999999999999999999999999999887653


Q ss_pred             cccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH---HHHHh
Q 017232          217 THVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL---HELVD  292 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  292 (375)
                      . ..+..+.|.+|+|||++.| ..|+++.|+||+|||+.||++++|.|.....-++.+..-...+...+...   .++..
T Consensus       232 k-~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~  310 (419)
T KOG0663|consen  232 K-PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA  310 (419)
T ss_pred             c-cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence            3 2355678999999998776 56999999999999999999999999877655443322222221111100   00000


Q ss_pred             h-hcCC--CCCh----HHH--HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          293 Q-TLGY--ESDN----KVR--RTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       293 ~-~l~~--~~~~----~~~--~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      - ....  .+..    ...  .+.+.-.+|+..+|..||.+|.|+++.++.
T Consensus       311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            0 0000  0000    000  134678899999999999999999988753

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=9.7e-43  Score=311.52  Aligned_cols=257  Identities=27%  Similarity=0.456  Sum_probs=204.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCC------CCEEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           61 NYFDSARELGDGGFGTVYYGELQD------GRAVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      ++|.+.+.||+|+||.||+|...+      +..||+|.+...... ..+.+.+|+++++.++|+||+++++++.. ....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-GDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-CCCe
Confidence            458889999999999999996543      478999998765443 45688999999999999999999997776 5779


Q ss_pred             EEEEecccCCChhHhhccCC----------CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEE
Q 017232          134 LLVYEFISNGTVADHLHGER----------AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKV  203 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~----------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl  203 (375)
                      ++||||+++++|.+++....          .....+++..+..++.|++.|+.+||++|++|+||||+||+++.++.++|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl  163 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI  163 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence            99999999999999996542          12345788999999999999999999999999999999999999999999


Q ss_pred             eeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHH
Q 017232          204 ADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINK  281 (375)
Q Consensus       204 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  281 (375)
                      +|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.......      .    
T Consensus       164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~------~----  233 (280)
T cd05049         164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE------V----  233 (280)
T ss_pred             CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH------H----
Confidence            99999875432211 11123345678999999999999999999999999999998 999986433211      0    


Q ss_pred             hhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          282 IQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                           .. .+.   ...........+..+.+++.+||+.+|++||++.||++.|++
T Consensus       234 -----~~-~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~  280 (280)
T cd05049         234 -----IE-CIT---QGRLLQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK  280 (280)
T ss_pred             -----HH-HHH---cCCcCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence                 00 000   111111112345679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.4e-42  Score=323.50  Aligned_cols=261  Identities=20%  Similarity=0.169  Sum_probs=195.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      ++|++.+.||+|+||.||++.. .+++.||+|...      ...+.+|+.+++.++||||+++++++.. ....++|+|+
T Consensus        92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~lv~e~  164 (391)
T PHA03212         92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTY-NKFTCLILPR  164 (391)
T ss_pred             CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEE-CCeeEEEEec
Confidence            5799999999999999999955 478899999653      2346789999999999999999997766 5678999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +. ++|..++..    ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus       165 ~~-~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~  239 (391)
T PHA03212        165 YK-TDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANK  239 (391)
T ss_pred             CC-CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccc
Confidence            95 788888743    2458899999999999999999999999999999999999999999999999987543322222


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccc----hhHHHHHHh----------hhh
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEIN----LSNLAINKI----------QNK  285 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~----~~~~~~~~~----------~~~  285 (375)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|..||-.........    .........          ...
T Consensus       240 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~  319 (391)
T PHA03212        240 YYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQA  319 (391)
T ss_pred             cccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhH
Confidence            334569999999999998899999999999999999999997764322111100    000000000          000


Q ss_pred             HHHHHHhh---hcC---CCC--ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          286 ALHELVDQ---TLG---YES--DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       286 ~~~~~~~~---~l~---~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .....+..   ...   ...  .......+.++.+++.+||+.||.+|||++|+++
T Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        320 NLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            01111100   000   000  0112245668999999999999999999999985

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.5e-43  Score=315.65  Aligned_cols=267  Identities=21%  Similarity=0.282  Sum_probs=196.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|++.++||.|+||.||+|..+ ++..||+|.+.... ......+.+|+.+++.++||||+++++++.. ....++|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHT-ERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcC-CCeEEEEEe
Confidence            56899999999999999999655 68899999986442 2223467789999999999999999997765 567899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |++ ++|.+++...   ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        84 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~-  158 (288)
T cd07871          84 YLD-SDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK-  158 (288)
T ss_pred             CCC-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc-
Confidence            997 5898888532   33578899999999999999999999999999999999999999999999999875432221 


Q ss_pred             cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH---------H
Q 017232          219 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL---------H  288 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------~  288 (375)
                      ......+++.|+|||.+.+ ..++.++||||+||++|+|++|++||........................         .
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            1233457899999998765 56899999999999999999999999754422211100000000000000         0


Q ss_pred             HHHhhhcCCCC-ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          289 ELVDQTLGYES-DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       289 ~~~~~~l~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ....+...... .........++.+++.+||..||.+|||++|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            00000000000 0000123456889999999999999999999974

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=9.4e-43  Score=319.27  Aligned_cols=263  Identities=25%  Similarity=0.392  Sum_probs=205.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCc
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENN-YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  131 (375)
                      .++|++.+.||+|+||.||+|...      +++.||+|++.... ....+.+.+|+.++.++ +|+||+++++++...+.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            357999999999999999999532      35789999886542 33446678899999999 79999999998877677


Q ss_pred             eeEEEEecccCCChhHhhccCCCC--------------------------------------------------------
Q 017232          132 ELLLVYEFISNGTVADHLHGERAK--------------------------------------------------------  155 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------------------  155 (375)
                      .++++|||+++++|.+++......                                                        
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            899999999999999988543210                                                        


Q ss_pred             -CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc-ccCCCCCccccCcc
Q 017232          156 -PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV-STAPQGTPGYVDPE  233 (375)
Q Consensus       156 -~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE  233 (375)
                       ...+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++..+....... .....++..|+|||
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  245 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  245 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence             1368899999999999999999999999999999999999999999999999998654322211 22234567899999


Q ss_pred             cccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHH
Q 017232          234 YHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAE  312 (375)
Q Consensus       234 ~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~  312 (375)
                      ++.+..++.++|||||||++|+|++ |..||.......      .....+.         .......   .......+.+
T Consensus       246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~------~~~~~~~---------~~~~~~~---~~~~~~~~~~  307 (337)
T cd05054         246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE------EFCRRLK---------EGTRMRA---PEYATPEIYS  307 (337)
T ss_pred             HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH------HHHHHHh---------ccCCCCC---CccCCHHHHH
Confidence            9999999999999999999999998 999986432111      0001111         1000000   1123457899


Q ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          313 LAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       313 li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      ++.+||+.+|++||++.++++.|+++..
T Consensus       308 l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         308 IMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             HHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            9999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.4e-42  Score=305.72  Aligned_cols=254  Identities=30%  Similarity=0.492  Sum_probs=203.0

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .++|++.+.||+|+||.||+|...++..+++|.+..... ..+.+.+|+.+++.++|+|++++++++..  ...+++|||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~   81 (260)
T cd05070           5 RESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE--EPIYIVTEY   81 (260)
T ss_pred             hHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC--CCcEEEEEe
Confidence            356889999999999999999888888899999865433 23568899999999999999999997643  457899999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +.+++|.+++...  ....+++..++.++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++..........
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05070          82 MSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             cCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence            9999999998643  23458999999999999999999999999999999999999999999999999997654332222


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      .....++..|+|||...+..++.++||||||+++|+|++ |.+||.......      .          .+.+.....  
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~----------~~~~~~~~~--  221 (260)
T cd05070         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE------V----------LEQVERGYR--  221 (260)
T ss_pred             ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH------H----------HHHHHcCCC--
Confidence            222235568999999888889999999999999999999 889986432110      0          001111111  


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                       .+.....+..+.+++.+|+..+|++|||+.++.+.|++
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 -MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence             11112345679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.7e-42  Score=315.32  Aligned_cols=261  Identities=22%  Similarity=0.351  Sum_probs=205.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGR----AVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      .+|+..+.||+|+||.||+|.+. ++.    .||+|.+.... ....+.+.+|+.+++.++||||+++++++...  ..+
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~~~   84 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ   84 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--Cce
Confidence            46899999999999999999754 333    48999986543 34456788999999999999999999977653  467


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +++||+.+|+|.+++...   ...+++..++.++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.....
T Consensus        85 ~v~e~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~  161 (316)
T cd05108          85 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  161 (316)
T ss_pred             eeeecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccC
Confidence            999999999999998643   34588899999999999999999999999999999999999999999999999987653


Q ss_pred             Ccccc-ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          215 HVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       215 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ..... ......+..|+|||.+.+..++.++||||||+++|||++ |..||+......                ...++.
T Consensus       162 ~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~----------------~~~~~~  225 (316)
T cd05108         162 DEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILE  225 (316)
T ss_pred             CCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH----------------HHHHHh
Confidence            32211 122234678999999998899999999999999999997 999986432110                011111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDD  345 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~~  345 (375)
                      ....   .+....+...+.+++.+||..+|++||++.+++..|..+..+....
T Consensus       226 ~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~~~~  275 (316)
T cd05108         226 KGER---LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRY  275 (316)
T ss_pred             CCCC---CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCCchh
Confidence            1111   0111224457889999999999999999999999999987766543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.6e-42  Score=304.88  Aligned_cols=260  Identities=25%  Similarity=0.418  Sum_probs=209.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|++|.||+|... +|+.|++|.+...   .......+.+|+.++++++|+|++++++++.. ....++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-NNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEEEE
Confidence            57899999999999999999766 7899999988532   23335678899999999999999999997776 5678999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++.........+++..++.++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            99999999999987654455668999999999999999999999999999999999999999999999999987654322


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||......    ...             +.+....
T Consensus       161 ~~-~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~----~~~-------------~~~~~~~  222 (267)
T cd08224         161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYS-------------LCKKIEK  222 (267)
T ss_pred             cc-cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc----HHH-------------HHhhhhc
Confidence            11 22335788999999998888999999999999999999999998643211    000             0100000


Q ss_pred             CCCChH-HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          297 YESDNK-VRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       297 ~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      ....+. ....+..+.+++.+||..+|++|||+.+|+++|.++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         223 CDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             CCCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            011111 1134567899999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.2e-42  Score=306.90  Aligned_cols=252  Identities=27%  Similarity=0.483  Sum_probs=200.6

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ++|++.+.||+|+||.||+|...++..+|+|.+..... ....+.+|+.+++.++||||+++++++.. ....++||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMKLSHEKLVQLYGVCTK-QRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc-cHHHHHHHHHHHhcCCCCCeeeEEEEEcc-CCCcEEEEEcC
Confidence            35788899999999999999887777899998865433 23568899999999999999999997765 56689999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      .+++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+...........
T Consensus        82 ~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~  158 (256)
T cd05113          82 SNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSS  158 (256)
T ss_pred             CCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeec
Confidence            999999998543   23589999999999999999999999999999999999999999999999999876543322222


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      . .        ..+. ...   .
T Consensus       159 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~------~-~--------~~~~-~~~---~  219 (256)
T cd05113         159 VGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE------T-V--------EKVS-QGL---R  219 (256)
T ss_pred             CCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH------H-H--------HHHh-cCC---C
Confidence            22335678999999988889999999999999999998 999986443110      0 0        0011 000   0


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                      .......+..+.+++.+||+.+|++||++.++++.|+
T Consensus       220 ~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         220 LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence            0111123467899999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=3.2e-42  Score=306.00  Aligned_cols=261  Identities=24%  Similarity=0.381  Sum_probs=208.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||+|... +++.||+|.+...   .......+.+|+.+++.++|||++++++++.. ....+++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-DNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-CCeEEEE
Confidence            47899999999999999999654 7899999987542   33445578899999999999999999997766 5678999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      +||+++++|.+++.........+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            99999999999886654445668999999999999999999999999999999999999999999999999987654322


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .. .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.......    ....          ..+...  
T Consensus       161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~----~~~~----------~~~~~~--  223 (267)
T cd08228         161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----FSLC----------QKIEQC--  223 (267)
T ss_pred             HH-HhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH----HHHH----------HHHhcC--
Confidence            21 123357889999999988889999999999999999999999985432110    0000          001000  


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      ..........+..+.+++.+||..+|++||++.+|++.|++++
T Consensus       224 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         224 DYPPLPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             CCCCCChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence            0111111234567999999999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-43  Score=288.63  Aligned_cols=248  Identities=27%  Similarity=0.430  Sum_probs=207.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|.||.||.|+.+ ++--||+|++.+...   ....++.+|+++-+.|+||||+++|+++.+ ...+||+
T Consensus        22 ~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd-~~riyLi  100 (281)
T KOG0580|consen   22 DDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHD-SKRIYLI  100 (281)
T ss_pred             hhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheec-cceeEEE
Confidence            56889999999999999999655 677899999976532   334678999999999999999999997776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      +||..+|+|...|...  ....+++...+.++.|++.||.|+|.++++||||||+|+|++..+.+|++|||-+...+   
T Consensus       101 lEya~~gel~k~L~~~--~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---  175 (281)
T KOG0580|consen  101 LEYAPRGELYKDLQEG--RMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---  175 (281)
T ss_pred             EEecCCchHHHHHHhc--ccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC---
Confidence            9999999999999654  34568999999999999999999999999999999999999999999999999987643   


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .......+||..|.+||+..+...+...|+|++|++.||++.|.+||+....               +..+..+..-.+.
T Consensus       176 ~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~---------------~etYkrI~k~~~~  240 (281)
T KOG0580|consen  176 SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH---------------SETYKRIRKVDLK  240 (281)
T ss_pred             CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh---------------HHHHHHHHHcccc
Confidence            3334566899999999999999999999999999999999999999985431               1222222222221


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ..     ...+..+.++|.+|+..+|.+|.+..|++..
T Consensus       241 ~p-----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  241 FP-----STISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             CC-----cccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            11     2355689999999999999999999998864

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.7e-42  Score=309.36  Aligned_cols=273  Identities=25%  Similarity=0.365  Sum_probs=204.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeee-cCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-----QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS-RHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~~  134 (375)
                      ..|++.+.||+|+||.||++..     .++..|++|.+........+.+.+|+.+++.++||||+++++++. .+...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   83 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR   83 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence            4688899999999999999964     357899999987776666778899999999999999999999654 3345689


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~  160 (284)
T cd05081          84 LVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQ  160 (284)
T ss_pred             EEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccC
Confidence            999999999999998543   24589999999999999999999999999999999999999999999999999986643


Q ss_pred             Ccccc--ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          215 HVTHV--STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       215 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .....  .....++..|+|||++.+..++.++||||||+++|||++|..++.........................+.+.
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05081         161 DKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLK  240 (284)
T ss_pred             CCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHh
Confidence            32211  1112234569999999888899999999999999999998776543221100000000000000001111111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      ....   .+....++..+.+++.+||..+|++|||+.+|++.|+.++
T Consensus       241 ~~~~---~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~  284 (284)
T cd05081         241 NNGR---LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR  284 (284)
T ss_pred             cCCc---CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence            1111   1111234567999999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=3e-42  Score=305.41  Aligned_cols=255  Identities=29%  Similarity=0.470  Sum_probs=203.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .++|++.++||+|+||.||+|...++..|++|.+..... ..+.+.+|+.+++.++||||+++++.+..  ...++||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECC--CCcEEEEEc
Confidence            356899999999999999999877777899999875432 23568899999999999999999986643  457899999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||.+..........
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~  159 (262)
T cd05071          82 MSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA  159 (262)
T ss_pred             CCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccc
Confidence            9999999999643  23457899999999999999999999999999999999999999999999999997654433222


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      .....++..|+|||...+..++.++||||||+++|+|++ |..||.......       ....         ...   ..
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~-------~~~~---------~~~---~~  220 (262)
T cd05071         160 RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-------VLDQ---------VER---GY  220 (262)
T ss_pred             ccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHH-------HHHH---------Hhc---CC
Confidence            223346678999999988889999999999999999999 888886442110       0000         000   00


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                      ..+....++..+.+++.+|++.+|++||++.++++.|++.
T Consensus       221 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         221 RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence            1111234567789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2e-42  Score=316.80  Aligned_cols=264  Identities=23%  Similarity=0.342  Sum_probs=202.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|++.+.||+|+||.||++... ++..||+|.+... .......+.+|+.+++.++||||+++++++.. +...++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEEe
Confidence            467999999999999999999665 6888999988654 33345678999999999999999999997766 56799999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+. +++|+||||+|||++.++.++|+|||++.......
T Consensus        83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  158 (331)
T cd06649          83 EHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (331)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccccc
Confidence            99999999999853    24588999999999999999999986 69999999999999999999999999987553322


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHh--------------
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKI--------------  282 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~--------------  282 (375)
                         .....+++.|+|||++.+..++.++|||||||++|+|++|+.||.......   +........              
T Consensus       159 ---~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  232 (331)
T cd06649         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE---LEAIFGRPVVDGEEGEPHSISPR  232 (331)
T ss_pred             ---cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHhcccccccccCCccccCcc
Confidence               223458999999999998899999999999999999999999996433211   000000000              


Q ss_pred             ----------------hhhHHHHHHhhhcCCCCCh-HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          283 ----------------QNKALHELVDQTLGYESDN-KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       283 ----------------~~~~~~~~~~~~l~~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                                      ......+..+......... ....++.++.+|+.+||+.||++|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         233 PRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             cccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                            0000011111111000000 011245679999999999999999999999876

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=2.6e-42  Score=310.58  Aligned_cols=261  Identities=28%  Similarity=0.442  Sum_probs=207.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      .+|.+.+.||+|+||.||+|...      ++..+++|.+........+.+.+|+.+++.++|+||+++++++.. ....+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD-GDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc-CCceE
Confidence            35788899999999999999642      345689998877666666788999999999999999999997766 56789


Q ss_pred             EEEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEE
Q 017232          135 LVYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVK  202 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~k  202 (375)
                      +||||+++++|.+++.....            ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~  163 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK  163 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence            99999999999999965321            224588999999999999999999999999999999999999999999


Q ss_pred             EeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHH
Q 017232          203 VADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       203 l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      |+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......       ...
T Consensus       164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~-------~~~  236 (291)
T cd05094         164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE-------VIE  236 (291)
T ss_pred             ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence            999999875433221 11223346788999999998899999999999999999998 999986543211       000


Q ss_pred             HhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          281 KIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .         ...   .........++..+.+++.+||+.+|++|||+.+|+++|+++.+.
T Consensus       237 ~---------~~~---~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         237 C---------ITQ---GRVLERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             H---------HhC---CCCCCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            0         111   011111122456789999999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-42  Score=305.35  Aligned_cols=255  Identities=26%  Similarity=0.446  Sum_probs=202.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCC----CCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQD----GRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|++.+.||+|+||.||+|.+..    ...|++|.+.... ......+.+|+.+++.++||||+++++.+.. ....++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~i   82 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTK-SRPVMI   82 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEec-CCceEE
Confidence            568899999999999999997642    4578999886543 3344678899999999999999999997665 567899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||+|+||++++++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999998543   236899999999999999999999999999999999999999999999999999876421


Q ss_pred             cc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          216 VT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       216 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      .. .......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......       ...         .+..
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~-------~~~---------~~~~  223 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD-------VIK---------AVED  223 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH-------HHH---------HHHc
Confidence            11 11122235678999999998889999999999999999998 998885432110       000         0100


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                         ....+....++..+.+++.+|++.+|++||++.+|++.|+++
T Consensus       224 ---~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         224 ---GYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ---CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence               001111123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.1e-43  Score=305.08  Aligned_cols=272  Identities=24%  Similarity=0.326  Sum_probs=203.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCC-eEEEeeeeecCCc-----
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKN-LVSLYGCTSRHSR-----  131 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~-----  131 (375)
                      ..|..+++||+|+||+||+|+.+ +|+.||+|++.....  ..-....+|+.+++.++|+| |+.+++++.....     
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            34666778999999999999554 789999999965533  23356789999999999999 9999997776543     


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      .+++|+||++ .+|..++.........++...++.++.||+.||+|||+++|+||||||.||||++.|.+||+|||+|+.
T Consensus        91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra  169 (323)
T KOG0594|consen   91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARA  169 (323)
T ss_pred             eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHH
Confidence            7899999995 789999976643324677789999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh---HH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK---AL  287 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~  287 (375)
                      +.-+.. ..+..++|.+|+|||++.|. .|+...||||+|||++||+++++.|......++....-...+.....   ..
T Consensus       170 ~~ip~~-~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  170 FSIPMR-TYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             hcCCcc-cccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            543222 23455789999999988775 79999999999999999999999998765422211111111100000   00


Q ss_pred             HHHHhhhcCCCCC----hHH---HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          288 HELVDQTLGYESD----NKV---RRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       288 ~~~~~~~l~~~~~----~~~---~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ..+.+....+...    +..   ........+++.+||+.+|.+|.|++.++++
T Consensus       249 ~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  249 SSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             cccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1111111110000    001   1112478899999999999999999999876

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=8.8e-43  Score=313.47  Aligned_cols=265  Identities=24%  Similarity=0.358  Sum_probs=194.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC--CCCEEEEEEecccch--hhHHHHHHHHHHHHhc---CCCCeEEEeeeeec----C
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ--DGRAVAVKRLYENNY--KRVEQFMNEVDILARL---RHKNLVSLYGCTSR----H  129 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----~  129 (375)
                      ++|++.+.||+|+||.||+|...  ++..||+|.+.....  .....+.+|+.+++.+   +||||+++++++..    .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            36899999999999999999653  468899998864322  2233456677777666   69999999997642    3


Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      ...+++||||+. ++|.+++...  ....+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  157 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccce
Confidence            456899999996 6898888543  2345899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh---hhH
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ---NKA  286 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~  286 (375)
                      ......  .......+++.|+|||.+.+..++.++|||||||++|+|++|.+||.........   ........   ...
T Consensus       158 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~---~~i~~~~~~~~~~~  232 (290)
T cd07862         158 RIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGEED  232 (290)
T ss_pred             EeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHH---HHHHHHhCCCChhh
Confidence            765433  1223445899999999998888999999999999999999999999765422111   00000000   000


Q ss_pred             HHH---HHhhhcCCCCC----hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          287 LHE---LVDQTLGYESD----NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       287 ~~~---~~~~~l~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ...   ...........    ......+..+.+++.+||+.+|++|||+.++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            000   00000000000    011123456789999999999999999999984

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.9e-42  Score=315.73  Aligned_cols=241  Identities=25%  Similarity=0.336  Sum_probs=192.5

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccC
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISN  142 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  142 (375)
                      +.||+|+||.||++... +|..||+|++...   .......+.+|+.+++.++||||+++++++.. ....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCEEEEEEeCCCC
Confidence            36999999999999654 6899999998654   22344567789999999999999999997766 5689999999999


Q ss_pred             CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccC
Q 017232          143 GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA  222 (375)
Q Consensus       143 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  222 (375)
                      ++|..++..    ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++....... .....
T Consensus        80 ~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~-~~~~~  154 (323)
T cd05595          80 GELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG-ATMKT  154 (323)
T ss_pred             CcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC-Ccccc
Confidence            999988843    3468999999999999999999999999999999999999999999999999987532211 11233


Q ss_pred             CCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChH
Q 017232          223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNK  302 (375)
Q Consensus       223 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  302 (375)
                      ..|++.|+|||++.+..++.++|||||||++|+|++|+.||.......      .         ...+......  .   
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~---------~~~~~~~~~~--~---  214 (323)
T cd05595         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------L---------FELILMEEIR--F---  214 (323)
T ss_pred             ccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH------H---------HHHHhcCCCC--C---
Confidence            468999999999998899999999999999999999999996443110      0         0011111111  0   


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 017232          303 VRRTINAVAELAFQCLQSEKDLRP-----YMVDVLD  333 (375)
Q Consensus       303 ~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~  333 (375)
                      +..++..+.+++.+||+.+|++||     ++.++++
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence            112456788999999999999998     7888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-43  Score=316.57  Aligned_cols=239  Identities=25%  Similarity=0.344  Sum_probs=190.2

Q ss_pred             cCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCC
Q 017232           69 LGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~  144 (375)
                      ||+|+||.||+|... +++.||+|++...   .......+.+|+.++..++||||+++++++.. ....++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQS-PEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEec-CCeEEEEEcCCCCCc
Confidence            799999999999665 6889999998653   22344567889999999999999999997765 678999999999999


Q ss_pred             hhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCC
Q 017232          145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ  224 (375)
Q Consensus       145 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  224 (375)
                      |.+++..    ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++....... .......
T Consensus        80 L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~  154 (312)
T cd05585          80 LFHHLQR----EGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFC  154 (312)
T ss_pred             HHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC-Ccccccc
Confidence            9999853    3458999999999999999999999999999999999999999999999999987533221 1223346


Q ss_pred             CCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHH
Q 017232          225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVR  304 (375)
Q Consensus       225 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  304 (375)
                      ||+.|+|||++.+..++.++|||||||++|+|++|++||......      ...         ..+......     .+.
T Consensus       155 gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~------~~~---------~~~~~~~~~-----~~~  214 (312)
T cd05585         155 GTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN------EMY---------RKILQEPLR-----FPD  214 (312)
T ss_pred             CCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH------HHH---------HHHHcCCCC-----CCC
Confidence            899999999999989999999999999999999999999743211      110         111111111     112


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCH---HHHHH
Q 017232          305 RTINAVAELAFQCLQSEKDLRPYM---VDVLD  333 (375)
Q Consensus       305 ~~~~~l~~li~~cl~~~P~~Rpt~---~evl~  333 (375)
                      ..+..+.+++.+||..+|.+||++   .+++.
T Consensus       215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~  246 (312)
T cd05585         215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN  246 (312)
T ss_pred             cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence            245678899999999999999864   55543

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=2.4e-42  Score=305.66  Aligned_cols=255  Identities=25%  Similarity=0.448  Sum_probs=204.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .+.|++.++||+|+||.||+|...+++.||+|.+..... ....+.+|+.+++.++|+|++++++++.  ....+++|||
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~~v~e~   81 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM-SPEAFLAEANLMKQLQHPRLVRLYAVVT--QEPIYIITEY   81 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC-cHHHHHHHHHHHHhcCCcCeeeEEEEEc--cCCcEEEEEc
Confidence            457899999999999999999888889999999865443 2467889999999999999999998654  3468999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +.+++|.+++...  .+..+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++..........
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~  159 (260)
T cd05067          82 MENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTA  159 (260)
T ss_pred             CCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCccc
Confidence            9999999998543  33568999999999999999999999999999999999999999999999999987654322222


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      .....++..|+|||.+.+..++.++||||||+++|+|++ |++||.......      .          ...+...... 
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~----------~~~~~~~~~~-  222 (260)
T cd05067         160 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPE------V----------IQNLERGYRM-  222 (260)
T ss_pred             ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHH------H----------HHHHHcCCCC-
Confidence            223345678999999988889999999999999999998 999997443111      0          0011111110 


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                        +.....+.++.+++.+|+..+|++||+++++++.|+.+
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  260 (260)
T cd05067         223 --PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLEDF  260 (260)
T ss_pred             --CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhcC
Confidence              11122346799999999999999999999999999753

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=4.7e-43  Score=321.38  Aligned_cols=245  Identities=25%  Similarity=0.378  Sum_probs=197.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCC--CCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQD--GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|++.+.||+|+||.||+|..++  +..||+|.+....   ....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~l  108 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKD-ESYLYL  108 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEe-CCEEEE
Confidence            458889999999999999996543  3689999886432   2334568889999999999999999997766 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+.+|+|.+++..    ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++......
T Consensus       109 v~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~  184 (340)
T PTZ00426        109 VLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR  184 (340)
T ss_pred             EEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC
Confidence            9999999999999853    345899999999999999999999999999999999999999999999999999765432


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .    ....||+.|+|||++.+..++.++|||||||++|+|++|.+||......       ...        ..+.....
T Consensus       185 ~----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------~~~--------~~i~~~~~  245 (340)
T PTZ00426        185 T----YTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPL-------LIY--------QKILEGII  245 (340)
T ss_pred             c----ceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHH-------HHH--------HHHhcCCC
Confidence            1    2346899999999999888999999999999999999999999754311       000        11111111


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLDA  334 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~~  334 (375)
                      .  .+   ...+..+.+++.+||+.+|.+|+     +++++++.
T Consensus       246 ~--~p---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        246 Y--FP---KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             C--CC---CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            0  11   12345688999999999999995     78887754

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-42  Score=302.86  Aligned_cols=253  Identities=25%  Similarity=0.336  Sum_probs=208.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC-CCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .+.|++++.||.|.-|+||+++.++ +..+|+|++.+...   +...+...|-+||+.++||.+..+|..++. +...|+
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet-~~~~cl  154 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFET-DKYSCL  154 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeec-cceeEE
Confidence            3568888999999999999998774 58899999976533   344567789999999999999999998877 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC-
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN-  214 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-  214 (375)
                      |||||+||+|..+++.+  ..+.+++..+..++.+++.||+|||..|||.|||||+||||.++|++.|+||+++..... 
T Consensus       155 ~meyCpGGdL~~LrqkQ--p~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~  232 (459)
T KOG0610|consen  155 VMEYCPGGDLHSLRQKQ--PGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS  232 (459)
T ss_pred             EEecCCCccHHHHHhhC--CCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence            99999999999998654  556799999999999999999999999999999999999999999999999998743310 


Q ss_pred             --------------------------------Ccc----------------------ccccCCCCCccccCcccccccCC
Q 017232          215 --------------------------------HVT----------------------HVSTAPQGTPGYVDPEYHQCYQL  240 (375)
Q Consensus       215 --------------------------------~~~----------------------~~~~~~~~~~~y~aPE~~~~~~~  240 (375)
                                                      ...                      ......+||-+|+|||++.|...
T Consensus       233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH  312 (459)
T KOG0610|consen  233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH  312 (459)
T ss_pred             CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence                                            000                      01122358999999999999999


Q ss_pred             CCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCC
Q 017232          241 TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQS  320 (375)
Q Consensus       241 ~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~  320 (375)
                      +.+.|+|+||+++|||+.|..||...+..               ..+..++.+.+.+...+   ..+..+.+||++.|.+
T Consensus       313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~---------------~Tl~NIv~~~l~Fp~~~---~vs~~akDLIr~LLvK  374 (459)
T KOG0610|consen  313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------ETLRNIVGQPLKFPEEP---EVSSAAKDLIRKLLVK  374 (459)
T ss_pred             CchhhHHHHHHHHHHHHhCCCCcCCCCch---------------hhHHHHhcCCCcCCCCC---cchhHHHHHHHHHhcc
Confidence            99999999999999999999999876632               33445555555443332   4567899999999999


Q ss_pred             CCCCCCC----HHHHHH
Q 017232          321 EKDLRPY----MVDVLD  333 (375)
Q Consensus       321 ~P~~Rpt----~~evl~  333 (375)
                      ||.+|..    +.||.+
T Consensus       375 dP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  375 DPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             ChhhhhccccchHHhhc
Confidence            9999998    666654

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=1.7e-42  Score=316.33  Aligned_cols=244  Identities=27%  Similarity=0.398  Sum_probs=191.1

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHH---HhcCCCCeEEEeeeeecCCceeEE
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDIL---ARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      |++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|..++   +.++||||+++++++.. ....|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~-~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQT-EDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEc-CCEEEE
Confidence            677889999999999999655 68999999986542   22344566666655   45679999999997766 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|...+.     ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++......
T Consensus        80 v~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          80 VMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             EEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            999999999998873     245899999999999999999999999999999999999999999999999998643221


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      . .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......      .         ...+.....
T Consensus       155 ~-~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~------~---------~~~i~~~~~  218 (324)
T cd05589         155 G-DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE------V---------FDSIVNDEV  218 (324)
T ss_pred             C-CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH------H---------HHHHHhCCC
Confidence            1 11233468999999999999899999999999999999999999997543211      0         011111111


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLD  333 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~  333 (375)
                      .     .+..++..+.+++.+||+.+|.+||     ++.++++
T Consensus       219 ~-----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         219 R-----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             C-----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            1     1112456788999999999999999     4666655

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.8e-42  Score=320.84  Aligned_cols=264  Identities=24%  Similarity=0.339  Sum_probs=205.1

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecC
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENN-YKRVEQFMNEVDILARLR-HKNLVSLYGCTSRH  129 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~  129 (375)
                      ...++|.+.++||+|+||.||+|...      .+..||+|++.... ....+.+.+|+.+++.+. ||||+++++++.. 
T Consensus        34 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~-  112 (400)
T cd05105          34 FPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTK-  112 (400)
T ss_pred             ccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEcc-
Confidence            34567899999999999999999643      23469999986543 334467899999999996 9999999998766 


Q ss_pred             CceeEEEEecccCCChhHhhccCCC-------------------------------------------------------
Q 017232          130 SRELLLVYEFISNGTVADHLHGERA-------------------------------------------------------  154 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~-------------------------------------------------------  154 (375)
                      ....++||||+++|+|.+++.....                                                       
T Consensus       113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (400)
T cd05105         113 SGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPML  192 (400)
T ss_pred             CCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhh
Confidence            6779999999999999998864321                                                       


Q ss_pred             -------------------------------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          155 -------------------------------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       155 -------------------------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                                                           ....+++..+..++.|++.||.|||+.+++|+||||+|||++.
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~  272 (400)
T cd05105         193 EIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQ  272 (400)
T ss_pred             hhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeC
Confidence                                                 0134788888999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccccccCCCccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchh
Q 017232          198 NFCVKVADFGLSRLFPNHVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLS  275 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~  275 (375)
                      ++.+||+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......     
T Consensus       273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~-----  347 (400)
T cd05105         273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDS-----  347 (400)
T ss_pred             CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhH-----
Confidence            999999999998765432221 1122346778999999988889999999999999999997 888886432111     


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                       ...         ..+.....   ......++..+.+++.+||+.+|++|||+.+|.++|+.+.+
T Consensus       348 -~~~---------~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         348 -TFY---------NKIKSGYR---MAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             -HHH---------HHHhcCCC---CCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence             000         01111110   11112355679999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=7.9e-43  Score=319.76  Aligned_cols=252  Identities=24%  Similarity=0.311  Sum_probs=195.8

Q ss_pred             CCCCCCccCCCCcEEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCce
Q 017232           62 YFDSARELGDGGFGTVYYGEL----QDGRAVAVKRLYENN----YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  132 (375)
                      +|++.+.||+|+||.||++..    .+++.||+|++....    ....+.+..|+.++..+ +|+||+++++++.. ...
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQT-EAK   79 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEec-CCE
Confidence            478899999999999999865    357899999986432    22345678899999999 49999999987765 567


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      +++||||+++|+|.+++..    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        80 ~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~  155 (332)
T cd05614          80 LHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (332)
T ss_pred             EEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence            8999999999999999853    345899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCccccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|..||.........  ... ..        .+.
T Consensus       156 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~--~~~-~~--------~~~  224 (332)
T cd05614         156 LSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ--SEV-SR--------RIL  224 (332)
T ss_pred             cccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH--HHH-HH--------HHh
Confidence            43332223345689999999998765 4788999999999999999999999754322110  000 00        011


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLDA  334 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~~  334 (375)
                      ..  .   .......+..+.+++.+||+.+|++||     +++++++.
T Consensus       225 ~~--~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         225 KC--D---PPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             cC--C---CCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            00  0   001112345788999999999999999     67777653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-42  Score=303.79  Aligned_cols=250  Identities=27%  Similarity=0.469  Sum_probs=199.1

Q ss_pred             CCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           62 YFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +|++.+.||+|+||.||++..+++..+++|.+..... ....+.+|+.+++.++||||+++++++.. ....++||||++
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~   82 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAM-SEDDFIEEAKVMMKLSHPNLVQLYGVCTK-QRPIFIVTEYMA   82 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEEEEEEEEcC-CCceEEEEecCC
Confidence            4788999999999999999887778899998865432 23467889999999999999999997665 567899999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++............
T Consensus        83 ~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (256)
T cd05059          83 NGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ  159 (256)
T ss_pred             CCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccC
Confidence            99999998543   236899999999999999999999999999999999999999999999999998765432222222


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCC
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD  300 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  300 (375)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      . ..         .+.........
T Consensus       160 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~-~~---------~~~~~~~~~~~  223 (256)
T cd05059         160 GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE------V-VE---------SVSAGYRLYRP  223 (256)
T ss_pred             CCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH------H-HH---------HHHcCCcCCCC
Confidence            2234457999999998899999999999999999998 889987543211      0 00         01111110111


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017232          301 NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL  335 (375)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L  335 (375)
                         ..++..+.+++.+||..+|++|||+.++++.|
T Consensus       224 ---~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         224 ---KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ---CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence               12456799999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=2.8e-42  Score=308.10  Aligned_cols=259  Identities=25%  Similarity=0.428  Sum_probs=201.0

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  131 (375)
                      ..++|++.+.||+|+||.||+|...      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.. +.
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CC
Confidence            4567999999999999999998643      24679999885432 3344568899999999999999999997765 56


Q ss_pred             eeEEEEecccCCChhHhhccCCCC------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEee
Q 017232          132 ELLLVYEFISNGTVADHLHGERAK------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD  205 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~D  205 (375)
                      ..++||||+++++|.+++......      ...+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence            789999999999999998653321      13457788899999999999999999999999999999999999999999


Q ss_pred             eccccccCCCccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhh
Q 017232          206 FGLSRLFPNHVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQ  283 (375)
Q Consensus       206 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  283 (375)
                      ||++......... ......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.......      . ..   
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~------~-~~---  232 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQ------V-LR---  232 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH------H-HH---
Confidence            9998754332211 1122345778999999988889999999999999999998 788886432110      0 00   


Q ss_pred             hhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       284 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                           .......    ......++..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       233 -----~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~  277 (277)
T cd05062         233 -----FVMEGGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE  277 (277)
T ss_pred             -----HHHcCCc----CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence                 0011100    11112245678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=4.6e-42  Score=307.16  Aligned_cols=247  Identities=28%  Similarity=0.368  Sum_probs=194.6

Q ss_pred             cCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCC
Q 017232           69 LGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~  144 (375)
                      ||+|+||+||++... +++.||+|.+.....   ...+.+..|+.+++.++|+||+++.+++.. ....++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQT-KTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcC-CCeEEEEEeCCCCCC
Confidence            799999999999654 688999999865432   223566789999999999999999987766 567999999999999


Q ss_pred             hhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCC
Q 017232          145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ  224 (375)
Q Consensus       145 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  224 (375)
                      |...+.........+++..++.++.|++.||.|||++|++||||||+||+++.++.++|+|||++......... .....
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~  158 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK-TKGYA  158 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCcc-ccccC
Confidence            99888654445567999999999999999999999999999999999999999999999999998765433221 22346


Q ss_pred             CCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHH
Q 017232          225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVR  304 (375)
Q Consensus       225 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  304 (375)
                      +++.|+|||.+.+..++.++|||||||++|+|++|+.||........       .        .......... ......
T Consensus       159 g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~-------~--------~~~~~~~~~~-~~~~~~  222 (280)
T cd05608         159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE-------N--------KELKQRILND-SVTYPD  222 (280)
T ss_pred             CCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchh-------H--------HHHHHhhccc-CCCCcc
Confidence            89999999999999999999999999999999999999975432110       0        0000010100 001112


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 017232          305 RTINAVAELAFQCLQSEKDLRP-----YMVDVLD  333 (375)
Q Consensus       305 ~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~  333 (375)
                      .++..+.+++.+||+.+|++||     +++++++
T Consensus       223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence            3456789999999999999999     6677765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-43  Score=320.93  Aligned_cols=267  Identities=28%  Similarity=0.429  Sum_probs=210.4

Q ss_pred             HHHHhcCCCCCCccCCCCcEEEEEEEeCC--C---CEEEEEEecc---cchhhHHHHHHHHHHHHhcCCCCeEEEeeeee
Q 017232           56 LEEATNYFDSARELGDGGFGTVYYGELQD--G---RAVAVKRLYE---NNYKRVEQFMNEVDILARLRHKNLVSLYGCTS  127 (375)
Q Consensus        56 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~---~~vaiK~~~~---~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~  127 (375)
                      ++...++..+.++||+|+||.||+|+.+.  +   ..||+|....   ........+.+|+++|++++|||||++||+..
T Consensus       152 Wel~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~  231 (474)
T KOG0194|consen  152 WELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAV  231 (474)
T ss_pred             cEEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            44445566777999999999999996553  2   2389998875   34566788999999999999999999999666


Q ss_pred             cCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeec
Q 017232          128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFG  207 (375)
Q Consensus       128 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg  207 (375)
                      . ...++||||+|.||+|.++|...   .+.++..+...++.+.+.||+|||+++++||||-.+|+|++.++.+||+|||
T Consensus       232 ~-~~Pl~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFG  307 (474)
T KOG0194|consen  232 L-EEPLMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFG  307 (474)
T ss_pred             C-CCccEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccc
Confidence            5 67899999999999999999643   2359999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhH
Q 017232          208 LSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKA  286 (375)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (375)
                      +++.-... ........-...|+|||.+....+++++|||||||++||+++ |..||......       .+...+    
T Consensus       308 Ls~~~~~~-~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~-------~v~~kI----  375 (474)
T KOG0194|consen  308 LSRAGSQY-VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY-------EVKAKI----  375 (474)
T ss_pred             cccCCcce-eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH-------HHHHHH----
Confidence            98754311 111111135678999999999999999999999999999998 78888754421       111111    


Q ss_pred             HHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 017232          287 LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDD  345 (375)
Q Consensus       287 ~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~~  345 (375)
                          .........+   ...+..+..++.+|+..+|++||+|.++.+.|+.+.......
T Consensus       376 ----~~~~~r~~~~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~~  427 (474)
T KOG0194|consen  376 ----VKNGYRMPIP---SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEAF  427 (474)
T ss_pred             ----HhcCccCCCC---CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccccc
Confidence                0111111111   134567889999999999999999999999999988876543

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.4e-42  Score=314.17  Aligned_cols=241  Identities=26%  Similarity=0.354  Sum_probs=191.9

Q ss_pred             CccCCCCcEEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           67 RELGDGGFGTVYYGEL----QDGRAVAVKRLYENN----YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +.||+|+||.||++..    .+++.||+|++....    ......+.+|+.+++.++||||+++++++.. +...++|||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv~e   80 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQT-GGKLYLILE   80 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEec-CCeEEEEEe
Confidence            6799999999999964    357899999986532    2233567789999999999999999997766 567999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+.+++|.+++..    .+.+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ 
T Consensus        81 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (323)
T cd05584          81 YLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT-  155 (323)
T ss_pred             CCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence            9999999999853    34578889999999999999999999999999999999999999999999999864322211 


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ......|++.|+|||++.+..++.++|||||||++|+|++|+.||.......               ....+......  
T Consensus       156 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---------------~~~~~~~~~~~--  218 (323)
T cd05584         156 VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---------------TIDKILKGKLN--  218 (323)
T ss_pred             cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---------------HHHHHHcCCCC--
Confidence            1223468999999999998889999999999999999999999997543110               01111111111  


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLD  333 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~  333 (375)
                      .   +..++..+.+++.+||+.+|++||     ++.++++
T Consensus       219 ~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         219 L---PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             C---CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence            1   112345788999999999999999     7888776

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.9e-42  Score=316.34  Aligned_cols=242  Identities=25%  Similarity=0.325  Sum_probs=193.1

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccC
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISN  142 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  142 (375)
                      +.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++.. ....++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQT-KDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCEEEEEEeCCCC
Confidence            36999999999999654 68999999986542   2345677889999999999999999987765 6789999999999


Q ss_pred             CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccC
Q 017232          143 GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA  222 (375)
Q Consensus       143 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  222 (375)
                      ++|..++..    ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... .....
T Consensus        80 g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~-~~~~~  154 (328)
T cd05593          80 GELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA-ATMKT  154 (328)
T ss_pred             CCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc-ccccc
Confidence            999988843    3458999999999999999999999999999999999999999999999999987532221 11233


Q ss_pred             CCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChH
Q 017232          223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNK  302 (375)
Q Consensus       223 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  302 (375)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .. ..        +.....     ..
T Consensus       155 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~------~~-~~--------~~~~~~-----~~  214 (328)
T cd05593         155 FCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------LF-EL--------ILMEDI-----KF  214 (328)
T ss_pred             ccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH------HH-HH--------hccCCc-----cC
Confidence            468999999999998899999999999999999999999996433110      00 00        000000     01


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017232          303 VRRTINAVAELAFQCLQSEKDLRP-----YMVDVLDA  334 (375)
Q Consensus       303 ~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~~  334 (375)
                      +..++..+.+++.+||..+|++||     ++.++++.
T Consensus       215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence            112456788999999999999997     88888764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.4e-42  Score=308.55  Aligned_cols=270  Identities=27%  Similarity=0.436  Sum_probs=203.6

Q ss_pred             cCC-CCCCccCCCCcEEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-Cce
Q 017232           61 NYF-DSARELGDGGFGTVYYGEL-----QDGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-SRE  132 (375)
Q Consensus        61 ~~y-~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~  132 (375)
                      ++| ++.+.||+|+||+||++..     .++..||+|.+.... ......+.+|+.+++.++||||+++++++... ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKG   82 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCce
Confidence            344 8899999999999988642     357789999986553 23456788999999999999999999976543 346


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      .+++|||+++++|.+++..     ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        83 ~~lv~e~~~~~~l~~~~~~-----~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~  157 (283)
T cd05080          83 LQLIMEYVPLGSLRDYLPK-----HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  157 (283)
T ss_pred             EEEEecCCCCCCHHHHHHH-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence            8999999999999999843     34899999999999999999999999999999999999999999999999998865


Q ss_pred             CCCccc--cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          213 PNHVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       213 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ......  ......++..|+|||.+.+..++.++||||||+++|+|++|..|+........ ................+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~  236 (283)
T cd05080         158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE-EMIGPKQGQMTVVRLIEL  236 (283)
T ss_pred             CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh-hhhcccccccchhhhhhh
Confidence            432221  11222356679999999888899999999999999999999999864432110 000000001111111122


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      .+.....   +....++..+.+++.+|++.+|++|||++++++.|+++.
T Consensus       237 ~~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         237 LERGMRL---PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhcCCCC---CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            2211111   111234568999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=1.5e-42  Score=328.29  Aligned_cols=274  Identities=23%  Similarity=0.290  Sum_probs=197.3

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeec-------CC
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR-------HS  130 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-------~~  130 (375)
                      ...+|++.+.||+|+||.||+|... +++.||+|++....    ....+|+.+++.++||||+++++++..       ..
T Consensus        64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~  139 (440)
T PTZ00036         64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN  139 (440)
T ss_pred             cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence            3467999999999999999999664 68899999885442    223579999999999999999885432       12


Q ss_pred             ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC-cEEEeeeccc
Q 017232          131 RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF-CVKVADFGLS  209 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~  209 (375)
                      ..+++||||++ ++|.+++.........+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++
T Consensus       140 ~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla  218 (440)
T PTZ00036        140 IFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSA  218 (440)
T ss_pred             eEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccc
Confidence            34679999996 578777765444556799999999999999999999999999999999999998665 6999999999


Q ss_pred             cccCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      ..+.....  .....+|+.|+|||++.+ ..++.++|||||||++|||++|.+||.........................
T Consensus       219 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~  296 (440)
T PTZ00036        219 KNLLAGQR--SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLK  296 (440)
T ss_pred             hhccCCCC--cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            86543222  123457999999998765 468999999999999999999999997544222110000000000000000


Q ss_pred             HHHhhh-----cCCCCChH-----HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhhhc
Q 017232          289 ELVDQT-----LGYESDNK-----VRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDIES  340 (375)
Q Consensus       289 ~~~~~~-----l~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i~~  340 (375)
                      . +.+.     ........     +...+.++.+|+.+||..+|.+|||+.|+++.  +..+..
T Consensus       297 ~-~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~~~  359 (440)
T PTZ00036        297 E-MNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDLRD  359 (440)
T ss_pred             H-hchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhhhc
Confidence            0 0000     00000000     01134578999999999999999999999854  555443

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3.1e-42  Score=318.32  Aligned_cols=248  Identities=25%  Similarity=0.366  Sum_probs=191.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|+..+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++|+||+++++++.. ...+++|||
T Consensus        74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  152 (353)
T PLN00034         74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH-NGEIQVLLE  152 (353)
T ss_pred             HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc-CCeEEEEEe
Confidence            34667889999999999999655 68999999986543 3334678899999999999999999997765 677999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+..        ...+..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........ 
T Consensus       153 ~~~~~~L~~~~--------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-  223 (353)
T PLN00034        153 FMDGGSLEGTH--------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD-  223 (353)
T ss_pred             cCCCCcccccc--------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceecccccc-
Confidence            99999886532        246677889999999999999999999999999999999999999999999876543221 


Q ss_pred             cccCCCCCccccCcccccc-----cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          219 VSTAPQGTPGYVDPEYHQC-----YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ......|+..|+|||++..     ...+.++|||||||++|||++|+.||.......   .....             ..
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~---~~~~~-------------~~  287 (353)
T PLN00034        224 PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD---WASLM-------------CA  287 (353)
T ss_pred             cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc---HHHHH-------------HH
Confidence            1233468999999998743     234568999999999999999999997332111   00000             00


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ............+...+.+++.+||..+|++|||+.|+++.
T Consensus       288 ~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        288 ICMSQPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HhccCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000111112345678999999999999999999999874

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=5.2e-42  Score=317.88  Aligned_cols=253  Identities=23%  Similarity=0.316  Sum_probs=193.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||+||+|... +++.||+|++....   ......+.+|+.++..++|+||+++++.+.. ...+++|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~-~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQD-KLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCeEEEE
Confidence            46889999999999999999654 68999999986542   2334567889999999999999999997766 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~  155 (363)
T cd05628          80 MEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH  155 (363)
T ss_pred             EcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence            999999999999853    3568999999999999999999999999999999999999999999999999987543211


Q ss_pred             c----------------------------------ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 017232          217 T----------------------------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPA  262 (375)
Q Consensus       217 ~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  262 (375)
                      .                                  ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence            0                                  001234699999999999998999999999999999999999999


Q ss_pred             ccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcC--CCCCCCCCHHHHHHH
Q 017232          263 VDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQ--SEKDLRPYMVDVLDA  334 (375)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~--~~P~~Rpt~~evl~~  334 (375)
                      |.......      .         ...+.........++ ....+..+.+++.+++.  .++..||+++|+++.
T Consensus       236 f~~~~~~~------~---------~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         236 FCSETPQE------T---------YKKVMNWKETLIFPP-EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCCCCHHH------H---------HHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            97543211      0         011110000000000 01134567777777554  233356899999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.4e-43  Score=322.00  Aligned_cols=250  Identities=25%  Similarity=0.401  Sum_probs=201.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|.+.+.||+|+||.||+|... +++.||+|++....   ......+..|+.++..++||||+++++++.. +...++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQD-EEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheec-CCeEEEE
Confidence            46889999999999999999665 68999999986542   2334568889999999999999999997765 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++...    ..+++..++.++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~  155 (350)
T cd05573          80 MEYMPGGDLMNLLIRK----DVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAK  155 (350)
T ss_pred             EcCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccC
Confidence            9999999999999543    568999999999999999999999999999999999999999999999999987654332


Q ss_pred             ----------------------------cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCcccccc
Q 017232          217 ----------------------------THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRH  268 (375)
Q Consensus       217 ----------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~  268 (375)
                                                  ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~  235 (350)
T cd05573         156 DREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL  235 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence                                        1122334689999999999998999999999999999999999999975431


Q ss_pred             ccccchhHHHHHHhhhhHHHHHHh--hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHH
Q 017232          269 RHEINLSNLAINKIQNKALHELVD--QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY-MVDVLDA  334 (375)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~--~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-~~evl~~  334 (375)
                      ..               ....+..  ..+.....   ..++..+.+++.+|+. +|.+||+ ++++++.
T Consensus       236 ~~---------------~~~~i~~~~~~~~~p~~---~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         236 QE---------------TYNKIINWKESLRFPPD---PPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HH---------------HHHHHhccCCcccCCCC---CCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            11               0111111  11111010   1145678999999997 9999999 9999874

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=2.1e-42  Score=320.53  Aligned_cols=255  Identities=22%  Similarity=0.293  Sum_probs=198.8

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      ...++|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++.. +..+
T Consensus        40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-~~~~  118 (370)
T cd05621          40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQD-DKYL  118 (370)
T ss_pred             CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEE
Confidence            34578999999999999999999765 58899999986432   2233457789999999999999999997766 6789


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++||||+++|+|.+++..     ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       119 ~lv~Ey~~gg~L~~~l~~-----~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~  193 (370)
T cd05621         119 YMVMEYMPGGDLVNLMSN-----YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMD  193 (370)
T ss_pred             EEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecc
Confidence            999999999999999843     347889999999999999999999999999999999999999999999999998664


Q ss_pred             CCccccccCCCCCccccCcccccccC----CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          214 NHVTHVSTAPQGTPGYVDPEYHQCYQ----LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       214 ~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                      ...........||+.|+|||++.+..    ++.++||||+||++|+|++|.+||.......               ....
T Consensus       194 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~---------------~~~~  258 (370)
T cd05621         194 ETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG---------------TYSK  258 (370)
T ss_pred             cCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH---------------HHHH
Confidence            33322233456999999999886543    7889999999999999999999997543110               1111


Q ss_pred             HHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 017232          290 LVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDL--RPYMVDVLDA  334 (375)
Q Consensus       290 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~evl~~  334 (375)
                      +......... +.....+..+.+++..||..++.+  |+++.++++.
T Consensus       259 i~~~~~~~~~-p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         259 IMDHKNSLNF-PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHhCCcccCC-CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            2211111111 111234567888999999865544  8999998876

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=6.6e-42  Score=304.00  Aligned_cols=261  Identities=25%  Similarity=0.401  Sum_probs=207.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|++|.||+|.. .++..+++|.+...   .......+.+|+.+++.++|+||+++++++.. +...+++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-CCeEEEE
Confidence            4688899999999999999965 47899999987543   23344678899999999999999999997766 5678999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++.........+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            99999999999986544445678999999999999999999999999999999999999999999999999987654332


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .. .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......    ....         ..+....  
T Consensus       161 ~~-~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~----~~~~---------~~~~~~~--  224 (267)
T cd08229         161 TA-AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL----YSLC---------KKIEQCD--  224 (267)
T ss_pred             cc-cccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH----HHHh---------hhhhcCC--
Confidence            21 123458889999999988889999999999999999999999986432110    0000         0000000  


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                       .........+..+.+++.+|+..+|++|||+.+|++.++++.
T Consensus       225 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         225 -YPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             -CCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence             000111235567999999999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=7.9e-42  Score=305.68  Aligned_cols=263  Identities=22%  Similarity=0.350  Sum_probs=209.2

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC-----CCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD-----GRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      .++|++.+.||+|+||.||+|....     +..|++|.+... .......+.+|+.+++.++|+|++++++++...+...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~   84 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP   84 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence            4578889999999999999997665     678999988654 3444567889999999999999999999777666778


Q ss_pred             EEEEecccCCChhHhhccCCCC----CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          134 LLVYEFISNGTVADHLHGERAK----PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~----~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      +++++|+.+++|.+++......    +..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.+||+|||++
T Consensus        85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~  164 (280)
T cd05043          85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALS  164 (280)
T ss_pred             EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCc
Confidence            9999999999999998654322    156899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHH
Q 017232          210 RLFPNHVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKAL  287 (375)
Q Consensus       210 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (375)
                      +.+...... ......++..|+|||.+.+..++.++||||||+++|++++ |+.||.......      +          
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~----------  228 (280)
T cd05043         165 RDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE------M----------  228 (280)
T ss_pred             ccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH------H----------
Confidence            765332211 1122335678999999988889999999999999999998 999997543211      0          


Q ss_pred             HHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          288 HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       288 ~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ...+.....   ......++..+.+++.+|+..+|++|||+.++++.|+++.++
T Consensus       229 ~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         229 AAYLKDGYR---LAQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             HHHHHcCCC---CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            001111111   011122456789999999999999999999999999988654

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.6e-42  Score=321.67  Aligned_cols=254  Identities=22%  Similarity=0.287  Sum_probs=199.8

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ..++|++.+.||+|+||.||++... ++..||+|++....   ......+.+|+.+++.++||||+++++++.. ....+
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~-~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQD-DKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCEEE
Confidence            3467999999999999999999665 68899999986432   2233457789999999999999999997765 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++|+|.+++..     ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       120 lv~Ey~~gg~L~~~l~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~  194 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN-----YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA  194 (370)
T ss_pred             EEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence            99999999999999843     3478889999999999999999999999999999999999999999999999876543


Q ss_pred             CccccccCCCCCccccCccccccc----CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCY----QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ..........||+.|+|||++.+.    .++.++|||||||++|||++|++||......               .....+
T Consensus       195 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~---------------~~~~~i  259 (370)
T cd05596         195 NGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV---------------GTYSKI  259 (370)
T ss_pred             CCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH---------------HHHHHH
Confidence            322223345699999999987653    4788999999999999999999999754311               011111


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDL--RPYMVDVLDA  334 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~evl~~  334 (375)
                      ......... +.....+..+.+++.+||+.+|.+  |+++.++++.
T Consensus       260 ~~~~~~~~~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         260 MDHKNSLTF-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HcCCCcCCC-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            111100001 111124567899999999999988  9999999765

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=6.5e-43  Score=309.03  Aligned_cols=249  Identities=35%  Similarity=0.544  Sum_probs=191.8

Q ss_pred             CCCccCCCCcEEEEEEEeC-----CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           65 SARELGDGGFGTVYYGELQ-----DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +.+.||.|.||.||+|.+.     .+..|+||.+... .....+.+.+|++.+++++||||++++|++.. ....++|||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~-~~~~~lv~e   81 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIE-NEPLFLVME   81 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEES-SSSEEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccc-ccccccccc
Confidence            3567999999999999776     3568999999654 33447889999999999999999999998874 566999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc-c
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-T  217 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  217 (375)
                      |+++|+|.+++...  ....+++..++.++.|++.||.|||+++++|+||+++||+++.++.+||+|||++....... .
T Consensus        82 ~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~  159 (259)
T PF07714_consen   82 YCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKY  159 (259)
T ss_dssp             --TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSE
T ss_pred             cccccccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999765  34568999999999999999999999999999999999999999999999999998663221 1


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      ...........|+|||.+.+..++.++||||||+++|||++ |+.||.......      . ...        + .....
T Consensus       160 ~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~------~-~~~--------~-~~~~~  223 (259)
T PF07714_consen  160 KNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEE------I-IEK--------L-KQGQR  223 (259)
T ss_dssp             EESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHH------H-HHH--------H-HTTEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccc------c-ccc--------c-ccccc
Confidence            22233446778999999988889999999999999999999 678875442110      0 011        1 11111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL  335 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L  335 (375)
                         ......++..+.+++.+||..+|++|||+.++++.|
T Consensus       224 ---~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 ---LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             ---TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             ---ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence               111123456799999999999999999999999886

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=322.24  Aligned_cols=252  Identities=23%  Similarity=0.334  Sum_probs=197.6

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.++..++||||+++++++.. ...+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQD-ENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEc-CCeEEEE
Confidence            46889999999999999999665 68999999986542   2334567889999999999999999997776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus        80 ~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  155 (364)
T cd05599          80 MEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSH  155 (364)
T ss_pred             ECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccc
Confidence            999999999999853    3458999999999999999999999999999999999999999999999999986542211


Q ss_pred             cc-------------------------------------cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 017232          217 TH-------------------------------------VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS  259 (375)
Q Consensus       217 ~~-------------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg  259 (375)
                      ..                                     .....+||+.|+|||++.+..++.++|||||||++|+|++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcC
Confidence            00                                     11123589999999999988999999999999999999999


Q ss_pred             CCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHH
Q 017232          260 MPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY---MVDVLDA  334 (375)
Q Consensus       260 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---~~evl~~  334 (375)
                      .+||.......      .         ...+.........+ .....+..+.+++.+|+. +|.+|++   +.++++.
T Consensus       236 ~~Pf~~~~~~~------~---------~~~i~~~~~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         236 YPPFCSDNPQE------T---------YRKIINWKETLQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCCCCHHH------H---------HHHHHcCCCccCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            99997543211      0         01111100000000 001234678899999996 9999998   8888763

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.3e-41  Score=300.96  Aligned_cols=253  Identities=29%  Similarity=0.469  Sum_probs=201.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ++|.+.+.||+|++|.||+|...++..+++|.+..... ..+.+.+|+.+++.++|+|++++++++..  ...+++|||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~   82 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM-MPEAFLQEAQIMKKLRHDKLVPLYAVVSE--EPIYIVTEFM   82 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc-cHHHHHHHHHHHHhCCCCCeeeEEEEEcC--CCcEEEEEcC
Confidence            45888999999999999999887777899998765432 23568889999999999999999997643  4578999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      .+++|.+++...  ....+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++...........
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05069          83 GKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             CCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCccccc
Confidence            999999999643  234578999999999999999999999999999999999999999999999999976543322222


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....++..|+|||...+..++.++||||||+++|+|++ |..||.......       ..         +.+.....   
T Consensus       161 ~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~-------~~---------~~~~~~~~---  221 (260)
T cd05069         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE-------VL---------EQVERGYR---  221 (260)
T ss_pred             CCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH-------HH---------HHHHcCCC---
Confidence            22345678999999988889999999999999999999 899986432110       00         00110000   


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                      .+.....+..+.+++.+||..+|++||++++|++.|++
T Consensus       222 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence            11112345679999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-42  Score=302.35  Aligned_cols=256  Identities=29%  Similarity=0.491  Sum_probs=205.0

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ..++|.+.+.||+|+||.||+|..+++..+++|.+..... ..+.+.+|+.+++.++|+|++++++++.. ....++|||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM-SPEAFLQEAQIMKKLRHDKLVQLYAVCSE-EEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc-CHHHHHHHHHHHhhCCCCCEeeeeeeeec-CCceEEEEe
Confidence            3467999999999999999999888888999998875443 34678899999999999999999997665 567899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++...  ....+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++.........
T Consensus        82 ~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~  159 (261)
T cd05034          82 YMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT  159 (261)
T ss_pred             ccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence            99999999999653  2346899999999999999999999999999999999999999999999999998766432222


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                      .......+..|+|||.+.+..++.++|+||+|+++|+|++ |+.||.......      . .        ..+ ..... 
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~-~--------~~~-~~~~~-  222 (261)
T cd05034         160 AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE------V-L--------EQV-ERGYR-  222 (261)
T ss_pred             hhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH------H-H--------HHH-HcCCC-
Confidence            2222234568999999988889999999999999999998 999986432110      0 0        000 00000 


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                        .+.....+..+.+++.+|+..+|++||+++++++.|+.
T Consensus       223 --~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         223 --MPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             --CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence              01111235678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1e-41  Score=304.36  Aligned_cols=248  Identities=23%  Similarity=0.315  Sum_probs=192.4

Q ss_pred             cCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCC
Q 017232           69 LGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~  144 (375)
                      ||+|+||.||++..+ +|+.||+|.+.....   .....+..|+++++.++||||+++++++.. +...++||||+++++
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFES-KTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEec-CCeEEEEEecCCCCC
Confidence            799999999999665 689999999864322   122345679999999999999999997765 678999999999999


Q ss_pred             hhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCC
Q 017232          145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ  224 (375)
Q Consensus       145 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  224 (375)
                      |.+++...  ....+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........  .....
T Consensus        80 L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~  155 (277)
T cd05607          80 LKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT--ITQRA  155 (277)
T ss_pred             HHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce--eeccC
Confidence            99888543  234588899999999999999999999999999999999999999999999999876543222  22345


Q ss_pred             CCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHH
Q 017232          225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVR  304 (375)
Q Consensus       225 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  304 (375)
                      ++..|+|||++.+..++.++||||+||++|+|++|..||........  .     ..        +..............
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~--~-----~~--------~~~~~~~~~~~~~~~  220 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA--K-----EE--------LKRRTLEDEVKFEHQ  220 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh--H-----HH--------HHHHhhccccccccc
Confidence            88999999999888899999999999999999999999964321110  0     00        001111101111111


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          305 RTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       305 ~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                      .++.++.+++.+||+.+|++||++.|+++.+.
T Consensus       221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~  252 (277)
T cd05607         221 NFTEESKDICRLFLAKKPEDRLGSREKNDDPR  252 (277)
T ss_pred             cCCHHHHHHHHHHhccCHhhCCCCccchhhhh
Confidence            34567899999999999999999988764433

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.8e-41  Score=302.09  Aligned_cols=257  Identities=25%  Similarity=0.353  Sum_probs=198.4

Q ss_pred             CCCCCccCCCCcEEEEEEEeCC-CC--EEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-----Cce
Q 017232           63 FDSARELGDGGFGTVYYGELQD-GR--AVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-----SRE  132 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~  132 (375)
                      |.+.+.||+|+||.||+|...+ +.  .+|+|.+...  .....+.+.+|+.+++.++|+||+++++++...     ...
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3567889999999999997654 32  6899987654  334467788999999999999999999965321     234


Q ss_pred             eEEEEecccCCChhHhhccCC--CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          133 LLLVYEFISNGTVADHLHGER--AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      .+++|||+.+++|.+++...+  .....+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            689999999999998874332  233458999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          211 LFPNHVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       211 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      ........ ......+++.|++||...+..++.++||||||+++|+|++ |..||.......       ....+..    
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-------~~~~~~~----  229 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE-------IYDYLRQ----  229 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHHHHc----
Confidence            65432211 1122245678999999998899999999999999999999 888886432110       0011110    


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                              .........++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       230 --------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         230 --------GNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             --------CCCCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                    000011123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-42  Score=340.07  Aligned_cols=265  Identities=28%  Similarity=0.421  Sum_probs=216.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCC--CC----EEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           61 NYFDSARELGDGGFGTVYYGELQD--GR----AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~--~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      .+.+..+.||+|+||.||.|...+  |.    .||+|.+... ......+|.+|..+|+.++|||||+++|++.. ....
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~-~~~~  770 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLD-SGPP  770 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecC-CCCc
Confidence            345667889999999999996543  43    4899988665 45667889999999999999999999998888 6778


Q ss_pred             EEEEecccCCChhHhhccCCCC---CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          134 LLVYEFISNGTVADHLHGERAK---PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      +|++|||+||+|..+|+..+..   ...++..+.+.++.+|+.|+.||+++++|||||...|+|++....+||+|||+|+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR  850 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence            9999999999999999776432   4568899999999999999999999999999999999999999999999999999


Q ss_pred             ccCCCccccccC-CCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          211 LFPNHVTHVSTA-PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       211 ~~~~~~~~~~~~-~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      .+-....+.... ..-...|||||.+..+.++.|+|||||||++||++| |..||......+                  
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~------------------  912 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE------------------  912 (1025)
T ss_pred             hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH------------------
Confidence            543322222222 234568999999999999999999999999999998 889997654221                  


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDD  345 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~~  345 (375)
                       ++...+.+..-+.+..|+..+.+++.+||+.+|++||++..|++.+..+.+.....
T Consensus       913 -v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~~  968 (1025)
T KOG1095|consen  913 -VLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALGT  968 (1025)
T ss_pred             -HHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhccC
Confidence             12211222233444568888999999999999999999999999999887755443

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.1e-41  Score=308.15  Aligned_cols=266  Identities=22%  Similarity=0.324  Sum_probs=195.2

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|++.+.||.|+||.||+|... +++.||+|++..... .....+.+|+.+++.++||||+++++++.. ....++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEec-CCeEEEEE
Confidence            467999999999999999999765 688999999865432 223456789999999999999999997766 56899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+. ++|.+++...   ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++....... 
T Consensus        83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  157 (303)
T cd07869          83 EYVH-TDLCQYMDKH---PGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-  157 (303)
T ss_pred             ECCC-cCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC-
Confidence            9995 6787777532   3458899999999999999999999999999999999999999999999999987543221 


Q ss_pred             ccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH------
Q 017232          218 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL------  290 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------  290 (375)
                      .......+++.|+|||++.+ ..++.++||||+||++|+|++|.+||........  ................+      
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  235 (303)
T cd07869         158 HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFLVLGTPNEDTWPGVHSL  235 (303)
T ss_pred             ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHHhCCCChhhccchhhc
Confidence            12233468899999998765 4578899999999999999999999975432110  00000000000000000      


Q ss_pred             --Hhh-hcCCCCChHH------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          291 --VDQ-TLGYESDNKV------RRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       291 --~~~-~l~~~~~~~~------~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        ..+ ..........      ...+..+.+++.+||+.||++|||+.++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             cccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence              000 0000000000      012346789999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-42  Score=306.63  Aligned_cols=252  Identities=25%  Similarity=0.345  Sum_probs=198.5

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .|++.+.||+|+||.||++... +++.||+|++.....   .....+.+|+.+++.++||||+++++++.. +..+++||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecC-CCeEEEEE
Confidence            4788899999999999999654 689999999865422   223457789999999999999999997766 56899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+.+++|.+++...  ....+++..+..++.|++.||.|||+.|++|+||||+||++++++.++|+|||++........
T Consensus        80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  157 (285)
T cd05605          80 TLMNGGDLKFHIYNM--GNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET  157 (285)
T ss_pred             eccCCCcHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence            999999999888543  234689999999999999999999999999999999999999999999999999876543222


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                        .....+++.|+|||.+.+..++.++||||+||++|+|++|..||........       ..     .....+..    
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~-------~~-----~~~~~~~~----  219 (285)
T cd05605         158 --IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK-------RE-----EVERRVKE----  219 (285)
T ss_pred             --cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH-------HH-----HHHHHhhh----
Confidence              1234689999999999888899999999999999999999999975432110       00     00011110    


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLDA  334 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~~  334 (375)
                      .........+..+.+++.+||..||.+||     +++++++.
T Consensus       220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            01111123456789999999999999999     77777654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.7e-42  Score=308.17  Aligned_cols=262  Identities=24%  Similarity=0.397  Sum_probs=205.1

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeCC------CCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecC
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQD------GRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRH  129 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  129 (375)
                      ...++|++.+.||+|+||.||++....      ...+++|.+... .......+.+|+.+++.+ +|+||+++++++.. 
T Consensus         9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-   87 (293)
T cd05053           9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ-   87 (293)
T ss_pred             cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC-
Confidence            344678899999999999999996542      367899988654 333456688999999999 79999999997766 


Q ss_pred             CceeEEEEecccCCChhHhhccCC------------CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          130 SRELLLVYEFISNGTVADHLHGER------------AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      +...+++|||+++++|.+++....            .....+++..++.++.|++.||.|||+.|++|+||||+||+++.
T Consensus        88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~  167 (293)
T cd05053          88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE  167 (293)
T ss_pred             CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence            567999999999999999986432            23456889999999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccccccCCCccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchh
Q 017232          198 NFCVKVADFGLSRLFPNHVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLS  275 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~  275 (375)
                      ++.++|+|||++......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......     
T Consensus       168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----  242 (293)
T cd05053         168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-----  242 (293)
T ss_pred             CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH-----
Confidence            999999999999865432211 1122235678999999988889999999999999999997 888886432110     


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                                 ....+.....   ......+...+.+++.+|+..+|++|||+.++++.|+.+.
T Consensus       243 -----------~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         243 -----------LFKLLKEGYR---MEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             -----------HHHHHHcCCc---CCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence                       0011111111   1111224567899999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.4e-41  Score=300.14  Aligned_cols=250  Identities=26%  Similarity=0.450  Sum_probs=200.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      .+|++.+.||+|+||.||++... |..+++|.+....  ..+.+.+|+.+++.++|+|++++++++...+...+++|||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence            46888999999999999999765 7889999886543  24578899999999999999999997665567789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      ++++|.+++...  ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.......    
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~----  156 (256)
T cd05082          83 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----  156 (256)
T ss_pred             CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC----
Confidence            999999998643  23358899999999999999999999999999999999999999999999999987543221    


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      .....+..|+|||++.+..++.++|||||||++|+|++ |+.||.....      .... .         .+.....   
T Consensus       157 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~------~~~~-~---------~~~~~~~---  217 (256)
T cd05082         157 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL------KDVV-P---------RVEKGYK---  217 (256)
T ss_pred             CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCH------HHHH-H---------HHhcCCC---
Confidence            12234568999999988889999999999999999997 9998864321      0110 0         0101011   


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                      ......++..+.+++.+|++.+|++|||+.++++.|+.+
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         218 MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence            111123456789999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=5e-42  Score=319.96  Aligned_cols=252  Identities=25%  Similarity=0.310  Sum_probs=194.6

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .|++++.||+|+||.||+|... +++.||+|++....   ......+.+|+.+++.++||||+++++++.. ...+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~-~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEec-CCEEEEEE
Confidence            5888999999999999999554 68899999986542   2345678899999999999999999998776 67899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+++|+|.+++..    ...+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..+.....
T Consensus        81 E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          81 DYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             ecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            99999999999853    34588999999999999999999999999999999999999999999999998753311000


Q ss_pred             ----------------------------------------------ccccCCCCCccccCcccccccCCCCchhHHHHHH
Q 017232          218 ----------------------------------------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGV  251 (375)
Q Consensus       218 ----------------------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  251 (375)
                                                                    ......+||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~  236 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV  236 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence                                                          0012346899999999999888999999999999


Q ss_pred             HHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHH--hcCCCCCCCCCHH
Q 017232          252 VLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQ--CLQSEKDLRPYMV  329 (375)
Q Consensus       252 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~--cl~~~P~~Rpt~~  329 (375)
                      ++|||++|.+||.......      ..         ..+........ .+....++.++.+++.+  |+..+|..||++.
T Consensus       237 il~elltG~~Pf~~~~~~~------~~---------~~i~~~~~~~~-~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~  300 (381)
T cd05626         237 ILFEMLVGQPPFLAPTPTE------TQ---------LKVINWENTLH-IPPQVKLSPEAVDLITKLCCSAEERLGRNGAD  300 (381)
T ss_pred             HHHHHHhCCCCCcCCCHHH------HH---------HHHHccccccC-CCCCCCCCHHHHHHHHHHccCcccccCCCCHH
Confidence            9999999999997543211      00         00110000000 01111234567888887  4456666799999


Q ss_pred             HHHHH
Q 017232          330 DVLDA  334 (375)
Q Consensus       330 evl~~  334 (375)
                      ++++.
T Consensus       301 ~~l~h  305 (381)
T cd05626         301 DIKAH  305 (381)
T ss_pred             HHhcC
Confidence            99875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=1.3e-41  Score=311.41  Aligned_cols=255  Identities=22%  Similarity=0.286  Sum_probs=196.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||++..+ +++.+|+|++....   ......+..|+.++..++|+||+++++++.. ...+++|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQD-ENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCEEEEE
Confidence            36889999999999999999765 57889999985432   2223457889999999999999999997766 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+.+|+|.+++...   ...+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus        80 ~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~  156 (332)
T cd05623          80 MDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  156 (332)
T ss_pred             EeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence            9999999999999542   2458999999999999999999999999999999999999999999999999987554333


Q ss_pred             cccccCCCCCccccCccccc-----ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          217 THVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ........||+.|+|||++.     ...++.++|||||||++|||++|+.||.......      .         ...+.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~------~---------~~~i~  221 (332)
T cd05623         157 TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------T---------YGKIM  221 (332)
T ss_pred             cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH------H---------HHHHh
Confidence            32233446899999999875     3457889999999999999999999997443111      0         01111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDL--RPYMVDVLDA  334 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~evl~~  334 (375)
                      ........+.....++..+.+++.+|+..++++  |+++.++++.
T Consensus       222 ~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         222 NHKERFQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             CCCccccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            111111111212234567889999988655544  6889988876

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8e-42  Score=312.67  Aligned_cols=255  Identities=21%  Similarity=0.281  Sum_probs=196.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||++... +++.||+|.+...   .......+.+|..++..++|+||+++++++.. .+..++|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~-~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQD-ENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence            46899999999999999999765 6788999998643   22234457889999999999999999997766 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+.+|+|.+++...   ...+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  156 (331)
T cd05624          80 MDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG  156 (331)
T ss_pred             EeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence            9999999999999642   2458899999999999999999999999999999999999999999999999987654433


Q ss_pred             cccccCCCCCccccCcccccc-----cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          217 THVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ........|++.|+|||++.+     ..++.++|||||||++|+|++|+.||.......      .         ...+.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~------~---------~~~i~  221 (331)
T cd05624         157 TVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE------T---------YGKIM  221 (331)
T ss_pred             ceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH------H---------HHHHH
Confidence            322233468999999998865     467889999999999999999999996443110      0         01111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDL--RPYMVDVLDA  334 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~evl~~  334 (375)
                      ........+......+..+.+++.+|+...+++  |++++++++.
T Consensus       222 ~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         222 NHEERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             cCCCcccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            111111111112234567889999999876554  4678877754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=4.8e-42  Score=312.10  Aligned_cols=240  Identities=26%  Similarity=0.386  Sum_probs=187.3

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|... +++.||+|++....   ....+.+..|..++... +||||+++++++.. ...+++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~-~~~~~lv~e~~~   79 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQT-KEHLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            36999999999999665 57899999986542   22334455677776654 79999999997766 668999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|..++..    ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....... ....
T Consensus        80 gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~  154 (316)
T cd05592          80 GGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKAS  154 (316)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Cccc
Confidence            9999998853    3458999999999999999999999999999999999999999999999999987543222 2223


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||.......      . .        ..+...     ...
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~------~-~--------~~i~~~-----~~~  214 (316)
T cd05592         155 TFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDE------L-F--------DSILND-----RPH  214 (316)
T ss_pred             cccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHH------H-H--------HHHHcC-----CCC
Confidence            4468999999999998889999999999999999999999997543110      0 0        001100     001


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMV-DVL  332 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~-evl  332 (375)
                      .+..++..+.+++.+||+.+|++||++. +++
T Consensus       215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            1112345688999999999999999975 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.4e-41  Score=308.08  Aligned_cols=264  Identities=25%  Similarity=0.379  Sum_probs=205.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecC
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ--------DGRAVAVKRLYENN-YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRH  129 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  129 (375)
                      .++|.+.+.||+|+||.||+|...        ++..+|+|.+.... ......+.+|+.+++.+ +||||+++++++.. 
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~-   95 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   95 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-
Confidence            356899999999999999999642        23469999887542 34456788899999999 79999999997766 


Q ss_pred             CceeEEEEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          130 SRELLLVYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      ....++||||+.+++|.+++.....            ....+++..++.++.|++.||+|||++|++|+||||+||+++.
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~  175 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  175 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence            5678999999999999999965432            1235888999999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccccccCCCcccc-ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchh
Q 017232          198 NFCVKVADFGLSRLFPNHVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLS  275 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~  275 (375)
                      ++.++|+|||.+.......... .....++..|+|||.+.+..++.++|||||||++|+|++ |.+||......      
T Consensus       176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~------  249 (307)
T cd05098         176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------  249 (307)
T ss_pred             CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH------
Confidence            9999999999987554321111 112224568999999988889999999999999999998 88888643211      


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                      ..          ...+....   .......++..+.+++.+||..+|++|||+.+|++.|+++.+...
T Consensus       250 ~~----------~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         250 EL----------FKLLKEGH---RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             HH----------HHHHHcCC---CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence            00          00111111   111112345688999999999999999999999999999877644

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-41  Score=300.84  Aligned_cols=257  Identities=25%  Similarity=0.416  Sum_probs=200.8

Q ss_pred             CCCCCccCCCCcEEEEEEEeCC----CCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-----c
Q 017232           63 FDSARELGDGGFGTVYYGELQD----GRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-----R  131 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~  131 (375)
                      |++.+.||+|+||.||+|....    +..||+|++...  .......+.+|+..++.++||||+++++++....     .
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            5678899999999999996542    367999998654  2334567899999999999999999999665432     2


Q ss_pred             eeEEEEecccCCChhHhhccCCC--CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERA--KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      ..+++|||+++++|..++...+.  ....+++..++.++.|++.||.|||+.|++|+||||+||++++++.+||+|||++
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~  160 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLS  160 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccce
Confidence            47999999999999998855432  2346899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCcccc-ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHH
Q 017232          210 RLFPNHVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKAL  287 (375)
Q Consensus       210 ~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (375)
                      .......... ......+..|+|||.+.+..++.++|||||||++|||++ |.+||.......                 
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~-----------------  223 (273)
T cd05035         161 KKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHE-----------------  223 (273)
T ss_pred             eeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHH-----------------
Confidence            7654332211 112234668999999988889999999999999999999 889886433110                 


Q ss_pred             HHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          288 HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       288 ~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                        +.+..........+..++..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       224 --~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         224 --IYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             --HHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              0111111111111223556899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1e-41  Score=312.22  Aligned_cols=267  Identities=23%  Similarity=0.336  Sum_probs=200.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|++.++||.|+||.||++... ++..+|+|.+... .......+.+|+.+++.++||||+++++++.. +...++||
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   82 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM   82 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-CCEEEEEE
Confidence            467999999999999999999766 6788999987654 33345678899999999999999999998777 66899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||+++++|.+++..    ...+++..+..++.|++.||.|||+. +++|+||||+|||++.++.+||+|||++.......
T Consensus        83 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~  158 (333)
T cd06650          83 EHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM  158 (333)
T ss_pred             ecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhc
Confidence            99999999999853    34588899999999999999999985 79999999999999999999999999987543321


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhH--------------------
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN--------------------  276 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~--------------------  276 (375)
                         .....++..|+|||++.+..++.++|||||||++|+|++|+.||.............                    
T Consensus       159 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         159 ---ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             ---cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence               123458899999999998889999999999999999999999996433211000000                    


Q ss_pred             HHHHHhh-----hhHHHHHHhhhcCCCCChH-HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          277 LAINKIQ-----NKALHELVDQTLGYESDNK-VRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       277 ~~~~~~~-----~~~~~~~~~~~l~~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .......     ......+.+.......... ....+.++.+++.+||+.||++|||+.|++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence            0000000     0000011111111000000 01134568999999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-41  Score=304.17  Aligned_cols=257  Identities=29%  Similarity=0.445  Sum_probs=202.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      .+|...++||+|+||.||++...      ++..+++|.+..........+.+|+++++.++|+||+++++++.. ....+
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-GRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-CCceE
Confidence            45788999999999999999532      356789998877666667789999999999999999999997766 56789


Q ss_pred             EEEecccCCChhHhhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEE
Q 017232          135 LVYEFISNGTVADHLHGERA-----------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKV  203 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl  203 (375)
                      ++|||+++++|.+++.....           ....+++..++.++.|++.||+|||+.|++|+||||+||++++++.++|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL  163 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI  163 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence            99999999999999865421           1135889999999999999999999999999999999999999999999


Q ss_pred             eeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHH
Q 017232          204 ADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINK  281 (375)
Q Consensus       204 ~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  281 (375)
                      +|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||........          
T Consensus       164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~----------  233 (280)
T cd05092         164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEA----------  233 (280)
T ss_pred             CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHH----------
Confidence            99999875432221 11122235678999999998899999999999999999998 8999864332110          


Q ss_pred             hhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          282 IQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                           .. ...   ..........++..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       234 -----~~-~~~---~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~  280 (280)
T cd05092         234 -----IE-CIT---QGRELERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA  280 (280)
T ss_pred             -----HH-HHH---cCccCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence                 00 000   101111112345678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.8e-42  Score=319.13  Aligned_cols=260  Identities=22%  Similarity=0.288  Sum_probs=200.2

Q ss_pred             HHHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC
Q 017232           54 GELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRH  129 (375)
Q Consensus        54 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  129 (375)
                      .++....++|++.+.||+|+||.||++..+ +++.||+|++....   ......+.+|+.+++.++||||+++++++.. 
T Consensus        36 ~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~-  114 (371)
T cd05622          36 RDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-  114 (371)
T ss_pred             hhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-
Confidence            344455678999999999999999999665 68899999985432   2234457789999999999999999997766 


Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      +...++||||+++|+|.+++..     ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus       115 ~~~~~lv~Ey~~gg~L~~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a  189 (371)
T cd05622         115 DRYLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC  189 (371)
T ss_pred             CCEEEEEEcCCCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCce
Confidence            6789999999999999999843     34788899999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCCCCccccCcccccccC----CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ----LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK  285 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (375)
                      ...............||+.|+|||++.+..    ++.++|||||||++|+|++|.+||.......               
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---------------  254 (371)
T cd05622         190 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG---------------  254 (371)
T ss_pred             eEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH---------------
Confidence            866443322233456999999999886543    7889999999999999999999997543110               


Q ss_pred             HHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHHH
Q 017232          286 ALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDL--RPYMVDVLDAL  335 (375)
Q Consensus       286 ~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~evl~~L  335 (375)
                      ....+....-.... +.....+..+.+++.+||...+.+  |+++.++++..
T Consensus       255 ~~~~i~~~~~~~~~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         255 TYSKIMNHKNSLTF-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHHHHHcCCCcccC-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            01111111000000 111234567889999999844443  77888888753

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.7e-41  Score=300.23  Aligned_cols=255  Identities=23%  Similarity=0.455  Sum_probs=204.0

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .++|++.+.||+|+||.||+|...++..+++|.+.... .....+.+|+.+++.++|+|++++++++..  ...+++|||
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~   81 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEF   81 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEe
Confidence            46789999999999999999987778889999886543 334678899999999999999999997665  568999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++++|.+++...  ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..........
T Consensus        82 ~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  159 (260)
T cd05073          82 MAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  159 (260)
T ss_pred             CCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCccc
Confidence            9999999999643  23457888999999999999999999999999999999999999999999999987654332222


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      .....++..|+|||++.+..++.++|+||||+++|++++ |..||.......      . ..         .+.....  
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~------~-~~---------~~~~~~~--  221 (260)
T cd05073         160 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE------V-IR---------ALERGYR--  221 (260)
T ss_pred             ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH------H-HH---------HHhCCCC--
Confidence            223345677999999988889999999999999999998 999986432110      0 00         0111110  


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                       .+.....+..+.+++.+|++.+|++||++.++.+.|+.+
T Consensus       222 -~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~  260 (260)
T cd05073         222 -MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF  260 (260)
T ss_pred             -CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence             011123456799999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=1.5e-42  Score=320.15  Aligned_cols=265  Identities=24%  Similarity=0.325  Sum_probs=205.1

Q ss_pred             cCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-C-----CCeEEEeeeeecCCcee
Q 017232           61 NYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-H-----KNLVSLYGCTSRHSREL  133 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~  133 (375)
                      -+|.+.+.||+|+||.|-+| +.++++.||||+++... .-..+...|+.+|..|+ |     -|+|++++++.. .+++
T Consensus       186 ~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k-~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~f-r~Hl  263 (586)
T KOG0667|consen  186 YRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKK-RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYF-RNHL  263 (586)
T ss_pred             EEEEEEEEecccccceeEEEEecCCCcEEEEEeeccCh-HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccc-ccce
Confidence            37899999999999999999 66679999999986553 44566778999999997 3     489999997766 7899


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC--cEEEeeeccccc
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF--CVKVADFGLSRL  211 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~  211 (375)
                      |||+|.+ ..+|++++...+.+  .++...+..++.||+.||.+||+.||||+||||+|||+.+.+  .+||+|||.++.
T Consensus       264 ciVfELL-~~NLYellK~n~f~--Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~  340 (586)
T KOG0667|consen  264 CIVFELL-STNLYELLKNNKFR--GLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCF  340 (586)
T ss_pred             eeeehhh-hhhHHHHHHhcCCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccc
Confidence            9999999 58999999876544  599999999999999999999999999999999999997543  699999999987


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH----
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL----  287 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~----  287 (375)
                      ......    ....+..|+|||++.|.+|+.+.||||||||++||++|.|.|......++........+.....-+    
T Consensus       341 ~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~  416 (586)
T KOG0667|consen  341 ESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAK  416 (586)
T ss_pred             cCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            543322    446888999999999999999999999999999999999999877766544333222221111000    


Q ss_pred             --HHHHhh-----------------------------hcC--CC-----CChHHH-HHHHHHHHHHHHhcCCCCCCCCCH
Q 017232          288 --HELVDQ-----------------------------TLG--YE-----SDNKVR-RTINAVAELAFQCLQSEKDLRPYM  328 (375)
Q Consensus       288 --~~~~~~-----------------------------~l~--~~-----~~~~~~-~~~~~l~~li~~cl~~~P~~Rpt~  328 (375)
                        ...++.                             ...  ..     ...... .....+.+++++||..||.+|+|.
T Consensus       417 ~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp  496 (586)
T KOG0667|consen  417 KAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITP  496 (586)
T ss_pred             ccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCH
Confidence              000000                             000  00     000001 223468999999999999999999


Q ss_pred             HHHHHH
Q 017232          329 VDVLDA  334 (375)
Q Consensus       329 ~evl~~  334 (375)
                      .+.++.
T Consensus       497 ~qal~H  502 (586)
T KOG0667|consen  497 AQALNH  502 (586)
T ss_pred             HHHhcC
Confidence            999875

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2e-41  Score=303.53  Aligned_cols=257  Identities=26%  Similarity=0.415  Sum_probs=200.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-----CCCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-----QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ..|++.+.||+|+||.||+|..     .++..|++|.+... .......+.+|+.+++.++||||+++++++.. +...+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-EQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-CCceE
Confidence            4578889999999999999964     24678999998643 33344678899999999999999999997665 56789


Q ss_pred             EEEecccCCChhHhhccCCC-------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcE
Q 017232          135 LVYEFISNGTVADHLHGERA-------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV  201 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~-------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~  201 (375)
                      +||||+.+++|.+++.....             ....+++.++..++.|++.||.|||++|++|+||||+||+++.++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence            99999999999999853211             12357888999999999999999999999999999999999999999


Q ss_pred             EEeeeccccccCCCc-cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHH
Q 017232          202 KVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAI  279 (375)
Q Consensus       202 kl~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  279 (375)
                      ||+|||++....... ........++..|+|||.+.+..++.++||||||+++|||++ |..||......       ...
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~-------~~~  236 (283)
T cd05090         164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ-------EVI  236 (283)
T ss_pred             EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH-------HHH
Confidence            999999997653222 111223345678999999988889999999999999999998 98898643210       001


Q ss_pred             HHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          280 NKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       280 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                      .         .+....   ..+....++..+.+++.+|++.+|.+||++.+|++.|+.
T Consensus       237 ~---------~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 E---------MVRKRQ---LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             H---------HHHcCC---cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            1         111100   001112245678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-42  Score=319.04  Aligned_cols=252  Identities=24%  Similarity=0.350  Sum_probs=194.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.+++.++||||+++++++.. ....|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~-~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQD-AQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCeeEEE
Confidence            36889999999999999999654 78999999986532   2345668889999999999999999997776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++|+|.+++..    ...+++..+..++.|++.||+|||+.||+||||||+|||++.++.++|+|||++..+....
T Consensus        80 ~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~  155 (377)
T cd05629          80 MEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQH  155 (377)
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            999999999999853    3458899999999999999999999999999999999999999999999999986321100


Q ss_pred             c------------c----------------------------------cccCCCCCccccCcccccccCCCCchhHHHHH
Q 017232          217 T------------H----------------------------------VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFG  250 (375)
Q Consensus       217 ~------------~----------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG  250 (375)
                      .            .                                  ......||+.|+|||++.+..++.++||||||
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG  235 (377)
T cd05629         156 DSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecc
Confidence            0            0                                  00123589999999999988999999999999


Q ss_pred             HHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCC---CC
Q 017232          251 VVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLR---PY  327 (375)
Q Consensus       251 ~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---pt  327 (375)
                      |++|||++|.+||.......      . ...+..     . ...+..   +.....+..+.+++.+||. +|.+|   ++
T Consensus       236 vil~elltG~~Pf~~~~~~~------~-~~~i~~-----~-~~~~~~---p~~~~~s~~~~dli~~lL~-~~~~r~~r~~  298 (377)
T cd05629         236 AIMFECLIGWPPFCSENSHE------T-YRKIIN-----W-RETLYF---PDDIHLSVEAEDLIRRLIT-NAENRLGRGG  298 (377)
T ss_pred             hhhhhhhcCCCCCCCCCHHH------H-HHHHHc-----c-CCccCC---CCCCCCCHHHHHHHHHHhc-CHhhcCCCCC
Confidence            99999999999996543211      0 000000     0 000100   0001234578899999997 66665   59


Q ss_pred             HHHHHHH
Q 017232          328 MVDVLDA  334 (375)
Q Consensus       328 ~~evl~~  334 (375)
                      +.++++.
T Consensus       299 ~~~~l~h  305 (377)
T cd05629         299 AHEIKSH  305 (377)
T ss_pred             HHHHhcC
Confidence            9998875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.8e-41  Score=307.00  Aligned_cols=265  Identities=24%  Similarity=0.388  Sum_probs=206.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC--------CCCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecC
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ--------DGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRH  129 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  129 (375)
                      ..+|.+.+.||+|+||.||+|...        ++..|++|.+... .......+.+|+.+++.+ +||||+++++++.. 
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-   92 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-   92 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec-
Confidence            456888999999999999999631        2457899988654 234456788999999999 89999999997766 


Q ss_pred             CceeEEEEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          130 SRELLLVYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      ....+++|||+.+++|.+++.....            ....+++..+..++.|++.||.|||++|++|+||||+||+++.
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~  172 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE  172 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence            5678999999999999999975422            1235788889999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccccccCCCcccc-ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchh
Q 017232          198 NFCVKVADFGLSRLFPNHVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLS  275 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~  275 (375)
                      ++.+||+|||++.......... .....++..|+|||++.+..++.++||||||+++|+|++ |..||......      
T Consensus       173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~------  246 (304)
T cd05101         173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE------  246 (304)
T ss_pred             CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH------
Confidence            9999999999998664332221 122345678999999988889999999999999999998 77887543211      


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYD  344 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~  344 (375)
                      .. ...+.         ...   .......++..+.+++.+||+.+|++|||+.++++.|+++.....+
T Consensus       247 ~~-~~~~~---------~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~~~~  302 (304)
T cd05101         247 EL-FKLLK---------EGH---RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTLTTN  302 (304)
T ss_pred             HH-HHHHH---------cCC---cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHhhhc
Confidence            11 11111         000   0011123456799999999999999999999999999998776543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=3.4e-41  Score=296.85  Aligned_cols=247  Identities=27%  Similarity=0.405  Sum_probs=194.7

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCC
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~  144 (375)
                      +.||+|+||.||+|... +++.||+|.+.... ......+.+|+++++.++||||+++++++.. ....++||||+.+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCeEEEEeeccCCc
Confidence            46999999999999664 68899999876543 3445678899999999999999999997766 567899999999999


Q ss_pred             hhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc-ccCC
Q 017232          145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV-STAP  223 (375)
Q Consensus       145 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~  223 (375)
                      |.+++...   ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......... ....
T Consensus        80 L~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  156 (252)
T cd05084          80 FLTFLRTE---GPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMK  156 (252)
T ss_pred             HHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCC
Confidence            99998532   3458899999999999999999999999999999999999999999999999987543221111 0111


Q ss_pred             CCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChH
Q 017232          224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNK  302 (375)
Q Consensus       224 ~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  302 (375)
                      ..+..|+|||.+.+..++.++||||||+++|+|++ |..||......                .....+......   ..
T Consensus       157 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~----------------~~~~~~~~~~~~---~~  217 (252)
T cd05084         157 QIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ----------------QTREAIEQGVRL---PC  217 (252)
T ss_pred             CCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHH----------------HHHHHHHcCCCC---CC
Confidence            23457999999988889999999999999999997 88888643211                011111111111   11


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          303 VRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       303 ~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                      ...++..+.+++.+||+.+|++|||+.+|+++|.
T Consensus       218 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         218 PELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence            1234567899999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.5e-42  Score=317.57  Aligned_cols=253  Identities=22%  Similarity=0.241  Sum_probs=199.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||++... +++.||+|++.....   .....+.+|+.+++.++|+||+++++++.. ....++|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQD-KDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEec-CCeEEEE
Confidence            46889999999999999999654 689999999875422   344567889999999999999999997766 5679999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++...   ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~  156 (330)
T cd05601          80 MEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANK  156 (330)
T ss_pred             ECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCC
Confidence            9999999999998643   2468999999999999999999999999999999999999999999999999998665433


Q ss_pred             cccccCCCCCccccCccccc------ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          217 THVSTAPQGTPGYVDPEYHQ------CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ........+|+.|+|||++.      +..++.++|||||||++|+|++|..||.......               ....+
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~---------------~~~~i  221 (330)
T cd05601         157 MVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAK---------------TYNNI  221 (330)
T ss_pred             ceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHH---------------HHHHH
Confidence            33333446899999999876      4567889999999999999999999997543111               01111


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ......... +.....+..+.+++.+||. +|.+|||+.++++.
T Consensus       222 ~~~~~~~~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         222 MNFQRFLKF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HcCCCccCC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            110000000 1111245678899999998 99999999998853

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.2e-41  Score=305.34  Aligned_cols=260  Identities=28%  Similarity=0.383  Sum_probs=201.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCC-CC--EEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQD-GR--AVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|++.+.||+|+||.||+|..++ +.  .+++|.+... .....+.+.+|+.++.++ +||||+++++++.. ....++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~l   80 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACEN-RGYLYI   80 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEcc-CCcceE
Confidence            468899999999999999996653 33  4688877643 333456788999999999 79999999997766 567899


Q ss_pred             EEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEE
Q 017232          136 VYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKV  203 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl  203 (375)
                      +|||+++++|.+++.....            ....+++..++.++.|++.||+|||++|++|+||||+||+++.++.+||
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl  160 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKI  160 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEE
Confidence            9999999999999865321            1235889999999999999999999999999999999999999999999


Q ss_pred             eeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHh
Q 017232          204 ADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKI  282 (375)
Q Consensus       204 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  282 (375)
                      +|||++........  ......+..|+|||.+.+..++.++|||||||++|+|++ |..||.......      .. .  
T Consensus       161 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~------~~-~--  229 (297)
T cd05089         161 ADFGLSRGEEVYVK--KTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE------LY-E--  229 (297)
T ss_pred             CCcCCCccccceec--cCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH------HH-H--
Confidence            99999864322111  111223557999999988889999999999999999997 999996443111      00 0  


Q ss_pred             hhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          283 QNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       283 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                             ........   .....++..+.+++.+|++.+|.+||+++++++.|+.+....
T Consensus       230 -------~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         230 -------KLPQGYRM---EKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             -------HHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence                   01111111   111224567899999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.2e-41  Score=303.29  Aligned_cols=259  Identities=25%  Similarity=0.393  Sum_probs=202.4

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      +|++.+.||+|+||.||+|...      ....+++|.+.... ......+.+|+.+++.++||||+++++.+.. ....+
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ-DGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec-CCCcE
Confidence            4788899999999999999643      23568888876543 3345678899999999999999999997766 56689


Q ss_pred             EEEecccCCChhHhhccCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEE
Q 017232          135 LVYEFISNGTVADHLHGERA--------------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNIL  194 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nil  194 (375)
                      +++||+.+++|.+++...+.                    ....+++..++.++.|++.||.|||+.|++||||||+||+
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            99999999999998864321                    1235788999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeeccccccCCCccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCcccccccccc
Q 017232          195 LDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEI  272 (375)
Q Consensus       195 l~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~  272 (375)
                      +++++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--  237 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPER--  237 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHH--
Confidence            999999999999998755332221 1122345678999999888889999999999999999998 999986432110  


Q ss_pred             chhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          273 NLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                                    ..+.........   ....++..+.+++.+|++.+|++||++.++++.|+++-.
T Consensus       238 --------------~~~~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         238 --------------LFNLLKTGYRME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             --------------HHHHHhCCCCCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence                          111111111111   112345679999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1e-41  Score=305.41  Aligned_cols=256  Identities=24%  Similarity=0.366  Sum_probs=199.8

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      +|++.+.||.|+||.||+|...      ++..||+|++...... ....+.+|+.++..++||||+++++++.. ....+
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~   84 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK-EQPLS   84 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC-CCceE
Confidence            4677889999999999999653      2478999998755332 34568889999999999999999997766 55689


Q ss_pred             EEEecccCCChhHhhccCC------------CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEE
Q 017232          135 LVYEFISNGTVADHLHGER------------AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVK  202 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~k  202 (375)
                      +++||+.+++|.+++....            .....+++..++.++.|++.||.|||++|++||||||+||++++++.+|
T Consensus        85 ~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~k  164 (283)
T cd05091          85 MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVK  164 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceE
Confidence            9999999999999985321            1124578888999999999999999999999999999999999999999


Q ss_pred             EeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHH
Q 017232          203 VADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       203 l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      |+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |..||......      .. ..
T Consensus       165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~------~~-~~  237 (283)
T cd05091         165 ISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ------DV-IE  237 (283)
T ss_pred             ecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH------HH-HH
Confidence            999999875532221 11223345778999999988889999999999999999998 88888643211      00 11


Q ss_pred             HhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          281 KIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                      .        +...    ...+....++..+.+++.+|++.+|++||++++|+..|+.
T Consensus       238 ~--------i~~~----~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         238 M--------IRNR----QVLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H--------HHcC----CcCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            1        1111    1111122456779999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=309.58  Aligned_cols=252  Identities=26%  Similarity=0.394  Sum_probs=210.5

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchh---hHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCce
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK---RVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  132 (375)
                      .....|++.+.||+|.||.||++..+ +|+.+|+|.+.+....   ....+.+|+.+|+++. |||||.+++.++. ...
T Consensus        32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~-~~~  110 (382)
T KOG0032|consen   32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFED-PDS  110 (382)
T ss_pred             cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEc-CCe
Confidence            34567999999999999999999666 5999999999765432   3468899999999998 9999999998887 568


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC----CcEEEeeecc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN----FCVKVADFGL  208 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~  208 (375)
                      +++|||+|.||.|.+.+...     .+++..+..++.|++.++.|||+.|++||||||+|+|+...    +.+|++|||+
T Consensus       111 ~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl  185 (382)
T KOG0032|consen  111 VYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL  185 (382)
T ss_pred             EEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence            99999999999999999654     29999999999999999999999999999999999999533    5799999999


Q ss_pred             ccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      +.....  .......+||+.|+|||++....|+..+||||+|+++|.|++|.+||.........               .
T Consensus       186 a~~~~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~---------------~  248 (382)
T KOG0032|consen  186 AKFIKP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF---------------L  248 (382)
T ss_pred             ceEccC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH---------------H
Confidence            998766  33455678999999999999999999999999999999999999999866532211               1


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .+......+ ..+.....+..+.+++..|+..||..|+|+.++++
T Consensus       249 ~i~~~~~~f-~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  249 AILRGDFDF-TSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHHcCCCCC-CCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            122111111 12233455778999999999999999999999998

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-41  Score=310.22  Aligned_cols=255  Identities=23%  Similarity=0.297  Sum_probs=195.6

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||++... +++.||+|++...   .....+.+.+|+.++..++|+||+++++++.. +..+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQD-ENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEec-CCeEEEE
Confidence            46889999999999999999765 6889999998642   22234567889999999999999999997776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+.+++|.+++...   ...+++..+..++.||+.||+|||++|++||||||+|||++.++.+||+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  156 (331)
T cd05597          80 MDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG  156 (331)
T ss_pred             EecCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence            9999999999998542   3458999999999999999999999999999999999999999999999999987654333


Q ss_pred             cccccCCCCCccccCcccccc-----cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          217 THVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ........||+.|+|||++.+     ..++.++|||||||++|+|++|+.||.......      ..         ..+.
T Consensus       157 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~------~~---------~~i~  221 (331)
T cd05597         157 TVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------TY---------GKIM  221 (331)
T ss_pred             CccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHH------HH---------HHHH
Confidence            222233468999999998863     457889999999999999999999996432110      00         0111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCC--CCCCHHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKD--LRPYMVDVLDA  334 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~--~Rpt~~evl~~  334 (375)
                      ...............+..+.+++.+||...++  .||++.++++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         222 NHKEHFQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             cCCCcccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            10000111111122456788899888865443  37899888876

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=4.5e-41  Score=295.70  Aligned_cols=247  Identities=26%  Similarity=0.425  Sum_probs=195.9

Q ss_pred             CccCCCCcEEEEEEEeCCCCEEEEEEecccch-hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCCh
Q 017232           67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNY-KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTV  145 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L  145 (375)
                      +.||+|+||.||+|...++..+|+|.+..... .....+.+|+.+++.++||||+++++++.. ....++||||+++++|
T Consensus         1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~L   79 (250)
T cd05085           1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-RQPIYIVMELVPGGDF   79 (250)
T ss_pred             CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-CCccEEEEECCCCCcH
Confidence            36999999999999888889999998866543 334568899999999999999999997766 5678999999999999


Q ss_pred             hHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCCC
Q 017232          146 ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG  225 (375)
Q Consensus       146 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  225 (375)
                      .+++...   ...+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++...............+
T Consensus        80 ~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          80 LSFLRKK---KDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            9988543   2357899999999999999999999999999999999999999999999999987543322211122234


Q ss_pred             CccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHH
Q 017232          226 TPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVR  304 (375)
Q Consensus       226 ~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  304 (375)
                      +..|+|||++.+..++.++||||||+++|++++ |..||.......       ....         .........   ..
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~-------~~~~---------~~~~~~~~~---~~  217 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ-------AREQ---------VEKGYRMSC---PQ  217 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH-------HHHH---------HHcCCCCCC---CC
Confidence            567999999988889999999999999999998 999986432111       0000         000011011   11


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          305 RTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       305 ~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                      .++..+.+++.+|++.+|++||++.++++.|.
T Consensus       218 ~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         218 KCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             CCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence            24567999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=1.7e-41  Score=312.01  Aligned_cols=264  Identities=25%  Similarity=0.383  Sum_probs=203.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCc
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL------QDGRAVAVKRLYENN-YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  131 (375)
                      .++|++.+.||+|+||.||+|..      .+++.||+|.+.... ......+.+|+.++..+ +||||+++++++...+.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            35799999999999999999953      347889999986543 33446688999999999 68999999997776667


Q ss_pred             eeEEEEecccCCChhHhhccCCCC--------------------------------------------------------
Q 017232          132 ELLLVYEFISNGTVADHLHGERAK--------------------------------------------------------  155 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~--------------------------------------------------------  155 (375)
                      ..+++|||+++|+|.+++......                                                        
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            789999999999999998643210                                                        


Q ss_pred             -------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc-cccCCCCCc
Q 017232          156 -------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP  227 (375)
Q Consensus       156 -------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~  227 (375)
                             ...+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......... ......++.
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  245 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence                   124678888999999999999999999999999999999999999999999998764322211 112223567


Q ss_pred             cccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHH
Q 017232          228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRT  306 (375)
Q Consensus       228 ~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  306 (375)
                      .|+|||.+.+..++.++||||||+++|+|++ |..||.......      .....+.         .......   +...
T Consensus       246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~------~~~~~~~---------~~~~~~~---~~~~  307 (343)
T cd05103         246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFCRRLK---------EGTRMRA---PDYT  307 (343)
T ss_pred             ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH------HHHHHHh---------ccCCCCC---CCCC
Confidence            8999999988889999999999999999997 888886432110      0000000         0000000   0112


Q ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          307 INAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       307 ~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      +..+.+++.+||+.+|++|||+.+|++.|+.+.+.
T Consensus       308 ~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~~  342 (343)
T cd05103         308 TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  342 (343)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            35688999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.2e-42  Score=311.40  Aligned_cols=237  Identities=29%  Similarity=0.416  Sum_probs=185.7

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHH-HHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVD-ILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|... +|+.||+|++....   ......+..|.. +++.++||||+++++.+.. ....++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~-~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-ADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEe-CCEEEEEEcCCC
Confidence            36999999999999665 68999999986542   122334555554 4677899999999997766 678999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|..++..    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus        80 ~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (323)
T cd05575          80 GGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS-KTTS  154 (323)
T ss_pred             CCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC-Cccc
Confidence            9999998853    3468999999999999999999999999999999999999999999999999986432211 1223


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|.+||......      ..         ...+.......    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~------~~---------~~~i~~~~~~~----  215 (323)
T cd05575         155 TFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA------EM---------YDNILNKPLRL----  215 (323)
T ss_pred             cccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH------HH---------HHHHHcCCCCC----
Confidence            346899999999999989999999999999999999999999654311      00         11111111111    


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMV  329 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~  329 (375)
                       ....+..+.+++.+||+.+|.+||++.
T Consensus       216 -~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         216 -KPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             -CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence             112356789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-41  Score=296.58  Aligned_cols=250  Identities=25%  Similarity=0.442  Sum_probs=202.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ++|++.+.||.|++|.||+|... |+.|++|.+..... ..+.+.+|+.+++.++|+|++++++++.. ....++||||+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~   82 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQ-GNPLYIVTEYM   82 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcC-CCCeEEEEEec
Confidence            56888999999999999999875 78899999876654 45778999999999999999999997766 67789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      ++++|.+++...  ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        83 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~---  157 (256)
T cd05039          83 AKGSLVDYLRSR--GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD---  157 (256)
T ss_pred             CCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc---
Confidence            999999998543  223689999999999999999999999999999999999999999999999999876532221   


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                       ....+..|+|||.+.+..++.++||||||+++|+|++ |..||.......       .         ...+......  
T Consensus       158 -~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~-------~---------~~~~~~~~~~--  218 (256)
T cd05039         158 -SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD-------V---------VPHVEKGYRM--  218 (256)
T ss_pred             -cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-------H---------HHHHhcCCCC--
Confidence             2235567999999988889999999999999999997 999986442111       0         0001010010  


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                       .....++..+.+++.+||..+|++|||+.+++++|+.+
T Consensus       219 -~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         219 -EAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             -CCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence             11122456789999999999999999999999999764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=4.7e-42  Score=319.31  Aligned_cols=264  Identities=22%  Similarity=0.337  Sum_probs=197.8

Q ss_pred             CCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----ceeE
Q 017232           62 YFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----RELL  134 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~  134 (375)
                      +|++.+.||+|+||.||++.. .+++.||+|++...  .......+.+|+.+++.++|+||+++++++....    ...+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            478899999999999999965 47899999988643  3334567889999999999999999999776533    2689


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+. ++|.+.+.    ....+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.....
T Consensus        81 lv~e~~~-~~l~~~~~----~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          81 VVTELMQ-SDLHKIIV----SPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEeeccc-cCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            9999996 67877773    335689999999999999999999999999999999999999999999999999976543


Q ss_pred             CccccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh--------
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK--------  285 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~--------  285 (375)
                      ..........+++.|+|||.+.+. .++.++||||+||++|||++|++||...........   ........        
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~---i~~~~g~~~~~~~~~~  232 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL---ITDLLGTPSLEAMRSA  232 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH---HHHHcCCCCHHHHHHh
Confidence            332223344578899999988764 478999999999999999999999976543221110   00000000        


Q ss_pred             --HHHHHHhhhcCCCCChH------HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          286 --ALHELVDQTLGYESDNK------VRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       286 --~~~~~~~~~l~~~~~~~------~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                        .....+..... .....      .......+.+++.+||+.||++|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         233 CEGARAHILRGPH-KPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             hHHHHHHHHhCCC-CCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence              00000100000 00000      01124578899999999999999999999874

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.4e-42  Score=312.89  Aligned_cols=238  Identities=26%  Similarity=0.317  Sum_probs=190.0

Q ss_pred             CccCCCCcEEEEEEEe----CCCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           67 RELGDGGFGTVYYGEL----QDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      +.||+|+||.||++..    .+|+.||+|++.....  .....+..|+.++++++||||+++++++.. ....++||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQT-EGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCEEEEEEcCC
Confidence            5799999999999854    3578999999865432  233456789999999999999999997766 66899999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      ++++|.+++..    ...+++..++.++.||+.||.|||+.|++||||||+||+++.++.++|+|||++........ ..
T Consensus        81 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-~~  155 (318)
T cd05582          81 RGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-KA  155 (318)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC-ce
Confidence            99999998843    34589999999999999999999999999999999999999999999999999875433211 12


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD  300 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  300 (375)
                      ....|++.|+|||.+.+..++.++|||||||++|+|++|+.||.......               ....+......  . 
T Consensus       156 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---------------~~~~i~~~~~~--~-  217 (318)
T cd05582         156 YSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---------------TMTMILKAKLG--M-  217 (318)
T ss_pred             ecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---------------HHHHHHcCCCC--C-
Confidence            33468999999999988889999999999999999999999997543110               00111111111  0 


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 017232          301 NKVRRTINAVAELAFQCLQSEKDLRPYMVD  330 (375)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e  330 (375)
                        +..++..+.+++.+||+.+|++||++.+
T Consensus       218 --p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         218 --PQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             --CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence              1124467889999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.1e-41  Score=303.62  Aligned_cols=270  Identities=23%  Similarity=0.384  Sum_probs=202.1

Q ss_pred             CCCCCCccCCCCcEEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-CceeE
Q 017232           62 YFDSARELGDGGFGTVYYGEL-----QDGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-SRELL  134 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~  134 (375)
                      .|++.+.||+|+||.||++..     .++..|++|.+.... ......+.+|+.+++.++|||++++++++... ....+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIK   84 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceE
Confidence            478899999999999999963     357889999986543 34456789999999999999999999977664 35689


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.....
T Consensus        85 lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  161 (284)
T cd05079          85 LIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  161 (284)
T ss_pred             EEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccccccc
Confidence            999999999999998532   23589999999999999999999999999999999999999999999999999886543


Q ss_pred             Cccc--cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          215 HVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       215 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ....  ......++..|+|||.+.+..++.++||||||+++|+|++++.|.......... .................+.
T Consensus       162 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  240 (284)
T cd05079         162 DKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLK-MIGPTHGQMTVTRLVRVLE  240 (284)
T ss_pred             CccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhh-hcccccccccHHHHHHHHH
Confidence            2211  112334667899999988888999999999999999999987665322110000 0000000000000001111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                      ...   ..+....++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       241 ~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         241 EGK---RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cCc---cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            111   1111123456899999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.5e-41  Score=297.72  Aligned_cols=245  Identities=25%  Similarity=0.389  Sum_probs=194.4

Q ss_pred             ccCCCCcEEEEEEEe---CCCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccC
Q 017232           68 ELGDGGFGTVYYGEL---QDGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISN  142 (375)
Q Consensus        68 ~lg~G~~g~V~~~~~---~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  142 (375)
                      .||+|+||.||+|.+   .++..+|+|++....  ....+.+.+|+.+++.++||||+++++++.  ....++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE--AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc--CCCcEEEEecCCC
Confidence            599999999999954   357889999886442  334567889999999999999999999764  3467899999999


Q ss_pred             CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc--c
Q 017232          143 GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV--S  220 (375)
Q Consensus       143 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~  220 (375)
                      ++|.+++..    ...+++..+..++.|++.||.|||++|++|+||||.||+++.++.++|+|||++..........  .
T Consensus        80 ~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  155 (257)
T cd05116          80 GPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK  155 (257)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeec
Confidence            999999853    2458999999999999999999999999999999999999999999999999997654332211  1


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....++..|+|||.+.+..++.++|+|||||++|||++ |.+||.......                ....+.....   
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~i~~~~~---  216 (257)
T cd05116         156 THGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNE----------------VTQMIESGER---  216 (257)
T ss_pred             CCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHCCCC---
Confidence            12234578999999988888999999999999999998 999997543211                0111111111   


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                      .+.+..++..+.+++.+|++.+|++||++.+|.+.|++
T Consensus       217 ~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~  254 (257)
T cd05116         217 MECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRN  254 (257)
T ss_pred             CCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhc
Confidence            11112355678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=302.51  Aligned_cols=258  Identities=26%  Similarity=0.428  Sum_probs=202.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD------GRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      .++|.+.+.||+|+||.||+|...+      +..|++|.+.... ......+.+|+.+++.++||||+++++++.. ...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVST-GQP   83 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcC-CCC
Confidence            4578899999999999999996542      4689999986543 3445678899999999999999999997766 577


Q ss_pred             eEEEEecccCCChhHhhccCCCC------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeee
Q 017232          133 LLLVYEFISNGTVADHLHGERAK------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADF  206 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Df  206 (375)
                      .++||||+++++|.+++......      ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~df  163 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDF  163 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCc
Confidence            89999999999999998654321      234788899999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhh
Q 017232          207 GLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       207 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      |++........ .......++..|+|||.+.+..++.++|||||||++|+|++ |.+||.......      . .     
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~-~-----  231 (277)
T cd05032         164 GMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE------V-L-----  231 (277)
T ss_pred             ccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH------H-H-----
Confidence            99875533221 11223346778999999988889999999999999999998 999986433211      0 0     


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                         . ....   ......+..++..+.+++.+||+.+|++|||+.++++.|+.
T Consensus       232 ---~-~~~~---~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  277 (277)
T cd05032         232 ---K-FVID---GGHLDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD  277 (277)
T ss_pred             ---H-HHhc---CCCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence               0 1110   00111112235679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.8e-41  Score=306.68  Aligned_cols=261  Identities=28%  Similarity=0.415  Sum_probs=201.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCC--EEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGR--AVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|++.+.||+|+||.||+|..+ ++.  .+++|.+... .......+.+|+.++.++ +|+||+++++++.. +...++
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~-~~~~~l   85 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYL   85 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECC-CCCceE
Confidence            46888999999999999999764 444  4577776543 233456788899999999 89999999997766 567999


Q ss_pred             EEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEE
Q 017232          136 VYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKV  203 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl  203 (375)
                      ||||+++++|.+++.....            ....+++..++.++.|++.||+|||++|++||||||+|||++.++.++|
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl  165 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI  165 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEe
Confidence            9999999999999865421            2246889999999999999999999999999999999999999999999


Q ss_pred             eeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHh
Q 017232          204 ADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKI  282 (375)
Q Consensus       204 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  282 (375)
                      +|||++........  ......+..|+|||.+.+..++.++|||||||++|+|+| |..||.......      .. .  
T Consensus       166 ~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~-~--  234 (303)
T cd05088         166 ADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY-E--  234 (303)
T ss_pred             CccccCcccchhhh--cccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHH------HH-H--
Confidence            99999864221111  111224567999999988889999999999999999998 999986432110      00 0  


Q ss_pred             hhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          283 QNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       283 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                             .........   .....+..+.+++.+|++.+|++||++.++++.|+.+.....
T Consensus       235 -------~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~~  285 (303)
T cd05088         235 -------KLPQGYRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  285 (303)
T ss_pred             -------HHhcCCcCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhh
Confidence                   000101000   111234578899999999999999999999999998766554

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=5.2e-42  Score=313.65  Aligned_cols=248  Identities=23%  Similarity=0.353  Sum_probs=192.2

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|..++..+ +||||+++++++.. ...+++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~-~~~~~lv~e~~~   79 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQT-ESRLFFVIEFVS   79 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEc-CCEEEEEEeCCC
Confidence            36999999999999665 68899999997542   23345678899999988 69999999997766 568999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|.+++..    ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++....... ....
T Consensus        80 ~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~-~~~~  154 (329)
T cd05588          80 GGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG-DTTS  154 (329)
T ss_pred             CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC-Cccc
Confidence            9999988843    3468999999999999999999999999999999999999999999999999986422111 1123


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccc--cchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHE--INLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ...||+.|+|||++.+..++.++|+|||||++|+|++|+.||+.......  .....+....        +......   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------~~~~~~~---  223 (329)
T cd05588         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQV--------ILEKQIR---  223 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHH--------HHcCCCC---
Confidence            34689999999999998999999999999999999999999975432211  1111111111        1111111   


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCC------HHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPY------MVDVLD  333 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt------~~evl~  333 (375)
                        .+..++..+.+++.+||+.+|.+||+      +.++++
T Consensus       224 --~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05588         224 --IPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS  261 (329)
T ss_pred             --CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence              11123457889999999999999998      556654

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5e-41  Score=296.40  Aligned_cols=250  Identities=27%  Similarity=0.416  Sum_probs=202.8

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|.+.+.||+|++|.||+|..+ +++.|++|.+...  .......+.+|+.+++.++|||++++++++.. ....++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLD-KGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeecc-CCEEEEEEE
Confidence            4778899999999999999665 6899999988643  34455678899999999999999999997766 568999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++...  ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~  157 (256)
T cd08529          80 YAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF  157 (256)
T ss_pred             eCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccch
Confidence            99999999999654  2356899999999999999999999999999999999999999999999999998765443221


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                       .....+++.|+|||++.+..++.++|+||||+++|+|++|+.||.......                   .........
T Consensus       158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------------------~~~~~~~~~  217 (256)
T cd08529         158 -ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGA-------------------LILKIIRGV  217 (256)
T ss_pred             -hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-------------------HHHHHHcCC
Confidence             223457889999999998889999999999999999999999997543110                   000111111


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .......++..+.+++.+|++.+|++||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence            122222456789999999999999999999999863

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3e-42  Score=321.15  Aligned_cols=252  Identities=24%  Similarity=0.317  Sum_probs=194.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.+++.++|+||+++++.+.. .+.+++|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQD-KDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEc-CCEEEEE
Confidence            36899999999999999999654 68999999986432   2234567889999999999999999997776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++|+|.+++..    .+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|||++..+....
T Consensus        80 ~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~  155 (376)
T cd05598          80 MDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH  155 (376)
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence            999999999999853    3458889999999999999999999999999999999999999999999999975321000


Q ss_pred             ------------------------------------------cccccCCCCCccccCcccccccCCCCchhHHHHHHHHH
Q 017232          217 ------------------------------------------THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLI  254 (375)
Q Consensus       217 ------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~  254 (375)
                                                                ........||+.|+|||++.+..++.++|||||||++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily  235 (376)
T cd05598         156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence                                                      00011246899999999999989999999999999999


Q ss_pred             HHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCC---CHHHH
Q 017232          255 ELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRP---YMVDV  331 (375)
Q Consensus       255 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp---t~~ev  331 (375)
                      +|++|+.||........      ... +...      ...+.   .+....++..+.+++.+|+ .+|.+|+   ++.++
T Consensus       236 ell~G~~Pf~~~~~~~~------~~~-i~~~------~~~~~---~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~el  298 (376)
T cd05598         236 EMLVGQPPFLADTPAET------QLK-VINW------ETTLH---IPSQAKLSREASDLILRLC-CGAEDRLGKNGADEI  298 (376)
T ss_pred             ehhhCCCCCCCCCHHHH------HHH-Hhcc------Ccccc---CCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHH
Confidence            99999999975432110      000 0000      00000   0001123456778888876 5999999   88888


Q ss_pred             HHH
Q 017232          332 LDA  334 (375)
Q Consensus       332 l~~  334 (375)
                      ++.
T Consensus       299 l~h  301 (376)
T cd05598         299 KAH  301 (376)
T ss_pred             hCC
Confidence            865

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.4e-41  Score=299.98  Aligned_cols=257  Identities=25%  Similarity=0.393  Sum_probs=203.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCC----CCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQD----GRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|.+.+.||+|+||.||+|...+    ...|++|...... ....+.+.+|+.+++.++|||++++++++..  ...++
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~l   83 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWI   83 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEE
Confidence            458889999999999999996543    2468999886554 4456688999999999999999999997654  45789


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        84 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~  160 (270)
T cd05056          84 VMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDE  160 (270)
T ss_pred             EEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccc
Confidence            99999999999999543   235899999999999999999999999999999999999999999999999998765443


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .........++..|+|||.+.+..++.++||||||+++|+|++ |.+||.......      .. ..+         .. 
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~-~~~---------~~-  223 (270)
T cd05056         161 SYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND------VI-GRI---------EN-  223 (270)
T ss_pred             cceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH------HH-HHH---------Hc-
Confidence            2222223334568999999988889999999999999999986 999996543211      00 000         00 


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                        .........++..+.+++.+|+..+|++|||+.++++.|+++...
T Consensus       224 --~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         224 --GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             --CCcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              001111123456799999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-41  Score=302.19  Aligned_cols=255  Identities=23%  Similarity=0.330  Sum_probs=198.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++..........+.+|+.+++.++||||+++++.+.. ....++|||
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-~~~~~iv~e   86 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-REKLWICME   86 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-CCEEEEEEe
Confidence            35699999999999999999975 4688999999876544455678889999999999999999997766 567899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ 
T Consensus        87 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~-  161 (267)
T cd06646          87 YCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA-  161 (267)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccccc-
Confidence            9999999998853    34689999999999999999999999999999999999999999999999999876543221 


Q ss_pred             cccCCCCCccccCccccc---ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          219 VSTAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      ......++..|+|||.+.   ...++.++|+||+||++|+|++|..||..........  .             +.....
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~-------------~~~~~~  226 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--L-------------MSKSNF  226 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--e-------------eecCCC
Confidence            112335788999999874   3457889999999999999999999985332111100  0             000000


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL  335 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L  335 (375)
                      ...........+..+.+++.+||..+|++|||++++++.|
T Consensus       227 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         227 QPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             CCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence            0000000112346789999999999999999999998753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.1e-41  Score=302.31  Aligned_cols=263  Identities=26%  Similarity=0.416  Sum_probs=202.2

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  131 (375)
                      ..++|++.+.||+|+||.||+|..+      .+..||+|.+.... ......+.+|+.+++.++||||+++++++.. ..
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSK-GQ   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcC-CC
Confidence            4567999999999999999999543      24579999876443 2334467889999999999999999997665 56


Q ss_pred             eeEEEEecccCCChhHhhccCCCC------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEee
Q 017232          132 ELLLVYEFISNGTVADHLHGERAK------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD  205 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~D  205 (375)
                      ..++||||+++|+|.+++......      ....++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence            789999999999999999653211      23456678889999999999999999999999999999999999999999


Q ss_pred             eccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhh
Q 017232          206 FGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQ  283 (375)
Q Consensus       206 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  283 (375)
                      ||++........ .......++..|+|||.+.+..++.++|+|||||++|||++ |..||.......      .      
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~------~------  230 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ------V------  230 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH------H------
Confidence            999875432221 11122235678999999988889999999999999999998 788886432110      0      


Q ss_pred             hhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       284 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                         ...+....    .......++..+.+++.+||+.+|++|||+.++++.|++....
T Consensus       231 ---~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~  281 (288)
T cd05061         231 ---LKFVMDGG----YLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHP  281 (288)
T ss_pred             ---HHHHHcCC----CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCC
Confidence               00111110    0111112346799999999999999999999999999986543

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.8e-41  Score=313.93  Aligned_cols=265  Identities=23%  Similarity=0.329  Sum_probs=197.2

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----  130 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  130 (375)
                      ...++|++.+.||+|+||.||++... +|..||+|++...  .......+.+|+.+++.++||||+++++++....    
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   97 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE   97 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence            34578999999999999999999654 6899999998643  2334566789999999999999999999765432    


Q ss_pred             -ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          131 -RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       131 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                       ..+++||||++ ++|...+.      ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        98 ~~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a  170 (359)
T cd07876          98 FQDVYLVMELMD-ANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  170 (359)
T ss_pred             cceeEEEEeCCC-cCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCc
Confidence             35799999996 45666652      23788899999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh-----
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN-----  284 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-----  284 (375)
                      .......  ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.........   .........     
T Consensus       171 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~---~~~~~~~~~~~~~~  245 (359)
T cd07876         171 RTACTNF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQW---NKVIEQLGTPSAEF  245 (359)
T ss_pred             cccccCc--cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCcHHH
Confidence            7543221  123346899999999999999999999999999999999999999755321110   000000000     


Q ss_pred             -----hHHHHHHhhhcCCCC---------------ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          285 -----KALHELVDQTLGYES---------------DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       285 -----~~~~~~~~~~l~~~~---------------~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                           ...............               ..........+.+++.+||..||++|||+.|+++.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence                 000111111000000               00001123568899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=5.7e-41  Score=307.64  Aligned_cols=264  Identities=24%  Similarity=0.379  Sum_probs=204.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC--------CCCEEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecC
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ--------DGRAVAVKRLYENN-YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRH  129 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  129 (375)
                      ..+|++.+.||+|+||.||+|...        .+..||+|.+.... ......+.+|+.+++++ +||||+++++++.. 
T Consensus        11 ~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-   89 (334)
T cd05100          11 RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-   89 (334)
T ss_pred             HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc-
Confidence            356899999999999999999542        12368999876542 34456788999999999 79999999997766 


Q ss_pred             CceeEEEEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          130 SRELLLVYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      ....+++|||+++++|.+++.....            ....+++..+..++.|++.||.|||++|++|+||||+||+++.
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~  169 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence            5678999999999999999865321            2235788899999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccccccCCCcccc-ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchh
Q 017232          198 NFCVKVADFGLSRLFPNHVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLS  275 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~  275 (375)
                      ++.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......     
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----  244 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE-----  244 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHH-----
Confidence            9999999999987654322111 122234567999999998889999999999999999998 888886432110     


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                       .. .         .+....   .......++..+.+++.+|++.+|++|||+.++++.|+++.....
T Consensus       245 -~~-~---------~~~~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~~~  298 (334)
T cd05100         245 -LF-K---------LLKEGH---RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTVTS  298 (334)
T ss_pred             -HH-H---------HHHcCC---CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhhcC
Confidence             00 0         010101   111112345678899999999999999999999999999886443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-41  Score=297.38  Aligned_cols=251  Identities=26%  Similarity=0.417  Sum_probs=199.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccc-----hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN-----YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ++|++.+.||+|++|.||++.. .+++.|++|.+....     ......+.+|+.+++.++||||+++++++.. ....+
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRD-DETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEcc-CCeEE
Confidence            4688999999999999999965 468999999875432     1234568889999999999999999997776 56899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +|+||+++++|.+++...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~  156 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAY----GALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT  156 (263)
T ss_pred             EEEEECCCCcHHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence            999999999999988533    4588899999999999999999999999999999999999999999999999875533


Q ss_pred             Cccccc--cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          215 HVTHVS--TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       215 ~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ......  ....++..|+|||.+.+..++.++||||||+++|+|++|+.||.......      ..         .....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~---------~~~~~  221 (263)
T cd06625         157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA------AI---------FKIAT  221 (263)
T ss_pred             cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH------HH---------HHHhc
Confidence            221111  23357789999999998889999999999999999999999996432110      00         00000


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ...   .......+...+.+++.+||..+|++|||+.++++.
T Consensus       222 ~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         222 QPT---NPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             cCC---CCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence            000   111112345678899999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-42  Score=324.21  Aligned_cols=259  Identities=24%  Similarity=0.411  Sum_probs=215.5

Q ss_pred             CCCCCCccCCCCcEEEEEEEeCC----CCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQD----GRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..++.+.||.|.||.||+|+++.    ...||||.++... .+...+|..|+.||-+++||||+++.|+... .+.+.||
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-s~PvMIi  708 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-SKPVMII  708 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-CceeEEE
Confidence            45677899999999999997762    4579999998764 4456789999999999999999999996655 7889999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      +|||++|+|..+|+..   .+.+++.+...++++|+.|++||.+.|+|||||...|||++.+..+|++|||+++.+.++.
T Consensus       709 TEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~  785 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  785 (996)
T ss_pred             hhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCC
Confidence            9999999999999654   3559999999999999999999999999999999999999999999999999999876554


Q ss_pred             cccccCCC--CCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          217 THVSTAPQ--GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       217 ~~~~~~~~--~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ....+...  -..+|.|||.+....++.++||||||++|||.++ |..|+-.-..                   .+++..
T Consensus       786 ~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSN-------------------QdVIka  846 (996)
T KOG0196|consen  786 EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN-------------------QDVIKA  846 (996)
T ss_pred             CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccch-------------------HHHHHH
Confidence            33333322  3458999999999999999999999999999886 8888743221                   122222


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                      ...+-..+.+.+|+..+.+|++.||+.|-.+||.+.+|+..|+++..+-.
T Consensus       847 Ie~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrnP~  896 (996)
T KOG0196|consen  847 IEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRNPN  896 (996)
T ss_pred             HHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcCch
Confidence            23333455667899999999999999999999999999999999766543

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=5.7e-41  Score=299.94  Aligned_cols=258  Identities=22%  Similarity=0.355  Sum_probs=200.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGR----AVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ++|++.+.||+|+||.||+|.+. ++.    .+++|.+.... ......+..|+..+..++||||+++++++.  +...+
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~--~~~~~   84 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP--GASLQ   84 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC--CCccE
Confidence            45888999999999999999764 344    47778775432 233456778888999999999999999764  34578


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +++||+.+|+|.+++...   ...+++..+..++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~i~e~~~~gsL~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQH---RDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEEeCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            999999999999999643   34589999999999999999999999999999999999999999999999999976533


Q ss_pred             Ccc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          215 HVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       215 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ... .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......                ..+++.
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~----------------~~~~~~  225 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE----------------VPDLLE  225 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH----------------HHHHHH
Confidence            221 11223346678999999988889999999999999999998 999986543110                011111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      ....   ......+...+.+++.+|+..+|++|||+.|+++.|..+..+.
T Consensus       226 ~~~~---~~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~~  272 (279)
T cd05111         226 KGER---LAQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARDP  272 (279)
T ss_pred             CCCc---CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhCC
Confidence            1110   0001113456788999999999999999999999999877543

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=2.6e-41  Score=307.62  Aligned_cols=242  Identities=26%  Similarity=0.386  Sum_probs=191.3

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|... ++..||+|++....   ......+..|..++..+ +||||+++++++.. ...+++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~   79 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQT-KDRLFFVMEYVN   79 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            46999999999999665 57899999987542   23345667888888888 69999999997766 668999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|...+..    ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........ ...
T Consensus        80 ~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (318)
T cd05570          80 GGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV-TTS  154 (318)
T ss_pred             CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC-ccc
Confidence            9999988843    34689999999999999999999999999999999999999999999999999864221111 122


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...+++.|+|||++.+..++.++|||||||++|+|++|+.||.......      . .        ..+......     
T Consensus       155 ~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~------~-~--------~~i~~~~~~-----  214 (318)
T cd05570         155 TFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE------L-F--------QSILEDEVR-----  214 (318)
T ss_pred             ceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHH------H-H--------HHHHcCCCC-----
Confidence            3458999999999999999999999999999999999999997443110      0 0        011111110     


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYM-----VDVLDA  334 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~-----~evl~~  334 (375)
                      .+..++..+.+++.+||..+|++||++     .++++.
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence            011245678999999999999999999     777653

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=4.5e-42  Score=313.69  Aligned_cols=242  Identities=24%  Similarity=0.330  Sum_probs=191.8

Q ss_pred             CccCCCCcEEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccC
Q 017232           67 RELGDGGFGTVYYGEL-QDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISN  142 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  142 (375)
                      +.||+|+||.||++.. .+|..||+|++....   ......+..|+.++..++||||+++++++.. ....++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEc-CCEEEEEEeCCCC
Confidence            3699999999999965 478999999986542   2334567789999999999999999987766 5689999999999


Q ss_pred             CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          143 GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       143 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      ++|..++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++.+||+|||++........ ...
T Consensus        80 ~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~-~~~  154 (325)
T cd05594          80 GELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA-TMK  154 (325)
T ss_pred             CcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc-ccc
Confidence            999988843    3458999999999999999999997 7999999999999999999999999999864322211 122


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||.......      . .        ..+.......    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~------~-~--------~~i~~~~~~~----  215 (325)
T cd05594         155 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------L-F--------ELILMEEIRF----  215 (325)
T ss_pred             cccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH------H-H--------HHHhcCCCCC----
Confidence            3468999999999998899999999999999999999999996443110      0 0        0011011110    


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLDA  334 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~~  334 (375)
                       +...+..+.+++.+||+.||++|+     ++.++++.
T Consensus       216 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         216 -PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence             112345788999999999999997     89998754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.4e-41  Score=304.07  Aligned_cols=265  Identities=24%  Similarity=0.359  Sum_probs=200.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-----------------CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-----------------DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS  121 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-----------------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~  121 (375)
                      .++|++.+.||+|+||.||++...                 ++..+|+|.+... .......+.+|+.+++.++|+||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~   83 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIR   83 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcce
Confidence            356999999999999999998532                 2346899988654 3334567899999999999999999


Q ss_pred             EeeeeecCCceeEEEEecccCCChhHhhccCCCC-------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEE
Q 017232          122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAK-------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNIL  194 (375)
Q Consensus       122 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nil  194 (375)
                      +++++.. ....++||||+.+++|.+++......       ...+++..++.++.|++.||+|||+.|++|+||||+||+
T Consensus        84 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          84 LLAVCIT-SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEec-CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            9997766 56789999999999999998654321       234778899999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeeccccccCCCcccc-ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh--CCCCccccccccc
Q 017232          195 LDNNFCVKVADFGLSRLFPNHVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS--SMPAVDITRHRHE  271 (375)
Q Consensus       195 l~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~p~~~~~~~~~  271 (375)
                      ++.++.++|+|||++..+....... ......+..|++||...+..++.++|||||||++|||++  |..||....... 
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~-  241 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ-  241 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH-
Confidence            9999999999999987653322111 112234678999998888889999999999999999998  667775432111 


Q ss_pred             cchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          272 INLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                           ...      ...............+....++..+.+++.+||+.+|++||++.+|++.|++
T Consensus       242 -----~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         242 -----VIE------NTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             -----HHH------HHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence                 000      0011111100000011112245679999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=1.1e-41  Score=310.31  Aligned_cols=237  Identities=28%  Similarity=0.398  Sum_probs=187.7

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|..+ +++.||+|++....   ......+..|..++..+ +||||+++++++.. ...+++||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~-~~~~~iv~Ey~~   79 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQT-PDRLFFVMEFVN   79 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEc-CCEEEEEEcCCC
Confidence            36999999999999765 68899999986542   23345667888888876 69999999997766 678999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|.+++..    ...+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++........ ...
T Consensus        80 ~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~-~~~  154 (320)
T cd05590          80 GGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK-TTS  154 (320)
T ss_pred             CchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCC-ccc
Confidence            9999988853    34589999999999999999999999999999999999999999999999999875322111 123


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      . ..        .+......     
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~------~-~~--------~i~~~~~~-----  214 (320)
T cd05590         155 TFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDD------L-FE--------AILNDEVV-----  214 (320)
T ss_pred             ccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------H-HH--------HHhcCCCC-----
Confidence            3468999999999998899999999999999999999999997543211      0 01        11111000     


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMV  329 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~  329 (375)
                      .+...+..+.+++.+||+.||.+||++.
T Consensus       215 ~~~~~~~~~~~li~~~L~~dP~~R~~~~  242 (320)
T cd05590         215 YPTWLSQDAVDILKAFMTKNPTMRLGSL  242 (320)
T ss_pred             CCCCCCHHHHHHHHHHcccCHHHCCCCC
Confidence            0112346788999999999999999983

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.1e-41  Score=310.50  Aligned_cols=242  Identities=25%  Similarity=0.361  Sum_probs=191.0

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|..++..+ +||||+++++++.. ....++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~-~~~~~lv~E~~~   79 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQT-KDRLFFVMEYVN   79 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEc-CCeEEEEEeCCC
Confidence            36999999999999665 57899999986542   23345567888888876 79999999997776 567999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|...+..    ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ ...
T Consensus        80 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~-~~~  154 (321)
T cd05591          80 GGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV-TTT  154 (321)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc-ccc
Confidence            9999988853    34588999999999999999999999999999999999999999999999999875322221 123


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...|++.|+|||++.+..++.++|||||||++|+|++|+.||.......      .         ...+......  .  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~------~---------~~~i~~~~~~--~--  215 (321)
T cd05591         155 TFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD------L---------FESILHDDVL--Y--  215 (321)
T ss_pred             ccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH------H---------HHHHHcCCCC--C--
Confidence            3468999999999998899999999999999999999999997543211      0         0111111100  0  


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCC-------CHHHHHHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRP-------YMVDVLDA  334 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rp-------t~~evl~~  334 (375)
                       +..++..+.+++.+||..+|++||       ++.++++.
T Consensus       216 -p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         216 -PVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             -CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence             011346788999999999999999       77777654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=8.5e-42  Score=318.73  Aligned_cols=250  Identities=24%  Similarity=0.317  Sum_probs=192.9

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .|+.++.||+|+||.||+|... +++.||+|++....   ......+.+|+.+++.++||||+++++++.. ...+++||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~-~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEe-CCEEEEEE
Confidence            5888999999999999999654 68899999986542   2334578889999999999999999998776 67899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc-
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  216 (375)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..+.... 
T Consensus        81 E~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~  156 (382)
T cd05625          81 DYIPGGDMMSLLIRM----GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD  156 (382)
T ss_pred             eCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence            999999999998532    458899999999999999999999999999999999999999999999999975321000 


Q ss_pred             ---------------------------------------------cccccCCCCCccccCcccccccCCCCchhHHHHHH
Q 017232          217 ---------------------------------------------THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGV  251 (375)
Q Consensus       217 ---------------------------------------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~  251 (375)
                                                                   ........||+.|+|||++.+..++.++|||||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv  236 (382)
T cd05625         157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV  236 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence                                                         00011236899999999999889999999999999


Q ss_pred             HHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC---H
Q 017232          252 VLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY---M  328 (375)
Q Consensus       252 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---~  328 (375)
                      ++|||++|++||.......      .         ...+........ .+.....+..+.+++.+|+ .+|.+|++   +
T Consensus       237 il~elltG~~Pf~~~~~~~------~---------~~~i~~~~~~~~-~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~  299 (382)
T cd05625         237 ILYEMLVGQPPFLAQTPLE------T---------QMKVINWQTSLH-IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGA  299 (382)
T ss_pred             HHHHHHhCCCCCCCCCHHH------H---------HHHHHccCCCcC-CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCH
Confidence            9999999999997543211      0         000110000000 0111123456778888876 49999997   7


Q ss_pred             HHHHH
Q 017232          329 VDVLD  333 (375)
Q Consensus       329 ~evl~  333 (375)
                      .++++
T Consensus       300 ~ei~~  304 (382)
T cd05625         300 DEIKA  304 (382)
T ss_pred             HHHhc
Confidence            77665

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5e-41  Score=300.03  Aligned_cols=258  Identities=26%  Similarity=0.383  Sum_probs=199.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD------GRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      .++|.+.+.||+|++|.||+|...+      +..|++|.+.... ......+.+|+.+++.++|+||+++++++.. ...
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-RLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCC
Confidence            4568899999999999999996653      5678999876443 3334568899999999999999999997766 456


Q ss_pred             eEEEEecccCCChhHhhccCCC---CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC---cEEEeee
Q 017232          133 LLLVYEFISNGTVADHLHGERA---KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADF  206 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~---~~kl~Df  206 (375)
                      .++||||+.+++|.+++...+.   ....+++..+..++.||+.||.|||+++++|+||+|+||+++.++   .+||+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df  163 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF  163 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence            7999999999999999865432   123588999999999999999999999999999999999998655   5999999


Q ss_pred             ccccccCCCcccc-ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhh
Q 017232          207 GLSRLFPNHVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       207 g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      |++.......... ......+..|+|||++.+..++.++|||||||++|+|++ |..||.......              
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--------------  229 (277)
T cd05036         164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--------------  229 (277)
T ss_pred             ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--------------
Confidence            9998653222111 112223568999999988889999999999999999997 999987543211              


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                        ....+........   +..++..+.+++.+|++.+|++||++.+|++.|..
T Consensus       230 --~~~~~~~~~~~~~---~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~~  277 (277)
T cd05036         230 --VMEFVTGGGRLDP---PKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQY  277 (277)
T ss_pred             --HHHHHHcCCcCCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhhC
Confidence              0111111111111   12345678899999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4e-41  Score=297.11  Aligned_cols=251  Identities=29%  Similarity=0.507  Sum_probs=199.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      .+|++.+.||+|+||.||+|...++..+++|.+...... ...+.+|+++++.++|||++++++++.. ....++||||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~-~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS-EEDFIEEAQVMMKLSHPKLVQLYGVCTE-RSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC-HHHHHHHHHHHHhCCCCCeeeEEEEEcc-CCceEEEEEcC
Confidence            357888999999999999998777889999988654332 3568889999999999999999997665 56789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      .+++|.+++...   ...+++..++.++.|++.||.+||+.+++|+||+|+||+++.++.++|+|||++...........
T Consensus        82 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  158 (256)
T cd05112          82 EHGCLSDYLRAQ---RGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSS  158 (256)
T ss_pred             CCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCccccc
Confidence            999999998543   24578999999999999999999999999999999999999999999999999876543322222


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      . ...        +. .......
T Consensus       159 ~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~-~~~--------~~-~~~~~~~  222 (256)
T cd05112         159 TGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE------V-VET--------IN-AGFRLYK  222 (256)
T ss_pred             CCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH------H-HHH--------Hh-CCCCCCC
Confidence            22335678999999988889999999999999999998 999987443110      0 000        00 0000000


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL  335 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L  335 (375)
                         +...+..+.+++.+||+.+|++|||+.++++.|
T Consensus       223 ---~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         223 ---PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             ---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence               011346799999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1.5e-41  Score=310.13  Aligned_cols=241  Identities=26%  Similarity=0.366  Sum_probs=190.0

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCC-CeEEEeeeeecCCceeEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHK-NLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~lv  136 (375)
                      +|++.+.||+|+||.||+|... +++.||+|++....   ....+.+..|..++..++|+ +|+++++++.. ...+++|
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLYFV   79 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEc-CCEEEEE
Confidence            4788999999999999999665 57899999986542   23445677899999999765 57778876665 6679999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++..    ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~  155 (324)
T cd05587          80 MEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG  155 (324)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence            999999999998853    3458899999999999999999999999999999999999999999999999986432111


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      . ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.......               ....+......
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---------------~~~~i~~~~~~  219 (324)
T cd05587         156 K-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---------------LFQSIMEHNVS  219 (324)
T ss_pred             C-ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---------------HHHHHHcCCCC
Confidence            1 1223468999999999999899999999999999999999999997543110               01111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYM  328 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  328 (375)
                        .   +...+..+.+++.+||..+|.+|++.
T Consensus       220 --~---~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         220 --Y---PKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             --C---CCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence              0   11234578899999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.3e-42  Score=283.12  Aligned_cols=255  Identities=24%  Similarity=0.366  Sum_probs=205.0

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEE-eCCCCEEEEEEeccc-------c-hhhHHHHHHHHHHHHhc-CCCCeEEEeeee
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYEN-------N-YKRVEQFMNEVDILARL-RHKNLVSLYGCT  126 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-------~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~  126 (375)
                      ...-++|...+.||+|..++|-+.. ..+|..+|+|++...       + ..-.+.-.+|+.+|+++ .||+|+.+.+.+
T Consensus        13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y   92 (411)
T KOG0599|consen   13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY   92 (411)
T ss_pred             hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence            3445678888999999999998884 447888999987422       1 12234567899999998 599999999988


Q ss_pred             ecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeee
Q 017232          127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADF  206 (375)
Q Consensus       127 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Df  206 (375)
                      +. +..+++|+|.|+.|.|.+++.    ..-+++++....|+.|+++|++|||.++||||||||+|||++++.+++|+||
T Consensus        93 es-~sF~FlVFdl~prGELFDyLt----s~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDF  167 (411)
T KOG0599|consen   93 ES-DAFVFLVFDLMPRGELFDYLT----SKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDF  167 (411)
T ss_pred             cC-cchhhhhhhhcccchHHHHhh----hheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEecc
Confidence            77 678999999999999999995    3456999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCccccccCCCCCccccCccccccc------CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHH
Q 017232          207 GLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY------QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       207 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      |+++.+.....  ....+|||+|+|||.+.+.      .|+...|+|++|+|+|.|+.|.+||-....       ....+
T Consensus       168 GFa~~l~~Gek--LrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ-------mlMLR  238 (411)
T KOG0599|consen  168 GFACQLEPGEK--LRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ-------MLMLR  238 (411)
T ss_pred             ceeeccCCchh--HHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH-------HHHHH
Confidence            99998765543  3456799999999987642      477889999999999999999999953321       01111


Q ss_pred             HhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          281 KIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .        ++..... ...+.-.+.+....+||.+||+.||.+|.|++|++..
T Consensus       239 ~--------ImeGkyq-F~speWadis~~~KdLIsrlLqVdp~~Ritake~LaH  283 (411)
T KOG0599|consen  239 M--------IMEGKYQ-FRSPEWADISATVKDLISRLLQVDPTKRITAKEALAH  283 (411)
T ss_pred             H--------HHhcccc-cCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcC
Confidence            1        1111111 2234556677889999999999999999999999874

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=8.8e-41  Score=295.04  Aligned_cols=251  Identities=25%  Similarity=0.406  Sum_probs=201.0

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|++.+.||.|++|.||++... +++.|++|++...  .....+.+.+|+.+++.++|+|++++++.+......++++||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e   80 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG   80 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence            4888999999999999999654 5789999998643  233456688899999999999999999876655667899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++...  ....+++.+++.++.+++.|+.+||+.|++|+||+|+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~-  157 (257)
T cd08223          81 FCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD-  157 (257)
T ss_pred             ccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCC-
Confidence            99999999998643  234689999999999999999999999999999999999999999999999999876543222 


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||......      ...         ..+....    
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~------~~~---------~~~~~~~----  218 (257)
T cd08223         158 MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMN------SLV---------YRIIEGK----  218 (257)
T ss_pred             ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH------HHH---------HHHHhcC----
Confidence            223345788999999999888999999999999999999999998743211      000         0011111    


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ........+..+.+++.+|++.+|++|||+.++++.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         219 LPPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             CCCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            111112345679999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-42  Score=313.99  Aligned_cols=263  Identities=26%  Similarity=0.422  Sum_probs=223.2

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC---CC--CEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ---DG--RAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~---~~--~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      .......++||.|-||.||+|...   .|  -.||||..+.+ ..+..+.|..|..+|+.++||||++++|++..  ...
T Consensus       388 Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e--~P~  465 (974)
T KOG4257|consen  388 RELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE--QPM  465 (974)
T ss_pred             hhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec--cce
Confidence            344556788999999999999543   23  35899988774 55667889999999999999999999998875  468


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      +||||.++.|.|..++....   ..++......++.||..||.|||+..+|||||...|||+.....+||+|||+++.+.
T Consensus       466 WivmEL~~~GELr~yLq~nk---~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~e  542 (974)
T KOG4257|consen  466 WIVMELAPLGELREYLQQNK---DSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLE  542 (974)
T ss_pred             eEEEecccchhHHHHHHhcc---ccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhcc
Confidence            99999999999999996543   458888889999999999999999999999999999999999999999999999988


Q ss_pred             CCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          214 NHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       214 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .+..+..+...-...|||||-+....++.++|||.|||++||++. |..||......+                   ++.
T Consensus       543 d~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD-------------------VI~  603 (974)
T KOG4257|consen  543 DDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD-------------------VIG  603 (974)
T ss_pred             ccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc-------------------eEE
Confidence            777766666566779999999999999999999999999999985 999997655332                   222


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCCCC
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDK  346 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~~~  346 (375)
                      ....++..+.+++|+..+..|+.+||..+|.+||.+.++...|.++........
T Consensus       604 ~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~qeek~~~  657 (974)
T KOG4257|consen  604 HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQEEKINS  657 (974)
T ss_pred             EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHHHhhhhh
Confidence            223456667778899999999999999999999999999999999887544433

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.3e-41  Score=310.93  Aligned_cols=243  Identities=23%  Similarity=0.360  Sum_probs=188.2

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|... +++.||+|++...   .......+..|+.++..+ +||||+++++++.. ....++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~E~~~   79 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFFVIEYVN   79 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEe-CCEEEEEEeCCC
Confidence            46999999999999665 6789999998654   233445677888888777 79999999997766 678999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|..++..    ...+++..+..++.|++.||.|||++|++||||||+||+++.++.+||+|||++........ ...
T Consensus        80 ~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~-~~~  154 (329)
T cd05618          80 GGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD-TTS  154 (329)
T ss_pred             CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC-ccc
Confidence            9999888743    34689999999999999999999999999999999999999999999999999875322111 122


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCcccccccccc--chhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEI--NLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||.........  ....+....        +......   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~--------i~~~~~~---  223 (329)
T cd05618         155 TFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQV--------ILEKQIR---  223 (329)
T ss_pred             cccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHH--------HhcCCCC---
Confidence            346899999999999999999999999999999999999999643221111  001111111        1111111   


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYM  328 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  328 (375)
                        .+...+..+.+++.+||+.+|++||++
T Consensus       224 --~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         224 --IPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             --CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence              111234568899999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=4.8e-41  Score=303.02  Aligned_cols=265  Identities=26%  Similarity=0.393  Sum_probs=201.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC-----------------CCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD-----------------GRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVS  121 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~-----------------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~  121 (375)
                      .++|++.+.||+|+||.||+|....                 +..||+|.+.... ....+.+.+|+.+++.++|||+++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            3578999999999999999986542                 2458999886553 345567889999999999999999


Q ss_pred             EeeeeecCCceeEEEEecccCCChhHhhccCCC-------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEE
Q 017232          122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERA-------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNIL  194 (375)
Q Consensus       122 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nil  194 (375)
                      +++++.. +...+++|||+.+++|.+++.....       ....+++..++.++.|++.||.|||+.|++|+||||+||+
T Consensus        84 ~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil  162 (296)
T cd05051          84 LLGVCTV-DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEec-CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence            9997766 5678999999999999999865431       1236899999999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh--CCCCccccccccc
Q 017232          195 LDNNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS--SMPAVDITRHRHE  271 (375)
Q Consensus       195 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~p~~~~~~~~~  271 (375)
                      ++.++.++|+|||++........ .......++..|+|||.+.+..++.++|||||||++|+|++  |..||....... 
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~-  241 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQ-  241 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHH-
Confidence            99999999999999875433221 11223346778999999888889999999999999999998  667775432111 


Q ss_pred             cchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          272 INLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                            .....     .............+....++.++.+++.+||+.+|++|||+.+|++.|++
T Consensus       242 ------~~~~~-----~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~  296 (296)
T cd05051         242 ------VIENA-----GHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR  296 (296)
T ss_pred             ------HHHHH-----HhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence                  00000     00000000000001112234679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.9e-41  Score=307.03  Aligned_cols=240  Identities=28%  Similarity=0.392  Sum_probs=187.9

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|..+ +|+.||+|.+....   ......+..|..++... +||||+++++++.. ...+++||||+.
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv~E~~~   79 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQT-KEHLFFVMEFLN   79 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEe-CCEEEEEECCCC
Confidence            46999999999999765 68899999986542   12344566777777754 89999999997766 678999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|..++..    ...+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||++...... .....
T Consensus        80 ~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~  154 (316)
T cd05620          80 GGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRAS  154 (316)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCcee
Confidence            9999998853    345889999999999999999999999999999999999999999999999998643211 11123


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||.......       ....+.        ....     .
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~-------~~~~~~--------~~~~-----~  214 (316)
T cd05620         155 TFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDE-------LFESIR--------VDTP-----H  214 (316)
T ss_pred             ccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH-------HHHHHH--------hCCC-----C
Confidence            4468999999999999899999999999999999999999997543110       001100        0000     0


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMV-DVL  332 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~-evl  332 (375)
                      .+..+...+.+++.+||+.||++||++. +++
T Consensus       215 ~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         215 YPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence            0112345788999999999999999985 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.7e-41  Score=295.17  Aligned_cols=247  Identities=24%  Similarity=0.398  Sum_probs=194.4

Q ss_pred             ccCCCCcEEEEEEEeC---CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCC
Q 017232           68 ELGDGGFGTVYYGELQ---DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG  143 (375)
Q Consensus        68 ~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~  143 (375)
                      .||+|+||.||+|.+.   ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++..  ...++||||++++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~--~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA--EALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC--CCeEEEEEeCCCC
Confidence            3899999999999654   35579999886553 2334668899999999999999999997653  4679999999999


Q ss_pred             ChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc--cc
Q 017232          144 TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV--ST  221 (375)
Q Consensus       144 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~  221 (375)
                      +|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++..........  ..
T Consensus        80 ~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05115          80 PLNKFLSGK---KDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS  156 (257)
T ss_pred             CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccC
Confidence            999998532   3468999999999999999999999999999999999999999999999999987554332211  11


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCC
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD  300 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  300 (375)
                      ...++..|+|||.+.+..++.++||||||+++|+|++ |..||.......                ....+......   
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~~~~~~---  217 (257)
T cd05115         157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE----------------VMSFIEQGKRL---  217 (257)
T ss_pred             CCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH----------------HHHHHHCCCCC---
Confidence            2223578999999988889999999999999999996 999997443110                11111111111   


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          301 NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                      .....++.++.+++.+||..+|++||++.+|++.|+.+
T Consensus       218 ~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         218 DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence            11123456788999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=5.7e-41  Score=302.46  Aligned_cols=250  Identities=23%  Similarity=0.363  Sum_probs=201.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .+|++.+.||+|++|.||+|.. .++..|++|.+..........+.+|+.+++.++|+|++++++.+.. +...++||||
T Consensus        20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-~~~~~lv~e~   98 (296)
T cd06654          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEY   98 (296)
T ss_pred             cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-CCEEEEeecc
Confidence            5789999999999999999965 4688999999876655556778899999999999999999997765 5689999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++++|.+++..     ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus        99 ~~~~~L~~~~~~-----~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~-~  172 (296)
T cd06654          99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (296)
T ss_pred             cCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccc-c
Confidence            999999999842     3478899999999999999999999999999999999999999999999999875432221 1


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      .....+++.|+|||.+.+..++.++|||||||++|+|++|+.||........     +. ..        ....   ...
T Consensus       173 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-----~~-~~--------~~~~---~~~  235 (296)
T cd06654         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-----LY-LI--------ATNG---TPE  235 (296)
T ss_pred             cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-----HH-HH--------hcCC---CCC
Confidence            2233588899999999888889999999999999999999999965432110     00 00        0000   000


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ..........+.+++.+||..+|++||++.++++.
T Consensus       236 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence            01112345678899999999999999999999973

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=8.4e-41  Score=298.92  Aligned_cols=258  Identities=24%  Similarity=0.390  Sum_probs=203.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCC----EEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGR----AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ++|++.+.||+|+||+||+|.+. ++.    .||+|.+... .......+.+|+.++..++||||+++++++..  ...+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~   84 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT--STVQ   84 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC--CCcE
Confidence            56888999999999999999653 444    4899988654 33345678899999999999999999997764  3468


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +++||+++|+|.+++...   ...+++..+..++.|++.||.|||++|++|+||||+||++++++.+||+|||++.....
T Consensus        85 l~~~~~~~g~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~  161 (279)
T cd05109          85 LVTQLMPYGCLLDYVREN---KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDI  161 (279)
T ss_pred             EEEEcCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccc
Confidence            999999999999998542   34589999999999999999999999999999999999999999999999999986643


Q ss_pred             Ccccc-ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          215 HVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       215 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ..... .....++..|+|||...+..++.++|||||||++|||++ |.+||+......                ....+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~  225 (279)
T cd05109         162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE----------------IPDLLE  225 (279)
T ss_pred             ccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH----------------HHHHHH
Confidence            22211 112235678999999988889999999999999999998 899986433110                111111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      ...   ..+....++..+.+++.+||..+|++||++.++++.|+.+..+.
T Consensus       226 ~~~---~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~~  272 (279)
T cd05109         226 KGE---RLPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARDP  272 (279)
T ss_pred             CCC---cCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcCC
Confidence            111   11111234567889999999999999999999999998876654

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4.7e-41  Score=313.31  Aligned_cols=264  Identities=23%  Similarity=0.372  Sum_probs=204.3

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcC-CCCeEEEeeeeec
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENN-YKRVEQFMNEVDILARLR-HKNLVSLYGCTSR  128 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  128 (375)
                      +...++|.+.+.||+|+||.||+|.+.      .+..||+|++.... ....+.+.+|+.++..+. ||||+++++++..
T Consensus        33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~  112 (401)
T cd05107          33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK  112 (401)
T ss_pred             eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc
Confidence            334456888999999999999999753      34679999997553 333457889999999997 9999999998776


Q ss_pred             CCceeEEEEecccCCChhHhhccCCC------------------------------------------------------
Q 017232          129 HSRELLLVYEFISNGTVADHLHGERA------------------------------------------------------  154 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------------------------------------  154 (375)
                       ....++||||+++|+|.++++....                                                      
T Consensus       113 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (401)
T cd05107         113 -GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP  191 (401)
T ss_pred             -CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence             5679999999999999999865321                                                      


Q ss_pred             ----------------------------------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEE
Q 017232          155 ----------------------------------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNIL  194 (375)
Q Consensus       155 ----------------------------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nil  194 (375)
                                                              ....+++..+..++.|++.||.|||+.+++||||||+|||
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL  271 (401)
T cd05107         192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL  271 (401)
T ss_pred             hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence                                                    1124677788999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCcccccccccc
Q 017232          195 LDNNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEI  272 (375)
Q Consensus       195 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~  272 (375)
                      ++.++.++|+|||++........ .......++..|+|||.+.+..++.++||||||+++|||++ |..||.......  
T Consensus       272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~--  349 (401)
T cd05107         272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNE--  349 (401)
T ss_pred             EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchH--
Confidence            99999999999999876432221 11122346788999999988889999999999999999998 888886432111  


Q ss_pred             chhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          273 NLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                          .         ....+.......   .+..++..+.+++.+|+..+|.+||++++|++.|+++.
T Consensus       350 ----~---------~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         350 ----Q---------FYNAIKRGYRMA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             ----H---------HHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence                0         011111111101   11123567999999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=9.3e-41  Score=295.34  Aligned_cols=250  Identities=29%  Similarity=0.471  Sum_probs=201.5

Q ss_pred             CccCCCCcEEEEEEEeCC----CCEEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQD----GRAVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|....    +..|++|.+...... ....+.+|+.+++.++|+|++++++++.. ....++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-EEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-CCceEEEEEecc
Confidence            469999999999996653    788999998765433 36788899999999999999999997766 678999999999


Q ss_pred             CCChhHhhccCCCC-----CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          142 NGTVADHLHGERAK-----PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       142 ~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      +++|.+++......     ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            99999999654221     3679999999999999999999999999999999999999999999999999998765432


Q ss_pred             c-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          217 T-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       217 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      . .......++..|+|||.+.+..++.++||||+|+++|+|++ |..||.......      . ...+        ..  
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~-~~~~--------~~--  222 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEE------V-LEYL--------RK--  222 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHH------H-HHHH--------Hc--
Confidence            1 11233457889999999988889999999999999999999 699997552110      0 0010        00  


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                        .........++..+.+++.+||+.+|++|||+.++++.|+
T Consensus       223 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         223 --GYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             --CCCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence              1111112234678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=5.7e-41  Score=298.07  Aligned_cols=255  Identities=25%  Similarity=0.443  Sum_probs=201.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-C---CCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-D---GRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .+|++.+.||+|+||.||+|... +   +..+++|.+.... ......+.+|+.+++.++||||+++++++.. +...++
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   82 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SKPVMI   82 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CCccEE
Confidence            46888999999999999999653 2   3478999886543 3345678899999999999999999997765 567899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++...   ...+++.++..++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          83 VTEYMENGSLDAFLRKH---DGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999543   245899999999999999999999999999999999999999999999999999866443


Q ss_pred             ccccc--cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          216 VTHVS--TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       216 ~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .....  ....++..|+|||.+.+..++.++|+||||+++|++++ |..||.......      . ...+..        
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~------~-~~~~~~--------  224 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD------V-IKAIEE--------  224 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH------H-HHHHhC--------
Confidence            22111  11223568999999998889999999999999999886 999986543211      0 000000        


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                       ...   .+....++..+.+++.+|++.+|++||++.++++.|+++
T Consensus       225 -~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 -GYR---LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -CCc---CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence             000   011122456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=5e-41  Score=330.93  Aligned_cols=267  Identities=22%  Similarity=0.313  Sum_probs=205.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.++||+|+||.||+|... +|+.||+|++...   .....+.+.+|+.+++.++||||+++++++.. ++..++|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d-~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSD-GDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEee-CCEEEEE
Confidence            57899999999999999999655 6899999998653   22334578899999999999999999997766 5678999


Q ss_pred             EecccCCChhHhhccCCCC-------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          137 YEFISNGTVADHLHGERAK-------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~-------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      |||++|++|.+++......       ...+++..++.++.||+.||+|||+.||+||||||+||+++.++.++|+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999998643211       234567788899999999999999999999999999999999999999999999


Q ss_pred             cccCCCc-----------------cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCcccccccccc
Q 017232          210 RLFPNHV-----------------THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEI  272 (375)
Q Consensus       210 ~~~~~~~-----------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~  272 (375)
                      .......                 ........||+.|+|||.+.+..++.++|||||||++|||+||..||.........
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            7652110                 00112246899999999999989999999999999999999999999653211100


Q ss_pred             chhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhhhcCCCCC
Q 017232          273 NLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLR-PYMVDVLDALRDIESDGYDD  345 (375)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-pt~~evl~~L~~i~~~~~~~  345 (375)
                           .....        ..+. .   .......+..+.+++.+|+..+|++| ++++++++.|+........|
T Consensus       241 -----~~~~i--------~~P~-~---~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq~~p~w  297 (932)
T PRK13184        241 -----YRDVI--------LSPI-E---VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQGSPEW  297 (932)
T ss_pred             -----hhhhc--------cChh-h---ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcCccc
Confidence                 00000        0000 0   00012345678899999999999999 56788888888876654433

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.9e-41  Score=296.40  Aligned_cols=250  Identities=24%  Similarity=0.365  Sum_probs=200.7

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      +|++.+.||.|+||.||++... ++..+++|.+... .....+.+.+|+.+++.++|+|++++++.+.. +..++++|||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA-DGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE-CCEEEEEEee
Confidence            4788899999999999999655 6889999988543 33445678889999999999999999997766 6789999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++++|.+++...  ....+++..++.++.|++.||.+||++|++|+||+|+||+++.++.++++|||.+........ .
T Consensus        80 ~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~-~  156 (255)
T cd08219          80 CDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA-Y  156 (255)
T ss_pred             CCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc-c
Confidence            9999999988543  334578999999999999999999999999999999999999999999999999876543222 1


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      .....+++.|+|||++.+..++.++|+||||+++|+|++|..||.......      ..         ..+.    ....
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~---------~~~~----~~~~  217 (255)
T cd08219         157 ACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN------LI---------LKVC----QGSY  217 (255)
T ss_pred             cccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH------HH---------HHHh----cCCC
Confidence            223458889999999998889999999999999999999999997432110      00         0000    0111


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .+....++..+.+++.+||+.+|++||++.+++..
T Consensus       218 ~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence            11112345678899999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=8.3e-41  Score=303.99  Aligned_cols=263  Identities=23%  Similarity=0.377  Sum_probs=204.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC--------CCCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCC
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ--------DGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHS  130 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  130 (375)
                      ++|.+.+.||+|+||.||+|...        ....+|+|.+... .......+.+|+.+++.+ +||||+++++++.. .
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~   90 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQ-E   90 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEcc-C
Confidence            56888999999999999999642        2456899988654 234456788999999999 69999999997765 5


Q ss_pred             ceeEEEEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC
Q 017232          131 RELLLVYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN  198 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~  198 (375)
                      ...+++|||+.+++|.+++.....            ....+++..+..++.|++.||.|||++|++|+||||+||+++.+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~  170 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED  170 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC
Confidence            678999999999999999965421            22458889999999999999999999999999999999999999


Q ss_pred             CcEEEeeeccccccCCCcccc-ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhH
Q 017232          199 FCVKVADFGLSRLFPNHVTHV-STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSN  276 (375)
Q Consensus       199 ~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~  276 (375)
                      +.+||+|||++.......... .....++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      
T Consensus       171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~------  244 (314)
T cd05099         171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEE------  244 (314)
T ss_pred             CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHH------
Confidence            999999999997654322111 112224467999999988889999999999999999999 888886432110      


Q ss_pred             HHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          277 LAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                       ....+.         ...   .......++..+.+++.+||..+|++|||+.++++.|.++.....
T Consensus       245 -~~~~~~---------~~~---~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~  298 (314)
T cd05099         245 -LFKLLR---------EGH---RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVS  298 (314)
T ss_pred             -HHHHHH---------cCC---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhc
Confidence             011111         100   001112344578899999999999999999999999999876543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1e-40  Score=295.49  Aligned_cols=252  Identities=28%  Similarity=0.436  Sum_probs=194.0

Q ss_pred             CccCCCCcEEEEEEEeC----CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ----DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|...    ....+|+|.+... .....+.+.+|+.+++.++|||++++++++...+...+++|||+.
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~   80 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK   80 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence            46899999999999653    2357899988543 344567788999999999999999999976655666899999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc---c
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT---H  218 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~  218 (375)
                      +++|.+++...   ....++..+..++.|++.||.|||+.+++|+||||+||+++.++.+||+|||++........   .
T Consensus        81 ~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  157 (262)
T cd05058          81 HGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVH  157 (262)
T ss_pred             CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeec
Confidence            99999998543   23467778889999999999999999999999999999999999999999999875432211   1


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |.+||......      ...             ......
T Consensus       158 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~------~~~-------------~~~~~~  218 (262)
T cd05058         158 NHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF------DIT-------------VYLLQG  218 (262)
T ss_pred             ccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH------HHH-------------HHHhcC
Confidence            1112345678999999988889999999999999999999 46666532210      000             000111


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      ........++..+.+++.+||..+|++||++.+|++.|+++..
T Consensus       219 ~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         219 RRLLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CCCCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            1111112234678899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=303.43  Aligned_cols=265  Identities=24%  Similarity=0.366  Sum_probs=198.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC---------------CCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD---------------GRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLY  123 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~---------------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~  123 (375)
                      .++|++.+.||+|+||.||++...+               ...||+|.+... .......+.+|+++++.++|+|+++++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   83 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLL   83 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEE
Confidence            3579999999999999999986532               235899988654 333456789999999999999999999


Q ss_pred             eeeecCCceeEEEEecccCCChhHhhccCCC--------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe
Q 017232          124 GCTSRHSRELLLVYEFISNGTVADHLHGERA--------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL  195 (375)
Q Consensus       124 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill  195 (375)
                      +++.. ....++||||+.+++|.+++.....        ....+++..++.++.|++.||.|||+.|++|+||||+||++
T Consensus        84 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill  162 (295)
T cd05097          84 GVCVS-DDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLV  162 (295)
T ss_pred             EEEcC-CCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEE
Confidence            97765 6678999999999999999854321        11246888999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh--CCCCcccccccccc
Q 017232          196 DNNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEI  272 (375)
Q Consensus       196 ~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~p~~~~~~~~~~  272 (375)
                      +.++.+||+|||++........ .......++..|+|||.+.+..++.++||||||+++|+|++  |..||.......  
T Consensus       163 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~--  240 (295)
T cd05097         163 GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ--  240 (295)
T ss_pred             cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH--
Confidence            9999999999999875432221 11122335678999999888889999999999999999998  556765432111  


Q ss_pred             chhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          273 NLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                          ... .     ....................+..+.+++.+|++.+|++||++++|++.|.+
T Consensus       241 ----~~~-~-----~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~  295 (295)
T cd05097         241 ----VIE-N-----TGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE  295 (295)
T ss_pred             ----HHH-H-----HHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence                000 0     000000000000000011234679999999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-40  Score=294.69  Aligned_cols=248  Identities=26%  Similarity=0.410  Sum_probs=195.7

Q ss_pred             CccCCCCcEEEEEEEeC-C---CCEEEEEEecccch-hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-D---GRAVAVKRLYENNY-KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~---~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      ++||+|+||.||+|... .   +..+++|.+..... ...+.+.+|+.+++.++|+|++++++++.  ....++||||+.
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK--GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc--CCceEEEEEeCC
Confidence            46999999999999543 2   26899999875543 34567889999999999999999999765  346799999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|.+++...    ..+++..++.++.|++.||.|||..+++|+||||+||+++.++.++|+|||++............
T Consensus        79 ~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          79 LGPLLKYLKKR----REIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999999543    36899999999999999999999999999999999999999999999999998866433222111


Q ss_pred             --CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          222 --APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       222 --~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                        ...++..|+|||.+.+..++.++||||||+++|+|++ |.+||+......   .    ...         +...   .
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~---~----~~~---------~~~~---~  215 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAE---V----IAM---------LESG---E  215 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHH---H----HHH---------HHcC---C
Confidence              1123457999999998899999999999999999998 999997543110   0    000         1000   0


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      .......++..+.+++.+||..+|++||++.++++.|+++.
T Consensus       216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence            11111234567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.8e-41  Score=307.96  Aligned_cols=237  Identities=28%  Similarity=0.392  Sum_probs=184.2

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHH-HHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVD-ILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|... +++.||+|++.....   .....+..|.. +++.++||||+++++++.. ....++||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQT-AEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCEEEEEEcCCC
Confidence            36999999999999765 688999999865421   22334455554 6788999999999987765 668999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|...+..    ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.+||+|||++....... ....
T Consensus        80 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (321)
T cd05603          80 GGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE-ETTS  154 (321)
T ss_pred             CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC-Cccc
Confidence            9999888843    3458889999999999999999999999999999999999999999999999987532211 1223


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...|++.|+|||++.+..++.++|||||||++|+|++|.+||......      ..         ...+......  .  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~------~~---------~~~i~~~~~~--~--  215 (321)
T cd05603         155 TFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS------QM---------YDNILHKPLQ--L--  215 (321)
T ss_pred             cccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH------HH---------HHHHhcCCCC--C--
Confidence            346899999999999888999999999999999999999999654310      00         0111111111  0  


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMV  329 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~  329 (375)
                       +......+.+++.+||+.+|.+||++.
T Consensus       216 -~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         216 -PGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             -CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence             112345688999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-42  Score=316.41  Aligned_cols=245  Identities=24%  Similarity=0.386  Sum_probs=203.0

Q ss_pred             ccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCChh
Q 017232           68 ELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVA  146 (375)
Q Consensus        68 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~  146 (375)
                      +||+|.||+||-|+.. +...+|||.+...+....+-+..|+.+.+.|+|.|||+++|++.+ ++.+-|.||.++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~se-nGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSE-NGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCC-CCeEEEEeecCCCCcHH
Confidence            5999999999999654 567899999988887778889999999999999999999997766 56889999999999999


Q ss_pred             HhhccCCCCCCCC--ChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec-CCCcEEEeeeccccccCCCccccccCC
Q 017232          147 DHLHGERAKPGAL--PWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAP  223 (375)
Q Consensus       147 ~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~  223 (375)
                      +++..   +-+++  .+..+-.+..||++||.|||.+.|||||||.+||||+ -.|.+||+|||.++.+..-++ .....
T Consensus       661 sLLrs---kWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP-~TETF  736 (1226)
T KOG4279|consen  661 SLLRS---KWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINP-CTETF  736 (1226)
T ss_pred             HHHHh---ccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCc-ccccc
Confidence            99964   34556  6778889999999999999999999999999999996 578999999999987754333 22344


Q ss_pred             CCCccccCccccccc--CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          224 QGTPGYVDPEYHQCY--QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       224 ~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      -||..|||||++..+  .|..++|||||||++.||.||+|||-..+....                 .++.-.+-..-++
T Consensus       737 TGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-----------------AMFkVGmyKvHP~  799 (1226)
T KOG4279|consen  737 TGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-----------------AMFKVGMYKVHPP  799 (1226)
T ss_pred             ccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-----------------hhhhhcceecCCC
Confidence            599999999998764  588999999999999999999999965543221                 1111112122344


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .+.+.+.+...+|.+|+.++|.+||++.++++-
T Consensus       800 iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  800 IPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             CcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence            556788899999999999999999999999863

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=3.1e-41  Score=306.69  Aligned_cols=241  Identities=27%  Similarity=0.383  Sum_probs=188.2

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|... +++.||+|++....   ......+..|..++... +||||+++++++.. ...+++||||++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv~ey~~   79 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQT-KENLFFVMEYLN   79 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEe-CCEEEEEEeCCC
Confidence            36999999999999765 57899999986542   22334566777887764 89999999997776 567999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +|+|.+++..    ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++........ ...
T Consensus        80 ~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~  154 (316)
T cd05619          80 GGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA-KTC  154 (316)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC-cee
Confidence            9999999853    24588999999999999999999999999999999999999999999999999864322111 122


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...||+.|+|||++.+..++.++||||+||++|+|++|..||.......      . ...+.        ....  .   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~-~~~i~--------~~~~--~---  214 (316)
T cd05619         155 TFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEE------L-FQSIR--------MDNP--C---  214 (316)
T ss_pred             eecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHH------H-HHHHH--------hCCC--C---
Confidence            3458999999999998899999999999999999999999997543110      0 00000        0000  0   


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMV-DVLD  333 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~-evl~  333 (375)
                      .+..+...+.+++.+||+.+|++||++. ++++
T Consensus       215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  247 (316)
T cd05619         215 YPRWLTREAKDILVKLFVREPERRLGVKGDIRQ  247 (316)
T ss_pred             CCccCCHHHHHHHHHHhccCHhhcCCChHHHHc
Confidence            0112345688999999999999999997 5543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=2.1e-41  Score=307.30  Aligned_cols=267  Identities=21%  Similarity=0.287  Sum_probs=196.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|.+.+.||+|+||.||+|..+ +++.||+|.+..... .....+.+|+.+++.++||||+++++++.. +...++|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-DKSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-CCeEEEEEe
Confidence            56889999999999999999665 678899999864432 223457789999999999999999997766 567999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |++ ++|.+++...   ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ 
T Consensus        85 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  159 (309)
T cd07872          85 YLD-KDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK-  159 (309)
T ss_pred             CCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcc-
Confidence            997 5888877433   34578899999999999999999999999999999999999999999999999875433221 


Q ss_pred             cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH------H
Q 017232          219 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL------V  291 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~  291 (375)
                      ......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||......+...................+      .
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            1223457889999998764 46889999999999999999999999755432211111000000000000000      0


Q ss_pred             hhhcCCCC----ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 DQTLGYES----DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 ~~~l~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      +.......    .......+.++.+++.+||+.+|.+|||+.|+++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence            00000000    0011224567889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.3e-41  Score=315.02  Aligned_cols=251  Identities=23%  Similarity=0.338  Sum_probs=193.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||++... +++.||+|++....   ......+.+|+.++..++|+||+++++.+.. ...+++|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~-~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQD-KRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCEEEEE
Confidence            36888999999999999999665 68999999986432   2334567889999999999999999997765 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++|+|.+++..    ...+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++.......
T Consensus        80 ~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~  155 (360)
T cd05627          80 MEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAH  155 (360)
T ss_pred             EeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccc
Confidence            999999999999853    3458999999999999999999999999999999999999999999999999986542211


Q ss_pred             c----------------------------------ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 017232          217 T----------------------------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPA  262 (375)
Q Consensus       217 ~----------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  262 (375)
                      .                                  ......+||+.|+|||++.+..++.++|||||||++|||++|++|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCC
Confidence            0                                  011234689999999999999999999999999999999999999


Q ss_pred             ccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHH
Q 017232          263 VDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY---MVDVLD  333 (375)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---~~evl~  333 (375)
                      |.......      . .        ..+.........++ ....+..+.+++.+|+. +|.+|++   +.++++
T Consensus       236 f~~~~~~~------~-~--------~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~  292 (360)
T cd05627         236 FCSETPQE------T-Y--------RKVMNWKETLVFPP-EVPISEKAKDLILRFCT-DSENRIGSNGVEEIKS  292 (360)
T ss_pred             CCCCCHHH------H-H--------HHHHcCCCceecCC-CCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhc
Confidence            97543211      0 0        01110000000000 01134568888888774 9999986   455543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1e-40  Score=296.54  Aligned_cols=255  Identities=27%  Similarity=0.465  Sum_probs=201.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CC---CEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DG---RAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|+..+.||+|+||.||+|... ++   ..+++|.+... .....+.+..|+.+++.++|+|++++++++.. ....++
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   83 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTK-FKPAMI   83 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEcc-CCCcEE
Confidence            46788899999999999999764 33   36899988655 33445678899999999999999999997765 567899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++...   ...+++.++..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDH---DGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999998542   346899999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccc--CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          216 VTHVST--APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       216 ~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ......  ....+..|+|||.+.+..++.++|||||||++|+|++ |..||.......       ..        ..+ .
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~-------~~--------~~i-~  224 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE-------VM--------KAI-N  224 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH-------HH--------HHH-h
Confidence            221111  1123457999999988889999999999999999997 999986432110       00        001 1


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                      ...   ..+....++..+.+++.+|++.+|++||++.+|++.|+++
T Consensus       225 ~~~---~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         225 DGF---RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             cCC---CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            101   1111123456789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=2.5e-41  Score=308.52  Aligned_cols=241  Identities=24%  Similarity=0.360  Sum_probs=190.3

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      +|++.+.||+|+||.||+|... +++.||+|++....   ......+..|..++..+ +|++|+++++++.. ...+++|
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQT-MDRLYFV   79 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEec-CCEEEEE
Confidence            4788999999999999999665 57899999986542   22334566778888777 58889999987766 6689999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++|+|.+.+..    ...+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        80 ~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~  155 (323)
T cd05616          80 MEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG  155 (323)
T ss_pred             EcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence            999999999988853    2458899999999999999999999999999999999999999999999999987533211


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      . ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .         ...+......
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~------~---------~~~i~~~~~~  219 (323)
T cd05616         156 V-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE------L---------FQSIMEHNVA  219 (323)
T ss_pred             C-ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHH------H---------HHHHHhCCCC
Confidence            1 1233468999999999999999999999999999999999999997543211      0         1111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYM  328 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  328 (375)
                        .   +...+..+.+++.+||+.+|++|++.
T Consensus       220 --~---p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         220 --Y---PKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             --C---CCcCCHHHHHHHHHHcccCHHhcCCC
Confidence              1   11245678899999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.8e-41  Score=321.21  Aligned_cols=269  Identities=19%  Similarity=0.251  Sum_probs=194.6

Q ss_pred             HHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCC------CCeEEEeeeee
Q 017232           55 ELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRH------KNLVSLYGCTS  127 (375)
Q Consensus        55 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h------~niv~~~~~~~  127 (375)
                      ++....++|++.++||+|+||+||+|... +++.||||++.... .....+..|+.++..++|      .+++++++++.
T Consensus       123 ~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~  201 (467)
T PTZ00284        123 DIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQ  201 (467)
T ss_pred             ccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEE
Confidence            34445688999999999999999999654 67889999985432 223345567777777754      45888888887


Q ss_pred             cCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCCC-------
Q 017232          128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNNF-------  199 (375)
Q Consensus       128 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~~-------  199 (375)
                      ....++|+|||++ +++|.+++..    ...+++..+..++.||+.||.|||+ .||+||||||+|||++.++       
T Consensus       202 ~~~~~~~iv~~~~-g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~  276 (467)
T PTZ00284        202 NETGHMCIVMPKY-GPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT  276 (467)
T ss_pred             cCCceEEEEEecc-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence            7677899999998 7788888853    3468999999999999999999998 5999999999999998765       


Q ss_pred             ---------cEEEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCcccccccc
Q 017232          200 ---------CVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH  270 (375)
Q Consensus       200 ---------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~  270 (375)
                               .+||+|||.+.....    ......||+.|+|||++.+..++.++|||||||++|||++|++||.......
T Consensus       277 ~~~~~~~~~~vkl~DfG~~~~~~~----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~  352 (467)
T PTZ00284        277 NRALPPDPCRVRICDLGGCCDERH----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLE  352 (467)
T ss_pred             ccccCCCCceEEECCCCccccCcc----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH
Confidence                     499999998764322    1234568999999999999999999999999999999999999997654322


Q ss_pred             ccchhHHHHHHhhh--------hHHHHHHhhhc--CCCCCh------------HHHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017232          271 EINLSNLAINKIQN--------KALHELVDQTL--GYESDN------------KVRRTINAVAELAFQCLQSEKDLRPYM  328 (375)
Q Consensus       271 ~~~~~~~~~~~~~~--------~~~~~~~~~~l--~~~~~~------------~~~~~~~~l~~li~~cl~~~P~~Rpt~  328 (375)
                      .........+.+..        ....+++....  .....+            ........+.+||.+||+.||++|||+
T Consensus       353 ~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta  432 (467)
T PTZ00284        353 HLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNA  432 (467)
T ss_pred             HHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCH
Confidence            11111100000000        00011111000  000000            000113467899999999999999999


Q ss_pred             HHHHH
Q 017232          329 VDVLD  333 (375)
Q Consensus       329 ~evl~  333 (375)
                      +|+++
T Consensus       433 ~e~L~  437 (467)
T PTZ00284        433 RQMTT  437 (467)
T ss_pred             HHHhc
Confidence            99997

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=4.2e-41  Score=307.39  Aligned_cols=244  Identities=23%  Similarity=0.350  Sum_probs=189.8

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|... +++.||+|++....   ......+.+|..++.++ +||||+++++++.. ...+++||||++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   79 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQT-TSRLFLVIEYVN   79 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEe-CCEEEEEEeCCC
Confidence            46999999999999665 67899999997542   23345678899999888 69999999997766 677999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|...+..    ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||+|||++....... ....
T Consensus        80 ~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~  154 (327)
T cd05617          80 GGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG-DTTS  154 (327)
T ss_pred             CCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC-Ccee
Confidence            9999988843    3458999999999999999999999999999999999999999999999999987432211 1123


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|..||..................+        ......     
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~--------~~~~~~-----  221 (327)
T cd05617         155 TFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVI--------LEKPIR-----  221 (327)
T ss_pred             cccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHH--------HhCCCC-----
Confidence            3468999999999999899999999999999999999999997543222111111111111        111110     


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMV  329 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~  329 (375)
                      .+...+..+.+++.+||+.+|.+|+++.
T Consensus       222 ~p~~~~~~~~~li~~~L~~dP~~R~~~~  249 (327)
T cd05617         222 IPRFLSVKASHVLKGFLNKDPKERLGCQ  249 (327)
T ss_pred             CCCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence            1112345688999999999999999853

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.8e-41  Score=332.37  Aligned_cols=262  Identities=23%  Similarity=0.376  Sum_probs=201.9

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeec-CCce
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSR-HSRE  132 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~  132 (375)
                      ....++|.+.+.||+|+||+||+|... ++..+|+|.+...  .......+..|+.+++.++||||+++++++.. ....
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~   88 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK   88 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence            445578999999999999999999665 5778899988643  33345678899999999999999999996643 3467


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-------CceeccCCCCCEEecC--------
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-------DIIHRDVKTNNILLDN--------  197 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-------~ivH~dlkp~Nill~~--------  197 (375)
                      ++|||||+++++|.+++.........+++..++.|+.||+.||.|||+.       +|+|+||||+||||+.        
T Consensus        89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i  168 (1021)
T PTZ00266         89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI  168 (1021)
T ss_pred             EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence            8999999999999999976544446799999999999999999999984       4999999999999964        


Q ss_pred             ---------CCcEEEeeeccccccCCCccccccCCCCCccccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCcccc
Q 017232          198 ---------NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC--YQLTDKSDVFSFGVVLIELISSMPAVDIT  266 (375)
Q Consensus       198 ---------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~p~~~~  266 (375)
                               .+.+||+|||++........  .....+|+.|+|||++.+  ..++.++|||||||+||+|++|..||...
T Consensus       169 ~~~~~n~ng~~iVKLsDFGlAr~l~~~s~--~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        169 TAQANNLNGRPIAKIGDFGLSKNIGIESM--AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             cccccccCCCCceEEccCCcccccccccc--ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence                     34589999999976543221  233468999999998854  45889999999999999999999999643


Q ss_pred             ccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHHhhh
Q 017232          267 RHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD--ALRDIE  339 (375)
Q Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~--~L~~i~  339 (375)
                      ...     .... ..+.         ..    ........+..+.+||..||..+|.+||++.+++.  .|..+.
T Consensus       247 ~~~-----~qli-~~lk---------~~----p~lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i~  302 (1021)
T PTZ00266        247 NNF-----SQLI-SELK---------RG----PDLPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNVG  302 (1021)
T ss_pred             CcH-----HHHH-HHHh---------cC----CCCCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhcC
Confidence            211     1110 0000         00    00011123467899999999999999999999984  454443

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.1e-40  Score=299.66  Aligned_cols=258  Identities=28%  Similarity=0.408  Sum_probs=200.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      .++|++.+.||+|+||.||+|...      ++..|++|.+.... ......+.+|+.+++.++|||++++++++.. +..
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~-~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAV-GKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCc
Confidence            457899999999999999999753      46789999886553 3344678899999999999999999997765 567


Q ss_pred             eEEEEecccCCChhHhhccCCC------------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEE
Q 017232          133 LLLVYEFISNGTVADHLHGERA------------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNIL  194 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nil  194 (375)
                      .++||||+++++|.+++.....                  ....+++..++.++.|++.||.|||+.|++|+||+|+||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil  162 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL  162 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence            8999999999999999864321                  1234788899999999999999999999999999999999


Q ss_pred             ecCCCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCcccccccccc
Q 017232          195 LDNNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEI  272 (375)
Q Consensus       195 l~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~  272 (375)
                      ++.++.++|+|||++........ ........+..|+|||.+.+..++.++|||||||++|+|++ |..||......   
T Consensus       163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~---  239 (288)
T cd05050         163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE---  239 (288)
T ss_pred             ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence            99999999999999875432211 11112234567999999988889999999999999999997 87787533211   


Q ss_pred             chhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          273 NLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                         .. ...+        .....    ......++..+.+++.+||+.+|++|||+.|+++.|++
T Consensus       240 ---~~-~~~~--------~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 ---EV-IYYV--------RDGNV----LSCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             ---HH-HHHH--------hcCCC----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence               00 0011        10101    01111245679999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=8.2e-41  Score=297.35  Aligned_cols=255  Identities=25%  Similarity=0.462  Sum_probs=199.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CC---CEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DG---RAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      +.|++.+.||+|+||.||+|... ++   ..|++|.+... .......+..|+.+++.++||||+++++++.. +...++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~l   82 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK-SRPVMI   82 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECC-CCceEE
Confidence            34788999999999999999664 23   36999998654 34456789999999999999999999997665 667899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++...   .+.+++.+++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          83 ITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccC
Confidence            99999999999998543   345899999999999999999999999999999999999999999999999998765432


Q ss_pred             cccc--ccCC--CCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          216 VTHV--STAP--QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       216 ~~~~--~~~~--~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ....  ....  ..+..|+|||.+.+..++.++|||||||++|||++ |..||.......      .          ...
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~------~----------~~~  223 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQD------V----------INA  223 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHH------H----------HHH
Confidence            2111  1111  12457999999998899999999999999999886 999986432110      0          000


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                      +....   ..+....++..+.+++.+||+.+|++||++.+|++.|+++
T Consensus       224 i~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         224 IEQDY---RLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HHcCC---cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            10000   0111123456789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-40  Score=297.91  Aligned_cols=250  Identities=26%  Similarity=0.360  Sum_probs=195.9

Q ss_pred             CCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           62 YFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      +|++.+.||+|+||.||+|.. .++..||+|.+... .......+.+|+.++++++|||++++++++.. ....++||||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   80 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-ENRISICTEF   80 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-CCEEEEEEec
Confidence            578889999999999999965 47889999988654 33444678899999999999999999997776 5678999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++++|..+.        .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......   
T Consensus        81 ~~~~~l~~~~--------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~---  149 (279)
T cd06619          81 MDGGSLDVYR--------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI---  149 (279)
T ss_pred             CCCCChHHhh--------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc---
Confidence            9999986542        36788899999999999999999999999999999999999999999999987653322   


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............        .....+........ 
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~--------~~~~~~~~~~~~~~-  220 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPL--------QLLQCIVDEDPPVL-  220 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchH--------HHHHHHhccCCCCC-
Confidence            223468899999999998889999999999999999999999996533221110000        00000111000000 


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                        .....+..+.+++.+|++.+|++||+++++++.
T Consensus       221 --~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         221 --PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              011234568899999999999999999999865

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=295.35  Aligned_cols=251  Identities=28%  Similarity=0.423  Sum_probs=193.8

Q ss_pred             CccCCCCcEEEEEEEeCC-CC--EEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQD-GR--AVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|..++ +.  .+++|.+... .....+.+.+|+.++.++ +||||+++++++.. ....++||||++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~~~~lv~e~~~   79 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYLAIEYAP   79 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEec-CCCceEEEEeCC
Confidence            359999999999997653 43  4688887643 334456788999999999 79999999997776 566899999999


Q ss_pred             CCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          142 NGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       142 ~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      +++|.+++...+.            ....+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~  159 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS  159 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCc
Confidence            9999999865431            1235789999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      ........  ......+..|+|||.+.+..++.++||||||+++|+|++ |..||.......      ..         .
T Consensus       160 ~~~~~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~------~~---------~  222 (270)
T cd05047         160 RGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------LY---------E  222 (270)
T ss_pred             cccchhhh--ccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHH------HH---------H
Confidence            53221111  111224567999999988889999999999999999997 999986432110      00         0


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                       .+......   .....++..+.+++.+|+..+|.+|||+.+++..|+++.
T Consensus       223 -~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         223 -KLPQGYRL---EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             -HHhCCCCC---CCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence             01110110   111124457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-40  Score=293.11  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=202.6

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      ++|++.+.||.|++|.||+|... +++.+++|.+........+.+.+|+.+++.++|||++++++++.. ...++++|||
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l~~e~   81 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-RDKLWIVMEY   81 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-CCEEEEEEeC
Confidence            57889999999999999999664 578899999877665567788999999999999999999997765 6679999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +.+++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        82 ~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  157 (262)
T cd06613          82 CGGGSLQDIYQVT---RGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA-K  157 (262)
T ss_pred             CCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhh-c
Confidence            9999999988543   24689999999999999999999999999999999999999999999999999876543221 1


Q ss_pred             ccCCCCCccccCccccccc---CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          220 STAPQGTPGYVDPEYHQCY---QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .....++..|+|||.+.+.   .++.++|+||||+++|+|++|.+||.........               .......+.
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~---------------~~~~~~~~~  222 (262)
T cd06613         158 RKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRAL---------------FLISKSNFP  222 (262)
T ss_pred             cccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHHhccCC
Confidence            2234578899999998776   7889999999999999999999999654321100               000000001


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..........+..+.+++.+||..+|.+|||+.+|+.
T Consensus       223 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         223 PPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             CccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0111112234567899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=3.7e-41  Score=311.49  Aligned_cols=265  Identities=20%  Similarity=0.299  Sum_probs=197.7

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----  130 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  130 (375)
                      ...++|++.+.||+|+||.||++... .++.||+|++...  .......+.+|+.+++.++||||+++++++....    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~   93 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE   93 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence            45678999999999999999999654 6889999998654  3334567788999999999999999999765422    


Q ss_pred             -ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          131 -RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       131 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                       ...++||||++ ++|.+.+.      ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        94 ~~~~~lv~e~~~-~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~  166 (355)
T cd07874          94 FQDVYLVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  166 (355)
T ss_pred             cceeEEEhhhhc-ccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCccc
Confidence             35799999996 46766663      23788899999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh------
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ------  283 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  283 (375)
                      .......  ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||..........   .....+.      
T Consensus       167 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~---~~~~~~~~~~~~~  241 (355)
T cd07874         167 RTAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN---KVIEQLGTPCPEF  241 (355)
T ss_pred             ccCCCcc--ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHHhCCCCHHH
Confidence            7654322  1233468999999999999899999999999999999999999997543211100   0000000      


Q ss_pred             ----hhHHHHHHhhhcCCC--------------C-ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          284 ----NKALHELVDQTLGYE--------------S-DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       284 ----~~~~~~~~~~~l~~~--------------~-~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                          ...............              . ..........+.+++.+||..||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                000111111000000              0 00001123568899999999999999999999975

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.2e-40  Score=301.25  Aligned_cols=258  Identities=24%  Similarity=0.369  Sum_probs=202.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCc
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENN-YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  131 (375)
                      .++|.+.+.||+|+||.||++...      .+..||+|.+.... ....+.+.+|+.+++++ +|+||+++++++.. ..
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~~  112 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-GG  112 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-CC
Confidence            456899999999999999999642      34579999886543 33456788999999999 79999999997765 56


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ..++||||+.+++|.+++....  ...+++.++..++.|++.||.|||+++++|+||||+||+++.++.++|+|||++..
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~  190 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKR--ESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARD  190 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccc
Confidence            7899999999999999986432  23489999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          212 FPNHVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       212 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                      ....... ......++..|+|||.+.+..++.++||||+||++|+|++ |.+||.......               ....
T Consensus       191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~---------------~~~~  255 (302)
T cd05055         191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS---------------KFYK  255 (302)
T ss_pred             ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH---------------HHHH
Confidence            5433221 1122345678999999988889999999999999999998 999986443211               0111


Q ss_pred             HHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          290 LVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       290 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                      ..........   ....+..+.+++.+||+.+|++|||+.++++.|+++
T Consensus       256 ~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         256 LIKEGYRMAQ---PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             HHHcCCcCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            1111111110   012345789999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=288.71  Aligned_cols=252  Identities=22%  Similarity=0.337  Sum_probs=200.7

Q ss_pred             HhcCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      +.+.|++.+.||+|.|+.||+. ...+|+.+|+|.+...  .....+.+.+|+.+-+.|+||||+++.+.+.+ ....||
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~-~~~~yl   87 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYL   87 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcc-cceeEE
Confidence            4567888899999999999998 4457899999887433  33356788999999999999999999996655 667899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec---CCCcEEEeeecccccc
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD---NNFCVKVADFGLSRLF  212 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~  212 (375)
                      |+|++.|++|..-+-..    ..+++..+-..++||+++|.|+|.+||||||+||+|+++.   ...-+||+|||++..+
T Consensus        88 vFe~m~G~dl~~eIV~R----~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l  163 (355)
T KOG0033|consen   88 VFDLVTGGELFEDIVAR----EFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEV  163 (355)
T ss_pred             EEecccchHHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEe
Confidence            99999999987666432    3478888899999999999999999999999999999994   3445999999999987


Q ss_pred             CCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      +.  ........|||.|||||++...+|+..+|||+.|++||-|+.|.+||-.....               .-+..++.
T Consensus       164 ~~--g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---------------rlye~I~~  226 (355)
T KOG0033|consen  164 ND--GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---------------RLYEQIKA  226 (355)
T ss_pred             CC--ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---------------HHHHHHhc
Confidence            73  23334567999999999999999999999999999999999999999753211               00111111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .... ...+.-....++..+|+.+||..||.+|.|+.|.++
T Consensus       227 g~yd-~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~  266 (355)
T KOG0033|consen  227 GAYD-YPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK  266 (355)
T ss_pred             cccC-CCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence            1111 111233455678999999999999999999998774

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.4e-41  Score=303.78  Aligned_cols=264  Identities=25%  Similarity=0.327  Sum_probs=192.0

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHHhc---CCCCeEEEeeeeecC----Cc
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--KRVEQFMNEVDILARL---RHKNLVSLYGCTSRH----SR  131 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~----~~  131 (375)
                      +|++.+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+.+++.+   +||||+++++++...    ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            4888999999999999999655 688999998864321  1123455677766655   799999999976432    34


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ..+++|||+. ++|.+++...  ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++..
T Consensus        81 ~~~lv~e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~  157 (288)
T cd07863          81 KVTLVFEHVD-QDLRTYLDKV--PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARI  157 (288)
T ss_pred             eEEEEEcccc-cCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccc
Confidence            5799999997 5888888543  234589999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh---hhHHH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ---NKALH  288 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  288 (375)
                      ......  .....++..|+|||++.+..++.++||||+||++|+|++|.+||.........  .. ......   .....
T Consensus       158 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~--~~-~~~~~~~~~~~~~~  232 (288)
T cd07863         158 YSCQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL--GK-IFDLIGLPPEDDWP  232 (288)
T ss_pred             ccCccc--CCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH--HH-HHHHhCCCChhhCc
Confidence            543221  22345789999999998888999999999999999999999999654322110  00 000000   00000


Q ss_pred             HH-------HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          289 EL-------VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       289 ~~-------~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..       ..+............+...+.+++.+||+.||++|||+.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         233 RDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             ccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            00       0000000000111234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.8e-40  Score=292.81  Aligned_cols=250  Identities=26%  Similarity=0.436  Sum_probs=201.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .++|++.+.||.|+||.||+|...+ +..+++|.+.....  .+.+.+|+.+++.++|+|++++++++.. ....++++|
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e   78 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK-NTDLWIVME   78 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec-CCcEEEEEe
Confidence            3578999999999999999997764 78999999865533  5788999999999999999999997776 578999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+.+++|.+++...   ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        79 ~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~-  154 (256)
T cd06612          79 YCGAGSVSDIMKIT---NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA-  154 (256)
T ss_pred             cCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence            99999999998532   35689999999999999999999999999999999999999999999999999886544321 


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ......++..|+|||.+.+..++.++||||||+++|+|++|++||.........               .. ... ....
T Consensus       155 ~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~---------------~~-~~~-~~~~  217 (256)
T cd06612         155 KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI---------------FM-IPN-KPPP  217 (256)
T ss_pred             ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh---------------hh-hcc-CCCC
Confidence            122334788999999998888999999999999999999999999754321100               00 000 0000


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ...........+.+++.+|++.+|++|||+.++++
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         218 TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence            01111234567899999999999999999999985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3.5e-41  Score=307.87  Aligned_cols=241  Identities=27%  Similarity=0.393  Sum_probs=186.4

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHH-HHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVD-ILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|... +++.||+|++.....   .....+..|.. +++.++||||+++++++.. ....++||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~-~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEc-CCeEEEEEeCCC
Confidence            36999999999999665 578899999865421   22233444443 5678899999999997766 667999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|.+++..    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus        80 ~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~-~~~~  154 (325)
T cd05602          80 GGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN-GTTS  154 (325)
T ss_pred             CCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC-CCcc
Confidence            9999998853    3457888999999999999999999999999999999999999999999999987532211 1123


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...||+.|+|||++.+..++.++|||||||++|+|++|.+||.......      .         ...+.......    
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~---------~~~i~~~~~~~----  215 (325)
T cd05602         155 TFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE------M---------YDNILNKPLQL----  215 (325)
T ss_pred             cccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH------H---------HHHHHhCCcCC----
Confidence            4468999999999999999999999999999999999999997443111      0         01111111111    


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       ....+..+.+++.+||+.+|.+||++.+.+.
T Consensus       216 -~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~  246 (325)
T cd05602         216 -KPNITNSARHLLEGLLQKDRTKRLGAKDDFM  246 (325)
T ss_pred             -CCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence             1124567889999999999999999875443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1.8e-41  Score=299.78  Aligned_cols=252  Identities=32%  Similarity=0.499  Sum_probs=197.6

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHH--HHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE--QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~--~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      |++.+.||+|+||+||++... +++.||+|.+.........  ...+|+.+++.++||||+++++++.. ....++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-DNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-SSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-cccccccccc
Confidence            567889999999999999766 4668999999776544332  34569999999999999999997776 6778999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +.+++|.+++.    ....+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||.+..... ....
T Consensus        80 ~~~~~L~~~l~----~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~-~~~~  154 (260)
T PF00069_consen   80 CPGGSLQDYLQ----KNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE-NNEN  154 (260)
T ss_dssp             ETTEBHHHHHH----HHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS-TTSE
T ss_pred             ccccccccccc----cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc-cccc
Confidence            99999999996    334589999999999999999999999999999999999999999999999999875421 1222


Q ss_pred             ccCCCCCccccCccccc-ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQ-CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      .....++..|+|||++. +..++.++||||+|+++|+|++|..||.........       ..+................
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~  227 (260)
T PF00069_consen  155 FNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQL-------EIIEKILKRPLPSSSQQSR  227 (260)
T ss_dssp             BSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHH-------HHHHHHHHTHHHHHTTSHT
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccchhhh-------hhhhhcccccccccccccc
Confidence            34456899999999988 788999999999999999999999999855211110       0111110001111100000


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                            .....+.+++.+||+.+|++||++.++++
T Consensus       228 ------~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  228 ------EKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             ------TSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ------hhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                  01267999999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.7e-41  Score=298.04  Aligned_cols=252  Identities=24%  Similarity=0.358  Sum_probs=197.6

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      ++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.+++.++||||+++++.+.. ....++||||
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-~~~~~lv~e~   87 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-RDKLWICMEF   87 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-CCEEEEEEec
Confidence            46778889999999999999654 688999999876655555678889999999999999999997766 6778999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++++|.+++..    .+.+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... ..
T Consensus        88 ~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~  162 (267)
T cd06645          88 CGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK  162 (267)
T ss_pred             cCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence            999999998853    3468999999999999999999999999999999999999999999999999987554321 11


Q ss_pred             ccCCCCCccccCccccc---ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          220 STAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .....++..|+|||.+.   ...++.++|+|||||++|+|++|..||.........      ..         .......
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~------~~---------~~~~~~~  227 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRAL------FL---------MTKSNFQ  227 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhH------Hh---------hhccCCC
Confidence            23345889999999874   456888999999999999999999998543211100      00         0000000


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .........++..+.+++.+||..+|++||++++|++
T Consensus       228 ~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         228 PPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             CCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            0000001123456889999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.1e-40  Score=292.46  Aligned_cols=250  Identities=28%  Similarity=0.419  Sum_probs=202.7

Q ss_pred             CCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|+..+.||.|+||.||.++. .++..+++|.+...  .......+.+|+.++++++|+||+++++++.. ....+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-DNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-CCeEEEEEE
Confidence            488899999999999999954 46889999987544  34445678899999999999999999998776 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++....  ...+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||.+........ 
T Consensus        80 ~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~-  156 (256)
T cd08221          80 YANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS-  156 (256)
T ss_pred             ecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc-
Confidence            999999999986432  35689999999999999999999999999999999999999999999999999876544332 


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......      .         ...+.    ...
T Consensus       157 ~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~------~---------~~~~~----~~~  217 (256)
T cd08221         157 MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN------L---------VVKIV----QGN  217 (256)
T ss_pred             cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHH------H---------HHHHH----cCC
Confidence            2233458899999999988888999999999999999999999996432110      0         01111    111


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .......++..+.+++.+||+.+|++||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         218 YTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             CCCCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence            111123345678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=2.9e-40  Score=300.93  Aligned_cols=199  Identities=27%  Similarity=0.420  Sum_probs=160.9

Q ss_pred             CCccCCCCcEEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeec-CCceeEEEEeccc
Q 017232           66 ARELGDGGFGTVYYGELQ---DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR-HSRELLLVYEFIS  141 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e~~~  141 (375)
                      .++||+|+||.||+|...   +++.||+|.+.....  ...+.+|+.+++.++||||+++++++.. .+...+++|||+.
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI--SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE   83 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC--cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence            468999999999999754   467899998865432  2356789999999999999999996643 3456899999995


Q ss_pred             CCChhHhhccCCC-----CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe----cCCCcEEEeeecccccc
Q 017232          142 NGTVADHLHGERA-----KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLF  212 (375)
Q Consensus       142 ~~~L~~~l~~~~~-----~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~  212 (375)
                       ++|.+++.....     ....+++..++.++.||+.||.|||+.||+||||||+|||+    +..+.+||+|||++...
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07868          84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceecc
Confidence             578877653321     22358899999999999999999999999999999999999    45678999999999866


Q ss_pred             CCCccc--cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccc
Q 017232          213 PNHVTH--VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITR  267 (375)
Q Consensus       213 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~  267 (375)
                      ......  ......+|+.|+|||++.+ ..++.++||||+||++|+|++|++||....
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            433211  1234468999999998876 458899999999999999999999997544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=4.6e-41  Score=307.03  Aligned_cols=241  Identities=27%  Similarity=0.396  Sum_probs=186.9

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHH-HHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVD-ILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|... +|+.||+|++....   ......+..|.. +++.++||||+++++.+.. ....++||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~-~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQT-TEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEec-CCEEEEEEcCCC
Confidence            36999999999999654 68999999986542   223344555554 4677899999999997766 678999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|..++..    ...+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++........ ...
T Consensus        80 ~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~-~~~  154 (325)
T cd05604          80 GGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD-TTT  154 (325)
T ss_pred             CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC-Ccc
Confidence            9999988843    34689999999999999999999999999999999999999999999999999874322111 123


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...|++.|+|||++.+..++.++|||||||++|+|++|.+||.......      .         ...+....+...   
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~------~---------~~~~~~~~~~~~---  216 (325)
T cd05604         155 TFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE------M---------YDNILHKPLVLR---  216 (325)
T ss_pred             cccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH------H---------HHHHHcCCccCC---
Confidence            4468999999999999899999999999999999999999997543110      0         011111111111   


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        ...+..+.+++.+||..+|.+||++.+.++
T Consensus       217 --~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~  246 (325)
T cd05604         217 --PGASLTAWSILEELLEKDRQRRLGAKEDFL  246 (325)
T ss_pred             --CCCCHHHHHHHHHHhccCHHhcCCCCCCHH
Confidence              123456889999999999999999864333

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=4.4e-41  Score=311.95  Aligned_cols=264  Identities=20%  Similarity=0.306  Sum_probs=196.6

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-----C
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-----S  130 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~  130 (375)
                      ..++|++.+.||+|+||.||++... .++.||+|++...  .......+.+|+.+++.++||||+++++++...     .
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~  101 (364)
T cd07875          22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF  101 (364)
T ss_pred             hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence            4578999999999999999999654 6889999998653  233446678899999999999999999866432     2


Q ss_pred             ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          131 RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      ..+++||||++ ++|.+.+.      ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       102 ~~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~  174 (364)
T cd07875         102 QDVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  174 (364)
T ss_pred             CeEEEEEeCCC-CCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcc
Confidence            35799999996 56777663      237888999999999999999999999999999999999999999999999997


Q ss_pred             ccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh-------
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ-------  283 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-------  283 (375)
                      ......  ......++..|+|||++.+..++.++|||||||++|+|++|+.||.........   ......+.       
T Consensus       175 ~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~  249 (364)
T cd07875         175 TAGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW---NKVIEQLGTPCPEFM  249 (364)
T ss_pred             ccCCCC--cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCCHHHH
Confidence            654322  123346899999999999999999999999999999999999999754322110   00000000       


Q ss_pred             ---hhHHHHHHhhhcCCC--------------C-ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          284 ---NKALHELVDQTLGYE--------------S-DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       284 ---~~~~~~~~~~~l~~~--------------~-~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                         ...............              . ..........+.+++.+||+.||.+|||+.++++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         250 KKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence               000000111000000              0 00001123468899999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=2.6e-40  Score=292.13  Aligned_cols=248  Identities=29%  Similarity=0.461  Sum_probs=197.5

Q ss_pred             CccCCCCcEEEEEEEeCC--C--CEEEEEEecccch-hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQD--G--RAVAVKRLYENNY-KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~--~--~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|++|.||+|.+.+  +  ..||+|.+..... ...+.+.+|+.++++++||||+++++.+..  ...++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecC
Confidence            468999999999996543  3  3689999977765 566789999999999999999999997665  67899999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc--c
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH--V  219 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~  219 (375)
                      +++|.+++.....  ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++.........  .
T Consensus        79 ~~~L~~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  156 (257)
T cd05040          79 LGSLLDRLRKDAL--GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVM  156 (257)
T ss_pred             CCcHHHHHHhccc--ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceec
Confidence            9999999965432  46899999999999999999999999999999999999999999999999999876432211  1


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      .....++..|+|||.+.+..++.++|||||||++|+|++ |..||.......      ... .        +....   .
T Consensus       157 ~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~------~~~-~--------~~~~~---~  218 (257)
T cd05040         157 EEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ------ILK-K--------IDKEG---E  218 (257)
T ss_pred             ccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH------HHH-H--------HHhcC---C
Confidence            112346778999999998889999999999999999998 999986433211      000 0        00000   0


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                      ........+..+.+++.+|++.+|++||++.++++.|.
T Consensus       219 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            00111224567999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=3e-40  Score=294.65  Aligned_cols=258  Identities=23%  Similarity=0.339  Sum_probs=201.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      .+|++...||.|+||.||+|..+      +...|++|.+...... ....+.+|+.++++++|+|++++++++.. ....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCRE-AEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECC-CCcc
Confidence            46888999999999999999754      2467899988654433 45678999999999999999999997655 5678


Q ss_pred             EEEEecccCCChhHhhccCCCC-----CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecc
Q 017232          134 LLVYEFISNGTVADHLHGERAK-----PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL  208 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~-----~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  208 (375)
                      ++||||+++++|.+++......     ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++|||+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~  163 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL  163 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence            9999999999999999655422     12689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHH
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKAL  287 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (375)
                      +...............++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      ..         
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~------~~---------  228 (275)
T cd05046         164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE------VL---------  228 (275)
T ss_pred             ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHH------HH---------
Confidence            86543222222223346778999999888888999999999999999998 788886432110      00         


Q ss_pred             HHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          288 HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       288 ~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                      ............   ...++..+.+++.+||+.+|++|||+.+++..|.+
T Consensus       229 ~~~~~~~~~~~~---~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         229 NRLQAGKLELPV---PEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             HHHHcCCcCCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence            001101111111   11245679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=295.59  Aligned_cols=249  Identities=25%  Similarity=0.382  Sum_probs=200.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|++.+.||.|++|.||+|... +++.|++|.+.... ......+.+|+.+++.++|+|++++++++.. +...++|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-GSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-CCeEEEEEE
Confidence            36888999999999999999655 68899999986553 3445678899999999999999999997766 578999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++...     .+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        80 ~~~~~~L~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-  153 (274)
T cd06609          80 YCGGGSCLDLLKPG-----KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-  153 (274)
T ss_pred             eeCCCcHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc-
Confidence            99999999998532     689999999999999999999999999999999999999999999999999977654321 


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|..||+......      .. ..         +.......
T Consensus       154 ~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~------~~-~~---------~~~~~~~~  217 (274)
T cd06609         154 KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR------VL-FL---------IPKNNPPS  217 (274)
T ss_pred             ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH------HH-HH---------hhhcCCCC
Confidence            2233457889999999988889999999999999999999999997543111      00 00         00000000


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ...  ..++..+.+++.+||..+|++|||++++++.
T Consensus       218 ~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         218 LEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             Ccc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence            000  0145678999999999999999999999863

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.2e-40  Score=297.09  Aligned_cols=250  Identities=23%  Similarity=0.333  Sum_probs=195.2

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      |+..+.||.|+||+||+|... +++.||+|.+.....   .....+.+|+.+++.++|+|++++.+++.. +...++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYET-KDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEec-CCEEEEEEE
Confidence            667788999999999999664 688999999865432   223457789999999999999999987766 568999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+.+++|.+++...  ....+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-  157 (285)
T cd05632          81 IMNGGDLKFHIYNM--GNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES-  157 (285)
T ss_pred             eccCccHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc-
Confidence            99999999888543  234699999999999999999999999999999999999999999999999999875433221 


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.........       ..+.    .......    
T Consensus       158 -~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~-------~~~~----~~~~~~~----  221 (285)
T cd05632         158 -IRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR-------EEVD----RRVLETE----  221 (285)
T ss_pred             -ccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHH----Hhhhccc----
Confidence             12346899999999998888999999999999999999999999754321100       0000    0000000    


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPY-----MVDVLD  333 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~evl~  333 (375)
                       .......+..+.+++..|++.+|++||+     +.+++.
T Consensus       222 -~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         222 -EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             -cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence             0011224456889999999999999999     556655

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.3e-40  Score=298.53  Aligned_cols=268  Identities=22%  Similarity=0.293  Sum_probs=196.4

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|++.+.||.|++|.||+|... ++..||+|.+....  ......+.+|+.+++.++|||++++++++.. +...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-ESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-CCeEEEEEe
Confidence            4788899999999999999765 68999999886432  2234567889999999999999999997776 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+. ++|.+++.... .+..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        80 ~~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-~  156 (285)
T cd07861          80 FLS-MDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-R  156 (285)
T ss_pred             cCC-CCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc-c
Confidence            997 68888875432 23568999999999999999999999999999999999999999999999999987543322 1


Q ss_pred             cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh---------hHHH
Q 017232          219 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN---------KALH  288 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---------~~~~  288 (375)
                      ......+++.|+|||.+.+ ..++.++|||||||++|+|++|++||....................+         ....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (285)
T cd07861         157 VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYK  236 (285)
T ss_pred             cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHH
Confidence            1223356889999998765 35788999999999999999999999754321110000000000000         0000


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..................+.++.+++.+||..||++|||+.+|++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         237 NTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             hhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            000000000000111124567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=1e-40  Score=299.34  Aligned_cols=264  Identities=29%  Similarity=0.422  Sum_probs=202.6

Q ss_pred             chHHHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeee--
Q 017232           52 SYGELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTS--  127 (375)
Q Consensus        52 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~--  127 (375)
                      .++.+..+.++|++.+.||+|+||.||++... +++.+++|++..... ....+.+|+.+++.+ +||||+++++++.  
T Consensus         9 ~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~   87 (286)
T cd06638           9 IFDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHD-IDEEIEAEYNILKALSDHPNVVKFYGMYYKK   87 (286)
T ss_pred             EeecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccc-hHHHHHHHHHHHHHHhcCCCeeeeeeeeeec
Confidence            34455667789999999999999999999654 688999998754322 235677899999999 6999999999663  


Q ss_pred             --cCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEee
Q 017232          128 --RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD  205 (375)
Q Consensus       128 --~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~D  205 (375)
                        ..+...++||||+++++|.+++.........+++..++.++.|++.||.|||+.+++|+||||+||+++.++.++|+|
T Consensus        88 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          88 DVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             ccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEcc
Confidence              234578999999999999998865444456789999999999999999999999999999999999999999999999


Q ss_pred             eccccccCCCccccccCCCCCccccCcccccc-----cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHH
Q 017232          206 FGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       206 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      ||++........ ......+++.|+|||.+.+     ..++.++||||+||++|+|++|+.||........     . . 
T Consensus       168 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~-----~-~-  239 (286)
T cd06638         168 FGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRA-----L-F-  239 (286)
T ss_pred             CCceeecccCCC-ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHH-----H-h-
Confidence            999876543221 1223458899999998753     4578899999999999999999999864431110     0 0 


Q ss_pred             HhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          281 KIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .....     .....     .....+...+.+++.+||+.+|++|||+.|+++.
T Consensus       240 ~~~~~-----~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         240 KIPRN-----PPPTL-----HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             hcccc-----CCCcc-----cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            00000     00000     0001134568899999999999999999999875

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2e-40  Score=298.92  Aligned_cols=250  Identities=22%  Similarity=0.382  Sum_probs=201.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .+|++.+.||.|++|.||+|.. .+++.|++|.+........+.+.+|+.+++.++|||++++++.+.. ....++|+||
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   97 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVVMEY   97 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec-CceEEEEEEe
Confidence            4588899999999999999964 5789999999876555556678899999999999999999997765 6789999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +.+++|..++..     ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus        98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~  171 (296)
T cd06655          98 LAGGSLTDVVTE-----TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS-K  171 (296)
T ss_pred             cCCCcHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc-c
Confidence            999999998842     3589999999999999999999999999999999999999999999999999876543222 1


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.........               ..+....  ...
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~---------------~~~~~~~--~~~  234 (296)
T cd06655         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---------------YLIATNG--TPE  234 (296)
T ss_pred             CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH---------------HHHHhcC--Ccc
Confidence            22345888999999998888999999999999999999999999754321100               0000000  000


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ......++..+.+++.+||..+|++||++.++++.
T Consensus       235 ~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         235 LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            01112345678899999999999999999999854

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.7e-40  Score=292.44  Aligned_cols=250  Identities=26%  Similarity=0.435  Sum_probs=198.2

Q ss_pred             CCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccc------hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENN------YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      +|++.+.||+|+||.||+|...+++.+|+|.+....      ......+.+|+++++.++|+||+++++++.. ....++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l   79 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD-DNTISI   79 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeec-CCeEEE
Confidence            478899999999999999988789999999886432      2234568899999999999999999997776 578999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      +|||+++++|.+++...    ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  155 (265)
T cd06631          80 FMEFVPGGSISSILNRF----GPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV  155 (265)
T ss_pred             EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence            99999999999998532    45889999999999999999999999999999999999999999999999998754321


Q ss_pred             -----ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          216 -----VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       216 -----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                           .........++..|+|||.+.+..++.++|+||||+++|+|++|..||........     .          ...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-----~----------~~~  220 (265)
T cd06631         156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-----M----------FYI  220 (265)
T ss_pred             cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-----H----------HHh
Confidence                 11112234578899999999988899999999999999999999999964321110     0          000


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ...  ..........++..+.+++.+||..+|++||++.++++
T Consensus       221 ~~~--~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         221 GAH--RGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             hhc--cCCCCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            000  00000111224567899999999999999999999875

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.5e-40  Score=299.94  Aligned_cols=250  Identities=24%  Similarity=0.384  Sum_probs=201.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ..+|++.+.||+|++|.||++.. .+++.||+|.+........+.+.+|+.+++.++|+|++++++++.. +...++|||
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e   96 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVME   96 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEeec
Confidence            36799999999999999999965 4789999999876655555678899999999999999999997766 668999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++..     ..+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ 
T Consensus        97 ~~~~~~L~~~~~~-----~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~-  170 (297)
T cd06656          97 YLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-  170 (297)
T ss_pred             ccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc-
Confidence            9999999999842     3478899999999999999999999999999999999999999999999999875433221 


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.............      .           ....
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~------~-----------~~~~  233 (297)
T cd06656         171 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------T-----------NGTP  233 (297)
T ss_pred             CcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeec------c-----------CCCC
Confidence            1223457889999999988889999999999999999999999996543211110000      0           0000


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ........+..+.+++.+||..+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         234 ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00111234456889999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.7e-41  Score=307.97  Aligned_cols=266  Identities=20%  Similarity=0.298  Sum_probs=196.1

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-----
Q 017232           58 EATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRH-----  129 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----  129 (375)
                      ...++|++.+.||.|+||.||+|.. .++..||+|++.....  .....+.+|+.+++.++||||+++++++...     
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   91 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN   91 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence            3457899999999999999999965 4688999999865422  2345677899999999999999999865432     


Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      ....+++++++ +++|.+++.     ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++
T Consensus        92 ~~~~~~~~~~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~  165 (343)
T cd07878          92 FNEVYLVTNLM-GADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLA  165 (343)
T ss_pred             cCcEEEEeecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccc
Confidence            24578999998 788988773     345899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchh--------HHHHH
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLS--------NLAIN  280 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~--------~~~~~  280 (375)
                      ......    .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||............        .....
T Consensus       166 ~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  241 (343)
T cd07878         166 RQADDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLK  241 (343)
T ss_pred             eecCCC----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            865432    223458999999998876 56889999999999999999999999654321110000        00000


Q ss_pred             HhhhhHHHHHHhhhcCCCCChH----HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          281 KIQNKALHELVDQTLGYESDNK----VRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~~~~----~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .+.......... .+.......    .......+.+++.+||..||++|||+.|+++.
T Consensus       242 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         242 KISSEHARKYIQ-SLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hcchhhHHHHhh-ccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            000000010000 000000000    01123457899999999999999999999964

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2e-40  Score=300.67  Aligned_cols=266  Identities=24%  Similarity=0.342  Sum_probs=200.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|++.+.||+|+||.||++... ++..+++|.+... ......++.+|+++++.++||||+++++++.. +..+++|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-DGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCEEEEEee
Confidence            36889999999999999999655 6788899988654 23344668899999999999999999998776 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      |+++++|.+++...    ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... 
T Consensus        80 y~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  154 (308)
T cd06615          80 HMDGGSLDQVLKKA----GRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM-  154 (308)
T ss_pred             ccCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc-
Confidence            99999999998533    458899999999999999999998 599999999999999999999999999986543221 


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHh---------------
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKI---------------  282 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---------------  282 (375)
                        .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...................               
T Consensus       155 --~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (308)
T cd06615         155 --ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPD  232 (308)
T ss_pred             --cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCC
Confidence              123457889999999988889999999999999999999999986433111000000000000               


Q ss_pred             --hhhHHHHHHhhhcCCCCCh-HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          283 --QNKALHELVDQTLGYESDN-KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       283 --~~~~~~~~~~~~l~~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                        ......+..+......... ....++.++.+++.+||..+|++|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         233 SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             ccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              0000111111111110000 001245678999999999999999999999876

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.8e-40  Score=295.99  Aligned_cols=252  Identities=27%  Similarity=0.388  Sum_probs=199.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .+.|++.+.||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+|++++++++.. +...++|||
T Consensus        11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   89 (292)
T cd06644          11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-DGKLWIMIE   89 (292)
T ss_pred             chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-CCeEEEEEe
Confidence            356889999999999999999765 588999999987776777888999999999999999999997766 567999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|..++...   ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        90 ~~~~~~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-~  165 (292)
T cd06644          90 FCPGGAVDAIMLEL---DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-Q  165 (292)
T ss_pred             cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc-c
Confidence            99999998887432   2458999999999999999999999999999999999999999999999999886533221 1


Q ss_pred             cccCCCCCccccCccccc-----ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          219 VSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ......++..|+|||.+.     ...++.++|||||||++|+|++|.+||......      ...         ..+...
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~------~~~---------~~~~~~  230 (292)
T cd06644         166 RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPM------RVL---------LKIAKS  230 (292)
T ss_pred             ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHH------HHH---------HHHhcC
Confidence            122335788999999874     345678999999999999999999998643211      000         000000


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..  ........++..+.+++.+||..+|++||+++++++
T Consensus       231 ~~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         231 EP--PTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             CC--ccCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00  000111234457889999999999999999999975

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=4.2e-40  Score=291.76  Aligned_cols=253  Identities=26%  Similarity=0.403  Sum_probs=204.0

Q ss_pred             CCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeec-CCceeEEEE
Q 017232           62 YFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSR-HSRELLLVY  137 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~  137 (375)
                      +|++.+.||.|+||.||++.. .++..+++|.+...  .....+.+..|+.+++.++|+|++++++++.. .+...+++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM   80 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence            478889999999999999954 46889999988643  33445678899999999999999999986543 355689999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHh-----hCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH-----ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-----~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      ||+++++|.+++.........+++..++.++.|++.||.|||     +.+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~  160 (265)
T cd08217          81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL  160 (265)
T ss_pred             hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence            999999999999766555677999999999999999999999     889999999999999999999999999998876


Q ss_pred             CCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..||.......       ....+         .
T Consensus       161 ~~~~~~-~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-------~~~~~---------~  223 (265)
T cd08217         161 GHDSSF-AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ-------LASKI---------K  223 (265)
T ss_pred             cCCccc-ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH-------HHHHH---------h
Confidence            543321 223458899999999988889999999999999999999999997543110       00011         1


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                         ...........+..+.+++.+|++.+|++||++.+|++.
T Consensus       224 ---~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         224 ---EGKFRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ---cCCCCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence               111111222455689999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.8e-40  Score=295.10  Aligned_cols=250  Identities=28%  Similarity=0.405  Sum_probs=197.3

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      |++.+.||.|+||.||+|... ++..+++|.+........+.+.+|+.+++.++|||++++++++.. +...++|+||++
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~~v~e~~~   85 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEFCA   85 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-CCEEEEEEEecC
Confidence            677889999999999999665 577889998876666667788899999999999999999997766 567899999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|..++...   ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ...
T Consensus        86 ~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~-~~~  161 (282)
T cd06643          86 GGAVDAVMLEL---ERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ-RRD  161 (282)
T ss_pred             CCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEcccccccccccccc-ccc
Confidence            99998887532   34689999999999999999999999999999999999999999999999999875432211 122


Q ss_pred             CCCCCccccCccccc-----ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          222 APQGTPGYVDPEYHQ-----CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      ...++..|+|||++.     +..++.++|||||||++|+|++|.+||.......      ....         .... ..
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~~~---------~~~~-~~  225 (282)
T cd06643         162 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR------VLLK---------IAKS-EP  225 (282)
T ss_pred             cccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH------HHHH---------Hhhc-CC
Confidence            345888999999873     4557889999999999999999999986443110      0000         0000 00


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       ........++..+.+++.+||+.+|++||++.++++.
T Consensus       226 -~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         226 -PTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             -CCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0000112245678999999999999999999988753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.8e-40  Score=295.53  Aligned_cols=254  Identities=26%  Similarity=0.415  Sum_probs=197.0

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecC-----C
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRH-----S  130 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~  130 (375)
                      .+.+.|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.+ +|+|++++++++...     .
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~   81 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD   81 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence            35567888999999999999999655 68889999886443 2335678899999998 699999999976542     2


Q ss_pred             ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          131 RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      ...+++|||+.+++|.+++...  ....+++..+..++.|++.||.|||+++++|+||+|+||++++++.++|+|||++.
T Consensus        82 ~~~~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~  159 (272)
T cd06637          82 DQLWLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSA  159 (272)
T ss_pred             cEEEEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCce
Confidence            4689999999999999998653  23468899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccccccCCCCCccccCccccc-----ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK  285 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (375)
                      ....... ......++..|+|||++.     +..++.++||||+||++|+|++|..||........     .        
T Consensus       160 ~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~-----~--------  225 (272)
T cd06637         160 QLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRA-----L--------  225 (272)
T ss_pred             ecccccc-cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHH-----H--------
Confidence            6533221 223345888999999875     34578899999999999999999999964321100     0        


Q ss_pred             HHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          286 ALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       286 ~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        ........   .......++..+.+++.+||..+|.+|||+.++++
T Consensus       226 --~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         226 --FLIPRNPA---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             --HHHhcCCC---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence              00000000   00001123457899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.9e-40  Score=297.42  Aligned_cols=250  Identities=25%  Similarity=0.344  Sum_probs=196.2

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      |+..+.||+|+||.||++... +++.||+|.+....   ......+.+|+.+++.++|+|++++++.+.. ....++|||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~-~~~~~lv~e   80 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYET-KDALCLVLT   80 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEec-CCEEEEEEE
Confidence            677888999999999999654 68899999886442   2223456789999999999999999997766 568999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+.+++|.+++...  ....+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........ 
T Consensus        81 ~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-  157 (285)
T cd05630          81 LMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT-  157 (285)
T ss_pred             ecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc-
Confidence            99999999988543  234589999999999999999999999999999999999999999999999999875433221 


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                       .....|+..|+|||.+.+..++.++||||+|+++|+|++|..||.........            ............  
T Consensus       158 -~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~------------~~~~~~~~~~~~--  222 (285)
T cd05630         158 -IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR------------EEVERLVKEVQE--  222 (285)
T ss_pred             -ccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH------------HHHHhhhhhhhh--
Confidence             12346899999999999889999999999999999999999999754321100            000000000000  


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPY-----MVDVLD  333 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~evl~  333 (375)
                        .....+...+.+++.+||+.+|++|||     ++|+++
T Consensus       223 --~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         223 --EYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             --hcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence              001123456889999999999999999     778876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6e-40  Score=288.72  Aligned_cols=248  Identities=26%  Similarity=0.427  Sum_probs=196.4

Q ss_pred             CccCCCCcEEEEEEEeCCCCEEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCCh
Q 017232           67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTV  145 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L  145 (375)
                      ++||.|++|.||++...+++.|++|.+...... ....+.+|+.++++++|+||+++++++.. ....++||||+.+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~~~~~~l   79 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQ-KQPIYIVMELVPGGSL   79 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEec-CCCeEEEEEcCCCCcH
Confidence            469999999999998777999999988765433 45678999999999999999999997765 5678999999999999


Q ss_pred             hHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc-cCCC
Q 017232          146 ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS-TAPQ  224 (375)
Q Consensus       146 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~-~~~~  224 (375)
                      .+++...   ...+++..+..++.+++.||.|||+++++|+||+|+||+++.++.++|+|||++........... ....
T Consensus        80 ~~~l~~~---~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (251)
T cd05041          80 LTFLRKK---KNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQ  156 (251)
T ss_pred             HHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCc
Confidence            9998542   23578889999999999999999999999999999999999999999999999876542221111 1122


Q ss_pred             CCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHH
Q 017232          225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKV  303 (375)
Q Consensus       225 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  303 (375)
                      .+..|+|||.+.+..++.++|+||||+++|+|++ |..||.......                ....+......   ...
T Consensus       157 ~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~----------------~~~~~~~~~~~---~~~  217 (251)
T cd05041         157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ----------------TRERIESGYRM---PAP  217 (251)
T ss_pred             ceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH----------------HHHHHhcCCCC---CCC
Confidence            3567999999988889999999999999999998 888886443110                00111111000   011


Q ss_pred             HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          304 RRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       304 ~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                      ..++..+.+++.+|+..+|++|||+.||++.|+.
T Consensus       218 ~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~~  251 (251)
T cd05041         218 QLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQI  251 (251)
T ss_pred             ccCCHHHHHHHHHHhccChhhCcCHHHHHHHhhC
Confidence            2345679999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-40  Score=294.15  Aligned_cols=257  Identities=23%  Similarity=0.389  Sum_probs=202.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGR----AVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      .+|++.+.||+|+||.||+|..+ +|.    .+++|.+.... ......+.+|+.+++.++|||++++++++..  ...+
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~   84 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQ   84 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceE
Confidence            46888999999999999999654 333    58999876553 3345678899999999999999999997765  5789


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++++|.+++...   ...+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+.....
T Consensus        85 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~  161 (279)
T cd05057          85 LITQLMPLGCLLDYVRNH---KDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDV  161 (279)
T ss_pred             EEEecCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccC
Confidence            999999999999998543   33589999999999999999999999999999999999999999999999999986653


Q ss_pred             Cccccc-cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          215 HVTHVS-TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       215 ~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ...... ....++..|+|||.+....++.++|+||||+++||+++ |..||+......                ....+.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~  225 (279)
T cd05057         162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE----------------IPDLLE  225 (279)
T ss_pred             cccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH----------------HHHHHh
Confidence            322111 11223568999999988889999999999999999998 999997543111                011111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ..   ...+.+..+...+.+++.+||..+|++||++.++++.|+++.++
T Consensus       226 ~~---~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         226 KG---ERLPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             CC---CCCCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence            10   01111112345688999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=4.7e-40  Score=290.34  Aligned_cols=251  Identities=30%  Similarity=0.507  Sum_probs=199.1

Q ss_pred             CCCCCccCCCCcEEEEEEEeCC-----CCEEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           63 FDSARELGDGGFGTVYYGELQD-----GRAVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      +++.+.||.|+||.||++....     +..||+|.+...... ..+.+..|+.+++.++|+||+++++++.. ....+++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-EEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-CCeeEEE
Confidence            4567889999999999996653     378999998665433 56788999999999999999999997776 4679999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++....  ...+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       80 MEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             EeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            99999999999986432  1228999999999999999999999999999999999999999999999999997665432


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      ........+++.|+|||.+.+..++.++||||+|+++++|++ |.+||.......      ..          ..+... 
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~------~~----------~~~~~~-  220 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEE------VL----------EYLKKG-  220 (258)
T ss_pred             ccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHH------HH----------HHHhcC-
Confidence            222212336789999999988889999999999999999998 888886532110      00          000000 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL  335 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L  335 (375)
                        .........+..+.+++.+|+..+|++|||+.++++.|
T Consensus       221 --~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      221 --YRLPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --CCCCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence              01111122556799999999999999999999999864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.4e-40  Score=293.14  Aligned_cols=240  Identities=24%  Similarity=0.382  Sum_probs=186.6

Q ss_pred             CccCCCCcEEEEEEEeCC-------------CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           67 RELGDGGFGTVYYGELQD-------------GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      +.||+|+||.||+|...+             ...+++|.+..........+..|+.+++.++||||+++++++.. ....
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-DVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCCC
Confidence            368999999999996532             23588898766555555678889999999999999999997766 5567


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc-------EEEeee
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC-------VKVADF  206 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~-------~kl~Df  206 (375)
                      ++||||+++++|..++...   ...+++..++.++.|++.||+|||++|++||||||+|||++.++.       ++++||
T Consensus        80 ~lv~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~  156 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRK---SDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDP  156 (262)
T ss_pred             EEEEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCC
Confidence            9999999999998887432   345899999999999999999999999999999999999987664       899999


Q ss_pred             ccccccCCCccccccCCCCCccccCccccc-ccCCCCchhHHHHHHHHHHHH-hCCCCccccccccccchhHHHHHHhhh
Q 017232          207 GLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ-CYQLTDKSDVFSFGVVLIELI-SSMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       207 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      |++......     ....++..|+|||.+. +..++.++|||||||++|+|+ +|..|+.......      .       
T Consensus       157 g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~-------  218 (262)
T cd05077         157 GIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAE------K-------  218 (262)
T ss_pred             CCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhH------H-------
Confidence            998654322     1234778899999876 567889999999999999997 5888876432110      0       


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                         ............     .....+.+++.+||+.+|++||++.+|++.|+
T Consensus       219 ---~~~~~~~~~~~~-----~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         219 ---ERFYEGQCMLVT-----PSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             ---HHHHhcCccCCC-----CChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence               000111111000     12356889999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=9.5e-41  Score=301.85  Aligned_cols=264  Identities=21%  Similarity=0.302  Sum_probs=196.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|.+.+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++||||+++++++.. ....++|||
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~-~~~~~lv~e   84 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFE   84 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEec-CCeEEEEEe
Confidence            56889999999999999999665 68899999986442 2223457789999999999999999997766 677999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+. ++|.+++...   ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........ 
T Consensus        85 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~-  159 (301)
T cd07873          85 YLD-KDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  159 (301)
T ss_pred             ccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC-
Confidence            996 6888888543   34588999999999999999999999999999999999999999999999999875432221 


Q ss_pred             cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHh---hhhHHHHHHhh-
Q 017232          219 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKI---QNKALHELVDQ-  293 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~-  293 (375)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|++||.........   ......+   .......++.. 
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  236 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNE  236 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCChhhchhhhccc
Confidence            1223357889999998765 45788999999999999999999999754322111   0000000   00001111100 


Q ss_pred             -----hcCCCCC----hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          294 -----TLGYESD----NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       294 -----~l~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                           .......    .....++..+.+++.+||..+|.+|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence                 0000000    001124557889999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.7e-40  Score=290.28  Aligned_cols=249  Identities=23%  Similarity=0.402  Sum_probs=200.8

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|++.+.||+|+||.||++... +|+.|++|.+...  .......+.+|+.+++.++||||+++++++.. ....++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEE-NGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecC-CCeEEEEEe
Confidence            5888999999999999999554 6889999998643  23345678899999999999999999997765 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+.+++|.+.+...  ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  157 (256)
T cd08218          80 YCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL  157 (256)
T ss_pred             cCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh
Confidence            99999999988543  2235788999999999999999999999999999999999999999999999998765432211


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                       .....+++.|+|||.+.+..++.++|+||||+++++|++|..||......                   +.+...+...
T Consensus       158 -~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~-------------------~~~~~~~~~~  217 (256)
T cd08218         158 -ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK-------------------NLVLKIIRGS  217 (256)
T ss_pred             -hhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH-------------------HHHHHHhcCC
Confidence             12234788899999998888999999999999999999999998643211                   1111111111


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .......+...+.+++.+||+.+|++||++.+|++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         218 YPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             CCCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence            22222345567999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=6.1e-40  Score=291.72  Aligned_cols=255  Identities=26%  Similarity=0.420  Sum_probs=201.1

Q ss_pred             CCCCCCccCCCCcEEEEEEEeCC--CCEEEEEEeccc----------chhhHHHHHHHHHHHHh-cCCCCeEEEeeeeec
Q 017232           62 YFDSARELGDGGFGTVYYGELQD--GRAVAVKRLYEN----------NYKRVEQFMNEVDILAR-LRHKNLVSLYGCTSR  128 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~----------~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~  128 (375)
                      .|++.+.||+|+||.||+|....  ++.+++|.+...          .......+.+|+.++.. ++|||++++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999997654  688999987532          22334567788888765 799999999997766


Q ss_pred             CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCCCcEEEeeec
Q 017232          129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNNFCVKVADFG  207 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~~~~kl~Dfg  207 (375)
                       +...+++|||+++++|.+++.........+++..++.++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||
T Consensus        81 -~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg  159 (269)
T cd08528          81 -NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG  159 (269)
T ss_pred             -CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence             678999999999999999886554455678999999999999999999996 689999999999999999999999999


Q ss_pred             cccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH
Q 017232          208 LSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL  287 (375)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (375)
                      .+.......  ......++..|+|||.+.+..++.++|+||||+++|+|++|.+||.......      .. .       
T Consensus       160 ~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~------~~-~-------  223 (269)
T cd08528         160 LAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS------LA-T-------  223 (269)
T ss_pred             ceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH------HH-H-------
Confidence            997654432  2234458889999999988889999999999999999999999986443110      00 0       


Q ss_pred             HHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          288 HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       288 ~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                       .+........   .....+..+.+++.+||+.+|++||++.|+..++++
T Consensus       224 -~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~~  269 (269)
T cd08528         224 -KIVEAVYEPL---PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMISD  269 (269)
T ss_pred             -HHhhccCCcC---CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhcC
Confidence             1111110000   001234678999999999999999999999998863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.7e-40  Score=309.22  Aligned_cols=265  Identities=23%  Similarity=0.267  Sum_probs=197.1

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ---DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ...+|.+.+.||.|+||.||++...   .+..|++|.+....     ...+|+.+++.++||||+++++++.. ....++
T Consensus        90 ~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~-----~~~~E~~il~~l~h~~iv~~~~~~~~-~~~~~l  163 (392)
T PHA03207         90 VRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK-----TPGREIDILKTISHRAIINLIHAYRW-KSTVCM  163 (392)
T ss_pred             ccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc-----cHHHHHHHHHhcCCCCccceeeeEee-CCEEEE
Confidence            3457999999999999999999643   35789999875432     34579999999999999999997765 567899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      |||++. ++|.+++.    ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus       164 v~e~~~-~~l~~~l~----~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        164 VMPKYK-CDLFTYVD----RSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EehhcC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            999995 68888883    3356899999999999999999999999999999999999999999999999998765433


Q ss_pred             cc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh---------
Q 017232          216 VT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK---------  285 (375)
Q Consensus       216 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------  285 (375)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................+.+...         
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            22 12234568999999999999899999999999999999999999996544322111111111110000         


Q ss_pred             -HHHHHHhhh---cCCCC--ChH--HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          286 -ALHELVDQT---LGYES--DNK--VRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       286 -~~~~~~~~~---l~~~~--~~~--~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       .....+...   .....  +..  ......++.+++.+||..+|++|||+.|++..
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence             000000000   00000  000  01124568889999999999999999999875

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.1e-39  Score=289.68  Aligned_cols=250  Identities=27%  Similarity=0.436  Sum_probs=194.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-----chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-Ccee
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-----NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-SREL  133 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~  133 (375)
                      .+|+..+.||+|+||.||+|... ++..|++|.+...     .......+.+|+.+++.++||||+++++++... ....
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            46889999999999999999654 6889999987543     123345688899999999999999999976543 4678


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++++||+++++|.+++..    ...+++...+.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~  157 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ  157 (266)
T ss_pred             EEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence            899999999999999853    2358899999999999999999999999999999999999999999999999987553


Q ss_pred             CCcc--ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          214 NHVT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       214 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ....  .......++..|+|||.+.+..++.++||||+||++|+|++|+.||.......               ......
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~---------------~~~~~~  222 (266)
T cd06651         158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA---------------AIFKIA  222 (266)
T ss_pred             cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHH---------------HHHHHh
Confidence            2111  11122347889999999998889999999999999999999999997432110               000000


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                         ........+......+.+++ +|+..+|++||+++||++
T Consensus       223 ---~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         223 ---TQPTNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             ---cCCCCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence               00001111122345566777 688899999999999975

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=6.6e-40  Score=291.37  Aligned_cols=254  Identities=22%  Similarity=0.344  Sum_probs=197.0

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..++++.....||+|+||.||+|... ++..|++|.+........+.+.+|+.+++.++|+||+++++++.. +...++|
T Consensus         5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv   83 (268)
T cd06624           5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSE-NGFFKIF   83 (268)
T ss_pred             cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeecc-CCEEEEE
Confidence            34455666678999999999999654 678899999877766667789999999999999999999997766 5789999


Q ss_pred             EecccCCChhHhhccCCCCCCCC--ChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC-CCcEEEeeeccccccC
Q 017232          137 YEFISNGTVADHLHGERAKPGAL--PWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-NFCVKVADFGLSRLFP  213 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l--~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~  213 (375)
                      +||+++++|.+++....   ..+  ++..+..++.|++.||.|||+.|++|+||||+||+++. ++.++|+|||.+....
T Consensus        84 ~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          84 MEQVPGGSLSALLRSKW---GPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             EecCCCCCHHHHHHHhc---ccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99999999999986432   234  77888899999999999999999999999999999976 6799999999987653


Q ss_pred             CCccccccCCCCCccccCccccccc--CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          214 NHVTHVSTAPQGTPGYVDPEYHQCY--QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       214 ~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      .... ......+++.|+|||.+.+.  .++.++|+||||+++|+|++|.+||.........   .+.             
T Consensus       161 ~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~---~~~-------------  223 (268)
T cd06624         161 GINP-CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA---MFK-------------  223 (268)
T ss_pred             cCCC-ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh---Hhh-------------
Confidence            3221 12223478899999987654  3788999999999999999999998643211100   000             


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       ..........+..+...+.+++.+||+.+|++|||+.+++.
T Consensus       224 -~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         224 -VGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             -hhhhccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence             00000001111234567889999999999999999999885

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.4e-40  Score=295.60  Aligned_cols=271  Identities=25%  Similarity=0.405  Sum_probs=204.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-----CCCEEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEeeeeec-CCcee
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYGCTSR-HSREL  133 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~  133 (375)
                      ..|++.+.||+|+||.||+|...     ++..+|+|.+...... ....+.+|+.+++.++|+||+++++++.. .....
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~   83 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL   83 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence            35778899999999999999753     3678999998765443 46789999999999999999999996654 24468


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      +++|||+++++|.+++....   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus        84 ~lv~e~~~~~~l~~~l~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  160 (284)
T cd05038          84 RLIMEYLPSGSLRDYLQRHR---DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLP  160 (284)
T ss_pred             EEEEecCCCCCHHHHHHhCc---cccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccc
Confidence            99999999999999996432   358999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcccc--ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          214 NHVTHV--STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       214 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ......  .....++..|+|||...+..++.++||||||+++|+|++|..|+............. ...........+.+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  239 (284)
T cd05038         161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGI-AQGQMIVTRLLELL  239 (284)
T ss_pred             cCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcccccc-ccccccHHHHHHHH
Confidence            322211  112234567999999988889999999999999999999998875432111000000 00000011111122


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                      ......   +....++..+.+++.+||+.+|++|||+.+|+++|+.+
T Consensus       240 ~~~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         240 KEGERL---PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HcCCcC---CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            211111   11123456799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.1e-40  Score=296.26  Aligned_cols=265  Identities=28%  Similarity=0.377  Sum_probs=204.1

Q ss_pred             cchHHHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeec
Q 017232           51 FSYGELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSR  128 (375)
Q Consensus        51 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  128 (375)
                      +...++..+.++|.+.+.||+|+||.||++... +++.+|+|.+..... ....+.+|+.+++.+ +|||++++++++..
T Consensus        12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~-~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISD-VDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccccc-HHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            445556667889999999999999999999664 688999998865432 235677899999999 79999999997654


Q ss_pred             CC----ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEe
Q 017232          129 HS----RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVA  204 (375)
Q Consensus       129 ~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~  204 (375)
                      .+    ...++||||+++++|.+++.........+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~  170 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLV  170 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEe
Confidence            22    46899999999999999886544455678999999999999999999999999999999999999999999999


Q ss_pred             eeccccccCCCccccccCCCCCccccCccccccc-----CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHH
Q 017232          205 DFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY-----QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAI  279 (375)
Q Consensus       205 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  279 (375)
                      |||++........ ......++..|+|||.+...     .++.++|||||||++|+|++|++||........        
T Consensus       171 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~--------  241 (291)
T cd06639         171 DFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT--------  241 (291)
T ss_pred             ecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHH--------
Confidence            9999876543221 11234578899999987543     368899999999999999999999964321110        


Q ss_pred             HHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          280 NKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       280 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                             ...+...... .. .........+.+++.+||+.+|++||++.++++.
T Consensus       242 -------~~~~~~~~~~-~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         242 -------LFKIPRNPPP-TL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             -------HHHHhcCCCC-CC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                   0000000000 00 0012234568999999999999999999999863

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.2e-39  Score=291.22  Aligned_cols=248  Identities=25%  Similarity=0.402  Sum_probs=200.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ..|+..+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.+++.++|+|++++++++.. +...++|||
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   82 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIME   82 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEEEe
Confidence            34778889999999999999765 58899999886543 3445678899999999999999999997776 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++..     ..+++.++..++.|++.||+|||+.+++|+||+|+||+++.++.++|+|||++........ 
T Consensus        83 ~~~~~~L~~~i~~-----~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~-  156 (277)
T cd06640          83 YLGGGSALDLLRA-----GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-  156 (277)
T ss_pred             cCCCCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence            9999999998842     3588899999999999999999999999999999999999999999999999876543221 


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.........                ...   ....
T Consensus       157 ~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~----------------~~~---~~~~  217 (277)
T cd06640         157 KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVL----------------FLI---PKNN  217 (277)
T ss_pred             ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHh----------------hhh---hcCC
Confidence            122335788999999998888999999999999999999999998744321100                000   0011


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .......++..+.+++.+||+.+|++||++.++++.
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence            112223456778999999999999999999999765

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-40  Score=294.39  Aligned_cols=253  Identities=28%  Similarity=0.420  Sum_probs=201.4

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .++|++.+.||.|++|.||++... ++..+++|.+........+.+.+|+.+++.++|||++++++.+.. +...++|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFY-ENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEec-CCeEEEEee
Confidence            356889999999999999999764 688999999877766677789999999999999999999997766 667899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ 
T Consensus        83 ~~~~~~L~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~-  158 (280)
T cd06611          83 FCDGGALDSIMLEL---ERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ-  158 (280)
T ss_pred             ccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccccc-
Confidence            99999999998543   24589999999999999999999999999999999999999999999999998865433221 


Q ss_pred             cccCCCCCccccCccccc-----ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          219 VSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ......+++.|+|||.+.     ...++.++|+||||+++|+|++|++||.......      ..         ..+...
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~------~~---------~~~~~~  223 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR------VL---------LKILKS  223 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH------HH---------HHHhcC
Confidence            112335888999999864     3457789999999999999999999997543110      00         000000


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                        ..........++..+.+++.+||..+|.+||++.++++.
T Consensus       224 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         224 --EPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             --CCCCcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence              000001112345678899999999999999999999764

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.2e-40  Score=290.93  Aligned_cols=248  Identities=25%  Similarity=0.421  Sum_probs=196.6

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---------hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---------KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  131 (375)
                      +|.+...||.|++|.||+|... +++.|++|.+.....         ...+.+.+|+.+++.++||||+++++++.. ..
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD-AD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe-CC
Confidence            4778899999999999999654 688999998854321         123567889999999999999999997766 56


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ..++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+..
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~  155 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNY----GAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK  155 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence            789999999999999999532    4588899999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcc-----ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH
Q 017232          212 FPNHVT-----HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA  286 (375)
Q Consensus       212 ~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (375)
                      ......     .......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.......               .
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---------------~  220 (267)
T cd06628         156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ---------------A  220 (267)
T ss_pred             cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH---------------H
Confidence            642111     11112347889999999988889999999999999999999999997532110               0


Q ss_pred             HHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          287 LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       287 ~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ......    ..........+..+.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         221 IFKIGE----NASPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHhc----cCCCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            000000    0011111234567899999999999999999999885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.8e-40  Score=302.73  Aligned_cols=242  Identities=24%  Similarity=0.363  Sum_probs=190.1

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv  136 (375)
                      +|+..+.||+|+||.||+|... +|+.||+|++....   ....+.+..|..++..+. |++|+++++++.. ...+++|
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~-~~~~~lv   79 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQT-VDRLYFV   79 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEec-CCEEEEE
Confidence            3677889999999999999654 68999999986542   233456778888888886 5677788886665 5679999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++..    ...+++.++..++.|++.||.|||++|++||||||+|||++.++.++|+|||++.......
T Consensus        80 ~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~  155 (323)
T cd05615          80 MEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG  155 (323)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence            999999999998843    3458999999999999999999999999999999999999999999999999987532221


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      . ......||+.|+|||++.+..++.++||||+||++|+|++|.+||.......               ....+......
T Consensus       156 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~---------------~~~~i~~~~~~  219 (323)
T cd05615         156 V-TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE---------------LFQSIMEHNVS  219 (323)
T ss_pred             c-cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHH---------------HHHHHHhCCCC
Confidence            1 1223458999999999998899999999999999999999999997543110               01111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMV  329 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~  329 (375)
                        .   +...+..+.+++.+||+.+|.+|++..
T Consensus       220 --~---p~~~~~~~~~li~~~l~~~p~~R~~~~  247 (323)
T cd05615         220 --Y---PKSLSKEAVSICKGLMTKHPSKRLGCG  247 (323)
T ss_pred             --C---CccCCHHHHHHHHHHcccCHhhCCCCC
Confidence              0   112346788999999999999999853

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4e-40  Score=295.30  Aligned_cols=263  Identities=25%  Similarity=0.336  Sum_probs=203.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|++.+.||+|+||+||++... ++..||+|++.... ....+.+.+|+++++.++||||+++++++.. ...+++|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   83 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLN-ENNICMCME   83 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEec-CCEEEEEEe
Confidence            56888999999999999999655 68899999876543 3345678899999999999999999997776 578999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      |+++++|.+++..    .+.+++..+..++.+++.||.|||+ .+++|+||+|+||++++++.++|+|||++........
T Consensus        84 ~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~  159 (284)
T cd06620          84 FMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIA  159 (284)
T ss_pred             cCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhcc
Confidence            9999999998843    3468999999999999999999997 5899999999999999999999999998865432211


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                         ....++..|+|||++.+..++.++|+|||||++|+|++|..||...........        ......+........
T Consensus       160 ---~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~--------~~~~~~~~~~~~~~~  228 (284)
T cd06620         160 ---DTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD--------DPMGILDLLQQIVQE  228 (284)
T ss_pred             ---CccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhh--------hhhHHHHHHHHHhhc
Confidence               234588999999998888899999999999999999999999975443211000        000011111111111


Q ss_pred             CC-ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          298 ES-DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       298 ~~-~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      .. ......++..+.+++.+|++.+|++|||+.|+++...-++
T Consensus       229 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         229 PPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             cCCCCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            00 0011124567899999999999999999999998744333

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.7e-40  Score=294.13  Aligned_cols=253  Identities=23%  Similarity=0.380  Sum_probs=198.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|++.+.||+|+||.||++... ++..||+|.+... .......+.+|+.++++++|+||+++++++.. ....++|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFI-EGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheec-CCeEEEEEe
Confidence            35888999999999999999765 7899999988654 33445678899999999999999999997766 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      |+++++|..++.... ....+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||++....... 
T Consensus        80 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~-  157 (286)
T cd06622          80 YMDAGSLDKLYAGGV-ATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL-  157 (286)
T ss_pred             ecCCCCHHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence            999999998885431 23468999999999999999999997 599999999999999999999999999987553322 


Q ss_pred             ccccCCCCCccccCccccccc------CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          218 HVSTAPQGTPGYVDPEYHQCY------QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                        .....+++.|+|||.+.+.      .++.++|+|||||++|+|++|..||.......      .          ...+
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~------~----------~~~~  219 (286)
T cd06622         158 --AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN------I----------FAQL  219 (286)
T ss_pred             --cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh------H----------HHHH
Confidence              1233578899999987553      35789999999999999999999996432110      0          0000


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ..............+..++.+++.+||+.+|++||++.++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         220 SAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             HHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence            1111111112223356788999999999999999999999873

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=4.8e-40  Score=289.91  Aligned_cols=247  Identities=28%  Similarity=0.457  Sum_probs=197.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ++|++.+.||+|+||.||++.. +++.|++|.+....  ....+.+|+.+++.++|||++++++++..  ...+++|||+
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~--~~~~~v~e~~   80 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH--NGLYIVMELM   80 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC--CCcEEEEECC
Confidence            4588999999999999999875 57889999886543  23578899999999999999999997754  3479999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      .+++|.+++...  ....+++..++.++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.......    
T Consensus        81 ~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~----  154 (254)
T cd05083          81 SKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV----  154 (254)
T ss_pred             CCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC----
Confidence            999999999643  23458899999999999999999999999999999999999999999999999987543211    


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      .....+..|+|||.+.+..++.++|+||||+++|+|++ |.+||.......      .          ............
T Consensus       155 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~------~----------~~~~~~~~~~~~  218 (254)
T cd05083         155 DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE------V----------KECVEKGYRMEP  218 (254)
T ss_pred             CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH------H----------HHHHhCCCCCCC
Confidence            12234568999999988889999999999999999997 999986443110      0          011111111111


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                         ...++..+.+++.+||+.+|++||++.++++.|++
T Consensus       219 ---~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         219 ---PEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ---CCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence               12345678899999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.8e-40  Score=302.45  Aligned_cols=193  Identities=24%  Similarity=0.301  Sum_probs=161.5

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ...+|++.+.||+|+||.||+|... ++..||+|.....      ....|+.+++.++||||+++++++.. ....++||
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~  136 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVS-GAITCMVL  136 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEe-CCeeEEEE
Confidence            3467999999999999999999665 5778999975332      23468999999999999999997776 56789999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      |++. ++|.+++..   ....+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... 
T Consensus       137 e~~~-~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-  211 (357)
T PHA03209        137 PHYS-SDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP-  211 (357)
T ss_pred             EccC-CcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCc-
Confidence            9995 688888743   33568999999999999999999999999999999999999999999999999987432211 


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCC-CCcc
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSM-PAVD  264 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~p~~  264 (375)
                       ......||..|+|||++.+..++.++|||||||++|||+++. ++|+
T Consensus       212 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~  258 (357)
T PHA03209        212 -AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFE  258 (357)
T ss_pred             -ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcccc
Confidence             122345899999999999889999999999999999999854 4444

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.6e-40  Score=295.08  Aligned_cols=266  Identities=24%  Similarity=0.378  Sum_probs=197.6

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|++.+.||+|++|.||+|..+ +++.||+|++....  ....+.+.+|+.+++.++|+|++++++++.. ....++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRR-KRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEee-CCEEEEEE
Confidence            46889999999999999999766 58999999886442  2223567889999999999999999997776 66789999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+++++|..++.    ....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        80 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07847          80 EYCDHTVLNELEK----NPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD  155 (286)
T ss_pred             eccCccHHHHHHh----CCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc
Confidence            9999888887763    234589999999999999999999999999999999999999999999999999986644321


Q ss_pred             ccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh----
Q 017232          218 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD----  292 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  292 (375)
                       ......++..|+|||.+.+ ..++.++||||||+++|+|++|.+||...................... ..+..+    
T Consensus       156 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  233 (286)
T cd07847         156 -DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPR-HQQIFSTNQF  233 (286)
T ss_pred             -cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChH-Hhhhcccccc
Confidence             1123347788999998765 457889999999999999999999997544222110000000000000 000000    


Q ss_pred             ------hhcCCCC--ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          293 ------QTLGYES--DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       293 ------~~l~~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                            +......  .......+..+.+++.+||+.+|++||++.+++.
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         234 FKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             cccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence                  0000000  0011223567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.2e-39  Score=289.79  Aligned_cols=254  Identities=25%  Similarity=0.309  Sum_probs=188.2

Q ss_pred             CccCCCCcEEEEEEEeCC---CCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccC
Q 017232           67 RELGDGGFGTVYYGELQD---GRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISN  142 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  142 (375)
                      +.||+|+||.||+|...+   +..+++|.+.... ......+.+|+.+++.++||||+++++++.. ....++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTE-VTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CCCcEEEEECCCC
Confidence            359999999999997643   4578999886543 2334578889999999999999999997765 5678999999999


Q ss_pred             CChhHhhccCCC-CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc-cc
Q 017232          143 GTVADHLHGERA-KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VS  220 (375)
Q Consensus       143 ~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~  220 (375)
                      ++|.+++..... .....++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......... ..
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            999999965432 2234567778889999999999999999999999999999999999999999998754332211 11


Q ss_pred             cCCCCCccccCccccccc-------CCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          221 TAPQGTPGYVDPEYHQCY-------QLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ....++..|+|||++.+.       .++.++||||||+++|||++ |..||.........      ....        ..
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~------~~~~--------~~  225 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVL------TYTV--------RE  225 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHH------HHHh--------hc
Confidence            233567889999987642       35789999999999999996 99999654321100      0000        00


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                      .................+.+++..|+ .+|++|||+++|+..|.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         226 QQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00100111101123356788999998 68999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.6e-39  Score=335.46  Aligned_cols=263  Identities=25%  Similarity=0.400  Sum_probs=205.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ...|...+.||+|+||.||+|.. .++..||+|++......    ...|+.++++++||||+++++++.. ....++|||
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~-~~~~~lv~E  763 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRS-EKGAYLIHE  763 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEc-CCCCEEEEe
Confidence            34578888999999999999976 47899999988644322    2346889999999999999998876 567899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHh---hCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH---ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      |+++|+|.+++.       .++|..+..++.|++.||+|||   +.+++||||||+||+++.++..++. |+........
T Consensus       764 y~~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~  835 (968)
T PLN00113        764 YIEGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD  835 (968)
T ss_pred             CCCCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC
Confidence            999999999994       2789999999999999999999   6699999999999999999888875 6654332111


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                           ....+++.|+|||++.+..++.++|||||||++|||+||+.||+.... .......|............++++.+
T Consensus       836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  909 (968)
T PLN00113        836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCYSDCHLDMWIDPSI  909 (968)
T ss_pred             -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhcCccchhheeCccc
Confidence                 122578999999999998999999999999999999999999954322 22234444443333334444555554


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      ...... ..+...++.+++.+|++.+|++||||.||++.|+++.+..
T Consensus       910 ~~~~~~-~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~~  955 (968)
T PLN00113        910 RGDVSV-NQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRSS  955 (968)
T ss_pred             cCCCCc-cHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhccc
Confidence            332221 2344567889999999999999999999999999876543

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.6e-40  Score=309.82  Aligned_cols=264  Identities=21%  Similarity=0.230  Sum_probs=193.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ..+|.+.+.||+|+||.||+|... .++.||+|....      ..+.+|+.++++++|+||+++++++.. +...++|||
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~------~~~~~E~~iL~~L~HpnIv~l~~~~~~-~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY------ASSVHEARLLRRLSHPAVLALLDVRVV-GGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc------cCHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEEE
Confidence            346999999999999999999665 578899996422      235689999999999999999997766 567899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc-
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT-  217 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-  217 (375)
                      ++. ++|.+++...   ...+++.+++.++.|++.||.|||++||+||||||+|||++.++.++|+|||++........ 
T Consensus       241 ~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~  316 (461)
T PHA03211        241 KYR-SDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST  316 (461)
T ss_pred             ccC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc
Confidence            995 7888887432   24689999999999999999999999999999999999999999999999999976543221 


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCc-cccccccccchhHHHHHHhhhhH----------
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAV-DITRHRHEINLSNLAINKIQNKA----------  286 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~----------  286 (375)
                      .......||..|+|||++.+..++.++|||||||++|||++|..++ ................+.+....          
T Consensus       317 ~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~  396 (461)
T PHA03211        317 PFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHA  396 (461)
T ss_pred             ccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCc
Confidence            1122346899999999999989999999999999999999987543 33221111111111111111100          


Q ss_pred             ---HHHHHhhhc----C--CCC--ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          287 ---LHELVDQTL----G--YES--DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       287 ---~~~~~~~~l----~--~~~--~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                         +...+....    .  ...  ..........+.+|+.+||+.||.+|||+.|+++.
T Consensus       397 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        397 GSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             chHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence               000000000    0  000  01111233468899999999999999999999864

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=5.7e-40  Score=291.20  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=200.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|+..+.||.|++|.||++..+ +++.+++|.+.... ......+.+|+++++.++||||+++++.+.. ....++++|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-NGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-CCEEEEEEE
Confidence            35778899999999999999665 68899999886653 3445678899999999999999999997766 578999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      |+.+++|.+++....   ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus        80 ~~~~~~L~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          80 YMDGGSLDKILKEVQ---GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             ecCCCcHHHHHHHcc---CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            999999999986432   568899999999999999999999 9999999999999999999999999999875532221


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                      .   ...++..|+|||.+.+..++.++||||||+++|+|++|..||.........              ..+........
T Consensus       157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~--------------~~~~~~~~~~~  219 (265)
T cd06605         157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG--------------IFELLQYIVNE  219 (265)
T ss_pred             h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccccccc--------------HHHHHHHHhcC
Confidence            1   145888999999999889999999999999999999999999654321110              00111111111


Q ss_pred             CCChHHH-HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          298 ESDNKVR-RTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       298 ~~~~~~~-~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ....... .++..+.+++.+||..+|++|||+.+++.
T Consensus       220 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         220 PPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             CCCCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            1111111 15567999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=5.6e-40  Score=292.69  Aligned_cols=239  Identities=25%  Similarity=0.378  Sum_probs=184.8

Q ss_pred             ccCCCCcEEEEEEEeCC-------------------------CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEE
Q 017232           68 ELGDGGFGTVYYGELQD-------------------------GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL  122 (375)
Q Consensus        68 ~lg~G~~g~V~~~~~~~-------------------------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~  122 (375)
                      .||+|+||.||+|....                         ...|++|.+..........+.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            59999999999996421                         13588898866554445678889999999999999999


Q ss_pred             eeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC---
Q 017232          123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF---  199 (375)
Q Consensus       123 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~---  199 (375)
                      ++++.. ....++||||+++++|..++...   ...+++..+..++.|++.||+|||++|++||||||+||+++..+   
T Consensus        82 ~~~~~~-~~~~~lv~ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~  157 (274)
T cd05076          82 HGVCVR-GSENIMVEEFVEHGPLDVCLRKE---KGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAE  157 (274)
T ss_pred             EEEEEe-CCceEEEEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCccc
Confidence            998776 56789999999999999988532   34688999999999999999999999999999999999997643   


Q ss_pred             ----cEEEeeeccccccCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHH-hCCCCccccccccccc
Q 017232          200 ----CVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELI-SSMPAVDITRHRHEIN  273 (375)
Q Consensus       200 ----~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~ell-tg~~p~~~~~~~~~~~  273 (375)
                          .++++|||.+......     ....++..|+|||.+.+ ..++.++||||||+++|||+ +|..||........  
T Consensus       158 ~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~--  230 (274)
T cd05076         158 GTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK--  230 (274)
T ss_pred             CccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH--
Confidence                3899999987543221     12246788999998765 56889999999999999995 79999865432110  


Q ss_pred             hhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          274 LSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                                    ........... .    .....+.+++.+||+.+|++|||+.+|++.|.
T Consensus       231 --------------~~~~~~~~~~~-~----~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         231 --------------ERFYEKKHRLP-E----PSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             --------------HHHHHhccCCC-C----CCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence                          00111111100 0    12246889999999999999999999998873

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=295.85  Aligned_cols=252  Identities=23%  Similarity=0.338  Sum_probs=199.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|++|.||+|... +++.||+|.+.....   .....+..|+.+++.++|+||+++++.+.. ....++|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQT-ETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeec-CCEEEEE
Confidence            36888999999999999999665 589999999865432   245678899999999999999999997765 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+.+++|.+++...  ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++.......
T Consensus        80 ~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  157 (316)
T cd05574          80 MDYCPGGELFRLLQRQ--PGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEP  157 (316)
T ss_pred             EEecCCCCHHHHHHhC--CCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccc
Confidence            9999999999998633  33568999999999999999999999999999999999999999999999999986543211


Q ss_pred             cc----------------------------cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCcccccc
Q 017232          217 TH----------------------------VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRH  268 (375)
Q Consensus       217 ~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~  268 (375)
                      ..                            ......|+..|+|||++.+..++.++||||||+++|+|++|..||.....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~  237 (316)
T cd05574         158 PPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR  237 (316)
T ss_pred             cccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence            10                            01123578899999999888899999999999999999999999975432


Q ss_pred             ccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC----HHHHHH
Q 017232          269 RHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY----MVDVLD  333 (375)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt----~~evl~  333 (375)
                      ..               ....+.........   ....+..+.+++.+||..+|++||+    +++++.
T Consensus       238 ~~---------------~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~  288 (316)
T cd05574         238 DE---------------TFSNILKKEVTFPG---SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ  288 (316)
T ss_pred             HH---------------HHHHHhcCCccCCC---ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence            11               11111111111111   1114568999999999999999999    666555

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=5e-40  Score=294.83  Aligned_cols=265  Identities=21%  Similarity=0.334  Sum_probs=200.0

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|++.+.||.|++|.||+|... +|+.|++|++....  ......+.+|+.+++.++|||++++++++.. +...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPH-GSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEec-CCeeEEEec
Confidence            4888999999999999999764 68999999986553  2334678899999999999999999997766 678899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+ +++|.+++....   ..+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~-~~~L~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          80 YM-PSDLSEVLRDEE---RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             cc-CCCHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            99 999999985432   56899999999999999999999999999999999999999999999999998866543322


Q ss_pred             cccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH---HHHHH---
Q 017232          219 VSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA---LHELV---  291 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~---  291 (375)
                      ......++..|+|||.+.+. .++.++||||+|+++|+|++|.++|........   .......+....   ..+..   
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  232 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQ---LAIVFRTLGTPNEETWPGLTSLP  232 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHH---HHHHHHHcCCCChHHHhhccCcc
Confidence            23344688899999987654 468899999999999999999888865432111   001111100000   00000   


Q ss_pred             h-hhcCC--CC----ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          292 D-QTLGY--ES----DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       292 ~-~~l~~--~~----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      + ..+..  ..    .....+....+.+++.+||+.+|++|||++++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0 00000  00    00011234789999999999999999999999863

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.4e-39  Score=294.43  Aligned_cols=258  Identities=26%  Similarity=0.411  Sum_probs=200.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCC----EEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGR----AVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ++|+..+.||+|+||.||+|.+. +|.    .+|+|.+.... ......+.+|+.+++.++||||+++++++..  ...+
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~--~~~~   84 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLS--PTIQ   84 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcC--CCce
Confidence            45788899999999999999653 444    57888876543 2334468899999999999999999997764  3467


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +++||+++|+|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus        85 ~v~e~~~~g~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~  161 (303)
T cd05110          85 LVTQLMPHGCLLDYVHEH---KDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEG  161 (303)
T ss_pred             eeehhcCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccC
Confidence            999999999999998543   33588999999999999999999999999999999999999999999999999986543


Q ss_pred             Cccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          215 HVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       215 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......                ..+++.
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~  225 (303)
T cd05110         162 DEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE----------------IPDLLE  225 (303)
T ss_pred             cccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHH
Confidence            2221 1122345678999999998899999999999999999997 888886432110                011111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      ....   .+....++..+.+++..|+..+|++||++.++++.|+.+..+.
T Consensus       226 ~~~~---~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~~  272 (303)
T cd05110         226 KGER---LPQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARDP  272 (303)
T ss_pred             CCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhch
Confidence            1110   0111123457889999999999999999999999999886543

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.3e-39  Score=289.53  Aligned_cols=251  Identities=25%  Similarity=0.391  Sum_probs=194.6

Q ss_pred             CccCCCCcEEEEEEEeCC-------CCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           67 RELGDGGFGTVYYGELQD-------GRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +.||+|+||.||+|...+       +..+++|.+.... ......+.+|+.+++.++||||+++++++.. ....++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLL-NEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecC-CCCeEEEEe
Confidence            359999999999996542       2578999875543 2345678899999999999999999997765 567899999


Q ss_pred             cccCCChhHhhccCCC---CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC-----cEEEeeecccc
Q 017232          139 FISNGTVADHLHGERA---KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF-----CVKVADFGLSR  210 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~-----~~kl~Dfg~~~  210 (375)
                      |+++++|.+++.....   ....+++..+..++.|++.||.|||+.+++|+||+|+||+++.++     .++|+|||++.
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            9999999999965322   224578899999999999999999999999999999999999887     89999999987


Q ss_pred             ccCCCccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          211 LFPNHVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       211 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      ........ ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      . ..        
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~------~-~~--------  224 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE------V-LQ--------  224 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH------H-HH--------
Confidence            54322111 1122245678999999998899999999999999999998 999986433111      0 00        


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                       .+.....   .......+..+.+++.+||..+|++||++.+|++.|.+
T Consensus       225 -~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  269 (269)
T cd05044         225 -HVTAGGR---LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN  269 (269)
T ss_pred             -HHhcCCc---cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence             0000000   01112345678999999999999999999999999863

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.5e-39  Score=287.16  Aligned_cols=247  Identities=27%  Similarity=0.455  Sum_probs=197.5

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-----hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-----YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      +|+..+.||+|++|.||+|... ++..|++|.+....     .+..+.+.+|+.+++.++|+|++++++++.. ...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE-EDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEec-CCeEEE
Confidence            4777889999999999999766 78999999886543     2345678899999999999999999997665 567899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ++||+++++|.+++...    ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++......
T Consensus        80 v~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~  155 (258)
T cd06632          80 FLELVPGGSLAKLLKKY----GSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF  155 (258)
T ss_pred             EEEecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence            99999999999998532    45889999999999999999999999999999999999999999999999998765433


Q ss_pred             ccccccCCCCCccccCcccccccC-CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQ-LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .  ......++..|++||.+.... ++.++|+||||+++|+|++|.+||.......      ....         .... 
T Consensus       156 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~------~~~~---------~~~~-  217 (258)
T cd06632         156 S--FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA------AVFK---------IGRS-  217 (258)
T ss_pred             c--cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH------HHHH---------HHhc-
Confidence            2  123345888999999887666 8999999999999999999999997543110      0000         0000 


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        .............+.+++.+||+.+|++||++.+++.
T Consensus       218 --~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         218 --KELPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             --ccCCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence              0011111224467889999999999999999999975

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.2e-39  Score=291.83  Aligned_cols=260  Identities=27%  Similarity=0.415  Sum_probs=200.1

Q ss_pred             chHHHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeec-
Q 017232           52 SYGELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSR-  128 (375)
Q Consensus        52 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-  128 (375)
                      ++.+.....+.|++.+.||.|+||.||+|... +++.+++|.+.... .....+..|+.+++.+ +|+|++++++++.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~   85 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK   85 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence            34444556678999999999999999999664 68899999875543 2335678899999998 69999999997642 


Q ss_pred             ----CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEe
Q 017232          129 ----HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVA  204 (375)
Q Consensus       129 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~  204 (375)
                          .....+++|||+.+++|.+++....  ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+
T Consensus        86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~  163 (282)
T cd06636          86 SPPGHDDQLWLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLV  163 (282)
T ss_pred             cccCCCCEEEEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEe
Confidence                2457899999999999999986542  3457888899999999999999999999999999999999999999999


Q ss_pred             eeccccccCCCccccccCCCCCccccCccccc-----ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHH
Q 017232          205 DFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAI  279 (375)
Q Consensus       205 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~  279 (375)
                      |||++........ ......++..|+|||.+.     ...++.++|+|||||++|+|++|..||.........       
T Consensus       164 dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~-------  235 (282)
T cd06636         164 DFGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRAL-------  235 (282)
T ss_pred             eCcchhhhhcccc-CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhh-------
Confidence            9999875432211 122345888999999875     345788999999999999999999999643211100       


Q ss_pred             HHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          280 NKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       280 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                              .......   ........++..+.+++.+||+.+|.+|||+.|+++
T Consensus       236 --------~~~~~~~---~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         236 --------FLIPRNP---PPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             --------hhHhhCC---CCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence                    0000000   011111234567999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.8e-39  Score=294.37  Aligned_cols=199  Identities=26%  Similarity=0.413  Sum_probs=159.8

Q ss_pred             CCccCCCCcEEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeec-CCceeEEEEeccc
Q 017232           66 ARELGDGGFGTVYYGELQ---DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR-HSRELLLVYEFIS  141 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~e~~~  141 (375)
                      ..+||+|+||.||+|...   ++..||+|.+.....  ...+.+|+.+++.++||||+++++++.. .+...++||||+.
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~   83 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE   83 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC--cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence            357999999999999765   357899998865432  2356789999999999999999997643 3567899999986


Q ss_pred             CCChhHhhccCC-----CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe----cCCCcEEEeeecccccc
Q 017232          142 NGTVADHLHGER-----AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLF  212 (375)
Q Consensus       142 ~~~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~  212 (375)
                       ++|.+++....     .....+++..++.++.|++.||.|||+.|++||||||+||++    +.++.+||+|||++...
T Consensus        84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~  162 (317)
T cd07867          84 -HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  162 (317)
T ss_pred             -CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceecc
Confidence             57777764321     122358889999999999999999999999999999999999    56678999999999866


Q ss_pred             CCCccc--cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccc
Q 017232          213 PNHVTH--VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITR  267 (375)
Q Consensus       213 ~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~  267 (375)
                      ......  ......+|+.|+|||.+.+ ..++.++|||||||++|+|+||.+||....
T Consensus       163 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         163 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence            433221  1223457899999998876 457899999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.2e-39  Score=287.59  Aligned_cols=248  Identities=27%  Similarity=0.428  Sum_probs=198.1

Q ss_pred             CCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|+..+.||+|++|.||++.. .++..+++|.+...  .......+.+|+.+++.++|||++++++.+.. +...++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLE-DKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEec-CCEEEEEEe
Confidence            588899999999999999955 46889999988654  23345678899999999999999999997665 677999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC-CcEEEeeeccccccCCCcc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN-FCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~~~  217 (375)
                      |+++++|.+++...  ....+++..+..++.+++.||.|||++|++|+||+|+||+++.+ +.++|+|||.+........
T Consensus        80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (256)
T cd08220          80 YAPGGTLAEYIQKR--CNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK  157 (256)
T ss_pred             cCCCCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc
Confidence            99999999999653  23458999999999999999999999999999999999999855 4689999999986643322


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                        .....++..|+|||.+.+..++.++||||||+++|+|++|..||+......      ...         ....    .
T Consensus       158 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~------~~~---------~~~~----~  216 (256)
T cd08220         158 --AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA------LVL---------KIMS----G  216 (256)
T ss_pred             --ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH------HHH---------HHHh----c
Confidence              123457889999999998888999999999999999999999986543211      110         0010    0


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ...+.....+..+.+++.+||..+|++|||+.++++
T Consensus       217 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         217 TFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             CCCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            011111224567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.6e-39  Score=287.02  Aligned_cols=250  Identities=27%  Similarity=0.414  Sum_probs=195.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-----chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-Ccee
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-----NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-SREL  133 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~  133 (375)
                      ++|++.+.||+|+||.||+|... ++..|++|.+...     .....+.+.+|+.+++.++||||+++++++... ...+
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL   81 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence            46888999999999999999654 6899999987532     123356788899999999999999999976543 3568


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      +++|||+++++|.+++...    ..+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~~v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~  157 (265)
T cd06652          82 SIFMEHMPGGSIKDQLKSY----GALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQ  157 (265)
T ss_pred             EEEEEecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCccccccc
Confidence            8999999999999998532    347888899999999999999999999999999999999999999999999987543


Q ss_pred             CCcc--ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          214 NHVT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       214 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ....  .......++..|+|||.+.+..++.++||||||+++|+|++|+.||.......               ......
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~---------------~~~~~~  222 (265)
T cd06652         158 TICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA---------------AIFKIA  222 (265)
T ss_pred             cccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH---------------HHHHHh
Confidence            2111  11122357889999999988889999999999999999999999996432110               000000


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .   .......+......+.+++.+|+. +|++||+++++++
T Consensus       223 ~---~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         223 T---QPTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             c---CCCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            0   001111122345678889999995 9999999999885

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.7e-39  Score=288.66  Aligned_cols=252  Identities=25%  Similarity=0.439  Sum_probs=198.3

Q ss_pred             CCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccc------hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           62 YFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN------YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      +|+..+.||+|++|.||+|.. .+++.||+|.+....      ....+.+.+|+.+++.++|+|++++++++.. ....+
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCE-DSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceecc-CCeEE
Confidence            478889999999999999965 578999999886432      2235678899999999999999999997765 66889


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC-cEEEeeeccccccC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF-CVKVADFGLSRLFP  213 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  213 (375)
                      +||||+.+++|.+++..    ...+++..++.++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||.+....
T Consensus        80 ~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          80 LFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             EEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99999999999999853    24588999999999999999999999999999999999998776 59999999987664


Q ss_pred             CCccc---cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          214 NHVTH---VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       214 ~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      .....   ......++..|+|||.+.+..++.++|+||+|+++|+|++|..||.........   ..         ....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~---~~---------~~~~  223 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHL---AL---------IFKI  223 (268)
T ss_pred             cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchH---HH---------HHHH
Confidence            33211   112235788999999998888999999999999999999999999643321100   00         0000


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .   ...............+.+++.+||..+|++||++.++++
T Consensus       224 ~---~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         224 A---SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             h---ccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            0   001111222345577999999999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=303.93  Aligned_cols=240  Identities=25%  Similarity=0.321  Sum_probs=183.3

Q ss_pred             cCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhc---CCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           69 LGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARL---RHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      ||+|+||.||+|... +++.||+|++.....   ........|..++...   +||||+++++.+.. ....++||||+.
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~-~~~~~lv~e~~~   79 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQT-DSDLYLVTDYMS   79 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEec-CCeEEEEEcCCC
Confidence            799999999999655 689999999864321   2233455666776665   69999999997766 677999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|..++..    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........ ...
T Consensus        80 ~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~-~~~  154 (330)
T cd05586          80 GGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK-TTN  154 (330)
T ss_pred             CChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC-Ccc
Confidence            9999988853    34689999999999999999999999999999999999999999999999999875322211 123


Q ss_pred             CCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCC
Q 017232          222 APQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD  300 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  300 (375)
                      ...||+.|+|||++.+. .++.++|||||||++|+|++|..||.......      .         ...+........  
T Consensus       155 ~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~------~---------~~~i~~~~~~~~--  217 (330)
T cd05586         155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ------M---------YRNIAFGKVRFP--  217 (330)
T ss_pred             CccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH------H---------HHHHHcCCCCCC--
Confidence            44689999999988654 47899999999999999999999996432110      0         011111111100  


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCC----CHHHHHH
Q 017232          301 NKVRRTINAVAELAFQCLQSEKDLRP----YMVDVLD  333 (375)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~~P~~Rp----t~~evl~  333 (375)
                        ...++..+.+++.+||+.+|++||    ++.++++
T Consensus       218 --~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         218 --KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             --CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence              012346788999999999999998    4566554

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=5.1e-40  Score=293.52  Aligned_cols=247  Identities=26%  Similarity=0.418  Sum_probs=197.1

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .|+..+.||+|+||.||+|... ++..||+|.+.... ....+.+.+|+.+++.++||||+++++++.. ....++||||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   83 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTKLWIIMEY   83 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhccccc-CCceEEEEEc
Confidence            3566778999999999999654 67889999886443 3445678899999999999999999997765 6679999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++++|.+++.     ...+++..+..++.|++.|+.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus        84 ~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06642          84 LGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             cCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcch-h
Confidence            99999999883     24588999999999999999999999999999999999999999999999999876543221 1


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|..|+........      ..          ......   .
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~------~~----------~~~~~~---~  218 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV------LF----------LIPKNS---P  218 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH------Hh----------hhhcCC---C
Confidence            1223578899999999988899999999999999999999999864321110      00          000000   0


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .......+..+.+++.+|++.+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         219 PTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence            01111245678899999999999999999999984

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2e-39  Score=288.97  Aligned_cols=257  Identities=28%  Similarity=0.429  Sum_probs=197.5

Q ss_pred             CCCCCccCCCCcEEEEEEEeC----CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-----c
Q 017232           63 FDSARELGDGGFGTVYYGELQ----DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-----R  131 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~  131 (375)
                      |.+.+.||+|+||.||+|...    ++..||+|++...  .....+.+.+|+.+++.++|||++++++++....     .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            567889999999999999643    3688999988654  3344567889999999999999999999654322     1


Q ss_pred             eeEEEEecccCCChhHhhccCCC--CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERA--KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      ..+++++|+.+++|.+++...+.  ....+++..++.++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~  160 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLS  160 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECccccc
Confidence            34789999999999888754322  2235788899999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHH
Q 017232          210 RLFPNHVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKAL  287 (375)
Q Consensus       210 ~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (375)
                      ......... ......+++.|++||.+.+..++.++||||||+++|+|++ |.+||.......      . ...      
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~------~-~~~------  227 (273)
T cd05074         161 KKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSE------I-YNY------  227 (273)
T ss_pred             ccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHH------H-HHH------
Confidence            865432211 1122235678999999988889999999999999999999 889886443110      0 000      


Q ss_pred             HHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          288 HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       288 ~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                        +...    .........+..+.+++.+|++.+|++||++.++++.|+++
T Consensus       228 --~~~~----~~~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         228 --LIKG----NRLKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             --HHcC----CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              0000    00000112346799999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.3e-39  Score=292.35  Aligned_cols=262  Identities=26%  Similarity=0.323  Sum_probs=201.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeec-CCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSR-HSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv~  137 (375)
                      ++|+..+.||.|++|.||++... +++.+|+|.+.... ......+.+|+++++.++||||+++++++.. ....+++||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   80 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM   80 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence            35788899999999999999764 68899999886543 2345678899999999999999999997643 345689999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+++++|.+++.........+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (287)
T cd06621          81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA  160 (287)
T ss_pred             EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccccc
Confidence            99999999998765444556789999999999999999999999999999999999999999999999999865432221


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                         ....++..|+|||.+.+..++.++||||||+++|+|++|..||+........ ..... ..+.....     ..+..
T Consensus       161 ---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~-~~~~~-~~~~~~~~-----~~~~~  230 (287)
T cd06621         161 ---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLG-PIELL-SYIVNMPN-----PELKD  230 (287)
T ss_pred             ---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCC-hHHHH-HHHhcCCc-----hhhcc
Confidence               1234778899999998889999999999999999999999999765321100 01110 00000000     00100


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .. ......+..+.+++.+||..+|++|||+.|+++
T Consensus       231 ~~-~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         231 EP-GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             CC-CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            00 000123467899999999999999999999997

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-39  Score=288.86  Aligned_cols=256  Identities=29%  Similarity=0.454  Sum_probs=200.6

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecC-----Cc
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRH-----SR  131 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-----~~  131 (375)
                      ..++|++.+.||+|++|.||+|... +++.+++|++..... ....+.+|+.+++.+ +|+||+++++++...     ..
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4578999999999999999999765 678899998865543 346788999999999 699999999976542     34


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      .+++||||+++++|.+++.........+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++..
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~  162 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ  162 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcccee
Confidence            58999999999999999866543456789999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCccccccCCCCCccccCcccccc-----cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA  286 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (375)
                      ...... ......++..|+|||.+.+     ..++.++||||||+++|+|++|.+||.......      ..        
T Consensus       163 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~~--------  227 (275)
T cd06608         163 LDSTLG-RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR------AL--------  227 (275)
T ss_pred             cccchh-hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH------HH--------
Confidence            533221 1223458889999998653     346788999999999999999999996432110      00        


Q ss_pred             HHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          287 LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       287 ~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       ..+.....  .........+..+.+++.+||..||++|||+.++++
T Consensus       228 -~~~~~~~~--~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         228 -FKIPRNPP--PTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             -HHhhccCC--CCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence             00110000  001111234567899999999999999999999985

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.5e-39  Score=286.83  Aligned_cols=252  Identities=26%  Similarity=0.426  Sum_probs=204.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|++.+.||.|++|.||+|... +++.|++|++..... .....+.+|+..+..++|+|++++++++.. ....++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYK-EGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcc-CCeEEEEEE
Confidence            36888999999999999999766 589999999876643 445778999999999999999999997766 578999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      |+++++|.+++...    ..+++..++.++.|++.|+.|||+ .|++|+||+|+||+++.++.++|+|||.+........
T Consensus        80 ~~~~~~L~~~l~~~----~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~  155 (264)
T cd06623          80 YMDGGSLADLLKKV----GKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD  155 (264)
T ss_pred             ecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC
Confidence            99999999999543    568999999999999999999999 9999999999999999999999999999876543322


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++|..||.......   ....         ...+...    
T Consensus       156 ~-~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~---~~~~---------~~~~~~~----  218 (264)
T cd06623         156 Q-CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPS---FFEL---------MQAICDG----  218 (264)
T ss_pred             c-ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccC---HHHH---------HHHHhcC----
Confidence            2 123357889999999988889999999999999999999999997654211   0000         0111111    


Q ss_pred             CCChHHHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          298 ESDNKVRR-TINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       298 ~~~~~~~~-~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ........ ++..+.+++.+||..+|++||++.++++.
T Consensus       219 ~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         219 PPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             CCCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            11111112 45679999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.5e-39  Score=291.28  Aligned_cols=252  Identities=26%  Similarity=0.407  Sum_probs=193.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHH-HHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDI-LARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.... ......+..|+.+ ++.++|||++++++++.. +...+++|
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-~~~~~lv~   79 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-EGDVWICM   79 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-CCcEEEEh
Confidence            46888999999999999999665 68999999986542 2233455556665 666789999999997766 56799999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||++ ++|.+++.........+++..++.++.|++.||.|||++ +++|+||||+||+++.++.+||+|||++.......
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  158 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV  158 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc
Confidence            9996 788888865544456799999999999999999999997 99999999999999999999999999987653321


Q ss_pred             cccccCCCCCccccCcccccc----cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          217 THVSTAPQGTPGYVDPEYHQC----YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .  .....++..|+|||.+.+    ..++.++|+|||||++|+|++|..||.......    .          .......
T Consensus       159 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~----------~~~~~~~  222 (283)
T cd06617         159 A--KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF----Q----------QLKQVVE  222 (283)
T ss_pred             c--cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH----H----------HHHHHHh
Confidence            1  122357889999998765    456889999999999999999999996422110    0          0011111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      . .....  ....++..+.+++.+||..+|++||++.++++
T Consensus       223 ~-~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         223 E-PSPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             c-CCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0 00000  01124567899999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=7.7e-40  Score=294.48  Aligned_cols=248  Identities=25%  Similarity=0.412  Sum_probs=197.0

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      |.....||+|+||.||++... ++..||+|.+........+.+.+|+.+++.++|+|++++++.+.. +...++||||++
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-~~~~~lv~e~~~  102 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-GDELWVVMEFLE  102 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheec-CCeEEEEEeCCC
Confidence            444567999999999999654 688999999876665666778899999999999999999997765 567899999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|.+++..     ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++......... ..
T Consensus       103 ~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~  176 (292)
T cd06658         103 GGALTDIVTH-----TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPK-RK  176 (292)
T ss_pred             CCcHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccccc-Cc
Confidence            9999998732     34889999999999999999999999999999999999999999999999998754332221 12


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...++..|+|||.+.+..++.++|+||||+++|||++|..||.......      .. ..     ....+.....     
T Consensus       177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~~-~~-----~~~~~~~~~~-----  239 (292)
T cd06658         177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ------AM-RR-----IRDNLPPRVK-----  239 (292)
T ss_pred             eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH-HH-----HHhcCCCccc-----
Confidence            3457889999999988889999999999999999999999986433111      00 00     0000111110     


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ........+.+++.+|+..+|.+|||++++++.
T Consensus       240 ~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         240 DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            111234568899999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-40  Score=294.96  Aligned_cols=248  Identities=23%  Similarity=0.355  Sum_probs=204.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhh--HHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKR--VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .+-|.+.+.||+|.|++|-+|++- +|..||||++.+...+.  ...+.+|+..|+.++|||||++|++... ...+|||
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDT-QTKlyLi   95 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDT-QTKLYLI   95 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcc-cceEEEE
Confidence            355888899999999999999554 79999999997664443  4578899999999999999999996655 6679999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec-CCCcEEEeeeccccccCCC
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~  215 (375)
                      +|.-++|+|.+++...   ...+.+..+.+++.||+.|+.|+|+..+|||||||+||.+. .-|-+||.|||++..+...
T Consensus        96 LELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   96 LELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999999654   34589999999999999999999999999999999998764 6788999999999877554


Q ss_pred             ccccccCCCCCccccCcccccccCCCC-chhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTD-KSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ..  ....+|+..|.|||++.|..|+. +.||||||||||.|++|++||+.....+.               +.-++|-.
T Consensus       173 ~k--L~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET---------------LTmImDCK  235 (864)
T KOG4717|consen  173 KK--LTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET---------------LTMIMDCK  235 (864)
T ss_pred             ch--hhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh---------------hhhhhccc
Confidence            33  34557999999999999988875 78999999999999999999986553321               11122221


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .     ..+...+.++++||..||..||.+|.+.+||..
T Consensus       236 Y-----tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  236 Y-----TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             c-----cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence            1     122345678999999999999999999998874

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.6e-39  Score=295.78  Aligned_cols=265  Identities=22%  Similarity=0.250  Sum_probs=191.6

Q ss_pred             CCCccCCC--CcEEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           65 SARELGDG--GFGTVYYGEL-QDGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        65 ~~~~lg~G--~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      +.++||+|  +|++||++.. .+|+.||+|++....  ......+.+|+.+++.++||||+++++++.. +...++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-CCEEEEEEec
Confidence            46789999  7889999955 478999999986542  2334567789999999999999999998776 5678999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc-
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-  218 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-  218 (375)
                      +++++|.+++....  ...+++..++.++.|++.||.|||++|++||||||+||+++.++.++++||+........... 
T Consensus        81 ~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  158 (327)
T cd08227          81 MAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRL  158 (327)
T ss_pred             cCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccc
Confidence            99999999985432  235899999999999999999999999999999999999999999999999865433211110 


Q ss_pred             -----cccCCCCCccccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh---h-h--
Q 017232          219 -----VSTAPQGTPGYVDPEYHQC--YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ---N-K--  285 (375)
Q Consensus       219 -----~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~-~--  285 (375)
                           ......++..|+|||++.+  ..++.++|||||||++|+|++|..||........  ..........   + .  
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~  236 (327)
T cd08227         159 RVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM--LLEKLNGTVPCLLDTTTI  236 (327)
T ss_pred             cccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHH--HHHHhcCCccccccccch
Confidence                 0112246678999999875  4688999999999999999999999964321110  0000000000   0 0  


Q ss_pred             HHHHHH--------hhhc--------------CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          286 ALHELV--------DQTL--------------GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       286 ~~~~~~--------~~~l--------------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ...++.        +...              .....+........+.+++.+||+.||++|||+.++++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence            000000        0000              000011112345678999999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=2.4e-39  Score=287.88  Aligned_cols=254  Identities=24%  Similarity=0.322  Sum_probs=186.2

Q ss_pred             CccCCCCcEEEEEEEeCC---CCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccC
Q 017232           67 RELGDGGFGTVYYGELQD---GRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISN  142 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~---~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  142 (375)
                      +.||+|+||.||+|...+   ...+++|.+.... ......+.+|+.+++.++|+||+++++.+.. ....++||||+++
T Consensus         1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~-~~~~~lv~e~~~~   79 (269)
T cd05042           1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIE-SIPYLLVLEFCPL   79 (269)
T ss_pred             CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECC-CCceEEEEEeCCC
Confidence            359999999999996543   3568888775443 3334567889999999999999999997765 5678999999999


Q ss_pred             CChhHhhccCCCC-CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc-ccc
Q 017232          143 GTVADHLHGERAK-PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT-HVS  220 (375)
Q Consensus       143 ~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~  220 (375)
                      |+|.+++...... ....++..+..++.|++.||+|||++|++||||||+||+++.++.+||+|||++........ ...
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  159 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITK  159 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheecc
Confidence            9999999665322 23356778889999999999999999999999999999999999999999999865322211 111


Q ss_pred             cCCCCCccccCccccc-------ccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          221 TAPQGTPGYVDPEYHQ-------CYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ....++..|+|||++.       ...++.++|||||||++|+|++ |..||.......      .........       
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~------~~~~~~~~~-------  226 (269)
T cd05042         160 DCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ------VLKQVVREQ-------  226 (269)
T ss_pred             CCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH------HHHHHhhcc-------
Confidence            2334567899999864       2456789999999999999998 788886442111      000000000       


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                       ............++..+.+++..|+ .+|++|||+++|++.|.
T Consensus       227 -~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         227 -DIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             -CccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence             0000001111234456777888888 59999999999999873

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-40  Score=298.64  Aligned_cols=253  Identities=21%  Similarity=0.320  Sum_probs=198.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecc--cchhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ...|+++++||.||.+.||++...+.+-||+|++..  .+...+..|.+|+.+|.+|+ |.+||+++++... ++.+|+|
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~-d~~lYmv  438 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVT-DGYLYMV  438 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeecc-CceEEEE
Confidence            356999999999999999999888888889887643  46667788999999999995 9999999996555 7889999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||+- .-+|..+|....   ..++.-.++.+..|++.++.++|++||||.||||.|+|+- .|.+||+|||.|..+..+.
T Consensus       439 mE~G-d~DL~kiL~k~~---~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT  513 (677)
T KOG0596|consen  439 MECG-DIDLNKILKKKK---SIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT  513 (677)
T ss_pred             eecc-cccHHHHHHhcc---CCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccc
Confidence            9986 478999995432   2233337888999999999999999999999999999884 5689999999999887665


Q ss_pred             ccc-ccCCCCCccccCcccccccC-----------CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh
Q 017232          217 THV-STAPQGTPGYVDPEYHQCYQ-----------LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       217 ~~~-~~~~~~~~~y~aPE~~~~~~-----------~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      +.. ....+||+.||+||.+....           .+.++||||+|||||+|+.|++||.....              .-
T Consensus       514 TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--------------~~  579 (677)
T KOG0596|consen  514 TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--------------QI  579 (677)
T ss_pred             cceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--------------HH
Confidence            543 33567999999999765432           56789999999999999999999974321              01


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ..+..+.++.-..+++....  ..++.++++.||..||++||+..|+++.
T Consensus       580 aKl~aI~~P~~~Iefp~~~~--~~~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  580 AKLHAITDPNHEIEFPDIPE--NDELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             HHHHhhcCCCccccccCCCC--chHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            22334444433222221111  1238999999999999999999999864

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=300.95  Aligned_cols=264  Identities=25%  Similarity=0.367  Sum_probs=211.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhh-HHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .....+.++||+|-||.|.+.....+..||+|.++...... ...|.+|+++|.+++||||+.++|+|.. ++.+++++|
T Consensus       537 Rs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~-DePicmI~E  615 (807)
T KOG1094|consen  537 RSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQ-DDPLCMITE  615 (807)
T ss_pred             hhheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeec-CCchHHHHH
Confidence            45677889999999999999998888999999998775544 4789999999999999999999999888 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |++.|+|..++......  .+.-.....||.||+.|++||.+.++|||||.+.|+|+++++++||+|||+++.+-....+
T Consensus       616 YmEnGDLnqFl~aheap--t~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  616 YMENGDLNQFLSAHELP--TAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HHhcCcHHHHHHhccCc--ccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            99999999999766332  2455666789999999999999999999999999999999999999999999854433333


Q ss_pred             c-ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh--CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          219 V-STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       219 ~-~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt--g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      . -...+-..+|||+|.+..+.++.++|+|+||+++||+++  ...||.......           +. ++..++++..-
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~-----------vv-en~~~~~~~~~  761 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ-----------VV-ENAGEFFRDQG  761 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH-----------HH-HhhhhhcCCCC
Confidence            2 233456779999999888899999999999999999864  667776443211           11 11222232222


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                      .......+.-|+..+.+++.+|++.+-.+||+++++...|.+.
T Consensus       762 ~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  762 RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            2222233345677889999999999999999999999887653

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.4e-39  Score=285.16  Aligned_cols=238  Identities=27%  Similarity=0.392  Sum_probs=186.6

Q ss_pred             CccCCCCcEEEEEEEeCCCC-----------EEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           67 RELGDGGFGTVYYGELQDGR-----------AVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~-----------~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      +.||+|+||.||+|...+..           .+++|.+...... ...+.+|+.+++.++||||+++++++..  ...++
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~l   77 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR--DENIM   77 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec--CCcEE
Confidence            46999999999999765432           5788876554433 5778899999999999999999997765  45789


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC-------cEEEeeecc
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF-------CVKVADFGL  208 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~-------~~kl~Dfg~  208 (375)
                      ||||+++++|.+++....   ..+++..+..++.|++.||.|||++|++|+||||+||+++.++       .++|+|||+
T Consensus        78 v~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~  154 (259)
T cd05037          78 VEEYVKFGPLDVFLHREK---NNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGI  154 (259)
T ss_pred             EEEcCCCCcHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCc
Confidence            999999999999986432   2688999999999999999999999999999999999999888       799999999


Q ss_pred             ccccCCCccccccCCCCCccccCccccccc--CCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhh
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQCY--QLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNK  285 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (375)
                      +.....     .....++..|+|||.+.+.  .++.++||||||+++|+|++ |..||.........       ....  
T Consensus       155 a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~-------~~~~--  220 (259)
T cd05037         155 PITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE-------RFYQ--  220 (259)
T ss_pred             cccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHH-------HHHh--
Confidence            876543     1223466789999998876  78999999999999999999 57777654311100       0000  


Q ss_pred             HHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          286 ALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       286 ~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                            ........      ....+.+++.+||..+|++|||+.++++.|+
T Consensus       221 ------~~~~~~~~------~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         221 ------DQHRLPMP------DCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ------cCCCCCCC------CchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                  00000000      1157889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.8e-39  Score=285.82  Aligned_cols=253  Identities=23%  Similarity=0.308  Sum_probs=186.0

Q ss_pred             ccCCCCcEEEEEEEeCCC---CEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCC
Q 017232           68 ELGDGGFGTVYYGELQDG---RAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG  143 (375)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~  143 (375)
                      .||+|+||.||+|...++   ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+.. ....++||||++++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVE-AIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecC-CCccEEEEecCCCC
Confidence            599999999999965433   345677665443 3445678999999999999999999997766 56789999999999


Q ss_pred             ChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC-CccccccC
Q 017232          144 TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN-HVTHVSTA  222 (375)
Q Consensus       144 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~-~~~~~~~~  222 (375)
                      +|.+++..........++..++.++.|++.||+|||+.+++|+||||+|||++.++.++|+|||++..... ........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  160 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD  160 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence            99999976543344567778889999999999999999999999999999999999999999998754221 11111223


Q ss_pred             CCCCccccCcccccc-------cCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          223 PQGTPGYVDPEYHQC-------YQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       223 ~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ..++..|+|||++..       ..++.++||||||+++|||++ |..||......      ......+.. ....+.++.
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~------~~~~~~~~~-~~~~~~~~~  233 (268)
T cd05086         161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR------EVLNHVIKD-QQVKLFKPQ  233 (268)
T ss_pred             CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH------HHHHHHHhh-cccccCCCc
Confidence            457889999998743       245789999999999999997 56777543211      111111111 001111111


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                      +.       ......+.+++..|+ .+|++||++++|++.|.
T Consensus       234 ~~-------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         234 LE-------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             cC-------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence            11       113456788999999 67999999999998874

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.8e-40  Score=292.15  Aligned_cols=240  Identities=24%  Similarity=0.361  Sum_probs=186.2

Q ss_pred             CccCCCCcEEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           67 RELGDGGFGTVYYGELQD--------GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +.||+|+||.||+|....        ...+++|.+........+.+.+|+.+++.++|||++++++++.. +...++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~-~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVC-GDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEe-CCCcEEEEe
Confidence            469999999999996532        23488888765555555678889999999999999999997776 466899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc--------EEEeeecccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC--------VKVADFGLSR  210 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~--------~kl~Dfg~~~  210 (375)
                      |+++|+|.+++...   ...+++..+..++.|++.||.|||++|++||||||+||+++.++.        ++++|||.+.
T Consensus        80 ~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~  156 (258)
T cd05078          80 YVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISI  156 (258)
T ss_pred             cCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEeccccccc
Confidence            99999999998643   235889999999999999999999999999999999999987765        6999999886


Q ss_pred             ccCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCC-CCccccccccccchhHHHHHHhhhhHHH
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSM-PAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      .....     ....++..|+|||.+.+ ..++.++||||||+++|+|++|. +|+........                .
T Consensus       157 ~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~----------------~  215 (258)
T cd05078         157 TVLPK-----EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK----------------L  215 (258)
T ss_pred             ccCCc-----hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH----------------H
Confidence            54321     12347788999998876 45789999999999999999984 56543321110                0


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                      ........  .+   ......+.+++.+||+.+|++|||++++++.|+
T Consensus       216 ~~~~~~~~--~~---~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         216 QFYEDRHQ--LP---APKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             HHHHcccc--CC---CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            01111000  01   012346889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-39  Score=293.96  Aligned_cols=248  Identities=25%  Similarity=0.402  Sum_probs=196.4

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      |.....||+|+||.||+|... +++.|++|.+........+.+.+|+.+++.++|||++++++++.. +...++|+||++
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~iv~e~~~  101 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWVLMEFLQ  101 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-CCeEEEEEecCC
Confidence            334557999999999999654 689999999866554555678899999999999999999997766 677899999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|..++.     ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......... ..
T Consensus       102 ~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~-~~  175 (297)
T cd06659         102 GGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-RK  175 (297)
T ss_pred             CCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc-cc
Confidence            999998773     245889999999999999999999999999999999999999999999999998754432221 12


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...++..|+|||.+.+..++.++|||||||++|+|++|..||........      . ..+...         . .....
T Consensus       176 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~------~-~~~~~~---------~-~~~~~  238 (297)
T cd06659         176 SLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQA------M-KRLRDS---------P-PPKLK  238 (297)
T ss_pred             ceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH------H-HHHhcc---------C-CCCcc
Confidence            34588999999999888899999999999999999999999964331110      0 000000         0 00000


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ........+.+++.+||+.+|++||+++++++.
T Consensus       239 ~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         239 NAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             ccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            111234568899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-40  Score=294.74  Aligned_cols=268  Identities=23%  Similarity=0.359  Sum_probs=199.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|++.+.||+|++|.||+|... +++.|++|++...  .....+.+.+|+.+++.++|+||+++++++.. +...++||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-KGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-CCEEEEEE
Confidence            36889999999999999999765 5889999988643  22334678899999999999999999998776 67799999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||++++.+..+..    +...+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        80 e~~~~~~l~~~~~----~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~  155 (288)
T cd07833          80 EYVERTLLELLEA----SPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA  155 (288)
T ss_pred             ecCCCCHHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence            9998766665552    234589999999999999999999999999999999999999999999999999887654433


Q ss_pred             ccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH-hhhc
Q 017232          218 HVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV-DQTL  295 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l  295 (375)
                      .......++..|+|||++.+. .++.++||||||+++|+|++|.+||..........................+. +...
T Consensus       156 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07833         156 SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRF  235 (288)
T ss_pred             ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccc
Confidence            223344578899999998887 78899999999999999999999997543221110000000000000000000 0000


Q ss_pred             CC------CCChH-----HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          296 GY------ESDNK-----VRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       296 ~~------~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..      .....     ...++..+.+++.+||..+|++||+++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         236 AGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             cccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            00      00000     0112567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=4.9e-39  Score=291.18  Aligned_cols=255  Identities=24%  Similarity=0.349  Sum_probs=198.6

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||++... +++.|++|.+....   ......+.+|+.+++.++||||+++++.+.. +...++|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFET-KRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEec-CCEEEEE
Confidence            46888999999999999999665 57899999886543   2334567889999999999999999997765 6689999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~  155 (305)
T cd05609          80 MEYVEGGDCATLLKNI----GALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSL  155 (305)
T ss_pred             EecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCc
Confidence            9999999999999532    458999999999999999999999999999999999999999999999999876321100


Q ss_pred             --------------cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHh
Q 017232          217 --------------THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKI  282 (375)
Q Consensus       217 --------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  282 (375)
                                    ........++..|+|||.+.+..++.++|+||||+++|+|++|..||......      ...    
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~------~~~----  225 (305)
T cd05609         156 TTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE------ELF----  225 (305)
T ss_pred             cccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH------HHH----
Confidence                          00111234678899999988888999999999999999999999999643211      000    


Q ss_pred             hhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          283 QNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       283 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                           .........  .......++..+.+++.+||+.+|++||+..++.+.|+.
T Consensus       226 -----~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         226 -----GQVISDDIE--WPEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             -----HHHHhcccC--CCCccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence                 001100000  000111245678999999999999999998777777766

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.2e-39  Score=285.83  Aligned_cols=257  Identities=27%  Similarity=0.420  Sum_probs=201.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|++.+.||.|++|.||+|... ++..+++|++.... ......+.+|+.+++.++|+|++++++.+.. +...++|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-GDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-CCEEEEEEe
Confidence            46899999999999999999754 67899999986543 2356778999999999999999999997665 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      ++++++|.+++..... ...+++..+..++.|++.||.+||+.|++|+||+|+||++++++.++|+|||++.........
T Consensus        80 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~  158 (267)
T cd06610          80 YLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR  158 (267)
T ss_pred             ccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccc
Confidence            9999999999965322 246899999999999999999999999999999999999999999999999998765433222


Q ss_pred             ---cccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          219 ---VSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       219 ---~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                         ......++..|+|||.+... .++.++|+||||+++|+|++|+.||.......      .........      ...
T Consensus       159 ~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~------~~~~~~~~~------~~~  226 (267)
T cd06610         159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK------VLMLTLQND------PPS  226 (267)
T ss_pred             cccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh------hHHHHhcCC------CCC
Confidence               12333578899999988766 78899999999999999999999997543211      000000000      000


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .  ........++..+.+++.+||..+|++||++.++++
T Consensus       227 ~--~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         227 L--ETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             c--CCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0  011111245577899999999999999999999985

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.1e-39  Score=291.46  Aligned_cols=244  Identities=28%  Similarity=0.451  Sum_probs=197.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|++|.||++... +++.+|+|.+....   ......+.+|+++++.++||||+++++++.. +...++|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQD-DSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEc-CCeEEEE
Confidence            46888999999999999999665 68999999886542   2345678899999999999999999997766 6779999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        80 ~e~~~~~~L~~~~~~~----~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-  154 (290)
T cd05580          80 MEYVPGGELFSHLRKS----GRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-  154 (290)
T ss_pred             EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-
Confidence            9999999999998533    46899999999999999999999999999999999999999999999999998765443 


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                         .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......       .        ......... 
T Consensus       155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~--------~~~~~~~~~-  215 (290)
T cd05580         155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQ-------I--------YEKILEGKV-  215 (290)
T ss_pred             ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH-------H--------HHHHhcCCc-
Confidence               223458899999999988888999999999999999999999996543100       0        001111100 


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLD  333 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~  333 (375)
                          ..+......+.+++.+||..+|.+|+     +++++++
T Consensus       216 ----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         216 ----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             ----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence                00112346788999999999999999     6666664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=4.2e-39  Score=285.40  Aligned_cols=251  Identities=25%  Similarity=0.423  Sum_probs=198.6

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|++.+.||+|+||.||+|... +++.|++|.+.....  .....+.+|+.+++.++|+||+++++++.. ....++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVH-REKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEec-CCEEEEEEe
Confidence            5888999999999999999654 688999999876544  356788999999999999999999997655 677999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++..    ...+++..+..++.+++.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~  155 (264)
T cd06626          80 YCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTT  155 (264)
T ss_pred             cCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCc
Confidence            9999999999853    345788999999999999999999999999999999999999999999999998876443322


Q ss_pred             cc---cCCCCCccccCcccccccC---CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          219 VS---TAPQGTPGYVDPEYHQCYQ---LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       219 ~~---~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ..   ....++..|+|||.+.+..   ++.++||||||+++|+|++|..||.......     .....         ...
T Consensus       156 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~-----~~~~~---------~~~  221 (264)
T cd06626         156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEF-----QIMFH---------VGA  221 (264)
T ss_pred             ccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchH-----HHHHH---------Hhc
Confidence            11   1345788999999988766   8889999999999999999999996432110     00000         000


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       ... ...+........+.+++.+||+.+|++|||+.+++.
T Consensus       222 -~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         222 -GHK-PPIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             -CCC-CCCCcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence             000 000111123567889999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=6.3e-40  Score=294.24  Aligned_cols=266  Identities=25%  Similarity=0.387  Sum_probs=196.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++.....  ...+.+.+|+++++.++||||+++++++.. +...++||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRR-KKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhccc-CCeEEEEE
Confidence            46888999999999999999775 589999998754322  234567889999999999999999997765 67899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+++++|..+...    ...+++.+++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........
T Consensus        80 e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~  155 (286)
T cd07846          80 EFVDHTVLDDLEKY----PNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE  155 (286)
T ss_pred             ecCCccHHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc
Confidence            99999888877632    23489999999999999999999999999999999999999999999999999876543322


Q ss_pred             ccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh----
Q 017232          218 HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD----  292 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----  292 (375)
                       ......++..|+|||++.+ ..++.++||||||+++|+|++|.+||..................+.. ......+    
T Consensus       156 -~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  233 (286)
T cd07846         156 -VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIP-RHQEIFQKNPL  233 (286)
T ss_pred             -ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCch-hhHHHhccchH
Confidence             1223457889999998765 34678999999999999999999999654321100000000000000 0000000    


Q ss_pred             --hhcCCCC---C---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          293 --QTLGYES---D---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       293 --~~l~~~~---~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        .......   .   .....++..+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             hhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence              0000000   0   001134567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.7e-39  Score=309.48  Aligned_cols=276  Identities=18%  Similarity=0.244  Sum_probs=189.4

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEEeCC--CCEEEEEEe--------------c---ccchhhHHHHHHHHHHHHhcCCC
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGELQD--GRAVAVKRL--------------Y---ENNYKRVEQFMNEVDILARLRHK  117 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~--------------~---~~~~~~~~~~~~e~~~l~~l~h~  117 (375)
                      ....++|++.++||+|+||.||++..+.  +...+.|.+              .   .........+.+|+.+++.++||
T Consensus       144 ~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~Hp  223 (501)
T PHA03210        144 DEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHE  223 (501)
T ss_pred             hhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCC
Confidence            3456789999999999999999985432  222222211              0   11222345678999999999999


Q ss_pred             CeEEEeeeeecCCceeEEEEecccCCChhHhhccCCCC-CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec
Q 017232          118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK-PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD  196 (375)
Q Consensus       118 niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~  196 (375)
                      ||+++++++.. ....++|++++. ++|.+++...... .......++..++.||+.||.|||++||+||||||+|||++
T Consensus       224 nIv~l~~~~~~-~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~  301 (501)
T PHA03210        224 NILKIEEILRS-EANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN  301 (501)
T ss_pred             CcCcEeEEEEE-CCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence            99999998776 567899999995 6777776433211 22334567788999999999999999999999999999999


Q ss_pred             CCCcEEEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCC-Cccccccccccchh
Q 017232          197 NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP-AVDITRHRHEINLS  275 (375)
Q Consensus       197 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~-p~~~~~~~~~~~~~  275 (375)
                      .++.+||+|||++..+............||..|+|||++.+..++.++|||||||++|||++|.. |+..........+.
T Consensus       302 ~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~  381 (501)
T PHA03210        302 CDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLL  381 (501)
T ss_pred             CCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHH
Confidence            99999999999998765443333334569999999999999999999999999999999999874 44322211111111


Q ss_pred             HHHH------HHhhh--hHHHHHHhhh-cCCCC---ChHH--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          276 NLAI------NKIQN--KALHELVDQT-LGYES---DNKV--RRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       276 ~~~~------~~~~~--~~~~~~~~~~-l~~~~---~~~~--~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ....      ..+.+  ....+.+... .....   ....  ......+.+++.+||+.||++|||+.|+++.
T Consensus       382 ~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        382 KIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1000      00000  0011111100 00000   0000  0123467788999999999999999999864

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.1e-39  Score=285.77  Aligned_cols=253  Identities=22%  Similarity=0.362  Sum_probs=195.2

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch----------hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY----------KRVEQFMNEVDILARLRHKNLVSLYGCTSRHS  130 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  130 (375)
                      +|...+.||.|++|.||+|... +|+.||+|.+.....          ...+.+.+|+.+++.++|||++++++++.. .
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETT-E   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEecc-C
Confidence            4778899999999999999654 688999998753211          113467889999999999999999997765 6


Q ss_pred             ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          131 RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      ...++||||+++++|.+++...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~  156 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTY----GRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK  156 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence            7789999999999999998543    468899999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccc-cccCCCCCccccCcccccccC--CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH
Q 017232          211 LFPNHVTH-VSTAPQGTPGYVDPEYHQCYQ--LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL  287 (375)
Q Consensus       211 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (375)
                      ........ ......++..|+|||.+.+..  ++.++|+||||+++|++++|..||.......      .         .
T Consensus       157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~---------~  221 (272)
T cd06629         157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA------A---------M  221 (272)
T ss_pred             cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH------H---------H
Confidence            64332111 122335788999999887654  7889999999999999999999986332110      0         0


Q ss_pred             HHHHhhhcCCCC-ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          288 HELVDQTLGYES-DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       288 ~~~~~~~l~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .+.......... ......++..+.+++.+||..+|++||++++|++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         222 FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             HHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            000000000000 01112345679999999999999999999999863

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=3.8e-39  Score=290.19  Aligned_cols=250  Identities=24%  Similarity=0.388  Sum_probs=200.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      ++|++.+.||+|+||.||++.. .++..|++|.+........+.+.+|+.+++.++|||++++++.+.. ....++|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~   97 (293)
T cd06647          19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-GDELWVVMEY   97 (293)
T ss_pred             hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-CCcEEEEEec
Confidence            6799999999999999999965 4688999999865554555678899999999999999999997766 5678999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++++|.+++..     ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ .
T Consensus        98 ~~~~~L~~~~~~-----~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~-~  171 (293)
T cd06647          98 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  171 (293)
T ss_pred             CCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc-c
Confidence            999999999843     3478899999999999999999999999999999999999999999999998875543222 1


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      .....+++.|+|||.+.+..++.++|+||||+++|++++|..||.............      ..        ..   ..
T Consensus       172 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~------~~--------~~---~~  234 (293)
T cd06647         172 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA------TN--------GT---PE  234 (293)
T ss_pred             cccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehh------cC--------CC---CC
Confidence            223357889999999988888999999999999999999999997543221110000      00        00   00


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .......+..+.+++.+||..+|++||++.+++..
T Consensus       235 ~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         235 LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00111234568899999999999999999999865

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=301.89  Aligned_cols=242  Identities=29%  Similarity=0.472  Sum_probs=193.5

Q ss_pred             CCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           63 FDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      |.-++.||.|+||.||.|+. .+...||||++.-..   .+..+++..|+..|++++|||++.+-|||.. ....|||||
T Consensus        28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLr-e~TaWLVME  106 (948)
T KOG0577|consen   28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLR-EHTAWLVME  106 (948)
T ss_pred             HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeec-cchHHHHHH
Confidence            55678899999999999954 578899999986443   2345678999999999999999999998887 556899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      || -|+-.+++.-.   .+++-+.++..|+.+.+.||.|||+.+.+|||||..|||+++.|.|||+|||.+.....    
T Consensus       107 YC-lGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P----  178 (948)
T KOG0577|consen  107 YC-LGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP----  178 (948)
T ss_pred             HH-hccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCc----
Confidence            99 57778877543   45689999999999999999999999999999999999999999999999999976543    


Q ss_pred             cccCCCCCccccCcccc---cccCCCCchhHHHHHHHHHHHHhCCCCc-cccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          219 VSTAPQGTPGYVDPEYH---QCYQLTDKSDVFSFGVVLIELISSMPAV-DITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                       ....+|||.|||||++   ..+.|+-++||||||+++.||.-.+||. +...           ...     +..+-.. 
T Consensus       179 -AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNA-----------MSA-----LYHIAQN-  240 (948)
T KOG0577|consen  179 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA-----------MSA-----LYHIAQN-  240 (948)
T ss_pred             -hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchH-----------HHH-----HHHHHhc-
Confidence             2345799999999975   4578999999999999999999999885 3221           000     0011100 


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        ..+.-...+-+..+++++..||+.-|.+|||.++++.
T Consensus       241 --esPtLqs~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  241 --ESPTLQSNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             --CCCCCCCchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence              0011112234567999999999999999999998765

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=5.2e-39  Score=283.49  Aligned_cols=251  Identities=29%  Similarity=0.491  Sum_probs=204.2

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|++.+.||.|++|.||++... ++..+++|++.....  .....+.+|+++++.++|+|++++++.+.. ....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-KGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-CCEEEEEEE
Confidence            4788899999999999999665 688999999865533  455678899999999999999999997766 478999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+.+.........+++..++.++.+++.||.+||+.|++|+||+|+||+++.++.++|+|||.+....... .
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-~  158 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV-D  158 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-c
Confidence            999999999997654445679999999999999999999999999999999999999999999999999987665433 1


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ......+++.|+|||...+..++.++|+||+|+++++|++|..||......      ....         .....    .
T Consensus       159 ~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~------~~~~---------~~~~~----~  219 (258)
T cd08215         159 LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL------ELAL---------KILKG----Q  219 (258)
T ss_pred             eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH------HHHH---------HHhcC----C
Confidence            223346888999999988888999999999999999999999998644311      0100         01111    1


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .......+...+.+++.+||..+|++|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         220 YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11111134567899999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-42  Score=286.75  Aligned_cols=248  Identities=24%  Similarity=0.411  Sum_probs=202.9

Q ss_pred             CCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           63 FDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      |.++++||+|+||.||+|.+ ..|+.+|||.+.-.  ..++.+..|+.+|++++.|++|++||.+.. ...+++|||||.
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK-~sDLWIVMEYCG  111 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFK-HSDLWIVMEYCG  111 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhcc-CCceEeehhhcC
Confidence            56788999999999999954 47999999987543  456788999999999999999999997766 456999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      .|++.+.++.   +++++++.++..++...+.||+|||...-+|||||..|||++.+|..||+|||.+-.+..... ...
T Consensus       112 AGSiSDI~R~---R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA-KRN  187 (502)
T KOG0574|consen  112 AGSISDIMRA---RRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA-KRN  187 (502)
T ss_pred             CCcHHHHHHH---hcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHH-hhC
Confidence            9999999954   457899999999999999999999999999999999999999999999999999976643222 234


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...|||.|||||++..-.|+.++||||||++..||.-|++|+....+-...                 ++-+.-....-.
T Consensus       188 TVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAI-----------------FMIPT~PPPTF~  250 (502)
T KOG0574|consen  188 TVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAI-----------------FMIPTKPPPTFK  250 (502)
T ss_pred             ccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccccccee-----------------EeccCCCCCCCC
Confidence            567999999999999999999999999999999999999999643221100                 000000000111


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ++..-+.++.+++++||-.+|++|.|+.++++.
T Consensus       251 KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  251 KPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             ChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence            234456789999999999999999999998864

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1e-38  Score=285.06  Aligned_cols=247  Identities=26%  Similarity=0.438  Sum_probs=197.9

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      -|+..+.||.|+||.||+|... ++..||+|.+.... ......+.+|+.++..++||||+++++++.. +...++||||
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~   83 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIMEY   83 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEe-CCeEEEEEEe
Confidence            3778899999999999999654 68899999876443 3345678899999999999999999997776 5678999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++++|.+++.     ...+++..+..++.|++.|+.+||+.|++|+||+|+||+++.++.++|+|||++........ .
T Consensus        84 ~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~-~  157 (277)
T cd06641          84 LGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI-K  157 (277)
T ss_pred             CCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchh-h
Confidence            99999999884     23588999999999999999999999999999999999999999999999999876543221 1


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      .....++..|+|||.+.+..++.++|+|||||++|+|++|..||.......      ..         . .+..   ...
T Consensus       158 ~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~------~~---------~-~~~~---~~~  218 (277)
T cd06641         158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK------VL---------F-LIPK---NNP  218 (277)
T ss_pred             hccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH------HH---------H-HHhc---CCC
Confidence            223357889999999988888999999999999999999999996432110      00         0 0000   001


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ......++..+.+++.+|++.+|.+||++.++++.
T Consensus       219 ~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            11112245678899999999999999999999984

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.5e-39  Score=283.27  Aligned_cols=249  Identities=27%  Similarity=0.402  Sum_probs=202.6

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|++.+.||.|++|.||++... ++..+++|.+....  ......+.+|+.+++.++|+||+++++++.. ....++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-GNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-CCEEEEEeh
Confidence            4788999999999999999554 68899999986542  3344567889999999999999999997666 578999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++.........+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......   
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~---  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN---  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC---
Confidence            99999999998664444467899999999999999999999999999999999999999999999999999776543   


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.......      .          ....   ....
T Consensus       157 ~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~------~----------~~~~---~~~~  217 (256)
T cd08530         157 MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD------L----------RYKV---QRGK  217 (256)
T ss_pred             CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H----------HHHH---hcCC
Confidence            1223457889999999998889999999999999999999999997543110      0          0000   1111


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..........++.+++.+|+..+|++||++.++++
T Consensus       218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            11222245678999999999999999999999985

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-38  Score=289.64  Aligned_cols=271  Identities=20%  Similarity=0.299  Sum_probs=196.4

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC---CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-CceeE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ---DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-SRELL  134 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~  134 (375)
                      +|++.++||+|++|.||+|...   ++..||+|.+....   ......+.+|+.+++.++||||+++++++... ...++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            4788899999999999999665   47899999987632   33345678899999999999999999977653 26799


Q ss_pred             EEEecccCCChhHhhccCCCCC-CCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC----CCcEEEeeeccc
Q 017232          135 LVYEFISNGTVADHLHGERAKP-GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN----NFCVKVADFGLS  209 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~-~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~~  209 (375)
                      +||||++ ++|.+.+....... ..+++..++.++.|++.||.|||+.+++|+||||+||+++.    ++.+||+|||++
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~  159 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA  159 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence            9999996 56777765443333 37899999999999999999999999999999999999999    999999999998


Q ss_pred             cccCCCcc--ccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccch--hHHH----HH
Q 017232          210 RLFPNHVT--HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL--SNLA----IN  280 (375)
Q Consensus       210 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~--~~~~----~~  280 (375)
                      ........  .......++..|+|||.+.+ ..++.++||||||+++|+|++|++||...........  ....    ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (316)
T cd07842         160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE  239 (316)
T ss_pred             cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence            86543322  11223357889999998765 4578999999999999999999999976544321100  0000    00


Q ss_pred             Hhhhh------------HHHHHHhhhcCCCCC--hHHH------HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          281 KIQNK------------ALHELVDQTLGYESD--NKVR------RTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       281 ~~~~~------------~~~~~~~~~l~~~~~--~~~~------~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .+...            ......+........  ....      .....+.+++.+||+.+|++|||+.|+++
T Consensus       240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~  312 (316)
T cd07842         240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE  312 (316)
T ss_pred             HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00000            000000000000000  0000      23356889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-39  Score=285.80  Aligned_cols=247  Identities=26%  Similarity=0.428  Sum_probs=196.1

Q ss_pred             CCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHHhcC---CCCeEEEeeeeecCCceeEEE
Q 017232           62 YFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLR---HKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .|+..+.||+|+||.||+|.. .++..|++|.+... .......+.+|+.+++.++   |||++++++++.. +...++|
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~-~~~~~lv   80 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLK-GPRLWII   80 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeee-CCEEEEE
Confidence            477889999999999999965 47899999988654 3344567888999999997   9999999997765 6678999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++..     ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~-----~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          81 MEYAEGGSVRTLMKA-----GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EecCCCCcHHHHHHc-----cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            999999999998842     368999999999999999999999999999999999999999999999999987665433


Q ss_pred             cccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          217 THVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .. .....++..|+|||.+.+ ..++.++|+||||+++|+|++|.+||.........       ..+...     ..+.+
T Consensus       156 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~-------~~~~~~-----~~~~~  222 (277)
T cd06917         156 SK-RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM-------MLIPKS-----KPPRL  222 (277)
T ss_pred             cc-cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh-------hccccC-----CCCCC
Confidence            21 223358889999998764 45788999999999999999999999754321100       000000     00001


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..      ...+..+.+++.+||+.+|++||++.+++.
T Consensus       223 ~~------~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         223 ED------NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             Cc------ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence            00      013467899999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.9e-39  Score=290.93  Aligned_cols=264  Identities=22%  Similarity=0.298  Sum_probs=192.8

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|++.+.||+|+||.||+|... +|+.|++|.+....  ......+.+|+.+++.++|||++++++++.. ....++|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHS-DKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhcc-CCceEEEEe
Confidence            4788899999999999999665 68999999986432  2223457789999999999999999997765 567999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+. ++|.+++...   ...+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++........ 
T Consensus        80 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~-  154 (284)
T cd07839          80 YCD-QDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR-  154 (284)
T ss_pred             cCC-CCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC-
Confidence            996 5788777432   34589999999999999999999999999999999999999999999999999876543221 


Q ss_pred             cccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh------HHHHHH
Q 017232          219 VSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK------ALHELV  291 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  291 (375)
                      ......++..|+|||.+.+. .++.++|||||||++|+|++|..|+....... ..+ ..........      ......
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~-~~~-~~~~~~~~~~~~~~~~~~~~~~  232 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVD-DQL-KRIFRLLGTPTEESWPGVSKLP  232 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHH-HHH-HHHHHHhCCCChHHhHHhhhcc
Confidence            12234578899999987664 47899999999999999999888753222111 000 0000000000      000000


Q ss_pred             hhhcCCCC------ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 DQTLGYES------DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 ~~~l~~~~------~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      +.......      ......++..+.+++.+||+.+|.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence            00000000      0111234567889999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.8e-39  Score=290.99  Aligned_cols=263  Identities=22%  Similarity=0.314  Sum_probs=196.8

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchh-----hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK-----RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      +|++.+.||.|++|.||+|... +++.|++|.+......     ....+..|+.+++.++|+||+++++++.. ....++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGH-KSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeec-CCEEEE
Confidence            4788899999999999999754 6899999998654322     23456789999999999999999997776 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+ +++|.+++....   ..+++..++.++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~-~~~L~~~i~~~~---~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~  155 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKS---IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP  155 (298)
T ss_pred             EEccc-CCCHHHHHhccC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence            99999 899999985432   36899999999999999999999999999999999999999999999999999866543


Q ss_pred             ccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH---
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV---  291 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  291 (375)
                      ... .....++..|+|||.+.+ ..++.++|+|||||++|+|++|.++|........   ...............+.   
T Consensus       156 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~  231 (298)
T cd07841         156 NRK-MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQ---LGKIFEALGTPTEENWPGVT  231 (298)
T ss_pred             Ccc-ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHH---HHHHHHHcCCCchhhhhhcc
Confidence            221 122346788999998754 4578899999999999999999888865432111   00000000000000000   


Q ss_pred             ---hhh---cC--CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 ---DQT---LG--YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 ---~~~---l~--~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                         ...   ..  ..........+..+.+++.+||+.+|++|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         232 SLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence               000   00  0000111233567899999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2e-38  Score=278.66  Aligned_cols=249  Identities=30%  Similarity=0.480  Sum_probs=201.6

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      .|...+.||+|++|.||++... ++..+++|++..........+.+|+.+++.++|+|++++++++.. ....++++||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-KDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEEecC
Confidence            3778899999999999999765 688999999977665566788999999999999999999997766 57789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      ++++|.+++....   ..+++..+..++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+........  .
T Consensus        80 ~~~~L~~~~~~~~---~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~  154 (253)
T cd05122          80 SGGSLKDLLKSTN---QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--R  154 (253)
T ss_pred             CCCcHHHHHhhcC---CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc--c
Confidence            9999999985432   4689999999999999999999999999999999999999999999999999877654332  2


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD  300 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  300 (375)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|..||........      ..          .... ......
T Consensus       155 ~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~------~~----------~~~~-~~~~~~  217 (253)
T cd05122         155 NTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA------LF----------KIAT-NGPPGL  217 (253)
T ss_pred             cceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH------HH----------HHHh-cCCCCc
Confidence            334588899999999888889999999999999999999999875431110      00          0000 000000


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          301 NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ......+..+.+++.+||+.+|++|||+.++++
T Consensus       218 ~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         218 RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111112467899999999999999999999985

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.9e-38  Score=284.70  Aligned_cols=254  Identities=24%  Similarity=0.419  Sum_probs=202.9

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ...+.|+....||+|++|.||+|... ++..+++|++..... ..+.+.+|+++++.++|+|++++++++.. ....+++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv   93 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLV-GDELWVV   93 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEE-CCEEEEE
Confidence            34566888899999999999999766 688999999876544 45678899999999999999999997776 5789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      +||+++++|.+++....   ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        94 ~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  170 (286)
T cd06614          94 MEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEK  170 (286)
T ss_pred             EeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccch
Confidence            99999999999996532   368999999999999999999999999999999999999999999999999886544322


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      . ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......      ..         ..+..... 
T Consensus       171 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~------~~---------~~~~~~~~-  233 (286)
T cd06614         171 S-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLR------AL---------FLITTKGI-  233 (286)
T ss_pred             h-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHH------HH---------HHHHhcCC-
Confidence            1 1122347789999999988889999999999999999999999986432111      00         00000000 


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       ........++..+.+++.+|++.+|.+||++.++++.
T Consensus       234 -~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         234 -PPLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             -CCCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence             0011112245678999999999999999999999863

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.3e-39  Score=288.85  Aligned_cols=265  Identities=22%  Similarity=0.309  Sum_probs=195.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchh--hHHHHHHHHHHHHhcCCCCeEEEeeeeecC-CceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK--RVEQFMNEVDILARLRHKNLVSLYGCTSRH-SRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv  136 (375)
                      ++|++.+.||.|+||.||+|... +++.+++|.+......  ....+.+|+.+++.++||||+++++++... ....++|
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            46888999999999999999765 5889999998654322  223567899999999999999999976553 2789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+. ++|.+++....   ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        85 ~e~~~-~~L~~~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVE-HDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcC-cCHHHHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99997 58988885432   358999999999999999999999999999999999999999999999999988665432


Q ss_pred             cccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh---hhHHHHHHh
Q 017232          217 THVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ---NKALHELVD  292 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  292 (375)
                      .. .....+++.|+|||.+.+. .++.++|+||+|+++|+|++|.+||..........  . ......   +.....+..
T Consensus       161 ~~-~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         161 KP-YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN--K-IFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cc-cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH--H-HHHHhCCCchHHHHHhhc
Confidence            11 2233578899999988654 46889999999999999999999997543221100  0 000000   000000000


Q ss_pred             ---hh---cCCCC----ChHHHH--HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          293 ---QT---LGYES----DNKVRR--TINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       293 ---~~---l~~~~----~~~~~~--~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                         ..   .....    ......  ....+.+++.+||+.+|++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence               00   00000    000011  2556889999999999999999999985

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=3.2e-38  Score=286.15  Aligned_cols=246  Identities=29%  Similarity=0.415  Sum_probs=193.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..|+..+.||+|+||.||+|... +++.|++|.+...   .......+.+|+.+++.++|||++++++++.. ....++|
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~-~~~~~lv   93 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLR-EHTAWLV   93 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEe-CCeEEEE
Confidence            45888999999999999999665 6899999988543   22334568899999999999999999998776 5678999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+. |++.+.+...   ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        94 ~e~~~-g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          94 MEYCL-GSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HHhhC-CCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99996 6777776432   245899999999999999999999999999999999999999999999999998754322 


Q ss_pred             cccccCCCCCccccCccccc---ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          217 THVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                          ....++..|+|||.+.   ...++.++||||||+++|+|++|.+||.......      ..         ..+.. 
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~------~~---------~~~~~-  228 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------AL---------YHIAQ-  228 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHH------HH---------HHHhc-
Confidence                2235788999999874   4568889999999999999999999986432111      00         00000 


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                        ..........++..+.+++.+||+.+|++||++.+++..
T Consensus       229 --~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         229 --NDSPTLSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --CCCCCCCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              000111112345678999999999999999999999875

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.5e-38  Score=285.22  Aligned_cols=247  Identities=26%  Similarity=0.430  Sum_probs=196.8

Q ss_pred             CCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           63 FDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      |...+.||.|++|.||++.. .+++.+++|++........+.+.+|+.+++.++|||++++++++.. ....++++||+.
T Consensus        21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-~~~~~~v~e~~~   99 (285)
T cd06648          21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-GDELWVVMEFLE   99 (285)
T ss_pred             hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-CCeEEEEEeccC
Confidence            44457899999999999965 4688999999866555555678899999999999999999997665 677899999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|.+++..     ..+++..+..++.|++.||.+||++|++||||+|+||+++.++.++|+|||.+........ ...
T Consensus       100 ~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~~~  173 (285)
T cd06648         100 GGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-RRK  173 (285)
T ss_pred             CCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc-ccc
Confidence            9999999843     3588999999999999999999999999999999999999999999999998765443222 122


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...+++.|+|||.+.+..++.++||||||+++|+|++|..||.......      .. ..+...     ..+..     .
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~------~~-~~~~~~-----~~~~~-----~  236 (285)
T cd06648         174 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQ------AM-KRIRDN-----LPPKL-----K  236 (285)
T ss_pred             cccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHH------HH-HHHHhc-----CCCCC-----c
Confidence            3458889999999988889999999999999999999999986432110      00 000000     00000     0


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ....++..+.+++.+||..+|++||++.++++
T Consensus       237 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         237 NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence            11124467999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-39  Score=289.72  Aligned_cols=265  Identities=21%  Similarity=0.333  Sum_probs=193.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|++.+.||.|++|.||+|..+ +++.|++|.+...... ....+.+|+++++.++|+||+++++++.. ....++|||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   83 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHT-KKTLTLVFE   83 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEec-CCeEEEEEe
Confidence            57889999999999999999765 6899999998654322 22456789999999999999999997765 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+. ++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........ 
T Consensus        84 ~~~-~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~-  158 (291)
T cd07844          84 YLD-TDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK-  158 (291)
T ss_pred             cCC-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCc-
Confidence            997 5899888543   23688999999999999999999999999999999999999999999999999865432111 


Q ss_pred             cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh---hhHHHHHHhh-
Q 017232          219 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ---NKALHELVDQ-  293 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-  293 (375)
                      ......++..|+|||.+.+ ..++.++||||+|+++|+|++|++||........  ..........   .......... 
T Consensus       159 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  236 (291)
T cd07844         159 TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVED--QLHKIFRVLGTPTEETWPGVSSNP  236 (291)
T ss_pred             cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHHhcCCCChhhhhhhhhcc
Confidence            1122346788999998765 4578899999999999999999999964431110  0000000000   0000000000 


Q ss_pred             -----hcCCCCChHH----HHH--HHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          294 -----TLGYESDNKV----RRT--INAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       294 -----~l~~~~~~~~----~~~--~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                           ..........    ...  ...+.+++.+||+.+|++|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             ccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence                 0000000000    011  156789999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=297.47  Aligned_cols=270  Identities=22%  Similarity=0.349  Sum_probs=197.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----cee
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----REL  133 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~  133 (375)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|.+.... ......+.+|+.+++.++|+||+++++++....    ...
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            46799999999999999999965 468999999986432 233456788999999999999999998654322    357


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++|+||+. ++|...+.     ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          84 YIVQELME-TDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEehhcc-cCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            99999996 57877773     3458999999999999999999999999999999999999999999999999987654


Q ss_pred             CCccc--cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh---hhHH
Q 017232          214 NHVTH--VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ---NKAL  287 (375)
Q Consensus       214 ~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~  287 (375)
                      .....  ......++..|+|||.+.+ ..++.++||||+|+++|+|++|++||........   .......+.   ....
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~---~~~~~~~~~~~~~~~~  234 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ---LNLILGVLGTPSQEDL  234 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH---HHHHHHHcCCCCHHHH
Confidence            32211  1123457889999997654 5688999999999999999999999965432110   000000000   0001


Q ss_pred             HHHHhhh-------cCCCCC----hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhh
Q 017232          288 HELVDQT-------LGYESD----NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDI  338 (375)
Q Consensus       288 ~~~~~~~-------l~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i  338 (375)
                      ..+....       ......    ......+..+.+++.+||+.+|++|||+.++++.  ++..
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         235 NCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            1111000       000000    0111235678999999999999999999999986  5544

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=7e-39  Score=287.19  Aligned_cols=264  Identities=22%  Similarity=0.355  Sum_probs=194.9

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|+..+.||.|++|.||+|... ++..|++|.+....  ......+.+|++++++++||||+++++++.. ....++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhccc-CCcEEEEee
Confidence            4788999999999999999665 68899999886442  2233568889999999999999999997765 668999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+. ++|.+++...  ....+++..++.++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........ 
T Consensus        80 ~~~-~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~-  155 (284)
T cd07860          80 FLH-QDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR-  155 (284)
T ss_pred             ccc-cCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc-
Confidence            995 6888888543  235689999999999999999999999999999999999999999999999999875543221 


Q ss_pred             cccCCCCCccccCcccccccC-CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh------HHHHHH
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQ-LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK------ALHELV  291 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  291 (375)
                      ......++..|+|||.+.+.. ++.++||||||+++|+|+||+.||.........  .... ......      ....+.
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~  232 (284)
T cd07860         156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL--FRIF-RTLGTPDEVVWPGVTSLP  232 (284)
T ss_pred             ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH--HHHH-HHhCCCChhhhhhhhHHH
Confidence            112234678899999876644 588999999999999999999999654321110  0000 000000      000000


Q ss_pred             hhhc------CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 DQTL------GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 ~~~l------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ....      ..............+.+++.+||+.||.+|||++++++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         233 DYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             HHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            0000      00000001123456889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-39  Score=297.47  Aligned_cols=265  Identities=29%  Similarity=0.443  Sum_probs=219.6

Q ss_pred             HHHHHHhcCCCCCCccCCCCcEEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           54 GELEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        54 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      ++++-...+....++||-|-||.||.|.|+. .-.||||.++.+..+ .+.|..|+.+|+.++|||+|+++|+|.. ...
T Consensus       260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMe-veEFLkEAAvMKeikHpNLVqLLGVCT~-EpP  337 (1157)
T KOG4278|consen  260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTH-EPP  337 (1157)
T ss_pred             chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchh-HHHHHHHHHHHHhhcCccHHHHhhhhcc-CCC
Confidence            4455555567778999999999999998875 567999998766544 5889999999999999999999998876 567


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      +|||+|||..|+|.++|+..  +...++....++++.||..|++||..++++||||...|.|+.++..+|++|||++++.
T Consensus       338 FYIiTEfM~yGNLLdYLRec--nr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlM  415 (1157)
T KOG4278|consen  338 FYIITEFMCYGNLLDYLREC--NRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLM  415 (1157)
T ss_pred             eEEEEecccCccHHHHHHHh--chhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhh
Confidence            99999999999999999765  3445777788999999999999999999999999999999999999999999999988


Q ss_pred             CCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ..+.............|.|||-+....++.++|||+|||+|||+.| |..|+...+      +          ..+.+++
T Consensus       416 tgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid------l----------SqVY~LL  479 (1157)
T KOG4278|consen  416 TGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID------L----------SQVYGLL  479 (1157)
T ss_pred             cCCceecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCcc------H----------HHHHHHH
Confidence            7665554444556778999999888889999999999999999987 888886443      1          1223344


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      +...+.+   .+..|++.+.+|++.||+++|.+||++.|+-+.++.+-.+
T Consensus       480 EkgyRM~---~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  480 EKGYRMD---GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             hcccccc---CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence            3333222   2245778899999999999999999999999999976553

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.7e-39  Score=285.82  Aligned_cols=247  Identities=24%  Similarity=0.305  Sum_probs=198.5

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      +|++.+.||.|+||.||+|... ++..|++|.+....   ....+.+.+|+.++++++||||+++++++.. ....++|+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQD-EENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcC-CCeEEEEE
Confidence            4788999999999999999765 68999999986542   2345778899999999999999999997665 67899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+.+++|.+++...    ..+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||.+....... 
T Consensus        80 e~~~~~~L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-  154 (258)
T cd05578          80 DLLLGGDLRYHLSQK----VKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-  154 (258)
T ss_pred             eCCCCCCHHHHHHhc----CCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence            999999999998532    468999999999999999999999999999999999999999999999999987654332 


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                       ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.......    ......         ....    
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~----~~~~~~---------~~~~----  216 (258)
T cd05578         155 -LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTI----RDQIRA---------KQET----  216 (258)
T ss_pred             -cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccH----HHHHHH---------Hhcc----
Confidence             1233457889999999988889999999999999999999999997554210    000000         0000    


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHH
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYM--VDVL  332 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~--~evl  332 (375)
                      .....+...+..+.+++.+||+.+|.+||++  .|++
T Consensus       217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence            0111112345788999999999999999999  5554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.7e-39  Score=296.13  Aligned_cols=265  Identities=21%  Similarity=0.328  Sum_probs=198.4

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----  130 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  130 (375)
                      ...++|++.+.||+|+||.||+|... +++.||+|.+...  .......+.+|+.+++.++|+||+++++++....    
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   92 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEE   92 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccc
Confidence            35678999999999999999999654 7899999998643  3334456778999999999999999999765432    


Q ss_pred             -ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          131 -RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       131 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                       ...++||||+. ++|.+.+..      .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++|+|||++
T Consensus        93 ~~~~~lv~e~~~-~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~  165 (353)
T cd07850          93 FQDVYLVMELMD-ANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA  165 (353)
T ss_pred             cCcEEEEEeccC-CCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccc
Confidence             35799999995 588887732      1788899999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh------
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ------  283 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~------  283 (375)
                      ........  .....++..|+|||.+.+..++.++|||||||++|+|++|+.||.........   ......+.      
T Consensus       166 ~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~  240 (353)
T cd07850         166 RTAGTSFM--MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQW---NKIIEQLGTPSDEF  240 (353)
T ss_pred             eeCCCCCC--CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHH---HHHHHhcCCCCHHH
Confidence            86543222  22335788999999999989999999999999999999999999754321110   00000000      


Q ss_pred             ----hhHHHHHHhhhcCCCC----------------ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          284 ----NKALHELVDQTLGYES----------------DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       284 ----~~~~~~~~~~~l~~~~----------------~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                          ................                .......+..+.+++.+||+.||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         241 MSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             HHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                0000111111000000                00011235568899999999999999999999864

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.6e-39  Score=297.03  Aligned_cols=273  Identities=21%  Similarity=0.314  Sum_probs=200.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----ce
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----RE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~  132 (375)
                      .++|.+.+.||+|+||+||+|.. .+++.||+|.+...  .......+.+|+.+++.++|+||+++++++....    ..
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            45799999999999999999965 46899999988653  2233456778999999999999999998665432    35


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      .++|+||+. ++|.+++..    ...+++..+..++.|++.||.|||+++++|+||+|+||+++.++.++|+|||++...
T Consensus        84 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  158 (337)
T cd07858          84 VYIVYELMD-TDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTT  158 (337)
T ss_pred             EEEEEeCCC-CCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccccc
Confidence            799999995 788888743    356899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHH--------HHHhh
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA--------INKIQ  283 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~  283 (375)
                      .... .......++..|+|||.+.+ ..++.++|||||||++|+|++|++||...............        ...+.
T Consensus       159 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (337)
T cd07858         159 SEKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR  237 (337)
T ss_pred             CCCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcC
Confidence            4322 11223357889999998764 46889999999999999999999999654321110000000        00011


Q ss_pred             hhHHHHHHhhhcC---CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhh
Q 017232          284 NKALHELVDQTLG---YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDI  338 (375)
Q Consensus       284 ~~~~~~~~~~~l~---~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i  338 (375)
                      .............   .........++..+.+++.+||+.+|++|||++++++.  ++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         238 NEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             chhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence            1111111111000   00011112355678999999999999999999999987  6554

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=8e-39  Score=287.06  Aligned_cols=264  Identities=22%  Similarity=0.314  Sum_probs=196.3

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-CceeEEEEe
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-SRELLLVYE  138 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~e  138 (375)
                      |++.+.||.|++|.||+|... +++.+++|.+....  ......+.+|+.+++.++|+|++++++++... ....++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e   80 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE   80 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence            667889999999999999766 58899999997653  33345688899999999999999999977664 368999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |++ ++|.+++...   ...+++..++.++.|++.||+|||+.|++|+||+|+||++++++.++|+|||.+.........
T Consensus        81 ~~~-~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          81 YMD-HDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             ccc-ccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            997 5888887432   246899999999999999999999999999999999999999999999999999866544322


Q ss_pred             cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh---hHHHHHH---
Q 017232          219 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN---KALHELV---  291 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---  291 (375)
                      ......++..|+|||.+.+ ..++.++||||||+++|+|++|++||..........   ........   .......   
T Consensus       157 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07840         157 DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLE---KIFELCGSPTDENWPGVSKLP  233 (287)
T ss_pred             cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHhCCCchhhccccccch
Confidence            2233456788999997664 457899999999999999999999997544221110   00000000   0000000   


Q ss_pred             -hhhcCC--CC----ChHHHH-HHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 -DQTLGY--ES----DNKVRR-TINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 -~~~l~~--~~----~~~~~~-~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       ......  ..    ...... ++..+.+++.+||+.+|.+||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         234 WFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             hhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence             000000  00    000011 2567899999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=9.5e-39  Score=282.00  Aligned_cols=250  Identities=23%  Similarity=0.424  Sum_probs=197.5

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|.+.+.||+|+||.||++... +|..+|+|.+....  ......+.+|+.+++.++|+|++++++.+.. ....++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE-NGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheecc-CCeEEEEEe
Confidence            4778899999999999999665 58889999986542  2334567899999999999999999997766 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc-EEEeeeccccccCCCcc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC-VKVADFGLSRLFPNHVT  217 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~~  217 (375)
                      |+.+++|.+++...  ....+++..+..++.|++.||.|||+.+++|+||+|+||++++++. ++|+|||.+........
T Consensus        80 ~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~  157 (257)
T cd08225          80 YCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME  157 (257)
T ss_pred             cCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc
Confidence            99999999998643  2345789999999999999999999999999999999999998864 69999999876643322


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                       ......+++.|+|||...+..++.++|+||||+++|+|++|..||......      ....         ........ 
T Consensus       158 -~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~------~~~~---------~~~~~~~~-  220 (257)
T cd08225         158 -LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLH------QLVL---------KICQGYFA-  220 (257)
T ss_pred             -cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH------HHHH---------HHhcccCC-
Confidence             122335788999999988888999999999999999999999998643211      1111         11111111 


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                         ......+..+.+++.+|+..+|++|||+.++++.
T Consensus       221 ---~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         221 ---PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ---CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence               1111234579999999999999999999999853

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.1e-38  Score=286.90  Aligned_cols=266  Identities=23%  Similarity=0.269  Sum_probs=192.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccch-hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNY-KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      +++|++.+.||+|+||.||+|.. .++..|++|.+..... .....+.+|+.+++.++|+||+++++++.. +...++||
T Consensus         4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~-~~~~~lv~   82 (291)
T cd07870           4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHT-KETLTFVF   82 (291)
T ss_pred             cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEec-CCeEEEEE
Confidence            46799999999999999999965 4688999999865432 223456789999999999999999997765 56789999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+. ++|.+++...   ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        83 e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  158 (291)
T cd07870          83 EYMH-TDLAQYMIQH---PGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ  158 (291)
T ss_pred             eccc-CCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC
Confidence            9995 6777776432   24578888999999999999999999999999999999999999999999999875432221


Q ss_pred             ccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh---hhHHHHH---
Q 017232          218 HVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ---NKALHEL---  290 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---  290 (375)
                      . .....+++.|+|||.+.+. .++.++||||||+++|+|++|..||......... +. .....+.   +.....+   
T Consensus       159 ~-~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~  235 (291)
T cd07870         159 T-YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQ-LE-KIWTVLGVPTEDTWPGVSKL  235 (291)
T ss_pred             C-CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHH-HH-HHHHHcCCCChhhhhhhhhc
Confidence            1 1233478899999988753 5788999999999999999999999754321100 00 0000000   0000000   


Q ss_pred             ---HhhhcCCCCChHH------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          291 ---VDQTLGYESDNKV------RRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       291 ---~~~~l~~~~~~~~------~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                         .............      ......+.+++.+|+..+|++|||+.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence               0000000000000      011356889999999999999999999874

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.5e-39  Score=292.59  Aligned_cols=271  Identities=24%  Similarity=0.332  Sum_probs=200.7

Q ss_pred             HHHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC
Q 017232           54 GELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS  130 (375)
Q Consensus        54 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  130 (375)
                      +++..+.++|++.+.||.|+||.||+|... +++.||+|++....  ....+.+.+|+.+++.++|||++++++++....
T Consensus         3 ~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~   82 (328)
T cd07856           3 GTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPL   82 (328)
T ss_pred             cceeccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCC
Confidence            344557789999999999999999999654 78999999875432  223466788999999999999999999877656


Q ss_pred             ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          131 RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      ...++++||+ +++|..++.     ..++++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.
T Consensus        83 ~~~~lv~e~~-~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~  156 (328)
T cd07856          83 EDIYFVTELL-GTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLAR  156 (328)
T ss_pred             CcEEEEeehh-ccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCcccccc
Confidence            6789999999 568888873     3357888889999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhH--------HHHHH
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN--------LAINK  281 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~  281 (375)
                      ......    ....++..|+|||.+.+ ..++.++||||||+++|+|++|++||.............        .....
T Consensus       157 ~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (328)
T cd07856         157 IQDPQM----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINT  232 (328)
T ss_pred             ccCCCc----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            543211    22346788999998765 568999999999999999999999997543211110000        00000


Q ss_pred             hhhhHHHHHHhhhcCCCCCh---HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          282 IQNKALHELVDQTLGYESDN---KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~~~~~~---~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .......+.+.........+   ....++..+.+++.+||+.+|++|||+.+++..
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         233 ICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             ccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            00111111111100000001   111234679999999999999999999998755

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2e-38  Score=284.22  Aligned_cols=268  Identities=22%  Similarity=0.329  Sum_probs=196.9

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      +|++.+.||.|++|.||+|... +|..||+|.+..... .....+.+|+.+++.++|+|++++++++.. .+..++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-ENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-CCcEEEEEec
Confidence            4888999999999999999765 688999999865532 234567789999999999999999997776 5678999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +. ++|.+++.... ....+++..+..++.|++.||.|||+.|++|+||+|+||++++++.++|+|||++........ .
T Consensus        80 ~~-~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  156 (284)
T cd07836          80 MD-KDLKKYMDTHG-VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN-T  156 (284)
T ss_pred             CC-ccHHHHHHhcC-CCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-c
Confidence            97 58888875443 234689999999999999999999999999999999999999999999999999875433211 1


Q ss_pred             ccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh-hhcCC
Q 017232          220 STAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD-QTLGY  297 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~  297 (375)
                      .....++..|++||.+.+ ..++.++||||||+++|+|++|.+||..........................+.. +....
T Consensus       157 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd07836         157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKP  236 (284)
T ss_pred             cccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcc
Confidence            123356889999998765 3568899999999999999999999975432211000000000000000000000 00000


Q ss_pred             C--------CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          298 E--------SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       298 ~--------~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .        ........+..+.+++.+|++.+|.+||++.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         237 TFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             cccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0        00011234567899999999999999999999885

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5e-39  Score=291.68  Aligned_cols=266  Identities=26%  Similarity=0.362  Sum_probs=194.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchh--hHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-ceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK--RVEQFMNEVDILARLRHKNLVSLYGCTSRHS-RELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~l  135 (375)
                      .++|++.+.||.|+||.||+|... +|+.||+|.+......  ....+.+|+.++++++|+|++++++++.... ...++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            357999999999999999999664 6899999998644322  1234567999999999999999999765433 56899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+. ++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        86 v~e~~~-~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCE-QDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCC-CCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            999996 5888887543   246899999999999999999999999999999999999999999999999998866433


Q ss_pred             ccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh---HHHHHH
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK---ALHELV  291 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  291 (375)
                      .. ......++..|+|||.+.+ ..++.++||||+|+++|+|++|.+||.........   ..........   ......
T Consensus       162 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~---~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         162 AK-PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQL---DLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cC-CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHhcCCCChhhchhhh
Confidence            21 1122345778999998765 45789999999999999999999999754322111   0000000000   000000


Q ss_pred             h------hhcCCCCC----hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 D------QTLGYESD----NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 ~------~~l~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .      ..+.....    ......+..+.+++.+||+.||++|||+.+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             cccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0      00000000    000113566789999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1e-38  Score=293.10  Aligned_cols=274  Identities=23%  Similarity=0.360  Sum_probs=200.0

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeec-CCcee
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSR-HSREL  133 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~-~~~~~  133 (375)
                      ..++|++.+.||+|+||.||+|... +++.+++|++...  .......+.+|+.+++++ +||||+++++++.. +....
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~   84 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI   84 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence            4567899999999999999999765 6889999988542  233345677899999999 99999999997654 34568


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++||||+. ++|..++..     ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        85 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~  158 (337)
T cd07852          85 YLVFEYME-TDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS  158 (337)
T ss_pred             EEEecccc-cCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccc
Confidence            99999996 588888742     267888999999999999999999999999999999999999999999999987654


Q ss_pred             CCcc----ccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHH--------HH
Q 017232          214 NHVT----HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA--------IN  280 (375)
Q Consensus       214 ~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~  280 (375)
                      ....    .......++..|+|||.+.+ ..++.++||||||+++|+|++|++||...............        ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07852         159 ELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIE  238 (337)
T ss_pred             cccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence            3221    12223457889999997754 45788999999999999999999999654322111000000        00


Q ss_pred             HhhhhHHHHHHhhhcCCCC---ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhh
Q 017232          281 KIQNKALHELVDQTLGYES---DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDI  338 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i  338 (375)
                      .+.......+++.......   ......++..+.+++.+||+.+|++|||+.++++.  +.+.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         239 SIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             HHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence            0000111111111000000   01111245678999999999999999999999975  4444

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=3.8e-39  Score=295.62  Aligned_cols=269  Identities=19%  Similarity=0.334  Sum_probs=198.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeec---CCcee
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSR---HSREL  133 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~  133 (375)
                      .++|++.+.||+|++|.||+|... +|..|++|++....  ......+.+|+.+++.++||||+++++++..   .....
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            367999999999999999999654 68999999986542  2345667889999999999999999886543   23568


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++||||+. ++|.+++..    ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++....
T Consensus        84 ~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~  158 (334)
T cd07855          84 YVVMDLME-SDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLS  158 (334)
T ss_pred             EEEEehhh-hhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeec
Confidence            99999995 688888843    3458999999999999999999999999999999999999999999999999987653


Q ss_pred             CCcc---ccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHH--------HHHH
Q 017232          214 NHVT---HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL--------AINK  281 (375)
Q Consensus       214 ~~~~---~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~  281 (375)
                      ....   .......++..|+|||.+.+ ..++.++||||||+++|+|++|++||..............        ....
T Consensus       159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~  238 (334)
T cd07855         159 SSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR  238 (334)
T ss_pred             ccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhh
Confidence            3221   11123468889999998755 4588999999999999999999999965432211100000        0000


Q ss_pred             hhhhHHHHHHhhhcCCCC----ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          282 IQNKALHELVDQTLGYES----DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .......+.... .....    .......+..+.+++.+||+.+|++||++.+++..
T Consensus       239 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         239 IGSDRVRKYIQN-LPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hchhhHHHHHhh-cccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            011111111111 10000    11112346789999999999999999999998874

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=5.3e-38  Score=277.13  Aligned_cols=251  Identities=27%  Similarity=0.442  Sum_probs=201.7

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-ceeEEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-RELLLVY  137 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~  137 (375)
                      +|+..+.||+|++|.||+|... +++.|++|++....  ....+.+.+|+.++++++|+||+++++.+.... ...++++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   80 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL   80 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence            4778899999999999999766 68899999986554  245678899999999999999999999776531 6789999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+++++|.+++...    ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........
T Consensus        81 e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          81 EYVSGGSLSSLLKKF----GKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EecCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            999999999998543    2689999999999999999999999999999999999999999999999999887654332


Q ss_pred             c-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          218 H-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       218 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      . ......++..|+|||...+...+.++||||||+++++|++|..||......     ......         +..   .
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-----~~~~~~---------~~~---~  219 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-----MAALYK---------IGS---S  219 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-----HHHHHh---------ccc---c
Confidence            1 122345888999999998888999999999999999999999999755410     000000         000   0


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ......+...+..+.+++.+|+..+|++||++.+++.
T Consensus       220 ~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         220 GEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             CCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence            0111111233567999999999999999999999985

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=2.8e-38  Score=282.26  Aligned_cols=244  Identities=25%  Similarity=0.364  Sum_probs=189.6

Q ss_pred             cCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCC
Q 017232           69 LGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~  144 (375)
                      ||+|+||+||++... +|+.|++|.+....   ......+..|+.+++.++|||++++++.+.. ....|+||||+++++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFET-KDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEec-CCeEEEEEecCCCCc
Confidence            699999999999654 68899999886432   2234456789999999999999999997766 567899999999999


Q ss_pred             hhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCC
Q 017232          145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ  224 (375)
Q Consensus       145 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  224 (375)
                      |.+++....  ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+.......  ......
T Consensus        80 L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~--~~~~~~  155 (277)
T cd05577          80 LKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK--KIKGRA  155 (277)
T ss_pred             HHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC--cccccc
Confidence            999986432  2468999999999999999999999999999999999999999999999999987654321  122345


Q ss_pred             CCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHH
Q 017232          225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVR  304 (375)
Q Consensus       225 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  304 (375)
                      ++..|+|||.+.+..++.++||||+|+++|+|++|+.||.........       ..+...    ...     .......
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------~~~~~~----~~~-----~~~~~~~  219 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK-------EELKRR----TLE-----MAVEYPD  219 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccH-------HHHHhc----ccc-----ccccCCc
Confidence            788999999988888999999999999999999999999654321100       000000    000     0001111


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 017232          305 RTINAVAELAFQCLQSEKDLRP-----YMVDVLD  333 (375)
Q Consensus       305 ~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~  333 (375)
                      ..+..+.+++.+||+.+|.+||     ++.++++
T Consensus       220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  253 (277)
T cd05577         220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE  253 (277)
T ss_pred             cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence            2356789999999999999999     6665654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=278.32  Aligned_cols=273  Identities=26%  Similarity=0.387  Sum_probs=198.0

Q ss_pred             CCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHh--cCCCCeEEEeeeeecC---CceeEEEE
Q 017232           63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR--LRHKNLVSLYGCTSRH---SRELLLVY  137 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~---~~~~~lv~  137 (375)
                      .+..+.+|+|+||.||+|... ++.||||++..   ...+.|.+|-+|.+.  ++|+||++++++....   ...++||+
T Consensus       212 l~l~eli~~Grfg~V~KaqL~-~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  212 LQLLELIGRGRFGCVWKAQLD-NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             hhhHHHhhcCccceeehhhcc-CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            345678999999999999887 58999998843   344567777777665  4799999999854432   23789999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC---------CceeccCCCCCEEecCCCcEEEeeecc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---------DIIHRDVKTNNILLDNNFCVKVADFGL  208 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---------~ivH~dlkp~Nill~~~~~~kl~Dfg~  208 (375)
                      +|.+.|+|.++|.     ...++|....+++..+++||+|||+.         .|+|||||..||||.+|++..|+|||+
T Consensus       288 ~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL  362 (534)
T KOG3653|consen  288 EFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL  362 (534)
T ss_pred             eeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence            9999999999994     45699999999999999999999984         599999999999999999999999999


Q ss_pred             ccccCCCcc-ccccCCCCCccccCcccccccC-CC-----CchhHHHHHHHHHHHHhCCCCccc-cccccccchhHHHHH
Q 017232          209 SRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQ-LT-----DKSDVFSFGVVLIELISSMPAVDI-TRHRHEINLSNLAIN  280 (375)
Q Consensus       209 ~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~-----~~~DiwslG~il~elltg~~p~~~-~~~~~~~~~~~~~~~  280 (375)
                      |..+..... ......+||.+|||||++.|.- +.     .+.||||+|.+||||++....+.. ..+.....+...+..
T Consensus       363 Al~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~  442 (534)
T KOG3653|consen  363 ALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGN  442 (534)
T ss_pred             eEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcC
Confidence            988753222 2223367999999999987732 22     268999999999999986655431 111111111111111


Q ss_pred             HhhhhHHHHH-HhhhcCCCCChHH--HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 017232          281 KIQNKALHEL-VDQTLGYESDNKV--RRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYD  344 (375)
Q Consensus       281 ~~~~~~~~~~-~~~~l~~~~~~~~--~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~  344 (375)
                      ...-+.+.+. +..+.+.......  ......+++.+..||..||+.|.|+.=+.+++.++.....+
T Consensus       443 hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~~~  509 (534)
T KOG3653|consen  443 HPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLWED  509 (534)
T ss_pred             CCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccCCc
Confidence            1111111111 1111221111111  12346789999999999999999999999999988776654

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.1e-38  Score=283.72  Aligned_cols=261  Identities=22%  Similarity=0.293  Sum_probs=190.6

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecC-CceeEEEEe
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLR-HKNLVSLYGCTSRH-SRELLLVYE  138 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~-~~~~~lv~e  138 (375)
                      |++.+.||+|+||.||+|... ++..||+|.+.... ........+|+.++.++. |+|++++++++... .+..++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            667889999999999999654 68899999886542 122233457888888885 99999999977653 267899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+. ++|.+.+...   ...+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||++.........
T Consensus        81 ~~~-~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          81 LMD-MNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             cCC-ccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            996 5788777532   246899999999999999999999999999999999999999 99999999999765433221


Q ss_pred             cccCCCCCccccCccccc-ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh--hHHHHHHhhh-
Q 017232          219 VSTAPQGTPGYVDPEYHQ-CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN--KALHELVDQT-  294 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~-  294 (375)
                        ....++..|+|||.+. +..++.++||||+||++|+|++|.+||......+..   .........  .......... 
T Consensus       156 --~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07831         156 --TEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQI---AKIHDVLGTPDAEVLKKFRKSR  230 (282)
T ss_pred             --CCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHH---HHHHHHcCCCCHHHHHhhcccc
Confidence              2234788999999754 455788999999999999999999999754422110   000000000  0000000000 


Q ss_pred             -cCCCC--------ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 -LGYES--------DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 -l~~~~--------~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       .....        .......+..+.+++.+||+.+|++||++.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         231 HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence             00000        0111234678999999999999999999999985

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-38  Score=278.46  Aligned_cols=250  Identities=27%  Similarity=0.410  Sum_probs=195.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-----chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-Ccee
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-----NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-SREL  133 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~  133 (375)
                      .+|++.+.||+|+||.||+|... ++..|++|.+...     .......+.+|+.+++.++|+||+++++++... ...+
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            46889999999999999999654 6899999987432     233456788999999999999999999976543 3568


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++++||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....
T Consensus        82 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~  157 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQ  157 (264)
T ss_pred             EEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECccccccccc
Confidence            899999999999999853    2357889999999999999999999999999999999999999999999999987653


Q ss_pred             CCcc--ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          214 NHVT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       214 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ....  .......++..|+|||.+.+..++.++|+|||||++|+|++|++||.......               ......
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---------------~~~~~~  222 (264)
T cd06653         158 TICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA---------------AIFKIA  222 (264)
T ss_pred             cccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH---------------HHHHHH
Confidence            2111  11123357889999999988889999999999999999999999996432110               000111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ....   ....+......+.+++.+|+. +|..||++.+++.
T Consensus       223 ~~~~---~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         223 TQPT---KPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             cCCC---CCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            0001   111122345679999999999 5799999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-38  Score=283.60  Aligned_cols=264  Identities=22%  Similarity=0.320  Sum_probs=194.3

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      |++.+.||.|++|.||+|... +|..|++|++....  ......+.+|+.+++.++|||++++++++.. ....+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~-~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS-ENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc-CCeEEEEEec
Confidence            677889999999999999654 79999999886543  2223567889999999999999999997765 5789999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      ++ ++|.+++....  ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++......... 
T Consensus        80 ~~-~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~-  155 (283)
T cd07835          80 LD-LDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT-  155 (283)
T ss_pred             cC-cCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc-
Confidence            95 68999885432  246899999999999999999999999999999999999999999999999998755322111 


Q ss_pred             ccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHH--hhhh---HHH---HH
Q 017232          220 STAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK--IQNK---ALH---EL  290 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~--~~~~---~~~---~~  290 (375)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++|.+||.........  .......  ....   ...   +.
T Consensus       156 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T cd07835         156 YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL--FRIFRTLGTPDEDVWPGVTSLPDY  233 (283)
T ss_pred             cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHHhCCCChHHhhhhhhchhh
Confidence            1223468899999987654 5788999999999999999999999754321110  0000000  0000   000   00


Q ss_pred             HhhhcCC---CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          291 VDQTLGY---ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       291 ~~~~l~~---~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .......   .........+..+.+++.+|++.+|.+|||++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         234 KPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             hhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0000000   000111223467889999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=1.3e-38  Score=287.12  Aligned_cols=268  Identities=20%  Similarity=0.279  Sum_probs=193.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCc----e
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--KRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSR----E  132 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~----~  132 (375)
                      ++|++.+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+.+++.+. ||||+++++++.....    .
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            46889999999999999999665 689999998754422  22356788999999995 6999999997655332    3


Q ss_pred             eEEEEecccCCChhHhhccCCCC-CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC-CCcEEEeeecccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAK-PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-NFCVKVADFGLSR  210 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~  210 (375)
                      .++||||+++ +|.+++...... ...+++..++.++.||+.||.|||++|++|+||+|+||+++. ++.++|+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            7999999975 788887654332 456899999999999999999999999999999999999998 8999999999987


Q ss_pred             ccCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH--
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL--  287 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~--  287 (375)
                      .+..... ......+++.|+|||.+.+ ..++.++||||||+++|+|++|.+||.........  .. ....+.....  
T Consensus       160 ~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~--~~-~~~~~~~~~~~~  235 (295)
T cd07837         160 AFSIPVK-SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQL--LH-IFKLLGTPTEQV  235 (295)
T ss_pred             ecCCCcc-ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHH--HH-HHHHhCCCChhh
Confidence            5532211 1122346788999998754 45789999999999999999999999654321100  00 0000000000  


Q ss_pred             -HHHH---hh--hcCCC---CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          288 -HELV---DQ--TLGYE---SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       288 -~~~~---~~--~l~~~---~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       ....   ..  .....   ........+..+.+++.+||..+|.+||++.+++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence             0000   00  00000   00001234567899999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-40  Score=299.44  Aligned_cols=247  Identities=26%  Similarity=0.366  Sum_probs=198.5

Q ss_pred             CCCCCccCCCCcEEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      |.++..||.|+||.||+|..+. +-..|.|++.......++++.-|++||..++||+||++++.|.. .+.++++.|||.
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~-enkLwiliEFC~  112 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYF-ENKLWILIEFCG  112 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhc-cCceEEEEeecC
Confidence            5678889999999999996663 45567788877777888999999999999999999999996555 456899999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      ||.+...+...   +..+++.++..+|+|++.||.|||+++|+|||||..|||++-+|.++|+|||.+...... .....
T Consensus       113 GGAVDaimlEL---~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qkRD  188 (1187)
T KOG0579|consen  113 GGAVDAIMLEL---GRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQKRD  188 (1187)
T ss_pred             CchHhHHHHHh---ccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhH-Hhhhc
Confidence            99999888554   356999999999999999999999999999999999999999999999999998653221 22234


Q ss_pred             CCCCCccccCccccc-----ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          222 APQGTPGYVDPEYHQ-----CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      ...|||.|||||++.     ..+|+.++||||||++|.||..+.||-....      .........             .
T Consensus       189 sFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln------pMRVllKia-------------K  249 (1187)
T KOG0579|consen  189 SFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN------PMRVLLKIA-------------K  249 (1187)
T ss_pred             cccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc------hHHHHHHHh-------------h
Confidence            567999999999754     4689999999999999999999999865332      111111110             1


Q ss_pred             CCCC--hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          297 YESD--NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       297 ~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .+++  -.+..-...+.+++.+||..||..||++.++++
T Consensus       250 SePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  250 SEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             cCCCcccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence            1111  111233467899999999999999999999885

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.4e-38  Score=285.87  Aligned_cols=255  Identities=27%  Similarity=0.382  Sum_probs=191.0

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|...+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.++. |+||+++++++.. ....+++||
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-~~~~~~~~e   83 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-EGDCWICME   83 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-CCcEEEEEe
Confidence            3556778999999999999654 68999999886542 334567889999999996 9999999997765 567889999


Q ss_pred             cccCCChhHhhccC-CCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          139 FISNGTVADHLHGE-RAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       139 ~~~~~~L~~~l~~~-~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |+. +++.++.... ......+++..+..++.|++.||+|||+. +++||||||+||+++.++.++|+|||++.......
T Consensus        84 ~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          84 LMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             ccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            985 4555443211 11235689999999999999999999975 99999999999999999999999999987554322


Q ss_pred             cccccCCCCCccccCccccccc---CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          217 THVSTAPQGTPGYVDPEYHQCY---QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ..  ....++..|+|||.+.+.   .++.++||||+|+++|+|++|+.||.....     ....         .......
T Consensus       163 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~~---------~~~~~~~  226 (288)
T cd06616         163 AK--TRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFDQ---------LTQVVKG  226 (288)
T ss_pred             cc--ccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHHH---------HhhhcCC
Confidence            21  223478899999988765   688999999999999999999999964320     0000         0001000


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ............++..+.+++.+||+.+|++|||+++|++.
T Consensus       227 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         227 DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000001112355679999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.8e-38  Score=287.16  Aligned_cols=272  Identities=23%  Similarity=0.312  Sum_probs=196.0

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----  130 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----  130 (375)
                      ...++|++.+.||.|+||.||+|..+ +++.|++|.+.....  .....+.+|+.+++.++|||++++++++....    
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence            45678999999999999999999765 588999999865432  22345678999999999999999999765422    


Q ss_pred             -----ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEee
Q 017232          131 -----RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD  205 (375)
Q Consensus       131 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~D  205 (375)
                           ..+++|+||+++ ++...+...   ...+++..+..++.|++.||.|||+.|++|+||+|+||++++++.+||+|
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~d  159 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESG---LVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLAD  159 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCc
Confidence                 378999999975 677766432   34689999999999999999999999999999999999999999999999


Q ss_pred             eccccccCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh
Q 017232          206 FGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       206 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      ||++...............++..|+|||.+.+ ..++.++|||||||++|+|++|++||.....................
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~  239 (302)
T cd07864         160 FGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCP  239 (302)
T ss_pred             ccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            99988664433222222345778999997754 45788999999999999999999999754321110000000000000


Q ss_pred             hHHHHHHhhhcC----------CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          285 KALHELVDQTLG----------YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       285 ~~~~~~~~~~l~----------~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ....++......          ..........+..+.+++.+||+.+|.+||++.+++.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         240 AVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             hhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            000000000000          0000011123567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=5.8e-38  Score=277.90  Aligned_cols=242  Identities=26%  Similarity=0.352  Sum_probs=192.3

Q ss_pred             cCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCC
Q 017232           69 LGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~  144 (375)
                      ||.|++|.||++... ++..|++|++....   ....+.+.+|+.+++.++||||+++++.+.. +...++++||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKD-KKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEc-CCccEEEEecCCCCc
Confidence            799999999999765 58899999986542   2334678899999999999999999997665 677999999999999


Q ss_pred             hhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCC
Q 017232          145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ  224 (375)
Q Consensus       145 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  224 (375)
                      |.+++...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  ......
T Consensus        80 L~~~l~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~  153 (262)
T cd05572          80 LWTILRDR----GLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFC  153 (262)
T ss_pred             HHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--cccccc
Confidence            99999532    348899999999999999999999999999999999999999999999999988664432  122345


Q ss_pred             CCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHH
Q 017232          225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVR  304 (375)
Q Consensus       225 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  304 (375)
                      ++..|++||.+.+..++.++|+||+|+++|+|++|..||.......    ...         ...+.........   +.
T Consensus       154 ~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~----~~~---------~~~~~~~~~~~~~---~~  217 (262)
T cd05572         154 GTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP----MEI---------YNDILKGNGKLEF---PN  217 (262)
T ss_pred             CCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH----HHH---------HHHHhccCCCCCC---Cc
Confidence            7889999999888889999999999999999999999997554210    000         1111110111111   11


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 017232          305 RTINAVAELAFQCLQSEKDLRPY-----MVDVLD  333 (375)
Q Consensus       305 ~~~~~l~~li~~cl~~~P~~Rpt-----~~evl~  333 (375)
                      ..+..+.+++.+||+.+|++||+     ++|+++
T Consensus       218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence            22567999999999999999999     666665

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.2e-38  Score=276.17  Aligned_cols=247  Identities=27%  Similarity=0.467  Sum_probs=200.2

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|++.+.||+|++|.||++... +++.|++|.+.....  .....+.+|+++++.++|+|++++++++.. ....+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-SDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-CCEEEEEEe
Confidence            4788899999999999999655 678999999876643  456788999999999999999999997765 578999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++...    ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||.+.........
T Consensus        80 ~~~~~~L~~~~~~~----~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  155 (254)
T cd06627          80 YAENGSLRQIIKKF----GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD  155 (254)
T ss_pred             cCCCCcHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc
Confidence            99999999998543    56899999999999999999999999999999999999999999999999999876543321


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                       .....++..|+|||...+..++.++|||++|+++|+|++|..||.......     .. .         ...    ...
T Consensus       156 -~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~-----~~-~---------~~~----~~~  215 (254)
T cd06627         156 -DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMA-----AL-F---------RIV----QDD  215 (254)
T ss_pred             -ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHH-----HH-H---------HHh----ccC
Confidence             223457889999999888788999999999999999999999986433100     00 0         000    001


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ........+..+.+++.+||..+|++|||+.+++.
T Consensus       216 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         216 HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence            11111223567889999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.6e-37  Score=282.77  Aligned_cols=251  Identities=28%  Similarity=0.416  Sum_probs=195.5

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .|+..+.||+|+||.||+|... ++..|++|.+...   .......+.+|+.+++.++|||++++++++.. +...++||
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~  104 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-EHTAWLVM  104 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-CCeEEEEE
Confidence            3777889999999999999654 6889999998643   22344578889999999999999999997776 56789999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+. |+|.+.+...   ...+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++......  
T Consensus       105 e~~~-g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~--  178 (317)
T cd06635         105 EYCL-GSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA--  178 (317)
T ss_pred             eCCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc--
Confidence            9996 5777776432   345899999999999999999999999999999999999999999999999988654321  


Q ss_pred             ccccCCCCCccccCccccc---ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          218 HVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                         ....++..|+|||.+.   +..++.++|||||||++|+|++|.+||.......      .         ...+....
T Consensus       179 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~------~---------~~~~~~~~  240 (317)
T cd06635         179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------A---------LYHIAQNE  240 (317)
T ss_pred             ---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHH------H---------HHHHHhcc
Confidence               2235788999999863   4568899999999999999999999986432110      0         00111110


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      .   ........+..+.+++.+||+.+|.+||++.++++.+..+..
T Consensus       241 ~---~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         241 S---PTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             C---CCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence            0   011112244568999999999999999999999987655443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=5.5e-38  Score=280.62  Aligned_cols=242  Identities=24%  Similarity=0.312  Sum_probs=183.5

Q ss_pred             ccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHH---hcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           68 ELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILA---RLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        68 ~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~---~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      .||+|+||.||++... +++.+|+|.+.....   .....+.+|..+++   ..+|||++.+++.+.. .+..++||||+
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~   79 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-PDKLCFILDLM   79 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-CCeEEEEEecC
Confidence            4899999999999664 688999998854321   11222334443333   3479999999987766 56789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      .+++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........   
T Consensus        80 ~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~---  152 (279)
T cd05633          80 NGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---  152 (279)
T ss_pred             CCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccCc---
Confidence            99999988853    34589999999999999999999999999999999999999999999999999875433221   


Q ss_pred             cCCCCCccccCccccc-ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQ-CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....++..|+|||.+. +..++.++||||+||++|+|++|..||.........        .+..     .. .....  
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~--------~~~~-----~~-~~~~~--  216 (279)
T cd05633         153 HASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH--------EIDR-----MT-LTVNV--  216 (279)
T ss_pred             cCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH--------HHHH-----Hh-hcCCc--
Confidence            2335899999999876 456889999999999999999999999754322110        0000     00 00000  


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLDA  334 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~~  334 (375)
                       .....++..+.+++.+||+.+|.+||     |++++++.
T Consensus       217 -~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         217 -ELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             -CCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence             11123456789999999999999999     59888875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-39  Score=314.28  Aligned_cols=288  Identities=23%  Similarity=0.273  Sum_probs=218.6

Q ss_pred             HHHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC
Q 017232           54 GELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH  129 (375)
Q Consensus        54 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  129 (375)
                      .++....++|.+++.||+|+||.|.+++.+ +++.||+|++.+.   .......|..|-++|..-+.+=|+.++-+|.+ 
T Consensus        68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD-  146 (1317)
T KOG0612|consen   68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD-  146 (1317)
T ss_pred             HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC-
Confidence            444555678999999999999999999765 6888999998763   23344678889999998888889998876766 


Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      ..++|+||||++||+|..++...    ..+++..+..++..|+.||+.||+.|+|||||||+|||+|..|++||+|||.+
T Consensus       147 ~~~LYlVMdY~pGGDlltLlSk~----~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsC  222 (1317)
T KOG0612|consen  147 ERYLYLVMDYMPGGDLLTLLSKF----DRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSC  222 (1317)
T ss_pred             ccceEEEEecccCchHHHHHhhc----CCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhH
Confidence            78899999999999999999544    36999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCCCCccccCccccc----c-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQ----C-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~----~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      .....+..-.....+|||.|.+||++.    + +.|++.+|+||+||++|||+.|..||-...-.               
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv---------------  287 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV---------------  287 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH---------------
Confidence            988877777778889999999999865    2 56899999999999999999999999543211               


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC---HHHHHHHHHhhhcCCCCCCccccccccCCCCccc
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY---MVDVLDALRDIESDGYDDKKTHEEMMTQSPDSVT  361 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt---~~evl~~L~~i~~~~~~~~~~~~~~~~~~~~~~~  361 (375)
                      +.+..++.-.-...++ .....+....+||.+.+. +|+.|..   ++++...   --=.+.+|....++.+|--|+..+
T Consensus       288 eTY~KIm~hk~~l~FP-~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H---pFF~g~~W~~iR~~~pP~vPevss  362 (1317)
T KOG0612|consen  288 ETYGKIMNHKESLSFP-DETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH---PFFEGIDWDNIRESVPPVVPEVSS  362 (1317)
T ss_pred             HHHHHHhchhhhcCCC-cccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC---ccccCCChhhhhhcCCCCCCcCCC
Confidence            2223333332222222 223367788889988775 5666766   5554432   001233444444444444444444


Q ss_pred             ccccc
Q 017232          362 LSWTS  366 (375)
Q Consensus       362 ~~~~~  366 (375)
                      +..+|
T Consensus       363 d~DTs  367 (1317)
T KOG0612|consen  363 DDDTS  367 (1317)
T ss_pred             CCccc
Confidence            44443

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5e-38  Score=282.59  Aligned_cols=244  Identities=25%  Similarity=0.413  Sum_probs=194.2

Q ss_pred             CCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCC
Q 017232           66 ARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~  144 (375)
                      ..+||+|+||.||++..+ ++..||+|++..........+.+|+.+++.++|+|++++++.+.. ....++||||+++++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~~~~  103 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLEGGA  103 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-CCEEEEEEecCCCCc
Confidence            356999999999999664 689999999865555556678899999999999999999997766 678999999999999


Q ss_pred             hhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCC
Q 017232          145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ  224 (375)
Q Consensus       145 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  224 (375)
                      |.+++..     ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||++........ ......
T Consensus       104 L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~  177 (292)
T cd06657         104 LTDIVTH-----TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-RRKSLV  177 (292)
T ss_pred             HHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc-cccccc
Confidence            9988732     3578999999999999999999999999999999999999999999999998875543221 122345


Q ss_pred             CCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHH
Q 017232          225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVR  304 (375)
Q Consensus       225 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  304 (375)
                      ++..|+|||.+.+..++.++|+||+|+++|+|++|..||........       .         ..+...+.... ....
T Consensus       178 ~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~-------~---------~~~~~~~~~~~-~~~~  240 (292)
T cd06657         178 GTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA-------M---------KMIRDNLPPKL-KNLH  240 (292)
T ss_pred             cCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-------H---------HHHHhhCCccc-CCcc
Confidence            78899999998888889999999999999999999999864321100       0         00111111000 0111


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          305 RTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       305 ~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..+..+.+++.+||..+|.+||++.++++
T Consensus       241 ~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         241 KVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             cCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence            23456889999999999999999999887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=283.01  Aligned_cols=262  Identities=22%  Similarity=0.335  Sum_probs=197.6

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchh--hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK--RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      |++.+.||.|++|.||++... +++.+++|.+......  ....+.+|+.+++.++|+|++++++++.. +...++|+||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH-KGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc-CCCEEEEEec
Confidence            567889999999999999665 6889999998654332  34678889999999999999999997665 5789999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      ++ ++|.+.+...   ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        80 ~~-~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~  154 (283)
T cd05118          80 MD-TDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP  154 (283)
T ss_pred             cC-CCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence            96 4888877542   2468999999999999999999999999999999999999999999999999987665433 11


Q ss_pred             ccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh---hHHHHHHh---
Q 017232          220 STAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN---KALHELVD---  292 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~---  292 (375)
                      .....++..|+|||.+.+. .++.++|+||+|+++|+|++|++||.........   ......+..   .....+..   
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL---FKIFRTLGTPDPEVWPKFTSLAR  231 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHcCCCchHhcccchhhhh
Confidence            2233577889999988776 7889999999999999999999999654421110   000000000   00000000   


Q ss_pred             ------h-hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          293 ------Q-TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       293 ------~-~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                            + .............+..+.+++.+||+.+|.+||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence                  0 0000001122345678999999999999999999999985

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=2.5e-38  Score=284.24  Aligned_cols=263  Identities=24%  Similarity=0.291  Sum_probs=201.2

Q ss_pred             CCCCCCccCCCCcEEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCce
Q 017232           62 YFDSARELGDGGFGTVYYGEL----QDGRAVAVKRLYENN----YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  132 (375)
                      +|++.+.||.|++|.||++..    .+++.||+|.+....    ......+.+|+.++..+ +||||+++++.+.. +..
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~-~~~   79 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQT-DTK   79 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeec-CCE
Confidence            477889999999999999864    256889999886432    22345678899999999 59999999987665 567


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      .++||||+.+++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~  155 (288)
T cd05583          80 LHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF  155 (288)
T ss_pred             EEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence            8999999999999998843    345889999999999999999999999999999999999999999999999998765


Q ss_pred             CCCccccccCCCCCccccCcccccccC--CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCYQ--LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ............++..|+|||.+.+..  .+.++|+||||+++|+|++|..||........  .....         ...
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~~~---------~~~  224 (288)
T cd05583         156 LAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS--QSEIS---------RRI  224 (288)
T ss_pred             ccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch--HHHHH---------HHH
Confidence            433222223345788999999887654  78899999999999999999999964321110  00000         001


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDD  345 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~~  345 (375)
                      ...    . .+....+...+.+++.+||+.+|++|||+.++.+.|+..--...+|
T Consensus       225 ~~~----~-~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         225 LKS----K-PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             Hcc----C-CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            111    0 1111224467889999999999999999999988887754344433

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=293.13  Aligned_cols=252  Identities=25%  Similarity=0.398  Sum_probs=206.3

Q ss_pred             CCCCCccCCCCcEEEEEEEeC--CCC--EEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           63 FDSARELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~--~~~--~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ....++||+|.||+|++|.|.  +|+  .||||.+..+... ...+|.+|+.+|.+|+|+|++++||+...  ....+||
T Consensus       112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV~  189 (1039)
T KOG0199|consen  112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMVF  189 (1039)
T ss_pred             HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHHh
Confidence            345678999999999999776  344  5799999877544 67899999999999999999999997664  5678999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      |.++.|+|.+.|+.  .....+.......++.||+.|+.||.++++|||||-..|+|+...-.+||+|||+.+-++....
T Consensus       190 ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned  267 (1039)
T KOG0199|consen  190 ELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENED  267 (1039)
T ss_pred             hhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence            99999999999976  3556788889999999999999999999999999999999999999999999999987764433


Q ss_pred             cc-cc-CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          218 HV-ST-APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       218 ~~-~~-~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .. .. .......|+|||.+....++-++|||+|||++|||++ |..|+-.....                .+.+.+|  
T Consensus       268 ~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~----------------qIL~~iD--  329 (1039)
T KOG0199|consen  268 MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI----------------QILKNID--  329 (1039)
T ss_pred             ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH----------------HHHHhcc--
Confidence            22 22 2234568999999999999999999999999999998 77787654321                1122222  


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                       .++..+.+..|++++.+++.+||..+|.+|||+..|.+.+-.
T Consensus       330 -~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  330 -AGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             -ccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence             233444555689999999999999999999999999855443

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-38  Score=291.35  Aligned_cols=275  Identities=22%  Similarity=0.320  Sum_probs=204.2

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----ceeE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----RELL  134 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~  134 (375)
                      +|++.+.||.|++|.||+|... ++..|++|.+....  ....+.+.+|+.+++.++|+||+++++++....    ...+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            5888999999999999999765 58999999986543  344567889999999999999999999766543    4689


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      ++|||+. ++|.+++..    ...+++..++.++.|++.||.+||+.|++|+||||+||+++.++.++|+|||++.....
T Consensus        81 lv~e~~~-~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          81 IVTELME-TDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEecchh-hhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            9999997 578888843    23789999999999999999999999999999999999999999999999999987654


Q ss_pred             Ccc--ccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHH--------HHHhh
Q 017232          215 HVT--HVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA--------INKIQ  283 (375)
Q Consensus       215 ~~~--~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~~  283 (375)
                      ...  .......++..|+|||.+.+. .++.++|+||||+++|+|++|.+||...............        .....
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            321  112334578899999998887 7899999999999999999999999755422110000000        00000


Q ss_pred             hhHHHHHHhhhcCC---CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhhhcC
Q 017232          284 NKALHELVDQTLGY---ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDIESD  341 (375)
Q Consensus       284 ~~~~~~~~~~~l~~---~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i~~~  341 (375)
                      .....+.+......   .........+..+.+++.+||+.+|++||++.+++..  ++.+...
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~~~  298 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLHDP  298 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhccc
Confidence            00011111100000   0000111245678999999999999999999999974  6655543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-38  Score=276.21  Aligned_cols=244  Identities=24%  Similarity=0.340  Sum_probs=186.6

Q ss_pred             CccCCCCcEEEEEEEeC-CCCEEEEEEecccchh---hHHHHHHHHHHH-HhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK---RVEQFMNEVDIL-ARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||.|+||.||+|... +++.||+|.+......   ....+..|..++ ...+|+|++++++++.. +...++|+||++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~   80 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQS-KDYLYLVMEYLN   80 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEc-CCeEEEEEeccC
Confidence            56999999999999654 6889999998654321   222344454443 44589999999997776 678999999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      +++|.+++...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....     ..
T Consensus        81 ~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~  151 (260)
T cd05611          81 GGDCASLIKTL----GGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NK  151 (260)
T ss_pred             CCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc-----cc
Confidence            99999998532    4589999999999999999999999999999999999999999999999998875432     12


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN  301 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  301 (375)
                      ...++..|+|||.+.+..++.++||||||+++|+|++|..||.......      . .        ..+....... ...
T Consensus       152 ~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~------~-~--------~~~~~~~~~~-~~~  215 (260)
T cd05611         152 KFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA------V-F--------DNILSRRINW-PEE  215 (260)
T ss_pred             cCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH------H-H--------HHHHhcccCC-CCc
Confidence            3347889999999988888999999999999999999999996443110      0 0        0011111110 111


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          302 KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       302 ~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                      ....++..+.+++.+||..+|++||++.++.+.|+
T Consensus       216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            11235578999999999999999998876655443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=4e-38  Score=283.78  Aligned_cols=265  Identities=21%  Similarity=0.321  Sum_probs=192.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|++.+.||.|++|.||+|..+ +|+.|++|.+.....  .....+.+|+.+++.++|||++++++++.. ....++||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHS-EKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEec-CCeEEEEE
Confidence            46889999999999999999765 688999998854422  233567889999999999999999997766 67899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC-CCcEEEeeeccccccCCCc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-NFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||++ ++|.+.+...  ....+++..++.++.||+.||+|||++|++|+||+|+||+++. ++.+||+|||++.......
T Consensus        81 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~  157 (294)
T PLN00009         81 EYLD-LDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV  157 (294)
T ss_pred             eccc-ccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc
Confidence            9996 5787777432  2234678888999999999999999999999999999999985 5679999999987654321


Q ss_pred             cccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH---------
Q 017232          217 THVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA---------  286 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------  286 (375)
                      . ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|.+||..........  . .........         
T Consensus       158 ~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~--~-~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        158 R-TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELF--K-IFRILGTPNEETWPGVTS  233 (294)
T ss_pred             c-ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH--H-HHHHhCCCChhhcccccc
Confidence            1 1223356889999998765 457889999999999999999999997543211100  0 000000000         


Q ss_pred             HHHHHhhhcCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          287 LHELVDQTLGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       287 ~~~~~~~~l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..+...........   ......+..+.+++.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00000000000000   001123456889999999999999999999986

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.7e-37  Score=275.66  Aligned_cols=249  Identities=21%  Similarity=0.315  Sum_probs=190.6

Q ss_pred             HHHHHHhcCCCCCCcc--CCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecC
Q 017232           54 GELEEATNYFDSAREL--GDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRH  129 (375)
Q Consensus        54 ~~~~~~~~~y~~~~~l--g~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  129 (375)
                      .+.....++|++.+.+  |.|+||.||++..+ ++..+++|.+.......     .|+.....+ +|||++++++.+.. 
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~-   80 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTT-   80 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEec-
Confidence            3444556778888877  99999999999654 68889999886443221     122222223 69999999997776 


Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC-cEEEeeecc
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF-CVKVADFGL  208 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~  208 (375)
                      ....++||||+++++|.+++...    ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++ .++|+|||+
T Consensus        81 ~~~~~iv~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~  156 (267)
T PHA03390         81 LKGHVLIMDYIKDGDLFDLLKKE----GKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGL  156 (267)
T ss_pred             CCeeEEEEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCcc
Confidence            56799999999999999999533    3689999999999999999999999999999999999999998 999999999


Q ss_pred             ccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      +.......     ...++..|+|||++.+..++.++||||+|+++|+|++|..||....... .....+..         
T Consensus       157 ~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~~~~~~~~---------  221 (267)
T PHA03390        157 CKIIGTPS-----CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-LDLESLLK---------  221 (267)
T ss_pred             ceecCCCc-----cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-hhHHHHHH---------
Confidence            87554321     2357889999999998889999999999999999999999997433211 11111110         


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY-MVDVLD  333 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-~~evl~  333 (375)
                       ...     .........+..+.+++.+||+.+|.+||+ ++++++
T Consensus       222 -~~~-----~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        222 -RQQ-----KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             -hhc-----ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence             000     011111235667999999999999999996 588874

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.9e-38  Score=286.72  Aligned_cols=270  Identities=24%  Similarity=0.321  Sum_probs=192.0

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC------
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHS------  130 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  130 (375)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.....  .....+.+|+.+++.++||||+++++++....      
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   90 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY   90 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence            356999999999999999999665 689999998854322  22234568999999999999999999765422      


Q ss_pred             -ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          131 -RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       131 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                       ...++||||+. ++|.+.+...   ...+++.+++.++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++
T Consensus        91 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~  166 (310)
T cd07865          91 KGSFYLVFEFCE-HDLAGLLSNK---NVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLA  166 (310)
T ss_pred             CceEEEEEcCCC-cCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCc
Confidence             34699999996 5788777432   246899999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCcc---ccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh
Q 017232          210 RLFPNHVT---HVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK  285 (375)
Q Consensus       210 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (375)
                      ........   .......++..|+|||.+.+. .++.++||||||+++|+|++|.+||................+.+...
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (310)
T cd07865         167 RAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE  246 (310)
T ss_pred             ccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            76533221   111233567889999987654 47889999999999999999999997544221111101000000000


Q ss_pred             HH-----HHHHhh-hcCCCCChHH-H-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          286 AL-----HELVDQ-TLGYESDNKV-R-----RTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       286 ~~-----~~~~~~-~l~~~~~~~~-~-----~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..     .+..+. .......... .     .....+.+++.+||..+|.+|||++++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         247 VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             hcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            00     000000 0000000000 0     01245779999999999999999999985

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.5e-38  Score=292.54  Aligned_cols=267  Identities=21%  Similarity=0.339  Sum_probs=194.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC--------
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS--------  130 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  130 (375)
                      .++|.+.+.||.|+||.||+|... ++..|++|.+........+.+.+|+.+++.++||||+++++++....        
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            367999999999999999999654 68999999987666566677889999999999999999998554432        


Q ss_pred             -----ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec-CCCcEEEe
Q 017232          131 -----RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVA  204 (375)
Q Consensus       131 -----~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~-~~~~~kl~  204 (375)
                           ...++||||++ ++|.+++.     ...+++..++.++.|++.||.|||+.|++|+||||+||+++ .++.++|+
T Consensus        84 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYME-TDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeeccc-ccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEEC
Confidence                 35789999996 58888873     23588999999999999999999999999999999999997 45678999


Q ss_pred             eeccccccCCCccc--cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHH
Q 017232          205 DFGLSRLFPNHVTH--VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK  281 (375)
Q Consensus       205 Dfg~~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  281 (375)
                      |||.+.........  ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||.........  .......
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~--~~~~~~~  235 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQM--QLILESV  235 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHHhc
Confidence            99998765332111  1122357889999997643 56788999999999999999999999654321110  0000000


Q ss_pred             -h-hh----h---HHHHHHhhhcCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          282 -I-QN----K---ALHELVDQTLGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       282 -~-~~----~---~~~~~~~~~l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       . ..    .   .....+.........   .........+.+++.+||+.+|.+|||+.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence             0 00    0   000000000000000   0011244678899999999999999999999853

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-39  Score=283.23  Aligned_cols=249  Identities=27%  Similarity=0.331  Sum_probs=204.0

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchh---hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYK---RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .+.|+.-+.||+|+||.||-... .+|+.||.|++.+...+   ......+|-.+|.+++.+.||.+--+++. ...+|+
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT-kd~LCl  262 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET-KDALCL  262 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC-CCceEE
Confidence            35688889999999999998854 47999999988554322   23456789999999999999998877776 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      |+..|+||+|.-.|...  .+..+++..+..++.+|+.||++||+.+||.||+||+|||+|+.|+++|+|+|+|..+...
T Consensus       263 VLtlMNGGDLkfHiyn~--g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g  340 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNH--GNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEG  340 (591)
T ss_pred             EEEeecCCceeEEeecc--CCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence            99999999999888655  3357999999999999999999999999999999999999999999999999999987665


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .+.  ...+||.+|||||++.+..|+...|+|||||++|||+.|+.||.......            ..    +-++.+.
T Consensus       341 ~~~--~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKv------------k~----eEvdrr~  402 (591)
T KOG0986|consen  341 KPI--RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKV------------KR----EEVDRRT  402 (591)
T ss_pred             Ccc--ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhh------------hH----HHHHHHH
Confidence            443  34479999999999999999999999999999999999999997654321            11    1222222


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMV  329 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~  329 (375)
                      .......+..++++..++....|..||.+|..-.
T Consensus       403 ~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  403 LEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             hcchhhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence            2223333356778899999999999999996544

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1e-37  Score=280.52  Aligned_cols=251  Identities=24%  Similarity=0.319  Sum_probs=192.6

Q ss_pred             CCCCCCccCCCCcEEEEEEEe----CCCCEEEEEEecccch----hhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCce
Q 017232           62 YFDSARELGDGGFGTVYYGEL----QDGRAVAVKRLYENNY----KRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  132 (375)
                      +|++.+.||.|+||.||+|..    .+|..||+|++.....    ...+.+.+|+.++..+ +|+||+++++++.. +..
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-~~~   79 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-DTK   79 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeec-CCe
Confidence            478889999999999999965    3688999999865322    2345678899999999 59999999987766 567


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      .++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        80 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  155 (290)
T cd05613          80 LHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF  155 (290)
T ss_pred             EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence            8999999999999999853    245888999999999999999999999999999999999999999999999998765


Q ss_pred             CCCccccccCCCCCccccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQC--YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ............++..|+|||.+.+  ..++.++||||||+++|+|++|..||........  ...             +
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~-------------~  220 (290)
T cd05613         156 HEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS--QAE-------------I  220 (290)
T ss_pred             ccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCcccc--HHH-------------H
Confidence            4332222223457889999998765  3467899999999999999999999964322110  000             0


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLD  333 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~  333 (375)
                      ........ .+....+...+.+++.+|++.+|++||     ++.+++.
T Consensus       221 ~~~~~~~~-~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~  267 (290)
T cd05613         221 SRRILKSE-PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK  267 (290)
T ss_pred             HHHhhccC-CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence            11100000 011122446788999999999999997     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-39  Score=297.44  Aligned_cols=204  Identities=31%  Similarity=0.487  Sum_probs=173.1

Q ss_pred             CCCCCccCCCCcEEEEEEE-eCCCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-----ceeEE
Q 017232           63 FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-----RELLL  135 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~l  135 (375)
                      +...+.||+|+||.||+|+ ..+|+.||||.+... .....+...+|+++|++++|+|||+++++-+...     ....+
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl   94 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL   94 (732)
T ss_pred             eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence            3446779999999999997 558999999998664 3344567789999999999999999999654432     35689


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec--CCC--cEEEeeeccccc
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD--NNF--CVKVADFGLSRL  211 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~--~~~--~~kl~Dfg~~~~  211 (375)
                      |||||.||+|...+.... +...+++.+.+.++.++..||.|||.+||+||||||.||++-  ++|  ..||+|||.|+.
T Consensus        95 vmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Are  173 (732)
T KOG4250|consen   95 VMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARE  173 (732)
T ss_pred             EEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccccccc
Confidence            999999999999997653 456799999999999999999999999999999999999984  323  489999999998


Q ss_pred             cCCCccccccCCCCCccccCccccc-ccCCCCchhHHHHHHHHHHHHhCCCCccccccc
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQ-CYQLTDKSDVFSFGVVLIELISSMPAVDITRHR  269 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~p~~~~~~~  269 (375)
                      +..+.  ......||..|++||++. ...|+..+|.|||||++|+..||..||......
T Consensus       174 l~d~s--~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~p  230 (732)
T KOG4250|consen  174 LDDNS--LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGP  230 (732)
T ss_pred             CCCCC--eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCc
Confidence            76654  456678999999999988 478899999999999999999999999765543

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=2.4e-37  Score=278.57  Aligned_cols=260  Identities=17%  Similarity=0.217  Sum_probs=183.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC----CCEEEEEEecccchhh-H----------HHHHHHHHHHHhcCCCCeEEEee
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKR-V----------EQFMNEVDILARLRHKNLVSLYG  124 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~-~----------~~~~~e~~~l~~l~h~niv~~~~  124 (375)
                      .++|++.+.||+|+||.||+|...+    +..+++|......... .          .....+...+..+.|+|++++++
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~   90 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYG   90 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEE
Confidence            3679999999999999999997654    3456666543222111 0          11223334456678999999998


Q ss_pred             eeecCCc---eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcE
Q 017232          125 CTSRHSR---ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV  201 (375)
Q Consensus       125 ~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~  201 (375)
                      +......   ..+++++++. .++.+.+...    ...++..+..++.|++.||.|||+.+++||||||+|||++.++.+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         91 CGSFKRCRMYYRFILLEKLV-ENTKEIFKRI----KCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             eeeEecCCceEEEEEEehhc-cCHHHHHHhh----ccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcE
Confidence            6543222   3467888773 4666665322    235678889999999999999999999999999999999999999


Q ss_pred             EEeeeccccccCCCcc------ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchh
Q 017232          202 KVADFGLSRLFPNHVT------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLS  275 (375)
Q Consensus       202 kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~  275 (375)
                      +|+|||++..+.....      .......||+.|+|||++.+..++.++|||||||++|||++|..||.........  .
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~--~  243 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNL--I  243 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHH--H
Confidence            9999999976532211      1112235899999999999999999999999999999999999999755321110  0


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                      ..    ........+.....      ....++..+.+++..|+..+|++||++.++++.|+
T Consensus       244 ~~----~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~~  294 (294)
T PHA02882        244 HA----AKCDFIKRLHEGKI------KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIFD  294 (294)
T ss_pred             HH----hHHHHHHHhhhhhh------ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhhC
Confidence            00    00001111111111      11223567899999999999999999999998764

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=7.9e-38  Score=277.15  Aligned_cols=245  Identities=25%  Similarity=0.406  Sum_probs=192.7

Q ss_pred             cCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCC
Q 017232           69 LGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~  144 (375)
                      ||.|+||.||++... +|+.+++|.+.....   .....+.+|+.+++.++|||++++++.+.. +...+++|||+.+++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQG-KKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheec-CcEEEEEEecCCCCc
Confidence            689999999999776 489999999865433   345678899999999999999999987665 677899999999999


Q ss_pred             hhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc-------
Q 017232          145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT-------  217 (375)
Q Consensus       145 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-------  217 (375)
                      |.+++...    ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++........       
T Consensus        80 L~~~l~~~----~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  155 (265)
T cd05579          80 LASLLENV----GSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE  155 (265)
T ss_pred             HHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence            99998643    3689999999999999999999999999999999999999999999999999875432211       


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                      .......++..|++||...+...+.++|+||||+++|+|++|..||.......      .         .......... 
T Consensus       156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~------~---------~~~~~~~~~~-  219 (265)
T cd05579         156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE------I---------FQNILNGKIE-  219 (265)
T ss_pred             ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH------H---------HHHHhcCCcC-
Confidence            11223457789999999888888999999999999999999999997543110      0         0111110110 


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                       . +.....+..+.+++.+||+.+|.+|||+.++.+.|+
T Consensus       220 -~-~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         220 -W-PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -C-CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence             0 111112567899999999999999999966655554

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.7e-38  Score=288.41  Aligned_cols=271  Identities=22%  Similarity=0.319  Sum_probs=198.5

Q ss_pred             hHHHHHHhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC
Q 017232           53 YGELEEATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRH  129 (375)
Q Consensus        53 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  129 (375)
                      ..++....++|.+.+.||+|+||.||+|.. .+++.||+|++....  ....+.+.+|+.+++.++||||+++++++...
T Consensus         9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~   88 (345)
T cd07877           9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA   88 (345)
T ss_pred             HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence            345566778999999999999999999954 578999999986542  22345678899999999999999999866432


Q ss_pred             -----CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEe
Q 017232          130 -----SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVA  204 (375)
Q Consensus       130 -----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~  204 (375)
                           ....+++++++ +++|.+++..     ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+
T Consensus        89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~  162 (345)
T cd07877          89 RSLEEFNDVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL  162 (345)
T ss_pred             ccccccccEEEEehhc-ccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEe
Confidence                 23478888887 7889887732     358999999999999999999999999999999999999999999999


Q ss_pred             eeccccccCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchh--------
Q 017232          205 DFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLS--------  275 (375)
Q Consensus       205 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~--------  275 (375)
                      |||++......    .....++..|+|||.+.+ ..++.++|||||||++|+|++|++||............        
T Consensus       163 dfg~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (345)
T cd07877         163 DFGLARHTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG  238 (345)
T ss_pred             ccccccccccc----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99998754322    123357889999998766 56888999999999999999999999644321110000        


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCC----ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          276 NLAINKIQNKALHELVDQTLGYES----DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ......+......... ..+....    ..........+.+++.+||+.+|.+||++.+++..
T Consensus       239 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         239 AELLKKISSESARNYI-QSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHhhcccHhHHHHH-HHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            0000000000001110 0000000    00001124568899999999999999999998865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.2e-37  Score=284.71  Aligned_cols=267  Identities=21%  Similarity=0.342  Sum_probs=196.3

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC---
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS---  130 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---  130 (375)
                      ....++|++.+.||+|+||.||+|.. .++..||+|++....  ......+.+|+.+++.++||||+++++++....   
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence            34567899999999999999999954 478999999985432  223456789999999999999999999776533   


Q ss_pred             --ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecc
Q 017232          131 --RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL  208 (375)
Q Consensus       131 --~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  208 (375)
                        ...++||||+ +++|.+++.     ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||+
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~  164 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL  164 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence              2468999999 778988874     24589999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccch--------hHHHH
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL--------SNLAI  279 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~--------~~~~~  279 (375)
                      +.......    ....+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.+||...........        .....
T Consensus       165 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  240 (343)
T cd07880         165 ARQTDSEM----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFV  240 (343)
T ss_pred             ccccccCc----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHH
Confidence            87653321    22347889999998765 4578899999999999999999999975432110000        00000


Q ss_pred             HHhhhhHHHHHHhhhcCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          280 NKIQNKALHELVDQTLGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       280 ~~~~~~~~~~~~~~~l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..+..................   .....+...+.+++.+||..+|++|||+.+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         241 QKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            000000011111100000000   001123456889999999999999999999984

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=8.6e-38  Score=276.49  Aligned_cols=250  Identities=24%  Similarity=0.348  Sum_probs=193.6

Q ss_pred             CCCCCCccCCCCcEEEEEEEeCC-CCEEEEEEeccc-----chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYEN-----NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      +|.+.+.||+|+||.||++.... +..+++|.++..     .......+..|+.+++.++|||++++++++.. ....++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLE-RDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhc-CCceEE
Confidence            58889999999999999996553 444556655431     12223456779999999999999999997665 567899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++.........+++..++.++.|++.||.|||+.|++|+||+|+||+++. +.++|+|||.+......
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence            99999999999998765445567999999999999999999999999999999999999975 56999999998765332


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .. ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.....      ....         ...    .
T Consensus       159 ~~-~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~------~~~~---------~~~----~  218 (260)
T cd08222         159 CD-LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNF------LSVV---------LRI----V  218 (260)
T ss_pred             cc-cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccH------HHHH---------HHH----H
Confidence            21 12233578899999998888889999999999999999999999863321      0000         001    1


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..........++..+.+++.+|+..+|++||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         219 EGPTPSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             cCCCCCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            11111112345568899999999999999999999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-38  Score=269.66  Aligned_cols=242  Identities=26%  Similarity=0.341  Sum_probs=195.3

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ..++|..+++||+|.||.|.+++-+ +++.||+|++++.   ..+....-..|-.+|+..+||.+..+--.++. ...+|
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt-~drlC  244 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQT-QDRLC  244 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhcc-CceEE
Confidence            3467899999999999999999554 7999999999765   23344555678899999999999887665655 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      .||||..||.|.-.+..    ...+++..+..+...|+.||.|||+++||.||||.+|+|+|.+|++||+|||+++.--.
T Consensus       245 FVMeyanGGeLf~HLsr----er~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  245 FVMEYANGGELFFHLSR----ERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             EEEEEccCceEeeehhh----hhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence            99999999999888854    34689999999999999999999999999999999999999999999999999974322


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .. ......+|||.|+|||++....|..+.|+|.+|+++|||++|+.||-..+...               -..-++...
T Consensus       321 ~g-~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k---------------LFeLIl~ed  384 (516)
T KOG0690|consen  321 YG-DTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK---------------LFELILMED  384 (516)
T ss_pred             cc-ceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH---------------HHHHHHhhh
Confidence            21 22356789999999999999999999999999999999999999996443211               011111122


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCC
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRP  326 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp  326 (375)
                      +++.     ..++++...|+...|..||.+|.
T Consensus       385 ~kFP-----r~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  385 LKFP-----RTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             ccCC-----ccCCHHHHHHHHHHhhcChHhhc
Confidence            2211     23456788999999999999995

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-37  Score=278.09  Aligned_cols=263  Identities=24%  Similarity=0.318  Sum_probs=192.8

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHHhc---CCCCeEEEeeeeecCCc----e
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--KRVEQFMNEVDILARL---RHKNLVSLYGCTSRHSR----E  132 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~----~  132 (375)
                      |++.+.||.|+||.||+|..+ +++.||+|++.....  .....+.+|+.+++.+   +|+|++++++++.....    .
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            567889999999999999776 489999999864322  1223456777777666   59999999997765332    3


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      .+++|||+. ++|.+++...  ....+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...
T Consensus        81 ~~l~~e~~~-~~l~~~l~~~--~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          81 LTLVFEHVD-QDLATYLSKC--PKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             eEEEehhcc-cCHHHHHHHc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            899999996 5788888543  2235899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH-----
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL-----  287 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-----  287 (375)
                      ......  ....++..|+|||.+.+..++.++|+|||||++|+|++|.+||.........  .... ........     
T Consensus       158 ~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~  232 (287)
T cd07838         158 SFEMAL--TSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQL--DKIF-DVIGLPSEEEWPR  232 (287)
T ss_pred             cCCccc--ccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHH--HHHH-HHcCCCChHhcCC
Confidence            433221  2234788899999999888999999999999999999999999754322110  0000 00000000     


Q ss_pred             -----HHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          288 -----HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       288 -----~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                           ......................+.+++.+||+.+|.+||++.+++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         233 NVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence                 0000000000111112344577889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=3.2e-38  Score=286.61  Aligned_cols=270  Identities=23%  Similarity=0.304  Sum_probs=192.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchh--hHHHHHHHHHHHHhcCCCCeEEEeeeeecC-------
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK--RVEQFMNEVDILARLRHKNLVSLYGCTSRH-------  129 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  129 (375)
                      .++|++.+.||.|++|.||+|... +++.+++|++......  ....+.+|+++++.++||||+++++++...       
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            467999999999999999999765 6889999988544322  224567899999999999999999865432       


Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      ...+++|+||+. ++|...+..   ....+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++
T Consensus        87 ~~~~~lv~~~~~-~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~  162 (311)
T cd07866          87 RGSVYMVTPYMD-HDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA  162 (311)
T ss_pred             CceEEEEEecCC-cCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccc
Confidence            235799999996 467776643   2346999999999999999999999999999999999999999999999999998


Q ss_pred             cccCCCccc----------cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHH
Q 017232          210 RLFPNHVTH----------VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA  278 (375)
Q Consensus       210 ~~~~~~~~~----------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~  278 (375)
                      .........          ......+++.|+|||.+.+ ..++.++||||||+++|+|++|++||...............
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~  242 (311)
T cd07866         163 RPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKL  242 (311)
T ss_pred             hhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            765432211          1122346788999998765 45789999999999999999999999754322111000000


Q ss_pred             HHHhhhhHHH------HHHhhhcCCCCCh----HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          279 INKIQNKALH------ELVDQTLGYESDN----KVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       279 ~~~~~~~~~~------~~~~~~l~~~~~~----~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..........      .............    ........+.+++.+||+.+|.+|||+.+++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         243 CGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             hCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            0000000000      0000000000000    01122357889999999999999999999875

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1e-37  Score=279.54  Aligned_cols=265  Identities=22%  Similarity=0.343  Sum_probs=193.4

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEEEEec
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-KRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      |++.+.||+|++|.||+|... +++.|++|++..... .......+|+..+..++ |+|++++++++.. +...++||||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv~e~   79 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-NDELYFVFEY   79 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-CCcEEEEEec
Confidence            667889999999999999765 578899998865422 22234457899999999 9999999997766 6789999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      + +++|.+.+....  ...+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||.+........  
T Consensus        80 ~-~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~--  154 (283)
T cd07830          80 M-EGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP--  154 (283)
T ss_pred             C-CCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC--
Confidence            9 789998885432  34689999999999999999999999999999999999999999999999999876543222  


Q ss_pred             ccCCCCCccccCccccc-ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH------HHHHHh
Q 017232          220 STAPQGTPGYVDPEYHQ-CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA------LHELVD  292 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~  292 (375)
                      .....++..|+|||.+. +..++.++|+||||+++++|++|.+||.......................      ......
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07830         155 YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLG  234 (283)
T ss_pred             cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcccc
Confidence            12335788999999774 45578999999999999999999999965543221100000000000000      000000


Q ss_pred             hhcCCCC----ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          293 QTLGYES----DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       293 ~~l~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .......    ..........+.+++.+||+.+|++|||++|++.
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         235 FRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            0000000    0001112357899999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=2.9e-38  Score=307.42  Aligned_cols=256  Identities=28%  Similarity=0.397  Sum_probs=191.5

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeec------
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSR------  128 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~------  128 (375)
                      ....++|+.++.||+||||.||+++.+ ||+.||||++.... ......+.+|+..+.+|+|||||+++..+.+      
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~  554 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT  554 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence            456677888999999999999999777 89999999996553 3445678899999999999999998753110      


Q ss_pred             -----------------------------------------------------------------------C--------
Q 017232          129 -----------------------------------------------------------------------H--------  129 (375)
Q Consensus       129 -----------------------------------------------------------------------~--------  129 (375)
                                                                                             +        
T Consensus       555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS  634 (1351)
T KOG1035|consen  555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS  634 (1351)
T ss_pred             cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence                                                                                   0        


Q ss_pred             -------------------------C--------ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHH
Q 017232          130 -------------------------S--------RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT  176 (375)
Q Consensus       130 -------------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~  176 (375)
                                               .        ..+||-||||+..++.+++.......   .....|.++.+|+.||.
T Consensus       635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~---~~d~~wrLFreIlEGLa  711 (1351)
T KOG1035|consen  635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS---QRDEAWRLFREILEGLA  711 (1351)
T ss_pred             ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch---hhHHHHHHHHHHHHHHH
Confidence                                     0        24688999999888888885543221   46788999999999999


Q ss_pred             HHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC-----------------CCccccccCCCCCccccCcccccccC
Q 017232          177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-----------------NHVTHVSTAPQGTPGYVDPEYHQCYQ  239 (375)
Q Consensus       177 ~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~-----------------~~~~~~~~~~~~~~~y~aPE~~~~~~  239 (375)
                      |+|+.|||||||||.||+++.++.|||+|||+++...                 .......+..+||.-|.|||++.+..
T Consensus       712 YIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~  791 (1351)
T KOG1035|consen  712 YIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTS  791 (1351)
T ss_pred             HHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccc
Confidence            9999999999999999999999999999999998621                 01111234567999999999988755


Q ss_pred             ---CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHH
Q 017232          240 ---LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQ  316 (375)
Q Consensus       240 ---~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~  316 (375)
                         |+.|+|+||||+|++||+.   ||+..-..              ...+..+-+..+... .....+....-..+|.+
T Consensus       792 ~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMER--------------a~iL~~LR~g~iP~~-~~f~~~~~~~e~slI~~  853 (1351)
T KOG1035|consen  792 SNKYNSKIDMYSLGIVLFEMLY---PFGTSMER--------------ASILTNLRKGSIPEP-ADFFDPEHPEEASLIRW  853 (1351)
T ss_pred             cccccchhhhHHHHHHHHHHhc---cCCchHHH--------------HHHHHhcccCCCCCC-cccccccchHHHHHHHH
Confidence               9999999999999999985   35432110              011111112222222 11111223345689999


Q ss_pred             hcCCCCCCCCCHHHHHH
Q 017232          317 CLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       317 cl~~~P~~Rpt~~evl~  333 (375)
                      |++.||++|||+.|+++
T Consensus       854 Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  854 LLSHDPSKRPTATELLN  870 (1351)
T ss_pred             HhcCCCccCCCHHHHhh
Confidence            99999999999999985

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=6.9e-37  Score=279.90  Aligned_cols=269  Identities=20%  Similarity=0.302  Sum_probs=192.4

Q ss_pred             CccCCC--CcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDG--GFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      ..||+|  +||+||+|... +|+.||+|.+...  .....+.+.+|+.+++.++||||+++++++.. +...++|+||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~-~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTT-GSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEec-CCceEEEEeccc
Confidence            346666  99999999664 7899999998643  33445778899999999999999999998776 567899999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc---
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH---  218 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~---  218 (375)
                      +++|.+++....  ...+++..+..++.|++.||+|||+.|++||||||+||+++.++.++++||+.+.........   
T Consensus        83 ~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~  160 (328)
T cd08226          83 YGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKV  160 (328)
T ss_pred             CCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccc
Confidence            999999986542  235889999999999999999999999999999999999999999999999865332111100   


Q ss_pred             c---ccCCCCCccccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHH---------------
Q 017232          219 V---STAPQGTPGYVDPEYHQC--YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA---------------  278 (375)
Q Consensus       219 ~---~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~---------------  278 (375)
                      .   .....++..|+|||++.+  ..++.++|||||||++|+|++|.+||.........  ....               
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  238 (328)
T cd08226         161 VYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML--LQKLKGPPYSPLDITTFPC  238 (328)
T ss_pred             cccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHH--HHHhcCCCCCCccccccch
Confidence            0   001124567999999876  34788999999999999999999999754321100  0000               


Q ss_pred             -HHHhhhh--HH-----HHHHhh----hc--CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhhhc
Q 017232          279 -INKIQNK--AL-----HELVDQ----TL--GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDIES  340 (375)
Q Consensus       279 -~~~~~~~--~~-----~~~~~~----~l--~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i~~  340 (375)
                       .......  ..     ......    ..  .....+....+...+.+|+.+||+.+|++|||+.++++.  ++.+..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~  316 (328)
T cd08226         239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKE  316 (328)
T ss_pred             hhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHH
Confidence             0000000  00     000000    00  000112223466789999999999999999999999854  444444

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=4.1e-37  Score=279.82  Aligned_cols=265  Identities=20%  Similarity=0.227  Sum_probs=190.9

Q ss_pred             CCCCccCCCCcEEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           64 DSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      .+.+.+|.|+++.||++.. +++.||+|++...  .......+.+|+.+++.++|+||+++++++.. ....+++|||++
T Consensus         5 ~i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-~~~~~~~~e~~~   82 (314)
T cd08216           5 LIGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-DSELYVVSPLMA   82 (314)
T ss_pred             hhhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-CCeEEEEEeccC
Confidence            3444556666666666554 6899999998654  34556789999999999999999999997766 567899999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc----
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT----  217 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~----  217 (375)
                      +++|.+++...  ....+++..+..++.|++.||.|||+++|+|+||||+||+++.++.++|+|||.+........    
T Consensus        83 ~~~l~~~l~~~--~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~  160 (314)
T cd08216          83 YGSCEDLLKTH--FPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV  160 (314)
T ss_pred             CCCHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccc
Confidence            99999998654  234588999999999999999999999999999999999999999999999998865432111    


Q ss_pred             --ccccCCCCCccccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHh----hhhHHHH
Q 017232          218 --HVSTAPQGTPGYVDPEYHQC--YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKI----QNKALHE  289 (375)
Q Consensus       218 --~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~  289 (375)
                        .......++..|+|||++.+  ..++.++|+|||||++|+|++|..||........  ......+..    .......
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~~~~~~~  238 (314)
T cd08216         161 VHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM--LLEKVRGTVPCLLDKSTYPL  238 (314)
T ss_pred             cccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccCccccccCchhh
Confidence              11122346778999998865  3588999999999999999999999975332110  000000000    0000000


Q ss_pred             H-----------Hhhhc-CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          290 L-----------VDQTL-GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       290 ~-----------~~~~l-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .           ..... ..............+.+++.+||..+|++|||++++++.
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         239 YEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             hcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence            0           00000 000011122345678999999999999999999999975

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.3e-38  Score=279.80  Aligned_cols=248  Identities=25%  Similarity=0.396  Sum_probs=198.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|.+.+.||+|++|.||+|... ++..|++|++...   .......+.+|+.+++.++ |+||+++++++.. ....++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~l   79 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQD-EENLYF   79 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcC-CceEEE
Confidence            46889999999999999999665 7899999988653   2233456788999999998 9999999997665 567899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      |||++.+++|.+++...    ..+++..++.++.|++.||.+||+.|++|+||+|+||+++.++.++|+|||++......
T Consensus        80 v~e~~~~~~L~~~l~~~----~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~  155 (280)
T cd05581          80 VLEYAPNGELLQYIRKY----GSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPN  155 (280)
T ss_pred             EEcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCc
Confidence            99999999999999543    36999999999999999999999999999999999999999999999999998765432


Q ss_pred             cc-------------------ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhH
Q 017232          216 VT-------------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN  276 (375)
Q Consensus       216 ~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~  276 (375)
                      ..                   .......++..|+|||...+..++.++|+||||++++++++|..||.......      
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------  229 (280)
T cd05581         156 SSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL------  229 (280)
T ss_pred             cccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHH------
Confidence            21                   11223357889999999888889999999999999999999999998554110      


Q ss_pred             HHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCH----HHHHH
Q 017232          277 LAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYM----VDVLD  333 (375)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~----~evl~  333 (375)
                               .......  ......   ...+..+.+++.+||+.+|++||++    +++++
T Consensus       230 ---------~~~~~~~--~~~~~~---~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         230 ---------TFQKILK--LEYSFP---PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             ---------HHHHHHh--cCCCCC---CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence                     0011111  111111   1235678999999999999999999    77664

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.2e-38  Score=289.82  Aligned_cols=250  Identities=27%  Similarity=0.389  Sum_probs=204.8

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ...+.|.+...||+|.|+.|.+|.+. ++..||||.+.+.  +......+.+|+.+|+.++|||||+++.+... ...+|
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t-~~~ly  131 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIET-EATLY  131 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeee-cceeE
Confidence            34567999999999999999999554 7999999999765  44555668999999999999999999997776 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+.+|.+.+++..    .+.+.+..+..++.|+..|++|||+++|||||||++|||++.+.++||+|||++..+..
T Consensus       132 lV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~  207 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDY  207 (596)
T ss_pred             EEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecc
Confidence            99999999999999953    45577789999999999999999999999999999999999999999999999998764


Q ss_pred             CccccccCCCCCccccCcccccccCC-CCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ..  .....+|++.|.|||++.+..| .+++|+||+|+++|.|+.|..||+...-..                   +-..
T Consensus       208 ~~--~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~-------------------Lr~r  266 (596)
T KOG0586|consen  208 GL--MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE-------------------LRPR  266 (596)
T ss_pred             cc--cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc-------------------ccch
Confidence            33  3456689999999999998776 468999999999999999999998543211                   0001


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .+.+... .+.-...+..++++++|-.+|.+|++++++.+.
T Consensus       267 vl~gk~r-Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  267 VLRGKYR-IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             heeeeec-ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence            1110000 001123467889999999999999999988764

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.2e-38  Score=268.91  Aligned_cols=208  Identities=25%  Similarity=0.388  Sum_probs=173.0

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-C----CCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-D----GRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      ...|+.+..||+|.||.||+|..+ +    ...+|+|.++....  ..-....+|+.+++.++|||++.+..++...+..
T Consensus        23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~  102 (438)
T KOG0666|consen   23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK  102 (438)
T ss_pred             HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence            346899999999999999999333 2    23689998865421  1224567899999999999999999988877889


Q ss_pred             eEEEEecccCCChhHhhccCCC-CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC----CcEEEeeec
Q 017232          133 LLLVYEFISNGTVADHLHGERA-KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN----FCVKVADFG  207 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~----~~~kl~Dfg  207 (375)
                      +++++||.+ -+|...++..+. ....++...++.|++||+.|+.|||++=|+||||||.|||+..+    |.+||+|||
T Consensus       103 v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlG  181 (438)
T KOG0666|consen  103 VWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLG  181 (438)
T ss_pred             EEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeeccc
Confidence            999999996 578888876543 33568889999999999999999999999999999999999887    899999999


Q ss_pred             cccccCCCcccc--ccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCcccccc
Q 017232          208 LSRLFPNHVTHV--STAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRH  268 (375)
Q Consensus       208 ~~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~  268 (375)
                      +++.+.+.....  ....+.|.+|+|||.+.| ..|+.+.|||+.|||+.||+|-.|.|.....
T Consensus       182 laR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~  245 (438)
T KOG0666|consen  182 LARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREE  245 (438)
T ss_pred             HHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhh
Confidence            999987654433  234568999999998776 5699999999999999999999999865543

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=9.4e-38  Score=286.55  Aligned_cols=265  Identities=18%  Similarity=0.222  Sum_probs=192.6

Q ss_pred             hcCCCC-CCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhh--------------HHHHHHHHHHHHhcCCCCeEEEe
Q 017232           60 TNYFDS-ARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKR--------------VEQFMNEVDILARLRHKNLVSLY  123 (375)
Q Consensus        60 ~~~y~~-~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~  123 (375)
                      .++|.. .+.||.|+||+||+|... +++.||+|.+.......              ...+.+|+.+++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            355654 567999999999999654 68999999886542221              12467899999999999999999


Q ss_pred             eeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEE
Q 017232          124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKV  203 (375)
Q Consensus       124 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl  203 (375)
                      +++.. ....++||||+. ++|.+++..    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|
T Consensus        87 ~~~~~-~~~~~lv~e~~~-~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl  160 (335)
T PTZ00024         87 DVYVE-GDFINLVMDIMA-SDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKI  160 (335)
T ss_pred             EEEec-CCcEEEEEeccc-cCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEE
Confidence            97765 568899999996 689888843    345899999999999999999999999999999999999999999999


Q ss_pred             eeeccccccCCCc-------------cccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccc
Q 017232          204 ADFGLSRLFPNHV-------------THVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHR  269 (375)
Q Consensus       204 ~Dfg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~  269 (375)
                      +|||++.......             ........++..|+|||.+.+. .++.++|+|||||++|+|++|.+||......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~  240 (335)
T PTZ00024        161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI  240 (335)
T ss_pred             CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999987654110             1111223467889999988764 4688999999999999999999999755422


Q ss_pred             cccchhHHHHHHhhhhH---HHHHHh-----h---hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          270 HEINLSNLAINKIQNKA---LHELVD-----Q---TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       270 ~~~~~~~~~~~~~~~~~---~~~~~~-----~---~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..   ............   ......     +   .............+..+.+++.+||+.+|++|||+++++.
T Consensus       241 ~~---~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  312 (335)
T PTZ00024        241 DQ---LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK  312 (335)
T ss_pred             HH---HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence            11   000001000000   000000     0   0000000001123467889999999999999999999985

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=3e-38  Score=265.12  Aligned_cols=255  Identities=23%  Similarity=0.295  Sum_probs=201.3

Q ss_pred             HhcCCCCC-CccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeec---CCce
Q 017232           59 ATNYFDSA-RELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSR---HSRE  132 (375)
Q Consensus        59 ~~~~y~~~-~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---~~~~  132 (375)
                      .+++|.+. ++||-|-.|.|-.... .+++++|+|++...     ...++|+++.-.. .|||||.++++|+.   ...+
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            45667664 5799999999988844 47999999988543     3446788765544 69999999996543   3567


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC---CCcEEEeeeccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLS  209 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~  209 (375)
                      +.+|||.++||.|...+.+.  ....+++.++..|+.||..|+.|||+.+|.||||||+|+|...   +..+||+|||+|
T Consensus       134 LLiVmE~meGGeLfsriq~~--g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFA  211 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDR--GDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFA  211 (400)
T ss_pred             eEeeeecccchHHHHHHHHc--ccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccc
Confidence            89999999999999999765  3456999999999999999999999999999999999999964   556999999999


Q ss_pred             cccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                      +.....  ......+.||.|.|||++....|+..+|+||+||++|-|++|.+||-....   ..++-...+.+..+.   
T Consensus       212 K~t~~~--~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg---~aispgMk~rI~~gq---  283 (400)
T KOG0604|consen  212 KETQEP--GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG---LAISPGMKRRIRTGQ---  283 (400)
T ss_pred             cccCCC--ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC---ccCChhHHhHhhccC---
Confidence            865432  334566799999999999999999999999999999999999999954332   112222222222211   


Q ss_pred             HHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          290 LVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       290 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                            -..+.++-...++...++|+.+|..+|.+|.|+.+++..
T Consensus       284 ------y~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  284 ------YEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             ------ccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                  113345556778889999999999999999999999864

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.6e-37  Score=277.09  Aligned_cols=244  Identities=28%  Similarity=0.412  Sum_probs=190.2

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      |...+.||+|+||.||+|... ++..|++|.+...   .......+.+|+.+++.++|||++++++++.. ....++|||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e  101 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-EHTAWLVME  101 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEEEe
Confidence            666788999999999999654 6889999998643   22344568889999999999999999997776 567899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+. ++|.+++..   ....+++.++..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.....    
T Consensus       102 ~~~-~~l~~~l~~---~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~----  173 (313)
T cd06633         102 YCL-GSASDLLEV---HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP----  173 (313)
T ss_pred             cCC-CCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC----
Confidence            995 677777743   234589999999999999999999999999999999999999999999999998864321    


Q ss_pred             cccCCCCCccccCccccc---ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          219 VSTAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                       .....++..|+|||.+.   ...++.++||||||+++|+|++|.+||.......      ....         ......
T Consensus       174 -~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~------~~~~---------~~~~~~  237 (313)
T cd06633         174 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------ALYH---------IAQNDS  237 (313)
T ss_pred             -CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHH------HHHH---------HHhcCC
Confidence             12345788999999874   4568889999999999999999999986443111      0000         000000


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                         ........+..+.+++.+||+.+|.+||++.+++..
T Consensus       238 ---~~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 ---PTLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             ---CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               000011233568899999999999999999999854

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.2e-37  Score=274.80  Aligned_cols=241  Identities=24%  Similarity=0.330  Sum_probs=182.8

Q ss_pred             ccCCCCcEEEEEEEe-CCCCEEEEEEecccchh---hHHHHHHHH---HHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           68 ELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYK---RVEQFMNEV---DILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        68 ~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~---~~~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      .||+|+||.||+|.. .+++.||+|.+......   ....+..|.   ..++...|||++.+++++.. ....++||||+
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~   79 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKLSFILDLM   79 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-CCEEEEEEecC
Confidence            489999999999965 46889999988654221   111233333   34445579999999987776 56789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      .+++|..++..    ...+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++........   
T Consensus        80 ~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~---  152 (278)
T cd05606          80 NGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---  152 (278)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccCC---
Confidence            99999988842    34689999999999999999999999999999999999999999999999999875533222   


Q ss_pred             cCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....++..|+|||.+.+ ..++.++||||+|+++|+|++|..||..........        .     .... .......
T Consensus       153 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~--------~-----~~~~-~~~~~~~  218 (278)
T cd05606         153 HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE--------I-----DRMT-LTMAVEL  218 (278)
T ss_pred             cCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHH--------H-----HHHh-hccCCCC
Confidence            23358899999998874 468899999999999999999999997543211100        0     0000 0000011


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLD  333 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~  333 (375)
                      .   ...+..+.+++.+||..+|.+||     ++.++++
T Consensus       219 ~---~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         219 P---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             C---CcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence            1   12356789999999999999999     8999875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5e-37  Score=278.33  Aligned_cols=250  Identities=28%  Similarity=0.403  Sum_probs=193.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      +.|...+.||+|++|.||+|... ++..+++|.+...   .......+.+|+.+++.++|+|++++++++.. ....++|
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   93 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV   93 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-CCeeEEE
Confidence            34667888999999999999754 6788999988542   22344567889999999999999999997776 5678999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+. ++|.+.+...   ...+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... 
T Consensus        94 ~e~~~-~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~-  168 (308)
T cd06634          94 MEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (308)
T ss_pred             EEccC-CCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence            99996 6787776432   345889999999999999999999999999999999999999999999999998754322 


Q ss_pred             cccccCCCCCccccCccccc---ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          217 THVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                          ....++..|+|||.+.   ...++.++|||||||++|+|++|..||.......      ..         ......
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~---------~~~~~~  229 (308)
T cd06634         169 ----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------AL---------YHIAQN  229 (308)
T ss_pred             ----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHH------HH---------HHHhhc
Confidence                2234788999999864   3467889999999999999999999985432110      00         000000


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                      .   .........+..+.+++.+||..+|++||++.++++.-...
T Consensus       230 ~---~~~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~  271 (308)
T cd06634         230 E---SPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL  271 (308)
T ss_pred             C---CCCcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCcccc
Confidence            0   01111123456788999999999999999999999764433

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.9e-37  Score=284.04  Aligned_cols=268  Identities=21%  Similarity=0.325  Sum_probs=192.1

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-C--CCEEEEEEeccc--chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeec---CCce
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-D--GRAVAVKRLYEN--NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSR---HSRE  132 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~--~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---~~~~  132 (375)
                      +|++.+.||+|+||.||++... .  +..||+|.+...  .....+.+.+|+.+++.+ +||||+++++....   ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            4778899999999999999665 3  778999988643  222345678899999999 59999999985432   2345


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      ++++++++. ++|.+++.    ....+++..++.++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++...
T Consensus        81 ~~~~~e~~~-~~L~~~l~----~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          81 LYLYEELME-ADLHQIIR----SGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             EEEEEeccc-CCHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            789999985 68888884    3346899999999999999999999999999999999999999999999999999765


Q ss_pred             CCCccc---cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhH--------HHHH
Q 017232          213 PNHVTH---VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN--------LAIN  280 (375)
Q Consensus       213 ~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~--------~~~~  280 (375)
                      ......   ......++..|+|||.+.+ ..++.++||||+|+++|+|++|.+||.............        ....
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            432211   1123458889999998765 568899999999999999999999997543211000000        0000


Q ss_pred             HhhhhHHHHHHhhhcCCCC---ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          281 KIQNKALHELVDQTLGYES---DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~---~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .+............-....   ..........+.+++.+||+.+|.+|||+.+++..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000111111100000000   00001124678999999999999999999998743

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-39  Score=317.56  Aligned_cols=253  Identities=25%  Similarity=0.376  Sum_probs=201.3

Q ss_pred             HhcCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .+-++.-...||.|.||.||-| ...+|.-.|+|.+.-.  .........+|..++..++|||+|+++|+-. +++.++|
T Consensus      1233 V~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEv-HRekv~I 1311 (1509)
T KOG4645|consen 1233 VTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEV-HREKVYI 1311 (1509)
T ss_pred             ceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceee-cHHHHHH
Confidence            3456777889999999999999 5567999999987533  3344566788999999999999999999544 4777899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      .||||++|+|.+.+..    +...++.....+..|++.|+.|||++|||||||||.||+++.+|.+|++|||.|..+.+.
T Consensus      1312 FMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~ 1387 (1509)
T KOG4645|consen 1312 FMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNN 1387 (1509)
T ss_pred             HHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCc
Confidence            9999999999999943    334566677788999999999999999999999999999999999999999999887654


Q ss_pred             cc---ccccCCCCCccccCcccccccC---CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          216 VT---HVSTAPQGTPGYVDPEYHQCYQ---LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       216 ~~---~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                      ..   .......||+-|||||++.+..   -..++||||+||+++||.||+.|+...+..       |+           
T Consensus      1388 ~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne-------~a----------- 1449 (1509)
T KOG4645|consen 1388 AQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE-------WA----------- 1449 (1509)
T ss_pred             hhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch-------hH-----------
Confidence            32   2223457999999999987643   455899999999999999999999754421       11           


Q ss_pred             HHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          290 LVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       290 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ++-..-.+..+..+...+.+-++++.+||..||+.|.++.|+++.
T Consensus      1450 IMy~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1450 IMYHVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             HHhHHhccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            111112233444445577888999999999999999988877654

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.7e-37  Score=277.70  Aligned_cols=251  Identities=24%  Similarity=0.394  Sum_probs=191.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCC-CCEEEEEEecccc-hhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN-YKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|++.+.||+|++|.||+|...+ ++.||+|.+.... ......+..|+.++.... |+||+++++++.. ....+++|
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~   93 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFIT-DSDVFICM   93 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeec-CCeEEEEe
Confidence            568889999999999999997764 8999999986543 233455667777776665 9999999997766 66799999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||+. ++|.+++...   ...+++..+..++.|++.||.|||+ .|++|+||+|+||++++++.++|+|||++.......
T Consensus        94 e~~~-~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~  169 (296)
T cd06618          94 ELMS-TCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK  169 (296)
T ss_pred             eccC-cCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC
Confidence            9985 5777766432   2368999999999999999999997 599999999999999999999999999987654322


Q ss_pred             cccccCCCCCccccCcccccccC----CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQ----LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ..  ....++..|+|||.+.+..    ++.++||||||+++|+|++|+.||.......              ......+.
T Consensus       170 ~~--~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--------------~~~~~~~~  233 (296)
T cd06618         170 AK--TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF--------------EVLTKILQ  233 (296)
T ss_pred             cc--cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH--------------HHHHHHhc
Confidence            21  2234778999999887543    7889999999999999999999996432110              00111111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .......  ....++..+.+++.+||..+|++||++.++++.
T Consensus       234 ~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         234 EEPPSLP--PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             CCCCCCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1110000  001245678999999999999999999999865

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-38  Score=275.98  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=199.4

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHh--cCCCCeEEEeeeeecCC---ce
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR--LRHKNLVSLYGCTSRHS---RE  132 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~---~~  132 (375)
                      ....+..+.+.||+|.||.||+|.++ |+.||||++...+..   .+.+|.++.+.  |+|+||+.+++....+.   ..
T Consensus       208 TiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~srdE~---SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  208 TIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSSRDER---SWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hhhheeEEEEEecCccccceeecccc-CCceEEEEecccchh---hhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            34567888999999999999999998 789999999765433   45667777665  59999999998644333   35


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC--------CceeccCCCCCEEecCCCcEEEe
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS--------DIIHRDVKTNNILLDNNFCVKVA  204 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--------~ivH~dlkp~Nill~~~~~~kl~  204 (375)
                      ++||++|.+.|+|.|+|.     ..+++...+++++..++.||++||..        .|.|||||..||||..+|.+-|+
T Consensus       284 LwLvTdYHe~GSL~DyL~-----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA  358 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLN-----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA  358 (513)
T ss_pred             EEEeeecccCCcHHHHHh-----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence            899999999999999994     35689999999999999999999974        59999999999999999999999


Q ss_pred             eeccccccCCCccc---cccCCCCCccccCcccccccC------CCCchhHHHHHHHHHHHHhC----------CCCccc
Q 017232          205 DFGLSRLFPNHVTH---VSTAPQGTPGYVDPEYHQCYQ------LTDKSDVFSFGVVLIELISS----------MPAVDI  265 (375)
Q Consensus       205 Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~------~~~~~DiwslG~il~elltg----------~~p~~~  265 (375)
                      |+|+|....+....   .....+||.+|||||++...-      --..+||||||.++||+...          ++||-.
T Consensus       359 DLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd  438 (513)
T KOG2052|consen  359 DLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYD  438 (513)
T ss_pred             eceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCccc
Confidence            99999876554322   234568999999999887521      11258999999999999852          244432


Q ss_pred             cccccccchhHHHHHHhhhhHHHHH----HhhhcCCCCC--hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          266 TRHRHEINLSNLAINKIQNKALHEL----VDQTLGYESD--NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       266 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~l~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      .-+.+              ....++    ..+.++...+  ....+....+.++++.||..+|..|.|+-.+.+.|.++.
T Consensus       439 ~Vp~D--------------Ps~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~  504 (513)
T KOG2052|consen  439 VVPSD--------------PSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS  504 (513)
T ss_pred             CCCCC--------------CCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence            21111              111111    1222322222  223456778999999999999999999999999999988


Q ss_pred             c
Q 017232          340 S  340 (375)
Q Consensus       340 ~  340 (375)
                      +
T Consensus       505 ~  505 (513)
T KOG2052|consen  505 N  505 (513)
T ss_pred             c
Confidence            5

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-37  Score=284.89  Aligned_cols=266  Identities=20%  Similarity=0.320  Sum_probs=196.7

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-----
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-----  130 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----  130 (375)
                      ..++|++.+.||+|++|.||+|... ++..||+|++...  .......+.+|+.+++.++|||++++++++....     
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            4567999999999999999999765 6789999988643  2233456778999999999999999988654422     


Q ss_pred             ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          131 RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      ...++|+||+ +++|.+++..     ..+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~  166 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-----QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR  166 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccc
Confidence            2489999999 6799998843     458999999999999999999999999999999999999999999999999987


Q ss_pred             ccCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchh--------HHHHHH
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLS--------NLAINK  281 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~--------~~~~~~  281 (375)
                      .....    .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||............        ......
T Consensus       167 ~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  242 (343)
T cd07851         167 HTDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQK  242 (343)
T ss_pred             ccccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhh
Confidence            65432    223357889999998765 36788999999999999999999999654321110000        000000


Q ss_pred             hhhhHHHHHHhhhcCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          282 IQNKALHELVDQTLGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      +........+.........   ......+..+.+++.+||+.+|++|||+.+|++.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         243 ISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             ccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            1111111111111100000   1111235679999999999999999999999863

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.8e-38  Score=288.05  Aligned_cols=245  Identities=24%  Similarity=0.391  Sum_probs=191.8

Q ss_pred             CCCCccCCCCcEEEEEEEe-CCCCEEEEEEecc----cchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-ceeEEEE
Q 017232           64 DSARELGDGGFGTVYYGEL-QDGRAVAVKRLYE----NNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-RELLLVY  137 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~----~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv~  137 (375)
                      +....||+|+|-+||+|.. .+|..||--.++.    ......+.|..|+.+|+.|+||||+++|..|.+.. ..+.+|+
T Consensus        43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT  122 (632)
T KOG0584|consen   43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT  122 (632)
T ss_pred             ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence            4456799999999999944 4677776543322    23455688999999999999999999999776533 4678999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC--CceeccCCCCCEEecC-CCcEEEeeeccccccCC
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS--DIIHRDVKTNNILLDN-NFCVKVADFGLSRLFPN  214 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~  214 (375)
                      |.+..|+|..++...    +.++...++.|++||+.||.|||++  .|+|||||-+||||++ .|.|||+|+|+|.....
T Consensus       123 EL~TSGtLr~Y~kk~----~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~  198 (632)
T KOG0584|consen  123 ELFTSGTLREYRKKH----RRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRK  198 (632)
T ss_pred             ecccCCcHHHHHHHh----ccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhc
Confidence            999999999999655    3478889999999999999999998  5999999999999975 58899999999998754


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ...   ....|||.|||||++. ..|++..||||||++++||+|+..|+..-....+++      +++..+.-.    ..
T Consensus       199 s~a---ksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIY------KKV~SGiKP----~s  264 (632)
T KOG0584|consen  199 SHA---KSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIY------KKVTSGIKP----AA  264 (632)
T ss_pred             ccc---ceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHH------HHHHcCCCH----HH
Confidence            433   2357999999999988 589999999999999999999999997655332211      111111100    01


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      +....       .++++++|.+||.. ..+|||+.|+|.-
T Consensus       265 l~kV~-------dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  265 LSKVK-------DPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             hhccC-------CHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            11111       24689999999999 9999999999863

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-38  Score=294.94  Aligned_cols=253  Identities=26%  Similarity=0.399  Sum_probs=206.9

Q ss_pred             CCCCccCCCCcEEEEEEEeC-CC----CEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           64 DSARELGDGGFGTVYYGELQ-DG----RAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~-~~----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      +..++||+|+||+||+|.+- .|    -+||+|++... ..+....+.+|+.+|.+++|||++++++++....  +.||+
T Consensus       699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~--~qlvt  776 (1177)
T KOG1025|consen  699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST--LQLVT  776 (1177)
T ss_pred             hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch--HHHHH
Confidence            44678999999999999553 33    47899988655 3445678899999999999999999999887633  78999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      +|+++|+|.++++..+   ..+..+..+.|+.||++|+.|||.+++|||||-..||||.....+|+.|||+++.+.....
T Consensus       777 q~mP~G~LlDyvr~hr---~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~  853 (1177)
T KOG1025|consen  777 QLMPLGCLLDYVREHR---DNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEK  853 (1177)
T ss_pred             HhcccchHHHHHHHhh---ccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccc
Confidence            9999999999997654   4588899999999999999999999999999999999999999999999999998865544


Q ss_pred             cccc-CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          218 HVST-APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       218 ~~~~-~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .... ...-.+.|||-|.+....++.++|||||||++||++| |..|++....                ..+.+++..  
T Consensus       854 ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~----------------~eI~dlle~--  915 (1177)
T KOG1025|consen  854 EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPA----------------EEIPDLLEK--  915 (1177)
T ss_pred             cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCH----------------HHhhHHHhc--
Confidence            3322 2334568999999999999999999999999999997 8888764431                122223322  


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                       ++....++.|..++..++.+||..|+..||+++++...+.+.-.
T Consensus       916 -geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  916 -GERLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             -cccCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence             23344445678899999999999999999999999999886443

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.8e-37  Score=284.02  Aligned_cols=270  Identities=19%  Similarity=0.311  Sum_probs=195.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-----c
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-----R  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~  131 (375)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++....  ......+.+|+.+++.++||||+++++++....     .
T Consensus        14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            468999999999999999999754 68999999986532  222356788999999999999999999765432     3


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ..++|+||+. .+|...+      ...+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++..
T Consensus        94 ~~~lv~e~~~-~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~  166 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARH  166 (342)
T ss_pred             eEEEEecccc-cCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcC
Confidence            4699999995 4666654      13488999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHH--------HHHh
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA--------INKI  282 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~  282 (375)
                      ....    .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||...............        ....
T Consensus       167 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (342)
T cd07879         167 ADAE----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKL  242 (342)
T ss_pred             CCCC----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            4321    123346888999998765 46888999999999999999999999754321100000000        0000


Q ss_pred             hhhHHHHHHhhhcC---CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhhhc
Q 017232          283 QNKALHELVDQTLG---YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDIES  340 (375)
Q Consensus       283 ~~~~~~~~~~~~l~---~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i~~  340 (375)
                      .+............   .............+.+++.+||+.+|++||++.+++..  ++..+.
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~  305 (342)
T cd07879         243 EDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRD  305 (342)
T ss_pred             cccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhccc
Confidence            00000001000000   00000011234568899999999999999999999954  766643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-37  Score=276.31  Aligned_cols=262  Identities=24%  Similarity=0.359  Sum_probs=195.9

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      |+..+.||+|++|.||+|... +++.|++|.+....  ....+.+..|+.+++.++|+|++++++++.. ....++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT-ERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc-CCceEEEecC
Confidence            566788999999999999666 58999999987653  2334567889999999999999999997766 5789999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      ++ ++|.+++....   ..+++..++.++.|++.||.+||+.|++|+||+|+||++++++.++|+|||.+........ .
T Consensus        80 ~~-~~l~~~i~~~~---~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  154 (282)
T cd07829          80 CD-MDLKKYLDKRP---GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T  154 (282)
T ss_pred             cC-cCHHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence            97 58999985432   4689999999999999999999999999999999999999999999999999876543322 1


Q ss_pred             ccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh---hhHHHHHH----
Q 017232          220 STAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ---NKALHELV----  291 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~----  291 (375)
                      .....++..|+|||.+.+. .++.++||||||+++|+|++|.+||.........   ....+...   +.....+.    
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL---FKIFQILGTPTEESWPGVTKLPD  231 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH---HHHHHHhCCCcHHHHHhhccccc
Confidence            2223457789999988765 7889999999999999999999999754421110   00000000   00000000    


Q ss_pred             -hhhc----CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 -DQTL----GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 -~~~l----~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       +...    ..............+.+++.+||..+|++||++.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             ccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence             0000    00000111123567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-37  Score=258.54  Aligned_cols=251  Identities=25%  Similarity=0.407  Sum_probs=194.6

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++.+.+..||.|..|+|++++.+ +|..+|||.+... +.+..+.+...++++.... +|+||+++|+|.. +..+++.|
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~-n~dV~IcM  170 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFIT-NTDVFICM  170 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEee-CchHHHHH
Confidence            34556778999999999999766 5889999998654 6677788888888877665 9999999998887 45578899


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |.+. ..+..++...   .+++++..+-++...++.||.||..+ ||+|||+||+|||+|+.|++||+|||.+-.+-...
T Consensus       171 elMs-~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSk  246 (391)
T KOG0983|consen  171 ELMS-TCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSK  246 (391)
T ss_pred             HHHH-HHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccc
Confidence            9883 5556666433   35689988899999999999999986 89999999999999999999999999987654433


Q ss_pred             cccccCCCCCccccCccccccc---CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          217 THVSTAPQGTPGYVDPEYHQCY---QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      .+  +...|.+.|||||.+...   .|+-++||||||+.++||.||+.||.....+-.      +..++.+.     .-+
T Consensus       247 Ah--trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe------~ltkvln~-----ePP  313 (391)
T KOG0983|consen  247 AH--TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFE------VLTKVLNE-----EPP  313 (391)
T ss_pred             cc--ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHH------HHHHHHhc-----CCC
Confidence            33  233488999999987643   578899999999999999999999986542210      11111110     001


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .+...     ..++..+++++..||..|+.+||...++++.
T Consensus       314 ~L~~~-----~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  314 LLPGH-----MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             CCCcc-----cCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence            22211     2266789999999999999999999998864

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=263.05  Aligned_cols=259  Identities=24%  Similarity=0.344  Sum_probs=199.0

Q ss_pred             CCccCCCCcEEEEEE-EeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEEEEecccCC
Q 017232           66 ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNG  143 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~~  143 (375)
                      .+.||+|+|+.|--+ ...+|..||||++.+...-......+|++++.+.+ |+||++++++|++ +..+|||||-+.||
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEd-d~~FYLVfEKm~GG  161 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFED-DTRFYLVFEKMRGG  161 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcc-cceEEEEEecccCc
Confidence            356999999999887 66789999999997765556678899999999995 9999999997776 67799999999999


Q ss_pred             ChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc---EEEeeeccccccC--CC---
Q 017232          144 TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC---VKVADFGLSRLFP--NH---  215 (375)
Q Consensus       144 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~--~~---  215 (375)
                      +|...+...    .-+++.++..+..+|+.||+|||.+||.|||+||+|||......   +||+||.+..-..  .+   
T Consensus       162 plLshI~~~----~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp  237 (463)
T KOG0607|consen  162 PLLSHIQKR----KHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP  237 (463)
T ss_pred             hHHHHHHHh----hhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence            999998643    45899999999999999999999999999999999999976554   8999998875332  11   


Q ss_pred             -ccccccCCCCCccccCccccc-----ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          216 -VTHVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       216 -~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                       .+......+|+..|||||+..     ..-|+.++|.||||+|+|-||+|.+||-.....+-.    |..+..-..--..
T Consensus       238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCG----WdrGe~Cr~CQ~~  313 (463)
T KOG0607|consen  238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCG----WDRGEVCRVCQNK  313 (463)
T ss_pred             CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCC----ccCCCccHHHHHH
Confidence             122234567899999999753     235888999999999999999999999766543321    1111111111111


Q ss_pred             HHhhhc--CCCC-ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          290 LVDQTL--GYES-DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       290 ~~~~~l--~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ++...-  .+++ +..-...+.+..+++...|..++.+|.++..+++
T Consensus       314 LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln  360 (463)
T KOG0607|consen  314 LFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN  360 (463)
T ss_pred             HHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence            111111  1122 3333456778889999999999999999998887

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9e-38  Score=270.51  Aligned_cols=273  Identities=20%  Similarity=0.309  Sum_probs=200.9

Q ss_pred             ccchHHHHHHhcCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCC--C----CeEEE
Q 017232           50 VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRH--K----NLVSL  122 (375)
Q Consensus        50 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~----niv~~  122 (375)
                      +|..++.  ..++|.+...+|+|.||.|-.. +...+..||||+++.-. ...+...-|++++.++.+  |    -+|.+
T Consensus        80 v~~~gD~--l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~DP~g~~rcv~m  156 (415)
T KOG0671|consen   80 VYQVGDI--LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVD-KYREAALIEIEVLQKINESDPNGKFRCVQM  156 (415)
T ss_pred             EEEeccc--cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhcCCCCceEEEee
Confidence            4555554  3789999999999999999988 44457899999875432 333556679999999942  2    25666


Q ss_pred             eeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec------
Q 017232          123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD------  196 (375)
Q Consensus       123 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~------  196 (375)
                      .+++. ..++.|||+|.+ |.++.+++..+  +-.+++..++..+++|++.++++||+.+++|.||||+|||+.      
T Consensus       157 ~~wFd-yrghiCivfell-G~S~~dFlk~N--~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~  232 (415)
T KOG0671|consen  157 RDWFD-YRGHICIVFELL-GLSTFDFLKEN--NYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFK  232 (415)
T ss_pred             ehhhh-ccCceEEEEecc-ChhHHHHhccC--CccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEE
Confidence            66444 478999999998 67999999654  335688999999999999999999999999999999999992      


Q ss_pred             --------------CCCcEEEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 017232          197 --------------NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPA  262 (375)
Q Consensus       197 --------------~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  262 (375)
                                    .+..++++|||.|+......    ...+.|..|+|||++.+-.|+.++||||+||||+|+.+|...
T Consensus       233 ~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~L  308 (415)
T KOG0671|consen  233 TYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETL  308 (415)
T ss_pred             EeccCCccceeccCCCcceEEEecCCcceeccCc----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeecccee
Confidence                          13458999999998754433    345689999999999999999999999999999999999999


Q ss_pred             ccccccccccchhHHHHHHhhhhHHHHH-----H-hhhcCC--------------CCChH------HHHHHHHHHHHHHH
Q 017232          263 VDITRHRHEINLSNLAINKIQNKALHEL-----V-DQTLGY--------------ESDNK------VRRTINAVAELAFQ  316 (375)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~-~~~l~~--------------~~~~~------~~~~~~~l~~li~~  316 (375)
                      |......+.....+...+.+....+...     + ...+.+              .+.+.      .......+++|+.+
T Consensus       309 FqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~  388 (415)
T KOG0671|consen  309 FQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRR  388 (415)
T ss_pred             cccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHH
Confidence            9877744433222222222111111110     0 000100              00000      01233579999999


Q ss_pred             hcCCCCCCCCCHHHHHH
Q 017232          317 CLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       317 cl~~~P~~Rpt~~evl~  333 (375)
                      ||..||.+|+|+.|++.
T Consensus       389 mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  389 MLEFDPARRITLREALS  405 (415)
T ss_pred             HHccCccccccHHHHhc
Confidence            99999999999999885

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-36  Score=265.25  Aligned_cols=236  Identities=29%  Similarity=0.401  Sum_probs=189.0

Q ss_pred             cCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCC
Q 017232           69 LGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus        69 lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~  144 (375)
                      ||.|+||.||++... +++.+++|.+.....   .....+..|+.+++.++|+|++++++.+.. +...++||||+.+++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQT-EEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeec-CCeeEEEEecCCCCc
Confidence            699999999999765 588999998865432   244578889999999999999999987665 678999999999999


Q ss_pred             hhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCC
Q 017232          145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ  224 (375)
Q Consensus       145 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  224 (375)
                      |.+++...    ..+++..++.++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... .......
T Consensus        80 L~~~l~~~----~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~  154 (250)
T cd05123          80 LFSHLSKE----GRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFC  154 (250)
T ss_pred             HHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCc
Confidence            99998533    358999999999999999999999999999999999999999999999999987654322 1123345


Q ss_pred             CCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHH
Q 017232          225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVR  304 (375)
Q Consensus       225 ~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  304 (375)
                      ++..|++||...+..++.++|+||||+++|+|++|..||......      ..         ...+......     ...
T Consensus       155 ~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~------~~---------~~~~~~~~~~-----~~~  214 (250)
T cd05123         155 GTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRK------EI---------YEKILKDPLR-----FPE  214 (250)
T ss_pred             CCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH------HH---------HHHHhcCCCC-----CCC
Confidence            788999999998888899999999999999999999999654320      00         0111111111     111


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHH
Q 017232          305 RTINAVAELAFQCLQSEKDLRPYMVD  330 (375)
Q Consensus       305 ~~~~~l~~li~~cl~~~P~~Rpt~~e  330 (375)
                      ..+..+.+++.+||..+|++||++.+
T Consensus       215 ~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         215 FLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence            12467889999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=282.77  Aligned_cols=241  Identities=25%  Similarity=0.331  Sum_probs=193.0

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEE-eCCCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      +...|.+...+|.|+|+.|-++. ..+++..++|++....    .+..+|+.++... +|||+++..+.+.. +.+.|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~-~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYED-GKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecC-Cceeeee
Confidence            35678999999999999998884 4468889999986652    2234567665555 69999999997776 7789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe-cCCCcEEEeeeccccccCCC
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL-DNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill-~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||.+.|+-|.+.+...     +....++..|+.+|+.|+.|||++|++||||||+|||+ ++.++++|+|||.+......
T Consensus       395 ~e~l~g~ell~ri~~~-----~~~~~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  395 MELLDGGELLRRIRSK-----PEFCSEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             ehhccccHHHHHHHhc-----chhHHHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            9999999888877432     22336777899999999999999999999999999999 69999999999999876554


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                          ....+-|..|.|||+.....|++++||||||++||+||+|+.||.......      .....+..+          
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~------ei~~~i~~~----------  529 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGI------EIHTRIQMP----------  529 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchH------HHHHhhcCC----------
Confidence                234467889999999999999999999999999999999999998664321      111111111          


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                           ......+....+|+.+||+.+|.+||+|.++...
T Consensus       530 -----~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  530 -----KFSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             -----ccccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence                 1113456789999999999999999999988753

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=6.9e-36  Score=295.50  Aligned_cols=145  Identities=34%  Similarity=0.502  Sum_probs=128.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|.+.++||+|+||.||+|... +++.||+|++....   ......+..|+.++..++||||+++++++.. ...+|+|
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lV   82 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQS-ANNVYLV   82 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEE-CCEEEEE
Confidence            57889999999999999999665 68999999986542   3334678889999999999999999987665 6689999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      |||+.+++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus        83 mEy~~g~~L~~li~~~----~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          83 MEYLIGGDVKSLLHIY----GYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            9999999999998533    357889999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-37  Score=240.62  Aligned_cols=266  Identities=23%  Similarity=0.297  Sum_probs=201.2

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +|.-.++||+|.||+||+|+.. +++.||+|.+..++  ...-....+|+-+++.++|.|||++++.... ++.+.+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-dkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-CceeEEeHH
Confidence            4666788999999999999554 68899999986553  3334678899999999999999999997666 567899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      ||. .+|..+....   ++.++.+.+..++.|++.||.++|++++.|||+||.|+||+.+|.+|++|||+++-++-+.. 
T Consensus        82 ~cd-qdlkkyfdsl---ng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvr-  156 (292)
T KOG0662|consen   82 FCD-QDLKKYFDSL---NGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR-  156 (292)
T ss_pred             Hhh-HHHHHHHHhc---CCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceE-
Confidence            995 6788887543   45689999999999999999999999999999999999999999999999999987765432 


Q ss_pred             cccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHH---HHHHhh
Q 017232          219 VSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKAL---HELVDQ  293 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  293 (375)
                      .....+.|.+|++|.++.|. -|+...|+||.|||+.|+.. |++.|...+..++....-+..+...+...   ..+.+.
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            23445689999999988764 58889999999999999984 88989876654433222222222222111   111111


Q ss_pred             hcCC------CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          294 TLGY------ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       294 ~l~~------~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..-.      ......+.+...=++++.+.|.-+|.+|.++++.++
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            1100      001122334445678888999999999999998764

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.5e-38  Score=258.13  Aligned_cols=270  Identities=24%  Similarity=0.368  Sum_probs=201.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhh--HHHHHHHHHHHHhcCCCCeEEEeeeee-------cCC
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKR--VEQFMNEVDILARLRHKNLVSLYGCTS-------RHS  130 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~-------~~~  130 (375)
                      +.|.-..++|+|.||.||+|+.+ +|+.||+|++.-.+.+.  -....+|+.+|..++|+|++.+++.|.       .+.
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            34666788999999999999655 57888998765433221  245678999999999999999888542       223


Q ss_pred             ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          131 RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      ..+|+||.+|+ -+|..++...   ...++..++.+++.++..||.|+|...|+|||+|+.|+||+.+|.+||+|||+++
T Consensus        97 ~t~ylVf~~ce-hDLaGlLsn~---~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCE-HDLAGLLSNR---KVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhh-hhHHHHhcCc---cccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeecccccc
Confidence            45899999996 5788888543   2458999999999999999999999999999999999999999999999999996


Q ss_pred             ccCC---CccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH
Q 017232          211 LFPN---HVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA  286 (375)
Q Consensus       211 ~~~~---~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (375)
                      .+..   ......+..+.|.+|++||.+.| ..|+++.|||..|||+.||+|+.+.+..........+.....+.+..+.
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            5532   22223445567999999997765 5799999999999999999999999988776666555555444433321


Q ss_pred             HHH-----HHhhh----cCCCCChHHHHHH------HHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          287 LHE-----LVDQT----LGYESDNKVRRTI------NAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       287 ~~~-----~~~~~----l~~~~~~~~~~~~------~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ..+     ++...    +....-....+..      .+..+|+.+++..||.+|+++++++..
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            111     11110    0000001111122      267899999999999999999988754

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=289.73  Aligned_cols=263  Identities=25%  Similarity=0.383  Sum_probs=208.8

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC----C----CCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeec
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ----D----GRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSR  128 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~----~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  128 (375)
                      ..++..+.+.||.|.||.|++|...    .    ...||||.++.. .....+.+..|+++|+.+ +|+||+.++|++..
T Consensus       294 ~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~  373 (609)
T KOG0200|consen  294 PRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ  373 (609)
T ss_pred             chhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc
Confidence            3444566679999999999999533    1    356899998654 335667899999999999 49999999998877


Q ss_pred             CCceeEEEEecccCCChhHhhccCC---CC-------C--CCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec
Q 017232          129 HSRELLLVYEFISNGTVADHLHGER---AK-------P--GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD  196 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~---~~-------~--~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~  196 (375)
                       +..+++|+||+..|+|.++++..+   .-       .  ..++..+.+.++.||+.|++||++.+++||||-..|||+.
T Consensus       374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~  452 (609)
T KOG0200|consen  374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLIT  452 (609)
T ss_pred             -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEec
Confidence             778999999999999999998776   00       1  2388899999999999999999999999999999999999


Q ss_pred             CCCcEEEeeeccccccCCCccccccCCC--CCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccc
Q 017232          197 NNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEIN  273 (375)
Q Consensus       197 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~  273 (375)
                      .+..+||+|||+++..............  -...|||||.+....++.++||||||++||||++ |..|+......    
T Consensus       453 ~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~----  528 (609)
T KOG0200|consen  453 KNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPT----  528 (609)
T ss_pred             CCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcH----
Confidence            9999999999999876554444322222  3456999999999999999999999999999998 77888642100    


Q ss_pred             hhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          274 LSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                                    .+++...-.+.....+..|..++.++++.||+.+|++||++.++.+.|+....
T Consensus       529 --------------~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  529 --------------EELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             --------------HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence                          01111111122233444567889999999999999999999999999999544

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=272.76  Aligned_cols=245  Identities=29%  Similarity=0.383  Sum_probs=195.1

Q ss_pred             CCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccC
Q 017232           66 ARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISN  142 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~  142 (375)
                      .+.||+|-||+||-|.. ++|+.||||++.+.  ..+...++++|+.+|+++.||.||.+.-.++. .+.+++|||-+.|
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET-~ervFVVMEKl~G  647 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFET-PERVFVVMEKLHG  647 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecC-CceEEEEehhhcc
Confidence            46899999999999954 58999999998654  23344789999999999999999998876666 6779999999964


Q ss_pred             CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC---CCcEEEeeeccccccCCCcccc
Q 017232          143 GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       143 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      .-|.-.+..   ..+.+++...+.++.||+.||.|||.+||+|+||||+|||+..   ...+||+|||+|+.++...-  
T Consensus       648 DMLEMILSs---EkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksF--  722 (888)
T KOG4236|consen  648 DMLEMILSS---EKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSF--  722 (888)
T ss_pred             hHHHHHHHh---hcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhhh--
Confidence            444444433   3467999999999999999999999999999999999999964   34699999999999876433  


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....+|||.|+|||++....|...-|+||+|+|+|--++|..||+....-.         ..+++..   ++      -+
T Consensus       723 RrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn---------dQIQNAa---FM------yP  784 (888)
T KOG4236|consen  723 RRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN---------DQIQNAA---FM------YP  784 (888)
T ss_pred             hhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchh---------HHhhccc---cc------cC
Confidence            345679999999999999999999999999999999999999998654211         1111111   00      11


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      +..-.+......+||...|+..-.+|.|.+.-+..
T Consensus       785 p~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  785 PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence            22234556778899999999999999998876543

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=264.26  Aligned_cols=241  Identities=27%  Similarity=0.397  Sum_probs=191.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .+|..+..||+|+||.|-+|..+ +.+.||||+++++..   +..+--+.|-.+|... +-|.+++++.+++. -+.+|.
T Consensus       349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQT-mDRLyF  427 (683)
T KOG0696|consen  349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQT-MDRLYF  427 (683)
T ss_pred             cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhh-hhheee
Confidence            46888999999999999999655 578899999876522   2233345566666665 46788888887766 567999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+.||+|.-.+..    -+.+.+..+..++..|+-||-+||++||+.||||.+|||++.+|++||+|||++..---.
T Consensus       428 VMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~  503 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFD  503 (683)
T ss_pred             EEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccC
Confidence            9999999999888843    356888899999999999999999999999999999999999999999999998742111


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                       .......+|||.|+|||++..++|+...|+||+|++||||+.|++||+..+...               -...+.+...
T Consensus       504 -~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e---------------lF~aI~ehnv  567 (683)
T KOG0696|consen  504 -GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE---------------LFQAIMEHNV  567 (683)
T ss_pred             -CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH---------------HHHHHHHccC
Confidence             112345689999999999999999999999999999999999999998765321               2223333333


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPY  327 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  327 (375)
                      .+     +..++.+...+....|...|.+|..
T Consensus       568 sy-----PKslSkEAv~ickg~ltK~P~kRLG  594 (683)
T KOG0696|consen  568 SY-----PKSLSKEAVAICKGLLTKHPGKRLG  594 (683)
T ss_pred             cC-----cccccHHHHHHHHHHhhcCCccccC
Confidence            22     2235677889999999999999954

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-35  Score=261.17  Aligned_cols=261  Identities=23%  Similarity=0.332  Sum_probs=195.1

Q ss_pred             cCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-----C---CCeEEEeeee---ec
Q 017232           61 NYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-----H---KNLVSLYGCT---SR  128 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h---~niv~~~~~~---~~  128 (375)
                      ++|.+.++||+|.|++||++ +.++.+.||+|+.+...-. .+....||.+|++++     |   .+||++++.|   ..
T Consensus        78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhY-tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp  156 (590)
T KOG1290|consen   78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHY-TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP  156 (590)
T ss_pred             ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHH-HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence            78999999999999999999 6778899999998655322 355678999999984     2   4799999965   34


Q ss_pred             CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecC----------
Q 017232          129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDN----------  197 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~----------  197 (375)
                      ++.++|+|+|++ |.+|..++.....  ..++...++.|++||+.||.|||.. ||+|.||||+|||+..          
T Consensus       157 NG~HVCMVfEvL-GdnLLklI~~s~Y--rGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~  233 (590)
T KOG1290|consen  157 NGQHVCMVFEVL-GDNLLKLIKYSNY--RGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAR  233 (590)
T ss_pred             CCcEEEEEehhh-hhHHHHHHHHhCC--CCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhh
Confidence            578999999999 7899999976644  4588999999999999999999986 9999999999999900          


Q ss_pred             --------------------------------------------------------------------------------
Q 017232          198 --------------------------------------------------------------------------------  197 (375)
Q Consensus       198 --------------------------------------------------------------------------------  197 (375)
                                                                                                      
T Consensus       234 ~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~  313 (590)
T KOG1290|consen  234 EAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNE  313 (590)
T ss_pred             hhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccccccccccCCCccc
Confidence                                                                                            


Q ss_pred             ----------------------------------------------------------------------------CCcE
Q 017232          198 ----------------------------------------------------------------------------NFCV  201 (375)
Q Consensus       198 ----------------------------------------------------------------------------~~~~  201 (375)
                                                                                                  +..+
T Consensus       314 ~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~v  393 (590)
T KOG1290|consen  314 STVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRV  393 (590)
T ss_pred             cchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCccccccccccCCCCCCCccceeE
Confidence                                                                                        0024


Q ss_pred             EEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccc----cc--hh
Q 017232          202 KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHE----IN--LS  275 (375)
Q Consensus       202 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~----~~--~~  275 (375)
                      ||+|||.|+.+...    ++....|..|+|||++.|..|++.+||||++|++|||.||...|+......-    ..  +.
T Consensus       394 KIaDlGNACW~~kh----FT~DIQTRQYRapEVllGsgY~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i  469 (590)
T KOG1290|consen  394 KIADLGNACWVHKH----FTEDIQTRQYRAPEVLLGSGYSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALI  469 (590)
T ss_pred             EEeeccchhhhhhh----hchhhhhhhccCcceeecCCCCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHH
Confidence            56666666544322    2233478899999999999999999999999999999999999976543321    11  11


Q ss_pred             HHHHHHhhhh---------------------------HHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017232          276 NLAINKIQNK---------------------------ALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYM  328 (375)
Q Consensus       276 ~~~~~~~~~~---------------------------~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  328 (375)
                      ....+.+...                           .+.+++.....+     ..+...++.+++.-||+.+|++|||+
T Consensus       470 ~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~-----s~e~A~~fsdFL~PmLef~PeKR~tA  544 (590)
T KOG1290|consen  470 MELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEW-----SEEDAQQFSDFLSPMLEFDPEKRPTA  544 (590)
T ss_pred             HHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCC-----CHHHHHHHHHHHHHHHhcCccccccH
Confidence            1111111110                           122222222211     13456789999999999999999999


Q ss_pred             HHHHHH
Q 017232          329 VDVLDA  334 (375)
Q Consensus       329 ~evl~~  334 (375)
                      .+.++.
T Consensus       545 ~~cl~h  550 (590)
T KOG1290|consen  545 AQCLKH  550 (590)
T ss_pred             HHHhcC
Confidence            999854

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=2.1e-35  Score=257.62  Aligned_cols=220  Identities=20%  Similarity=0.197  Sum_probs=173.3

Q ss_pred             CCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCChhHhhc
Q 017232           72 GGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLH  150 (375)
Q Consensus        72 G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  150 (375)
                      |.+|.||++.. .+++.||+|.+....     .+..|...+....|||++++++++.. ....++||||+++++|.+++.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVS-EDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheec-CCeEEEEEecCCCCCHHHHHH
Confidence            89999999955 478999999986543     22345555556679999999997765 578999999999999999985


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCCCCcccc
Q 017232          151 GERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV  230 (375)
Q Consensus       151 ~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~  230 (375)
                      ..    ..+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++++|||.+.......    ....++..|+
T Consensus        78 ~~----~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~y~  149 (237)
T cd05576          78 KF----LNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC----DGEAVENMYC  149 (237)
T ss_pred             Hh----cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc----ccCCcCcccc
Confidence            33    348999999999999999999999999999999999999999999999999876543321    2234567899


Q ss_pred             CcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHH
Q 017232          231 DPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAV  310 (375)
Q Consensus       231 aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  310 (375)
                      |||...+..++.++|+||+|+++|+|++|..|+........                     .......+   ...+..+
T Consensus       150 aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~---------------------~~~~~~~~---~~~~~~~  205 (237)
T cd05576         150 APEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN---------------------THTTLNIP---EWVSEEA  205 (237)
T ss_pred             CCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc---------------------cccccCCc---ccCCHHH
Confidence            99999888889999999999999999999988753211000                     00000000   1234568


Q ss_pred             HHHHHHhcCCCCCCCCCHH
Q 017232          311 AELAFQCLQSEKDLRPYMV  329 (375)
Q Consensus       311 ~~li~~cl~~~P~~Rpt~~  329 (375)
                      .+++.+||+.||++||++.
T Consensus       206 ~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         206 RSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             HHHHHHHccCCHHHhcCCC
Confidence            8999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=271.35  Aligned_cols=242  Identities=24%  Similarity=0.313  Sum_probs=196.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCC-EEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGR-AVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~-~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .+++.+..||-|+||.|=++..+... .+|+|++++.   +.+..+....|-.+|...+.|.||++|.-|.+ .+.+|+.
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd-~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRD-SKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhcc-chhhhhh
Confidence            45667788999999999999776443 4888888665   33445567789999999999999999995554 7889999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||-|-||.|...+.    ..+.++...+..++..+++|++|||++||+.|||||+|++++.+|-+||.|||+|+.+....
T Consensus       499 mEaClGGElWTiLr----dRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~  574 (732)
T KOG0614|consen  499 MEACLGGELWTILR----DRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR  574 (732)
T ss_pred             HHhhcCchhhhhhh----hcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC
Confidence            99999999999994    44668999999999999999999999999999999999999999999999999999887654


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      ..  ...+|||+|.|||++.+...+.++|.||||+++|||++|.|||...++-...   +            .++...- 
T Consensus       575 KT--wTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktY---n------------~ILkGid-  636 (732)
T KOG0614|consen  575 KT--WTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTY---N------------LILKGID-  636 (732)
T ss_pred             ce--eeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHH---H------------HHHhhhh-
Confidence            43  4567999999999999999999999999999999999999999876532111   0            0111000 


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPY  327 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  327 (375)
                        .-..+........+|+++.+..+|.+|..
T Consensus       637 --~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  637 --KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             --hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence              01111234567889999999999999965

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-35  Score=277.52  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=202.7

Q ss_pred             HHHHhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeee----cC
Q 017232           56 LEEATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTS----RH  129 (375)
Q Consensus        56 ~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~----~~  129 (375)
                      +...++.|++.+.||.|.+|.||+++. ++++..|+|+...... .-+.+..|+++++.+ .|||++.++|++.    ..
T Consensus        14 lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d-~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~   92 (953)
T KOG0587|consen   14 LPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED-EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGN   92 (953)
T ss_pred             CCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc-ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCC
Confidence            334456788999999999999999954 4688889998755432 235667788999888 5999999999653    23


Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      ++.+|||||||.+|+..+++....  +..+.|..+..|++.++.|+.+||.+.++|||||-.|||++.++.+||+|||++
T Consensus        93 ~DqLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS  170 (953)
T KOG0587|consen   93 GDQLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS  170 (953)
T ss_pred             CCeEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence            568999999999999999998765  778999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCccccccCCCCCccccCccccccc-----CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCY-----QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      ..+.... .......|||.|||||++...     .|+..+|+||||++..||--|.+|+...-+.      .......++
T Consensus       171 aQldsT~-grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPm------raLF~IpRN  243 (953)
T KOG0587|consen  171 AQLDSTV-GRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPM------RALFLIPRN  243 (953)
T ss_pred             eeeeccc-ccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchh------hhhccCCCC
Confidence            8775433 223455799999999988653     4677899999999999999999998643221      111111111


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..           .....+..-...+.++|..||..|-.+||++.++++
T Consensus       244 PP-----------PkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  244 PP-----------PKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             CC-----------ccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            10           001112334567999999999999999999998875

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.9e-34  Score=250.60  Aligned_cols=238  Identities=31%  Similarity=0.432  Sum_probs=189.9

Q ss_pred             CcEEEEEEEeC-CCCEEEEEEecccchhh-HHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCChhHhhc
Q 017232           73 GFGTVYYGELQ-DGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLH  150 (375)
Q Consensus        73 ~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  150 (375)
                      +||.||+|... +++.+++|++....... .+.+.+|+..++.++|+|++++++++.. ....++++||+.+++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-EDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-CCEEEEEEeCCCCCCHHHHHH
Confidence            58999999776 48999999987665444 6788999999999999999999997766 567899999999999999985


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCCCCcccc
Q 017232          151 GERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV  230 (375)
Q Consensus       151 ~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~  230 (375)
                      ...    .+++..++.++.+++.++.+||+.+++|+||+|+||+++.++.++|+|||.+.......  ......++..|+
T Consensus        80 ~~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~  153 (244)
T smart00220       80 KRG----RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYM  153 (244)
T ss_pred             hcc----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCC
Confidence            432    28899999999999999999999999999999999999999999999999998765432  223445788999


Q ss_pred             CcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHH
Q 017232          231 DPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAV  310 (375)
Q Consensus       231 aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l  310 (375)
                      +||...+..++.++||||||+++++|++|..||.......      .         ..+...... .........++..+
T Consensus       154 ~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~------~---------~~~~~~~~~-~~~~~~~~~~~~~~  217 (244)
T smart00220      154 APEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLL------E---------LFKKIGKPK-PPFPPPEWKISPEA  217 (244)
T ss_pred             CHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHH------H---------HHHHHhccC-CCCccccccCCHHH
Confidence            9999988888999999999999999999999997532110      0         000010000 00000000145678


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHH
Q 017232          311 AELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       311 ~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .+++.+|+..+|++||++.++++
T Consensus       218 ~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      218 KDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             HHHHHHHccCCchhccCHHHHhh
Confidence            99999999999999999999986

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.4e-34  Score=279.56  Aligned_cols=263  Identities=21%  Similarity=0.242  Sum_probs=168.2

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-C----CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeee----e-ec
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-D----GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC----T-SR  128 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~----~-~~  128 (375)
                      ..++|.+.+.||+|+||.||+|... +    +..||+|++.......  ....+  .+....+.++..+...    . ..
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e--~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE--IWMNE--RVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH--HHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence            4568999999999999999999765 4    6899999875432211  11111  1122222222222211    1 13


Q ss_pred             CCceeEEEEecccCCChhHhhccCCCC----------------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCC
Q 017232          129 HSRELLLVYEFISNGTVADHLHGERAK----------------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNN  192 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~~~----------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~N  192 (375)
                      .....++||||+.+++|.+++......                ........+..++.|++.||.|||++||+||||||+|
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N  285 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN  285 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence            356789999999999999988643210                0111234466899999999999999999999999999


Q ss_pred             EEecC-CCcEEEeeeccccccCCCccccccCCCCCccccCccccccc----------------------CCCCchhHHHH
Q 017232          193 ILLDN-NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY----------------------QLTDKSDVFSF  249 (375)
Q Consensus       193 ill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------------------~~~~~~Diwsl  249 (375)
                      ||++. ++.+||+|||++...............+++.|+|||.+...                      .++.++|||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            99985 57999999999986544333333455689999999965322                      23446799999


Q ss_pred             HHHHHHHHhCCCCccccccccccchhHHHHHHhhh--hHHHHHHhhhcCCCCChHHH-------HHHHHHHHHHHHhcCC
Q 017232          250 GVVLIELISSMPAVDITRHRHEINLSNLAINKIQN--KALHELVDQTLGYESDNKVR-------RTINAVAELAFQCLQS  320 (375)
Q Consensus       250 G~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~~~~~~-------~~~~~l~~li~~cl~~  320 (375)
                      ||++|||+++..+++...       ..+ ...+..  .....+... ......+...       .......+|+.+||+.
T Consensus       366 GviL~el~~~~~~~~~~~-------~~~-~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~  436 (566)
T PLN03225        366 GLIFLQMAFPNLRSDSNL-------IQF-NRQLKRNDYDLVAWRKL-VEPRASPDLRRGFEVLDLDGGAGWELLKSMMRF  436 (566)
T ss_pred             HHHHHHHHhCcCCCchHH-------HHH-HHHHHhcCCcHHHHHHh-hccccchhhhhhhhhccccchHHHHHHHHHccC
Confidence            999999998765543210       000 000000  000001000 0000000000       0112455899999999


Q ss_pred             CCCCCCCHHHHHHH
Q 017232          321 EKDLRPYMVDVLDA  334 (375)
Q Consensus       321 ~P~~Rpt~~evl~~  334 (375)
                      ||++|||+.++++.
T Consensus       437 dP~kR~ta~e~L~H  450 (566)
T PLN03225        437 KGRQRISAKAALAH  450 (566)
T ss_pred             CcccCCCHHHHhCC
Confidence            99999999999974

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-35  Score=261.65  Aligned_cols=254  Identities=24%  Similarity=0.367  Sum_probs=194.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEeccc-chhh------HHHHHHHHHHHHhcCCCCeEEEeeeeecCCc
Q 017232           60 TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYEN-NYKR------VEQFMNEVDILARLRHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~-~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  131 (375)
                      .++|-++.+||+|+|+.||+| +....+.||+|+-..+ ++..      .+...+|..+.+.|+||.||++|+++.-+..
T Consensus       462 n~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtd  541 (775)
T KOG1151|consen  462 NDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTD  541 (775)
T ss_pred             HHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccc
Confidence            356778899999999999999 5556788999975322 2221      3457789999999999999999998887788


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC--CceeccCCCCCEEec---CCCcEEEeee
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS--DIIHRDVKTNNILLD---NNFCVKVADF  206 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--~ivH~dlkp~Nill~---~~~~~kl~Df  206 (375)
                      .+|-|+|||+|.+|.-+|..    ...+++.++..|+.||+.||.||...  .|+|-||||.|||+-   .-|.+||+||
T Consensus       542 sFCTVLEYceGNDLDFYLKQ----hklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKITDF  617 (775)
T KOG1151|consen  542 SFCTVLEYCEGNDLDFYLKQ----HKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKITDF  617 (775)
T ss_pred             cceeeeeecCCCchhHHHHh----hhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEeeec
Confidence            89999999999999999854    35699999999999999999999987  599999999999994   4577999999


Q ss_pred             ccccccCCCccc------cccCCCCCccccCcccccc----cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhH
Q 017232          207 GLSRLFPNHVTH------VSTAPQGTPGYVDPEYHQC----YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN  276 (375)
Q Consensus       207 g~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~  276 (375)
                      |++.....+...      ...-..||.+|++||.+--    -.++.+.||||+|||+|..+.|+.||+......      
T Consensus       618 GLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQ------  691 (775)
T KOG1151|consen  618 GLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQ------  691 (775)
T ss_pred             chhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHH------
Confidence            999987644332      1223469999999996542    246779999999999999999999997543211      


Q ss_pred             HHHHHhhhhHHHHHHhh-hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 017232          277 LAINKIQNKALHELVDQ-TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL  332 (375)
Q Consensus       277 ~~~~~~~~~~~~~~~~~-~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl  332 (375)
                         ..+....   ++.. ...+...   +-...+...+|++||...-++|....++.
T Consensus       692 ---dILqeNT---IlkAtEVqFP~K---PvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  692 ---DILQENT---ILKATEVQFPPK---PVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             ---HHHhhhc---hhcceeccCCCC---CccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence               1111111   1111 1111111   12345788999999999999998877665

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-33  Score=267.00  Aligned_cols=266  Identities=22%  Similarity=0.273  Sum_probs=178.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-----------------CCCCEEEEEEecccchhhHHH--------------HHHHH
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-----------------QDGRAVAVKRLYENNYKRVEQ--------------FMNEV  108 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-----------------~~~~~vaiK~~~~~~~~~~~~--------------~~~e~  108 (375)
                      .++|++.++||+|+||.||+|..                 ..++.||||++........+.              ...|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            56899999999999999999953                 235679999986543322222              33466


Q ss_pred             HHHHhcCCCCe-----EEEeeeeec-------CCceeEEEEecccCCChhHhhccCCC--------------------CC
Q 017232          109 DILARLRHKNL-----VSLYGCTSR-------HSRELLLVYEFISNGTVADHLHGERA--------------------KP  156 (375)
Q Consensus       109 ~~l~~l~h~ni-----v~~~~~~~~-------~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~  156 (375)
                      .++.+++|.++     +++++++..       .....+|||||+++++|.++++....                    ..
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            67777766554     556665432       13467999999999999999864311                    11


Q ss_pred             CCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCCCCccccCccccc
Q 017232          157 GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ  236 (375)
Q Consensus       157 ~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  236 (375)
                      ..+++..++.++.|++.+|.|||+.+++||||||+|||++.++.+||+|||++...............+++.|+|||.+.
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~  383 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELV  383 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhc
Confidence            23467788999999999999999999999999999999999999999999998755432222222233578999999765


Q ss_pred             ccC----------------------CCCchhHHHHHHHHHHHHhCCC-CccccccccccchhHHHHHHhhhhHHHHHHh-
Q 017232          237 CYQ----------------------LTDKSDVFSFGVVLIELISSMP-AVDITRHRHEINLSNLAINKIQNKALHELVD-  292 (375)
Q Consensus       237 ~~~----------------------~~~~~DiwslG~il~elltg~~-p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  292 (375)
                      ...                      ...+.||||+||++++|++|.. ||........     . ... .+.....+.. 
T Consensus       384 ~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~-----~-~~~-~~~~~~~~r~~  456 (507)
T PLN03224        384 MPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT-----E-LRQ-YDNDLNRWRMY  456 (507)
T ss_pred             CCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh-----H-Hhh-ccchHHHHHhh
Confidence            321                      1124699999999999999874 6642211100     0 000 0000000000 


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCC---CCCCCHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEK---DLRPYMVDVLD  333 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P---~~Rpt~~evl~  333 (375)
                      ........ ..........+++.+||..+|   .+|+|+.|+++
T Consensus       457 ~~~~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 KGQKYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             cccCCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence            00011111 112345678899999999766   68999999985

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=250.78  Aligned_cols=248  Identities=27%  Similarity=0.365  Sum_probs=188.0

Q ss_pred             CCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHH-HhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           65 SARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-KRVEQFMNEVDIL-ARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      -+..||.|+||+|++..++ .|+..|||++...+. ...+++..|.+.. +.-++||||++||+... .+..|+.||.++
T Consensus        68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~-EGdcWiCMELMd  146 (361)
T KOG1006|consen   68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS-EGDCWICMELMD  146 (361)
T ss_pred             HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc-CCceeeeHHHHh
Confidence            3667999999999999555 799999999977654 5667888888764 44579999999997776 455789999995


Q ss_pred             CCChhHhhcc-CCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          142 NGTVADHLHG-ERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       142 ~~~L~~~l~~-~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                       .+|..+... ...+...+++.-.-.|....+.||+||... .|+|||+||+|||++..|.+||+|||.+-.+.....  
T Consensus       147 -~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiA--  223 (361)
T KOG1006|consen  147 -ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIA--  223 (361)
T ss_pred             -hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHHH--
Confidence             565544321 112345688888888888899999999976 899999999999999999999999999865543322  


Q ss_pred             ccCCCCCccccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          220 STAPQGTPGYVDPEYHQC--YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                      .+...|...|||||.+..  ..|+-++||||||++|+|+.||..|+.....                  ..+-+.....+
T Consensus       224 kT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s------------------vfeql~~Vv~g  285 (361)
T KOG1006|consen  224 KTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS------------------VFEQLCQVVIG  285 (361)
T ss_pred             hhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH------------------HHHHHHHHHcC
Confidence            233458889999998764  3488899999999999999999999864321                  01111111111


Q ss_pred             C-----CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          298 E-----SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       298 ~-----~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .     .+....+.+..+..++..||..|-+.||...++++.
T Consensus       286 dpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  286 DPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             CCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            1     112223456789999999999999999999988764

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-35  Score=248.75  Aligned_cols=249  Identities=22%  Similarity=0.352  Sum_probs=194.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  134 (375)
                      .++|.+++.||+|+|+.|-+++.+ +.+-||+|++++.   +.+.....+.|-.+..+. +||.+|.+..|+.. ...++
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqt-esrlf  327 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQT-ESRLF  327 (593)
T ss_pred             cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcc-cceEE
Confidence            467999999999999999999665 6788999998654   333445556677777666 69999999997776 67799


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      .|.||++||+|.-.+..    +..++++.+..+...|..||.|||++||+.||||.+|||++..|++||+|+|+++.--.
T Consensus       328 fvieyv~ggdlmfhmqr----qrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~  403 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG  403 (593)
T ss_pred             EEEEEecCcceeeehhh----hhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence            99999999999877743    34699999999999999999999999999999999999999999999999999874322


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccc-cchhHHHHHHhhhhHHHHHHhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHE-INLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      +. ...+..+|||.|.|||++.|..|....|+|+||++++||+.|+.||+..+-... .+-..+.        ..-+++.
T Consensus       404 ~g-d~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedyl--------fqvilek  474 (593)
T KOG0695|consen  404 PG-DTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYL--------FQVILEK  474 (593)
T ss_pred             CC-cccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHH--------HHHHhhh
Confidence            22 223567899999999999999999999999999999999999999987653221 1111111        1222223


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY  327 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  327 (375)
                      .++..     ..++-....+++..|+.||.+|..
T Consensus       475 qirip-----rslsvkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  475 QIRIP-----RSLSVKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             ccccc-----ceeehhhHHHHHHhhcCCcHHhcC
Confidence            23211     123345667899999999999854

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=231.28  Aligned_cols=208  Identities=28%  Similarity=0.432  Sum_probs=169.9

Q ss_pred             HHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCce
Q 017232           56 LEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        56 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  132 (375)
                      ++...+....+..||+|++|.|-+.++. +|...|+|.+... +.+..++..+|+++..+. .+|.+|.+||.+.. ...
T Consensus        41 ~eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~r-egd  119 (282)
T KOG0984|consen   41 FEVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFR-EGD  119 (282)
T ss_pred             cccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhc-ccc
Confidence            3344455556778999999999888554 7999999998654 344556778888876555 69999999997666 456


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      +++.||.+. .+|..+...-..+++.+++..+-+|+..++.||.|||++ .++|||+||+|||++.+|.+|+||||.+-.
T Consensus       120 vwIcME~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~  198 (282)
T KOG0984|consen  120 VWICMELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGY  198 (282)
T ss_pred             EEEeHHHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEccccccee
Confidence            899999994 788877766556788899999999999999999999998 899999999999999999999999999876


Q ss_pred             cCCCccccccCCCCCccccCcccccc----cCCCCchhHHHHHHHHHHHHhCCCCccccc
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQC----YQLTDKSDVFSFGVVLIELISSMPAVDITR  267 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~----~~~~~~~DiwslG~il~elltg~~p~~~~~  267 (375)
                      +.+....  +...|...|+|||.+..    ..|+-++||||||+++.||.+++.|++...
T Consensus       199 L~dSiAk--t~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~  256 (282)
T KOG0984|consen  199 LVDSIAK--TMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWG  256 (282)
T ss_pred             ehhhhHH--HHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccC
Confidence            6543322  22347889999998654    368899999999999999999999997544

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.7e-36  Score=247.25  Aligned_cols=269  Identities=22%  Similarity=0.349  Sum_probs=199.8

Q ss_pred             CCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----ceeE
Q 017232           62 YFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----RELL  134 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~~  134 (375)
                      +.+..+.||.|+||+||.+.. ++|+.|++|++..-  +....+.+.+|+.+|..++|.|++..+++.....    ..+|
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY  133 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY  133 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence            345678899999999999854 47999999987432  3344567889999999999999999888554322    2467


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +++|.+. .+|...+    .....++.+.++-+++||++||+|||+.||.||||||.|+|++.+..+||+|||+++....
T Consensus       134 V~TELmQ-SDLHKII----VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  134 VLTELMQ-SDLHKII----VSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHH-hhhhhee----ccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccch
Confidence            8888884 6777766    4667899999999999999999999999999999999999999999999999999987665


Q ss_pred             CccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh--------hh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ--------NK  285 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~--------~~  285 (375)
                      ......+..+.|..|+|||++.| ..|+.+.||||+|||+.||+..+-.|....+.....+.....+...        ++
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            55544555567889999998876 5699999999999999999999999987665554433322222111        11


Q ss_pred             HHHHHHhhhcCCCCChHH------HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017232          286 ALHELVDQTLGYESDNKV------RRTINAVAELAFQCLQSEKDLRPYMVDVLDAL  335 (375)
Q Consensus       286 ~~~~~~~~~l~~~~~~~~------~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L  335 (375)
                      ....++....+....+..      .....+...++.+++..||+.|.+..+.+..+
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            111122111110000000      11223567888999999999999998887654

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2e-34  Score=271.36  Aligned_cols=246  Identities=27%  Similarity=0.401  Sum_probs=185.0

Q ss_pred             CCCCCccCCCCcEE-EEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEEecc
Q 017232           63 FDSARELGDGGFGT-VYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        63 y~~~~~lg~G~~g~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      |.-.+.+|.|+.|+ ||+|... |+.||||++-...   ..-..+|+..|+.- +|||||++++ .+.++...||..|.|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~e~---~~~A~rEi~lL~eSD~H~NviRyyc-~E~d~qF~YIalELC  585 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLEEF---FDFAQREIQLLQESDEHPNVIRYYC-SEQDRQFLYIALELC  585 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeC-CceehHHHHhhHh---HHHHHHHHHHHHhccCCCceEEEEe-eccCCceEEEEehHh
Confidence            44456789999988 6999886 7899999885443   23457899999988 4999999998 566688999999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC---C--CcEEEeeeccccccCCC
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN---N--FCVKVADFGLSRLFPNH  215 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~---~--~~~kl~Dfg~~~~~~~~  215 (375)
                      . .+|.+++...............+.++.|++.||++||+.+||||||||.||||..   +  ..++|+|||+++.+...
T Consensus       586 ~-~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~  664 (903)
T KOG1027|consen  586 A-CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGG  664 (903)
T ss_pred             h-hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCC
Confidence            4 8999999763111111222456788999999999999999999999999999975   2  46899999999987654


Q ss_pred             ccc--cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhC-CCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          216 VTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS-MPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       216 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ...  ......||.+|+|||++....-+.++||||+||++|+.++| .+||+..-..+.        ..+....  .  -
T Consensus       665 ~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--------NIl~~~~--~--L  732 (903)
T KOG1027|consen  665 KSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--------NILTGNY--T--L  732 (903)
T ss_pred             cchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--------hhhcCcc--c--e
Confidence            322  23445699999999999988888899999999999999985 899985432110        0000000  0  0


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..+.  ..   .++  +..+||.+|+.++|..||++.+|+.
T Consensus       733 ~~L~--~~---~d~--eA~dLI~~ml~~dP~~RPsa~~VL~  766 (903)
T KOG1027|consen  733 VHLE--PL---PDC--EAKDLISRMLNPDPQLRPSATDVLN  766 (903)
T ss_pred             eeec--cC---chH--HHHHHHHHhcCCCcccCCCHHHHhC
Confidence            0011  01   111  6889999999999999999999974

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-33  Score=257.70  Aligned_cols=203  Identities=28%  Similarity=0.398  Sum_probs=169.7

Q ss_pred             CCCCCccCCCCcEEEEEEE-eCCCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           63 FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~-~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      |..++.||-|+||.|.+++ ..+...||+|.+.+.+.   ........|-+||...+.+-||++|-.|.+ .+.+|+||+
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQD-kdnLYFVMd  709 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQD-KDNLYFVMD  709 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEecc-CCceEEEEe
Confidence            6667889999999999994 44577899998876533   233456678999999999999999986666 778999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC--Cc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HV  216 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~--~~  216 (375)
                      |++||++-.+|...    +-+.+..+..++.++..|+++.|..|+|||||||+|||||.+|++||+|||++.-+..  +.
T Consensus       710 YIPGGDmMSLLIrm----gIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  710 YIPGGDMMSLLIRM----GIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             ccCCccHHHHHHHh----ccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            99999999999644    5588999999999999999999999999999999999999999999999999864420  00


Q ss_pred             ------c---------------------------------ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHH
Q 017232          217 ------T---------------------------------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI  257 (375)
Q Consensus       217 ------~---------------------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ell  257 (375)
                            .                                 ......+||+.|+|||++....++.-+|+||.|||||||+
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~  865 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEML  865 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHh
Confidence                  0                                 0001224999999999999999999999999999999999


Q ss_pred             hCCCCcccccccc
Q 017232          258 SSMPAVDITRHRH  270 (375)
Q Consensus       258 tg~~p~~~~~~~~  270 (375)
                      .|++||-...+..
T Consensus       866 ~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  866 VGQPPFLADTPGE  878 (1034)
T ss_pred             hCCCCccCCCCCc
Confidence            9999997666544

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3.4e-34  Score=256.69  Aligned_cols=276  Identities=21%  Similarity=0.229  Sum_probs=208.8

Q ss_pred             cchHHHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcC------CCCeEEEe
Q 017232           51 FSYGELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLR------HKNLVSLY  123 (375)
Q Consensus        51 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~------h~niv~~~  123 (375)
                      |.+.-.+..-++|.+....|+|-|++|.+|... .|..||||++..+.. -.+.=..|+++|++|+      .-|+++++
T Consensus       422 Yrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~-M~KtGl~EleiLkKL~~AD~Edk~Hclrl~  500 (752)
T KOG0670|consen  422 YRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV-MHKTGLKELEILKKLNDADPEDKFHCLRLF  500 (752)
T ss_pred             EEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH-HhhhhhHHHHHHHHhhccCchhhhHHHHHH
Confidence            444445566789999999999999999999544 578999999865533 2344568999999996      34788888


Q ss_pred             eeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC-CcEE
Q 017232          124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN-FCVK  202 (375)
Q Consensus       124 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~-~~~k  202 (375)
                      ..|.. .+++|||+|-+ ..+|.+.|.... .+-.+....+..++.|++.||..|...||+|.||||+|||+++. ..+|
T Consensus       501 r~F~h-knHLClVFE~L-slNLRevLKKyG-~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLK  577 (752)
T KOG0670|consen  501 RHFKH-KNHLCLVFEPL-SLNLREVLKKYG-RNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILK  577 (752)
T ss_pred             HHhhh-cceeEEEehhh-hchHHHHHHHhC-cccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceee
Confidence            76655 78999999998 589999997664 44567888999999999999999999999999999999999865 5689


Q ss_pred             EeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHh
Q 017232          203 VADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKI  282 (375)
Q Consensus       203 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  282 (375)
                      |||||.|.......   .+....+..|.|||++.|.+|+...|+||+||+||||.||+..|........+.+..-+.+.+
T Consensus       578 LCDfGSA~~~~ene---itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~  654 (752)
T KOG0670|consen  578 LCDFGSASFASENE---ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKF  654 (752)
T ss_pred             eccCcccccccccc---ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCC
Confidence            99999998654432   223335668999999999999999999999999999999999998766544333222222222


Q ss_pred             hhhHH--HHHHhh------------------------------------hcC--CCCChHHHHHHHHHHHHHHHhcCCCC
Q 017232          283 QNKAL--HELVDQ------------------------------------TLG--YESDNKVRRTINAVAELAFQCLQSEK  322 (375)
Q Consensus       283 ~~~~~--~~~~~~------------------------------------~l~--~~~~~~~~~~~~~l~~li~~cl~~~P  322 (375)
                      ....+  ..+.++                                    .+.  ...+.........+.+|+.+||..||
T Consensus       655 p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP  734 (752)
T KOG0670|consen  655 PNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDP  734 (752)
T ss_pred             cHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccCh
Confidence            21110  000010                                    111  11233445566789999999999999


Q ss_pred             CCCCCHHHHHH
Q 017232          323 DLRPYMVDVLD  333 (375)
Q Consensus       323 ~~Rpt~~evl~  333 (375)
                      ++|.|..+.|.
T Consensus       735 ~KRit~nqAL~  745 (752)
T KOG0670|consen  735 EKRITVNQALK  745 (752)
T ss_pred             hhcCCHHHHhc
Confidence            99999998875

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-33  Score=241.66  Aligned_cols=267  Identities=21%  Similarity=0.255  Sum_probs=209.4

Q ss_pred             HHHHHHhcCCCCCCccCCCCcEEEEEEEeCC------CCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeee
Q 017232           54 GELEEATNYFDSARELGDGGFGTVYYGELQD------GRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCT  126 (375)
Q Consensus        54 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~  126 (375)
                      .++.....+++....+-+|.||.||+|.+.+      .+.|.+|.++.. ..-....+..|...+..+.|||+.++.+++
T Consensus       277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~  356 (563)
T KOG1024|consen  277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS  356 (563)
T ss_pred             HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence            3444556778889999999999999995543      345666766544 233455678899999999999999999987


Q ss_pred             ecCCceeEEEEecccCCChhHhhccCC----CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEE
Q 017232          127 SRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVK  202 (375)
Q Consensus       127 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~k  202 (375)
                      .++....++++.+..-|+|..++...+    .....++..+...++.|++.|++|||++|++|.||...|.+|++...+|
T Consensus       357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVk  436 (563)
T KOG1024|consen  357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVK  436 (563)
T ss_pred             eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEE
Confidence            777788899999999999999997332    2235677788889999999999999999999999999999999999999


Q ss_pred             EeeeccccccCCCcccccc-CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHH
Q 017232          203 VADFGLSRLFPNHVTHVST-APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       203 l~Dfg~~~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      |+|=.+++.+-....+... .......||+||.+....|+.++|+||||++||||+| |+.|+...++.+          
T Consensus       437 ltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE----------  506 (563)
T KOG1024|consen  437 LTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE----------  506 (563)
T ss_pred             eccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH----------
Confidence            9999998865333322222 2234568999999999999999999999999999998 888876444211          


Q ss_pred             HhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          281 KIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                            ....+   .++-.-..+.+|++++..++..||...|++||+++++..-|.+.-
T Consensus       507 ------m~~yl---kdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~  556 (563)
T KOG1024|consen  507 ------MEHYL---KDGYRLAQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH  556 (563)
T ss_pred             ------HHHHH---hccceecCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence                  11111   122223344578899999999999999999999999999888753

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.4e-33  Score=227.33  Aligned_cols=262  Identities=17%  Similarity=0.268  Sum_probs=191.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CCCeEEEeeeee-cCCceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCTS-RHSRELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~-~~~~~~~lv  136 (375)
                      .++|++.+++|+|.|+.||.| ...++++++||+++.-.   .+.+.+|+.+|..|. ||||+++++... .......|+
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVk---kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLi  113 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVK---KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLI  113 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHH---HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhH
Confidence            467999999999999999999 45578899999985432   356789999999997 999999999543 334567899


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC-CcEEEeeeccccccCCC
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN-FCVKVADFGLSRLFPNH  215 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~~~  215 (375)
                      +||+++.+...+.       .+++...+..++.+++.||.|+|+.||.|||+||.|++|+.. -.++|+|+|+|..+...
T Consensus       114 FE~v~n~Dfk~ly-------~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~  186 (338)
T KOG0668|consen  114 FEYVNNTDFKQLY-------PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPG  186 (338)
T ss_pred             hhhhccccHHHHh-------hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCC
Confidence            9999888777665       347788899999999999999999999999999999999854 56999999999987544


Q ss_pred             ccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCcc-ccccccccchhHHHH------HHh-----
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVD-ITRHRHEINLSNLAI------NKI-----  282 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~-~~~~~~~~~~~~~~~------~~~-----  282 (375)
                      ...  ...+.+..|.-||.+-. ..|+..-|+|||||++..|+..+.||- ..+..++.-....+.      ..+     
T Consensus       187 ~eY--nVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i  264 (338)
T KOG0668|consen  187 KEY--NVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQI  264 (338)
T ss_pred             cee--eeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHcc
Confidence            332  23346667889997654 568889999999999999999888873 222222211000000      000     


Q ss_pred             -hhhHHHHHHhhhcCCCCCh-----HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          283 -QNKALHELVDQTLGYESDN-----KVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       283 -~~~~~~~~~~~~l~~~~~~-----~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       .+....+++....+.....     ...-..+++.+++.+.|..|-.+|+|+.|.+.
T Consensus       265 ~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  265 DLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             CCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence             1122223332222111100     00112367889999999999999999999875

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.98  E-value=8e-31  Score=223.54  Aligned_cols=210  Identities=39%  Similarity=0.659  Sum_probs=180.2

Q ss_pred             cCCCCcEEEEEEEeCC-CCEEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCChh
Q 017232           69 LGDGGFGTVYYGELQD-GRAVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVA  146 (375)
Q Consensus        69 lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~  146 (375)
                      ||.|.+|.||++...+ ++.+++|++...... ..+.+.+|+..++.++|++++++++++.. ....++++|++.+++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-ENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-CCeEEEEEecCCCCcHH
Confidence            6899999999997764 899999998766543 34678899999999999999999997766 46789999999999999


Q ss_pred             HhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC-CCcEEEeeeccccccCCCccccccCCCC
Q 017232          147 DHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-NFCVKVADFGLSRLFPNHVTHVSTAPQG  225 (375)
Q Consensus       147 ~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  225 (375)
                      +++....   ..+++..++.++.+++.++.+||+.|++|+||+|.||+++. ++.++|+|||.+........ ......+
T Consensus        80 ~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~  155 (215)
T cd00180          80 DLLKENE---GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIVG  155 (215)
T ss_pred             HHHHhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhcccC
Confidence            9985432   35889999999999999999999999999999999999999 89999999999876544321 1223457


Q ss_pred             CccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHH
Q 017232          226 TPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVR  304 (375)
Q Consensus       226 ~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  304 (375)
                      ...|++||..... ..+.++|+|++|+++++|                                                
T Consensus       156 ~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l------------------------------------------------  187 (215)
T cd00180         156 TPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL------------------------------------------------  187 (215)
T ss_pred             CCCccChhHhcccCCCCchhhhHHHHHHHHHH------------------------------------------------
Confidence            8899999998876 788899999999999999                                                


Q ss_pred             HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          305 RTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       305 ~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                         ..+.+++..|++.+|++||++.++++.
T Consensus       188 ---~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 ---PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             ---HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence               247789999999999999999999864

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-32  Score=233.62  Aligned_cols=264  Identities=23%  Similarity=0.325  Sum_probs=193.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-----c
Q 017232           60 TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-----R  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~  131 (375)
                      ..+|.-+..+|.|.- .|.-| +.-.+++||+|++...  +....+...+|..++..++|+|+++++.++....     .
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            346777888999998 55555 4446899999988544  3444567789999999999999999999765432     3


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ..|+|||++. .+|...+.-      .++-..+.+++.|++.|++|||+.||+||||||+||++..+..+||.|||+++.
T Consensus        95 e~y~v~e~m~-~nl~~vi~~------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~  167 (369)
T KOG0665|consen   95 EVYLVMELMD-ANLCQVILM------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLART  167 (369)
T ss_pred             hHHHHHHhhh-hHHHHHHHH------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhcc
Confidence            5799999995 788888752      256677899999999999999999999999999999999999999999999986


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHH------------
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAI------------  279 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~------------  279 (375)
                      -...  ...+..+.|..|+|||++-+..+.+.+||||+||++.||++|...|.+...-++........            
T Consensus       168 e~~~--~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~  245 (369)
T KOG0665|consen  168 EDTD--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQ  245 (369)
T ss_pred             cCcc--cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhh
Confidence            4332  34566678999999999998889999999999999999999999997544322211111000            


Q ss_pred             ----HHhhhh------HHHHHHhhhc-CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          280 ----NKIQNK------ALHELVDQTL-GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       280 ----~~~~~~------~~~~~~~~~l-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                          ......      ...+.+...+ ....... ..-...+++++.+||-.+|++|.++++++..
T Consensus       246 ~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~-~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  246 PTVRNYVENRPQYQAISFSELFPDSLFPVVLEGS-KLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHHhhcChHhhccchhhhCCcccccccccCC-ccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                000000      0000110000 0000000 1123468899999999999999999999864

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=4.1e-32  Score=225.34  Aligned_cols=256  Identities=18%  Similarity=0.296  Sum_probs=189.2

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..+.|.+.+.||+|.||.+-+++++ +.+.+++|.+... .....+|.+|...--.| .|.||+..|+...+..+.++.+
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~  100 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFV  100 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEe
Confidence            3456899999999999999999776 5778899977544 34567888998766556 4899999998544446788899


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec--CCCcEEEeeeccccccCC
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD--NNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||++.|+|..-+..     ..+.+...+.++.|+++||.|+|++++||||||.+||||.  +...+||+|||..+..+.
T Consensus       101 qE~aP~gdL~snv~~-----~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~  175 (378)
T KOG1345|consen  101 QEFAPRGDLRSNVEA-----AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT  175 (378)
T ss_pred             eccCccchhhhhcCc-----ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc
Confidence            999999999988843     4588899999999999999999999999999999999994  445799999999876543


Q ss_pred             CccccccCCCCCccccCcccccc-----cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                      -..    ....+..|.+||....     ....+.+|+|.||+++|.++||.+|++...-.+.   ..|....+..+..  
T Consensus       176 tV~----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~---~Y~~~~~w~~rk~--  246 (378)
T KOG1345|consen  176 TVK----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK---PYWEWEQWLKRKN--  246 (378)
T ss_pred             eeh----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc---hHHHHHHHhcccC--
Confidence            221    2235667999996543     2356789999999999999999999984332221   1222211111111  


Q ss_pred             HHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          290 LVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       290 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                             ...+.....+++.+.++.++-|.++|++|--..++.++-.
T Consensus       247 -------~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk  286 (378)
T KOG1345|consen  247 -------PALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRK  286 (378)
T ss_pred             -------ccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHH
Confidence                   1112222334567888999999999999966665555433

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=9.2e-32  Score=243.95  Aligned_cols=195  Identities=22%  Similarity=0.364  Sum_probs=163.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--------hhHHHHHHHHHHHHhcC---CCCeEEEeeeeec
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--------KRVEQFMNEVDILARLR---HKNLVSLYGCTSR  128 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~  128 (375)
                      ..|..++.+|.|+||.|++|.++ +...|+||.+++...        ..+-..-.|+.||..++   |+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            45899999999999999999666 466789998865421        11223557999999997   9999999998777


Q ss_pred             CCceeEEEEeccc-CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeec
Q 017232          129 HSRELLLVYEFIS-NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFG  207 (375)
Q Consensus       129 ~~~~~~lv~e~~~-~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg  207 (375)
                       ++.+||+||.-. +-+|.+++.    ....+++.++..|+.|++.|+++||+.||||||||-+||.++.+|-+||+|||
T Consensus       641 -dd~yyl~te~hg~gIDLFd~IE----~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfg  715 (772)
T KOG1152|consen  641 -DDYYYLETEVHGEGIDLFDFIE----FKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFG  715 (772)
T ss_pred             -CCeeEEEecCCCCCcchhhhhh----ccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeecc
Confidence             678999999763 457888884    34569999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccCCCCCccccCcccccccCCCC-chhHHHHHHHHHHHHhCCCCc
Q 017232          208 LSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD-KSDVFSFGVVLIELISSMPAV  263 (375)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~p~  263 (375)
                      .+....+..   ....+||..|.|||++.|..|-- .-|||++|++||.++....||
T Consensus       716 saa~~ksgp---fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpy  769 (772)
T KOG1152|consen  716 SAAYTKSGP---FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPY  769 (772)
T ss_pred             chhhhcCCC---cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCC
Confidence            998665433   23456999999999999987754 579999999999999887776

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=4.7e-30  Score=221.52  Aligned_cols=199  Identities=34%  Similarity=0.546  Sum_probs=170.4

Q ss_pred             CCCCCccCCCCcEEEEEEEeCC-CCEEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           63 FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      |.+.+.||.|++|.||++...+ ++.+++|.+...... ..+.+.+|+..++.++|+|++++++++.. ....++++|++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-PEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-CCceEEEEecc
Confidence            5667889999999999997764 889999999776554 56788999999999999999999997665 56789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      ++++|.+++.....   .+++...+.++.+++.++.+||+.+++|+||+|.||+++.++.++|+|||.+...........
T Consensus        80 ~~~~L~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~  156 (225)
T smart00221       80 EGGDLFDYLRKKGG---KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALL  156 (225)
T ss_pred             CCCCHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccc
Confidence            99999999864321   178899999999999999999999999999999999999999999999999887654431122


Q ss_pred             cCCCCCccccCcccc-cccCCCCchhHHHHHHHHHHHHhCCCCccc
Q 017232          221 TAPQGTPGYVDPEYH-QCYQLTDKSDVFSFGVVLIELISSMPAVDI  265 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~p~~~  265 (375)
                      ....++..|++||.+ ....++.++|+|+||+++++|++|+.||..
T Consensus       157 ~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      157 KTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             cceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            334577889999988 667788899999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=5.6e-32  Score=249.02  Aligned_cols=251  Identities=25%  Similarity=0.371  Sum_probs=198.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .++|.....+|.|.||.||+|+. .+++..|+|+++.......+-+++|+-+++..+||||+.++|.+.. ...++++||
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr-~dklwicME   92 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLR-RDKLWICME   92 (829)
T ss_pred             ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhh-hcCcEEEEE
Confidence            45688899999999999999954 4799999999988777777788899999999999999999997776 556899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      ||.+|+|.+..+    -.+++++.++..+++..+.||+|||+.|-+|||||-.||++++.|.+|+.|||.+-.++.... 
T Consensus        93 ycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~-  167 (829)
T KOG0576|consen   93 YCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-  167 (829)
T ss_pred             ecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhh-
Confidence            999999999874    346799999999999999999999999999999999999999999999999999876654322 


Q ss_pred             cccCCCCCccccCcccc---cccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          219 VSTAPQGTPGYVDPEYH---QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      ......||+.|||||+-   ..+.|...+|||++|+...|+---++|....-+-      +.           -++....
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm------r~-----------l~LmTkS  230 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM------RA-----------LFLMTKS  230 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchH------HH-----------HHHhhcc
Confidence            23456799999999953   4567899999999999999998776664321100      00           0011111


Q ss_pred             CCCCC--hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          296 GYESD--NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       296 ~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .+...  .....-.+.+.++++.|+-.+|++|||++.++.
T Consensus       231 ~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  231 GFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             CCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            11110  111123456889999999999999999987754

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=8.5e-30  Score=223.90  Aligned_cols=200  Identities=27%  Similarity=0.429  Sum_probs=161.4

Q ss_pred             HHHHhcCCCCCCccCCCCcEEEEEEEeC----CCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCC
Q 017232           56 LEEATNYFDSARELGDGGFGTVYYGELQ----DGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHS  130 (375)
Q Consensus        56 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  130 (375)
                      +....+.|..+++||.|.|++||+|...    .++.||+|.+......  ..+.+|+++|..+. +.||+++.+++.. .
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p--~ri~~El~~L~~~gG~~ni~~~~~~~rn-n  107 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP--SRILNELEMLYRLGGSDNIIKLNGCFRN-N  107 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc--hHHHHHHHHHHHhccchhhhcchhhhcc-C
Confidence            3445677999999999999999999443    4678999988655332  45788999999995 8999999996555 7


Q ss_pred             ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC-CCcEEEeeeccc
Q 017232          131 RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-NFCVKVADFGLS  209 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~  209 (375)
                      +.+++|+||+++....++..       .++..++..+++.++.||.++|..|||||||||+|+|.+. .+.-.|+|||++
T Consensus       108 d~v~ivlp~~~H~~f~~l~~-------~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA  180 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLYR-------SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA  180 (418)
T ss_pred             CeeEEEecccCccCHHHHHh-------cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence            78999999999999998883       2678899999999999999999999999999999999974 567899999998


Q ss_pred             cccCCCc-------------c------------------------------ccccCCCCCccccCcccccc-cCCCCchh
Q 017232          210 RLFPNHV-------------T------------------------------HVSTAPQGTPGYVDPEYHQC-YQLTDKSD  245 (375)
Q Consensus       210 ~~~~~~~-------------~------------------------------~~~~~~~~~~~y~aPE~~~~-~~~~~~~D  245 (375)
                      .......             .                              .......||++|+|||++.. ...+++.|
T Consensus       181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD  260 (418)
T KOG1167|consen  181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID  260 (418)
T ss_pred             HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence            6221000             0                              00011239999999998765 45688999


Q ss_pred             HHHHHHHHHHHHhCCCCccc
Q 017232          246 VFSFGVVLIELISSMPAVDI  265 (375)
Q Consensus       246 iwslG~il~elltg~~p~~~  265 (375)
                      |||.|+|++.+++++.||-.
T Consensus       261 iws~GVI~Lslls~~~PFf~  280 (418)
T KOG1167|consen  261 IWSAGVILLSLLSRRYPFFK  280 (418)
T ss_pred             eeeccceeehhhcccccccc
Confidence            99999999999999999843

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=5.9e-29  Score=251.92  Aligned_cols=192  Identities=16%  Similarity=0.210  Sum_probs=133.1

Q ss_pred             CCeEEEeeeee------cCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCC
Q 017232          117 KNLVSLYGCTS------RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKT  190 (375)
Q Consensus       117 ~niv~~~~~~~------~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp  190 (375)
                      +||..+++.+.      .....+++++|++ +++|.+++...   ...+++.+++.++.||+.||+|||++||+||||||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP  108 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP---DRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRP  108 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc---cccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCc
Confidence            45665665431      1124577889987 67999999532   34589999999999999999999999999999999


Q ss_pred             CCEEecCCCc-------------------EEEeeeccccccCCCc---------------cccccCCCCCccccCccccc
Q 017232          191 NNILLDNNFC-------------------VKVADFGLSRLFPNHV---------------THVSTAPQGTPGYVDPEYHQ  236 (375)
Q Consensus       191 ~Nill~~~~~-------------------~kl~Dfg~~~~~~~~~---------------~~~~~~~~~~~~y~aPE~~~  236 (375)
                      +||||+..+.                   +|++|||+++......               ........+|+.|+|||++.
T Consensus       109 ~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~  188 (793)
T PLN00181        109 SCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDN  188 (793)
T ss_pred             hhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhc
Confidence            9999965444                   4555555554221000               00001134788899999999


Q ss_pred             ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHH
Q 017232          237 CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQ  316 (375)
Q Consensus       237 ~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~  316 (375)
                      +..++.++|||||||+||||++|.+|+.....         ....+.        ...+    ++...........++.+
T Consensus       189 ~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~---------~~~~~~--------~~~~----~~~~~~~~~~~~~~~~~  247 (793)
T PLN00181        189 GSSSNCASDVYRLGVLLFELFCPVSSREEKSR---------TMSSLR--------HRVL----PPQILLNWPKEASFCLW  247 (793)
T ss_pred             cCCCCchhhhhhHHHHHHHHhhCCCchhhHHH---------HHHHHH--------Hhhc----ChhhhhcCHHHHHHHHH
Confidence            99999999999999999999999888653210         000000        0000    01111112345678899


Q ss_pred             hcCCCCCCCCCHHHHHH
Q 017232          317 CLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       317 cl~~~P~~Rpt~~evl~  333 (375)
                      ||+.+|.+||++.|+++
T Consensus       248 ~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        248 LLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             hCCCChhhCcChHHHhh
Confidence            99999999999999976

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=1.2e-27  Score=198.86  Aligned_cols=167  Identities=20%  Similarity=0.215  Sum_probs=127.0

Q ss_pred             CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccC
Q 017232          143 GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA  222 (375)
Q Consensus       143 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~  222 (375)
                      |+|.+++...   +..+++.+++.++.|++.||.|||+.+      ||+|||++.++.+++  ||++.......      
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc------
Confidence            6888888532   346999999999999999999999998      999999999999999  99987654321      


Q ss_pred             CCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC--C
Q 017232          223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES--D  300 (375)
Q Consensus       223 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~--~  300 (375)
                      ..+++.|+|||++.+..++.++|||||||++|||++|+.||.......     ...         ..+.........  .
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~-----~~~---------~~~~~~~~~~~~~~~  129 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELS-----AIL---------EILLNGMPADDPRDR  129 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhc-----HHH---------HHHHHHhccCCcccc
Confidence            258899999999999999999999999999999999999996432111     000         111111110000  0


Q ss_pred             hHHHHHHH--HHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          301 NKVRRTIN--AVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       301 ~~~~~~~~--~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      ........  .+.+++.+||..+|++||++.++++.+..+..
T Consensus       130 ~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      130 SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            11122233  68999999999999999999999999887654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=2.4e-26  Score=208.42  Aligned_cols=167  Identities=20%  Similarity=0.126  Sum_probs=128.3

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEEeC--CCCEEEEEEeccc-----chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGELQ--DGRAVAVKRLYEN-----NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH  129 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  129 (375)
                      ....++|.+.+.||+|+||+||+|..+  +++.||||++...     .......+.+|+++|+.++|+|+++.+..+   
T Consensus        14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---   90 (365)
T PRK09188         14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---   90 (365)
T ss_pred             ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---
Confidence            345678999999999999999999654  5777899986532     122345689999999999999998533212   


Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccC-CCCCEEecCCCcEEEeeecc
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDV-KTNNILLDNNFCVKVADFGL  208 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dl-kp~Nill~~~~~~kl~Dfg~  208 (375)
                       ...++||||++|++|.. +.    .   ..   ...++.+++.||.|||+.||+|||| ||+|||++.++.++|+|||+
T Consensus        91 -~~~~LVmE~~~G~~L~~-~~----~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl  158 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHL-AR----P---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL  158 (365)
T ss_pred             -CCcEEEEEccCCCCHHH-hC----c---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence             34799999999999963 21    1   01   1467889999999999999999999 99999999999999999999


Q ss_pred             ccccCCCccccc-------cCCCCCccccCccccccc
Q 017232          209 SRLFPNHVTHVS-------TAPQGTPGYVDPEYHQCY  238 (375)
Q Consensus       209 ~~~~~~~~~~~~-------~~~~~~~~y~aPE~~~~~  238 (375)
                      +..+........       ....+++.|+|||.+...
T Consensus       159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            987654321111       234577889999987643

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-25  Score=202.41  Aligned_cols=263  Identities=20%  Similarity=0.277  Sum_probs=193.2

Q ss_pred             CCCCCCccCCCCcEEEEEEEeCCC--CEEEEEEecccchhhHHHHHHHHHHHHhcCC----CCeEEEeeeeecCCceeEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQDG--RAVAVKRLYENNYKRVEQFMNEVDILARLRH----KNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~~~--~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h----~niv~~~~~~~~~~~~~~l  135 (375)
                      +|++.++||+|+||.||.+.....  ..+|+|.-..........+..|..++..+..    +++..+++.........++
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            799999999999999999976543  4788887755432222256778888888863    5788888755334667899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC-----CcEEEeeecccc
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN-----FCVKVADFGLSR  210 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~-----~~~kl~Dfg~~~  210 (375)
                      ||+.+ |.+|.++.....  .+.++...+..++.|++.+|++||+.|++||||||.|+++...     ..+.|.|||+++
T Consensus        99 VM~l~-G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar  175 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLAR  175 (322)
T ss_pred             EEecc-CccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCc
Confidence            99998 789999875443  5679999999999999999999999999999999999999765     469999999998


Q ss_pred             --ccCCCc----ccc---ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHH
Q 017232          211 --LFPNHV----THV---STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK  281 (375)
Q Consensus       211 --~~~~~~----~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  281 (375)
                        .+....    ...   .....||..|.++....+...+.+.|+||++.++.+++.|..|+........       ...
T Consensus       176 ~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~-------~~~  248 (322)
T KOG1164|consen  176 RFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL-------KSK  248 (322)
T ss_pred             cccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch-------HHH
Confidence              322111    111   1234599999999999999999999999999999999999988854432211       011


Q ss_pred             hhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          282 IQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      +...........        .....+..+.++...+-..+...+|....+...|.+.....
T Consensus       249 ~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  249 FEKDPRKLLTDR--------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HHHHhhhhcccc--------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            111110100000        00112345666666666789999999999999988766543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.93  E-value=3.4e-26  Score=221.65  Aligned_cols=247  Identities=21%  Similarity=0.282  Sum_probs=179.8

Q ss_pred             CCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccc-hhh---HHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENN-YKR---VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      +|...+.||++.|=.|.+|+++.|. |+||++.+.+ .-.   ..+...|+. ...+++||++++...... .+..|||-
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t-~kAAylvR  100 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVT-DKAAYLVR  100 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHh-hHHHHHHH
Confidence            5777889999999999999988887 9999985543 223   334444555 556689999998774333 56678888


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc--cCCC
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL--FPNH  215 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~--~~~~  215 (375)
                      +|.. -+|+|.+.    .+..+...+.+.|+.|++.||..+|..||+|||||.+||||+.-+.+.|+||...+.  ++.+
T Consensus       101 qyvk-hnLyDRlS----TRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD  175 (1431)
T KOG1240|consen  101 QYVK-HNLYDRLS----TRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED  175 (1431)
T ss_pred             HHHh-hhhhhhhc----cchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence            8884 68888884    334577788899999999999999999999999999999999999999999987642  2333


Q ss_pred             ccccc----cCCCCCccccCccccccc----------C-CCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHH
Q 017232          216 VTHVS----TAPQGTPGYVDPEYHQCY----------Q-LTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAI  279 (375)
Q Consensus       216 ~~~~~----~~~~~~~~y~aPE~~~~~----------~-~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~  279 (375)
                      ++...    .....-.+|+|||.+...          + .+++.||||+||+++||++ |+|+|+...         +..
T Consensus       176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---------L~a  246 (1431)
T KOG1240|consen  176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---------LLA  246 (1431)
T ss_pred             CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---------HHh
Confidence            32222    222344589999976431          2 6788999999999999987 799997432         110


Q ss_pred             HHhh-hhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          280 NKIQ-NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       280 ~~~~-~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                      -.-. ......++.. +.          ...+++++..|++.||.+|.++++.++.-.
T Consensus       247 Yr~~~~~~~e~~Le~-Ie----------d~~~Rnlil~Mi~rdPs~RlSAedyL~~yr  293 (1431)
T KOG1240|consen  247 YRSGNADDPEQLLEK-IE----------DVSLRNLILSMIQRDPSKRLSAEDYLQKYR  293 (1431)
T ss_pred             HhccCccCHHHHHHh-Cc----------CccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence            0000 0000111111 10          125889999999999999999999998844

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-24  Score=184.82  Aligned_cols=201  Identities=19%  Similarity=0.343  Sum_probs=166.6

Q ss_pred             CCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEEEEec
Q 017232           62 YFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .|++.++||.|.||+++.| ..-++++||||.=..  .....++..|+...+.|. .++|...|- |...+.+-.||+|.
T Consensus        29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYY-FGqeG~~NiLVidL  105 (449)
T KOG1165|consen   29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYY-FGQEGKYNILVIDL  105 (449)
T ss_pred             cceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceee-eccccchhhhhhhh
Confidence            5899999999999999999 455899999995322  233457888999888885 788888775 55557778899999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC-----CCcEEEeeeccccccCC
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-----NFCVKVADFGLSRLFPN  214 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~~  214 (375)
                      + |.+|.+++.-.   +..++.+.+..++.|++.-++++|++.+|.|||||+|+||..     ...+.++|||+|+.+..
T Consensus       106 L-GPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrD  181 (449)
T KOG1165|consen  106 L-GPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRD  181 (449)
T ss_pred             h-CcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcC
Confidence            9 78888887533   345999999999999999999999999999999999999964     34589999999998755


Q ss_pred             Cccc------cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccc
Q 017232          215 HVTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHR  269 (375)
Q Consensus       215 ~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~  269 (375)
                      ..+.      .....-||.+||+-.-..|.+-+.+.|+-|||-++.+.|.|..||.....+
T Consensus       182 p~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  182 PKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             ccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCc
Confidence            4332      223446999999999999999999999999999999999999999876544

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.92  E-value=5.1e-26  Score=219.52  Aligned_cols=253  Identities=19%  Similarity=0.263  Sum_probs=184.9

Q ss_pred             CCCCccCCCCcEEEEEEEeC-CCCEEEEEEec----cc-chhh-HHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           64 DSARELGDGGFGTVYYGELQ-DGRAVAVKRLY----EN-NYKR-VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~----~~-~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .....+|.|++|.|+.+... .....+.|...    .. .... ...+..|+-+-..+.|+|++..+......... .-+
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~-~~~  399 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGI-LQS  399 (601)
T ss_pred             CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccc-hhh
Confidence            45678999999988777433 33434444332    11 1111 12256677778888999998877755443333 334


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||||++ +|..++...    ..+...++..++.|++.|++|+|+.|+.|||+|++|+++..+|.+||+|||.+..+....
T Consensus       400 mE~~~~-Dlf~~~~~~----~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~  474 (601)
T KOG0590|consen  400 MEYCPY-DLFSLVMSN----GKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW  474 (601)
T ss_pred             hhcccH-HHHHHHhcc----cccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence            999998 999998432    468888999999999999999999999999999999999999999999999998765433


Q ss_pred             c---ccccCCCCCccccCcccccccCCCC-chhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          217 T---HVSTAPQGTPGYVDPEYHQCYQLTD-KSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       217 ~---~~~~~~~~~~~y~aPE~~~~~~~~~-~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .   ......+|+..|+|||.+.+..|++ ..||||.|+++..|.+|+.||......+.......     ..      ..
T Consensus       475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~-----~~------~~  543 (601)
T KOG0590|consen  475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNN-----YS------DQ  543 (601)
T ss_pred             chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhc-----cc------cc
Confidence            3   4455678999999999999999987 57999999999999999999976654433210000     00      00


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .............++...+.++.+||+.+|.+|.|+++|++
T Consensus       544 ~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  544 RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence            00111222333456678889999999999999999999885

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.92  E-value=2.6e-23  Score=189.75  Aligned_cols=260  Identities=32%  Similarity=0.509  Sum_probs=194.1

Q ss_pred             CCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchh---hHHHHHHHHHHHHhcCCC-CeEEEeeeeecCCceeEEEEe
Q 017232           63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYK---RVEQFMNEVDILARLRHK-NLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~lv~e  138 (375)
                      |.+...||.|+||.||++...  ..+++|.+......   ....+.+|+.++..+.|+ +++++++.+.. ....+++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~-~~~~~~~~~   78 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQD-EGSLYLVME   78 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEec-CCEEEEEEe
Confidence            667888999999999999776  78899988655332   367789999999999988 79999997744 555799999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC-cEEEeeeccccccCCCcc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF-CVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~  217 (375)
                      ++.++++.+++...... ..+.......++.|++.++.++|+.+++|||+||+||+++..+ .++++|||.+........
T Consensus        79 ~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          79 YVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             cCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            99999999776433211 3688999999999999999999999999999999999999988 799999999875543322


Q ss_pred             c-----cccCCCCCccccCcccccc---cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          218 H-----VSTAPQGTPGYVDPEYHQC---YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       218 ~-----~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                      .     ......++..|++||.+.+   ...+...|+|++|++++++++|..||......   .........+....   
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~---~~~~~~~~~~~~~~---  231 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNS---SATSQTLKIILELP---  231 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCcc---ccHHHHHHHHHhcC---
Confidence            1     2355679999999999887   57888999999999999999999997654421   00000000000000   


Q ss_pred             HHhhhcCCCCChH-HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          290 LVDQTLGYESDNK-VRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       290 ~~~~~l~~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                        .+......... .......+.+++..|+..+|..|.+..+....
T Consensus       232 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         232 --TPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             --CcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence              00000000000 01123468899999999999999999987765

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.92  E-value=1.8e-24  Score=177.19  Aligned_cols=259  Identities=19%  Similarity=0.266  Sum_probs=185.0

Q ss_pred             hcCCCCCCccCCCCcEEEEEE-EeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCC-CCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRH-KNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|+++++||.|+||.+|.| ...+|..||||+=....  ...++..|..+...|++ ..|..+.. +......-.+||
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~-y~~e~~ynvlVM   90 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRH-YGTEKDYNVLVM   90 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhh-hccccccceeee
Confidence            478999999999999999999 56689999999754332  22467788899999975 44555544 444466778999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC---CCcEEEeeeccccccCC
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPN  214 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~~  214 (375)
                      +.+ |.+|.+++.-..   ..++...++-++-|++.-++|+|.++++||||||+|+|..-   ...+.++|||+++.+-+
T Consensus        91 dLL-GPsLEdLfnfC~---R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d  166 (341)
T KOG1163|consen   91 DLL-GPSLEDLFNFCS---RRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRD  166 (341)
T ss_pred             ecc-CccHHHHHHHHh---hhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhcc
Confidence            999 789999886543   34888999999999999999999999999999999999863   35689999999987643


Q ss_pred             Ccc------ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          215 HVT------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       215 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      ..+      .......||..|.+-...-+..-+.+.|+-|+|.+|.++..|..||+........            ....
T Consensus       167 ~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~------------QKyE  234 (341)
T KOG1163|consen  167 IRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK------------QKYE  234 (341)
T ss_pred             ccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH------------HHHH
Confidence            222      1223446999999988888888889999999999999999999999866533221            1111


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                      .+.+..+..........++.++...+.-|-..--++-|...-+.+.+.-
T Consensus       235 kI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFri  283 (341)
T KOG1163|consen  235 KISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRI  283 (341)
T ss_pred             HHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHH
Confidence            2222222211111112233455555555655555555665555555443

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.91  E-value=2e-24  Score=182.48  Aligned_cols=172  Identities=13%  Similarity=0.154  Sum_probs=132.7

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhh---HHH------HHHHHHHHHhcCCCCeEEEeeeeecC
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKR---VEQ------FMNEVDILARLRHKNLVSLYGCTSRH  129 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~---~~~------~~~e~~~l~~l~h~niv~~~~~~~~~  129 (375)
                      ..++|++.+.||.|+||.||++.. ++..+|+|.+.......   ...      +.+|+..+.++.|++|..+..++...
T Consensus        29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            468899999999999999999866 46789999996543222   222      67899999999999999888754422


Q ss_pred             -------CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEE
Q 017232          130 -------SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVK  202 (375)
Q Consensus       130 -------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~k  202 (375)
                             ....+|||||++|.+|.++..        ++.    ....+++.++..+|+.|++|||++|+||+++.+| ++
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~--------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~  174 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMPE--------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LR  174 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhhh--------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EE
Confidence                   235789999999999988741        222    3456999999999999999999999999999988 99


Q ss_pred             EeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHH
Q 017232          203 VADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI  257 (375)
Q Consensus       203 l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ell  257 (375)
                      |+|||...........             ..++....+..++|+|+||+++..+.
T Consensus       175 liDfg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        175 IIDLSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEECCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            9999987644221110             01334445667999999999987664

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.90  E-value=2e-23  Score=174.43  Aligned_cols=140  Identities=18%  Similarity=0.163  Sum_probs=107.6

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchh--h------------------------HHHHHHHHHHHHhcCCCCe
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYK--R------------------------VEQFMNEVDILARLRHKNL  119 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~ni  119 (375)
                      .+.||+|++|.||+|...+|+.||+|++......  .                        ......|+..+..+.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v   81 (190)
T cd05147           2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI   81 (190)
T ss_pred             CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence            4679999999999998778999999998654211  0                        0122459999999987766


Q ss_pred             EEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHH-hhCCceeccCCCCCEEecCC
Q 017232          120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL-HASDIIHRDVKTNNILLDNN  198 (375)
Q Consensus       120 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~ivH~dlkp~Nill~~~  198 (375)
                      .........   ..+|||||++++++.....    ....++...+..++.|++.+|.++ |+.||+||||||+|||++ +
T Consensus        82 ~~p~~~~~~---~~~iVmE~i~g~~l~~~~~----~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~  153 (190)
T cd05147          82 PCPEPILLK---SHVLVMEFIGDDGWAAPRL----KDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-D  153 (190)
T ss_pred             CCCcEEEec---CCEEEEEEeCCCCCcchhh----hcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-C
Confidence            332221111   2379999998877654432    224688899999999999999999 799999999999999998 4


Q ss_pred             CcEEEeeeccccccC
Q 017232          199 FCVKVADFGLSRLFP  213 (375)
Q Consensus       199 ~~~kl~Dfg~~~~~~  213 (375)
                      +.++|+|||++....
T Consensus       154 ~~v~LiDFG~a~~~~  168 (190)
T cd05147         154 GKLYIIDVSQSVEHD  168 (190)
T ss_pred             CcEEEEEccccccCC
Confidence            789999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.3e-24  Score=179.66  Aligned_cols=246  Identities=17%  Similarity=0.284  Sum_probs=184.0

Q ss_pred             CCCCccCCCCcEEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           64 DSARELGDGGFGTVYYGELQDGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      .+..+|.....|..|+|++++ ..+++|++.-..  ...-.+|..|.-.|+.+.||||+++++.|.. ...+.++..|++
T Consensus       193 nl~tkl~e~hsgelwrgrwqg-ndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacns-ppnlv~isq~mp  270 (448)
T KOG0195|consen  193 NLITKLAESHSGELWRGRWQG-NDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNS-PPNLVIISQYMP  270 (448)
T ss_pred             hhhhhhccCCCcccccccccC-cchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccC-CCCceEeeeecc
Confidence            445678999999999999984 556777765432  2223568889999999999999999998887 467899999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC--ceeccCCCCCEEecCCCcEEEe--eeccccccCCCcc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--IIHRDVKTNNILLDNNFCVKVA--DFGLSRLFPNHVT  217 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--ivH~dlkp~Nill~~~~~~kl~--Dfg~~~~~~~~~~  217 (375)
                      .|+|+..++..  .+-.++-.++.+++.+++.|+.|||+..  |-..-|+...|+||++.+.+|+  |--++.       
T Consensus       271 ~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsf-------  341 (448)
T KOG0195|consen  271 FGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSF-------  341 (448)
T ss_pred             chHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeee-------
Confidence            99999999765  3334667789999999999999999974  4445688999999999988875  222211       


Q ss_pred             ccccCCCCCccccCcccccccCCC---CchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLT---DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~---~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                       ........|.|++||.++..+-+   .++|+|||++++|||.|...||....+-+..       -++           .
T Consensus       342 -qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg-------mki-----------a  402 (448)
T KOG0195|consen  342 -QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG-------MKI-----------A  402 (448)
T ss_pred             -eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh-------hhh-----------h
Confidence             11223467889999988765433   4799999999999999999999755432110       000           0


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      +.+.....++..+..+.+|+.-|++.||.+||.+..|+-.|++.+
T Consensus       403 leglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  403 LEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             hccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence            111111122335567899999999999999999999999998764

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=6.1e-23  Score=202.29  Aligned_cols=200  Identities=22%  Similarity=0.257  Sum_probs=157.7

Q ss_pred             HHHHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC---CCCeEEEeeeeecCCc
Q 017232           55 ELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR---HKNLVSLYGCTSRHSR  131 (375)
Q Consensus        55 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~  131 (375)
                      +.+.....|.+.+.||+|+||.||+|...+|+.||+|+-+..+...   |.--..++.+|+   -+.|+.+..++.. .+
T Consensus       692 ~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~-~~  767 (974)
T KOG1166|consen  692 EFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVF-QN  767 (974)
T ss_pred             eeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHcc-CC
Confidence            4455567899999999999999999988889999999877665432   111122334444   2345555554333 33


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec-------CCCcEEEe
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-------NNFCVKVA  204 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~-------~~~~~kl~  204 (375)
                      .-+||+||.+.|+|.++++    ..+.+++..+..+..|++..++.||..+|||+||||+|+||.       +...++|+
T Consensus       768 ~S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lI  843 (974)
T KOG1166|consen  768 ASVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLI  843 (974)
T ss_pred             cceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEE
Confidence            4579999999999999996    456799999999999999999999999999999999999994       23459999


Q ss_pred             eeccccccCCC-ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 017232          205 DFGLSRLFPNH-VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPA  262 (375)
Q Consensus       205 Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  262 (375)
                      |||.+....-- ........++|..+-.+|+..|.+|+.+.|.|.++.+++.||.|+..
T Consensus       844 DfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~  902 (974)
T KOG1166|consen  844 DFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM  902 (974)
T ss_pred             ecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence            99998754321 12345667899999999999999999999999999999999999754

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=4.4e-22  Score=167.00  Aligned_cols=141  Identities=18%  Similarity=0.149  Sum_probs=109.7

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchh--------------------------hHHHHHHHHHHHHhcCCCCe
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYK--------------------------RVEQFMNEVDILARLRHKNL  119 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--------------------------~~~~~~~e~~~l~~l~h~ni  119 (375)
                      .+.||+|++|.||+|...+|+.||||++......                          ....+..|+..+.++.|+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5689999999999998778999999998654210                          01234578999999999887


Q ss_pred             EEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCC
Q 017232          120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNN  198 (375)
Q Consensus       120 v~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~  198 (375)
                      .....+...   ..++||||++|+++.....    ....++......++.|++.++.++|+ .||+||||||+||+++ +
T Consensus        82 ~~p~~~~~~---~~~lVmE~~~g~~~~~~~l----~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~  153 (190)
T cd05145          82 PVPEPILLK---KNVLVMEFIGDDGSPAPRL----KDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-D  153 (190)
T ss_pred             CCceEEEec---CCEEEEEEecCCCchhhhh----hhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-C
Confidence            433332222   2389999998875543321    12347788899999999999999999 9999999999999999 8


Q ss_pred             CcEEEeeeccccccCC
Q 017232          199 FCVKVADFGLSRLFPN  214 (375)
Q Consensus       199 ~~~kl~Dfg~~~~~~~  214 (375)
                      +.++|+|||++.....
T Consensus       154 ~~~~liDFG~a~~~~~  169 (190)
T cd05145         154 GKPYIIDVSQAVELDH  169 (190)
T ss_pred             CCEEEEEcccceecCC
Confidence            8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.88  E-value=1.2e-21  Score=162.08  Aligned_cols=187  Identities=14%  Similarity=0.090  Sum_probs=139.0

Q ss_pred             CCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhh----HHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEEEEe
Q 017232           64 DSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKR----VEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .+...|++|+||+||.+.. ++.+++.+.+.....-.    ...+.+|+++|+++. |+++.+++++     ...+++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEe
Confidence            3467799999999998866 67888888776554311    225789999999995 5788888874     23589999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccC-CCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDV-KTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dl-kp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      |+.|.+|.....    .       ....++.|++.+|.++|+.||+|||| ||+|||++.++.++|+|||++........
T Consensus        79 yI~G~~L~~~~~----~-------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         79 YLAGAAMYQRPP----R-------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             eecCccHHhhhh----h-------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            999988865431    0       11357789999999999999999999 79999999999999999999985543221


Q ss_pred             c----c--------ccCCCCCccccCccccccc-CCC-CchhHHHHHHHHHHHHhCCCCccccc
Q 017232          218 H----V--------STAPQGTPGYVDPEYHQCY-QLT-DKSDVFSFGVVLIELISSMPAVDITR  267 (375)
Q Consensus       218 ~----~--------~~~~~~~~~y~aPE~~~~~-~~~-~~~DiwslG~il~elltg~~p~~~~~  267 (375)
                      .    .        ......++.|++|+...-. ..+ ...+.++.|+-+|.++|+..++-..+
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            0    0        0112267788888743321 223 46789999999999999987764433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=1.9e-22  Score=175.55  Aligned_cols=234  Identities=20%  Similarity=0.262  Sum_probs=146.8

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCC----------CC------eEEE
Q 017232           63 FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRH----------KN------LVSL  122 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h----------~n------iv~~  122 (375)
                      +...+.||.|+++.||.++.. +|+.+++|++....   ....+++.+|.-....+.+          -.      ++++
T Consensus        14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i   93 (288)
T PF14531_consen   14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI   93 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred             EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence            344678999999999999665 68999999874432   2335566666544433221          11      2222


Q ss_pred             ee---eeecC--Cc-----eeEEEEecccCCChhHhhccCCC---CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCC
Q 017232          123 YG---CTSRH--SR-----ELLLVYEFISNGTVADHLHGERA---KPGALPWPTRLKIAIETASALTYLHASDIIHRDVK  189 (375)
Q Consensus       123 ~~---~~~~~--~~-----~~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlk  189 (375)
                      -+   +....  ..     ..+++|+-+ .++|.+++.....   ....+.......+..|+++.+++||+.|++|+||+
T Consensus        94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~  172 (288)
T PF14531_consen   94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIK  172 (288)
T ss_dssp             TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-S
T ss_pred             cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccc
Confidence            21   11111  11     236788877 4788777543211   11223344446677999999999999999999999


Q ss_pred             CCCEEecCCCcEEEeeeccccccCCCccccccCCCCCccccCcccccc--------cCCCCchhHHHHHHHHHHHHhCCC
Q 017232          190 TNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC--------YQLTDKSDVFSFGVVLIELISSMP  261 (375)
Q Consensus       190 p~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~  261 (375)
                      |+|++++.+|.++|+||+.....+.....    ...+..|.|||....        ..++.+.|.|+||+++|.|++|..
T Consensus       173 ~~nfll~~~G~v~Lg~F~~~~r~g~~~~~----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  173 PENFLLDQDGGVFLGDFSSLVRAGTRYRC----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             GGGEEE-TTS-EEE--GGGEEETTEEEEG----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             eeeEEEcCCCCEEEcChHHHeecCceeec----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999999999999987654432221    235577999996543        357889999999999999999999


Q ss_pred             CccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCC
Q 017232          262 AVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLR  325 (375)
Q Consensus       262 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  325 (375)
                      ||+..........                       ....+. +.++.+..||..+|+.+|.+|
T Consensus       249 Pf~~~~~~~~~~~-----------------------~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW-----------------------DFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG-----------------------GGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc-----------------------cchhcC-CcCHHHHHHHHHHccCCcccC
Confidence            9986653322211                       011122 466789999999999999988

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=4.3e-23  Score=190.80  Aligned_cols=233  Identities=25%  Similarity=0.253  Sum_probs=179.5

Q ss_pred             ccCCCCcEEEEEEEe----CCCCEEEEEEecccchhh--HHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEEEEecc
Q 017232           68 ELGDGGFGTVYYGEL----QDGRAVAVKRLYENNYKR--VEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        68 ~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~~~~--~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      .+|.|.||.|++++.    ..|..|++|++++.....  ......|-.++...+ ||.++++..+++. +...+++++|.
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt-~~kl~l~ld~~   79 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQT-DGKLYLILDFL   79 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeecc-ccchhHhhhhc
Confidence            379999999998732    346788999886542211  113445777788886 9999999887776 56789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      .+|.|...+.    +...+.+.....+...++.+++++|+.+++|+|+|++||+++.+|++++.|||+++..-....   
T Consensus        80 rgg~lft~l~----~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~---  152 (612)
T KOG0603|consen   80 RGGDLFTRLS----KEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI---  152 (612)
T ss_pred             ccchhhhccc----cCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh---
Confidence            9999988874    334567778888899999999999999999999999999999999999999999986432221   


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD  300 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  300 (375)
                        .+||..|||||++.  ....++|.||||+++++|+||..||...                   ....++..     ..
T Consensus       153 --~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~-------------------~~~~Il~~-----~~  204 (612)
T KOG0603|consen  153 --ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD-------------------TMKRILKA-----EL  204 (612)
T ss_pred             --cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH-------------------HHHHHhhh-----cc
Confidence              27999999999998  4578999999999999999999999741                   01111111     12


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCCCH--HHHHHHHH
Q 017232          301 NKVRRTINAVAELAFQCLQSEKDLRPYM--VDVLDALR  336 (375)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~--~evl~~L~  336 (375)
                      ..+.+....+.+++..++..+|..|.-.  ..+.+..+
T Consensus       205 ~~p~~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~  242 (612)
T KOG0603|consen  205 EMPRELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQ  242 (612)
T ss_pred             CCchhhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhc
Confidence            2334567788899999999999999766  34444444

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=4.2e-21  Score=161.88  Aligned_cols=136  Identities=18%  Similarity=0.213  Sum_probs=104.8

Q ss_pred             CCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhc-----CCCCeEEEeeeeecCC--ce-eEE
Q 017232           64 DSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-----RHKNLVSLYGCTSRHS--RE-LLL  135 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~--~~-~~l  135 (375)
                      .-...||+|+||.||. .-.++.. +||++........+.+.+|+.+++.+     .||||++++++++.+.  +. +.+
T Consensus         5 ~~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~   82 (210)
T PRK10345          5 SEQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV   82 (210)
T ss_pred             CCcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence            3467899999999996 3334444 79988665444556789999999999     5799999999887754  23 347


Q ss_pred             EEec--ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHH-HHHhhCCceeccCCCCCEEecC----CCcEEEeeecc
Q 017232          136 VYEF--ISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL-TYLHASDIIHRDVKTNNILLDN----NFCVKVADFGL  208 (375)
Q Consensus       136 v~e~--~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l-~~Lh~~~ivH~dlkp~Nill~~----~~~~kl~Dfg~  208 (375)
                      |+||  +.+++|.+++...     .+++.  ..++.+++.++ +|||+++|+||||||+|||++.    ++.++|+||+-
T Consensus        83 I~e~~G~~~~tL~~~l~~~-----~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G  155 (210)
T PRK10345         83 IADFDGKPSITLTEFAEQC-----RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIG  155 (210)
T ss_pred             EecCCCCcchhHHHHHHcc-----cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCC
Confidence            8999  5579999999432     25544  35677888777 9999999999999999999974    34799999443

>smart00090 RIO RIO-like kinase

Probab=99.83  E-value=6.5e-20  Score=158.45  Aligned_cols=142  Identities=18%  Similarity=0.116  Sum_probs=110.6

Q ss_pred             cCCCCCCccCCCCcEEEEEEE--eCCCCEEEEEEecccchh------------------------hHHHHHHHHHHHHhc
Q 017232           61 NYFDSARELGDGGFGTVYYGE--LQDGRAVAVKRLYENNYK------------------------RVEQFMNEVDILARL  114 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~--~~~~~~vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l  114 (375)
                      .-|.+.+.||.|++|.||+|.  ..+|+.||+|++......                        ....+.+|+..+..+
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            358899999999999999997  568999999998643210                        112356899999999


Q ss_pred             CCC--CeEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC-ceeccCCCC
Q 017232          115 RHK--NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD-IIHRDVKTN  191 (375)
Q Consensus       115 ~h~--niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-ivH~dlkp~  191 (375)
                      .+.  .+.++++.    . ..++||||+++.+|.....    ....+....+..++.|++.++.+||+.| ++|+||||+
T Consensus       108 ~~~~i~~p~~~~~----~-~~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~  178 (237)
T smart00090      108 YEAGVPVPKPIAW----R-RNVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEY  178 (237)
T ss_pred             HhcCCCCCeeeEe----c-CceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChh
Confidence            753  23444432    1 2479999999888776542    2233556667899999999999999999 999999999


Q ss_pred             CEEecCCCcEEEeeecccccc
Q 017232          192 NILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       192 Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      ||+++ ++.++|+|||.+...
T Consensus       179 NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      179 NILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             hEEEE-CCCEEEEEChhhhcc
Confidence            99999 889999999998753

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.82  E-value=4.8e-20  Score=170.50  Aligned_cols=218  Identities=22%  Similarity=0.415  Sum_probs=161.6

Q ss_pred             HHhcCCCCeEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCc-eeccCC
Q 017232          111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI-IHRDVK  189 (375)
Q Consensus       111 l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i-vH~dlk  189 (375)
                      |+.+.|.|+.+++|.+.. +...++|.+||..|+|.+.+..   ....+++.....+.++++.||.|||...| .|+.++
T Consensus         1 l~~l~h~n~~~f~g~~~~-~~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~   76 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVD-GPEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALK   76 (484)
T ss_pred             CcccchhhhhhheeeEec-CCceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence            356889999999998777 4789999999999999999965   34458899999999999999999999876 999999


Q ss_pred             CCCEEecCCCcEEEeeeccccccCCC-ccccccCCCCCccccCccccccc-------CCCCchhHHHHHHHHHHHHhCCC
Q 017232          190 TNNILLDNNFCVKVADFGLSRLFPNH-VTHVSTAPQGTPGYVDPEYHQCY-------QLTDKSDVFSFGVVLIELISSMP  261 (375)
Q Consensus       190 p~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~DiwslG~il~elltg~~  261 (375)
                      ..|.+++..-.+||+|||+....... ............-|.|||.+.+.       ..+.++||||||++++|+++...
T Consensus        77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~  156 (484)
T KOG1023|consen   77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG  156 (484)
T ss_pred             cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence            99999999999999999998765421 01111111234579999987763       14667999999999999999999


Q ss_pred             CccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChH-HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          262 AVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNK-VRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       262 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      ||+........  ...+.. +..       ...-...+... ..+..+.+..++.+||..+|.+||+++.|...++.+..
T Consensus       157 ~~~~~~~~~~~--~eii~~-~~~-------~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  157 PFDLRNLVEDP--DEIILR-VKK-------GGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccccCCh--HHHHHH-HHh-------cCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            99864432211  111111 110       00000011111 01344578999999999999999999999999998877


Q ss_pred             CC
Q 017232          341 DG  342 (375)
Q Consensus       341 ~~  342 (375)
                      ..
T Consensus       227 ~~  228 (484)
T KOG1023|consen  227 GG  228 (484)
T ss_pred             cc
Confidence            54

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=1.6e-19  Score=158.27  Aligned_cols=202  Identities=21%  Similarity=0.224  Sum_probs=142.5

Q ss_pred             CCCCeEEEeeeeec--------------------------CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHH
Q 017232          115 RHKNLVSLYGCTSR--------------------------HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA  168 (375)
Q Consensus       115 ~h~niv~~~~~~~~--------------------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~  168 (375)
                      +|||||++.++|.+                          ....+|+||..++ -+|..++...     ..+.....-++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~~-----~~s~r~~~~~l  347 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWTR-----HRSYRTGRVIL  347 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhcC-----CCchHHHHHHH
Confidence            59999999875321                          2346899999884 6899998543     34556677789


Q ss_pred             HHHHHHHHHHhhCCceeccCCCCCEEec--CCC--cEEEeeeccccccCCCc---cc--cccCCCCCccccCcccccccC
Q 017232          169 IETASALTYLHASDIIHRDVKTNNILLD--NNF--CVKVADFGLSRLFPNHV---TH--VSTAPQGTPGYVDPEYHQCYQ  239 (375)
Q Consensus       169 ~~i~~~l~~Lh~~~ivH~dlkp~Nill~--~~~--~~kl~Dfg~~~~~~~~~---~~--~~~~~~~~~~y~aPE~~~~~~  239 (375)
                      .|+++|+.|||.+|+.|||+|.+|||+.  +++  .+.++|||++.-.....   +.  ..-...|...-||||+....+
T Consensus       348 aQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  348 AQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            9999999999999999999999999993  333  47899999875332211   11  112334777899999865432


Q ss_pred             ------CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHH
Q 017232          240 ------LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAEL  313 (375)
Q Consensus       240 ------~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~l  313 (375)
                            .-.++|.|+.|.+.||+++...||-..+.. ..+...     .++.            +.+..+..++..++++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem-~L~~r~-----Yqe~------------qLPalp~~vpp~~rql  489 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM-LLDTRT-----YQES------------QLPALPSRVPPVARQL  489 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchh-eechhh-----hhhh------------hCCCCcccCChHHHHH
Confidence                  124899999999999999999999653311 111111     1111            1222334456789999


Q ss_pred             HHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          314 AFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       314 i~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      +...|+.||++|++..-....|.--..
T Consensus       490 V~~lL~r~pskRvsp~iAANvl~LsLw  516 (598)
T KOG4158|consen  490 VFDLLKRDPSKRVSPNIAANVLNLSLW  516 (598)
T ss_pred             HHHHhcCCccccCCccHHHhHHHHHHh
Confidence            999999999999998877777664333

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.82  E-value=2.4e-19  Score=151.60  Aligned_cols=148  Identities=18%  Similarity=0.099  Sum_probs=113.9

Q ss_pred             chHHHHHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccch----------------------hhHHHHHHHHH
Q 017232           52 SYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNY----------------------KRVEQFMNEVD  109 (375)
Q Consensus        52 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----------------------~~~~~~~~e~~  109 (375)
                      ..+++......|.+.+.||+|+||.||++...+|+.||||++.....                      .....+..|+.
T Consensus         6 ~~~~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~   85 (198)
T cd05144           6 ALHTLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFA   85 (198)
T ss_pred             HHHHHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHH
Confidence            34455555555888999999999999999888899999998654320                      01123567888


Q ss_pred             HHHhcCCCC--eEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceecc
Q 017232          110 ILARLRHKN--LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD  187 (375)
Q Consensus       110 ~l~~l~h~n--iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~d  187 (375)
                      ++..+.|++  +...++     ....++||||++|++|......          .....++.+++.++.++|+.|++|+|
T Consensus        86 ~l~~l~~~~i~v~~~~~-----~~~~~lv~e~~~g~~L~~~~~~----------~~~~~~~~~i~~~l~~lh~~gi~H~D  150 (198)
T cd05144          86 ALKALYEEGFPVPKPID-----WNRHAVVMEYIDGVELYRVRVL----------EDPEEVLDEILEEIVKAYKHGIIHGD  150 (198)
T ss_pred             HHHHHHHcCCCCCceee-----cCCceEEEEEeCCcchhhcccc----------ccHHHHHHHHHHHHHHHHHCCCCcCC
Confidence            999987774  444443     1235899999999988765420          24567889999999999999999999


Q ss_pred             CCCCCEEecCCCcEEEeeeccccccCC
Q 017232          188 VKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       188 lkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      |+|+||+++.++.++|+|||++.....
T Consensus       151 l~p~Nill~~~~~~~liDfg~~~~~~~  177 (198)
T cd05144         151 LSEFNILVDDDEKIYIIDWPQMVSTDH  177 (198)
T ss_pred             CCcccEEEcCCCcEEEEECCccccCCC
Confidence            999999999999999999999865443

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=3.2e-20  Score=168.70  Aligned_cols=174  Identities=24%  Similarity=0.351  Sum_probs=129.7

Q ss_pred             ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          131 RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      .++|+.|++|...+|.+|+...+ .....++.....++.|++.|++|   ++.+|+|+||.||++..+..+||+|||+..
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~-~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRR-TGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCC-cccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence            35889999999999999996543 34557788899999999999999   999999999999999999999999999987


Q ss_pred             ccCCCc-----cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhC-CCCccccccccccchhHHHHHHhhh
Q 017232          211 LFPNHV-----THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS-MPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       211 ~~~~~~-----~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      ......     ....+...||..||+||.+.+..|+.++|||+||++|+||+.- .-.++-.          .....+++
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------~t~~d~r~  474 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------ATLTDIRD  474 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH----------Hhhhhhhc
Confidence            655443     2233455799999999999999999999999999999999971 1111100          01111122


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHH
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD  330 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e  330 (375)
                      +.+.            +....-.+.-..|+.+++...|.+||++.+
T Consensus       475 g~ip------------~~~~~d~p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  475 GIIP------------PEFLQDYPEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             CCCC------------hHHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence            1111            111111123447899999999999995443

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.80  E-value=8.9e-19  Score=149.85  Aligned_cols=134  Identities=23%  Similarity=0.387  Sum_probs=108.2

Q ss_pred             CccCCCCcEEEEEEEeCCCCEEEEEEecccch--------hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNY--------KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      +.||+|++|.||+|.. .|..+++|+......        .....+.+|+.++..+.|+++.....++.. ....+++||
T Consensus         2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e   79 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVD-PENFIIVME   79 (211)
T ss_pred             cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEe-CCCCEEEEE
Confidence            5799999999999987 577899997653321        112457789999999999887655544433 345789999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      |++|++|.+++...       .. ....++.+++.+|.++|+.|++|+|++|.||+++ ++.++|+|||.+..
T Consensus        80 ~~~G~~L~~~~~~~-------~~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         80 YIEGEPLKDLINSN-------GM-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EeCCcCHHHHHHhc-------cH-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999998432       11 7788999999999999999999999999999999 78899999998763

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.79  E-value=1.4e-19  Score=175.96  Aligned_cols=211  Identities=23%  Similarity=0.329  Sum_probs=142.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ..+|+.++.+..|+||.||.++++ +.+.+|+| +.+.+.-     .+-  ++.....|.+|                  
T Consensus        82 e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~li-----lRn--ilt~a~npfvv------------------  135 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLI-----LRN--ILTFAGNPFVV------------------  135 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeeccccccchhhc-ccccchh-----hhc--cccccCCccee------------------
Confidence            357999999999999999999776 46677874 3332211     000  22222222222                  


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc--
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV--  216 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--  216 (375)
                          |+-...+.    .-++++...        +.+++|||+.||+|||+||+|++|+.-|++|++|||++.......  
T Consensus       136 ----gDc~tllk----~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~at  199 (1205)
T KOG0606|consen  136 ----GDCATLLK----NIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLAT  199 (1205)
T ss_pred             ----chhhhhcc----cCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccc
Confidence                33333332    223344332        778999999999999999999999999999999999986432111  


Q ss_pred             ------------cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh
Q 017232          217 ------------THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       217 ------------~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                                  .......+||+.|+|||++.-+.|....|+|++|+|+||.+-|+.||....+..-+            
T Consensus       200 nl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelf------------  267 (1205)
T KOG0606|consen  200 NLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELF------------  267 (1205)
T ss_pred             hhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHH------------
Confidence                        01122347999999999999999999999999999999999999999876543211            


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMV  329 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~  329 (375)
                         ..++...+  +....-...+.++++++.+.|+.+|..|--..
T Consensus       268 ---g~visd~i--~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~  307 (1205)
T KOG0606|consen  268 ---GQVISDDI--EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG  307 (1205)
T ss_pred             ---hhhhhhhc--cccccCcCCCHHHHHHHHHHHHhChHhhcccc
Confidence               11111111  01111223456789999999999999995433

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.77  E-value=2.7e-18  Score=145.48  Aligned_cols=130  Identities=23%  Similarity=0.366  Sum_probs=101.8

Q ss_pred             ccCCCCcEEEEEEEeCCCCEEEEEEecccch--------hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNY--------KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .||+|++|.||+|.. ++..+++|.......        .....+.+|+.++..+.|+++.....++.. ....++||||
T Consensus         1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~~~lv~e~   78 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVD-PDNKTIVMEY   78 (199)
T ss_pred             CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEE-CCCCEEEEEE
Confidence            489999999999985 478899998654321        123567789999999988764332222222 3446899999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ++|++|.+.+....           ..++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus        79 ~~g~~l~~~~~~~~-----------~~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        79 IEGKPLKDVIEEGN-----------DELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ECCccHHHHHhhcH-----------HHHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            99999998874210           07899999999999999999999999999999 88999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.77  E-value=2.8e-18  Score=166.45  Aligned_cols=140  Identities=21%  Similarity=0.293  Sum_probs=109.7

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEeccc--c------hhhHHHHHHHHHHHHhcCCCCeEEEeeeeec
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--N------YKRVEQFMNEVDILARLRHKNLVSLYGCTSR  128 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  128 (375)
                      ......|...+.||+|+||.||++...+. .+++|+....  .      ....+.+.+|+.++..++|++++....+...
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~~-~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~  407 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLGR-DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVD  407 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecCc-cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEe
Confidence            33345567789999999999999977644 3444433211  1      1123567899999999999998876654444


Q ss_pred             CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecc
Q 017232          129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL  208 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  208 (375)
                       ....++||||+++++|.+++.            ....++.+++.+|.+||+.|++||||||+||++ .++.++|+|||+
T Consensus       408 -~~~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGl  473 (535)
T PRK09605        408 -PEEKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGL  473 (535)
T ss_pred             -CCCCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCcc
Confidence             445689999999999999883            346789999999999999999999999999999 678899999999


Q ss_pred             ccc
Q 017232          209 SRL  211 (375)
Q Consensus       209 ~~~  211 (375)
                      +..
T Consensus       474 a~~  476 (535)
T PRK09605        474 GKY  476 (535)
T ss_pred             ccc
Confidence            864

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.73  E-value=8e-17  Score=139.49  Aligned_cols=136  Identities=20%  Similarity=0.227  Sum_probs=102.9

Q ss_pred             CCccC-CCCcEEEEEEEeCCCCEEEEEEecccc-------------hhhHHHHHHHHHHHHhcCCCCe--EEEeeeeecC
Q 017232           66 ARELG-DGGFGTVYYGELQDGRAVAVKRLYENN-------------YKRVEQFMNEVDILARLRHKNL--VSLYGCTSRH  129 (375)
Q Consensus        66 ~~~lg-~G~~g~V~~~~~~~~~~vaiK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~  129 (375)
                      ...|| .|+.|+||++... +..++||.+....             ......+.+|+.++..+.|+++  +..+++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~  114 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR  114 (239)
T ss_pred             CceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence            34587 8888999998775 6789998774321             1123457889999999998774  5666643332


Q ss_pred             Cce---eEEEEecccC-CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEee
Q 017232          130 SRE---LLLVYEFISN-GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD  205 (375)
Q Consensus       130 ~~~---~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~D  205 (375)
                      ...   .++|||+++| .+|.+++..     ..++..    .+.+++.+|.+||+.||+|+||||.|||++.++.++|+|
T Consensus       115 ~~~~~~~~lV~e~l~G~~~L~~~l~~-----~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        115 HGLFYRADILIERIEGARDLVALLQE-----APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             cCcceeeeEEEEecCCCCCHHHHHhc-----CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEE
Confidence            222   3599999997 688888742     234443    357899999999999999999999999999999999999


Q ss_pred             eccccc
Q 017232          206 FGLSRL  211 (375)
Q Consensus       206 fg~~~~  211 (375)
                      ||.+..
T Consensus       186 fg~~~~  191 (239)
T PRK01723        186 FDRGEL  191 (239)
T ss_pred             CCCccc
Confidence            998864

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.72  E-value=5.2e-17  Score=136.18  Aligned_cols=136  Identities=23%  Similarity=0.250  Sum_probs=97.6

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchh--hHHH----------------------HHHHHHHHHhcCCCC--e
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYK--RVEQ----------------------FMNEVDILARLRHKN--L  119 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--~~~~----------------------~~~e~~~l~~l~h~n--i  119 (375)
                      .+.||+|+||.||+|...+|+.||+|++......  ....                      ...|...+..+.+..  +
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            5679999999999998778999999988653211  1111                      134556666664432  3


Q ss_pred             EEEeeeeecCCceeEEEEecccCCChhH-hhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecC
Q 017232          120 VSLYGCTSRHSRELLLVYEFISNGTVAD-HLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDN  197 (375)
Q Consensus       120 v~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~  197 (375)
                      .+.+++     ...++||||++++.+.. .+....     .. .++..++.+++.++.++|. .|++|+||+|+||+++ 
T Consensus        82 ~~~~~~-----~~~~lv~e~~~g~~~~~~~l~~~~-----~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-  149 (187)
T cd05119          82 PKPIDL-----NRHVLVMEFIGGDGIPAPRLKDVR-----LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-  149 (187)
T ss_pred             CceEec-----CCCEEEEEEeCCCCccChhhhhhh-----hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-
Confidence            444432     23589999999854322 111110     11 5678899999999999999 9999999999999999 


Q ss_pred             CCcEEEeeeccccccC
Q 017232          198 NFCVKVADFGLSRLFP  213 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~  213 (375)
                      ++.++|+|||.+....
T Consensus       150 ~~~~~liDfg~a~~~~  165 (187)
T cd05119         150 DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCcEEEEECccccccc
Confidence            8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.68  E-value=3.3e-18  Score=165.57  Aligned_cols=255  Identities=21%  Similarity=0.292  Sum_probs=186.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCC--CCEEEEEEecccc--hhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQD--GRAVAVKRLYENN--YKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~l  135 (375)
                      ..|.+.+.||+|+|+.|-......  ...++.|.+....  .........|..+-..+. |+|++.+++.... ....++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~-~~~~~~   98 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSS-PRSYLL   98 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCC-Cccccc
Confidence            347778889999999998885533  3456666654433  222344455777777776 9999999996555 677899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHh-hCCceeccCCCCCEEecCCC-cEEEeeeccccccC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH-ASDIIHRDVKTNNILLDNNF-CVKVADFGLSRLFP  213 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  213 (375)
                      .+++..|+++.+.+..  .....++...+..++.|+..++.|+| ..++.|+|++|+|.+++..+ ..++.|||+|..+.
T Consensus        99 ~~~~s~g~~~f~~i~~--~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~  176 (601)
T KOG0590|consen   99 SLSYSDGGSLFSKISH--PDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYR  176 (601)
T ss_pred             ccCccccccccccccc--CCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcccc
Confidence            9999999999888731  12224677788889999999999999 99999999999999999999 99999999998776


Q ss_pred             C--CccccccCCCC-CccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          214 N--HVTHVSTAPQG-TPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       214 ~--~~~~~~~~~~~-~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                      .  .........+| ++.|.|||...+. -..+..|+||.|+++..+++|..|++........+. .|.           
T Consensus       177 ~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~-~~~-----------  244 (601)
T KOG0590|consen  177 NKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYS-SWK-----------  244 (601)
T ss_pred             ccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccce-eec-----------
Confidence            5  33334445668 9999999988874 446689999999999999999999876654432211 111           


Q ss_pred             HHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          290 LVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       290 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        ..... ..............+++.+++..+|..|.+.+++..
T Consensus       245 --~~~~~-~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  245 --SNKGR-FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             --ccccc-cccCccccCChhhhhcccccccCCchhccccccccc
Confidence              11000 000111123345778889999999999998887654

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.67  E-value=8.9e-16  Score=123.77  Aligned_cols=132  Identities=22%  Similarity=0.209  Sum_probs=108.5

Q ss_pred             CCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCC--CCeEEEeeeeecCCceeEEEEecccC
Q 017232           65 SARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRH--KNLVSLYGCTSRHSRELLLVYEFISN  142 (375)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~lv~e~~~~  142 (375)
                      +.+.||.|.++.||++...+ ..+++|.......  ...+.+|+..+..++|  .++.+++..... .+..+++|||+.+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~-~~~~~~v~e~~~g   77 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGES-DGWSYLLMEWIEG   77 (155)
T ss_pred             cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCC-CCccEEEEEecCC
Confidence            35779999999999998764 7899998765543  4568889999999976  488888875554 4678999999988


Q ss_pred             CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC---CceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          143 GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---DIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       143 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      +.+...           +......++.+++.++.++|..   +++|+|++|+||+++..+.++++|||.+..
T Consensus        78 ~~~~~~-----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          78 ETLDEV-----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             eecccC-----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            766543           3456677889999999999985   699999999999999999999999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.62  E-value=5e-15  Score=139.20  Aligned_cols=142  Identities=23%  Similarity=0.254  Sum_probs=100.9

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHH----------------------------------------HHH
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVE----------------------------------------QFM  105 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~----------------------------------------~~~  105 (375)
                      .+.||.|++|.||+|+.++|+.||||+..........                                        ++.
T Consensus       122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            3679999999999999999999999998654221100                                        234


Q ss_pred             HHHHHHHhc----CCCCeEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHH-HHHHHhh
Q 017232          106 NEVDILARL----RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS-ALTYLHA  180 (375)
Q Consensus       106 ~e~~~l~~l----~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~-~l~~Lh~  180 (375)
                      +|+..+.++    +|.+-+.+-..+.......+|||||++|++|.+.......   ..   ....++..++. .+..+|.
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~---~~---~~~~ia~~~~~~~l~ql~~  275 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA---GL---DRKALAENLARSFLNQVLR  275 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc---CC---CHHHHHHHHHHHHHHHHHh
Confidence            455555554    2333344444343334456899999999999887642211   12   23445566655 4788999


Q ss_pred             CCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       181 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      .|++|+|++|.||+++.++.++++|||++..+.
T Consensus       276 ~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       276 DGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             CCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            999999999999999999999999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.54  E-value=9.3e-15  Score=135.74  Aligned_cols=248  Identities=21%  Similarity=0.231  Sum_probs=177.9

Q ss_pred             cCCCCCCccCC--CCcEEEEEEEe---CCCCEEEEEEecccch--hhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCce
Q 017232           61 NYFDSARELGD--GGFGTVYYGEL---QDGRAVAVKRLYENNY--KRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        61 ~~y~~~~~lg~--G~~g~V~~~~~---~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~  132 (375)
                      ..|.+...+|.  |.+|.||.+..   .++..+|+|+-+....  .....=.+|+...+.++ |+|.++.+..++. ++.
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~-~~~  192 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEG-SGI  192 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccccc-CCc
Confidence            45777888999  99999999965   4678899987433322  22222345666666664 9999998887766 678


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHH----HHHHHhhCCceeccCCCCCEEecCC-CcEEEeeec
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS----ALTYLHASDIIHRDVKTNNILLDNN-FCVKVADFG  207 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~----~l~~Lh~~~ivH~dlkp~Nill~~~-~~~kl~Dfg  207 (375)
                      .++-+|.|. .+|..+.+..   ...++....+..+.+...    ||.++|+.+++|-|++|.||+...+ ...+++|||
T Consensus       193 lfiqtE~~~-~sl~~~~~~~---~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~  268 (524)
T KOG0601|consen  193 LFIQTELCG-ESLQSYCHTP---CNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFG  268 (524)
T ss_pred             ceeeecccc-chhHHhhhcc---cccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCcc
Confidence            999999994 7787777543   234788888999999999    9999999999999999999999999 889999999


Q ss_pred             cccccCCCcc----ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh
Q 017232          208 LSRLFPNHVT----HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ  283 (375)
Q Consensus       208 ~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  283 (375)
                      +...+....-    .......+...|++||...+ -++..+|+|++|.++.+..++..+.-.....      .|.  .++
T Consensus       269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~------~W~--~~r  339 (524)
T KOG0601|consen  269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVGKNS------SWS--QLR  339 (524)
T ss_pred             eeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCCCCC------Ccc--ccc
Confidence            9887654431    11122357889999998886 5688999999999999999887655432110      010  000


Q ss_pred             hhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       284 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..-+           ...........+...+.+|++.+|-.|++.+.+..
T Consensus       340 ~~~i-----------p~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  340 QGYI-----------PLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             cccC-----------chhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            0000           00011112235566899999999999998876653

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.53  E-value=6.2e-14  Score=133.42  Aligned_cols=147  Identities=19%  Similarity=0.228  Sum_probs=97.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC-CCEEEEEEecccchhh----------------------------------HH--
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKR----------------------------------VE--  102 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~----------------------------------~~--  102 (375)
                      ...|+. +.||.|++|.||+|..++ |+.||||++.+.-...                                  .+  
T Consensus       119 F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l  197 (537)
T PRK04750        119 FDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTL  197 (537)
T ss_pred             HHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHH
Confidence            345776 789999999999999887 9999999997542110                                  01  


Q ss_pred             ----HHHHHHHHHHhc----CCCCeEEEeeeeecCCceeEEEEecccCCChhHhh--ccCCCCCCCCChHHHHHHHHHHH
Q 017232          103 ----QFMNEVDILARL----RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETA  172 (375)
Q Consensus       103 ----~~~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l--~~~~~~~~~l~~~~~~~i~~~i~  172 (375)
                          ++.+|+..+.++    .+.+.+.+-..+.+.....+|||||+.|+.+.+.-  .........+....+..++.|  
T Consensus       198 ~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Q--  275 (537)
T PRK04750        198 HDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQ--  275 (537)
T ss_pred             HHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHH--
Confidence                133444444444    24444555454444455678999999999997742  111111112333333333444  


Q ss_pred             HHHHHHhhCCceeccCCCCCEEecCCC----cEEEeeeccccccCC
Q 017232          173 SALTYLHASDIIHRDVKTNNILLDNNF----CVKVADFGLSRLFPN  214 (375)
Q Consensus       173 ~~l~~Lh~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~~~~~~~  214 (375)
                           +...|++|+|++|.||+++.++    .++++|||+...++.
T Consensus       276 -----if~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        276 -----VFRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             -----HHhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence                 3458999999999999999888    999999999876643

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.52  E-value=1.3e-14  Score=124.82  Aligned_cols=205  Identities=20%  Similarity=0.291  Sum_probs=142.3

Q ss_pred             HHHHHhcCCCCeEEEeeeeecC----CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC--
Q 017232          108 VDILARLRHKNLVSLYGCTSRH----SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS--  181 (375)
Q Consensus       108 ~~~l~~l~h~niv~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--  181 (375)
                      ..-|-++.|.|+|+++.++.+.    ......++||+.-|++..+|+..+.....+......+|+.||+.||.|||+.  
T Consensus       118 FdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  118 FDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            3445566799999998876442    3357889999999999999998888888899999999999999999999998  


Q ss_pred             CceeccCCCCCEEecCCCcEEEeeecccccc---CCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh
Q 017232          182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLF---PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS  258 (375)
Q Consensus       182 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~---~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  258 (375)
                      -|+|+++.-+.|++..+|-+|++--.-....   ............+-++|.+||.-.....+.++|||+||+..++|..
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemai  277 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAI  277 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHH
Confidence            4999999999999999988887532111100   0001111122346789999998777777889999999999999987


Q ss_pred             CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          259 SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       259 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      +..-........           ..+......    ..+..+       ..-+.++..|++..|+.||+|++++-.
T Consensus       278 lEiq~tnseS~~-----------~~ee~ia~~----i~~len-------~lqr~~i~kcl~~eP~~rp~ar~llfH  331 (458)
T KOG1266|consen  278 LEIQSTNSESKV-----------EVEENIANV----IIGLEN-------GLQRGSITKCLEGEPNGRPDARLLLFH  331 (458)
T ss_pred             heeccCCCccee-----------ehhhhhhhh----eeeccC-------ccccCcCcccccCCCCCCcchhhhhcC
Confidence            654321111000           000000000    000000       112357789999999999999988754

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.52  E-value=4.4e-13  Score=126.01  Aligned_cols=166  Identities=20%  Similarity=0.222  Sum_probs=124.7

Q ss_pred             EeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCC
Q 017232           81 ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP  160 (375)
Q Consensus        81 ~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~  160 (375)
                      +..++.+|.++.....+........+-+..|+.++||||++++..++. ....|||+|.+.  .|..++..       +.
T Consensus        33 ~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~-~~~~ylvTErV~--Pl~~~lk~-------l~  102 (690)
T KOG1243|consen   33 RKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEE-EGTLYLVTERVR--PLETVLKE-------LG  102 (690)
T ss_pred             eeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcc-cCceEEEeeccc--cHHHHHHH-------hH
Confidence            445688888888766655445567778899999999999999997776 568999999984  56666643       33


Q ss_pred             hHHHHHHHHHHHHHHHHHh-hCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCCCCccccCcccccccC
Q 017232          161 WPTRLKIAIETASALTYLH-ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ  239 (375)
Q Consensus       161 ~~~~~~i~~~i~~~l~~Lh-~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  239 (375)
                      ......-++||+.||.||| ..+++|++|..+-|+|+..|..||++|.++.....-.. .......--.|..|+.+....
T Consensus       103 ~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~-~~~~~~~~~s~~~P~~~~~s~  181 (690)
T KOG1243|consen  103 KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA-PAKSLYLIESFDDPEEIDPSE  181 (690)
T ss_pred             HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc-ccccchhhhcccChhhcCccc
Confidence            5667778999999999997 56899999999999999999999999988754322111 111112223466666544322


Q ss_pred             CCCchhHHHHHHHHHHHHhC
Q 017232          240 LTDKSDVFSFGVVLIELISS  259 (375)
Q Consensus       240 ~~~~~DiwslG~il~elltg  259 (375)
                        -..|.|.|||++++++.|
T Consensus       182 --~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  182 --WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             --cchhhhhHHHHHHHHhCc
Confidence              246999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.47  E-value=2.9e-13  Score=111.48  Aligned_cols=127  Identities=20%  Similarity=0.175  Sum_probs=94.8

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeE-EEeeeeecCCceeEEEEecccCCC
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV-SLYGCTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~~~~~  144 (375)
                      .+.|+.|.++.||+++.. +..|++|....... ....+..|+.+++.+.+.+++ +++.+ ..  ...++||||++|.+
T Consensus         3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~-~~--~~~~lv~e~i~G~~   77 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYF-DP--ETGVLITEFIEGSE   77 (170)
T ss_pred             eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEE-eC--CCCeEEEEecCCCc
Confidence            456899999999999875 77899998754432 123457889999988655544 34443 22  23479999999987


Q ss_pred             hhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCc-----eeccCCCCCEEecCCCcEEEeeecccc
Q 017232          145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI-----IHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       145 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~i-----vH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      +....         .   ....++.+++.+|..||+.++     +|+|++|.||+++ ++.++++||+.+.
T Consensus        78 l~~~~---------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          78 LLTED---------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccccc---------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            65430         1   113456789999999999985     9999999999999 6689999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.43  E-value=3.2e-12  Score=105.96  Aligned_cols=138  Identities=17%  Similarity=0.141  Sum_probs=97.4

Q ss_pred             CCccCCCCcEEEEEEEeCC-------CCEEEEEEeccc-------------c---------hhhHHH----HHHHHHHHH
Q 017232           66 ARELGDGGFGTVYYGELQD-------GRAVAVKRLYEN-------------N---------YKRVEQ----FMNEVDILA  112 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~-------------~---------~~~~~~----~~~e~~~l~  112 (375)
                      ...||.|--+.||.|...+       +..+|||+.+..             +         ......    ..+|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            4579999999999996543       478999976311             0         001122    337999999


Q ss_pred             hcCC--CCeEEEeeeeecCCceeEEEEecccCCChhH-hhccCCCCCCCCChHHHHHHHHHHHHHHHHH-hhCCceeccC
Q 017232          113 RLRH--KNLVSLYGCTSRHSRELLLVYEFISNGTVAD-HLHGERAKPGALPWPTRLKIAIETASALTYL-HASDIIHRDV  188 (375)
Q Consensus       113 ~l~h--~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~ivH~dl  188 (375)
                      ++..  -++...+++     ..-+|||||+.+..+.. .+.     ...++..+...+..+++.+|..| |..|++|+||
T Consensus        82 rl~~~Gv~vP~pi~~-----~~~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL  151 (197)
T cd05146          82 RMQKAGIPCPEVVVL-----KKHVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADL  151 (197)
T ss_pred             HHHHcCCCCCeEEEe-----cCCEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            9853  345555543     23479999997653322 221     12244556677889999999998 8999999999


Q ss_pred             CCCCEEecCCCcEEEeeeccccccCC
Q 017232          189 KTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       189 kp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      ++.||++. ++.+.|+|||.+....+
T Consensus       152 s~~NIL~~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         152 SEYNMLWH-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             CHHHEEEE-CCcEEEEECCCceeCCC
Confidence            99999997 46799999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.36  E-value=1.4e-11  Score=98.78  Aligned_cols=129  Identities=27%  Similarity=0.435  Sum_probs=95.0

Q ss_pred             CccCCCCcEEEEEEEeCCCCEEEEEEecccchh--------hHHHHHHHHHHHHhcCCC--CeEEEeeeeecCCceeEEE
Q 017232           67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYK--------RVEQFMNEVDILARLRHK--NLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~~~~~lv  136 (375)
                      ..+++|+-+.+|.+.+. |.++++|.-.+..+.        ....-.+|+.++.+++--  ++..++++.   .....|+
T Consensus         2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD---~~~~~I~   77 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVD---PDNGLIV   77 (204)
T ss_pred             chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEc---CCCCEEE
Confidence            35889999999999775 445777754332111        123456789998888533  233344322   3345799


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      |||++|..|.+.+...           ...++..+-..+.-||..||+|+||.++||++..++ +.++|||++..
T Consensus        78 me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          78 MEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999999888533           245777888888999999999999999999998776 99999999874

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.36  E-value=5.4e-11  Score=108.93  Aligned_cols=172  Identities=19%  Similarity=0.268  Sum_probs=128.4

Q ss_pred             CcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeee---cCCceeEEEEecccC-CChhH
Q 017232           73 GFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS---RHSRELLLVYEFISN-GTVAD  147 (375)
Q Consensus        73 ~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~---~~~~~~~lv~e~~~~-~~L~~  147 (375)
                      .-.+.|++.. .+|..|++|+++.+..........-++.++++.|+|+|++.+++.   .++..+++|++|.++ ++|.+
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            3456899944 489999999994443322223345678899999999999988544   345678999999986 46776


Q ss_pred             hhccCC-----------CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          148 HLHGER-----------AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       148 ~l~~~~-----------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ......           ..+..+++...|.++.|+..||.++|+.|+..+-|.|.+|+++++..++|+..|....+..+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP  447 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence            654322           123457789999999999999999999999999999999999999999998888766543322


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPA  262 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  262 (375)
                      .               |-+.+   -.+-|.=.||.+++.|.||..-
T Consensus       448 ~---------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  448 T---------------EPLES---QQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             C---------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence            0               11111   2367999999999999999653

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.35  E-value=5e-11  Score=106.57  Aligned_cols=270  Identities=19%  Similarity=0.172  Sum_probs=166.3

Q ss_pred             CCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEee-----eee-cCCceeEEE
Q 017232           64 DSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYG-----CTS-RHSRELLLV  136 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~-----~~~-~~~~~~~lv  136 (375)
                      ...+.||+|+-+.+|-..--  ...+.|+..........+...|   |... .||-+..-+.     .+. ..+...-++
T Consensus        14 ~~gr~LgqGgea~ly~l~e~--~d~VAKIYh~Pppa~~aqk~a~---la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGfl   88 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGEV--RDQVAKIYHAPPPAAQAQKVAE---LAATPDAPLLNYRVAWPQATLHGGRRGKVIGFL   88 (637)
T ss_pred             CCCccccCCccceeeecchh--hchhheeecCCCchHHHHHHHH---hccCCCCcchhhhhcccHHHhhCCCccceeEEe
Confidence            34678999999999965221  1235677766554433332222   2222 4553332111     111 112336778


Q ss_pred             EecccCCC-hhHhhccC--CCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          137 YEFISNGT-VADHLHGE--RAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       137 ~e~~~~~~-L~~~l~~~--~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      |..+.+.. ...++...  +..-....|....++++.++.+...||..|.+-+|++++|+|+.+++.+.|.|-+......
T Consensus        89 mP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~  168 (637)
T COG4248          89 MPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINA  168 (637)
T ss_pred             cccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeecc
Confidence            88887653 33333211  1223457799999999999999999999999999999999999999999999865544332


Q ss_pred             CCccccccCCCCCccccCccccc-----ccCCCCchhHHHHHHHHHHHHhC-CCCccccccccccchhHHHHHHhhhhHH
Q 017232          214 NHVTHVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVFSFGVVLIELISS-MPAVDITRHRHEINLSNLAINKIQNKAL  287 (375)
Q Consensus       214 ~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (375)
                      +  .....+.+|.+.|.+||.-.     +..-+...|.|.||+++++++.| ++||..........-..  ...+..+.+
T Consensus       169 n--g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~--E~~Ia~g~f  244 (637)
T COG4248         169 N--GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPL--ETDIAHGRF  244 (637)
T ss_pred             C--CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcc--hhhhhccee
Confidence            2  23345667999999999643     44567789999999999999876 99996432211100000  000111111


Q ss_pred             HHHHhhhcCC---CCChHHHHHHHHHHHHHHHhcCC--CCCCCCCHHHHHHHHHhhhcCC
Q 017232          288 HELVDQTLGY---ESDNKVRRTINAVAELAFQCLQS--EKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       288 ~~~~~~~l~~---~~~~~~~~~~~~l~~li~~cl~~--~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      ....+..-..   .......-++..+.-+..+|+..  ++.-|||++.++..|..+.+..
T Consensus       245 ~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L  304 (637)
T COG4248         245 AYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQL  304 (637)
T ss_pred             eechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhh
Confidence            0011111110   11122233456777888899864  3678999999999999877643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.31  E-value=1.4e-12  Score=121.35  Aligned_cols=248  Identities=21%  Similarity=0.239  Sum_probs=174.5

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEEe--CCCCEEEEEEecccchhhHHH--HHHHHHHHHhc-CCCCeEEEeeeeecCCc
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGEL--QDGRAVAVKRLYENNYKRVEQ--FMNEVDILARL-RHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~~~~~~~--~~~e~~~l~~l-~h~niv~~~~~~~~~~~  131 (375)
                      .....+|..+..||.|.|+.|+....  .++..|++|.+.+.-.....+  -..|+-+...+ .|.+++..+..+.+ ..
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~-~r  339 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQ-LR  339 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccc-cc
Confidence            33456788899999999999998843  368889999886654433322  23466666666 48888887776666 34


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC-CcEEEeeecccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN-FCVKVADFGLSR  210 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~  210 (375)
                      ..++--|||+++++.....    -...+.+...+.+..|++.++.++|+..++|+|++|+||++..+ +..+++|||+..
T Consensus       340 ~~~ip~e~~~~~s~~l~~~----~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t  415 (524)
T KOG0601|consen  340 QGYIPLEFCEGGSSSLRSV----TSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWT  415 (524)
T ss_pred             cccCchhhhcCcchhhhhH----HHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccc
Confidence            5679999999998776662    23457788889999999999999999999999999999999886 888999999986


Q ss_pred             ccCCCccccccCCCCCcccc--CcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          211 LFPNHVTHVSTAPQGTPGYV--DPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~--aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      .+.-..    .......++.  +++......+..+.|++|||..+.+..+|.+.-........          +..+   
T Consensus       416 ~~~~~~----~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~----------i~~~---  478 (524)
T KOG0601|consen  416 RLAFSS----GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT----------IRSG---  478 (524)
T ss_pred             ccceec----ccccccccccccchhhccccccccccccccccccccccccCcccCccccccee----------eecc---
Confidence            432111    1111333344  55566677888899999999999999998765443221110          0000   


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                               .. +........+..+...++..++..||.+.++....+
T Consensus       479 ---------~~-p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~  516 (524)
T KOG0601|consen  479 ---------DT-PNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE  516 (524)
T ss_pred             ---------cc-cCCCchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence                     00 000111245677888999999999999887765544

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.30  E-value=3.2e-11  Score=103.80  Aligned_cols=140  Identities=22%  Similarity=0.283  Sum_probs=103.2

Q ss_pred             CccCCCCcEEEEEEEeCCCCEEEEEEecccch-hhHHHHHHHHHHHHhcCCC--CeEEEeeeeecCC--ceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNY-KRVEQFMNEVDILARLRHK--NLVSLYGCTSRHS--RELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~--niv~~~~~~~~~~--~~~~lv~e~~~  141 (375)
                      +.|+.|..+.||++...+|..+++|....... .....+..|+.++..+.+.  ++.+++.+.....  +..++||||++
T Consensus         4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~   83 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD   83 (223)
T ss_pred             eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence            56899999999999887678999998755432 1345678899999999753  3455665443321  25689999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-----------------------------------------
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-----------------------------------------  180 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-----------------------------------------  180 (375)
                      |.++.+.+..     ..++..+...++.+++.+|..||+                                         
T Consensus        84 G~~l~~~~~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (223)
T cd05154          84 GRVLRDRLLR-----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAME  158 (223)
T ss_pred             CEecCCCCCC-----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHH
Confidence            9888776521     235666666777777777777773                                         


Q ss_pred             ---------------CCceeccCCCCCEEecC--CCcEEEeeeccccc
Q 017232          181 ---------------SDIIHRDVKTNNILLDN--NFCVKVADFGLSRL  211 (375)
Q Consensus       181 ---------------~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~  211 (375)
                                     ..++|+|+.|.||+++.  ++.+.|+||+.+..
T Consensus       159 ~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         159 RLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           23699999999999998  67789999998763

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.30  E-value=5.2e-11  Score=95.07  Aligned_cols=141  Identities=26%  Similarity=0.324  Sum_probs=99.5

Q ss_pred             CCCccCCCCcEEEEEEEeCCCCEEEEEEecccchh--------hHHHHHHHHHHHHhcCCCCe--EEEeeeeecCCceeE
Q 017232           65 SARELGDGGFGTVYYGELQDGRAVAVKRLYENNYK--------RVEQFMNEVDILARLRHKNL--VSLYGCTSRHSRELL  134 (375)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~--------~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~  134 (375)
                      ....+-+|+-+.|+++.+. |+.++||.-....+.        ......+|+..+.++.--.|  ..++. +..  ..-.
T Consensus        11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~-~D~--~~~~   86 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIF-IDT--YGGQ   86 (229)
T ss_pred             cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEE-Eec--CCCe
Confidence            5677999999999999886 788888865433221        13456678988888753222  22222 222  2236


Q ss_pred             EEEecccC-CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc---EEEeeecccc
Q 017232          135 LVYEFISN-GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC---VKVADFGLSR  210 (375)
Q Consensus       135 lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~  210 (375)
                      |+|||++| .++.+++......  .........++..|-+.+.-||..+++|+||..+||++..++.   +.++|||++.
T Consensus        87 i~ME~~~g~~~vk~~i~~~~~~--~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~  164 (229)
T KOG3087|consen   87 IYMEFIDGASTVKDFILSTMED--ESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSS  164 (229)
T ss_pred             EEEEeccchhHHHHHHHHHccC--cccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchh
Confidence            89999976 4788887654322  1222333788999999999999999999999999999975553   5899999986


Q ss_pred             c
Q 017232          211 L  211 (375)
Q Consensus       211 ~  211 (375)
                      .
T Consensus       165 ~  165 (229)
T KOG3087|consen  165 V  165 (229)
T ss_pred             c
Confidence            4

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.25  E-value=1.3e-10  Score=96.02  Aligned_cols=126  Identities=26%  Similarity=0.275  Sum_probs=83.4

Q ss_pred             EEEEEEeCCCCEEEEEEecccch--------------------------hhHHHHHHHHHHHHhcCCC--CeEEEeeeee
Q 017232           76 TVYYGELQDGRAVAVKRLYENNY--------------------------KRVEQFMNEVDILARLRHK--NLVSLYGCTS  127 (375)
Q Consensus        76 ~V~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~--niv~~~~~~~  127 (375)
                      .||.|...+|..+|+|+......                          .......+|++.|..+..-  ++.+.+++ .
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-~   79 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-N   79 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE-E
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE-e
Confidence            38999888899999998632100                          0123467899999999765  45555553 2


Q ss_pred             cCCceeEEEEeccc--CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHH-HhhCCceeccCCCCCEEecCCCcEEEe
Q 017232          128 RHSRELLLVYEFIS--NGTVADHLHGERAKPGALPWPTRLKIAIETASALTY-LHASDIIHRDVKTNNILLDNNFCVKVA  204 (375)
Q Consensus       128 ~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~-Lh~~~ivH~dlkp~Nill~~~~~~kl~  204 (375)
                      .    -+|||||++  |..+..+....      ++......++.+++..+.. +|..|++|+|+++.||+++++ .+.|+
T Consensus        80 ~----~~ivME~I~~~G~~~~~l~~~~------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI  148 (188)
T PF01163_consen   80 R----NVIVMEYIGEDGVPLPRLKDVD------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII  148 (188)
T ss_dssp             T----TEEEEE--EETTEEGGCHHHCG------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred             C----CEEEEEecCCCccchhhHHhcc------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence            2    369999998  65555443211      2234567788888885555 679999999999999999988 89999


Q ss_pred             eeccccccC
Q 017232          205 DFGLSRLFP  213 (375)
Q Consensus       205 Dfg~~~~~~  213 (375)
                      |||.+....
T Consensus       149 Df~qav~~~  157 (188)
T PF01163_consen  149 DFGQAVDSS  157 (188)
T ss_dssp             -GTTEEETT
T ss_pred             ecCcceecC
Confidence            999887543

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.20  E-value=5.1e-12  Score=124.05  Aligned_cols=249  Identities=19%  Similarity=0.242  Sum_probs=167.6

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ..+.+.+.+-+-+|.++.++.+.-. .|...++|+.....   ....+....+-.++-...+|-++....-+ ......+
T Consensus       802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-~~rsP~~  880 (1205)
T KOG0606|consen  802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-PCRSPLP  880 (1205)
T ss_pred             CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-CCCCCcc
Confidence            3455677778999999999987433 34444444332221   11112222233333333456666544322 2356789


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      |+++|+.+++|...++..    +..+...+......+..++++||+..+.|+|++|.|.++..++..++.||+.....+.
T Consensus       881 L~~~~~~~~~~~Skl~~~----~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  881 LVGHYLNGGDLPSKLHNS----GCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             hhhHHhccCCchhhhhcC----CCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            999999999999998643    2355555666777888999999999999999999999999999999999984322210


Q ss_pred             C------------------------------ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCcc
Q 017232          215 H------------------------------VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD  264 (375)
Q Consensus       215 ~------------------------------~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~  264 (375)
                      .                              .........+|+.|.+||...+......+|+|++|++++|.++|.+||+
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~n 1036 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFN 1036 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCC
Confidence            0                              0011223458999999999999999999999999999999999999998


Q ss_pred             ccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHH
Q 017232          265 ITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMV  329 (375)
Q Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~  329 (375)
                      ...+....               ..+....+  ....-+........+++...+..+|.+|-.+.
T Consensus      1037 a~tpq~~f---------------~ni~~~~~--~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1037 AETPQQIF---------------ENILNRDI--PWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             Ccchhhhh---------------hccccCCC--CCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            76543211               11111111  11122233445688899999999999998876

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.19  E-value=3.2e-10  Score=96.48  Aligned_cols=137  Identities=20%  Similarity=0.146  Sum_probs=102.9

Q ss_pred             CCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccc----------------------hhhHHHHHHHHHHHHhcCCC--
Q 017232           62 YFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENN----------------------YKRVEQFMNEVDILARLRHK--  117 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~----------------------~~~~~~~~~e~~~l~~l~h~--  117 (375)
                      -+.+..+||-|--+.||.|....|.++|+|.=....                      .-......+|.++|..|...  
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HHhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            356678999999999999999999999999532110                      01123467899999999644  


Q ss_pred             CeEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       118 niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      .+.+.++     .+.-++|||+++|..|...-         ++......++..|+.-+..+-..|+||+|+++-||++++
T Consensus       172 ~VP~P~~-----~nRHaVvMe~ieG~eL~~~r---------~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~  237 (304)
T COG0478         172 KVPKPIA-----WNRHAVVMEYIEGVELYRLR---------LDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTE  237 (304)
T ss_pred             CCCCccc-----cccceeeeehcccceeeccc---------CcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEec
Confidence            4555554     23357999999986665432         234455667777788787777999999999999999999


Q ss_pred             CCcEEEeeecccccc
Q 017232          198 NFCVKVADFGLSRLF  212 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~  212 (375)
                      +|.+.++||-.+...
T Consensus       238 dg~~~vIDwPQ~v~~  252 (304)
T COG0478         238 DGDIVVIDWPQAVPI  252 (304)
T ss_pred             CCCEEEEeCcccccC
Confidence            999999999987643

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.15  E-value=1.5e-09  Score=95.15  Aligned_cols=139  Identities=16%  Similarity=0.127  Sum_probs=95.7

Q ss_pred             cCCCCcEEEEEEEeCCCCEEEEEEecccchhh-HH----------HHHHHHHHHHhcCCCC--eEEEeeeeecC----Cc
Q 017232           69 LGDGGFGTVYYGELQDGRAVAVKRLYENNYKR-VE----------QFMNEVDILARLRHKN--LVSLYGCTSRH----SR  131 (375)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-~~----------~~~~e~~~l~~l~h~n--iv~~~~~~~~~----~~  131 (375)
                      +-......|.+... +|+.|.||......... .+          .+.+|+..+..+...+  +...+++....    ..
T Consensus        30 v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~  108 (268)
T PRK15123         30 FRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATR  108 (268)
T ss_pred             EecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccc
Confidence            33333344667665 47889999775443221 11          3678888887774222  22233322211    23


Q ss_pred             eeEEEEecccCC-ChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC-------CCcEEE
Q 017232          132 ELLLVYEFISNG-TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-------NFCVKV  203 (375)
Q Consensus       132 ~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~-------~~~~kl  203 (375)
                      .-+||||++++. +|.+++....  ....+......++.+++..+..||..|++|+|+++.|||++.       +..+.+
T Consensus       109 ~s~LVte~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~L  186 (268)
T PRK15123        109 TSFIITEDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSV  186 (268)
T ss_pred             eeEEEEeeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEE
Confidence            468999999876 7988885332  133456677789999999999999999999999999999975       467999


Q ss_pred             eeecccc
Q 017232          204 ADFGLSR  210 (375)
Q Consensus       204 ~Dfg~~~  210 (375)
                      +||+.+.
T Consensus       187 IDl~r~~  193 (268)
T PRK15123        187 IDLHRAQ  193 (268)
T ss_pred             EECCccc
Confidence            9999875

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.97  E-value=9.1e-11  Score=111.10  Aligned_cols=148  Identities=20%  Similarity=0.235  Sum_probs=105.0

Q ss_pred             HHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc--------cCCCCCccccCcccccccCC
Q 017232          170 ETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS--------TAPQGTPGYVDPEYHQCYQL  240 (375)
Q Consensus       170 ~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~  240 (375)
                      +++.|+.|+|.. ++||++|.|++|.++.++..||+.|+.+...........        ........|.|||++.+...
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            445899999987 899999999999999999999999998765443222111        11124568999999998888


Q ss_pred             CCchhHHHHHHHHHHHH-hCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcC
Q 017232          241 TDKSDVFSFGVVLIELI-SSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQ  319 (375)
Q Consensus       241 ~~~~DiwslG~il~ell-tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~  319 (375)
                      +.++|+||+|+++|.+. +|+..+...+......+.....         +.-..       ....+.+.++.+-+.+++.
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~---------~~~~~-------~~s~~~p~el~~~l~k~l~  250 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL---------NAGAF-------GYSNNLPSELRESLKKLLN  250 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc---------ccccc-------cccccCcHHHHHHHHHHhc
Confidence            99999999999999999 6777776554332211111100         00000       0012355678888999999


Q ss_pred             CCCCCCCCHHHHHH
Q 017232          320 SEKDLRPYMVDVLD  333 (375)
Q Consensus       320 ~~P~~Rpt~~evl~  333 (375)
                      .++.-||++.++..
T Consensus       251 ~~~~~rp~~~~l~~  264 (700)
T KOG2137|consen  251 GDSAVRPTLDLLLS  264 (700)
T ss_pred             CCcccCcchhhhhc
Confidence            99999998776653

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.93  E-value=1.6e-08  Score=85.85  Aligned_cols=106  Identities=23%  Similarity=0.235  Sum_probs=78.5

Q ss_pred             HHHHHHHHHHHhcCCC--CeEEEeeeeecC---CceeEEEEecccCC-ChhHhhccCCCCCCCCChHHHHHHHHHHHHHH
Q 017232          102 EQFMNEVDILARLRHK--NLVSLYGCTSRH---SRELLLVYEFISNG-TVADHLHGERAKPGALPWPTRLKIAIETASAL  175 (375)
Q Consensus       102 ~~~~~e~~~l~~l~h~--niv~~~~~~~~~---~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l  175 (375)
                      ....+|...+..|..-  .+...+++....   ....++|+|++++. +|.+++.....    .+......++.+++..+
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~----~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ----LDPSQRRELLRALARLI  131 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc----cchhhHHHHHHHHHHHH
Confidence            3567788777776422  223333332221   13458999999874 78988854321    55667788999999999


Q ss_pred             HHHhhCCceeccCCCCCEEecCCC---cEEEeeeccccc
Q 017232          176 TYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRL  211 (375)
Q Consensus       176 ~~Lh~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~  211 (375)
                      .-||..|++|+|+++.|||++.++   .+.++||+-+..
T Consensus       132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999999887   899999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.92  E-value=4.4e-08  Score=81.57  Aligned_cols=139  Identities=18%  Similarity=0.142  Sum_probs=99.5

Q ss_pred             cCCCCcEEEEEEEeCCCCEEEEEEecccc------hhhHHHHHHHHHHHHhcCCCC--eEEEeeee-e--cCCceeEEEE
Q 017232           69 LGDGGFGTVYYGELQDGRAVAVKRLYENN------YKRVEQFMNEVDILARLRHKN--LVSLYGCT-S--RHSRELLLVY  137 (375)
Q Consensus        69 lg~G~~g~V~~~~~~~~~~vaiK~~~~~~------~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~-~--~~~~~~~lv~  137 (375)
                      -|+||.+-|++.... |..+-+|.-....      +-....|.+|+..+..|..-+  +.+...+. .  .....-+||+
T Consensus        26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT  104 (216)
T PRK09902         26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT  104 (216)
T ss_pred             cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence            567899999998776 4478899764211      223467889999998885322  33333211 1  1122357999


Q ss_pred             ecccC-CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc--EEEeeecccc
Q 017232          138 EFISN-GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC--VKVADFGLSR  210 (375)
Q Consensus       138 e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~  210 (375)
                      |-+.+ -+|.+++....  -.+.+..+...++.+++..+.-||+.|+.|+|+.+.||+++.++.  +.++||.-++
T Consensus       105 e~L~g~~~L~~~l~~~~--~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        105 EDMAGFISIADWYAQHA--VSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             EeCCCCccHHHHHhcCC--cCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            97754 47888874431  224567777899999999999999999999999999999986677  9999998765

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.89  E-value=6.8e-09  Score=98.56  Aligned_cols=142  Identities=20%  Similarity=0.211  Sum_probs=93.9

Q ss_pred             CccCCCCcEEEEEEEeCCCCEEEEEEecccchhhH----------------------------------------HHHHH
Q 017232           67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV----------------------------------------EQFMN  106 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~----------------------------------------~~~~~  106 (375)
                      ..|+.++-|.||+|+.++|+.||||+..++-.+..                                        -++.+
T Consensus       131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~  210 (517)
T COG0661         131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR  210 (517)
T ss_pred             CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence            67999999999999999999999999865422110                                        01334


Q ss_pred             HHHHHHhcC----CCCeEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHH-HHHHhhC
Q 017232          107 EVDILARLR----HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA-LTYLHAS  181 (375)
Q Consensus       107 e~~~l~~l~----h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~-l~~Lh~~  181 (375)
                      |..-+.+++    ...-+.+-..+.+....-.|+|||++|-.+.+...-.   ...++...   ++..++.+ +..+-..
T Consensus       211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~---~~g~d~k~---ia~~~~~~f~~q~~~d  284 (517)
T COG0661         211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALK---SAGIDRKE---LAELLVRAFLRQLLRD  284 (517)
T ss_pred             HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHH---hcCCCHHH---HHHHHHHHHHHHHHhc
Confidence            444444442    2223333334444345568999999998888774211   12244322   22222222 3344447


Q ss_pred             CceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       182 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      |+.|.|.+|.||+++.+|.+.+.|||+...++.
T Consensus       285 gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         285 GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            999999999999999999999999999866543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.80  E-value=1.1e-07  Score=80.38  Aligned_cols=152  Identities=20%  Similarity=0.156  Sum_probs=101.5

Q ss_pred             cchHHHHHHhcCCCCCC---ccCCCCcEEEEEEEeCCCCEEEEEEecccchhh------------------------HHH
Q 017232           51 FSYGELEEATNYFDSAR---ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKR------------------------VEQ  103 (375)
Q Consensus        51 ~~~~~~~~~~~~y~~~~---~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~------------------------~~~  103 (375)
                      .+...+....++..+..   .|+.|--+.||+|...++..+|+|++......-                        ...
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W  114 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW  114 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence            34445555555554443   567888899999988889999999885321110                        011


Q ss_pred             HHHHHHHHHhcC--CCCeEEEeeeeecCCceeEEEEecccCCC-hhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh
Q 017232          104 FMNEVDILARLR--HKNLVSLYGCTSRHSRELLLVYEFISNGT-VADHLHGERAKPGALPWPTRLKIAIETASALTYLHA  180 (375)
Q Consensus       104 ~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~lv~e~~~~~~-L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~  180 (375)
                      ...|+.-|.++.  +-.+.+-+.+.     .-.|||||+.... -.-.|     +.-.+...++..+..++++.+.-|-.
T Consensus       115 ~~kEf~NL~R~~eAGVrvP~Pi~~~-----~nVLvMEfIg~~g~pAP~L-----kDv~~e~~e~~~~~~~~v~~~~~l~~  184 (268)
T COG1718         115 ARKEFRNLKRAYEAGVRVPEPIAFR-----NNVLVMEFIGDDGLPAPRL-----KDVPLELEEAEGLYEDVVEYMRRLYK  184 (268)
T ss_pred             HHHHHHHHHHHHHcCCCCCCceeec-----CCeEEEEeccCCCCCCCCc-----ccCCcCchhHHHHHHHHHHHHHHHHH
Confidence            345777777774  33333444422     2369999995431 11111     11223333677788899999998888


Q ss_pred             -CCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          181 -SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       181 -~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                       .++||+||+.-|||+. ++.+.|+|||.+....
T Consensus       185 ~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         185 EAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             hcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence             8999999999999999 8899999999987654

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.80  E-value=1.3e-07  Score=79.13  Aligned_cols=138  Identities=19%  Similarity=0.258  Sum_probs=91.6

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHH---------HHHHHHHHHhcC---CCCeEEEeeee
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQ---------FMNEVDILARLR---HKNLVSLYGCT  126 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~---------~~~e~~~l~~l~---h~niv~~~~~~  126 (375)
                      ..++|++.+.+-......|.+.... |..+++|..........+.         ..+.+..+..++   -...+.++.+.
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~  107 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA  107 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence            3577888888888888888887775 6889999876554322222         123333333332   22222322211


Q ss_pred             e----cCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEE
Q 017232          127 S----RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVK  202 (375)
Q Consensus       127 ~----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~k  202 (375)
                      .    .-....+++|||++|..|.+...        +++    .+...+.+++.-||..|++|+|.+|.|+++++++ ++
T Consensus       108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~--------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~  174 (229)
T PF06176_consen  108 EKKIFRYTSSYVLLMEYIEGVELNDIED--------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IR  174 (229)
T ss_pred             eeeeccceeEEEEEEEEecCeecccchh--------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EE
Confidence            1    11234578999999988776541        222    2445677889999999999999999999998655 99


Q ss_pred             Eeeecccc
Q 017232          203 VADFGLSR  210 (375)
Q Consensus       203 l~Dfg~~~  210 (375)
                      ++||+...
T Consensus       175 iID~~~k~  182 (229)
T PF06176_consen  175 IIDTQGKR  182 (229)
T ss_pred             EEECcccc
Confidence            99998654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.66  E-value=4.3e-07  Score=78.08  Aligned_cols=135  Identities=16%  Similarity=0.221  Sum_probs=79.1

Q ss_pred             CccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCe--EEEeeeeecCCceeEEEEecccCCC
Q 017232           67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL--VSLYGCTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~lv~e~~~~~~  144 (375)
                      .+||+|..+.||+.   .+..+++|......  ......+|.++++.+..-.+  .+.+++... .....+|||+++|.+
T Consensus         7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~-~~~~glv~e~i~G~~   80 (226)
T TIGR02172         7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVED-GGRLGLIYELIVGKR   80 (226)
T ss_pred             eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEec-CCeeeeeeeecCCcc
Confidence            56899999999984   24567888775433  22456789999988853333  444543333 455788999999863


Q ss_pred             -hhHhh---------------------ccCCCCCCCCChHHHHHHH-H----------HHHH-HHHHHhh----CCceec
Q 017232          145 -VADHL---------------------HGERAKPGALPWPTRLKIA-I----------ETAS-ALTYLHA----SDIIHR  186 (375)
Q Consensus       145 -L~~~l---------------------~~~~~~~~~l~~~~~~~i~-~----------~i~~-~l~~Lh~----~~ivH~  186 (375)
                       +...+                     +......  .+......-. .          .+.. ...+|..    ..++|+
T Consensus        81 ~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~--~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~Hg  158 (226)
T TIGR02172        81 SFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDT--STFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHG  158 (226)
T ss_pred             chhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCC--CcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEec
Confidence             21111                     1110011  1111100000 0          0011 1122221    147899


Q ss_pred             cCCCCCEEecCCCcEEEeeecccc
Q 017232          187 DVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       187 dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      |+.|.||++++++ +.++||+.+.
T Consensus       159 D~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       159 DFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CCCCCcEEEcCCC-cEEEechhcC
Confidence            9999999999888 9999999875

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.59  E-value=5.3e-07  Score=72.17  Aligned_cols=130  Identities=21%  Similarity=0.230  Sum_probs=93.3

Q ss_pred             CCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCC
Q 017232           64 DSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG  143 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~  143 (375)
                      +..+.|++|++|.||++.+. |..+|+|+-..+.+.  ..+..|+++|..+.-.++.+-+-.+..    -++.|||+.|-
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~ds~r--~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~   97 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-GGEVALKVRRRDSPR--RNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGR   97 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-CceEEEEEecCCcch--hhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCc
Confidence            44678999999999999987 458899987655433  567889999999987777654432322    24569999988


Q ss_pred             ChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCC-CCEEecCCCcEEEeeeccccc
Q 017232          144 TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKT-NNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       144 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp-~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      +|.++-...       +    .+-...+++..--|-..||-|+.|+- ...++.+++.+.|+||..|+.
T Consensus        98 ~L~~~~~~~-------~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~  155 (201)
T COG2112          98 PLGKLEIGG-------D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATF  155 (201)
T ss_pred             chhhhhhcc-------c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhh
Confidence            888776321       1    23345566666677788999999874 444444555899999998873

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.57  E-value=6.7e-07  Score=84.91  Aligned_cols=144  Identities=18%  Similarity=0.195  Sum_probs=92.4

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhh-------------------------------HH------HHHHHH
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKR-------------------------------VE------QFMNEV  108 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-------------------------------~~------~~~~e~  108 (375)
                      .+.||.-+.|.||+|+.++|+.||||+-++.-...                               .+      +|.+|+
T Consensus       166 ~~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  166 EEPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             cchhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            36799999999999999999999999876542211                               01      123333


Q ss_pred             HH----HHhcCCCC---eEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC
Q 017232          109 DI----LARLRHKN---LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS  181 (375)
Q Consensus       109 ~~----l~~l~h~n---iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~  181 (375)
                      +-    .+.+.|-+   -|.+-.++.+......|+|||++|..+.+.-.-   ....++...+...+.+..  ++-+-..
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i---~~~gi~~~~i~~~l~~~~--~~qIf~~  320 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAI---DKRGISPHDILNKLVEAY--LEQIFKT  320 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHH---HHcCCCHHHHHHHHHHHH--HHHHHhc
Confidence            32    22334555   222333444445567899999999877665321   122355554443333322  2233345


Q ss_pred             CceeccCCCCCEEec----CCCcEEEeeeccccccCC
Q 017232          182 DIIHRDVKTNNILLD----NNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       182 ~ivH~dlkp~Nill~----~~~~~kl~Dfg~~~~~~~  214 (375)
                      |++|+|-.|.||++.    .++.+.+.|||+......
T Consensus       321 GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  321 GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            899999999999998    467899999999876543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.53  E-value=5.7e-07  Score=77.89  Aligned_cols=79  Identities=19%  Similarity=0.238  Sum_probs=55.3

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCC--eEEEeeeee--cCCceeEEEEeccc
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN--LVSLYGCTS--RHSRELLLVYEFIS  141 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~--~~~~~~~lv~e~~~  141 (375)
                      ++.|+.|..+.||+....+ ..+++|.....  .....+..|..+++.+....  +.+++....  ......+++|++++
T Consensus         2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~   78 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP   78 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred             CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence            3568999999999999887 68999987555  44566778888888885332  344554221  22334689999999


Q ss_pred             CCChhH
Q 017232          142 NGTVAD  147 (375)
Q Consensus       142 ~~~L~~  147 (375)
                      |..+..
T Consensus        79 g~~~~~   84 (239)
T PF01636_consen   79 GRPLDD   84 (239)
T ss_dssp             SEEHHH
T ss_pred             cccccc
Confidence            887777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.43  E-value=9.6e-06  Score=67.77  Aligned_cols=133  Identities=23%  Similarity=0.321  Sum_probs=92.6

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccc----------------hhhHHHHHHHHHHHHhcC------CCCeEEEe
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENN----------------YKRVEQFMNEVDILARLR------HKNLVSLY  123 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~----------------~~~~~~~~~e~~~l~~l~------h~niv~~~  123 (375)
                      ...||+|+.-.||.  +.++...+||+.....                .....+..+|+.....+.      +.+|.+++
T Consensus         6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            56799999999995  4456668899886655                122455667777666665      78899999


Q ss_pred             eeeecCCceeEEEEecccC------CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          124 GCTSRHSRELLLVYEFISN------GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       124 ~~~~~~~~~~~lv~e~~~~------~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      |..+. +.-..+|+|.+..      .+|.+++.     .+.++.    .+...+-+-.++|-..+|+.+|++|.||++..
T Consensus        84 G~veT-~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~----~~~~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~  153 (199)
T PF10707_consen   84 GFVET-NLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE----ELRQALDEFKRYLLDHHIVIRDLNPHNIVVQR  153 (199)
T ss_pred             EEEec-CCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH----HHHHHHHHHHHHHHHcCCeecCCCcccEEEEe
Confidence            97666 4556888887643      26777773     223444    33444455567888899999999999999953


Q ss_pred             CC----cEEEee-ecccc
Q 017232          198 NF----CVKVAD-FGLSR  210 (375)
Q Consensus       198 ~~----~~kl~D-fg~~~  210 (375)
                      ..    .+.|+| ||...
T Consensus       154 ~~~~~~~lvlIDG~G~~~  171 (199)
T PF10707_consen  154 RDSGEFRLVLIDGLGEKE  171 (199)
T ss_pred             cCCCceEEEEEeCCCCcc
Confidence            22    577777 56543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.36  E-value=7.3e-06  Score=71.58  Aligned_cols=137  Identities=17%  Similarity=0.113  Sum_probs=80.4

Q ss_pred             cCCCCc-EEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEEEEecccCCChh
Q 017232           69 LGDGGF-GTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVA  146 (375)
Q Consensus        69 lg~G~~-g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~  146 (375)
                      |..|.. ..||+.... +..+++|......   ...+.+|+.+++.+. +--+.+++++... .+..++|||+++|.+|.
T Consensus         6 ~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~lv~e~i~G~~l~   80 (244)
T cd05150           6 VTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSD-DGRAWLLTSAVPGVPAA   80 (244)
T ss_pred             cCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEec-CCccEEEEEeeCCccHh
Confidence            445555 789999765 4778888775443   235667888888884 3334455654443 34578999999987776


Q ss_pred             Hhh-------------------ccCCCCCCCCChH--HHHHHHH--------------------HHHHHHHHHh------
Q 017232          147 DHL-------------------HGERAKPGALPWP--TRLKIAI--------------------ETASALTYLH------  179 (375)
Q Consensus       147 ~~l-------------------~~~~~~~~~l~~~--~~~~i~~--------------------~i~~~l~~Lh------  179 (375)
                      ...                   +.......++...  .......                    .+...+..|-      
T Consensus        81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  160 (244)
T cd05150          81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE  160 (244)
T ss_pred             HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence            432                   1110000011100  0000000                    0111122221      


Q ss_pred             -hCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          180 -ASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       180 -~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                       ...++|+|+.|.|||+++++.+.|+||+.+.
T Consensus       161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             CceEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence             1248999999999999998888899999775

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.33  E-value=2.6e-05  Score=64.88  Aligned_cols=102  Identities=23%  Similarity=0.265  Sum_probs=79.3

Q ss_pred             HHHHHHHHhcCC-CCeEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC--
Q 017232          105 MNEVDILARLRH-KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS--  181 (375)
Q Consensus       105 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--  181 (375)
                      ..|.-+++.+.+ +++.+++|.|..     ++|.||...+++....... ..--.-+|..+.+++.++++.+.+|+..  
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~-----~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~   80 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR-----FYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELDHGPL   80 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC-----EEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHhcCCC
Confidence            358888888975 699999998754     5799999877654321000 0112368999999999999999999983  


Q ss_pred             -CceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          182 -DIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       182 -~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                       .+.-.|++++|+-+++++.+|++|.+.....
T Consensus        81 ~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   81 GFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             CcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence             5777999999999999999999999876543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK05231 homoserine kinase; Provisional

Probab=98.30  E-value=2.4e-05  Score=71.28  Aligned_cols=156  Identities=15%  Similarity=0.185  Sum_probs=82.8

Q ss_pred             cchHHHHHHhcCCCC-----CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-----CCCeE
Q 017232           51 FSYGELEEATNYFDS-----ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-----HKNLV  120 (375)
Q Consensus        51 ~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv  120 (375)
                      .+..++......|.+     .+.|+.|....+|+.+..+| .+++|+......   +.+..|+.++..|.     .|.++
T Consensus         7 ls~~~l~~~l~~y~~~~~~~~~~l~~G~~n~~y~v~t~~g-~~vLK~~~~~~~---~~l~~~~~~l~~L~~~glpvP~~i   82 (319)
T PRK05231          7 VSDDELAAFLAPYDLGELLSLKGIAEGIENSNFFLTTTQG-EYVLTLFERLTA---EDLPFFLGLMQHLAARGVPVPAPV   82 (319)
T ss_pred             CCHHHHHHHHHhcCCchhhccchhccccccceEEEEeCCC-cEEEEEeccCCh---HHhHHHHHHHHHHHHCCCCCCcce
Confidence            344444444445544     35577788889999987665 688898752222   23334555555552     33333


Q ss_pred             EEee--eeecCCceeEEEEecccCCChhH-----------h---hccCCC-------CCCCCCh-HHHHH----------
Q 017232          121 SLYG--CTSRHSRELLLVYEFISNGTVAD-----------H---LHGERA-------KPGALPW-PTRLK----------  166 (375)
Q Consensus       121 ~~~~--~~~~~~~~~~lv~e~~~~~~L~~-----------~---l~~~~~-------~~~~l~~-~~~~~----------  166 (375)
                      +..+  .+....+..+++++|++|..+..           .   ++....       ....+.+ .....          
T Consensus        83 ~~~~G~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (319)
T PRK05231         83 ARRDGAALGELAGKPAAIVTFLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQ  162 (319)
T ss_pred             eCCCCCEeeeeCCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhH
Confidence            3111  11122345789999998864311           1   111000       0001111 11110          


Q ss_pred             --HHHH-HHHHHHHHh-------hCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          167 --IAIE-TASALTYLH-------ASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       167 --i~~~-i~~~l~~Lh-------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                        .+.+ +...++.+.       ..+++|+|+.|+||+++++...-|+||+.+.
T Consensus       163 ~~~l~~~~~~~~~~~~~~~~~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        163 AALLEAELAAQLAFLASAAWPALPRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             HHHHHHHHHHHHHhhhccccccCCcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence              1111 111223332       2379999999999999977666899999875

>PLN02876 acyl-CoA dehydrogenase

Probab=98.26  E-value=1.4e-05  Score=81.96  Aligned_cols=80  Identities=13%  Similarity=0.292  Sum_probs=55.5

Q ss_pred             CCccCCCCcEEEEEEEeCCC---CEEEEEEecccc-hhhHHHHHHHHHHHHhcC-CCCe--EEEeeeeecC--CceeEEE
Q 017232           66 ARELGDGGFGTVYYGELQDG---RAVAVKRLYENN-YKRVEQFMNEVDILARLR-HKNL--VSLYGCTSRH--SRELLLV  136 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~---~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~--~~~~~lv  136 (375)
                      .+.++.|.++.+|+....++   ..+++|+..... ......+.+|+.+++.+. |.++  .+++.++.+.  .+..++|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            56789999999999876654   467888754332 122346789999999995 6654  6666654432  1356899


Q ss_pred             EecccCCCh
Q 017232          137 YEFISNGTV  145 (375)
Q Consensus       137 ~e~~~~~~L  145 (375)
                      |||++|..+
T Consensus       123 ME~v~G~~~  131 (822)
T PLN02876        123 MEYLEGRIF  131 (822)
T ss_pred             EEecCCccc
Confidence            999987643

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.25  E-value=1.2e-07  Score=89.60  Aligned_cols=189  Identities=19%  Similarity=0.178  Sum_probs=131.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCC-eEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN-LVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~lv~e  138 (375)
                      +..+...+-+++|+++.++|.+-...+....+.+...     ....-++++|.+++||| .+..++-+.. ....+++++
T Consensus       241 ~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~-E~~~~i~~~  314 (829)
T KOG0576|consen  241 TKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDG-EDYLWIPMR  314 (829)
T ss_pred             ccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCc-ccccchhhh
Confidence            3445555668899999999885443333445555433     33456889999999999 6665553333 567789999


Q ss_pred             cccCC-ChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          139 FISNG-TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       139 ~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ++.++ +......   .....+...+...+++.-+.+++++|+..=+|+|    ||+..+ +..+..||+....+.... 
T Consensus       315 i~s~~rs~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-  385 (829)
T KOG0576|consen  315 ICSTGRSSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-  385 (829)
T ss_pred             hhcCCccccccCC---hhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCccc-
Confidence            99876 2222211   1112233445566777778889999998778888    776655 678999999987665433 


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCcc
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD  264 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~  264 (375)
                       ......+++.++|||+.....+....|.|++|.--.++--|.+|-.
T Consensus       386 -~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~  431 (829)
T KOG0576|consen  386 -KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS  431 (829)
T ss_pred             -ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence             2344569999999999999899999999999987777776766654

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.24  E-value=4.4e-05  Score=63.31  Aligned_cols=126  Identities=26%  Similarity=0.318  Sum_probs=87.9

Q ss_pred             cCCCCCCccCCCCc-EEEEEEEeCCCCEEEEEEecc---cch------------------hhHHHHHHHHHHHHhc---C
Q 017232           61 NYFDSARELGDGGF-GTVYYGELQDGRAVAVKRLYE---NNY------------------KRVEQFMNEVDILARL---R  115 (375)
Q Consensus        61 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~vaiK~~~~---~~~------------------~~~~~~~~e~~~l~~l---~  115 (375)
                      ..++.++.||.|.- |.||+++.. |..||+|.+..   ...                  .....|..|.....+|   .
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~  115 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG  115 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence            67888999999999 999999986 67999999321   000                  1123466777766665   4


Q ss_pred             CCCe--EEEeeeeecC-----------------CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHH
Q 017232          116 HKNL--VSLYGCTSRH-----------------SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT  176 (375)
Q Consensus       116 h~ni--v~~~~~~~~~-----------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~  176 (375)
                      +.++  |+++|+..-.                 ...+.||.||++...             .+.    ..-+.+|.+-+.
T Consensus       116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~-------------~~~----~~~~~~~~~dl~  178 (207)
T PF13095_consen  116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP-------------PLQ----IRDIPQMLRDLK  178 (207)
T ss_pred             ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc-------------ccc----hhHHHHHHHHHH
Confidence            5666  8998854211                 123467777765432             112    234567778889


Q ss_pred             HHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       177 ~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      .+|..||+-+|+++.|..     .-+|+|||.+
T Consensus       179 ~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999999986     3489999864

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.13  E-value=3.5e-05  Score=66.86  Aligned_cols=74  Identities=18%  Similarity=0.178  Sum_probs=44.1

Q ss_pred             CccCCCCcEE-EEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCC---CeEEEeeeeecC--CceeEEEEecc
Q 017232           67 RELGDGGFGT-VYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHK---NLVSLYGCTSRH--SRELLLVYEFI  140 (375)
Q Consensus        67 ~~lg~G~~g~-V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~--~~~~~lv~e~~  140 (375)
                      +.++.|+... ||+.    +..+++|......  ....+.+|..++..+...   -+...++.....  ....+++|+++
T Consensus         3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~~--~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i   76 (235)
T cd05155           3 EPVDSGGTDNATFRL----GDDMSVRLPSAAG--YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL   76 (235)
T ss_pred             eeccCCCcccceEEc----CCceEEEcCCccc--hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence            4577777764 8875    2357788654322  234788899998887531   222333322111  12347899999


Q ss_pred             cCCChh
Q 017232          141 SNGTVA  146 (375)
Q Consensus       141 ~~~~L~  146 (375)
                      +|.++.
T Consensus        77 ~G~~l~   82 (235)
T cd05155          77 EGETAT   82 (235)
T ss_pred             cCCCCC
Confidence            987764

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=98.12  E-value=5.9e-05  Score=68.26  Aligned_cols=154  Identities=18%  Similarity=0.239  Sum_probs=85.2

Q ss_pred             HHHHHHhcCCCC-----CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCC--eEEEeee-
Q 017232           54 GELEEATNYFDS-----ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN--LVSLYGC-  125 (375)
Q Consensus        54 ~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~-  125 (375)
                      +++......|.+     .+.++.|....+|+....+| .+++|+......  ......|+.++..|....  +.+++.. 
T Consensus        10 ~~l~~~l~~y~~~~~~~i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~~--~~~i~~e~~~l~~L~~~g~pvp~~i~t~   86 (307)
T TIGR00938        10 EEMSSFLDGYDLGELLSLKGIAEGVENSNYLLTTDVG-RYILTLYEKRVK--AEELPFFLALTTHLAARGLPVPKPVKSR   86 (307)
T ss_pred             HHHHHHHHhcCCCCceeccccCCccccceEEEEeCCC-cEEEEEecCCCC--HHHHHHHHHHHHHHHHCCCCCCccccCC
Confidence            444444444544     45677888889999876655 588887654321  223445666666663222  2333321 


Q ss_pred             ----eecCCceeEEEEecccCCChhH--------------hhccCCC---CC--C--CC-ChHHHH------------HH
Q 017232          126 ----TSRHSRELLLVYEFISNGTVAD--------------HLHGERA---KP--G--AL-PWPTRL------------KI  167 (375)
Q Consensus       126 ----~~~~~~~~~lv~e~~~~~~L~~--------------~l~~~~~---~~--~--~l-~~~~~~------------~i  167 (375)
                          .....+..+++++|++|..+..              .++....   ..  .  .+ .|....            ..
T Consensus        87 ~g~~~~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~  166 (307)
T TIGR00938        87 DGRQLSTLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHM  166 (307)
T ss_pred             CCCeehhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHH
Confidence                1122345789999998854321              0111000   00  0  00 011100            00


Q ss_pred             HHHHHHHHHHHhh-------CCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          168 AIETASALTYLHA-------SDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       168 ~~~i~~~l~~Lh~-------~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      ...+...++++..       .+++|+|+.+.||++++++.+.|+||+.+.
T Consensus       167 ~~~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       167 GAELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             HHHHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            1122334555532       589999999999999998877899999875

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.08  E-value=8.2e-05  Score=66.96  Aligned_cols=141  Identities=18%  Similarity=0.211  Sum_probs=82.2

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCC--eEEEeee-----eecCCceeEEEEe
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN--LVSLYGC-----TSRHSRELLLVYE  138 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~-----~~~~~~~~~lv~e  138 (375)
                      .+.|..|....+|+....+ ..+++|+....   .......|+.++..+.+.+  +.+++..     .....+..++|++
T Consensus        19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~~---~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~   94 (296)
T cd05153          19 FEGISAGIENTNYFVTTDS-GRYVLTLFEKV---SAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE   94 (296)
T ss_pred             eecccCccccceEEEEeCC-CcEEEEEcCCC---ChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence            5567888888999987654 46888987542   2345566777777774322  3343331     1112345689999


Q ss_pred             cccCCChhH--------------hhccC----CCC---CCCCChHHHH----------HHHHHHHHHHHHHhh-------
Q 017232          139 FISNGTVAD--------------HLHGE----RAK---PGALPWPTRL----------KIAIETASALTYLHA-------  180 (375)
Q Consensus       139 ~~~~~~L~~--------------~l~~~----~~~---~~~l~~~~~~----------~i~~~i~~~l~~Lh~-------  180 (375)
                      +++|..+..              .++..    ...   .....|....          .....+..++.++..       
T Consensus        95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~  174 (296)
T cd05153          95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP  174 (296)
T ss_pred             eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence            998866532              01100    000   0001111100          011112334444443       


Q ss_pred             CCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          181 SDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       181 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      .+++|+|+.|.||++++++.+.|+||+.+.
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence            379999999999999998778999999875

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.04  E-value=7.4e-05  Score=65.74  Aligned_cols=137  Identities=15%  Similarity=0.098  Sum_probs=77.4

Q ss_pred             ccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeE-EEeeeeecCCceeEEEEecccCCChh
Q 017232           68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV-SLYGCTSRHSRELLLVYEFISNGTVA  146 (375)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~~~~~L~  146 (375)
                      .+..|-.+.+|+... ++..+++|........-.-...+|..+++.+....++ +++.. ..    -++||||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~-~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILV-NE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEE-eC----CEEEEEeccCcccc
Confidence            356788889999874 4678888875433221111346788888888643333 23332 22    26899999986653


Q ss_pred             Hh-----------------hccCCCCCCCCChHHH-HHHHHH---------HHHHHHHHhh--------CCceeccCCCC
Q 017232          147 DH-----------------LHGERAKPGALPWPTR-LKIAIE---------TASALTYLHA--------SDIIHRDVKTN  191 (375)
Q Consensus       147 ~~-----------------l~~~~~~~~~l~~~~~-~~i~~~---------i~~~l~~Lh~--------~~ivH~dlkp~  191 (375)
                      ..                 ++.......+++.... ..+..+         +...+..+-.        ..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            21                 2111111112222111 111111         1111222211        24899999999


Q ss_pred             CEEecCCCcEEEeeeccccc
Q 017232          192 NILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       192 Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ||++++++ +.|+||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999877 78999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.01  E-value=7.2e-05  Score=64.86  Aligned_cols=73  Identities=22%  Similarity=0.247  Sum_probs=47.6

Q ss_pred             CccCCCCcEEEEEEEeCC--CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeE-EEeeeeecCCceeEEEEecccCC
Q 017232           67 RELGDGGFGTVYYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV-SLYGCTSRHSRELLLVYEFISNG  143 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~--~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~~~~  143 (375)
                      +.|..|-...+|+....+  +..|++|+...... ..-...+|+.++..+...+++ ++++.. . +   .++|||++|.
T Consensus         4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~-~-~---~~l~e~i~G~   77 (235)
T cd05157           4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATF-Q-N---GLIYEFIPGR   77 (235)
T ss_pred             EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEe-C-C---cEEEEeeCCC
Confidence            457888889999997764  67899997654322 112334688888888543333 344322 2 2   3799999987


Q ss_pred             Ch
Q 017232          144 TV  145 (375)
Q Consensus       144 ~L  145 (375)
                      ++
T Consensus        78 ~l   79 (235)
T cd05157          78 TL   79 (235)
T ss_pred             cC
Confidence            65

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK10593 hypothetical protein; Provisional

Probab=97.98  E-value=0.00013  Score=65.52  Aligned_cols=79  Identities=11%  Similarity=0.075  Sum_probs=54.9

Q ss_pred             CCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCC---CCeEEEeeeeec--CCceeEEEEe
Q 017232           64 DSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRH---KNLVSLYGCTSR--HSRELLLVYE  138 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h---~niv~~~~~~~~--~~~~~~lv~e  138 (375)
                      ...+.||.|..+.||+....++ .+++|..+...  ....+..|...|+.+.-   -.+.++++.+..  ..+..+||||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~~~--~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE   93 (297)
T PRK10593         17 SRVECISEQPYAALWALYDSQG-NPMPLMARSFS--TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLE   93 (297)
T ss_pred             heeeecCCccceeEEEEEcCCC-CEEEEEecccc--cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEe
Confidence            3456799999999999976655 46777643211  22477889999988853   356677765432  2355799999


Q ss_pred             cccCCCh
Q 017232          139 FISNGTV  145 (375)
Q Consensus       139 ~~~~~~L  145 (375)
                      ++++.++
T Consensus        94 ~i~G~~~  100 (297)
T PRK10593         94 RLRGVSV  100 (297)
T ss_pred             ccCCEec
Confidence            9998764

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.96  E-value=1.7e-05  Score=69.74  Aligned_cols=137  Identities=14%  Similarity=0.104  Sum_probs=97.5

Q ss_pred             CCCCCCccCCCCcEEEEEEEeCCCCEEEEEEeccc---------ch-----------hh--HHHHHHHHHHHHhcC-CCC
Q 017232           62 YFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN---------NY-----------KR--VEQFMNEVDILARLR-HKN  118 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~---------~~-----------~~--~~~~~~e~~~l~~l~-h~n  118 (375)
                      -+.+.++||-|--+-||.+-...|++.++|.=...         +.           -.  .-...+|+..|+.|. |-.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf  172 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF  172 (465)
T ss_pred             hhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence            36778999999999999999888999999842111         00           00  112456888888884 332


Q ss_pred             -eEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          119 -LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       119 -iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                       +.+.++     ...-++|||++.|.+|...-+-          .....+...+..-+.-|..+|+||+|++--||++++
T Consensus       173 pVPkpiD-----~~RH~Vvmelv~g~Pl~~v~~v----------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~d  237 (465)
T KOG2268|consen  173 PVPKPID-----HNRHCVVMELVDGYPLRQVRHV----------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKD  237 (465)
T ss_pred             CCCCccc-----ccceeeHHHhhcccceeeeeec----------CChHHHHHHHHHHHHHHHHcCceecccchheeEEec
Confidence             222232     2345899999998887654421          122345666677788899999999999999999999


Q ss_pred             CCcEEEeeeccccccC
Q 017232          198 NFCVKVADFGLSRLFP  213 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~  213 (375)
                      ++.++++||-......
T Consensus       238 d~~i~vIDFPQmvS~s  253 (465)
T KOG2268|consen  238 DDKIVVIDFPQMVSTS  253 (465)
T ss_pred             CCCEEEeechHhhccC
Confidence            9999999998765443

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=97.85  E-value=0.00012  Score=74.48  Aligned_cols=200  Identities=17%  Similarity=0.211  Sum_probs=134.9

Q ss_pred             HHHHHHHHHHHhcCCCCeEEEeeeeecCCc---eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 017232          102 EQFMNEVDILARLRHKNLVSLYGCTSRHSR---ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL  178 (375)
Q Consensus       102 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  178 (375)
                      .....|...+....|+|++.++.+......   ...+.-++|...++...+.    .-..++....+.+..++..||.++
T Consensus       227 ~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q----~v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  227 QTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ----SVGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh----hccccCHHHHHHHHHHHhhhHHHH
Confidence            344557777888899999999885433211   2234567777777777774    335678888899999999999999


Q ss_pred             hhCCceeccCCCC---CEEecCCCcEEEe--eeccccccCCCccccccCCCCCccccCcccccccCCCC--chhHHHHHH
Q 017232          179 HASDIIHRDVKTN---NILLDNNFCVKVA--DFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD--KSDVFSFGV  251 (375)
Q Consensus       179 h~~~ivH~dlkp~---Nill~~~~~~kl~--Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~--~~DiwslG~  251 (375)
                      |+....|.-+..+   +.-.+..+.+.++  ||+....++.....  .....+..+.++|.......+.  ..|+|.+|.
T Consensus       303 h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~--~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  303 HSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS--FSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             HHhccceeEEecccccccccCccceeecchhhhcccccCCCcccc--hhhcCccccccccccccccchhhhhhHHHHHHH
Confidence            9997666666555   4455667777777  88887765443222  1223455677888666544444  479999999


Q ss_pred             HHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Q 017232          252 VLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDV  331 (375)
Q Consensus       252 il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~ev  331 (375)
                      .+..+..|..+-......                  ..+++.    .       ....+.+...+|+..++++|+++.++
T Consensus       381 l~~~~~~~~~i~~~~~~~------------------~~~l~~----~-------~~~~~~d~~~~~~~~~~~~Rl~~~~l  431 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAVP------------------VSLLDV----L-------STSELLDALPKCLDEDSEERLSALEL  431 (1351)
T ss_pred             HHhhhhhcCcccccccch------------------hhhhcc----c-------cchhhhhhhhhhcchhhhhccchhhh
Confidence            999999876554322100                  001100    0       01146678889999999999999999


Q ss_pred             HHHHH
Q 017232          332 LDALR  336 (375)
Q Consensus       332 l~~L~  336 (375)
                      +...-
T Consensus       432 l~~~f  436 (1351)
T KOG1035|consen  432 LTHPF  436 (1351)
T ss_pred             hhchh
Confidence            87643

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.80  E-value=0.00033  Score=65.02  Aligned_cols=76  Identities=22%  Similarity=0.274  Sum_probs=52.1

Q ss_pred             CCccCCCCcEEEEEEEeCCC-CEEEEEEeccc------c-hhhHHHHHHHHHHHHhcC---CCCeEEEeeeeecCCceeE
Q 017232           66 ARELGDGGFGTVYYGELQDG-RAVAVKRLYEN------N-YKRVEQFMNEVDILARLR---HKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~-~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~  134 (375)
                      .+.||.|.+..||++...+| +.++||.-...      . .-.......|.+.|+.+.   ..++.+++.+.   ....+
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D---~~~~~  107 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD---EELAV  107 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC---CCCCE
Confidence            35699999999999988776 48999974311      1 123456677888888763   23566666542   34468


Q ss_pred             EEEecccCCC
Q 017232          135 LVYEFISNGT  144 (375)
Q Consensus       135 lv~e~~~~~~  144 (375)
                      +|||++++..
T Consensus       108 lVME~L~~~~  117 (401)
T PRK09550        108 TVMEDLSDHK  117 (401)
T ss_pred             EEEecCCCcc
Confidence            9999998643

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.72  E-value=0.00026  Score=63.95  Aligned_cols=74  Identities=27%  Similarity=0.334  Sum_probs=47.6

Q ss_pred             CccCCCCcEEEEEEEeCC-------CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeE-EEeeeeecCCceeEEEEe
Q 017232           67 RELGDGGFGTVYYGELQD-------GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV-SLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e  138 (375)
                      +.|..|-...+|+....+       ++.+++|+..... .......+|..++..+...++. ++++++.  +   .+|+|
T Consensus         4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~---~~v~e   77 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--N---GRIEE   77 (302)
T ss_pred             EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--C---Cchhh
Confidence            456677778899987664       5789999865432 2233456788888888543333 3444332  2   25899


Q ss_pred             cccCCChh
Q 017232          139 FISNGTVA  146 (375)
Q Consensus       139 ~~~~~~L~  146 (375)
                      |++|.++.
T Consensus        78 ~i~G~~l~   85 (302)
T cd05156          78 FIPSRTLT   85 (302)
T ss_pred             eeCCCcCC
Confidence            99887664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.63  E-value=0.00092  Score=59.91  Aligned_cols=136  Identities=19%  Similarity=0.228  Sum_probs=84.2

Q ss_pred             CCCccCCCCcEEEEEEEeCCCCEEEEEEec--ccchhhHHHHHHHHHHHHhcCC--CCeEEEeeeeecCC-ceeEEEEec
Q 017232           65 SARELGDGGFGTVYYGELQDGRAVAVKRLY--ENNYKRVEQFMNEVDILARLRH--KNLVSLYGCTSRHS-RELLLVYEF  139 (375)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~--~~~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~-~~~~lv~e~  139 (375)
                      +.+.+..|....+|..... ++++++. ..  ...........+|+.+++.+.-  --+...+++|.... ...+.||+|
T Consensus        29 ~v~~~~~G~sn~t~~~~~~-~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT-GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             eeeeccCCcccceEEEecC-CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            3444444444445555443 7788888 33  1234445667788888888743  22334455555544 467999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHH-HHHHHHHHHHhh--------------------------------------
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIA-IETASALTYLHA--------------------------------------  180 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~-~~i~~~l~~Lh~--------------------------------------  180 (375)
                      ++|..+.+.+...     ...    ..++ ..++..|..||+                                      
T Consensus       107 veGe~~~~~~~~~-----~~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~  177 (321)
T COG3173         107 VEGEVVWSALPPE-----SLG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRI  177 (321)
T ss_pred             ecceeccCcCCcc-----cch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCC
Confidence            9885443333111     000    1122 255555555554                                      


Q ss_pred             ------------C--------CceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          181 ------------S--------DIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       181 ------------~--------~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                                  +        .++|+|+.+.|++++.++.+=+.||+++..
T Consensus       178 p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         178 PLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             chHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence                        1        489999999999999999999999999875

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.50  E-value=0.0018  Score=58.45  Aligned_cols=142  Identities=18%  Similarity=0.195  Sum_probs=94.8

Q ss_pred             CCCCccCCCCcEEEEEEEeCCCCEEEEEEeccc------------------------chhh--HHHHHHHHHHHHhcCCC
Q 017232           64 DSARELGDGGFGTVYYGELQDGRAVAVKRLYEN------------------------NYKR--VEQFMNEVDILARLRHK  117 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~------------------------~~~~--~~~~~~e~~~l~~l~h~  117 (375)
                      .+..+|..|--+.||.|...+|..+|||+++..                        ++..  ......|+.-|.+++..
T Consensus       147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a  226 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA  226 (520)
T ss_pred             ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence            456789999999999999999999999987421                        1111  11245677777777644


Q ss_pred             CeEEEee-eeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEe
Q 017232          118 NLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILL  195 (375)
Q Consensus       118 niv~~~~-~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill  195 (375)
                      .|. +-. +..   ..-.|||+|+....-    -..+-+...++...+..+-.+++..+.-|.+ +++||.||+--|+|+
T Consensus       227 GIP-~PePIlL---k~hVLVM~FlGrdgw----~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly  298 (520)
T KOG2270|consen  227 GIP-CPEPILL---KNHVLVMEFLGRDGW----AAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY  298 (520)
T ss_pred             CCC-CCCceee---ecceEeeeeccCCCC----cCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE
Confidence            422 111 111   123699999953211    1111233456666777788888888887765 489999999999998


Q ss_pred             cCCCcEEEeeeccccccCC
Q 017232          196 DNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       196 ~~~~~~kl~Dfg~~~~~~~  214 (375)
                      . +|.+.|+|-+.+.....
T Consensus       299 h-dG~lyiIDVSQSVE~DH  316 (520)
T KOG2270|consen  299 H-DGKLYIIDVSQSVEHDH  316 (520)
T ss_pred             E-CCEEEEEEccccccCCC
Confidence            5 46799999888765433

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.47  E-value=2.2e-05  Score=81.54  Aligned_cols=159  Identities=14%  Similarity=0.060  Sum_probs=117.7

Q ss_pred             HHHHHHHHHhcCCCCeEEEee-eeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-
Q 017232          104 FMNEVDILARLRHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-  181 (375)
Q Consensus       104 ~~~e~~~l~~l~h~niv~~~~-~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-  181 (375)
                      ...|.+-++...|+++...+. .........+.+++++.+|.+.+.+...-.+...+....+.....+...+..-.|+. 
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            334445556678998887665 333334556889999999999999876555555555555555555546666666654 


Q ss_pred             ----CceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHH
Q 017232          182 ----DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI  257 (375)
Q Consensus       182 ----~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ell  257 (375)
                          --+|+++++-|.+|..+..++++++|+.+...+ .........+++-|+.|++...-.++.++|+|..|+-+|+..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp-~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNP-VLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCc-hHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence                268999999999999999999999999984332 223334456788899999988888888999999999999999


Q ss_pred             hCCCCc
Q 017232          258 SSMPAV  263 (375)
Q Consensus       258 tg~~p~  263 (375)
                      .|.++|
T Consensus      1435 ~~n~~f 1440 (2724)
T KOG1826|consen 1435 DGNAYF 1440 (2724)
T ss_pred             cccHHH
Confidence            887776

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.45  E-value=0.0027  Score=56.42  Aligned_cols=30  Identities=20%  Similarity=0.454  Sum_probs=25.1

Q ss_pred             CceeccCCCCCEEecCCCc-EEEeeeccccc
Q 017232          182 DIIHRDVKTNNILLDNNFC-VKVADFGLSRL  211 (375)
Q Consensus       182 ~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~  211 (375)
                      .++|+|++|.||++++++. .-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997555 56999998764

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.36  E-value=0.0012  Score=62.02  Aligned_cols=49  Identities=20%  Similarity=0.327  Sum_probs=39.6

Q ss_pred             HHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCChhHhhcc
Q 017232          102 EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHG  151 (375)
Q Consensus       102 ~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  151 (375)
                      .+......+++.+.|+|....+.+.........+|+|++ +.+|.+.+..
T Consensus        27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~   75 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKT   75 (725)
T ss_pred             HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHh
Confidence            345566788999999999999987766666789999999 5889988843

>PLN02236 choline kinase

Probab=97.31  E-value=0.0021  Score=59.06  Aligned_cols=139  Identities=19%  Similarity=0.218  Sum_probs=78.4

Q ss_pred             CccCCCCcEEEEEEEeCC-----CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeE-EEeeeeecCCceeEEEEecc
Q 017232           67 RELGDGGFGTVYYGELQD-----GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV-SLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ..|-.|-...+|++...+     ++.|++|+...... ..-.-.+|..+++.+...++. ++++.+ .++    .|++|+
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~-~~idR~~E~~~~~~l~~~gl~P~~~~~~-~~g----~v~efi  115 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVE-LFFDRDDEIRTFECMSRHGQGPRLLGRF-PNG----RVEEFI  115 (344)
T ss_pred             EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCC-eeechHHHHHHHHHHHHcCCCCceEEEE-CCc----eEEEee
Confidence            345567888899986532     36789997755432 222235688888888644443 344533 222    579999


Q ss_pred             cCCChhHh-----------------hccCCCCCC--CCChHHHHHHHHHH-----------------HHHHHHH----h-
Q 017232          141 SNGTVADH-----------------LHGERAKPG--ALPWPTRLKIAIET-----------------ASALTYL----H-  179 (375)
Q Consensus       141 ~~~~L~~~-----------------l~~~~~~~~--~l~~~~~~~i~~~i-----------------~~~l~~L----h-  179 (375)
                      ++.+|...                 ++.......  ...+.++..+..++                 ...+..|    . 
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87665321                 111111111  11223332332211                 1111111    1 


Q ss_pred             ---hCCceeccCCCCCEEecC-CCcEEEeeeccccc
Q 017232          180 ---ASDIIHRDVKTNNILLDN-NFCVKVADFGLSRL  211 (375)
Q Consensus       180 ---~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~  211 (375)
                         ...++|+|+++.||++++ ++.+.++||..+..
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence               125899999999999986 46899999988753

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.30  E-value=0.0034  Score=57.22  Aligned_cols=79  Identities=23%  Similarity=0.238  Sum_probs=48.7

Q ss_pred             ccCCCCcEEEEEEEeCCC-CEEEEEEecc-------cchhhHHHHHHHHHHHHhcC--CCC-eEEEeeeeecCCceeEEE
Q 017232           68 ELGDGGFGTVYYGELQDG-RAVAVKRLYE-------NNYKRVEQFMNEVDILARLR--HKN-LVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~-~~vaiK~~~~-------~~~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~~lv  136 (375)
                      .||.|....||++...+| +.|+||.-..       .-+-......-|.+.|+...  .|. +.+++. +.  .....+|
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~-~D--~e~~~~v   78 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFH-FD--TEMAVTV   78 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEE-Ec--cccceeh
Confidence            489999999999987654 5899996421       11222344556777777664  353 444554 32  3445699


Q ss_pred             EecccCC-ChhHhh
Q 017232          137 YEFISNG-TVADHL  149 (375)
Q Consensus       137 ~e~~~~~-~L~~~l  149 (375)
                      ||+++.. .|.+.+
T Consensus        79 MEdL~~~~ilR~~L   92 (370)
T TIGR01767        79 MEDLSHHKIARKGL   92 (370)
T ss_pred             HhhCccchHHHHHH
Confidence            9999543 343443

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.25  E-value=0.0047  Score=55.91  Aligned_cols=30  Identities=13%  Similarity=0.226  Sum_probs=27.7

Q ss_pred             CceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          182 DIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       182 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      +++|+|+.++|+++++++.+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            799999999999999999999999998763

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.06  E-value=0.0037  Score=57.70  Aligned_cols=74  Identities=22%  Similarity=0.180  Sum_probs=48.0

Q ss_pred             CCccCCCCcEEEEEEEeCC-CCEEEEEEecc------cchhhHHHHHHHHHHHHhcC--CCC-eEEEeeeeecCCceeEE
Q 017232           66 ARELGDGGFGTVYYGELQD-GRAVAVKRLYE------NNYKRVEQFMNEVDILARLR--HKN-LVSLYGCTSRHSRELLL  135 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~------~~~~~~~~~~~e~~~l~~l~--h~n-iv~~~~~~~~~~~~~~l  135 (375)
                      .+.||.|.-..||++...+ ++.|+||.-..      .-+-..++..-|.+.|+...  .|. +.+++. +.  .....+
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~-~D--~e~~~~  110 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL-FD--SVMNCC  110 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE-EC--cHHhhH
Confidence            4579999999999998643 56799986421      11223455666778877764  454 444554 32  334578


Q ss_pred             EEecccC
Q 017232          136 VYEFISN  142 (375)
Q Consensus       136 v~e~~~~  142 (375)
                      |||+++.
T Consensus       111 vMEdL~~  117 (409)
T PRK12396        111 VMEDLSD  117 (409)
T ss_pred             HHHhCcc
Confidence            9999864

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.97  E-value=0.021  Score=51.63  Aligned_cols=29  Identities=34%  Similarity=0.436  Sum_probs=25.4

Q ss_pred             CCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          181 SDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       181 ~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      .+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999988 678999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.93  E-value=0.0077  Score=55.05  Aligned_cols=139  Identities=17%  Similarity=0.209  Sum_probs=76.6

Q ss_pred             CccCCCCcEEEEEEEeCC----CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeE-EEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV-SLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.|..|-...+|+....+    +..|++|+...... ..-.-.+|..+++.+..-++. ++++++ . .+   +|.+|++
T Consensus        20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~-~~IdR~~E~~il~~l~~~gl~P~~l~~~-~-~G---~i~~fi~   93 (330)
T PLN02421         20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTD-YVIDRERELQAIKYLSAAGFGAKLLGVF-G-NG---MIQSFIN   93 (330)
T ss_pred             EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcC-eEechHHHHHHHHHHHhcCCCCceeEEe-C-Cc---Eeehhhc
Confidence            345557777889886543    23788897754322 222235688888888654443 344433 2 22   5889987


Q ss_pred             CCChhH-----------------hhccCCCCCC--CCChHHHHHHHHHH-------------------------HHHHHH
Q 017232          142 NGTVAD-----------------HLHGERAKPG--ALPWPTRLKIAIET-------------------------ASALTY  177 (375)
Q Consensus       142 ~~~L~~-----------------~l~~~~~~~~--~l~~~~~~~i~~~i-------------------------~~~l~~  177 (375)
                      +.+|..                 .++.......  +-.+..+..+..++                         +..+..
T Consensus        94 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~  173 (330)
T PLN02421         94 ARTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKE  173 (330)
T ss_pred             CCCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHH
Confidence            765521                 1111111111  11222222222221                         111111


Q ss_pred             Hh-hC----CceeccCCCCCEEecC-CCcEEEeeeccccc
Q 017232          178 LH-AS----DIIHRDVKTNNILLDN-NFCVKVADFGLSRL  211 (375)
Q Consensus       178 Lh-~~----~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~  211 (375)
                      +. ..    -++|+|+.+.||++++ ++.++++||..+-.
T Consensus       174 ~~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        174 ITDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             HhccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            11 11    2799999999999974 57899999988753

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.91  E-value=0.0038  Score=53.10  Aligned_cols=29  Identities=31%  Similarity=0.476  Sum_probs=21.0

Q ss_pred             CceeccCCCCCEEe-cCCCcEEEeeecccc
Q 017232          182 DIIHRDVKTNNILL-DNNFCVKVADFGLSR  210 (375)
Q Consensus       182 ~ivH~dlkp~Nill-~~~~~~kl~Dfg~~~  210 (375)
                      .++|+|+.+.||++ +.++.++++||..+.
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~  173 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAG  173 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-E
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHh
Confidence            48999999999999 889999999999875

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=96.86  E-value=0.014  Score=53.04  Aligned_cols=139  Identities=22%  Similarity=0.290  Sum_probs=81.0

Q ss_pred             ccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC---CCCeEE---Eee-eeecCC--ceeEEEEe
Q 017232           68 ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR---HKNLVS---LYG-CTSRHS--RELLLVYE  138 (375)
Q Consensus        68 ~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~---~~~-~~~~~~--~~~~lv~e  138 (375)
                      .|.+ .-..+|+....+|+. ++|+....  ....++.-|...+..|.   .+=.++   .=| ....-.  ...+-+++
T Consensus        33 ~l~s-~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~  108 (331)
T COG2334          33 GLNS-EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFE  108 (331)
T ss_pred             cccc-ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEE
Confidence            3444 566789998887776 88877665  33355666777777773   221122   111 111112  36788999


Q ss_pred             cccCCChhH-h--------------hc----cCCC-CC---CCCChH-------------HHHHHHHHHHHHHHHHhhC-
Q 017232          139 FISNGTVAD-H--------------LH----GERA-KP---GALPWP-------------TRLKIAIETASALTYLHAS-  181 (375)
Q Consensus       139 ~~~~~~L~~-~--------------l~----~~~~-~~---~~l~~~-------------~~~~i~~~i~~~l~~Lh~~-  181 (375)
                      |++|..+.. .              ++    .... ..   ....|.             .......++...++.+... 
T Consensus       109 ~l~G~~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~  188 (331)
T COG2334         109 YLPGRPLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARL  188 (331)
T ss_pred             ecCCcCcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhc
Confidence            999877762 1              00    0000 11   112222             0011233444555555543 


Q ss_pred             -------C--ceeccCCCCCEEecCCCc-EEEeeecccc
Q 017232          182 -------D--IIHRDVKTNNILLDNNFC-VKVADFGLSR  210 (375)
Q Consensus       182 -------~--ivH~dlkp~Nill~~~~~-~kl~Dfg~~~  210 (375)
                             +  +||+|+.|+||+++.+.. +-++||+-+.
T Consensus       189 ~~~lp~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         189 PAHLPALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             hhhCCcccceeeecCCCccceeEcCCCCeeeEEEccccc
Confidence                   3  999999999999999885 8999999775

>PRK06148 hypothetical protein; Provisional

Probab=96.81  E-value=0.028  Score=59.18  Aligned_cols=142  Identities=18%  Similarity=0.224  Sum_probs=78.1

Q ss_pred             CccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhc-------CCCCeEEEee--e---eec-CC-ce
Q 017232           67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-------RHKNLVSLYG--C---TSR-HS-RE  132 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-------~h~niv~~~~--~---~~~-~~-~~  132 (375)
                      +.|+ |..-.+|+.+..+|..+++|+.......  .....|...|..|       ..|.+++..+  .   ... .+ ..
T Consensus        31 ~~L~-s~~d~nf~v~~~~g~~yVLKi~~~~~~~--~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~  107 (1013)
T PRK06148         31 TPLD-GERDLNFRLTTDDGADYILKIVNPSEPR--VESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPR  107 (1013)
T ss_pred             eecC-CcCCceEEEEeCCCCeEEEEEcCCccch--hHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceE
Confidence            4564 4567889998888889999998754322  2223344444433       2344454332  1   111 12 24


Q ss_pred             eEEEEecccCCChhHhhc---------------------cCCC--CCCCCChH-----------------HHHHHHHHHH
Q 017232          133 LLLVYEFISNGTVADHLH---------------------GERA--KPGALPWP-----------------TRLKIAIETA  172 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~---------------------~~~~--~~~~l~~~-----------------~~~~i~~~i~  172 (375)
                      .+-+++|++|..+.+...                     ....  ....+.|.                 ....++.+++
T Consensus       108 ~vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~  187 (1013)
T PRK06148        108 LLRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFL  187 (1013)
T ss_pred             EEEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHH
Confidence            677899999877754110                     0000  00112221                 1122222333


Q ss_pred             HHHHH-----Hh--hCCceeccCCCCCEEecCCC--cEE-Eeeeccccc
Q 017232          173 SALTY-----LH--ASDIIHRDVKTNNILLDNNF--CVK-VADFGLSRL  211 (375)
Q Consensus       173 ~~l~~-----Lh--~~~ivH~dlkp~Nill~~~~--~~k-l~Dfg~~~~  211 (375)
                      .....     +.  ..++||+|+++.||+++.++  .+. |+|||-+..
T Consensus       188 ~~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        188 ARFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            32221     21  14799999999999999875  454 999998753

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.77  E-value=0.073  Score=48.56  Aligned_cols=98  Identities=16%  Similarity=0.093  Sum_probs=54.2

Q ss_pred             CcccccchHHHHHHhcCCCCC---C-ccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCC--e
Q 017232           46 HGVQVFSYGELEEATNYFDSA---R-ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN--L  119 (375)
Q Consensus        46 ~~~~~~~~~~~~~~~~~y~~~---~-~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--i  119 (375)
                      +++..++.+.+..+...+-+.   + ..=.+.-..||+....++..+++|+..... .....+..|+..+..|....  +
T Consensus         6 ~~~~~l~p~~~~~a~~~~g~~~~~~~~~l~s~eN~vy~v~~~~~~~~vlKv~r~~~-~~~~~i~~E~~~l~~L~~~gipv   84 (325)
T PRK11768          6 FPFQTLTPDLILDALESLGLRVDGRLLALNSYENRVYQFGDEDGRRVVAKFYRPER-WSDAQILEEHAFALELAEAEIPV   84 (325)
T ss_pred             CCCCCCChHHHHHHHHHcCCCCccceEeeccccceEEEEecCCCCEEEEEEcCccc-CCHHHHHHHHHHHHHHHHCCCCC
Confidence            344455555555555444321   1 122345567999988888889999775332 23455667777777663211  2


Q ss_pred             EEEe---e-eeecCCceeEEEEecccCCC
Q 017232          120 VSLY---G-CTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus       120 v~~~---~-~~~~~~~~~~lv~e~~~~~~  144 (375)
                      +...   | .....++..+.++++++|..
T Consensus        85 ~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         85 VAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             CCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            2111   1 11122345778999998754

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.76  E-value=0.024  Score=52.75  Aligned_cols=73  Identities=16%  Similarity=0.210  Sum_probs=47.6

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccch-------hhHHHHHHHHHHHHhcC---CCCeEEEeeeeecCCceeEE
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNY-------KRVEQFMNEVDILARLR---HKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~l  135 (375)
                      .+.||.|....||+.... +..++||.-.....       -.......|...|+.+.   ..++.+++.++..   ..++
T Consensus        37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded---~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT---MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC---CCEE
Confidence            567899999999999765 45699997541110       12333445566666654   2466677775543   3578


Q ss_pred             EEecccC
Q 017232          136 VYEFISN  142 (375)
Q Consensus       136 v~e~~~~  142 (375)
                      +||++++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            9999976

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.68  E-value=0.014  Score=52.67  Aligned_cols=106  Identities=20%  Similarity=0.204  Sum_probs=70.1

Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeecc
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGL  208 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~  208 (375)
                      ....|++|++- |+++. .+       ....+.++..++++.+..++-+..+ ..-|||+.-+||||+ +|++.|+||-+
T Consensus       298 ~~y~yl~~kdh-gt~is-~i-------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfkl  367 (488)
T COG5072         298 TLYLYLHFKDH-GTPIS-II-------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKL  367 (488)
T ss_pred             ceEEEEEEecC-Cceee-ee-------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeee
Confidence            45567777774 34433 22       2246788899999999888888776 689999999999999 99999999999


Q ss_pred             ccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHH
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVV  252 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~i  252 (375)
                      ++.-..+ ...     .....--|-.+.|.. +.+-+||-+--.
T Consensus       368 sRl~~~q-~~i-----sy~rldhp~lF~G~d-d~QFeIYrlMr~  404 (488)
T COG5072         368 SRLSYSQ-GII-----SYNRLDHPDLFNGVD-DYQFEIYRLMRR  404 (488)
T ss_pred             eecccCC-cee-----eccccCchhhhcCcc-ceeeeHHHHHHH
Confidence            9843221 111     111223344444433 556677765333

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.57  E-value=0.018  Score=51.29  Aligned_cols=74  Identities=22%  Similarity=0.283  Sum_probs=44.2

Q ss_pred             CCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC---CCCeEEEeeeeecCCceeEEEEeccc
Q 017232           65 SARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR---HKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      -.+.++.|....+|+.+ .++..+.+|.-..   .....|..|.+-|+.|.   .-.+.+.++.... ...-+|||||++
T Consensus        21 ~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~-~~~~fLlle~l~   95 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD-TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEY-DDDAFLLLEFLE   95 (288)
T ss_dssp             EEEEE--SSSSEEEEEE-TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE--SSCCEEEEE---
T ss_pred             eeEecCCCChhheEEEE-CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEee-cCCceEEEEeec
Confidence            35668989999999988 5678899997652   22346778888888883   3345566664433 344589999998


Q ss_pred             CC
Q 017232          142 NG  143 (375)
Q Consensus       142 ~~  143 (375)
                      .+
T Consensus        96 ~~   97 (288)
T PF03881_consen   96 MG   97 (288)
T ss_dssp             --
T ss_pred             CC
Confidence            66

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.52  E-value=0.02  Score=48.16  Aligned_cols=148  Identities=19%  Similarity=0.216  Sum_probs=85.5

Q ss_pred             CCcEEEEEEEeCCCCEEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCChhHhhc
Q 017232           72 GGFGTVYYGELQDGRAVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLH  150 (375)
Q Consensus        72 G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  150 (375)
                      |+.++.-.++.+-|. ..+|++..-... ...-+..+++++.++.  .|+++..   ++...+-++.|+|-...      
T Consensus        73 ~gNsTl~~~kt~iG~-L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~N---Dn~~~yGvIlE~Cy~~~------  140 (308)
T PF07387_consen   73 NGNSTLLIGKTKIGP-LFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLKN---DNNYKYGVILERCYKIK------  140 (308)
T ss_pred             CCceEEEEeccccch-hhhhhccCCCcccchhhhhhhhhHHHHhh--heeEeec---CCCceeEEEEeeccCcc------
Confidence            344444444333333 345555333222 3345677888888874  5677663   23445678999984210      


Q ss_pred             cCCCCCCCCChHHHHHHHHHHHHHHHHHhhC--CceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCCCCcc
Q 017232          151 GERAKPGALPWPTRLKIAIETASALTYLHAS--DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG  228 (375)
Q Consensus       151 ~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  228 (375)
                             -+.    ..++.--+.+|.-.|+.  +.+|||..|+||+-|..|.+||.|-+.-.  ....           .
T Consensus       141 -------i~~----~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll--~~~V-----------~  196 (308)
T PF07387_consen  141 -------INF----SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPVCLL--ENQV-----------N  196 (308)
T ss_pred             -------cch----hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChhhhh--hhee-----------e
Confidence                   011    11222224667778854  79999999999999999999999987542  1111           1


Q ss_pred             ccCcccccccCCCCchhHHHHHHHHHHHHh
Q 017232          229 YVDPEYHQCYQLTDKSDVFSFGVVLIELIS  258 (375)
Q Consensus       229 y~aPE~~~~~~~~~~~DiwslG~il~ellt  258 (375)
                      |.--|   ....+.++.+=+|-.-++++..
T Consensus       197 ~vN~~---Y~~lT~~aE~~~fv~s~l~~v~  223 (308)
T PF07387_consen  197 MVNIE---YESLTQEAEVKVFVKSCLKLVE  223 (308)
T ss_pred             EEeee---ccccChHHHHHHHHHHHHHHHH
Confidence            11111   1234666777776666666654

The function of this family is unknown.

>PTZ00384 choline kinase; Provisional

Probab=96.20  E-value=0.051  Score=50.56  Aligned_cols=75  Identities=20%  Similarity=0.260  Sum_probs=43.8

Q ss_pred             CCccCCCCcEEEEEEEeCCC--CE-----EEEEEecccchhhHHHHHHHHHHHHhcCCCCeEE-EeeeeecCCceeEEEE
Q 017232           66 ARELGDGGFGTVYYGELQDG--RA-----VAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS-LYGCTSRHSRELLLVY  137 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~--~~-----vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~~lv~  137 (375)
                      .+.|..|-...+|++...++  ..     |+++.. .......-+-.+|+.+++.+...++.+ +++.+ .    -+++.
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~-g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f-~----~g~l~  128 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKS-STYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRF-G----DFTIQ  128 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEec-cCCCceEeccHHHHHHHHHHHhCCCCCeEEEec-C----CEEEE
Confidence            34566688889999865533  22     333332 111111112356888999997655554 44433 2    15899


Q ss_pred             ecccCCChh
Q 017232          138 EFISNGTVA  146 (375)
Q Consensus       138 e~~~~~~L~  146 (375)
                      ||++|.+|.
T Consensus       129 efIeGr~l~  137 (383)
T PTZ00384        129 EWVEGNTMG  137 (383)
T ss_pred             EEeccccCC
Confidence            999987664

>PF04655 APH_6_hur: Aminoglycoside/hydroxyurea antibiotic resistance kinase; InterPro: IPR006748 The aminoglycosides are a large group of biologically active bacterial secondary metabolites, best known for their antibiotic properties []

Probab=95.57  E-value=0.09  Score=45.83  Aligned_cols=79  Identities=14%  Similarity=0.045  Sum_probs=54.3

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccC-CC
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISN-GT  144 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~-~~  144 (375)
                      ...+..|..+.|+.+...+|.+.++|+........  .-......|+..+-...|++++....   .-.|++|.+.+ .+
T Consensus         7 ~~~~~~g~~s~V~pv~~~dG~~avLKl~~p~~~~~--~E~~g~~~L~~w~G~GaVrll~~d~~---~~AlLLErl~~g~~   81 (253)
T PF04655_consen    7 DGPPAHGSSSLVVPVRRADGTPAVLKLAPPHAEAE--HEARGEAALRWWNGRGAVRLLAADPE---RGALLLERLDPGRS   81 (253)
T ss_pred             CCCCCCCcceEEEEEEcCCCCeEEEEecCCcccch--hhhhHHhHhheeCCCCceeeeccccc---cchhhhhhccCCCc
Confidence            44577899999999999999999999876443211  11112245777787888999985422   34688999944 46


Q ss_pred             hhHhh
Q 017232          145 VADHL  149 (375)
Q Consensus       145 L~~~l  149 (375)
                      |.+..
T Consensus        82 L~~~~   86 (253)
T PF04655_consen   82 LASLP   86 (253)
T ss_pred             hhhcc
Confidence            66554

Aminoglycoside phosphotransferases achieve inactivation of these enzymes by phosphorylation, utilising ATP. Likewise, hydroxyurea is inactivated by phosphorylation of the hydroxy group in the hydroxylamine moiety.; GO: 0016773 phosphotransferase activity, alcohol group as acceptor, 0006468 protein phosphorylation, 0019748 secondary metabolic process

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.56  E-value=0.061  Score=49.54  Aligned_cols=59  Identities=22%  Similarity=0.264  Sum_probs=41.9

Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHH-hhCCceeccCCCCCEEec
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL-HASDIIHRDVKTNNILLD  196 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L-h~~~ivH~dlkp~Nill~  196 (375)
                      ..|+-+|..|.++..++.     ....++....+++.-...|+--+ --.+++|.|+.|.||++.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~-----~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlir  379 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVK-----WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIR  379 (565)
T ss_pred             ceeeeeccccccHHhhhh-----cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEE
Confidence            467778888888888883     23345556666666666665433 345899999999999994

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	375
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-48
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-48
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-47
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-47
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		8e-38
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-37
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-37
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-36
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-29
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		9e-29
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-26
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		9e-26
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-25
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-25
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-25
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-25
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		2e-25
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		2e-25
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		2e-25
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-25
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-25
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-25
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		2e-25
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-25
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		3e-25
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		3e-25
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		4e-25
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-25
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		9e-25
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-25
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-24
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-24
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-24
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-24
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-24
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-24
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-24
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-24
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		5e-24
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-24
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		7e-24
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-24
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		9e-24
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		9e-24
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		9e-24
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		1e-23
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		1e-23
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-23
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		1e-23
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		1e-23
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		1e-23
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		1e-23
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-23
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-23
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-23
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		1e-23
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-23
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-23
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-23
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-23
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-23
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-23
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-23
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-23
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-23
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-23
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-23
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-23
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-23
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-23
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-23
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		4e-23
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		4e-23
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		6e-23
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		8e-23
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-23
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-23
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-22
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-22
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		1e-22
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-22
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-22
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-22
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-22
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-22
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-22
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-22
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-22
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-22
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-22
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-22
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-22
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-22
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-22
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		3e-22
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-22
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		3e-22
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-22
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		3e-22
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		3e-22
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-22
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-22
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-22
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		4e-22
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-22
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-22
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		6e-22
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-21
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-21
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-21
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-21
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-21
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		4e-21
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		4e-21
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		4e-21
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		5e-21
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		5e-21
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-21
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-21
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		9e-21
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		9e-21
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-20
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		1e-20
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		1e-20
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-20
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-20
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		1e-20
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-20
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-20
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		1e-20
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		1e-20
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-20
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-20
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		2e-20
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-20
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-20
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-20
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		4e-20
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		4e-20
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		4e-20
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-20
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-20
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-20
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		5e-20
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		5e-20
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-20
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-20
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-20
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		6e-20
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		6e-20
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-20
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-20
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-20
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		6e-20
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-20
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-20
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-20
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		1e-19
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		1e-19
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-19
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-19
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-19
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-19
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-19
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		3e-19
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-19
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		3e-19
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		6e-19
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-19
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		7e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		7e-19
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-19
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		8e-19
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-19
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		8e-19
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-19
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-19
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-19
4fie_A	423	Full-Length Human Pak4 Length = 423		8e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		8e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		9e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		9e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-18
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-18
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-18
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-18
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-18
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-18
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-18
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-18
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-18
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-18
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-18
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-18
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-18
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-18
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-18
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-18
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-18
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-18
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-18
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-18
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-18
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-18
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-18
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-18
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-18
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-18
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		3e-18
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		3e-18
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		3e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		3e-18
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		3e-18
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-18
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-18
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-18
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-18
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-18
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		4e-18
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-18
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-18
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-18
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		6e-18
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-18
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		7e-18
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		8e-18
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-18
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		9e-18
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		9e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-17
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-17
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-17
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		1e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-17
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-17
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-17
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-17
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		2e-17
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-17
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-17
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-17
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-17
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-17
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		3e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		3e-17
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-17
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		3e-17
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		3e-17
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		4e-17
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		4e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		4e-17
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-17
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		4e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		4e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-17
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		4e-17
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-17
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-17
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		5e-17
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-17
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-17
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		6e-17
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-17
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		6e-17
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-17
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-17
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		8e-17
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-17
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-16
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-16
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-16
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-16
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-16
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-16
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-16
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-16
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-16
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-16
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-16
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-16
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-16
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-16
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-16
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-16
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-16
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-16
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-16
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-16
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-16
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-16
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-16
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		4e-16
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		5e-16
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		5e-16
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-16
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		6e-16
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		7e-16
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		7e-16
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		9e-16
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		1e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-15
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-15
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-15
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		2e-15
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		2e-15
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-15
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-15
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		2e-15
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-15
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-15
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-15
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		5e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-15
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		6e-15
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		7e-15
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		7e-15
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-15
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-15
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-15
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		8e-15
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		8e-15
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		8e-15
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-14
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-14
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-14
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-14
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-14
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-14
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-14
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-14
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-14
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-14
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		2e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-14
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-14
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-14
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		2e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-14
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-14
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		2e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-14
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		2e-14
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		2e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		3e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		3e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		3e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		3e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		3e-14
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-14
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-14
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-14
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		3e-14
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-14
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-14
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-14
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		4e-14
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		4e-14
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-14
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		4e-14
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		4e-14
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-14
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-14
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-14
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-14
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		4e-14
3b2t_A	311	Structure Of Phosphotransferase Length = 311		4e-14
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-14
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-14
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-14
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-14
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-14
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-14
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-14
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-14
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-14
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		5e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-14
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-14
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-14
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		6e-14
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-14
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-14
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		6e-14
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-14
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-14
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		7e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-14
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-14
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		7e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-14
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		7e-14
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-14
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-14
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-14
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-14
1fvr_A	327	Tie2 Kinase Domain Length = 327		8e-14
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		8e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		8e-14
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-14
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		8e-14
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-14
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		8e-14
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-14
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		8e-14
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		8e-14
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		8e-14
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		8e-14
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		8e-14
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		9e-14
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		9e-14
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		9e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		9e-14
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		9e-14
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-13
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-13
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-13
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-13
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		1e-13
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-13
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-13
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		1e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		1e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		1e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		1e-13
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-13
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		1e-13
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-13
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-13
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-13
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-13
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		2e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-13
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-13
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-13
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		2e-13
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-13
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-13
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-13
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-13
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-13
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		2e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		2e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-13
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-13
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-13
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		2e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		3e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		3e-13
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-13
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-13
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		3e-13
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		3e-13
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-13
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		3e-13
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-13
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-13
4ae9_A	343	Structure And Function Of The Human Sperm-specific		4e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		5e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		5e-13
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-13
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		5e-13
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		5e-13
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		5e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		5e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-13
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		5e-13
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-13
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		6e-13
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-13
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-13
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-13
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		7e-13
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-13
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-13
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		8e-13
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-13
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		9e-13
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		9e-13
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		1e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		1e-12
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		1e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-12
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		1e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		1e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		1e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		1e-12
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		1e-12
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-12
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-12
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-12
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-12
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-12
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		1e-12
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-12
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-12
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-12
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-12
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-12
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-12
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-12
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-12
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-12
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		4e-12
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-12
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-12
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-12
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		5e-12
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-12
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		5e-12
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-12
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		5e-12
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		5e-12
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-12
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-12
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		6e-12
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		6e-12
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-12
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		6e-12
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		6e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-12
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-12
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-12
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		7e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		7e-12
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		8e-12
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		8e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		8e-12
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		8e-12
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		8e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-12
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		9e-12
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		9e-12
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		9e-12
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-12
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-12
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-12
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-12
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		9e-12
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-12
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-11
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		1e-11
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-11
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		1e-11
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-11
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		1e-11
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-11
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-11
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-11
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		1e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		1e-11
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-11
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-11
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-11
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-11
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-11
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		1e-11
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-11
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		1e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		1e-11
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-11
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-11
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-11
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-11
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-11
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		2e-11
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-11
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-11
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-11
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-11
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-11
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-11
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-11
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-11
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-11
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-11
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-11
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-11
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		2e-11
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-11
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-11
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-11
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-11
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-11
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-11
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-11
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-11
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		2e-11
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-11
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		3e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-11
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-11
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		3e-11
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		3e-11
3kk9_A	282	Camkii Substrate Complex B Length = 282		3e-11
3kk8_A	284	Camkii Substrate Complex A Length = 284		3e-11
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-11
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-11
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-11
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-11
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-11
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-11
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-11
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-11
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-11
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-11
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-11
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-11
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-11
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-11
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-11
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-11
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-11
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-11
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-11
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-11
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-11
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-11
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		6e-11
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		6e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		7e-11
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-11
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-11
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		8e-11
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		8e-11
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		9e-11
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		9e-11
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-11
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-10
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-10
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-10
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-10
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-10
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-10
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		1e-10
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-10
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-10
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-10
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-10
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		1e-10
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-10
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		1e-10
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		1e-10
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		1e-10
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		1e-10
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		1e-10
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		2e-10
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-10
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		2e-10
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		2e-10
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		2e-10
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-10
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-10
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-10
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-10
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-10
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-10
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-10
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-10
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-10
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-10
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-10
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-10
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-10
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-10
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-10
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		4e-10
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		4e-10
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		4e-10
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		4e-10
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		4e-10
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-10
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-10
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-10
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		5e-10
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-10
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		5e-10
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-10
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		6e-10
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		6e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		7e-10
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		7e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		8e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		8e-10
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-09
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-09
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		2e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-09
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		2e-09
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-09
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-09
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		2e-09
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-09
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		3e-09
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		3e-09
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		3e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-09
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		3e-09
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-09
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-09
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-09
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		4e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-09
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		5e-09
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-09
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		6e-09
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		7e-09
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		7e-09
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		8e-09
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		9e-09
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		9e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		9e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		9e-09
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		9e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		9e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		9e-09
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		9e-09
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-08
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-08
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-08
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-08
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-08
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-08
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-08
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		1e-08
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-08
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-08
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-08
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-08
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-08
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		1e-08
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-08
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-08
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-08
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-08
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-08
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-08
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		1e-08
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		1e-08
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		1e-08
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-08
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-08
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		1e-08
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		1e-08
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		1e-08
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-08
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		1e-08
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		1e-08
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-08
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-08
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-08
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		1e-08
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-08
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-08
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-08
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-08
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-08
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-08
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-08
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-08
3soa_A	444	Full-Length Human Camkii Length = 444		2e-08
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-08
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-08
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-08
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		3e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		3e-08
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		3e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		3e-08
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		3e-08
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		4e-08
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		4e-08
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-08
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		4e-08
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		4e-08
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		5e-08
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		6e-08
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-08
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		6e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		8e-08
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		8e-08
2oza_A	356	Structure Of P38alpha Complex Length = 356		8e-08
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		8e-08
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		9e-08
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		9e-08
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		9e-08
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		9e-08
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		9e-08
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		9e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-07
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		1e-07
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		1e-07
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		1e-07
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		1e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		1e-07
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-07
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		1e-07
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		1e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-07
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		1e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-07
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-07
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-07
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-07
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-07
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		2e-07
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		2e-07
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		3e-07
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-07
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-07
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-07
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-07
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-07
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-07
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		3e-07
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-07
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-07
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		4e-07
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-07
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-07
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		4e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		4e-07
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		5e-07
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-07
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-07
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		9e-07
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		9e-07
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		9e-07
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		9e-07
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		1e-06
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-06
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-06
2v62_A	345	Structure Of Vaccinia-Related Kinase 2 Length = 345		2e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		2e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		2e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		2e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		2e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		2e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		2e-06
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		2e-06
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		2e-06
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-06
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		3e-06
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		3e-06
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-06
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-06
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		3e-06
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-06
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-06
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-06
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		3e-06
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-06
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		3e-06
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		3e-06
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-06
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-06

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 117/284 (41%), Positives = 168/284 (59%), Gaps = 9/284 (3%)
Query: 55  ELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL 114
           +LEEATN FD    +G G FG VY G L+DG  VA+KR    + + +E+F  E++ L+  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 115 RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
           RH +LVSL G C  R+  E++L+Y+++ NG +  HL+G      ++ W  RL+I I  A 
Sbjct: 93  RHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN-HVTHVSTAPQGTPGYVDP 232
            L YLH   IIHRDVK+ NILLD NF  K+ DFG+S+       TH+    +GT GY+DP
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDP 210
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           EY    +LT+KSDV+SFGVVL E++ +  A+  +  R  +NL+  A+    N  L ++VD
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 293 QTLGYESDNKVR-RTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
             L     +K+R  ++    + A +CL    + RP M DVL  L
Sbjct: 271 PNLA----DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  190 bits (482), Expect = 1e-48,   Method: Compositional matrix adjust.
 Identities = 117/284 (41%), Positives = 168/284 (59%), Gaps = 9/284 (3%)
Query: 55  ELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL 114
           +LEEATN FD    +G G FG VY G L+DG  VA+KR    + + +E+F  E++ L+  
Sbjct: 33  DLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFC 92
Query: 115 RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
           RH +LVSL G C  R+  E++L+Y+++ NG +  HL+G      ++ W  RL+I I  A 
Sbjct: 93  RHPHLVSLIGFCDERN--EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR 150
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN-HVTHVSTAPQGTPGYVDP 232
            L YLH   IIHRDVK+ NILLD NF  K+ DFG+S+       TH+    +GT GY+DP
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDP 210
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           EY    +LT+KSDV+SFGVVL E++ +  A+  +  R  +NL+  A+    N  L ++VD
Sbjct: 211 EYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVD 270
Query: 293 QTLGYESDNKVR-RTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
             L     +K+R  ++    + A +CL    + RP M DVL  L
Sbjct: 271 PNLA----DKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  186 bits (471), Expect = 2e-47,   Method: Compositional matrix adjust.
 Identities = 127/319 (39%), Positives = 177/319 (55%), Gaps = 26/319 (8%)
Query: 51  FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVE-QFMNEVD 109
           FS  EL+ A++ F +   LG GGFG VY G L DG  VAVKRL E   +  E QF  EV+
Sbjct: 28  FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGELQFQTEVE 87
Query: 110 ILARLRHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP---WPTRL 165
           +++   H+NL+ L G C +   R  LLVY +++NG+VA  L   R +P + P   WP R 
Sbjct: 88  MISMAVHRNLLRLRGFCMTPTER--LLVYPYMANGSVASCL---RERPESQPPLDWPKRQ 142
Query: 166 KIAIETASALTYLHA---SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
           +IA+ +A  L YLH      IIHRDVK  NILLD  F   V DFGL++L      HV  A
Sbjct: 143 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA 202
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITR--HRHEINLSNLAIN 280
            +GT G++ PEY    + ++K+DVF +GV+L+ELI+   A D+ R  +  ++ L +    
Sbjct: 203 VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 262
Query: 281 KIQNKALHELVDQTL-GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE 339
            ++ K L  LVD  L G   D +V + I    ++A  C QS    RP M +V   +R +E
Sbjct: 263 LLKEKKLEALVDVDLQGNYKDEEVEQLI----QVALLCTQSSPMERPKMSEV---VRMLE 315
Query: 340 SDGYDDKKTH---EEMMTQ 355
            DG  ++      EEM  Q
Sbjct: 316 GDGLAERWEEWQKEEMFRQ 334

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  184 bits (467), Expect = 8e-47,   Method: Compositional matrix adjust.
 Identities = 126/319 (39%), Positives = 176/319 (55%), Gaps = 26/319 (8%)
Query: 51  FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVE-QFMNEVD 109
           FS  EL+ A++ F +   LG GGFG VY G L DG  VAVKRL E   +  E QF  EV+
Sbjct: 20  FSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGELQFQTEVE 79
Query: 110 ILARLRHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP---WPTRL 165
           +++   H+NL+ L G C +   R  LLVY +++NG+VA  L   R +P + P   WP R 
Sbjct: 80  MISMAVHRNLLRLRGFCMTPTER--LLVYPYMANGSVASCL---RERPESQPPLDWPKRQ 134
Query: 166 KIAIETASALTYLHA---SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
           +IA+ +A  L YLH      IIHRDVK  NILLD  F   V DFGL++L      HV  A
Sbjct: 135 RIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXA 194
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITR--HRHEINLSNLAIN 280
            +G  G++ PEY    + ++K+DVF +GV+L+ELI+   A D+ R  +  ++ L +    
Sbjct: 195 VRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG 254
Query: 281 KIQNKALHELVDQTL-GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE 339
            ++ K L  LVD  L G   D +V + I    ++A  C QS    RP M +V   +R +E
Sbjct: 255 LLKEKKLEALVDVDLQGNYKDEEVEQLI----QVALLCTQSSPMERPKMSEV---VRMLE 307
Query: 340 SDGYDDKKTH---EEMMTQ 355
            DG  ++      EEM  Q
Sbjct: 308 GDGLAERWEEWQKEEMFRQ 326

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 170/300 (56%), Gaps = 22/300 (7%)
Query: 51  FSYGELEEATNYFD------SARELGDGGFGTVYYGELQDGRAVAVKRLYE----NNYKR 100
           FS+ EL+  TN FD         ++G+GGFG VY G + +   VAVK+L         + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 101 VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
            +QF  E+ ++A+ +H+NLV L G +S    +L LVY ++ NG++ D L      P  L 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLS 131
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THV 219
           W  R KIA   A+ + +LH +  IHRD+K+ NILLD  F  K++DFGL+R       T +
Sbjct: 132 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH-EINLSNLA 278
            +   GT  Y+ PE  +  ++T KSD++SFGVVL+E+I+ +PAVD   HR  ++ L    
Sbjct: 192 XSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLLLDIKE 248
Query: 279 INKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
             + + K + + +D+ +  ++D+    ++ A+  +A QCL  +K+ RP +  V   L+++
Sbjct: 249 EIEDEEKTIEDYIDKKMN-DADST---SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  153 bits (387), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 169/300 (56%), Gaps = 22/300 (7%)
Query: 51  FSYGELEEATNYFD------SARELGDGGFGTVYYGELQDGRAVAVKRLYE----NNYKR 100
           FS+ EL+  TN FD         ++G+GGFG VY G + +   VAVK+L         + 
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 73
Query: 101 VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
            +QF  E+ ++A+ +H+NLV L G +S    +L LVY ++ NG++ D L      P  L 
Sbjct: 74  KQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLS 131
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THV 219
           W  R KIA   A+ + +LH +  IHRD+K+ NILLD  F  K++DFGL+R       T +
Sbjct: 132 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM 191
Query: 220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH-EINLSNLA 278
                GT  Y+ PE  +  ++T KSD++SFGVVL+E+I+ +PAVD   HR  ++ L    
Sbjct: 192 XXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLLLDIKE 248
Query: 279 INKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
             + + K + + +D+ +  ++D+    ++ A+  +A QCL  +K+ RP +  V   L+++
Sbjct: 249 EIEDEEKTIEDYIDKKMN-DADST---SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 105/302 (34%), Positives = 169/302 (55%), Gaps = 22/302 (7%)
Query: 51  FSYGELEEATNYFD------SARELGDGGFGTVYYGELQDGRAVAVKRLYE----NNYKR 100
           FS+ EL+  TN FD         ++G+GGFG VY G + +   VAVK+L         + 
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 67
Query: 101 VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
            +QF  E+ ++A+ +H+NLV L G +S    +L LVY ++ NG++ D L      P  L 
Sbjct: 68  KQQFDQEIKVMAKCQHENLVELLGFSS-DGDDLCLVYVYMPNGSLLDRLSCLDGTP-PLS 125
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS 220
           W  R KIA   A+ + +LH +  IHRD+K+ NILLD  F  K++DFGL+R        V 
Sbjct: 126 WHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVM 185
Query: 221 TAP-QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH-EINLSNLA 278
                GT  Y+ PE  +  ++T KSD++SFGVVL+E+I+ +PAVD   HR  ++ L    
Sbjct: 186 XXRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLLLDIKE 242
Query: 279 INKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
             + + K + + +D+ +  ++D+    ++ A+  +A QCL  +K+ RP +  V   L+++
Sbjct: 243 EIEDEEKTIEDYIDKKMN-DADST---SVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 298
Query: 339 ES 340
            +
Sbjct: 299 TA 300

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  147 bits (372), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 104/299 (34%), Positives = 161/299 (53%), Gaps = 22/299 (7%)
Query: 51  FSYGELEEATNYFD------SARELGDGGFGTVYYGELQDGRAVAVKRLYE----NNYKR 100
           FS+ EL+  TN FD         + G+GGFG VY G + +   VAVK+L         + 
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNN-TTVAVKKLAAMVDITTEEL 64
Query: 101 VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
            +QF  E+ + A+ +H+NLV L G +S    +L LVY +  NG++ D L      P  L 
Sbjct: 65  KQQFDQEIKVXAKCQHENLVELLGFSS-DGDDLCLVYVYXPNGSLLDRLSCLDGTP-PLS 122
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS 220
           W  R KIA   A+ + +LH +  IHRD+K+ NILLD  F  K++DFGL+R        V 
Sbjct: 123 WHXRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVX 182
Query: 221 TAP-QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH-EINLSNLA 278
            +   GT  Y  PE  +  ++T KSD++SFGVVL+E+I+ +PAVD   HR  ++ L    
Sbjct: 183 XSRIVGTTAYXAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVD--EHREPQLLLDIKE 239
Query: 279 INKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD 337
             + + K + + +D+    + ++    ++ A   +A QCL  +K+ RP +  V   L++
Sbjct: 240 EIEDEEKTIEDYIDK----KXNDADSTSVEAXYSVASQCLHEKKNKRPDIKKVQQLLQE 294

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 96/277 (34%), Positives = 143/277 (51%), Gaps = 30/277 (10%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGC 125
           ++G G FGTV+  E   G  VAVK L E ++  +RV +F+ EV I+ RLRH N+V   G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--I 183
            ++    L +V E++S G++   LH   A+   L    RL +A + A  + YLH  +  I
Sbjct: 103 VTQPP-NLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           +HRD+K+ N+L+D  + VKV DFGLSRL  +       A  GTP ++ PE  +     +K
Sbjct: 161 VHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXA-AGTPEWMAPEVLRDEPSNEK 219
Query: 244 SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN-K 302
           SDV+SFGV+L EL         T  +   NL     N  Q       V   +G++    +
Sbjct: 220 SDVYSFGVILWEL--------ATLQQPWGNL-----NPAQ-------VVAAVGFKCKRLE 259
Query: 303 VRRTINA-VAELAFQCLQSEKDLRPYMVDVLDALRDI 338
           + R +N  VA +   C  +E   RP    ++D LR +
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  124 bits (311), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 95/277 (34%), Positives = 144/277 (51%), Gaps = 30/277 (10%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGC 125
           ++G G FGTV+  E   G  VAVK L E ++  +RV +F+ EV I+ RLRH N+V   G 
Sbjct: 44  KIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA 102
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--I 183
            ++    L +V E++S G++   LH   A+   L    RL +A + A  + YLH  +  I
Sbjct: 103 VTQPP-NLSIVTEYLSRGSLYRLLHKSGAR-EQLDERRRLSMAYDVAKGMNYLHNRNPPI 160
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           +HR++K+ N+L+D  + VKV DFGLSRL  +      +A  GTP ++ PE  +     +K
Sbjct: 161 VHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSA-AGTPEWMAPEVLRDEPSNEK 219
Query: 244 SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN-K 302
           SDV+SFGV+L EL         T  +   NL     N  Q       V   +G++    +
Sbjct: 220 SDVYSFGVILWEL--------ATLQQPWGNL-----NPAQ-------VVAAVGFKCKRLE 259
Query: 303 VRRTINA-VAELAFQCLQSEKDLRPYMVDVLDALRDI 338
           + R +N  VA +   C  +E   RP    ++D LR +
Sbjct: 260 IPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL 296

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 67/191 (35%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L   N    E F+ E  ++ +LRH+ LV LY   S
Sbjct: 192 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 250
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 251 EEP--IYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 306
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL RL  ++        +    +  PE     + T KSDV+
Sbjct: 307 LRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 366
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 367 SFGILLTELTT 377

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 84  EEP--IYIVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 15  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 73
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 74  EEP--IXIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 129
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 130 LRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVW 189
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 190 SFGILLTELTT 200

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  113 bits (283), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 84  EEP--IYIVIEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 84  EEP--IYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 18  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 76
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 77  EEP--IYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 132
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 133 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 192
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 193 SFGILLTELTT 203

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 84  EEP--IYIVCEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 250 EEP--IYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 366 SFGILLTELTT 376

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 250 EEP--IYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 366 SFGILLTELTT 376

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 16  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 74
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 75  EEP--IYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 130
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 131 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 190
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 191 SFGILLTELTT 201

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G + D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 84  EEP--IYIVMEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 14  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 72
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 73  EEP--IYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 128
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 129 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 188
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 189 SFGILLTELTT 199

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 274 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 332
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 333 EEP--IYIVTEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 388
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 389 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 448
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 449 SFGILLTELTT 459

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  112 bits (281), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G + D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 84  EEP--IYIVTEYMSKGCLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 191 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 249
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 250 EEP--IYIVGEYMSKGSLLDFLKGETGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 305
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 306 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 365
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 366 SFGILLTELTT 376

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 65/191 (34%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ ++RH+ LV LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKIRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 84  EEP--IYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 140 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 66/191 (34%), Positives = 99/191 (51%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 25  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVVS 83
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +HRD
Sbjct: 84  EEP--IYIVTEYMSKGSLLDFLKGEMGK--YLRLPQLVDMAAQIASGMAYVERMNYVHRD 139
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           +   NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 140 LAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 199
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 200 SFGILLTELTT 210

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  111 bits (277), Expect = 7e-25,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 5/192 (2%)
Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +E+G G FG V+ G   +   VA+K + E      E F+ E +++ +L H  LV LYG  
Sbjct: 13  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 71
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
              +  + LV+EF+ +G ++D+L  +R   G     T L + ++    + YL  + +IHR
Sbjct: 72  LEQA-PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEASVIHR 127
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D+   N L+  N  +KV+DFG++R   +     ST  +    +  PE     + + KSDV
Sbjct: 128 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 187
Query: 247 FSFGVVLIELIS 258
           +SFGV++ E+ S
Sbjct: 188 WSFGVLMWEVFS 199

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 62/192 (32%), Positives = 101/192 (52%), Gaps = 5/192 (2%)
Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           + LG+G FG V+ G       VA+K L        E F+ E  I+ +L+H  LV LY   
Sbjct: 15  KRLGNGQFGEVWMGTWNGNTKVAIKTLKPGTMSP-ESFLEEAQIMKKLKHDKLVQLYAVV 73
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           S     + +V E+++ G++ D L     +  AL  P  + +A + A+ + Y+   + IHR
Sbjct: 74  SEEP--IYIVTEYMNKGSLLDFLKDGEGR--ALKLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D+++ NIL+ N    K+ADFGL+RL  ++        +    +  PE     + T KSDV
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 247 FSFGVVLIELIS 258
           +SFG++L EL++
Sbjct: 190 WSFGILLTELVT 201

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  110 bits (276), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E+++ G++ D L GE  K   L  P  + ++ + AS + Y+   + +HRD
Sbjct: 81  EEP--IYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 197 SFGILLTELTT 207

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 64/191 (33%), Positives = 100/191 (52%), Gaps = 5/191 (2%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   S
Sbjct: 22  KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVS 80
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
                + +V E+++ G++ D L GE  K   L  P  + ++ + AS + Y+   + +HRD
Sbjct: 81  EEP--IYIVTEYMNKGSLLDFLKGETGK--YLRLPQLVDMSAQIASGMAYVERMNYVHRD 136
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF 247
           ++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV+
Sbjct: 137 LRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVW 196
Query: 248 SFGVVLIELIS 258
           SFG++L EL +
Sbjct: 197 SFGILLTELTT 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 102/193 (52%), Gaps = 5/193 (2%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            +E+G G FG V+ G   +   VA+K + E      E F+ E +++ +L H  LV LYG 
Sbjct: 10  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGV 68
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               +  + LV+EF+ +G ++D+L  +R   G     T L + ++    + YL  + +IH
Sbjct: 69  CLEQA-PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH 124
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  +KV+DFG++R   +     ST  +    +  PE     + + KSD
Sbjct: 125 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 184
Query: 246 VFSFGVVLIELIS 258
           V+SFGV++ E+ S
Sbjct: 185 VWSFGVLMWEVFS 197

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 71/242 (29%), Positives = 124/242 (51%), Gaps = 22/242 (9%)
Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +ELG G FG V  G+ +    VAVK + E +    ++F  E   + +L H  LV  YG  
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSE-DEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 127 SRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
           S+    + +V E+ISNG + ++L  HG+  +P  L     L++  +    + +L +   I
Sbjct: 73  SK-EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDVCEGMAFLESHQFI 126
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 244
           HRD+   N L+D + CVKV+DFG++R   +     S   +    +  PE    ++ + KS
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKS 186
Query: 245 DVFSFGVVLIELIS--SMP---------AVDITR-HR-HEINLSNLAINKIQNKALHELV 291
           DV++FG+++ E+ S   MP          + +++ HR +  +L++  I +I     HEL 
Sbjct: 187 DVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIYQIMYSCWHELP 246
Query: 292 DQ 293
           ++
Sbjct: 247 EK 248

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 102/193 (52%), Gaps = 5/193 (2%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            +E+G G FG V+ G   +   VA+K + E      E F+ E +++ +L H  LV LYG 
Sbjct: 12  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGV 70
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               +  + LV+EF+ +G ++D+L  +R   G     T L + ++    + YL  + +IH
Sbjct: 71  CLEQA-PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH 126
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  +KV+DFG++R   +     ST  +    +  PE     + + KSD
Sbjct: 127 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 186
Query: 246 VFSFGVVLIELIS 258
           V+SFGV++ E+ S
Sbjct: 187 VWSFGVLMWEVFS 199

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 61/192 (31%), Positives = 102/192 (53%), Gaps = 5/192 (2%)
Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +E+G G FG V+ G   +   VA+K + E      E F+ E +++ +L H  LV LYG  
Sbjct: 16  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGVC 74
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
              +  + LV+EF+ +G ++D+L  +R   G     T L + ++    + YL  + +IHR
Sbjct: 75  LEQA-PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIHR 130
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D+   N L+  N  +KV+DFG++R   +     ST  +    +  PE     + + KSDV
Sbjct: 131 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 190
Query: 247 FSFGVVLIELIS 258
           +SFGV++ E+ S
Sbjct: 191 WSFGVLMWEVFS 202

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 60/193 (31%), Positives = 103/193 (53%), Gaps = 5/193 (2%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            +E+G G FG V+ G   +   VA+K + E +    + F+ E +++ +L H  LV LYG 
Sbjct: 32  VQEIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSE-DDFIEEAEVMMKLSHPKLVQLYGV 90
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               +  + LV+EF+ +G ++D+L  +R   G     T L + ++    + YL  + +IH
Sbjct: 91  CLEQA-PICLVFEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH 146
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  +KV+DFG++R   +     ST  +    +  PE     + + KSD
Sbjct: 147 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 206
Query: 246 VFSFGVVLIELIS 258
           V+SFGV++ E+ S
Sbjct: 207 VWSFGVLMWEVFS 219

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  108 bits (270), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 73/209 (34%), Positives = 112/209 (53%), Gaps = 17/209 (8%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 80  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 135
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPEYHQCYQLTD 242
           RD+   N L+  N  VKVADFGLSRL         TAP G      +  PE     + + 
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 243 KSDVFSFGVVLIEL----ISSMPAVDITR 267
           KSDV++FGV+L E+    +S  P +D+++
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 221

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 73/209 (34%), Positives = 112/209 (53%), Gaps = 17/209 (8%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 81  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 136
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPEYHQCYQLTD 242
           RD+   N L+  N  VKVADFGLSRL         TAP G      +  PE     + + 
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLM---TGDTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 243 KSDVFSFGVVLIEL----ISSMPAVDITR 267
           KSDV++FGV+L E+    +S  P +D+++
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQ 222

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  108 bits (270), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 61/193 (31%), Positives = 101/193 (52%), Gaps = 5/193 (2%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            +E+G G FG V+ G   +   VA+K + E      E F+ E +++ +L H  LV LYG 
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               +  + LV EF+ +G ++D+L  +R   G     T L + ++    + YL  + +IH
Sbjct: 72  CLEQA-PICLVTEFMEHGCLSDYLRTQR---GLFAAETLLGMCLDVCEGMAYLEEACVIH 127
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  +KV+DFG++R   +     ST  +    +  PE     + + KSD
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSD 187
Query: 246 VFSFGVVLIELIS 258
           V+SFGV++ E+ S
Sbjct: 188 VWSFGVLMWEVFS 200

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G FG VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 18  KLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 77  TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D ++
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQ 218

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  108 bits (269), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 21  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 79
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 80  TREP-PFYIIIEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 135
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 136 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 195
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 196 VWAFGVLLWEIATYGMSPYPGIDLSQ 221

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  107 bits (268), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 84  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQ 225

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 79  TREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ 220

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 84  TREP-PFYIIIEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQ 225

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 79  TREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ 220

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 79  TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ 220

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 79  TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ 220

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 33  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 91
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 92  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 147
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 148 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 207
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 208 VWAFGVLLWEIATYGMSPYPGIDLSQ 233

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G 
Sbjct: 15  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 74
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +++   +L +V ++    ++  HLH    K   +     + IA +TA  + YLHA  IIH
Sbjct: 75  STK--PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 129
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
           RD+K+NNI L  +  VK+ DFGL+ +      +H      G+  ++ PE     ++ DK 
Sbjct: 130 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 186
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
                SDV++FG+VL EL++                  L  + I N+      DQ +   
Sbjct: 187 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 224
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
             GY S +  KVR     A+  L  +CL+ ++D RP    +L ++
Sbjct: 225 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 269

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 84  TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQ 225

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G 
Sbjct: 40  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 99
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +++   +L +V ++    ++  HLH    K   +     + IA +TA  + YLHA  IIH
Sbjct: 100 STKP--QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 154
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
           RD+K+NNI L  +  VK+ DFGL+ +      +H      G+  ++ PE     ++ DK 
Sbjct: 155 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 211
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
                SDV++FG+VL EL++                  L  + I N+      DQ +   
Sbjct: 212 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 249
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
             GY S +  KVR     A+  L  +CL+ ++D RP    +L ++
Sbjct: 250 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 294

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G 
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +++   +L +V ++    ++  HLH    K   +     + IA +TA  + YLHA  IIH
Sbjct: 101 STKP--QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 155
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
           RD+K+NNI L  +  VK+ DFGL+ +      +H      G+  ++ PE     ++ DK 
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 212
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
                SDV++FG+VL EL++                  L  + I N+      DQ +   
Sbjct: 213 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 250
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
             GY S +  KVR     A+  L  +CL+ ++D RP    +L ++
Sbjct: 251 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 295

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 24  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 82
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 83  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 138
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 139 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 198
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 199 VWAFGVLLWEIATYGMSPYPGIDLSQ 224

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 84  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQ 225

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 81  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 136
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDLSQ 222

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G 
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +++   +L +V ++    ++  HLH    K   +     + IA +TA  + YLHA  IIH
Sbjct: 78  STK--PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
           RD+K+NNI L  +  VK+ DFGL+ +      +H      G+  ++ PE     ++ DK 
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 189
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
                SDV++FG+VL EL++                  L  + I N+      DQ +   
Sbjct: 190 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 227
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
             GY S +  KVR     A+  L  +CL+ ++D RP    +L ++
Sbjct: 228 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 272

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 25  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 83
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 84  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 139
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 140 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 199
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 200 VWAFGVLLWEIATYGMSPYPGIDLSQ 225

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 79  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ 220

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 22  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 80
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 81  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 136
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 137 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 196
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 197 VWAFGVLLWEIATYGMSPYPGIDLSQ 222

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G 
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +++   +L +V ++    ++  HLH    K   +     + IA +TA  + YLHA  IIH
Sbjct: 73  STK--PQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 127
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
           RD+K+NNI L  +  VK+ DFGL+ +      +H      G+  ++ PE     ++ DK 
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 184
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
                SDV++FG+VL EL++                  L  + I N+      DQ +   
Sbjct: 185 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 222
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
             GY S +  KVR     A+  L  +CL+ ++D RP    +L ++
Sbjct: 223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 84/295 (28%), Positives = 141/295 (47%), Gaps = 41/295 (13%)
Query: 53  YGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILA 112
           Y E+E A+    S R +G G FGTVY G+     AV + ++ +   ++ + F NEV +L 
Sbjct: 30  YWEIE-ASEVMLSTR-IGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLR 87
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
           + RH N++   G  ++ +  L +V ++    ++  HLH +  K         + IA +TA
Sbjct: 88  KTRHVNILLFMGYMTKDN--LAIVTQWCEGSSLYKHLHVQETKFQMF---QLIDIARQTA 142
Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVD 231
             + YLHA +IIHRD+K+NNI L     VK+ DFGL+ +      +     P G+  ++ 
Sbjct: 143 QGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 232 PEYHQCYQ---LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH 288
           PE  +       + +SDV+S+G+VL EL++                  L  + I N+   
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMT----------------GELPYSHINNR--- 243
Query: 289 ELVDQTL-----GYESDNKVRRTIN---AVAELAFQCLQSEKDLRPYMVDVLDAL 335
              DQ +     GY S +  +   N   A+  L   C++  K+ RP    +L ++
Sbjct: 244 ---DQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSI 295

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 20  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 78
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 79  TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 194
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 195 VWAFGVLLWEIATYGMSPYPGIDLSQ 220

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score =  107 bits (266), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G 
Sbjct: 18  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 77
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +++   +L +V ++    ++  HLH    K   +     + IA +TA  + YLHA  IIH
Sbjct: 78  STKP--QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
           RD+K+NNI L  +  VK+ DFGL+ +      +H      G+  ++ PE     ++ DK 
Sbjct: 133 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 189
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
                SDV++FG+VL EL++                  L  + I N+      DQ +   
Sbjct: 190 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 227
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
             GY S +  KVR     A+  L  +CL+ ++D RP    +L ++
Sbjct: 228 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 272

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 138/285 (48%), Gaps = 45/285 (15%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G 
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           ++  + +L +V ++    ++  HLH    K   +     + IA +TA  + YLHA  IIH
Sbjct: 73  ST--APQLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 127
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDK- 243
           RD+K+NNI L  +  VK+ DFGL+ +      +H      G+  ++ PE     ++ DK 
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE---VIRMQDKN 184
Query: 244 -----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL--- 295
                SDV++FG+VL EL++                  L  + I N+      DQ +   
Sbjct: 185 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQIIFMV 222
Query: 296 --GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
             GY S +  KVR     A+  L  +CL+ ++D RP    +L ++
Sbjct: 223 GRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 77  TREP-PFYIIIEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D ++
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQ 218

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 139/288 (48%), Gaps = 51/288 (17%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G 
Sbjct: 41  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 100
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +++   +L +V ++    ++  HLH    K   +     + IA +TA  + YLHA  IIH
Sbjct: 101 STKP--QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 155
Query: 186 RDVKTNNILLDNNFCVKVADFGL----SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           RD+K+NNI L  +  VK+ DFGL    SR   +H     +   G+  ++ PE     ++ 
Sbjct: 156 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPE---VIRMQ 209
Query: 242 DK------SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
           DK      SDV++FG+VL EL++                  L  + I N+      DQ +
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQII 247
Query: 296 -----GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
                GY S +  KVR     A+  L  +CL+ ++D RP    +L ++
Sbjct: 248 FMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 295

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 108/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 18  KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 76
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 77  TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 133 RDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIKSD 192
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D ++
Sbjct: 193 VWAFGVLLWEIATYGMSPYPGIDPSQ 218

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 68  ELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ELG+G FG V+  E       QD   VAVK L E +    + F  E ++L  L+H+++V 
Sbjct: 25  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 84
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAK---------PGALPWPTRLKIAI 169
            +G CT    R LL+V+E++ +G +   L  HG  AK         PG L     L +A 
Sbjct: 85  FFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 142
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPG 228
           + A+ + YL     +HRD+ T N L+     VK+ DFG+SR ++      V         
Sbjct: 143 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
           ++ PE     + T +SDV+SFGVVL E+ +
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 139/288 (48%), Gaps = 51/288 (17%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G 
Sbjct: 13  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 72
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +++   +L +V ++    ++  HLH    K   +     + IA +TA  + YLHA  IIH
Sbjct: 73  STKP--QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 127
Query: 186 RDVKTNNILLDNNFCVKVADFGL----SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           RD+K+NNI L  +  VK+ DFGL    SR   +H     +   G+  ++ PE     ++ 
Sbjct: 128 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPE---VIRMQ 181
Query: 242 DK------SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
           DK      SDV++FG+VL EL++                  L  + I N+      DQ +
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQII 219
Query: 296 -----GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
                GY S +  KVR     A+  L  +CL+ ++D RP    +L ++
Sbjct: 220 FMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 267

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score =  105 bits (263), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 139/288 (48%), Gaps = 51/288 (17%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G 
Sbjct: 33  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 92
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +++   +L +V ++    ++  HLH    K   +     + IA +TA  + YLHA  IIH
Sbjct: 93  STKP--QLAIVTQWCEGSSLYHHLHIIETKFEMI---KLIDIARQTAQGMDYLHAKSIIH 147
Query: 186 RDVKTNNILLDNNFCVKVADFGL----SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           RD+K+NNI L  +  VK+ DFGL    SR   +H     +   G+  ++ PE     ++ 
Sbjct: 148 RDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPE---VIRMQ 201
Query: 242 DK------SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
           DK      SDV++FG+VL EL++                  L  + I N+      DQ +
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNR------DQII 239
Query: 296 -----GYESDN--KVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDAL 335
                GY S +  KVR     A+  L  +CL+ ++D RP    +L ++
Sbjct: 240 FMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASI 287

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 68  ELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ELG+G FG V+  E       QD   VAVK L E +    + F  E ++L  L+H+++V 
Sbjct: 19  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 78
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAK---------PGALPWPTRLKIAI 169
            +G CT    R LL+V+E++ +G +   L  HG  AK         PG L     L +A 
Sbjct: 79  FFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 136
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPG 228
           + A+ + YL     +HRD+ T N L+     VK+ DFG+SR ++      V         
Sbjct: 137 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
           ++ PE     + T +SDV+SFGVVL E+ +
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 71/210 (33%), Positives = 106/210 (50%), Gaps = 21/210 (10%)
Query: 68  ELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ELG+G FG V+  E       QD   VAVK L E +    + F  E ++L  L+H+++V 
Sbjct: 48  ELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVR 107
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAK---------PGALPWPTRLKIAI 169
            +G CT    R LL+V+E++ +G +   L  HG  AK         PG L     L +A 
Sbjct: 108 FFGVCTE--GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPG 228
           + A+ + YL     +HRD+ T N L+     VK+ DFG+SR ++      V         
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
           ++ PE     + T +SDV+SFGVVL E+ +
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score =  105 bits (262), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 134/279 (48%), Gaps = 27/279 (9%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G 
Sbjct: 17  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 76
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +++   +L +V ++    ++  HLH    K         + IA +TA  + YLHA  IIH
Sbjct: 77  STKP--QLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKSIIH 131
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE---YHQCYQLT 241
           RD+K+NNI L  +  VK+ DFGL+ +      +H      G+  ++ PE          +
Sbjct: 132 RDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYS 191
Query: 242 DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK-ALHELVDQTLGYESD 300
            +SDV++FG+VL EL++                  L  + I N+  + E+V +       
Sbjct: 192 FQSDVYAFGIVLYELMT----------------GQLPYSNINNRDQIIEMVGRGSLSPDL 235
Query: 301 NKVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
           +KVR      +  L  +CL+ ++D RP    +L  + ++
Sbjct: 236 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 227 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 285
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 286 TREP-PFYIITEFMTYGNLLDYLRECNRQEVSAV---VLLYMATQISSAMEYLEKKNFIH 341
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           R++   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 342 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 401
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 402 VWAFGVLLWEIATYGMSPYPGIDLSQ 427

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 72/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           R+LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ EF+  G++ ++L  H ER     L     L+   +    + YL
Sbjct: 79  YKGVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKL-----LQYTSQICKGMEYL 133
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  104 bits (259), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 109/206 (52%), Gaps = 11/206 (5%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G  
Sbjct: 266 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 324
Query: 127 SRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +R      ++ EF++ G + D+L    R +  A+     L +A + +SA+ YL   + IH
Sbjct: 325 TREP-PFYIITEFMTYGNLLDYLRECNRQEVNAV---VLLYMATQISSAMEYLEKKNFIH 380
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           R++   N L+  N  VKVADFGLSRL            +    +  PE     + + KSD
Sbjct: 381 RNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSD 440
Query: 246 VFSFGVVLIEL----ISSMPAVDITR 267
           V++FGV+L E+    +S  P +D+++
Sbjct: 441 VWAFGVLLWEIATYGMSPYPGIDLSQ 466

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 109/217 (50%), Gaps = 7/217 (3%)
Query: 47  GVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMN 106
           G     YG  E         +ELG G FG V YG+ +    VA+K + E +    ++F+ 
Sbjct: 1   GTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIE 59
Query: 107 EVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK 166
           E  ++  L H+ LV LYG  ++  R + ++ E+++NG + ++L   R +         L+
Sbjct: 60  EAKVMMNLSHEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLE 115
Query: 167 IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGT 226
           +  +   A+ YL +   +HRD+   N L+++   VKV+DFGLSR   +     S   +  
Sbjct: 116 MCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFP 175
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS--SMP 261
             +  PE     + + KSD+++FGV++ E+ S   MP
Sbjct: 176 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 212

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 135/282 (47%), Gaps = 33/282 (11%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G 
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +++   +L +V ++    ++  HLH    K         + IA +TA  + YLHA  IIH
Sbjct: 89  STKP--QLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKSIIH 143
Query: 186 RDVKTNNILLDNNFCVKVADFGL----SRLFPNHVTHVSTAPQGTPGYVDPE---YHQCY 238
           RD+K+NNI L  +  VK+ DFGL    SR   +H     +   G+  ++ PE        
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPEVIRMQDSN 200
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK-ALHELVDQTLGY 297
             + +SDV++FG+VL EL++                  L  + I N+  + E+V +    
Sbjct: 201 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNRDQIIEMVGRGSLS 244
Query: 298 ESDNKVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
              +KVR      +  L  +CL+ ++D RP    +L  + ++
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 145/307 (47%), Gaps = 43/307 (14%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
           VF   E E +       RELG G FG VY G  +D   G A   VAVK + E+   R   
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
           +F+NE  ++      ++V L G  S+  +  L+V E +++G +  +L   R +    PG 
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
            P PT    +++A E A  + YL+A   +HRD+   N ++ ++F VK+ DFG++R     
Sbjct: 125 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 179
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
           +       +G  G     ++ PE  +    T  SD++SFGVVL E+ S      +    +
Sbjct: 180 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
           +  LSN        + L  ++D     + DN   R    V +L   C Q    +RP  ++
Sbjct: 234 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPKMRPTFLE 281
Query: 331 VLDALRD 337
           +++ L+D
Sbjct: 282 IVNLLKD 288

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 108/213 (50%), Gaps = 7/213 (3%)
Query: 51  FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDI 110
             YG  E         +ELG G FG V YG+ +    VA+K + E +    ++F+ E  +
Sbjct: 14  LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKV 72
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           +  L H+ LV LYG  ++  R + ++ E+++NG + ++L   R +         L++  +
Sbjct: 73  MMNLSHEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKD 128
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
              A+ YL +   +HRD+   N L+++   VKV+DFGLSR   +     S   +    + 
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWS 188
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELIS--SMP 261
            PE     + + KSD+++FGV++ E+ S   MP
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 145/307 (47%), Gaps = 43/307 (14%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
           VF   E E +       RELG G FG VY G  +D   G A   VAVK + E+   R   
Sbjct: 3   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 62
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
           +F+NE  ++      ++V L G  S+  +  L+V E +++G +  +L   R +    PG 
Sbjct: 63  EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 121
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
            P PT    +++A E A  + YL+A   +HRD+   N ++ ++F VK+ DFG++R     
Sbjct: 122 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 176
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
           +       +G  G     ++ PE  +    T  SD++SFGVVL E+ S      +    +
Sbjct: 177 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 230
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
           +  LSN        + L  ++D     + DN   R    V +L   C Q    +RP  ++
Sbjct: 231 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPKMRPTFLE 278
Query: 331 VLDALRD 337
           +++ L+D
Sbjct: 279 IVNLLKD 285

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKL-----LQYTSQICKGMEYL 133
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 79/282 (28%), Positives = 135/282 (47%), Gaps = 33/282 (11%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G 
Sbjct: 29  GQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY 88
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           ++  + +L +V ++    ++  HLH    K         + IA +TA  + YLHA  IIH
Sbjct: 89  ST--APQLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKSIIH 143
Query: 186 RDVKTNNILLDNNFCVKVADFGL----SRLFPNHVTHVSTAPQGTPGYVDPE---YHQCY 238
           RD+K+NNI L  +  VK+ DFGL    SR   +H     +   G+  ++ PE        
Sbjct: 144 RDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLS---GSILWMAPEVIRMQDSN 200
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK-ALHELVDQTLGY 297
             + +SDV++FG+VL EL++                  L  + I N+  + E+V +    
Sbjct: 201 PYSFQSDVYAFGIVLYELMT----------------GQLPYSNINNRDQIIEMVGRGSLS 244
Query: 298 ESDNKVRRTI-NAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
              +KVR      +  L  +CL+ ++D RP    +L  + ++
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 108/213 (50%), Gaps = 7/213 (3%)
Query: 51  FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDI 110
             YG  E         +ELG G FG V YG+ +    VA+K + E +    ++F+ E  +
Sbjct: 14  LGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKV 72
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           +  L H+ LV LYG  ++  R + ++ E+++NG + ++L   R +         L++  +
Sbjct: 73  MMNLSHEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKD 128
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
              A+ YL +   +HRD+   N L+++   VKV+DFGLSR   +     S   +    + 
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWS 188
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELIS--SMP 261
            PE     + + KSD+++FGV++ E+ S   MP
Sbjct: 189 PPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMP 221

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 19  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 79  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 133
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 134 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 193
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 194 ESKFSVASDVWSFGVVLYELFT 215

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 161
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 221
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 14  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 73
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 74  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 128
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 129 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 188
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 189 ESKFSVASDVWSFGVVLYELFT 210

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 21  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 80
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 81  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 135
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 136 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 195
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 196 ESKFSVASDVWSFGVVLYELFT 217

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +ELG G FG V YG+ +    VA+K + E +    ++F+ E  ++  L H+ LV LYG  
Sbjct: 14  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 72
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++  R + ++ E+++NG + ++L   R +         L++  +   A+ YL +   +HR
Sbjct: 73  TKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQFLHR 128
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D+   N L+++   VKV+DFGLSR   +     S   +    +  PE     + + KSD+
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 188
Query: 247 FSFGVVLIELIS--SMP 261
           ++FGV++ E+ S   MP
Sbjct: 189 WAFGVLMWEIYSLGKMP 205

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 22  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 81
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 82  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 136
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 137 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 196
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 197 ESKFSVASDVWSFGVVLYELFT 218

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 15  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 74
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 75  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 129
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 130 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 189
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 190 ESKFSVASDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score =  103 bits (256), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 20  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 79
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 80  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 134
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 135 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 194
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 195 ESKFSVASDVWSFGVVLYELFT 216

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 130
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +ELG G FG V YG+ +    VA+K + E +    ++F+ E  ++  L H+ LV LYG  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 68
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++  R + ++ E+++NG + ++L   R +         L++  +   A+ YL +   +HR
Sbjct: 69  TKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQFLHR 124
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D+   N L+++   VKV+DFGLSR   +     S   +    +  PE     + + KSD+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 247 FSFGVVLIELIS--SMP 261
           ++FGV++ E+ S   MP
Sbjct: 185 WAFGVLMWEIYSLGKMP 201

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 23  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 82
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 83  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 137
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 138 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 197
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 198 ESKFSVASDVWSFGVVLYELFT 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 130
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 190
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 103/202 (50%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 130
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P           G     +  PE   
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLT 190
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +ELG G FG V YG+ +    VA+K + E +    ++F+ E  ++  L H+ LV LYG  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++  R + ++ E+++NG + ++L   R +         L++  +   A+ YL +   +HR
Sbjct: 74  TKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D+   N L+++   VKV+DFGLSR   +     S   +    +  PE     + + KSD+
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 247 FSFGVVLIELIS--SMP 261
           ++FGV++ E+ S   MP
Sbjct: 190 WAFGVLMWEIYSLGKMP 206

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 88/307 (28%), Positives = 146/307 (47%), Gaps = 43/307 (14%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
           V+   E E +       RELG G FG VY G  +D   G A   VAVK + E+   R   
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
           +F+NE  ++      ++V L G  S+  +  L+V E +++G +  +L   R +    PG 
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
            P PT    +++A E A  + YL+A   +HRD+   N ++ ++F VK+ DFG++R     
Sbjct: 125 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 179
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
           +       +G  G     ++ PE  +    T  SD++SFGVVL E+ S      +    +
Sbjct: 180 IXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
           +  LSN        + L  ++D     + DN   R    V +L   C Q   ++RP  ++
Sbjct: 234 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPNMRPTFLE 281
Query: 331 VLDALRD 337
           +++ L+D
Sbjct: 282 IVNLLKD 288

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 71/202 (35%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 34  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 93
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 94  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQ 236
                IHRD+ T NIL++N   VK+ DFGL+++ P       V    +    +  PE   
Sbjct: 149 GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLT 208
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 209 ESKFSVASDVWSFGVVLYELFT 230

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 146/307 (47%), Gaps = 43/307 (14%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
           VF   E E +       RELG G FG VY G  +D   G A   VAVK + E+   R   
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
           +F+NE  ++      ++V L G  S+  +  L+V E +++G +  +L   R +    PG 
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
            P PT    +++A E A  + YL+A   +HRD+   N ++ ++F VK+ DFG++R     
Sbjct: 125 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 179
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
           +   +   +G  G     ++ PE  +    T  SD++SFGVVL E+ S      +    +
Sbjct: 180 IYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
           +  LSN        + L  ++D     + DN   R    V +L   C Q    +RP  ++
Sbjct: 234 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPKMRPTFLE 281
Query: 331 VLDALRD 337
           +++ L+D
Sbjct: 282 IVNLLKD 288

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  102 bits (253), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 105/197 (53%), Gaps = 7/197 (3%)
Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +ELG G FG V YG+ +    VA+K + E +    ++F+ E  ++  L H+ LV LYG  
Sbjct: 15  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGVC 73
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++  R + ++ E+++NG + ++L   R +         L++  +   A+ YL +   +HR
Sbjct: 74  TKQ-RPIFIITEYMANGCLLNYLREMRHRFQT---QQLLEMCKDVCEAMEYLESKQFLHR 129
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D+   N L+++   VKV+DFGLSR   +     S   +    +  PE     + + KSD+
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 247 FSFGVVLIELIS--SMP 261
           ++FGV++ E+ S   MP
Sbjct: 190 WAFGVLMWEIYSLGKMP 206

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 104/202 (51%), Gaps = 15/202 (7%)
Query: 67  RELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V    Y  LQD  G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 17  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 76
Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYL 178
             G C S   R L L+ E++  G++ D+L  H ER     L     L+   +    + YL
Sbjct: 77  YKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKL-----LQYTSQICKGMEYL 131
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQ 236
                IHR++ T NIL++N   VK+ DFGL+++ P    +      G     +  PE   
Sbjct: 132 GTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLT 191
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 192 ESKFSVASDVWSFGVVLYELFT 213

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 89/307 (28%), Positives = 145/307 (47%), Gaps = 43/307 (14%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
           VF   E E +       RELG G FG VY G  +D   G A   VAVK + E+   R   
Sbjct: 6   VFVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
           +F+NE  ++      ++V L G  S+  +  L+V E +++G +  +L   R +    PG 
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
            P PT    +++A E A  + YL+A   +HRD+   N ++ ++F VK+ DFG++R     
Sbjct: 125 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----D 179
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
           +       +G  G     ++ PE  +    T  SD++SFGVVL E+ S      +    +
Sbjct: 180 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
           +  LSN        + L  ++D     + DN   R    V +L   C Q    +RP  ++
Sbjct: 234 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPKMRPTFLE 281
Query: 331 VLDALRD 337
           +++ L+D
Sbjct: 282 IVNLLKD 288

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 70/207 (33%), Positives = 107/207 (51%), Gaps = 13/207 (6%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-C 125
           +LG G +G VY G  +     VAVK L E+  + VE+F+ E  ++  ++H NLV L G C
Sbjct: 39  KLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLGVC 97
Query: 126 TSRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
           T        +V E++  G + D+L    R +  A+     L +A + +SA+ YL   + I
Sbjct: 98  TLEPP--FYIVTEYMPYGNLLDYLRECNREEVTAV---VLLYMATQISSAMEYLEKKNFI 152
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 244
           HRD+   N L+  N  VKVADFGLSRL            +    +  PE       + KS
Sbjct: 153 HRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKS 212
Query: 245 DVFSFGVVLIEL----ISSMPAVDITR 267
           DV++FGV+L E+    +S  P +D+++
Sbjct: 213 DVWAFGVLLWEIATYGMSPYPGIDLSQ 239

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 127/275 (46%), Gaps = 30/275 (10%)
Query: 69  LGDGGFGTVYYGELQDGRA-----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSL 122
           +G G FG VY G L+         VA+K L      K+   F+ E  I+ +  H N++ L
Sbjct: 52  IGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRL 111
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
            G  S++ + ++++ E++ NG +   L   R K G       + +    A+ + YL   +
Sbjct: 112 EGVISKY-KPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLANMN 167
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQCYQL 240
            +HRD+   NIL+++N   KV+DFGLSR+  +    T+ ++  +    +  PE     + 
Sbjct: 168 YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKF 227
Query: 241 TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD 300
           T  SDV+SFG+V+ E+++          R    LSN  + K  N          L    D
Sbjct: 228 TSASDVWSFGIVMWEVMT-------YGERPYWELSNHEVMKAINDGFR------LPTPMD 274
Query: 301 NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
                  +A+ +L  QC Q E+  RP   D++  L
Sbjct: 275 CP-----SAIYQLMMQCWQQERARRPKFADIVSIL 304

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 99/192 (51%), Gaps = 4/192 (2%)
Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           + LG G FG V+ G   +   VAVK L       V+ F+ E +++  L+H  LV LY   
Sbjct: 19  KRLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 77
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           +R    + ++ E+++ G++ D L  +    G +  P  +  + + A  + Y+   + IHR
Sbjct: 78  TREE-PIYIITEYMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKNYIHR 134
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D++  N+L+  +   K+ADFGL+R+  ++        +    +  PE       T KSDV
Sbjct: 135 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDV 194
Query: 247 FSFGVVLIELIS 258
           +SFG++L E+++
Sbjct: 195 WSFGILLYEIVT 206

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 103/211 (48%), Gaps = 20/211 (9%)
Query: 67  RELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
           RELG+G FG V+  E       +D   VAVK L +      + F  E ++L  L+H+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHL--HGE----------RAKPGALPWPTRLKIA 168
             YG        L++V+E++ +G +   L  HG           R   G L     L IA
Sbjct: 81  KFYGVCG-DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTP 227
            + AS + YL +   +HRD+ T N L+  N  VK+ DFG+SR ++      V        
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
            ++ PE     + T +SDV+SFGV+L E+ +
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/290 (29%), Positives = 140/290 (48%), Gaps = 43/290 (14%)
Query: 67  RELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           RELG G FG VY G  +D   G A   VAVK + E+   R   +F+NE  ++      ++
Sbjct: 22  RELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHV 81
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGALPWPT---RLKIAIETA 172
           V L G  S+  +  L+V E +++G +  +L   R +    PG  P PT    +++A E A
Sbjct: 82  VRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP-PTLQEMIQMAAEIA 139
Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG---- 228
             + YL+A   +HRD+   N ++ ++F VK+ DFG++R     +       +G  G    
Sbjct: 140 DGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 195
Query: 229 -YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL 287
            ++ PE  +    T  SD++SFGVVL E+ S      +    ++  LSN        + L
Sbjct: 196 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPYQ-GLSN-------EQVL 241
Query: 288 HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD 337
             ++D     + DN   R    V +L   C Q    +RP  +++++ L+D
Sbjct: 242 KFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPKMRPTFLEIVNLLKD 287

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 54/192 (28%), Positives = 100/192 (52%), Gaps = 4/192 (2%)
Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ++LG G FG V+ G   +   VAVK L       V+ F+ E +++  L+H  LV LY   
Sbjct: 18  KKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTMS-VQAFLEEANLMKTLQHDKLVRLYAVV 76
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++    + ++ EF++ G++ D L  +    G +  P  +  + + A  + Y+   + IHR
Sbjct: 77  TKE-EPIYIITEFMAKGSLLDFLKSDEG--GKVLLPKLIDFSAQIAEGMAYIERKNYIHR 133
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D++  N+L+  +   K+ADFGL+R+  ++        +    +  PE       T KS+V
Sbjct: 134 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNV 193
Query: 247 FSFGVVLIELIS 258
           +SFG++L E+++
Sbjct: 194 WSFGILLYEIVT 205

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 133/285 (46%), Gaps = 24/285 (8%)
Query: 67  RELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
           RELG+G FG V+  E       QD   VAVK L + +    + F  E ++L  L+H+++V
Sbjct: 19  RELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIV 78
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHL--HGERA-------KPGALPWPTRLKIAIET 171
             YG        L++V+E++ +G +   L  HG  A        P  L     L IA + 
Sbjct: 79  KFYGVCVE-GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQI 137
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYV 230
           A+ + YL +   +HRD+ T N L+  N  VK+ DFG+SR ++      V         ++
Sbjct: 138 AAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALH 288
            PE     + T +SDV+S GVVL E+ +    P   ++ +     ++   + +       
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPRTCPQ 257
Query: 289 ELVDQTLG-YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
           E+ +  LG ++ +  +R+ I  +  L    LQ+     P  +D+L
Sbjct: 258 EVYELMLGCWQREPHMRKNIKGIHTL----LQNLAKASPVYLDIL 298

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 146/307 (47%), Gaps = 43/307 (14%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
           V+   E E +       RELG G FG VY G  +D   G A   VAVK + E+   R   
Sbjct: 7   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 66
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
           +F+NE  ++      ++V L G  S+  +  L+V E +++G +  +L   R +    PG 
Sbjct: 67  EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 125
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
            P PT    +++A E A  + YL+A   +HR++   N ++ ++F VK+ DFG++R     
Sbjct: 126 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTR----D 180
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
           +       +G  G     ++ PE  +    T  SD++SFGVVL E+ S      +    +
Sbjct: 181 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 234
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
           +  LSN        + L  ++D     + DN   R    V +L   C Q   ++RP  ++
Sbjct: 235 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPNMRPTFLE 282
Query: 331 VLDALRD 337
           +++ L+D
Sbjct: 283 IVNLLKD 289

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 98.6 bits (244), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 86/306 (28%), Positives = 138/306 (45%), Gaps = 28/306 (9%)
Query: 61  NYFDSARELGDGGFGTV---YYGELQDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL 114
            Y    R+LG+G FG V    Y    DG    VAVK L  +   +    +  E+DIL  L
Sbjct: 31  RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 115 RHKNLVSLYGCTS-RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
            H++++   GC     +  L LV E++  G++ D+L         L     L  A +   
Sbjct: 91  YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICE 145
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTP-GYVD 231
            + YLHA   IHRD+   N+LLDN+  VK+ DFGL++  P  H  +       +P  +  
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYA 205
Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV 291
           PE  + Y+    SDV+SFGV L EL++   +      +  + L  +A  ++    L EL+
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELL 264
Query: 292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEE 351
           ++    E   +  +    V  L   C ++E   RP   +++  L+ +          HE+
Sbjct: 265 ERG---ERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTV----------HEK 311
Query: 352 MMTQSP 357
              Q+P
Sbjct: 312 YQGQAP 317

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 99/192 (51%), Gaps = 5/192 (2%)
Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ++LG G FG V+         VAVK +   +   VE F+ E +++  L+H  LV L+   
Sbjct: 21  KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 79
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++    + ++ EF++ G++ D L  +       P P  +  + + A  + ++   + IHR
Sbjct: 80  TKEP--IYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 135
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D++  NIL+  +   K+ADFGL+R+  ++        +    +  PE       T KSDV
Sbjct: 136 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 195
Query: 247 FSFGVVLIELIS 258
           +SFG++L+E+++
Sbjct: 196 WSFGILLMEIVT 207

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 87/307 (28%), Positives = 146/307 (47%), Gaps = 43/307 (14%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYGELQD---GRA---VAVKRLYENNYKRVE- 102
           V+   E E +       RELG G FG VY G  +D   G A   VAVK + E+   R   
Sbjct: 6   VYVPDEWEVSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERI 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
           +F+NE  ++      ++V L G  S+  +  L+V E +++G +  +L   R +    PG 
Sbjct: 66  EFLNEASVMKGFTCHHVVRLLGVVSK-GQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR 124
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
            P PT    +++A E A  + YL+A   +HR++   N ++ ++F VK+ DFG++R     
Sbjct: 125 PP-PTLQEMIQMAAEIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTR----D 179
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
           +       +G  G     ++ PE  +    T  SD++SFGVVL E+ S      +    +
Sbjct: 180 IYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS------LAEQPY 233
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
           +  LSN        + L  ++D     + DN   R    V +L   C Q   ++RP  ++
Sbjct: 234 Q-GLSN-------EQVLKFVMDGGYLDQPDNCPER----VTDLMRMCWQFNPNMRPTFLE 281
Query: 331 VLDALRD 337
           +++ L+D
Sbjct: 282 IVNLLKD 288

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 53/192 (27%), Positives = 99/192 (51%), Gaps = 5/192 (2%)
Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ++LG G FG V+         VAVK +   +   VE F+ E +++  L+H  LV L+   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 252
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++    + ++ EF++ G++ D L  +       P P  +  + + A  + ++   + IHR
Sbjct: 253 TKEP--IYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 308
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D++  NIL+  +   K+ADFGL+R+  ++        +    +  PE       T KSDV
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDV 368
Query: 247 FSFGVVLIELIS 258
           +SFG++L+E+++
Sbjct: 369 WSFGILLMEIVT 380

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 97.8 bits (242), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 19/220 (8%)
Query: 61  NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNL 119
           ++++   ELGDG FG VY  + ++   +A  ++ +  + + +E +M E+DILA   H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYL 178
           V L      +   L ++ EF + G V D +  E  +P      +++++   +T  AL YL
Sbjct: 97  VKLLDAF-YYENNLWILIEFCAGGAV-DAVMLELERPLT---ESQIQVVCKQTLDALNYL 151
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H + IIHRD+K  NIL   +  +K+ADFG+S      +    +   GTP ++ PE   C 
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDSF-IGTPYWMAPEVVMCE 210
Query: 239 QLTD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
              D     K+DV+S G+ LIE+       +I    HE+N
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM------AEIEPPHHELN 244

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 19/220 (8%)
Query: 61  NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNL 119
           ++++   ELGDG FG VY  + ++   +A  ++ +  + + +E +M E+DILA   H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYL 178
           V L      +   L ++ EF + G V D +  E  +P      +++++   +T  AL YL
Sbjct: 97  VKLLDAF-YYENNLWILIEFCAGGAV-DAVMLELERPLT---ESQIQVVCKQTLDALNYL 151
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H + IIHRD+K  NIL   +  +K+ADFG+S      +    +   GTP ++ PE   C 
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF-IGTPYWMAPEVVMCE 210
Query: 239 QLTD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
              D     K+DV+S G+ LIE+       +I    HE+N
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEM------AEIEPPHHELN 244

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 97.8 bits (242), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 70/206 (33%), Positives = 103/206 (50%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           FD  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV    + E  K              E A+AL+Y 
Sbjct: 74  ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALSYC 128
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +N  +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 185
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +  MP  +
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 80/286 (27%), Positives = 131/286 (45%), Gaps = 18/286 (6%)
Query: 62  YFDSARELGDGGFGTV---YYGELQDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARLR 115
           Y    R+LG+G FG V    Y    DG    VAVK L  +   +    +  E+DIL  L 
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 116 HKNLVSLYGCTS-RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
           H++++   GC   +  + L LV E++  G++ D+L         L     L  A +    
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEG 129
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDP 232
           + YLHA   IHR++   N+LLDN+  VK+ DFGL++  P    +      G     +  P
Sbjct: 130 MAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E  + Y+    SDV+SFGV L EL++   +      +  + L  +A  ++    L EL++
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLE 248
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
           +    E   +  +    V  L   C ++E   RP   +++  L+ +
Sbjct: 249 RG---ERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 35  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 94
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + YL +   
Sbjct: 95  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 151
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R   +   +  H  T  +    ++  E  Q  + 
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 211
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 255
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 256 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 33  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 92
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + YL +   
Sbjct: 93  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 149
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R   +   +  H  T  +    ++  E  Q  + 
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 209
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 210 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 253
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 254 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 291

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + YL +   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 152
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R   +   +  H  T  +    ++  E  Q  + 
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 212
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 213 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 256
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 257 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 294

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + YL +   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 153
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R   +   +  H  T  +    ++  E  Q  + 
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 213
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 214 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 257
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 258 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 295

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 30  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 89
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + YL +   
Sbjct: 90  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 146
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R   +   +  H  T  +    ++  E  Q  + 
Sbjct: 147 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 206
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 207 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 250
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 251 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 288

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + YL +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 154
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R   +   +  H  T  +    ++  E  Q  + 
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 258
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 259 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 296

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + YL +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 154
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R   +   +  H  T  +    ++  E  Q  + 
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 258
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 259 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 296

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 56  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 115
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + YL +   
Sbjct: 116 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 172
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R   +   +  H  T  +    ++  E  Q  + 
Sbjct: 173 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 232
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 233 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 276
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 277 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 314

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 76/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 57  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 116
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + YL +   
Sbjct: 117 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 173
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R   +   +  H  T  +    ++  E  Q  + 
Sbjct: 174 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKF 233
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 234 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 277
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 278 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 315

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 97.1 bits (240), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 112/220 (50%), Gaps = 19/220 (8%)
Query: 61  NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNL 119
           ++++   ELGDG FG VY  + ++   +A  ++ +  + + +E +M E+DILA   H N+
Sbjct: 37  DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNI 96
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYL 178
           V L      +   L ++ EF + G V D +  E  +P      +++++   +T  AL YL
Sbjct: 97  VKLLDAF-YYENNLWILIEFCAGGAV-DAVMLELERPLT---ESQIQVVCKQTLDALNYL 151
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H + IIHRD+K  NIL   +  +K+ADFG+S      +        GTP ++ PE   C 
Sbjct: 152 HDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQRRDXF-IGTPYWMAPEVVMCE 210
Query: 239 QLTD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
              D     K+DV+S G+ LIE+    P        HE+N
Sbjct: 211 TSKDRPYDYKADVWSLGITLIEMAEIEPP------HHELN 244

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 131/286 (45%), Gaps = 18/286 (6%)
Query: 62  YFDSARELGDGGFGTV---YYGELQDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARLR 115
           Y    R+LG+G FG V    Y    DG    VAVK L  +   +    +  E+DIL  L 
Sbjct: 15  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 116 HKNLVSLYGCTS-RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
           H++++   GC   +  + L LV E++  G++ D+L         L     L  A +    
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQL-----LLFAQQICEG 129
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDP 232
           + YLH+   IHR++   N+LLDN+  VK+ DFGL++  P    +      G     +  P
Sbjct: 130 MAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 189
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E  + Y+    SDV+SFGV L EL++   +      +  + L  +A  ++    L EL++
Sbjct: 190 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQMTVLRLTELLE 248
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
           +    E   +  +    V  L   C ++E   RP   +++  L+ +
Sbjct: 249 RG---ERLPRPDKCPCEVYHLMKNCWETEASFRPTFENLIPILKTV 291

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 37  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 96
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + YL +   
Sbjct: 97  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKYLASKKF 153
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNH---VTHVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R   +      H  T  +    ++  E  Q  + 
Sbjct: 154 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKF 213
Query: 241 TDKSDVFSFGVVLIELIS 258
           T KSDV+SFGV+L EL++
Sbjct: 214 TTKSDVWSFGVLLWELMT 231

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 69/206 (33%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           FD  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 14  FDIGRPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV    + E  K              E A+AL+Y 
Sbjct: 74  ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSRFDEQRTATYITELANALSYC 128
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +N  +K+ADFG S   P+          GT  Y+ PE  +  
Sbjct: 129 HSKRVIHRDIKPENLLLGSNGELKIADFGWSVHAPSSRRDTLC---GTLDYLPPEMIEGR 185
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +  MP  +
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 65/208 (31%), Positives = 100/208 (48%), Gaps = 18/208 (8%)
Query: 69  LGDGGFG-TVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           LG G FG  +     + G  + +K L   + +    F+ EV ++  L H N++   G   
Sbjct: 18  LGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
           +  R L  + E+I  GT+   +   ++     PW  R+  A + AS + YLH+ +IIHRD
Sbjct: 78  KDKR-LNFITEYIKGGTLRGII---KSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133
Query: 188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS-----TAPQ--------GTPGYVDPEY 234
           + ++N L+  N  V VADFGL+RL  +  T          P         G P ++ PE 
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMPA 262
                  +K DVFSFG+VL E+I  + A
Sbjct: 194 INGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 95.9 bits (237), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 22  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               + ++ E++ NG++ D L    G +     L     L +A + A  + ++   + IH
Sbjct: 81  EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 133
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSD
Sbjct: 134 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 193
Query: 246 VFSFGVVLIELIS 258
           V+SFG++L E+++
Sbjct: 194 VWSFGILLTEIVT 206

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               + ++ E++ NG++ D L    G +     L     L +A + A  + ++   + IH
Sbjct: 86  EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 138
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSD
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 246 VFSFGVVLIELIS 258
           V+SFG++L E+++
Sbjct: 199 VWSFGILLTEIVT 211

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 29  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               + ++ E++ NG++ D L    G +     L     L +A + A  + ++   + IH
Sbjct: 88  EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 140
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSD
Sbjct: 141 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 200
Query: 246 VFSFGVVLIELIS 258
           V+SFG++L E+++
Sbjct: 201 VWSFGILLTEIVT 213

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               + ++ E++ NG++ D L    G +     L     L +A + A  + ++   + IH
Sbjct: 80  EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 246 VFSFGVVLIELIS 258
           V+SFG++L E+++
Sbjct: 193 VWSFGILLTEIVT 205

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 30  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               + ++ E++ NG++ D L    G +     L     L +A + A  + ++   + IH
Sbjct: 89  EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 141
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSD
Sbjct: 142 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 201
Query: 246 VFSFGVVLIELIS 258
           V+SFG++L E+++
Sbjct: 202 VWSFGILLTEIVT 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 23  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               + ++ E++ NG++ D L    G +     L     L +A + A  + ++   + IH
Sbjct: 82  EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 134
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSD
Sbjct: 135 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 194
Query: 246 VFSFGVVLIELIS 258
           V+SFG++L E+++
Sbjct: 195 VWSFGILLTEIVT 207

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               + ++ E++ NG++ D L    G +     L     L +A + A  + ++   + IH
Sbjct: 80  EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 246 VFSFGVVLIELIS 258
           V+SFG++L E+++
Sbjct: 193 VWSFGILLTEIVT 205

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 146/320 (45%), Gaps = 43/320 (13%)
Query: 43  GNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYEN 96
           G++    V+   E E A      +RELG G FG VY G      + +    VA+K + E 
Sbjct: 1   GSFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 60
Query: 97  NYKRVE-QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK 155
              R   +F+NE  ++      ++V L G  S   +  L++ E ++ G +  +L   R +
Sbjct: 61  ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPE 119
Query: 156 ----PGALPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL 208
               P   P P+    +++A E A  + YL+A+  +HRD+   N ++  +F VK+ DFG+
Sbjct: 120 MENNPVLAP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 209 SRLFPNHVTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAV 263
           +R     +       +G  G     ++ PE  +    T  SDV+SFGVVL E+ +     
Sbjct: 179 TR----DIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----- 229
Query: 264 DITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKD 323
            +    ++  LSN        + L  +++  L  + DN      + + EL   C Q    
Sbjct: 230 -LAEQPYQ-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPK 276
Query: 324 LRPYMVDVLDALRDIESDGY 343
           +RP  ++++ ++++    G+
Sbjct: 277 MRPSFLEIISSIKEEMEPGF 296

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/198 (32%), Positives = 99/198 (50%), Gaps = 11/198 (5%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + +L +   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 155
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNH---VTHVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R   +      H  T  +    ++  E  Q  + 
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKF 215
Query: 241 TDKSDVFSFGVVLIELIS 258
           T KSDV+SFGV+L EL++
Sbjct: 216 TTKSDVWSFGVLLWELMT 233

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + +L +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 154
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHV--THVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R ++       H  T  +    ++  E  Q  + 
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 258
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 259 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 296

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 38  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 97
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + +L +   
Sbjct: 98  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 154
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHV--THVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R ++       H  T  +    ++  E  Q  + 
Sbjct: 155 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 214
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 215 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 258
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 259 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 296

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 26  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               + ++ E++ NG++ D L    G +     L     L +A + A  + ++   + IH
Sbjct: 85  EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 137
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSD
Sbjct: 138 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 197
Query: 246 VFSFGVVLIELIS 258
           V+SFG++L E+++
Sbjct: 198 VWSFGILLTEIVT 210

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 39  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 98
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + +L +   
Sbjct: 99  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 155
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHV--THVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R ++       H  T  +    ++  E  Q  + 
Sbjct: 156 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 215
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 216 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 259
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 260 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 297

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 27  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               + ++ E++ NG++ D L    G +     L     L +A + A  + ++   + IH
Sbjct: 86  EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 138
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSD
Sbjct: 139 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 198
Query: 246 VFSFGVVLIELIS 258
           V+SFG++L E+++
Sbjct: 199 VWSFGILLTEIVT 211

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 36  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 95
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + +L +   
Sbjct: 96  GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 152
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHV--THVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R ++       H  T  +    ++  E  Q  + 
Sbjct: 153 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 212
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 213 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 256
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 257 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 294

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 31  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-PDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               + ++ E++ NG++ D L    G +     L     L +A + A  + ++   + IH
Sbjct: 90  EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 142
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSD
Sbjct: 143 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 202
Query: 246 VFSFGVVLIELIS 258
           V+SFG++L E+++
Sbjct: 203 VWSFGILLTEIVT 215

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 100/193 (51%), Gaps = 11/193 (5%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 21  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               + ++ E++ NG++ D L    G +     L     L +A + A  + ++   + IH
Sbjct: 80  EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 246 VFSFGVVLIELIS 258
           V+SFG++L E+++
Sbjct: 193 VWSFGILLTEIVT 205

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 43  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 102
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + +L +   
Sbjct: 103 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 159
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHV--THVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R ++       H  T  +    ++  E  Q  + 
Sbjct: 160 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 219
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 220 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 263
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 264 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 301

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 94.7 bits (234), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 33/282 (11%)
Query: 69  LGDGGFGTVYYGEL--QDGRAV--AVKRLYE-NNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG VY+G L   DG+ +  AVK L    +   V QF+ E  I+    H N++SL 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLL 156
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G   R     L+V  ++ +G + + +  E   P        +   ++ A  + +L +   
Sbjct: 157 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV---KDLIGFGLQVAKGMKFLASKKF 213
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHV--THVSTAPQGTPGYVDPEYHQCYQL 240
           +HRD+   N +LD  F VKVADFGL+R ++       H  T  +    ++  E  Q  + 
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 273
Query: 241 TDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           T KSDV+SFGV+L EL++  + P  D       +N  ++ +  +Q + L +         
Sbjct: 274 TTKSDVWSFGVLLWELMTRGAPPYPD-------VNTFDITVYLLQGRRLLQ--------- 317
Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
                    + + E+  +C   + ++RP   +++  +  I S
Sbjct: 318 ----PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 355

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 16  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR--LKIAIETASALTYLHASDIIHR 186
               + ++ E++ NG++ D L      P  +       L +A + A  + ++   + IHR
Sbjct: 75  EP--IYIITEYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 128
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSDV
Sbjct: 129 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 188
Query: 247 FSFGVVLIELIS 258
           +SFG++L E+++
Sbjct: 189 WSFGILLTEIVT 200

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 56/195 (28%), Positives = 98/195 (50%), Gaps = 21/195 (10%)
Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ++LG G FG V+         VAVK +   +   VE F+ E +++  L+H  LV L+   
Sbjct: 188 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVV 246
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++    + ++ EF++ G++ D L  +       P P  +  + + A  + ++   + IHR
Sbjct: 247 TKEP--IYIITEFMAKGSLLDFLKSDEG--SKQPLPKLIDFSAQIAEGMAFIEQRNYIHR 302
Query: 187 DVKTNNILLDNNFCVKVADFGLSRL---FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           D++  NIL+  +   K+ADFGL+R+   FP   T              PE       T K
Sbjct: 303 DLRAANILVSASLVCKIADFGLARVGAKFPIKWTA-------------PEAINFGSFTIK 349
Query: 244 SDVFSFGVVLIELIS 258
           SDV+SFG++L+E+++
Sbjct: 350 SDVWSFGILLMEIVT 364

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 63/200 (31%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKN 118
           F   R LG G FG V+      +GR  A+K L +      K+VE   +E  +L+ + H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ ++G T + ++++ ++ ++I  G +   L     K    P P     A E   AL YL
Sbjct: 68  IIRMWG-TFQDAQQIFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAAEVCLALEYL 122
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+ DII+RD+K  NILLD N  +K+ DFG ++  P+    V+    GTP Y+ PE     
Sbjct: 123 HSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD----VTYXLCGTPDYIAPEVVSTK 178
Query: 239 QLTDKSDVFSFGVVLIELIS 258
                 D +SFG+++ E+++
Sbjct: 179 PYNKSIDWWSFGILIYEMLA 198

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 99/190 (52%), Gaps = 9/190 (4%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V  G+ + G  VAVK +   N    + F+ E  ++ +LRH NLV L G    
Sbjct: 14  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDV 188
               L +V E+++ G++ D+L   R +   L     LK +++   A+ YL  ++ +HRD+
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLR-SRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 128
Query: 189 KTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
              N+L+  +   KV+DFGL++      +      +    +  PE  +  + + KSDV+S
Sbjct: 129 AARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 184
Query: 249 FGVVLIELIS 258
           FG++L E+ S
Sbjct: 185 FGILLWEIYS 194

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 99/190 (52%), Gaps = 9/190 (4%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V  G+ + G  VAVK +   N    + F+ E  ++ +LRH NLV L G    
Sbjct: 29  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDV 188
               L +V E+++ G++ D+L   R +   L     LK +++   A+ YL  ++ +HRD+
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLR-SRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 143
Query: 189 KTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
              N+L+  +   KV+DFGL++      +      +    +  PE  +  + + KSDV+S
Sbjct: 144 AARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 199
Query: 249 FGVVLIELIS 258
           FG++L E+ S
Sbjct: 200 FGILLWEIYS 209

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 99/190 (52%), Gaps = 9/190 (4%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V  G+ + G  VAVK +   N    + F+ E  ++ +LRH NLV L G    
Sbjct: 201 IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDV 188
               L +V E+++ G++ D+L   R +   L     LK +++   A+ YL  ++ +HRD+
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLR-SRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 315
Query: 189 KTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
              N+L+  +   KV+DFGL++      +      +    +  PE  +  + + KSDV+S
Sbjct: 316 AARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDVWS 371
Query: 249 FGVVLIELIS 258
           FG++L E+ S
Sbjct: 372 FGILLWEIYS 381

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/320 (25%), Positives = 146/320 (45%), Gaps = 43/320 (13%)
Query: 43  GNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYEN 96
           G++    V+   E E A      +RELG G FG VY G      + +    VA+K + E 
Sbjct: 1   GSFSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA 60
Query: 97  NYKRVE-QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK 155
              R   +F+NE  ++      ++V L G  S   +  L++ E ++ G +  +L   R +
Sbjct: 61  ASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPE 119
Query: 156 ----PGALPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL 208
               P   P P+    +++A E A  + YL+A+  +HRD+   N ++  +F VK+ DFG+
Sbjct: 120 MENNPVLAP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 209 SRLFPNHVTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAV 263
           +R     +       +G  G     ++ PE  +    T  SDV+SFGVVL E+ +     
Sbjct: 179 TR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT----- 229
Query: 264 DITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKD 323
            +    ++  LSN        + L  +++  L  + DN      + + EL   C Q    
Sbjct: 230 -LAEQPYQ-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPK 276
Query: 324 LRPYMVDVLDALRDIESDGY 343
           +RP  ++++ ++++    G+
Sbjct: 277 MRPSFLEIISSIKEEMEPGF 296

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 29/218 (13%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ELGDG FG VY  + ++  A+A  ++ E  + + +E ++ E++ILA   H  +V L G  
Sbjct: 26  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAY 85
Query: 127 SRHSRELLLVYEFISNGTV-ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
             H  +L ++ EF   G V A  L  +R     L  P    +  +   AL +LH+  IIH
Sbjct: 86  Y-HDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSKRIIH 140
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-----GTPGYVDPEYHQCYQL 240
           RD+K  N+L+     +++ADFG+S        ++ T  +     GTP ++ PE   C  +
Sbjct: 141 RDLKAGNVLMTLEGDIRLADFGVS------AKNLKTLQKRDSFIGTPYWMAPEVVMCETM 194
Query: 241 TD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
            D     K+D++S G+ LIE+    P        HE+N
Sbjct: 195 KDTPYDYKADIWSLGITLIEMAQIEPP------HHELN 226

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 109/218 (50%), Gaps = 29/218 (13%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ELGDG FG VY  + ++  A+A  ++ E  + + +E ++ E++ILA   H  +V L G  
Sbjct: 18  ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLG-A 76
Query: 127 SRHSRELLLVYEFISNGTV-ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
             H  +L ++ EF   G V A  L  +R     L  P    +  +   AL +LH+  IIH
Sbjct: 77  YYHDGKLWIMIEFCPGGAVDAIMLELDRG----LTEPQIQVVCRQMLEALNFLHSKRIIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-----GTPGYVDPEYHQCYQL 240
           RD+K  N+L+     +++ADFG+S        ++ T  +     GTP ++ PE   C  +
Sbjct: 133 RDLKAGNVLMTLEGDIRLADFGVS------AKNLKTLQKRDSFIGTPYWMAPEVVMCETM 186
Query: 241 TD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
            D     K+D++S G+ LIE+    P        HE+N
Sbjct: 187 KDTPYDYKADIWSLGITLIEMAQIEPP------HHELN 218

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 72/281 (25%), Positives = 134/281 (47%), Gaps = 35/281 (12%)
Query: 67  RELGDGGFG-TVYYGELQDGRAVAVKRL--YENNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +++G+G FG  +     +DGR   +K +     + K  E+   EV +LA ++H N+V  Y
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQ-Y 88
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERA----KPGALPWPTRLKIAIETASALTYLH 179
             +   +  L +V ++   G +   ++ ++     +   L W       ++   AL ++H
Sbjct: 89  RESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDW------FVQICLALKHVH 142
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              I+HRD+K+ NI L  +  V++ DFG++R+  N    ++ A  GTP Y+ PE  +   
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL-NSTVELARACIGTPYYLSPEICENKP 201
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEI-NLSNLAINKIQNKA----------LH 288
             +KSD+++ G VL EL +        +H  E  ++ NL +  I              L 
Sbjct: 202 YNNKSDIWALGCVLYELCT-------LKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLR 254
Query: 289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMV 329
            LV Q   ++ + + R ++N++ E  F   + EK L P ++
Sbjct: 255 SLVSQL--FKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLI 293

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 98/190 (51%), Gaps = 9/190 (4%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V  G+ + G  VAVK +   N    + F+ E  ++ +LRH NLV L G    
Sbjct: 20  IGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDV 188
               L +V E+++ G++ D+L   R +   L     LK +++   A+ YL  ++ +HRD+
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLR-SRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDL 134
Query: 189 KTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
              N+L+  +   KV+DFGL++      +      +    +  PE  +    + KSDV+S
Sbjct: 135 AARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREAAFSTKSDVWS 190
Query: 249 FGVVLIELIS 258
           FG++L E+ S
Sbjct: 191 FGILLWEIYS 200

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 55/192 (28%), Positives = 99/192 (51%), Gaps = 9/192 (4%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 17  LGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR--LKIAIETASALTYLHASDIIHR 186
               + ++ E++ NG++ D L      P  +       L +A + A  + ++   + IHR
Sbjct: 76  EP--IYIITEYMENGSLVDFLK----TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHR 129
Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           +++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSDV
Sbjct: 130 NLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 189
Query: 247 FSFGVVLIELIS 258
           +SFG++L E+++
Sbjct: 190 WSFGILLTEIVT 201

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 86/361 (23%), Positives = 161/361 (44%), Gaps = 54/361 (14%)
Query: 4   MAAIFLIYLRRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYF 63
           +  +  ++ R++ N    + +L+ + + E  S  D           V+   E E A    
Sbjct: 1   LVIMLYVFHRKRNNSRLGNGVLYASVNPEYFSAAD-----------VYVPDEWEVAREKI 49
Query: 64  DSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE-QFMNEVDILARLRH 116
             +RELG G FG VY G      + +    VA+K + E    R   +F+NE  ++     
Sbjct: 50  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNC 109
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGALPWPT---RLKIAI 169
            ++V L G  S   +  L++ E ++ G +  +L   R +    P   P P+    +++A 
Sbjct: 110 HHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP-PSLSKMIQMAG 167
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG- 228
           E A  + YL+A+  +HRD+   N ++  +F VK+ DFG++R     +       +G  G 
Sbjct: 168 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGL 223
Query: 229 ----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN 284
               ++ PE  +    T  SDV+SFGVVL E+ +      +    ++  LSN        
Sbjct: 224 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQ-GLSN-------E 269
Query: 285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYD 344
           + L  +++  L  + DN      + + EL   C Q    +RP  ++++ ++++    G+ 
Sbjct: 270 QVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 325
Query: 345 D 345
           +
Sbjct: 326 E 326

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 80/309 (25%), Positives = 144/309 (46%), Gaps = 45/309 (14%)
Query: 55  ELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYE--NNYKRVEQFMN 106
           E E A      +RELG G FG VY G      + +    VA+K + E  +  +R+E F+N
Sbjct: 4   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE-FLN 62
Query: 107 EVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGALPWP 162
           E  ++      ++V L G  S   +  L++ E ++ G +  +L   R +    P   P P
Sbjct: 63  EASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP-P 120
Query: 163 T---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV 219
           +    +++A E A  + YL+A+  +HRD+   N ++  +F VK+ DFG++R     +   
Sbjct: 121 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIXET 176
Query: 220 STAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL 274
               +G  G     ++ PE  +    T  SDV+SFGVVL E+ +      +    ++  L
Sbjct: 177 DXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQ-GL 229
Query: 275 SNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA 334
           SN        + L  +++  L  + DN      + + EL   C Q    +RP  ++++ +
Sbjct: 230 SN-------EQVLRFVMEGGLLDKPDN----CPDMLLELMRMCWQYNPKMRPSFLEIISS 278
Query: 335 LRDIESDGY 343
           +++    G+
Sbjct: 279 IKEEMEPGF 287

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 112/218 (51%), Gaps = 27/218 (12%)
Query: 59  ATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN-------YKRVEQFMNEVDI 110
           A N  +  +++G GGFG V+ G L +D   VA+K L   +        ++ ++F  EV I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           ++ L H N+V LYG      R   +V EF+  G +   L  ++A P  + W  +L++ ++
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR---MVMEFVPCGDLYHRLL-DKAHP--IKWSVKLRLMLD 130
Query: 171 TASALTYLHASD--IIHRDVKTNNIL---LDNN--FCVKVADFGLSRLFPNHVTHVSTAP 223
            A  + Y+   +  I+HRD+++ NI    LD N   C KVADFGLS+       H  +  
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ----QSVHSVSGL 186
Query: 224 QGTPGYVDPEYHQCYQ--LTDKSDVFSFGVVLIELISS 259
            G   ++ PE     +   T+K+D +SF ++L  +++ 
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/206 (33%), Positives = 104/206 (50%), Gaps = 25/206 (12%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLY----ENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           +G GGFG VY      G  VAVK       E+  + +E    E  + A L+H N+++L G
Sbjct: 15  IGIGGFGKVYRA-FWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRG 73
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH---AS 181
              +    L LV EF   G +   L G+R  P  L     +  A++ A  + YLH     
Sbjct: 74  VCLKEP-NLCLVMEFARGGPLNRVLSGKRIPPDIL-----VNWAVQIARGMNYLHDEAIV 127
Query: 182 DIIHRDVKTNNILLD--------NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
            IIHRD+K++NIL+         +N  +K+ DFGL+R + +  T +S A  G   ++ PE
Sbjct: 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW-HRTTKMSAA--GAYAWMAPE 184
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
             +    +  SDV+S+GV+L EL++ 
Sbjct: 185 VIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 105/212 (49%), Gaps = 25/212 (11%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF---MNEVDILARLRHKN 118
           F   RE+G G FG VY+  ++++   VA+K++  +  +  E++   + EV  L +LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 119 LVSLYGCTSR-HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL-- 175
            +   GC  R H+  L++ Y     G+ +D L   + KP        ++IA  T  AL  
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCL---GSASDLLEVHK-KPL-----QEVEIAAVTHGALQG 166
Query: 176 -TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
             YLH+ ++IHRDVK  NILL     VK+ DFG + +       V     GTP ++ PE 
Sbjct: 167 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 221
Query: 235 HQCY---QLTDKSDVFSFGVVLIELISSMPAV 263
                  Q   K DV+S G+  IEL    P +
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 253

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 16/206 (7%)
Query: 61  NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           +Y D+  ++G+G  G V    ++  G+ VAVK++     +R E   NEV I+   +H+N+
Sbjct: 29  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 88
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V +Y  +     EL +V EF+  G + D +   R     +       + +    AL+ LH
Sbjct: 89  VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 142
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
           A  +IHRD+K+++ILL ++  VK++DFG    +S+  P     V     GTP ++ PE  
Sbjct: 143 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-----GTPYWMAPELI 197
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMP 261
                  + D++S G+++IE++   P
Sbjct: 198 SRLPYGPEVDIWSLGIMVIEMVDGEP 223

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 71  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 125
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSCHAP---SSRRTTLSGTLDYLPPEMIEGR 182
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 104/215 (48%), Gaps = 12/215 (5%)
Query: 54  GELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVD 109
           G+ + A   F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+
Sbjct: 1   GKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           I + LRH N++ LYG     +R + L+ E+   GTV   L     K              
Sbjct: 61  IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 115
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           E A+AL+Y H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTXLCGTLDY 172
Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
           + PE  +     +K D++S GV+  E +   P  +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 107/206 (51%), Gaps = 16/206 (7%)
Query: 61  NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           +Y D+  ++G+G  G V    ++  G+ VAVK++     +R E   NEV I+   +H+N+
Sbjct: 31  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 90
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V +Y  +     EL +V EF+  G + D +   R     +       + +    AL+ LH
Sbjct: 91  VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 144
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
           A  +IHRD+K+++ILL ++  VK++DFG    +S+  P     V     GTP ++ PE  
Sbjct: 145 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-----GTPYWMAPELI 199
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMP 261
                  + D++S G+++IE++   P
Sbjct: 200 SRLPYGPEVDIWSLGIMVIEMVDGEP 225

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 8/202 (3%)
Query: 61  NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           +Y D+  ++G+G  G V    ++  G+ VAVK++     +R E   NEV I+   +H+N+
Sbjct: 20  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V +Y  +     EL +V EF+  G + D +   R     +       + +    AL+ LH
Sbjct: 80  VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 133
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
           A  +IHRD+K+++ILL ++  VK++DFG        V        GTP ++ PE      
Sbjct: 134 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLP 192
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
              + D++S G+++IE++   P
Sbjct: 193 YGPEVDIWSLGIMVIEMVDGEP 214

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 56/193 (29%), Positives = 98/193 (50%), Gaps = 11/193 (5%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           LG G  G V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   ++
Sbjct: 21  LGAGQAGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 129 HSRELLLVYEFISNGTVADHLH---GERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               + ++ E++ NG++ D L    G +     L     L +A + A  + ++   + IH
Sbjct: 80  EP--IYIITEYMENGSLVDFLKTPSGIKLTINKL-----LDMAAQIAEGMAFIEERNYIH 132
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+ +    K+ADFGL+RL  +         +    +  PE       T KSD
Sbjct: 133 RDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSD 192
Query: 246 VFSFGVVLIELIS 258
           V+SFG++L E+++
Sbjct: 193 VWSFGILLTEIVT 205

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 59/202 (29%), Positives = 103/202 (50%), Gaps = 8/202 (3%)
Query: 61  NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           +Y D+  ++G+G  G V    ++  G+ VAVK++     +R E   NEV I+   +H+N+
Sbjct: 24  SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 83
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V +Y  +     EL +V EF+  G + D +   R     +       + +    AL+ LH
Sbjct: 84  VEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALSVLH 137
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
           A  +IHRD+K+++ILL ++  VK++DFG        V        GTP ++ PE      
Sbjct: 138 AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLP 196
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
              + D++S G+++IE++   P
Sbjct: 197 YGPEVDIWSLGIMVIEMVDGEP 218

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 130/284 (45%), Gaps = 18/284 (6%)
Query: 62  YFDSARELGDGGFGTV---YYGELQDGRA--VAVKRLYENNYKRVEQ-FMNEVDILARLR 115
           Y    R+LG+G FG V    Y    DG    VAVK L E    ++   +  E++IL  L 
Sbjct: 9   YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 68
Query: 116 HKNLVSLYGCTS-RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
           H+++V   GC   +  + + LV E++  G++ D+L         L     L  A +    
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEG 123
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-TP-GYVDP 232
           + YLHA   IHR +   N+LLDN+  VK+ DFGL++  P    +      G +P  +  P
Sbjct: 124 MAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 183
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E  +  +    SDV+SFGV L EL++   + + + H     L      ++    L EL++
Sbjct: 184 ECLKECKFYYASDVWSFGVTLYELLTYCDS-NQSPHTKFTELIGHTQGQMTVLRLTELLE 242
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR 336
           +    E   +  R    +  L   C ++E   RP   +++  L+
Sbjct: 243 RG---ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 283

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 130/284 (45%), Gaps = 18/284 (6%)
Query: 62  YFDSARELGDGGFGTV---YYGELQDGRA--VAVKRLYENNYKRVEQ-FMNEVDILARLR 115
           Y    R+LG+G FG V    Y    DG    VAVK L E    ++   +  E++IL  L 
Sbjct: 10  YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 69
Query: 116 HKNLVSLYGCTS-RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
           H+++V   GC   +  + + LV E++  G++ D+L         L     L  A +    
Sbjct: 70  HEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQL-----LLFAQQICEG 124
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-TP-GYVDP 232
           + YLHA   IHR +   N+LLDN+  VK+ DFGL++  P    +      G +P  +  P
Sbjct: 125 MAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 184
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E  +  +    SDV+SFGV L EL++   + + + H     L      ++    L EL++
Sbjct: 185 ECLKECKFYYASDVWSFGVTLYELLTYCDS-NQSPHTKFTELIGHTQGQMTVLRLTELLE 243
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR 336
           +    E   +  R    +  L   C ++E   RP   +++  L+
Sbjct: 244 RG---ERLPRPDRCPCEIYHLMKNCWETEASFRPTFQNLVPILQ 284

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 58  EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRH 116
           +  +Y D+  ++G+G  G V    ++  G+ VAVK++     +R E   NEV I+   +H
Sbjct: 148 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 207
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           +N+V +Y  +     EL +V EF+  G + D +   R     +       + +    AL+
Sbjct: 208 ENVVEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALS 261
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDP 232
            LHA  +IHRD+K+++ILL ++  VK++DFG    +S+  P     V     GTP ++ P
Sbjct: 262 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-----GTPYWMAP 316
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPA 262
           E         + D++S G+++IE++   P 
Sbjct: 317 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 346

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 54  GELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVD 109
           G  + A   F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+
Sbjct: 4   GSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           I + LRH N++ LYG     +R + L+ E+   GTV   L     K              
Sbjct: 64  IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 118
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           E A+AL+Y H+  +IHRD+K  N+LL +   +K+ADFG S   P   +    A  GT  Y
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGTLDY 175
Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
           + PE  +     +K D++S GV+  E +   P  +
Sbjct: 176 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 54  GELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVD 109
           G  + A   F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+
Sbjct: 1   GPRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           I + LRH N++ LYG     +R + L+ E+   GTV   L     K              
Sbjct: 61  IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 115
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           E A+AL+Y H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDY 172
Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
           + PE  +     +K D++S GV+  E +   P  +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 70/212 (33%), Positives = 105/212 (49%), Gaps = 25/212 (11%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF---MNEVDILARLRHKN 118
           F   RE+G G FG VY+  ++++   VA+K++  +  +  E++   + EV  L +LRH N
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 119 LVSLYGCTSR-HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL-- 175
            +   GC  R H+  L++ Y     G+ +D L   + KP        ++IA  T  AL  
Sbjct: 77  TIQYRGCYLREHTAWLVMEYCL---GSASDLLEVHK-KPL-----QEVEIAAVTHGALQG 127
Query: 176 -TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
             YLH+ ++IHRDVK  NILL     VK+ DFG + +       V     GTP ++ PE 
Sbjct: 128 LAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFV-----GTPYWMAPEV 182
Query: 235 HQCY---QLTDKSDVFSFGVVLIELISSMPAV 263
                  Q   K DV+S G+  IEL    P +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPL 214

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 27  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 86
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 87  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 141
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 142 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 198
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 199 MHDEKVDLWSLGVLCYEFLVGKPPFE 224

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 108/210 (51%), Gaps = 16/210 (7%)
Query: 58  EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRH 116
           +  +Y D+  ++G+G  G V    ++  G+ VAVK++     +R E   NEV I+   +H
Sbjct: 71  DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQH 130
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           +N+V +Y  +     EL +V EF+  G + D +   R     +       + +    AL+
Sbjct: 131 ENVVEMYN-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQI-----AAVCLAVLQALS 184
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDP 232
            LHA  +IHRD+K+++ILL ++  VK++DFG    +S+  P     V     GTP ++ P
Sbjct: 185 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLV-----GTPYWMAP 239
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPA 262
           E         + D++S G+++IE++   P 
Sbjct: 240 ELISRLPYGPEVDIWSLGIMVIEMVDGEPP 269

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 81/313 (25%), Positives = 143/313 (45%), Gaps = 43/313 (13%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE- 102
           VF   E E A      +RELG G FG VY G      + +    VA+K + E    R   
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 64
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
           +F+NE  ++      ++V L G  S   +  L++ E ++ G +  +L   R +    P  
Sbjct: 65  EFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 123
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
            P P+    +++A E A  + YL+A+  +HRD+   N ++  +F VK+ DFG++R     
Sbjct: 124 AP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----D 178
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
           +       +G  G     ++ PE  +    T  SDV+SFGVVL E+ +      +    +
Sbjct: 179 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPY 232
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
           +  LSN        + L  +++  L  + DN      + + EL   C Q    +RP  ++
Sbjct: 233 Q-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLE 280
Query: 331 VLDALRDIESDGY 343
           ++ ++++    G+
Sbjct: 281 IISSIKEEMEPGF 293

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 54  GELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVD 109
           G  + A   F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+
Sbjct: 1   GPRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           I + LRH N++ LYG     +R + L+ E+   GTV   L     K              
Sbjct: 61  IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 115
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           E A+AL+Y H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTELCGTLDY 172
Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
           + PE  +     +K D++S GV+  E +   P  +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 73  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 127
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 184
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 19/272 (6%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VE-QFMNEVDILARLRHKN 118
           FD  R LG G FG VY   E Q+   +A+K L+++  ++  VE Q   E++I + LRH N
Sbjct: 17  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 76
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ +Y       R + L+ EF   G     L+ E  K G            E A AL Y 
Sbjct: 77  ILRMYNYFHDRKR-IYLMLEFAPRGE----LYKELQKHGRFDEQRSATFMEELADALHYC 131
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H   +IHRD+K  N+L+     +K+ADFG S   P+          GT  Y+ PE  +  
Sbjct: 132 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC---GTLDYLPPEMIEGK 188
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD----ITRHRHEINLSNLAINKIQNKALHELVDQT 294
              +K D++  GV+  E +  MP  D       HR  +N+ +L      +    +L+ + 
Sbjct: 189 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLKFPPFLSDGSKDLISKL 247
Query: 295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
           L Y    ++   +  V E  +    S + L P
Sbjct: 248 LRYHPPQRL--PLKGVMEHPWVKANSRRVLPP 277

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 73  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 127
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 184
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 75  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 129
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 186
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 130/281 (46%), Gaps = 36/281 (12%)
Query: 67  RELGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRVEQFMNEVDILARLRHKNL 119
           R +G G FG V  G L+  G+   AVA+K L   Y    +R   F+ E  I+ +  H N+
Sbjct: 49  RVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRR--DFLCEASIMGQFDHPNV 106
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V L G  +R  + +++V EF+ NG +   L   R   G       + +    A+ + YL 
Sbjct: 107 VHLEGVVTR-GKPVMIVIEFMENGALDAFL---RKHDGQFTVIQLVGMLRGIAAGMRYLA 162
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQC 237
               +HRD+   NIL+++N   KV+DFGLSR+  +    V T   G     +  PE  Q 
Sbjct: 163 DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQY 222
Query: 238 YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY 297
            + T  SDV+S+G+V+ E++S          R   ++SN  +     KA+ E      GY
Sbjct: 223 RKFTSASDVWSYGIVMWEVMS-------YGERPYWDMSNQDV----IKAIEE------GY 265
Query: 298 ESDNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
                +      + +L   C Q E+  RP    +V +LD +
Sbjct: 266 RLPAPM-DCPAGLHQLMLDCWQKERAERPKFEQIVGILDKM 305

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 122/272 (44%), Gaps = 19/272 (6%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VE-QFMNEVDILARLRHKN 118
           FD  R LG G FG VY   E Q+   +A+K L+++  ++  VE Q   E++I + LRH N
Sbjct: 16  FDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ +Y       R + L+ EF   G     L+ E  K G            E A AL Y 
Sbjct: 76  ILRMYNYFHDRKR-IYLMLEFAPRGE----LYKELQKHGRFDEQRSATFMEELADALHYC 130
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H   +IHRD+K  N+L+     +K+ADFG S   P+          GT  Y+ PE  +  
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRXMC---GTLDYLPPEMIEGK 187
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD----ITRHRHEINLSNLAINKIQNKALHELVDQT 294
              +K D++  GV+  E +  MP  D       HR  +N+ +L      +    +L+ + 
Sbjct: 188 THDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-DLKFPPFLSDGSKDLISKL 246
Query: 295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
           L Y    ++   +  V E  +    S + L P
Sbjct: 247 LRYHPPQRL--PLKGVMEHPWVKANSRRVLPP 276

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 80/318 (25%), Positives = 144/318 (45%), Gaps = 43/318 (13%)
Query: 45  YHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNY 98
           +    V+   E E A      +RELG G FG VY G      + +    VA+K + E   
Sbjct: 9   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 99  KRVE-QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK-- 155
            R   +F+NE  ++      ++V L G  S   +  L++ E ++ G +  +L   R +  
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEME 127
Query: 156 --PGALPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR 210
             P   P P+    +++A E A  + YL+A+  +HRD+   N ++  +F VK+ DFG++R
Sbjct: 128 NNPVLAP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
Query: 211 LFPNHVTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDI 265
                +       +G  G     ++ PE  +    T  SDV+SFGVVL E+ +      +
Sbjct: 187 ----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------L 236
Query: 266 TRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLR 325
               ++  LSN        + L  +++  L  + DN      + + EL   C Q    +R
Sbjct: 237 AEQPYQ-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMR 284
Query: 326 PYMVDVLDALRDIESDGY 343
           P  ++++ ++++    G+
Sbjct: 285 PSFLEIISSIKEEMEPGF 302

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/317 (25%), Positives = 143/317 (45%), Gaps = 41/317 (12%)
Query: 45  YHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNY 98
           +    V+   E E A      +RELG G FG VY G      + +    VA+K + E   
Sbjct: 9   FSAADVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAAS 68
Query: 99  KRVE-QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---A 154
            R   +F+NE  ++      ++V L G  S   +  L++ E ++ G +  +L   R   A
Sbjct: 69  MRERIEFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMA 127
Query: 155 KPGALPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
               L  P+    +++A E A  + YL+A+  +HRD+   N ++  +F VK+ DFG++R 
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR- 186
Query: 212 FPNHVTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDIT 266
               +       +G  G     ++ PE  +    T  SDV+SFGVVL E+ +      + 
Sbjct: 187 ---DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LA 237
Query: 267 RHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
              ++  LSN        + L  +++  L  + DN      + + EL   C Q    +RP
Sbjct: 238 EQPYQ-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRP 285
Query: 327 YMVDVLDALRDIESDGY 343
             ++++ ++++    G+
Sbjct: 286 SFLEIISSIKEEMEPGF 302

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 75  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 129
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEXIEGR 186
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 187 XHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 9   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 68
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV    + E  K              E A+AL+Y 
Sbjct: 69  ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC 123
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 124 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 180
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 181 MHDEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 96  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 150
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 207
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 208 MHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV    + E  K              E A+AL+Y 
Sbjct: 70  ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC 124
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +    A  GT  Y+ PE  +  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGTLDYLPPEMIEGR 181
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 14  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 73
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 74  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 128
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 129 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 185
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 186 MHDEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 102/206 (49%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAV-AVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY    ++ + + A+K L++   ++     Q   EV+I + LRH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV    + E  K              E A+AL+Y 
Sbjct: 70  ILRLYGYFHDSTR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC 124
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +    A  GT  Y+ PE  +  
Sbjct: 125 HSKKVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRAALCGTLDYLPPEMIEGR 181
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   G V   L     K              E A+AL+Y 
Sbjct: 75  ILRLYGYFHDATR-VYLILEYAPRGEVYKELQ----KLSKFDEQRTATYITELANALSYC 129
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 186
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/215 (31%), Positives = 103/215 (47%), Gaps = 12/215 (5%)
Query: 54  GELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVD 109
           G+ + A   F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+
Sbjct: 1   GKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           I + LRH N++ LYG     +R + L+ E+   GTV   L     K              
Sbjct: 61  IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYIT 115
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           E A+AL+Y H+  +IHRD+K  N+LL +   +K+ADFG S   P+          GT  Y
Sbjct: 116 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---GTLDY 172
Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
           + PE  +     +K D++S GV+  E +   P  +
Sbjct: 173 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 143/313 (45%), Gaps = 43/313 (13%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE- 102
           V+   E E A      +RELG G FG VY G      + +    VA+K + E    R   
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
           +F+NE  ++      ++V L G  S   +  L++ E ++ G +  +L   R +    P  
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
            P P+    +++A E A  + YL+A+  +HRD+   N ++  +F VK+ DFG++R     
Sbjct: 126 AP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----D 180
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
           +       +G  G     ++ PE  +    T  SDV+SFGVVL E+ +      +    +
Sbjct: 181 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPY 234
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
           +  LSN        + L  +++  L  + DN      + + EL   C Q    +RP  ++
Sbjct: 235 Q-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLE 282
Query: 331 VLDALRDIESDGY 343
           ++ ++++    G+
Sbjct: 283 IISSIKEEMEPGF 295

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 7   FEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 66
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV    + E  K              E A+AL+Y 
Sbjct: 67  ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC 121
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 122 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 178
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 179 MHDEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV    + E  K              E A+AL+Y 
Sbjct: 70  ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC 124
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEGR 181
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 75  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 129
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEGR 186
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 10  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 69
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV    + E  K              E A+AL+Y 
Sbjct: 70  ILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSYC 124
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 125 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEGR 181
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 182 MHDEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 89.7 bits (221), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 71  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 125
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +   T   GT  Y+ PE  +  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRTDLCGTLDYLPPEMIEGR 182
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 143/313 (45%), Gaps = 43/313 (13%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE- 102
           V+   E E A      +RELG G FG VY G      + +    VA+K + E    R   
Sbjct: 7   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 66
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
           +F+NE  ++      ++V L G  S   +  L++ E ++ G +  +L   R +    P  
Sbjct: 67  EFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 125
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
            P P+    +++A E A  + YL+A+  +HRD+   N ++  +F VK+ DFG++R     
Sbjct: 126 AP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----D 180
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
           +       +G  G     ++ PE  +    T  SDV+SFGVVL E+ +      +    +
Sbjct: 181 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPY 234
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
           +  LSN        + L  +++  L  + DN      + + EL   C Q    +RP  ++
Sbjct: 235 Q-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLE 282
Query: 331 VLDALRDIESDGY 343
           ++ ++++    G+
Sbjct: 283 IISSIKEEMEPGF 295

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 111/218 (50%), Gaps = 27/218 (12%)
Query: 59  ATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN-------YKRVEQFMNEVDI 110
           A N  +  +++G GGFG V+ G L +D   VA+K L   +        ++ ++F  EV I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           ++ L H N+V LYG      R   +V EF+  G +   L  ++A P  + W  +L++ ++
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR---MVMEFVPCGDLYHRLL-DKAHP--IKWSVKLRLMLD 130
Query: 171 TASALTYLHASD--IIHRDVKTNNIL---LDNN--FCVKVADFGLSRLFPNHVTHVSTAP 223
            A  + Y+   +  I+HRD+++ NI    LD N   C KVADFG S+       H  +  
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ----QSVHSVSGL 186
Query: 224 QGTPGYVDPEYHQCYQ--LTDKSDVFSFGVVLIELISS 259
            G   ++ PE     +   T+K+D +SF ++L  +++ 
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 80/312 (25%), Positives = 142/312 (45%), Gaps = 41/312 (13%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE- 102
           V+   E E A      +RELG G FG VY G      + +    VA+K + E    R   
Sbjct: 4   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 63
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGAL 159
           +F+NE  ++      ++V L G  S   +  L++ E ++ G +  +L   R   A    L
Sbjct: 64  EFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVL 122
Query: 160 PWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV 216
             P+    +++A E A  + YL+A+  +HRD+   N ++  +F VK+ DFG++R     +
Sbjct: 123 APPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DI 178
Query: 217 THVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHE 271
                  +G  G     ++ PE  +    T  SDV+SFGVVL E+ +      +    ++
Sbjct: 179 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQ 232
Query: 272 INLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDV 331
             LSN        + L  +++  L  + DN      + + EL   C Q    +RP  +++
Sbjct: 233 -GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEI 280
Query: 332 LDALRDIESDGY 343
           + ++++    G+
Sbjct: 281 ISSIKEEMEPGF 292

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 82/299 (27%), Positives = 135/299 (45%), Gaps = 41/299 (13%)
Query: 53  YGELEEA----TNYFDSARELGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRV 101
           +G +E A     +Y      +G G FG V  G L+  G+    VA+K L   Y    +R 
Sbjct: 2   WGSMEFAKEIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR- 60
Query: 102 EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPW 161
            +F++E  I+ +  H N++ L G  + +S  ++++ EF+ NG +   L   R   G    
Sbjct: 61  -EFLSEASIMGQFEHPNIIRLEGVVT-NSMPVMILTEFMENGALDSFL---RLNDGQFTV 115
Query: 162 PTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH---VTH 218
              + +    AS + YL     +HRD+   NIL+++N   KV+DFGLSR    +    T+
Sbjct: 116 IQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTY 175
Query: 219 VSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL 277
            S+     P  +  PE     + T  SD +S+G+V+ E++S          R   ++SN 
Sbjct: 176 TSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS-------FGERPYWDMSNQ 228
Query: 278 -AINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
             IN I+        D  L    D        ++ +L   C Q +++ RP    V+ AL
Sbjct: 229 DVINAIEQ-------DYRLPPPPDCP-----TSLHQLMLDCWQKDRNARPRFPQVVSAL 275

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 77/278 (27%), Positives = 129/278 (46%), Gaps = 35/278 (12%)
Query: 69  LGDGGFGTVYYGELQ-DGRA---VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG V  G L+  G+    VA+K L      K+   F++E  I+ +  H N++ L 
Sbjct: 41  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 100
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G  ++ S  ++++ EF+ NG++   L   R   G       + +    A+ + YL   + 
Sbjct: 101 GVVTK-STPVMIITEFMENGSLDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 156
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV---THVSTAPQGTP-GYVDPEYHQCYQ 239
           +HRD+   NIL+++N   KV+DFGLSR   +     T+ S      P  +  PE  Q  +
Sbjct: 157 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 216
Query: 240 LTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY 297
            T  SDV+S+G+V+ E++S    P  D+T            IN I+        D  L  
Sbjct: 217 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--------VINAIEQ-------DYRLPP 261
Query: 298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
             D       +A+ +L   C Q +++ RP    +++ L
Sbjct: 262 PMDCP-----SALHQLMLDCWQKDRNHRPKFGQIVNTL 294

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 79/308 (25%), Positives = 141/308 (45%), Gaps = 43/308 (13%)
Query: 55  ELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE-QFMNE 107
           E E A      +RELG G FG VY G      + +    VA+K + E    R   +F+NE
Sbjct: 6   EWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNE 65
Query: 108 VDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGALPWPT 163
             ++      ++V L G  S   +  L++ E ++ G +  +L   R +    P   P P+
Sbjct: 66  ASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAP-PS 123
Query: 164 ---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS 220
               +++A E A  + YL+A+  +HRD+   N ++  +F VK+ DFG++R     +    
Sbjct: 124 LSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETD 179
Query: 221 TAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLS 275
              +G  G     ++ PE  +    T  SDV+SFGVVL E+ +      +    ++  LS
Sbjct: 180 YYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPYQ-GLS 232
Query: 276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
           N        + L  +++  L  + DN      + + EL   C Q    +RP  ++++ ++
Sbjct: 233 N-------EQVLRFVMEGGLLDKPDN----CPDMLFELMRMCWQYNPKMRPSFLEIISSI 281
Query: 336 RDIESDGY 343
           ++    G+
Sbjct: 282 KEEMEPGF 289

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/220 (29%), Positives = 105/220 (47%), Gaps = 16/220 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARL 114
           L +    F+    +G+G +G VY G  ++ G+  A+K + +      E+   E+++L + 
Sbjct: 19  LRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIK-VMDVTGDEEEEIKQEINMLKKY 77
Query: 115 -RHKNLVSLYGCTSRHSR-----ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
             H+N+ + YG   + +      +L LV EF   G+V D +   +       W     I 
Sbjct: 78  SHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY--IC 135
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            E    L++LH   +IHRD+K  N+LL  N  VK+ DFG+S      V   +T   GTP 
Sbjct: 136 REILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-IGTPY 194
Query: 229 YVDPEYHQCYQLTD-----KSDVFSFGVVLIELISSMPAV 263
           ++ PE   C +  D     KSD++S G+  IE+    P +
Sbjct: 195 WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 105/219 (47%), Gaps = 20/219 (9%)
Query: 54  GELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVD 109
           G  + A   F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+
Sbjct: 4   GSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 63
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           I + LRH N++ LYG     +R + L+ E+   GTV    + E  K              
Sbjct: 64  IQSHLRHPNILRLYGYFHDATR-VYLILEYAPLGTV----YRELQKLSKFDEQRTATYIT 118
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ----G 225
           E A+AL+Y H+  +IHRD+K  N+LL +   +K+ADFG S        H  ++ +    G
Sbjct: 119 ELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCG 171
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
           T  Y+ PE  +     +K D++S GV+  E +   P  +
Sbjct: 172 TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 59  ATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN-------YKRVEQFMNEVDI 110
           A N  +  +++G GGFG V+ G L +D   VA+K L   +        ++ ++F  EV I
Sbjct: 17  ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           ++ L H N+V LYG      R   +V EF+  G +   L  ++A P  + W  +L++ ++
Sbjct: 77  MSNLNHPNIVKLYGLMHNPPR---MVMEFVPCGDLYHRLL-DKAHP--IKWSVKLRLMLD 130
Query: 171 TASALTYLHASD--IIHRDVKTNNIL---LDNN--FCVKVADFGLSRLFPNHVTHVSTAP 223
            A  + Y+   +  I+HRD+++ NI    LD N   C KVADF LS+       H  +  
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ----QSVHSVSGL 186
Query: 224 QGTPGYVDPEYHQCYQ--LTDKSDVFSFGVVLIELIS 258
            G   ++ PE     +   T+K+D +SF ++L  +++
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILT 223

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 69/200 (34%), Positives = 103/200 (51%), Gaps = 13/200 (6%)
Query: 68  ELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           +LG G FG+V    Y  L D  G  VAVK+L  +   +   F  E+ IL  L    +V  
Sbjct: 14  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 73
Query: 123 YGCTSRHSR-ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASALTYLHA 180
            G +    R EL LV E++ +G + D L   RA+  A    +RL + + +    + YL +
Sbjct: 74  RGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDA----SRLLLYSSQICKGMEYLGS 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTP-GYVDPEYHQCY 238
              +HRD+   NIL+++   VK+ADFGL++L P +    V   P  +P  +  PE     
Sbjct: 130 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDN 189
Query: 239 QLTDKSDVFSFGVVLIELIS 258
             + +SDV+SFGVVL EL +
Sbjct: 190 IFSRQSDVWSFGVVLYELFT 209

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 72  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 126
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P+          GT  Y+ PE  +  
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---GTLDYLPPEMIEGR 183
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 71  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 125
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P+          GT  Y+ PE  +  
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDTLC---GTLDYLPPEMIEGR 182
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 183 MHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/206 (31%), Positives = 98/206 (47%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 15  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 74
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   G V   L     K              E A+AL+Y 
Sbjct: 75  ILRLYGYFHDATR-VYLILEYAPRGEVYKELQ----KLSKFDEQRTATYITELANALSYC 129
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P   +       GT  Y+ PE  +  
Sbjct: 130 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP---SSRRXXLXGTLDYLPPEMIEGR 186
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 187 MHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 73  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 127
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+ADFG S   P+          GT  Y+ PE  +  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRXXLC---GTLDYLPPEMIEGR 184
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 12  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 71
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 72  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 126
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+A+FG S   P   +   T   GT  Y+ PE  +  
Sbjct: 127 HSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 183
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 184 MHDEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/206 (32%), Positives = 100/206 (48%), Gaps = 12/206 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 13  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 72
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 73  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 127
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  +IHRD+K  N+LL +   +K+A+FG S   P   +   T   GT  Y+ PE  +  
Sbjct: 128 HSKRVIHRDIKPENLLLGSAGELKIANFGWSVHAP---SSRRTTLCGTLDYLPPEMIEGR 184
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVD 264
              +K D++S GV+  E +   P  +
Sbjct: 185 MHDEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 80/313 (25%), Positives = 142/313 (45%), Gaps = 43/313 (13%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVE- 102
           V+   E E A      +RELG G FG VY G      + +    VA+K + E    R   
Sbjct: 1   VYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERI 60
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK----PGA 158
           +F+NE  ++      ++V L G  S   +  L++ E ++ G +  +L   R +    P  
Sbjct: 61  EFLNEASVMKEFNCHHVVRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVL 119
Query: 159 LPWPT---RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
            P P+    +++A E A  + YL+A+  +HRD+   N  +  +F VK+ DFG++R     
Sbjct: 120 AP-PSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTR----D 174
Query: 216 VTHVSTAPQGTPG-----YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH 270
           +       +G  G     ++ PE  +    T  SDV+SFGVVL E+ +      +    +
Sbjct: 175 IYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT------LAEQPY 228
Query: 271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD 330
           +  LSN        + L  +++  L  + DN      + + EL   C Q    +RP  ++
Sbjct: 229 Q-GLSN-------EQVLRFVMEGGLLDKPDN----CPDMLLELMRMCWQYNPKMRPSFLE 276
Query: 331 VLDALRDIESDGY 343
           ++ ++++    G+
Sbjct: 277 IISSIKEEMEPGF 289

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 66/210 (31%), Positives = 101/210 (48%), Gaps = 20/210 (9%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---EQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++   ++     Q   EV+I + LRH N
Sbjct: 36  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 95
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 96  ILRLYGYFHDATR-VYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYC 150
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ----GTPGYVDPEY 234
           H+  +IHRD+K  N+LL +   +K+ADFG S        H  ++ +    GT  Y+ PE 
Sbjct: 151 HSKRVIHRDIKPENLLLGSAGELKIADFGWS-------VHAPSSRRDDLCGTLDYLPPEM 203
Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMPAVD 264
            +     +K D++S GV+  E +   P  +
Sbjct: 204 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 233

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 18/214 (8%)
Query: 68  ELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           +LG G FG+V    Y  L D  G  VAVK+L  +   +   F  E+ IL  L    +V  
Sbjct: 17  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 76
Query: 123 YGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASALTYLHA 180
            G +    R+ L LV E++ +G + D L   RA+  A    +RL + + +    + YL +
Sbjct: 77  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA----SRLLLYSSQICKGMEYLGS 132
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTP-GYVDPEYHQCY 238
              +HRD+   NIL+++   VK+ADFGL++L P +   +V   P  +P  +  PE     
Sbjct: 133 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 192
Query: 239 QLTDKSDVFSFGVVLIELI-----SSMPAVDITR 267
             + +SDV+SFGVVL EL      S  P+ +  R
Sbjct: 193 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 226

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 18/214 (8%)
Query: 68  ELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           +LG G FG+V    Y  L D  G  VAVK+L  +   +   F  E+ IL  L    +V  
Sbjct: 30  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 89
Query: 123 YGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASALTYLHA 180
            G +    R+ L LV E++ +G + D L   RA+  A    +RL + + +    + YL +
Sbjct: 90  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA----SRLLLYSSQICKGMEYLGS 145
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTP-GYVDPEYHQCY 238
              +HRD+   NIL+++   VK+ADFGL++L P +   +V   P  +P  +  PE     
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 205
Query: 239 QLTDKSDVFSFGVVLIELI-----SSMPAVDITR 267
             + +SDV+SFGVVL EL      S  P+ +  R
Sbjct: 206 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 239

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 109/213 (51%), Gaps = 11/213 (5%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
           + S G+ ++    F+   ++G G  GTVY   ++  G+ VA++++      + E  +NE+
Sbjct: 12  IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
            ++   ++ N+V+ Y  +     EL +V E+++ G++ D +       G +    R    
Sbjct: 69  LVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 123
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            E   AL +LH++ +IHRD+K++NILL  +  VK+ DFG         +  ST   GTP 
Sbjct: 124 -ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY 181
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           ++ PE         K D++S G++ IE+I   P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 71/214 (33%), Positives = 108/214 (50%), Gaps = 18/214 (8%)
Query: 68  ELGDGGFGTV---YYGELQD--GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           +LG G FG+V    Y  L D  G  VAVK+L  +   +   F  E+ IL  L    +V  
Sbjct: 18  QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKY 77
Query: 123 YGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASALTYLHA 180
            G +    R+ L LV E++ +G + D L   RA+  A    +RL + + +    + YL +
Sbjct: 78  RGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA----SRLLLYSSQICKGMEYLGS 133
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTP-GYVDPEYHQCY 238
              +HRD+   NIL+++   VK+ADFGL++L P +   +V   P  +P  +  PE     
Sbjct: 134 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN 193
Query: 239 QLTDKSDVFSFGVVLIELI-----SSMPAVDITR 267
             + +SDV+SFGVVL EL      S  P+ +  R
Sbjct: 194 IFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR 227

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/202 (34%), Positives = 101/202 (50%), Gaps = 16/202 (7%)
Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
           + +G G F  V     +  GR VAVK + +   N   +++   EV I+  L H N+V L+
Sbjct: 21  KTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                  + L LV E+ S G V D+L  HG   +  A     R K   +  SA+ Y H  
Sbjct: 81  EVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEKEA-----RAKFR-QIVSAVQYCHQK 133
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
            I+HRD+K  N+LLD +  +K+ADFG S  F   V +      G+P Y  PE  Q  +  
Sbjct: 134 YIVHRDLKAENLLLDGDMNIKIADFGFSNEFT--VGNKLDTFCGSPPYAAPELFQGKKYD 191
Query: 242 D-KSDVFSFGVVLIELIS-SMP 261
             + DV+S GV+L  L+S S+P
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLP 213

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+       +VA+K L   Y    +R   F+ E  I+ +  H N++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ S+ +++V E++ NG++   L    A+   +     L+     AS + YL   
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFGLSR+  +      T   G     +  PE     +
Sbjct: 167 GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+VL E++S          R    +SN  + K         VD+  GY  
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +     A+ +L   C Q +++ RP    +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/204 (30%), Positives = 100/204 (49%), Gaps = 16/204 (7%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
            DS  ++G+G  G V    E   GR VAVK +     +R E   NEV I+   +H N+V 
Sbjct: 47  LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           +Y  +     EL ++ EF+  G + D +   R     +       +      AL YLHA 
Sbjct: 107 MYK-SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQIA-----TVCEAVLQALAYLHAQ 160
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
            +IHRD+K+++ILL  +  VK++DFG    +S+  P     V     GTP ++ PE    
Sbjct: 161 GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKXLV-----GTPYWMAPEVISR 215
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                + D++S G+++IE++   P
Sbjct: 216 SLYATEVDIWSLGIMVIEMVDGEP 239

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 127/279 (45%), Gaps = 37/279 (13%)
Query: 69  LGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+  G+    VA+K L   Y    +R  +F++E  I+ +  H N++ 
Sbjct: 24  IGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRR--EFLSEASIMGQFEHPNIIR 81
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  + +S  ++++ EF+ NG +   L   R   G       + +    AS + YL   
Sbjct: 82  LEGVVT-NSMPVMILTEFMENGALDSFL---RLNDGQFTVIQLVGMLRGIASGMRYLAEM 137
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH---VTHVSTAPQGTP-GYVDPEYHQC 237
             +HRD+   NIL+++N   KV+DFGLSR    +    T  S+     P  +  PE    
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAF 197
Query: 238 YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL-AINKIQNKALHELVDQTLG 296
            + T  SD +S+G+V+ E++S          R   ++SN   IN I+        D  L 
Sbjct: 198 RKFTSASDAWSYGIVMWEVMS-------FGERPYWDMSNQDVINAIEQ-------DYRLP 243
Query: 297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
              D        ++ +L   C Q +++ RP    V+ AL
Sbjct: 244 PPPD-----CPTSLHQLMLDCWQKDRNARPRFPQVVSAL 277

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 107/217 (49%), Gaps = 19/217 (8%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
           V S G+  E   Y  +  ++G+G  G V    E   G+ VAVK++     +R E   NEV
Sbjct: 37  VVSPGDPRE---YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEV 93
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
            I+    H N+V +Y  +     EL +V EF+  G + D +   R     +       + 
Sbjct: 94  VIMRDYHHDNVVDMYS-SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIA-----TVC 147
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQ 224
           +    AL+YLH   +IHRD+K+++ILL ++  +K++DFG    +S+  P     V     
Sbjct: 148 LSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKXLV----- 202
Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           GTP ++ PE         + D++S G+++IE+I   P
Sbjct: 203 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP 239

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 96/202 (47%), Gaps = 15/202 (7%)
Query: 74  FGTVYYGELQ------DGRAVAVKRLYENNYKRVEQFM--NEVDILARLRHKNLVSLYG- 124
            GT  YG  Q      DG+ +  K L   +    E+ M  +EV++L  L+H N+V  Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH----- 179
              R +  L +V E+   G +A  +     +   L     L++  +   AL   H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              ++HRD+K  N+ LD    VK+ DFGL+R+  NH T  + A  GTP Y+ PE      
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFVGTPYYMSPEQMNRMS 192
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
             +KSD++S G +L EL + MP
Sbjct: 193 YNEKSDIWSLGCLLYELCALMP 214

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 115/244 (47%), Gaps = 14/244 (5%)
Query: 68  ELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYG- 124
           ++G G FG V+ G L+ D   VAVK   E     ++ +F+ E  IL +  H N+V L G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
           CT +    + +V E +  G     L  E A+   L   T L++  + A+ + YL +   I
Sbjct: 181 CTQKQP--IYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDK 243
           HRD+   N L+     +K++DFG+SR   + V   S   +  P  +  PE     + + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 244 SDVFSFGVVLIELI----SSMPAVDITRHRHEINLSN-LAINKIQNKALHELVDQTLGYE 298
           SDV+SFG++L E      S  P +   + R  +     L   ++   A+  L++Q   YE
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYE 355
Query: 299 SDNK 302
              +
Sbjct: 356 PGQR 359

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+       +VA+K L   Y    +R   F+ E  I+ +  H N++ 
Sbjct: 41  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 98
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ S+ +++V E++ NG++   L    A+   +     L+     AS + YL   
Sbjct: 99  LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 154
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFGLSR+  +      T   G     +  PE     +
Sbjct: 155 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 214
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+VL E++S          R    +SN  + K         VD+  GY  
Sbjct: 215 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIK--------AVDE--GYRL 257
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +     A+ +L   C Q +++ RP    +V +LD L
Sbjct: 258 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 295

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+       +VA+K L   Y    +R   F+ E  I+ +  H N++ 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 81
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ S+ +++V E++ NG++   L    A+   +     L+     AS + YL   
Sbjct: 82  LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 137
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFGLSR+  +      T   G     +  PE     +
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+VL E++S          R    +SN  + K         VD+  GY  
Sbjct: 198 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIK--------AVDE--GYRL 240
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +     A+ +L   C Q +++ RP    +V +LD L
Sbjct: 241 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 110/214 (51%), Gaps = 13/214 (6%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
           + S G+ ++    F+   ++G G  GTVY   ++  G+ VA++++      + E  +NE+
Sbjct: 12  IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
            ++   ++ N+V+ Y  +     EL +V E+++ G++ D +       G +    R    
Sbjct: 69  LVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 123
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTP 227
            E   AL +LH++ +IHRD+K++NILL  +  VK+ DFG  +++ P           GTP
Sbjct: 124 -ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMV--GTP 180
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
            ++ PE         K D++S G++ IE+I   P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 110/214 (51%), Gaps = 13/214 (6%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
           + S G+ ++    F+   ++G G  GTVY   ++  G+ VA++++      + E  +NE+
Sbjct: 13  IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 69
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
            ++   ++ N+V+ Y  +     EL +V E+++ G++ D +       G +    R    
Sbjct: 70  LVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 124
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTP 227
            E   AL +LH++ +IHRD+K++NILL  +  VK+ DFG  +++ P           GTP
Sbjct: 125 -ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV--GTP 181
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
            ++ PE         K D++S G++ IE+I   P
Sbjct: 182 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
           + +G G F  V     +  GR VA+K + +   N   +++   EV I+  L H N+V L+
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 80
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                  + L L+ E+ S G V D+L  HG   +  A     R K   +  SA+ Y H  
Sbjct: 81  EVIETE-KTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----RSKFR-QIVSAVQYCHQK 133
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
            I+HRD+K  N+LLD +  +K+ADFG S  F   V     A  G P Y  PE  Q  +  
Sbjct: 134 RIVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDAFCGAPPYAAPELFQGKKYD 191
Query: 242 D-KSDVFSFGVVLIELIS-SMP 261
             + DV+S GV+L  L+S S+P
Sbjct: 192 GPEVDVWSLGVILYTLVSGSLP 213

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+       +VA+K L   Y    +R   F+ E  I+ +  H N++ 
Sbjct: 51  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 108
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ S+ +++V E++ NG++   L    A+   +     L+     AS + YL   
Sbjct: 109 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 164
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFGLSR+  +      T   G     +  PE     +
Sbjct: 165 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 224
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+VL E++S          R    +SN  + K         VD+  GY  
Sbjct: 225 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 267
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +     A+ +L   C Q +++ RP    +V +LD L
Sbjct: 268 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 305

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 110/214 (51%), Gaps = 13/214 (6%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
           + S G+ ++    F+   ++G G  GTVY   ++  G+ VA++++      + E  +NE+
Sbjct: 12  IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 68
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
            ++   ++ N+V+ Y  +     EL +V E+++ G++ D +       G +    R    
Sbjct: 69  LVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 123
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTP 227
            E   AL +LH++ +IHRD+K++NILL  +  VK+ DFG  +++ P           GTP
Sbjct: 124 -ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMV--GTP 180
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
            ++ PE         K D++S G++ IE+I   P
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+       +VA+K L   Y    +R   F+ E  I+ +  H N++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ S+ +++V E++ NG++   L    A+   +     L+     AS + YL   
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFGLSR+  +      T   G     +  PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+VL E++S          R    +SN  + K         VD+  GY  
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +     A+ +L   C Q +++ RP    +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+       +VA+K L   Y    +R   F+ E  I+ +  H N++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ S+ +++V E++ NG++   L    A+   +     L+     AS + YL   
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFGLSR+  +      T   G     +  PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+VL E++S          R    +SN  + K         VD+  GY  
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +     A+ +L   C Q +++ RP    +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+       +VA+K L   Y    +R   F+ E  I+ +  H N++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ S+ +++V E++ NG++   L    A+   +     L+     AS + YL   
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFGLSR+  +      T   G     +  PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+VL E++S          R    +SN  + K         VD+  GY  
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +     A+ +L   C Q +++ RP    +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+       +VA+K L   Y    +R   F+ E  I+ +  H N++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ S+ +++V E++ NG++   L    A+   +     L+     AS + YL   
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFGLSR+  +      T   G     +  PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+VL E++S          R    +SN  + K         VD+  GY  
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +     A+ +L   C Q +++ RP    +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 115/244 (47%), Gaps = 14/244 (5%)
Query: 68  ELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYG- 124
           ++G G FG V+ G L+ D   VAVK   E     ++ +F+ E  IL +  H N+V L G 
Sbjct: 121 QIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 180
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
           CT +    + +V E +  G     L  E A+   L   T L++  + A+ + YL +   I
Sbjct: 181 CTQKQP--IYIVMELVQGGDFLTFLRTEGAR---LRVKTLLQMVGDAAAGMEYLESKCCI 235
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDK 243
           HRD+   N L+     +K++DFG+SR   + V   S   +  P  +  PE     + + +
Sbjct: 236 HRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295
Query: 244 SDVFSFGVVLIELI----SSMPAVDITRHRHEINLSN-LAINKIQNKALHELVDQTLGYE 298
           SDV+SFG++L E      S  P +   + R  +     L   ++   A+  L++Q   YE
Sbjct: 296 SDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPCPELCPDAVFRLMEQCWAYE 355
Query: 299 SDNK 302
              +
Sbjct: 356 PGQR 359

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 133/283 (46%), Gaps = 40/283 (14%)
Query: 67  RELGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRVEQFMNEVDILARLRHKNL 119
           R +G G FG V  G L+  G+    VA+K L   Y    +R   F+ E  I+ +  H N+
Sbjct: 28  RVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNI 85
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           + L G  ++ S+ +++V E++ NG++   L     +   +     L+     ++ + YL 
Sbjct: 86  IHLEGVVTK-SKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLR---GISAGMKYLS 141
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQC 237
               +HRD+   NIL+++N   KV+DFGLSR+  +      T   G     +  PE    
Sbjct: 142 DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAF 201
Query: 238 YQLTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
            + T  SDV+S+G+V+ E++S    P  ++T             N+   KA+ E      
Sbjct: 202 RKFTSASDVWSYGIVMWEVVSYGERPYWEMT-------------NQDVIKAVEE------ 242
Query: 296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPY---MVDVLDAL 335
           GY   + +     A+ +L   C Q E++ RP    +V++LD L
Sbjct: 243 GYRLPSPM-DCPAALYQLMLDCWQKERNSRPKFDEIVNMLDKL 284

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68  ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
           +LGDG FG V  GE     G+  +VAVK L  +   + E    F+ EV+ +  L H+NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            LYG     +  + +V E    G++ D L   R   G     T  + A++ A  + YL +
Sbjct: 85  RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
              IHRD+   N+LL     VK+ DFGL R  P +  H V    +  P  +  PE  +  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 199
Query: 239 QLTDKSDVFSFGVVLIELIS 258
             +  SD + FGV L E+ +
Sbjct: 200 TFSHASDTWMFGVTLWEMFT 219

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68  ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
           +LGDG FG V  GE     G+  +VAVK L  +   + E    F+ EV+ +  L H+NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            LYG     +  + +V E    G++ D L   R   G     T  + A++ A  + YL +
Sbjct: 79  RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
              IHRD+   N+LL     VK+ DFGL R  P +  H V    +  P  +  PE  +  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 239 QLTDKSDVFSFGVVLIELIS 258
             +  SD + FGV L E+ +
Sbjct: 194 TFSHASDTWMFGVTLWEMFT 213

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68  ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
           +LGDG FG V  GE     G+  +VAVK L  +   + E    F+ EV+ +  L H+NL+
Sbjct: 19  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 78
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            LYG     +  + +V E    G++ D L   R   G     T  + A++ A  + YL +
Sbjct: 79  RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 133
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
              IHRD+   N+LL     VK+ DFGL R  P +  H V    +  P  +  PE  +  
Sbjct: 134 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 193
Query: 239 QLTDKSDVFSFGVVLIELIS 258
             +  SD + FGV L E+ +
Sbjct: 194 TFSHASDTWMFGVTLWEMFT 213

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68  ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
           +LGDG FG V  GE     G+  +VAVK L  +   + E    F+ EV+ +  L H+NL+
Sbjct: 25  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 84
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            LYG     +  + +V E    G++ D L   R   G     T  + A++ A  + YL +
Sbjct: 85  RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 139
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
              IHRD+   N+LL     VK+ DFGL R  P +  H V    +  P  +  PE  +  
Sbjct: 140 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 199
Query: 239 QLTDKSDVFSFGVVLIELIS 258
             +  SD + FGV L E+ +
Sbjct: 200 TFSHASDTWMFGVTLWEMFT 219

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68  ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
           +LGDG FG V  GE     G+  +VAVK L  +   + E    F+ EV+ +  L H+NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            LYG     +  + +V E    G++ D L   R   G     T  + A++ A  + YL +
Sbjct: 75  RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
              IHRD+   N+LL     VK+ DFGL R  P +  H V    +  P  +  PE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTR 189
Query: 239 QLTDKSDVFSFGVVLIELIS 258
             +  SD + FGV L E+ +
Sbjct: 190 TFSHASDTWMFGVTLWEMFT 209

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/202 (33%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
           + +G G F  V     +  GR VA+K + +   N   +++   EV I+  L H N+V L+
Sbjct: 18  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLF 77
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                  + L L+ E+ S G V D+L  HG   +  A     R K   +  SA+ Y H  
Sbjct: 78  EVIETE-KTLYLIMEYASGGEVFDYLVAHGRMKEKEA-----RSKFR-QIVSAVQYCHQK 130
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
            I+HRD+K  N+LLD +  +K+ADFG S  F   V        G+P Y  PE  Q  +  
Sbjct: 131 RIVHRDLKAENLLLDADMNIKIADFGFSNEFT--VGGKLDTFCGSPPYAAPELFQGKKYD 188
Query: 242 D-KSDVFSFGVVLIELIS-SMP 261
             + DV+S GV+L  L+S S+P
Sbjct: 189 GPEVDVWSLGVILYTLVSGSLP 210

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 128/278 (46%), Gaps = 35/278 (12%)
Query: 69  LGDGGFGTVYYGELQ-DGRA---VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLY 123
           +G G FG V  G L+  G+    VA+K L      K+   F++E  I+ +  H N++ L 
Sbjct: 15  IGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLE 74
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G  ++ S  ++++ EF+ NG++   L   R   G       + +    A+ + YL   + 
Sbjct: 75  GVVTK-STPVMIITEFMENGSLDSFL---RQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 130
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV---THVSTAPQGTP-GYVDPEYHQCYQ 239
           +HR +   NIL+++N   KV+DFGLSR   +     T+ S      P  +  PE  Q  +
Sbjct: 131 VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 190
Query: 240 LTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY 297
            T  SDV+S+G+V+ E++S    P  D+T            IN I+        D  L  
Sbjct: 191 FTSASDVWSYGIVMWEVMSYGERPYWDMTNQD--------VINAIEQ-------DYRLPP 235
Query: 298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
             D       +A+ +L   C Q +++ RP    +++ L
Sbjct: 236 PMDCP-----SALHQLMLDCWQKDRNHRPKFGQIVNTL 268

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68  ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
           +LGDG FG V  GE     G+  +VAVK L  +   + E    F+ EV+ +  L H+NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            LYG     +  + +V E    G++ D L   R   G     T  + A++ A  + YL +
Sbjct: 75  RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
              IHRD+   N+LL     VK+ DFGL R  P +  H V    +  P  +  PE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 239 QLTDKSDVFSFGVVLIELIS 258
             +  SD + FGV L E+ +
Sbjct: 190 TFSHASDTWMFGVTLWEMFT 209

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 100/202 (49%), Gaps = 16/202 (7%)
Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
           + +G G F  V     +  G+ VAVK + +   N   +++   EV I+  L H N+V L+
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                  + L LV E+ S G V D+L  HG   +  A     R K   +  SA+ Y H  
Sbjct: 80  EVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEKEA-----RAKFR-QIVSAVQYCHQK 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
            I+HRD+K  N+LLD +  +K+ADFG S  F     +   A  G P Y  PE  Q  +  
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFT--FGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 242 D-KSDVFSFGVVLIELIS-SMP 261
             + DV+S GV+L  L+S S+P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 65/200 (32%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 68  ELGDGGFGTVYYGELQ--DGR--AVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLV 120
           +LGDG FG V  GE     G+  +VAVK L  +   + E    F+ EV+ +  L H+NL+
Sbjct: 15  KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLI 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            LYG     +  + +V E    G++ D L   R   G     T  + A++ A  + YL +
Sbjct: 75  RLYGVVL--TPPMKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTP-GYVDPEYHQCY 238
              IHRD+   N+LL     VK+ DFGL R  P +  H V    +  P  +  PE  +  
Sbjct: 130 KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR 189
Query: 239 QLTDKSDVFSFGVVLIELIS 258
             +  SD + FGV L E+ +
Sbjct: 190 TFSHASDTWMFGVTLWEMFT 209

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 129/279 (46%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+       +VA+K L   Y    +R   F+ E  I+ +  H N++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ S+ +++V E++ NG++   L    A+   +     L+     AS + YL   
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFGL+R+  +      T   G     +  PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+VL E++S          R    +SN  + K         VD+  GY  
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +     A+ +L   C Q +++ RP    +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 109/213 (51%), Gaps = 11/213 (5%)
Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEV 108
           + S G+ ++    F+   ++G G  GTVY   ++  G+ VA++++      + E  +NE+
Sbjct: 13  IVSVGDPKKKYTRFE---KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEI 69
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
            ++   ++ N+V+ Y  +     EL +V E+++ G++ D +       G +    R    
Sbjct: 70  LVMRENKNPNIVN-YLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCR---- 124
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            E   AL +LH++ +IHR++K++NILL  +  VK+ DFG         +  ST   GTP 
Sbjct: 125 -ECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPY 182
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           ++ PE         K D++S G++ IE+I   P
Sbjct: 183 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 62/204 (30%), Positives = 96/204 (47%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 92  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 146
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      + A  GT  YV PE    
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTE 206
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLP 230

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
           + +G G F  V     +  G+ VAVK + +   N   +++   EV I+  L H N+V L+
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                  + L LV E+ S G V D+L  HG   +  A     R K   +  SA+ Y H  
Sbjct: 80  EVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEKEA-----RAKFR-QIVSAVQYCHQK 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
            I+HRD+K  N+LLD +  +K+ADFG S    F N +        G+P Y  PE  Q  +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKK 188
Query: 240 LTD-KSDVFSFGVVLIELIS-SMP 261
               + DV+S GV+L  L+S S+P
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
           + +G G F  V     +  G+ VAVK + +   N   +++   EV I+  L H N+V L+
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                  + L LV E+ S G V D+L  HG   +  A     R K   +  SA+ Y H  
Sbjct: 80  EVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEKEA-----RAKFR-QIVSAVQYCHQK 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
            I+HRD+K  N+LLD +  +K+ADFG S    F N +        G+P Y  PE  Q  +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKK 188
Query: 240 L-TDKSDVFSFGVVLIELIS-SMP 261
               + DV+S GV+L  L+S S+P
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY C  +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 99  FVKLYFCF-QDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 153
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 154 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 213
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 214 KSACKSSDLWALGCIIYQLVAGLP 237

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/221 (32%), Positives = 106/221 (47%), Gaps = 11/221 (4%)
Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENN-YK--RVEQFMNEVDILARLRHKN 118
           F     LG G F  VY  E +  G  VA+K + +   YK   V++  NEV I  +L+H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LY      S  + LV E   NG +  +L   R KP +          I T   + YL
Sbjct: 73  ILELYN-YFEDSNYVYLVLEMCHNGEMNRYLKN-RVKPFSENEARHFMHQIITG--MLYL 128
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H+  I+HRD+  +N+LL  N  +K+ADFGL ++L   H  H +    GTP Y+ PE    
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC--GTPNYISPEIATR 186
Query: 238 YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA 278
                +SDV+S G +   L+   P  D    ++ +N   LA
Sbjct: 187 SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA 227

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/202 (31%), Positives = 95/202 (47%), Gaps = 15/202 (7%)
Query: 74  FGTVYYGELQ------DGRAVAVKRLYENNYKRVEQFM--NEVDILARLRHKNLVSLYG- 124
            GT  YG  Q      DG+ +  K L   +    E+ M  +EV++L  L+H N+V  Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH----- 179
              R +  L +V E+   G +A  +     +   L     L++  +   AL   H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              ++HRD+K  N+ LD    VK+ DFGL+R+  NH T  +    GTP Y+ PE      
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKTFVGTPYYMSPEQMNRMS 192
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
             +KSD++S G +L EL + MP
Sbjct: 193 YNEKSDIWSLGCLLYELCALMP 214

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/278 (26%), Positives = 126/278 (45%), Gaps = 34/278 (12%)
Query: 69  LGDGGFGTVYYGEL----QDGRAVAVKRLYENNYKRVEQ-FMNEVDILARLRHKNLVSLY 123
           +G G  G V YG L    Q    VA+K L     +R  + F++E  I+ +  H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G  +R  R  ++V E++ NG++   L   R   G       + +     + + YL     
Sbjct: 117 GVVTR-GRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           +HRD+   N+L+D+N   KV+DFGLSR+  +     + +T  +    +  PE       +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 242 DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL-AINKIQNKALHELVDQTLGYESD 300
             SDV+SFGVV+ E+++          R   N++N   I+ ++            GY   
Sbjct: 233 SASDVWSFGVVMWEVLA-------YGERPYWNMTNRDVISSVEE-----------GYRLP 274
Query: 301 NKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
             +    +A+ +L   C   ++  RP    +V VLDAL
Sbjct: 275 APM-GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+       +VA+K L   Y    +R   F+ E  I+ +  H N++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ S+ +++V E + NG++   L    A+   +     L+     AS + YL   
Sbjct: 111 LEGVVTK-SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFGLSR+  +      T   G     +  PE     +
Sbjct: 167 GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+VL E++S          R    +SN  + K         VD+  GY  
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +     A+ +L   C Q +++ RP    +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+       +VA+K L   Y    +R   F+ E  I+ +  H N++ 
Sbjct: 24  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 81
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ S+ +++V E + NG++   L    A+   +     L+     AS + YL   
Sbjct: 82  LEGVVTK-SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 137
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFGLSR+  +      T   G     +  PE     +
Sbjct: 138 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 197
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+VL E++S          R    +SN  + K         VD+  GY  
Sbjct: 198 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIK--------AVDE--GYRL 240
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +     A+ +L   C Q +++ RP    +V +LD L
Sbjct: 241 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 278

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
           + +G G F  V     +  G+ VAV+ + +   N   +++   EV I+  L H N+V L+
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                  + L LV E+ S G V D+L  HG   +  A     R K   +  SA+ Y H  
Sbjct: 80  EVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEKEA-----RAKFR-QIVSAVQYCHQK 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
            I+HRD+K  N+LLD +  +K+ADFG S    F N +        G+P Y  PE  Q  +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC----GSPPYAAPELFQGKK 188
Query: 240 LTD-KSDVFSFGVVLIELIS-SMP 261
               + DV+S GV+L  L+S S+P
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/279 (27%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+       +VA+K L   Y    +R   F+ E  I+ +  H N++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ S+ +++V E++ NG++   L    A+   +     L+     AS + YL   
Sbjct: 111 LEGVVTK-SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFGL R+  +      T   G     +  PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+VL E++S          R    +SN  + K         VD+  GY  
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +     A+ +L   C Q +++ RP    +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/200 (29%), Positives = 98/200 (49%), Gaps = 6/200 (3%)
Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKN 118
           F   +++G G F  VY    L DG  VA+K++      + K     + E+D+L +L H N
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++  Y  +     EL +V E    G ++  +   + +   +P  T  K  ++  SAL ++
Sbjct: 94  VIKYYA-SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHM 152
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+  ++HRD+K  N+ +     VK+ D GL R F +  T   +   GTP Y+ PE     
Sbjct: 153 HSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHEN 211
Query: 239 QLTDKSDVFSFGVVLIELIS 258
               KSD++S G +L E+ +
Sbjct: 212 GYNFKSDIWSLGCLLYEMAA 231

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+  G+    VA+K L   Y +  +R   F++E  I+ +  H N++ 
Sbjct: 37  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDHPNIIH 94
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++  + ++++ E++ NG++   L   R   G       + +     S + YL   
Sbjct: 95  LEGVVTK-CKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMKYLSDM 150
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFG+SR+  +      T   G     +  PE     +
Sbjct: 151 SAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 210
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+V+ E++S          R   ++SN  +     KA+ E      GY  
Sbjct: 211 FTSASDVWSYGIVMWEVMS-------YGERPYWDMSNQDV----IKAIEE------GYRL 253
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +   I A+ +L   C Q E+  RP    +V++LD L
Sbjct: 254 PPPMDCPI-ALHQLMLDCWQKERSDRPKFGQIVNMLDKL 291

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 97/204 (47%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 94  FVKLY-FTFQDDEKLYFGLSYAKNGCLLKYIR----KIGSFDETCTRFYTAEIVSALEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      + +  GT  YV PE    
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 208
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
              +  SD+++ G ++ +L++ +P
Sbjct: 209 KSASKSSDLWALGCIIYQLVAGLP 232

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 79/279 (28%), Positives = 128/279 (45%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+       +VA+K L   Y    +R   F+ E  I+ +  H N++ 
Sbjct: 53  VGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR--DFLGEASIMGQFDHPNIIR 110
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++ S+ +++V E + NG++   L    A+   +     L+     AS + YL   
Sbjct: 111 LEGVVTK-SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLR---GIASGMKYLSDM 166
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFGLSR+  +      T   G     +  PE     +
Sbjct: 167 GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+VL E++S          R    +SN  + K         VD+  GY  
Sbjct: 227 FTSASDVWSYGIVLWEVMS-------YGERPYWEMSNQDVIKA--------VDE--GYRL 269
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +     A+ +L   C Q +++ RP    +V +LD L
Sbjct: 270 PPPM-DCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL 307

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 76/278 (27%), Positives = 124/278 (44%), Gaps = 34/278 (12%)
Query: 69  LGDGGFGTVYYGEL----QDGRAVAVKRLYENNYKRVEQ-FMNEVDILARLRHKNLVSLY 123
           +G G  G V YG L    Q    VA+K L     +R  + F++E  I+ +  H N++ L 
Sbjct: 57  IGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLE 116
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G  +R  R  ++V E++ NG++   L   R   G       + +     + + YL     
Sbjct: 117 GVVTR-GRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY 172
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQLT 241
           +HRD+   N+L+D+N   KV+DFGLSR+  +      T   G     +  PE       +
Sbjct: 173 VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 242 DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL-AINKIQNKALHELVDQTLGYESD 300
             SDV+SFGVV+ E+++          R   N++N   I+ ++            GY   
Sbjct: 233 SASDVWSFGVVMWEVLA-------YGERPYWNMTNRDVISSVEE-----------GYRLP 274
Query: 301 NKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
             +    +A+ +L   C   ++  RP    +V VLDAL
Sbjct: 275 APM-GCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDAL 311

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+  G+    VA+K L   Y +  +R   F++E  I+ +  H N++ 
Sbjct: 22  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDHPNIIH 79
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++  + ++++ E++ NG++   L   R   G       + +     S + YL   
Sbjct: 80  LEGVVTK-CKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFG+SR+  +      T   G     +  PE     +
Sbjct: 136 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 195
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+V+ E++S          R   ++SN  +     KA+ E      GY  
Sbjct: 196 FTSASDVWSYGIVMWEVMS-------YGERPYWDMSNQDV----IKAIEE------GYRL 238
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +   I A+ +L   C Q E+  RP    +V++LD L
Sbjct: 239 PPPMDCPI-ALHQLMLDCWQKERSDRPKFGQIVNMLDKL 276

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/204 (33%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
           + +G G F  V     +  G+ VAVK + +   N   +++   EV I+  L H N+V L+
Sbjct: 13  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 72
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                  + L LV E+ S G V D+L  HG   +  A     R K   +  SA+ Y H  
Sbjct: 73  EVIETE-KTLYLVMEYASGGEVFDYLVAHGWMKEKEA-----RAKFR-QIVSAVQYCHQK 125
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
            I+HRD+K  N+LLD +  +K+ADFG S    F N +        G+P Y  PE  Q  +
Sbjct: 126 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKK 181
Query: 240 LTD-KSDVFSFGVVLIELIS-SMP 261
               + DV+S GV+L  L+S S+P
Sbjct: 182 YDGPEVDVWSLGVILYTLVSGSLP 205

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 122/257 (47%), Gaps = 25/257 (9%)
Query: 88  VAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR-ELLLVYEFISNGTV 145
           VA+KR+  E     +++ + E+  +++  H N+VS Y  TS   + EL LV + +S G+V
Sbjct: 43  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY--TSFVVKDELWLVMKLLSGGSV 100
Query: 146 ADHLH-----GERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC 200
            D +      GE  K G L   T   I  E    L YLH +  IHRDVK  NILL  +  
Sbjct: 101 LDIIKHIVAKGEH-KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 159
Query: 201 VKVADFGLSRLFPN--HVTH--VSTAPQGTPGYVDPEYHQCYQLTD-KSDVFSFGVVLIE 255
           V++ADFG+S        +T   V     GTP ++ PE  +  +  D K+D++SFG+  IE
Sbjct: 160 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 219
Query: 256 LISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAF 315
           L +           H+     + +  +QN    +      G +    +++   +  ++  
Sbjct: 220 LATGAAPY------HKYPPMKVLMLTLQN----DPPSLETGVQDKEMLKKYGKSFRKMIS 269
Query: 316 QCLQSEKDLRPYMVDVL 332
            CLQ + + RP   ++L
Sbjct: 270 LCLQKDPEKRPTAAELL 286

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/262 (26%), Positives = 120/262 (45%), Gaps = 22/262 (8%)
Query: 65  SARELGDGGFGTVYYGEL----QDGRAVAVKRLYE-NNYKRVEQFMNEVDILARLRHKNL 119
           S R +G G FG VY+GE     Q+    A+K L      ++VE F+ E  ++  L H N+
Sbjct: 25  SDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNV 84
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           ++L G          ++  ++ +G +   +   +  P        +   ++ A  + YL 
Sbjct: 85  LALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV---KDLISFGLQVARGMEYLA 141
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQ 236
               +HRD+   N +LD +F VKVADFGL+R   +   +        +    +   E  Q
Sbjct: 142 EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQ 201
Query: 237 CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN-------LAINKIQNKALHE 289
            Y+ T KSDV+SFGV+L EL++        RH    +L++       L   +    +L++
Sbjct: 202 TYRFTTKSDVWSFGVLLWELLTR--GAPPYRHIDPFDLTHFLAQGRRLPQPEYCPDSLYQ 259
Query: 290 LVDQTLGYESDNKVRRTINAVA 311
           ++ Q   +E+D  VR T   + 
Sbjct: 260 VMQQC--WEADPAVRPTFRVLV 279

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/257 (29%), Positives = 122/257 (47%), Gaps = 25/257 (9%)
Query: 88  VAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR-ELLLVYEFISNGTV 145
           VA+KR+  E     +++ + E+  +++  H N+VS Y  TS   + EL LV + +S G+V
Sbjct: 38  VAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY--TSFVVKDELWLVMKLLSGGSV 95
Query: 146 ADHLH-----GERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC 200
            D +      GE  K G L   T   I  E    L YLH +  IHRDVK  NILL  +  
Sbjct: 96  LDIIKHIVAKGEH-KSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGS 154
Query: 201 VKVADFGLSRLFPN--HVTH--VSTAPQGTPGYVDPEYHQCYQLTD-KSDVFSFGVVLIE 255
           V++ADFG+S        +T   V     GTP ++ PE  +  +  D K+D++SFG+  IE
Sbjct: 155 VQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIE 214
Query: 256 LISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAF 315
           L +           H+     + +  +QN    +      G +    +++   +  ++  
Sbjct: 215 LATGAAPY------HKYPPMKVLMLTLQN----DPPSLETGVQDKEMLKKYGKSFRKMIS 264
Query: 316 QCLQSEKDLRPYMVDVL 332
            CLQ + + RP   ++L
Sbjct: 265 LCLQKDPEKRPTAAELL 281

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 131/279 (46%), Gaps = 36/279 (12%)
Query: 69  LGDGGFGTVYYGELQ-DGR---AVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVS 121
           +G G FG V  G L+  G+    VA+K L   Y +  +R   F++E  I+ +  H N++ 
Sbjct: 16  IGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRR--DFLSEASIMGQFDHPNIIH 73
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  ++  + ++++ E++ NG++   L   R   G       + +     S + YL   
Sbjct: 74  LEGVVTK-CKPVMIITEYMENGSLDAFL---RKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG--YVDPEYHQCYQ 239
             +HRD+   NIL+++N   KV+DFG+SR+  +      T   G     +  PE     +
Sbjct: 130 SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK 189
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            T  SDV+S+G+V+ E++S          R   ++SN  +     KA+ E      GY  
Sbjct: 190 FTSASDVWSYGIVMWEVMS-------YGERPYWDMSNQDV----IKAIEE------GYRL 232
Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRP---YMVDVLDAL 335
              +   I A+ +L   C Q E+  RP    +V++LD L
Sbjct: 233 PPPMDCPI-ALHQLMLDCWQKERSDRPKFGQIVNMLDKL 270

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 101/204 (49%), Gaps = 20/204 (9%)
Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
           + +G G F  V     +  G+ VAV+ + +   N   +++   EV I+  L H N+V L+
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLF 79
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                  + L LV E+ S G V D+L  HG   +  A     R K   +  SA+ Y H  
Sbjct: 80  EVIETE-KTLYLVMEYASGGEVFDYLVAHGRMKEKEA-----RAKFR-QIVSAVQYCHQK 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
            I+HRD+K  N+LLD +  +K+ADFG S    F N +        G+P Y  PE  Q  +
Sbjct: 133 FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC----GSPPYAAPELFQGKK 188
Query: 240 LTD-KSDVFSFGVVLIELIS-SMP 261
               + DV+S GV+L  L+S S+P
Sbjct: 189 YDGPEVDVWSLGVILYTLVSGSLP 212

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 91  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 145
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      + +  GT  YV PE    
Sbjct: 146 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 205
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLP 229

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 77/226 (34%), Positives = 109/226 (48%), Gaps = 19/226 (8%)
Query: 41  KGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYK 99
           K GN  G+ V S   L    + F+  R LG G FG V    +++ G   AVK L ++   
Sbjct: 7   KEGN--GIGVNSSNRL--GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 100 R---VEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK 155
           +   VE  M E  IL+  R H  L  L+ C     R L  V EF++ G +  H+   R  
Sbjct: 63  QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR-LFFVMEFVNGGDLMFHIQKSRRF 121
Query: 156 PGALPWPTRLKI-AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL-FP 213
             A     R +  A E  SAL +LH   II+RD+K +N+LLD+    K+ADFG+ +    
Sbjct: 122 DEA-----RARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIC 176
Query: 214 NHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS 259
           N VT  +    GTP Y+ PE  Q        D ++ GV+L E++  
Sbjct: 177 NGVTTATFC--GTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCG 220

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 95  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 149
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      + +  GT  YV PE    
Sbjct: 150 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE 209
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLP 233

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 107/197 (54%), Gaps = 21/197 (10%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V   + +  + VA+K++   + ++   F+ E+  L+R+ H N+V LYG    
Sbjct: 17  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGACLN 73
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR---LKIAIETASALTYLHASD--- 182
               + LV E+   G++ + LHG  A+P  LP+ T    +   ++ +  + YLH+     
Sbjct: 74  ---PVCLVMEYAEGGSLYNVLHG--AEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 126
Query: 183 IIHRDVKTNNILL-DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           +IHRD+K  N+LL      +K+ DFG +     H+T+     +G+  ++ PE  +    +
Sbjct: 127 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN----KGSAAWMAPEVFEGSNYS 182
Query: 242 DKSDVFSFGVVLIELIS 258
           +K DVFS+G++L E+I+
Sbjct: 183 EKCDVFSWGIILWEVIT 199

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 107/197 (54%), Gaps = 21/197 (10%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V   + +  + VA+K++   + ++   F+ E+  L+R+ H N+V LYG    
Sbjct: 16  VGRGAFGVVCKAKWR-AKDVAIKQIESESERKA--FIVELRQLSRVNHPNIVKLYGACLN 72
Query: 129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR---LKIAIETASALTYLHASD--- 182
               + LV E+   G++ + LHG  A+P  LP+ T    +   ++ +  + YLH+     
Sbjct: 73  ---PVCLVMEYAEGGSLYNVLHG--AEP--LPYYTAAHAMSWCLQCSQGVAYLHSMQPKA 125
Query: 183 IIHRDVKTNNILL-DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           +IHRD+K  N+LL      +K+ DFG +     H+T+     +G+  ++ PE  +    +
Sbjct: 126 LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN----KGSAAWMAPEVFEGSNYS 181
Query: 242 DKSDVFSFGVVLIELIS 258
           +K DVFS+G++L E+I+
Sbjct: 182 EKCDVFSWGIILWEVIT 198

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 91  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 145
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG +++  P      +    GT  YV PE    
Sbjct: 146 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 205
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 206 KSACKSSDLWALGCIIYQLVAGLP 229

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 94  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLP 232

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 92  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 146
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLP 230

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 94  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 209 KSAXKSSDLWALGCIIYQLVAGLP 232

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 92  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 146
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLP 230

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/202 (31%), Positives = 98/202 (48%), Gaps = 13/202 (6%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
           LG GG   V+   +L+D R VAVK L  +  +      +F  E    A L H  +V++Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 125 CTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                +    L Y   E++   T+ D +H E    G +     +++  +   AL + H +
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN 135
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV--STAPQGTPGYVDPEYHQCYQ 239
            IIHRDVK  NIL+     VKV DFG++R   +    V  + A  GT  Y+ PE  +   
Sbjct: 136 GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDS 195
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
           +  +SDV+S G VL E+++  P
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEP 217

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 94  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLP 232

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 94  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLP 232

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 76  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 130
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG +++  P      +    GT  YV PE    
Sbjct: 131 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 190
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 191 KSACKSSDLWALGCIIYQLVAGLP 214

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 69  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 123
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 124 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 183
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 184 KSACKSSDLWALGCIIYQLVAGLP 207

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 82/286 (28%), Positives = 134/286 (46%), Gaps = 35/286 (12%)
Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYE-NNYKRVEQF-MNEVDILARLRHKNLVSLYGC 125
           +G+G +G V     +D GR VA+K+  E ++ K V++  M E+ +L +LRH+NLV+L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
             +  R   LV+EF+ + T+ D L      P  L +    K   +  + + + H+ +IIH
Sbjct: 93  CKKKKR-WYLVFEFVDH-TILDDLE---LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIH 147
Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLF--PNHV------THVSTAPQGTPGYVDPEYHQC 237
           RD+K  NIL+  +  VK+ DFG +R    P  V      T    AP+   G  D +Y + 
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVG--DVKYGKA 205
Query: 238 YQLTDKSDVFSFGVVLIELISSMPAV----DITRHRH-EINLSNLA------INKIQNKA 286
                  DV++ G ++ E+    P      DI +  H  + L NL        NK    A
Sbjct: 206 ------VDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA 259
Query: 287 LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
              L +       + +  +    V +LA +CL  + D RP+  ++L
Sbjct: 260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELL 305

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 70  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 124
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 125 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 184
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 185 KSACKSSDLWALGCIIYQLVAGLP 208

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 95  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 149
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 150 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 209
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 210 KSACKSSDLWALGCIIYQLVAGLP 233

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 94  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 148
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 149 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 208
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 209 KSACKSSDLWALGCIIYQLVAGLP 232

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 97  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 151
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 152 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 211
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 212 KSACKSSDLWALGCIIYQLVAGLP 235

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/202 (34%), Positives = 98/202 (48%), Gaps = 16/202 (7%)
Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLY 123
           + +G G F  V     +  G+ VAVK + +   N   +++   EV I   L H N+V L+
Sbjct: 20  KTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLF 79
Query: 124 GCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                  + L LV E+ S G V D+L  HG   +  A     R K   +  SA+ Y H  
Sbjct: 80  EVIETE-KTLYLVXEYASGGEVFDYLVAHGRXKEKEA-----RAKFR-QIVSAVQYCHQK 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
            I+HRD+K  N+LLD +  +K+ADFG S  F     +   A  G P Y  PE  Q  +  
Sbjct: 133 FIVHRDLKAENLLLDADXNIKIADFGFSNEFT--FGNKLDAFCGAPPYAAPELFQGKKYD 190
Query: 242 DKS-DVFSFGVVLIELIS-SMP 261
               DV+S GV+L  L+S S+P
Sbjct: 191 GPEVDVWSLGVILYTLVSGSLP 212

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
           LG GG   V+   +L+D R VAVK L  +  +      +F  E    A L H  +V++Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 125 CTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                +    L Y   E++   T+ D +H E    G +     +++  +   AL + H +
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN 135
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFP---NHVTHVSTAPQGTPGYVDPEYHQCY 238
            IIHRDVK  NI++     VKV DFG++R      N VT  + A  GT  Y+ PE  +  
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQARGD 194
Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
            +  +SDV+S G VL E+++  P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEP 217

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 11  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 71  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 125
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 126 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 185
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 186 KSACKSSDLWALGCIIYQLVAGLP 209

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/203 (32%), Positives = 99/203 (48%), Gaps = 15/203 (7%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
           LG GG   V+   +L+D R VAVK L  +  +      +F  E    A L H  +V++Y 
Sbjct: 20  LGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 125 CTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                +    L Y   E++   T+ D +H E    G +     +++  +   AL + H +
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN 135
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFP---NHVTHVSTAPQGTPGYVDPEYHQCY 238
            IIHRDVK  NI++     VKV DFG++R      N VT  + A  GT  Y+ PE  +  
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQARGD 194
Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
            +  +SDV+S G VL E+++  P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEP 217

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 12  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 72  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 126
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 127 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 186
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 187 KSACKSSDLWALGCIIYQLVAGLP 210

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 94/202 (46%), Gaps = 15/202 (7%)
Query: 74  FGTVYYGELQ------DGRAVAVKRLYENNYKRVEQFM--NEVDILARLRHKNLVSLYG- 124
            GT  YG  Q      DG+ +  K L   +    E+ M  +EV++L  L+H N+V  Y  
Sbjct: 14  IGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH----- 179
              R +  L +V E+   G +A  +     +   L     L++  +   AL   H     
Sbjct: 74  IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDG 133
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              ++HRD+K  N+ LD    VK+ DFGL+R+  NH    +    GTP Y+ PE      
Sbjct: 134 GHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDEDFAKEFVGTPYYMSPEQMNRMS 192
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
             +KSD++S G +L EL + MP
Sbjct: 193 YNEKSDIWSLGCLLYELCALMP 214

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 61/204 (29%), Positives = 95/204 (46%), Gaps = 10/204 (4%)
Query: 63  FDSARELGDGGFGT-VYYGELQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F   + LG+G F T V   EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 32  FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            V LY  T +   +L     +  NG +  ++     K G+           E  SAL YL
Sbjct: 92  FVKLY-FTFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYL 146
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H   IIHRD+K  NILL+ +  +++ DFG ++ L P      +    GT  YV PE    
Sbjct: 147 HGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTE 206
Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
                 SD+++ G ++ +L++ +P
Sbjct: 207 KSACKSSDLWALGCIIYQLVAGLP 230

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 67  RELGDGGFGTVYYGELQDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS 121
           R LG+G FG VY G   + +     VAVK   ++      E+FM+E  I+  L H ++V 
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G        +++  E    G +  +L  ER K  +L   T +  +++   A+ YL + 
Sbjct: 74  LIGIIEEEPTWIIM--ELYPYGELGHYL--ERNK-NSLKVLTLVLYSLQICKAMAYLESI 128
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           + +HRD+   NIL+ +  CVK+ DFGLSR   +   + ++  +    ++ PE     + T
Sbjct: 129 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 188
Query: 242 DKSDVFSFGVVLIELIS 258
             SDV+ F V + E++S
Sbjct: 189 TASDVWMFAVCMWEILS 205

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 67  RELGDGGFGTVYYGELQDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS 121
           R LG+G FG VY G   + +     VAVK   ++      E+FM+E  I+  L H ++V 
Sbjct: 30  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 89
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G        +++  E    G +  +L  ER K  +L   T +  +++   A+ YL + 
Sbjct: 90  LIGIIEEEPTWIIM--ELYPYGELGHYL--ERNK-NSLKVLTLVLYSLQICKAMAYLESI 144
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           + +HRD+   NIL+ +  CVK+ DFGLSR   +   + ++  +    ++ PE     + T
Sbjct: 145 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 204
Query: 242 DKSDVFSFGVVLIELIS 258
             SDV+ F V + E++S
Sbjct: 205 TASDVWMFAVCMWEILS 221

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 10/197 (5%)
Query: 67  RELGDGGFGTVYYGELQDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS 121
           R LG+G FG VY G   + +     VAVK   ++      E+FM+E  I+  L H ++V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G        +++  E    G +  +L  ER K  +L   T +  +++   A+ YL + 
Sbjct: 78  LIGIIEEEPTWIIM--ELYPYGELGHYL--ERNK-NSLKVLTLVLYSLQICKAMAYLESI 132
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           + +HRD+   NIL+ +  CVK+ DFGLSR   +   + ++  +    ++ PE     + T
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFT 192
Query: 242 DKSDVFSFGVVLIELIS 258
             SDV+ F V + E++S
Sbjct: 193 TASDVWMFAVCMWEILS 209

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 69  LGDGGFGTVYYG-ELQDGRAV----AVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSL 122
           LG G FGTVY G  + +G  V    A+K L E    +   +FM+E  I+A + H +LV L
Sbjct: 23  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 82
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
            G     S  + LV + + +G + +++H  +   G+      L   ++ A  + YL    
Sbjct: 83  LGVCL--SPTIQLVTQLMPHGCLLEYVHEHKDNIGS---QLLLNWCVQIAKGMMYLEERR 137
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLT 241
           ++HRD+   N+L+ +   VK+ DFGL+RL        +      P  ++  E     + T
Sbjct: 138 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 197
Query: 242 DKSDVFSFGVVLIELIS 258
            +SDV+S+GV + EL++
Sbjct: 198 HQSDVWSYGVTIWELMT 214

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 62  YFDSARELGDGGFGTV---YYGELQD--GRAVAVKRLY-ENNYKRVEQFMNEVDILARLR 115
           +    R+LG+G FG V    Y    D  G  VAVK L  E+    +     E++IL  L 
Sbjct: 22  FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 81
Query: 116 HKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
           H+N+V   G CT      + L+ EF+ +G++ ++L   + K   +    +LK A++    
Sbjct: 82  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKG 138
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP--NHVTHVSTAPQGTPGYVDP 232
           + YL +   +HRD+   N+L+++   VK+ DFGL++          V         +  P
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS 258
           E     +    SDV+SFGV L EL++
Sbjct: 199 ECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 12/206 (5%)
Query: 62  YFDSARELGDGGFGTV---YYGELQD--GRAVAVKRLY-ENNYKRVEQFMNEVDILARLR 115
           +    R+LG+G FG V    Y    D  G  VAVK L  E+    +     E++IL  L 
Sbjct: 10  FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 69
Query: 116 HKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
           H+N+V   G CT      + L+ EF+ +G++ ++L   + K   +    +LK A++    
Sbjct: 70  HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNK---INLKQQLKYAVQICKG 126
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP--NHVTHVSTAPQGTPGYVDP 232
           + YL +   +HRD+   N+L+++   VK+ DFGL++          V         +  P
Sbjct: 127 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS 258
           E     +    SDV+SFGV L EL++
Sbjct: 187 ECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 99/197 (50%), Gaps = 12/197 (6%)
Query: 69  LGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSL 122
           LG G FGTVY G  + +G      VA+K L E    +   +FM+E  I+A + H +LV L
Sbjct: 46  LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 105
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
            G     S  + LV + + +G + +++H  +   G+      L   ++ A  + YL    
Sbjct: 106 LGVCL--SPTIQLVTQLMPHGCLLEYVHEHKDNIGSQ---LLLNWCVQIAKGMMYLEERR 160
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLT 241
           ++HRD+   N+L+ +   VK+ DFGL+RL        +      P  ++  E     + T
Sbjct: 161 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 220
Query: 242 DKSDVFSFGVVLIELIS 258
            +SDV+S+GV + EL++
Sbjct: 221 HQSDVWSYGVTIWELMT 237

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 57/200 (28%), Positives = 101/200 (50%), Gaps = 8/200 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           FD   +LG+G +G+VY     + G+ VA+K++   +   +++ + E+ I+ +    ++V 
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVK 88
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
            YG   +++ +L +V E+   G+V+D +   R +   L       I   T   L YLH  
Sbjct: 89  YYGSYFKNT-DLWIVMEYCGAGSVSDII---RLRNKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
             IHRD+K  NILL+     K+ADFG++    + +   +    GTP ++ PE  Q     
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXV-IGTPFWMAPEVIQEIGYN 203
Query: 242 DKSDVFSFGVVLIELISSMP 261
             +D++S G+  IE+    P
Sbjct: 204 CVADIWSLGITAIEMAEGKP 223

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 13/209 (6%)
Query: 61  NYFDSARELGDGGFGTVYYGEL--QDGRA--VAVK--RLYENNYKRVEQFMNEVDILARL 114
           N     + LG+G FG+V  G L  +DG +  VAVK  +L  ++ + +E+F++E   +   
Sbjct: 34  NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 115 RHKNLVSLYG-CTSRHSREL---LLVYEFISNGTVADHLHGERAKPGA--LPWPTRLKIA 168
            H N++ L G C    S+ +   +++  F+  G +  +L   R + G   +P  T LK  
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTP 227
           ++ A  + YL   + +HRD+   N +L ++  V VADFGLS +++           +   
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV 213
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
            ++  E       T KSDV++FGV + E+
Sbjct: 214 KWIAIESLADRVYTSKSDVWAFGVTMWEI 242

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 97/197 (49%), Gaps = 10/197 (5%)
Query: 66  ARELGDGGFGTVYYG----ELQDGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
            R +G+G FG V+ G          AVA+K         V E+F+ E   + +  H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G  + +   + ++ E  + G +   L   + +  +L   + +  A + ++AL YL +
Sbjct: 455 KLIGVITENP--VWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLES 509
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              +HRD+   N+L+ +N CVK+ DFGLSR   +   + ++  +    ++ PE     + 
Sbjct: 510 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 241 TDKSDVFSFGVVLIELI 257
           T  SDV+ FGV + E++
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 98/211 (46%), Gaps = 24/211 (11%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           F     +G GGFG V+  + + DG+   +KR+  NN    E+   EV  LA+L H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVH 68
Query: 122 LYGC--------------TSRHSRELLLV-YEFISNGTVADHLHGERAKPGALPWPTRLK 166
             GC              +SR   + L +  EF   GT+   +   R +   L     L+
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE--KLDKVLALE 126
Query: 167 IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGT 226
           +  +    + Y+H+  +I+RD+K +NI L +   VK+ DFGL     N      +  +GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRS--KGT 184
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
             Y+ PE         + D+++ G++L EL+
Sbjct: 185 LRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 108/230 (46%), Gaps = 29/230 (12%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE------LQDGRAVAVKRLYENNYKRVEQ-FMNEVD 109
           E   N  +  R++G+G FG V+          +    VAVK L E     ++  F  E  
Sbjct: 43  EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG------------TVADHLHGE---RA 154
           ++A   + N+V L G  +   + + L++E+++ G            TV    H +   RA
Sbjct: 103 LMAEFDNPNIVKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 155 K---PGALPWPT--RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS 209
           +   PG  P     +L IA + A+ + YL     +HRD+ T N L+  N  VK+ADFGLS
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLS 221
Query: 210 RLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
           R   +   + +      P  ++ PE     + T +SDV+++GVVL E+ S
Sbjct: 222 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66  ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
            R +G+G FG V+ G          AVA+K         V E+F+ E   + +  H ++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G  + +   + ++ E  + G +   L     +  +L   + +  A + ++AL YL +
Sbjct: 75  KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              +HRD+   N+L+ +N CVK+ DFGLSR   +   + ++  +    ++ PE     + 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 241 TDKSDVFSFGVVLIELI 257
           T  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66  ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
            R +G+G FG V+ G          AVA+K         V E+F+ E   + +  H ++V
Sbjct: 18  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 77
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G  + +   + ++ E  + G +   L     +  +L   + +  A + ++AL YL +
Sbjct: 78  KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 132
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              +HRD+   N+L+ +N CVK+ DFGLSR   +   + ++  +    ++ PE     + 
Sbjct: 133 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 192
Query: 241 TDKSDVFSFGVVLIELI 257
           T  SDV+ FGV + E++
Sbjct: 193 TSASDVWMFGVCMWEIL 209

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
           LG GG   V+   +L+  R VAVK L  +  +      +F  E    A L H  +V++Y 
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYA 79
Query: 125 CTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                +    L Y   E++   T+ D +H E    G +     +++  +   AL + H +
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN 135
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFP---NHVTHVSTAPQGTPGYVDPEYHQCY 238
            IIHRDVK  NI++     VKV DFG++R      N VT  + A  GT  Y+ PE  +  
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQARGD 194
Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
            +  +SDV+S G VL E+++  P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEP 217

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 95/197 (48%), Gaps = 10/197 (5%)
Query: 66  ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
            R +G+G FG V+ G          AVA+K         V E+F+ E   + +  H ++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G  + +   + ++ E  + G +   L     +  +L   + +  A + ++AL YL +
Sbjct: 75  KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              +HRD+   N+L+ +N CVK+ DFGLSR   +     ++  +    ++ PE     + 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRF 189
Query: 241 TDKSDVFSFGVVLIELI 257
           T  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66  ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
            R +G+G FG V+ G          AVA+K         V E+F+ E   + +  H ++V
Sbjct: 12  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 71
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G  + +   + ++ E  + G +   L     +  +L   + +  A + ++AL YL +
Sbjct: 72  KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 126
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              +HRD+   N+L+ +N CVK+ DFGLSR   +   + ++  +    ++ PE     + 
Sbjct: 127 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 186
Query: 241 TDKSDVFSFGVVLIELI 257
           T  SDV+ FGV + E++
Sbjct: 187 TSASDVWMFGVCMWEIL 203

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66  ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
            R +G+G FG V+ G          AVA+K         V E+F+ E   + +  H ++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G  + +   + ++ E  + G +   L     +  +L   + +  A + ++AL YL +
Sbjct: 80  KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 134
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              +HRD+   N+L+ +N CVK+ DFGLSR   +   + ++  +    ++ PE     + 
Sbjct: 135 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 194
Query: 241 TDKSDVFSFGVVLIELI 257
           T  SDV+ FGV + E++
Sbjct: 195 TSASDVWMFGVCMWEIL 211

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66  ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
            R +G+G FG V+ G          AVA+K         V E+F+ E   + +  H ++V
Sbjct: 17  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 76
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G  + +   + ++ E  + G +   L     +  +L   + +  A + ++AL YL +
Sbjct: 77  KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 131
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              +HRD+   N+L+ +N CVK+ DFGLSR   +   + ++  +    ++ PE     + 
Sbjct: 132 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 191
Query: 241 TDKSDVFSFGVVLIELI 257
           T  SDV+ FGV + E++
Sbjct: 192 TSASDVWMFGVCMWEIL 208

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66  ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
            R +G+G FG V+ G          AVA+K         V E+F+ E   + +  H ++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G  + +   + ++ E  + G +   L     +  +L   + +  A + ++AL YL +
Sbjct: 75  KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              +HRD+   N+L+ +N CVK+ DFGLSR   +   + ++  +    ++ PE     + 
Sbjct: 130 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 241 TDKSDVFSFGVVLIELI 257
           T  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 10/197 (5%)
Query: 66  ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
            R +G+G FG V+ G          AVA+K         V E+F+ E   + +  H ++V
Sbjct: 43  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 102
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G  + +   + ++ E  + G +   L     +  +L   + +  A + ++AL YL +
Sbjct: 103 KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLES 157
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              +HRD+   N+L+ +N CVK+ DFGLSR   +   + ++  +    ++ PE     + 
Sbjct: 158 KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 217
Query: 241 TDKSDVFSFGVVLIELI 257
           T  SDV+ FGV + E++
Sbjct: 218 TSASDVWMFGVCMWEIL 234

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 104/220 (47%), Gaps = 26/220 (11%)
Query: 59  ATNYFDSARELGDGGFGTVYYGELQDG---RAVAV-------KRLYENNYKRVEQF---- 104
             +YF   R+LG G +G V   + ++G   +A+ V       K  Y ++ K +E+F    
Sbjct: 35  GESYF-KVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEI 93
Query: 105 MNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
            NE+ +L  L H N++ L+       +   LV EF   G + + +   R K         
Sbjct: 94  YNEISLLKSLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGELFEQIIN-RHKFDECDAANI 151
Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNN---FCVKVADFGLSRLFPNHVTHVST 221
           +K   +  S + YLH  +I+HRD+K  NILL+N      +K+ DFGLS  F     +   
Sbjct: 152 MK---QILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK--DYKLR 206
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
              GT  Y+ PE  +  +  +K DV+S GV++  L+   P
Sbjct: 207 DRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYP 245

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/203 (29%), Positives = 99/203 (48%), Gaps = 10/203 (4%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQ--FMNEVDILARLRHKNL 119
           ++   ++G+G +G V+    +D G+ VA+K+  E+    V +   + E+ +L +L+H NL
Sbjct: 5   YEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNL 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V+L     R  R L LV+E+  +  + +    +R  P  L       I  +T  A+ + H
Sbjct: 65  VNLLE-VFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHL----VKSITWQTLQAVNFCH 119
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC-Y 238
             + IHRDVK  NIL+  +  +K+ DFG +RL      +       T  Y  PE      
Sbjct: 120 KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDE-VATRWYRSPELLVGDT 178
Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
           Q     DV++ G V  EL+S +P
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVP 201

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
           LG GG   V+   +L+  R VAVK L  +  +      +F  E    A L H  +V++Y 
Sbjct: 20  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 79
Query: 125 CTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                +    L Y   E++   T+ D +H E    G +     +++  +   AL + H +
Sbjct: 80  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN 135
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFP---NHVTHVSTAPQGTPGYVDPEYHQCY 238
            IIHRDVK  NI++     VKV DFG++R      N VT  + A  GT  Y+ PE  +  
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQARGD 194
Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
            +  +SDV+S G VL E+++  P
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEP 217

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/203 (31%), Positives = 98/203 (48%), Gaps = 15/203 (7%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
           LG GG   V+   +L+  R VAVK L  +  +      +F  E    A L H  +V++Y 
Sbjct: 37  LGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD 96
Query: 125 CTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                +    L Y   E++   T+ D +H E    G +     +++  +   AL + H +
Sbjct: 97  TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQN 152
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFP---NHVTHVSTAPQGTPGYVDPEYHQCY 238
            IIHRDVK  NI++     VKV DFG++R      N VT  + A  GT  Y+ PE  +  
Sbjct: 153 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ-TAAVIGTAQYLSPEQARGD 211
Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
            +  +SDV+S G VL E+++  P
Sbjct: 212 SVDARSDVYSLGCVLYEVLTGEP 234

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/200 (31%), Positives = 102/200 (51%), Gaps = 18/200 (9%)
Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL---YG 124
           LG G F  V+  + +  G+  A+K + ++   R     NE+ +L +++H+N+V+L   Y 
Sbjct: 17  LGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE 76
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
            T+ +     LV + +S G + D +  ER   G         +  +  SA+ YLH + I+
Sbjct: 77  STTHY----YLVMQLVSGGELFDRIL-ER---GVYTEKDASLVIQQVLSAVKYLHENGIV 128
Query: 185 HRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           HRD+K  N+L    + N  + + DFGLS++  N +  +STA  GTPGYV PE       +
Sbjct: 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTA-CGTPGYVAPEVLAQKPYS 185
Query: 242 DKSDVFSFGVVLIELISSMP 261
              D +S GV+   L+   P
Sbjct: 186 KAVDCWSIGVITYILLCGYP 205

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 37/224 (16%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           F     +G GGFG V+  + + DG+   ++R+  NN    E+   EV  LA+L H N+V 
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNN----EKAEREVKALAKLDHVNIVH 69
Query: 122 LYGC---------------------------TSRHSRELLLV-YEFISNGTVADHLHGER 153
             GC                           +SR   + L +  EF   GT+   +   R
Sbjct: 70  YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 154 AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP 213
            +   L     L++  +    + Y+H+  +IHRD+K +NI L +   VK+ DFGL     
Sbjct: 130 GE--KLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLK 187
Query: 214 NHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           N      T  +GT  Y+ PE         + D+++ G++L EL+
Sbjct: 188 NDGKR--TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/297 (26%), Positives = 128/297 (43%), Gaps = 53/297 (17%)
Query: 66  ARELGDGGFGTVYYGEL--QDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKN 118
            + LG+G FG V         GRA    VAVK L EN +   +   ++E ++L ++ H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER-AKPG-------------------A 158
           ++ LYG  S+    LLL+ E+   G++   L   R   PG                   A
Sbjct: 88  VIKLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 159 LPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH 218
           L     +  A + +  + YL    ++HRD+   NIL+     +K++DFGLSR      ++
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSY 206
Query: 219 VSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL 277
           V  +    P  ++  E    +  T +SDV+SFGV+L E+++               L   
Sbjct: 207 VKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT---------------LGGN 251
Query: 278 AINKIQNKALHELVDQTLGYESDNKVRRTINAVAE---LAFQCLQSEKDLRPYMVDV 331
               I  + L  L+      ++ +++ R  N   E   L  QC + E D RP   D+
Sbjct: 252 PYPGIPPERLFNLL------KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADI 302

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 9/198 (4%)
Query: 68  ELGDGGFGTVYYGELQD-GRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +LG GG  TVY  E       VA+K ++       + +++F  EV   ++L H+N+VS+ 
Sbjct: 18  KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
                      LV E+I   T+++++       G L   T +    +    + + H   I
Sbjct: 78  DVDEEDDC-YYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMRI 132
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           +HRD+K  NIL+D+N  +K+ DFG+++         +    GT  Y  PE  +     + 
Sbjct: 133 VHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDEC 192
Query: 244 SDVFSFGVVLIELISSMP 261
           +D++S G+VL E++   P
Sbjct: 193 TDIYSIGIVLYEMLVGEP 210

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAV----AVKRLYENNYKRVEQFMNEVDILARL-RHK 117
           FD  R +G G +  V    L+    +     VK+   N+ + ++    E  +  +   H 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
            LV L+ C    SR L  V E+++ G +  H+  +R     LP       + E + AL Y
Sbjct: 114 FLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNY 168
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYH 235
           LH   II+RD+K +N+LLD+   +K+ D+G+ +  L P   T       GTP Y+ PE  
Sbjct: 169 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAPEIL 225
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDIT 266
           +        D ++ GV++ E+++     DI 
Sbjct: 226 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAV----AVKRLYENNYKRVEQFMNEVDILARL-RHK 117
           FD  R +G G +  V    L+    +     VK+   N+ + ++    E  +  +   H 
Sbjct: 22  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 81
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
            LV L+ C    SR L  V E+++ G +  H+  +R     LP       + E + AL Y
Sbjct: 82  FLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNY 136
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYH 235
           LH   II+RD+K +N+LLD+   +K+ D+G+ +  L P   T       GTP Y+ PE  
Sbjct: 137 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC---GTPNYIAPEIL 193
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDIT 266
           +        D ++ GV++ E+++     DI 
Sbjct: 194 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 224

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKR---VEQFMNEVDILARLRHKNLVSLYG 124
           LG G FG V  GE Q  G  VAVK L     +    V +   E+  L   RH +++ LY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
             S  + +  +V E++S G + D++     K G +      ++  +  SA+ Y H   ++
Sbjct: 79  VISTPT-DFFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY--HQCYQLTD 242
           HRD+K  N+LLD +   K+ADFGLS +  +          G+P Y  PE    + Y    
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRTSCGSPNYAAPEVISGRLYA-GP 190
Query: 243 KSDVFSFGVVLIELISSMPAVD 264
           + D++S GV+L  L+      D
Sbjct: 191 EVDIWSCGVILYALLCGTLPFD 212

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 37/219 (16%)
Query: 68  ELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
           ELG+  FG VY G L      +  +AVA+K L +     + E+F +E  + ARL+H N+V
Sbjct: 33  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 92
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHL------------HGERAKPGALPWPTRLKIA 168
            L G  ++  + L +++ + S+G + + L              +R    AL  P  + + 
Sbjct: 93  CLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 151
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR---------LFPNHVTHV 219
            + A+ + YL +  ++H+D+ T N+L+ +   VK++D GL R         L  N +  +
Sbjct: 152 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 211
Query: 220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
                    ++ PE     + +  SD++S+GVVL E+ S
Sbjct: 212 R--------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 66  ARELGDGGFGTVYYG----ELQDGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
            R +G+G FG V+ G          AVA+K         V E+F+ E   + +  H ++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G  + +   + ++ E  + G +   L     +  +L   + +  A + ++AL YL +
Sbjct: 455 KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLES 509
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              +HRD+   N+L+    CVK+ DFGLSR   +   + ++  +    ++ PE     + 
Sbjct: 510 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 569
Query: 241 TDKSDVFSFGVVLIELI 257
           T  SDV+ FGV + E++
Sbjct: 570 TSASDVWMFGVCMWEIL 586

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 128/301 (42%), Gaps = 61/301 (20%)
Query: 66  ARELGDGGFGTVYYGEL--QDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKN 118
            + LG+G FG V         GRA    VAVK L EN +   +   ++E ++L ++ H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER-AKPG-------------------A 158
           ++ LYG  S+    LLL+ E+   G++   L   R   PG                   A
Sbjct: 88  VIKLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 159 LPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH 218
           L     +  A + +  + YL    ++HRD+   NIL+     +K++DFGLSR     V  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSR----DVYE 202
Query: 219 VSTAPQGTPGYVDPEYHQCYQLTD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
             +  + + G +  ++     L D     +SDV+SFGV+L E+++               
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------------- 247
Query: 274 LSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAE---LAFQCLQSEKDLRPYMVD 330
           L       I  + L  L+      ++ +++ R  N   E   L  QC + E D RP   D
Sbjct: 248 LGGNPYPGIPPERLFNLL------KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 331 V 331
           +
Sbjct: 302 I 302

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAV----AVKRLYENNYKRVEQFMNEVDILARL-RHK 117
           FD  R +G G +  V    L+    +     VK+   N+ + ++    E  +  +   H 
Sbjct: 7   FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 66
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
            LV L+ C    SR L  V E+++ G +  H+  +R     LP       + E + AL Y
Sbjct: 67  FLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNY 121
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYH 235
           LH   II+RD+K +N+LLD+   +K+ D+G+ +  L P   T       GTP Y+ PE  
Sbjct: 122 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC---GTPNYIAPEIL 178
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDIT 266
           +        D ++ GV++ E+++     DI 
Sbjct: 179 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 209

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 69  LGDGGFGTVYYGELQDGRAV-AVKRLYENNYKR---VEQFMNEVDILARL-RHKNLVSLY 123
           LG G FG V   + +    + A+K L ++   +   VE  M E  +LA L +   L  L+
Sbjct: 27  LGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLH 86
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
            C     R L  V E+++ G +  H+     + G    P  +  A E +  L +LH   I
Sbjct: 87  SCFQTVDR-LYFVMEYVNGGDLMYHIQ----QVGKFKEPQAVFYAAEISIGLFFLHKRGI 141
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPEYHQCYQLT 241
           I+RD+K +N++LD+   +K+ADFG+ +    H+    T  +  GTP Y+ PE    YQ  
Sbjct: 142 IYRDLKLDNVMLDSEGHIKIADFGMCK---EHMMDGVTTREFCGTPDYIAPEI-IAYQPY 197
Query: 242 DKS-DVFSFGVVLIELISSMPAVD 264
            KS D +++GV+L E+++  P  D
Sbjct: 198 GKSVDWWAYGVLLYEMLAGQPPFD 221

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 128/301 (42%), Gaps = 61/301 (20%)
Query: 66  ARELGDGGFGTVYYGEL--QDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKN 118
            + LG+G FG V         GRA    VAVK L EN +   +   ++E ++L ++ H +
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER-AKPG-------------------A 158
           ++ LYG  S+    LLL+ E+   G++   L   R   PG                   A
Sbjct: 88  VIKLYGACSQDG-PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146
Query: 159 LPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH 218
           L     +  A + +  + YL    ++HRD+   NIL+     +K++DFGLSR     V  
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSR----DVYE 202
Query: 219 VSTAPQGTPGYVDPEYHQCYQLTD-----KSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
             +  + + G +  ++     L D     +SDV+SFGV+L E+++               
Sbjct: 203 EDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT--------------- 247
Query: 274 LSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAE---LAFQCLQSEKDLRPYMVD 330
           L       I  + L  L+      ++ +++ R  N   E   L  QC + E D RP   D
Sbjct: 248 LGGNPYPGIPPERLFNLL------KTGHRMERPDNCSEEMYRLMLQCWKQEPDKRPVFAD 301
Query: 331 V 331
           +
Sbjct: 302 I 302

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/210 (31%), Positives = 97/210 (46%), Gaps = 12/210 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VE-QFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E +    VA+K L+++  ++  VE Q   E++I A L H N
Sbjct: 25  FEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPN 84
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LY       R + L+ E+   G     L+ E  K           I  E A AL Y 
Sbjct: 85  ILRLYNYFY-DRRRIYLILEYAPRG----ELYKELQKSCTFDEQRTATIMEELADALMYC 139
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H   +IHRD+K  N+LL     +K+ADFG S   P+          GT  Y+ PE  +  
Sbjct: 140 HGKKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRRKTMC---GTLDYLPPEMIEGR 196
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVDITRH 268
              +K D++  GV+  EL+   P  +   H
Sbjct: 197 MHNEKVDLWCIGVLCYELLVGNPPFESASH 226

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 98/211 (46%), Gaps = 15/211 (7%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAV----AVKRLYENNYKRVEQFMNEVDILARL-RHK 117
           FD  R +G G +  V    L+    +     VK+   N+ + ++    E  +  +   H 
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
            LV L+ C    SR L  V E+++ G +  H+  +R     LP       + E + AL Y
Sbjct: 71  FLVGLHSCFQTESR-LFFVIEYVNGGDLMFHMQRQRK----LPEEHARFYSAEISLALNY 125
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDPEYH 235
           LH   II+RD+K +N+LLD+   +K+ D+G+ +  L P   T       GTP Y+ PE  
Sbjct: 126 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFC---GTPNYIAPEIL 182
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDIT 266
           +        D ++ GV++ E+++     DI 
Sbjct: 183 RGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 213

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 14/202 (6%)
Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKR---VEQFMNEVDILARLRHKNLVSLYG 124
           LG G FG V  GE Q  G  VAVK L     +    V +   E+  L   RH +++ LY 
Sbjct: 19  LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
             S  + +  +V E++S G + D++     K G +      ++  +  SA+ Y H   ++
Sbjct: 79  VISTPT-DFFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY--HQCYQLTD 242
           HRD+K  N+LLD +   K+ADFGLS +  +          G+P Y  PE    + Y    
Sbjct: 134 HRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRDSCGSPNYAAPEVISGRLYA-GP 190
Query: 243 KSDVFSFGVVLIELISSMPAVD 264
           + D++S GV+L  L+      D
Sbjct: 191 EVDIWSCGVILYALLCGTLPFD 212

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/280 (24%), Positives = 131/280 (46%), Gaps = 32/280 (11%)
Query: 61  NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN-NYKR----VEQFMNEVDILARLR 115
           + F   R+LG G FG V+   L + R+  ++R+ +  N  R    +EQ   E+++L  L 
Sbjct: 22  DLFIFKRKLGSGAFGDVH---LVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           H N++ ++     +   + +V E    G + + +   +A+  AL      ++  +  +AL
Sbjct: 79  HPNIIKIFEVFEDY-HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
            Y H+  ++H+D+K  NIL  +   +  +K+ DFGL+ LF +     ST   GT  Y+ P
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS--DEHSTNAAGTALYMAP 195
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E  +   +T K D++S GVV+  L++             +  +  ++ ++Q KA ++  +
Sbjct: 196 EVFK-RDVTFKCDIWSAGVVMYFLLTGC-----------LPFTGTSLEEVQQKATYKEPN 243
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
             +      + R       +L  Q L  + + RP    VL
Sbjct: 244 YAV------ECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 94/197 (47%), Gaps = 10/197 (5%)
Query: 66  ARELGDGGFGTVYYGELQD----GRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
            R +G+G FG V+ G          AVA+K         V E+F+ E   + +  H ++V
Sbjct: 15  GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 74
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G  + +   + ++ E  + G +   L     +  +L   + +  A + ++AL YL +
Sbjct: 75  KLIGVITENP--VWIIMELCTLGELRSFLQ---VRKFSLDLASLILYAYQLSTALAYLES 129
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              +HRD+   N+L+    CVK+ DFGLSR   +   + ++  +    ++ PE     + 
Sbjct: 130 KRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRF 189
Query: 241 TDKSDVFSFGVVLIELI 257
           T  SDV+ FGV + E++
Sbjct: 190 TSASDVWMFGVCMWEIL 206

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 107/219 (48%), Gaps = 37/219 (16%)
Query: 68  ELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
           ELG+  FG VY G L      +  +AVA+K L +     + E+F +E  + ARL+H N+V
Sbjct: 16  ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVV 75
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHL------------HGERAKPGALPWPTRLKIA 168
            L G  ++  + L +++ + S+G + + L              +R    AL  P  + + 
Sbjct: 76  CLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLV 134
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR---------LFPNHVTHV 219
            + A+ + YL +  ++H+D+ T N+L+ +   VK++D GL R         L  N +  +
Sbjct: 135 AQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPI 194
Query: 220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
                    ++ PE     + +  SD++S+GVVL E+ S
Sbjct: 195 R--------WMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++   K +   ++E++++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              + + 
Sbjct: 100 HKNIITLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R   N   +  T 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
               P  ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 68/211 (32%), Positives = 103/211 (48%), Gaps = 29/211 (13%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I A L
Sbjct: 9   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINAML 62
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIE 170
            H+N+V  YG    H RE     L  E+ S G + D     R +P   +P P   +   +
Sbjct: 63  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQ 113
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGY 229
             + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 230 VDPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
           V PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/209 (32%), Positives = 104/209 (49%), Gaps = 19/209 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAV-AVKRLYEN---NYKRVEQFMNEVDILAR-LRHK 117
           F   + +G G FG V     +      AVK L +      K  +  M+E ++L + ++H 
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
            LV L+  + + + +L  V ++I+ G +  HL  ER        P     A E ASAL Y
Sbjct: 100 FLVGLH-FSFQTADKLYFVLDYINGGELFYHLQRERC----FLEPRARFYAAEIASALGY 154
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE-- 233
           LH+ +I++RD+K  NILLD+   + + DFGL +    ++ H ST     GTP Y+ PE  
Sbjct: 155 LHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK---ENIEHNSTTSTFCGTPEYLAPEVL 211
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISSMPA 262
           + Q Y  T   D +  G VL E++  +P 
Sbjct: 212 HKQPYDRT--VDWWCLGAVLYEMLYGLPP 238

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           F    ++G G FG V+ G + +  + VA+K +  E     +E    E+ +L++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             YG   + ++ L ++ E++  G+  D L     +PG L       I  E    L YLH+
Sbjct: 69  KYYGSYLKDTK-LWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 122
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              IHRD+K  N+LL  +  VK+ADFG++    +     +T   GTP ++ PE  +    
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAY 181
Query: 241 TDKSDVFSFGVVLIELISSMP 261
             K+D++S G+  IEL    P
Sbjct: 182 DSKADIWSLGITAIELARGEP 202

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/201 (28%), Positives = 97/201 (48%), Gaps = 9/201 (4%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           F    ++G G FG V+ G + +  + VA+K +  E     +E    E+ +L++     + 
Sbjct: 29  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 88
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             YG   + ++ L ++ E++  G+  D L     +PG L       I  E    L YLH+
Sbjct: 89  KYYGSYLKDTK-LWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 142
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
              IHRD+K  N+LL  +  VK+ADFG++    +     +T   GTP ++ PE  +    
Sbjct: 143 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIKQSAY 201
Query: 241 TDKSDVFSFGVVLIELISSMP 261
             K+D++S G+  IEL    P
Sbjct: 202 DSKADIWSLGITAIELARGEP 222

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKNLVSLYG 124
           LG G FG V  G+ +  G  VAVK L     + ++   +   E+  L   RH +++ LY 
Sbjct: 24  LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
             S  S ++ +V E++S G + D++     K G L      ++  +  S + Y H   ++
Sbjct: 84  VISTPS-DIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRHMVV 138
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY--HQCYQLTD 242
           HRD+K  N+LLD +   K+ADFGLS +  +          G+P Y  PE    + Y    
Sbjct: 139 HRDLKPENVLLDAHMNAKIADFGLSNMMSD--GEFLRXSCGSPNYAAPEVISGRLYA-GP 195
Query: 243 KSDVFSFGVVLIELISSMPAVD 264
           + D++S GV+L  L+      D
Sbjct: 196 EVDIWSSGVILYALLCGTLPFD 217

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 109/219 (49%), Gaps = 30/219 (13%)
Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++   K +   ++E++++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              + + 
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R   N   + +T 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
               P  ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  A+P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 53  YGELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFM-NEVDI 110
           + + E+  + +D    LG G F  V   E  +  + VA+K + +   +  E  M NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 69
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           L +++H N+V+L          L L+ + +S G + D +     + G        ++  +
Sbjct: 70  LHKIKHPNIVALDDIYESGGH-LYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQ 124
Query: 171 TASALTYLHASDIIHRDVKTNNIL---LDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGT 226
              A+ YLH   I+HRD+K  N+L   LD +  + ++DFGLS++  P  V  +STA  GT
Sbjct: 125 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTA-CGT 181
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           PGYV PE       +   D +S GV+   L+   P
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 61  NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
           N FD  + LG G FG V    E   GR  A+K L +        V   + E  +L   RH
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 69
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
             L +L      H R L  V E+ + G +  HL  ER          R +    E  SAL
Sbjct: 70  PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 123
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
            YLH+ D+++RD+K  N++LD +  +K+ DFGL +     ++  +T     GTP Y+ PE
Sbjct: 124 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPE 180
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
             +        D +  GVV+ E++  
Sbjct: 181 VLEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 61  NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
           N FD  + LG G FG V    E   GR  A+K L +        V   + E  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
             L +L      H R L  V E+ + G +  HL  ER          R +    E  SAL
Sbjct: 65  PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
            YLH+ D+++RD+K  N++LD +  +K+ DFGL +     ++  +T     GTP Y+ PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPE 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
             +        D +  GVV+ E++  
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + +G G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    +KVADFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 110/223 (49%), Gaps = 38/223 (17%)
Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++   K +   ++E++++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              + + 
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEXSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R     + ++   
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DINNIDXX 213
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
            + T G     ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 214 KKTTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 53  YGELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFM-NEVDI 110
           + + E+  + +D    LG G F  V   E  +  + VA+K + +   +  E  M NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           L +++H N+V+L          L L+ + +S G + D +     + G        ++  +
Sbjct: 70  LHKIKHPNIVALDDIYESGGH-LYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQ 124
Query: 171 TASALTYLHASDIIHRDVKTNNIL---LDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGT 226
              A+ YLH   I+HRD+K  N+L   LD +  + ++DFGLS++  P  V  +STA  GT
Sbjct: 125 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTAC-GT 181
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           PGYV PE       +   D +S GV+   L+   P
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 53  YGELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFM-NEVDI 110
           + + E+  + +D    LG G F  V   E  +  + VA+K + +   +  E  M NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           L +++H N+V+L          L L+ + +S G + D +     + G        ++  +
Sbjct: 70  LHKIKHPNIVALDDIYESGGH-LYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQ 124
Query: 171 TASALTYLHASDIIHRDVKTNNIL---LDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGT 226
              A+ YLH   I+HRD+K  N+L   LD +  + ++DFGLS++  P  V  +STA  GT
Sbjct: 125 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTAC-GT 181
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           PGYV PE       +   D +S GV+   L+   P
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 176
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 177 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGATWTLCGTPEYLAPEIIL 232
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 30/219 (13%)
Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++   K +   ++E++++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              + + 
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R   N      T 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
               P  ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 9   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEIXINKML 62
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE  + Y   E+ S G + D +  +      +P P   +   + 
Sbjct: 63  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 114
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 174
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
            PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLXGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLAGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 99/216 (45%), Gaps = 18/216 (8%)
Query: 59  ATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFM-----NEVDILA 112
           AT+ ++   E+G G +GTVY   +   G  VA+K +   N       +      EV +L 
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 113 RLR---HKNLVSLYG--CTSRHSREL--LLVYEFISNGTVADHLHGERAKPGALPWPTRL 165
           RL    H N+V L     TSR  RE+   LV+E +         + ++A P  LP  T  
Sbjct: 67  RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL---RTYLDKAPPPGLPAETIK 123
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG 225
            +  +    L +LHA+ I+HRD+K  NIL+ +   VK+ADFGL+R++   +         
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVV--V 181
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           T  Y  PE           D++S G +  E+    P
Sbjct: 182 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 217

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 105/215 (48%), Gaps = 14/215 (6%)
Query: 53  YGELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFM-NEVDI 110
           + + E+  + +D    LG G F  V   E  +  + VA+K + +   +  E  M NE+ +
Sbjct: 10  WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAV 69
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           L +++H N+V+L          L L+ + +S G + D +     + G        ++  +
Sbjct: 70  LHKIKHPNIVALDDIYESGGH-LYLIMQLVSGGELFDRI----VEKGFYTERDASRLIFQ 124
Query: 171 TASALTYLHASDIIHRDVKTNNIL---LDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGT 226
              A+ YLH   I+HRD+K  N+L   LD +  + ++DFGLS++  P  V  +STA  GT
Sbjct: 125 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV--LSTA-CGT 181
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           PGYV PE       +   D +S GV+   L+   P
Sbjct: 182 PGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 216

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 8   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEIXINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE     L  E+ S G + D +  +      +P P   +   + 
Sbjct: 62  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
            PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 61  NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
           N FD  + LG G FG V    E   GR  A+K L +        V   + E  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
             L +L      H R L  V E+ + G +  HL  ER          R +    E  SAL
Sbjct: 65  PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
            YLH+ D+++RD+K  N++LD +  +K+ DFGL +     ++  +T     GTP Y+ PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPE 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
             +        D +  GVV+ E++  
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 59  ATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF--MNEVDILARLR 115
           AT+ ++   E+G G +GTVY   +   G  VA+K +   N +       + EV +L RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 116 ---HKNLVSLYG--CTSRHSREL--LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
              H N+V L     TSR  RE+   LV+E +         + ++A P  LP  T   + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL---RTYLDKAPPPGLPAETIKDLM 118
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L +LHA+ I+HRD+K  NIL+ +   VK+ADFGL+R++   +         T  
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVV--VTLW 176
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           Y  PE           D++S G +  E+    P
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 61  NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
           N FD  + LG G FG V    E   GR  A+K L +        V   + E  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
             L +L      H R L  V E+ + G +  HL  ER          R +    E  SAL
Sbjct: 65  PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
            YLH+ D+++RD+K  N++LD +  +K+ DFGL +     ++  +T     GTP Y+ PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
             +        D +  GVV+ E++  
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 61  NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
           N FD  + LG G FG V    E   GR  A+K L +        V   + E  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
             L +L      H R L  V E+ + G +  HL  ER          R +    E  SAL
Sbjct: 65  PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
            YLH+ D+++RD+K  N++LD +  +K+ DFGL +     ++  +T     GTP Y+ PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
             +        D +  GVV+ E++  
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 56/197 (28%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 68  ELGDGGFGTVYYGELQDGRA---VAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVSLY 123
           ELG G FG+V  G  +  +    VA+K L +   K   E+ M E  I+ +L +  +V L 
Sbjct: 17  ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G     +  L+LV E    G +   L G+R +   +P     ++  + +  + YL   + 
Sbjct: 77  GVC--QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKNF 131
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS--TAPQGTPGYVDPEYHQCYQLT 241
           +HRD+   N+LL N    K++DFGLS+      ++ +  +A +    +  PE     + +
Sbjct: 132 VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 191
Query: 242 DKSDVFSFGVVLIELIS 258
            +SDV+S+GV + E +S
Sbjct: 192 SRSDVWSYGVTMWEALS 208

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/204 (31%), Positives = 94/204 (46%), Gaps = 16/204 (7%)
Query: 61  NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
           N FD  + LG G FG V    E   GR  A+K L +        V   + E  +L   RH
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 67
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
             L +L      H R L  V E+ + G +  HL  ER          R +    E  SAL
Sbjct: 68  PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 121
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
            YLH+ D+++RD+K  N++LD +  +K+ DFGL +     ++  +T     GTP Y+ PE
Sbjct: 122 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKTFCGTPEYLAPE 178
Query: 234 YHQCYQLTDKSDVFSFGVVLIELI 257
             +        D +  GVV+ E++
Sbjct: 179 VLEDNDYGRAVDWWGLGVVMYEMM 202

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 18/220 (8%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYK-RVEQFMNE 107
           + E   N     + LG G FG V        G+      VAVK L    +    E  M+E
Sbjct: 32  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 91
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHL----HGERAKPGALPW 161
           + I++ L +H+N+V+L G CT  H   +L++ E+   G + + L      +  K    P 
Sbjct: 92  LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 149
Query: 162 PTR--LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV 219
             R  L  + + A  + +L + + IHRDV   N+LL N    K+ DFGL+R   N   ++
Sbjct: 150 ELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 209
Query: 220 STAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
                  P  ++ PE       T +SDV+S+G++L E+ S
Sbjct: 210 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 62/202 (30%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           F     +G G FG V+ G + +  + VA+K +  E     +E    E+ +L++     + 
Sbjct: 25  FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVT 84
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP-GALPWPTRLKIAIETASALTYLH 179
             YG   + S+ L ++ E++  G+  D L   RA P       T LK   E    L YLH
Sbjct: 85  KYYGSYLKGSK-LWIIMEYLGGGSALDLL---RAGPFDEFQIATMLK---EILKGLDYLH 137
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
           +   IHRD+K  N+LL     VK+ADFG++    +     +T   GTP ++ PE  Q   
Sbjct: 138 SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIQQSA 196
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
              K+D++S G+  IEL    P
Sbjct: 197 YDSKADIWSLGITAIELAKGEP 218

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 61  NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
           N FD  + LG G FG V    E   GR  A+K L +        V   + E  +L   RH
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
             L +L      H R L  V E+ + G +  HL  ER          R +    E  SAL
Sbjct: 65  PFLTALKYAFQTHDR-LCFVMEYANGGELFFHLSRERVFT-----EERARFYGAEIVSAL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
            YLH+ D+++RD+K  N++LD +  +K+ DFGL +     ++  +T     GTP Y+ PE
Sbjct: 119 EYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK---EGISDGATMKXFCGTPEYLAPE 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
             +        D +  GVV+ E++  
Sbjct: 176 VLEDNDYGRAVDWWGLGVVMYEMMCG 201

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/220 (29%), Positives = 103/220 (46%), Gaps = 18/220 (8%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYK-RVEQFMNE 107
           + E   N     + LG G FG V        G+      VAVK L    +    E  M+E
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHL----HGERAKPGALPW 161
           + I++ L +H+N+V+L G CT  H   +L++ E+   G + + L      +  K    P 
Sbjct: 100 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPL 157
Query: 162 PTR--LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV 219
             R  L  + + A  + +L + + IHRDV   N+LL N    K+ DFGL+R   N   ++
Sbjct: 158 ELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 217
Query: 220 STAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
                  P  ++ PE       T +SDV+S+G++L E+ S
Sbjct: 218 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 119/289 (41%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++L H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 110
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 111 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG++R       +        P  ++ P
Sbjct: 170 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 273
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 274 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 106/228 (46%), Gaps = 28/228 (12%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYK-RVEQFMNE 107
           + E   N     + LG G FG V        G+      VAVK L    +    E  M+E
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPW---P 162
           + I++ L +H+N+V+L G CT  H   +L++ E+   G + + L   R +P  L +   P
Sbjct: 100 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFL--RRKRPPGLEYSYNP 155
Query: 163 TR-----------LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
           +            L  + + A  + +L + + IHRDV   N+LL N    K+ DFGL+R 
Sbjct: 156 SHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARD 215
Query: 212 FPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
             N   ++       P  ++ PE       T +SDV+S+G++L E+ S
Sbjct: 216 IMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 119/289 (41%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++L H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNI 96
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 97  VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG++R       +        P  ++ P
Sbjct: 156 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 259
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 260 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + +G G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    +KVADFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 59  ATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF--MNEVDILARLR 115
           AT+ ++   E+G G +GTVY   +   G  VA+K +   N +       + EV +L RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 116 ---HKNLVSLYG--CTSRHSREL--LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
              H N+V L     TSR  RE+   LV+E +         + ++A P  LP  T   + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL---RTYLDKAPPPGLPAETIKDLM 118
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L +LHA+ I+HRD+K  NIL+ +   VK+ADFGL+R++   +         T  
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVV--VTLW 176
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           Y  PE           D++S G +  E+    P
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + +G G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    +KVADFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++   K +   ++E++++  + +
Sbjct: 32  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 91
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              + + 
Sbjct: 92  HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 149
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R   N   +  T 
Sbjct: 150 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
               P  ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 210 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++   K +   ++E++++  + +
Sbjct: 29  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 88
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              + + 
Sbjct: 89  HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 146
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R   N   +  T 
Sbjct: 147 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
               P  ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 207 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 243

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 102/217 (47%), Gaps = 28/217 (12%)
Query: 66  ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
            + LG G FG V     +G  +    R VAVK L E   +      M+E+ IL  +  H 
Sbjct: 33  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 92
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
           N+V+L G  ++    L+++ EF   G ++ +L  +R +   +P+ T              
Sbjct: 93  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKTPEDLYKDFLTLEHL 150
Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
           +  + + A  + +L +   IHRD+   NILL     VK+ DFGL+R        V     
Sbjct: 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 225 GTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
             P  ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 211 RLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 245

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 107/219 (48%), Gaps = 30/219 (13%)
Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++   K +   ++E++++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
           HKN++ L G  ++    L ++ E+ S G + ++L   R  PG              + + 
Sbjct: 100 HKNIIHLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R   N   +  T 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
               P  ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 8   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE     L  E+ S G + D +  +      +P P   +   + 
Sbjct: 62  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
            PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 8   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEIXINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE     L  E+ S G + D +  +      +P P   +   + 
Sbjct: 62  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
            PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 8   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE     L  E+ S G + D +  +      +P P   +   + 
Sbjct: 62  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
            PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           F    ++G G FG V+ G + +  + VA+K +  E     +E    E+ +L++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             YG   + ++ L ++ E++  G+  D L     +PG L       I  E    L YLH+
Sbjct: 84  KYYGSYLKDTK-LWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 137
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              IHRD+K  N+LL  +  VK+ADFG++ +L    +        GTP ++ PE  +   
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV--GTPFWMAPEVIKQSA 195
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
              K+D++S G+  IEL    P
Sbjct: 196 YDSKADIWSLGITAIELARGEP 217

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++   K +   ++E++++  + +
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              + + 
Sbjct: 146 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 203
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R   N   +  T 
Sbjct: 204 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
               P  ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 264 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 300

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 8   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIE 170
            H+N+V  YG    H RE     L  E+ S G + D     R +P   +P P   +   +
Sbjct: 62  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQ 112
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGY 229
             + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPY 172
Query: 230 VDPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
           V PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++   K +   ++E++++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              + + 
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +    + A  + YL +   IHRD+   N+L+  N  +++ADFGL+R   N   +  T 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
               P  ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 44  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++   K +   ++E++++  + +
Sbjct: 27  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 86
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              + + 
Sbjct: 87  HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 144
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R   N   +  T 
Sbjct: 145 DLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
               P  ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 205 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 241

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/282 (25%), Positives = 119/282 (42%), Gaps = 40/282 (14%)
Query: 63  FDSARELGDGGFGTVYYGEL--QDGR--AVAVKRLYENNYKR--VEQFMNEVDILARLRH 116
           F   R LG G FG+V   +L  +DG    VAVK L  +      +E+F+ E   +    H
Sbjct: 25  FTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDH 84
Query: 117 KNLVSLYGCT--SRHSREL---LLVYEFISNGTVADHLHGERA--KPGALPWPTRLKIAI 169
            ++  L G +  SR    L   +++  F+ +G +   L   R    P  LP  T ++  +
Sbjct: 85  PHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           + A  + YL + + IHRD+   N +L  +  V VADFGLSR     +       QG    
Sbjct: 145 DIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCASK 200
Query: 230 VDPEYHQCYQLTDK-----SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN 284
           +  ++     L D      SDV++FGV + E+++                       I+N
Sbjct: 201 LPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR---------------GQTPYAGIEN 245
Query: 285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
               E+ +  +G     +    +  V +L +QC  ++   RP
Sbjct: 246 A---EIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRP 284

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 106/233 (45%), Gaps = 31/233 (13%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYK-RVEQFMNE 107
           + E   N     + LG G FG V        G+      VAVK L    +    E  M+E
Sbjct: 25  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 84
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTV-------ADHLHGERAKPGA 158
           + I++ L +H+N+V+L G CT  H   +L++ E+   G +       A+ + G    PG 
Sbjct: 85  LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPGQ 142
Query: 159 LP--------WPTRLK----IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADF 206
            P         P  L+     + + A  + +L + + IHRDV   N+LL N    K+ DF
Sbjct: 143 DPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 202
Query: 207 GLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
           GL+R   N   ++       P  ++ PE       T +SDV+S+G++L E+ S
Sbjct: 203 GLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 109/223 (48%), Gaps = 38/223 (17%)
Query: 66  ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E       +  R   VAVK L  +   K +   ++E++++  + +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              L   
Sbjct: 93  HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEFSFNPSHNPEEQLSSK 150
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R     + H+   
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDXX 206
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
            + T G     ++ PE  + + Y  T +SDV+SFGV+L E+ +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT 247

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/202 (28%), Positives = 97/202 (48%), Gaps = 11/202 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           F    ++G G FG V+ G + +  + VA+K +  E     +E    E+ +L++     + 
Sbjct: 9   FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 68
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             YG   + ++ L ++ E++  G+  D L     +PG L       I  E    L YLH+
Sbjct: 69  KYYGSYLKDTK-LWIIMEYLGGGSALDLL-----EPGPLDETQIATILREILKGLDYLHS 122
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              IHRD+K  N+LL  +  VK+ADFG++ +L    +        GTP ++ PE  +   
Sbjct: 123 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFV--GTPFWMAPEVIKQSA 180
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
              K+D++S G+  IEL    P
Sbjct: 181 YDSKADIWSLGITAIELARGEP 202

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 66  ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
            + LG G FG V     +G  +    R VAVK L E   +      M+E+ IL  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK----------I 167
           N+V+L G  ++    L+++ EF   G ++ +L  +R +   +P+    K           
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKDLYKDFLTLEHLICY 149
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           + + A  + +L +   IHRD+   NILL     VK+ DFGL+R       +V       P
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 209
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
             ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 210 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 241

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 25/214 (11%)
Query: 66  ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
            + LG G FG V     +G  +    R VAVK L E   +      M+E+ IL  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK----------I 167
           N+V+L G  ++    L+++ EF   G ++ +L  +R +   +P+    K           
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKDLYKDFLTLEHLIXY 149
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           + + A  + +L +   IHRD+   NILL     VK+ DFGL+R       +V       P
Sbjct: 150 SFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLP 209
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
             ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 210 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 241

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 108/219 (49%), Gaps = 30/219 (13%)
Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYENNYKR-VEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++  +  +   ++E++++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              + + 
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R   N   +  T 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
               P  ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 9   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE  + Y   E+ S G + D +  +      +P P   +   + 
Sbjct: 63  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 114
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
            PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 9   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE  + Y   E+ S G + D +  +      +P P   +   + 
Sbjct: 63  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 114
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
            PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 9   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE  + Y   E+ S G + D +  +      +P P   +   + 
Sbjct: 63  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 114
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
            PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 30  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 89
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 90  LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 142
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 143 YLHSLDLIYRDLKPENLLIDEQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 198
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 199 SKGYNKAVDWWALGVLIYEMAAGYP 223

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 7   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 60
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE     L  E+ S G + D +  +      +P P   +   + 
Sbjct: 61  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 112
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 113 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
            PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 9   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE  + Y   E+ S G + D +  +      +P P   +   + 
Sbjct: 63  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 114
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
            PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 97/212 (45%), Gaps = 12/212 (5%)
Query: 55  ELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFM-NEVDILA 112
           + E+    F+    LG G F  V   E +  G+  AVK + +   K  E  + NE+ +L 
Sbjct: 16  QAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLR 75
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
           +++H+N+V+L          L LV + +S G + D +     + G         +  +  
Sbjct: 76  KIKHENIVALEDIY-ESPNHLYLVMQLVSGGELFDRI----VEKGFYTEKDASTLIRQVL 130
Query: 173 SALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
            A+ YLH   I+HRD+K  N+L    D    + ++DFGLS++       V +   GTPGY
Sbjct: 131 DAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM--EGKGDVMSTACGTPGY 188
Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           V PE       +   D +S GV+   L+   P
Sbjct: 189 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 220

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 102/210 (48%), Gaps = 27/210 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 8   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE  + Y   E+ S G + D +  +      +P P   +   + 
Sbjct: 62  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
            PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 9   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE  + Y   E+ S G + D +  +      +P P   +   + 
Sbjct: 63  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 114
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELIS 258
            PE  +  +   +  DV+S G+VL  +++
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLA 203

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 63/216 (29%), Positives = 101/216 (46%), Gaps = 27/216 (12%)
Query: 66  ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
            + LG G FG V     +G  +    R VAVK L E   +      M+E+ IL  +  H 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------L 165
           N+V+L G  ++    L+++ EF   G ++ +L  +R +   +P+               +
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKPEDLYKDFLTLEHLI 151
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG 225
             + + A  + +L +   IHRD+   NILL     VK+ DFGL+R        V      
Sbjct: 152 XYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDAR 211
Query: 226 TP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
            P  ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 212 LPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 245

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 8   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIE 170
            H+N+V  YG    H RE     L  E+ S G + D     R +P   +P P   +   +
Sbjct: 62  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQ 112
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGY 229
             + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 230 VDPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
           V PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 121/243 (49%), Gaps = 21/243 (8%)
Query: 61  NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQF---MNEVDILARLRH 116
           ++F   R LG GGFG V+  +++  G+  A K+L +   K+ + +   M E  ILA++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 117 KNLVSL-YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           + +VSL Y   ++   +L LV   ++ G +  H++           P  +    +  S L
Sbjct: 245 RFIVSLAYAFETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            +LH  +II+RD+K  N+LLD++  V+++D GL+       T  +    GTPG++ PE  
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELL 361
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE-LVDQT 294
              +     D F+ GV L E+I+   A    R R E         K++NK L + +++Q 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIA---ARGPFRARGE---------KVENKELKQRVLEQA 409
Query: 295 LGY 297
           + Y
Sbjct: 410 VTY 412

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 8   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIE 170
            H+N+V  YG    H RE     L  E+ S G + D     R +P   +P P   +   +
Sbjct: 62  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQ 112
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGY 229
             + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 230 VDPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
           V PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 8   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIE 170
            H+N+V  YG    H RE     L  E+ S G + D     R +P   +P P   +   +
Sbjct: 62  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQ 112
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGY 229
             + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  Y
Sbjct: 113 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 172
Query: 230 VDPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
           V PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 173 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 8   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE     L  E+ S G + D +  +      +P P   +   + 
Sbjct: 62  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
            PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 100/213 (46%), Gaps = 15/213 (7%)
Query: 59  ATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF--MNEVDILARLR 115
           AT+ ++   E+G G +GTVY   +   G  VA+K +   N +       + EV +L RL 
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLE 61
Query: 116 ---HKNLVSLYG--CTSRHSREL--LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
              H N+V L     TSR  RE+   LV+E +         + ++A P  LP  T   + 
Sbjct: 62  AFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDL---RTYLDKAPPPGLPAETIKDLM 118
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L +LHA+ I+HRD+K  NIL+ +   VK+ADFGL+R++   +         T  
Sbjct: 119 RQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVV--VTLW 176
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           Y  PE           D++S G +  E+    P
Sbjct: 177 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKP 209

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/211 (31%), Positives = 102/211 (48%), Gaps = 29/211 (13%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 9   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 62
Query: 115 RHKNLVSLYGCTSRHSRE---LLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIE 170
            H+N+V  YG    H RE     L  E+ S G + D     R +P   +P P   +   +
Sbjct: 63  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFD-----RIEPDIGMPEPDAQRFFHQ 113
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGY 229
             + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  Y
Sbjct: 114 LMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 173
Query: 230 VDPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
           V PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 174 VAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G   +P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 121/243 (49%), Gaps = 21/243 (8%)
Query: 61  NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQF---MNEVDILARLRH 116
           ++F   R LG GGFG V+  +++  G+  A K+L +   K+ + +   M E  ILA++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 117 KNLVSL-YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           + +VSL Y   ++   +L LV   ++ G +  H++           P  +    +  S L
Sbjct: 245 RFIVSLAYAFETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            +LH  +II+RD+K  N+LLD++  V+++D GL+       T  +    GTPG++ PE  
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELL 361
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE-LVDQT 294
              +     D F+ GV L E+I+   A    R R E         K++NK L + +++Q 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIA---ARGPFRARGE---------KVENKELKQRVLEQA 409
Query: 295 LGY 297
           + Y
Sbjct: 410 VTY 412

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 65/209 (31%), Positives = 102/209 (48%), Gaps = 27/209 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G +G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 8   WDLVQTLGEGAYGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE  + Y   E+ S G + D +  +      +P P   +   + 
Sbjct: 62  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELIS 258
            PE  +  +   +  DV+S G+VL  +++
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLA 202

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 121/243 (49%), Gaps = 21/243 (8%)
Query: 61  NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQF---MNEVDILARLRH 116
           ++F   R LG GGFG V+  +++  G+  A K+L +   K+ + +   M E  ILA++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 117 KNLVSL-YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           + +VSL Y   ++   +L LV   ++ G +  H++           P  +    +  S L
Sbjct: 245 RFIVSLAYAFETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            +LH  +II+RD+K  N+LLD++  V+++D GL+       T  +    GTPG++ PE  
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELL 361
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE-LVDQT 294
              +     D F+ GV L E+I+   A    R R E         K++NK L + +++Q 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIA---ARGPFRARGE---------KVENKELKQRVLEQA 409
Query: 295 LGY 297
           + Y
Sbjct: 410 VTY 412

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 69  LGDGGFGTVYYGELQ-DGRAV--AVKRLYENNYKRVEQ-FMNEVDILARL-RHKNLVSLY 123
           +G+G FG V    ++ DG  +  A+KR+ E   K   + F  E+++L +L  H N+++L 
Sbjct: 23  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 82
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGER------------AKPGALPWPTRLKIAIET 171
           G    H   L L  E+  +G + D L   R            +    L     L  A + 
Sbjct: 83  G-ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 141
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
           A  + YL     IHRD+   NIL+  N+  K+ADFGLSR     V    T  +    ++ 
Sbjct: 142 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMA 199
Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELIS 258
            E       T  SDV+S+GV+L E++S
Sbjct: 200 IESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G   +P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/244 (28%), Positives = 111/244 (45%), Gaps = 36/244 (14%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLV 120
           F+  + LG GGFG V+  + + D    A+KR+   N +   E+ M EV  LA+L H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66
Query: 121 SLY-GCTSRHSRELLL-----VYEFIS-----NGTVADHLHG-----ERAKPGALPWPTR 164
             +     +++ E L      VY +I         + D ++G     ER +   L     
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCL----- 121
Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL-----------SRLFP 213
             I ++ A A+ +LH+  ++HRD+K +NI    +  VKV DFGL           + L P
Sbjct: 122 -HIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 180
Query: 214 NHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
                  T   GT  Y+ PE       + K D+FS G++L EL+    +  + R R   +
Sbjct: 181 MPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYPF-STQMERVRTLTD 239
Query: 274 LSNL 277
           + NL
Sbjct: 240 VRNL 243

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++  H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 110
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 111 VRCIG-VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG++R       +        P  ++ P
Sbjct: 170 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 273
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 274 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 121/243 (49%), Gaps = 21/243 (8%)
Query: 61  NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQF---MNEVDILARLRH 116
           ++F   R LG GGFG V+  +++  G+  A K+L +   K+ + +   M E  ILA++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 117 KNLVSL-YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           + +VSL Y   ++   +L LV   ++ G +  H++           P  +    +  S L
Sbjct: 245 RFIVSLAYAFETKT--DLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            +LH  +II+RD+K  N+LLD++  V+++D GL+       T  +    GTPG++ PE  
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK-TKGYAGTPGFMAPELL 361
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE-LVDQT 294
              +     D F+ GV L E+I+   A    R R E         K++NK L + +++Q 
Sbjct: 362 LGEEYDFSVDYFALGVTLYEMIA---ARGPFRARGE---------KVENKELKQRVLEQA 409
Query: 295 LGY 297
           + Y
Sbjct: 410 VTY 412

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 38  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 97
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G   +P A  +  ++ +  E      
Sbjct: 98  LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 150
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 151 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 206
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 207 SKGYNKAVDWWALGVLIYEMAAGYP 231

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 69  LGDGGFGTVYYGELQ-DGRAV--AVKRLYENNYKRVEQ-FMNEVDILARL-RHKNLVSLY 123
           +G+G FG V    ++ DG  +  A+KR+ E   K   + F  E+++L +L  H N+++L 
Sbjct: 33  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 92
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGER------------AKPGALPWPTRLKIAIET 171
           G    H   L L  E+  +G + D L   R            +    L     L  A + 
Sbjct: 93  G-ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
           A  + YL     IHRD+   NIL+  N+  K+ADFGLSR     V    T  +    ++ 
Sbjct: 152 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMA 209
Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELIS 258
            E       T  SDV+S+GV+L E++S
Sbjct: 210 IESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++  H+N+
Sbjct: 53  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 112
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 113 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 171
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG++R       +        P  ++ P
Sbjct: 172 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 231
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 232 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 275
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 276 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 322

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 106/243 (43%), Gaps = 35/243 (14%)
Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           F+    LG G FG V       D R  A+K++  +  +++   ++EV +LA L H+ +V 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 122 LYGC------------TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
            Y                +    L +  E+  NGT+ D +H E        +    +  +
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG- 228
           E   AL+Y+H+  IIHRD+K  NI +D +  VK+ DFGL++     +  +    Q  PG 
Sbjct: 127 E---ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 229 ------------YVDPE-YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDITRHRHE 271
                       YV  E         +K D++S G++  E+I    + M  V+I +    
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS 243
Query: 272 INL 274
           +++
Sbjct: 244 VSI 246

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++  H+N+
Sbjct: 43  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 102
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 103 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 161
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG++R       +        P  ++ P
Sbjct: 162 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 221
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 222 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 265
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 266 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 312

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 96  VRCIG-VSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG++R       +        P  ++ P
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 258
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 259 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G   +P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 64  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G   +P A  +  ++ +  E      
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 176
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 177 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 232
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++  H+N+
Sbjct: 63  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 122
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 123 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 181
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG++R       +        P  ++ P
Sbjct: 182 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 241
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 242 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 285
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 286 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 332

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 111/249 (44%), Gaps = 14/249 (5%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V+  E +   +  A+K L ++       VE  M E  +L+      
Sbjct: 20  FELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 79
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            ++   CT +    L  V E+++ G +  H+         L   T    A E    L +L
Sbjct: 80  FLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQS--CHKFDLSRATF--YAAEIILGLQFL 135
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPEYHQC 237
           H+  I++RD+K +NILLD +  +K+ADFG+ +   N +    T    GTP Y+ PE    
Sbjct: 136 HSKGIVYRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 238 YQLTDKSDVFSFGVVLIELI---SSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT 294
            +     D +SFGV+L E++   S     D     H I + N    +   K   +L+ + 
Sbjct: 194 QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKL 253
Query: 295 LGYESDNKV 303
              E + ++
Sbjct: 254 FVREPEKRL 262

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWTLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++  H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 97  VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG++R       +        P  ++ P
Sbjct: 156 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 215
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 259
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 260 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 29  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 88
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 89  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 141
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 142 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWTLCGTPEYLAPEIIL 197
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 198 SKGYNKAVDWWALGVLIYEMAAGYP 222

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 61/210 (29%), Positives = 99/210 (47%), Gaps = 18/210 (8%)
Query: 60  TNYFDSARELGDGGFGTVYYGELQDG-----RAVAVKRLYENNYKRVEQFMNEVDILARL 114
           +  +   ++LG G +G V     +D      RA+ + R    +     + + EV +L  L
Sbjct: 36  SEMYQRVKKLGSGAYGEVLL--CRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
            H N++ LY       R   LV E    G + D +   R K   +     +K   +  S 
Sbjct: 94  DHPNIMKLYDFF-EDKRNYYLVMECYKGGELFDEII-HRMKFNEVDAAVIIK---QVLSG 148
Query: 175 LTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
           +TYLH  +I+HRD+K  N+LL++   +  +K+ DFGLS +F N          GT  Y+ 
Sbjct: 149 VTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIA 206
Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           PE  +  +  +K DV+S GV+L  L++  P
Sbjct: 207 PEVLR-KKYDEKCDVWSIGVILFILLAGYP 235

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 96  VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG++R       +        P  ++ P
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 214
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 215 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 258
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 259 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 305

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++  H+N+
Sbjct: 28  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 87
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 88  VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 146
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG++R       +        P  ++ P
Sbjct: 147 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 206
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 207 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 250
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 251 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 297

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 57/197 (28%), Positives = 97/197 (49%), Gaps = 12/197 (6%)
Query: 69  LGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLVSL 122
           LG G FGTVY G  + DG      VA+K L EN   +  ++ ++E  ++A +    +  L
Sbjct: 25  LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRL 84
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
            G     + +L  V + +  G + DH+   R + G+      L   ++ A  ++YL    
Sbjct: 85  LGICLTSTVQL--VTQLMPYGCLLDHVRENRGRLGS---QDLLNWCMQIAKGMSYLEDVR 139
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQLT 241
           ++HRD+   N+L+ +   VK+ DFGL+RL     T         P  ++  E     + T
Sbjct: 140 LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFT 199
Query: 242 DKSDVFSFGVVLIELIS 258
            +SDV+S+GV + EL++
Sbjct: 200 HQSDVWSYGVTVWELMT 216

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 103/227 (45%), Gaps = 28/227 (12%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYK-RVEQFMNE 107
           + E   N     + LG G FG V        G+      VAVK L    +    E  M+E
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRL 165
           + I++ L +H+N+V+L G CT  H   +L++ E+   G + + L   R K   L      
Sbjct: 100 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAF 154
Query: 166 KIAIETAS-------------ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF 212
            IA  TAS              + +L + + IHRDV   N+LL N    K+ DFGL+R  
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 213 PNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
            N   ++       P  ++ PE       T +SDV+S+G++L E+ S
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ ++ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYQMAAGYP 236

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 30/219 (13%)
Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++   K +   ++E++++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
           HKN+++L G  ++    L ++  + S G + ++L   R  PG              + + 
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVAYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R   N   +  T 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
               P  ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 99/205 (48%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+++D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLIIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIII 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++  H+N+
Sbjct: 77  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 136
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 137 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG++R       +        P  ++ P
Sbjct: 196 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 255
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 256 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 299
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 300 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 346

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/214 (29%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 67  RELGDGGFGTVYYGELQD---GRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSL 122
           R L +GGF  VY  E QD   GR  A+KRL  N  ++    + EV  + +L  H N+V  
Sbjct: 34  RVLAEGGFAFVY--EAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF 91
Query: 123 YGCTS-------RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
               S           E LL+ E +  G + + L    ++ G L   T LKI  +T  A+
Sbjct: 92  CSAASIGKEESDTGQAEFLLLTE-LCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAV 149
Query: 176 TYLH--ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--------- 224
            ++H     IIHRD+K  N+LL N   +K+ DFG +    ++  +  +A +         
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209
Query: 225 --GTPGYVDPEYHQCYQ---LTDKSDVFSFGVVL 253
              TP Y  PE    Y    + +K D+++ G +L
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++  H+N+
Sbjct: 51  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNI 110
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 111 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 169
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG++R       +        P  ++ P
Sbjct: 170 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP 229
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 230 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 273
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 274 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 320

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 100/203 (49%), Gaps = 25/203 (12%)
Query: 60  TNYFDSARELGDGGFGTVYYGELQDG--RAVAVKRLYENNYKRVEQFMNEVDILARLRHK 117
           +++F+   ELG G    VY  + Q G  +  A+K L +   K++ +   E+ +L RL H 
Sbjct: 52  SDFFEVESELGRGATSIVYRCK-QKGTQKPYALKVLKKTVDKKIVR--TEIGVLLRLSHP 108
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHL-----HGERAKPGALPWPTRLKIAIETA 172
           N++ L       + E+ LV E ++ G + D +     + ER    A+          +  
Sbjct: 109 NIIKLKEIFETPT-EISLVLELVTGGELFDRIVEKGYYSERDAADAVK---------QIL 158
Query: 173 SALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
            A+ YLH + I+HRD+K  N+L      +  +K+ADFGLS++  + V   +    GTPGY
Sbjct: 159 EAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GTPGY 216
Query: 230 VDPEYHQCYQLTDKSDVFSFGVV 252
             PE  +      + D++S G++
Sbjct: 217 CAPEILRGCAYGPEVDMWSVGII 239

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++  H+N+
Sbjct: 54  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 113
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 114 VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 172
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG++R       +        P  ++ P
Sbjct: 173 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP 232
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 233 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 276
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 277 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 323

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K +E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+   G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+++D    +KV DFGL++        +     GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLC----GTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66  ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E       +  R   VAVK L  +   K +   ++E++++  + +
Sbjct: 26  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 85
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              L   
Sbjct: 86  HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSK 143
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R     + H+   
Sbjct: 144 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 199
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
            + T G     ++ PE  + + Y  T +SDV+SFGV+L E+     S  P V +
Sbjct: 200 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 251

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 107/219 (48%), Gaps = 30/219 (13%)
Query: 66  ARELGDGGFGTVYYGEL--------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E         ++   VAVK L ++   K +   ++E++++  + +
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA-------------LPWP 162
           HKN+++L G  ++    L ++  + S G + ++L   R  PG              + + 
Sbjct: 100 HKNIINLLGACTQDG-PLYVIVGYASKGNLREYLRARRP-PGMEYSYDINRVPEEQMTFK 157
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R   N   +  T 
Sbjct: 158 DLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 223 PQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
               P  ++ PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 218 NGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66  ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E       +  R   VAVK L  +   K +   ++E++++  + +
Sbjct: 25  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 84
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              L   
Sbjct: 85  HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSK 142
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R     + H+   
Sbjct: 143 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 198
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
            + T G     ++ PE  + + Y  T +SDV+SFGV+L E+     S  P V +
Sbjct: 199 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 250

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66  ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E       +  R   VAVK L  +   K +   ++E++++  + +
Sbjct: 22  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 81
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              L   
Sbjct: 82  HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSK 139
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R     + H+   
Sbjct: 140 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 195
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
            + T G     ++ PE  + + Y  T +SDV+SFGV+L E+     S  P V +
Sbjct: 196 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 247

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66  ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E       +  R   VAVK L  +   K +   ++E++++  + +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              L   
Sbjct: 93  HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSK 150
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R     + H+   
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
            + T G     ++ PE  + + Y  T +SDV+SFGV+L E+     S  P V +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 258

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66  ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E       +  R   VAVK L  +   K +   ++E++++  + +
Sbjct: 18  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 77
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              L   
Sbjct: 78  HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYCYNPSHNPEEQLSSK 135
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R     + H+   
Sbjct: 136 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 191
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
            + T G     ++ PE  + + Y  T +SDV+SFGV+L E+     S  P V +
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 243

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 66  ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
            + LG G FG V     +G  +    R VAVK L E   +      M+E+ IL  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
           N+V+L G  ++    L+++ EF   G ++ +L  +R +   +P+                
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 149
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
            +  + + A  + +L +   IHRD+   NILL     VK+ DFGL+R       +V    
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 209
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
              P  ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 210 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 245

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 29/218 (13%)
Query: 66  ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
            + LG G FG V     +G  +    R VAVK L E   +      M+E+ IL  +  H 
Sbjct: 69  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 128
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
           N+V+L G  ++    L+++ EF   G ++ +L  +R +   +P+                
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 186
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
            +  + + A  + +L +   IHRD+   NILL     VK+ DFGL+R       +V    
Sbjct: 187 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 246
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
              P  ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 247 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 282

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G   +P A  +  ++ +  E      
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66  ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E       +  R   VAVK L  +   K +   ++E++++  + +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              L   
Sbjct: 93  HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYCYNPSHNPEEQLSSK 150
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R     + H+   
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
            + T G     ++ PE  + + Y  T +SDV+SFGV+L E+     S  P V +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 258

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 66  ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
            + LG G FG V     +G  +    R VAVK L E   +      M+E+ IL  +  H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
           N+V+L G  ++    L+++ EF   G ++ +L  +R +   +P+                
Sbjct: 83  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 140
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
            +  + + A  + +L +   IHRD+   NILL     VK+ DFGL+R        V    
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
              P  ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 201 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 236

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G   +P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G   +P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 66  ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
            + LG G FG V     +G  +    R VAVK L E   +      M+E+ IL  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
           N+V+L G  ++    L+++ EF   G ++ +L  +R +   +P+                
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 149
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
            +  + + A  + +L +   IHRD+   NILL     VK+ DFGL+R        V    
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
              P  ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 210 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 245

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66  ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E       +  R   VAVK L  +   K +   ++E++++  + +
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              L   
Sbjct: 134 HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQARRP-PGLEYSYNPSHNPEEQLSSK 191
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R     + H+   
Sbjct: 192 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 247
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
            + T G     ++ PE  + + Y  T +SDV+SFGV+L E+     S  P V +
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 299

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 42/234 (17%)
Query: 66  ARELGDGGFGTVYYGEL------QDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-R 115
            + LG+G FG V   E       +  R   VAVK L  +   K +   ++E++++  + +
Sbjct: 33  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 92
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-------------ALPWP 162
           HKN+++L G  ++    L ++ E+ S G + ++L   R  PG              L   
Sbjct: 93  HKNIINLLGACTQDG-PLYVIVEYASKGNLREYLQA-REPPGLEYSYNPSHNPEEQLSSK 150
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
             +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R     + H+   
Sbjct: 151 DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLAR----DIHHIDYY 206
Query: 223 PQGTPG-----YVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
            + T G     ++ PE  + + Y  T +SDV+SFGV+L E+     S  P V +
Sbjct: 207 KKTTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFTLGGSPYPGVPV 258

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 60  TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV---EQFMNEVDILARLR 115
           ++ +   R LG G FG V   + +  G+  AVK + +   K+    E  + EV +L +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           H N++ LY           LV E  + G + D +   +            +I  +  S +
Sbjct: 85  HPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGI 139
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
           TY+H + I+HRD+K  N+LL++   +  +++ DFGLS  F    +       GT  Y+ P
Sbjct: 140 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 197
Query: 233 E-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
           E  H  Y   +K DV+S GV+L  L+S  P
Sbjct: 198 EVLHGTYD--EKCDVWSTGVILYILLSGCP 225

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 66  ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
            + LG G FG V     +G  +    R VAVK L E   +      M+E+ IL  +  H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
           N+V+L G  ++    L+++ EF   G ++ +L  +R +   +P+                
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 140
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
            +  + + A  + +L +   IHRD+   NILL     VK+ DFGL+R       +V    
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
              P  ++ PE  + + Y  T +SDV+SFGV+L E+     S  P V I
Sbjct: 201 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFSLGASPYPGVKI 247

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 60  TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV---EQFMNEVDILARLR 115
           ++ +   R LG G FG V   + +  G+  AVK + +   K+    E  + EV +L +L 
Sbjct: 49  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 108
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           H N++ LY           LV E  + G + D +   +            +I  +  S +
Sbjct: 109 HPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGI 163
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
           TY+H + I+HRD+K  N+LL++   +  +++ DFGLS  F    +       GT  Y+ P
Sbjct: 164 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 221
Query: 233 E-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
           E  H  Y   +K DV+S GV+L  L+S  P
Sbjct: 222 EVLHGTYD--EKCDVWSTGVILYILLSGCP 249

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/229 (28%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 66  ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
            + LG G FG V     +G  +    R VAVK L E   +      M+E+ IL  +  H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
           N+V+L G  ++    L+++ EF   G ++ +L  +R +   +P+                
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 140
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
            +  + + A  + +L +   IHRD+   NILL     VK+ DFGL+R       +V    
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 200
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
              P  ++ PE  + + Y  T +SDV+SFGV+L E+     S  P V I
Sbjct: 201 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFSLGASPYPGVKI 247

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 66  ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
            + LG G FG V     +G  +    R VAVK L E   +      M+E+ IL  +  H 
Sbjct: 23  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 82
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
           N+V+L G  ++    L+++ EF   G ++ +L  +R +   +P+                
Sbjct: 83  NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 140
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
            +  + + A  + +L +   IHRD+   NILL     VK+ DFGL+R        V    
Sbjct: 141 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 200
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
              P  ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 201 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 236

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+   G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+++D    +KV DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 17/210 (8%)
Query: 60  TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV---EQFMNEVDILARLR 115
           ++ +   R LG G FG V   + +  G+  AVK + +   K+    E  + EV +L +L 
Sbjct: 48  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 107
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           H N++ LY           LV E  + G + D +   +            +I  +  S +
Sbjct: 108 HPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGI 162
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
           TY+H + I+HRD+K  N+LL++   +  +++ DFGLS  F    +       GT  Y+ P
Sbjct: 163 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKMKDKIGTAYYIAP 220
Query: 233 E-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
           E  H  Y   +K DV+S GV+L  L+S  P
Sbjct: 221 EVLHGTYD--EKCDVWSTGVILYILLSGCP 248

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVK---RLYENNYKRVEQFMNEVD---ILARLRHKNLVS 121
           LG G FGTV+ G  + +G ++ +    ++ E+   R + F    D    +  L H ++V 
Sbjct: 39  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVR 97
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G     S  L LV +++  G++ DH+   R   GAL     L   ++ A  + YL   
Sbjct: 98  LLGLCPGSS--LQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH 152
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQL 240
            ++HR++   N+LL +   V+VADFG++ L P     +  +   TP  ++  E     + 
Sbjct: 153 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 212
Query: 241 TDKSDVFSFGVVLIELIS 258
           T +SDV+S+GV + EL++
Sbjct: 213 THQSDVWSYGVTVWELMT 230

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/212 (31%), Positives = 98/212 (46%), Gaps = 26/212 (12%)
Query: 72  GGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR 131
           G FG V+  +L +   VAVK ++    K+  Q   EV  L  ++H+N++   G   R + 
Sbjct: 35  GRFGCVWKAQLLN-EYVAVK-IFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS 92
Query: 132 ---ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--------- 179
              +L L+  F   G+++D L     K   + W     IA   A  L YLH         
Sbjct: 93  VDVDLWLITAFHEKGSLSDFL-----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 180 -ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-GTPGYVDPEYHQC 237
               I HRD+K+ N+LL NN    +ADFGL+  F    +   T  Q GT  Y+ PE  + 
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEG 207
Query: 238 ---YQLTD--KSDVFSFGVVLIELISSMPAVD 264
              +Q     + D+++ G+VL EL S   A D
Sbjct: 208 AINFQRDAFLRIDMYAMGLVLWELASRCTAAD 239

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 29/218 (13%)
Query: 66  ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
            + LG G FG V     +G  +    R VAVK L E   +      M+E+ IL  +  H 
Sbjct: 34  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 93
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPW---PTRL--------- 165
           N+V+L G  ++    L+++ EF   G ++ +L  +R +   +P+   P  L         
Sbjct: 94  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKEAPEDLYKDFLTLEH 151
Query: 166 --KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
               + + A  + +L +   IHRD+   NILL     VK+ DFGL+R       +V    
Sbjct: 152 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGD 211
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
              P  ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 212 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 247

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ P    
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPAIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 102/206 (49%), Gaps = 15/206 (7%)
Query: 61  NYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFM--NEVDILARLRHK 117
           +Y+D   ELG G FG V+   E   GR    K  + N    ++++   NE+ I+ +L H 
Sbjct: 51  DYYDILEELGSGAFGVVHRCVEKATGRVFVAK--FINTPYPLDKYTVKNEISIMNQLHHP 108
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
            L++L+        E++L+ EF+S G + D +  E  K         ++ A E    L +
Sbjct: 109 KLINLHDAFE-DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACE---GLKH 164
Query: 178 LHASDIIHRDVKTNNILLDNNFC--VKVADFGL-SRLFPNHVTHVSTAPQGTPGYVDPEY 234
           +H   I+H D+K  NI+ +      VK+ DFGL ++L P+ +  V+TA   T  +  PE 
Sbjct: 165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA---TAEFAAPEI 221
Query: 235 HQCYQLTDKSDVFSFGVVLIELISSM 260
                +   +D+++ GV+   L+S +
Sbjct: 222 VDREPVGFYTDMWAIGVLGYVLLSGL 247

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 97/197 (49%), Gaps = 11/197 (5%)
Query: 68  ELGDGGFGTVYYGELQDGRA---VAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVSLY 123
           ELG G FG+V  G  +  +    VA+K L +   K   E+ M E  I+ +L +  +V L 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
           G     +  L+LV E    G +   L G+R +   +P     ++  + +  + YL   + 
Sbjct: 403 GVC--QAEALMLVMEMAGGGPLHKFLVGKREE---IPVSNVAELLHQVSMGMKYLEEKNF 457
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS--TAPQGTPGYVDPEYHQCYQLT 241
           +HR++   N+LL N    K++DFGLS+      ++ +  +A +    +  PE     + +
Sbjct: 458 VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 242 DKSDVFSFGVVLIELIS 258
            +SDV+S+GV + E +S
Sbjct: 518 SRSDVWSYGVTMWEALS 534

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  R LG G FG V   + ++ G   A+K L +      K++E  +NE  I   +    
Sbjct: 44  FERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+   G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 104 LVKL-EFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    +KVADFG    F   V   +    GTP Y+ PE   
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIKVADFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/221 (29%), Positives = 105/221 (47%), Gaps = 35/221 (15%)
Query: 69  LGDGGFGTVY----YGELQDGRA--VAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLV 120
           LG G FG V     YG  + G +  VAVK L E  +    E  M+E+ ++ +L  H+N+V
Sbjct: 53  LGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIV 112
Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAK-------------------PGALP 160
           +L G CT   S  + L++E+   G + ++L  +R K                      L 
Sbjct: 113 NLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLT 170
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS 220
           +   L  A + A  + +L     +HRD+   N+L+ +   VK+ DFGL+R   +   +V 
Sbjct: 171 FEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV 230
Query: 221 TAPQGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
                 P  ++ PE  +   Y  T KSDV+S+G++L E+ S
Sbjct: 231 RGNARLPVKWMAPESLFEGIY--TIKSDVWSYGILLWEIFS 269

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 102/215 (47%), Gaps = 27/215 (12%)
Query: 60  TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV---EQFMNEVDILARLR 115
           ++ +   R LG G FG V   + +  G+  AVK + +   K+    E  + EV +L +L 
Sbjct: 31  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 90
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           H N++ LY           LV E  + G + D +   +            +I  +  S +
Sbjct: 91  HPNIMKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGI 145
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQ-----GTP 227
           TY+H + I+HRD+K  N+LL++   +  +++ DFGLS       TH   + +     GT 
Sbjct: 146 TYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLS-------THFEASKKMKDKIGTA 198
Query: 228 GYVDPE-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
            Y+ PE  H  Y   +K DV+S GV+L  L+S  P
Sbjct: 199 YYIAPEVLHGTYD--EKCDVWSTGVILYILLSGCP 231

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 66/243 (27%), Positives = 109/243 (44%), Gaps = 14/243 (5%)
Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYG 124
           LG G FG V+  E +   +  A+K L ++       VE  M E  +L+       ++   
Sbjct: 25  LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMF 84
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
           CT +    L  V E+++ G +  H+  +      L   T    A E    L +LH+  I+
Sbjct: 85  CTFQTKENLFFVMEYLNGGDLMYHI--QSCHKFDLSRATF--YAAEIILGLQFLHSKGIV 140
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPEYHQCYQLTDK 243
           +RD+K +NILLD +  +K+ADFG+ +   N +    T    GTP Y+ PE     +    
Sbjct: 141 YRDLKLDNILLDKDGHIKIADFGMCK--ENMLGDAKTNXFCGTPDYIAPEILLGQKYNHS 198
Query: 244 SDVFSFGVVLIELI---SSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD 300
            D +SFGV+L E++   S     D     H I + N    +   K   +L+ +    E +
Sbjct: 199 VDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPE 258
Query: 301 NKV 303
            ++
Sbjct: 259 KRL 261

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 46/279 (16%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           LG G +G VY G +L +   +A+K + E + +  +    E+ +   L+HKN+V   G  S
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS---ALTYLHASDII 184
            +   + +  E +  G+++  L   R+K G L       I   T      L YLH + I+
Sbjct: 90  ENGF-IKIFMEQVPGGSLSALL---RSKWGPLK-DNEQTIGFYTKQILEGLKYLHDNQIV 144
Query: 185 HRDVKTNNILLDN-NFCVKVADFGLSRLFP--NHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           HRD+K +N+L++  +  +K++DFG S+     N  T   T   GT  Y+ PE      + 
Sbjct: 145 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYMAPE------II 195
Query: 242 DK--------SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ 293
           DK        +D++S G  +IE+ +  P        +E+     A+ K+    +H  + +
Sbjct: 196 DKGPRGYGKAADIWSLGCTIIEMATGKPPF------YELGEPQAAMFKVGMFKVHPEIPE 249
Query: 294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
           ++  E+                +C + + D R    D+L
Sbjct: 250 SMSAEA-----------KAFILKCFEPDPDKRACANDLL 277

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVK---RLYENNYKRVEQFMNEVD---ILARLRHKNLVS 121
           LG G FGTV+ G  + +G ++ +    ++ E+   R + F    D    +  L H ++V 
Sbjct: 21  LGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGR-QSFQAVTDHMLAIGSLDHAHIVR 79
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G     S  L LV +++  G++ DH+   R   GAL     L   ++ A  + YL   
Sbjct: 80  LLGLCPGSS--LQLVTQYLPLGSLLDHVRQHR---GALGPQLLLNWGVQIAKGMYYLEEH 134
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDPEYHQCYQL 240
            ++HR++   N+LL +   V+VADFG++ L P     +  +   TP  ++  E     + 
Sbjct: 135 GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKY 194
Query: 241 TDKSDVFSFGVVLIELIS 258
           T +SDV+S+GV + EL++
Sbjct: 195 THQSDVWSYGVTVWELMT 212

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 96  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 148
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 149 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 204
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYP 229

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 157 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 101/210 (48%), Gaps = 27/210 (12%)
Query: 63  FDSARELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRV----EQFMNEVDILARL 114
           +D  + LG+G  G V   +L   R    AVAVK +   + KR     E    E+ I   L
Sbjct: 8   WDLVQTLGEGAAGEV---QLAVNRVTEEAVAVKIV---DMKRAVDCPENIKKEICINKML 61
Query: 115 RHKNLVSLYGCTSRHSRELLLVY---EFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            H+N+V  YG    H RE  + Y   E+ S G + D +  +      +P P   +   + 
Sbjct: 62  NHENVVKFYG----HRREGNIQYLFLEYCSGGELFDRIEPDIG----MPEPDAQRFFHQL 113
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYV 230
            + + YLH   I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV
Sbjct: 114 MAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 231 DPEYHQCYQL-TDKSDVFSFGVVLIELISS 259
            PE  +  +   +  DV+S G+VL  +++ 
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/199 (30%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 69  LGDGGFGTVYYGE---LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           LG G FG V   +    Q   AV V        K     + EV++L +L H N++ L+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               S    +V E  + G + D +     K          +I  +  S +TY+H  +I+H
Sbjct: 90  L-EDSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 186 RDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           RD+K  NILL++   +  +K+ DFGLS  F  +         GT  Y+ PE  +     +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRG-TYDE 201
Query: 243 KSDVFSFGVVLIELISSMP 261
           K DV+S GV+L  L+S  P
Sbjct: 202 KCDVWSAGVILYILLSGTP 220

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/202 (29%), Positives = 93/202 (46%), Gaps = 11/202 (5%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           F     +G G FG VY G +      VA+K +  E     +E    E+ +L++     + 
Sbjct: 21  FTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 80
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             +G   + S +L ++ E++  G+  D L     KPG L       I  E    L YLH+
Sbjct: 81  RYFGSYLK-STKLWIIMEYLGGGSALDLL-----KPGPLEETYIATILREILKGLDYLHS 134
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              IHRD+K  N+LL     VK+ADFG++ +L    +        GTP ++ PE  +   
Sbjct: 135 ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFV--GTPFWMAPEVIKQSA 192
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
              K+D++S G+  IEL    P
Sbjct: 193 YDFKADIWSLGITAIELAKGEP 214

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/289 (25%), Positives = 118/289 (40%), Gaps = 33/289 (11%)
Query: 67  RELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E   ++ E  F+ E  I+++  H+N+
Sbjct: 37  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 96
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G  S  S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 97  VRCIG-VSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 155
Query: 177 YLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP-GYVDP 232
           YL  +  IHRD+   N LL         K+ DFG+++       +        P  ++ P
Sbjct: 156 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPP 215
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E       T K+D +SFGV+L E+ S               L  +      N+ + E V 
Sbjct: 216 EAFMEGIFTSKTDTWSFGVLLWEIFS---------------LGYMPYPSKSNQEVLEFV- 259
Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
            T G   D   +     V  +  QC Q + + RP    +L+ +     D
Sbjct: 260 -TSGGRMDPP-KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD 306

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 29/218 (13%)
Query: 66  ARELGDGGFGTVY----YG--ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHK 117
            + LG G FG V     +G  +    R VAVK L E   +      M+E+ IL  +  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR------------- 164
           N+V+L G  ++    L+++ EF   G ++ +L  +R +   +P+                
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNE--FVPYKVAPEDLYKDFLTLEH 149
Query: 165 -LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
            +  + + A  + +L +   IHRD+   NILL     VK+ DFGL+R        V    
Sbjct: 150 LICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGD 209
Query: 224 QGTP-GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
              P  ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 210 ARLPLKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 245

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 64  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 123
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 124 LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 176
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 177 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 232
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 233 SKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 20/207 (9%)
Query: 69  LGDGGFGTVYYGELQ-DGRAV--AVKRLYENNYKRVEQ-FMNEVDILARL-RHKNLVSLY 123
           +G+G FG V    ++ DG  +  A+KR+ E   K   + F  E+++L +L  H N+++L 
Sbjct: 30  IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 89
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGER------------AKPGALPWPTRLKIAIET 171
           G    H   L L  E+  +G + D L   R            +    L     L  A + 
Sbjct: 90  G-ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 148
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
           A  + YL     IHR++   NIL+  N+  K+ADFGLSR     V    T  +    ++ 
Sbjct: 149 ARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMA 206
Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELIS 258
            E       T  SDV+S+GV+L E++S
Sbjct: 207 IESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K +E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+   G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+++D    ++V DFGL++        +     GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLC----GTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+   G +  HL   G   +P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+++D    +KV DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 102/227 (44%), Gaps = 28/227 (12%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYK-RVEQFMNE 107
           + E   N     + LG G FG V        G+      VAVK L    +    E  M+E
Sbjct: 40  KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSE 99
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRL 165
           + I++ L +H+N+V+L G CT  H   +L++ E+   G + + L   R K   L      
Sbjct: 100 LKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDLLNFL---RRKSRVLETDPAF 154
Query: 166 KIAIET-------------ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF 212
            IA  T             A  + +L + + IHRDV   N+LL N    K+ DFGL+R  
Sbjct: 155 AIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 213 PNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
            N   ++       P  ++ PE       T +SDV+S+G++L E+ S
Sbjct: 215 MNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 70/279 (25%), Positives = 125/279 (44%), Gaps = 46/279 (16%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           LG G +G VY G +L +   +A+K + E + +  +    E+ +   L+HKN+V   G  S
Sbjct: 16  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 75
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS---ALTYLHASDII 184
            +   + +  E +  G+++  L   R+K G L       I   T      L YLH + I+
Sbjct: 76  ENGF-IKIFMEQVPGGSLSALL---RSKWGPLK-DNEQTIGFYTKQILEGLKYLHDNQIV 130
Query: 185 HRDVKTNNILLDN-NFCVKVADFGLSRLFP--NHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           HRD+K +N+L++  +  +K++DFG S+     N  T   T   GT  Y+ PE      + 
Sbjct: 131 HRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT---GTLQYMAPE------II 181
Query: 242 DK--------SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ 293
           DK        +D++S G  +IE+ +  P        +E+     A+ K+    +H  + +
Sbjct: 182 DKGPRGYGKAADIWSLGCTIIEMATGKPPF------YELGEPQAAMFKVGMFKVHPEIPE 235
Query: 294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
           ++  E+                +C + + D R    D+L
Sbjct: 236 SMSAEA-----------KAFILKCFEPDPDKRACANDLL 263

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 36  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 95
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E++  G +  HL   G   +P A  +  ++ +  E      
Sbjct: 96  LVKL-EFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 148
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 149 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 204
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 205 SKGYNKAVDWWALGVLIYEMAAGYP 229

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           ++    LG GGFG V     QD G  VA+K+   E + K  E++  E+ I+ +L H N+V
Sbjct: 16  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 75
Query: 121 SLY----GCTSRHSREL-LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           S      G       +L LL  E+   G +  +L+      G    P R  ++ + +SAL
Sbjct: 76  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSAL 134
Query: 176 TYLHASDIIHRDVKTNNILLD---NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
            YLH + IIHRD+K  NI+L         K+ D G ++        + T   GT  Y+ P
Sbjct: 135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQYLAP 192
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS 258
           E  +  + T   D +SFG +  E I+
Sbjct: 193 ELLEQKKYTVTVDYWSFGTLAFECIT 218

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 64/206 (31%), Positives = 97/206 (47%), Gaps = 13/206 (6%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           ++    LG GGFG V     QD G  VA+K+   E + K  E++  E+ I+ +L H N+V
Sbjct: 17  WEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVV 76
Query: 121 SLY----GCTSRHSREL-LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           S      G       +L LL  E+   G +  +L+      G    P R  ++ + +SAL
Sbjct: 77  SAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS-DISSAL 135
Query: 176 TYLHASDIIHRDVKTNNILLD---NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
            YLH + IIHRD+K  NI+L         K+ D G ++        + T   GT  Y+ P
Sbjct: 136 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQYLAP 193
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS 258
           E  +  + T   D +SFG +  E I+
Sbjct: 194 ELLEQKKYTVTVDYWSFGTLAFECIT 219

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+++ G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+L+D    ++V DFG    F   V   +    GTP  + PE   
Sbjct: 156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEALAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 96/205 (46%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+   G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 103 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+++D    ++V DFG    F   V   +    GTP Y+ PE   
Sbjct: 156 YLHSLDLIYRDLKPENLMIDQQGYIQVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 211
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 212 SKGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 69  LGDGGFGTVYYGE---LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           LG G FG V   +    Q   AV V        K     + EV++L +L H N++ L+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               S    +V E  + G + D +     K          +I  +  S +TY+H  +I+H
Sbjct: 90  LE-DSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 186 RDVKTNNILLDNNF--C-VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           RD+K  NILL++    C +K+ DFGLS  F  +         GT  Y+ PE  +     +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRG-TYDE 201
Query: 243 KSDVFSFGVVLIELISSMP 261
           K DV+S GV+L  L+S  P
Sbjct: 202 KCDVWSAGVILYILLSGTP 220

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 97/205 (47%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           LV L   + + +  L +V E+   G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 104 LVKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+++D    +KV DFG    F   V   +    GTP Y+ PE   
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 39/217 (17%)
Query: 66  ARELGDGGFGTVYYGELQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKNLVSL 122
            +++G G +G V+ G+ + G  VAVK  +   E ++ R  +    V     +RH+N++  
Sbjct: 42  VKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEEASWFRETEIYQTV----LMRHENILGF 96
Query: 123 YGCTSRHS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
                + +    +L L+ ++  NG++ D+L     K   L   + LK+A  + S L +LH
Sbjct: 97  IAADIKGTGSWTQLYLITDYHENGSLYDYL-----KSTTLDAKSMLKLAYSSVSGLCHLH 151
Query: 180 AS--------DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPG 228
                      I HRD+K+ NIL+  N    +AD GL+  F +    V   P    GT  
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR 211
Query: 229 YVDPE---------YHQCYQLTDKSDVFSFGVVLIEL 256
           Y+ PE         + Q Y +   +D++SFG++L E+
Sbjct: 212 YMPPEVLDESLNRNHFQSYIM---ADMYSFGLILWEV 245

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           L  L   + + +  L +V E+   G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+++D    +KV DFG    F   V   +    GTP Y+ PE   
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 95/205 (46%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           L  L   + + +  L +V E+   G +  HL   G  ++P A  +  ++ +  E      
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+++D    +KV DFG    F   V   +    GTP Y+ PE   
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 179 -GTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/199 (30%), Positives = 91/199 (45%), Gaps = 14/199 (7%)
Query: 69  LGDGGFGTVYYGE---LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           LG G FG V   +    Q   AV V        K     + EV++L +L H N++ L+  
Sbjct: 30  LGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI 89
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
               S    +V E  + G + D +     K          +I  +  S +TY+H  +I+H
Sbjct: 90  LE-DSSSFYIVGELYTGGELFDEI----IKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 186 RDVKTNNILLDNNF--C-VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           RD+K  NILL++    C +K+ DFGLS  F  +         GT  Y+ PE  +     +
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTAYYIAPEVLRG-TYDE 201
Query: 243 KSDVFSFGVVLIELISSMP 261
           K DV+S GV+L  L+S  P
Sbjct: 202 KCDVWSAGVILYILLSGTP 220

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 54  GELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDIL 111
           GEL++  + F+   ELG G  G V+    +    V  ++L     K     Q + E+ +L
Sbjct: 20  GELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 77
Query: 112 ARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
                  +V  YG       E+ +  E +  G++   L     K G +P     K++I  
Sbjct: 78  HECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAV 132
Query: 172 ASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
              LTYL     I+HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+
Sbjct: 133 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYM 189
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIEL 256
            PE  Q    + +SD++S G+ L+E+
Sbjct: 190 SPERLQGTHYSVQSDIWSMGLSLVEM 215

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 112/237 (47%), Gaps = 18/237 (7%)
Query: 28  NTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTV-YYGELQDGR 86
            TSS P   +D  K     G Q F     E   +  +   ELG G +G V     +  G+
Sbjct: 24  QTSSTPPRDLD-SKACISIGNQNF-----EVKADDLEPIMELGRGAYGVVEKMRHVPSGQ 77
Query: 87  AVAVKRLYEN-NYKRVEQFMNEVDILAR-LRHKNLVSLYGCTSRHSRELLLVYEFISNGT 144
            +AVKR+    N +  ++ + ++DI  R +     V+ YG   R   ++ +  E +   T
Sbjct: 78  IMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG-DVWICMELMD--T 134
Query: 145 VADHLHGERAKPG-ALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVK 202
             D  + +    G  +P     KIA+    AL +LH+   +IHRDVK +N+L++    VK
Sbjct: 135 SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVK 194
Query: 203 VADFGLSRLFPNHVTHVSTA---PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
           + DFG+S    + V     A   P   P  ++PE +Q    + KSD++S G+ +IEL
Sbjct: 195 MCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQ-KGYSVKSDIWSLGITMIEL 250

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 69  LGDGGFGTVYYGELQDGRAV-AVKRLYENNYKR---VEQFMNEVDILARL-RHKNLVSLY 123
           LG G FG V   E +    + AVK L ++   +   VE  M E  +LA   +   L  L+
Sbjct: 28  LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 87
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
            C     R L  V E+++ G +  H+     + G    P  +  A E A  L +L +  I
Sbjct: 88  SCFQTMDR-LYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSKGI 142
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPEYHQCYQLTD 242
           I+RD+K +N++LD+   +K+ADFG+ +   N    V+T    GTP Y+ PE    YQ   
Sbjct: 143 IYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEI-IAYQPYG 199
Query: 243 KS-DVFSFGVVLIELISS 259
           KS D ++FGV+L E+++ 
Sbjct: 200 KSVDWWAFGVLLYEMLAG 217

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 54  GELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDIL 111
           GEL++  + F+   ELG G  G V+    +    V  ++L     K     Q + E+ +L
Sbjct: 28  GELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 85
Query: 112 ARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
                  +V  YG       E+ +  E +  G++   L     K G +P     K++I  
Sbjct: 86  HECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAV 140
Query: 172 ASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
              LTYL     I+HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYM 197
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIEL 256
            PE  Q    + +SD++S G+ L+E+
Sbjct: 198 SPERLQGTHYSVQSDIWSMGLSLVEM 223

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 98/206 (47%), Gaps = 13/206 (6%)
Query: 54  GELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDIL 111
           GEL++  + F+   ELG G  G V+    +    V  ++L     K     Q + E+ +L
Sbjct: 63  GELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL 120
Query: 112 ARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
                  +V  YG       E+ +  E +  G++   L     K G +P     K++I  
Sbjct: 121 HECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAV 175
Query: 172 ASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
              LTYL     I+HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+
Sbjct: 176 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYM 232
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIEL 256
            PE  Q    + +SD++S G+ L+E+
Sbjct: 233 SPERLQGTHYSVQSDIWSMGLSLVEM 258

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 17/210 (8%)
Query: 60  TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRV---EQFMNEVDILARLR 115
           ++ +   R LG G FG V   + +  G+  AVK + +   K+    E  + EV +L +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           H N+  LY           LV E  + G + D +   +            +I  +  S +
Sbjct: 85  HPNIXKLYEFFEDKGY-FYLVGEVYTGGELFDEIISRKR----FSEVDAARIIRQVLSGI 139
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
           TY H + I+HRD+K  N+LL++   +  +++ DFGLS  F    +       GT  Y+ P
Sbjct: 140 TYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHF--EASKKXKDKIGTAYYIAP 197
Query: 233 E-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
           E  H  Y   +K DV+S GV+L  L+S  P
Sbjct: 198 EVLHGTYD--EKCDVWSTGVILYILLSGCP 225

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 105/243 (43%), Gaps = 35/243 (14%)
Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           F+    LG G FG V       D R  A+K++  +  +++   ++EV +LA L H+ +V 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVR 66
Query: 122 LYGC------------TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
            Y                +    L +  E+  N T+ D +H E        +    +  +
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG- 228
           E   AL+Y+H+  IIHRD+K  NI +D +  VK+ DFGL++     +  +    Q  PG 
Sbjct: 127 E---ALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 229 ------------YVDPE-YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDITRHRHE 271
                       YV  E         +K D++S G++  E+I    + M  V+I +    
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKKLRS 243
Query: 272 INL 274
           +++
Sbjct: 244 VSI 246

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 17/205 (8%)
Query: 63  FDSARELGDGGFGTVYY-GELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V     ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 44  FERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 103
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETASALT 176
           L  L   + + +  L +V E+   G +  HL   G   +P A  +  ++ +  E      
Sbjct: 104 LTKL-EFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFE------ 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           YLH+ D+I+RD+K  N+++D    +KV DFG    F   V   +    GTP Y+ PE   
Sbjct: 157 YLHSLDLIYRDLKPENLMIDQQGYIKVTDFG----FAKRVKGRTWXLCGTPEYLAPEIIL 212
Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                   D ++ GV++ E+ +  P
Sbjct: 213 SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 98/209 (46%), Gaps = 13/209 (6%)
Query: 51  FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEV 108
            + GEL++  + F+   ELG G  G V+    +    V  ++L     K     Q + E+
Sbjct: 1   MALGELKD--DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIREL 58
Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
            +L       +V  YG       E+ +  E +  G++   L     K G +P     K++
Sbjct: 59  QVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVS 113
Query: 169 IETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           I     LTYL     I+HRDVK +NIL+++   +K+ DFG+S      +  ++    GT 
Sbjct: 114 IAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDEMANEFVGTR 170
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
            Y+ PE  Q    + +SD++S G+ L+E+
Sbjct: 171 SYMSPERLQGTHYSVQSDIWSMGLSLVEM 199

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           +G G +G V+ G  Q G  VAVK      E ++ R  +  N V     LRH+N++     
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 70
Query: 126 --TSRHSR-ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--- 179
             TSRHS  +L L+  +   G++ D+L     +   L   + L+I +  AS L +LH   
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 180 -----ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH--VSTAPQ-GTPGYVD 231
                   I HRD+K+ NIL+  N    +AD GL+ +         V   P+ GT  Y+ 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 232 PEYH------QCYQLTDKSDVFSFGVVLIELISSM 260
           PE         C+    + D+++FG+VL E+   M
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           +G G +G V+ G  Q G  VAVK      E ++ R  +  N V     LRH+N++     
Sbjct: 16  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 70
Query: 126 --TSRHSR-ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--- 179
             TSRHS  +L L+  +   G++ D+L     +   L   + L+I +  AS L +LH   
Sbjct: 71  DMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 180 -----ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH--VSTAPQ-GTPGYVD 231
                   I HRD+K+ NIL+  N    +AD GL+ +         V   P+ GT  Y+ 
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 232 PEYH------QCYQLTDKSDVFSFGVVLIELISSM 260
           PE         C+    + D+++FG+VL E+   M
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 220

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 66  ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 120
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 177
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 178 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 232

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 6   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 66  ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 120
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 121 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 177
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 178 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 232

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/198 (32%), Positives = 100/198 (50%), Gaps = 15/198 (7%)
Query: 69  LGDGGFGTVYYGELQDGRAV-AVKRLYENNYKR---VEQFMNEVDILARL-RHKNLVSLY 123
           LG G FG V   E +    + AVK L ++   +   VE  M E  +LA   +   L  L+
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
            C     R L  V E+++ G +  H+     + G    P  +  A E A  L +L +  I
Sbjct: 409 SCFQTMDR-LYFVMEYVNGGDLMYHIQ----QVGRFKEPHAVFYAAEIAIGLFFLQSKGI 463
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP-QGTPGYVDPEYHQCYQLTD 242
           I+RD+K +N++LD+   +K+ADFG+ +   N    V+T    GTP Y+ PE    YQ   
Sbjct: 464 IYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXFCGTPDYIAPEI-IAYQPYG 520
Query: 243 KS-DVFSFGVVLIELISS 259
           KS D ++FGV+L E+++ 
Sbjct: 521 KSVDWWAFGVLLYEMLAG 538

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 102/209 (48%), Gaps = 12/209 (5%)
Query: 56  LEEATNYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILAR 113
           +E   +  +   ELG G +G V     +  G+ +AVKR+    N +  ++ + ++DI  R
Sbjct: 2   MEVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMR 61
Query: 114 -LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIET 171
            +     V+ YG   R   ++ +  E +   T  D  + +    G  +P     KIA+  
Sbjct: 62  TVDCPFTVTFYGALFREG-DVWICMELMD--TSLDKFYKQVIDKGQTIPEDILGKIAVSI 118
Query: 172 ASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH---VSTAPQGTP 227
             AL +LH+   +IHRDVK +N+L++    VK+ DFG+S    + V         P   P
Sbjct: 119 VKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAP 178
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
             ++PE +Q    + KSD++S G+ +IEL
Sbjct: 179 ERINPELNQ-KGYSVKSDIWSLGITMIEL 206

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDILAR 113
           +E   + F+   ELG G  G V+    +    V  ++L     K     Q + E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
                +V  YG       E+ +  E +  G++   L     K G +P     K++I    
Sbjct: 61  CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIK 115
Query: 174 ALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
            LTYL     I+HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 233 EYHQCYQLTDKSDVFSFGVVLIEL 256
           E  Q    + +SD++S G+ L+E+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDILAR 113
           +E   + F+   ELG G  G V+    +    V  ++L     K     Q + E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
                +V  YG       E+ +  E +  G++   L     K G +P     K++I    
Sbjct: 61  CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIK 115
Query: 174 ALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
            LTYL     I+HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 233 EYHQCYQLTDKSDVFSFGVVLIEL 256
           E  Q    + +SD++S G+ L+E+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDG-RAVAVKRLYENNYKRVEQF--MNEVDIL 111
           L  A   ++   E+G+G +G V+   +L++G R VA+KR+     +       + EV +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 112 ARLR---HKNLVSLYG-CT-SRHSRE--LLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
             L    H N+V L+  CT SR  RE  L LV+E +         + ++     +P  T 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETI 122
Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
             +  +    L +LH+  ++HRD+K  NIL+ ++  +K+ADFGL+R++   +   S    
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-- 180
Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
            T  Y  PE           D++S G +  E+    P
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 106/219 (48%), Gaps = 20/219 (9%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDG-RAVAVKRLYENNYKRVEQF--MNEVDIL 111
           L  A   ++   E+G+G +G V+   +L++G R VA+KR+     +       + EV +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 112 ARLR---HKNLVSLYG-CT-SRHSRE--LLLVYEFISNG--TVADHLHGERAKPGALPWP 162
             L    H N+V L+  CT SR  RE  L LV+E +     T  D +     +PG +P  
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKV----PEPG-VPTE 120
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA 222
           T   +  +    L +LH+  ++HRD+K  NIL+ ++  +K+ADFGL+R++   +   S  
Sbjct: 121 TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV 180
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
              T  Y  PE           D++S G +  E+    P
Sbjct: 181 --VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 95/204 (46%), Gaps = 11/204 (5%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDILAR 113
           +E   + F+   ELG G  G V+    +    V  ++L     K     Q + E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
                +V  YG       E+ +  E +  G++   L     K G +P     K++I    
Sbjct: 61  CNSPYIVGFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIK 115
Query: 174 ALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
            LTYL     I+HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSP 172
Query: 233 EYHQCYQLTDKSDVFSFGVVLIEL 256
           E  Q    + +SD++S G+ L+E+
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEM 196

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARLRHKNLV 120
           F+   ELG G  G V+    +    V  ++L     K     Q + E+ +L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             YG       E+ +  E +  G++   L     K G +P     K++I     LTYL  
Sbjct: 68  GFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 181 S-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              I+HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ PE  Q   
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTH 179
Query: 240 LTDKSDVFSFGVVLIEL 256
            + +SD++S G+ L+E+
Sbjct: 180 YSVQSDIWSMGLSLVEM 196

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 100/215 (46%), Gaps = 33/215 (15%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           +G G +G V+ G  Q G  VAVK      E ++ R  +  N V     LRH+N++     
Sbjct: 45  VGKGRYGEVWRGSWQ-GENVAVKIFSSRDEKSWFRETELYNTV----MLRHENILGFIAS 99
Query: 126 --TSRHSR-ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--- 179
             TSRHS  +L L+  +   G++ D+L     +   L   + L+I +  AS L +LH   
Sbjct: 100 DMTSRHSSTQLWLITHYHEMGSLYDYL-----QLTTLDTVSCLRIVLSIASGLAHLHIEI 154
Query: 180 -----ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH--VSTAPQ-GTPGYVD 231
                   I HRD+K+ NIL+  N    +AD GL+ +         V   P+ GT  Y+ 
Sbjct: 155 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 214
Query: 232 PEYH------QCYQLTDKSDVFSFGVVLIELISSM 260
           PE         C+    + D+++FG+VL E+   M
Sbjct: 215 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRM 249

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 101/203 (49%), Gaps = 16/203 (7%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN---EVDILARLRHKNLVSLYG 124
           LG+G FG V      +  + VA+K +     K+ +  M    E+  L  LRH +++ LY 
Sbjct: 17  LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD 76
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
             +  + ++++V E+ + G + D++     +   +      +   +   A+ Y H   I+
Sbjct: 77  VITTPT-DIVMVIEY-AGGELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCHRHKIV 130
Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY--HQCYQLTD 242
           HRD+K  N+LLD+N  VK+ADFGLS +  +   +      G+P Y  PE    + Y    
Sbjct: 131 HRDLKPENLLLDDNLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPEVINGKLYA-GP 187
Query: 243 KSDVFSFGVVL-IELISSMPAVD 264
           + DV+S G+VL + L+  +P  D
Sbjct: 188 EVDVWSCGIVLYVMLVGRLPFDD 210

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/197 (27%), Positives = 92/197 (46%), Gaps = 11/197 (5%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARLRHKNLV 120
           F+   ELG G  G V+    +    V  ++L     K     Q + E+ +L       +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67
Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             YG       E+ +  E +  G++   L     K G +P     K++I     LTYL  
Sbjct: 68  GFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE 122
Query: 181 S-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
              I+HRDVK +NIL+++   +K+ DFG+S      +  ++ +  GT  Y+ PE  Q   
Sbjct: 123 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTH 179
Query: 240 LTDKSDVFSFGVVLIEL 256
            + +SD++S G+ L+E+
Sbjct: 180 YSVQSDIWSMGLSLVEM 196

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 95/196 (48%), Gaps = 11/196 (5%)
Query: 69  LGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           LG G FG V+  E    G  +A K +     K  E+  NE+ ++ +L H NL+ LY    
Sbjct: 97  LGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE 156
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRD 187
             + +++LV E++  G + D +  E      L     +K   +    + ++H   I+H D
Sbjct: 157 SKN-DIVLVMEYVDGGELFDRIIDESYNLTELDTILFMK---QICEGIRHMHQMYILHLD 212
Query: 188 VKTNNILLDNNFC--VKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 244
           +K  NIL  N     +K+ DFGL+R + P     V+    GTP ++ PE      ++  +
Sbjct: 213 LKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPEFLAPEVVNYDFVSFPT 269
Query: 245 DVFSFGVVLIELISSM 260
           D++S GV+   L+S +
Sbjct: 270 DMWSVGVIAYMLLSGL 285

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 103/217 (47%), Gaps = 16/217 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDG-RAVAVKRLYENNYKRVEQF--MNEVDIL 111
           L  A   ++   E+G+G +G V+   +L++G R VA+KR+     +       + EV +L
Sbjct: 6   LCRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVL 65
Query: 112 ARLR---HKNLVSLYG-CT-SRHSRE--LLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
             L    H N+V L+  CT SR  RE  L LV+E +         + ++     +P  T 
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTT---YLDKVPEPGVPTETI 122
Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
             +  +    L +LH+  ++HRD+K  NIL+ ++  +K+ADFGL+R++   +   S    
Sbjct: 123 KDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV-- 180
Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
            T  Y  PE           D++S G +  E+    P
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 13  RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSAREL 69
           R +    + S    +  S+  S KV  +K G+     V + G+     +  +Y D+ + +
Sbjct: 4   RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVI 62
Query: 70  GDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----Y 123
           G+G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L H N+V L    Y
Sbjct: 63  GNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 124 GCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
               +     L LV +++         H  RAK   LP         +   +L Y+H+  
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 183 IIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL- 240
           I HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   Y++  +L 
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSRYYRAPELI 228
Query: 241 ------TDKSDVFSFGVVLIELISSMP 261
                 T   DV+S G VL EL+   P
Sbjct: 229 FGATDYTSSIDVWSAGCVLAELLLGQP 255

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 13  RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSAREL 69
           R +    + S    +  S+  S KV  +K G+     V + G+     +  +Y D+ + +
Sbjct: 6   RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVI 64
Query: 70  GDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----Y 123
           G+G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L H N+V L    Y
Sbjct: 65  GNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFY 119
Query: 124 GCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
               +     L LV +++         H  RAK   LP         +   +L Y+H+  
Sbjct: 120 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFG 178
Query: 183 IIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL- 240
           I HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   Y++  +L 
Sbjct: 179 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSRYYRAPELI 230
Query: 241 ------TDKSDVFSFGVVLIELISSMP 261
                 T   DV+S G VL EL+   P
Sbjct: 231 FGATDYTSSIDVWSAGCVLAELLLGQP 257

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/198 (28%), Positives = 96/198 (48%), Gaps = 28/198 (14%)
Query: 88  VAVKRLYENNYKRV-EQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTV 145
           V  +RL     + V E    E  IL ++  H ++++L   +   S  + LV++ +  G +
Sbjct: 129 VTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID-SYESSSFMFLVFDLMRKGEL 187
Query: 146 ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD 205
            D+L     +  AL       I      A+++LHA++I+HRD+K  NILLD+N  ++++D
Sbjct: 188 FDYL----TEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSD 243
Query: 206 FGLSRLFPNHVTHVSTAPQ-----GTPGYVDPEYHQCYQ------LTDKSDVFSFGVVLI 254
           FG S        H+    +     GTPGY+ PE  +C           + D+++ GV+L 
Sbjct: 244 FGFS-------CHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF 296
Query: 255 ELISSMPAVDITRHRHEI 272
            L++  P      HR +I
Sbjct: 297 TLLAGSPPF---WHRRQI 311

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKT-DVILILELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/238 (28%), Positives = 114/238 (47%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-----LQDGRAVAVKRLYENNYKRV--EQFMNEVD 109
           E   +Y+D+  ELG G F  V         LQ       KR  +++ + V  E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  ++H N+++L+      + +++L+ E ++ G + D L    A+  +L      +   
Sbjct: 67  ILKEIQHPNVITLHEVYENKT-DVILIGELVAGGELFDFL----AEKESLTEEEATEFLK 121
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRL--FPNHVTHVSTAP 223
           +  + + YLH+  I H D+K  NI LLD N     +K+ DFGL+    F N   ++    
Sbjct: 122 QILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIF--- 178
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 179 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVS--AVN 233

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 13  RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSAREL 69
           R +    + S    +  S+  S KV  +K G+     V + G+     +  +Y D+ + +
Sbjct: 8   RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVI 66
Query: 70  GDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----Y 123
           G+G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L H N+V L    Y
Sbjct: 67  GNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFY 121
Query: 124 GCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
               +     L LV +++         H  RAK   LP         +   +L Y+H+  
Sbjct: 122 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFG 180
Query: 183 IIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL- 240
           I HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   Y++  +L 
Sbjct: 181 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSRYYRAPELI 232
Query: 241 ------TDKSDVFSFGVVLIELISSMP 261
                 T   DV+S G VL EL+   P
Sbjct: 233 FGATDYTSSIDVWSAGCVLAELLLGQP 259

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 122/267 (45%), Gaps = 33/267 (12%)
Query: 13  RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSAREL 69
           R +    + S    +  S+  S KV  +K G+     V + G+     +  +Y D+ + +
Sbjct: 49  RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVI 107
Query: 70  GDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----Y 123
           G+G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L H N+V L    Y
Sbjct: 108 GNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFY 162
Query: 124 GCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
               +     L LV +++         H  RAK   LP         +   +L Y+H+  
Sbjct: 163 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFG 221
Query: 183 IIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL- 240
           I HRD+K  N+LLD +  V K+ DFG ++       +VS        Y+   Y++  +L 
Sbjct: 222 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------YICSRYYRAPELI 273
Query: 241 ------TDKSDVFSFGVVLIELISSMP 261
                 T   DV+S G VL EL+   P
Sbjct: 274 FGATDYTSSIDVWSAGCVLAELLLGQP 300

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 101/211 (47%), Gaps = 33/211 (15%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           +G G +G V+ G L  G +VAVK      E ++ R  +  N V     LRH N++     
Sbjct: 16  VGKGRYGEVWRG-LWHGESVAVKIFSSRDEQSWFRETEIYNTV----LLRHDNILGFIAS 70
Query: 126 --TSRHSR-ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-- 180
             TSR+S  +L L+  +  +G++ D L  +  +P        L++A+  A  L +LH   
Sbjct: 71  DMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPH-----LALRLAVSAACGLAHLHVEI 125
Query: 181 ------SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH--VSTAPQ-GTPGYVD 231
                   I HRD K+ N+L+ +N    +AD GL+ +      +  +   P+ GT  Y+ 
Sbjct: 126 FGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMA 185
Query: 232 PEY------HQCYQLTDKSDVFSFGVVLIEL 256
           PE         C++    +D+++FG+VL E+
Sbjct: 186 PEVLDEQIRTDCFESYKWTDIWAFGLVLWEI 216

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQDG----RAVAVKRLYENNYK---RVEQFMNEVDILARLR 115
           F+  + LG G FG V+  +   G    +  A+K L +   K   RV   M E DIL  + 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVN 84
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASA 174
           H  +V L+       + L L+ +F+  G +   L  E      +     +K  + E A A
Sbjct: 85  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALA 138
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDP 232
           L +LH+  II+RD+K  NILLD    +K+ DFGLS+     + H   A    GT  Y+ P
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAP 195
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISS 259
           E       T  +D +SFGV++ E+++ 
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 72/246 (29%), Positives = 115/246 (46%), Gaps = 33/246 (13%)
Query: 34  SSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSARELGDGGFGTVYYGELQD-GRAVA 89
           S KV  +K G+     V + G+     +  +Y D+ + +G+G FG VY  +L D G  VA
Sbjct: 19  SMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVA 77
Query: 90  VKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----YGCTSRHSRELL-LVYEFISNG 143
           +K++ ++     ++F N E+ I+ +L H N+V L    Y    +     L LV +++   
Sbjct: 78  IKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET 132
Query: 144 TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV-K 202
                 H  RAK   LP         +   +L Y+H+  I HRD+K  N+LLD +  V K
Sbjct: 133 VYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 191
Query: 203 VADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL-------TDKSDVFSFGVVLIE 255
           + DFG ++       +VS        Y+   Y++  +L       T   DV+S G VL E
Sbjct: 192 LCDFGSAKQLVRGEPNVS--------YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 243
Query: 256 LISSMP 261
           L+   P
Sbjct: 244 LLLGQP 249

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQDG----RAVAVKRLYENNYK---RVEQFMNEVDILARLR 115
           F+  + LG G FG V+  +   G    +  A+K L +   K   RV   M E DIL  + 
Sbjct: 27  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVN 85
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASA 174
           H  +V L+       + L L+ +F+  G +   L  E      +     +K  + E A A
Sbjct: 86  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALA 139
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDP 232
           L +LH+  II+RD+K  NILLD    +K+ DFGLS+     + H   A    GT  Y+ P
Sbjct: 140 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAP 196
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISS 259
           E       T  +D +SFGV++ E+++ 
Sbjct: 197 EVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 104/223 (46%), Gaps = 12/223 (5%)
Query: 59  ATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRH 116
           +++ F    +LG+G + TVY G     G  VA+K +  ++        + E+ ++  L+H
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA----IETA 172
           +N+V LY      ++ L LV+EF+ N       + +    G  P    L +      +  
Sbjct: 63  ENIVRLYDVIHTENK-LTLVFEFMDNDLKK---YMDSRTVGNTPRGLELNLVKYFQWQLL 118
Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
             L + H + I+HRD+K  N+L++    +K+ DFGL+R F   V   S+    T  Y  P
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSE-VVTLWYRAP 177
Query: 233 EYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           +     +    S D++S G +L E+I+  P    T    ++ L
Sbjct: 178 DVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKL 220

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/207 (31%), Positives = 99/207 (47%), Gaps = 20/207 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQDG----RAVAVKRLYENNYK---RVEQFMNEVDILARLR 115
           F+  + LG G FG V+  +   G    +  A+K L +   K   RV   M E DIL  + 
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKM-ERDILVEVN 84
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASA 174
           H  +V L+       + L L+ +F+  G +   L  E      +     +K  + E A A
Sbjct: 85  HPFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALA 138
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDP 232
           L +LH+  II+RD+K  NILLD    +K+ DFGLS+     + H   A    GT  Y+ P
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---ESIDHEKKAYSFCGTVEYMAP 195
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISS 259
           E       T  +D +SFGV++ E+++ 
Sbjct: 196 EVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 106/225 (47%), Gaps = 32/225 (14%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLR-HKN 118
           ++  ++LG G +G V+   + + G  VAVK++++   N    ++   E+ IL  L  H+N
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHEN 70
Query: 119 LVSLYGCT-SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           +V+L     + + R++ LV++++        LH    +   L    +  +  +    + Y
Sbjct: 71  IVNLLNVLRADNDRDVYLVFDYMETD-----LHAV-IRANILEPVHKQYVVYQLIKVIKY 124
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGT----------- 226
           LH+  ++HRD+K +NILL+    VKVADFGLSR F N     +  P              
Sbjct: 125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQ 184
Query: 227 ---PGYVDPEYHQCYQL-------TDKSDVFSFGVVLIELISSMP 261
                YV   +++  ++       T   D++S G +L E++   P
Sbjct: 185 PILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKP 229

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/246 (30%), Positives = 116/246 (47%), Gaps = 35/246 (14%)
Query: 35  SKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAV 90
           SKV  +K G+     V + G+     +  +Y D+ + +G+G FG VY  +L D G  VA+
Sbjct: 4   SKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAI 62
Query: 91  KRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----YGCTSRHSRELL-LVYEFISNGT 144
           K++ ++     ++F N E+ I+ +L H N+V L    Y    +     L LV +++    
Sbjct: 63  KKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETV 117
Query: 145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV-KV 203
                H  RAK   LP         +   +L Y+H+  I HRD+K  N+LLD +  V K+
Sbjct: 118 YRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKL 176
Query: 204 ADFG----LSRLFPNHVTHVST----APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIE 255
            DFG    L R  PN V+ + +    AP+   G  D         T   DV+S G VL E
Sbjct: 177 CDFGSAKQLVRGEPN-VSXICSRYYRAPELIFGATD--------YTSSIDVWSAGCVLAE 227
Query: 256 LISSMP 261
           L+   P
Sbjct: 228 LLLGQP 233

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67  RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           +ELG G FGTV  G  Q        AV + +   N+    ++ + E +++ +L +  +V 
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           + G     S   +LV E    G +  +L   R           +++  + +  + YL  S
Sbjct: 83  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 136
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
           + +HRD+   N+LL      K++DFGLS+       +      G     +  PE    Y+
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 196
Query: 240 LTDKSDVFSFGVVLIELIS 258
            + KSDV+SFGV++ E  S
Sbjct: 197 FSSKSDVWSFGVLMWEAFS 215

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67  RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           +ELG G FGTV  G  Q        AV + +   N+    ++ + E +++ +L +  +V 
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           + G     S   +LV E    G +  +L   R           +++  + +  + YL  S
Sbjct: 93  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 146
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
           + +HRD+   N+LL      K++DFGLS+       +      G     +  PE    Y+
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 240 LTDKSDVFSFGVVLIELIS 258
            + KSDV+SFGV++ E  S
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67  RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           +ELG G FGTV  G  Q        AV + +   N+    ++ + E +++ +L +  +V 
Sbjct: 33  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 92
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           + G     S   +LV E    G +  +L   R           +++  + +  + YL  S
Sbjct: 93  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 146
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
           + +HRD+   N+LL      K++DFGLS+       +      G     +  PE    Y+
Sbjct: 147 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 206
Query: 240 LTDKSDVFSFGVVLIELIS 258
            + KSDV+SFGV++ E  S
Sbjct: 207 FSSKSDVWSFGVLMWEAFS 225

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67  RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           +ELG G FGTV  G  Q        AV + +   N+    ++ + E +++ +L +  +V 
Sbjct: 31  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 90
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           + G     S   +LV E    G +  +L   R           +++  + +  + YL  S
Sbjct: 91  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 144
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
           + +HRD+   N+LL      K++DFGLS+       +      G     +  PE    Y+
Sbjct: 145 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 204
Query: 240 LTDKSDVFSFGVVLIELIS 258
            + KSDV+SFGV++ E  S
Sbjct: 205 FSSKSDVWSFGVLMWEAFS 223

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 79/268 (29%), Positives = 123/268 (45%), Gaps = 35/268 (13%)
Query: 13  RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSAREL 69
           R +    + S    +  S+  S KV  +K G+     V + G+     +  +Y D+ + +
Sbjct: 4   RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVI 62
Query: 70  GDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----Y 123
           G+G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L H N+V L    Y
Sbjct: 63  GNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFY 117
Query: 124 GCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
               +     L LV +++         H  RAK   LP         +   +L Y+H+  
Sbjct: 118 SSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFG 176
Query: 183 IIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST----APQGTPGYVDPE 233
           I HRD+K  N+LLD +  V K+ DFG    L R  PN V+ + +    AP+   G  D  
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYRAPELIFGATD-- 233
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISSMP 261
                  T   DV+S G VL EL+   P
Sbjct: 234 ------YTSSIDVWSAGCVLAELLLGQP 255

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67  RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           +ELG G FGTV  G  Q        AV + +   N+    ++ + E +++ +L +  +V 
Sbjct: 11  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 70
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           + G     S   +LV E    G +  +L   R           +++  + +  + YL  S
Sbjct: 71  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 124
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
           + +HRD+   N+LL      K++DFGLS+       +      G     +  PE    Y+
Sbjct: 125 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 184
Query: 240 LTDKSDVFSFGVVLIELIS 258
            + KSDV+SFGV++ E  S
Sbjct: 185 FSSKSDVWSFGVLMWEAFS 203

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67  RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           +ELG G FGTV  G  Q        AV + +   N+    ++ + E +++ +L +  +V 
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           + G     S   +LV E    G +  +L   R           +++  + +  + YL  S
Sbjct: 77  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 130
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
           + +HRD+   N+LL      K++DFGLS+       +      G     +  PE    Y+
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 190
Query: 240 LTDKSDVFSFGVVLIELIS 258
            + KSDV+SFGV++ E  S
Sbjct: 191 FSSKSDVWSFGVLMWEAFS 209

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 76/247 (30%), Positives = 116/247 (46%), Gaps = 35/247 (14%)
Query: 34  SSKVDLEKGGNYHGVQVFSYGE---LEEATNYFDSARELGDGGFGTVYYGELQD-GRAVA 89
           S KV  +K G+     V + G+     +  +Y D+ + +G+G FG VY  +L D G  VA
Sbjct: 3   SMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVA 61
Query: 90  VKRLYENNYKRVEQFMN-EVDILARLRHKNLVSL----YGCTSRHSRELL-LVYEFISNG 143
           +K++ ++     ++F N E+ I+ +L H N+V L    Y    +     L LV +++   
Sbjct: 62  IKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPET 116
Query: 144 TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV-K 202
                 H  RAK   LP         +   +L Y+H+  I HRD+K  N+LLD +  V K
Sbjct: 117 VYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLK 175
Query: 203 VADFG----LSRLFPNHVTHVST----APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLI 254
           + DFG    L R  PN V+ + +    AP+   G  D         T   DV+S G VL 
Sbjct: 176 LCDFGSAKQLVRGEPN-VSXICSRYYRAPELIFGATD--------YTSSIDVWSAGCVLA 226
Query: 255 ELISSMP 261
           EL+   P
Sbjct: 227 ELLLGQP 233

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67  RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           +ELG G FGTV  G  Q        AV + +   N+    ++ + E +++ +L +  +V 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           + G     S   +LV E    G +  +L   R           +++  + +  + YL  S
Sbjct: 73  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 126
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
           + +HRD+   N+LL      K++DFGLS+       +      G     +  PE    Y+
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186
Query: 240 LTDKSDVFSFGVVLIELIS 258
            + KSDV+SFGV++ E  S
Sbjct: 187 FSSKSDVWSFGVLMWEAFS 205

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           ++G+G +G VY  +   G   A+K  RL + +       + E+ IL  L+H N+V LY  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAK-----PGALPWPTRLKIAIETASALTYLHA 180
                R L+LV+E         HL  +  K      G L   T     ++  + + Y H 
Sbjct: 69  IHTKKR-LVLVFE---------HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YHQCYQ 239
             ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+      +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVVTLWYRAPDVLMGSKK 177
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
            +   D++S G +  E+++  P
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTP 199

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           ++G+G +G VY  +   G   A+K  RL + +       + E+ IL  L+H N+V LY  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAK-----PGALPWPTRLKIAIETASALTYLHA 180
                R L+LV+E         HL  +  K      G L   T     ++  + + Y H 
Sbjct: 69  IHTKKR-LVLVFE---------HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YHQCYQ 239
             ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+      +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEVVTLWYRAPDVLMGSKK 177
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
            +   D++S G +  E+++  P
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGAP 199

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L++  + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 77  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/202 (27%), Positives = 93/202 (46%), Gaps = 19/202 (9%)
Query: 68  ELGDGGFGTVYYGELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           ++G+G +G VY  +   G   A+K  RL + +       + E+ IL  L+H N+V LY  
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAK-----PGALPWPTRLKIAIETASALTYLHA 180
                R L+LV+E         HL  +  K      G L   T     ++  + + Y H 
Sbjct: 69  IHTKKR-LVLVFE---------HLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YHQCYQ 239
             ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  P+      +
Sbjct: 119 RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKY-THEIVTLWYRAPDVLMGSKK 177
Query: 240 LTDKSDVFSFGVVLIELISSMP 261
            +   D++S G +  E+++  P
Sbjct: 178 YSTTIDIWSVGCIFAEMVNGTP 199

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 91/199 (45%), Gaps = 13/199 (6%)
Query: 67  RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           +ELG G FGTV  G  Q        AV + +   N+    ++ + E +++ +L +  +V 
Sbjct: 17  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 76
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           + G     S   +LV E    G +  +L   R           +++  + +  + YL  S
Sbjct: 77  MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 130
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
           + +HRD+   N+LL      K++DFGLS+      +     T  +    +  PE    Y+
Sbjct: 131 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYYK 190
Query: 240 LTDKSDVFSFGVVLIELIS 258
            + KSDV+SFGV++ E  S
Sbjct: 191 FSSKSDVWSFGVLMWEAFS 209

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 27/213 (12%)
Query: 72  GGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR 131
           G FG V+  +L +   VAVK ++    K+  Q   E+     ++H+NL+       R S 
Sbjct: 26  GRFGCVWKAQLMND-FVAVK-IFPLQDKQSWQSEREIFSTPGMKHENLLQFIAAEKRGSN 83
Query: 132 ---ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--------- 179
              EL L+  F   G++ D+L G       + W     +A   +  L+YLH         
Sbjct: 84  LEVELWLITAFHDKGSLTDYLKG-----NIITWNELCHVAETMSRGLSYLHEDVPWCRGE 138
Query: 180 --ASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
                I HRD K+ N+LL ++    +ADFGL+ R  P      +    GT  Y+ PE  +
Sbjct: 139 GHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEVLE 198
Query: 237 C---YQLTD--KSDVFSFGVVLIELISSMPAVD 264
               +Q     + D+++ G+VL EL+S   A D
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V L       ++ L LV+EF+S   + D +         +P P       +    L + H
Sbjct: 68  VKLLDVIHTENK-LYLVFEFLSMD-LKDFMDASALT--GIPLPLIKSYLFQLLQGLAFCH 123
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE-YHQC 237
           +  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE    C
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEILLGC 181
Query: 238 YQLTDKSDVFSFGVVLIELIS 258
              +   D++S G +  E+++
Sbjct: 182 KYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 92/201 (45%), Gaps = 11/201 (5%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V L       ++ L LV+EF+S   + D +         +P P       +    L + H
Sbjct: 67  VKLLDVIHTENK-LYLVFEFLSMD-LKDFMDASALT--GIPLPLIKSYLFQLLQGLAFCH 122
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE-YHQC 237
           +  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE    C
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEILLGC 180
Query: 238 YQLTDKSDVFSFGVVLIELIS 258
              +   D++S G +  E+++
Sbjct: 181 KYYSTAVDIWSLGCIFAEMVT 201

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L++  + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 78  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 132
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 133 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 193 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 17/204 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 65  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
           ++ H+  ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PE  
Sbjct: 117 SFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
             C   +   D++S G +  E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 33/223 (14%)
Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           F+    LG G FG V       D R  A+K++  +  +++   ++EV +LA L H+ +V 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVR 66
Query: 122 LYGC------------TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
            Y                +    L +  E+  N T+ D +H E        +    +  +
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL--------------SRLFPNH 215
           E   AL+Y+H+  IIHR++K  NI +D +  VK+ DFGL              S+  P  
Sbjct: 127 E---ALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 216 VTHVSTAPQGTPGYVDPE-YHQCYQLTDKSDVFSFGVVLIELI 257
             ++++A  GT  YV  E         +K D +S G++  E I
Sbjct: 184 SDNLTSAI-GTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEXI 225

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L++  + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 80  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 134
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 195 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 18  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L++  + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 78  PHVCRLLGICLTSTVQLIM--QLMPFGXLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 132
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 133 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 192
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 193 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 230

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 21/223 (9%)
Query: 47  GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---- 101
           G++ F   ++E   +++D   ELG G F  V    E   G   A K + +   +      
Sbjct: 1   GMETFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 102 --EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL 159
             E+   EV IL ++ H N+++L+      + +++L+ E +S G + D L    A+  +L
Sbjct: 58  CREEIEREVSILRQVLHPNIITLHDVYENRT-DVVLILELVSGGELFDFL----AQKESL 112
Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFPNH 215
                     +    + YLH   I H D+K  NI LLD N     +K+ DFGL+    + 
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
           V   +    GTP +V PE      L  ++D++S GV+   L+S
Sbjct: 173 VEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 58  EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
           +  +Y D+ + +G+G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L 
Sbjct: 31  QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 84
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           H N+V L    Y    +     L LV +++         H  RAK   LP         +
Sbjct: 85  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 143
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGY 229
              +L Y+H+  I HRD+K  N+LLD +  V K+ DFG ++       +VS        Y
Sbjct: 144 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 195
Query: 230 VDPEYHQCYQL-------TDKSDVFSFGVVLIELISSMP 261
           +   Y++  +L       T   DV+S G VL EL+   P
Sbjct: 196 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 234

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L++  + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 79  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 104/220 (47%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L++  + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 81  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 135
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 136 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 196 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 30/219 (13%)
Query: 58  EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
           +  +Y D+ + +G+G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L 
Sbjct: 23  QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 76
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           H N+V L    Y    +     L LV +++         H  RAK   LP         +
Sbjct: 77  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 135
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGY 229
              +L Y+H+  I HRD+K  N+LLD +  V K+ DFG ++       +VS        Y
Sbjct: 136 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 187
Query: 230 VDPEYHQCYQL-------TDKSDVFSFGVVLIELISSMP 261
           +   Y++  +L       T   DV+S G VL EL+   P
Sbjct: 188 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 226

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 94/213 (44%), Gaps = 18/213 (8%)
Query: 54  GELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDI 110
           G L +  N F    ++G+G +G VY    +  G  VA+K  RL           + E+ +
Sbjct: 1   GPLVDMEN-FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISL 59
Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLK 166
           L  L H N+V L       ++ L LV+EF+         A  L G       +P P    
Sbjct: 60  LKELNHPNIVKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKS 111
Query: 167 IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGT 226
              +    L + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T
Sbjct: 112 YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVT 170
Query: 227 PGYVDPE-YHQCYQLTDKSDVFSFGVVLIELIS 258
             Y  PE    C   +   D++S G +  E+++
Sbjct: 171 LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 58  EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
           +  +Y D+ + +G+G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L 
Sbjct: 18  QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 71
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           H N+V L    Y    +     L LV +++         H  RAK   LP         +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
              +L Y+H+  I HRD+K  N+LLD +  V K+ DFG    L R  PN V+++ +    
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYR 189
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           AP+   G  D         T   DV+S G VL EL+   P
Sbjct: 190 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 221

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67  RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           +ELG G FGTV  G  Q        AV + +   N+    ++ + E +++ +L +  +V 
Sbjct: 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 434
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           + G     S   +LV E    G +  +L   R           +++  + +  + YL  S
Sbjct: 435 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 488
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
           + +HRD+   N+LL      K++DFGLS+       +      G     +  PE    Y+
Sbjct: 489 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 548
Query: 240 LTDKSDVFSFGVVLIELIS 258
            + KSDV+SFGV++ E  S
Sbjct: 549 FSSKSDVWSFGVLMWEAFS 567

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 35/245 (14%)
Query: 36  KVDLEKGGNYHGVQVFSYGE---LEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVK 91
           KV  +K G+     V + G+     +  +Y D+ + +G+G FG VY  +L D G  VA+K
Sbjct: 1   KVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIK 59
Query: 92  RLYENNYKRVEQFMN-EVDILARLRHKNLVSL----YGCTSRHSRELL-LVYEFISNGTV 145
           ++ ++     ++F N E+ I+ +L H N+V L    Y    +     L LV +++     
Sbjct: 60  KVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 114
Query: 146 ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV-KVA 204
               H  RAK   LP         +   +L Y+H+  I HRD+K  N+LLD +  V K+ 
Sbjct: 115 RVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 173
Query: 205 DFG----LSRLFPNHVTHVST----APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
           DFG    L R  PN V+ + +    AP+   G  D         T   DV+S G VL EL
Sbjct: 174 DFGSAKQLVRGEPN-VSXICSRYYRAPELIFGATD--------YTSSIDVWSAGCVLAEL 224
Query: 257 ISSMP 261
           +   P
Sbjct: 225 LLGQP 229

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 115/245 (46%), Gaps = 35/245 (14%)
Query: 36  KVDLEKGGNYHGVQVFSYGE---LEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVK 91
           KV  +K G+     V + G+     +  +Y D+ + +G+G FG VY  +L D G  VA+K
Sbjct: 12  KVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIK 70
Query: 92  RLYENNYKRVEQFMN-EVDILARLRHKNLVSL----YGCTSRHSRELL-LVYEFISNGTV 145
           ++ ++     ++F N E+ I+ +L H N+V L    Y    +     L LV +++     
Sbjct: 71  KVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY 125
Query: 146 ADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV-KVA 204
               H  RAK   LP         +   +L Y+H+  I HRD+K  N+LLD +  V K+ 
Sbjct: 126 RVARHYSRAK-QTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLC 184
Query: 205 DFG----LSRLFPNHVTHVST----APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
           DFG    L R  PN V+ + +    AP+   G  D         T   DV+S G VL EL
Sbjct: 185 DFGSAKQLVRGEPN-VSXICSRYYRAPELIFGATD--------YTSSIDVWSAGCVLAEL 235
Query: 257 ISSMP 261
           +   P
Sbjct: 236 LLGQP 240

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 61  NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
           N F+  + LG G FG V    E   GR  A+K L +        V   + E  +L   RH
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 210
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
             L +L      H R L  V E+ + G +  HL  ER          R +    E  SAL
Sbjct: 211 PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 264
Query: 176 TYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
            YLH+  ++++RD+K  N++LD +  +K+ DFGL +        + T   GTP Y+ PE 
Sbjct: 265 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 323
Query: 235 HQCYQLTDKSDVFSFGVVLIELI 257
            +        D +  GVV+ E++
Sbjct: 324 LEDNDYGRAVDWWGLGVVMYEMM 346

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V+ G+ + G  VAVK ++ +  +R      E+     LRH+N++      ++
Sbjct: 11  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 68
Query: 129 HS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---- 181
            +    +L LV ++  +G++ D+L+        +     +K+A+ TAS L +LH      
Sbjct: 69  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 123
Query: 182 ----DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEY 234
                I HRD+K+ NIL+  N    +AD GL+    +    +  AP    GT  Y+ PE 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183
Query: 235 ------HQCYQLTDKSDVFSFGVVLIEL 256
                  + ++   ++D+++ G+V  E+
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 66  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 117
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PE  
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 176
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
             C   +   D++S G +  E+++
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 90/199 (45%), Gaps = 13/199 (6%)
Query: 67  RELGDGGFGTVYYGELQ-----DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           +ELG G FGTV  G  Q        AV + +   N+    ++ + E +++ +L +  +V 
Sbjct: 376 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 435
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           + G     S   +LV E    G +  +L   R           +++  + +  + YL  S
Sbjct: 436 MIGICEAES--WMLVMEMAELGPLNKYLQQNRHVKDK----NIIELVHQVSMGMKYLEES 489
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP--GYVDPEYHQCYQ 239
           + +HRD+   N+LL      K++DFGLS+       +      G     +  PE    Y+
Sbjct: 490 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 549
Query: 240 LTDKSDVFSFGVVLIELIS 258
            + KSDV+SFGV++ E  S
Sbjct: 550 FSSKSDVWSFGVLMWEAFS 568

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 65  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PE  
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
             C   +   D++S G +  E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 64  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 115
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PE  
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 174
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
             C   +   D++S G +  E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 64  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 115
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PE  
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 174
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
             C   +   D++S G +  E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V+ G+ + G  VAVK ++ +  +R      E+     LRH+N++      ++
Sbjct: 17  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 74
Query: 129 HS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---- 181
            +    +L LV ++  +G++ D+L+        +     +K+A+ TAS L +LH      
Sbjct: 75  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 129
Query: 182 ----DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEY 234
                I HRD+K+ NIL+  N    +AD GL+    +    +  AP    GT  Y+ PE 
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 189
Query: 235 ------HQCYQLTDKSDVFSFGVVLIEL 256
                  + ++   ++D+++ G+V  E+
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 62/203 (30%), Positives = 92/203 (45%), Gaps = 13/203 (6%)
Query: 61  NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
           N F+  + LG G FG V    E   GR  A+K L +        V   + E  +L   RH
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
             L +L      H R L  V E+ + G +  HL  ER          R +    E  SAL
Sbjct: 208 PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 261
Query: 176 TYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
            YLH+  ++++RD+K  N++LD +  +K+ DFGL +        + T   GTP Y+ PE 
Sbjct: 262 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFC-GTPEYLAPEV 320
Query: 235 HQCYQLTDKSDVFSFGVVLIELI 257
            +        D +  GVV+ E++
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMM 343

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V+ G+ + G  VAVK ++ +  +R      E+     LRH+N++      ++
Sbjct: 37  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 94
Query: 129 HS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---- 181
            +    +L LV ++  +G++ D+L+        +     +K+A+ TAS L +LH      
Sbjct: 95  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 149
Query: 182 ----DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEY 234
                I HRD+K+ NIL+  N    +AD GL+    +    +  AP    GT  Y+ PE 
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 209
Query: 235 ------HQCYQLTDKSDVFSFGVVLIEL 256
                  + ++   ++D+++ G+V  E+
Sbjct: 210 LDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 65  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PE  
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
             C   +   D++S G +  E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V+ G+ + G  VAVK ++ +  +R      E+     LRH+N++      ++
Sbjct: 14  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 71
Query: 129 HS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---- 181
            +    +L LV ++  +G++ D+L+        +     +K+A+ TAS L +LH      
Sbjct: 72  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 126
Query: 182 ----DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEY 234
                I HRD+K+ NIL+  N    +AD GL+    +    +  AP    GT  Y+ PE 
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 186
Query: 235 ------HQCYQLTDKSDVFSFGVVLIEL 256
                  + ++   ++D+++ G+V  E+
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V+ G+ + G  VAVK ++ +  +R      E+     LRH+N++      ++
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 107
Query: 129 HS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---- 181
            +    +L LV ++  +G++ D+L+        +     +K+A+ TAS L +LH      
Sbjct: 108 DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 162
Query: 182 ----DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEY 234
                I HRD+K+ NIL+  N    +AD GL+    +    +  AP    GT  Y+ PE 
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 222
Query: 235 ------HQCYQLTDKSDVFSFGVVLIEL 256
                  + ++   ++D+++ G+V  E+
Sbjct: 223 LDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 27/208 (12%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR 128
           +G G FG V+ G+ + G  VAVK ++ +  +R      E+     LRH+N++      ++
Sbjct: 12  IGKGRFGEVWRGKWR-GEEVAVK-IFSSREERSWFREAEIYQTVMLRHENILGFIAADNK 69
Query: 129 HS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---- 181
            +    +L LV ++  +G++ D+L+        +     +K+A+ TAS L +LH      
Sbjct: 70  DNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGM-----IKLALSTASGLAHLHMEIVGT 124
Query: 182 ----DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDPEY 234
                I HRD+K+ NIL+  N    +AD GL+    +    +  AP    GT  Y+ PE 
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 184
Query: 235 ------HQCYQLTDKSDVFSFGVVLIEL 256
                  + ++   ++D+++ G+V  E+
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 25/206 (12%)
Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-----EVDILARLRHKNLVSL 122
           LG+G F TVY    ++  + VA+K++   +    +  +N     E+ +L  L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77
Query: 123 YGCTSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKI-AIETASALTYL 178
                 H   + LV++F+       + D+          +  P+ +K   + T   L YL
Sbjct: 78  LDAFG-HKSNISLVFDFMETDLEVIIKDN--------SLVLTPSHIKAYMLMTLQGLEYL 128
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHVTHVSTAPQGTPGYVDPEYHQ 236
           H   I+HRD+K NN+LLD N  +K+ADFGL++ F  PN           T  Y  PE   
Sbjct: 129 HQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVV---TRWYRAPELLF 185
Query: 237 CYQLTDKS-DVFSFGVVLIELISSMP 261
             ++     D+++ G +L EL+  +P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVP 211

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/197 (29%), Positives = 94/197 (47%), Gaps = 11/197 (5%)
Query: 68  ELGDGGFGTV-YYGELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRH-KNLVSLYG 124
           E+G G +G+V        G+ +AVKR+    + K  +Q + ++D++ R      +V  YG
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DI 183
              R   +  +  E +S      + +        +P     KI + T  AL +L  +  I
Sbjct: 89  ALFREG-DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA---PQGTPGYVDPEY-HQCYQ 239
           IHRD+K +NILLD +  +K+ DFG+S    + +     A   P   P  +DP    Q Y 
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYD 207
Query: 240 LTDKSDVFSFGVVLIEL 256
           +  +SDV+S G+ L EL
Sbjct: 208 V--RSDVWSLGITLYEL 222

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 107/261 (40%), Gaps = 51/261 (19%)
Query: 51  FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAV-AVKRLYEN-----NYKRVEQF 104
           F  G L E    +     +G G +G V        RA+ A+K + +N     N K VE+ 
Sbjct: 16  FQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERI 75
Query: 105 MNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLH-------GERA--- 154
             EV ++ +L H N+  LY       + + LV E    G + D L+       G+ A   
Sbjct: 76  KTEVRLMKKLHHPNIARLYE-VYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDV 134
Query: 155 -KPGALPWPTRLKIAI-------------------------ETASALTYLHASDIIHRDV 188
            K    P P   + AI                         +  SAL YLH   I HRD+
Sbjct: 135 VKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDI 194
Query: 189 KTNNILLDNN--FCVKVADFGLSRLF---PNHVTHVSTAPQGTPGYVDPEYHQCYQLT-- 241
           K  N L   N  F +K+ DFGLS+ F    N   +  T   GTP +V PE       +  
Sbjct: 195 KPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYG 254
Query: 242 DKSDVFSFGVVL-IELISSMP 261
            K D +S GV+L + L+ ++P
Sbjct: 255 PKCDAWSAGVLLHLLLMGAVP 275

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 72  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 123
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PE  
Sbjct: 124 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 182
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
             C   +   D++S G +  E+++
Sbjct: 183 LGCKYYSTAVDIWSLGCIFAEMVT 206

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKN 118
           +   + LG+G FG V        G+ VA+K + +    + +   +   E+  L  LRH +
Sbjct: 16  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 75
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTV-----ADHLHGERAKPGALPWPTRLKIAIETAS 173
           ++ LY    +   E+++V E+  N         D +  + A+          +   +  S
Sbjct: 76  IIKLYDVI-KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQIIS 124
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
           A+ Y H   I+HRD+K  N+LLD +  VK+ADFGLS +  +   +      G+P Y  PE
Sbjct: 125 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE 182
Query: 234 Y--HQCYQLTDKSDVFSFGVVL-IELISSMPAVD 264
               + Y    + DV+S GV+L + L   +P  D
Sbjct: 183 VISGKLYA-GPEVDVWSCGVILYVMLCRRLPFDD 215

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKN 118
           +   + LG+G FG V        G+ VA+K + +    + +   +   E+  L  LRH +
Sbjct: 6   YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 65
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTV-----ADHLHGERAKPGALPWPTRLKIAIETAS 173
           ++ LY    +   E+++V E+  N         D +  + A+          +   +  S
Sbjct: 66  IIKLYDVI-KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQIIS 114
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
           A+ Y H   I+HRD+K  N+LLD +  VK+ADFGLS +  +   +      G+P Y  PE
Sbjct: 115 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE 172
Query: 234 Y--HQCYQLTDKSDVFSFGVVL-IELISSMPAVD 264
               + Y    + DV+S GV+L + L   +P  D
Sbjct: 173 VISGKLYA-GPEVDVWSCGVILYVMLCRRLPFDD 205

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKN 118
           +   + LG+G FG V        G+ VA+K + +    + +   +   E+  L  LRH +
Sbjct: 15  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 74
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTV-----ADHLHGERAKPGALPWPTRLKIAIETAS 173
           ++ LY    +   E+++V E+  N         D +  + A+          +   +  S
Sbjct: 75  IIKLYDVI-KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQIIS 123
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
           A+ Y H   I+HRD+K  N+LLD +  VK+ADFGLS +  +   +      G+P Y  PE
Sbjct: 124 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE 181
Query: 234 Y--HQCYQLTDKSDVFSFGVVL-IELISSMPAVD 264
               + Y    + DV+S GV+L + L   +P  D
Sbjct: 182 VISGKLYA-GPEVDVWSCGVILYVMLCRRLPFDD 214

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 61  NYFDSARELGDGGFGTVYY----GELQDGRAVAVKRLYENNYK---RVEQFMNEVDILAR 113
           ++F+  + LG G FG V+          G   A+K L +   K   RV   M E DILA 
Sbjct: 28  SHFELLKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKM-ERDILAD 86
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETA 172
           + H  +V L+       + L L+ +F+  G +   L  E      +     +K  + E A
Sbjct: 87  VNHPFVVKLHYAFQTEGK-LYLILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELA 140
Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
             L +LH+  II+RD+K  NILLD    +K+ DFGLS+   +H     +   GT  Y+ P
Sbjct: 141 LGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSF-CGTVEYMAP 199
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS-SMP 261
           E       +  +D +S+GV++ E+++ S+P
Sbjct: 200 EVVNRQGHSHSADWWSYGVLMFEMLTGSLP 229

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 32/220 (14%)
Query: 58  EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
           +  +Y D+ + +G+G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L 
Sbjct: 18  QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 71
Query: 116 HKNLVSL--YGCTSRHSRELL---LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           H N+V L  +  +S   ++++   LV +++         H  RAK   LP         +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
              +L Y+H+  I HRD+K  N+LLD +  V K+ DFG    L R  PN V+ + +    
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYR 189
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           AP+   G  D         T   DV+S G VL EL+   P
Sbjct: 190 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 221

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 22/244 (9%)
Query: 47  GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---- 101
           G++ F   ++E   +++D   ELG G F  V    E   G   A K + +   +      
Sbjct: 1   GMEPFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 102 --EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL 159
             E+   EV IL ++ H N+++L+      + +++L+ E +S G + D L    A+  +L
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFL----AQKESL 112
Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFPNH 215
                     +    + YLH   I H D+K  NI LLD N     +K+ DFGL+    + 
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINL 274
           V   +    GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+
Sbjct: 173 VEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 275 SNLA 278
           ++++
Sbjct: 231 TSVS 234

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 26/214 (12%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE---QFMNEVDILARLRHKN 118
           +   + LG+G FG V        G+ VA+K + +    + +   +   E+  L  LRH +
Sbjct: 10  YQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPH 69
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTV-----ADHLHGERAKPGALPWPTRLKIAIETAS 173
           ++ LY    +   E+++V E+  N         D +  + A+          +   +  S
Sbjct: 70  IIKLYDVI-KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEAR----------RFFQQIIS 118
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
           A+ Y H   I+HRD+K  N+LLD +  VK+ADFGLS +  +   +      G+P Y  PE
Sbjct: 119 AVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD--GNFLKTSCGSPNYAAPE 176
Query: 234 Y--HQCYQLTDKSDVFSFGVVL-IELISSMPAVD 264
               + Y    + DV+S GV+L + L   +P  D
Sbjct: 177 VISGKLYA-GPEVDVWSCGVILYVMLCRRLPFDD 209

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 94/205 (45%), Gaps = 16/205 (7%)
Query: 61  NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQ-----FMNEVDILARLR 115
           ++F+  R +G G FG V   +  D + +   + Y N  K VE+        E+ I+  L 
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMK-YMNKQKCVERNEVRNVFKELQIMQGLE 73
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           H  LV+L+  + +   ++ +V + +  G +  HL     +       T      E   AL
Sbjct: 74  HPFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFICELVMAL 128
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            YL    IIHRD+K +NILLD +  V + DF ++ + P   T ++T   GT  Y+ PE  
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-TQITTM-AGTKPYMAPEMF 186
Query: 236 QCYQLTDKS---DVFSFGVVLIELI 257
              +    S   D +S GV   EL+
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELL 211

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 100/206 (48%), Gaps = 17/206 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNLV 120
           +    ++G+G +G VY  +   GR VA+KR  L   +       + E+ +L  L H N+V
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 121 SLYGCTSRHS-RELLLVYEFISN--GTVADHLHGERAKPGALPWPTRLKIAI-ETASALT 176
           SL      HS R L LV+EF+      V D       K G     +++KI + +    + 
Sbjct: 83  SLIDVI--HSERCLTLVFEFMEKDLKKVLDE-----NKTGLQD--SQIKIYLYQLLRGVA 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YH 235
           + H   I+HRD+K  N+L++++  +K+ADFGL+R F   V    T    T  Y  P+   
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSY-THEVVTLWYRAPDVLM 192
Query: 236 QCYQLTDKSDVFSFGVVLIELISSMP 261
              + +   D++S G +  E+I+  P
Sbjct: 193 GSKKYSTSVDIWSIGCIFAEMITGKP 218

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 27  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 87  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 141
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 142 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 201
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 202 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 239

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 116/238 (48%), Gaps = 25/238 (10%)
Query: 57  EEATNYFDSARELGDGGFGTV----YYGELQDGRAVAVKRLYENNYKR---VEQFMNEVD 109
           E+  ++++   ELG G F  V      G  ++  A  +K+   ++ +R    E+   EV+
Sbjct: 8   EDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 67
Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           IL  +RH N+++L+      + +++L+ E +S G + D L    A+  +L      +   
Sbjct: 68  ILREIRHPNIITLHDIFENKT-DVVLILELVSGGELFDFL----AEKESLTEDEATQFLK 122
Query: 170 ETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFP--NHVTHVSTAP 223
           +    + YLH+  I H D+K  NI LLD N     +K+ DFG++      N   ++    
Sbjct: 123 QILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF--- 179
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 180 -GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS--AVN 234

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 61  NYFDSARELGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           +++D   ELG G FG V+   E   G   A K +   +    E    E+  ++ LRH  L
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 110
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V+L+        E++++YEF+S G + + +  E  K   +     ++   +    L ++H
Sbjct: 111 VNLHDAFE-DDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMH 166
Query: 180 ASDIIHRDVKTNNILLDNNFC--VKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
            ++ +H D+K  NI+        +K+ DFGL+  L P     V+T   GT  +  PE  +
Sbjct: 167 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 223
Query: 237 CYQLTDKSDVFSFGVVLIELISSM 260
              +   +D++S GV+   L+S +
Sbjct: 224 GKPVGYYTDMWSVGVLSYILLSGL 247

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 77  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY----YGELQDGRA--VAVKRLYENNY-KRVEQFMNE 107
           + E   N     + LG G FG V     YG ++   A  VAVK L  + +    E  M+E
Sbjct: 33  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 92
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGER-------AKPGA 158
           + +L+ L  H N+V+L G CT       L++ E+   G + + L  +R         P  
Sbjct: 93  LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 150
Query: 159 LPWPTRL-------KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
           +               + + A  + +L + + IHRD+   NILL +    K+ DFGL+R 
Sbjct: 151 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 210
Query: 212 FPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
             N   +V       P  ++ PE       T +SDV+S+G+ L EL S
Sbjct: 211 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY----YGELQDGRA--VAVKRLYENNY-KRVEQFMNE 107
           + E   N     + LG G FG V     YG ++   A  VAVK L  + +    E  M+E
Sbjct: 40  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 99
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGER-------AKPGA 158
           + +L+ L  H N+V+L G CT       L++ E+   G + + L  +R         P  
Sbjct: 100 LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 157
Query: 159 LPWPTRL-------KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
           +               + + A  + +L + + IHRD+   NILL +    K+ DFGL+R 
Sbjct: 158 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARH 217
Query: 212 FPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
             N   +V       P  ++ PE       T +SDV+S+G+ L EL S
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 71  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 125
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 186 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 223

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 79  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 80  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 134
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 195 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 22/244 (9%)
Query: 47  GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---- 101
           G++ F   ++E   +++D   ELG G F  V    E   G   A K + +   +      
Sbjct: 1   GMEPFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 102 --EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL 159
             E+   EV IL ++ H N+++L+      + +++L+ E +S G + D L    A+  +L
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFL----AQKESL 112
Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFPNH 215
                     +    + YLH   I H D+K  NI LLD N     +K+ DFGL+    + 
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINL 274
           V   +    GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+
Sbjct: 173 VEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 275 SNLA 278
           ++++
Sbjct: 231 TSVS 234

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 91/201 (45%), Gaps = 11/201 (5%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V L       ++ L LV+EF+    + D +         +P P       +    L + H
Sbjct: 65  VKLLDVIHTENK-LYLVFEFLHQD-LKDFMDASALT--GIPLPLIKSYLFQLLQGLAFCH 120
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE-YHQC 237
           +  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE    C
Sbjct: 121 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEILLGC 178
Query: 238 YQLTDKSDVFSFGVVLIELIS 258
              +   D++S G +  E+++
Sbjct: 179 KYYSTAVDIWSLGCIFAEMVT 199

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 76/289 (26%), Positives = 124/289 (42%), Gaps = 62/289 (21%)
Query: 68  ELGDGGFGTVYYG------------ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR 115
           E+G G F TVY G            ELQD +    +R         ++F  E + L  L+
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER---------QRFKEEAEXLKGLQ 83
Query: 116 HKNLVSLYG---CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP----WPTRLKIA 168
           H N+V  Y     T +  + ++LV E  ++GT+  +L  +R K   +     W  ++   
Sbjct: 84  HPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYL--KRFKVXKIKVLRSWCRQI--- 138
Query: 169 IETASALTYLH--ASDIIHRDVKTNNILLDN-NFCVKVADFGLSRLFPNHVTHVSTAPQG 225
                 L +LH     IIHRD+K +NI +      VK+ D GL+ L        + A  G
Sbjct: 139 ---LKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIG 192
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK 285
           TP +  PE ++  +  +  DV++FG   +E  +                S    ++ QN 
Sbjct: 193 TPEFXAPEXYE-EKYDESVDVYAFGXCXLEXAT----------------SEYPYSECQNA 235
Query: 286 A-LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD 333
           A ++  V   +   S +KV   I  V E+   C++  KD R  + D+L+
Sbjct: 236 AQIYRRVTSGVKPASFDKV--AIPEVKEIIEGCIRQNKDERYSIKDLLN 282

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 61  NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
           N F+  + LG G FG V    E   GR  A+K L +        V   + E  +L   RH
Sbjct: 9   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 68
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
             L +L      H R L  V E+ + G +  HL  ER          R +    E  SAL
Sbjct: 69  PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 122
Query: 176 TYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDP 232
            YLH+  ++++RD+K  N++LD +  +K+ DFGL +     +   +T     GTP Y+ P
Sbjct: 123 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 179
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISS 259
           E  +        D +  GVV+ E++  
Sbjct: 180 EVLEDNDYGRAVDWWGLGVVMYEMMCG 206

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 84  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 138
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 199 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 58  EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
           +  +Y D+ + +G+G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L 
Sbjct: 18  QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 71
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           H N+V L    Y    +     L LV +++         H  RAK   LP         +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
              +L Y+H+  I HRD+K  N+LLD +  V K+ DFG    L R  PN V+ + +    
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYR 189
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           AP+   G  D         T   DV+S G VL EL+   P
Sbjct: 190 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 221

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY----YGELQDGRA--VAVKRLYENNY-KRVEQFMNE 107
           + E   N     + LG G FG V     YG ++   A  VAVK L  + +    E  M+E
Sbjct: 17  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 76
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGER-------AKPGA 158
           + +L+ L  H N+V+L G CT       L++ E+   G + + L  +R         P  
Sbjct: 77  LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 134
Query: 159 LPWPTRL-------KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
           +               + + A  + +L + + IHRD+   NILL +    K+ DFGL+R 
Sbjct: 135 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 194
Query: 212 FPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
             N   +V       P  ++ PE       T +SDV+S+G+ L EL S
Sbjct: 195 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 54/204 (26%), Positives = 97/204 (47%), Gaps = 11/204 (5%)
Query: 61  NYFDSARELGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           +++D   ELG G FG V+   E   G   A K +   +    E    E+  ++ LRH  L
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 216
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V+L+        E++++YEF+S G + + +  E  K   +     ++   +    L ++H
Sbjct: 217 VNLHDAFE-DDNEMVMIYEFMSGGELFEKVADEHNK---MSEDEAVEYMRQVCKGLCHMH 272
Query: 180 ASDIIHRDVKTNNILLDNNFC--VKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
            ++ +H D+K  NI+        +K+ DFGL+  L P     V+T   GT  +  PE  +
Sbjct: 273 ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAE 329
Query: 237 CYQLTDKSDVFSFGVVLIELISSM 260
              +   +D++S GV+   L+S +
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGL 353

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 77  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+S        A  L G       +P P       +    L
Sbjct: 68  VKLLDVIHTENK-LYLVFEFLSMDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 119
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 120 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 177
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 80  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 134
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 195 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 60  TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQ---FMNEVDILARLR 115
           ++ +   ++LG G +G V   + +  G   A+K + +++          ++EV +L +L 
Sbjct: 3   SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 62
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           H N++ LY       R   LV E    G + D +   R K   +     +K   +  S  
Sbjct: 63  HPNIMKLYEFFE-DKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMK---QVLSGT 117
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
           TYLH  +I+HRD+K  N+LL++   +  +K+ DFGLS  F   V        GT  Y+ P
Sbjct: 118 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERLGTAYYIAP 175
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           E  +  +  +K DV+S GV+L  L+   P
Sbjct: 176 EVLR-KKYDEKCDVWSCGVILYILLCGYP 203

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 23  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 83  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 137
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 138 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 197
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 198 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 235

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 20  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 80  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 134
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 135 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 194
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 195 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 232

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 92/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+S        A  L G       +P P       +    L
Sbjct: 66  VKLLDVIHTENK-LYLVFEFLSMDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 117
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 118 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 14  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 74  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAEGMN 128
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 129 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 188
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 189 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 226

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 42  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 102 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 156
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 157 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 216
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 217 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 254

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY----YGELQDGRA--VAVKRLYENNY-KRVEQFMNE 107
           + E   N     + LG G FG V     YG ++   A  VAVK L  + +    E  M+E
Sbjct: 35  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 94
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGER-------AKPGA 158
           + +L+ L  H N+V+L G CT       L++ E+   G + + L  +R         P  
Sbjct: 95  LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 152
Query: 159 LPWPTRL-------KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
           +               + + A  + +L + + IHRD+   NILL +    K+ DFGL+R 
Sbjct: 153 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 212
Query: 212 FPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
             N   +V       P  ++ PE       T +SDV+S+G+ L EL S
Sbjct: 213 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 101/209 (48%), Gaps = 23/209 (11%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNLV 120
           +    ++G+G +G VY  +   GR VA+KR  L   +       + E+ +L  L H N+V
Sbjct: 23  YQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIV 82
Query: 121 SLYGCTSRHS-RELLLVYEFISN--GTVADHLHGERAKPGALPWPTRLKIAI-ETASALT 176
           SL      HS R L LV+EF+      V D       K G     +++KI + +    + 
Sbjct: 83  SLIDVI--HSERCLTLVFEFMEKDLKKVLDE-----NKTGLQD--SQIKIYLYQLLRGVA 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV---THVSTAPQGTPGYVDPE 233
           + H   I+HRD+K  N+L++++  +K+ADFGL+R F   V   TH       T  Y  P+
Sbjct: 134 HCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVV----TLWYRAPD 189
Query: 234 -YHQCYQLTDKSDVFSFGVVLIELISSMP 261
                 + +   D++S G +  E+I+  P
Sbjct: 190 VLMGSKKYSTSVDIWSIGCIFAEMITGKP 218

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 114/244 (46%), Gaps = 22/244 (9%)
Query: 47  GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---- 101
           G++ F   ++E   +++D   ELG G F  V    E   G   A K + +   +      
Sbjct: 1   GMEPFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 102 --EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL 159
             E+   EV IL ++ H N+++L+      + +++L+ E +S G + D L    A+  +L
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFL----AQKESL 112
Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFPNH 215
                     +    + YLH   I H D+K  NI LLD N     +K+ DFGL+    + 
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINL 274
           V   +    GTP +V PE      L  ++D++S GV+   L+S + P +  T+     N+
Sbjct: 173 VEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANI 230
Query: 275 SNLA 278
           ++++
Sbjct: 231 TSVS 234

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 61  NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
           N F+  + LG G FG V    E   GR  A+K L +        V   + E  +L   RH
Sbjct: 10  NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 69
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
             L +L      H R L  V E+ + G +  HL  ER          R +    E  SAL
Sbjct: 70  PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 123
Query: 176 TYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDP 232
            YLH+  ++++RD+K  N++LD +  +K+ DFGL +     +   +T     GTP Y+ P
Sbjct: 124 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 180
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISS 259
           E  +        D +  GVV+ E++  
Sbjct: 181 EVLEDNDYGRAVDWWGLGVVMYEMMCG 207

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 58  EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
           +  +Y D+ + +G+G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L 
Sbjct: 18  QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 71
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           H N+V L    Y    +     L LV +++         H  RAK   LP         +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
              +L Y+H+  I HRD+K  N+LLD +  V K+ DFG    L R  PN V+ + +    
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYR 189
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           AP+   G  D         T   DV+S G VL EL+   P
Sbjct: 190 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 221

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 58  EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
           +  +Y D+ + +G+G FG VY  +L D G  VA+K++ +      + F N E+ I+ +L 
Sbjct: 18  QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLD 71
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           H N+V L    Y    +     L LV +++         H  RAK   LP         +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGY 229
              +L Y+H+  I HRD+K  N+LLD +  V K+ DFG ++       +VS        Y
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 182
Query: 230 VDPEYHQCYQL-------TDKSDVFSFGVVLIELISSMP 261
           +   Y++  +L       T   DV+S G VL EL+   P
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 26/228 (11%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY----YGELQDGRA--VAVKRLYENNY-KRVEQFMNE 107
           + E   N     + LG G FG V     YG ++   A  VAVK L  + +    E  M+E
Sbjct: 40  KWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSE 99
Query: 108 VDILARL-RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGER-------AKPGA 158
           + +L+ L  H N+V+L G CT       L++ E+   G + + L  +R         P  
Sbjct: 100 LKVLSYLGNHMNIVNLLGACTI--GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAI 157
Query: 159 LPWPTRL-------KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
           +               + + A  + +L + + IHRD+   NILL +    K+ DFGL+R 
Sbjct: 158 MEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARD 217
Query: 212 FPNHVTHVSTAPQGTP-GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
             N   +V       P  ++ PE       T +SDV+S+G+ L EL S
Sbjct: 218 IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 77  PHVCRLLGICLTSTVQL--ITQLMPFGXLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/207 (29%), Positives = 93/207 (44%), Gaps = 17/207 (8%)
Query: 61  NYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRH 116
           N F+  + LG G FG V    E   GR  A+K L +        V   + E  +L   RH
Sbjct: 8   NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 67
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI-AIETASAL 175
             L +L      H R L  V E+ + G +  HL  ER          R +    E  SAL
Sbjct: 68  PFLTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFS-----EDRARFYGAEIVSAL 121
Query: 176 TYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDP 232
            YLH+  ++++RD+K  N++LD +  +K+ DFGL +     +   +T     GTP Y+ P
Sbjct: 122 DYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK---EGIKDGATMKXFCGTPEYLAP 178
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISS 259
           E  +        D +  GVV+ E++  
Sbjct: 179 EVLEDNDYGRAVDWWGLGVVMYEMMCG 205

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 58  EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
           +  +Y D+ + +G+G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L 
Sbjct: 19  QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 72
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           H N+V L    Y    +     L LV +++         H  RAK   LP         +
Sbjct: 73  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 131
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
              +L Y+H+  I HRD+K  N+LLD +  V K+ DFG    L R  PN V+ + +    
Sbjct: 132 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYR 190
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           AP+   G  D         T   DV+S G VL EL+   P
Sbjct: 191 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 222

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 65/219 (29%), Positives = 102/219 (46%), Gaps = 30/219 (13%)
Query: 58  EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
           +  +Y D+ + +G+G FG VY  +L D G  VA+K++ +      + F N E+ I+ +L 
Sbjct: 18  QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLD 71
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           H N+V L    Y    +     L LV +++         H  RAK   LP         +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGY 229
              +L Y+H+  I HRD+K  N+LLD +  V K+ DFG ++       +VS        Y
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVS--------Y 182
Query: 230 VDPEYHQCYQL-------TDKSDVFSFGVVLIELISSMP 261
           +   Y++  +L       T   DV+S G VL EL+   P
Sbjct: 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 105/220 (47%), Gaps = 32/220 (14%)
Query: 58  EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
           +  +Y D+ + +G+G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L 
Sbjct: 22  QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLD 75
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           H N+V L    Y    +     L LV +++         H  RAK   LP         +
Sbjct: 76  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
              +L Y+H+  I HRD+K  N+LLD +  V K+ DFG    L R  PN V+ + +    
Sbjct: 135 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYR 193
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           AP+   G  D         T   DV+S G VL EL+   P
Sbjct: 194 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 225

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 22/231 (9%)
Query: 61  NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           N F   R +G GGFG VY     D G+  A+K L   + KR++    E   L      +L
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSL 244
Query: 120 VSLYGCT-------SRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
           VS   C        + H+ + L  + + ++ G +  HL    ++ G          A E 
Sbjct: 245 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEI 300
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
              L ++H   +++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ 
Sbjct: 301 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 357
Query: 232 PEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVD--ITRHRHEINLSNLAI 279
           PE  Q     D S D FS G +L +L+          T+ +HEI+   L +
Sbjct: 358 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 408

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 21/223 (9%)
Query: 47  GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---- 101
           G++ F   ++E   +++D   ELG G F  V    E   G   A K + +   +      
Sbjct: 1   GMEPFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 102 --EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL 159
             E+   EV IL ++ H N+++L+      + +++L+ E +S G + D L    A+  +L
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFL----AQKESL 112
Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFPNH 215
                     +    + YLH   I H D+K  NI LLD N     +K+ DFGL+    + 
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
           V   +    GTP +V PE      L  ++D++S GV+   L+S
Sbjct: 173 VEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 61  NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE---QFMNEVDILARLRH 116
           N F   R LG GGFG V   +++  G+  A K+L +   K+ +     +NE  IL ++  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 117 KNLVSL-YGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETAS 173
           + +VSL Y   ++ +  L LV   ++ G +  H++  G+   P A      +  A E   
Sbjct: 244 RFVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHMGQAGFPEA----RAVFYAAEICC 297
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
            L  LH   I++RD+K  NILLD++  ++++D GL+   P   T       GT GY+ PE
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPE 355
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
             +  + T   D ++ G +L E+I+ 
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/197 (29%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 68  ELGDGGFGTVYYGE-LQDGRAVAVKRLYEN-NYKRVEQFMNEVDILAR-LRHKNLVSLYG 124
           ELG G +G V     +  G+  AVKR+    N +  ++ + ++DI  R +     V+ YG
Sbjct: 41  ELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYG 100
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPG-ALPWPTRLKIAIETASALTYLHAS-D 182
              R   ++ +  E     T  D  + +    G  +P     KIA+    AL +LH+   
Sbjct: 101 ALFREG-DVWICXELXD--TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS 157
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH---VSTAPQGTPGYVDPEYHQCYQ 239
           +IHRDVK +N+L++    VK  DFG+S    + V         P   P  ++PE +Q   
Sbjct: 158 VIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQ-KG 216
Query: 240 LTDKSDVFSFGVVLIEL 256
            + KSD++S G+  IEL
Sbjct: 217 YSVKSDIWSLGITXIEL 233

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 22/231 (9%)
Query: 61  NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           N F   R +G GGFG VY     D G+  A+K L   + KR++    E   L      +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSL 245
Query: 120 VSLYGCT-------SRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
           VS   C        + H+ + L  + + ++ G +  HL    ++ G          A E 
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEI 301
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
              L ++H   +++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ 
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358
Query: 232 PEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVD--ITRHRHEINLSNLAI 279
           PE  Q     D S D FS G +L +L+          T+ +HEI+   L +
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 100/209 (47%), Gaps = 15/209 (7%)
Query: 60  TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQ---FMNEVDILARLR 115
           ++ +   ++LG G +G V   + +  G   A+K + +++          ++EV +L +L 
Sbjct: 20  SDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLD 79
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           H N++ LY       R   LV E    G + D +   R K   +     +K   +  S  
Sbjct: 80  HPNIMKLYEFFE-DKRNYYLVMEVYRGGELFDEII-LRQKFSEVDAAVIMK---QVLSGT 134
Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
           TYLH  +I+HRD+K  N+LL++   +  +K+ DFGLS  F   V        GT  Y+ P
Sbjct: 135 TYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHF--EVGGKMKERLGTAYYIAP 192
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           E  +  +  +K DV+S GV+L  L+   P
Sbjct: 193 EVLR-KKYDEKCDVWSCGVILYILLCGYP 220

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/206 (30%), Positives = 103/206 (50%), Gaps = 15/206 (7%)
Query: 61  NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVE---QFMNEVDILARLRH 116
           N F   R LG GGFG V   +++  G+  A K+L +   K+ +     +NE  IL ++  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 117 KNLVSL-YGCTSRHSRELLLVYEFISNGTVADHLH--GERAKPGALPWPTRLKIAIETAS 173
           + +VSL Y   ++ +  L LV   ++ G +  H++  G+   P A      +  A E   
Sbjct: 244 RFVVSLAYAYETKDA--LCLVLTLMNGGDLKFHIYHMGQAGFPEA----RAVFYAAEICC 297
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
            L  LH   I++RD+K  NILLD++  ++++D GL+   P   T       GT GY+ PE
Sbjct: 298 GLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPE 355
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
             +  + T   D ++ G +L E+I+ 
Sbjct: 356 VVKNERYTFSPDWWALGCLLYEMIAG 381

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 21/223 (9%)
Query: 47  GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV---- 101
           G++ F   ++E   +++D   ELG G F  V    E   G   A K + +   +      
Sbjct: 1   GMEPFKQQKVE---DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57
Query: 102 --EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL 159
             E+   EV IL ++ H N+++L+      + +++L+ E +S G + D L    A+  +L
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHDVYENRT-DVVLILELVSGGELFDFL----AQKESL 112
Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFPNH 215
                     +    + YLH   I H D+K  NI LLD N     +K+ DFGL+    + 
Sbjct: 113 SEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDG 172
Query: 216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
           V   +    GTP +V PE      L  ++D++S GV+   L+S
Sbjct: 173 VEFKNIF--GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLS 213

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 101/210 (48%), Gaps = 28/210 (13%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYE----NNYKRVEQ-----FMNEVDILAR 113
           +D  + +G G FG     E+Q  R  A +++Y     + ++ +++     F  E DI+A 
Sbjct: 77  YDVVKVIGRGAFG-----EVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAF 131
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
                +V L+ C  +  + L +V E++  G + + +         +P         E   
Sbjct: 132 ANSPWVVQLF-CAFQDDKYLYMVMEYMPGGDLVNLMSNYD-----VPEKWAKFYTAEVVL 185
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDP 232
           AL  +H+  +IHRDVK +N+LLD +  +K+ADFG   ++    + H  TA  GTP Y+ P
Sbjct: 186 ALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTA-VGTPDYISP 244
Query: 233 EYHQCYQLTD-----KSDVFSFGVVLIELI 257
           E  +  Q  D     + D +S GV L E++
Sbjct: 245 EVLKS-QGGDGYYGRECDWWSVGVFLFEML 273

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 22/231 (9%)
Query: 61  NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           N F   R +G GGFG VY     D G+  A+K L   + KR++    E   L      +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSL 245
Query: 120 VSLYGCT-------SRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
           VS   C        + H+ + L  + + ++ G +  HL    ++ G          A E 
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEI 301
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
              L ++H   +++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ 
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358
Query: 232 PEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVD--ITRHRHEINLSNLAI 279
           PE  Q     D S D FS G +L +L+          T+ +HEI+   L +
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 104/231 (45%), Gaps = 22/231 (9%)
Query: 61  NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           N F   R +G GGFG VY     D G+  A+K L   + KR++    E   L      +L
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCL---DKKRIKMKQGETLALNERIMLSL 245
Query: 120 VSLYGCT-------SRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
           VS   C        + H+ + L  + + ++ G +  HL    ++ G          A E 
Sbjct: 246 VSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHL----SQHGVFSEADMRFYAAEI 301
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
              L ++H   +++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ 
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358
Query: 232 PEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVD--ITRHRHEINLSNLAI 279
           PE  Q     D S D FS G +L +L+          T+ +HEI+   L +
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM 409

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 60  TNYFDSARELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
           ++ +D   ELG G F  V        G     + +  K+L   +++++E+   E  I  +
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 84
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
           L+H N+V L+      S   L V++ ++ G      VA   + E      +         
Sbjct: 85  LQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFEDIVAREFYSEADASHCIQ-------- 135
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAPQG 225
            +   ++ Y H++ I+HR++K  N+LL +      VK+ADFGL+    +       A  G
Sbjct: 136 -QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--G 192
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
           TPGY+ PE  +    +   D+++ GV+L I L+   P  D  +HR
Sbjct: 193 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 237

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 60  TNYFDSARELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
           ++ +D   ELG G F  V        G     + +  K+L   +++++E+   E  I  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 61
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
           L+H N+V L+      S   L V++ ++ G      VA   + E      +         
Sbjct: 62  LQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFEDIVAREFYSEADASHCIQ-------- 112
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAPQG 225
            +   ++ Y H++ I+HR++K  N+LL +      VK+ADFGL+    +       A  G
Sbjct: 113 -QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--G 169
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
           TPGY+ PE  +    +   D+++ GV+L I L+   P  D  +HR
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 60  TNYFDSARELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
           ++ +D   ELG G F  V        G     + +  K+L   +++++E+   E  I  +
Sbjct: 4   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 60
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
           L+H N+V L+      S   L V++ ++ G      VA   + E      +         
Sbjct: 61  LQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFEDIVAREFYSEADASHCIQ-------- 111
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAPQG 225
            +   ++ Y H++ I+HR++K  N+LL +      VK+ADFGL+    +       A  G
Sbjct: 112 -QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--G 168
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
           TPGY+ PE  +    +   D+++ GV+L I L+   P  D  +HR
Sbjct: 169 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 213

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/225 (26%), Positives = 103/225 (45%), Gaps = 30/225 (13%)
Query: 60  TNYFDSARELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
           ++ +D   ELG G F  V        G     + +  K+L   +++++E+   E  I  +
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER---EARICRK 61
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
           L+H N+V L+      S   L V++ ++ G      VA   + E      +         
Sbjct: 62  LQHPNIVRLHDSIQEESFHYL-VFDLVTGGELFEDIVAREFYSEADASHCIQ-------- 112
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAPQG 225
            +   ++ Y H++ I+HR++K  N+LL +      VK+ADFGL+    +       A  G
Sbjct: 113 -QILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--G 169
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
           TPGY+ PE  +    +   D+++ GV+L I L+   P  D  +HR
Sbjct: 170 TPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR 214

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 65  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 174
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 65  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 174
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 66  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 117
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 67  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 176
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 88/200 (44%), Gaps = 9/200 (4%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V L       ++ L LV+EF+             A  G +P P       +    L + H
Sbjct: 65  VKLLDVIHTENK-LYLVFEFLHQDL--KKFMDASALTG-IPLPLIKSYLFQLLQGLAFCH 120
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YHQCY 238
           +  ++HRD+K  N+L++    +K+ADFGL+R F   V         T  Y  PE    C 
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLGCK 179
Query: 239 QLTDKSDVFSFGVVLIELIS 258
             +   D++S G +  E+++
Sbjct: 180 YYSTAVDIWSLGCIFAEMVT 199

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 21  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L++  + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 81  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 135
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFG ++L               P     ++  
Sbjct: 136 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 195
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 196 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 233

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 64  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 115
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 173
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 65  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 174
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 175 LLGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 66  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 117
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 118 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 175
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+   RL           + E+ +L  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 65  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PE  
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
             C   +   D++S G +  E+++
Sbjct: 176 LGCKYYSTAVDIWSLGCIFAEMVT 199

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 64  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 115
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 173
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 174 LLGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+   RL           + E+ +L  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 64  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 115
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PE  
Sbjct: 116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 174
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
             C   +   D++S G +  E+++
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVT 198

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + L  G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L++  + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 84  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 138
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 199 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 68  VKLLDVIHTENK-LYLVFEFLHQDLKTFMDASALTG-------IPLPLIKSYLFQLLQGL 119
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 177
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 68  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 119
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 177
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 67  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 119 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 176
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 68  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 119
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 177
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L++  + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 79  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFG ++L               P     ++  
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 103/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L++  + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 79  PHVCRLLGICLTSTVQLIM--QLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFG ++L               P     ++  
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 69  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 120
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 121 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 178
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 179 LLGCKYYSTAVDIWSLGCIFAEMVT 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 91/205 (44%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 7   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 67  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 118
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 119 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 176
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 177 LLGCKYYSTAVDIWSLGCIFAEMVT 201

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 89/204 (43%), Gaps = 17/204 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 66  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 117
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-Y 234
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V         T  Y  PE  
Sbjct: 118 AFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEIL 176
Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
             C   +   D++S G +  E+++
Sbjct: 177 LGCKYYSTAVDIWSLGCIFAEMVT 200

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 114/234 (48%), Gaps = 25/234 (10%)
Query: 61  NYFDSARELGDGGFGTV----YYGELQDGRAVAVKRLYENNYKR---VEQFMNEVDILAR 113
           ++++   ELG G F  V      G  ++  A  +K+   ++ +R    E+   EV+IL  
Sbjct: 5   DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILRE 64
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
           +RH N+++L+      + +++L+ E +S G + D L    A+  +L      +   +   
Sbjct: 65  IRHPNIITLHDIFENKT-DVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILD 119
Query: 174 ALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFP--NHVTHVSTAPQGTP 227
            + YLH+  I H D+K  NI LLD N     +K+ DFG++      N   ++     GTP
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTP 175
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 176 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS--AVN 227

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 103/220 (46%), Gaps = 32/220 (14%)
Query: 58  EATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLR 115
           +  +Y D+ + +G+G FG VY  +L D G  VA+K++ +      + F N E+ I+ +L 
Sbjct: 18  QEVSYTDT-KVIGNGSFGVVYQAKLCDSGELVAIKKVLQG-----KAFKNRELQIMRKLD 71
Query: 116 HKNLVSL----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           H N+V L    Y    +     L LV +++         H  RAK   LP         +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAK-QTLPVIYVKLYMYQ 130
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCV-KVADFG----LSRLFPNHVTHVST---- 221
              +L Y+H+  I HRD+K  N+LLD +  V K+ DFG    L R  PN V+ + +    
Sbjct: 131 LFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSXICSRYYR 189
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           AP+   G  D         T   DV+S G VL EL+   P
Sbjct: 190 APELIFGATD--------YTSSIDVWSAGCVLAELLLGQP 221

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 18/169 (10%)
Query: 102 EQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
           E  + EVDIL ++  H N++ L   T   +    LV++ +  G + D+L     +   L 
Sbjct: 55  EATLKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYL----TEKVTLS 109
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHV 219
                KI       +  LH  +I+HRD+K  NILLD++  +K+ DFG S +L P      
Sbjct: 110 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 169
Query: 220 STAPQGTPGYVDPEYHQCYQLTD-------KSDVFSFGVVLIELISSMP 261
                GTP Y+ PE  +C  + D       + D++S GV++  L++  P
Sbjct: 170 VC---GTPSYLAPEIIEC-SMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 214

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 13/202 (6%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 120 VSLYGCTSRHSRELLLVYEFISN--GTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           V L       ++ L LV+E +     T  D      +    +P P       +    L +
Sbjct: 64  VKLLDVIHTENK-LYLVFEHVHQDLKTFMD-----ASALTGIPLPLIKSYLFQLLQGLAF 117
Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YHQ 236
            H+  ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PE    
Sbjct: 118 CHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 176
Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
           C   +   D++S G +  E+++
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVT 198

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 64/234 (27%), Positives = 113/234 (48%), Gaps = 25/234 (10%)
Query: 61  NYFDSARELGDGGFGTV----YYGELQDGRAVAVKRLYENNYKR---VEQFMNEVDILAR 113
           ++++   ELG G F  V      G  ++  A  +K+    + +R    E+   EV+IL  
Sbjct: 26  DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILRE 85
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
           +RH N+++L+      + +++L+ E +S G + D L    A+  +L      +   +   
Sbjct: 86  IRHPNIITLHDIFENKT-DVVLILELVSGGELFDFL----AEKESLTEDEATQFLKQILD 140
Query: 174 ALTYLHASDIIHRDVKTNNI-LLDNNFC---VKVADFGLSRLFP--NHVTHVSTAPQGTP 227
            + YLH+  I H D+K  NI LLD N     +K+ DFG++      N   ++     GTP
Sbjct: 141 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIF----GTP 196
Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN 280
            +V PE      L  ++D++S GV+   L+S + P +  T+     N+S  A+N
Sbjct: 197 EFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNIS--AVN 248

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 18/169 (10%)
Query: 102 EQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
           E  + EVDIL ++  H N++ L   T   +    LV++ +  G + D+L     +   L 
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYL----TEKVTLS 122
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHV 219
                KI       +  LH  +I+HRD+K  NILLD++  +K+ DFG S +L P      
Sbjct: 123 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS 182
Query: 220 STAPQGTPGYVDPEYHQCYQLTD-------KSDVFSFGVVLIELISSMP 261
                GTP Y+ PE  +C  + D       + D++S GV++  L++  P
Sbjct: 183 VC---GTPSYLAPEIIEC-SMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 103/223 (46%), Gaps = 29/223 (13%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+  L E    +  ++ ++E  ++A + +
Sbjct: 51  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGA---LPWPTRLKIAIETAS 173
            ++  L G     + +L  + + +  G + D++   +   G+   L W       ++ A 
Sbjct: 111 PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAK 162
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYV 230
            + YL    ++HRD+   N+L+     VK+ DFGL++L               P     +
Sbjct: 163 GMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 222
Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
           +   H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 223 ESILHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 263

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 51/169 (30%), Positives = 82/169 (48%), Gaps = 18/169 (10%)
Query: 102 EQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
           E  + EVDIL ++  H N++ L   T   +    LV++ +  G + D+L     +   L 
Sbjct: 68  EATLKEVDILRKVSGHPNIIQLKD-TYETNTFFFLVFDLMKKGELFDYL----TEKVTLS 122
Query: 161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHV 219
                KI       +  LH  +I+HRD+K  NILLD++  +K+ DFG S +L P      
Sbjct: 123 EKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE 182
Query: 220 STAPQGTPGYVDPEYHQCYQLTD-------KSDVFSFGVVLIELISSMP 261
                GTP Y+ PE  +C  + D       + D++S GV++  L++  P
Sbjct: 183 VC---GTPSYLAPEIIEC-SMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 63  FDSARELGDGGFGTVY----YGELQDGRAVAVKRLYE----NNYKRVEQFMNEVDILARL 114
           F+  R LG GG+G V+          G+  A+K L +     N K       E +IL  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
           +H  +V L        + L L+ E++S G +   L  E    G     T      E + A
Sbjct: 79  KHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMA 133
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDP 232
           L +LH   II+RD+K  NI+L++   VK+ DFGL +  +    VTH      GT  Y+ P
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIEYMAP 190
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           E           D +S G ++ ++++  P
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + L  G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 24  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 84  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 138
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 199 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 65  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 116
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PE  
Sbjct: 117 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 175
Query: 236 QCYQLTDKS-DVFSFGVVLIELIS 258
              +    + D++S G +  E+++
Sbjct: 176 LGXKYYSTAVDIWSLGCIFAEMVT 199

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + L  G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 17  FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 77  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFGL++L               P     ++  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 19  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 79  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 133
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFG ++L               P     ++  
Sbjct: 134 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 193
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 194 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 231

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 17  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 77  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 131
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFG ++L               P     ++  
Sbjct: 132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 191
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 192 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 229

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 102/220 (46%), Gaps = 23/220 (10%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGR----AVAVKRLYENNYKRV-EQFMNEVDILARLRH 116
           F   + LG G FGTVY G  + +G      VA+K L E    +  ++ ++E  ++A + +
Sbjct: 24  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     + +L  + + +  G + D++   +   G+      L   ++ A  + 
Sbjct: 84  PHVCRLLGICLTSTVQL--ITQLMPFGCLLDYVREHKDNIGS---QYLLNWCVQIAKGMN 138
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP---GYVDPE 233
           YL    ++HRD+   N+L+     VK+ DFG ++L               P     ++  
Sbjct: 139 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESI 198
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDIT 266
            H+ Y  T +SDV+S+GV + EL++        +PA +I+
Sbjct: 199 LHRIY--THQSDVWSYGVTVWELMTFGSKPYDGIPASEIS 236

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 90/204 (44%), Gaps = 17/204 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+EF+         A  L G       +P P       +    L
Sbjct: 72  VKLLDVIHTENK-LYLVFEFLHQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 123
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V    T    T  Y  PE  
Sbjct: 124 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEIL 182
Query: 236 QCYQLTDKS-DVFSFGVVLIELIS 258
              +    + D++S G +  E+++
Sbjct: 183 LGXKYYSTAVDIWSLGCIFAEMVT 206

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  L   R VA+K++    ++   ++ +
Sbjct: 21  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 73
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHI--- 130
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 131 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 94/204 (46%), Gaps = 25/204 (12%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYK---RVEQFMNEVDILARLRHKNLVSLYGC 125
           LG G  GT+ Y  + D R VAVKR+    +    R  Q + E D      H N++  Y C
Sbjct: 32  LGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESD-----EHPNVIR-YFC 85
Query: 126 TSRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
           T +  R+   +   +   T+ +++   + A  G  P    + +  +T S L +LH+ +I+
Sbjct: 86  TEK-DRQFQYIAIELCAATLQEYVEQKDFAHLGLEP----ITLLQQTTSGLAHLHSLNIV 140
Query: 185 HRDVKTNNILLD-----NNFCVKVADFGLSRLFP--NHVTHVSTAPQGTPGYVDPEY--H 235
           HRD+K +NIL+            ++DFGL +      H     +   GT G++ PE    
Sbjct: 141 HRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSE 200
Query: 236 QCYQ-LTDKSDVFSFGVVLIELIS 258
            C +  T   D+FS G V   +IS
Sbjct: 201 DCKENPTYTVDIFSAGCVFYYVIS 224

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 99/211 (46%), Gaps = 13/211 (6%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRV--EQFMN 106
           Q    GEL++  + F+   ELG G  G V   + +    +  ++L     K     Q + 
Sbjct: 6   QKAKVGELKD--DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIR 63
Query: 107 EVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK 166
           E+ +L       +V  YG       E+ +  E +  G++ D +  E  +   +P     K
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDG-EISICMEHMDGGSL-DQVLKEAKR---IPEEILGK 118
Query: 167 IAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG 225
           ++I     L YL     I+HRDVK +NIL+++   +K+ DFG+S      +  ++ +  G
Sbjct: 119 VSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVG 175
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
           T  Y+ PE  Q    + +SD++S G+ L+EL
Sbjct: 176 TRSYMAPERLQGTHYSVQSDIWSMGLSLVEL 206

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/227 (26%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKRVEQ-FM 105
           QVF  G      +Y      +G+G +G V   Y  L   R VA+K++    ++   Q  +
Sbjct: 21  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYXQRTL 73
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 130
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 131 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHD 183
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 18/209 (8%)
Query: 63  FDSARELGDGGFGTVY----YGELQDGRAVAVKRLYE----NNYKRVEQFMNEVDILARL 114
           F+  R LG GG+G V+          G+  A+K L +     N K       E +IL  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
           +H  +V L        + L L+ E++S G +   L  E    G     T      E + A
Sbjct: 79  KHPFIVDLIYAFQTGGK-LYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMA 133
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDP 232
           L +LH   II+RD+K  NI+L++   VK+ DFGL +  +    VTH      GT  Y+ P
Sbjct: 134 LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFC---GTIEYMAP 190
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           E           D +S G ++ ++++  P
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGAP 219

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  L   R VA+K++    ++   ++ +
Sbjct: 15  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 67
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 68  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 124
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 125 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 177
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 178 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 224

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  L   R VA+K++    ++   ++ +
Sbjct: 15  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 67
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 68  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 124
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 125 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 177
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 178 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 224

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQDG-RAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNL 119
           ++   ++G+G +GTV+  + ++    VA+KR  L +++       + E+ +L  L+HKN+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 120 VSLYGCTSRHS-RELLLVYEFISNGTVA--DHLHGERAKPGALPWPTRLK-IAIETASAL 175
           V L+     HS ++L LV+EF         D  +G+         P  +K    +    L
Sbjct: 64  VRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGDLD-------PEIVKSFLFQLLKGL 114
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            + H+ +++HRD+K  N+L++ N  +K+ADFGL+R F   V    +A   T  Y  P+  
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSAEVVTLWYRPPDVL 173
Query: 236 QCYQLTDKS-DVFSFGVVLIELISS 259
              +L   S D++S G +  EL ++
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANA 198

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  L   R VA+K++    ++   ++ +
Sbjct: 21  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 73
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 130
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 131 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHD 183
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  L   R VA+K++    ++   ++ +
Sbjct: 22  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 74
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 75  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 131
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 132 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 184
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 185 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 231

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  L   R VA+K++    ++   ++ +
Sbjct: 23  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 75
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 76  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 132
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 133 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 185
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 186 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 232

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  L   R VA+K++    ++   ++ +
Sbjct: 14  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 66
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 67  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 123
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 124 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 176
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 177 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 223

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  L   R VA+K++    ++   ++ +
Sbjct: 21  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 73
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 130
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 131 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66  ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
           ++ LG G  G V    E +  + VA+K + +  +     +  +  +N   E++IL +L H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
             ++ +       + +  +V E +  G + D + G +          RLK A       +
Sbjct: 75  PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 122
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
              A+ YLH + IIHRD+K  N+LL   + +  +K+ DFG S++     T +     GTP
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 180
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
            Y+ PE          +   D +S GV+L   +S  P    + HR +++L +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 230

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/212 (25%), Positives = 104/212 (49%), Gaps = 35/212 (16%)
Query: 69  LGDGGFGTV--YYGELQDGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVS---- 121
           +G+G +G V   Y  ++  R VA+K++    ++   ++ + E+ IL R RH+N++     
Sbjct: 51  IGEGAYGMVSSAYDHVRKTR-VAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDI 109
Query: 122 LYGCTSRHSRELLLV--------YEFISNGTVA-DHLHGERAKPGALPWPTRLKIAIETA 172
           L   T    R++ +V        Y+ + +  ++ DH+                    +  
Sbjct: 110 LRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHI---------------CYFLYQIL 154
Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV-THVSTAPQGTPGYV 230
             L Y+H+++++HRD+K +N+L++    +K+ DFGL+R+  P H  T   T    T  Y 
Sbjct: 155 RGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYR 214
Query: 231 DPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            PE     +   KS D++S G +L E++S+ P
Sbjct: 215 APEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66  ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
           ++ LG G  G V    E +  + VA+K + +  +     +  +  +N   E++IL +L H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
             ++ +       + +  +V E +  G + D + G +          RLK A       +
Sbjct: 75  PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 122
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
              A+ YLH + IIHRD+K  N+LL   + +  +K+ DFG S++     T +     GTP
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 180
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
            Y+ PE          +   D +S GV+L   +S  P    + HR +++L +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 230

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66  ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
           ++ LG G  G V    E +  + VA+K + +  +     +  +  +N   E++IL +L H
Sbjct: 15  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 74
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
             ++ +       + +  +V E +  G + D + G +          RLK A       +
Sbjct: 75  PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 122
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
              A+ YLH + IIHRD+K  N+LL   + +  +K+ DFG S++     T +     GTP
Sbjct: 123 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 180
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
            Y+ PE          +   D +S GV+L   +S  P    + HR +++L +
Sbjct: 181 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 230

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66  ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
           ++ LG G  G V    E +  + VA+K + +  +     +  +  +N   E++IL +L H
Sbjct: 14  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 73
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
             ++ +       + +  +V E +  G + D + G +          RLK A       +
Sbjct: 74  PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 121
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
              A+ YLH + IIHRD+K  N+LL   + +  +K+ DFG S++     T +     GTP
Sbjct: 122 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 179
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
            Y+ PE          +   D +S GV+L   +S  P    + HR +++L +
Sbjct: 180 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 229

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66  ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
           ++ LG G  G V    E +  + VA+K + +  +     +  +  +N   E++IL +L H
Sbjct: 21  SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNH 80
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
             ++ +       + +  +V E +  G + D + G +          RLK A       +
Sbjct: 81  PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 128
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
              A+ YLH + IIHRD+K  N+LL   + +  +K+ DFG S++     T +     GTP
Sbjct: 129 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 186
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
            Y+ PE          +   D +S GV+L   +S  P    + HR +++L +
Sbjct: 187 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 236

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/223 (26%), Positives = 106/223 (47%), Gaps = 24/223 (10%)
Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYGCT 126
           LG+G +G V     +  G  VA+K++   +      + + E+ IL   +H+N+++++   
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 127 SRHS----RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHAS 181
              S     E+ ++ E +        LH  R     +     ++  I +T  A+  LH S
Sbjct: 79  RPDSFENFNEVYIIQELMQTD-----LH--RVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS--TAPQ-GTPGYVDPEYHQCY 238
           ++IHRD+K +N+L+++N  +KV DFGL+R+        S  T  Q G   YV   +++  
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATRWYRAP 191
Query: 239 QLTDKS-------DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           ++   S       DV+S G +L EL    P      +RH++ L
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 61  NYFDSARELGDGGFGTVYYGELQDGRAV--AVKRLYENNYKRVEQFMNEVDILARLRHKN 118
            Y+     +G G +G V    +Q G  +  A K++ +   + V++F  E++I+  L H N
Sbjct: 9   QYYTLENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LY  T   + ++ LV E  + G + + +  +R    +       +I  +  SA+ Y 
Sbjct: 68  IIRLYE-TFEDNTDIYLVMELCTGGELFERVVHKRVFRES----DAARIMKDVLSAVAYC 122
Query: 179 HASDIIHRDVKTNNILL---DNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTPGYVDPEY 234
           H  ++ HRD+K  N L      +  +K+ DFGL +R  P  +        GTP YV P+ 
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQV 179
Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMP 261
            +      + D +S GV++  L+   P
Sbjct: 180 LEGL-YGPECDEWSAGVMMYVLLCGYP 205

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 19/205 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQ-DGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY    +  G  VA+K  RL           + E+ +L  L H N+
Sbjct: 8   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPGALPWPTRLKIAIETASAL 175
           V L       ++ L LV+E +         A  L G       +P P       +    L
Sbjct: 68  VKLLDVIHTENK-LYLVFEHVDQDLKKFMDASALTG-------IPLPLIKSYLFQLLQGL 119
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-THVSTAPQGTPGYVDPE- 233
            + H+  ++HRD+K  N+L++    +K+ADFGL+R F   V T+       T  Y  PE 
Sbjct: 120 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEV--VTLWYRAPEI 177
Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
              C   +   D++S G +  E+++
Sbjct: 178 LLGCKYYSTAVDIWSLGCIFAEMVT 202

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  +   R VA+K++    ++   ++ +
Sbjct: 17  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 69
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 126
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 127 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHD 179
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 16/207 (7%)
Query: 61  NYFDSARELGDGGFGTVYYGELQDGRAV--AVKRLYENNYKRVEQFMNEVDILARLRHKN 118
            Y+     +G G +G V    +Q G  +  A K++ +   + V++F  E++I+  L H N
Sbjct: 26  QYYTLENTIGRGSWGEVKIA-VQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 84
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LY  T   + ++ LV E  + G + + +  +R    +       +I  +  SA+ Y 
Sbjct: 85  IIRLYE-TFEDNTDIYLVMELCTGGELFERVVHKRVFRES----DAARIMKDVLSAVAYC 139
Query: 179 HASDIIHRDVKTNNILL---DNNFCVKVADFGL-SRLFPNHVTHVSTAPQGTPGYVDPEY 234
           H  ++ HRD+K  N L      +  +K+ DFGL +R  P  +        GTP YV P+ 
Sbjct: 140 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV---GTPYYVSPQV 196
Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMP 261
            +      + D +S GV++  L+   P
Sbjct: 197 LEGL-YGPECDEWSAGVMMYVLLCGYP 222

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  +   R VA+K++    ++   ++ +
Sbjct: 17  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 69
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 126
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 127 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHD 179
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  L   R VA++++    ++   ++ +
Sbjct: 21  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIRKISPFEHQTYCQRTL 73
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 130
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 131 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 184 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  +   R VA+K++    ++   ++ +
Sbjct: 17  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 69
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 126
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 127 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 179
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/251 (26%), Positives = 109/251 (43%), Gaps = 19/251 (7%)
Query: 69  LGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           LG GGF   +        E+  G+ V  K L    ++R E+   E+ I   L H+++V  
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 82
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           +G    +   + +V E     ++ + LH  R    AL  P       +      YLH + 
Sbjct: 83  HGFFEDNDF-VFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR 137
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           +IHRD+K  N+ L+ +  VK+ DFGL+           T   GTP Y+ PE       + 
Sbjct: 138 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGHSF 196
Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRH---EINLSNLAINKIQNKALHELVDQTLGYES 299
           + DV+S G ++  L+   P  + +  +     I  +  +I K  N     L+ + L  ++
Sbjct: 197 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML--QT 254
Query: 300 DNKVRRTINAV 310
           D   R TIN +
Sbjct: 255 DPTARPTINEL 265

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 101/206 (49%), Gaps = 12/206 (5%)
Query: 61  NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYEN-NYKRVEQFMNEVDILARLRH-K 117
           N  ++  E+G G  G V+    +  G  +AVK++  + N +  ++ + ++D++ +     
Sbjct: 25  NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
            +V  +G T   + ++ +  E +  GT A+ L  ++   G +P     K+ +    AL Y
Sbjct: 85  YIVQCFG-TFITNTDVFIAMELM--GTCAEKL--KKRMQGPIPERILGKMTVAIVKALYY 139
Query: 178 LHAS-DIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVS--TAPQGTPGYVDPE 233
           L     +IHRDVK +NILLD    +K+ DFG+S RL  +     S   A    P  +DP 
Sbjct: 140 LKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPP 199
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISS 259
                    ++DV+S G+ L+EL + 
Sbjct: 200 DPTKPDYDIRADVWSLGISLVELATG 225

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 66/249 (26%), Positives = 108/249 (43%), Gaps = 19/249 (7%)
Query: 69  LGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           LG GGF   +        E+  G+ V  K L    ++R E+   E+ I   L H+++V  
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 86
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           +G    +   + +V E     ++ + LH  R    AL  P       +      YLH + 
Sbjct: 87  HGFFEDNDF-VFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR 141
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           +IHRD+K  N+ L+ +  VK+ DFGL+           T   GTP Y+ PE       + 
Sbjct: 142 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGHSF 200
Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRH---EINLSNLAINKIQNKALHELVDQTLGYES 299
           + DV+S G ++  L+   P  + +  +     I  +  +I K  N     L+ + L  ++
Sbjct: 201 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML--QT 258
Query: 300 DNKVRRTIN 308
           D   R TIN
Sbjct: 259 DPTARPTIN 267

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  +   R VA+K++    ++   ++ +
Sbjct: 19  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 71
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 72  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 128
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 129 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 181
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 182 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  +   R VA+K++    ++   ++ +
Sbjct: 25  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 77
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 78  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 134
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 135 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 187
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 188 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 234

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  +   R VA+K++    ++   ++ +
Sbjct: 17  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 69
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 126
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 127 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 179
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 65/252 (25%), Positives = 108/252 (42%), Gaps = 21/252 (8%)
Query: 69  LGDGGFGTVYYGELQDGRA-------VAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           LG GGF   +  E+ D          +  K L    ++R E+   E+ I   L H+++V 
Sbjct: 25  LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 81
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
            +G    +   + +V E     ++ + LH  R    AL  P       +      YLH +
Sbjct: 82  FHGFFEDNDF-VFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYLRQIVLGCQYLHRN 136
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
            +IHRD+K  N+ L+ +  VK+ DFGL+           T   GTP Y+ PE       +
Sbjct: 137 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTL-CGTPNYIAPEVLSKKGHS 195
Query: 242 DKSDVFSFGVVLIELISSMPAVDITRHRH---EINLSNLAINKIQNKALHELVDQTLGYE 298
            + DV+S G ++  L+   P  + +  +     I  +  +I K  N     L+ + L  +
Sbjct: 196 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML--Q 253
Query: 299 SDNKVRRTINAV 310
           +D   R TIN +
Sbjct: 254 TDPTARPTINEL 265

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  L   R VA+K++    ++   ++ +
Sbjct: 21  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 73
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 74  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 130
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 131 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 183
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T        T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 184 HTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  L   R VA+K++    ++   ++ +
Sbjct: 22  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNLNKVR-VAIKKISPFEHQTYCQRTL 74
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 75  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 131
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 132 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 184
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T        T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 185 HTGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 231

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  +   R VA+K++    ++   ++ +
Sbjct: 17  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 69
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 70  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 126
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 127 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHD 179
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 180 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 226

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/227 (25%), Positives = 106/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  +   R VA+K++    ++   ++ +
Sbjct: 37  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 89
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL R RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 90  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 146
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 147 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 199
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 200 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 101/231 (43%), Gaps = 40/231 (17%)
Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYGCT 126
           LG+G +G V     +  G  VA+K++   +      + + E+ IL   +H+N+++++   
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 127 SRHS----RELLLVYEF--------ISNGTVAD-HLHGERAKPGALPWPTRLKIAIETAS 173
              S     E+ ++ E         IS   ++D H+                    +T  
Sbjct: 79  RPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQ---------------YFIYQTLR 123
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF---------PNHVTHVSTAPQ 224
           A+  LH S++IHRD+K +N+L+++N  +KV DFGL+R+          P       T   
Sbjct: 124 AVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV 183
Query: 225 GTPGYVDPEYH-QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL 274
            T  Y  PE      + +   DV+S G +L EL    P      +RH++ L
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 59/219 (26%), Positives = 106/219 (48%), Gaps = 15/219 (6%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  +   R VA+K++    ++   ++ +
Sbjct: 37  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 89
Query: 106 NEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRL 165
            E+ IL R RH+N++ +       + E +     +++   AD    +  K   L      
Sbjct: 90  REIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLY--KLLKTQHLSNDHIC 147
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV-THVSTAP 223
               +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H  T   T  
Sbjct: 148 YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEY 207
Query: 224 QGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
             T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 208 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 246

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 21/209 (10%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCT 126
           LG+G +  V     LQ+G+  AVK + +       +   EV+ L + + +KN++ L    
Sbjct: 21  LGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIEFF 80
Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
              +R   LV+E +  G++  H+  ++            ++  + A+AL +LH   I HR
Sbjct: 81  EDDTR-FYLVFEKLQGGSILAHIQKQKH----FNEREASRVVRDVAAALDFLHTKGIAHR 135
Query: 187 DVKTNNILLDNN---FCVKVADF--GLSRLFPNHVTHVS----TAPQGTPGYVDPEYHQC 237
           D+K  NIL ++      VK+ DF  G      N  T ++    T P G+  Y+ PE  + 
Sbjct: 136 DLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEV 195
Query: 238 Y--QLT---DKSDVFSFGVVLIELISSMP 261
           +  Q T    + D++S GVVL  ++S  P
Sbjct: 196 FTDQATFYDKRCDLWSLGVVLYIMLSGYP 224

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 108/249 (43%), Gaps = 19/249 (7%)
Query: 69  LGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           LG GGF   +        E+  G+ V  K L    ++R E+   E+ I   L H+++V  
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 80
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           +G    +   + +V E     ++ + LH  R    AL  P       +      YLH + 
Sbjct: 81  HGFFEDNDF-VFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR 135
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           +IHRD+K  N+ L+ +  VK+ DFGL+     +         GTP Y+ PE       + 
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHSF 194
Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRH---EINLSNLAINKIQNKALHELVDQTLGYES 299
           + DV+S G ++  L+   P  + +  +     I  +  +I K  N     L+ + L  ++
Sbjct: 195 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML--QT 252
Query: 300 DNKVRRTIN 308
           D   R TIN
Sbjct: 253 DPTARPTIN 261

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 65/249 (26%), Positives = 108/249 (43%), Gaps = 19/249 (7%)
Query: 69  LGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           LG GGF   +        E+  G+ V  K L    ++R E+   E+ I   L H+++V  
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVP-KSLLLKPHQR-EKMSMEISIHRSLAHQHVVGF 104
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           +G    +   + +V E     ++ + LH  R    AL  P       +      YLH + 
Sbjct: 105 HGFFEDNDF-VFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYLRQIVLGCQYLHRNR 159
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           +IHRD+K  N+ L+ +  VK+ DFGL+     +         GTP Y+ PE       + 
Sbjct: 160 VIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHSF 218
Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRH---EINLSNLAINKIQNKALHELVDQTLGYES 299
           + DV+S G ++  L+   P  + +  +     I  +  +I K  N     L+ + L  ++
Sbjct: 219 EVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML--QT 276
Query: 300 DNKVRRTIN 308
           D   R TIN
Sbjct: 277 DPTARPTIN 285

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 59/218 (27%), Positives = 97/218 (44%), Gaps = 38/218 (17%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDI--LARLRHKNLVSLY--- 123
           +G G +G VY G L D R VAVK     ++   + F+NE +I  +  + H N+       
Sbjct: 21  IGRGRYGAVYKGSL-DERPVAVKVF---SFANRQNFINEKNIYRVPLMEHDNIARFIVGD 76
Query: 124 -GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS- 181
              T+    E LLV E+  NG++  +L    +      W +  ++A      L YLH   
Sbjct: 77  ERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD-----WVSSCRLAHSVTRGLAYLHTEL 131
Query: 182 --------DIIHRDVKTNNILLDNNFCVKVADFGLS------RLF-PNHVTHVSTAPQGT 226
                    I HRD+ + N+L+ N+    ++DFGLS      RL  P    + + +  GT
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGT 191
Query: 227 PGYVDPEYHQ-CYQLTD------KSDVFSFGVVLIELI 257
             Y+ PE  +    L D      + D+++ G++  E+ 
Sbjct: 192 IRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 107/250 (42%), Gaps = 21/250 (8%)
Query: 69  LGDGGFGTVYYGELQDGRA-------VAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           LG GGF   +  E+ D          +  K L    ++R E+   E+ I   L H+++V 
Sbjct: 49  LGKGGFAKCF--EISDADTKEVFAGKIVPKSLLLKPHQR-EKMSMEISIHRSLAHQHVVG 105
Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
            +G    +   + +V E     ++ + LH  R    AL  P       +      YLH +
Sbjct: 106 FHGFFEDNDF-VFVVLELCRRRSLLE-LHKRRK---ALTEPEARYYLRQIVLGCQYLHRN 160
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
            +IHRD+K  N+ L+ +  VK+ DFGL+     +         GTP Y+ PE       +
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV-EYDGERKKVLCGTPNYIAPEVLSKKGHS 219
Query: 242 DKSDVFSFGVVLIELISSMPAVDITRHRH---EINLSNLAINKIQNKALHELVDQTLGYE 298
            + DV+S G ++  L+   P  + +  +     I  +  +I K  N     L+ + L  +
Sbjct: 220 FEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKML--Q 277
Query: 299 SDNKVRRTIN 308
           +D   R TIN
Sbjct: 278 TDPTARPTIN 287

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/205 (27%), Positives = 105/205 (51%), Gaps = 18/205 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQDG-RAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNL 119
           ++   ++G+G +GTV+  + ++    VA+KR  L +++       + E+ +L  L+HKN+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63
Query: 120 VSLYGCTSRHS-RELLLVYEFISNGTVA--DHLHGERAKPGALPWPTRLK-IAIETASAL 175
           V L+     HS ++L LV+EF         D  +G+         P  +K    +    L
Sbjct: 64  VRLHDVL--HSDKKLTLVFEFCDQDLKKYFDSCNGDLD-------PEIVKSFLFQLLKGL 114
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            + H+ +++HRD+K  N+L++ N  +K+A+FGL+R F   V    +A   T  Y  P+  
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RCYSAEVVTLWYRPPDVL 173
Query: 236 QCYQLTDKS-DVFSFGVVLIELISS 259
              +L   S D++S G +  EL ++
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANA 198

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 75/299 (25%), Positives = 124/299 (41%), Gaps = 38/299 (12%)
Query: 66  ARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
            R LG GGF   Y        E+  G+ V    L + + K  E+   E+ I   L + ++
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK--EKMSTEIAIHKSLDNPHV 104
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V  +G        + +V E     ++ + LH  R    A+  P       +T   + YLH
Sbjct: 105 VGFHGFFEDDDF-VYVVLEICRRRSLLE-LHKRRK---AVTEPEARYFMRQTIQGVQYLH 159
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
            + +IHRD+K  N+ L+++  VK+ DFGL+           T   GTP Y+ PE      
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTL-CGTPNYIAPEVLCKKG 218
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            + + D++S G +L  L+   P  +          S L    I+ K            ++
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFET---------SCLKETYIRIK------------KN 257
Query: 300 DNKVRRTINAVAE-LAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEMMTQSP 357
           +  V R IN VA  L  + L ++  LRP + ++L    +  + GY   +     +T  P
Sbjct: 258 EYSVPRHINPVASALIRRMLHADPTLRPSVAELLTD--EFFTSGYAPMRLPTSCLTVPP 314

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66  ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
           ++ LG G  G V    E +  + VA++ + +  +     +  +  +N   E++IL +L H
Sbjct: 154 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 213
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
             ++ +       + +  +V E +  G + D + G +          RLK A       +
Sbjct: 214 PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 261
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
              A+ YLH + IIHRD+K  N+LL   + +  +K+ DFG S++     T +     GTP
Sbjct: 262 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 319
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
            Y+ PE          +   D +S GV+L   +S  P    + HR +++L +
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 369

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 61.6 bits (148), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 105/232 (45%), Gaps = 37/232 (15%)
Query: 66  ARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY-----KRVEQFMN---EVDILARLRH 116
           ++ LG G  G V    E +  + VA++ + +  +     +  +  +N   E++IL +L H
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNH 199
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI------E 170
             ++ +       + +  +V E +  G + D + G +          RLK A       +
Sbjct: 200 PCIIKIKNFFD--AEDYYIVLELMEGGELFDKVVGNK----------RLKEATCKLYFYQ 247
Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
              A+ YLH + IIHRD+K  N+LL   + +  +K+ DFG S++     T +     GTP
Sbjct: 248 MLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGE--TSLMRTLCGTP 305
Query: 228 GYVDPEYHQCYQLTDKS---DVFSFGVVLIELISSMPAVDITRHRHEINLSN 276
            Y+ PE          +   D +S GV+L   +S  P    + HR +++L +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPP--FSEHRTQVSLKD 355

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/157 (28%), Positives = 74/157 (47%), Gaps = 28/157 (17%)
Query: 101 VEQFMNEVDILARLRHKNLVSLYGCTSRHSRE-LLLVYEFISNGTVADHLHGERAKPGAL 159
           +EQ   E+ IL +L H N+V L       + + L +V+E ++ G V +            
Sbjct: 80  IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME------------ 127
Query: 160 PWPTRLKIAIETA--------SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
             PT   ++ + A          + YLH   IIHRD+K +N+L+  +  +K+ADFG+S  
Sbjct: 128 -VPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNE 186
Query: 212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
           F      +S    GTP ++ PE      L++   +FS
Sbjct: 187 FKGSDALLSNT-VGTPAFMAPE-----SLSETRKIFS 217

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 102/223 (45%), Gaps = 24/223 (10%)
Query: 69  LGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVE-QFMNEVDILARLRHKNLVSLYGCT 126
           LG+G +G V     +  G  VA+K++   +      + + E+ IL   +H+N+++++   
Sbjct: 19  LGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ 78
Query: 127 SRHS----RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHAS 181
              S     E+ ++ E +        LH  R     +     ++  I +T  A+  LH S
Sbjct: 79  RPDSFENFNEVYIIQELMQTD-----LH--RVISTQMLSDDHIQYFIYQTLRAVKVLHGS 131
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           ++IHRD+K +N+L+++N  +KV DFGL+R+        S       G V+    + Y+  
Sbjct: 132 NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAP 191
Query: 242 D----------KSDVFSFGVVLIELISSMPAVDITRHRHEINL 274
           +            DV+S G +L EL    P      +RH++ L
Sbjct: 192 EVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLL 234

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 61/126 (48%), Gaps = 16/126 (12%)
Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL------------- 211
           L I I+ A A+ +LH+  ++HRD+K +NI    +  VKV DFGL                
Sbjct: 167 LHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTP 226
Query: 212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHE 271
            P + TH      GT  Y+ PE       + K D+FS G++L EL+ S  +  + R R  
Sbjct: 227 MPAYATHXGQV--GTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSF-STQMERVRII 283
Query: 272 INLSNL 277
            ++ NL
Sbjct: 284 TDVRNL 289

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 56/227 (24%), Positives = 104/227 (45%), Gaps = 21/227 (9%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVE 102
           N HG   F  G     + Y D  + LG GG G V+     D  + VA+K++   + + V+
Sbjct: 3   NIHG---FDLG-----SRYMD-LKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVK 53
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELL----LVYEFISNGTVADHLHGERA---K 155
             + E+ I+ RL H N+V ++        +L      + E  S   V +++  + A   +
Sbjct: 54  HALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLE 113
Query: 156 PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-NFCVKVADFGLSRLFPN 214
            G L          +    L Y+H+++++HRD+K  N+ ++  +  +K+ DFGL+R+   
Sbjct: 114 QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDP 173
Query: 215 HVTHVSTAPQG--TPGYVDPE-YHQCYQLTDKSDVFSFGVVLIELIS 258
           H +H     +G  T  Y  P         T   D+++ G +  E+++
Sbjct: 174 HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLT 220

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/227 (25%), Positives = 97/227 (42%), Gaps = 33/227 (14%)
Query: 62  YFDSA----RELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDIL 111
           YF S      ELG G F  V        G+    + +  K+L   +++++E+   E  I 
Sbjct: 19  YFQSMYQLFEELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLER---EARIC 75
Query: 112 ARLRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLK 166
             L+H N+V L+   S      L +++ ++ G      VA   + E      +       
Sbjct: 76  RLLKHPNIVRLHDSISEEGHHYL-IFDLVTGGELFEDIVAREYYSEADASHCIQ------ 128
Query: 167 IAIETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAP 223
              +   A+ + H   ++HRD+K  N+LL +      VK+ADFGL+              
Sbjct: 129 ---QILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGF 184
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
            GTPGY+ PE  +        D+++ GV+L I L+   P  D  +HR
Sbjct: 185 AGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR 231

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 50/305 (16%)
Query: 66  ARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
            R LG GGF   Y        E+  G+ V    L + + K  E+   E+ I   L + ++
Sbjct: 31  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK--EKMSTEIAIHKSLDNPHV 88
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V  +G        + +V E     ++ + LH  R    A+  P       +T   + YLH
Sbjct: 89  VGFHGFFEDDDF-VYVVLEICRRRSLLE-LHKRRK---AVTEPEARYFMRQTIQGVQYLH 143
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ------GTPGYVDPE 233
            + +IHRD+K  N+ L+++  VK+ DFGL+       T +    +      GTP Y+ PE
Sbjct: 144 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKDLCGTPNYIAPE 196
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ 293
                  + + D++S G +L  L+   P  +          S L    I+ K        
Sbjct: 197 VLCKKGHSFEVDIWSLGCILYTLLVGKPPFET---------SCLKETYIRIK-------- 239
Query: 294 TLGYESDNKVRRTINAVAE-LAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEM 352
               +++  V R IN VA  L  + L ++  LRP + ++L    +  + GY   +     
Sbjct: 240 ----KNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLTD--EFFTSGYAPMRLPTSC 293
Query: 353 MTQSP 357
           +T  P
Sbjct: 294 LTVPP 298

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 74/299 (24%), Positives = 123/299 (41%), Gaps = 38/299 (12%)
Query: 66  ARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
            R LG GGF   Y        E+  G+ V    L + + K  E+   E+ I   L + ++
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK--EKMSTEIAIHKSLDNPHV 104
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V  +G        + +V E     ++ + LH  R    A+  P       +T   + YLH
Sbjct: 105 VGFHGFFEDDDF-VYVVLEICRRRSLLE-LHKRRK---AVTEPEARYFMRQTIQGVQYLH 159
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
            + +IHRD+K  N+ L+++  VK+ DFGL+               GTP Y+ PE      
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLATKI-EFDGERKKXLCGTPNYIAPEVLCKKG 218
Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            + + D++S G +L  L+   P  +          S L    I+ K            ++
Sbjct: 219 HSFEVDIWSLGCILYTLLVGKPPFET---------SCLKETYIRIK------------KN 257
Query: 300 DNKVRRTINAVAE-LAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEMMTQSP 357
           +  V R IN VA  L  + L ++  LRP + ++L    +  + GY   +     +T  P
Sbjct: 258 EYSVPRHINPVASALIRRMLHADPTLRPSVAELLTD--EFFTSGYAPMRLPTSCLTVPP 314

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 60  TNYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
           ++ ++  +++G G FG      + Q    VAVK + E   K  E    E+     LRH N
Sbjct: 17  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI-ERGEKIDENVKREIINHRSLRHPN 75
Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           +V       T  H   L +V E+ S G + + +       G            +  S ++
Sbjct: 76  IVRFKEVILTPTH---LAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 128
Query: 177 YLHASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
           Y HA  + HRD+K  N LLD +    +K+ DFG S+    H    ST   GTP Y+ PE 
Sbjct: 129 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEV 186
Query: 235 HQCYQLTDK-SDVFSFGVVL-IELISSMPAVD 264
               +   K +DV+S GV L + L+ + P  D
Sbjct: 187 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 218

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVS 121
           + + + +G+G FG V+  +L +   VA+K++ ++     ++F N E+ I+  ++H N+V 
Sbjct: 42  YTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPNVVD 96
Query: 122 L----YGCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           L    Y    +     L LV E++         H  + K   +P         +   +L 
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLK-QTMPMLLIKLYMYQLLRSLA 155
Query: 177 YLHASDIIHRDVKTNNILLDNNFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY- 234
           Y+H+  I HRD+K  N+LLD    V K+ DFG +++      +VS     +  Y  PE  
Sbjct: 156 YIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXI--CSRYYRAPELI 213
Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMP 261
                 T   D++S G V+ EL+   P
Sbjct: 214 FGATNYTTNIDIWSTGCVMAELMQGQP 240

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/305 (24%), Positives = 126/305 (41%), Gaps = 50/305 (16%)
Query: 66  ARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
            R LG GGF   Y        E+  G+ V    L + + K  E+   E+ I   L + ++
Sbjct: 47  GRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQK--EKMSTEIAIHKSLDNPHV 104
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V  +G        + +V E     ++ + LH  R    A+  P       +T   + YLH
Sbjct: 105 VGFHGFFEDDDF-VYVVLEICRRRSLLE-LHKRRK---AVTEPEARYFMRQTIQGVQYLH 159
Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ------GTPGYVDPE 233
            + +IHRD+K  N+ L+++  VK+ DFGL+       T +    +      GTP Y+ PE
Sbjct: 160 NNRVIHRDLKLGNLFLNDDMDVKIGDFGLA-------TKIEFDGERKKDLCGTPNYIAPE 212
Query: 234 YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ 293
                  + + D++S G +L  L+   P  +          S L    I+ K        
Sbjct: 213 VLCKKGHSFEVDIWSLGCILYTLLVGKPPFET---------SCLKETYIRIK-------- 255
Query: 294 TLGYESDNKVRRTINAVAE-LAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEM 352
               +++  V R IN VA  L  + L ++  LRP + ++L    +  + GY   +     
Sbjct: 256 ----KNEYSVPRHINPVASALIRRMLHADPTLRPSVAELLTD--EFFTSGYAPMRLPTSC 309
Query: 353 MTQSP 357
           +T  P
Sbjct: 310 LTVPP 314

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 47/246 (19%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF----MNEVDIL 111
           +E + Y   A+ +G G FG V+     + G+ VA+K++   N K  E F    + E+ IL
Sbjct: 15  DEVSKYEKLAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 71
Query: 112 ARLRHKNLVSLYG-CTSRHS------RELLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
             L+H+N+V+L   C ++ S        + LV++F  +  +A  L     K       + 
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEH-DLAGLLSNVLVKFTL----SE 126
Query: 165 LKIAIETA-SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-------PNH- 215
           +K  ++   + L Y+H + I+HRD+K  N+L+  +  +K+ADFGL+R F       PN  
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 216 ----VTHVSTAPQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRH 268
               VT     P+   G   Y  P            D++  G ++ E+ +  P +     
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPP-----------IDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 269 RHEINL 274
           +H++ L
Sbjct: 236 QHQLAL 241

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  +   R VA+K++    ++   ++ +
Sbjct: 19  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 71
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL   RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 72  REIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 128
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 129 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD 181
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 182 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 60  TNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
           T+ +    ELG G F  V        G+    + +  K+L   +++++E+   E  I   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
           L+H N+V L+   S      L V++ ++ G      VA   + E      +         
Sbjct: 60  LKHPNIVRLHDSISEEGFHYL-VFDLVTGGELFEDIVAREYYSEADASHCIQ-------- 110
Query: 169 IETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLS-RLFPNHVTHVSTAPQ 224
            +   ++ + H + I+HRD+K  N+LL        VK+ADFGL+  +  +       A  
Sbjct: 111 -QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-- 167
Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
           GTPGY+ PE  +        D+++ GV+L I L+   P  D  +HR
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHR 213

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 47/246 (19%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF----MNEVDIL 111
           +E + Y   A+ +G G FG V+     + G+ VA+K++   N K  E F    + E+ IL
Sbjct: 15  DEVSKYEKLAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 71
Query: 112 ARLRHKNLVSLYG-CTSRHSR------ELLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
             L+H+N+V+L   C ++ S        + LV++F  +  +A  L     K       + 
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD-LAGLLSNVLVKFTL----SE 126
Query: 165 LKIAIETA-SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-------PNH- 215
           +K  ++   + L Y+H + I+HRD+K  N+L+  +  +K+ADFGL+R F       PN  
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 216 ----VTHVSTAPQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRH 268
               VT     P+   G   Y  P            D++  G ++ E+ +  P +     
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPP-----------IDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 269 RHEINL 274
           +H++ L
Sbjct: 236 QHQLAL 241

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 31/226 (13%)
Query: 60  TNYFDSARELGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
           T+ +    ELG G F  V        G+    + +  K+L   +++++E+   E  I   
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
           L+H N+V L+   S      L V++ ++ G      VA   + E      +         
Sbjct: 60  LKHPNIVRLHDSISEEGFHYL-VFDLVTGGELFEDIVAREYYSEADASHCIQ-------- 110
Query: 169 IETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLS-RLFPNHVTHVSTAPQ 224
            +   ++ + H + I+HRD+K  N+LL        VK+ADFGL+  +  +       A  
Sbjct: 111 -QILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFA-- 167
Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
           GTPGY+ PE  +        D+++ GV+L I L+   P  D  +HR
Sbjct: 168 GTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVGYPPFWDEDQHR 213

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 47/246 (19%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF----MNEVDIL 111
           +E + Y   A+ +G G FG V+     + G+ VA+K++   N K  E F    + E+ IL
Sbjct: 15  DEVSKYEKLAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 71
Query: 112 ARLRHKNLVSLYG-CTSRHSR------ELLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
             L+H+N+V+L   C ++ S        + LV++F  +  +A  L     K       + 
Sbjct: 72  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTL----SE 126
Query: 165 LKIAIETA-SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-------PNH- 215
           +K  ++   + L Y+H + I+HRD+K  N+L+  +  +K+ADFGL+R F       PN  
Sbjct: 127 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 216 ----VTHVSTAPQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRH 268
               VT     P+   G   Y  P            D++  G ++ E+ +  P +     
Sbjct: 187 XNRVVTLWYRPPELLLGERDYGPP-----------IDLWGAGCIMAEMWTRSPIMQGNTE 235
Query: 269 RHEINL 274
           +H++ L
Sbjct: 236 QHQLAL 241

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 47/246 (19%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF----MNEVDIL 111
           +E + Y   A+ +G G FG V+     + G+ VA+K++   N K  E F    + E+ IL
Sbjct: 14  DEVSKYEKLAK-IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKIL 70
Query: 112 ARLRHKNLVSLYG-CTSRHSR------ELLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
             L+H+N+V+L   C ++ S        + LV++F  +  +A  L     K       + 
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTL----SE 125
Query: 165 LKIAIETA-SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-------PNH- 215
           +K  ++   + L Y+H + I+HRD+K  N+L+  +  +K+ADFGL+R F       PN  
Sbjct: 126 IKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 216 ----VTHVSTAPQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRH 268
               VT     P+   G   Y  P            D++  G ++ E+ +  P +     
Sbjct: 186 XNRVVTLWYRPPELLLGERDYGPP-----------IDLWGAGCIMAEMWTRSPIMQGNTE 234
Query: 269 RHEINL 274
           +H++ L
Sbjct: 235 QHQLAL 240

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/208 (26%), Positives = 93/208 (44%), Gaps = 21/208 (10%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNY---KRVEQ--FMNEVDILARLRHK 117
           F+  + +G G FG V   +L++   V   ++  N +   KR E   F  E D+L     K
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKIL-NKWEMLKRAETACFREERDVLVNGDSK 134
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIETASA 174
            + +L+    +    L LV ++   G   T+         +  A  +   + IAI++   
Sbjct: 135 WITTLHY-AFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
           L Y      +HRD+K +NIL+D N  +++ADFG         T  S+   GTP Y+ PE 
Sbjct: 194 LHY------VHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEI 247
Query: 235 HQCYQ-----LTDKSDVFSFGVVLIELI 257
            Q  +        + D +S GV + E++
Sbjct: 248 LQAMEGGKGRYGPECDWWSLGVCMYEML 275

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 130/303 (42%), Gaps = 28/303 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQ--FMNEVDILARLRHKN 118
           ++  + +G G FG V     +  R V   +L       KR +   F  E DI+A      
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 135
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +V L+    +  R L +V E++  G + + +           W  R   A E   AL  +
Sbjct: 136 VVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KW-ARFYTA-EVVLALDAI 189
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H+   IHRDVK +N+LLD +  +K+ADFG   ++    +    TA  GTP Y+ PE  + 
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKS 248
Query: 238 YQLTD-----KSDVFSFGVVLIE-LISSMPAVD---ITRHRHEINLSNLAINKIQNKALH 288
            Q  D     + D +S GV L E L+   P      +  +   +N  N       N    
Sbjct: 249 -QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 307
Query: 289 ELVDQTLGYESDNKVRRTINAVAE----LAFQCLQ-SEKDLRPYMVDVL-DALRDIESDG 342
           E  +    + +D +VR   N V E    L F+  Q + + LR  +  V+ D   DI++  
Sbjct: 308 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSN 367
Query: 343 YDD 345
           +DD
Sbjct: 368 FDD 370

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 117/264 (44%), Gaps = 49/264 (18%)
Query: 69  LGDGGFGTVY---------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           LG G F  ++         YG+L +   V +K L + +    E F     ++++L HK+L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETE-VLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 120 VSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           V  YG C      E +LV EF+  G++  +L   +     L W  +L++A + A+A+ +L
Sbjct: 75  VLNYGVCVC--GDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAAAMHFL 129
Query: 179 HASDIIHRDVKTNNILL--------DNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGY 229
             + +IH +V   NILL         N   +K++D G+S  + P  +       Q    +
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL------QERIPW 183
Query: 230 VDPE-YHQCYQLTDKSDVFSFGVVLIELISS----MPAVDITRH------RHEINLSNLA 278
           V PE       L   +D +SFG  L E+ S     + A+D  R       RH++     A
Sbjct: 184 VPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAA 243
Query: 279 INKIQNKALHELVDQTLGYESDNK 302
                   L  L++  + YE D++
Sbjct: 244 -------ELANLINNCMDYEPDHR 260

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 105/227 (46%), Gaps = 31/227 (13%)
Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVY--YGELQDGRAVAVKRLYENNYKR-VEQFM 105
           QVF  G      +Y      +G+G +G V   Y  +   R VA+K++    ++   ++ +
Sbjct: 19  QVFDVGPRYTNLSY------IGEGAYGMVCSAYDNVNKVR-VAIKKISPFEHQTYCQRTL 71
Query: 106 NEVDILARLRHKNLVSL----YGCTSRHSRELLLVYEFISNGTV----ADHLHGERAKPG 157
            E+ IL   RH+N++ +       T    +++ +V + +           HL  +     
Sbjct: 72  REIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHI--- 128
Query: 158 ALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHV 216
                       +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+  P+H 
Sbjct: 129 -------CYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHD 181
Query: 217 -THVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            T   T    T  Y  PE     +   KS D++S G +L E++S+ P
Sbjct: 182 HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 228

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/208 (27%), Positives = 104/208 (50%), Gaps = 30/208 (14%)
Query: 66  ARELGDGGFGTVYYGELQDGRAV--AVKRLYENNYKRV---EQFM--NEVDILARLRHKN 118
           A +LG G FG V+       R V  + K+ Y   + +V   +Q +   E+ IL   RH+N
Sbjct: 10  AEDLGRGEFGIVH-------RCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRN 62
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI--ETASALT 176
           ++ L+  +     EL++++EFIS   +      ER    A     R  ++   +   AL 
Sbjct: 63  ILHLHE-SFESMEELVMIFEFISGLDIF-----ERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 177 YLHASDIIHRDVKTNNILLDN--NFCVKVADFGLSR-LFP-NHVTHVSTAPQGTPGYVDP 232
           +LH+ +I H D++  NI+     +  +K+ +FG +R L P ++   + TAP+    Y  P
Sbjct: 117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPE----YYAP 172
Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSM 260
           E HQ   ++  +D++S G ++  L+S +
Sbjct: 173 EVHQHDVVSTATDMWSLGTLVYVLLSGI 200

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 83/303 (27%), Positives = 130/303 (42%), Gaps = 28/303 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQ--FMNEVDILARLRHKN 118
           ++  + +G G FG V     +  R V   +L       KR +   F  E DI+A      
Sbjct: 76  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 135
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +V L+    +  R L +V E++  G + + +           W  R   A E   AL  +
Sbjct: 136 VVQLF-YAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPE---KW-ARFYTA-EVVLALDAI 189
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H+   IHRDVK +N+LLD +  +K+ADFG   ++    +    TA  GTP Y+ PE  + 
Sbjct: 190 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKS 248
Query: 238 YQLTD-----KSDVFSFGVVLIE-LISSMPAVD---ITRHRHEINLSNLAINKIQNKALH 288
            Q  D     + D +S GV L E L+   P      +  +   +N  N       N    
Sbjct: 249 -QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 307
Query: 289 ELVDQTLGYESDNKVRRTINAVAE----LAFQCLQ-SEKDLRPYMVDVL-DALRDIESDG 342
           E  +    + +D +VR   N V E    L F+  Q + + LR  +  V+ D   DI++  
Sbjct: 308 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSN 367
Query: 343 YDD 345
           +DD
Sbjct: 368 FDD 370

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 131/303 (43%), Gaps = 28/303 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQ--FMNEVDILARLRHKN 118
           ++  + +G G FG V     +  R V   +L       KR +   F  E DI+A      
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +V L+    +  R L +V E++  G +  +L      P    W  R   A E   AL  +
Sbjct: 131 VVQLF-YAFQDDRYLYMVMEYMPGGDLV-NLMSNYDVPEK--W-ARFYTA-EVVLALDAI 184
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
           H+   IHRDVK +N+LLD +  +K+ADFG   ++    +    TA  GTP Y+ PE  + 
Sbjct: 185 HSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKS 243
Query: 238 YQLTD-----KSDVFSFGVVLIE-LISSMPAVD---ITRHRHEINLSNLAINKIQNKALH 288
            Q  D     + D +S GV L E L+   P      +  +   +N  N       N    
Sbjct: 244 -QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISK 302
Query: 289 ELVDQTLGYESDNKVRRTINAVAE----LAFQCLQ-SEKDLRPYMVDVL-DALRDIESDG 342
           E  +    + +D +VR   N V E    L F+  Q + + LR  +  V+ D   DI++  
Sbjct: 303 EAKNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLSSDIDTSN 362
Query: 343 YDD 345
           +DD
Sbjct: 363 FDD 365

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 64/254 (25%), Positives = 109/254 (42%), Gaps = 39/254 (15%)
Query: 34  SSKVDLEKGGNYHGVQVFSYGELEEATNYFDSAR---ELGDGGFGTVYYG------ELQD 84
           SS VDL       G +   +  +   T + D  +   ELG G F  V         +   
Sbjct: 8   SSGVDL-------GTENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYA 60
Query: 85  GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG- 143
            + +  K+L   +++++E+   E  I   L+H N+V L+   S      L V++ ++ G 
Sbjct: 61  AKIINTKKLSARDHQKLER---EARICRLLKHPNIVRLHDSISEEGFHYL-VFDLVTGGE 116
Query: 144 ----TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF 199
                VA   + E      +          +   ++ ++H  DI+HRD+K  N+LL +  
Sbjct: 117 LFEDIVAREYYSEADASHCIH---------QILESVNHIHQHDIVHRDLKPENLLLASKC 167
Query: 200 ---CVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVL-IE 255
               VK+ADFGL+ +             GTPGY+ PE  +        D+++ GV+L I 
Sbjct: 168 KGAAVKLADFGLA-IEVQGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYIL 226
Query: 256 LISSMPAVDITRHR 269
           L+   P  D  +H+
Sbjct: 227 LVGYPPFWDEDQHK 240

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 60  TNYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
           ++ ++  +++G G FG      + Q    VAVK + E   K       E+     LRH N
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI-ERGEKIAANVKREIINHRSLRHPN 76
Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           +V       T  H   L +V E+ S G + + +       G            +  S ++
Sbjct: 77  IVRFKEVILTPTH---LAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 129
Query: 177 YLHASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
           Y HA  + HRD+K  N LLD +    +K+ DFG S+    H    ST   GTP Y+ PE 
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEV 187
Query: 235 HQCYQLTDK-SDVFSFGVVL-IELISSMPAVD 264
               +   K +DV+S GV L + L+ + P  D
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 94/212 (44%), Gaps = 17/212 (8%)
Query: 60  TNYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
           ++ ++  +++G G FG      + Q    VAVK + E   K  E    E+     LRH N
Sbjct: 18  SDRYELVKDIGAGNFGVARLMRDKQANELVAVKYI-ERGEKIDENVKREIINHRSLRHPN 76
Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           +V       T  H   L +V E+ S G + + +       G            +  S ++
Sbjct: 77  IVRFKEVILTPTH---LAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 129
Query: 177 YLHASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
           Y HA  + HRD+K  N LLD +    +K+ADFG S+    H    S    GTP Y+ PE 
Sbjct: 130 YAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV--GTPAYIAPEV 187
Query: 235 HQCYQLTDK-SDVFSFGVVL-IELISSMPAVD 264
               +   K +DV+S GV L + L+ + P  D
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 69/279 (24%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR- 115
           +   N   S + LG G  GTV +     GR VAVKR+  +     +  + E+ +L     
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDD 67
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR---LKIAIETA 172
           H N++  Y C+    R L +  E + N  + D +  +      L        + +  + A
Sbjct: 68  HPNVIRYY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 173 SALTYLHASDIIHRDVKTNNILLDN-------------NFCVKVADFGLSRLFPNHVTHV 219
           S + +LH+  IIHRD+K  NIL+               N  + ++DFGL +   +  +  
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185
Query: 220 ST---APQGTPGYVDPE-------YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHR 269
            T    P GT G+  PE            +LT   D+FS G V   ++S        ++ 
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 270 HEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTIN 308
            E N+     +  + K LH   D++L  E+ + + + I+
Sbjct: 246 RESNIIRGIFSLDEMKCLH---DRSLIAEATDLISQMID 281

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 40/148 (27%), Positives = 68/148 (45%), Gaps = 21/148 (14%)
Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-CTS 127
           +G G FG VY+G      A+ +  +  +N  +++ F  EV    + RH+N+V   G C S
Sbjct: 41  IGKGRFGQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS 100
Query: 128 RHSRELLL-------VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
                ++        +Y  + +  +   ++  R            +IA E    + YLHA
Sbjct: 101 PPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTR------------QIAQEIVKGMGYLHA 148
Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGL 208
             I+H+D+K+ N+  DN   V + DFGL
Sbjct: 149 KGILHKDLKSKNVFYDNGKVV-ITDFGL 175

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 73  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLI 127
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 183
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 121/260 (46%), Gaps = 29/260 (11%)
Query: 34  SSKVDLEKGGNYHGVQVFSYGELEEATNYFD-SARELGDGGFGTVYY----GELQDGRAV 88
           SS VDL       G +   +  +E   N++  +++ELG G F  V         Q+  A 
Sbjct: 8   SSGVDL-------GTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAK 60
Query: 89  AVKRLYENNYKRVEQFMNEVDIL----ARLRHKNLVSLYGCTSRHSRELLLVYEFISNGT 144
            +K+       R E  ++E+ +L    +  R  NL  +Y  TS    E++L+ E+ + G 
Sbjct: 61  FLKKRRRGQDCRAE-ILHEIAVLELAKSCPRVINLHEVYENTS----EIILILEYAAGGE 115
Query: 145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC---V 201
           +      E A+   +     +++  +    + YLH ++I+H D+K  NILL + +    +
Sbjct: 116 IFSLCLPELAE--MVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDI 173
Query: 202 KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SM 260
           K+ DFG+SR    H   +     GTP Y+ PE      +T  +D+++ G++   L++ + 
Sbjct: 174 KIVDFGMSRKI-GHACELREI-MGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTS 231
Query: 261 PAVDITRHRHEINLSNLAIN 280
           P V        +N+S + ++
Sbjct: 232 PFVGEDNQETYLNISQVNVD 251

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 63  FDSARELGDGGFGTVYY----GELQDGRAVAVKRLYE----NNYKRVEQFMNEVDILARL 114
           F+  + LG G +G V+          G+  A+K L +       K  E    E  +L  +
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI---ET 171
           R    +       +   +L L+ ++I+ G +  HL  +R +       T  ++ I   E 
Sbjct: 116 RQSPFLVTLHYAFQTETKLHLILDYINGGELFTHL-SQRERF------TEHEVQIYVGEI 168
Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
             AL +LH   II+RD+K  NILLD+N  V + DFGLS+ F    T  +    GT  Y+ 
Sbjct: 169 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 228
Query: 232 PEYHQCYQLT-DKS-DVFSFGVVLIELISS 259
           P+  +      DK+ D +S GV++ EL++ 
Sbjct: 229 PDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 101/226 (44%), Gaps = 21/226 (9%)
Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYE-----NNYKRVEQFMNEVDILARLRHKNLVSL 122
           +G+G +G V     +  G+ VA+K++        N KR    + E+ IL   +H N++++
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT---LRELKILKHFKHDNIIAI 118
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK----IAIETASALTYL 178
                   R  +   EF S   V D +  +  +      P  L+       +    L Y+
Sbjct: 119 KDIL----RPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYM 174
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF---PNHVTHVSTAPQGTPGYVDPEYH 235
           H++ +IHRD+K +N+L++ N  +K+ DFG++R     P    +  T    T  Y  PE  
Sbjct: 175 HSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 234
Query: 236 -QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAIN 280
              ++ T   D++S G +  E+++         + H++ L  + + 
Sbjct: 235 LSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLG 280

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 115/263 (43%), Gaps = 47/263 (17%)
Query: 69  LGDGGFGTVY---------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           LG G F  ++         YG+L +   V +K L + +    E F     ++++L HK+L
Sbjct: 16  LGQGTFTKIFKGVRREVGDYGQLHETE-VLLKVLDKAHRNYSESFFEAASMMSKLSHKHL 74
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V  YG       E +LV EF+  G++  +L   +     L W  +L++A + A A+ +L 
Sbjct: 75  VLNYG-VCFCGDENILVQEFVKFGSLDTYLKKNKNCINIL-W--KLEVAKQLAWAMHFLE 130
Query: 180 ASDIIHRDVKTNNILL--------DNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYV 230
            + +IH +V   NILL         N   +K++D G+S  + P  +       Q    +V
Sbjct: 131 ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDIL------QERIPWV 184
Query: 231 DPE-YHQCYQLTDKSDVFSFGVVLIELISS----MPAVDITRH------RHEINLSNLAI 279
            PE       L   +D +SFG  L E+ S     + A+D  R       RH++     A 
Sbjct: 185 PPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYEDRHQLPAPKAA- 243
Query: 280 NKIQNKALHELVDQTLGYESDNK 302
                  L  L++  + YE D++
Sbjct: 244 ------ELANLINNCMDYEPDHR 260

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 17/225 (7%)
Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
           E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L  +
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIE 170
           +H+N++ L    +  +R L    E  ++  +  HL G       K   L       +  +
Sbjct: 86  KHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 140
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
               L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  Y 
Sbjct: 141 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRWYR 196
Query: 231 DPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
            PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGXVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 106/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L +   +    ++   E+ +L 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLK 88
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 89  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 143
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 144 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 199
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 84  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRW 194
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 97  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 151
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 152 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 207
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 84  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTADEMTGYVATRW 194
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 83  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 138 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 193
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 73  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 183
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 22  IWEVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 82  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 137 YQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRW 192
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 96  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 150
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 151 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 206
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 253

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 27  IWEVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 86
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 87  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 141
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 142 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 197
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 198 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 244

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 83  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 138 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 193
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 88  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 142
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 143 YQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRW 198
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 245

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 82  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 137 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 192
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/178 (28%), Positives = 83/178 (46%), Gaps = 16/178 (8%)
Query: 69  LGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVSLYG-- 124
           LG G    V+ G   + G   A+K     ++ R V+  M E ++L +L HKN+V L+   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 125 --CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
              T+RH    +L+ EF   G++   L  E +    LP    L +  +    + +L  + 
Sbjct: 77  EETTTRHK---VLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 183 IIHRDVKTNNILL----DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           I+HR++K  NI+     D     K+ DFG +R   +    VS    GT  Y+ P+ ++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSL--YGTEEYLHPDMYE 188

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 14/206 (6%)
Query: 106 NEVDILARLRHKNLVSLYGCT-SRHSRELLLVYEFISNGT--VADHLHGERAKPGALPWP 162
            E+ +L RLRHKN++ L     +   +++ +V E+   G   + D +  +R      P  
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-----FPVC 109
Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVST 221
                  +    L YLH+  I+H+D+K  N+LL     +K++  G++  L P        
Sbjct: 110 QAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCR 169
Query: 222 APQGTPGYVDPEYHQCYQLTD--KSDVFSFGVVLIELISSMPAVD---ITRHRHEINLSN 276
             QG+P +  PE           K D++S GV L  + + +   +   I +    I   +
Sbjct: 170 TSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS 229
Query: 277 LAINKIQNKALHELVDQTLGYESDNK 302
            AI       L +L+   L YE   +
Sbjct: 230 YAIPGDCGPPLSDLLKGMLEYEPAKR 255

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 97  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 151
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 152 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 207
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 52/94 (55%), Gaps = 5/94 (5%)
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           + + A  + +L +   IHRD+   NILL  N  VK+ DFGL+R    +  +V       P
Sbjct: 205 SFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLP 264
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
             ++ PE  + + Y  + KSDV+S+GV+L E+ S
Sbjct: 265 LKWMAPESIFDKIY--STKSDVWSYGVLLWEIFS 296

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 17/225 (7%)
Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
           E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L  +
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIE 170
           +H+N++ L    +  +R L    E  ++  +  HL G       K   L       +  +
Sbjct: 102 KHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 156
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
               L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  Y 
Sbjct: 157 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 212
Query: 231 DPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
            PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 213 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 257

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 17/225 (7%)
Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
           E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIE 170
           +H+N++ L    +  +R L    E  ++  +  HL G       K   L       +  +
Sbjct: 79  KHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
               L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  Y 
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 231 DPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
            PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 28  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 88  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 142
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 143 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 198
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 199 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 245

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 15  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 74
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 75  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 129
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 130 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 185
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 186 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 232

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 79  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 134 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 189
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 82  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 137 YQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLAR----HTDDEMTGYVATRW 192
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 89  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 143
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 144 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 199
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 29  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 89  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 143
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 144 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 199
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 200 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 246

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 24  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 84  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 138
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 139 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 194
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 241

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 79  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 134 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 189
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 22  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 82  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 136
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 137 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 192
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 193 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 239

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 16  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 75
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 76  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 130
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 131 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 186
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 187 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 233

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 116/275 (42%), Gaps = 31/275 (11%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR- 115
           +   N   S + LG G  GTV +     GR VAVKR+  +     +  + E+ +L     
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDD 85
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR---LKIAIETA 172
           H N++  Y C+    R L +  E + N  + D +  +      L        + +  + A
Sbjct: 86  HPNVIRYY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 173 SALTYLHASDIIHRDVKTNNILLDN-------------NFCVKVADFGLSRLFPNHVTHV 219
           S + +LH+  IIHRD+K  NIL+               N  + ++DFGL +   +     
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 220 S---TAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
                 P GT G+  PE  +     +LT   D+FS G V   ++S        ++  E N
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 274 LSNLAINKIQNKALHELVDQTLGYESDNKVRRTIN 308
           +     +  + K LH   D++L  E+ + + + I+
Sbjct: 264 IIRGIFSLDEMKCLH---DRSLIAEATDLISQMID 295

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 74  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 128
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 129 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 184
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 231

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 36  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 96  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 150
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 151 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 206
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 207 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 253

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/275 (24%), Positives = 116/275 (42%), Gaps = 31/275 (11%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR- 115
           +   N   S + LG G  GTV +     GR VAVKR+  +     +  + E+ +L     
Sbjct: 29  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDD 85
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR---LKIAIETA 172
           H N++  Y C+    R L +  E + N  + D +  +      L        + +  + A
Sbjct: 86  HPNVIRYY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 143
Query: 173 SALTYLHASDIIHRDVKTNNILLDN-------------NFCVKVADFGLSRLFPNHVTHV 219
           S + +LH+  IIHRD+K  NIL+               N  + ++DFGL +   +     
Sbjct: 144 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 203
Query: 220 S---TAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
                 P GT G+  PE  +     +LT   D+FS G V   ++S        ++  E N
Sbjct: 204 RXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRESN 263
Query: 274 LSNLAINKIQNKALHELVDQTLGYESDNKVRRTIN 308
           +     +  + K LH   D++L  E+ + + + I+
Sbjct: 264 IIRGIFSLDEMKCLH---DRSLIAEATDLISQMID 295

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 14  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 74  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 128
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 129 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 184
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 185 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 231

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 79  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 134 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 189
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 23  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 83  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 137
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 138 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 193
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 194 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 15/216 (6%)
Query: 60  TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           ++ +D  +++G G FG       +  + +   +  E      E    E+     LRH N+
Sbjct: 19  SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNI 78
Query: 120 VSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           V       T  H   L ++ E+ S G + + +       G            +  S ++Y
Sbjct: 79  VRFKEVILTPTH---LAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQLLSGVSY 131
Query: 178 LHASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            H+  I HRD+K  N LLD +    +K+ DFG S+    H    ST   GTP Y+ PE  
Sbjct: 132 CHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVL 189
Query: 236 QCYQLTDK-SDVFSFGVVL-IELISSMPAVDITRHR 269
              +   K +DV+S GV L + L+ + P  D    R
Sbjct: 190 LRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPR 225

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 107/224 (47%), Gaps = 31/224 (13%)
Query: 55  ELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYE-------------NNYK-- 99
           E ++  N +   R L  G F  +   E +D +  A+K+ YE             NN K  
Sbjct: 25  EKDKYINDYRIIRTLNQGKFNKIILCE-KDNKFYALKK-YEKSLLEKKRDFTKSNNDKIS 82
Query: 100 ---RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVA--DHLHGERA 154
              + + F NE+ I+  ++++  ++  G  + +  E+ ++YE++ N ++   D       
Sbjct: 83  IKSKYDDFKNELQIITDIKNEYCLTCEGIITNYD-EVYIIYEYMENDSILKFDEYFFVLD 141
Query: 155 KPGALPWPTR-LKIAIETA-SALTYLH-ASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
           K      P + +K  I++  ++ +Y+H   +I HRDVK +NIL+D N  VK++DFG S  
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201
Query: 212 FPNHVTHVSTAPQGTPGYVDPEY--HQCYQLTDKSDVFSFGVVL 253
               V       +GT  ++ PE+  ++      K D++S G+ L
Sbjct: 202 M---VDKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICL 242

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/204 (25%), Positives = 94/204 (46%), Gaps = 21/204 (10%)
Query: 69  LGDGGFGTVYYGELQ-DGRAVAVKRLYE-----NNYKRVEQFMNEVDILARLRHKNLVSL 122
           +G+G +G V     +  G+ VA+K++        N KR    + E+ IL   +H N++++
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRT---LRELKILKHFKHDNIIAI 119
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK----IAIETASALTYL 178
                   R  +   EF S   V D +  +  +      P  L+       +    L Y+
Sbjct: 120 KDIL----RPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYM 175
Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF---PNHVTHVSTAPQGTPGYVDPEYH 235
           H++ +IHRD+K +N+L++ N  +K+ DFG++R     P    +  T    T  Y  PE  
Sbjct: 176 HSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELM 235
Query: 236 -QCYQLTDKSDVFSFGVVLIELIS 258
              ++ T   D++S G +  E+++
Sbjct: 236 LSLHEYTQAIDLWSVGCIFGEMLA 259

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 17/212 (8%)
Query: 60  TNYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
           ++ ++  +++G G FG      + Q    VAVK + E   K  E    E+     LRH N
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI-ERGEKIDENVKREIINHRSLRHPN 76
Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           +V       T  H   L +V E+ S G + + +       G            +  S ++
Sbjct: 77  IVRFKEVILTPTH---LAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 129
Query: 177 YLHASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
           Y HA  + HRD+K  N LLD +    +K+  FG S+    H    ST   GTP Y+ PE 
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTV--GTPAYIAPEV 187
Query: 235 HQCYQLTDK-SDVFSFGVVL-IELISSMPAVD 264
               +   K +DV+S GV L + L+ + P  D
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 73  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 183
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 103/225 (45%), Gaps = 17/225 (7%)
Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
           E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIE 170
           +H+N++ L    +  +R L    E  ++  +  HL G       K   L       +  +
Sbjct: 79  KHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQ 133
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
               L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL R    H     T    T  Y 
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCR----HTDDEMTGYVATRWYR 189
Query: 231 DPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
            PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 190 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 19  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 79  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 133
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 134 YQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRW 189
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 190 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 236

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 56/225 (24%), Positives = 95/225 (42%), Gaps = 29/225 (12%)
Query: 60  TNYFDSARELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
           T  +    ELG G F  V        G+      +  K+L   +++++E+   E  I   
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLER---EARICRL 66
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
           L+H N+V L+   S      L +++ ++ G      VA   + E      +         
Sbjct: 67  LKHPNIVRLHDSISEEGHHYL-IFDLVTGGELFEDIVAREYYSEADASHCIQ-------- 117
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAPQG 225
            +   A+ + H   ++HR++K  N+LL +      VK+ADFGL+               G
Sbjct: 118 -QILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE-QQAWFGFAG 175
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
           TPGY+ PE  +        D+++ GV+L I L+   P  D  +HR
Sbjct: 176 TPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR 220

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 104/225 (46%), Gaps = 17/225 (7%)
Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
           E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L  +
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIE 170
           +H+N++ L    +  +R L    E  ++  +  HL G       K   L       +  +
Sbjct: 85  KHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 139
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
               L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  Y 
Sbjct: 140 ILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLAR----HTDDEMTGYVATRWYR 195
Query: 231 DPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
            PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 196 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 240

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 37  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 97  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 151
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H          T  
Sbjct: 152 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMXGXVATRW 207
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 208 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 254

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 100/225 (44%), Gaps = 17/225 (7%)
Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARL 114
           E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L  +
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIAIE 170
           +H+N++ L    +  +R L    E  ++  +  HL G       K   L       +  +
Sbjct: 79  KHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQ 133
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
               L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  Y 
Sbjct: 134 ILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRWYR 189
Query: 231 DPEYH-QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL 274
            PE            D++S G ++ EL++       T H  ++ L
Sbjct: 190 APEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 97/225 (43%), Gaps = 29/225 (12%)
Query: 60  TNYFDSARELGDGGFGTV------YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
           T+ +    ++G G F  V        G     + +  K+L   +++++E+   E  I   
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLER---EARICRL 59
Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLKIA 168
           L+H N+V L+   S      L V++ ++ G      VA   + E      +         
Sbjct: 60  LKHSNIVRLHDSISEEGFHYL-VFDLVTGGELFEDIVAREYYSEADASHCIQ-------- 110
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVSTAPQG 225
            +   A+ + H   ++HRD+K  N+LL +      VK+ADFGL+ +             G
Sbjct: 111 -QILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAG 168
Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVL-IELISSMPAVDITRHR 269
           TPGY+ PE  +        D+++ GV+L I L+   P  D  +H+
Sbjct: 169 TPGYLSPEVLRKEAYGKPVDIWACGVILYILLVGYPPFWDEDQHK 213

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 93/206 (45%), Gaps = 17/206 (8%)
Query: 63  FDSARELGDGGFGTVYYGELQDG-RAVAVKRLYENNY---KRVEQ--FMNEVDILARLRH 116
           F+  + +G G FG V   ++++  R  A+K L  N +   KR E   F  E D+L     
Sbjct: 92  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKIL--NKWEMLKRAETACFREERDVLVNGDC 149
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           + + +L+    +    L LV ++   G +   L     K   LP         E   A+ 
Sbjct: 150 QWITALH-YAFQDENHLYLVMDYYVGGDLLTLLSKFEDK---LPEDMARFYIGEMVLAID 205
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
            +H    +HRD+K +N+LLD N  +++ADFG      +  T  S+   GTP Y+ PE  Q
Sbjct: 206 SIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQ 265
Query: 237 CYQ-----LTDKSDVFSFGVVLIELI 257
             +        + D +S GV + E++
Sbjct: 266 AMEDGMGKYGPECDWWSLGVCMYEML 291

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 95/207 (45%), Gaps = 35/207 (16%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARLRHKNLVSLYGC 125
           +G G +G V    + + G  VA+K+LY      +  ++   E+ +L  +RH+N++ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 126 -----TSRHSRELLLVYEFISN--GTVADHLH-GERAKPGALPWPTRLKIAI-ETASALT 176
                T     +  LV  F+    G +  H   GE           R++  + +    L 
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGE----------DRIQFLVYQMLKGLR 142
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-----LFPNHVTHVSTAPQGTPGYVD 231
           Y+HA+ IIHRD+K  N+ ++ +  +K+ DFGL+R     +    VT    AP+    ++ 
Sbjct: 143 YIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTRWYRAPEVILNWM- 201
Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELIS 258
                  + T   D++S G ++ E+I+
Sbjct: 202 -------RYTQTVDIWSVGCIMAEMIT 221

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 19/207 (9%)
Query: 63  FDSARELGDGGFGTVYYGELQDG-RAVAVKRLYENNY---KRVEQ--FMNEVDILARLRH 116
           F+  + +G G FG V   ++++  R  A+K L  N +   KR E   F  E D+L     
Sbjct: 76  FEIIKVIGRGAFGEVAVVKMKNTERIYAMKIL--NKWEMLKRAETACFREERDVLVNGDC 133
Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHG-ERAKPGALPWPTRLKIAIETASAL 175
           + + +L+    +    L LV ++   G +   L   E   P  +    R  I  E   A+
Sbjct: 134 QWITALH-YAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDM---ARFYIG-EMVLAI 188
Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
             +H    +HRD+K +N+LLD N  +++ADFG      +  T  S+   GTP Y+ PE  
Sbjct: 189 DSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEIL 248
Query: 236 QCYQ-----LTDKSDVFSFGVVLIELI 257
           Q  +        + D +S GV + E++
Sbjct: 249 QAMEDGMGKYGPECDWWSLGVCMYEML 275

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 68/279 (24%), Positives = 115/279 (41%), Gaps = 35/279 (12%)
Query: 57  EEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR- 115
           +   N   S + LG G  GTV +     GR VAVKR+  +     +  + E+ +L     
Sbjct: 11  QSLKNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDD 67
Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR---LKIAIETA 172
           H N++  Y C+    R L +  E + N  + D +  +      L        + +  + A
Sbjct: 68  HPNVIRYY-CSETTDRFLYIALE-LCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIA 125
Query: 173 SALTYLHASDIIHRDVKTNNILLDN-------------NFCVKVADFGLSRLFPNHVTHV 219
           S + +LH+  IIHRD+K  NIL+               N  + ++DFGL +   +     
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXF 185
Query: 220 S---TAPQGTPGYVDPE-------YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHR 269
                 P GT G+  PE            +LT   D+FS G V   ++S        ++ 
Sbjct: 186 RXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS 245
Query: 270 HEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTIN 308
            E N+     +  + K LH   D++L  E+ + + + I+
Sbjct: 246 RESNIIRGIFSLDEMKCLH---DRSLIAEATDLISQMID 281

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H          T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H          T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 105/227 (46%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ D+GL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 13  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 73  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 127
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H          T  
Sbjct: 128 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMAGFVATRW 183
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 184 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 82/178 (46%), Gaps = 16/178 (8%)
Query: 69  LGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVSLYG-- 124
           LG G    V+ G   + G   A+K     ++ R V+  M E ++L +L HKN+V L+   
Sbjct: 17  LGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE 76
Query: 125 --CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
              T+RH    +L+ EF   G++   L  E +    LP    L +  +    + +L  + 
Sbjct: 77  EETTTRHK---VLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNHLRENG 132
Query: 183 IIHRDVKTNNILL----DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           I+HR++K  NI+     D     K+ DFG +R   +    V     GT  Y+ P+ ++
Sbjct: 133 IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXL--YGTEEYLHPDMYE 188

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 60/212 (28%), Positives = 92/212 (43%), Gaps = 17/212 (8%)
Query: 60  TNYFDSARELGDGGFGTV-YYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
           ++ ++  +++G G FG      + Q    VAVK + E   K  E    E+     LRH N
Sbjct: 18  SDRYELVKDIGSGNFGVARLMRDKQSNELVAVKYI-ERGEKIDENVKREIINHRSLRHPN 76
Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           +V       T  H   L +V E+ S G + + +       G            +  S ++
Sbjct: 77  IVRFKEVILTPTH---LAIVMEYASGGELFERI----CNAGRFSEDEARFFFQQLISGVS 129
Query: 177 YLHASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY 234
           Y HA  + HRD+K  N LLD +    +K+  FG S+    H     T   GTP Y+ PE 
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTV--GTPAYIAPEV 187
Query: 235 HQCYQLTDK-SDVFSFGVVL-IELISSMPAVD 264
               +   K +DV+S GV L + L+ + P  D
Sbjct: 188 LLKKEYDGKVADVWSCGVTLYVMLVGAYPFED 219

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 40  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 100 HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 154
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H          T  
Sbjct: 155 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMXGYVATRW 210
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 211 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 257

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 49/211 (23%), Positives = 98/211 (46%), Gaps = 17/211 (8%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    +++ G  +AVK+L     +    ++   E+ +L 
Sbjct: 46  IWEVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLK 105
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +       E  ++  +  HL G       K   L       + 
Sbjct: 106 HMKHENVIGLLDVFTPATS-----LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 160
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DFGL+R    H     T    T  
Sbjct: 161 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYVATRW 216
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELIS 258
           Y  PE    +   + + D++S G ++ EL++
Sbjct: 217 YRAPEIMLNWMHYNMTVDIWSVGCIMAELLT 247

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 55.1 bits (131), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 85/177 (48%), Gaps = 26/177 (14%)
Query: 103 QFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPW 161
           +   EV++L + + H+N++ L        R   LV+E +  G++  H+H  R        
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDR-FYLVFEKMRGGSILSHIHKRRHF------ 108
Query: 162 PTRLKIAI---ETASALTYLHASDIIHRDVKTNNILLDNN---FCVKVADFGLSRLFP-- 213
              L+ ++   + ASAL +LH   I HRD+K  NIL ++      VK+ DFGL       
Sbjct: 109 -NELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLN 167
Query: 214 NHVTHVST----APQGTPGYVDPEYHQCY----QLTDK-SDVFSFGVVLIELISSMP 261
              + +ST     P G+  Y+ PE  + +     + DK  D++S GV+L  L+S  P
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 79/175 (45%), Gaps = 28/175 (16%)
Query: 107 EVDILARLRHKNLVSLYGCTSRHS-RELLLVYEFISNGT--VADHLHGERA--KPGALPW 161
           E+ +L  L+H N++SL      H+ R++ L++++  +    +       +A  KP  LP 
Sbjct: 68  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPR 127
Query: 162 PTRLKIAIETASALTYLHASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLF----- 212
                +  +    + YLHA+ ++HRD+K  NIL+         VK+AD G +RLF     
Sbjct: 128 GMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187
Query: 213 ------PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
                 P  VT    AP+   G            T   D+++ G +  EL++S P
Sbjct: 188 PLADLDPVVVTFWYRAPELLLG--------ARHYTKAIDIWAIGCIFAELLTSEP 234

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
           +I      A+ YLH+ +I HRDVK  N+L  +   N  +K+ DFG ++   +H  +  T 
Sbjct: 171 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 228
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           P  TP YV PE     +     D++S GV++  L+   P
Sbjct: 229 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 267

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 32/93 (34%), Positives = 49/93 (52%), Gaps = 5/93 (5%)
Query: 172 ASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
             A+ YLH+ +I HRDVK  N+L  +   N  +K+ DFG ++   +H  +  T P  TP 
Sbjct: 127 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPY 184
Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           YV PE     +     D++S GV++  L+   P
Sbjct: 185 YVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
           +I      A+ YLH+ +I HRDVK  N+L  +   N  +K+ DFG ++   +H  +  T 
Sbjct: 165 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 222
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           P  TP YV PE     +     D++S GV++  L+   P
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 261

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
           +I      A+ YLH+ +I HRDVK  N+L  +   N  +K+ DFG ++   +H  +  T 
Sbjct: 135 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 192
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           P  TP YV PE     +     D++S GV++  L+   P
Sbjct: 193 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 231

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 57/206 (27%), Positives = 89/206 (43%), Gaps = 15/206 (7%)
Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL--Y 123
           ++LG+GGF  V   E L DG   A+KR+  +  +  E+   E D+     H N++ L  Y
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94
Query: 124 GCTSRHSR-ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
               R ++ E  L+  F   GT+ + +   + K   L     L + +     L  +HA  
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154
Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV--------THVSTAPQGTPGYVDPEY 234
             HRD+K  NILL +     + D G       HV             A + T  Y  PE 
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214
Query: 235 H--QCYQLTD-KSDVFSFGVVLIELI 257
              Q + + D ++DV+S G VL  ++
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
           +I      A+ YLH+ +I HRDVK  N+L  +   N  +K+ DFG ++   +H  +  T 
Sbjct: 120 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 177
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           P  TP YV PE     +     D++S GV++  L+   P
Sbjct: 178 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 216

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
           +I      A+ YLH+ +I HRDVK  N+L  +   N  +K+ DFG ++   +H  +  T 
Sbjct: 121 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 178
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           P  TP YV PE     +     D++S GV++  L+   P
Sbjct: 179 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 217

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
           +I      A+ YLH+ +I HRDVK  N+L  +   N  +K+ DFG ++   +H  +  T 
Sbjct: 119 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 176
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           P  TP YV PE     +     D++S GV++  L+   P
Sbjct: 177 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+  FGL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
           +I      A+ YLH+ +I HRDVK  N+L  +   N  +K+ DFG ++   +H  +  T 
Sbjct: 127 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 184
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           P  TP YV PE     +     D++S GV++  L+   P
Sbjct: 185 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 223

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           + + A  + +L +   IHRD+   NILL     VK+ DFGL+R       +V       P
Sbjct: 206 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 265
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
             ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 266 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 297

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
           +I      A+ YLH+ +I HRDVK  N+L  +   N  +K+ DFG ++   +H  +  T 
Sbjct: 125 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 182
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           P  TP YV PE     +     D++S GV++  L+   P
Sbjct: 183 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 221

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
           +I      A+ YLH+ +I HRDVK  N+L  +   N  +K+ DFG ++   +H  +  T 
Sbjct: 126 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 183
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           P  TP YV PE     +     D++S GV++  L+   P
Sbjct: 184 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 222

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 53/105 (50%), Gaps = 9/105 (8%)
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           + + A  + +L +   IHRD+   NILL     VK+ DFGL+R       +V       P
Sbjct: 197 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELI----SSMPAVDI 265
             ++ PE  + + Y  T +SDV+SFGV+L E+     S  P V I
Sbjct: 257 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFSLGASPYPGVKI 299

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           + + A  + +L +   IHRD+   NILL     VK+ DFGL+R       +V       P
Sbjct: 204 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
             ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 264 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 295

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 5/94 (5%)
Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           + + A  + +L +   IHRD+   NILL     VK+ DFGL+R       +V       P
Sbjct: 199 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 228 -GYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
             ++ PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 259 LKWMAPETIFDRVY--TIQSDVWSFGVLLWEIFS 290

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 31/226 (13%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKNL 119
           +   + +G G  G V    +   G  VAVK+L     N    ++   E+ +L  + HKN+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 120 VSLYGC-----TSRHSRELLLVYEFI-SNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
           +SL        T    +++ LV E + +N     H+  +  +   L +        +   
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLY--------QMLC 135
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
            + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R         ST    TP YV   
Sbjct: 136 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-------ASTNFMMTP-YVVTR 187
Query: 234 YHQCYQLT------DKSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
           Y++  ++       +  D++S G ++ EL+        T H  + N
Sbjct: 188 YYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 233

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ DF L+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
           +I      A+ YLH+ +I HRDVK  N+L  +   N  +K+ DFG ++   +H  +  T 
Sbjct: 119 EIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTE 176
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           P  TP YV PE     +     D++S GV++  L+   P
Sbjct: 177 PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYP 215

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 83/204 (40%), Gaps = 16/204 (7%)
Query: 63  FDSARELGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           F     LG G +G V+     +DGR  AVKR    +        +    LA +     V 
Sbjct: 59  FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKR----SMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 122 LYGCTSRHSRE-----LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            + C  R  +      +L +   +   ++  H     A   +LP         +T  AL 
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGA---SLPEAQVWGYLRDTLLALA 171
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           +LH+  ++H DVK  NI L      K+ DFGL  L            +G P Y+ PE  Q
Sbjct: 172 HLHSQGLVHLDVKPANIFLGPRGRCKLGDFGL--LVELGTAGAGEVQEGDPRYMAPELLQ 229
Query: 237 CYQLTDKSDVFSFGVVLIELISSM 260
               T  +DVFS G+ ++E+  +M
Sbjct: 230 GSYGT-AADVFSLGLTILEVACNM 252

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 89/211 (42%), Gaps = 13/211 (6%)
Query: 69  LGDGGFGTVY------YGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
           +G G F  V        G+    + V V +   +     E    E  I   L+H ++V L
Sbjct: 32  IGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL 91
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL-PWPTRLKIAIETASALTYLHAS 181
               S     L +V+EF+    +   +  +RA  G +           +   AL Y H +
Sbjct: 92  LETYSSDGM-LYMVFEFMDGADLCFEIV-KRADAGFVYSEAVASHYMRQILEALRYCHDN 149
Query: 182 DIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           +IIHRDVK  N+LL   +N+  VK+ DFG++         V+    GTP ++ PE  +  
Sbjct: 150 NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESGLVAGGRVGTPHFMAPEVVKRE 208
Query: 239 QLTDKSDVFSFGVVLIELISSMPAVDITRHR 269
                 DV+  GV+L  L+S       T+ R
Sbjct: 209 PYGKPVDVWGCGVILFILLSGCLPFYGTKER 239

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ D GL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN------EVDILARLR----HK 117
           LG GGFGTV+ G  L D   VA+K +  N         +      EV +L ++     H 
Sbjct: 39  LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
            ++ L          +L++   +    + D++  E+   G  P  +R     +  +A+ +
Sbjct: 99  GVIRLLDWFETQEGFMLVLERPLPAQDLFDYIT-EKGPLGEGP--SRCFFG-QVVAAIQH 154
Query: 178 LHASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY-- 234
            H+  ++HRD+K  NIL+D    C K+ DFG   L  +      T   GT  Y  PE+  
Sbjct: 155 CHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPY---TDFDGTRVYSPPEWIS 211
Query: 235 -HQCYQLTDKSDVFSFGVVLIELISS 259
            HQ + L   + V+S G++L +++  
Sbjct: 212 RHQYHAL--PATVWSLGILLYDMVCG 235

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ D GL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 98/227 (43%), Gaps = 33/227 (14%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKNL 119
           +   + +G G  G V    +   G  VAVK+L     N    ++   E+ +L  + HKN+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 120 VSLYGC-----TSRHSRELLLVYEFI-SNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
           +SL        T    +++ LV E + +N     H+  +  +   L +        +   
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLY--------QMLC 137
Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAPQGT 226
            + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP+  
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEIN 273
            G                D++S G ++ EL+        T H  + N
Sbjct: 198 LG---------MGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWN 235

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTV--YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS----------YLLYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 135 MLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 195 EVILG---------MGYKENVDIWSVGCIMGEMV 219

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 195 EVILG---------MGYKENVDIWSVGCIMGEMV 219

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/227 (23%), Positives = 104/227 (45%), Gaps = 17/227 (7%)
Query: 56  LEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           + E    + +   +G G +G+V    + + G  VAVK+L     +    ++   E+ +L 
Sbjct: 17  IWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER----AKPGALPWPTRLKIA 168
            ++H+N++ L    +  +R L    E  ++  +  HL G       K   L       + 
Sbjct: 77  HMKHENVIGLLDVFTP-ARSL----EEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLI 131
Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
            +    L Y+H++DIIHRD+K +N+ ++ +  +K+ D GL+R    H     T    T  
Sbjct: 132 YQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLAR----HTDDEMTGYVATRW 187
Query: 229 YVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINL 274
           Y  PE    +   +++ D++S G ++ EL++       T H  ++ L
Sbjct: 188 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 234

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKN 84
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS----------YLLYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 195 EVILG---------MGYKENVDIWSVGCIMGEMV 219

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/210 (21%), Positives = 98/210 (46%), Gaps = 20/210 (9%)
Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARL 114
           E    + S   +G G +G+V    + + G  VA+K+L       +  ++   E+ +L  +
Sbjct: 21  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 80
Query: 115 RHKNLVSLY-----GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           +H+N++ L        + R+  +  LV  F+   T    + G +     + +     +  
Sbjct: 81  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ--TDLQKIMGLKFSEEKIQY-----LVY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           +    L Y+H++ ++HRD+K  N+ ++ +  +K+ DFGL+R    H     T    T  Y
Sbjct: 134 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWY 189
Query: 230 VDPEYHQCYQLTDKS-DVFSFGVVLIELIS 258
             PE    +   +++ D++S G ++ E+++
Sbjct: 190 RAPEVILSWMHYNQTVDIWSVGCIMAEMLT 219

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 50/185 (27%), Positives = 81/185 (43%), Gaps = 23/185 (12%)
Query: 32  EPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAV 90
           EP   V+LE      G          E +  + +   LG G FG V+   + +  + V V
Sbjct: 5   EPPKAVELEGLAACEG----------EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVV 54
Query: 91  K-----RLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISN 142
           K     ++ E+ +    ++ +   E+ IL+R+ H N++ +            LV E   +
Sbjct: 55  KFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF-FQLVME--KH 111
Query: 143 GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVK 202
           G+  D        P  L  P    I  +  SA+ YL   DIIHRD+K  NI++  +F +K
Sbjct: 112 GSGLDLFAFIDRHP-RLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIK 170
Query: 203 VADFG 207
           + DFG
Sbjct: 171 LIDFG 175

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 135
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 196 EVILG---------MGYKENVDIWSVGCIMGEMV 220

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 195 EVILG---------MGYKENVDIWSVGCIMGEMV 219

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 135 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 195 EVILG---------MGYKENVDIWSVGCIMGEMV 219

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 83
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 84  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 133
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 134 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 193
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 194 EVILG---------MGYKENVDIWSVGCIMGEMV 218

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 127
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 128 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 188 EVILG---------MGYKENVDIWSVGCIMGEMV 212

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 85
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 86  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 135
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 136 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 195
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 196 EVILG---------MGYKENVDIWSVGCIMGEMV 220

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 128
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 189 EVILG---------MGYKENVDIWSVGCIMGEMV 213

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/210 (21%), Positives = 97/210 (46%), Gaps = 20/210 (9%)
Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV--EQFMNEVDILARL 114
           E    + S   +G G +G+V    + + G  VA+K+L       +  ++   E+ +L  +
Sbjct: 39  ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM 98
Query: 115 RHKNLVSLY-----GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
           +H+N++ L        + R+  +  LV  F+   T    + G       + +     +  
Sbjct: 99  QHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ--TDLQKIMGMEFSEEKIQY-----LVY 151
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           +    L Y+H++ ++HRD+K  N+ ++ +  +K+ DFGL+R    H     T    T  Y
Sbjct: 152 QMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVVTRWY 207
Query: 230 VDPEYHQCYQLTDKS-DVFSFGVVLIELIS 258
             PE    +   +++ D++S G ++ E+++
Sbjct: 208 RAPEVILSWMHYNQTVDIWSVGCIMAEMLT 237

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 78
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 128
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 129 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 188
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 189 EVILG---------MGYKENVDIWSVGCIMGEMV 213

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 172
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 233 EVILG---------MGYKENVDIWSVGCIMGEMV 257

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 77
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS----------YLLYQ 127
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 128 MLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 187
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 188 EVILG---------MGYKENVDIWSVGCIMGEMV 212

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 84
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMS----------YLLYQ 134
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 135 MLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 194
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 195 EVILG---------MGYKENVDIWSVGCIMGEMV 219

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 99/217 (45%), Gaps = 29/217 (13%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           F   R  G G FGTV  G E   G +VA+K++ ++   R  +     D LA L H N+V 
Sbjct: 25  FQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD-LAVLHHPNIVQ 83
Query: 122 L----YGCTSRHSRELLL--VYEFISNGTVADHLHG---ERAKPGALPWPTRLKIAI-ET 171
           L    Y    R  R++ L  V E+     V D LH       +    P P  +K+ + + 
Sbjct: 84  LQSYFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPILIKVFLFQL 138
Query: 172 ASALTYLH--ASDIIHRDVKTNNILLDN-NFCVKVADFG----LSRLFPNHVTHVSTAPQ 224
             ++  LH  + ++ HRD+K +N+L++  +  +K+ DFG    LS   PN V ++ +   
Sbjct: 139 IRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPN-VAYICSRYY 197
Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
             P  +    H     T   D++S G +  E++   P
Sbjct: 198 RAPELIFGNQH----YTTAVDIWSVGCIFAEMMLGEP 230

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTVY--YGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKN 118
           + + + +G G  G V   Y  + D R VA+K+L     N    ++   E+ ++  + HKN
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLD-RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKN 122
Query: 119 LVSLYGC-----TSRHSRELLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAIE 170
           ++SL        T    +++ LV E +       +   L  ER             +  +
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMS----------YLLYQ 172
Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTAP 223
               + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    AP
Sbjct: 173 MLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAP 232
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           +   G             +  D++S G ++ E++
Sbjct: 233 EVILG---------MGYKENVDIWSVGCIMGEMV 257

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 49/99 (49%), Gaps = 5/99 (5%)
Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTA 222
           +I      A+ YLH+ +I HRDVK  N+L  +   N  +K+ DFG ++   +H  +  T 
Sbjct: 165 EIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTT 222
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           P  TP YV PE     +     D +S GV+   L+   P
Sbjct: 223 PCYTPYYVAPEVLGPEKYDKSCDXWSLGVIXYILLCGYP 261

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/177 (28%), Positives = 84/177 (47%), Gaps = 26/177 (14%)
Query: 103 QFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPW 161
           +   EV++L + + H+N++ L        R   LV+E +  G++  H+H  R        
Sbjct: 56  RVFREVEMLYQCQGHRNVLELIEFFEEEDR-FYLVFEKMRGGSILSHIHKRRHF------ 108
Query: 162 PTRLKIAI---ETASALTYLHASDIIHRDVKTNNILLDNN---FCVKVADFGLSRLFP-- 213
              L+ ++   + ASAL +LH   I HRD+K  NIL ++      VK+ DF L       
Sbjct: 109 -NELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN 167
Query: 214 NHVTHVST----APQGTPGYVDPEYHQCY----QLTDK-SDVFSFGVVLIELISSMP 261
              + +ST     P G+  Y+ PE  + +     + DK  D++S GV+L  L+S  P
Sbjct: 168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP 224

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 32/219 (14%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRVEQF-MNEVDILA 112
           E  E  ++      LG G FG V+   + Q G   AVK++      R+E F + E+   A
Sbjct: 66  EYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRVEELVACA 119
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
            L    +V LYG   R    + +  E +  G++   +     + G LP    L    +  
Sbjct: 120 GLSSPRIVPLYGAV-REGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQAL 174
Query: 173 SALTYLHASDIIHRDVKTNNILLDNN------------FCVKVADFGLSRLFPNHVTHVS 220
             L YLH   I+H DVK +N+LL ++             C++    G S L  +++    
Sbjct: 175 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP--- 231
Query: 221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS 259
               GT  ++ PE         K D++S   +++ +++ 
Sbjct: 232 ----GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 44/147 (29%), Positives = 75/147 (51%), Gaps = 11/147 (7%)
Query: 68  ELGDGGFGTVYYGE--LQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           +LG+G + TVY G+  L D   VA+K +  E+        + EV +L  L+H N+V+L+ 
Sbjct: 9   KLGEGTYATVYKGKSKLTDN-LVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHD 67
Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHASDI 183
                 + L LV+E++        L       G +     +K+ + +    L Y H   +
Sbjct: 68  IIHT-EKSLTLVFEYLDKD-----LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKV 121
Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSR 210
           +HRD+K  N+L++    +K+ADFGL+R
Sbjct: 122 LHRDLKPQNLLINERGELKLADFGLAR 148

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
           + + + +G G  G V   Y   L+  R VA+K+L     N    ++   E+ ++  + HK
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFIS---NGTVADHLHGERAKPGALPWPTRLKIAI 169
           N++ L    T + S E    + +V E +    +  +   L  ER             +  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R          T+   TP Y
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-------AGTSFMMTP-Y 185
Query: 230 VDPEYHQCYQLT------DKSDVFSFGVVLIELI 257
           V   Y++  ++       +  D++S GV++ E+I
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 85  GRAVAVKRLYENNYKRVE-----QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF 139
           G+  A+K LY++   R E     Q      I+       ++ +Y       R LL++ E 
Sbjct: 54  GQKCALKLLYDSPKARQEVDHHWQASGGPHIVC------ILDVYENMHHGKRCLLIIMEC 107
Query: 140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL---D 196
           +  G +   +  ER    A       +I  +  +A+ +LH+ +I HRDVK  N+L    +
Sbjct: 108 MEGGELFSRIQ-ERGD-QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE 165
Query: 197 NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
            +  +K+ DFG ++       +    P  TP YV PE     +     D++S GV++  L
Sbjct: 166 KDAVLKLTDFGFAK---ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 222
Query: 257 ISSMP 261
           +   P
Sbjct: 223 LCGFP 227

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 100/214 (46%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
           + + + +G G  G V   Y   L+  R VA+K+L     N    ++   E+ ++  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFIS---NGTVADHLHGERAKPGALPWPTRLKIAI 169
           N++ L    T + S E    + +V E +    +  +   L  ER             +  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R          T+   TP Y
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-------AGTSFMMTP-Y 185
Query: 230 VDPEYHQCYQLT------DKSDVFSFGVVLIELI 257
           V   Y++  ++       +  D++S GV++ E+I
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMI 219

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 4/95 (4%)
Query: 167 IAIETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAP 223
           I  +  SA++++H   ++HRD+K  N+L    ++N  +K+ DFG +RL P     + T P
Sbjct: 111 IMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-P 169
Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
             T  Y  PE        +  D++S GV+L  ++S
Sbjct: 170 CFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLS 204

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 51.2 bits (121), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 81/185 (43%), Gaps = 19/185 (10%)
Query: 85  GRAVAVKRLYENNYKRVE-----QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF 139
           G+  A+K LY++   R E     Q      I+       ++ +Y       R LL++ E 
Sbjct: 35  GQKCALKLLYDSPKARQEVDHHWQASGGPHIVC------ILDVYENMHHGKRCLLIIMEC 88
Query: 140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL---D 196
           +  G +   +  ER    A       +I  +  +A+ +LH+ +I HRDVK  N+L    +
Sbjct: 89  MEGGELFSRIQ-ERGD-QAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKE 146
Query: 197 NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
            +  +K+ DFG ++       +    P  TP YV PE     +     D++S GV++  L
Sbjct: 147 KDAVLKLTDFGFAK---ETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 203
Query: 257 ISSMP 261
           +   P
Sbjct: 204 LCGFP 208

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 24/229 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 19  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 79  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFD 131
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 132 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELIS 258
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++ 
Sbjct: 192 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVC 237

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 67/288 (23%), Positives = 110/288 (38%), Gaps = 47/288 (16%)
Query: 55  ELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF-MNEVDILA 112
           E  E  ++      LG G FG V+  E  Q G   AVK++      R+E F   E+   A
Sbjct: 87  EYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRAEELMACA 140
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
            L    +V LYG   R    + +  E +  G++   +  +    G LP    L    +  
Sbjct: 141 GLTSPRIVPLYGAV-REGPWVNIFMELLEGGSLGQLVKEQ----GCLPEDRALYYLGQAL 195
Query: 173 SALTYLHASDIIHRDVKTNNILLDNN------------FCVKVADFGLSRLFPNHVTHVS 220
             L YLH+  I+H DVK +N+LL ++             C++    G S L  +++    
Sbjct: 196 EGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIP--- 252
Query: 221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSM-PAVDITRHRHEINLSN--- 276
               GT  ++ PE         K DV+S   +++ +++   P     R    + +++   
Sbjct: 253 ----GTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPP 308
Query: 277 -----------LAINKIQNKALHELVDQTLGYESDNKVRRTINAVAEL 313
                      L    IQ     E + +    E   KV R +  V  L
Sbjct: 309 PVREIPPSCAPLTAQAIQEGLRKEPIHRVSAAELGGKVNRALQQVGGL 356

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 95/201 (47%), Gaps = 19/201 (9%)
Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRH-KNLV 120
           +   R+LG G +  V+    + +   V VK L      ++++   E+ IL  LR   N++
Sbjct: 39  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR---EIKILENLRGGPNII 95
Query: 121 SLYGCTSRH-SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           +L        SR   LV+E ++N         ++       +  R  +  E   AL Y H
Sbjct: 96  TLADIVKDPVSRTPALVFEHVNNTDF------KQLYQTLTDYDIRFYM-YEILKALDYCH 148
Query: 180 ASDIIHRDVKTNNILLDNNF-CVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPEYHQC 237
           +  I+HRDVK +N+++D+    +++ D+GL+  + P    +V  A +   G   PE    
Sbjct: 149 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKG---PELLVD 205
Query: 238 YQLTDKS-DVFSFGVVLIELI 257
           YQ+ D S D++S G +L  +I
Sbjct: 206 YQMYDYSLDMWSLGCMLASMI 226

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 19  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 79  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 131
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 132 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 192 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 20  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 80  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 132
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 133 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 193 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 20  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 80  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 132
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 133 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 193 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 239

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 19  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 79  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 131
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 132 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 192 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 19  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 78
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 79  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 131
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 132 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 191
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 192 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 238

>pdb|2V62|A Chain A, Structure Of Vaccinia-Related Kinase 2 Length = 345

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 67/293 (22%), Positives = 114/293 (38%), Gaps = 41/293 (13%)
Query: 34  SSKVDLEKGGNYHGVQVFSYGEL--EEATNYFDSARELGDGGFGTVYYGELQDGRAVAVK 91
           SS VDL     Y     F  G++  +   N +   +++G GGFG +Y     +      +
Sbjct: 8   SSGVDLGTENLYFQSMPFPEGKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDAR 67
Query: 92  RLYENNYKRVEQFMNEVDILARLRHKNLVSLY-----------------GCTSRHSRELL 134
            + +  Y+      +E+    R+  K+ +  +                 G T    R   
Sbjct: 68  HVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRS-- 125
Query: 135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNIL 194
             Y F+    +   L     + G     T L++ I     L Y+H ++ +H D+K  N+L
Sbjct: 126 --YRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLL 183
Query: 195 L--DNNFCVKVADFGLS-RLFP--NHVTHVSTAPQGTPG---YVDPEYHQCYQLTDKSDV 246
           L   N   V +AD+GLS R  P  NH  +     +G  G   +   + H+   L+ +SDV
Sbjct: 184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDV 243
Query: 247 FSFGVVLIE-LISSMPAVDITRHRHEINLSN-LAINKIQNKALHELVDQTLGY 297
              G  ++  L   +P         E NL + +A+   +   L EL    L +
Sbjct: 244 EILGYCMLRWLCGKLP--------WEQNLKDPVAVQTAKTNLLDELPQSVLKW 288

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 39  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 98
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 99  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 151
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 152 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 211
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 212 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 258

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 24/228 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 20  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 80  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 132
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 133 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELI 257
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++
Sbjct: 193 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 32/219 (14%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRVEQF-MNEVDILA 112
           E  E  ++      +G G FG V+   + Q G   AVK++      R+E F + E+   A
Sbjct: 52  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRVEELVACA 105
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
            L    +V LYG   R    + +  E +  G++   +     + G LP    L    +  
Sbjct: 106 GLSSPRIVPLYGAV-REGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQAL 160
Query: 173 SALTYLHASDIIHRDVKTNNILLDNN------------FCVKVADFGLSRLFPNHVTHVS 220
             L YLH   I+H DVK +N+LL ++             C++    G S L  +++    
Sbjct: 161 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP--- 217
Query: 221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS 259
               GT  ++ PE         K D++S   +++ +++ 
Sbjct: 218 ----GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 34  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 93
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 94  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 146
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 147 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 206
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 207 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/219 (23%), Positives = 91/219 (41%), Gaps = 32/219 (14%)
Query: 55  ELEEATNYFDSARELGDGGFGTVY-YGELQDGRAVAVKRLYENNYKRVEQF-MNEVDILA 112
           E  E  ++      +G G FG V+   + Q G   AVK++      R+E F + E+   A
Sbjct: 68  EYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKV------RLEVFRVEELVACA 121
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
            L    +V LYG   R    + +  E +  G++   +     + G LP    L    +  
Sbjct: 122 GLSSPRIVPLYGAV-REGPWVNIFMELLEGGSLGQLIK----QMGCLPEDRALYYLGQAL 176
Query: 173 SALTYLHASDIIHRDVKTNNILLDNN------------FCVKVADFGLSRLFPNHVTHVS 220
             L YLH   I+H DVK +N+LL ++             C++    G S L  +++    
Sbjct: 177 EGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP--- 233
Query: 221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS 259
               GT  ++ PE         K D++S   +++ +++ 
Sbjct: 234 ----GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 34  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 93
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 94  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 146
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 147 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 206
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 207 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 253

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 7   DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 66
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 67  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 119
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 120 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 180 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 26  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 85
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 86  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 138
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 139 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 198
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 199 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 245

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 98/228 (42%), Gaps = 24/228 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 20  DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 79
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 80  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 132
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 133 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 192
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELI 257
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++
Sbjct: 193 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN------EVDILARLR--HKNL 119
           LG GGFG+VY G  + D   VA+K + ++      +  N      EV +L ++      +
Sbjct: 16  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 75
Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           + L     R    +L++        + D +     + GAL          +   A+ + H
Sbjct: 76  IRLLDWFERPDSFVLILERMEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHCH 131
Query: 180 ASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
              ++HRD+K  NIL+D N   +K+ DFG   L  + V    T   GT  Y  PE+ + +
Sbjct: 132 NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIRYH 188
Query: 239 QLTDKS-DVFSFGVVLIELISS 259
           +   +S  V+S G++L +++  
Sbjct: 189 RYHGRSAAVWSLGILLYDMVCG 210

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 7   DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 66
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 67  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 119
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 120 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 180 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 6   DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 66  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFD 118
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 119 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 178
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 179 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 63  FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
           + + + +G G  G V   Y   L+  R VA+K+L     N    ++   E+ ++  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAI 169
           N++ L    T + S E    + +V E +       +   L  ER             +  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
           +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRA 193
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           P+   G             +  D++S G ++ E+I
Sbjct: 194 PEVILG---------MGYKENVDIWSVGCIMGEMI 219

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 7   DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 66
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 67  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFD 119
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 120 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 179
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 180 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 226

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 81/180 (45%), Gaps = 12/180 (6%)
Query: 63  FDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKR---VEQFMNEVDILARLRHKN 118
           F+  + +G G F  V   ++ Q G+  A+K + + +  +   V  F  E D+L     + 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122
Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWPTRLKIAIETASALT 176
           +  L+    +    L LV E+   G +   L   GER  P  +    R  +A E   A+ 
Sbjct: 123 ITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERI-PAEM---ARFYLA-EIVMAID 176
Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
            +H    +HRD+K +NILLD    +++ADFG         T  S    GTP Y+ PE  Q
Sbjct: 177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQ 236

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 58/230 (25%), Positives = 98/230 (42%), Gaps = 24/230 (10%)
Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVE 102
           + H  ++    E E   + +     LG GGFG+VY G  + D   VA+K + ++      
Sbjct: 6   DLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWG 65
Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------ 156
           +  N   +        +V L   +S  S  + L+  F    +    L  ER +P      
Sbjct: 66  ELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFV--LILERPEPVQDLFD 118
Query: 157 -----GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSR 210
                GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG   
Sbjct: 119 FITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA 178
Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
           L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 179 LLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 225

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 96/221 (43%), Gaps = 43/221 (19%)
Query: 58  EATNYFDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           E        R +G G +G+V   Y   L+  + VAVK+L     +     +   E+ +L 
Sbjct: 25  EVPQRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLK 82
Query: 113 RLRHKNLVSLYGCTSRHSR-----ELLLVYEF----ISNGTVADHLHGERAKPGALPWPT 163
            L+H+N++ L    +  +      E+ LV       ++N   +  L  E  +        
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQ-------- 134
Query: 164 RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
              +  +    L Y+H++ IIHRD+K +N+ ++ +  +++ DFGL+R     +T      
Sbjct: 135 --FLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT------ 186
Query: 224 QGTPGYVDPEYHQCYQL-------TDKSDVFSFGVVLIELI 257
               GYV   +++  ++           D++S G ++ EL+
Sbjct: 187 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 63  FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
           + + + +G G  G V   Y   L+  R VA+K+L     N    ++   E+ ++  + HK
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 85
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAI 169
           N++ L    T + S E    + +V E +       +   L  ER             +  
Sbjct: 86  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS----------YLLY 135
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
           +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    A
Sbjct: 136 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRA 195
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           P+   G             +  D++S G ++ E+I
Sbjct: 196 PEVILG---------MGYKENVDIWSVGCIMGEMI 221

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/149 (30%), Positives = 71/149 (47%), Gaps = 12/149 (8%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVK---RLYEN--NYKRVEQFMNEVDILARLRHKNLVSL 122
           +G G +G VY   +    + VA+K   R++E+  + KR+   + E+ IL RL+   ++ L
Sbjct: 34  IGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREITILNRLKSDYIIRL 90
Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK-IAIETASALTYLHAS 181
           Y        +LL   E      +AD    +  K         +K I         ++H S
Sbjct: 91  YDLII--PDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHES 148
Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSR 210
            IIHRD+K  N LL+ +  VKV DFGL+R
Sbjct: 149 GIIHRDLKPANCLLNQDCSVKVCDFGLAR 177

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
           + + + +G G  G V   Y   L+  R VA+K+L     N    ++   E+ ++  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFIS---NGTVADHLHGERAKPGALPWPTRLKIAI 169
           N++ L    T + S E    + +V E +    +  +   L  ER             +  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R          T+   TP Y
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-------AGTSFMMTP-Y 185
Query: 230 VDPEYHQCYQLT------DKSDVFSFGVVLIELI 257
           V   Y++  ++       +  D++S G ++ E+I
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 63  FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
           + + + +G G  G V   Y   L+  R VA+K+L     N    ++   E+ ++  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFIS---NGTVADHLHGERAKPGALPWPTRLKIAI 169
           N++ L    T + S E    + +V E +    +  +   L  ER             +  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
           +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           P+   G             +  D++S G ++ E+I
Sbjct: 194 PEVILG---------MGYKENVDIWSVGCIMGEMI 219

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 95/221 (42%), Gaps = 43/221 (19%)
Query: 58  EATNYFDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           E        R +G G +G+V   Y   L+  + VAVK+L     +     +   E+ +L 
Sbjct: 17  EVPQRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLK 74
Query: 113 RLRHKNLVSLYGCTSRHSR-----ELLLVYEF----ISNGTVADHLHGERAKPGALPWPT 163
            L+H+N++ L    +  +      E+ LV       ++N      L  E  +        
Sbjct: 75  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQ-------- 126
Query: 164 RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
              +  +    L Y+H++ IIHRD+K +N+ ++ +  +++ DFGL+R     +T      
Sbjct: 127 --FLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT------ 178
Query: 224 QGTPGYVDPEYHQCYQL-------TDKSDVFSFGVVLIELI 257
               GYV   +++  ++           D++S G ++ EL+
Sbjct: 179 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 215

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/257 (22%), Positives = 97/257 (37%), Gaps = 36/257 (14%)
Query: 69  LGDGGFGTVYYGELQD---GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           LG+G FG V   E  D   G++    ++  N  K  E    E+++L +++ K+  + + C
Sbjct: 59  LGEGTFGKVV--ECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 116
Query: 126 TSRHSR-----ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
                       + + +E +   T  + L     +P   P P    +A +   AL +LH 
Sbjct: 117 VLMSDWFNFHGHMCIAFELLGKNTF-EFLKENNFQP--YPLPHVRHMAYQLCHALRFLHE 173
Query: 181 SDIIHRDVKTNNILLDN-------------------NFCVKVADFGLSRLFPNHVTHVST 221
           + + H D+K  NIL  N                   N  ++VADFG +    +H  H + 
Sbjct: 174 NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 231
Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK 281
               T  Y  PE           DV+S G +L E            +R  + +    +  
Sbjct: 232 V--ATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGP 289
Query: 282 IQNKALHELVDQTLGYE 298
           I +  +H    Q   Y+
Sbjct: 290 IPSHMIHRTRKQKYFYK 306

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 63  FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
           + + + +G G  G V   Y   L+  R VA+K+L     N    ++   E+ ++  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAI 169
           N++ L    T + S E    + +V E +       +   L  ER             +  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
           +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           P+   G             +  D++S G ++ E+I
Sbjct: 194 PEVILG---------MGYKENVDIWSVGCIMGEMI 219

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 63  FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
           + + + +G G  G V   Y   L+  R VA+K+L     N    ++   E+ ++  + HK
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 84
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAI 169
           N++ L    T + S E    + +V E +       +   L  ER             +  
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS----------YLLY 134
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
           +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    A
Sbjct: 135 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           P+   G             +  D++S G ++ E+I
Sbjct: 195 PEVILG---------MGYKENVDIWSVGCIMGEMI 220

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 95/215 (44%), Gaps = 41/215 (19%)
Query: 63  FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
           + + + +G G  G V   Y   L+  R VA+K+L     N    ++   E+ ++  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFISNG---TVADHLHGERAKPGALPWPTRLKIAI 169
           N++ L    T + S E    + +V E +       +   L  ER             +  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
           +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           P+   G             +  D++S G ++ E+I
Sbjct: 194 PEVILG---------MGYKENVDIWSVGCIMGEMI 219

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 69/156 (44%), Gaps = 14/156 (8%)
Query: 55  ELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQF-MNEVDILA 112
           E  E  ++      LG G FG V+  E  Q G   AVK++      R+E F   E+   A
Sbjct: 68  EYREEVHWATHQLRLGRGSFGEVHRMEDKQTGFQCAVKKV------RLEVFRAEELMACA 121
Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
            L    +V LYG   R    + +  E +  G++   +  +    G LP    L    +  
Sbjct: 122 GLTSPRIVPLYGAV-REGPWVNIFMELLEGGSLGQLVKEQ----GCLPEDRALYYLGQAL 176
Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFC-VKVADFG 207
             L YLH+  I+H DVK +N+LL ++     + DFG
Sbjct: 177 EGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFG 212

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 95/198 (47%), Gaps = 22/198 (11%)
Query: 72  GGFGTVYYGELQD--GRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLYGC--- 125
           GG G +Y    ++  GR V +K L +  + +     M E   LA + H ++V ++     
Sbjct: 91  GGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEH 150
Query: 126 TSRHSREL-LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
           T RH   +  +V E++   ++      +R+K   LP    +   +E   AL+YLH+  ++
Sbjct: 151 TDRHGDPVGYIVMEYVGGQSL------KRSKGQKLPVAEAIAYLLEILPALSYLHSIGLV 204
Query: 185 HRDVKTNNILLDNNFCVKVADFG-LSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           + D+K  NI+L     +K+ D G +SR+  N   ++     GTPG+  PE  +    T  
Sbjct: 205 YNDLKPENIMLTEE-QLKLIDLGAVSRI--NSFGYL----YGTPGFQAPEIVRTGP-TVA 256
Query: 244 SDVFSFGVVLIELISSMP 261
           +D+++ G  L  L   +P
Sbjct: 257 TDIYTVGRTLAALTLDLP 274

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 49/221 (22%), Positives = 95/221 (42%), Gaps = 43/221 (19%)
Query: 58  EATNYFDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILA 112
           E        R +G G +G+V   Y   L+  + VAVK+L     +     +   E+ +L 
Sbjct: 25  EVPQRLQGLRPVGSGAYGSVCSAYDARLR--QKVAVKKLSRPFQSLIHARRTYRELRLLK 82
Query: 113 RLRHKNLVSLYGCTSRHSR-----ELLLVYEF----ISNGTVADHLHGERAKPGALPWPT 163
            L+H+N++ L    +  +      E+ LV       ++N      L  E  +        
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQ-------- 134
Query: 164 RLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
              +  +    L Y+H++ IIHRD+K +N+ ++ +  +++ DFGL+R     +T      
Sbjct: 135 --FLVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT------ 186
Query: 224 QGTPGYVDPEYHQCYQL-------TDKSDVFSFGVVLIELI 257
               GYV   +++  ++           D++S G ++ EL+
Sbjct: 187 ----GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/214 (24%), Positives = 99/214 (46%), Gaps = 39/214 (18%)
Query: 63  FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
           + + + +G G  G V   Y   L+  R VA+K+L     N    ++   E+ ++  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFIS---NGTVADHLHGERAKPGALPWPTRLKIAI 169
           N++ L    T + S E    + +V E +    +  +   L  ER             +  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R          T+   TP Y
Sbjct: 134 QMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-------AGTSFMMTP-Y 185
Query: 230 VDPEYHQCYQLT------DKSDVFSFGVVLIELI 257
           V   Y++  ++       +  D++S G ++ E+I
Sbjct: 186 VVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 219

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/215 (24%), Positives = 96/215 (44%), Gaps = 41/215 (19%)
Query: 63  FDSARELGDGGFGTV---YYGELQDGRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHK 117
           + + + +G G  G V   Y   L+  R VA+K+L     N    ++   E+ ++  + HK
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILE--RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 83
Query: 118 NLVSLYGC-TSRHSRE----LLLVYEFIS---NGTVADHLHGERAKPGALPWPTRLKIAI 169
           N++ L    T + S E    + +V E +    +  +   L  ER             +  
Sbjct: 84  NIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMS----------YLLY 133
Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR-------LFPNHVTHVSTA 222
           +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R       + P  VT    A
Sbjct: 134 QMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRA 193
Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
           P+   G             +  D++S G ++ E+I
Sbjct: 194 PEVILG---------MGYKENVDIWSVGCIMGEMI 219

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 90/203 (44%), Gaps = 24/203 (11%)
Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           LG GGFG+VY G  + D   VA+K + ++      +  N   +        +V L   +S
Sbjct: 17  LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV-----PMEVVLLKKVSS 71
Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKP-----------GALPWPTRLKIAIETASALT 176
             S  + L+  F    +    L  ER +P           GAL          +   A+ 
Sbjct: 72  GFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 129
Query: 177 YLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
           + H   ++HRD+K  NIL+D N   +K+ DFG   L  + V    T   GT  Y  PE+ 
Sbjct: 130 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWI 186
Query: 236 QCYQLTDKS-DVFSFGVVLIELI 257
           + ++   +S  V+S G++L +++
Sbjct: 187 RYHRYHGRSAAVWSLGILLYDMV 209

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 60/231 (25%), Positives = 99/231 (42%), Gaps = 28/231 (12%)
Query: 47  GVQVFSYG----ELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRV 101
           G++V   G    E E   + +     LG GGFG+VY G  + D   VA+K + ++     
Sbjct: 13  GLEVLFQGPHMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDW 72
Query: 102 EQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP----- 156
            +  N   +        +V L   +S  S  + L+  F    +    L  ER +P     
Sbjct: 73  GELPNGTRV-----PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLIL--ERPEPVQDLF 125
Query: 157 ------GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLS 209
                 GAL          +   A+ + H   ++HRD+K  NIL+D N   +K+ DFG  
Sbjct: 126 DFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 185
Query: 210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISS 259
            L  + V    T   GT  Y  PE+ + ++   +S  V+S G++L +++  
Sbjct: 186 ALLKDTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCG 233
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	375
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-131
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-119
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-114
3soc_A	322	Activin receptor type-2A; structural genomics cons	8e-75
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-67
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-65
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-64
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	8e-64
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-62
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	1e-62
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-61
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-61
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	4e-58
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-55
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-55
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	3e-54
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-52
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	7e-47
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-45
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-45
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	1e-43
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	1e-43
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	5e-43
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-43
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	1e-42
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-42
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-42
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	3e-42
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	6e-42
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-41
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-41
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-41
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-41
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	5e-41
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	5e-41
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	5e-41
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	7e-41
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-40
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-40
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-40
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-40
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-40
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-40
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	3e-40
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	5e-40
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-40
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-40
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-39
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-39
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-39
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	3e-39
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-39
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-39
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-39
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	9e-39
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-38
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	1e-38
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-38
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-38
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-38
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-38
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-38
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-38
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	3e-38
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-38
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-37
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-37
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	4e-37
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	5e-37
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	7e-37
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-36
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-36
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	4e-36
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-36
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-36
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	9e-36
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-35
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-35
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-35
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-35
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-35
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	4e-35
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-35
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-35
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-35
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-34
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-34
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-34
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-34
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-34
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	3e-34
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-34
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	4e-34
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	5e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	7e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-33
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-33
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-33
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	4e-33
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	5e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-33
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	7e-33
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	9e-33
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	2e-32
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-32
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	5e-32
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	7e-32
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-31
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	2e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-31
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-30
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	2e-30
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	7e-30
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-29
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-29
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-29
3fme_A	290	Dual specificity mitogen-activated protein kinase;	3e-29
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	4e-29
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-29
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	8e-29
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	8e-29
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	9e-29
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-28
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-28
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-28
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-28
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	3e-28
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	4e-28
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	9e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-27
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-27
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-27
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-27
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-27
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	4e-27
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-27
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	4e-27
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-27
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-27
3bhy_A	283	Death-associated protein kinase 3; death associate	7e-27
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-26
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	2e-26
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-26
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-26
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	4e-26
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-26
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	7e-26
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	7e-26
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-25
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-25
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-25
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	2e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-25
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	4e-25
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	4e-25
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	4e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-25
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-07
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	8e-25
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	9e-25
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	9e-25
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-24
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-24
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-24
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	8e-24
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-23
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-23
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-23
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-22
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-22
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-22
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-22
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-22
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-22
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-22
3o0g_A	292	Cell division protein kinase 5; kinase activator c	5e-22
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	5e-22
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-21
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-21
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-21
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-21
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	6e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	6e-21
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	8e-21
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	2e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-20
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	3e-20
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-20
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	5e-20
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	7e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	1e-19
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	2e-19
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-18
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-17
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	2e-17
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-17
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	8e-17
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-17
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	5e-16
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	5e-16
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-15
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-15
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	1e-14
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-14
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-14
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	4e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	5e-14
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-13
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-13
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-13
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	2e-13
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-13
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-12
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-11
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-10
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	3e-10
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	5e-10
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	8e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-05
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-05

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  378 bits (972), Expect = e-131
 Identities = 125/322 (38%), Positives = 182/322 (56%), Gaps = 17/322 (5%)

Query: 17  NKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGT 76
           +K+S +T    N+ ++  S   L    +Y         +LEEATN FD    +G G FG 
Sbjct: 3   SKYSKAT----NSINDALSSSYLVPFESYR----VPLVDLEEATNNFDHKFLIGHGVFGK 54

Query: 77  VYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-CTSRHSRELLL 135
           VY G L+DG  VA+KR    + + +E+F  E++ L+  RH +LVSL G C  R+  E++L
Sbjct: 55  VYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN--EMIL 112

Query: 136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL 195
           +Y+++ NG +  HL+G      ++ W  RL+I I  A  L YLH   IIHRDVK+ NILL
Sbjct: 113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILL 172

Query: 196 DNNFCVKVADFGLSRLFPNH-VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLI 254
           D NF  K+ DFG+S+       TH+ST  +GT GY+DPEY    +LT+KSDV+SFGVVL 
Sbjct: 173 DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLF 232

Query: 255 ELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE-SDNKVRRTINAVAEL 313
           E++ +  A+  +  R  +NL+  A+    N  L ++VD  L  +     +R+      + 
Sbjct: 233 EVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRK----FGDT 288

Query: 314 AFQCLQSEKDLRPYMVDVLDAL 335
           A +CL    + RP M DVL  L
Sbjct: 289 AVKCLALSSEDRPSMGDVLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  346 bits (890), Expect = e-119
 Identities = 125/318 (39%), Positives = 175/318 (55%), Gaps = 18/318 (5%)

Query: 48  VQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVE-QFMN 106
           ++ FS  EL+ A++ F +   LG GGFG VY G L DG  VAVKRL E   +  E QF  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQT 76

Query: 107 EVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK 166
           EV++++   H+NL+ L G       E LLVY +++NG+VA  L         L WP R +
Sbjct: 77  EVEMISMAVHRNLLRLRGF-CMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQR 135

Query: 167 IAIETASALTYLH-ASD--IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAP 223
           IA+ +A  L YLH   D  IIHRDVK  NILLD  F   V DFGL++L     THV+TA 
Sbjct: 136 IALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAV 195

Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHE--INLSNLAINK 281
           +GT G++ PEY    + ++K+DVF +GV+L+ELI+   A D+ R  ++  + L +     
Sbjct: 196 RGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGL 255

Query: 282 IQNKALHELVDQTLGYE-SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
           ++ K L  LVD  L     D +V +    + ++A  C QS    RP M +V+  L   E 
Sbjct: 256 LKEKKLEALVDVDLQGNYKDEEVEQ----LIQVALLCTQSSPMERPKMSEVVRML---EG 308

Query: 341 DGY---DDKKTHEEMMTQ 355
           DG     ++   EEM  Q
Sbjct: 309 DGLAERWEEWQKEEMFRQ 326

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  333 bits (856), Expect = e-114
 Identities = 104/309 (33%), Positives = 159/309 (51%), Gaps = 28/309 (9%)

Query: 47  GVQVFSYGELEEATNYFDSARE------LGDGGFGTVYYGELQDGRAVAVKRLYENNYKR 100
               FS+ EL+  TN FD          +G+GGFG VY G + +   VAVK+L       
Sbjct: 11  RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69

Query: 101 VEQ----FMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP 156
            E+    F  E+ ++A+ +H+NLV L G  S    +L LVY ++ NG++ D L      P
Sbjct: 70  TEELKQQFDQEIKVMAKCQHENLVELLGF-SSDGDDLCLVYVYMPNGSLLDRLSCLDGTP 128

Query: 157 GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NH 215
             L W  R KIA   A+ + +LH +  IHRD+K+ NILLD  F  K++DFGL+R      
Sbjct: 129 -PLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187

Query: 216 VTHVSTAPQGTPGYVDPEY---HQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEI 272
            T +++   GT  Y+ PE         +T KSD++SFGVVL+E+I+ +PAVD   HR   
Sbjct: 188 QTVMTSRIVGTTAYMAPEALRGE----ITPKSDIYSFGVVLLEIITGLPAVD--EHREPQ 241

Query: 273 NLSNLAINKIQN-KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDV 331
            L ++        K + + +D+ +       V      +  +A QCL  +K+ RP +  V
Sbjct: 242 LLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEA----MYSVASQCLHEKKNKRPDIKKV 297

Query: 332 LDALRDIES 340
              L+++ +
Sbjct: 298 QQLLQEMTA 306

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  233 bits (597), Expect = 8e-75
 Identities = 71/314 (22%), Positives = 119/314 (37%), Gaps = 33/314 (10%)

Query: 51  FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDI 110
                L   +           G FG V+  +L     VAVK     + K+  Q   EV  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQD-KQSWQNEYEVYS 71

Query: 111 LARLRHKNLVSLYGC---TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI 167
           L  ++H+N++   G     +    +L L+  F   G+++D L         + W     I
Sbjct: 72  LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-----VVSWNELCHI 126

Query: 168 AIETASALTYLHASD----------IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT 217
           A   A  L YLH             I HRD+K+ N+LL NN    +ADFGL+  F    +
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186

Query: 218 HVSTAPQ-GTPGYVDPEY-----HQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHE 271
              T  Q GT  Y+ PE      +       + D+++ G+VL EL S   A D     + 
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246

Query: 272 INL-----SNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
           +        + ++  +Q   +H+     L      +    +  + E   +C   + + R 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVL--RDYWQKHAGMAMLCETIEECWDHDAEARL 304

Query: 327 YMVDVLDALRDIES 340
               V + +  ++ 
Sbjct: 305 SAGCVGERITQMQR 318

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  213 bits (544), Expect = 5e-67
 Identities = 71/297 (23%), Positives = 113/297 (38%), Gaps = 51/297 (17%)

Query: 67  RELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG- 124
             LG G FG        + G  + +K L   + +    F+ EV ++  L H N++   G 
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGV 75

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
                 + L  + E+I  GT+   +          PW  R+  A + AS + YLH+ +II
Sbjct: 76  LY--KDKRLNFITEYIKGGTLRGIIKS---MDSQYPWSQRVSFAKDIASGMAYLHSMNII 130

Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-------------VSTAPQGTPGYVD 231
           HRD+ ++N L+  N  V VADFGL+RL  +  T                    G P ++ 
Sbjct: 131 HRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMA 190

Query: 232 PE--YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE 289
           PE    + Y   +K DVFSFG+VL E+I  + A        +     +         L  
Sbjct: 191 PEMINGRSY--DEKVDVFSFGIVLCEIIGRVNA------DPDYLPRTMDFGLNVRGFL-- 240

Query: 290 LVDQTLGYESDNKVRRTI-----NAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
                          R        +   +  +C   + + RP  V +   L  +   
Sbjct: 241 --------------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  208 bits (532), Expect = 3e-65
 Identities = 94/321 (29%), Positives = 147/321 (45%), Gaps = 36/321 (11%)

Query: 30  SSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVA 89
              P S  D+    N +        +++      +   ++G G FGTV+  E   G  VA
Sbjct: 6   HHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVA 64

Query: 90  VKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVAD 147
           VK L E ++  +RV +F+ EV I+ RLRH N+V   G  ++    L +V E++S G++  
Sbjct: 65  VKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPN-LSIVTEYLSRGSLYR 123

Query: 148 HLHGERAKPGALPWPTRLKIAIETASALTYLHASD--IIHRDVKTNNILLDNNFCVKVAD 205
            LH   A+   L    RL +A + A  + YLH  +  I+HR++K+ N+L+D  + VKV D
Sbjct: 124 LLHKSGARE-QLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCD 182

Query: 206 FGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDI 265
           FGLSR         S +  GTP ++ PE  +     +KSDV+SFGV+L EL         
Sbjct: 183 FGLSR-LKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWEL--------A 233

Query: 266 TRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTI-----NAVAELAFQCLQS 320
           T  +   NL+   +       +  +  +          R  I       VA +   C  +
Sbjct: 234 TLQQPWGNLNPAQV-------VAAVGFKCK--------RLEIPRNLNPQVAAIIEGCWTN 278

Query: 321 EKDLRPYMVDVLDALRDIESD 341
           E   RP    ++D LR +   
Sbjct: 279 EPWKRPSFATIMDLLRPLIKS 299

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  206 bits (526), Expect = 1e-64
 Identities = 77/282 (27%), Positives = 132/282 (46%), Gaps = 29/282 (10%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYG 124
           + +G G FGTVY G+      VAVK L       ++++ F NEV +L + RH N++   G
Sbjct: 30  QRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG 87

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
            ++    +L +V ++    ++  HLH    K         + IA +TA  + YLHA  II
Sbjct: 88  YSTAP--QLAIVTQWCEGSSLYHHLHASETK---FEMKKLIDIARQTARGMDYLHAKSII 142

Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPN-HVTHVSTAPQGTPGYVDPE---YHQCYQL 240
           HRD+K+NNI L  +  VK+ DFGL+        +H      G+  ++ PE          
Sbjct: 143 HRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY 202

Query: 241 TDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
           + +SDV++FG+VL EL++  +P  +I              N+ Q   +  +   +L  + 
Sbjct: 203 SFQSDVYAFGIVLYELMTGQLPYSNIN-------------NRDQ--IIEMVGRGSLSPDL 247

Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
                     +  L  +CL+ ++D RP    +L  + ++  +
Sbjct: 248 SKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  200 bits (512), Expect = 1e-62
 Identities = 57/290 (19%), Positives = 114/290 (39%), Gaps = 53/290 (18%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYG 124
            +L +   G ++ G  Q G  + VK L   ++  ++   F  E   L    H N++ + G
Sbjct: 16  TKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLG 74

Query: 125 -CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD- 182
            C S  +    L+  ++  G++ + LH        +     +K A++ A  + +LH  + 
Sbjct: 75  ACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFV--VDQSQAVKFALDMARGMAFLHTLEP 132

Query: 183 -IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE--YHQCYQ 239
            I    + + ++++D +   +++   +   F       S      P +V PE    +   
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSF------QSPGRMYAPAWVAPEALQKKPED 186

Query: 240 L-TDKSDVFSFGVVLIELISSMPAVDITRHRHEI---NLSNL-AINKIQNKALHELVDQT 294
                +D++SF V+L EL        +TR   E+   +LSN+    K+  + L       
Sbjct: 187 TNRRSADMWSFAVLLWEL--------VTR---EVPFADLSNMEIGMKVALEGL------- 228

Query: 295 LGYESDNKVRRTI-----NAVAELAFQCLQSEKDLRPYMVDVLDALRDIE 339
                    R TI       V++L   C+  +   RP    ++  L  ++
Sbjct: 229 ---------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQ 269

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  201 bits (512), Expect = 1e-62
 Identities = 71/297 (23%), Positives = 125/297 (42%), Gaps = 59/297 (19%)

Query: 67  RELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-------KRVEQFMNEVDILARLRHKN 118
           +++G GGFG V+ G L  D   VA+K L   +        ++ ++F  EV I++ L H N
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPN 84

Query: 119 LVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           +V LYG           +V EF+  G +   L     K   + W  +L++ ++ A  + Y
Sbjct: 85  IVKLYGLMH----NPPRMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEY 137

Query: 178 LHASD--IIHRDVKTNNILLDN-----NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
           +   +  I+HRD+++ NI L +       C KVADFGLS+       H  +   G   ++
Sbjct: 138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSVSGLLGNFQWM 193

Query: 231 DPE----YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA 286
            PE      + Y  T+K+D +SF ++L  +        +T        S   I       
Sbjct: 194 APETIGAEEESY--TEKADTYSFAMILYTI--------LTGEGPFDEYSYGKI------- 236

Query: 287 LHELVDQTLGYESDNKVRRTI-----NAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
                 + +    +  +R TI       +  +   C   +   RP+   ++  L ++
Sbjct: 237 ------KFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  201 bits (513), Expect = 3e-62
 Identities = 62/291 (21%), Positives = 106/291 (36%), Gaps = 48/291 (16%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYG 124
             +G G FG VY+G       VA++ +        +++ F  EV    + RH+N+V   G
Sbjct: 39  ELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMG 96

Query: 125 -CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
            C S     L ++       T+   +   +     L      +IA E    + YLHA  I
Sbjct: 97  ACMSPP--HLAIITSLCKGRTLYSVVRDAKIV---LDVNKTRQIAQEIVKGMGYLHAKGI 151

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRL----FPNHVTHVSTAPQGTPGYVDPE------ 233
           +H+D+K+ N+  DN   V + DFGL  +                 G   ++ PE      
Sbjct: 152 LHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLS 210

Query: 234 -----YHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKAL 287
                    +  +  SDVF+ G +  EL +   P                 I ++     
Sbjct: 211 PDTEEDKLPF--SKHSDVFALGTIWYELHAREWPFKTQPAEA--------IIWQMGTGMK 260

Query: 288 HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
             L    +G E           ++++   C   E++ RP    ++D L  +
Sbjct: 261 PNLSQIGMGKE-----------ISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  199 bits (509), Expect = 1e-61
 Identities = 68/306 (22%), Positives = 126/306 (41%), Gaps = 48/306 (15%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
             +G G FG V   + +  + VA+K++   + +  + F+ E+  L+R+ H N+V LYG  
Sbjct: 14  EVVGRGAFGVVCKAKWR-AKDVAIKQIESESER--KAFIVELRQLSRVNHPNIVKLYGAC 70

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD---I 183
                 + LV E+   G++ + LHG    P        +   ++ +  + YLH+     +
Sbjct: 71  LNP---VCLVMEYAEGGSLYNVLHGAEPLP-YYTAAHAMSWCLQCSQGVAYLHSMQPKAL 126

Query: 184 IHRDVKTNNILLDNNF-CVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           IHRD+K  N+LL      +K+ DFG +      +    T  +G+  ++ PE  +    ++
Sbjct: 127 IHRDLKPPNLLLVAGGTVLKICDFGTACD----IQTHMTNNKGSAAWMAPEVFEGSNYSE 182

Query: 243 KSDVFSFGVVLIELISSMPAVDITRHR--HEINLSNLAINKIQNKALHELVDQTLGYESD 300
           K DVFS+G++L E+I        TR +   EI      I    +                
Sbjct: 183 KCDVFSWGIILWEVI--------TRRKPFDEIGGPAFRIMWAVHNGT------------- 221

Query: 301 NKVRRTI-----NAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD--GYDDKKTHEEMM 353
              R  +       +  L  +C   +   RP M +++  +  +     G D+   +    
Sbjct: 222 ---RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQYPCQH 278

Query: 354 TQSPDS 359
           +  P  
Sbjct: 279 SLPPGE 284

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  200 bits (510), Expect = 1e-61
 Identities = 70/355 (19%), Positives = 119/355 (33%), Gaps = 73/355 (20%)

Query: 51  FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDI 110
            +  E     +       +G G +G VY G L D R VAVK     N +    F+NE +I
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58

Query: 111 --LARLRHKNLVSLYGC----TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR 164
             +  + H N+          T+    E LLV E+  NG++  +L           W + 
Sbjct: 59  YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-----SDWVSS 113

Query: 165 LKIAIETASALTYLHASD---------IIHRDVKTNNILLDNNFCVKVADFGLSRLF--- 212
            ++A      L YLH            I HRD+ + N+L+ N+    ++DFGLS      
Sbjct: 114 CRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGN 173

Query: 213 ----PNHVTHVSTAPQGTPGYVDPEY-------HQCYQLTDKSDVFSFGVVLIELISSMP 261
               P    + + +  GT  Y+ PE                + D+++ G++  E+     
Sbjct: 174 RLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCT 233

Query: 262 AVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE------SDNKVRRTI-------- 307
            +       E  +           A    V     +E      S  K R           
Sbjct: 234 DLFPGESVPEYQM-----------AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENS 282

Query: 308 ---NAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEMMTQSPDS 359
               ++ E    C   + + R       + + ++           E   + SP +
Sbjct: 283 LAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMM-------IWERNKSVSPTA 330

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  189 bits (481), Expect = 4e-58
 Identities = 84/298 (28%), Positives = 127/298 (42%), Gaps = 65/298 (21%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRL----YENNYKRVEQFMNEVDILARLRHKNLVSL 122
             +G GGFG VY      G  VAVK       E+  + +E    E  + A L+H N+++L
Sbjct: 13  EIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71

Query: 123 YG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
            G C    +  L LV EF   G +   L G+R     +P    +  A++ A  + YLH  
Sbjct: 72  RGVCLKEPN--LCLVMEFARGGPLNRVLSGKR-----IPPDILVNWAVQIARGMNYLHDE 124

Query: 182 ---DIIHRDVKTNNILLDN--------NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
               IIHRD+K++NIL+          N  +K+ DFGL+R +  H T   +A  G   ++
Sbjct: 125 AIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW--HRTTKMSAA-GAYAWM 181

Query: 231 DPE--YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEI---NLSNLAINKIQNK 285
            PE      +  +  SDV+S+GV+L EL        +T    E+    +  LA+      
Sbjct: 182 APEVIRASMF--SKGSDVWSYGVLLWEL--------LTG---EVPFRGIDGLAV------ 222

Query: 286 ALHELVDQTLGYESDNKVRRTI-----NAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
                        + NK+   I        A+L   C   +   RP   ++LD L  I
Sbjct: 223 ---------AYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  184 bits (468), Expect = 2e-55
 Identities = 65/301 (21%), Positives = 120/301 (39%), Gaps = 37/301 (12%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDI--LARLRHKNLVSLYG 124
           +++G G +G V+ G+ + G  VAVK  +         +  E +I     +RH+N++    
Sbjct: 43  KQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIA 98

Query: 125 -CT--SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
                +    +L L+ ++  NG++ D+L         L   + LK+A  + S L +LH  
Sbjct: 99  ADIKGTGSWTQLYLITDYHENGSLYDYLKST-----TLDAKSMLKLAYSSVSGLCHLHTE 153

Query: 182 D--------IIHRDVKTNNILLDNNFCVKVADFGLSRLF---PNHVTHVSTAPQGTPGYV 230
                    I HRD+K+ NIL+  N    +AD GL+  F    N V        GT  Y+
Sbjct: 154 IFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYM 213

Query: 231 DPE------YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHR----HEINLSNLAIN 280
            PE          +Q    +D++SFG++L E+     +  I        H++  S+ +  
Sbjct: 214 PPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYE 273

Query: 281 KIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
            ++     +       + +       +  + +L  +C       R   + V   L  +  
Sbjct: 274 DMREIVCIK--KLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSE 331

Query: 341 D 341
            
Sbjct: 332 S 332

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  182 bits (464), Expect = 3e-55
 Identities = 69/306 (22%), Positives = 125/306 (40%), Gaps = 43/306 (14%)

Query: 66  AREL------GDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDI--LARLRHK 117
           AR++      G G +G V+ G  Q G  VAVK     + K    +  E ++     LRH+
Sbjct: 7   ARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSSRDEK---SWFRETELYNTVMLRHE 62

Query: 118 NLVSLYGCTSR---HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
           N++            S +L L+  +   G++ D+L         L   + L+I +  AS 
Sbjct: 63  NILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-----TLDTVSCLRIVLSIASG 117

Query: 175 LTYLHASD--------IIHRDVKTNNILLDNNFCVKVADFGLSRLF---PNHVTHVSTAP 223
           L +LH           I HRD+K+ NIL+  N    +AD GL+ +     N +   +   
Sbjct: 118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPR 177

Query: 224 QGTPGYVDPE------YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHR----HEIN 273
            GT  Y+ PE         C+    + D+++FG+VL E+   M +  I        +++ 
Sbjct: 178 VGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV 237

Query: 274 LSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD 333
            ++ +   ++     +   Q     +      T+ ++A+L  +C       R   + +  
Sbjct: 238 PNDPSFEDMRKVVCVD--QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

Query: 334 ALRDIE 339
            L  I+
Sbjct: 296 TLTKID 301

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  174 bits (444), Expect = 7e-52
 Identities = 62/305 (20%), Positives = 120/305 (39%), Gaps = 49/305 (16%)

Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDI--LARLRHKNLVSLYGCT 126
           +G G FG V+ G+ + G  VAVK       +    +  E +I     LRH+N++      
Sbjct: 50  IGKGRFGEVWRGKWR-GEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAAD 105

Query: 127 SRHSR---ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-- 181
           ++ +    +L LV ++  +G++ D+L+        +     +K+A+ TAS L +LH    
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY-----TVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 182 ------DIIHRDVKTNNILLDNNFCVKVADFGLSRLF---PNHVTHVSTAPQGTPGYVDP 232
                  I HRD+K+ NIL+  N    +AD GL+       + +        GT  Y+ P
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 233 E------YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA 286
           E        + ++   ++D+++ G+V  E+          R        +  +       
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEI--------ARRCSIGGIHEDYQLPYYDLVP 272

Query: 287 LHELVDQTLGYESDNKVRRTI----------NAVAELAFQCLQSEKDLRPYMVDVLDALR 336
               V++      + K+R  I            +A++  +C  +    R   + +   L 
Sbjct: 273 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 332

Query: 337 DIESD 341
            +   
Sbjct: 333 QLSQQ 337

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  160 bits (408), Expect = 7e-47
 Identities = 70/271 (25%), Positives = 122/271 (45%), Gaps = 22/271 (8%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVK--RLYEN-NYKRVEQFMNEVDILARLRHKNLVSL 122
           +++G G F  VY    L DG  VA+K  ++++  + K     + E+D+L +L H N++  
Sbjct: 38  KKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKY 97

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           Y        EL +V E    G ++  +   + +   +P  T  K  ++  SAL ++H+  
Sbjct: 98  YAS-FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR 156

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           ++HRD+K  N+ +     VK+ D GL R F +  T   +   GTP Y+ PE         
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHENGYNF 215

Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNK 302
           KSD++S G +L E+ +         +  ++NL +L   KI+      L       E    
Sbjct: 216 KSDIWSLGCLLYEMAALQSPF----YGDKMNLYSL-CKKIEQCDYPPLPSDHYSEE---- 266

Query: 303 VRRTINAVAELAFQCLQSEKDLRPYMVDVLD 333
                  + +L   C+  + + RP +  V D
Sbjct: 267 -------LRQLVNMCINPDPEKRPDVTYVYD 290

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  157 bits (398), Expect = 2e-45
 Identities = 54/205 (26%), Positives = 82/205 (40%), Gaps = 15/205 (7%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           ++LG+GGF  V   E L DG   A+KR+  +  +  E+   E D+     H N++ L   
Sbjct: 35  QKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAY 94

Query: 126 TSRHS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
             R      E  L+  F   GT+ + +   + K   L     L + +     L  +HA  
Sbjct: 95  CLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG 154

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--------GTPGYVDPEY 234
             HRD+K  NILL +     + D G       HV     A           T  Y  PE 
Sbjct: 155 YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPEL 214

Query: 235 HQCYQ---LTDKSDVFSFGVVLIEL 256
                   + +++DV+S G VL  +
Sbjct: 215 FSVQSHCVIDERTDVWSLGCVLYAM 239

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  154 bits (392), Expect = 9e-45
 Identities = 65/289 (22%), Positives = 116/289 (40%), Gaps = 52/289 (17%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           F     +G GGFG V+  +   DG+   +KR+    Y   E+   EV  LA+L H N+V 
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV---KYNN-EKAEREVKALAKLDHVNIVH 68

Query: 122 LYGC---------------TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK 166
             GC               +   ++ L +  EF   GT+   +   R +   L     L+
Sbjct: 69  YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK--LDKVLALE 126

Query: 167 IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGT 226
           +  +    + Y+H+  +I+RD+K +NI L +   VK+ DFGL     N      +   GT
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GT 184

Query: 227 PGYVDPE--YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN 284
             Y+ PE    Q Y    + D+++ G++L EL        +         S      +++
Sbjct: 185 LRYMSPEQISSQDY--GKEVDLYALGLILAEL--------LHVCDTAFETSKF-FTDLRD 233

Query: 285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD 333
             + ++ D+          +  +        + L  + + RP   ++L 
Sbjct: 234 GIISDIFDKKE--------KTLLQ-------KLLSKKPEDRPNTSEILR 267

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  153 bits (389), Expect = 1e-43
 Identities = 77/323 (23%), Positives = 136/323 (42%), Gaps = 27/323 (8%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNLVSLY 123
           +++G+G FG     +  +DGR   +K   +   + K  E+   EV +LA ++H N+V   
Sbjct: 30  QKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYR 89

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
                 +  L +V ++   G +   +     K         L   ++   AL ++H   I
Sbjct: 90  ES-FEENGSLYIVMDYCEGGDLFKRI--NAQKGVLFQEDQILDWFVQICLALKHVHDRKI 146

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           +HRD+K+ NI L  +  V++ DFG++R+  + V        GTP Y+ PE  +     +K
Sbjct: 147 LHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARAC-IGTPYYLSPEICENKPYNNK 205

Query: 244 SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN-----------KALHELVD 292
           SD+++ G VL EL +   A +        ++ NL + KI +             L  LV 
Sbjct: 206 SDIWALGCVLYELCTLKHAFEAG------SMKNL-VLKIISGSFPPVSLHYSYDLRSLVS 258

Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEM 352
           Q    + + + R ++N++ E  F   + EK L P ++     L+     G          
Sbjct: 259 QLF--KRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPA 316

Query: 353 MTQSPDSVTLSWTSTKTTPTSSS 375
             Q+  SV  +   TK       
Sbjct: 317 SGQNSISVMPAQKITKPAAKYGI 339

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  154 bits (391), Expect = 1e-43
 Identities = 62/205 (30%), Positives = 94/205 (45%), Gaps = 27/205 (13%)

Query: 67  RELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVSLYG 124
            ++G G FG V+ G L+ D   VAVK   E        +F+ E  IL +  H N+V L G
Sbjct: 120 EQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIG 179

Query: 125 -CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
            CT    + + +V E +  G     L   R +   L   T L++  + A+ + YL +   
Sbjct: 180 VCT--QKQPIYIVMELVQGGDFLTFL---RTEGARLRVKTLLQMVGDAAAGMEYLESKCC 234

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS----------TAPQGTPGYVDPE 233
           IHRD+   N L+     +K++DFG+SR   + V   S          TA         PE
Sbjct: 235 IHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTA---------PE 285

Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
                + + +SDV+SFG++L E  S
Sbjct: 286 ALNYGRYSSESDVWSFGILLWETFS 310

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  149 bits (379), Expect = 5e-43
 Identities = 59/200 (29%), Positives = 99/200 (49%), Gaps = 21/200 (10%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-C 125
           +ELG G FG V  G+ +    VAVK + E      ++F  E   + +L H  LV  YG C
Sbjct: 14  KELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVC 72

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +      + +V E+ISNG + ++L   R+    L     L++  +    + +L +   IH
Sbjct: 73  S--KEYPIYIVTEYISNGCLLNYL---RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIH 127

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-------TPGYVDPEYHQCY 238
           RD+   N L+D + CVKV+DFG++R   +       +  G       +     PE    +
Sbjct: 128 RDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSA----PEVFHYF 180

Query: 239 QLTDKSDVFSFGVVLIELIS 258
           + + KSDV++FG+++ E+ S
Sbjct: 181 KYSSKSDVWAFGILMWEVFS 200

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  150 bits (380), Expect = 8e-43
 Identities = 64/202 (31%), Positives = 100/202 (49%), Gaps = 15/202 (7%)

Query: 67  RELGDGGFGTVYYGEL-----QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V            G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 16  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 75

Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             G C S   R L L+ E++  G++ D+L   +     +     L+   +    + YL  
Sbjct: 76  YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 132

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYVD---PEYHQ 236
              IHRD+ T NIL++N   VK+ DFGL+++ P +        P  +P  +    PE   
Sbjct: 133 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESP--IFWYAPESLT 190

Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 191 ESKFSVASDVWSFGVVLYELFT 212

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  149 bits (378), Expect = 1e-42
 Identities = 65/271 (23%), Positives = 112/271 (41%), Gaps = 40/271 (14%)

Query: 68  ELGDGGFGTVYYG-ELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           E+G G F TVY G + +    VA    +  +      ++F  E ++L  L+H N+V  Y 
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 125 C---TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
               T +  + ++LV E +++GT+  +L     +   +          +    L +LH  
Sbjct: 93  SWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGLQFLHTR 148

Query: 182 D--IIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-YHQC 237
              IIHRD+K +NI +      VK+ D GL+ L          A  GTP ++ PE Y + 
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK---AVIGTPEFMAPEMYEEK 205

Query: 238 YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA--INKIQNKALHELVDQTL 295
           Y   +  DV++FG+ ++E+         T         N A    ++ +       D+  
Sbjct: 206 Y--DESVDVYAFGMCMLEMA--------TSEYPYSECQNAAQIYRRVTSGVKPASFDKVA 255

Query: 296 GYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
                 +V+  I         C++  KD R 
Sbjct: 256 ----IPEVKEIIE-------GCIRQNKDERY 275

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  148 bits (375), Expect = 3e-42
 Identities = 61/200 (30%), Positives = 103/200 (51%), Gaps = 21/200 (10%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-C 125
           +ELG G FG V YG+ +    VA+K + E      ++F+ E  ++  L H+ LV LYG C
Sbjct: 30  KELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVC 88

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           T    R + ++ E+++NG + ++L   R           L++  +   A+ YL +   +H
Sbjct: 89  T--KQRPIFIITEYMANGCLLNYL---REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLH 143

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-------TPGYVDPEYHQCY 238
           RD+   N L+++   VKV+DFGLSR   +      T+  G       +P    PE     
Sbjct: 144 RDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSP----PEVLMYS 196

Query: 239 QLTDKSDVFSFGVVLIELIS 258
           + + KSD+++FGV++ E+ S
Sbjct: 197 KFSSKSDIWAFGVLMWEIYS 216

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  147 bits (374), Expect = 3e-42
 Identities = 62/200 (31%), Positives = 100/200 (50%), Gaps = 21/200 (10%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-C 125
           +E+G G FG V+ G   +   VA+K + E      E F+ E +++ +L H  LV LYG C
Sbjct: 14  QEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVC 72

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
                  + LV EF+ +G ++D+L   R + G     T L + ++    + YL  + +IH
Sbjct: 73  L--EQAPICLVTEFMEHGCLSDYL---RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIH 127

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-------TPGYVDPEYHQCY 238
           RD+   N L+  N  +KV+DFG++R   +      T+  G             PE     
Sbjct: 128 RDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWAS----PEVFSFS 180

Query: 239 QLTDKSDVFSFGVVLIELIS 258
           + + KSDV+SFGV++ E+ S
Sbjct: 181 RYSSKSDVWSFGVLMWEVFS 200

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  149 bits (378), Expect = 3e-42
 Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 15/202 (7%)

Query: 67  RELGDGGFGTVYYGEL-----QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++LG G FG+V            G  VAVK+L  +  + +  F  E++IL  L+H N+V 
Sbjct: 47  QQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 106

Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             G C S   R L L+ E++  G++ D+L   +     +     L+   +    + YL  
Sbjct: 107 YKGVCYSAGRRNLKLIMEYLPYGSLRDYL---QKHKERIDHIKLLQYTSQICKGMEYLGT 163

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYVD---PEYHQ 236
              IHRD+ T NIL++N   VK+ DFGL+++ P +   +    P  +P  +    PE   
Sbjct: 164 KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESP--IFWYAPESLT 221

Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + +  SDV+SFGVVL EL +
Sbjct: 222 ESKFSVASDVWSFGVVLYELFT 243

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  147 bits (373), Expect = 6e-42
 Identities = 65/276 (23%), Positives = 112/276 (40%), Gaps = 29/276 (10%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNLVSLY 123
             +G G +G         DG+ +  K            +  ++EV++L  L+H N+V  Y
Sbjct: 12  YTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYY 71

Query: 124 GC-TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--- 179
                R +  L +V E+   G +A  +     +   L     L++  +   AL   H   
Sbjct: 72  DRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRS 131

Query: 180 --ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
                ++HRD+K  N+ LD    VK+ DFGL+R+  +  +   T   GTP Y+ PE    
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTF-VGTPYYMSPEQMNR 190

Query: 238 YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY 297
               +KSD++S G +L EL + MP           +   L   KI+      +  +   Y
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPPFTAF------SQKEL-AGKIREGKFRRIPYR---Y 240

Query: 298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD 333
             +  +   I        + L  +   RP + ++L+
Sbjct: 241 SDE--LNEIIT-------RMLNLKDYHRPSVEEILE 267

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  150 bits (382), Expect = 1e-41
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 23/199 (11%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           + +G G FG V  G+ + G  VAVK +  +     + F+ E  ++ +LRH NLV L G  
Sbjct: 199 QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 255

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
                 L +V E+++ G++ D+L         L     LK +++   A+ YL  ++ +HR
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 313

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-------TPGYVDPEYHQCYQ 239
           D+   N+L+  +   KV+DFGL++         S+           T     PE  +  +
Sbjct: 314 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTA----PEALREKK 362

Query: 240 LTDKSDVFSFGVVLIELIS 258
            + KSDV+SFG++L E+ S
Sbjct: 363 FSTKSDVWSFGILLWEIYS 381

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  151 bits (383), Expect = 1e-41
 Identities = 63/194 (32%), Positives = 98/194 (50%), Gaps = 7/194 (3%)

Query: 67  RELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG- 124
            +LG G +G VY G  +     VAVK L E+  +  E+F+ E  ++  ++H NLV L G 
Sbjct: 226 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
           CT        ++ EF++ G + D+L         +     L +A + +SA+ YL   + I
Sbjct: 285 CT--REPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFI 340

Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 244
           HR++   N L+  N  VKVADFGLSRL            +    +  PE     + + KS
Sbjct: 341 HRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKS 400

Query: 245 DVFSFGVVLIELIS 258
           DV++FGV+L E+ +
Sbjct: 401 DVWAFGVLLWEIAT 414

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  146 bits (371), Expect = 2e-41
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 20/205 (9%)

Query: 67  RELGDGGFGTVYYGEL-----QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLV 120
           R+LG+G FG V            G  VAVK L        +     E++IL  L H+N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
              G CT      + L+ EF+ +G++ ++L         +    +LK A++    + YL 
Sbjct: 87  KYKGICTEDGGNGIKLIMEFLPSGSLKEYL---PKNKNKINLKQQLKYAVQICKGMDYLG 143

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG------TPGYVDPE 233
           +   +HRD+   N+L+++   VK+ DFGL++       + +                 PE
Sbjct: 144 SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYA----PE 199

Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
                +    SDV+SFGV L EL++
Sbjct: 200 CLMQSKFYIASDVWSFGVTLHELLT 224

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  149 bits (377), Expect = 4e-41
 Identities = 65/193 (33%), Positives = 100/193 (51%), Gaps = 7/193 (3%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-C 125
            +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 248

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +      + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +H
Sbjct: 249 SEEP---IYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERMNYVH 303

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSD
Sbjct: 304 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 363

Query: 246 VFSFGVVLIELIS 258
           V+SFG++L EL +
Sbjct: 364 VWSFGILLTELTT 376

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  145 bits (367), Expect = 5e-41
 Identities = 61/206 (29%), Positives = 91/206 (44%), Gaps = 24/206 (11%)

Query: 67  RELGDGGFGTVYYGELQ----DGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNL 119
            +LGDG FG V  GE         +VAVK L     +  + ++ F+ EV+ +  L H+NL
Sbjct: 24  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 83

Query: 120 VSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           + LYG   +     + +V E    G++ D L   R   G     T  + A++ A  + YL
Sbjct: 84  IRLYGVVLTPP---MKMVTELAPLGSLLDRL---RKHQGHFLLGTLSRYAVQVAEGMGYL 137

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG------TPGYVDP 232
            +   IHRD+   N+LL     VK+ DFGL R  P +  H                   P
Sbjct: 138 ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA----P 193

Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS 258
           E  +    +  SD + FGV L E+ +
Sbjct: 194 ESLKTRTFSHASDTWMFGVTLWEMFT 219

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  144 bits (366), Expect = 5e-41
 Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 19/199 (9%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
             LG G FG V+ G       VAVK L +      + F+ E +++ +L+H+ LV LY   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++    + ++ E++ NG++ D L         L     L +A + A  + ++   + IHR
Sbjct: 78  TQEP--IYIITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEERNYIHR 133

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-------TPGYVDPEYHQCYQ 239
           D++  NIL+ +    K+ADFGL+RL  ++     TA +G       T     PE      
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTA----PEAINYGT 186

Query: 240 LTDKSDVFSFGVVLIELIS 258
            T KSDV+SFG++L E+++
Sbjct: 187 FTIKSDVWSFGILLTEIVT 205

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  145 bits (368), Expect = 5e-41
 Identities = 55/223 (24%), Positives = 94/223 (42%), Gaps = 35/223 (15%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           F+    LG G FG V       D R  A+K++  +  +++   ++EV +LA L H+ +V 
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVR 66

Query: 122 LYGC------------TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
            Y                +    L +  E+  NGT+ D +    ++          ++  
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI---HSENLNQQRDEYWRLFR 123

Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ----- 224
           +   AL+Y+H+  IIHRD+K  NI +D +  VK+ DFGL++     +  +    Q     
Sbjct: 124 QILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

Query: 225 --------GTPGYVDPEYHQCYQLTD---KSDVFSFGVVLIEL 256
                   GT  YV  E            K D++S G++  E+
Sbjct: 184 SDNLTSAIGTAMYVATE--VLDGTGHYNEKIDMYSLGIIFFEM 224

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  150 bits (379), Expect = 7e-41
 Identities = 65/193 (33%), Positives = 100/193 (51%), Gaps = 7/193 (3%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYG-C 125
            +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 331

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
           +      + +V E++S G++ D L GE  K   L  P  + +A + AS + Y+   + +H
Sbjct: 332 SEEP---IYIVTEYMSKGSLLDFLKGETGKY--LRLPQLVDMAAQIASGMAYVERMNYVH 386

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSD
Sbjct: 387 RDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSD 446

Query: 246 VFSFGVVLIELIS 258
           V+SFG++L EL +
Sbjct: 447 VWSFGILLTELTT 459

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  148 bits (375), Expect = 1e-40
 Identities = 55/195 (28%), Positives = 101/195 (51%), Gaps = 11/195 (5%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           ++LG G FG V+         VAVK +   +    E F+ E +++  L+H  LV L+   
Sbjct: 194 KKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV-EAFLAEANVMKTLQHDKLVKLHAVV 252

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++    + ++ EF++ G++ D L  +       P P  +  + + A  + ++   + IHR
Sbjct: 253 TKEP--IYIITEFMAKGSLLDFLKSDEGSK--QPLPKLIDFSAQIAEGMAFIEQRNYIHR 308

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD---PEYHQCYQLTDK 243
           D++  NIL+  +   K+ADFGL+R+  ++     TA +G    +    PE       T K
Sbjct: 309 DLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGSFTIK 365

Query: 244 SDVFSFGVVLIELIS 258
           SDV+SFG++L+E+++
Sbjct: 366 SDVWSFGILLMEIVT 380

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  143 bits (364), Expect = 1e-40
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 28/206 (13%)

Query: 67  RELGDGGFGTVYYGELQDGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS 121
           R LG+G FG VY G   + +     VAVK   ++      E+FM+E  I+  L H ++V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G          ++ E    G +  +L        +L   T +  +++   A+ YL + 
Sbjct: 78  LIGIIEEEP--TWIIMELYPYGELGHYL---ERNKNSLKVLTLVLYSLQICKAMAYLESI 132

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS---------TAPQGTPGYVDP 232
           + +HRD+   NIL+ +  CVK+ DFGLSR   +   + +          +         P
Sbjct: 133 NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMS---------P 183

Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS 258
           E     + T  SDV+ F V + E++S
Sbjct: 184 ESINFRRFTTASDVWMFAVCMWEILS 209

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  143 bits (364), Expect = 1e-40
 Identities = 66/202 (32%), Positives = 98/202 (48%), Gaps = 23/202 (11%)

Query: 67  RELGDGGFGTVYYGELQDGR-AVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            +LG G +G VY G  +     VAVK L E+    VE+F+ E  ++  ++H NLV L G 
Sbjct: 19  HKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
            +R      ++ EF++ G + D+L         +     L +A + +SA+ YL   + IH
Sbjct: 78  CTR-EPPFYIITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKKNFIH 134

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS---------TAPQGTPGYVDPEYHQ 236
           RD+   N L+  N  VKVADFGLSRL                  TA         PE   
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA---------PESLA 185

Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + + KSDV++FGV+L E+ +
Sbjct: 186 YNKFSIKSDVWAFGVLLWEIAT 207

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  144 bits (366), Expect = 2e-40
 Identities = 77/318 (24%), Positives = 120/318 (37%), Gaps = 36/318 (11%)

Query: 67  RELGDGGFGTVYYGEL-----QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
            +LG G FG+V            G  VAVK+L  +   +   F  E+ IL  L    +V 
Sbjct: 29  SQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVK 88

Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             G       + L LV E++ +G + D L   +     L     L  + +    + YL +
Sbjct: 89  YRGVSYGPGRQSLRLVMEYLPSGCLRDFL---QRHRARLDASRLLLYSSQICKGMEYLGS 145

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYVD---PEYHQ 236
              +HRD+   NIL+++   VK+ADFGL++L P +   +V   P  +P  +    PE   
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSP--IFWYAPESLS 203

Query: 237 CYQLTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT 294
               + +SDV+SFGVVL EL +               +              L EL+++ 
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPA---LSRLLELLEE- 259

Query: 295 LGYESDNKVR-----RTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTH 349
            G       R          V EL   C       RP    +   L  + S     +   
Sbjct: 260 -GQ------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS---GSRGCE 309

Query: 350 EEMMTQSPDSVTLSWTST 367
               T  P+    S + +
Sbjct: 310 THAFTAHPEGKHHSLSFS 327

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  143 bits (363), Expect = 2e-40
 Identities = 65/201 (32%), Positives = 96/201 (47%), Gaps = 16/201 (7%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  R LG G FG VY   E Q    +A+K L++          Q   EV+I + LRH N
Sbjct: 11  FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 70

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LYG     +R + L+ E+   GTV   L     K              E A+AL+Y 
Sbjct: 71  ILRLYGYFHDATR-VYLILEYAPLGTVYREL----QKLSKFDEQRTATYITELANALSYC 125

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE--YHQ 236
           H+  +IHRD+K  N+LL +   +K+ADFG S   P+          GT  Y+ PE    +
Sbjct: 126 HSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLC---GTLDYLPPEMIEGR 182

Query: 237 CYQLTDKSDVFSFGVVLIELI 257
            +   +K D++S GV+  E +
Sbjct: 183 MH--DEKVDLWSLGVLCYEFL 201

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  143 bits (362), Expect = 2e-40
 Identities = 58/199 (29%), Positives = 98/199 (49%), Gaps = 23/199 (11%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           + +G G FG V  G+ + G  VAVK +  +     + F+ E  ++ +LRH NLV L G  
Sbjct: 27  QTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVI 83

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
                 L +V E+++ G++ D+L         L     LK +++   A+ YL  ++ +HR
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHR 141

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-------TPGYVDPEYHQCYQ 239
           D+   N+L+  +   KV+DFGL++         S+           T     PE  +  +
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTA----PEALREKK 190

Query: 240 LTDKSDVFSFGVVLIELIS 258
            + KSDV+SFG++L E+ S
Sbjct: 191 FSTKSDVWSFGILLWEIYS 209

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  143 bits (363), Expect = 3e-40
 Identities = 60/223 (26%), Positives = 92/223 (41%), Gaps = 33/223 (14%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           F+  + LG GGFG V+  +   D    A+KR+   N     E+ M EV  LA+L H  +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 121 SLYGC-----------TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
             +              S     L +  +      + D ++G             L I +
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE-ERERSVCLHIFL 125

Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ----- 224
           + A A+ +LH+  ++HRD+K +NI    +  VKV DFGL           +         
Sbjct: 126 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185

Query: 225 ------GTPGYVDPEYHQC----YQLTDKSDVFSFGVVLIELI 257
                 GT  Y+ PE  Q     Y  + K D+FS G++L EL+
Sbjct: 186 RHTGQVGTKLYMSPE--QIHGNSY--SHKVDIFSLGLILFELL 224

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  142 bits (360), Expect = 5e-40
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 28/206 (13%)

Query: 67  RELGDGGFGTVYYGELQDGR----AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS 121
           R +G+G FG V+ G          AVA+K      +    E+F+ E   + +  H ++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  + +   + ++ E  + G +   L   + +  +L   + +  A + ++AL YL + 
Sbjct: 81  LIGVITENP--VWIIMELCTLGELRSFL---QVRKYSLDLASLILYAYQLSTALAYLESK 135

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS---------TAPQGTPGYVDP 232
             +HRD+   N+L+ +N CVK+ DFGLSR   +   + +          A         P
Sbjct: 136 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA---------P 186

Query: 233 EYHQCYQLTDKSDVFSFGVVLIELIS 258
           E     + T  SDV+ FGV + E++ 
Sbjct: 187 ESINFRRFTSASDVWMFGVCMWEILM 212

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  143 bits (362), Expect = 6e-40
 Identities = 66/203 (32%), Positives = 98/203 (48%), Gaps = 18/203 (8%)

Query: 67  RELGDGGFGTVYYGELQD-----GRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLV 120
           R+LG+G FG V            G  VAVK L  +   +    +  E+DIL  L H++++
Sbjct: 37  RDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHII 96

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
              G C    +  L LV E++  G++ D+L         +     L  A +    + YLH
Sbjct: 97  KYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS-----IGLAQLLLFAQQICEGMAYLH 151

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP-NHVTHVSTAPQGTPGYVD---PEYH 235
           A   IHRD+   N+LLDN+  VK+ DFGL++  P  H  +       +P  V    PE  
Sbjct: 152 AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP--VFWYAPECL 209

Query: 236 QCYQLTDKSDVFSFGVVLIELIS 258
           + Y+    SDV+SFGV L EL++
Sbjct: 210 KEYKFYYASDVWSFGVTLYELLT 232

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  142 bits (361), Expect = 9e-40
 Identities = 58/205 (28%), Positives = 98/205 (47%), Gaps = 22/205 (10%)

Query: 67  RELGDGGFGTVYYGELQDGRA-----VAVKRLYENNYKRVEQ-FMNEVDILARLRHKNLV 120
           + +G G FG VY G L+         VA+K L     ++    F+ E  I+ +  H N++
Sbjct: 50  KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNII 109

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
            L G  +    + ++++ E++ NG +   L   R K G       + +    A+ + YL 
Sbjct: 110 RLEGVISK--YKPMMIITEYMENGALDKFL---REKDGEFSVLQLVGMLRGIAAGMKYLA 164

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG------TPGYVDPE 233
             + +HRD+   NIL+++N   KV+DFGLSR+  +      T   G      T     PE
Sbjct: 165 NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA----PE 220

Query: 234 YHQCYQLTDKSDVFSFGVVLIELIS 258
                + T  SDV+SFG+V+ E+++
Sbjct: 221 AISYRKFTSASDVWSFGIVMWEVMT 245

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  141 bits (358), Expect = 1e-39
 Identities = 61/201 (30%), Positives = 91/201 (45%), Gaps = 16/201 (7%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKN 118
           FD  R LG G FG VY   E Q+   +A+K L+++         Q   E++I + LRH N
Sbjct: 16  FDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPN 75

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ +Y       R + L+ EF   G +   L     K G            E A AL Y 
Sbjct: 76  ILRMYNYFHDRKR-IYLMLEFAPRGELYKEL----QKHGRFDEQRSATFMEELADALHYC 130

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE--YHQ 236
           H   +IHRD+K  N+L+     +K+ADFG S   P+          GT  Y+ PE    +
Sbjct: 131 HERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMC---GTLDYLPPEMIEGK 187

Query: 237 CYQLTDKSDVFSFGVVLIELI 257
            +   +K D++  GV+  E +
Sbjct: 188 TH--DEKVDLWCAGVLCYEFL 206

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  142 bits (359), Expect = 1e-39
 Identities = 58/204 (28%), Positives = 94/204 (46%), Gaps = 21/204 (10%)

Query: 67  RELGDGGFGTVYYGELQDGR----AVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVS 121
           + +G G  G V YG L+        VA+K L      ++   F++E  I+ +  H N++ 
Sbjct: 55  KIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIR 114

Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
           L G  T    R  ++V E++ NG++   L   R   G       + +     + + YL  
Sbjct: 115 LEGVVTR--GRLAMIVTEYMENGSLDTFL---RTHDGQFTIMQLVGMLRGVGAGMRYLSD 169

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG------TPGYVDPEY 234
              +HRD+   N+L+D+N   KV+DFGLSR+  +      T   G      T     PE 
Sbjct: 170 LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTA----PEA 225

Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
                 +  SDV+SFGVV+ E+++
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLA 249

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  141 bits (359), Expect = 2e-39
 Identities = 53/226 (23%), Positives = 94/226 (41%), Gaps = 39/226 (17%)

Query: 67  RELGDGGFGTVYYGELQDGR-----AVAVKRLYENNYKRVEQ-FMNEVDILARLRHKNLV 120
           + LG G FGTVY G            VA+K L E    +  +  ++E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 121 SLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
            L G C +     + L+ + +  G + D++   R     +     L   ++ A  + YL 
Sbjct: 81  RLLGICLTS---TVQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLE 134

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS----------TAPQGTPGY 229
              ++HRD+   N+L+     VK+ DFGL++L                    A       
Sbjct: 135 DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA------- 187

Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELIS-------SMPAVDITRH 268
              E       T +SDV+S+GV + EL++        +PA +I+  
Sbjct: 188 --LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSI 231

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  140 bits (356), Expect = 3e-39
 Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 23/211 (10%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNL--VSL 122
           +++G GG   V+    +  +  A+K   L E + + ++ + NE+  L +L+  +   + L
Sbjct: 34  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 93

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           Y       + + +V E   N  +   L     K  ++    R         A+  +H   
Sbjct: 94  YDY-EITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHG 147

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-GTPGYVDPE-------- 233
           I+H D+K  N L+ +   +K+ DFG++       T V    Q GT  Y+ PE        
Sbjct: 148 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 206

Query: 234 ---YHQCYQLTDKSDVFSFGVVLIELISSMP 261
                   +++ KSDV+S G +L  +     
Sbjct: 207 RENGKSKSKISPKSDVWSLGCILYYMTYGKT 237

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  140 bits (354), Expect = 4e-39
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 21/203 (10%)

Query: 67  RELGDGGFGTVYYGELQDGR---AVAVKRLYENNYKRVEQ-FMNEVDILARLRHKNLVSL 122
            ELG G FG+V  G  +  +    VA+K L +   K   +  M E  I+ +L +  +V L
Sbjct: 16  IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRL 75

Query: 123 YG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
            G C +     L+LV E    G +   L     K   +P     ++  + +  + YL   
Sbjct: 76  IGVCQAE---ALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEEK 129

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG------TPGYVDPEYH 235
           + +HRD+   N+LL N    K++DFGLS+      ++ +    G            PE  
Sbjct: 130 NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECI 185

Query: 236 QCYQLTDKSDVFSFGVVLIELIS 258
              + + +SDV+S+GV + E +S
Sbjct: 186 NFRKFSSRSDVWSYGVTMWEALS 208

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  140 bits (355), Expect = 4e-39
 Identities = 54/201 (26%), Positives = 97/201 (48%), Gaps = 15/201 (7%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS 127
           LG G +G VY G +L +   +A+K + E + +  +    E+ +   L+HKN+V   G   
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGS-F 88

Query: 128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRL--KIAIETASALTYLHASDIIH 185
             +  + +  E +  G+++  L   R+K G L    +       +    L YLH + I+H
Sbjct: 89  SENGFIKIFMEQVPGGSLSALL---RSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVH 145

Query: 186 RDVKTNNILLDN-NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE----YHQCYQL 240
           RD+K +N+L++  +  +K++DFG S+          T   GT  Y+ PE      + Y  
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETF-TGTLQYMAPEIIDKGPRGY-- 202

Query: 241 TDKSDVFSFGVVLIELISSMP 261
              +D++S G  +IE+ +  P
Sbjct: 203 GKAADIWSLGCTIIEMATGKP 223

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  140 bits (354), Expect = 5e-39
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 23/206 (11%)

Query: 67  RELGDGGFGTVYYGELQDGR----AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS 121
           R +G G FG VY+GE  D        A+K L      ++VE F+ E  ++  L H N+++
Sbjct: 27  RVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLA 86

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G          ++  ++ +G +   +   +           +   ++ A  + YL   
Sbjct: 87  LIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQ---RNPTVKDLISFGLQVARGMEYLAEQ 143

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-------TPGYVDPE- 233
             +HRD+   N +LD +F VKVADFGL+R   +   +     +        T      E 
Sbjct: 144 KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTA----LES 199

Query: 234 -YHQCYQLTDKSDVFSFGVVLIELIS 258
                +  T KSDV+SFGV+L EL++
Sbjct: 200 LQTYRF--TTKSDVWSFGVLLWELLT 223

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  141 bits (357), Expect = 9e-39
 Identities = 60/204 (29%), Positives = 96/204 (47%), Gaps = 21/204 (10%)

Query: 67  RELGDGGFGTVYYGELQDGR----AVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVS 121
           + +G G FG V  G L+       +VA+K L      K+   F+ E  I+ +  H N++ 
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110

Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
           L G  T   S+ +++V E++ NG++   L   R           + +    AS + YL  
Sbjct: 111 LEGVVT--KSKPVMIVTEYMENGSLDSFL---RKHDAQFTVIQLVGMLRGIASGMKYLSD 165

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG------TPGYVDPEY 234
              +HRD+   NIL+++N   KV+DFGL R+  +      T   G      T     PE 
Sbjct: 166 MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTS----PEA 221

Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
               + T  SDV+S+G+VL E++S
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMS 245

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  139 bits (353), Expect = 1e-38
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 18/216 (8%)

Query: 61  NYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKN 118
           + +  +  LG G    V+ G   + G   A+K     ++ R V+  M E ++L +L HKN
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 119 LVSLYGC-TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           +V L+       +R  +L+ EF   G++   L  E +    LP    L +  +    + +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 178 LHASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
           L  + I+HR++K  NI+     D     K+ DFG +R   +    VS    GT  Y+ P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPD 185

Query: 234 YHQCYQLTD--------KSDVFSFGVVLIELISSMP 261
            ++   L            D++S GV      +   
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  139 bits (352), Expect = 1e-38
 Identities = 60/245 (24%), Positives = 93/245 (37%), Gaps = 17/245 (6%)

Query: 25  LFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNY---FDSARELGDGGFGTVYYG- 80
           L+  +  +   +    +G     +Q   Y      + +   F     LG G +G V+   
Sbjct: 18  LYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVR 77

Query: 81  ELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVY 137
             +DGR  AVK         K   + + EV    ++ +H   V L          L L  
Sbjct: 78  SKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAW-EEGGILYLQT 136

Query: 138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN 197
           E     ++  H     A   +LP         +T  AL +LH+  ++H DVK  NI L  
Sbjct: 137 EL-CGPSLQQHC---EAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP 192

Query: 198 NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ-CYQLTDKSDVFSFGVVLIEL 256
               K+ DFGL               +G P Y+ PE  Q  Y     +DVFS G+ ++E+
Sbjct: 193 RGRCKLGDFGLLVELGT--AGAGEVQEGDPRYMAPELLQGSY--GTAADVFSLGLTILEV 248

Query: 257 ISSMP 261
             +M 
Sbjct: 249 ACNME 253

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  139 bits (353), Expect = 1e-38
 Identities = 56/210 (26%), Positives = 90/210 (42%), Gaps = 22/210 (10%)

Query: 67  RELGDGGFGTVYYGELQDG----RAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLV 120
           R LG G FG+V   +L+        VAVK L  +      +E+F+ E   +    H ++ 
Sbjct: 29  RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVA 88

Query: 121 SLYG-CT----SRHSRELLLVYEFISNGTVADHLHGERA--KPGALPWPTRLKIAIETAS 173
            L G              +++  F+ +G +   L   R    P  LP  T ++  ++ A 
Sbjct: 89  KLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIAC 148

Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV--- 230
            + YL + + IHRD+   N +L  +  V VADFGLSR     +       QG    +   
Sbjct: 149 GMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRK----IYSGDYYRQGCASKLPVK 204

Query: 231 --DPEYHQCYQLTDKSDVFSFGVVLIELIS 258
               E       T  SDV++FGV + E+++
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  138 bits (350), Expect = 1e-38
 Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 44/218 (20%)

Query: 67  RELGDGGFGTVYYGELQDGRA--------VAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
             LG G F  ++ G  ++           V +K L + +    E F     ++++L HK+
Sbjct: 14  ESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKH 73

Query: 119 LVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           LV  YG C      E +LV EF+  G++  +L   +     +    +L++A + A+A+ +
Sbjct: 74  LVLNYGVCV--CGDENILVQEFVKFGSLDTYL---KKNKNCINILWKLEVAKQLAAAMHF 128

Query: 178 LHASDIIHRDVKTNNILLD--------NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           L  + +IH +V   NILL         N   +K++D G+S                    
Sbjct: 129 LEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV-----------LPKDIL 177

Query: 230 VDP---------EYHQCYQLTDKSDVFSFGVVLIELIS 258
            +          E  +       +D +SFG  L E+ S
Sbjct: 178 QERIPWVPPECIENPKNL--NLATDKWSFGTTLWEICS 213

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  140 bits (354), Expect = 1e-38
 Identities = 47/211 (22%), Positives = 87/211 (41%), Gaps = 23/211 (10%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNL--VSL 122
           +++G GG   V+    +  +  A+K   L E + + ++ + NE+  L +L+  +   + L
Sbjct: 15  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           Y       + + +V E   N  +   L     K  ++    R         A+  +H   
Sbjct: 75  YDY-EITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHG 128

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-GTPGYVDPE-------- 233
           I+H D+K  N L+ +   +K+ DFG++       T V    Q GT  Y+ PE        
Sbjct: 129 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSS 187

Query: 234 ---YHQCYQLTDKSDVFSFGVVLIELISSMP 261
                   +++ KSDV+S G +L  +     
Sbjct: 188 RENGKSKSKISPKSDVWSLGCILYYMTYGKT 218

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  138 bits (350), Expect = 2e-38
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 23/204 (11%)

Query: 67  RELGDGGFGTVYYGELQDGRA---VAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVS 121
           +ELG G FGTV  G  Q  +    VAVK L     +    ++ + E +++ +L +  +V 
Sbjct: 23  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 82

Query: 122 LYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
           + G C +      +LV E    G +  +L     +   +     +++  + +  + YL  
Sbjct: 83  MIGICEAES---WMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEE 135

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG------TPGYVDPEY 234
           S+ +HRD+   N+LL      K++DFGLS+       +      G            PE 
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA----PEC 191

Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
              Y+ + KSDV+SFGV++ E  S
Sbjct: 192 INYYKFSSKSDVWSFGVLMWEAFS 215

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  139 bits (352), Expect = 2e-38
 Identities = 53/249 (21%), Positives = 94/249 (37%), Gaps = 18/249 (7%)

Query: 20  SASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYY 79
           + +             + +  +G            E  E  ++      +G G FG V+ 
Sbjct: 17  AKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHR 76

Query: 80  G-ELQDGRAVAVKRLYENNYKRVEQF-MNEVDILARLRHKNLVSLYGCTSRHSRELLLVY 137
             + Q G   AVK++      R+E F + E+   A L    +V LYG   R    + +  
Sbjct: 77  MKDKQTGFQCAVKKV------RLEVFRVEELVACAGLSSPRIVPLYGA-VREGPWVNIFM 129

Query: 138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN 197
           E +  G++   +     + G LP    L    +    L YLH   I+H DVK +N+LL +
Sbjct: 130 ELLEGGSLGQLIK----QMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS 185

Query: 198 N-FCVKVADFGLSRLFPNHVTHVSTAP----QGTPGYVDPEYHQCYQLTDKSDVFSFGVV 252
           +     + DFG +          S        GT  ++ PE         K D++S   +
Sbjct: 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCM 245

Query: 253 LIELISSMP 261
           ++ +++   
Sbjct: 246 MLHMLNGCH 254

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  138 bits (350), Expect = 2e-38
 Identities = 62/204 (30%), Positives = 93/204 (45%), Gaps = 19/204 (9%)

Query: 67  RELGDGGFGTVYYGELQDGR----AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS 121
             +G G FG VY+G L D        AVK L    +   V QF+ E  I+    H N++S
Sbjct: 31  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G   R     L+V  ++ +G + + +   R +         +   ++ A  + YL + 
Sbjct: 91  LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKYLASK 147

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-------TPGYVDPEY 234
             +HRD+   N +LD  F VKVADFGL+R   +   +      G              E 
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMA----LES 203

Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
            Q  + T KSDV+SFGV+L EL++
Sbjct: 204 LQTQKFTTKSDVWSFGVLLWELMT 227

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  140 bits (355), Expect = 2e-38
 Identities = 46/211 (21%), Positives = 86/211 (40%), Gaps = 23/211 (10%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNL--VSL 122
           +++G GG   V+    +  +  A+K   L E + + ++ + NE+  L +L+  +   + L
Sbjct: 62  KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 121

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           Y       + + +V E   N  +   L     K  ++    R         A+  +H   
Sbjct: 122 YDY-EITDQYIYMVMEC-GNIDLNSWLK----KKKSIDPWERKSYWKNMLEAVHTIHQHG 175

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-GTPGYVDPE-------- 233
           I+H D+K  N L+ +   +K+ DFG++       T V    Q G   Y+ PE        
Sbjct: 176 IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSS 234

Query: 234 ---YHQCYQLTDKSDVFSFGVVLIELISSMP 261
                   +++ KSDV+S G +L  +     
Sbjct: 235 RENGKSKSKISPKSDVWSLGCILYYMTYGKT 265

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  138 bits (350), Expect = 3e-38
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 30/208 (14%)

Query: 67  RELGDGGFGTVYYGELQDGR-----AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLV 120
           + LG G FGTV+ G            V +K + +    +  +   + +  +  L H ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G     S  L LV +++  G++ DH+   R   GAL     L   ++ A  + YL  
Sbjct: 79  RLLGLCPGSS--LQLVTQYLPLGSLLDHV---RQHRGALGPQLLLNWGVQIAKGMYYLEE 133

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS----------TAPQGTPGYV 230
             ++HR++   N+LL +   V+VADFG++ L P     +            A        
Sbjct: 134 HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMA-------- 185

Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELIS 258
             E     + T +SDV+S+GV + EL++
Sbjct: 186 -LESIHFGKYTHQSDVWSYGVTVWELMT 212

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  136 bits (345), Expect = 7e-38
 Identities = 40/224 (17%), Positives = 81/224 (36%), Gaps = 30/224 (13%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKR--LYENNYKRVEQFMNEVDILARL-RHKN 118
           F    ++G G FG+V+   +  DG   A+KR           +  + EV   A L +H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           +V  +         +L+  E+ + G++AD +                 + ++    L Y+
Sbjct: 73  VVRYFSA-WAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 179 HASDIIHRDVKTNNILLDNN-------------------FCVKVADFGLSRLFPNHVTHV 219
           H+  ++H D+K +NI +                         K+ D G      +     
Sbjct: 132 HSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEE 191

Query: 220 STAPQGTPGYVDPE-YHQCYQLTDKSDVFSFGVVLIELISSMPA 262
                G   ++  E   + Y    K+D+F+  + ++    + P 
Sbjct: 192 -----GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPL 230

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  136 bits (345), Expect = 2e-37
 Identities = 69/293 (23%), Positives = 121/293 (41%), Gaps = 45/293 (15%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYG 124
           R L +GGF  VY  + +  GR  A+KRL  N  ++    + EV  + +L  H N+V    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93

Query: 125 CT------SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
                   S   +   L+   +  G + + L    ++ G L   T LKI  +T  A+ ++
Sbjct: 94  AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESR-GPLSCDTVLKIFYQTCRAVQHM 152

Query: 179 HASD--IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-----------G 225
           H     IIHRD+K  N+LL N   +K+ DFG +    ++  +  +A +            
Sbjct: 153 HRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNT 212

Query: 226 TPGYVDPEYHQCYQ---LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAI--- 279
           TP Y  PE    Y    + +K D+++ G +L  L       +        + + L I   
Sbjct: 213 TPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE--------DGAKLRIVNG 264

Query: 280 ------NKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
                 +  Q    H L+   L  + + + R +I  V     + + + +++ P
Sbjct: 265 KYSIPPHDTQYTVFHSLIRAML--QVNPEERLSIAEVVHQLQE-IAAARNVNP 314

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  135 bits (343), Expect = 3e-37
 Identities = 60/211 (28%), Positives = 102/211 (48%), Gaps = 25/211 (11%)

Query: 67  RELGDGGFGTVYYGELQDGR----AVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLV 120
           + LG+G FG+V  G L+        VAVK +  +N   + +E+F++E   +    H N++
Sbjct: 40  KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99

Query: 121 SLYG-CT---SRHSRELLLVYEFISNGTVADHLHGERAK--PGALPWPTRLKIAIETASA 174
            L G C    S+   + +++  F+  G +  +L   R +  P  +P  T LK  ++ A  
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV---- 230
           + YL   + +HRD+   N +L ++  V VADFGLS+     +       QG    +    
Sbjct: 160 MEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKK----IYSGDYYRQGRIAKMPVKW 215

Query: 231 -DPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
              E    + Y  T KSDV++FGV + E+ +
Sbjct: 216 IAIESLADRVY--TSKSDVWAFGVTMWEIAT 244

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  137 bits (346), Expect = 4e-37
 Identities = 53/216 (24%), Positives = 92/216 (42%), Gaps = 18/216 (8%)

Query: 61  NYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKN 118
           + +  +  LG G    V+ G   + G   A+K     ++ R V+  M E ++L +L HKN
Sbjct: 9   HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKN 68

Query: 119 LVSLYGC-TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
           +V L+       +R  +L+ EF   G++   L  E +    LP    L +  +    + +
Sbjct: 69  IVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE-EPSNAYGLPESEFLIVLRDVVGGMNH 127

Query: 178 LHASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
           L  + I+HR++K  NI+     D     K+ DFG +R   +    VS    GT  Y+ P+
Sbjct: 128 LRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY--GTEEYLHPD 185

Query: 234 YHQCYQLTD--------KSDVFSFGVVLIELISSMP 261
            ++   L            D++S GV      +   
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSL 221

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  135 bits (342), Expect = 5e-37
 Identities = 50/208 (24%), Positives = 88/208 (42%), Gaps = 30/208 (14%)

Query: 67  RELGDGGFGTVYYGELQDGR-----AVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLV 120
           + LG G FGTVY G            VA+K L E    K  ++ ++E  ++A + + ++ 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            L G     +  + L+ + +  G + D++   R     +     L   ++ A  + YL  
Sbjct: 81  RLLGICLTST--VQLITQLMPFGCLLDYV---REHKDNIGSQYLLNWCVQIAKGMNYLED 135

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS----------TAPQGTPGYV 230
             ++HRD+   N+L+     VK+ DFGL++L                    A        
Sbjct: 136 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA-------- 187

Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELIS 258
             E       T +SDV+S+GV + EL++
Sbjct: 188 -LESILHRIYTHQSDVWSYGVTVWELMT 214

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  136 bits (343), Expect = 7e-37
 Identities = 61/204 (29%), Positives = 92/204 (45%), Gaps = 19/204 (9%)

Query: 67  RELGDGGFGTVYYGELQDGR----AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVS 121
             +G G FG VY+G L D        AVK L    +   V QF+ E  I+    H N++S
Sbjct: 95  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G   R     L+V  ++ +G + + +   R +         +   ++ A  + +L + 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFI---RNETHNPTVKDLIGFGLQVAKGMKFLASK 211

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-------TPGYVDPEY 234
             +HRD+   N +LD  F VKVADFGL+R   +          G              E 
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA----LES 267

Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
            Q  + T KSDV+SFGV+L EL++
Sbjct: 268 LQTQKFTTKSDVWSFGVLLWELMT 291

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  136 bits (345), Expect = 1e-36
 Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 23/209 (11%)

Query: 63  FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVS 121
           F     LG G  GT+ Y  + D R VAVKR+    +   ++   EV +L     H N++ 
Sbjct: 26  FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFADR---EVQLLRESDEHPNVIR 82

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
            + CT +  +   +  E  +  T+ +++     K  A      + +  +T S L +LH+ 
Sbjct: 83  YF-CTEKDRQFQYIAIELCA-ATLQEYV---EQKDFAHLGLEPITLLQQTTSGLAHLHSL 137

Query: 182 DIIHRDVKTNNILLDN-----NFCVKVADFGLSRLFPN--HVTHVSTAPQGTPGYVDPE- 233
           +I+HRD+K +NIL+            ++DFGL +      H     +   GT G++ PE 
Sbjct: 138 NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEM 197

Query: 234 ----YHQCYQLTDKSDVFSFGVVLIELIS 258
                 +    T   D+FS G V   +IS
Sbjct: 198 LSEDCKENP--TYTVDIFSAGCVFYYVIS 224

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  138 bits (349), Expect = 3e-36
 Identities = 53/201 (26%), Positives = 95/201 (47%), Gaps = 18/201 (8%)

Query: 67  RELGDGGFGTVYYGELQDGR----AVAVKRLYENNYKRVEQ-FMNEVDILARLRHKNLVS 121
           R +G+G FG V+ G          AVA+K         V + F+ E   + +  H ++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  + +   + ++ E  + G +   L   + +  +L   + +  A + ++AL YL + 
Sbjct: 456 LIGVITENP--VWIIMELCTLGELRSFL---QVRKFSLDLASLILYAYQLSTALAYLESK 510

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTA---P-QGTPGYVDPEYHQC 237
             +HRD+   N+L+ +N CVK+ DFGLSR   +   + ++    P +       PE    
Sbjct: 511 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMA----PESINF 566

Query: 238 YQLTDKSDVFSFGVVLIELIS 258
            + T  SDV+ FGV + E++ 
Sbjct: 567 RRFTSASDVWMFGVCMWEILM 587

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  131 bits (333), Expect = 4e-36
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 25/207 (12%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKN 118
           F     LG G F  VY    +  G  VA+K + +        V++  NEV I  +L+H +
Sbjct: 13  FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPS 72

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           ++ LY      +  + LV E   NG +  +L     +              +  + + YL
Sbjct: 73  ILELYNYFEDSNY-VYLVLEMCHNGEMNRYLK---NRVKPFSENEARHFMHQIITGMLYL 128

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ------GTPGYVDP 232
           H+  I+HRD+  +N+LL  N  +K+ADFGL+       T +    +      GTP Y+ P
Sbjct: 129 HSHGILHRDLTLSNLLLTRNMNIKIADFGLA-------TQLKMPHEKHYTLCGTPNYISP 181

Query: 233 E--YHQCYQLTDKSDVFSFGVVLIELI 257
           E      +    +SDV+S G +   L+
Sbjct: 182 EIATRSAH--GLESDVWSLGCMFYTLL 206

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  137 bits (346), Expect = 5e-36
 Identities = 54/202 (26%), Positives = 91/202 (45%), Gaps = 21/202 (10%)

Query: 68  ELGDGGFGTVYYGELQDGRA---VAVKRLYENNYKRVEQ-FMNEVDILARLRHKNLVSLY 123
           ELG G FG+V  G  +  +    VA+K L +   K   +  M E  I+ +L +  +V L 
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402

Query: 124 G-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           G C +     L+LV E    G +   L     K   +P     ++  + +  + YL   +
Sbjct: 403 GVCQAE---ALMLVMEMAGGGPLHKFL---VGKREEIPVSNVAELLHQVSMGMKYLEEKN 456

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG------TPGYVDPEYHQ 236
            +HR++   N+LL N    K++DFGLS+      ++ +    G            PE   
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYA----PECIN 512

Query: 237 CYQLTDKSDVFSFGVVLIELIS 258
             + + +SDV+S+GV + E +S
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALS 534

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  137 bits (346), Expect = 8e-36
 Identities = 45/203 (22%), Positives = 83/203 (40%), Gaps = 22/203 (10%)

Query: 67  RELGDGGFGTVYYGE--LQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVSLY 123
             +  GG G +Y       +GR V +K L +  + +     M E   LA + H ++V ++
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145

Query: 124 --GCTSRHSRELL--LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
                +    + +  +V E++   ++             LP    +   +E   AL+YLH
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLH 199

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC-Y 238
           +  +++ D+K  NI+L     +K+ D G        +        GTPG+  PE      
Sbjct: 200 SIGLVYNDLKPENIMLTEEQ-LKLIDLGAVS----RINSFGYLY-GTPGFQAPE--IVRT 251

Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
             T  +D+++ G  L  L   +P
Sbjct: 252 GPTVATDIYTVGRTLAALTLDLP 274

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  131 bits (332), Expect = 9e-36
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 25/212 (11%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           ++   ELGDG FG VY     + G   A K +   + + +E ++ E++ILA   H  +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI---ETASALTYL 178
           L G       +L ++ EF   G V   +         L   T  +I +   +   AL +L
Sbjct: 81  LLGAYYHDG-KLWIMIEFCPGGAVDAIM---LELDRGL---TEPQIQVVCRQMLEALNFL 133

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVDPEY 234
           H+  IIHRD+K  N+L+     +++ADFG      +      + +     GTP ++ PE 
Sbjct: 134 HSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFI-----GTPYWMAPEV 188

Query: 235 HQCYQLTD-----KSDVFSFGVVLIELISSMP 261
             C  + D     K+D++S G+ LIE+    P
Sbjct: 189 VMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  131 bits (331), Expect = 1e-35
 Identities = 62/225 (27%), Positives = 99/225 (44%), Gaps = 40/225 (17%)

Query: 67  RELGDGGFGTVYYGELQDGR------AVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
           RELG+G FG V+  E  +         VAVK L +      + F  E ++L  L+H+++V
Sbjct: 21  RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIV 80

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGER------------AKPGALPWPTRLKIA 168
             YG        L++V+E++ +G +   L                   G L     L IA
Sbjct: 81  KFYGVCGD-GDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 139

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS-------- 220
            + AS + YL +   +HRD+ T N L+  N  VK+ DFG+SR   +   +          
Sbjct: 140 SQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199

Query: 221 --TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS--SMP 261
               P+     +  ++      T +SDV+SFGV+L E+ +    P
Sbjct: 200 RWMPPE---SIMYRKF------TTESDVWSFGVILWEIFTYGKQP 235

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  131 bits (332), Expect = 1e-35
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 27/212 (12%)

Query: 67  RELGDGGFGTVYYGELQDGR------AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNL 119
           RELG G FG VY G  +          VA+K + E  + +   +F+NE  ++      ++
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRL------KIAIETAS 173
           V L G  S+  +  L++ E ++ G +  +L   R      P           ++A E A 
Sbjct: 91  VRLLGVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149

Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV--- 230
            + YL+A+  +HRD+   N ++  +F VK+ DFG++R     +       +G  G +   
Sbjct: 150 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD----IYETDYYRKGGKGLLPVR 205

Query: 231 --DPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
              PE      +  T  SDV+SFGVVL E+ +
Sbjct: 206 WMSPESLKDGVF--TTYSDVWSFGVVLWEIAT 235

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  131 bits (331), Expect = 2e-35
 Identities = 64/224 (28%), Positives = 102/224 (45%), Gaps = 39/224 (17%)

Query: 67  RELGDGGFGTVYYGELQDGR------AVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV 120
            ELG+G FG V+  E  +         VAVK L E +    + F  E ++L  L+H+++V
Sbjct: 47  WELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIV 106

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHL-----------HGERAKPGALPWPTRLKIAI 169
             +G  +   R LL+V+E++ +G +   L            GE   PG L     L +A 
Sbjct: 107 RFFGVCTE-GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVAS 165

Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS--------- 220
           + A+ + YL     +HRD+ T N L+     VK+ DFG+SR   +   +           
Sbjct: 166 QVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225

Query: 221 -TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS--SMP 261
              P+     +  ++      T +SDV+SFGVVL E+ +    P
Sbjct: 226 WMPPE---SILYRKF------TTESDVWSFGVVLWEIFTYGKQP 260

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  130 bits (330), Expect = 2e-35
 Identities = 60/221 (27%), Positives = 94/221 (42%), Gaps = 37/221 (16%)

Query: 67  RELGDGGFGTVYYGELQD------GRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKN 118
           + LG G FG V   +          R VAVK L E   +      M+E+ IL  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK------------PGALPWPTRLK 166
           +V+L G  ++    L+++ EF   G ++ +L  +R +               L     + 
Sbjct: 93  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 152

Query: 167 IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG- 225
            + + A  + +L +   IHRD+   NILL     VK+ DFGL+R    +           
Sbjct: 153 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDI--YKDPDYVRKGDA 210

Query: 226 ------TPGYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
                       PE  + + Y  T +SDV+SFGV+L E+ S
Sbjct: 211 RLPLKWMA----PETIFDRVY--TIQSDVWSFGVLLWEIFS 245

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  129 bits (326), Expect = 4e-35
 Identities = 57/217 (26%), Positives = 97/217 (44%), Gaps = 31/217 (14%)

Query: 67  RELGDGGFGTVYYGELQDGR------AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNL 119
            ELG+  FG VY G L          AVA+K L +       E+F +E  + ARL+H N+
Sbjct: 15  EELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNV 74

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER------------AKPGALPWPTRLKI 167
           V L G  ++  + L +++ + S+G + + L                    AL  P  + +
Sbjct: 75  VCLLGVVTK-DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133

Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG-- 225
             + A+ + YL +  ++H+D+ T N+L+ +   VK++D GL R       +         
Sbjct: 134 VAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLG-NSLL 192

Query: 226 ----TPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
                     PE     + +  SD++S+GVVL E+ S
Sbjct: 193 PIRWMA----PEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  129 bits (326), Expect = 4e-35
 Identities = 55/196 (28%), Positives = 96/196 (48%), Gaps = 11/196 (5%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVSL 122
            +LG GG  TVY  E       VA+K +        + +++F  EV   ++L H+N+VS+
Sbjct: 17  DKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM 76

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
                       LV E+I   T+++++       G L   T +    +    + + H   
Sbjct: 77  ID-VDEEDDCYYLVMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMR 131

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           I+HRD+K  NIL+D+N  +K+ DFG+++ L    +T  +    GT  Y  PE  +     
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHV-LGTVQYFSPEQAKGEATD 190

Query: 242 DKSDVFSFGVVLIELI 257
           + +D++S G+VL E++
Sbjct: 191 ECTDIYSIGIVLYEML 206

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  130 bits (328), Expect = 6e-35
 Identities = 62/215 (28%), Positives = 96/215 (44%), Gaps = 25/215 (11%)

Query: 67  RELGDGGFGTVYYGELQDGR------AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNL 119
           R LG G FG VY G++           VAVK L E  + +    F+ E  I+++  H+N+
Sbjct: 36  RGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNI 95

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER---AKPGALPWPTRLKIAIETASALT 176
           V   G + + S    ++ E ++ G +   L   R   ++P +L     L +A + A    
Sbjct: 96  VRCIGVSLQ-SLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154

Query: 177 YLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV--- 230
           YL  +  IHRD+   N LL         K+ DFG++R     +   S   +G    +   
Sbjct: 155 YLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD----IYRASYYRKGGCAMLPVK 210

Query: 231 --DPEYHQCYQLTDKSDVFSFGVVLIELIS--SMP 261
              PE       T K+D +SFGV+L E+ S   MP
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  129 bits (326), Expect = 7e-35
 Identities = 62/200 (31%), Positives = 95/200 (47%), Gaps = 13/200 (6%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVSL 122
             LG GG   V+    L+D R VAVK L      +     +F  E    A L H  +V++
Sbjct: 18  EILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAV 77

Query: 123 Y--GCTSRHSRELL-LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           Y  G     +  L  +V E++   T+ D +H E    G +     +++  +   AL + H
Sbjct: 78  YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSH 133

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPEYHQC 237
            + IIHRDVK  NI++     VKV DFG++R   +    V+      GT  Y+ PE  + 
Sbjct: 134 QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG 193

Query: 238 YQLTDKSDVFSFGVVLIELI 257
             +  +SDV+S G VL E++
Sbjct: 194 DSVDARSDVYSLGCVLYEVL 213

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  128 bits (325), Expect = 7e-35
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 28/213 (13%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
              +    ++G G  GTVY   ++  G+ VA++++      + E  +NE+ ++   ++ N
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK---IAI---ETA 172
           +V+          EL +V E+++ G++ D +             T +    IA    E  
Sbjct: 79  IVNYLDSYLVGD-ELWVVMEYLAGGSLTDVVT-----------ETCMDEGQIAAVCRECL 126

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPG 228
            AL +LH++ +IHRD+K++NILL  +  VK+ DFG    ++       T V     GTP 
Sbjct: 127 QALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV-----GTPY 181

Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           ++ PE         K D++S G++ IE+I   P
Sbjct: 182 WMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  134 bits (338), Expect = 9e-35
 Identities = 59/204 (28%), Positives = 89/204 (43%), Gaps = 17/204 (8%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLY-ENNYKRVEQFMNEVDILARLRHKNLVSLY- 123
             LG GGFG V        G  VA+K+   E + K  E++  E+ I+ +L H N+VS   
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSARE 79

Query: 124 ----GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
                     +   LL  E+   G +  +L+ +      L       +  + +SAL YLH
Sbjct: 80  VPDGLQKLAPNDLPLLAMEYCEGGDLRKYLN-QFENCCGLKEGPIRTLLSDISSALRYLH 138

Query: 180 ASDIIHRDVKTNNILLD---NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE--Y 234
            + IIHRD+K  NI+L         K+ D G ++        + T   GT  Y+ PE   
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--GELCTEFVGTLQYLAPELLE 196

Query: 235 HQCYQLTDKSDVFSFGVVLIELIS 258
            + Y  T   D +SFG +  E I+
Sbjct: 197 QKKY--TVTVDYWSFGTLAFECIT 218

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  129 bits (326), Expect = 1e-34
 Identities = 54/247 (21%), Positives = 106/247 (42%), Gaps = 45/247 (18%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKR-----------------VEQFMNEVD 109
           R L  G F  +   E +D +  A+K+  ++  ++                  + F NE+ 
Sbjct: 37  RTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQ 95

Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHL----HGERAKPGALPWPTRL 165
           I+  ++++  ++  G    +  E+ ++YE++ N ++          ++     +P     
Sbjct: 96  IITDIKNEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 166 KIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
            I     ++ +Y+H   +I HRDVK +NIL+D N  VK++DFG S    +     S   +
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGS---R 211

Query: 225 GTPGYVDPE-------YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL 277
           GT  ++ PE       Y+       K D++S G+ L  +  ++          +I+L  L
Sbjct: 212 GTYEFMPPEFFSNESSYN-----GAKVDIWSLGICLYVMFYNVVPFS-----LKISLVEL 261

Query: 278 AINKIQN 284
             N I+ 
Sbjct: 262 -FNNIRT 267

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  128 bits (323), Expect = 2e-34
 Identities = 59/205 (28%), Positives = 100/205 (48%), Gaps = 17/205 (8%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           F    ++G G FG V+ G + +  + VA+K +  E     +E    E+ +L++     + 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI---ETASALTY 177
             YG   + + +L ++ E++  G+  D L     +PG L      +IA    E    L Y
Sbjct: 84  KYYGSYLKDT-KLWIIMEYLGGGSALDLL-----EPGPL---DETQIATILREILKGLDY 134

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
           LH+   IHRD+K  N+LL  +  VK+ADFG++ +L    +   +    GTP ++ PE  +
Sbjct: 135 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFV--GTPFWMAPEVIK 192

Query: 237 CYQLTDKSDVFSFGVVLIELISSMP 261
                 K+D++S G+  IEL    P
Sbjct: 193 QSAYDSKADIWSLGITAIELARGEP 217

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  129 bits (327), Expect = 2e-34
 Identities = 64/283 (22%), Positives = 103/283 (36%), Gaps = 39/283 (13%)

Query: 13  RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSY---GELEEATNYFDSA--- 66
               +  +   L F+          + +         +  Y         T+        
Sbjct: 9   HHDYDIPTTENLYFQGAMGSELQSPEYKLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEV 68

Query: 67  --------RELGDGGFGTVYYGELQDGR------AVAVKRLYEN-NYKRVEQFMNEVDIL 111
                   R LG G FG VY G++           VAVK L E  + +    F+ E  I+
Sbjct: 69  PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALII 128

Query: 112 ARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR---LKIA 168
           ++  H+N+V   G + + S    ++ E ++ G +   L   R +P           L +A
Sbjct: 129 SKFNHQNIVRCIGVSLQ-SLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVA 187

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQG 225
            + A    YL  +  IHRD+   N LL         K+ DFG++R     +       +G
Sbjct: 188 RDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARD----IYRAGYYRKG 243

Query: 226 TPGYV-----DPEYHQCYQLTDKSDVFSFGVVLIELIS--SMP 261
               +      PE       T K+D +SFGV+L E+ S   MP
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  128 bits (323), Expect = 2e-34
 Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 11/196 (5%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVSL 122
           R +G GG G VY  E     R VA+K +     ++     +   E     RL+  ++V +
Sbjct: 40  RLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPI 99

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           +        +L +    I+   +A  L  +    G L  P  + I  +  SAL   HA+ 
Sbjct: 100 HD-FGEIDGQLYVDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAG 154

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSR-LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
             HRDVK  NIL+  +    + DFG++       +T +     GT  Y+ PE       T
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTV-GTLYYMAPERFSESHAT 213

Query: 242 DKSDVFSFGVVLIELI 257
            ++D+++   VL E +
Sbjct: 214 YRADIYALTCVLYECL 229

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  130 bits (329), Expect = 2e-34
 Identities = 59/230 (25%), Positives = 90/230 (39%), Gaps = 40/230 (17%)

Query: 61  NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNL 119
           N   S + LG G  GTV +     GR VAVKR+        +  + E+ +L     H N+
Sbjct: 15  NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRM---LIDFCDIALMEIKLLTESDDHPNV 71

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA------- 172
           +  Y C+    R L +  E   N  + D +              +L+             
Sbjct: 72  IRYY-CSETTDRFLYIALELC-NLNLQDLV----ESKNVSDENLKLQKEYNPISLLRQIA 125

Query: 173 SALTYLHASDIIHRDVKTNNILLDN-------------NFCVKVADFGLSRLFPNHVTHV 219
           S + +LH+  IIHRD+K  NIL+               N  + ++DFGL +   +  +  
Sbjct: 126 SGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSF 185

Query: 220 STA---PQGTPGYVDPE-------YHQCYQLTDKSDVFSFGVVLIELISS 259
            T    P GT G+  PE            +LT   D+FS G V   ++S 
Sbjct: 186 RTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSK 235

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  127 bits (322), Expect = 3e-34
 Identities = 66/213 (30%), Positives = 101/213 (47%), Gaps = 28/213 (13%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
               DS  ++G+G  G V    E   GR VAVK +     +R E   NEV I+   +H N
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFN 103

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLK---IAI---ETA 172
           +V +Y        EL ++ EF+  G + D +              RL    IA       
Sbjct: 104 VVEMYKSYLVGE-ELWVLMEFLQGGALTDIVS-----------QVRLNEEQIATVCEAVL 151

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPG 228
            AL YLHA  +IHRD+K+++ILL  +  VK++DFG    +S+  P   + V     GTP 
Sbjct: 152 QALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV-----GTPY 206

Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           ++ PE         + D++S G+++IE++   P
Sbjct: 207 WMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  128 bits (324), Expect = 3e-34
 Identities = 39/230 (16%), Positives = 76/230 (33%), Gaps = 28/230 (12%)

Query: 55  ELEEATNYFDSARELGDGGFGTVYYGE------LQDGRAVAVKRLYENNYKRVEQFMNEV 108
           E +  +        LG+G F  VY          ++ +   +K     N          +
Sbjct: 59  EFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLM 118

Query: 109 DILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHL-HGERAKPGALPWPTRLKI 167
           + L        +  Y          +LV E  S GT+ + +   +      +P    +  
Sbjct: 119 ERLKPSMQHMFMKFYSAHL-FQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF 177

Query: 168 AIETASALTYLHASDIIHRDVKTNNILL-----------DNNFCVKVADFGLS---RLFP 213
           A+     +  +H  +IIH D+K +N +L           D +  + + D G S   +LFP
Sbjct: 178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFP 237

Query: 214 NHVTHVSTAPQGTPGYVDPE--YHQCYQLTDKSDVFSFGVVLIELISSMP 261
                 +     T G+   E   ++ +    + D F     +  ++    
Sbjct: 238 KGTIFTAKC--ETSGFQCVEMLSNKPW--NYQIDYFGVAATVYCMLFGTY 283

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  127 bits (321), Expect = 4e-34
 Identities = 65/222 (29%), Positives = 103/222 (46%), Gaps = 22/222 (9%)

Query: 55  ELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR 113
            L +    F+    +G+G +G VY G  ++ G+  A+K + +      E+   E+++L +
Sbjct: 18  ALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGDEEEEIKQEINMLKK 76

Query: 114 L-RHKNLVSLYGC-----TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI 167
              H+N+ + YG            +L LV EF   G+V D +   +       W     I
Sbjct: 77  YSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEW-----I 131

Query: 168 AI---ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
           A    E    L++LH   +IHRD+K  N+LL  N  VK+ DFG+S      V   +T   
Sbjct: 132 AYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTF-I 190

Query: 225 GTPGYVDPEYHQCYQLTD-----KSDVFSFGVVLIELISSMP 261
           GTP ++ PE   C +  D     KSD++S G+  IE+    P
Sbjct: 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  127 bits (321), Expect = 5e-34
 Identities = 60/218 (27%), Positives = 90/218 (41%), Gaps = 38/218 (17%)

Query: 67  RELGDGGFGTVYYGELQDG---RAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVS 121
             +G+G FG V    ++        A+KR+ E  +      F  E+++L +L  H N+++
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAK------------PGALPWPTRLKIAI 169
           L G        L L  E+  +G + D L   R                 L     L  A 
Sbjct: 91  LLGACEH-RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS-------TA 222
           + A  + YL     IHRD+   NIL+  N+  K+ADFGLSR    +V            A
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMA 209

Query: 223 PQGTPGYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
                     E   +  Y  T  SDV+S+GV+L E++S
Sbjct: 210 ---------IESLNYSVY--TTNSDVWSYGVLLWEIVS 236

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  126 bits (319), Expect = 7e-34
 Identities = 59/226 (26%), Positives = 100/226 (44%), Gaps = 41/226 (18%)

Query: 67  RELGDGGFGTVYYGELQDGR------AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNL 119
           + LG+G FG V        +       VAVK L EN +   +   ++E ++L ++ H ++
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER--------------------AKPGAL 159
           + LYG  S+    LLL+ E+   G++   L   R                        AL
Sbjct: 89  IKLYGACSQ-DGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERAL 147

Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV 219
                +  A + +  + YL    ++HRD+   NIL+     +K++DFGLSR     V   
Sbjct: 148 TMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRD----VYEE 203

Query: 220 STAPQGTPGYV-----DPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
            +  + + G +       E  +   Y  T +SDV+SFGV+L E+++
Sbjct: 204 DSYVKRSQGRIPVKWMAIESLFDHIY--TTQSDVWSFGVLLWEIVT 247

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  126 bits (318), Expect = 2e-33
 Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 24/206 (11%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSL 122
           R LG GGF   +   +       A K + ++      + E+   E+ I   L H+++V  
Sbjct: 47  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 106

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           +G    +   + +V E     ++ +       +  AL  P       +      YLH + 
Sbjct: 107 HGFFEDNDF-VFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRNR 161

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHVTHVSTAPQGTPGYVDPE-----YH 235
           +IHRD+K  N+ L+ +  VK+ DFGL+           V     GTP Y+ PE      H
Sbjct: 162 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGH 218

Query: 236 QCYQLTDKSDVFSFGVVLIELISSMP 261
                  + DV+S G ++  L+   P
Sbjct: 219 SF-----EVDVWSIGCIMYTLLVGKP 239

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  124 bits (314), Expect = 2e-33
 Identities = 49/203 (24%), Positives = 86/203 (42%), Gaps = 18/203 (8%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSL 122
           R LG GGF   +   +       A K + ++      + E+   E+ I   L H+++V  
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF 80

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           +G    +   + +V E     ++ +       +  AL  P       +      YLH + 
Sbjct: 81  HGFFEDNDF-VFVVLELCRRRSLLELH----KRRKALTEPEARYYLRQIVLGCQYLHRNR 135

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHVTHVSTAPQGTPGYVDPE--YHQCY 238
           +IHRD+K  N+ L+ +  VK+ DFGL+           V     GTP Y+ PE    + +
Sbjct: 136 VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLC---GTPNYIAPEVLSKKGH 192

Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
             + + DV+S G ++  L+   P
Sbjct: 193 --SFEVDVWSIGCIMYTLLVGKP 213

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  125 bits (316), Expect = 3e-33
 Identities = 59/230 (25%), Positives = 91/230 (39%), Gaps = 58/230 (25%)

Query: 67  RELGDGGFGTVYYGELQDGR------AVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKN 118
           + LG G FG V                VAVK L    +    E  M+E+ I++ L +H+N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111

Query: 119 LVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR----------LKI 167
           +V+L G CT  H   +L++ E+   G + + L  +       P              L  
Sbjct: 112 IVNLLGACT--HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169

Query: 168 AIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
           + + A  + +L + + IHRDV   N+LL N    K+ DFGL+R                 
Sbjct: 170 SSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI--------------- 214

Query: 228 GYVDPEY-------------------HQCYQLTDKSDVFSFGVVLIELIS 258
              D  Y                      Y  T +SDV+S+G++L E+ S
Sbjct: 215 -MNDSNYIVKGNARLPVKWMAPESIFDCVY--TVQSDVWSYGILLWEIFS 261

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  125 bits (315), Expect = 4e-33
 Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 36/221 (16%)

Query: 67  RELGDGGFGTVYYGELQDGR--------AVAVKRLYEN-NYKRVEQFMNEVDILARL-RH 116
           + LG+G FG V   E              VAVK L ++   K +   ++E++++  + +H
Sbjct: 41  KPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 100

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHL------------HGERAKPGALPWPTR 164
           KN+++L G  ++    L ++ E+ S G + ++L               R     + +   
Sbjct: 101 KNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
           +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R     + ++    +
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD----INNIDYYKK 215

Query: 225 GTPGYV-----DPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
            T G +      PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 216 TTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 254

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  126 bits (318), Expect = 5e-33
 Identities = 29/227 (12%), Positives = 63/227 (27%), Gaps = 37/227 (16%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLY----------------------------ENN 97
             LG             + G +  V   Y                            +  
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 98  YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-RELLLVYEFI--SNGTVADHLHGERA 154
            K   +F+   D++   + K ++ +              +Y  +  +  T  + L    +
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 155 KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN 214
              +L    RL++ ++    L  LH   ++H  ++  +I+LD    V +  F        
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263

Query: 215 HVTHVSTAPQGTPGYVDPEYHQCYQ-----LTDKSDVFSFGVVLIEL 256
                       P           Q     +T   D ++ G+ +  +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWI 310

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  124 bits (313), Expect = 5e-33
 Identities = 60/228 (26%), Positives = 92/228 (40%), Gaps = 42/228 (18%)

Query: 67  RELGDGGFGTVYYGELQDGRA------VAVKRLYEN-NYKRVEQFMNEVDILARL-RHKN 118
           + LG G FG V                VAVK L  + +    E  M+E+ +L+ L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK--------------PGALPWPTR 164
           +V+L G  +      L++ E+   G + + L  +R                  AL     
Sbjct: 89  IVNLLGACTI-GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
           L  + + A  + +L + + IHRD+   NILL +    K+ DFGL+R              
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDI--KNDSNYVVKG 205

Query: 225 G-------TPGYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS--SMP 261
                         PE  ++  Y  T +SDV+S+G+ L EL S  S P
Sbjct: 206 NARLPVKWMA----PESIFNCVY--TFESDVWSYGIFLWELFSLGSSP 247

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  124 bits (312), Expect = 7e-33
 Identities = 61/210 (29%), Positives = 102/210 (48%), Gaps = 22/210 (10%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
              FD   +LG+G +G+VY     + G+ VA+K++       +++ + E+ I+ +    +
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQV--PVESDLQEIIKEISIMQQCDSPH 85

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI---ETASAL 175
           +V  YG   +++ +L +V E+   G+V+D +   R +   L   T  +IA     T   L
Sbjct: 86  VVKYYGSYFKNT-DLWIVMEYCGAGSVSDII---RLRNKTL---TEDEIATILQSTLKGL 138

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFG----LSRLFPNHVTHVSTAPQGTPGYVD 231
            YLH    IHRD+K  NILL+     K+ADFG    L+       T +     GTP ++ 
Sbjct: 139 EYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI-----GTPFWMA 193

Query: 232 PEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           PE  Q       +D++S G+  IE+    P
Sbjct: 194 PEVIQEIGYNCVADIWSLGITAIEMAEGKP 223

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  125 bits (315), Expect = 9e-33
 Identities = 56/221 (25%), Positives = 105/221 (47%), Gaps = 36/221 (16%)

Query: 67  RELGDGGFGTVYYGELQDGR--------AVAVKRLYEN-NYKRVEQFMNEVDILARL-RH 116
           + LG+G FG V   E              VAVK L ++   K +   ++E++++  + +H
Sbjct: 87  KPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKH 146

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHL------------HGERAKPGALPWPTR 164
           KN+++L G  ++    L ++ E+ S G + ++L               R     + +   
Sbjct: 147 KNIINLLGACTQ-DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
           +    + A  + YL +   IHRD+   N+L+  N  +K+ADFGL+R     + ++    +
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD----INNIDYYKK 261

Query: 225 GTPGYV-----DPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
            T G +      PE  + + Y  T +SDV+SFGV++ E+ +
Sbjct: 262 TTNGRLPVKWMAPEALFDRVY--THQSDVWSFGVLMWEIFT 300

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  124 bits (314), Expect = 2e-32
 Identities = 59/221 (26%), Positives = 104/221 (47%), Gaps = 36/221 (16%)

Query: 67  RELGDGGFGTVYYGELQD--------GRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RH 116
           + LG+G FG V   E              VAVK L  +   K +   ++E++++  + +H
Sbjct: 75  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 134

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK------------PGALPWPTR 164
           KN+++L G  ++    L ++ E+ S G + ++L   R                 L     
Sbjct: 135 KNIINLLGACTQ-DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ 224
           +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R     + H+    +
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARD----IHHIDYYKK 249

Query: 225 GTPGYV-----DPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
            T G +      PE  + + Y  T +SDV+SFGV+L E+ +
Sbjct: 250 TTNGRLPVKWMAPEALFDRIY--THQSDVWSFGVLLWEIFT 288

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  124 bits (312), Expect = 2e-32
 Identities = 26/224 (11%), Positives = 55/224 (24%), Gaps = 37/224 (16%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLY---ENNYKRVEQFMNEVDILARLRHKNLVSL 122
             L  G    V+   +++     A+K      EN+   +E+        ARL  ++    
Sbjct: 68  EPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEA 127

Query: 123 Y-------------------------GCTSRHSRELLLVYEFI--SNGTVADHLHGERAK 155
                                     G         LL+          +   L      
Sbjct: 128 RDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVF 187

Query: 156 PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
            G         +  +       L +  ++H     +N+ +  +  + + D          
Sbjct: 188 RGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALW----K 243

Query: 216 VTHVSTAPQGTPGYVDPEYHQC--YQLTDKSDVFSFGVVLIELI 257
           V     A      Y   E+        T   + +  G+ +  + 
Sbjct: 244 VGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVW 287

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  121 bits (306), Expect = 5e-32
 Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 12/210 (5%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           ++    +G G    V           VA+KR+  E     +++ + E+  +++  H N+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAI---ETASALT 176
           S Y        EL LV + +S G+V D +    AK            IA    E    L 
Sbjct: 77  SYYTSFVVKD-ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLE 135

Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQ---GTPGYVDP 232
           YLH +  IHRDVK  NILL  +  V++ADFG+S  L        +   +   GTP ++ P
Sbjct: 136 YLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAP 195

Query: 233 E-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
           E   Q      K+D++SFG+  IEL +   
Sbjct: 196 EVMEQVRGYDFKADIWSFGITAIELATGAA 225

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  122 bits (307), Expect = 7e-32
 Identities = 60/226 (26%), Positives = 96/226 (42%), Gaps = 41/226 (18%)

Query: 67  RELGDGGFGTVYYGELQDGR------AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNL 119
           R++G+G FG V+               VAVK L E  +      F  E  ++A   + N+
Sbjct: 53  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 112

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER--------------------AKPGAL 159
           V L G  +   + + L++E+++ G + + L                          P  L
Sbjct: 113 VKLLGVCAV-GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171

Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV 219
               +L IA + A+ + YL     +HRD+ T N L+  N  VK+ADFGLSR     +   
Sbjct: 172 SCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRN----IYSA 227

Query: 220 STAPQGTPGYV-----DPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
                     +      PE  ++  Y  T +SDV+++GVVL E+ S
Sbjct: 228 DYYKADGNDAIPIRWMPPESIFYNRY--TTESDVWAYGVVLWEIFS 271

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  122 bits (306), Expect = 1e-31
 Identities = 32/235 (13%), Positives = 68/235 (28%), Gaps = 48/235 (20%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLY----------------------------ENN 97
             LG           + + G +  V   Y                            +  
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 98  YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-RELLLVYEFI--SNGTVADHLHGERA 154
            K   +F+   D++   + K ++ +              +Y  +  +  T  + L    +
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 155 KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN 214
              +L    RL++ ++    L  LH   ++H  ++  +I+LD    V +  F        
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258

Query: 215 HVTHVSTAPQGTPGYVDPEYHQCYQL-----------TDKSDVFSFGVVLIELIS 258
            V         + G+  PE                  T   D ++ G+V+  +  
Sbjct: 259 RVV-----SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWC 308

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  120 bits (304), Expect = 2e-31
 Identities = 57/228 (25%), Positives = 92/228 (40%), Gaps = 45/228 (19%)

Query: 67  RELGDGGFGTVYYGELQDGRA------VAVKRLYEN-NYKRVEQFMNEVDILARL-RHKN 118
           + LG G FG V                VAVK L E  +    E  M+E+ ++ +L  H+N
Sbjct: 51  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 110

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTR-------------- 164
           +V+L G  +  S  + L++E+   G + ++L  +R K                       
Sbjct: 111 IVNLLGACTL-SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 165 -----LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV 219
                L  A + A  + +L     +HRD+   N+L+ +   VK+ DFGL+R         
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDI--MSDSN 227

Query: 220 STAPQG-------TPGYVDPE--YHQCYQLTDKSDVFSFGVVLIELIS 258
                              PE  +   Y  T KSDV+S+G++L E+ S
Sbjct: 228 YVVRGNARLPVKWMA----PESLFEGIY--TIKSDVWSYGILLWEIFS 269

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  121 bits (306), Expect = 2e-31
 Identities = 43/206 (20%), Positives = 72/206 (34%), Gaps = 20/206 (9%)

Query: 70  GDGGFGTVYYG-ELQDGRAVAVKR--LYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           G     TV        G  V V+R  L   + + V     E+ +     H N+V      
Sbjct: 36  GFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI---ETASALTYLHASDI 183
              + EL +V  F++ G+  D +         +       IA        AL Y+H    
Sbjct: 96  IADN-ELWVVTSFMAYGSAKDLI--CTHFMDGMNELA---IAYILQGVLKALDYIHHMGY 149

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ------GTPGYVDPEYHQC 237
           +HR VK ++IL+  +  V ++    +    +H                   ++ PE  Q 
Sbjct: 150 VHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209

Query: 238 YQL--TDKSDVFSFGVVLIELISSMP 261
                  KSD++S G+   EL +   
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHV 235

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  120 bits (304), Expect = 2e-31
 Identities = 65/209 (31%), Positives = 98/209 (46%), Gaps = 23/209 (11%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKN 118
           F   RE+G G FG VY+  ++++   VA+K++    + + ++ +  + EV  L +LRH N
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI---ETASAL 175
            +   GC  R      LV E+   G+ +D L         L     ++IA         L
Sbjct: 116 TIQYRGCYLREH-TAWLVMEYCL-GSASDLL---EVHKKPL---QEVEIAAVTHGALQGL 167

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            YLH+ ++IHRDVK  NILL     VK+ DFG + +     + V     GTP ++ PE  
Sbjct: 168 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAPEVI 222

Query: 236 QCYQLTD---KSDVFSFGVVLIELISSMP 261
                     K DV+S G+  IEL    P
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKP 251

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  117 bits (296), Expect = 2e-30
 Identities = 60/198 (30%), Positives = 90/198 (45%), Gaps = 25/198 (12%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVK-----RLYENNYKRVEQFMNEVDILARLRHKNLV 120
           + +G G F  V     +  GR VA+K     +L   + +++ +   EV I+  L H N+V
Sbjct: 21  KTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR---EVRIMKILNHPNIV 77

Query: 121 SLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            L+    T +    L L+ E+ S G V D+L       G +          +  SA+ Y 
Sbjct: 78  KLFEVIETEKT---LYLIMEYASGGEVFDYL----VAHGRMKEKEARSKFRQIVSAVQYC 130

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPE--YH 235
           H   I+HRD+K  N+LLD +  +K+ADFG S  F             G P Y  PE    
Sbjct: 131 HQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC---GAPPYAAPELFQG 187

Query: 236 QCYQLTDKSDVFSFGVVL 253
           + Y    + DV+S GV+L
Sbjct: 188 KKYDGP-EVDVWSLGVIL 204

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  116 bits (292), Expect = 7e-30
 Identities = 67/266 (25%), Positives = 98/266 (36%), Gaps = 58/266 (21%)

Query: 49  QVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVK-----RLYENNYKRVE 102
             F  G L E    +     +G G +G V    E Q     A+K     ++ + N K VE
Sbjct: 14  LYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVE 73

Query: 103 QFMNEVDILARLRHKNLVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALP 160
           +   EV ++ +L H N+  LY      ++   + LV E    G + D L+          
Sbjct: 74  RIKTEVRLMKKLHHPNIARLYEVYEDEQY---ICLVMELCHGGHLLDKLNVFIDDSTGKC 130

Query: 161 WPTRLKIAIETA------------------------------------SALTYLHASDII 184
               +K  I                                       SAL YLH   I 
Sbjct: 131 AMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGIC 190

Query: 185 HRDVKTNNILL--DNNFCVKVADFGLSRLFPNHVT---HVSTAPQGTPGYVDPE----YH 235
           HRD+K  N L   + +F +K+ DFGLS+ F        +  T   GTP +V PE     +
Sbjct: 191 HRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTN 250

Query: 236 QCYQLTDKSDVFSFGVVLIELISSMP 261
           + Y    K D +S GV+L  L+    
Sbjct: 251 ESY--GPKCDAWSAGVLLHLLLMGAV 274

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  115 bits (289), Expect = 7e-30
 Identities = 55/210 (26%), Positives = 103/210 (49%), Gaps = 15/210 (7%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYK-RVEQFMNEVDILARLRHK 117
            + F   R+LG G FG V+   E   G    +K + ++  +  +EQ   E+++L  L H 
Sbjct: 21  DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80

Query: 118 NLVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           N++ ++       +   + +V E    G + + +   +A+  AL      ++  +  +AL
Sbjct: 81  NIIKIFEVFEDYHN---MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137

Query: 176 TYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
            Y H+  ++H+D+K  NIL  +   +  +K+ DFGL+ LF +     + A  GT  Y+ P
Sbjct: 138 AYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAA--GTALYMAP 195

Query: 233 E-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
           E + +    T K D++S GVV+  L++   
Sbjct: 196 EVFKRDV--TFKCDIWSAGVVMYFLLTGCL 223

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  115 bits (290), Expect = 1e-29
 Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 11/197 (5%)

Query: 68  ELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARL-RHKNLVSLYG 124
           E+G G +G+V        G+ +AVKR+    + K  +Q + ++D++ R      +V  YG
Sbjct: 29  EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYG 88

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD-I 183
              R   +  +  E +S      + +        +P     KI + T  AL +L  +  I
Sbjct: 89  ALFREG-DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD- 242
           IHRD+K +NILLD +  +K+ DFG+S    + +     A  G   Y+ PE          
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDA--GCRPYMAPERIDPSASRQG 205

Query: 243 ---KSDVFSFGVVLIEL 256
              +SDV+S G+ L EL
Sbjct: 206 YDVRSDVWSLGITLYEL 222

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  114 bits (288), Expect = 2e-29
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 22/210 (10%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F   + LG+G F TV    EL   R  A+K L + +     +V     E D+++RL H  
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAIETASALTY 177
            V LY       + L     +  NG +  ++     K G+     TR   A E  SAL Y
Sbjct: 92  FVKLYFTFQDDEK-LYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTA-EIVSALEY 145

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ-GTPGYVDPEYHQ 236
           LH   IIHRD+K  NILL+ +  +++ DFG +++              GT  YV PE   
Sbjct: 146 LHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL-- 203

Query: 237 CYQLTDK-----SDVFSFGVVLIELISSMP 261
              LT+K     SD+++ G ++ +L++ +P
Sbjct: 204 ---LTEKSACKSSDLWALGCIIYQLVAGLP 230

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  115 bits (291), Expect = 2e-29
 Identities = 52/208 (25%), Positives = 85/208 (40%), Gaps = 31/208 (14%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
            +Y+D   ELG G FG V+   E   GR    K +            NE+ I+ +L H  
Sbjct: 50  YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109

Query: 119 LVSLYGCTSRHSRELLLVYEFISNG------TVADHLHGERAKPGALPWPTRLKIAIETA 172
           L++L+        E++L+ EF+S G         D+   E                I   
Sbjct: 110 LINLHD-AFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAE-------------VINYM 155

Query: 173 ----SALTYLHASDIIHRDVKTNNILLDN--NFCVKVADFGLSRLF-PNHVTHVSTAPQG 225
                 L ++H   I+H D+K  NI+ +      VK+ DFGL+    P+ +  V+T    
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTT---A 212

Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVL 253
           T  +  PE      +   +D+++ GV+ 
Sbjct: 213 TAEFAAPEIVDREPVGFYTDMWAIGVLG 240

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  113 bits (285), Expect = 3e-29
 Identities = 57/202 (28%), Positives = 95/202 (47%), Gaps = 12/202 (5%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARL-RHKNL 119
            +   ELG G +G V     +  G+ +AVKR+    N +  ++ + ++DI  R       
Sbjct: 9   LEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFT 68

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V+ YG   R   ++ +  E + + ++         K   +P     KIA+    AL +LH
Sbjct: 69  VTFYGALFREG-DVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLH 126

Query: 180 ASD-IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE----Y 234
           +   +IHRDVK +N+L++    VK+ DFG+S    + V     A  G   Y+ PE     
Sbjct: 127 SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDA--GCKPYMAPERINPE 184

Query: 235 HQCYQLTDKSDVFSFGVVLIEL 256
                 + KSD++S G+ +IEL
Sbjct: 185 LNQKGYSVKSDIWSLGITMIEL 206

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  113 bits (285), Expect = 4e-29
 Identities = 54/222 (24%), Positives = 83/222 (37%), Gaps = 45/222 (20%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVK--------------------------RLYENNYK 99
            E+G G +G V       D    A+K                                  
Sbjct: 19  DEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRG 78

Query: 100 RVEQFMNEVDILARLRHKNLVSLY----GCTSRHSRELLLVYEFISNGTVADHLHGERAK 155
            +EQ   E+ IL +L H N+V L          H   L +V+E ++ G V +        
Sbjct: 79  PIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVME-----VPT 130

Query: 156 PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH 215
              L          +    + YLH   IIHRD+K +N+L+  +  +K+ADFG+S  F   
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190

Query: 216 VTHVSTAPQGTPGYVDPE----YHQCYQLTDKSDVFSFGVVL 253
              +S    GTP ++ PE      + +      DV++ GV L
Sbjct: 191 DALLSNTV-GTPAFMAPESLSETRKIFS-GKALDVWAMGVTL 230

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  112 bits (283), Expect = 6e-29
 Identities = 60/194 (30%), Positives = 91/194 (46%), Gaps = 16/194 (8%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVK---RLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
             LG G FG V  GE    G  VAVK   R    +   V +   E+  L   RH +++ L
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           Y   S    +  +V E++S G + D++     K G +      ++  +  SA+ Y H   
Sbjct: 77  YQVIST-PTDFFMVMEYVSGGELFDYI----CKHGRVEEMEARRLFQQILSAVDYCHRHM 131

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPE--YHQCYQ 239
           ++HRD+K  N+LLD +   K+ADFGLS +         S    G+P Y  PE    + Y 
Sbjct: 132 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYA 188

Query: 240 LTDKSDVFSFGVVL 253
              + D++S GV+L
Sbjct: 189 -GPEVDIWSCGVIL 201

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  114 bits (286), Expect = 6e-29
 Identities = 57/199 (28%), Positives = 93/199 (46%), Gaps = 15/199 (7%)

Query: 63  FDSARELGDGGFGTVYYGEL-QDGRAVAVKRLY-ENNYKRVEQFMNEVDILARLRHKNLV 120
           F+   ELG G  G V+       G  +A K ++ E       Q + E+ +L       +V
Sbjct: 35  FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 94

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             YG       E+ +  E +  G++   L     K G +P     K++I     LTYL  
Sbjct: 95  GFYGAFYSDG-EISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIKGLTYLRE 149

Query: 181 S-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV--THVSTAPQGTPGYVDPEYHQC 237
              I+HRDVK +NIL+++   +K+ DFG+S    + +  + V     GT  Y+ PE  Q 
Sbjct: 150 KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV-----GTRSYMSPERLQG 204

Query: 238 YQLTDKSDVFSFGVVLIEL 256
              + +SD++S G+ L+E+
Sbjct: 205 THYSVQSDIWSMGLSLVEM 223

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  115 bits (291), Expect = 8e-29
 Identities = 64/216 (29%), Positives = 99/216 (45%), Gaps = 29/216 (13%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR---VEQFMNEVDILARLR 115
           ++ +   R LG G FG V    +   G+  AVK + +   K+    E  + EV +L +L 
Sbjct: 25  SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84

Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHL-----HGER-AKPGALPWPTRLKIAI 169
           H N++ LY           LV E  + G + D +       E  A           +I  
Sbjct: 85  HPNIMKLYE-FFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAA----------RIIR 133

Query: 170 ETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGT 226
           +  S +TY+H + I+HRD+K  N+LL++   +  +++ DFGLS  F            GT
Sbjct: 134 QVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKI--GT 191

Query: 227 PGYVDPE-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
             Y+ PE  H  Y   +K DV+S GV+L  L+S  P
Sbjct: 192 AYYIAPEVLHGTY--DEKCDVWSTGVILYILLSGCP 225

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  115 bits (291), Expect = 8e-29
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 16/209 (7%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VEQFMNEVDILARLRH 116
           +  +   ++LG G +G V    +       A+K + + +       + + EV +L  L H
Sbjct: 36  SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            N++ LY       R   LV E    G + D +                 I  +  S +T
Sbjct: 96  PNIMKLYD-FFEDKRNYYLVMECYKGGELFDEI----IHRMKFNEVDAAVIIKQVLSGVT 150

Query: 177 YLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
           YLH  +I+HRD+K  N+LL++   +  +K+ DFGLS +F N          GT  Y+ PE
Sbjct: 151 YLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERL--GTAYYIAPE 208

Query: 234 -YHQCYQLTDKSDVFSFGVVLIELISSMP 261
              + Y   +K DV+S GV+L  L++  P
Sbjct: 209 VLRKKY--DEKCDVWSIGVILFILLAGYP 235

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  113 bits (284), Expect = 9e-29
 Identities = 58/243 (23%), Positives = 95/243 (39%), Gaps = 28/243 (11%)

Query: 27  RNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGE-LQDG 85
            ++S        +    + H  ++    E E   + +     LG GGFG+VY G  + D 
Sbjct: 9   HHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDN 68

Query: 86  RAVAVK---------RLYENNYKRVEQFMNEVDILARLRHK--NLVSLYGCTSRHSRELL 134
             VA+K              N  RV     EV +L ++      ++ L     R     +
Sbjct: 69  LPVAIKHVEKDRISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFER-PDSFV 124

Query: 135 LVYEFISN-GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNI 193
           L+ E       + D +     + GAL          +   A+ + H   ++HRD+K  NI
Sbjct: 125 LILERPEPVQDLFDFI----TERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI 180

Query: 194 LLDNNFC-VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEY--HQCYQLTDKSDVFSFG 250
           L+D N   +K+ DFG   L  + V        GT  Y  PE+  +  Y     + V+S G
Sbjct: 181 LIDLNRGELKLIDFGSGALLKDTVYTDF---DGTRVYSPPEWIRYHRYHGR-SAAVWSLG 236

Query: 251 VVL 253
           ++L
Sbjct: 237 ILL 239

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  116 bits (291), Expect = 1e-28
 Identities = 56/253 (22%), Positives = 107/253 (42%), Gaps = 11/253 (4%)

Query: 13  RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDG 72
           RR+         + R   +  S+  +                + +   +++D   ELG G
Sbjct: 109 RRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTG 168

Query: 73  GFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR 131
            FG V+   E   G   A K +   +    E    E+  ++ LRH  LV+L+        
Sbjct: 169 AFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD-AFEDDN 227

Query: 132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTN 191
           E++++YEF+S G + + +  E      +     ++   +    L ++H ++ +H D+K  
Sbjct: 228 EMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPE 284

Query: 192 NILLDN--NFCVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFS 248
           NI+     +  +K+ DFGL+    P     V+T   GT  +  PE  +   +   +D++S
Sbjct: 285 NIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT---GTAEFAAPEVAEGKPVGYYTDMWS 341

Query: 249 FGVVLIELISSMP 261
            GV+   L+S + 
Sbjct: 342 VGVLSYILLSGLS 354

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  111 bits (279), Expect = 2e-28
 Identities = 50/208 (24%), Positives = 86/208 (41%), Gaps = 30/208 (14%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
             +G G +G V    +       A K++ +   + V++F  E++I+  L H N++ LY  
Sbjct: 15  NTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYET 74

Query: 126 --TSRHSRELLLVYEFISNGTVAD------HLHGERAKPGALPWPTRLKIAIETASALTY 177
              +     + LV E  + G + +            A           +I  +  SA+ Y
Sbjct: 75  FEDNTD---IYLVMELCTGGELFERVVHKRVFRESDAA----------RIMKDVLSAVAY 121

Query: 178 LHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE- 233
            H  ++ HRD+K  N L      +  +K+ DFGL+  F       +    GTP YV P+ 
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV--GTPYYVSPQV 179

Query: 234 YHQCYQLTDKSDVFSFGVVLIELISSMP 261
               Y    + D +S GV++  L+   P
Sbjct: 180 LEGLY--GPECDEWSAGVMMYVLLCGYP 205

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  111 bits (281), Expect = 2e-28
 Identities = 51/204 (25%), Positives = 83/204 (40%), Gaps = 28/204 (13%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVK-------RLYENNYKRVEQFMNEVDILARLRHKN 118
             LG+G +G V      +     AVK       R   N    V++   E+ +L RLRHKN
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKK---EIQLLRRLRHKN 67

Query: 119 LVSLYGCTSRHSR-ELLLVYEFISNGTVA--DHLHGERAKPGALPWPTRLKIAIETASAL 175
           ++ L        + ++ +V E+   G     D +  +R      P         +    L
Sbjct: 68  VIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKR-----FPVCQAHGYFCQLIDGL 122

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF----PNHVTHVSTAPQGTPGYVD 231
            YLH+  I+H+D+K  N+LL     +K++  G++        +     S   QG+P +  
Sbjct: 123 EYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTS---QGSPAFQP 179

Query: 232 PEYHQCYQLTD--KSDVFSFGVVL 253
           PE           K D++S GV L
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTL 203

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  111 bits (281), Expect = 2e-28
 Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 24/204 (11%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN 118
              F     LG G F  V+   +   G+  A+K + ++   R     NE+ +L +++H+N
Sbjct: 8   RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHL--HG---ER-AKPGALPWPTRLKIAIETA 172
           +V+L       +    LV + +S G + D +   G   E+ A            +  +  
Sbjct: 68  IVTLED-IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDAS----------LVIQQVL 116

Query: 173 SALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           SA+ YLH + I+HRD+K  N+L    + N  + + DFGLS++  N +    +   GTPGY
Sbjct: 117 SAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM---STACGTPGY 173

Query: 230 VDPEYHQCYQLTDKSDVFSFGVVL 253
           V PE       +   D +S GV+ 
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVIT 197

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  114 bits (287), Expect = 3e-28
 Identities = 61/215 (28%), Positives = 97/215 (45%), Gaps = 28/215 (13%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VEQFMNEVDILARLRH 116
              ++    LG G FG V    +    +  AVK + + + K       + EV++L +L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHL--HG---ER-AKPGALPWPTRLKIAIE 170
            N++ L+      S    +V E  + G + D +       E  A           +I  +
Sbjct: 81  PNIMKLFE-ILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAA----------RIIKQ 129

Query: 171 TASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
             S +TY+H  +I+HRD+K  NILL++   +  +K+ DFGLS  F  +         GT 
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--GTA 187

Query: 228 GYVDPE-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
            Y+ PE     Y   +K DV+S GV+L  L+S  P
Sbjct: 188 YYIAPEVLRGTY--DEKCDVWSAGVILYILLSGTP 220

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  110 bits (278), Expect = 3e-28
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 17/200 (8%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLY-ENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           + LG+G +G V          AVAVK +  +      E    E+ I   L H+N+V  YG
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 125 C--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
                       L  E+ S G + D +         +P P   +   +  + + YLH   
Sbjct: 73  HRREGNI---QYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT--HVSTAPQGTPGYVDPE--YHQCY 238
           I HRD+K  N+LLD    +K++DFGL+ +F  +     ++    GT  YV PE    + +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184

Query: 239 QLTDKSDVFSFGVVLIELIS 258
              +  DV+S G+VL  +++
Sbjct: 185 H-AEPVDVWSCGIVLTAMLA 203

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  111 bits (280), Expect = 3e-28
 Identities = 54/228 (23%), Positives = 86/228 (37%), Gaps = 41/228 (17%)

Query: 47  GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVK------RLYENNYK 99
           G++ F   ++E+   ++D   ELG G F  V    E   G   A K              
Sbjct: 1   GMEPFKQQKVED---FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57

Query: 100 RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERA 154
             E+   EV IL ++ H N+++L+     +  +++L+ E +S G             E  
Sbjct: 58  SREEIEREVSILRQVLHHNVITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEE 116

Query: 155 KPGALPWPTRLKIAIETA----SALTYLHASDIIHRDVKTNNILL----DNNFCVKVADF 206
                        A          + YLH   I H D+K  NI+L         +K+ DF
Sbjct: 117 -------------ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163

Query: 207 GLSRLF-PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVL 253
           GL+                GTP +V PE      L  ++D++S GV+ 
Sbjct: 164 GLAHEIEDGVEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  113 bits (284), Expect = 4e-28
 Identities = 51/212 (24%), Positives = 85/212 (40%), Gaps = 27/212 (12%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRL--------YENNYKRVEQFMNEVDILARLRHK 117
           + LG G  G V    E +  + VA++ +                     E++IL +L H 
Sbjct: 141 KTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP 200

Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
            ++ +       + +  +V E +  G + D +         L   T      +   A+ Y
Sbjct: 201 CIIKIKNFFD--AEDYYIVLELMEGGELFDKV----VGNKRLKEATCKLYFYQMLLAVQY 254

Query: 178 LHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE- 233
           LH + IIHRD+K  N+LL   + +  +K+ DFG S++        +    GTP Y+ PE 
Sbjct: 255 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLC--GTPTYLAPEV 312

Query: 234 ----YHQCYQLTDKSDVFSFGVVLIELISSMP 261
                   Y      D +S GV+L   +S  P
Sbjct: 313 LVSVGTAGY--NRAVDCWSLGVILFICLSGYP 342

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  109 bits (275), Expect = 9e-28
 Identities = 60/217 (27%), Positives = 94/217 (43%), Gaps = 32/217 (14%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VEQFMNEVDILARLRH 116
              ++    LG G FG V    +    +  AVK + + + K       + EV++L +L H
Sbjct: 21  AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80

Query: 117 KNLVSLYGC--TSRHSRELLLVYEFISNGTVAD------HLHGERAKPGALPWPTRLKIA 168
            N++ L+     S       +V E  + G + D            A           +I 
Sbjct: 81  PNIMKLFEILEDSSS---FYIVGELYTGGELFDEIIKRKRFSEHDAA----------RII 127

Query: 169 IETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQG 225
            +  S +TY+H  +I+HRD+K  NILL   + +  +K+ DFGLS  F  +         G
Sbjct: 128 KQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRI--G 185

Query: 226 TPGYVDPE-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
           T  Y+ PE     Y   +K DV+S GV+L  L+S  P
Sbjct: 186 TAYYIAPEVLRGTY--DEKCDVWSAGVILYILLSGTP 220

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  112 bits (283), Expect = 1e-27
 Identities = 62/226 (27%), Positives = 93/226 (41%), Gaps = 39/226 (17%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-------------YENNYKRVEQFM 105
              +   R+LG G +G V    E       A+K +              +N  K  E+  
Sbjct: 35  GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94

Query: 106 NEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHL-----HGER-AKPGAL 159
           NE+ +L  L H N++ L+       +   LV EF   G + + +       E  A     
Sbjct: 95  NEISLLKSLDHPNIIKLFD-VFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAA---- 149

Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFPNHV 216
                  I  +  S + YLH  +I+HRD+K  NILL+N      +K+ DFGLS  F    
Sbjct: 150 ------NIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY 203

Query: 217 THVSTAPQGTPGYVDPE-YHQCYQLTDKSDVFSFGVVLIELISSMP 261
                   GT  Y+ PE   + Y   +K DV+S GV++  L+   P
Sbjct: 204 KLRDRL--GTAYYIAPEVLKKKY--NEKCDVWSCGVIMYILLCGYP 245

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  110 bits (278), Expect = 1e-27
 Identities = 52/205 (25%), Positives = 85/205 (41%), Gaps = 31/205 (15%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
                 LG G FG V+   E   G  +A K +     K  E+  NE+ ++ +L H NL+ 
Sbjct: 91  VSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQ 150

Query: 122 LYGCTSRHSRELLLVYEFISNG------TVADHLHGERAKPGALPWPTRLKIAIETA--- 172
           LY        +++LV E++  G          +   E                I      
Sbjct: 151 LYDAFE-SKNDIVLVMEYVDGGELFDRIIDESYNLTELD-------------TILFMKQI 196

Query: 173 -SALTYLHASDIIHRDVKTNNILLDN--NFCVKVADFGLSRLF-PNHVTHVSTAPQGTPG 228
              + ++H   I+H D+K  NIL  N     +K+ DFGL+R + P     V+    GTP 
Sbjct: 197 CEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNF---GTPE 253

Query: 229 YVDPEYHQCYQLTDKSDVFSFGVVL 253
           ++ PE      ++  +D++S GV+ 
Sbjct: 254 FLAPEVVNYDFVSFPTDMWSVGVIA 278

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  109 bits (275), Expect = 2e-27
 Identities = 56/200 (28%), Positives = 90/200 (45%), Gaps = 17/200 (8%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLY-ENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
           + LG+G +G V          AVAVK +  +      E    E+ I   L H+N+V  YG
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYG 72

Query: 125 C--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
                       L  E+ S G + D +         +P P   +   +  + + YLH   
Sbjct: 73  HRREGNI---QYLFLEYCSGGELFDRI----EPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT--HVSTAPQGTPGYVDPE--YHQCY 238
           I HRD+K  N+LLD    +K++DFGL+ +F  +     ++    GT  YV PE    + +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPELLKRREF 184

Query: 239 QLTDKSDVFSFGVVLIELIS 258
              +  DV+S G+VL  +++
Sbjct: 185 H-AEPVDVWSCGIVLTAMLA 203

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  109 bits (275), Expect = 3e-27
 Identities = 49/205 (23%), Positives = 80/205 (39%), Gaps = 15/205 (7%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVK-----RLYENNYKRVEQFMNEVDILAR 113
            + ++    +G G F  V      + G+  AVK     +   +     E    E  I   
Sbjct: 23  EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82

Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
           L+H ++V L    S     L +V+EF+    +   +                    +   
Sbjct: 83  LKHPHIVELLETYS-SDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE 141

Query: 174 ALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
           AL Y H ++IIHRDVK + +LL   +N+  VK+  FG++               GTP ++
Sbjct: 142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGR-VGTPHFM 200

Query: 231 DPE--YHQCYQLTDKSDVFSFGVVL 253
            PE    + Y      DV+  GV+L
Sbjct: 201 APEVVKREPY--GKPVDVWGCGVIL 223

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  108 bits (273), Expect = 3e-27
 Identities = 49/212 (23%), Positives = 84/212 (39%), Gaps = 34/212 (16%)

Query: 57  EEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR 115
           +E    +  A +LG G FG V+   E    +    K +             E+ IL   R
Sbjct: 1   KELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIAR 59

Query: 116 HKNLVSLYG-CTSRHSRELLLVYEFISNGT-----VADHLH-GERAKPGALPWPTRLKIA 168
           H+N++ L+    S    EL++++EFIS                ER               
Sbjct: 60  HRNILHLHESFESME--ELVMIFEFISGLDIFERINTSAFELNERE-------------I 104

Query: 169 IETA----SALTYLHASDIIHRDVKTNNILLDN--NFCVKVADFGLSRLF-PNHVTHVST 221
           +        AL +LH+ +I H D++  NI+     +  +K+ +FG +R   P     +  
Sbjct: 105 VSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF 164

Query: 222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVL 253
                P Y  PE HQ   ++  +D++S G ++
Sbjct: 165 ---TAPEYYAPEVHQHDVVSTATDMWSLGTLV 193

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  108 bits (273), Expect = 3e-27
 Identities = 49/221 (22%), Positives = 83/221 (37%), Gaps = 41/221 (18%)

Query: 57  EEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL--------YENNYKRVEQFMNE 107
           +   + +  ++ LG G  G V    E +  + VA+K +                     E
Sbjct: 6   KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETE 65

Query: 108 VDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG------TVADHLHGERAKPGALPW 161
           ++IL +L H  ++ +       + +  +V E +  G           L     K      
Sbjct: 66  IEILKKLNHPCIIKIKN--FFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCK------ 117

Query: 162 PTRLKIAIETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLF-PNHVT 217
                   +   A+ YLH + IIHRD+K  N+LL   + +  +K+ DFG S++     + 
Sbjct: 118 ----LYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 173

Query: 218 HVSTAPQGTPGYVDPE-----YHQCYQLTDKSDVFSFGVVL 253
                  GTP Y+ PE         Y      D +S GV+L
Sbjct: 174 RTLC---GTPTYLAPEVLVSVGTAGY--NRAVDCWSLGVIL 209

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  108 bits (272), Expect = 3e-27
 Identities = 50/198 (25%), Positives = 89/198 (44%), Gaps = 16/198 (8%)

Query: 68  ELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDILARL-RHKNLVSLYG 124
           E+G G  G V+     + G  +AVK++    N +  ++ + ++D++ +      +V  +G
Sbjct: 32  EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFG 91

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DI 183
               ++ ++ +  E +                G +P     K+ +    AL YL     +
Sbjct: 92  TFITNT-DVFIAMELMGTCAEKLKKR----MQGPIPERILGKMTVAIVKALYYLKEKHGV 146

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD- 242
           IHRDVK +NILLD    +K+ DFG+S    +      +A  G   Y+ PE       T  
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSA--GCAAYMAPERIDPPDPTKP 204

Query: 243 ----KSDVFSFGVVLIEL 256
               ++DV+S G+ L+EL
Sbjct: 205 DYDIRADVWSLGISLVEL 222

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  109 bits (274), Expect = 4e-27
 Identities = 60/264 (22%), Positives = 105/264 (39%), Gaps = 41/264 (15%)

Query: 15  KKNKHSASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGF 74
                +      +   ++P    +L         ++  +   +E    +D    +G G  
Sbjct: 48  PSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVS 107

Query: 75  GTVYYG-ELQDGRAVAVKRL--------YENNYKRVEQFMNEVDILARLR-HKNLVSLYG 124
             V        G   AVK +         E   +  E    E  IL ++  H ++++L  
Sbjct: 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID 167

Query: 125 C--TSRHSRELLLVYEFISNGTVADHL--HG---ERAKPGALPWPTRLKIAIETASALTY 177
              +S     + LV++ +  G + D+L       E+         TR  I      A+++
Sbjct: 168 SYESSSF---MFLVFDLMRKGELFDYLTEKVALSEKE--------TR-SIMRSLLEAVSF 215

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE---- 233
           LHA++I+HRD+K  NILLD+N  ++++DFG S               GTPGY+ PE    
Sbjct: 216 LHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--GEKLRELCGTPGYLAPEILKC 273

Query: 234 ----YHQCYQLTDKSDVFSFGVVL 253
                H  Y    + D+++ GV+L
Sbjct: 274 SMDETHPGY--GKEVDLWACGVIL 295

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  109 bits (274), Expect = 4e-27
 Identities = 54/228 (23%), Positives = 86/228 (37%), Gaps = 41/228 (17%)

Query: 47  GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVK------RLYENNYK 99
           G++ F   ++E+   ++D   ELG G F  V    E   G   A K              
Sbjct: 1   GMETFKQQKVED---FYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGV 57

Query: 100 RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERA 154
             E+   EV IL ++ H N+++L+     +  +++L+ E +S G             E  
Sbjct: 58  CREEIEREVSILRQVLHPNIITLHD-VYENRTDVVLILELVSGGELFDFLAQKESLSEEE 116

Query: 155 KPGALPWPTRLKIAIET----ASALTYLHASDIIHRDVKTNNILL----DNNFCVKVADF 206
                        A          + YLH   I H D+K  NI+L         +K+ DF
Sbjct: 117 -------------ATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDF 163

Query: 207 GLSRLF-PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVL 253
           GL+                GTP +V PE      L  ++D++S GV+ 
Sbjct: 164 GLAHEIEDGVEFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVIT 208

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  108 bits (271), Expect = 4e-27
 Identities = 51/205 (24%), Positives = 81/205 (39%), Gaps = 30/205 (14%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVK---------RLYENNYKRVEQFMNEVDILARLR- 115
             LG GGFGTV+ G  L D   VA+K             ++         EV +L ++  
Sbjct: 37  PLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPL---EVALLWKVGA 93

Query: 116 ---HKNLVSLYGCTSRHSRELLLVYEFISNGT-VADHLHGERAKPGALPWPTRLKIAIET 171
              H  ++ L           +LV E       + D++     + G L          + 
Sbjct: 94  GGGHPGVIRLLDWFET-QEGFMLVLERPLPAQDLFDYI----TEKGPLGEGPSRCFFGQV 148

Query: 172 ASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
            +A+ + H+  ++HRD+K  NIL+D    C K+ DFG   L  +          GT  Y 
Sbjct: 149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDF---DGTRVYS 205

Query: 231 DPEY--HQCYQLTDKSDVFSFGVVL 253
            PE+     Y     + V+S G++L
Sbjct: 206 PPEWISRHQYHAL-PATVWSLGILL 229

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  111 bits (278), Expect = 6e-27
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 18/211 (8%)

Query: 61  NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKR---VEQFMNEVDILARLRH 116
           ++F   R LG GGFG V+  +++  G+  A K+L +   K+    +  M E  ILA++  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244

Query: 117 KNLVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAIETAS 173
           + +VSL     T      L LV   ++ G +  H++           P      A +  S
Sbjct: 245 RFIVSLAYAFETKTD---LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTA-QIVS 300

Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
            L +LH  +II+RD+K  N+LLD++  V+++D GL+       T       GTPG++ PE
Sbjct: 301 GLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPE 359

Query: 234 --YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
               + Y   D S D F+ GV L E+I++  
Sbjct: 360 LLLGEEY---DFSVDYFALGVTLYEMIAARG 387

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  107 bits (270), Expect = 6e-27
 Identities = 62/207 (29%), Positives = 98/207 (47%), Gaps = 30/207 (14%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN--EVDILARLRHKNLVSLYGC 125
           +G+G +G V+       G+ VA+K+  E+    V + +   E+ +L +L+H NLV+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
             R  R L LV+E+  + TV   L         +P      I  +T  A+ + H  + IH
Sbjct: 71  F-RRKRRLHLVFEYCDH-TVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIH 125

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLF--PNHV-TH-VST----APQ---GTPGYVDPEY 234
           RDVK  NIL+  +  +K+ DFG +RL   P+      V+T    +P+   G   Y  P  
Sbjct: 126 RDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPP-- 183

Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMP 261
                     DV++ G V  EL+S +P
Sbjct: 184 ---------VDVWAIGCVFAELLSGVP 201

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  106 bits (268), Expect = 7e-27
 Identities = 50/216 (23%), Positives = 87/216 (40%), Gaps = 40/216 (18%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVK------RLYENNYKRVEQFMNEVDILA 112
            ++++   ELG G F  V    +   G+  A K                E+   EV+IL 
Sbjct: 4   EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63

Query: 113 RLRHKNLVSLYG-CTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTRLK 166
            +RH N+++L+    ++   +++L+ E +S G             E              
Sbjct: 64  EIRHPNIITLHDIFENKT--DVVLILELVSGGELFDFLAEKESLTEDE------------ 109

Query: 167 IAIET----ASALTYLHASDIIHRDVKTNNILLDN----NFCVKVADFGLSRLF-PNHVT 217
            A +        + YLH+  I H D+K  NI+L +    N  +K+ DFG++      +  
Sbjct: 110 -ATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEF 168

Query: 218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVL 253
                  GTP +V PE      L  ++D++S GV+ 
Sbjct: 169 KNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVIT 201

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  105 bits (265), Expect = 2e-26
 Identities = 50/208 (24%), Positives = 87/208 (41%), Gaps = 29/208 (13%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRH 116
           ++ +D   ELG G F  V        G   A K +       +  ++   E  I  +L+H
Sbjct: 5   SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVAD------HLHGERAKPGALPWPTRLKIAIE 170
            N+V L+  + +      LV++ ++ G + +            A               +
Sbjct: 65  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HCIQQ 113

Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
              ++ Y H++ I+HR++K  N+LL        VK+ADFGL+    +       A  GTP
Sbjct: 114 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTP 171

Query: 228 GYVDPE--YHQCYQLTDKSDVFSFGVVL 253
           GY+ PE      Y  +   D+++ GV+L
Sbjct: 172 GYLSPEVLKKDPY--SKPVDIWACGVIL 197

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  108 bits (272), Expect = 2e-26
 Identities = 59/194 (30%), Positives = 91/194 (46%), Gaps = 16/194 (8%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVK---RLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
             LG G FG V  G+    G  VAVK   R    +   V +   E+  L   RH +++ L
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           Y   S    ++ +V E++S G + D++     K G L      ++  +  S + Y H   
Sbjct: 82  YQVIST-PSDIFMVMEYVSGGELFDYI----CKNGRLDEKESRRLFQQILSGVDYCHRHM 136

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPE--YHQCYQ 239
           ++HRD+K  N+LLD +   K+ADFGLS +         S    G+P Y  PE    + Y 
Sbjct: 137 VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSC---GSPNYAAPEVISGRLYA 193

Query: 240 LTDKSDVFSFGVVL 253
              + D++S GV+L
Sbjct: 194 -GPEVDIWSSGVIL 206

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  106 bits (266), Expect = 3e-26
 Identities = 54/217 (24%), Positives = 91/217 (41%), Gaps = 36/217 (16%)

Query: 61  NYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKN 118
           +     + LG+G F         +  +A AVK +   + +       E+  L     H N
Sbjct: 11  DLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKII---SKRMEANTQKEITALKLCEGHPN 67

Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHG-----ER-AKPGALPWPTRLKIAIE 170
           +V L+       H     LV E ++ G + + +       E  A            I  +
Sbjct: 68  IVKLHEVFHDQLH---TFLVMELLNGGELFERIKKKKHFSETEAS----------YIMRK 114

Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
             SA++++H   ++HRD+K  N+L    ++N  +K+ DFG +RL P     + T P  T 
Sbjct: 115 LVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT-PCFTL 173

Query: 228 GYVDPE--YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            Y  PE      Y   D+S D++S GV+L  ++S   
Sbjct: 174 HYAAPELLNQNGY---DESCDLWSLGVILYTMLSGQV 207

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  106 bits (266), Expect = 3e-26
 Identities = 60/246 (24%), Positives = 97/246 (39%), Gaps = 37/246 (15%)

Query: 32  EPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAV 90
           EP   V+LE      G     Y               LG G FG V+     +  + V V
Sbjct: 5   EPPKAVELEGLAACEGEYSQKY-STM---------SPLGSGAFGFVWTAVDKEKNKEVVV 54

Query: 91  K-----RLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGC--TSRHSRELLLVYEFI 140
           K     ++ E+      ++ +   E+ IL+R+ H N++ +              LV E  
Sbjct: 55  KFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF---FQLVMEKH 111

Query: 141 SNGT-VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF 199
            +G  +   +     +   L  P    I  +  SA+ YL   DIIHRD+K  NI++  +F
Sbjct: 112 GSGLDLFAFI----DRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDF 167

Query: 200 CVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPE--YHQCYQLTDKSDVFSFGVVLIEL 256
            +K+ DFG +       + +      GT  Y  PE      Y+   + +++S GV L  L
Sbjct: 168 TIKLIDFGSAAYLERGKLFYTFC---GTIEYCAPEVLMGNPYR-GPELEMWSLGVTLYTL 223

Query: 257 IS-SMP 261
           +    P
Sbjct: 224 VFEENP 229

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  105 bits (265), Expect = 4e-26
 Identities = 53/218 (24%), Positives = 85/218 (38%), Gaps = 38/218 (17%)

Query: 57  EEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL------YENNYKRVEQFMNEVD 109
           E   +Y+D+  ELG G F  V    E   G   A K +              E    EV 
Sbjct: 7   ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 66

Query: 110 ILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG-----TVADHLHGERAKPGALPWPTR 164
           IL  ++H N+++L+     +  +++L+ E ++ G             E            
Sbjct: 67  ILKEIQHPNVITLHE-VYENKTDVILILELVAGGELFDFLAEKESLTEEE---------- 115

Query: 165 LKIAIETA----SALTYLHASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLF-PNH 215
              A E      + + YLH+  I H D+K  NI+L         +K+ DFGL+      +
Sbjct: 116 ---ATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN 172

Query: 216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVL 253
                    GTP +V PE      L  ++D++S GV+ 
Sbjct: 173 EFKNIF---GTPEFVAPEIVNYEPLGLEADMWSIGVIT 207

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  106 bits (266), Expect = 7e-26
 Identities = 60/253 (23%), Positives = 100/253 (39%), Gaps = 42/253 (16%)

Query: 20  SASTLLFRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYY 79
               L        P       +     G+Q+     +++   Y  +++ LG G  G V  
Sbjct: 24  PTPALPHPPAQPPPPPPQQFPQFHVKSGLQIKKNAIIDD---YKVTSQVLGLGINGKVLQ 80

Query: 80  G-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGC---TSRHSRELL 134
               +     A+K L     +   +   EV++  R  +  ++V +           + LL
Sbjct: 81  IFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135

Query: 135 LVYEFISNGTVADHLHG-------ER-AKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           +V E +  G +   +         ER A           +I      A+ YLH+ +I HR
Sbjct: 136 IVMECLDGGELFSRIQDRGDQAFTEREAS----------EIMKSIGEAIQYLHSINIAHR 185

Query: 187 DVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE--YHQCYQLT 241
           DVK  N+L      N  +K+ DFG ++   +H  +  T P  TP YV PE    + Y   
Sbjct: 186 DVKPENLLYTSKRPNAILKLTDFGFAKETTSH--NSLTTPCYTPYYVAPEVLGPEKY--- 240

Query: 242 DKS-DVFSFGVVL 253
           DKS D++S GV++
Sbjct: 241 DKSCDMWSLGVIM 253

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  105 bits (264), Expect = 7e-26
 Identities = 58/207 (28%), Positives = 99/207 (47%), Gaps = 30/207 (14%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN--EVDILARLRHKNLVSLYGC 125
           +G+G +G V        GR VA+K+  E++  ++ + +   E+ +L +LRH+NLV+L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
             +  +   LV+EF+ + T+ D L      P  L +    K   +  + + + H+ +IIH
Sbjct: 93  C-KKKKRWYLVFEFVDH-TILDDL---ELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIH 147

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLF--PNHV-TH-VST----APQ---GTPGYVDPEY 234
           RD+K  NIL+  +  VK+ DFG +R    P  V    V+T    AP+   G   Y     
Sbjct: 148 RDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKA-- 205

Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMP 261
                     DV++ G ++ E+    P
Sbjct: 206 ---------VDVWAIGCLVTEMFMGEP 223

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  104 bits (261), Expect = 1e-25
 Identities = 57/213 (26%), Positives = 85/213 (39%), Gaps = 42/213 (19%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVK---------RLYENNYKRVEQFMNEVDILARL-R 115
             LG G    V         +  AVK            E   +  E  + EVDIL ++  
Sbjct: 23  EILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSG 82

Query: 116 HKNLVSLYGC--TSRHSRELLLVYEFISNGTVADHL--HG---ERAKPGALPWPTRLKIA 168
           H N++ L     T+       LV++ +  G + D+L       E+         TR KI 
Sbjct: 83  HPNIIQLKDTYETNTF---FFLVFDLMKKGELFDYLTEKVTLSEKE--------TR-KIM 130

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPG 228
                 +  LH  +I+HRD+K  NILLD++  +K+ DFG S               GTP 
Sbjct: 131 RALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPS 188

Query: 229 YVDPE--------YHQCYQLTDKSDVFSFGVVL 253
           Y+ PE         H  Y    + D++S GV++
Sbjct: 189 YLAPEIIECSMNDNHPGY--GKEVDMWSTGVIM 219

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  104 bits (261), Expect = 1e-25
 Identities = 55/212 (25%), Positives = 85/212 (40%), Gaps = 43/212 (20%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGC- 125
           LG+G    V     L   +  AVK + +       +   EV++L + + H+N++ L    
Sbjct: 21  LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80

Query: 126 -TSRHSRELLLVYEFISNGTVADHLHG-----ER-AKPGALPWPTRLKIAIETASALTYL 178
                     LV+E +  G++  H+H      E  A            +  + ASAL +L
Sbjct: 81  EEEDR---FYLVFEKMRGGSILSHIHKRRHFNELEAS----------VVVQDVASALDFL 127

Query: 179 HASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLF-PNHVTHVSTAPQ-----GTPGY 229
           H   I HRD+K  NIL    +    VK+ DF L      N      + P+     G+  Y
Sbjct: 128 HNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187

Query: 230 VDPE-------YHQCYQLTDKS-DVFSFGVVL 253
           + PE           Y   DK  D++S GV+L
Sbjct: 188 MAPEVVEAFSEEASIY---DKRCDLWSLGVIL 216

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  104 bits (262), Expect = 1e-25
 Identities = 49/204 (24%), Positives = 83/204 (40%), Gaps = 38/204 (18%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYG 124
            ++G G +               AVK +     K       E++IL R  +H N+++L  
Sbjct: 28  EDIGVGSYSVCKRCIHKATNMEFAVKIID----KSKRDPTEEIEILLRYGQHPNIITLKD 83

Query: 125 C--TSRHSRELLLVYEFISNGTVADHLHG-----ER-AKPGALPWPTRLKIAIETASALT 176
                ++   + +V E +  G + D +       ER A            +       + 
Sbjct: 84  VYDDGKY---VYVVTELMKGGELLDKILRQKFFSEREAS----------AVLFTITKTVE 130

Query: 177 YLHASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
           YLHA  ++HRD+K +NIL      N   +++ DFG ++        + T P  T  +V P
Sbjct: 131 YLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANFVAP 189

Query: 233 E--YHQCYQLTDKS-DVFSFGVVL 253
           E    Q Y   D + D++S GV+L
Sbjct: 190 EVLERQGY---DAACDIWSLGVLL 210

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  104 bits (261), Expect = 2e-25
 Identities = 55/194 (28%), Positives = 90/194 (46%), Gaps = 17/194 (8%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVK---RLYENNYKRVEQFMNEVDILARLRHKNLVSL 122
             LG+G FG V      +  + VA+K   R          +   E+  L  LRH +++ L
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL 74

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           Y   +    ++++V E+   G + D++     +   +      +   +   A+ Y H   
Sbjct: 75  YDVITT-PTDIVMVIEYA-GGELFDYI----VEKKRMTEDEGRRFFQQIICAIEYCHRHK 128

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPE--YHQCYQ 239
           I+HRD+K  N+LLD+N  VK+ADFGLS +    +    S    G+P Y  PE    + Y 
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC---GSPNYAAPEVINGKLYA 185

Query: 240 LTDKSDVFSFGVVL 253
              + DV+S G+VL
Sbjct: 186 -GPEVDVWSCGIVL 198

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  103 bits (260), Expect = 3e-25
 Identities = 50/206 (24%), Positives = 88/206 (42%), Gaps = 25/206 (12%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VEQFMNEVDILARLRH 116
           ++ +D   ELG G F  V        G   A K +          ++   E  I  +L+H
Sbjct: 28  SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHL--HG---ER-AKPGALPWPTRLKIAIE 170
            N+V L+  + +      LV++ ++ G + + +       E  A               +
Sbjct: 88  PNIVRLHD-SIQEESFHYLVFDLVTGGELFEDIVAREFYSEADAS----------HCIQQ 136

Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
              ++ Y H++ I+HR++K  N+LL        VK+ADFGL+    +       A  GTP
Sbjct: 137 ILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFA--GTP 194

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVL 253
           GY+ PE  +    +   D+++ GV+L
Sbjct: 195 GYLSPEVLKKDPYSKPVDIWACGVIL 220

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  103 bits (259), Expect = 4e-25
 Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 25/207 (12%)

Query: 57  EEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR 115
           +  +++F+   ELG G    VY   +    +  A+K L        +    E+ +L RL 
Sbjct: 49  DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVL--KKTVDKKIVRTEIGVLLRLS 106

Query: 116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHL--HG---ER-AKPGALPWPTRLKIAI 169
           H N++ L         E+ LV E ++ G + D +   G   ER A               
Sbjct: 107 HPNIIKLKE-IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAA----------DAVK 155

Query: 170 ETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGT 226
           +   A+ YLH + I+HRD+K  N+L      +  +K+ADFGLS++  + V   +    GT
Sbjct: 156 QILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC--GT 213

Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVL 253
           PGY  PE  +      + D++S G++ 
Sbjct: 214 PGYCAPEILRGCAYGPEVDMWSVGIIT 240

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  103 bits (259), Expect = 4e-25
 Identities = 58/201 (28%), Positives = 83/201 (41%), Gaps = 32/201 (15%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVK-----RLYENNYKRVEQFMNEVDILARLRHKNLV 120
           +++G G FG             VAVK        + N +R      E+     LRH N+V
Sbjct: 26  KDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQR------EIINHRSLRHPNIV 79

Query: 121 SLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
                  T  H   L ++ E+ S G + + +       G            +  S ++Y 
Sbjct: 80  RFKEVILTPTH---LAIIMEYASGGELYERI----CNAGRFSEDEARFFFQQLLSGVSYC 132

Query: 179 HASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE--Y 234
           H+  I HRD+K  N LLD +    +K+ DFG S+    H    ST   GTP Y+ PE   
Sbjct: 133 HSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTV--GTPAYIAPEVLL 190

Query: 235 HQCYQLTD--KSDVFSFGVVL 253
            Q Y   D   +DV+S GV L
Sbjct: 191 RQEY---DGKIADVWSCGVTL 208

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  106 bits (265), Expect = 4e-25
 Identities = 60/211 (28%), Positives = 92/211 (43%), Gaps = 20/211 (9%)

Query: 61  NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKR---VEQFMNEVDILARLRH 116
           N F   R +G GGFG VY     D G+  A+K L +   K        +NE  +L+ +  
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248

Query: 117 KN---LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
            +   +V +     T      L  + + ++ G +  HL     + G          A E 
Sbjct: 249 GDCPFIVCMSYAFHTPDK---LSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEI 301

Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
              L ++H   +++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ 
Sbjct: 302 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV---GTHGYMA 358

Query: 232 PEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
           PE  Q     D S D FS G +L +L+    
Sbjct: 359 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHS 389

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  103 bits (257), Expect = 5e-25
 Identities = 42/179 (23%), Positives = 70/179 (39%), Gaps = 17/179 (9%)

Query: 97  NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP 156
           +   ++    ++  +     KN V      S     L +  +      + D ++  R   
Sbjct: 101 SPSPMDAPSVKIRRMDPFSTKNTVG-QLQPSSPKVYLYIQMQLCRKENLKDWMN-RRCSL 158

Query: 157 GALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV 216
                   L I I+ A A+ +LH+  ++HRD+K +NI    +  VKV DFGL        
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDE 218

Query: 217 THVSTAPQ-----------GTPGYVDPE--YHQCYQLTDKSDVFSFGVVLIELISSMPA 262
              +               GT  Y+ PE  +   Y  + K D+FS G++L EL+ S   
Sbjct: 219 EEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNY--SHKVDIFSLGLILFELLYSFST 275

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 21/65 (32%), Positives = 32/65 (49%), Gaps = 2/65 (3%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           F+  + +G GGFG V+  +   D    A+KR+   N     E+ M EV  LA+L H  +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 121 SLYGC 125
             +  
Sbjct: 68  RYFNA 72

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  103 bits (258), Expect = 8e-25
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 20/209 (9%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  R +G G FG V   +  D  +  A+K + +        V     E+ I+  L H  
Sbjct: 17  FEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPF 76

Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAIETASAL 175
           LV+L+           + +V + +  G +  HL     +         +L I  E   AL
Sbjct: 77  LVNLWYSFQDEED---MFMVVDLLLGGDLRYHLQ----QNVHFKEETVKLFIC-ELVMAL 128

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-- 233
            YL    IIHRD+K +NILLD +  V + DF ++ + P      + A  GT  Y+ PE  
Sbjct: 129 DYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMA--GTKPYMAPEMF 186

Query: 234 YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
             +       + D +S GV   EL+    
Sbjct: 187 SSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  104 bits (262), Expect = 9e-25
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 15/208 (7%)

Query: 61  NYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKR---VEQFMNEVDILARLRH 116
           N F   R LG GGFG V   +++  G+  A K+L +   K+       +NE  IL ++  
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           + +VSL          L LV   ++ G +  H++                 A E    L 
Sbjct: 244 RFVVSLAYAYETKDA-LCLVLTLMNGGDLKFHIYHMGQAGFPEAR-AVFYAA-EICCGLE 300

Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE--Y 234
            LH   I++RD+K  NILLD++  ++++D GL+   P   T       GT GY+ PE   
Sbjct: 301 DLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRV--GTVGYMAPEVVK 358

Query: 235 HQCYQLTDKS-DVFSFGVVLIELISSMP 261
           ++ Y     S D ++ G +L E+I+   
Sbjct: 359 NERY---TFSPDWWALGCLLYEMIAGQS 383

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  102 bits (256), Expect = 9e-25
 Identities = 53/204 (25%), Positives = 87/204 (42%), Gaps = 40/204 (19%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGC- 125
           LG G  G V      + G+  A+K L         +   EVD   +     ++V +    
Sbjct: 37  LGLGVNGKVLECFHRRTGQKCALKLL-----YDSPKARQEVDHHWQASGGPHIVCILDVY 91

Query: 126 --TSRHSRELLLVYEFISNGTVADHLHG-------ER-AKPGALPWPTRLKIAIETASAL 175
                  R LL++ E +  G +   +         ER A           +I  +  +A+
Sbjct: 92  ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAA----------EIMRDIGTAI 141

Query: 176 TYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
            +LH+ +I HRDVK  N+L    + +  +K+ DFG ++    +   + T P  TP YV P
Sbjct: 142 QFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQT-PCYTPYYVAP 198

Query: 233 E--YHQCYQLTDKS-DVFSFGVVL 253
           E    + Y   DKS D++S GV++
Sbjct: 199 EVLGPEKY---DKSCDMWSLGVIM 219

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (259), Expect = 1e-24
 Identities = 48/208 (23%), Positives = 81/208 (38%), Gaps = 28/208 (13%)

Query: 60  TNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VEQFMNEVDILARLRH 116
           T  +    ELG G F  V    ++  G+  A   +          ++   E  I   L+H
Sbjct: 10  TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHL--HG---ER-AKPGALPWPTRLKIAIE 170
            N+V L+   S       L+++ ++ G + + +       E  A               +
Sbjct: 70  PNIVRLHDSIS-EEGHHYLIFDLVTGGELFEDIVAREYYSEADAS----------HCIQQ 118

Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
              A+ + H   ++HR++K  N+LL        VK+ADFGL+               GTP
Sbjct: 119 ILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGF-AGTP 177

Query: 228 GYVDPE--YHQCYQLTDKSDVFSFGVVL 253
           GY+ PE      Y      D+++ GV+L
Sbjct: 178 GYLSPEVLRKDPY--GKPVDLWACGVIL 203

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  102 bits (257), Expect = 2e-24
 Identities = 55/211 (26%), Positives = 89/211 (42%), Gaps = 19/211 (9%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + +G G FG V   +L++  +  A+K L +           F  E D+L     K 
Sbjct: 76  FEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKW 135

Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAIETASAL 175
           + +L+       +   L LV ++   G +   L         LP    R  +A E   A+
Sbjct: 136 ITTLHYAFQDDNN---LYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLA-EMVIAI 188

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
             +H    +HRD+K +NIL+D N  +++ADFG         T  S+   GTP Y+ PE  
Sbjct: 189 DSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 236 QCYQLTDKS-----DVFSFGVVLIELISSMP 261
           Q  +          D +S GV + E++    
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  100 bits (251), Expect = 3e-24
 Identities = 46/215 (21%), Positives = 93/215 (43%), Gaps = 16/215 (7%)

Query: 47  GVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKR--VEQ 103
            +   S         Y  +++ELG G F  V        G+  A K L +    +    +
Sbjct: 17  NLYFQSMENFNN--FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAE 74

Query: 104 FMNEVDILARLRH-KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP 162
            ++E+ +L   +    +++L+     ++ E++L+ E+ + G +      E      +   
Sbjct: 75  ILHEIAVLELAKSCPRVINLHE-VYENTSEIILILEYAAGGEIFSLCLPE--LAEMVSEN 131

Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLF-PNHVTH 218
             +++  +    + YLH ++I+H D+K  NILL +      +K+ DFG+SR         
Sbjct: 132 DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELR 191

Query: 219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVL 253
                 GTP Y+ PE      +T  +D+++ G++ 
Sbjct: 192 EIM---GTPEYLAPEILNYDPITTATDMWNIGIIA 223

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  100 bits (252), Expect = 8e-24
 Identities = 54/216 (25%), Positives = 88/216 (40%), Gaps = 27/216 (12%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + +G G F  V   +++  G+  A+K + + +      V  F  E D+L     + 
Sbjct: 63  FEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRW 122

Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHL--HGERAKPGALPWP-TRLKIAIETAS 173
           +  L+       +   L LV E+   G +   L   GER     +P    R  +A E   
Sbjct: 123 ITQLHFAFQDENY---LYLVMEYYVGGDLLTLLSKFGER-----IPAEMARFYLA-EIVM 173

Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS-RLFPNHVTHVSTAPQGTPGYVDP 232
           A+  +H    +HRD+K +NILLD    +++ADFG   +L  +       A  GTP Y+ P
Sbjct: 174 AIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVA-VGTPDYLSP 232

Query: 233 E------YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
           E                  D ++ GV   E+     
Sbjct: 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 99.8 bits (249), Expect = 2e-23
 Identities = 55/213 (25%), Positives = 86/213 (40%), Gaps = 26/213 (12%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           ++  + +G G FG V     +   +  A+K L +           F  E DI+A      
Sbjct: 71  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 130

Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAIETASAL 175
           +V L+      R+   L +V E++  G + + +         +P    R   A E   AL
Sbjct: 131 VVQLFYAFQDDRY---LYMVMEYMPGGDLVNLMSNYD-----VPEKWARFYTA-EVVLAL 181

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE-- 233
             +H+   IHRDVK +N+LLD +  +K+ADFG                 GTP Y+ PE  
Sbjct: 182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVL 241

Query: 234 ----YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
                   Y    +  D +S GV L E++    
Sbjct: 242 KSQGGDGYY---GRECDWWSVGVFLYEMLVGDT 271

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 59/206 (28%), Positives = 98/206 (47%), Gaps = 19/206 (9%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   + ++ G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           LV L      +S  L +V E+++ G +  HL     + G    P     A +      YL
Sbjct: 103 LVKLEFSFKDNSN-LYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE--YHQ 236
           H+ D+I+RD+K  N+L+D    ++V DFG ++     V   +    GTP  + PE    +
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSK 213

Query: 237 CYQLTDKS-DVFSFGVVLIELISSMP 261
            Y   +K+ D ++ GV++ E+ +  P
Sbjct: 214 GY---NKAVDWWALGVLIYEMAAGYP 236

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 40/214 (18%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQ-------FMNEVDILARLRHKNLV 120
           LG+G + TVY G     G  VA+K +      +++         + E+ ++  L+H+N+V
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV------KLDSEEGTPSTAIREISLMKELKHENIV 66

Query: 121 SLYGCTSRHSRELLLVYEFISN--GTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            LY        +L LV+EF+ N      D        P  L          +    L + 
Sbjct: 67  RLYDVIH-TENKLTLVFEFMDNDLKKYMDS-RTVGNTPRGLELNLVKYFQWQLLQGLAFC 124

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHV-TH-VST----APQ---GTP 227
           H + I+HRD+K  N+L++    +K+ DFGL+R F  P +  +  V T    AP    G+ 
Sbjct: 125 HENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSR 184

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
            Y           +   D++S G +L E+I+  P
Sbjct: 185 TY-----------STSIDIWSCGCILAEMITGKP 207

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 95.2 bits (237), Expect = 1e-22
 Identities = 24/201 (11%), Positives = 57/201 (28%), Gaps = 43/201 (21%)

Query: 67  RELGDGGFGTVYYGELQD---GRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLV 120
              G       +     D    R VA+  +          +++ ++    L+R+    + 
Sbjct: 37  IFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVA 94

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
            +       +   L+V E+I  G++ +          +      ++     A+A    H 
Sbjct: 95  RVLDVVHTRAG-GLVVAEWIRGGSLQEVADT------SPSPVGAIRAMQSLAAAADAAHR 147

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL 240
           + +       + + +  +  V +A                T P   P             
Sbjct: 148 AGVALSIDHPSRVRVSIDGDVVLAYPA-------------TMPDANP------------- 181

Query: 241 TDKSDVFSFGVVLIELISSMP 261
             + D+   G  L  L+ +  
Sbjct: 182 --QDDIRGIGASLYALLVNRW 200

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 95.7 bits (239), Expect = 3e-22
 Identities = 62/212 (29%), Positives = 96/212 (45%), Gaps = 37/212 (17%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN-----EVDILARLRHKNLVSL 122
           LG+G F TVY   +    + VA+K++   +    +  +N     E+ +L  L H N++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 123 YGCTSRHSRELLLVYEFISNGTVADH-LHGE-RAKPGALPWPTRLKIAIETASALTYLHA 180
                 H   + LV++F+      +  L    +     L         + T   L YLH 
Sbjct: 78  LDAFG-HKSNISLVFDFM------ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQ 130

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHV-TH-VST----APQ---GTPGY 229
             I+HRD+K NN+LLD N  +K+ADFGL++ F  PN   TH V T    AP+   G   Y
Sbjct: 131 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMY 190

Query: 230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
                          D+++ G +L EL+  +P
Sbjct: 191 -----------GVGVDMWAVGCILAELLLRVP 211

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 94.5 bits (236), Expect = 3e-22
 Identities = 59/214 (27%), Positives = 94/214 (43%), Gaps = 45/214 (21%)

Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQF--------MNEVDILARLRHKNLV 120
           +G+G +G VY  +   GR VA+KR+      R++          + E+ +L  L H N+V
Sbjct: 29  VGEGTYGVVYKAKDSQGRIVALKRI------RLDAEDEGIPSTAIREISLLKELHHPNIV 82

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADH-LHGE-RAKPGALPWPTRLKIAIETASALTYL 178
           SL        R L LV+EF+      +  L          L          +    + + 
Sbjct: 83  SLIDVIH-SERCLTLVFEFM------EKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHC 135

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHV-TH-VST----APQ---GTP 227
           H   I+HRD+K  N+L++++  +K+ADFGL+R F  P    TH V T    AP    G+ 
Sbjct: 136 HQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
            Y           +   D++S G +  E+I+  P
Sbjct: 196 KY-----------STSVDIWSIGCIFAEMITGKP 218

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 94.6 bits (236), Expect = 4e-22
 Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 24/168 (14%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMN-----EVDILARLR---HKNL 119
           +G G +GTVY   +   G  VA+K +   N       +      EV +L RL    H N+
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 120 VSLY----GCTSRHSRELLLVYEFISNGTVADH-LHG--ERAKPGALPWPTRLKIAIETA 172
           V L        +    ++ LV+E +      D  L    ++A P  LP  T   +  +  
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHV------DQDLRTYLDKAPPPGLPAETIKDLMRQFL 130

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHVTH 218
             L +LHA+ I+HRD+K  NIL+ +   VK+ADFGL+R++     +T 
Sbjct: 131 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTP 178

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 96.0 bits (239), Expect = 4e-22
 Identities = 63/211 (29%), Positives = 94/211 (44%), Gaps = 25/211 (11%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F+  + LG G FG V   + +  GR  A+K L +        V   + E  +L   RH  
Sbjct: 150 FEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPF 209

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           L +L      H R L  V E+ + G +  HL  ER          R   A E  SAL YL
Sbjct: 210 LTALKYSFQTHDR-LCFVMEYANGGELFFHLSRERVFSEDR---ARFYGA-EIVSALDYL 264

Query: 179 HAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPEYH 235
           H+  ++++RD+K  N++LD +  +K+ DFGL +     +   +T     GTP Y+ PE  
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKE---GIKDGATMKTFCGTPEYLAPEV- 320

Query: 236 QCYQLTDKS-----DVFSFGVVLIELISSMP 261
               L D       D +  GVV+ E++    
Sbjct: 321 ----LEDNDYGRAVDWWGLGVVMYEMMCGRL 347

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 94.6 bits (236), Expect = 5e-22
 Identities = 64/214 (29%), Positives = 92/214 (42%), Gaps = 32/214 (14%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V     +  GR  A+K L +        V   + E  +L   RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 119 LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGER--AKPGALPWPTRLKIAIETASA 174
           L +L     T      L  V E+ + G +  HL  ER   +  A     R   A E  SA
Sbjct: 67  LTALKYAFQTHDR---LCFVMEYANGGELFFHLSRERVFTEERA-----RFYGA-EIVSA 117

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDP 232
           L YLH+ D+++RD+K  N++LD +  +K+ DFGL +  +             GTP Y+ P
Sbjct: 118 LEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFC---GTPEYLAP 174

Query: 233 EYHQCYQLTDKS-----DVFSFGVVLIELISSMP 261
           E      L D       D +  GVV+ E++    
Sbjct: 175 EV-----LEDNDYGRAVDWWGLGVVMYEMMCGRL 203

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 93.7 bits (234), Expect = 5e-22
 Identities = 54/212 (25%), Positives = 93/212 (43%), Gaps = 46/212 (21%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF--------MNEVDILARLRHKNL 119
           +G+G +GTV+     +    VA+KR+      R++          + E+ +L  L+HKN+
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRV------RLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADH-LHGE-RAKPGALPWPTRLKIAIETASALTY 177
           V L+       ++L LV+EF       D  L     +  G L          +    L +
Sbjct: 64  VRLHDVLH-SDKKLTLVFEFC------DQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF 116

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHV-TH-VST----APQ---GT 226
            H+ +++HRD+K  N+L++ N  +K+A+FGL+R F  P    +  V T     P    G 
Sbjct: 117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGA 176

Query: 227 PGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
             Y           +   D++S G +  EL +
Sbjct: 177 KLY-----------STSIDMWSAGCIFAELAN 197

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 93.7 bits (234), Expect = 5e-22
 Identities = 57/214 (26%), Positives = 96/214 (44%), Gaps = 45/214 (21%)

Query: 69  LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQF--------MNEVDILARLRHKNLV 120
           +G+G +G VY  +   G   A+K++      R+E+         + E+ IL  L+H N+V
Sbjct: 10  IGEGTYGVVYKAQNNYGETFALKKI------RLEKEDEGIPSTTIREISILKELKHSNIV 63

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADH-LHGE-RAKPGALPWPTRLKIAIETASALTYL 178
            LY       + L+LV+E +      D  L        G L   T     ++  + + Y 
Sbjct: 64  KLYDVIH-TKKRLVLVFEHL------DQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYC 116

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHV-TH-VST----APQ---GTP 227
           H   ++HRD+K  N+L++    +K+ADFGL+R F  P    TH + T    AP    G+ 
Sbjct: 117 HDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
            Y           +   D++S G +  E+++  P
Sbjct: 177 KY-----------STTIDIWSVGCIFAEMVNGTP 199

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 94.1 bits (234), Expect = 1e-21
 Identities = 39/160 (24%), Positives = 73/160 (45%), Gaps = 22/160 (13%)

Query: 69  LGDGGFGTVYYG---ELQDGRAVAVKRLYENNYKRVEQF----MNEVDILARLRHKNLVS 121
           +G G +G VY     + +D +  A+K++                 E+ +L  L+H N++S
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQI------EGTGISMSACREIALLRELKHPNVIS 82

Query: 122 LYG-CTSRHSRELLLVYEFISN--GTVADHLHGERAKPGALPWPTRL--KIAIETASALT 176
           L     S   R++ L++++  +    +       +A    +  P  +   +  +    + 
Sbjct: 83  LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142

Query: 177 YLHASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLF 212
           YLHA+ ++HRD+K  NIL+         VK+AD G +RLF
Sbjct: 143 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 92.6 bits (231), Expect = 2e-21
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 28/214 (13%)

Query: 63  FDSARELGDGGFGTVY----YGELQDGRAVAVKRLYE----NNYKRVEQFMNEVDILARL 114
           F+  R LG GG+G V+          G+  A+K L +     N K       E +IL  +
Sbjct: 19  FELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEV 78

Query: 115 RHKNLVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
           +H  +V L     T      L L+ E++S G +   L  E              +A E +
Sbjct: 79  KHPFIVDLIYAFQTGGK---LYLILEYLSGGELFMQLEREGIFMEDT---ACFYLA-EIS 131

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYV 230
            AL +LH   II+RD+K  NI+L++   VK+ DFGL +  +    VTH      GT  Y+
Sbjct: 132 MALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFC---GTIEYM 188

Query: 231 DPE--YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            PE      +   +++ D +S G ++ ++++  P
Sbjct: 189 APEILMRSGH---NRAVDWWSLGALMYDMLTGAP 219

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 92.2 bits (230), Expect = 3e-21
 Identities = 66/207 (31%), Positives = 106/207 (51%), Gaps = 21/207 (10%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKN 118
           F   R LG G FG V+    +  GR  A+K L +      K+VE   +E  +L+ + H  
Sbjct: 8   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 67

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAIETASALTY 177
           ++ ++G      + + ++ ++I  G +   L     K    P P  +   A E   AL Y
Sbjct: 68  IIRMWGTFQDAQQ-IFMIMDYIEGGELFSLLR----KSQRFPNPVAKFYAA-EVCLALEY 121

Query: 178 LHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE--YH 235
           LH+ DII+RD+K  NILLD N  +K+ DFG ++  P+ VT+      GTP Y+ PE    
Sbjct: 122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTYTLC---GTPDYIAPEVVST 177

Query: 236 QCYQLTDKS-DVFSFGVVLIELISSMP 261
           + Y   +KS D +SFG+++ E+++   
Sbjct: 178 KPY---NKSIDWWSFGILIYEMLAGYT 201

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 93.6 bits (233), Expect = 3e-21
 Identities = 72/271 (26%), Positives = 119/271 (43%), Gaps = 41/271 (15%)

Query: 13  RRKKNKHSASTLLFRNTSSEPSSKVDLEKGGNY--HGVQVFSYGELEEATNYFDSARELG 70
           R +    + S    +  S+  S KV  +K G+     V     G        +   + +G
Sbjct: 4   RPRTTSFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIG 63

Query: 71  DGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILARLRHKNLVSLYGC--- 125
           +G FG VY  +L D G  VA+K++ ++     ++F N E+ I+ +L H N+V L      
Sbjct: 64  NGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHCNIVRLRYFFYS 118

Query: 126 --TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHASD 182
               +    L LV +++   TV             LP    +K+ + +   +L Y+H+  
Sbjct: 119 SGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLP-VIYVKLYMYQLFRSLAYIHSFG 176

Query: 183 IIHRDVKTNNILLD-NNFCVKVADFGLSRLF----PNHVTHVST----APQ---GTPGYV 230
           I HRD+K  N+LLD +   +K+ DFG ++      PN V+++ +    AP+   G   Y 
Sbjct: 177 ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN-VSYICSRYYRAPELIFGATDY- 234

Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
                     T   DV+S G VL EL+   P
Sbjct: 235 ----------TSSIDVWSAGCVLAELLLGQP 255

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 91.9 bits (229), Expect = 4e-21
 Identities = 52/220 (23%), Positives = 89/220 (40%), Gaps = 45/220 (20%)

Query: 63  FDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQ-------FMNEVDILARL 114
           +    +LG+G + TVY G        VA+K +      R+E         + EV +L  L
Sbjct: 4   YIKLDKLGEGTYATVYKGKSKLTDNLVALKEI------RLEHEEGAPCTAIREVSLLKDL 57

Query: 115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADH-LHGE-RAKPGALPWPTRLKIAIETA 172
           +H N+V+L+       + L LV+E++      D  L          +          +  
Sbjct: 58  KHANIVTLHDIIH-TEKSLTLVFEYL------DKDLKQYLDDCGNIINMHNVKLFLFQLL 110

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHV-TH-VST----APQ 224
             L Y H   ++HRD+K  N+L++    +K+ADFGL+R    P     + V T     P 
Sbjct: 111 RGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPD 170

Query: 225 ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
              G+  Y           + + D++  G +  E+ +  P
Sbjct: 171 ILLGSTDY-----------STQIDMWGVGCIFYEMATGRP 199

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 91.9 bits (229), Expect = 6e-21
 Identities = 48/158 (30%), Positives = 82/158 (51%), Gaps = 22/158 (13%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF----MNEVDILARLRHKNLVSLY 123
           +G G FG V+     + G+ VA+K++   N K  E F    + E+ IL  L+H+N+V+L 
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEK--EGFPITALREIKILQLLKHENVVNLI 82

Query: 124 G-CTSRHSRE------LLLVYEFISNGTVADH-LHGERAKPGALPWPTRLK-IAIETASA 174
             C ++ S        + LV++F       +H L G  +        + +K +     + 
Sbjct: 83  EICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF 212
           L Y+H + I+HRD+K  N+L+  +  +K+ADFGL+R F
Sbjct: 137 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 174

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 92.0 bits (229), Expect = 6e-21
 Identities = 61/256 (23%), Positives = 108/256 (42%), Gaps = 40/256 (15%)

Query: 26  FRNTSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDG 85
             N          L+       V        E+    + + + +G+G FG V+  +L + 
Sbjct: 5   MSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKLVES 64

Query: 86  RAVAVKR-LYENNYK-RVEQFMNEVDILARLRHKNLVSLYGC-----TSRHSRELLLVYE 138
             VA+K+ L +  +K R      E+ I+  ++H N+V L          +    L LV E
Sbjct: 65  DEVAIKKVLQDKRFKNR------ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLE 118

Query: 139 FISNGTVADHLHGERAKPGALPWPTRLKIAI-ETASALTYLHASDIIHRDVKTNNILLD- 196
           ++   TV             +P    +K+ + +   +L Y+H+  I HRD+K  N+LLD 
Sbjct: 119 YVPE-TVYRASRHYAKLKQTMP-MLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDP 176

Query: 197 NNFCVKVADFGLSRLF----PNHVTHVST----APQ---GTPGYVDPEYHQCYQLTDKSD 245
            +  +K+ DFG +++     PN V+++ +    AP+   G   Y           T   D
Sbjct: 177 PSGVLKLIDFGSAKILIAGEPN-VSYICSRYYRAPELIFGATNY-----------TTNID 224

Query: 246 VFSFGVVLIELISSMP 261
           ++S G V+ EL+   P
Sbjct: 225 IWSTGCVMAELMQGQP 240

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 90.7 bits (226), Expect = 8e-21
 Identities = 47/173 (27%), Positives = 80/173 (46%), Gaps = 34/173 (19%)

Query: 69  LGDGGFGTVYYG--ELQDGRAVAVKRLYENNYKRVEQFMN--------EVDILARLR--- 115
           +G+G +G V+        GR VA+KR+      RV+            EV +L  L    
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRV------RVQTGEEGMPLSTIREVAVLRHLETFE 72

Query: 116 HKNLVSLY----GCTSRHSRELLLVYEFISNGTVADH-LHG--ERAKPGALPWPTRLKIA 168
           H N+V L+       +    +L LV+E +      D  L    ++     +P  T   + 
Sbjct: 73  HPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQDLTTYLDKVPEPGVPTETIKDMM 126

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF--PNHVTHV 219
            +    L +LH+  ++HRD+K  NIL+ ++  +K+ADFGL+R++     +T V
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSV 179

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 58/209 (27%), Positives = 95/209 (45%), Gaps = 21/209 (10%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYEN---NYKRVEQFMNEVDILAR-LRHK 117
           F   + LG G FG V+  E +   +  A+K L ++       VE  M E  +L+    H 
Sbjct: 19  FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 78

Query: 118 NLVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
            L  ++    T  +   L  V E+++ G +  H+                  A E    L
Sbjct: 79  FLTHMFCTFQTKEN---LFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGL 131

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
            +LH+  I++RD+K +NILLD +  +K+ADFG+ +    ++   +      GTP Y+ PE
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE---NMLGDAKTNTFCGTPDYIAPE 188

Query: 234 YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
                Q  + S D +SFGV+L E++    
Sbjct: 189 ILL-GQKYNHSVDWWSFGVLLYEMLIGQS 216

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 27/212 (12%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRL---YENNYKRVEQFMNEVDILAR-LRHK 117
           FD  R +G G +  V    L+   R  A+K +     N+ + ++    E  +  +   H 
Sbjct: 11  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHP 70

Query: 118 NLVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAIETASA 174
            LV L+ C  T      L  V E+++ G +  H+     +   LP    R   A E + A
Sbjct: 71  FLVGLHSCFQTESR---LFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSA-EISLA 122

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDP 232
           L YLH   II+RD+K +N+LLD+   +K+ D+G+ +  L P   T       GTP Y+ P
Sbjct: 123 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAP 179

Query: 233 E--YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
           E    + Y     S D ++ GV++ E+++   
Sbjct: 180 EILRGEDY---GFSVDWWALGVLMFEMMAGRS 208

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 92.4 bits (229), Expect = 2e-20
 Identities = 64/207 (30%), Positives = 96/207 (46%), Gaps = 17/207 (8%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYEN---NYKRVEQFMNEVDILAR-LRHK 117
           F+    LG G FG V   E +      AVK L ++       VE  M E  +LA   +  
Sbjct: 343 FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 402

Query: 118 NLVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
            L  L+ C  T      L  V E+++ G +  H+       G    P  +  A E A  L
Sbjct: 403 FLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGL 455

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH 235
            +L +  II+RD+K +N++LD+   +K+ADFG+ +          T   GTP Y+ PE  
Sbjct: 456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC-GTPDYIAPEII 514

Query: 236 QCYQLTDKS-DVFSFGVVLIELISSMP 261
             YQ   KS D ++FGV+L E+++   
Sbjct: 515 A-YQPYGKSVDWWAFGVLLYEMLAGQA 540

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 25/211 (11%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYEN---NYKRVEQFMNEVDILAR-LRHK 117
           F   + +G G FG V     +      AVK L +      K  +  M+E ++L + ++H 
Sbjct: 40  FHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHP 99

Query: 118 NLVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
            LV L+    T+     L  V ++I+ G +  HL  ER          R   A E ASAL
Sbjct: 100 FLVGLHFSFQTADK---LYFVLDYINGGELFYHLQRERCFLEPR---ARFYAA-EIASAL 152

Query: 176 TYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPE 233
            YLH+ +I++RD+K  NILLD+   + + DFGL +    ++ H ST     GTP Y+ PE
Sbjct: 153 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE---NIEHNSTTSTFCGTPEYLAPE 209

Query: 234 --YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
             + Q Y   D++ D +  G VL E++  +P
Sbjct: 210 VLHKQPY---DRTVDWWCLGAVLYEMLYGLP 237

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 51/219 (23%), Positives = 91/219 (41%), Gaps = 50/219 (22%)

Query: 69  LGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQF--------MNEVDILARLRHKNL 119
           LG+G +G VY   +      VA+KR+      R+E          + EV +L  L+H+N+
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRI------RLEHEEEGVPGTAIREVSLLKELQHRNI 95

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADH-LHGERAKPGALPWPTRLKIAIETASALTYL 178
           + L      H+  L L++E+       ++ L     K   +          +  + + + 
Sbjct: 96  IELKSVIH-HNHRLHLIFEYA------ENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFC 148

Query: 179 HASDIIHRDVKTNNILLDNNF-----CVKVADFGLSRLF--PNHV-TH-VST----APQ- 224
           H+   +HRD+K  N+LL  +       +K+ DFGL+R F  P    TH + T     P+ 
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI 208

Query: 225 --GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
             G+  Y           +   D++S   +  E++   P
Sbjct: 209 LLGSRHY-----------STSVDIWSIACIWAEMLMKTP 236

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 27/212 (12%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRL---YENNYKRVEQFMNEVDILAR-LRHK 117
           FD  R +G G +  V    L+   R  A++ +     N+ + ++    E  +  +   H 
Sbjct: 54  FDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHP 113

Query: 118 NLVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAIETASA 174
            LV L+ C  T      L  V E+++ G +  H+     +   LP    R   A E + A
Sbjct: 114 FLVGLHSCFQTESR---LFFVIEYVNGGDLMFHMQ----RQRKLPEEHARFYSA-EISLA 165

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDP 232
           L YLH   II+RD+K +N+LLD+   +K+ D+G+ +  L P   T       GTP Y+ P
Sbjct: 166 LNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFC---GTPNYIAP 222

Query: 233 E--YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
           E    + Y     S D ++ GV++ E+++   
Sbjct: 223 EILRGEDY---GFSVDWWALGVLMFEMMAGRS 251

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 89.2 bits (222), Expect = 5e-20
 Identities = 66/212 (31%), Positives = 94/212 (44%), Gaps = 27/212 (12%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILAR-LRHK 117
           F+  R LG G FG V    +++ G   AVK L ++       VE  M E  IL+    H 
Sbjct: 25  FEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHP 84

Query: 118 NLVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAIETASA 174
            L  L+ C  T      L  V EF++ G +  H+     K         R   A E  SA
Sbjct: 85  FLTQLFCCFQTPDR---LFFVMEFVNGGDLMFHIQ----KSRRFDEARARFYAA-EIISA 136

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS--RLFPNHVTHVSTAPQGTPGYVDP 232
           L +LH   II+RD+K +N+LLD+    K+ADFG+    +     T       GTP Y+ P
Sbjct: 137 LMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFC---GTPDYIAP 193

Query: 233 E--YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
           E      Y     + D ++ GV+L E++    
Sbjct: 194 EILQEMLY---GPAVDWWAMGVLLYEMLCGHA 222

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 88.8 bits (221), Expect = 7e-20
 Identities = 64/212 (30%), Positives = 98/212 (46%), Gaps = 27/212 (12%)

Query: 63  FDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN---YKRVEQFMNEVDILAR-LRHK 117
           F+    LG G FG V   E +      AVK L ++       VE  M E  +LA   +  
Sbjct: 22  FNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPP 81

Query: 118 NLVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAIETASA 174
            L  L+ C  T      L  V E+++ G +  H+       G    P      A E A  
Sbjct: 82  FLTQLHSCFQTMDR---LYFVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAA-EIAIG 133

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR--LFPNHVTHVSTAPQGTPGYVDP 232
           L +L +  II+RD+K +N++LD+   +K+ADFG+ +  ++    T       GTP Y+ P
Sbjct: 134 LFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFC---GTPDYIAP 190

Query: 233 E--YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
           E   +Q Y    KS D ++FGV+L E+++   
Sbjct: 191 EIIAYQPY---GKSVDWWAFGVLLYEMLAGQA 219

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 87.6 bits (218), Expect = 1e-19
 Identities = 62/212 (29%), Positives = 97/212 (45%), Gaps = 26/212 (12%)

Query: 63  FDSARELGDGGFGTVY----YGELQDGRAVAVKRLYENNYKRVEQF--MNEVDILARLRH 116
           F+  + LG G FG V+           +  A+K L +   K  ++     E DIL  + H
Sbjct: 26  FELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNH 85

Query: 117 KNLVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
             +V L+    T      L L+ +F+  G +   L  E           +  +A E A A
Sbjct: 86  PFIVKLHYAFQTEGK---LYLILDFLRGGDLFTRLSKEVMFTEED---VKFYLA-ELALA 138

Query: 175 LTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDP 232
           L +LH+  II+RD+K  NILLD    +K+ DFGLS+     + H   A    GT  Y+ P
Sbjct: 139 LDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKE---SIDHEKKAYSFCGTVEYMAP 195

Query: 233 E--YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
           E    + +    +S D +SFGV++ E+++   
Sbjct: 196 EVVNRRGH---TQSADWWSFGVLMFEMLTGTL 224

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 61/216 (28%), Positives = 97/216 (44%), Gaps = 28/216 (12%)

Query: 63  FDSARELGDGGFGTVY----YGELQDGRAVAVKRL----YENNYKRVEQFMNEVDILARL 114
           F+  + LG G +G V+          G+  A+K L         K  E    E  +L  +
Sbjct: 56  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 115

Query: 115 RHKN-LVSLYGC--TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP-TRLKIAIE 170
           R    LV+L+    T      L L+ ++I+ G +  HL    ++         ++ +  E
Sbjct: 116 RQSPFLVTLHYAFQTETK---LHLILDYINGGELFTHL----SQRERFTEHEVQIYVG-E 167

Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
              AL +LH   II+RD+K  NILLD+N  V + DFGLS+ F    T  +    GT  Y+
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 231 DPE----YHQCYQLTDKS-DVFSFGVVLIELISSMP 261
            P+        +   DK+ D +S GV++ EL++   
Sbjct: 228 APDIVRGGDSGH---DKAVDWWSLGVLMYELLTGAS 260

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 85.4 bits (212), Expect = 1e-18
 Identities = 52/293 (17%), Positives = 99/293 (33%), Gaps = 52/293 (17%)

Query: 39  LEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNY 98
           ++  G      +    EL    + +   R +  G +G V  G   +G  VA+KR++    
Sbjct: 2   MQAKGEAAMRDLI--AELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVS 59

Query: 99  KRVEQ--FMNEVD---------ILARLRHKNLVSLYGC----TSRHSRELLLVYEFISNG 143
                    +            +L    H N++ L             +L LV E +   
Sbjct: 60  DGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-- 117

Query: 144 TVADHLHGE-RAKPGALPWPTRLK-IAIETASALTYLHASDIIHRDVKTNNILLDNNFCV 201
              D L      +   +  P  ++         L  LH + ++HRD+   NILL +N  +
Sbjct: 118 --TD-LAQVIHDQRIVIS-PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDI 173

Query: 202 KVADFGLSRLFPNHVTHVSTAPQGTPGYVD------PE---YHQCYQLTDKSDVFSFGVV 252
            + DF L+R         +     T  YV       PE     + +  T   D++S G V
Sbjct: 174 TICDFNLAR-------EDTADANKT-HYVTHRWYRAPELVMQFKGF--TKLVDMWSAGCV 223

Query: 253 LIELISSMPAVDITRHRHEINL--------SNLAINKIQNKALHELVDQTLGY 297
           + E+ +       +   +++N             +    + +  + +  +L  
Sbjct: 224 MAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSN 276

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 40/164 (24%), Positives = 64/164 (39%), Gaps = 31/164 (18%)

Query: 61  NYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKN 118
           +Y  +++ LG G  G V      +     A+K L     +   +   EV++  R  +  +
Sbjct: 18  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 72

Query: 119 LVSLYGC---TSRHSRELLLVYEFISNG-------TVADHLHGER-AKPGALPWPTRLKI 167
           +V +           + LL+V E +  G          D    ER A           +I
Sbjct: 73  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREAS----------EI 122

Query: 168 AIETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGL 208
                 A+ YLH+ +I HRDVK  N+L      N  +K+ DFG 
Sbjct: 123 MKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 166

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 55/265 (20%), Positives = 107/265 (40%), Gaps = 39/265 (14%)

Query: 44  NYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL---YENNY- 98
           N++ V++            + + + +G G  G V    +    R VA+K+L   ++N   
Sbjct: 10  NFYSVEIG--DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTH 67

Query: 99  -KRVEQFMNEVDILARLRHKNLVSLY-----GCTSRHSRELLLVYEFIS---NGTVADHL 149
            KR      E+ ++  + HKN++ L        +    +++ +V E +       +   L
Sbjct: 68  AKRA---YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 124

Query: 150 HGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS 209
             ER             +  +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+
Sbjct: 125 DHERMSY----------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLA 174

Query: 210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHR 269
           R      + + T    T  Y  PE        +  D++S G ++ E+I        T H 
Sbjct: 175 RTAGT--SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 232

Query: 270 HEINL--------SNLAINKIQNKA 286
            + N             + K+Q   
Sbjct: 233 DQWNKVIEQLGTPCPEFMKKLQPTV 257

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 57/248 (22%), Positives = 102/248 (41%), Gaps = 45/248 (18%)

Query: 29  TSSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRA 87
           + +   + V+  +   Y   +     E     +Y    R+LG G +  V+    + +   
Sbjct: 6   SRARVYTDVNTHRPREYWDYESHVV-EWGNQDDY-QLVRKLGRGKYSEVFEAINITNNEK 63

Query: 88  VAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGC-TSRHSRELLLVYEFISNGTV 145
           V VK L     K++++   E+ IL  LR   N+++L        SR   LV+E ++N   
Sbjct: 64  VVVKILKPVKKKKIKR---EIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNN--- 117

Query: 146 ADHLHGERAKPGALPWPTRLKIAIETAS-------------ALTYLHASDIIHRDVKTNN 192
                            T  K   +T +             AL Y H+  I+HRDVK +N
Sbjct: 118 -----------------TDFKQLYQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHN 160

Query: 193 ILLDNNFC-VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS-DVFSFG 250
           +++D+    +++ D+GL+  +  H          +  +  PE    YQ+ D S D++S G
Sbjct: 161 VMIDHEHRKLRLIDWGLAEFY--HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLG 218

Query: 251 VVLIELIS 258
            +L  +I 
Sbjct: 219 CMLASMIF 226

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 49/252 (19%), Positives = 92/252 (36%), Gaps = 59/252 (23%)

Query: 56  LEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMN-EVDILAR 113
           LE ++  +   + LG G FG V      + G+  A+K++ ++      ++ N E+DI+  
Sbjct: 2   LETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQD-----PRYKNRELDIMKV 56

Query: 114 LRHKNLVSLYGC-TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPW----------- 161
           L H N++ L     +    E         +  +    +G      ++             
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 162 ----PTRLKIAIETAS--------------------ALTYLHASDIIHRDVKTNNILLDN 197
               P  L   +++                      A+ ++H+  I HRD+K  N+L+++
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 198 NFCV-KVADFGLSRLFPNHVTHVSTAPQGTPGYV------DPE-YHQCYQLTDKSDVFSF 249
                K+ DFG ++        V+        Y+       PE      + T   D++S 
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVA--------YICSRFYRAPELMLGATEYTPSIDLWSI 228

Query: 250 GVVLIELISSMP 261
           G V  ELI   P
Sbjct: 229 GCVFGELILGKP 240

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 79.6 bits (197), Expect = 8e-17
 Identities = 56/232 (24%), Positives = 101/232 (43%), Gaps = 37/232 (15%)

Query: 52  SYGELEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENN-YK-RVEQFMNEV 108
           +     +  + F   R  G G FGTV  G+ +  G +VA+K++ ++  ++ R  Q M + 
Sbjct: 14  ADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQD- 72

Query: 109 DILARLRHKNLVSLYGC----TSRHSRE--LLLVYEFISNGTVADHLHGERAKPGALPWP 162
             LA L H N+V L         R  R+  L +V E++ + T+         +  A P  
Sbjct: 73  --LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPI 129

Query: 163 TRLKIAIETASALTYLHAS--DIIHRDVKTNNILLDNNFCV-KVADFGLSR-LFPNH--V 216
                  +   ++  LH    ++ HRD+K +N+L++      K+ DFG ++ L P+   V
Sbjct: 130 LIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNV 189

Query: 217 THVST----APQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
            ++ +    AP+   G   Y           T   D++S G +  E++   P
Sbjct: 190 AYICSRYYRAPELIFGNQHY-----------TTAVDIWSVGCIFAEMMLGEP 230

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 78.1 bits (193), Expect = 3e-16
 Identities = 50/255 (19%), Positives = 103/255 (40%), Gaps = 42/255 (16%)

Query: 39  LEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL---Y 94
           L +   ++   V       E    + S   +G G +G+V    + + G  VA+K+L   +
Sbjct: 4   LIRKKGFYKQDVN--KTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF 61

Query: 95  ENNY--KRVEQFMNEVDILARLRHKNLVSLY-----GCTSRHSRELLLVYEFISNGTVAD 147
           ++    KR      E+ +L  ++H+N++ L        + R+  +  LV  F+      D
Sbjct: 62  QSEIFAKRA---YRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ----TD 114

Query: 148 HLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFG 207
            L   +             +  +    L Y+H++ ++HRD+K  N+ ++ +  +K+ DFG
Sbjct: 115 -LQ--KIMGLKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFG 171

Query: 208 LSRLFPNHVTH-VST----APQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS 259
           L+R     +T  V T    AP+       Y               D++S G ++ E+++ 
Sbjct: 172 LARHADAEMTGYVVTRWYRAPEVILSWMHY-----------NQTVDIWSVGCIMAEMLTG 220

Query: 260 MPAVDITRHRHEINL 274
                   +  ++  
Sbjct: 221 KTLFKGKDYLDQLTQ 235

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 77.9 bits (192), Expect = 5e-16
 Identities = 50/212 (23%), Positives = 80/212 (37%), Gaps = 51/212 (24%)

Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLY---ENNY--KRVEQFMNEVDIL 111
              + +     +G G +G VY   +    + VA+K++    E+    KR+   + E+ IL
Sbjct: 23  HVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRI---LREITIL 79

Query: 112 ARLRHKNLVSLYGC----TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI 167
            RL+   ++ LY            EL +V E                        + LK 
Sbjct: 80  NRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIA---------------------DSDLKK 118

Query: 168 AIETASALT----------------YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR- 210
             +T   LT                ++H S IIHRD+K  N LL+ +  VKV DFGL+R 
Sbjct: 119 LFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART 178

Query: 211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           +     T++    +          +   QLT 
Sbjct: 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTS 210

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 78.0 bits (192), Expect = 5e-16
 Identities = 56/268 (20%), Positives = 106/268 (39%), Gaps = 47/268 (17%)

Query: 45  YHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLY---ENNY-- 98
           ++ V+V            + + + +G G  G V    +    R VA+K+L    +N    
Sbjct: 48  FYSVEVG--DSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHA 105

Query: 99  KRVEQFMNEVDILARLRHKNLVSLY-----GCTSRHSRELLLVYEFISNGTVADHLHGER 153
           KR      E+ ++  + HKN++SL        T    +++ LV E +     A+ L    
Sbjct: 106 KRA---YRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD----AN-LCQVI 157

Query: 154 AKPGALPWPTRLK-IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF 212
                     R+  +  +    + +LH++ IIHRD+K +NI++ ++  +K+ DFGL+R  
Sbjct: 158 QME---LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-- 212

Query: 213 PNHVTHVSTAPQGTPGYVD------PEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDIT 266
                   T+   T  YV       PE        +  D++S G ++ E++         
Sbjct: 213 -----TAGTSFMMT-PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 266

Query: 267 RHRHEINL--------SNLAINKIQNKA 286
            +  + N             + K+Q   
Sbjct: 267 DYIDQWNKVIEQLGTPCPEFMKKLQPTV 294

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 75.8 bits (187), Expect = 2e-15
 Identities = 59/251 (23%), Positives = 106/251 (42%), Gaps = 47/251 (18%)

Query: 30  SSEPSSKVDLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAV 88
           SS P ++        ++  +V       E    +   + +G G +G V    + + G  V
Sbjct: 2   SSPPPAR------SGFYRQEVT--KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKV 53

Query: 89  AVKRL---YENNY--KRVEQFMNEVDILARLRHKNLVSLY-----GCTSRHSRELLLVYE 138
           A+K+L   +++    KR      E+ +L  +RH+N++ L        T     +  LV  
Sbjct: 54  AIKKLYRPFQSELFAKRA---YRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMP 110

Query: 139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN 198
           F+      D L  +  K   L       +  +    L Y+HA+ IIHRD+K  N+ ++ +
Sbjct: 111 FMG----TD-LG-KLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNED 164

Query: 199 FCVKVADFGLSRLFPNHVT-HVST----APQ---GTPGYVDPEYHQCYQLTDKSDVFSFG 250
             +K+ DFGL+R   + +T +V T    AP+       Y           T   D++S G
Sbjct: 165 CELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRY-----------TQTVDIWSVG 213

Query: 251 VVLIELISSMP 261
            ++ E+I+   
Sbjct: 214 CIMAEMITGKT 224

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 46/217 (21%), Positives = 79/217 (36%), Gaps = 56/217 (25%)

Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL---YENNY--KRVEQFMNEVDIL 111
           +  + ++    +G G +G V    +  + R VA+K++   +E+    KR+   + E+ IL
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRI---LREIAIL 106

Query: 112 ARLRHKNLVSLY----GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKI 167
            RL H ++V +             EL +V E                        +  K 
Sbjct: 107 NRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA---------------------DSDFKK 145

Query: 168 AIETASALT----------------YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
              T   LT                Y+H++ I+HRD+K  N L++ +  VKV DFGL+R 
Sbjct: 146 LFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLART 205

Query: 212 F------PNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
                   + +                  +   QLT 
Sbjct: 206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTG 242

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 74.6 bits (184), Expect = 4e-15
 Identities = 58/255 (22%), Positives = 102/255 (40%), Gaps = 66/255 (25%)

Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL--YENNY--KRVEQFMNEVDILA 112
             ++ F     LG+G +G V        G  VA+K++  ++      R    + E+ IL 
Sbjct: 8   NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRT---LREIKILK 64

Query: 113 RLRHKNLVSLYGC----TSRHSRELLLVYEF--------ISNGTVAD-H--------LHG 151
             +H+N+++++      +  +  E+ ++ E         IS   ++D H        L  
Sbjct: 65  HFKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIYQTLRA 124

Query: 152 ERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL 211
                        +K           LH S++IHRD+K +N+L+++N  +KV DFGL+R+
Sbjct: 125 -------------VK----------VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARI 161

Query: 212 FPNHVTHVSTAPQGTP---GYVD------PE---YHQCYQLTDKSDVFSFGVVLIELISS 259
                   S           +V       PE       Y  +   DV+S G +L EL   
Sbjct: 162 IDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKY--SRAMDVWSCGCILAELFLR 219

Query: 260 MPAVDITRHRHEINL 274
            P      +RH++ L
Sbjct: 220 RPIFPGRDYRHQLLL 234

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 43/169 (25%), Positives = 66/169 (39%), Gaps = 1/169 (0%)

Query: 91  KRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLH 150
           +  +     +  +F    D +  +       L   TS  S       E  S   V +   
Sbjct: 122 RNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 181

Query: 151 GERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR 210
            E      L     +  + + A  + +L +   IHRD+   NILL     VK+ DFGL+R
Sbjct: 182 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241

Query: 211 LFPNHVTHVSTAPQGTPG-YVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
                  +V       P  ++ PE       T +SDV+SFGV+L E+ S
Sbjct: 242 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 28/101 (27%), Positives = 46/101 (45%), Gaps = 8/101 (7%)

Query: 67  RELGDGGFGTVYYGEL------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKN 118
           + LG G FG V   +          R VAVK L E   +      M+E+ IL  +  H N
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGAL 159
           +V+L G  ++    L+++ EF   G ++ +L  +R +    
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY 128

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 50/202 (24%), Positives = 84/202 (41%), Gaps = 18/202 (8%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV-SLYG 124
           R++G G FG +Y G  +  G  VA+K   E    +  Q   E  I   ++    + ++  
Sbjct: 15  RKIGSGSFGDIYLGTDIAAGEEVAIK--LECVKTKHPQLHIESKIYKMMQGGVGIPTIRW 72

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
           C        ++V E +  G   + L             T L +A +  S + Y+H+ + I
Sbjct: 73  C-GAEGDYNVMVMELL--GPSLEDLF--NFCSRKFSLKTVLLLADQMISRIEYIHSKNFI 127

Query: 185 HRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHV------STAPQGTPGYVDPEYH 235
           HRDVK +N L+        V + DFGL++ + +  TH       +    GT  Y     H
Sbjct: 128 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 187

Query: 236 QCYQLTDKSDVFSFGVVLIELI 257
              + + + D+ S G VL+   
Sbjct: 188 LGIEQSRRDDLESLGYVLMYFN 209

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 53/258 (20%), Positives = 108/258 (41%), Gaps = 59/258 (22%)

Query: 45  YHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL---YENNY-- 98
           ++  ++     + E    + +   +G G +G+V    + + G  VAVK+L   +++    
Sbjct: 15  FYRQELN--KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHA 72

Query: 99  KRVEQFMNEVDILARLRHKNLVSLY-----GCTSRHSRELLLVYEFI---------SNGT 144
           KR      E+ +L  ++H+N++ L        +     ++ LV   +             
Sbjct: 73  KRT---YRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKL 129

Query: 145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVA 204
             DH+                 +  +    L Y+H++DIIHRD+K +N+ ++ +  +K+ 
Sbjct: 130 TDDHVQ---------------FLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKIL 174

Query: 205 DFGLSRLFPNHVT-HVST----APQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
           DFGL+R   + +T +V+T    AP+       Y               D++S G ++ EL
Sbjct: 175 DFGLARHTADEMTGYVATRWYRAPEIMLNWMHY-----------NQTVDIWSVGCIMAEL 223

Query: 257 ISSMPAVDITRHRHEINL 274
           ++       T H  ++ L
Sbjct: 224 LTGRTLFPGTDHIDQLKL 241

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 72.3 bits (178), Expect = 2e-14
 Identities = 44/278 (15%), Positives = 99/278 (35%), Gaps = 78/278 (28%)

Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNY--KRVEQFMNEVDILAR 113
           +  + +   + LG GG G V+   +    + VA+K++   +    K     + E+ I+ R
Sbjct: 8   DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHA---LREIKIIRR 64

Query: 114 LRHKNLVSLY-------------GCTSRHSRELLLVYEFI---------SNGTVADHLHG 151
           L H N+V ++               +      + +V E++             + +H   
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHAR- 123

Query: 152 ERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC-VKVADFGLSR 210
                             +    L Y+H+++++HRD+K  N+ ++     +K+ DFGL+R
Sbjct: 124 --------------LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLAR 169

Query: 211 LFPNHVTH-------VST----APQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
           +   H +H       + T    +P+       Y           T   D+++ G +  E+
Sbjct: 170 IMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNY-----------TKAIDMWAAGCIFAEM 218

Query: 257 ISSMPAVDITRHRHEINL--------SNLAINKIQNKA 286
           ++            ++ L              ++ +  
Sbjct: 219 LTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVI 256

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 71.2 bits (175), Expect = 4e-14
 Identities = 41/204 (20%), Positives = 81/204 (39%), Gaps = 20/204 (9%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV-SLYG 124
           R +G+G FG ++ G  L + + VA+K  +E       Q  +E      L     + ++Y 
Sbjct: 16  RRIGEGSFGVIFEGTNLLNNQQVAIK--FEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 73

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
              +     +LV + +  G   + L             T    A +  + +  +H   ++
Sbjct: 74  F-GQEGLHNVLVIDLL--GPSLEDLL--DLCGRKFSVKTVAMAAKQMLARVQSIHEKSLV 128

Query: 185 HRDVKTNNILL-----DNNFCVKVADFGLSRLFPNHVTHV------STAPQGTPGYVDPE 233
           +RD+K +N L+      N   + V DFG+ + + + VT             GT  Y+   
Sbjct: 129 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 188

Query: 234 YHQCYQLTDKSDVFSFGVVLIELI 257
            H   + + + D+ + G V +  +
Sbjct: 189 THLGREQSRRDDLEALGHVFMYFL 212

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 71.6 bits (176), Expect = 5e-14
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 49/209 (23%)

Query: 58  EATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLY---ENNY--KRVEQFMNEVDIL 111
                ++  ++LG G +G V+   + + G  VAVK+++   +N+   +R      E+ IL
Sbjct: 6   HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRT---FREIMIL 62

Query: 112 ARLR-HKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAI 169
             L  H+N+V+L     + + R++ LV++++      D LH                 A+
Sbjct: 63  TELSGHENIVNLLNVLRADNDRDVYLVFDYME----TD-LH-----------------AV 100

Query: 170 ETASALT----------------YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP 213
             A+ L                 YLH+  ++HRD+K +NILL+    VKVADFGLSR F 
Sbjct: 101 IRANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFV 160

Query: 214 NHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           N     +  P       +        LTD
Sbjct: 161 NIRRVTNNIPLSINENTENFDDDQPILTD 189

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 70.1 bits (172), Expect = 1e-13
 Identities = 44/204 (21%), Positives = 81/204 (39%), Gaps = 20/204 (9%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRH-KNLVSLYG 124
           +++G G FG +  G+ L     VA+K   E    R  Q   E     +L     +  +Y 
Sbjct: 15  KKIGCGNFGELRLGKNLYTNEYVAIK--LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYY 72

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
                 +   +V E +  G   + L             T L IAI+  S + Y+H+ ++I
Sbjct: 73  F-GPCGKYNAMVLELL--GPSLEDLF--DLCDRTFSLKTVLMIAIQLISRMEYVHSKNLI 127

Query: 185 HRDVKTNNILL-----DNNFCVKVADFGLSRLFPNHVTHV------STAPQGTPGYVDPE 233
           +RDVK  N L+          + + DF L++ + +  T          +  GT  Y+   
Sbjct: 128 YRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSIN 187

Query: 234 YHQCYQLTDKSDVFSFGVVLIELI 257
            H   + + + D+ + G + +  +
Sbjct: 188 THLGKEQSRRDDLEALGHMFMYFL 211

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 35/217 (16%), Positives = 71/217 (32%), Gaps = 28/217 (12%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYG 124
             +G GGFG +Y  ++    +V                    E+    R      +  + 
Sbjct: 41  LPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKW- 99

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERA----------------KPGALPWPTRLKIA 168
                  + L V ++  +G    +    R                         T L+++
Sbjct: 100 -IRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLS 158

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKV--ADFGLSRLFPNHVTHV------S 220
           +     L Y+H  + +H D+K +N+LL+     +V   D+GL+  +     H        
Sbjct: 159 LRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218

Query: 221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
               GT  +   + H     + + D+   G  +I+ +
Sbjct: 219 RCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWL 255

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 57/243 (23%), Positives = 97/243 (39%), Gaps = 35/243 (14%)

Query: 38  DLEKGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYEN 96
           D   GG YH       GE  +   Y    R+LG G F TV+  + + +   VA+K +   
Sbjct: 1   DYRPGG-YHPAFK---GEPYKDARY-ILVRKLGWGHFSTVWLAKDMVNNTHVAMK-IVRG 54

Query: 97  NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADH------LH 150
           +    E   +E+ +L R+   +        + H  +LL  +     G    H      + 
Sbjct: 55  DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK--GPNGVHVVMVFEVL 112

Query: 151 GE-------RAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLD------ 196
           GE       + +   +P     +I+ +    L Y+H    IIH D+K  N+L++      
Sbjct: 113 GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPE 172

Query: 197 NNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIE 255
           N   +K+AD G +  +  H T  + T       Y  PE          +D++S   ++ E
Sbjct: 173 NLIQIKIADLGNACWYDEHYTNSIQTRE-----YRSPEVLLGAPWGCGADIWSTACLIFE 227

Query: 256 LIS 258
           LI+
Sbjct: 228 LIT 230

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 48/202 (23%), Positives = 86/202 (42%), Gaps = 18/202 (8%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLV-SLYG 124
           R++G G FG +Y G  +Q    VA+K   EN   +  Q + E  I   L+    + ++  
Sbjct: 13  RKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRILQGGTGIPNVRW 70

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
                    +LV + +  G   + L         L   T L +A +  + + ++H+   +
Sbjct: 71  F-GVEGDYNVLVMDLL--GPSLEDLF--NFCSRKLSLKTVLMLADQMINRVEFVHSKSFL 125

Query: 185 HRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHV------STAPQGTPGYVDPEYH 235
           HRD+K +N L+        V + DFGL++ + +  TH       +    GT  Y     H
Sbjct: 126 HRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTH 185

Query: 236 QCYQLTDKSDVFSFGVVLIELI 257
              + + + D+ S G VL+  +
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFL 207

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 69.6 bits (171), Expect = 2e-13
 Identities = 52/229 (22%), Positives = 103/229 (44%), Gaps = 37/229 (16%)

Query: 53  YGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL--YENNY--KRVEQFMNE 107
            G++ +    + +   +G+G +G V    +  +   VA+K++  +E+    +R    + E
Sbjct: 19  RGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRT---LRE 75

Query: 108 VDILARLRHKNLVSLYGC----TSRHSRELLLVYEFI----SNGTVADHLHGERAKPGAL 159
           + IL R RH+N++ +       T    +++ +V + +           HL  +       
Sbjct: 76  IKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHIC---- 131

Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV 219
                     +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+      H 
Sbjct: 132 ------YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDH- 184

Query: 220 STAPQGTPGYVD------PEYHQCYQLTDKS-DVFSFGVVLIELISSMP 261
                 T  YV       PE     +   KS D++S G +L E++S+ P
Sbjct: 185 --TGFLT-EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 66.7 bits (163), Expect = 2e-12
 Identities = 43/215 (20%), Positives = 79/215 (36%), Gaps = 27/215 (12%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           +++G GGFG +Y           A   +     +      +E+    R+  K+ +  +  
Sbjct: 43  KKIGSGGFGLIYLAFPTNKPEKDARHVVKVEY-QENGPLFSELKFYQRVAKKDCIKKW-- 99

Query: 126 TSRHSRELLLVYEFISNGTVADH----------LHGE-----RAKPGALPWPTRLKIAIE 170
             R   + L +  F  +G                 G        + G     T L++ I 
Sbjct: 100 IERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIR 159

Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKV--ADFGLSRLFPNHVTHV------STA 222
               L Y+H ++ +H D+K  N+LL      +V  AD+GLS  +  +  H          
Sbjct: 160 MLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKG 219

Query: 223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
             GT  +   + H+   L+ +SDV   G  ++  +
Sbjct: 220 HNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWL 254

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 34/220 (15%), Positives = 73/220 (33%), Gaps = 34/220 (15%)

Query: 67  RELGDGGFGTVYYGE---------LQDGRAVAVK------------RLYENNYKRVEQFM 105
                   G +Y                +  ++K              ++   K ++  +
Sbjct: 48  SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQ--V 105

Query: 106 NEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRL 165
           N+   L       + +  G      +   LV   +  G           K   L   + L
Sbjct: 106 NKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL--GRSLQSALDVSPK-HVLSERSVL 162

Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKV--ADFGLSRLFPNHVTHVSTAP 223
           ++A     AL +LH ++ +H +V   NI +D     +V  A +G +  +     HV+   
Sbjct: 163 QVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVE 222

Query: 224 Q------GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELI 257
                  G   ++  + H+    + +SD+ S G  +++ +
Sbjct: 223 GSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWL 262

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 63.7 bits (154), Expect = 2e-11
 Identities = 33/196 (16%), Positives = 61/196 (31%), Gaps = 43/196 (21%)

Query: 59  ATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLY--------ENNYKRVEQFMNEVDI 110
            T       ++G+G FG V+     D   VA+K +          ++ K  E+ + E+ I
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 111 LARL---------RHKNLVSLYG---CTSRHSRELLLVYEFISNGTVADHLHGERAKPGA 158
              L         R +  + L         +   LL  ++  ++   + +   +  K   
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 159 LP---------------------WPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLD 196
           L                        T   I  +  ++L    AS    HRD+   N+LL 
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLK 196

Query: 197 NNFCVKVADFGLSRLF 212
                K+      +  
Sbjct: 197 KTSLKKLHYTLNGKSS 212

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.0 bits (156), Expect = 2e-11
 Identities = 57/217 (26%), Positives = 83/217 (38%), Gaps = 48/217 (22%)

Query: 69  LGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHK------NLVS 121
           +G G FG V      +  + VA+K +  N  +   Q   E+ IL  LR +      N++ 
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMV-RNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIH 163

Query: 122 LYGCTSRHSR-----ELLL--VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASA 174
           +    +  +      ELL   +YE I          G          P   K A      
Sbjct: 164 MLENFTFRNHICMTFELLSMNLYELIKKN----KFQG-------FSLPLVRKFAHSILQC 212

Query: 175 LTYLHASDIIHRDVKTNNILL--DNNFCVKVADFGLSRLFPNHV-THVST----APQ--- 224
           L  LH + IIH D+K  NILL       +KV DFG S      V T++ +    AP+   
Sbjct: 213 LDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQRVYTYIQSRFYRAPEVIL 272

Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           G        Y          D++S G +L EL++  P
Sbjct: 273 GAR------YGM------PIDMWSLGCILAELLTGYP 297

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 59/293 (20%), Positives = 99/293 (33%), Gaps = 80/293 (27%)

Query: 33  PSSKVDLE-----KGGNYHGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGE-LQDGR 86
            S   + E       G YH V++   G+L      +   R+LG G F TV+    +Q  +
Sbjct: 9   GSDDDEQEDPNDYCKGGYHLVKI---GDL--FNGRYHVIRKLGWGHFSTVWLSWDIQGKK 63

Query: 87  AVAVKRLYENNYKRVEQFMNEVDILARLR--------HKNLVSLYGC---TSRHSRELLL 135
            VA+K + ++     E  ++E+ +L  +R         + +V L      +  +   + +
Sbjct: 64  FVAMK-VVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICM 122

Query: 136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNIL 194
           V+E + +  +   +   ++    LP P   KI  +    L YLH    IIH D+K  NIL
Sbjct: 123 VFEVLGH-HLLKWI--IKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENIL 179

Query: 195 L-------------------------------------------------DNNFCVKVAD 205
           L                                                      VK+AD
Sbjct: 180 LSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIAD 239

Query: 206 FGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS 258
            G +     H T        T  Y   E          +D++S   +  EL +
Sbjct: 240 LGNACWVHKHFTEDIQ----TRQYRSLEVLIGSGYNTPADIWSTACMAFELAT 288

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 60.1 bits (146), Expect = 3e-10
 Identities = 51/218 (23%), Positives = 81/218 (37%), Gaps = 48/218 (22%)

Query: 69  LGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRH------KNLVS 121
           +G G FG V       +   VA+K + +N    + Q   EV +L  +          +V 
Sbjct: 62  IGKGSFGQVVKAYDRVEQEWVAIKII-KNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120

Query: 122 LYGCTSRHSR-----ELLLV--YEFI-SNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
           L       +      E+L    Y+ + +       L+  R            K A +  +
Sbjct: 121 LKRHFMFRNHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTR------------KFAQQMCT 168

Query: 174 ALTYLHASD--IIHRDVKTNNILLDN--NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGY 229
           AL +L   +  IIH D+K  NILL N     +K+ DFG S         +    Q +  Y
Sbjct: 169 ALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG-SSCQLGQ--RIYQYIQ-SRFY 224

Query: 230 VDPE------YHQCYQLTDKSDVFSFGVVLIELISSMP 261
             PE      Y          D++S G +L+E+ +  P
Sbjct: 225 RSPEVLLGMPYDL------AIDMWSLGCILVEMHTGEP 256

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 59.2 bits (144), Expect = 5e-10
 Identities = 59/236 (25%), Positives = 86/236 (36%), Gaps = 78/236 (33%)

Query: 69  LGDGGFGTVY--YGELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHK------N 118
           LG+G FG V         GR VAVK  +   N  +  E   +E+ +L  L          
Sbjct: 22  LGEGAFGKVVECIDHKAGGRHVAVKIVK---NVDRYCEAARSEIQVLEHLNTTDPNSTFR 78

Query: 119 LVSLYGCTSRHSR-----ELLL--VYEFI-SNGTVADHLHGERAKPGALPWPTRL--KIA 168
            V +      H       ELL    Y+FI  NG +              P+      K+A
Sbjct: 79  CVQMLEWFEHHGHICIVFELLGLSTYDFIKENGFL--------------PFRLDHIRKMA 124

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFC-------------------VKVADFGLS 209
            +   ++ +LH++ + H D+K  NIL   +                     +KV DFG S
Sbjct: 125 YQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFG-S 183

Query: 210 RLFPN--HVTHVST----APQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
             + +  H T VST    AP+            + Q        DV+S G +LIE 
Sbjct: 184 ATYDDEHHSTLVSTRHYRAPEVILALG------WSQ------PCDVWSIGCILIEY 227

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 58.5 bits (142), Expect = 9e-10
 Identities = 56/235 (23%), Positives = 85/235 (36%), Gaps = 76/235 (32%)

Query: 69  LGDGGFGTVY--YGELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHK------N 118
           LG+G FG V       +    VA+K  R   N  K  E    E+++L +++ K       
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKIIR---NVGKYREAARLEINVLKKIKEKDKENKFL 83

Query: 119 LVSLYGCTSRHSR-----ELLL--VYEFISNGTVADHLHGERAKPGALPWPTRL--KIAI 169
            V +    + H       ELL    +EF+                   P+P      +A 
Sbjct: 84  CVLMSDWFNFHGHMCIAFELLGKNTFEFLKEN-------------NFQPYPLPHVRHMAY 130

Query: 170 ETASALTYLHASDIIHRDVKTNNILLDNNFC-------------------VKVADFGLSR 210
           +   AL +LH + + H D+K  NIL  N+                     ++VADFG S 
Sbjct: 131 QLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFG-SA 189

Query: 211 LFPN--HVTHVST----APQ---GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL 256
            F +  H T V+T     P+            + Q        DV+S G +L E 
Sbjct: 190 TFDHEHHTTIVATRHYRPPEVILELG------WAQ------PCDVWSIGCILFEY 232

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 58.1 bits (141), Expect = 1e-09
 Identities = 57/238 (23%), Positives = 86/238 (36%), Gaps = 78/238 (32%)

Query: 69  LGDGGFGTVYYGE-LQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRH-----KNLV 120
           +GDG FG V   + + + +  AVK  R   N  K       E DIL ++++      N+V
Sbjct: 43  MGDGTFGRVLLCQHIDNKKYYAVKVVR---NIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 121 SLYGCTSRHSR-----ELLL--VYEFISNGTVADHLHGERAKPGALPWPTRL--KIAIET 171
             +G    +       E L   +YE I+        +          +         IE 
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGPSLYEIITR-------NNYN------GFHIEDIKLYCIEI 146

Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFC-------------------------VKVADF 206
             AL YL    + H D+K  NILLD+ +                          +K+ DF
Sbjct: 147 LKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDF 206

Query: 207 GLSRLFPN--HVTHVSTAPQGTPGYVDPE------YHQCYQLTDKSDVFSFGVVLIEL 256
           G    F +  H + ++T       Y  PE      +         SD++SFG VL EL
Sbjct: 207 G-CATFKSDYHGSIINTRQ-----YRAPEVILNLGWDV------SSDMWSFGCVLAEL 252

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.8 bits (110), Expect = 8e-06
 Identities = 58/382 (15%), Positives = 107/382 (28%), Gaps = 108/382 (28%)

Query: 39  LEKGGNYHGVQVFSYGELEEATNY-FDSAR---ELGDGGFGTVYYGELQDGRAVAVKRLY 94
           L K      VQ F    L    NY F  +    E       T  Y E +D      +   
Sbjct: 72  LSKQEE--MVQKFVEEVLR--INYKFLMSPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFA 127

Query: 95  ENNYKRVEQFMNEVDILARLRHKNLVSLYG------------------------------ 124
           + N  R++ ++     L  LR    V + G                              
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWL 187

Query: 125 ----CTSRHSR-ELL--LVYEFISNGTV-ADHLHGERAKPGAL-PWPTRLKIAIETASAL 175
               C S  +  E+L  L+Y+   N T  +DH    + +  ++     RL  +    + L
Sbjct: 188 NLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCL 247

Query: 176 TYLHASDIIHRDVKTNNILLDNNF---C--------VKVADFGLSRLFPNHVTHVSTAPQ 224
                  ++  +V+       N F   C         +V DF    L     TH+S    
Sbjct: 248 -------LVLLNVQNAKAW--NAFNLSCKILLTTRFKQVTDF----LSAATTTHISLDHH 294

Query: 225 GTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN-LAINKIQ 283
            +      E                   +  L+             E+  +N   ++ I 
Sbjct: 295 -SMTLTPDE-------------------VKSLLLKYLDCRPQDLPREVLTTNPRRLSII- 333

Query: 284 NKALHELVD--QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD--VLDALRDIE 339
            +++ + +       + + +K+   I    E +   L+   + R       V      I 
Sbjct: 334 AESIRDGLATWDNWKHVNCDKLTTII----ESSLNVLEPA-EYRKMFDRLSVFPPSAHIP 388

Query: 340 SD------GYDDKKTHEEMMTQ 355
           +           K     ++ +
Sbjct: 389 TILLSLIWFDVIKSDVMVVVNK 410

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 46.4 bits (109), Expect = 1e-05
 Identities = 54/399 (13%), Positives = 109/399 (27%), Gaps = 113/399 (28%)

Query: 26  FRNTSSEPSSKVDL---EKGGNYHGVQVFS---------YGELEEATNYFDSAREL---G 70
            +    +PS    +   ++   Y+  QVF+         Y +L +A      A+ +   G
Sbjct: 98  IKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDG 157

Query: 71  DGGFG-TVYYGE-LQDGRAVAVKRLYEN-----NYKRVEQFMNEVDILARLRHKNLVSLY 123
             G G T    +     +   V+   +      N K        +++L +L ++ +   +
Sbjct: 158 VLGSGKTWVALDVCLSYK---VQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQ-IDPNW 213

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
              S HS  + L    I        L   +     L                       +
Sbjct: 214 TSRSDHSSNIKLRIHSIQAEL--RRLLKSKPYENCL-----------------------L 248

Query: 184 IHRDVKTNNILLDNNF---C--------VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
           +  +V+       N F   C         +V DF    L     TH+S     +      
Sbjct: 249 VLLNVQNAKAW--NAFNLSCKILLTTRFKQVTDF----LSAATTTHISLDHH-SMTLTPD 301

Query: 233 E----YHQCYQLTDKS------DVFSFGVVLI-ELISSMPA-------VDITRHRHEINL 274
           E      +      +             + +I E I    A       V+  +    I  
Sbjct: 302 EVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTIIES 361

Query: 275 S--------------NLAI----NKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQ 316
           S               L++      I    L       + ++        +  V +L   
Sbjct: 362 SLNVLEPAEYRKMFDRLSVFPPSAHIPTILL-----SLIWFDVIKSDVMVV--VNKLHKY 414

Query: 317 CLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHEEMMTQ 355
            L  EK  +   + +     +++    ++   H  ++  
Sbjct: 415 SL-VEKQPKESTISIPSIYLELKVKLENEYALHRSIVDH 452

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.1 bits (103), Expect = 7e-05
 Identities = 58/378 (15%), Positives = 112/378 (29%), Gaps = 86/378 (22%)

Query: 37  VDLEKGGNYHG----VQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQD-----GRA 87
           +D E G + +     + VF     +   + FD  +++ D     +   E+          
Sbjct: 7   MDFETGEHQYQYKDILSVF----EDAFVDNFD-CKDVQDMPKSILSKEEIDHIIMSKDAV 61

Query: 88  VAVKRLY----ENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG 143
               RL+        + V++F+ EV    R+ +K L+S      R    +  +Y    + 
Sbjct: 62  SGTLRLFWTLLSKQEEMVQKFVEEVL---RINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118

Query: 144 TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--IIHRDV---KTNNILLDNN 198
              D    +      +    RL+  ++   AL  L  +   +I   +   KT    +  +
Sbjct: 119 LYND---NQVFAKYNVS---RLQPYLKLRQALLELRPAKNVLIDGVLGSGKT---WVALD 169

Query: 199 FCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ--CYQLTDKSDVFSFGVVLIEL 256
            C     + +       +  ++     +P  V  E  Q   YQ+                
Sbjct: 170 VC---LSYKVQCKMDFKIFWLNLKNCNSPETV-LEMLQKLLYQIDPN---------WTSR 216

Query: 257 ISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVR--RTINAVAELA 314
                 + +  H  +  L  L  +K     L  LV   L     N V+  +  NA     
Sbjct: 217 SDHSSNIKLRIHSIQAELRRLLKSKPYENCL--LV---L----LN-VQNAKAWNA---FN 263

Query: 315 FQC--------------LQSEKDLRPYMVDVLDALRDIESDGYDDKKTH-------EEMM 353
             C              L +       +      L   E      K           E++
Sbjct: 264 LSCKILLTTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVL 323

Query: 354 TQSPDSVTLSWTSTKTTP 371
           T +P  +++   S +   
Sbjct: 324 TTNPRRLSIIAESIRDGL 341

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	375
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.79
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.48
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.31
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.16
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.08
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.87
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.74
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.57
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.53
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.49
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.42
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.23
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.2
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.12
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.94
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.88
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.8
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.68
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.63
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.61
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.5
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.48
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.37
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.22
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.21
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	96.92
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.83
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.45
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.32
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	90.65
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.57
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	89.51
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	89.49
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	88.85
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	84.12

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.4e-60  Score=420.66  Aligned_cols=261  Identities=28%  Similarity=0.449  Sum_probs=213.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ++|.+.++||+|+||.||+|.+.      ++..||||++........+.|.+|+.+|++++|||||++++++.. ...++
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~   91 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE-GDPLI   91 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEE
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEE
Confidence            45788899999999999999764      477899999987777777889999999999999999999998876 56799


Q ss_pred             EEEecccCCChhHhhccCC---------CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEee
Q 017232          135 LVYEFISNGTVADHLHGER---------AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD  205 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~---------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~D  205 (375)
                      ||||||++|+|.+++....         .....+++.++..++.||+.||.|||+++|+||||||+|||++.++.+||+|
T Consensus        92 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~D  171 (299)
T 4asz_A           92 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD  171 (299)
T ss_dssp             EEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECC
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECC
Confidence            9999999999999997542         2345799999999999999999999999999999999999999999999999


Q ss_pred             eccccccCCCccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhh
Q 017232          206 FGLSRLFPNHVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQ  283 (375)
Q Consensus       206 fg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  283 (375)
                      ||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |+.||.......       ....  
T Consensus       172 FGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~~--  242 (299)
T 4asz_A          172 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-------VIEC--  242 (299)
T ss_dssp             CSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-------HHHH--
T ss_pred             cccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH-------HHHH--
Confidence            9999865433222 2233458999999999999999999999999999999998 899997543211       1111  


Q ss_pred             hhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       284 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                            +. ..   ...+.+..++.++.+|+.+||+.||++|||+.+|.+.|+++.+.
T Consensus       243 ------i~-~~---~~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          243 ------IT-QG---RVLQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             ------HH-HT---CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------HH-cC---CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence                  11 11   11111234567899999999999999999999999999988653

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.6e-59  Score=420.74  Aligned_cols=261  Identities=29%  Similarity=0.442  Sum_probs=208.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ++|.+.++||+|+||.||+|.++      +++.||||++........+.|.+|+.+|++++|||||++++++.. ...++
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~-~~~~~  119 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE-GRPLL  119 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSEE
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEE
Confidence            45777889999999999999764      478899999988777777889999999999999999999998876 56799


Q ss_pred             EEEecccCCChhHhhccCCC-----------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEE
Q 017232          135 LVYEFISNGTVADHLHGERA-----------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKV  203 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~-----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl  203 (375)
                      ||||||++|+|.+++.....           ...++++.++..++.||+.||.|||+++|+||||||+|||++.++.+||
T Consensus       120 lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki  199 (329)
T 4aoj_A          120 MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKI  199 (329)
T ss_dssp             EEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEE
T ss_pred             EEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEE
Confidence            99999999999999976432           2356999999999999999999999999999999999999999999999


Q ss_pred             eeeccccccCCCc-cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHH
Q 017232          204 ADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINK  281 (375)
Q Consensus       204 ~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~  281 (375)
                      +|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |+.||.......       ....
T Consensus       200 ~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~-------~~~~  272 (329)
T 4aoj_A          200 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTE-------AIDC  272 (329)
T ss_dssp             CCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHH-------HHHH
T ss_pred             cccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHH-------HHHH
Confidence            9999998654332 222334579999999999999999999999999999999999 899997543211       1111


Q ss_pred             hhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          282 IQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                               +.....   .+.+..++.++.+|+.+||+.||++|||+.||++.|+.+.+.
T Consensus       273 ---------i~~g~~---~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          273 ---------ITQGRE---LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             ---------HHHTCC---CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---------HHcCCC---CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence                     111111   111234567899999999999999999999999999998764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.6e-59  Score=422.01  Aligned_cols=250  Identities=25%  Similarity=0.404  Sum_probs=202.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|++++.||+|+||+||+|... +|+.||||++...  .....+.+.+|+.+|+.++|||||++++++.. ...+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-NGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            57999999999999999999664 7999999999654  34456789999999999999999999998876 67899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      |||+||+|.+++...  +...+++.+++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||+++.......
T Consensus       103 Ey~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~  180 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE  180 (350)
T ss_dssp             ECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH
T ss_pred             eCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc
Confidence            999999999999654  345688999999999999999999999999999999999999999999999999987643221


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                       .....+||+.|+|||++.+..|+.++|||||||++|||++|++||......      ...         ..+...    
T Consensus       181 -~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~------~~~---------~~i~~~----  240 (350)
T 4b9d_A          181 -LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK------NLV---------LKIISG----  240 (350)
T ss_dssp             -HHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH------HHH---------HHHHHT----
T ss_pred             -cccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH------HHH---------HHHHcC----
Confidence             223446999999999999999999999999999999999999999754321      111         111111    


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ...+....++.++.+||.+||+.||++|||+.|+++
T Consensus       241 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          241 SFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            111112235567999999999999999999999986

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=3.3e-58  Score=410.76  Aligned_cols=260  Identities=28%  Similarity=0.476  Sum_probs=205.2

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .+++++.++||+|+||+||+|.+++  .||||+++..  .....+.|.+|+.++++++|||||++++++..  +.++|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~--~~~~iVm  110 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK--DNLAIVT  110 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC--CeEEEEE
Confidence            3567889999999999999998763  5999998643  44556789999999999999999999997654  4589999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc-
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  216 (375)
                      |||++|+|.+++...   ...+++.++..++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+...... 
T Consensus       111 Ey~~gGsL~~~l~~~---~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          111 QWCEGSSLYKHLHVQ---ETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             ECCSSCBHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             EcCCCCCHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            999999999999643   3469999999999999999999999999999999999999999999999999998654322 


Q ss_pred             cccccCCCCCccccCcccccc---cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          217 THVSTAPQGTPGYVDPEYHQC---YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      .......+||+.|||||++.+   ..|+.++|||||||++|||+||+.||.......      ...         ..+..
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~------~~~---------~~~~~  252 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD------QII---------FMVGR  252 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHH---------HHHHT
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH------HHH---------HHHhc
Confidence            223345579999999998864   358999999999999999999999997543211      111         11111


Q ss_pred             hc-CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          294 TL-GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       294 ~l-~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .. ..........++..+.+|+.+||+.+|++|||+.||++.|+.++..
T Consensus       253 ~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~  301 (307)
T 3omv_A          253 GYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHS  301 (307)
T ss_dssp             TCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTT
T ss_pred             CCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcc
Confidence            11 1111112234567899999999999999999999999999988754

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=2.1e-58  Score=413.70  Aligned_cols=257  Identities=25%  Similarity=0.378  Sum_probs=208.8

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      .+++.++||+|+||+||+|.+.      +++.||||++.... ....+.|.+|+.++++++|||||+++|++.. ...++
T Consensus        27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~~  105 (308)
T 4gt4_A           27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK-DQPLS  105 (308)
T ss_dssp             GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCE
T ss_pred             HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE-CCEEE
Confidence            3566889999999999999763      46789999996543 3345789999999999999999999998876 56789


Q ss_pred             EEEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEE
Q 017232          135 LVYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVK  202 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~k  202 (375)
                      ||||||++|+|.++|.....            ....+++.++..++.||+.||+|||+++|+||||||+|||+++++.+|
T Consensus       106 lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~K  185 (308)
T 4gt4_A          106 MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVK  185 (308)
T ss_dssp             EEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEE
T ss_pred             EEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEE
Confidence            99999999999999965421            124689999999999999999999999999999999999999999999


Q ss_pred             EeeeccccccCCCc-cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHH
Q 017232          203 VADFGLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       203 l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      |+|||+++...... ........||+.|+|||++.+..++.++|||||||++|||+| |.+||.......       ...
T Consensus       186 i~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~-------~~~  258 (308)
T 4gt4_A          186 ISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQD-------VVE  258 (308)
T ss_dssp             ECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHH-------HHH
T ss_pred             ECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHH-------HHH
Confidence            99999998654322 222345579999999999999999999999999999999998 899997543211       111


Q ss_pred             HhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          281 KIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                               .+..   ....+.+..++..+.+|+.+||+.||++|||+.||++.|+..
T Consensus       259 ---------~i~~---~~~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          259 ---------MIRN---RQVLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             ---------HHHT---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             ---------HHHc---CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence                     1111   111222234677899999999999999999999999999864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=6.2e-58  Score=414.00  Aligned_cols=249  Identities=26%  Similarity=0.419  Sum_probs=207.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      ..|++.++||+|+||+||+|..+ +|+.||||++........+.+.+|+.+|+.++|||||++++++.. .+.+||||||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~ivmEy  152 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEF  152 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEECC
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEeC
Confidence            56999999999999999999765 799999999976555555678899999999999999999998877 6789999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      |+||+|.+++..     ..+++.++..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++..+..... .
T Consensus       153 ~~gg~L~~~l~~-----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~-~  226 (346)
T 4fih_A          153 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R  226 (346)
T ss_dssp             CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC-C
T ss_pred             CCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC-c
Confidence            999999999853     3599999999999999999999999999999999999999999999999999987654332 2


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....+||+.|+|||++.+..|+.++|||||||++|||++|++||.......       ....+        . ...... 
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i--------~-~~~~~~-  289 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMI--------R-DNLPPR-  289 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHH--------H-HSSCCC-
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHH--------H-cCCCCC-
Confidence            345689999999999999999999999999999999999999997543211       01111        1 111101 


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ......++.++.+|+.+||..||++|||+.|+++
T Consensus       290 ~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          290 LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            1111235578999999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.9e-57  Score=404.82  Aligned_cols=248  Identities=23%  Similarity=0.379  Sum_probs=206.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||+||+|... +|+.||+|++....   ....+.+.+|+.+|+.++|||||++++++.. ...+|||
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~yiv  110 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG  110 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEEE
Confidence            46999999999999999999654 79999999996542   2345678999999999999999999998876 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||||+||+|.+++...    +.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.+....
T Consensus       111 mEy~~gG~L~~~i~~~----~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~  186 (311)
T 4aw0_A          111 LSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  186 (311)
T ss_dssp             ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT
T ss_pred             EecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC
Confidence            9999999999999643    469999999999999999999999999999999999999999999999999998765332


Q ss_pred             -cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          217 -THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       217 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                       .......+||+.|+|||++.+..|+.++||||+||++|+|++|++||.......      . .        ..+.....
T Consensus       187 ~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~------~-~--------~~i~~~~~  251 (311)
T 4aw0_A          187 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL------I-F--------AKIIKLEY  251 (311)
T ss_dssp             TCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-H--------HHHHHTCC
T ss_pred             CcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------H-H--------HHHHcCCC
Confidence             223455689999999999999999999999999999999999999997543111      1 1        11111111


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        ..+   ..++.++.+|+.+||..||++|||++|++.
T Consensus       252 --~~p---~~~s~~~~dli~~lL~~dp~~R~t~~e~~~  284 (311)
T 4aw0_A          252 --DFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEG  284 (311)
T ss_dssp             --CCC---TTCCHHHHHHHHHHSCSSGGGSTTSGGGTC
T ss_pred             --CCC---cccCHHHHHHHHHHccCCHhHCcChHHHcC
Confidence              111   124567899999999999999999998743

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.2e-57  Score=408.12  Aligned_cols=256  Identities=19%  Similarity=0.238  Sum_probs=205.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      +.|++.++||+|+||.||+|..+ +|+.||||++.....     ..+|+.+++.++|||||++++++.. +..+||||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~-~~~~~ivmEy  131 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVRE-GPWVNIFMEL  131 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEE-TTEEEEEECC
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEec
Confidence            45788889999999999999765 699999999965432     2469999999999999999998776 6789999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC-cEEEeeeccccccCCCccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF-CVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+||+|.+++...    +.+++.++..++.||+.||+|||++||+||||||+|||++.+| .+||+|||+|+.+......
T Consensus       132 ~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~  207 (336)
T 4g3f_A          132 LEGGSLGQLIKQM----GCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLG  207 (336)
T ss_dssp             CTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------
T ss_pred             cCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcc
Confidence            9999999999643    4699999999999999999999999999999999999999987 5999999999876533211


Q ss_pred             ----cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          219 ----VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       219 ----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                          .....+||+.|||||++.+..|+.++|||||||++|||++|++||........   ...    +....      ..
T Consensus       208 ~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~---~~~----i~~~~------~~  274 (336)
T 4g3f_A          208 KSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPL---CLK----IASEP------PP  274 (336)
T ss_dssp             ------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCC---HHH----HHHSC------CG
T ss_pred             cceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHH---HHH----HHcCC------CC
Confidence                12335799999999999999999999999999999999999999975442221   111    10000      00


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                      .    ......++..+.+++.+||..||++|||+.|+++.|........
T Consensus       275 ~----~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          275 I----REIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             G----GGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             c----hhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence            0    00112345678999999999999999999999999887665433

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=9.8e-57  Score=415.89  Aligned_cols=249  Identities=26%  Similarity=0.421  Sum_probs=206.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      +.|++.++||+|+||.||+|..+ +|+.||||++........+.+.+|+.+|+.++|||||++++++.. .+.+||||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-~~~~~iVmEy  229 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEF  229 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-CCEEEEEEeC
Confidence            56999999999999999999765 799999999976655555678899999999999999999998877 6789999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      |+||+|.+++..     ..+++.++..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..+..... .
T Consensus       230 ~~gG~L~~~i~~-----~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~-~  303 (423)
T 4fie_A          230 LEGGALTDIVTH-----TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP-R  303 (423)
T ss_dssp             CTTEEHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC-C
T ss_pred             CCCCcHHHHHhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc-c
Confidence            999999999853     3589999999999999999999999999999999999999999999999999987654332 2


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....+||+.|||||++.+..|+.++|||||||++|||++|++||.......       ....+        . .......
T Consensus       304 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~-------~~~~i--------~-~~~~~~~  367 (423)
T 4fie_A          304 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK-------AMKMI--------R-DNLPPRL  367 (423)
T ss_dssp             BCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HHHHH--------H-HSCCCCC
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH-------HHHHH--------H-cCCCCCC
Confidence            345679999999999999999999999999999999999999996543111       01111        1 1110000


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       .....++.++.+||.+||..||++|||+.|+++
T Consensus       368 -~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          368 -KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             -SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence             111234567899999999999999999999876

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.1e-56  Score=394.56  Aligned_cols=245  Identities=24%  Similarity=0.372  Sum_probs=189.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||+||+|... +|+.||+|++....   ......+.+|+.+++.++|||||++++++.. ...+|+|
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKS-KDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEEEE
Confidence            68999999999999999999664 79999999986542   2335678999999999999999999998776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||| +|+|.+++..    .+.+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......
T Consensus        92 mEy~-~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             EECC-CEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             EeCC-CCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            9999 6899999854    3469999999999999999999999999999999999999999999999999998654332


Q ss_pred             cccccCCCCCccccCcccccccCC-CCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQL-TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                        .....+||+.|+|||++.+..+ +.++||||+||++|+|++|++||......      .. ..        .+.....
T Consensus       167 --~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~------~~-~~--------~i~~~~~  229 (275)
T 3hyh_A          167 --FLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP------VL-FK--------NISNGVY  229 (275)
T ss_dssp             ----------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH------HH-HH--------HHHHTCC
T ss_pred             --ccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH------HH-HH--------HHHcCCC
Confidence              2234579999999999998876 57999999999999999999999754311      11 11        1111111


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .  .+   ..++.++.+|+.+||+.||++|||++|+++
T Consensus       230 ~--~p---~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          230 T--LP---KFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             C--CC---TTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             C--CC---CCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            1  11   124567899999999999999999999987

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.3e-56  Score=408.92  Aligned_cols=271  Identities=24%  Similarity=0.356  Sum_probs=218.6

Q ss_pred             HHHHHHhcCCCCCCccCCCCcEEEEEEEeCC------CCEEEEEEecccc-hhhHHHHHHHHHHHHhcCC-CCeEEEeee
Q 017232           54 GELEEATNYFDSARELGDGGFGTVYYGELQD------GRAVAVKRLYENN-YKRVEQFMNEVDILARLRH-KNLVSLYGC  125 (375)
Q Consensus        54 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h-~niv~~~~~  125 (375)
                      ..++...++|++.+.||+|+||.||+|.+..      ++.||||.+.... ....+.+.+|+.+|.+++| ||||+++|+
T Consensus        57 ~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~  136 (353)
T 4ase_A           57 SKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA  136 (353)
T ss_dssp             HHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEE
Confidence            4455566889999999999999999997542      3579999997653 3445779999999999975 899999998


Q ss_pred             eecCCceeEEEEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCE
Q 017232          126 TSRHSRELLLVYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNI  193 (375)
Q Consensus       126 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Ni  193 (375)
                      +...+..++||||||++|+|.++|...+.            ....+++.++..++.||+.||+|||+++|+||||||+||
T Consensus       137 ~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NI  216 (353)
T 4ase_A          137 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI  216 (353)
T ss_dssp             ECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             EEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccce
Confidence            87766779999999999999999975432            134589999999999999999999999999999999999


Q ss_pred             EecCCCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccc
Q 017232          194 LLDNNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHE  271 (375)
Q Consensus       194 ll~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~  271 (375)
                      |++.++.+||+|||+|+....... .......||+.|||||++.+..|+.++|||||||++|||+| |++||....... 
T Consensus       217 Ll~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~-  295 (353)
T 4ase_A          217 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-  295 (353)
T ss_dssp             EECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH-
T ss_pred             eeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999987644332 22334568999999999999999999999999999999998 999997543211 


Q ss_pred             cchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          272 INLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                           .....         +........+   ..++.++.+++.+||+.||++|||+.||++.|+.+.+..
T Consensus       296 -----~~~~~---------i~~g~~~~~p---~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          296 -----EFCRR---------LKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             -----HHHHH---------HHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             -----HHHHH---------HHcCCCCCCC---ccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence                 11111         1111111111   234567999999999999999999999999999886543

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=4.8e-56  Score=393.98  Aligned_cols=245  Identities=26%  Similarity=0.407  Sum_probs=196.5

Q ss_pred             CCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeec---CCceeEEEE
Q 017232           64 DSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSR---HSRELLLVY  137 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~  137 (375)
                      ++.++||+|+||+||+|... ++..||+|++...  .....+.+.+|+.++++++|||||++++++..   ....+||||
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm  108 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT  108 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence            55678999999999999665 6899999998654  34456779999999999999999999997754   245689999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC--ceeccCCCCCEEecC-CCcEEEeeeccccccCC
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--IIHRDVKTNNILLDN-NFCVKVADFGLSRLFPN  214 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~  214 (375)
                      |||+||+|.+++...    ..+++..+..++.||+.||+|||++|  |+||||||+|||++. ++.+||+|||+|+....
T Consensus       109 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~  184 (290)
T 3fpq_A          109 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence            999999999999643    46899999999999999999999998  999999999999974 79999999999986433


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .   .....+||+.|||||++.+ .|+.++|||||||++|||+||++||.......      .....+...         
T Consensus       185 ~---~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~------~~~~~i~~~---------  245 (290)
T 3fpq_A          185 S---FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSG---------  245 (290)
T ss_dssp             T---SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTT---------
T ss_pred             C---ccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHH------HHHHHHHcC---------
Confidence            2   2234579999999998875 69999999999999999999999996433111      111111110         


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .  .........++++.+|+.+||..||++|||++|+++
T Consensus       246 ~--~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          246 V--KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             C--CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C--CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0  001111123457899999999999999999999985

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.3e-56  Score=401.23  Aligned_cols=273  Identities=22%  Similarity=0.330  Sum_probs=202.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC---ceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS---RELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~lv~  137 (375)
                      .+|.+.++||+|+||+||+|.+ +|+.||||++....... ..+..|+..+..++|||||++++++....   ..++|||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~-~g~~VAvK~l~~~~~~~-~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~   80 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE-TTEEEEEEEECGGGHHH-HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchhh-HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEe
Confidence            4577888999999999999987 48999999986553322 23345666677889999999999876543   3589999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC--------CceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS--------DIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--------~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      |||++|+|.++++.     ..+++..+..++.|++.||.|||++        +|+||||||+|||++.++.+||+|||++
T Consensus        81 Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             cCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCC
Confidence            99999999999954     3589999999999999999999987        9999999999999999999999999999


Q ss_pred             cccCCCccc---cccCCCCCccccCccccccc------CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHH
Q 017232          210 RLFPNHVTH---VSTAPQGTPGYVDPEYHQCY------QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       210 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      +........   .....+||+.|+|||++.+.      .++.++|||||||++|||+||.+||.......... ......
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~-~~~~~~  234 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPY-YDLVPS  234 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTT-TTTSCS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccc-hhcccc
Confidence            876443322   12235799999999988654      46789999999999999999999886543221110 000000


Q ss_pred             Hhh-hhHHHHHHhhhcCCCCChH--HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          281 KIQ-NKALHELVDQTLGYESDNK--VRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       281 ~~~-~~~~~~~~~~~l~~~~~~~--~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ... ......+....++...+..  ..+++..+.+|+.+||+.||++|||+.||++.|+++...
T Consensus       235 ~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             cchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence            000 0001111222222222221  224667899999999999999999999999999998764

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.1e-54  Score=388.40  Aligned_cols=251  Identities=25%  Similarity=0.381  Sum_probs=191.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC--------
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS--------  130 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~--------  130 (375)
                      ++|++++.||+|+||+||+|..+ +|+.||||++.... ....+.+.+|+.+|++++|||||++++++...+        
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            45899999999999999999765 78999999986543 344567899999999999999999999775432        


Q ss_pred             ---ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeec
Q 017232          131 ---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFG  207 (375)
Q Consensus       131 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg  207 (375)
                         ..+|+|||||++|+|.+++.... .....++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFG  163 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRC-TIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFG  163 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCC-SGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcC-CCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCc
Confidence               24799999999999999996432 22234566788999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccc-----------cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhH
Q 017232          208 LSRLFPNHVTH-----------VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN  276 (375)
Q Consensus       208 ~~~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~  276 (375)
                      +|+........           .....+||+.|||||++.+..|+.++|||||||++|||++   ||......       
T Consensus       164 la~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~-------  233 (299)
T 4g31_A          164 LVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMER-------  233 (299)
T ss_dssp             CC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHH-------
T ss_pred             cceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHH-------
Confidence            99876532211           1234579999999999999999999999999999999996   66422100       


Q ss_pred             HHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          277 LAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                                 ...+........++......+.+.+|+.+||+.||++|||+.|+++
T Consensus       234 -----------~~~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          234 -----------VRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             -----------HHHHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -----------HHHHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                       0011111122334444555667789999999999999999999986

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.8e-56  Score=395.84  Aligned_cols=242  Identities=26%  Similarity=0.312  Sum_probs=191.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC----CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ----DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ++|++.+.||+|+||+||+|+..    +++.||+|++....  ......+.+|+.+|++++|||||++++++.. .+.+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-EGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-TTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-CCEEE
Confidence            46899999999999999999653    47889999986542  1223467889999999999999999998876 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +|||||+||+|.+++...    +.+++.++..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|+....
T Consensus       103 ivmEy~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKE----VMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             EEECCCTTCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             EEEEcCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            999999999999999643    4699999999999999999999999999999999999999999999999999986543


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ... .....+||+.|+|||++.+..|+.++||||+||++|||+||++||.......      .         ...+....
T Consensus       179 ~~~-~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~------~---------~~~i~~~~  242 (304)
T 3ubd_A          179 HEK-KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE------T---------MTMILKAK  242 (304)
T ss_dssp             --C-CCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H---------HHHHHHCC
T ss_pred             CCc-cccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH------H---------HHHHHcCC
Confidence            222 2345679999999999999999999999999999999999999997543211      1         11111111


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYM  328 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  328 (375)
                      ..  .+   ..++.++.+|+.+||+.||++|||+
T Consensus       243 ~~--~p---~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          243 LG--MP---QFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             CC--CC---TTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             CC--CC---CcCCHHHHHHHHHHcccCHHHCCCC
Confidence            11  11   2245679999999999999999995

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.2e-53  Score=391.60  Aligned_cols=269  Identities=18%  Similarity=0.306  Sum_probs=201.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeec-----CCce
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSR-----HSRE  132 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~  132 (375)
                      ++|++++.||+|+||+||+|... +|+.||||++...  .....+.+.+|+.+|+.++|||||++++++..     +...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            57999999999999999999664 7999999999654  33445678899999999999999999997643     2467


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      +|||||||+ |+|.+++.    ..+.+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.+
T Consensus       134 ~~ivmE~~~-g~L~~~i~----~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          134 VYVVLDLME-SDLHQIIH----SSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             EEEEEECCS-EEHHHHHT----SSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEeCCC-CCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence            899999995 67999884    3457999999999999999999999999999999999999999999999999999866


Q ss_pred             CCCc---cccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh-----
Q 017232          213 PNHV---THVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ-----  283 (375)
Q Consensus       213 ~~~~---~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~-----  283 (375)
                      ....   .......+||+.|+|||++.+. .++.++||||+||++|||++|++||....................     
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            4321   2233456899999999998775 568999999999999999999999976543221110000000000     


Q ss_pred             ---hhHHHHHHhhhcCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          284 ---NKALHELVDQTLGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       284 ---~~~~~~~~~~~l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                         .......+.........   ......+.++.+|+.+||..||++|||+.|+++.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence               00000011000000000   0001234678899999999999999999998863

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.3e-51  Score=376.64  Aligned_cols=198  Identities=23%  Similarity=0.389  Sum_probs=168.0

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC----CCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCce
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ----DGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  132 (375)
                      ...++|++.++||+|+||+||+|..+    +++.||+|.+.....  ...+.+|+.+|+.+ +||||+++++++.. ...
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~--~~~~~~E~~~l~~~~~h~nIv~l~~~~~~-~~~   94 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSH--PIRIAAELQCLTVAGGQDNVMGVKYCFRK-NDH   94 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSC--HHHHHHHHHHHHHTCSBTTBCCCSEEEEE-TTE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccC--HHHHHHHHHHHHHhcCCCCCceEEEEEEE-CCE
Confidence            35678999999999999999999653    467899999865532  34678899999998 69999999998776 678


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC-CcEEEeeeccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN-FCVKVADFGLSRL  211 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~  211 (375)
                      +|+|||||++|+|.+++.       .+++.++..++.||+.||+|||++||+||||||+|||++.+ +.+||+|||+|+.
T Consensus        95 ~~lvmE~~~g~~L~~~~~-------~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~  167 (361)
T 4f9c_A           95 VVIAMPYLEHESFLDILN-------SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQG  167 (361)
T ss_dssp             EEEEEECCCCCCHHHHHT-------TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             EEEEEeCCCcccHHHHHc-------CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence            999999999999999982       38999999999999999999999999999999999999876 8999999999975


Q ss_pred             cCCCcc---------------------------ccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCc
Q 017232          212 FPNHVT---------------------------HVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAV  263 (375)
Q Consensus       212 ~~~~~~---------------------------~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~  263 (375)
                      ......                           ......+||+.|+|||++.+. .++.++||||+||++|||++|++||
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf  247 (361)
T 4f9c_A          168 THDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF  247 (361)
T ss_dssp             CTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSS
T ss_pred             cCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCC
Confidence            432211                           112334799999999988775 5899999999999999999999999


Q ss_pred             cc
Q 017232          264 DI  265 (375)
Q Consensus       264 ~~  265 (375)
                      ..
T Consensus       248 ~~  249 (361)
T 4f9c_A          248 YK  249 (361)
T ss_dssp             SC
T ss_pred             CC
Confidence            53

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=8.4e-51  Score=369.64  Aligned_cols=288  Identities=40%  Similarity=0.612  Sum_probs=233.2

Q ss_pred             ccchHHHHHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC
Q 017232           50 VFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH  129 (375)
Q Consensus        50 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  129 (375)
                      .+++.++....++|++.+.||+|+||.||+|..++++.||+|++........+.+.+|+.+++.++||||+++++++.. 
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-  106 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDE-  106 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCC-
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcC-
Confidence            4555566678899999999999999999999988899999999877766667789999999999999999999997765 


Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      ....++||||+++++|.+++.........+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++
T Consensus       107 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~  186 (321)
T 2qkw_B          107 RNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGIS  186 (321)
T ss_dssp             TTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTC
T ss_pred             CCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccc
Confidence            66789999999999999999765544557999999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCc-cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          210 RLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       210 ~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      ....... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||.............+...........
T Consensus       187 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  266 (321)
T 2qkw_B          187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLE  266 (321)
T ss_dssp             EECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCC
T ss_pred             cccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHH
Confidence            7654322 222233458999999999988899999999999999999999999998665544444443333222222222


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ..+++.+..   .....++..+.+++.+||+.+|++|||+.++++.|+.+...
T Consensus       267 ~~~~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          267 QIVDPNLAD---KIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             SSSSSSCTT---CSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HhcChhhcc---ccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            222222211   12245678899999999999999999999999999988654

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.1e-51  Score=394.17  Aligned_cols=252  Identities=21%  Similarity=0.336  Sum_probs=209.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|++........+.+.+|+.+|+.++|||||++++++.. ...+|||||
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~-~~~~~iv~E  234 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYE  234 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEe
Confidence            468999999999999999999665 799999999987776667789999999999999999999998876 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC--CcEEEeeeccccccCCCc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN--FCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~--~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||+||+|.+++..   ....+++.++..++.||+.||.|||++||+||||||+|||++.+  +.+||+|||++..+....
T Consensus       235 ~~~gg~L~~~i~~---~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          235 FMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             CCCCCBHHHHHTC---TTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             ecCCCcHHHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            9999999999853   23469999999999999999999999999999999999999854  899999999998765433


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .  ....+||+.|+|||++.+..|+.++||||+||++|+|++|.+||.......               .+..+......
T Consensus       312 ~--~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~---------------~~~~i~~~~~~  374 (573)
T 3uto_A          312 S--VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---------------TLRNVKSCDWN  374 (573)
T ss_dssp             E--EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---------------HHHHHHTTCCC
T ss_pred             c--eeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---------------HHHHHHhCCCC
Confidence            2  234469999999999999999999999999999999999999997543211               01111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       ........++..+.+||.+||..||.+|||+.|+++
T Consensus       375 -~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          375 -MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             -CCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             111222335567899999999999999999999987

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.7e-50  Score=368.45  Aligned_cols=293  Identities=39%  Similarity=0.604  Sum_probs=235.7

Q ss_pred             CcccccchHHHHHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchh-hHHHHHHHHHHHHhcCCCCeEEEee
Q 017232           46 HGVQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYK-RVEQFMNEVDILARLRHKNLVSLYG  124 (375)
Q Consensus        46 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~e~~~l~~l~h~niv~~~~  124 (375)
                      .....+++.++....++|++.+.||+|+||.||+|...+++.||+|++...... ....+.+|+.+++.++||||+++++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   94 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRG   94 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCE
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEE
Confidence            345678999999999999999999999999999998888999999998655322 2236889999999999999999999


Q ss_pred             eeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC---CceeccCCCCCEEecCCCcE
Q 017232          125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---DIIHRDVKTNNILLDNNFCV  201 (375)
Q Consensus       125 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---~ivH~dlkp~Nill~~~~~~  201 (375)
                      ++.. ....++||||+.+++|.+++.........+++..++.++.|++.||.|||+.   |++||||||+|||++.++.+
T Consensus        95 ~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           95 FCMT-PTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             EECC-SSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred             EEec-CCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence            7766 5678999999999999999987766667799999999999999999999999   99999999999999999999


Q ss_pred             EEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccc--cccchhHHHH
Q 017232          202 KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHR--HEINLSNLAI  279 (375)
Q Consensus       202 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~--~~~~~~~~~~  279 (375)
                      ||+|||++...............||+.|+|||++.+..++.++||||||+++|+|++|.+||+.....  .......+..
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            99999999876554444445566999999999998888999999999999999999999999643221  1222222322


Q ss_pred             HHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          280 NKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       280 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      ..........+.+..+....   ....+..+.+++.+||+.+|.+|||+.+|++.|+......
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~~~~~  313 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNY---KDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGDGLAE  313 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSC---CHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTSSCSS
T ss_pred             HHhhchhhhhhcChhhcccc---CHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCcchhh
Confidence            22222222222222222222   2456778999999999999999999999999999754443

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-50  Score=390.35  Aligned_cols=249  Identities=23%  Similarity=0.299  Sum_probs=197.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHH---HHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQF---MNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~---~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      .++|++.+.||+|+||.||+|..+ +|+.||+|++.+...   ......   ..++.+++.++|||||++++++.. ...
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~-~~~  266 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDK  266 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSE
T ss_pred             hHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEE-CCE
Confidence            367999999999999999999665 699999999964321   112223   334566677789999999998876 678


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      +|+|||||+||+|.+++..    .+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||+|..+
T Consensus       267 lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~  342 (689)
T 3v5w_A          267 LSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDF  342 (689)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeec
Confidence            9999999999999999964    346999999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccccccCCCCCccccCccccc-ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQ-CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ....   ....+||+.|+|||++. +..|+.++|||||||++|||++|.+||.........   .. .        ..+.
T Consensus       343 ~~~~---~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~---~i-~--------~~i~  407 (689)
T 3v5w_A          343 SKKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH---EI-D--------RMTL  407 (689)
T ss_dssp             SSCC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHH---HH-H--------HHHH
T ss_pred             CCCC---CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HH-H--------Hhhc
Confidence            5432   23457999999999986 567999999999999999999999999754332210   00 0        0111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY-----MVDVLD  333 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~evl~  333 (375)
                      ....  ..+   ..++.++.+||.+||..||++|++     ++||++
T Consensus       408 ~~~~--~~p---~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          408 TMAV--ELP---DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HCCC--CCC---TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             CCCC--CCC---ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            1111  111   124567999999999999999998     577665

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=6e-48  Score=346.84  Aligned_cols=251  Identities=22%  Similarity=0.363  Sum_probs=206.5

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++........+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~   96 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVM   96 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEE-CCEEEEEE
Confidence            346899999999999999999965 5789999999876655556778999999999999999999997776 66799999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+++++|.+++...     .+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        97 e~~~~~~L~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  171 (297)
T 3fxz_A           97 EYLAGGSLTDVVTET-----CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (297)
T ss_dssp             ECCTTCBHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             ECCCCCCHHHHHhhc-----CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc
Confidence            999999999999543     489999999999999999999999999999999999999999999999999876654322


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                       ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......      ..         ..+...... 
T Consensus       172 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~---------~~~~~~~~~-  234 (297)
T 3fxz_A          172 -KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------AL---------YLIATNGTP-  234 (297)
T ss_dssp             -CBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH---------HHHHHHCSC-
T ss_pred             -ccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH------HH---------HHHHhCCCC-
Confidence             2334569999999999999999999999999999999999999996543211      00         000100000 


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       .......++..+.+++.+||+.||++|||+.|+++
T Consensus       235 -~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          235 -ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -CCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -CCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence             00111234567899999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-47  Score=345.60  Aligned_cols=262  Identities=27%  Similarity=0.421  Sum_probs=213.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      ++|.+.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++.. +...++||||
T Consensus        10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~e~   88 (310)
T 3s95_A           10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-DKRLNFITEY   88 (310)
T ss_dssp             GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-CCeeEEEEEe
Confidence            46888999999999999999765 689999999977777777889999999999999999999998776 6779999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++++|.+++...   ...+++.+++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++..........
T Consensus        89 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (310)
T 3s95_A           89 IKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP  165 (310)
T ss_dssp             CTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC------
T ss_pred             cCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccc
Confidence            9999999999653   3458999999999999999999999999999999999999999999999999998654322211


Q ss_pred             -------------ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH
Q 017232          220 -------------STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA  286 (375)
Q Consensus       220 -------------~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (375)
                                   .....||+.|+|||++.+..++.++||||||+++|+|++|..|+.............          
T Consensus       166 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~----------  235 (310)
T 3s95_A          166 EGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLN----------  235 (310)
T ss_dssp             --------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBC----------
T ss_pred             cccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhh----------
Confidence                         114469999999999999999999999999999999999999987543322111110          


Q ss_pred             HHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          287 LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       287 ~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                      ...........       .++..+.+++.+||+.+|++|||+.++++.|+.++....
T Consensus       236 ~~~~~~~~~~~-------~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          236 VRGFLDRYCPP-------NCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             HHHHHHHTCCT-------TCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             hhccccccCCC-------CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence            01111111111       123468899999999999999999999999999986543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.7e-48  Score=354.85  Aligned_cols=260  Identities=24%  Similarity=0.428  Sum_probs=208.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC----CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ----DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      .++|++.+.||+|+||.||+|...    .+..||+|++... .....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~  126 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTR-GRLAM  126 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECG-GGCCE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCccE
Confidence            457889999999999999999764    3456999999765 44455778999999999999999999998765 67789


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++++|.+++...   ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus       127 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  203 (325)
T 3kul_A          127 IVTEYMENGSLDTFLRTH---DGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLED  203 (325)
T ss_dssp             EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred             EEeeCCCCCcHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence            999999999999999543   34699999999999999999999999999999999999999999999999999987654


Q ss_pred             Cccc--cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          215 HVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       215 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ....  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......                ....+
T Consensus       204 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------------~~~~~  267 (325)
T 3kul_A          204 DPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD----------------VISSV  267 (325)
T ss_dssp             ---CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH----------------HHHHH
T ss_pred             CccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH----------------HHHHH
Confidence            3221  2223346778999999998899999999999999999999 999996543211                00111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      .....   .+....++..+.+++.+||..+|++|||+.+|++.|+.+....
T Consensus       268 ~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          268 EEGYR---LPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             HTTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             HcCCC---CCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            11111   1111234567999999999999999999999999999987653

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=4.1e-48  Score=343.06  Aligned_cols=258  Identities=27%  Similarity=0.475  Sum_probs=212.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ++|++.+.||+|+||.||+|...++..||+|++...... .+.+.+|+.++++++||||+++++++.. ....++||||+
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   87 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFM   87 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEECC
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC-HHHHHHHHHHHHhCCCCCEeeEEEEEec-CCceEEEEEeC
Confidence            568889999999999999999888899999998755432 3678899999999999999999997766 56789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      ++++|.+++...   ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...........
T Consensus        88 ~~~~L~~~l~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  164 (269)
T 4hcu_A           88 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  164 (269)
T ss_dssp             TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCCcHHHHHHhc---CcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccc
Confidence            999999999543   34589999999999999999999999999999999999999999999999999987655443334


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....+++.|+|||.+.+..++.++||||+|+++|+|++ |..||.......      .         ...+.. ......
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~------~---------~~~~~~-~~~~~~  228 (269)
T 4hcu_A          165 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------V---------VEDIST-GFRLYK  228 (269)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H---------HHHHHT-TCCCCC
T ss_pred             cCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH------H---------HHHHhc-CccCCC
Confidence            44557889999999998899999999999999999999 999997543211      0         011111 111111


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                         ....+..+.+++.+||+.+|++|||+.++++.|+++....
T Consensus       229 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~g  268 (269)
T 4hcu_A          229 ---PRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAESG  268 (269)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             ---CCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHcc
Confidence               1123467899999999999999999999999999987653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=8e-48  Score=356.37  Aligned_cols=263  Identities=24%  Similarity=0.399  Sum_probs=212.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC--------CCCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecC
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ--------DGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRH  129 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  129 (375)
                      .++|++.+.||+|+||.||+|...        ++..||+|++... .....+.+.+|+.+++.+ +||||+++++++.. 
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~-  158 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-  158 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS-
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc-
Confidence            467889999999999999999652        3557999999765 344567899999999999 89999999997766 


Q ss_pred             CceeEEEEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          130 SRELLLVYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      ...+++||||+++|+|.+++.....            ....+++.+++.++.||+.||.|||++||+||||||+|||++.
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~  238 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE  238 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence            6679999999999999999976532            2245899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchh
Q 017232          198 NFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLS  275 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~  275 (375)
                      ++.+||+|||++........ .......+++.|+|||++.+..++.++|||||||++|||++ |..||.......     
T Consensus       239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~-----  313 (370)
T 2psq_A          239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-----  313 (370)
T ss_dssp             TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG-----
T ss_pred             CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHH-----
Confidence            99999999999986543322 12233457889999999999899999999999999999999 999997543211     


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                       . .         ..+.....   ......++..+.+++.+||+.+|++|||+.|+++.|+.+....
T Consensus       314 -~-~---------~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~  366 (370)
T 2psq_A          314 -L-F---------KLLKEGHR---MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLT  366 (370)
T ss_dssp             -H-H---------HHHHTTCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             -H-H---------HHHhcCCC---CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence             0 0         01111111   1111234567999999999999999999999999999987643

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=5.8e-48  Score=341.83  Aligned_cols=259  Identities=25%  Similarity=0.468  Sum_probs=212.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .++|++.+.||+|+||.||+|..+++..||+|++...... .+.+.+|+.+++.++||||+++++++.. ....++||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~   84 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS-EDEFFQEAQTMMKLSHPKLVKFYGVCSK-EYPIYIVTEY   84 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC-HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc-HHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCceEEEEEc
Confidence            4678999999999999999999988889999998655432 3568899999999999999999997765 6678999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++..........
T Consensus        85 ~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  161 (268)
T 3sxs_A           85 ISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVS  161 (268)
T ss_dssp             CTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEE
T ss_pred             cCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhc
Confidence            9999999999653   2358999999999999999999999999999999999999999999999999998765544444


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......      ..         ..+. ......
T Consensus       162 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~~---------~~~~-~~~~~~  225 (268)
T 3sxs_A          162 SVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE------VV---------LKVS-QGHRLY  225 (268)
T ss_dssp             CCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH------HH---------HHHH-TTCCCC
T ss_pred             ccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHH------HH---------HHHH-cCCCCC
Confidence            444557788999999998889999999999999999999 999997543211      00         0011 111001


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      .   ....+..+.+++.+||+.+|++|||+.++++.|+.++...
T Consensus       226 ~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~~  266 (268)
T 3sxs_A          226 R---PHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREKD  266 (268)
T ss_dssp             C---CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC--
T ss_pred             C---CCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhcc
Confidence            1   1123457899999999999999999999999999987653

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.8e-48  Score=353.07  Aligned_cols=275  Identities=24%  Similarity=0.335  Sum_probs=210.2

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC---ceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS---RELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~lv  136 (375)
                      .++|++.+.||+|+||.||+|... ++.||+|++...... ......|+.+++.++||||+++++++....   ..+++|
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv  100 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQDKQ-SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI  100 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecCchH-HHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence            467999999999999999999876 789999998655433 345567899999999999999999776532   347999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC----------CceeccCCCCCEEecCCCcEEEeee
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS----------DIIHRDVKTNNILLDNNFCVKVADF  206 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~----------~ivH~dlkp~Nill~~~~~~kl~Df  206 (375)
                      |||+++|+|.+++..     ..+++..++.++.|++.||.|||+.          ||+||||||+|||++.++.+||+||
T Consensus       101 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DF  175 (322)
T 3soc_A          101 TAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADF  175 (322)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCC
T ss_pred             EecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccC
Confidence            999999999999954     3489999999999999999999999          9999999999999999999999999


Q ss_pred             ccccccCCCccc-cccCCCCCccccCcccccc-----cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHH
Q 017232          207 GLSRLFPNHVTH-VSTAPQGTPGYVDPEYHQC-----YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       207 g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      |++......... ......||+.|+|||++.+     ..++.++|||||||++|+|++|++||.................
T Consensus       176 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~  255 (322)
T 3soc_A          176 GLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQ  255 (322)
T ss_dssp             TTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCS
T ss_pred             CcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhcc
Confidence            999766543221 2233568999999999876     3566789999999999999999999976544332222211111


Q ss_pred             HhhhhHHHHHH-hhhcCCCCCh--HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          281 KIQNKALHELV-DQTLGYESDN--KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       281 ~~~~~~~~~~~-~~~l~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ........... ..........  .....+..+.+++.+||+.||++|||+.+|++.|++++..
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          256 HPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            00111111111 1111111111  1123556799999999999999999999999999998753

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.5e-48  Score=349.13  Aligned_cols=276  Identities=25%  Similarity=0.392  Sum_probs=210.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeec-CCcee
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-----QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR-HSREL  133 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~  133 (375)
                      .++|++.+.||+|+||.||+|..     .+++.||+|++........+.+.+|+.+++.++||||+++++++.. ....+
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   88 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL   88 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCce
Confidence            35789999999999999999974     3688999999987777777889999999999999999999997643 23568


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++||||+++++|.+++....   ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++....
T Consensus        89 ~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~  165 (295)
T 3ugc_A           89 KLIMEYLPYGSLRDYLQKHK---ERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  165 (295)
T ss_dssp             EEEEECCTTCBHHHHHHHCG---GGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC---
T ss_pred             EEEEEeCCCCCHHHHHHhcc---cccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCccccccc
Confidence            99999999999999996542   348999999999999999999999999999999999999999999999999998764


Q ss_pred             CCcc--ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHH-hhhhHHHHH
Q 017232          214 NHVT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK-IQNKALHEL  290 (375)
Q Consensus       214 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  290 (375)
                      ....  .......++..|+|||.+.+..++.++||||||+++|+|++|..|+........    ...... .........
T Consensus       166 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~----~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          166 QDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFM----RMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             ----------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHH----HHHCTTCCTHHHHHHH
T ss_pred             CCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHH----hhhcCccccchhHHHH
Confidence            3322  122233477789999999998999999999999999999999999864421100    000000 000000111


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      ..........+....++..+.+++.+||+.+|++|||+.++++.|+.+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          242 IELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            1111111111122345678999999999999999999999999999998754

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=6e-48  Score=346.40  Aligned_cols=266  Identities=23%  Similarity=0.406  Sum_probs=208.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .++|++.+.||+|+||.||+|... ++..||+|.+...   .....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~l   88 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEE-DDCYYL   88 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEEC-SSEEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeee-CCeEEE
Confidence            467999999999999999999654 6899999998543   34455778999999999999999999997765 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus        89 v~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  164 (294)
T 4eqm_A           89 VMEYIEGPTLSEYIESH----GPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET  164 (294)
T ss_dssp             EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC---
T ss_pred             EEeCCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccc
Confidence            99999999999999643    45899999999999999999999999999999999999999999999999999876544


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .........||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......      .....+.... ... ....
T Consensus       165 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~~~-~~~-~~~~  236 (294)
T 4eqm_A          165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVS------IAIKHIQDSV-PNV-TTDV  236 (294)
T ss_dssp             ----------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHH------HHHHHHSSCC-CCH-HHHS
T ss_pred             cccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhhccC-CCc-chhc
Confidence            3333344569999999999999999999999999999999999999997543211      1111111000 000 0000


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhhhcCCCCC
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRP-YMVDVLDALRDIESDGYDD  345 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-t~~evl~~L~~i~~~~~~~  345 (375)
                             ...++..+.+++.+||+.+|.+|| +++++.+.|..+.......
T Consensus       237 -------~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~~~~~  280 (294)
T 4eqm_A          237 -------RKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHENRAN  280 (294)
T ss_dssp             -------CTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSSSSTT
T ss_pred             -------ccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhhccCC
Confidence                   012346799999999999999998 9999999999877655433

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=4.1e-48  Score=349.77  Aligned_cols=263  Identities=33%  Similarity=0.497  Sum_probs=202.7

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..++|++.+.||+|+||+||+|.. +|+.||+|++....  ....+.+.+|+.++++++||||+++++++.. ....++|
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv  112 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQ-PPNLSIV  112 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE-TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-TTCCEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE-CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCceEEE
Confidence            356799999999999999999977 48899999986553  4445678999999999999999999997766 5678999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC--ceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--IIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      |||+++++|.+++.... ....+++..++.++.|++.||.|||+.|  |+||||||+||+++.++.+||+|||++.....
T Consensus       113 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          113 TEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             EECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             EecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            99999999999996431 1124899999999999999999999999  99999999999999999999999999975433


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .. .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......      ..         ..+....
T Consensus       192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~------~~---------~~~~~~~  255 (309)
T 3p86_A          192 TF-LSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQ------VV---------AAVGFKC  255 (309)
T ss_dssp             -----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHH------HH---------HHHHHSC
T ss_pred             cc-cccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH---------HHHHhcC
Confidence            22 12234568999999999999999999999999999999999999997543211      00         0000000


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                      .....   ...++..+.+++.+||+.+|.+|||+.++++.|+.+.+...
T Consensus       256 ~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~~  301 (309)
T 3p86_A          256 KRLEI---PRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSAV  301 (309)
T ss_dssp             CCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC---
T ss_pred             CCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhCC
Confidence            11111   12345678999999999999999999999999999887654

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2e-46  Score=338.51  Aligned_cols=284  Identities=36%  Similarity=0.624  Sum_probs=225.5

Q ss_pred             cccccchHHHHHHhcCCCCC------CccCCCCcEEEEEEEeCCCCEEEEEEeccc----chhhHHHHHHHHHHHHhcCC
Q 017232           47 GVQVFSYGELEEATNYFDSA------RELGDGGFGTVYYGELQDGRAVAVKRLYEN----NYKRVEQFMNEVDILARLRH  116 (375)
Q Consensus        47 ~~~~~~~~~~~~~~~~y~~~------~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h  116 (375)
                      ....|++.++..++++|...      +.||+|+||.||+|.. +++.||+|++...    .....+.+.+|+.+++.++|
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h   89 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH   89 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence            35678999999999998877      8999999999999986 5889999998643    23345678999999999999


Q ss_pred             CCeEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec
Q 017232          117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD  196 (375)
Q Consensus       117 ~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~  196 (375)
                      |||+++++++.. ....++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.|++|+||||+||+++
T Consensus        90 ~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~  167 (307)
T 2nru_A           90 ENLVELLGFSSD-GDDLCLVYVYMPNGSLLDRLSCLD-GTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLD  167 (307)
T ss_dssp             TTBCCEEEEECS-SSSCEEEEECCTTCBHHHHHHTGG-GCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred             CCeEEEEEEEec-CCceEEEEEecCCCcHHHHHHhcc-CCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEc
Confidence            999999997766 567899999999999999986532 335689999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchh
Q 017232          197 NNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLS  275 (375)
Q Consensus       197 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~  275 (375)
                      .++.+||+|||++........ .......|++.|+|||.+.+ .++.++||||||+++|+|++|.+||........  ..
T Consensus       168 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~  244 (307)
T 2nru_A          168 EAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQL--LL  244 (307)
T ss_dssp             TTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSB--TT
T ss_pred             CCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHH--HH
Confidence            999999999999876543222 22234468999999998876 578999999999999999999999976543221  11


Q ss_pred             HHHHHHh-hhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          276 NLAINKI-QNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       276 ~~~~~~~-~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      .+..... ....+.+.++..+    .......+..+.+++.+||+.+|.+|||+.+|++.|+++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          245 DIKEEIEDEEKTIEDYIDKKM----NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HHHHHHHTTSCCHHHHSCSSC----SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             HHHHHhhhhhhhhhhhccccc----cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            1111111 1111222332222    22234567789999999999999999999999999999865

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1e-47  Score=349.59  Aligned_cols=248  Identities=27%  Similarity=0.396  Sum_probs=204.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~lv   92 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIET-EKTLYLI   92 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCEEEEE
Confidence            46799999999999999999976 57999999998654  44456778899999999999999999998766 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++...    +.+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~~----~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  168 (328)
T 3fe3_A           93 MEYASGGEVFDYLVAH----GRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG  168 (328)
T ss_dssp             ECCCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC
T ss_pred             EECCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC
Confidence            9999999999998543    458999999999999999999999999999999999999999999999999998654432


Q ss_pred             cccccCCCCCccccCcccccccCCC-CchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLT-DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .  ....+||+.|+|||++.+..++ .++||||+||++|+|++|..||.......      . .        ..+.....
T Consensus       169 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~-~--------~~i~~~~~  231 (328)
T 3fe3_A          169 K--LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE------L-R--------ERVLRGKY  231 (328)
T ss_dssp             G--GGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-H--------HHHHHCCC
T ss_pred             c--cccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH------H-H--------HHHHhCCC
Confidence            2  3455799999999999887765 78999999999999999999997543111      1 0        11111111


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .  .+   ...+..+.+++.+||..||.+|||++|+++.
T Consensus       232 ~--~p---~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 R--IP---FYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             C--CC---TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             C--CC---CCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1  11   1234678899999999999999999999864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=1e-46  Score=342.45  Aligned_cols=264  Identities=26%  Similarity=0.382  Sum_probs=212.1

Q ss_pred             cccccchHHHHHHhcC----------CCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcC
Q 017232           47 GVQVFSYGELEEATNY----------FDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLR  115 (375)
Q Consensus        47 ~~~~~~~~~~~~~~~~----------y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~  115 (375)
                      ....+++.++..+.+.          |+..+.||+|+||.||+|... +|+.||||++........+.+.+|+.+++.++
T Consensus        21 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~  100 (321)
T 2c30_A           21 QSGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ  100 (321)
T ss_dssp             ----CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC
T ss_pred             cCCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC
Confidence            3446778887777654          667789999999999999776 79999999997666556678899999999999


Q ss_pred             CCCeEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe
Q 017232          116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL  195 (375)
Q Consensus       116 h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill  195 (375)
                      ||||+++++++.. ....++||||+++++|.+++.     ...+++..++.++.|++.||.|||+.|++||||||+||++
T Consensus       101 h~niv~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll  174 (321)
T 2c30_A          101 HFNVVEMYKSYLV-GEELWVLMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILL  174 (321)
T ss_dssp             CTTBCCEEEEEEE-TTEEEEEECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred             CCCcceEEEEEEE-CCEEEEEEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence            9999999997776 567999999999999999984     2458999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchh
Q 017232          196 DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLS  275 (375)
Q Consensus       196 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~  275 (375)
                      +.++.+||+|||++......... .....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......     
T Consensus       175 ~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~-----  248 (321)
T 2c30_A          175 TLDGRVKLSDFGFCAQISKDVPK-RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQ-----  248 (321)
T ss_dssp             CTTCCEEECCCTTCEECCSSSCC-BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-----
T ss_pred             CCCCcEEEeeeeeeeecccCccc-cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-----
Confidence            99999999999998866543222 234569999999999999899999999999999999999999997543211     


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       . ...        +... ... .......++..+.+++.+||+.||++|||+.++++.
T Consensus       249 -~-~~~--------~~~~-~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          249 -A-MKR--------LRDS-PPP-KLKNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             -H-HHH--------HHHS-SCC-CCTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             -H-HHH--------HhcC-CCC-CcCccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence             0 000        1110 000 001112245678999999999999999999999864

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2e-47  Score=341.07  Aligned_cols=259  Identities=25%  Similarity=0.450  Sum_probs=209.9

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ..++|++.+.||+|+||.||++...++..||+|++...... .+.+.+|+.+++.++||||+++++++.. ....++|||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e   99 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITE   99 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC-HHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEEEEEC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC-HHHHHHHHHHHhcCCCCCEeeEEEEEec-CCCeEEEEe
Confidence            34678899999999999999999988889999999765432 3668899999999999999999997765 667899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus       100 ~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  176 (283)
T 3gen_A          100 YMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT  176 (283)
T ss_dssp             CCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHH
T ss_pred             ccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEccccccccccccccc
Confidence            99999999999643   245899999999999999999999999999999999999999999999999999876544333


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                      ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||.......                ....+......
T Consensus       177 ~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~----------------~~~~~~~~~~~  240 (283)
T 3gen_A          177 SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE----------------TAEHIAQGLRL  240 (283)
T ss_dssp             STTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH----------------HHHHHHTTCCC
T ss_pred             cccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhH----------------HHHHHhcccCC
Confidence            3344457889999999998899999999999999999998 999997543211                00111111111


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ...   ...+..+.+++.+||+.+|++|||+.++++.|.++..+
T Consensus       241 ~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          241 YRP---HLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             CCC---TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCC---CcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            111   12345789999999999999999999999999998754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.1e-47  Score=352.75  Aligned_cols=270  Identities=24%  Similarity=0.373  Sum_probs=216.3

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC--------CCCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeec
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ--------DGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSR  128 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~  128 (375)
                      ..++|.+.+.||+|+||.||+|...        .+..||+|++... .......+.+|+.+++.+ +||||+++++++..
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            4567999999999999999999652        2357999998665 344557889999999999 89999999997766


Q ss_pred             CCceeEEEEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec
Q 017232          129 HSRELLLVYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD  196 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~  196 (375)
                       ....++||||+++++|.+++.....            ....+++..++.++.|++.||.|||+.||+||||||+|||++
T Consensus       147 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~  225 (382)
T 3tt0_A          147 -DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT  225 (382)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred             -CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEc
Confidence             6678999999999999999976542            124689999999999999999999999999999999999999


Q ss_pred             CCCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccch
Q 017232          197 NNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINL  274 (375)
Q Consensus       197 ~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~  274 (375)
                      .++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......    
T Consensus       226 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~----  301 (382)
T 3tt0_A          226 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE----  301 (382)
T ss_dssp             TTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----
T ss_pred             CCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH----
Confidence            999999999999986644322 22233457889999999999999999999999999999999 999997543110    


Q ss_pred             hHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCCCCcc
Q 017232          275 SNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKT  348 (375)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~~~~~  348 (375)
                                  ....+........   ...++..+.+++.+||+.+|++|||+.+|++.|+.+..........
T Consensus       302 ------------~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  360 (382)
T 3tt0_A          302 ------------LFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQEMG  360 (382)
T ss_dssp             ------------HHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSCC--
T ss_pred             ------------HHHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcCCCC
Confidence                        1111111111111   1234567999999999999999999999999999998776655543

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.3e-46  Score=346.48  Aligned_cols=251  Identities=25%  Similarity=0.363  Sum_probs=204.9

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchh------hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK------RVEQFMNEVDILARLRHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  131 (375)
                      ..++|++.+.||+|+||.||+|..+ +|+.||+|++......      ..+.+.+|+.+++.++||||+++++++.. ..
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~   88 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYEN-RT   88 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SS
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEe-CC
Confidence            3467999999999999999999765 6899999998654322      24678899999999999999999998776 67


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC----cEEEeeec
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF----CVKVADFG  207 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~----~~kl~Dfg  207 (375)
                      .+++||||+++++|.+++..    ...+++..++.++.||+.||.|||+.||+||||||+|||++.++    .+||+|||
T Consensus        89 ~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG  164 (361)
T 2yab_A           89 DVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFG  164 (361)
T ss_dssp             EEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred             EEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence            89999999999999999943    35699999999999999999999999999999999999998877    79999999


Q ss_pred             cccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH
Q 017232          208 LSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL  287 (375)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (375)
                      ++........  .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.......      .         .
T Consensus       165 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~------~---------~  227 (361)
T 2yab_A          165 LAHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------T---------L  227 (361)
T ss_dssp             SCEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------H---------H
T ss_pred             CceEcCCCCc--cccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH------H---------H
Confidence            9987654322  234569999999999999899999999999999999999999997543111      0         0


Q ss_pred             HHHHhhhcCCCCC-hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          288 HELVDQTLGYESD-NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       288 ~~~~~~~l~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..+...  ..... ......+..+.+++.+||..||++|||+.|+++
T Consensus       228 ~~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          228 ANITAV--SYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             HHHHTT--CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHHhc--CCCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111111  11111 111234567899999999999999999999985

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=2.5e-47  Score=346.74  Aligned_cols=253  Identities=25%  Similarity=0.368  Sum_probs=201.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|++.+.||+|+||.||+|... +++.||+|++..... ...+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~   84 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFL   84 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEEEEE
Confidence            467999999999999999999765 789999999865432 234568899999999999999999997776 67889999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc-
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  216 (375)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..+.... 
T Consensus        85 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~  160 (323)
T 3tki_A           85 EYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  160 (323)
T ss_dssp             ECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             EcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence            99999999999843    3458999999999999999999999999999999999999999999999999997653222 


Q ss_pred             cccccCCCCCccccCcccccccCC-CCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQL-TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      ........||+.|+|||++.+..+ +.++|||||||++|+|++|..||.........              ...+.... 
T Consensus       161 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~--------------~~~~~~~~-  225 (323)
T 3tki_A          161 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE--------------YSDWKEKK-  225 (323)
T ss_dssp             ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHH--------------HHHHHTTC-
T ss_pred             ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHH--------------HHHHhccc-
Confidence            222334579999999999887765 77899999999999999999999754422110              00011110 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                        ........++..+.+++.+||..||++|||+.|+++.
T Consensus       226 --~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          226 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --ccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence              1111112345678899999999999999999999864

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.6e-47  Score=348.41  Aligned_cols=255  Identities=22%  Similarity=0.293  Sum_probs=204.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-----hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-----KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....     ...+.+.+|+.+++.++||||+++++++.. ...+
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~  101 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS-DGML  101 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEE
Confidence            467999999999999999999664 689999999854321     135678999999999999999999998776 6789


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc---EEEeeecccc
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC---VKVADFGLSR  210 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~  210 (375)
                      ++||||+++++|.+.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.   +||+|||++.
T Consensus       102 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~  181 (351)
T 3c0i_A          102 YMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAI  181 (351)
T ss_dssp             EEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCE
T ss_pred             EEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCccee
Confidence            9999999999999888654444456899999999999999999999999999999999999986655   9999999998


Q ss_pred             ccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ....... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.....        ..        ...+
T Consensus       182 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--------~~--------~~~i  244 (351)
T 3c0i_A          182 QLGESGL-VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE--------RL--------FEGI  244 (351)
T ss_dssp             ECCTTSC-BCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSHH--------HH--------HHHH
T ss_pred             EecCCCe-eecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcHH--------HH--------HHHH
Confidence            7654322 22345699999999999998999999999999999999999999975321        00        0111


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ...... ........++..+.+++.+||..||++|||+.++++
T Consensus       245 ~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          245 IKGKYK-MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHTCCC-CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HcCCCC-CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            111110 001111234567999999999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.8e-47  Score=351.74  Aligned_cols=273  Identities=24%  Similarity=0.361  Sum_probs=216.6

Q ss_pred             cchHHHHHHhcCCCCCCccCCCCcEEEEEEEe------CCCCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEE
Q 017232           51 FSYGELEEATNYFDSARELGDGGFGTVYYGEL------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSL  122 (375)
Q Consensus        51 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~  122 (375)
                      +....++...++|++.+.||+|+||.||+|.+      .+++.||+|++... .....+.+.+|+.++..+ +||||+++
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~   91 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL   91 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeee
Confidence            34445555678899999999999999999963      24678999999764 334456789999999999 79999999


Q ss_pred             eeeeecCCceeEEEEecccCCChhHhhccCCCC-----------------------------------------------
Q 017232          123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAK-----------------------------------------------  155 (375)
Q Consensus       123 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-----------------------------------------------  155 (375)
                      ++++...+...++||||+++|+|.+++......                                               
T Consensus        92 ~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (359)
T 3vhe_A           92 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEK  171 (359)
T ss_dssp             EEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------------------
T ss_pred             eeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcccccccccccccc
Confidence            998887667799999999999999999765321                                               


Q ss_pred             ---------------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc-cc
Q 017232          156 ---------------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT-HV  219 (375)
Q Consensus       156 ---------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~  219 (375)
                                     ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........ ..
T Consensus       172 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~  251 (359)
T 3vhe_A          172 SLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR  251 (359)
T ss_dssp             ------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEE
T ss_pred             ccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchh
Confidence                           12388999999999999999999999999999999999999999999999999986543222 22


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      .....+|+.|+|||++.+..++.++|||||||++|+|++ |.+||.......      ...         ..+.......
T Consensus       252 ~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~~~---------~~~~~~~~~~  316 (359)
T 3vhe_A          252 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------EFC---------RRLKEGTRMR  316 (359)
T ss_dssp             C--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH------HHH---------HHHHHTCCCC
T ss_pred             ccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhH------HHH---------HHHHcCCCCC
Confidence            334467889999999999899999999999999999998 999997543211      111         1111111111


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ..   ..++..+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus       317 ~~---~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          317 AP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CC---CCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence            11   12346789999999999999999999999999988653

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-47  Score=364.03  Aligned_cols=263  Identities=22%  Similarity=0.428  Sum_probs=214.3

Q ss_pred             HHHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           56 LEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        56 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++...++|++.+.||+|+||.||+|..+++..||||++.... ...+.+.+|+.+++.++||||+++++++.  ....++
T Consensus       183 ~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~--~~~~~l  259 (454)
T 1qcf_A          183 WEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT--KEPIYI  259 (454)
T ss_dssp             SBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEE
T ss_pred             eeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEe--CCccEE
Confidence            344567789999999999999999999888999999997654 34578999999999999999999999775  456899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+.+|+|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       260 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~  337 (454)
T 1qcf_A          260 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDN  337 (454)
T ss_dssp             EECCCTTCBHHHHHHSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCH
T ss_pred             EEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCC
Confidence            99999999999999643  1235788999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .........++..|+|||++.+..++.++|||||||++|||++ |+.||.......                ....+...
T Consensus       338 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~----------------~~~~i~~~  401 (454)
T 1qcf_A          338 EYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE----------------VIRALERG  401 (454)
T ss_dssp             HHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH----------------HHHHHHHT
T ss_pred             ceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcC
Confidence            3222334456789999999998899999999999999999999 999997543111                00111111


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      .....   +..++..+.+++.+||..+|++|||+.+|++.|+.+....
T Consensus       402 ~~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~  446 (454)
T 1qcf_A          402 YRMPR---PENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTAT  446 (454)
T ss_dssp             CCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSS
T ss_pred             CCCCC---CCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcc
Confidence            11111   1235678999999999999999999999999999987643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-46  Score=340.96  Aligned_cols=252  Identities=20%  Similarity=0.301  Sum_probs=204.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .++|++.+.||+|+||.||+|... +++.||+|.+.... .....+.+|+.+++.++||||+++++++.. ....++|||
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~e   81 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFES-MEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEec-CCEEEEEEE
Confidence            467999999999999999999765 68899999986543 334668899999999999999999998776 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC--CCcEEEeeeccccccCCCc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN--NFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |+++++|.+++...   ...+++..++.++.|++.||.|||++||+||||||+|||++.  ++.+||+|||++.......
T Consensus        82 ~~~g~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~  158 (321)
T 1tki_A           82 FISGLDIFERINTS---AFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             eCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC
Confidence            99999999999532   346899999999999999999999999999999999999987  7899999999998765433


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .  .....+|+.|+|||++.+..++.++|||||||++|+|++|.+||.......               ....+......
T Consensus       159 ~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---------------~~~~i~~~~~~  221 (321)
T 1tki_A          159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---------------IIENIMNAEYT  221 (321)
T ss_dssp             E--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------------HHHHHHHTCCC
T ss_pred             c--cccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---------------HHHHHHcCCCC
Confidence            2  223458999999999998889999999999999999999999997543211               01111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       ........++..+.+++.+||..||.+|||+.|+++.
T Consensus       222 -~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          222 -FDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -CCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -CChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence             0111122345689999999999999999999999984

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=5.4e-47  Score=351.07  Aligned_cols=259  Identities=25%  Similarity=0.434  Sum_probs=199.2

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC----CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ----DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      .++|++.+.||+|+||.||+|...    ++..||+|.+... .....+.+.+|+.++++++||||+++++++.. ....+
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~  122 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK-SKPVM  122 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCceE
Confidence            357999999999999999999764    5778999998755 34455679999999999999999999998766 56789


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++++|.+++...   ...+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       123 lv~e~~~~~sL~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~  199 (373)
T 2qol_A          123 IVTEYMENGSLDSFLRKH---DAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLED  199 (373)
T ss_dssp             EEEECCTTCBHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred             EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence            999999999999999643   34689999999999999999999999999999999999999999999999999987654


Q ss_pred             Ccccc--ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          215 HVTHV--STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       215 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      .....  .....+++.|+|||++.+..++.++||||||+++|||++ |..||.......                ....+
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~----------------~~~~i  263 (373)
T 2qol_A          200 DPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD----------------VIKAV  263 (373)
T ss_dssp             --------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHH----------------HHHHH
T ss_pred             CCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHH
Confidence            32211  122235678999999998899999999999999999998 999996443110                11111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ........   ...++..+.+++.+||+.+|++||++.+|++.|+.+...
T Consensus       264 ~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          264 DEGYRLPP---PMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             HTTEECCC---CTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             HcCCCCCC---CccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            11111111   123456799999999999999999999999999998764

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-46  Score=339.36  Aligned_cols=251  Identities=25%  Similarity=0.354  Sum_probs=204.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchh------hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK------RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      .++|++.+.||+|+||.||+|... +|+.||+|++......      ..+.+.+|+.+++.++||||+++++++.. ...
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~   88 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTD   88 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred             ccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCE
Confidence            356899999999999999999765 6899999998654321      35678899999999999999999998776 678


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC----cEEEeeecc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF----CVKVADFGL  208 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~  208 (375)
                      .++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.||+||||||+|||++.++    .+||+|||+
T Consensus        89 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~  164 (326)
T 2y0a_A           89 VILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  164 (326)
T ss_dssp             EEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence            9999999999999999943    35689999999999999999999999999999999999999887    799999999


Q ss_pred             ccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      +........  .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.......      .         ..
T Consensus       165 a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~---------~~  227 (326)
T 2y0a_A          165 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------T---------LA  227 (326)
T ss_dssp             CEECCTTSC--CCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------H---------HH
T ss_pred             CeECCCCCc--cccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH------H---------HH
Confidence            987643322  234569999999999998899999999999999999999999996543111      0         00


Q ss_pred             HHHhhhcCCCCC-hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          289 ELVDQTLGYESD-NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       289 ~~~~~~l~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .+...  ..... ......+..+.+++.+||..||++|||+.++++.
T Consensus       228 ~~~~~--~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          228 NVSAV--NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HHHHT--CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHhc--CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            01100  11111 1112345678999999999999999999999873

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.3e-47  Score=346.78  Aligned_cols=281  Identities=26%  Similarity=0.324  Sum_probs=213.6

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeee-cCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-----QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS-RHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~~  134 (375)
                      ++|++.+.||+|+||.||+|..     .+++.||+|++........+.+.+|+.+++.++||||+++++++. ......+
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~  102 (327)
T 3lxl_A           23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR  102 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred             hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence            5688999999999999999973     468899999998877777788999999999999999999999665 3456789


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++++|.+++....   ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus       103 lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  179 (327)
T 3lxl_A          103 LVMEYLPSGCLRDFLQRHR---ARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPL  179 (327)
T ss_dssp             EEEECCTTCBHHHHHHHHG---GGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCT
T ss_pred             EEEeecCCCCHHHHHHhcc---cCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceeccc
Confidence            9999999999999996532   3589999999999999999999999999999999999999999999999999987654


Q ss_pred             Ccc--ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          215 HVT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       215 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ...  .......+++.|+|||++.+..++.++||||||+++|+|++|..||........... ...............+.
T Consensus       180 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~  258 (327)
T 3lxl_A          180 DKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMM-GCERDVPALSRLLELLE  258 (327)
T ss_dssp             TCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHC-C----CCHHHHHHHHHH
T ss_pred             CCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhc-ccccccccHHHHHHHhh
Confidence            322  122344588889999999988899999999999999999999999865432110000 00000000011111222


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCCCCcc
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKT  348 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~~~~~  348 (375)
                      ....   ......++..+.+++.+||+.+|++|||+.++++.|+.+.....+....
T Consensus       259 ~~~~---~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~~~~  311 (327)
T 3lxl_A          259 EGQR---LPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGCETH  311 (327)
T ss_dssp             TTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC----------
T ss_pred             cccC---CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcCcccc
Confidence            2111   1112235578999999999999999999999999999998877665543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.4e-47  Score=351.15  Aligned_cols=262  Identities=26%  Similarity=0.383  Sum_probs=208.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      .++|++.+.||+|+||.||+|...      ++..||+|++... .......+.+|+.+++.++||||+++++++.. ...
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~  148 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLP  148 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCC
Confidence            467899999999999999999743      4668999998654 34445678899999999999999999997766 567


Q ss_pred             eEEEEecccCCChhHhhccCCC---CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC---cEEEeee
Q 017232          133 LLLVYEFISNGTVADHLHGERA---KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADF  206 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~---~~kl~Df  206 (375)
                      .++||||+++|+|.+++.....   ....+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DF  228 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF  228 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCC
Confidence            8999999999999999976542   234689999999999999999999999999999999999999555   5999999


Q ss_pred             ccccccCCCc-cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhh
Q 017232          207 GLSRLFPNHV-THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       207 g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      |++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |.+||.......              
T Consensus       229 G~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~--------------  294 (367)
T 3l9p_A          229 GMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--------------  294 (367)
T ss_dssp             HHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------------
T ss_pred             ccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--------------
Confidence            9997542211 112223457889999999998899999999999999999998 999997543211              


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                        ....+.......   ....++..+.+++.+||+.+|++|||+.+|++.|+.+...
T Consensus       295 --~~~~i~~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          295 --VLEFVTSGGRMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             --HHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --HHHHHHcCCCCC---CCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence              111111111111   1123456789999999999999999999999999998764

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=8.2e-47  Score=336.84  Aligned_cols=257  Identities=23%  Similarity=0.384  Sum_probs=196.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD----GRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      .++|++.+.||+|+||.||+|....    +..||+|.+... .....+.+.+|+.+++.++||||+++++++.  ....+
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~   91 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVW   91 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc--cCccE
Confidence            4678899999999999999997642    457999988654 3344567899999999999999999999764  45689


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++++|.+++...   ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        92 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  168 (281)
T 1mp8_A           92 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  168 (281)
T ss_dssp             EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCc
Confidence            999999999999999643   34589999999999999999999999999999999999999999999999999987654


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ..........+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.......      . ...        +...
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~------~-~~~--------i~~~  233 (281)
T 1mp8_A          169 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------V-IGR--------IENG  233 (281)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------H-HHH--------HHTT
T ss_pred             ccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH------H-HHH--------HHcC
Confidence            43333334457789999999998899999999999999999996 999997543221      0 000        1110


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                          ...+....++..+.+++.+||..+|++|||+.++++.|+++..
T Consensus       234 ----~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  276 (281)
T 1mp8_A          234 ----ERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  276 (281)
T ss_dssp             ----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence                0111112345678999999999999999999999999998764

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=8.7e-47  Score=346.20  Aligned_cols=265  Identities=26%  Similarity=0.384  Sum_probs=211.2

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS  130 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  130 (375)
                      ...++|++.+.||+|+||.||+|...      +++.||+|++... .......+.+|+.+++.++||||+++++++.. .
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~  122 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-G  122 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-S
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc-C
Confidence            34678999999999999999999764      3478999998765 33445678999999999999999999997766 6


Q ss_pred             ceeEEEEecccCCChhHhhccCCCC--------------------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCC
Q 017232          131 RELLLVYEFISNGTVADHLHGERAK--------------------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKT  190 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~--------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp  190 (375)
                      ...++||||+++++|.+++......                    ...+++.+++.++.||+.||.|||++||+||||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp  202 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  202 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence            6789999999999999999764321                    25689999999999999999999999999999999


Q ss_pred             CCEEecCCCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCcccccc
Q 017232          191 NNILLDNNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRH  268 (375)
Q Consensus       191 ~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~  268 (375)
                      +||+++.++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            999999999999999999976543221 12233457889999999998899999999999999999999 9999965431


Q ss_pred             ccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          269 RHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      ..       ..        ..+.....    ......++..+.+++.+||+.+|++|||+.++++.|+++....
T Consensus       283 ~~-------~~--------~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          283 EE-------VI--------YYVRDGNI----LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             HH-------HH--------HHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             HH-------HH--------HHHhCCCc----CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            10       00        11111111    1111234567999999999999999999999999999987643

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.6e-47  Score=354.07  Aligned_cols=260  Identities=27%  Similarity=0.396  Sum_probs=209.6

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..++|.+.+.||+|+||.||+|... +++.||+|.+.... ......+.+|+.+++.++||||+++++++.. ....++|
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv  190 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQ-KQPIYIV  190 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECS-SSSCEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEec-CCCcEEE
Confidence            3457888999999999999999876 78999999987543 3344568899999999999999999998765 5678999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++|+|.+++...   ...+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.......
T Consensus       191 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~  267 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGV  267 (377)
T ss_dssp             EECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSE
T ss_pred             EEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCc
Confidence            9999999999999643   2358999999999999999999999999999999999999999999999999997654332


Q ss_pred             cccc-cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          217 THVS-TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       217 ~~~~-~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .... ....+++.|+|||.+.+..++.++|||||||++|||++ |..||......                ...+.+...
T Consensus       268 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~----------------~~~~~~~~~  331 (377)
T 3cbl_A          268 YAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQ----------------QTREFVEKG  331 (377)
T ss_dssp             EECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH----------------HHHHHHHTT
T ss_pred             eeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH----------------HHHHHHHcC
Confidence            2111 11235678999999998889999999999999999998 99999754311                111112111


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .....   +..++..+.+++.+||+.+|++|||+.++++.|+.+.+.
T Consensus       332 ~~~~~---~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          332 GRLPC---PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCC---CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            11111   123456789999999999999999999999999998753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.9e-46  Score=341.03  Aligned_cols=262  Identities=18%  Similarity=0.206  Sum_probs=207.2

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....  ...+.+|+.+++.+ +||||+++++++.. ....++||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~~~~lv~   84 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPC-GKYNAMVL   84 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEE-TTEEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEec-CCccEEEE
Confidence            35789999999999999999975 5789999999865432  23578899999999 89999999997766 67889999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc-----EEEeeecccccc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC-----VKVADFGLSRLF  212 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~~~~~  212 (375)
                      ||+ +++|.+++...   ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.     +||+|||++...
T Consensus        85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~  160 (330)
T 2izr_A           85 ELL-GPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY  160 (330)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred             EeC-CCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence            999 99999999654   346999999999999999999999999999999999999998887     999999999865


Q ss_pred             CCCccc------cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH
Q 017232          213 PNHVTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA  286 (375)
Q Consensus       213 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (375)
                      ......      ......||+.|+|||++.+..++.++|||||||++|+|++|..||............    ..+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~----~~i~~~~  236 (330)
T 2izr_A          161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERY----QKIGDTK  236 (330)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHH----HHHHHHH
T ss_pred             ecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHH----HHHHhhh
Confidence            433221      123457999999999999999999999999999999999999999865422211111    1111100


Q ss_pred             HHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          287 LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       287 ~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ... ....+       ...++ .+.+++..||+.+|.+||++.+|++.|+++...
T Consensus       237 ~~~-~~~~~-------~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~  282 (330)
T 2izr_A          237 RAT-PIEVL-------CENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDR  282 (330)
T ss_dssp             HHS-CHHHH-------TTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             ccC-CHHHH-------hccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHH
Confidence            000 00000       00123 799999999999999999999999999987653

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=4.8e-46  Score=339.56  Aligned_cols=253  Identities=25%  Similarity=0.362  Sum_probs=202.2

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC------
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS------  130 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~------  130 (375)
                      ..++|++.+.||+|+||.||+|... +|+.||||++.... ....+.+.+|+.+++.++||||+++++++....      
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~   83 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQE   83 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhh
Confidence            3467999999999999999999776 79999999986543 334577899999999999999999999765432      


Q ss_pred             --------------------------------------------------ceeEEEEecccCCChhHhhccCCCCCCCCC
Q 017232          131 --------------------------------------------------RELLLVYEFISNGTVADHLHGERAKPGALP  160 (375)
Q Consensus       131 --------------------------------------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~  160 (375)
                                                                        ...++||||+++++|.+++.... .....+
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~  162 (332)
T 3qd2_B           84 EMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDRE  162 (332)
T ss_dssp             HHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSC
T ss_pred             hhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchh
Confidence                                                              23799999999999999997543 223456


Q ss_pred             hHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc-----------ccccCCCCCccc
Q 017232          161 WPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT-----------HVSTAPQGTPGY  229 (375)
Q Consensus       161 ~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~-----------~~~~~~~~~~~y  229 (375)
                      +..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++........           .......||+.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            667899999999999999999999999999999999999999999999987654321           122345699999


Q ss_pred             cCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHH
Q 017232          230 VDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINA  309 (375)
Q Consensus       230 ~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  309 (375)
                      +|||++.+..++.++|||||||++|+|++|..|+....                     ...........+.........
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~  301 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV---------------------RIITDVRNLKFPLLFTQKYPQ  301 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHHHH---------------------HHHHHHHTTCCCHHHHHHCHH
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhHHH---------------------HHHHHhhccCCCcccccCChh
Confidence            99999999899999999999999999999877653211                     011111222334444556677


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          310 VAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       310 l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      +.+++.+||+.||++|||+.|+++
T Consensus       302 ~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          302 EHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             HHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCCCCcCCCHHHHhh
Confidence            899999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=9e-47  Score=333.89  Aligned_cols=257  Identities=26%  Similarity=0.462  Sum_probs=211.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ++|++.+.||+|+||.||+|...++..||+|.+...... .+.+.+|+.+++.++||||+++++++.. ....++||||+
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~e~~   85 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS-EEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVTEFM   85 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC-HHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSCEEEECCC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC-HHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCeEEEEeCC
Confidence            568889999999999999999888889999998765432 3678899999999999999999997766 56789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      ++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...........
T Consensus        86 ~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  162 (267)
T 3t9t_A           86 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  162 (267)
T ss_dssp             TTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHST
T ss_pred             CCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccc
Confidence            999999999653   24589999999999999999999999999999999999999999999999999987654333333


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.......      . .        ..+. .......
T Consensus       163 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~-~--------~~i~-~~~~~~~  226 (267)
T 3t9t_A          163 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE------V-V--------EDIS-TGFRLYK  226 (267)
T ss_dssp             TSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H-H--------HHHH-TTCCCCC
T ss_pred             ccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH------H-H--------HHHh-cCCcCCC
Confidence            34457889999999998889999999999999999999 899997543111      0 0        0111 1111111


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .   ..++..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus       227 ~---~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (267)
T 3t9t_A          227 P---RLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  265 (267)
T ss_dssp             C---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             C---ccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhc
Confidence            1   12346789999999999999999999999999998764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.2e-46  Score=352.49  Aligned_cols=255  Identities=20%  Similarity=0.290  Sum_probs=204.4

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           58 EATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ...++|++.+.||+|+||.||+|.. .+|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~~   86 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISE-EGHHY   86 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEEC-SSEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEE-CCEEE
Confidence            3456799999999999999999965 478999999986543  3345678899999999999999999997776 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec---CCCcEEEeeeccccc
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD---NNFCVKVADFGLSRL  211 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~  211 (375)
                      +||||+.+|+|.+.+...    ..+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++..
T Consensus        87 lv~E~~~gg~L~~~i~~~----~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~  162 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAR----EYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE  162 (444)
T ss_dssp             EEECCCBCCBHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred             EEEEeCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence            999999999999998643    4589999999999999999999999999999999999998   568899999999986


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ...... ......||+.|+|||++.+..++.++||||+||++|+|++|.+||.......               ....+.
T Consensus       163 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~---------------~~~~i~  226 (444)
T 3soa_A          163 VEGEQQ-AWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHR---------------LYQQIK  226 (444)
T ss_dssp             CCTTCC-BCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------------HHHHHH
T ss_pred             ecCCCc-eeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHH---------------HHHHHH
Confidence            654322 2234579999999999999899999999999999999999999996543110               011111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ...... ..+....++..+.+++.+||+.||++|||+.|+++.
T Consensus       227 ~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          227 AGAYDF-PSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             HTCCCC-CTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hCCCCC-CccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            111111 111112345678999999999999999999999874

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.1e-46  Score=343.79  Aligned_cols=254  Identities=21%  Similarity=0.331  Sum_probs=205.1

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++...  .....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~  104 (362)
T 2bdw_A           26 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHY  104 (362)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEE
T ss_pred             CcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEE
Confidence            34567999999999999999999665 6899999998654  33455678899999999999999999997776 67889


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC---cEEEeeeccccc
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRL  211 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~  211 (375)
                      +||||+.+++|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++   .+||+|||++..
T Consensus       105 lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~  180 (362)
T 2bdw_A          105 LVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIE  180 (362)
T ss_dssp             EEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred             EEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence            99999999999999853    34689999999999999999999999999999999999998654   599999999987


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ......  .....||+.|+|||++.+..++.++|||||||++|+|++|.+||.......       .        ...+.
T Consensus       181 ~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~-------~--------~~~i~  243 (362)
T 2bdw_A          181 VNDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR-------L--------YAQIK  243 (362)
T ss_dssp             CTTCCS--CCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------H--------HHHHH
T ss_pred             ecCCcc--cccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------H--------HHHHH
Confidence            653322  234569999999999999899999999999999999999999997543110       0        01111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ...... .......++..+.+++.+||..||++|||+.++++.
T Consensus       244 ~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          244 AGAYDY-PSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HTCCCC-CTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hCCCCC-CcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            111111 111112345678999999999999999999998864

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3.4e-46  Score=340.58  Aligned_cols=248  Identities=26%  Similarity=0.344  Sum_probs=202.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||+|..+ +|+.||+|++....   ......+.+|+.+++.++||||+++++++.. ...+++|
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~-~~~~~lv   83 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEe-CCEEEEE
Confidence            56889999999999999999765 68999999986542   2345678899999999999999999997776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++|+|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus        84 ~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  159 (337)
T 1o6l_A           84 MEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             EeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC
Confidence            9999999999998543    458999999999999999999999999999999999999999999999999997543222


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      . .....+||+.|+|||++.+..++.++|||||||++|||++|.+||.......      .         ...+......
T Consensus       160 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~---------~~~i~~~~~~  223 (337)
T 1o6l_A          160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------L---------FELILMEEIR  223 (337)
T ss_dssp             C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------H---------HHHHHHCCCC
T ss_pred             C-cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHH------H---------HHHHHcCCCC
Confidence            1 2234569999999999999999999999999999999999999996543110      0         1111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLDA  334 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~~  334 (375)
                        .+   ..++..+.+++.+||+.+|++||     ++.++++.
T Consensus       224 --~p---~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          224 --FP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --CC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --CC---CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence              11   12456789999999999999999     89998764

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=4.9e-47  Score=343.55  Aligned_cols=263  Identities=26%  Similarity=0.389  Sum_probs=211.9

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEe------CCCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc
Q 017232           59 ATNYFDSARELGDGGFGTVYYGEL------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  131 (375)
                      ..++|.+.+.||+|+||.||+|..      .++..||+|++... .....+.+.+|+.+++.++||||+++++++.. ..
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~   99 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQ-DG   99 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEec-CC
Confidence            356789999999999999999965      24578999998754 34556788999999999999999999997766 56


Q ss_pred             eeEEEEecccCCChhHhhccCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCC
Q 017232          132 ELLLVYEFISNGTVADHLHGERA--------------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTN  191 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~  191 (375)
                      ..++||||+++++|.+++.....                    ....+++..++.++.|++.||.|||++|++||||||+
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~  179 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR  179 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence            78999999999999999976543                    1234889999999999999999999999999999999


Q ss_pred             CEEecCCCcEEEeeeccccccCCCccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccc
Q 017232          192 NILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHR  269 (375)
Q Consensus       192 Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~  269 (375)
                      ||+++.++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......
T Consensus       180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  259 (314)
T 2ivs_A          180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE  259 (314)
T ss_dssp             GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999999866433222 2233457889999999998889999999999999999999 99999754321


Q ss_pred             cccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          270 HEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .                ....+........   ...++..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus       260 ~----------------~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          260 R----------------LFNLLKTGHRMER---PDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             G----------------HHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             H----------------HHHHhhcCCcCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            1                0111111111111   123456799999999999999999999999999998654

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.9e-46  Score=336.48  Aligned_cols=260  Identities=24%  Similarity=0.385  Sum_probs=200.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHh--cCCCCeEEEeeeeec---CCceeE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR--LRHKNLVSLYGCTSR---HSRELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~---~~~~~~  134 (375)
                      .++|++.+.||+|+||.||+|.. +++.||+|++....   ...+..|.+++..  ++||||+++++++..   .....+
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~   82 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSSRD---EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW   82 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECGGG---HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecccc---chhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence            46799999999999999999987 58999999986543   3445667777776  789999999996433   245689


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHh--------hCCceeccCCCCCEEecCCCcEEEeee
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--------ASDIIHRDVKTNNILLDNNFCVKVADF  206 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~ivH~dlkp~Nill~~~~~~kl~Df  206 (375)
                      +||||+++|+|.+++.     ...+++..++.++.|++.||.|||        +.||+||||||+|||++.++.+||+||
T Consensus        83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Df  157 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL  157 (301)
T ss_dssp             EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCC
T ss_pred             EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeC
Confidence            9999999999999993     346899999999999999999999        999999999999999999999999999


Q ss_pred             ccccccCCCcccc---ccCCCCCccccCccccccc------CCCCchhHHHHHHHHHHHHhC----------CCCccccc
Q 017232          207 GLSRLFPNHVTHV---STAPQGTPGYVDPEYHQCY------QLTDKSDVFSFGVVLIELISS----------MPAVDITR  267 (375)
Q Consensus       207 g~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg----------~~p~~~~~  267 (375)
                      |++..........   .....||+.|+|||++.+.      .++.++|||||||++|||++|          .+||....
T Consensus       158 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~  237 (301)
T 3q4u_A          158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVV  237 (301)
T ss_dssp             TTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccC
Confidence            9997654332221   2234699999999998876      455799999999999999999          77775432


Q ss_pred             cccccchhHHHHHHhhhhHHHHHHh-hhcCCCCCh--HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          268 HRHEINLSNLAINKIQNKALHELVD-QTLGYESDN--KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~l~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      ..... ...          ...... .........  ....++..+.+++.+||+.||++|||+.+|++.|++|.
T Consensus       238 ~~~~~-~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  301 (301)
T 3q4u_A          238 PNDPS-FED----------MRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID  301 (301)
T ss_dssp             CSSCC-HHH----------HHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHC
T ss_pred             CCCcc-hhh----------hhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhccC
Confidence            22111 000          001110 001111111  12346678999999999999999999999999999873

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2e-46  Score=355.70  Aligned_cols=256  Identities=25%  Similarity=0.449  Sum_probs=209.5

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ..++|++.+.||+|+||.||+|... |+.||||++....  ..+.+.+|+.++++++||||+++++++.......++|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            3467888999999999999999876 7899999997654  346789999999999999999999987765667999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++|+|.+++...  ....+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|||++.......  
T Consensus       268 ~~~~g~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~--  343 (450)
T 1k9a_A          268 YMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  343 (450)
T ss_dssp             CCTTCBHHHHHHHH--CTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             ecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc--
Confidence            99999999999754  22347899999999999999999999999999999999999999999999999997543221  


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                        ....++..|+|||.+.+..++.++||||||+++|||++ |..||.......      . ..         .+......
T Consensus       344 --~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~------~-~~---------~i~~~~~~  405 (450)
T 1k9a_A          344 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------V-VP---------RVEKGYKM  405 (450)
T ss_dssp             -----CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTT------H-HH---------HHHTTCCC
T ss_pred             --cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH------H-HH---------HHHcCCCC
Confidence              12247889999999999999999999999999999998 999997543211      0 01         11111111


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      ..   +..++..+.+++.+||+.+|++|||+.++++.|+.+....
T Consensus       406 ~~---p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~~  447 (450)
T 1k9a_A          406 DA---PDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTHE  447 (450)
T ss_dssp             CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             CC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHhh
Confidence            11   1235678999999999999999999999999999988654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=7.1e-47  Score=355.76  Aligned_cols=263  Identities=22%  Similarity=0.278  Sum_probs=208.7

Q ss_pred             hHHHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchh---hHHHHHHHHHHHHhcCCCCeEEEeeeeec
Q 017232           53 YGELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK---RVEQFMNEVDILARLRHKNLVSLYGCTSR  128 (375)
Q Consensus        53 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~l~h~niv~~~~~~~~  128 (375)
                      +.++....++|++.++||+|+||.||+|..+ +++.||+|++......   ....+.+|..++..++||||+++++++..
T Consensus        66 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  145 (437)
T 4aw2_A           66 VKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQD  145 (437)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee
Confidence            3444556788999999999999999999776 5789999998653221   12347889999999999999999998776


Q ss_pred             CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecc
Q 017232          129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL  208 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  208 (375)
                       ...+++||||+++|+|.+++...   ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||+
T Consensus       146 -~~~~~lV~Ey~~gg~L~~~l~~~---~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGl  221 (437)
T 4aw2_A          146 -DNNLYLVMDYYVGGDLLTLLSKF---EDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS  221 (437)
T ss_dssp             -SSEEEEEECCCTTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             -CCEEEEEEecCCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhh
Confidence             67899999999999999999642   35699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccCCCCCccccCccccc-----ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ  283 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  283 (375)
                      +..............+||+.|+|||++.     ...++.++|||||||++|||++|++||.......      .      
T Consensus       222 a~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~------~------  289 (437)
T 4aw2_A          222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVE------T------  289 (437)
T ss_dssp             CEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H------
T ss_pred             hhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhH------H------
Confidence            9876554444445567999999999886     4578999999999999999999999997543211      0      


Q ss_pred             hhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 017232          284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDL--RPYMVDVLDA  334 (375)
Q Consensus       284 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~evl~~  334 (375)
                         ...++........+.....++..+.+|+.+||..+|++  ||+++|+++.
T Consensus       290 ---~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          290 ---YGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ---HHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ---HHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence               11111111011111111124567899999999988888  9999999874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.9e-47  Score=358.04  Aligned_cols=260  Identities=29%  Similarity=0.462  Sum_probs=206.1

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ..++|++.+.||+|+||.||+|...++..||||++..... ..+.+.+|+.+++.++||||+++++++..  ...++|||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~e  258 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTE  258 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEeh
Confidence            4567888999999999999999998888899999876542 34678999999999999999999997754  56899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++|+|.+++...  ....+++..++.++.|++.||+|||++|++||||||+|||++.++.+||+|||++.........
T Consensus       259 ~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  336 (452)
T 1fmk_A          259 YMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT  336 (452)
T ss_dssp             CCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC--------
T ss_pred             hhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee
Confidence            99999999999542  2245899999999999999999999999999999999999999999999999999876543322


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                      ......++..|+|||.+.+..++.++||||||+++|||++ |..||.......                ....+......
T Consensus       337 ~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~----------------~~~~i~~~~~~  400 (452)
T 1fmk_A          337 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVERGYRM  400 (452)
T ss_dssp             ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTCCC
T ss_pred             cccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCC
Confidence            2333457789999999998899999999999999999999 999997543111                01111111111


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      .   .+..++..+.+++.+||+.+|++|||+.+|++.|+.+....
T Consensus       401 ~---~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          401 P---CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             C---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence            1   11235677999999999999999999999999999987543

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1e-46  Score=343.02  Aligned_cols=270  Identities=24%  Similarity=0.376  Sum_probs=197.8

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCC-C---CEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc-
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQD-G---RAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR-  131 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~---~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-  131 (375)
                      ..++|++.+.||+|+||.||+|.... +   ..||+|++...  .....+.+.+|+.+++.++||||+++++++..... 
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~  100 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAK  100 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC---
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccc
Confidence            34679999999999999999997653 2   27999998654  33456788999999999999999999997765332 


Q ss_pred             ----eeEEEEecccCCChhHhhccCCC--CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEee
Q 017232          132 ----ELLLVYEFISNGTVADHLHGERA--KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD  205 (375)
Q Consensus       132 ----~~~lv~e~~~~~~L~~~l~~~~~--~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~D  205 (375)
                          ..++||||+.+++|.+++.....  ....+++..++.++.|++.||.|||++|++||||||+|||++.++.+||+|
T Consensus       101 ~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~D  180 (323)
T 3qup_A          101 GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVAD  180 (323)
T ss_dssp             ----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECC
T ss_pred             cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEEEee
Confidence                23899999999999999865432  223689999999999999999999999999999999999999999999999


Q ss_pred             eccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhh
Q 017232          206 FGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQ  283 (375)
Q Consensus       206 fg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  283 (375)
                      ||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |.+||.......      .      
T Consensus       181 fg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~------~------  248 (323)
T 3qup_A          181 FGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAE------I------  248 (323)
T ss_dssp             CCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG------H------
T ss_pred             ccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHH------H------
Confidence            999986543322 12223346789999999999899999999999999999999 999997544221      0      


Q ss_pred             hhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCCCCc
Q 017232          284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKK  347 (375)
Q Consensus       284 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~~~~  347 (375)
                         ...+....    .......++..+.+++.+||+.||++|||+.++++.|+++....+....
T Consensus       249 ---~~~~~~~~----~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          249 ---YNYLIGGN----RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             ---HHHHHTTC----CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             ---HHHHhcCC----CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence               00111110    1111123456799999999999999999999999999999887765444

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.6e-46  Score=339.82  Aligned_cols=266  Identities=23%  Similarity=0.322  Sum_probs=200.5

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..++|++.+.||+|+||+||+|...+|+.||+|++.....  .....+.+|+.+++.++||||+++++++.. ....++|
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv   97 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHS-ERCLTLV   97 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECC-SSCEEEE
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEcc-CCEEEEE
Confidence            4467999999999999999999988899999999865422  234678899999999999999999997765 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||++ ++|.+.+...   ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        98 ~e~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           98 FEFME-KDLKKVLDEN---KTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EECCS-EEHHHHHHTC---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EcCCC-CCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            99997 5788877543   3458999999999999999999999999999999999999999999999999998764332


Q ss_pred             cccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh---------H
Q 017232          217 THVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK---------A  286 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~  286 (375)
                      . ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||..........   .........         .
T Consensus       174 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~~~  249 (311)
T 3niz_A          174 R-SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP---KIFSILGTPNPREWPQVQE  249 (311)
T ss_dssp             C----CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH---HHHHHHCCCCTTTSGGGTT
T ss_pred             c-cccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH---HHHHHHCCCChHHhhhhhc
Confidence            2 2233468999999998876 568999999999999999999999997654332110   000000000         0


Q ss_pred             HHHHHhhhcCC-CCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          287 LHELVDQTLGY-ESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       287 ~~~~~~~~l~~-~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ...+....... ...   .....++.++.+|+.+||..||++|||+.|+++
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          250 LPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             SHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             cchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            00000000000 000   001123457889999999999999999999986

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=5.9e-46  Score=344.99  Aligned_cols=253  Identities=22%  Similarity=0.331  Sum_probs=205.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..........+.+|+.+++.++||||+++++++.. ....++|||
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~lv~E  128 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILE  128 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEe-CCEEEEEEE
Confidence            467999999999999999999665 689999999977766666788999999999999999999998776 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec--CCCcEEEeeeccccccCCCc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD--NNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |+.+++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||++  .++.+||+|||++.......
T Consensus       129 ~~~gg~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          129 FLSGGELFDRIAAE---DYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             CCCCCBHHHHTTCT---TCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             cCCCCcHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            99999999998532   34689999999999999999999999999999999999997  45779999999998765432


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      ..  ....+|+.|+|||++.+..++.++|||||||++|+|++|.+||.......      .         ...+......
T Consensus       206 ~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~------~---------~~~i~~~~~~  268 (387)
T 1kob_A          206 IV--KVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------T---------LQNVKRCDWE  268 (387)
T ss_dssp             CE--EEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------H---------HHHHHHCCCC
T ss_pred             ce--eeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH------H---------HHHHHhCCCC
Confidence            22  23369999999999999899999999999999999999999997543211      0         0111111110


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      . .......++..+.+++.+||..||++|||+.++++.
T Consensus       269 ~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          269 F-DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             C-CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             C-CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence            0 011112345678999999999999999999999874

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.5e-46  Score=341.67  Aligned_cols=266  Identities=24%  Similarity=0.356  Sum_probs=207.9

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEe------CCCCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecC
Q 017232           58 EATNYFDSARELGDGGFGTVYYGEL------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRH  129 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  129 (375)
                      ...++|++.+.||+|+||.||+|..      .++..||+|++... .....+.+.+|+.+++.+ +||||+++++++.. 
T Consensus        42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  120 (344)
T 1rjb_A           42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-  120 (344)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee-
Confidence            3457899999999999999999975      24568999998654 233456788999999999 89999999997766 


Q ss_pred             CceeEEEEecccCCChhHhhccCCCC-------------------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCC
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAK-------------------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKT  190 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~-------------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp  190 (375)
                      ....++||||+++++|.+++......                   ...+++..++.++.||+.||.|||++||+||||||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp  200 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA  200 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCh
Confidence            66799999999999999999754321                   13489999999999999999999999999999999


Q ss_pred             CCEEecCCCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCcccccc
Q 017232          191 NNILLDNNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRH  268 (375)
Q Consensus       191 ~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~  268 (375)
                      +||+++.++.+||+|||++........ .......+|+.|+|||.+.+..++.++||||||+++|+|++ |..||.....
T Consensus       201 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  280 (344)
T 1rjb_A          201 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV  280 (344)
T ss_dssp             GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred             hhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence            999999999999999999986543322 12233457789999999988899999999999999999998 9999975432


Q ss_pred             ccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          269 RHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      ..      .         ....+.........   ..++..+.+++.+||..+|.+|||+.++++.|+.+....
T Consensus       281 ~~------~---------~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          281 DA------N---------FYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             SH------H---------HHHHHHTTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             HH------H---------HHHHHhcCCCCCCC---CCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            11      0         11111111111111   124567999999999999999999999999999987654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.5e-46  Score=350.93  Aligned_cols=255  Identities=22%  Similarity=0.304  Sum_probs=205.3

Q ss_pred             HHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc
Q 017232           56 LEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        56 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  131 (375)
                      +....++|++.+.||+|+||.||+|..+ +++.||+|++.....   .....+.+|+.+++.++||||+++++++.. ..
T Consensus        64 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~  142 (410)
T 3v8s_A           64 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD-DR  142 (410)
T ss_dssp             HSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred             cccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CC
Confidence            3344678999999999999999999766 588999999865321   122347789999999999999999998776 67


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      .+++||||++||+|.+++..     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       143 ~~~lV~E~~~gg~L~~~l~~-----~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~  217 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMSN-----YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMK  217 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEEEEEeCCCCCcHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEe
Confidence            89999999999999999853     3489999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccCCCCCccccCcccccccC----CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQ----LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL  287 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~----~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (375)
                      ............+||+.|+|||++.+..    ++.++|||||||++|||++|.+||.......      .         .
T Consensus       218 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~---------~  282 (410)
T 3v8s_A          218 MNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG------T---------Y  282 (410)
T ss_dssp             CCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H---------H
T ss_pred             eccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhh------H---------H
Confidence            6554433444667999999999987655    7889999999999999999999997543211      1         1


Q ss_pred             HHHHhhh--cCCCCChHHHHHHHHHHHHHHHhcCCCCCC--CCCHHHHHHH
Q 017232          288 HELVDQT--LGYESDNKVRRTINAVAELAFQCLQSEKDL--RPYMVDVLDA  334 (375)
Q Consensus       288 ~~~~~~~--l~~~~~~~~~~~~~~l~~li~~cl~~~P~~--Rpt~~evl~~  334 (375)
                      ..++...  +....   ...++..+.+|+.+||..+|.+  ||+++||++.
T Consensus       283 ~~i~~~~~~~~~p~---~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          283 SKIMNHKNSLTFPD---DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             HHHHTHHHHCCCCT---TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             HHHHhccccccCCC---cccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            1111111  11110   0123467899999999999988  9999999875

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=8.7e-47  Score=336.25  Aligned_cols=260  Identities=24%  Similarity=0.419  Sum_probs=211.4

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ..++|++.+.||+|+||.||+|...++..||+|.+..... ..+.+.+|+.+++.++||||+++++++..  ...++|||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e   87 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITE   87 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc-cHHHHHHHHHHHHhCCCcCcceEEEEEcC--CCcEEEEe
Confidence            4467899999999999999999988888999999865532 34678899999999999999999997653  45899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++++|.+++...  ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.........
T Consensus        88 ~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  165 (279)
T 1qpc_A           88 YMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT  165 (279)
T ss_dssp             CCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred             cCCCCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc
Confidence            99999999999532  1225899999999999999999999999999999999999999999999999999876554433


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      . .         ..+......
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~-~---------~~~~~~~~~  229 (279)
T 1qpc_A          166 AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE------V-I---------QNLERGYRM  229 (279)
T ss_dssp             CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH------H-H---------HHHHTTCCC
T ss_pred             cccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH------H-H---------HHHhcccCC
Confidence            3344457889999999988889999999999999999999 999997543211      0 0         011111111


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      ..   ...++..+.+++.+||..+|++|||+.++++.|+++....
T Consensus       230 ~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  271 (279)
T 1qpc_A          230 VR---PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT  271 (279)
T ss_dssp             CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             CC---cccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhc
Confidence            11   1234567999999999999999999999999999987654

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.1e-45  Score=332.26  Aligned_cols=264  Identities=16%  Similarity=0.203  Sum_probs=209.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....  ...+.+|+.+++.+ +|+|++++++++.. ....++||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~lv~   85 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVI   85 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc--cHHHHHHHHHHHHHhcCCCCCeEEeecCC-CceeEEEE
Confidence            46799999999999999999975 5789999998864432  24577899999999 79999999997765 67889999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc-----EEEeeecccccc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC-----VKVADFGLSRLF  212 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~-----~kl~Dfg~~~~~  212 (375)
                      ||+ +++|.+++...   +..+++..++.++.|++.||.|||++||+||||||+||+++.++.     +||+|||++...
T Consensus        86 e~~-~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~  161 (298)
T 1csn_A           86 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  161 (298)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccc
Confidence            999 99999999653   345899999999999999999999999999999999999987776     999999999876


Q ss_pred             CCCccc------cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH
Q 017232          213 PNHVTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA  286 (375)
Q Consensus       213 ~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (375)
                      ......      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......................
T Consensus       162 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  241 (298)
T 1csn_A          162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  241 (298)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCcc
Confidence            543221      22345699999999999998999999999999999999999999976543221111111100000000


Q ss_pred             HHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          287 LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       287 ~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      ..            .....++..+.+++.+||+.+|++|||+.+|++.|+++....
T Consensus       242 ~~------------~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~  285 (298)
T 1csn_A          242 LR------------ELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL  285 (298)
T ss_dssp             HH------------HHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             HH------------HHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhc
Confidence            00            000123567999999999999999999999999999987643

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=333.96  Aligned_cols=276  Identities=20%  Similarity=0.286  Sum_probs=210.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-ceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-RELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv  136 (375)
                      .++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.... ...++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   87 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEE
Confidence            357899999999999999999766 58999999987543 334567789999999999999999999766533 478999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe----cCCCcEEEeeecccccc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLF  212 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~  212 (375)
                      |||+++++|.+++.... ....+++..++.++.|++.||.|||+.||+||||||+|||+    +.++.+||+|||++...
T Consensus        88 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~  166 (319)
T 4euu_A           88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (319)
T ss_dssp             EECCTTCBHHHHHHSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEEC
T ss_pred             EeCCCCCCHHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceec
Confidence            99999999999997543 22348999999999999999999999999999999999999    78888999999999876


Q ss_pred             CCCccccccCCCCCccccCccccc--------ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQ--------CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~--------~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      .....  .....+|+.|+|||++.        +..++.++|||||||++|+|++|..||.........  ..........
T Consensus       167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~--~~~~~~~~~~  242 (319)
T 4euu_A          167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITG  242 (319)
T ss_dssp             CTTCC--BCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGC--HHHHHHHHHH
T ss_pred             CCCCc--eeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchh--HHHHHHHhcC
Confidence            54332  23446999999999876        567899999999999999999999999754322211  1111111110


Q ss_pred             hHHHH------HHh------hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          285 KALHE------LVD------QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       285 ~~~~~------~~~------~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .....      ...      ..+. ............+.+++.+||+.||++|||++|+++...+....
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~~~  310 (319)
T 4euu_A          243 KPSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (319)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHTC-
T ss_pred             CCcccchhhhcccCCccccCccCC-cccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHhhc
Confidence            00000      000      0000 00112245677899999999999999999999999998865443

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=7.3e-47  Score=338.27  Aligned_cols=260  Identities=29%  Similarity=0.450  Sum_probs=214.2

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ..++|++.+.||+|+||.||+|... ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~~v~   88 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIIT   88 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCS-THHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCH-HHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-CCCEEEEE
Confidence            4567899999999999999999766 48899999986544 345778899999999999999999997765 66789999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+++++|.+++...  ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus        89 e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~  166 (288)
T 3kfa_A           89 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  166 (288)
T ss_dssp             ECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS
T ss_pred             EcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc
Confidence            999999999999654  335689999999999999999999999999999999999999999999999999987665444


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.......                ..+.+.....
T Consensus       167 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~----------------~~~~~~~~~~  230 (288)
T 3kfa_A          167 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKDYR  230 (288)
T ss_dssp             EEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------------HHHHHHTTCC
T ss_pred             ccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHhccCC
Confidence            33444457889999999998899999999999999999999 999997543211                1111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ....   ..++..+.+++.+||..+|.+|||+.++++.|+.+...
T Consensus       231 ~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~  272 (288)
T 3kfa_A          231 MERP---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  272 (288)
T ss_dssp             CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCC---CCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHh
Confidence            1111   23456799999999999999999999999999987654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.3e-46  Score=342.80  Aligned_cols=249  Identities=26%  Similarity=0.381  Sum_probs=198.6

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCcee
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  133 (375)
                      ..++|++.+.||+|+||.||+|..+ +++.||+|++...   .......+.+|..++..+ +||||+++++++.. ...+
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~   99 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQT-PDRL   99 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEE
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEe-CCEE
Confidence            3467999999999999999999765 6899999998754   223456678899999988 69999999997776 6789


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++||||+++|+|.+++...    ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus       100 ~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~  175 (353)
T 3txo_A          100 FFVMEFVNGGDLMFHIQKS----RRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGI  175 (353)
T ss_dssp             EEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSC
T ss_pred             EEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecc
Confidence            9999999999999999643    458999999999999999999999999999999999999999999999999997533


Q ss_pred             CCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          214 NHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       214 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ... ......+||+.|+|||++.+..++.++|||||||++|||++|.+||.......               ....+...
T Consensus       176 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---------------~~~~i~~~  239 (353)
T 3txo_A          176 CNG-VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---------------LFEAILND  239 (353)
T ss_dssp             C----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------HHHHHHHC
T ss_pred             cCC-ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---------------HHHHHHcC
Confidence            222 22334579999999999999899999999999999999999999997543211               11111111


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCH------HHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYM------VDVLD  333 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~------~evl~  333 (375)
                      ....  +   ...+..+.+++.+||..+|++||++      .++++
T Consensus       240 ~~~~--p---~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          240 EVVY--P---TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             CCCC--C---TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             CCCC--C---CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            1111  1   1244678999999999999999998      66665

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.6e-46  Score=360.31  Aligned_cols=260  Identities=29%  Similarity=0.452  Sum_probs=213.4

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ...+|++.+.||+|+||.||+|.+.. +..||||.+..... ..+.+.+|+.+++.++||||+++++++.. ...+++||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~~lv~  295 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM-EVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIIT  295 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc-chHHHHHHHHHHHhcCCCCEeeEEEEEec-CCcEEEEE
Confidence            34568889999999999999997764 88999999875533 35778999999999999999999998766 56789999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+++|+|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus       296 E~~~~g~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  373 (495)
T 1opk_A          296 EFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY  373 (495)
T ss_dssp             ECCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE
T ss_pred             EccCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCce
Confidence            999999999999654  234589999999999999999999999999999999999999999999999999987654433


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .......++..|+|||++.+..++.++|||||||++|||++ |..||.......                ..+.+.....
T Consensus       374 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~----------------~~~~~~~~~~  437 (495)
T 1opk_A          374 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYELLEKDYR  437 (495)
T ss_dssp             ECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG----------------HHHHHHTTCC
T ss_pred             eecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCC
Confidence            33334456789999999998899999999999999999999 999997543211                1111112111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ....   ..++..+.+|+.+||+.+|++|||+.+|++.|+.+...
T Consensus       438 ~~~~---~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~~  479 (495)
T 1opk_A          438 MERP---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  479 (495)
T ss_dssp             CCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCSS
T ss_pred             CCCC---CCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHhc
Confidence            1111   23456799999999999999999999999999987643

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.1e-46  Score=340.09  Aligned_cols=271  Identities=28%  Similarity=0.454  Sum_probs=210.8

Q ss_pred             CCCCCccCCCCcEEEEEEEeC-----CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-CceeEE
Q 017232           63 FDSARELGDGGFGTVYYGELQ-----DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-SRELLL  135 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~-----~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~l  135 (375)
                      |++.+.||+|+||.||++...     +++.||+|++.... ......+.+|+.+++.++||||+++++++... ...+++
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  112 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL  112 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred             HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence            388999999999999988543     57899999997653 34567789999999999999999999977654 467899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++...     .+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~~-----~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          113 VMEYVPLGSLRDYLPRH-----SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             EECCCTTCBHHHHGGGS-----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             EEecccCCcHHHHHhhC-----CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            99999999999999543     4899999999999999999999999999999999999999999999999999876543


Q ss_pred             cc--ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          216 VT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       216 ~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ..  .......++..|+|||.+.+..++.++||||||+++|+|++|..||......... ...+...........+.+..
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  266 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE-LIGIAQGQMTVLRLTELLER  266 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH-HHCSCCHHHHHHHHHHHHHT
T ss_pred             ccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh-hhcccccchhHHHHHHHHhc
Confidence            22  1223445788899999999888999999999999999999999999754321100 00000011111122222222


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      .....   ....++..+.+++.+||+.+|++|||+.++++.|+.+....
T Consensus       267 ~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  312 (318)
T 3lxp_A          267 GERLP---RPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKY  312 (318)
T ss_dssp             TCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             ccCCC---CCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhh
Confidence            22211   12235578999999999999999999999999999987543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=1.8e-46  Score=337.99  Aligned_cols=272  Identities=22%  Similarity=0.365  Sum_probs=207.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-----CCCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-Ccee
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-----QDGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-SREL  133 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~  133 (375)
                      ++|++.+.||+|+||.||+|..     .+++.||+|++.... ......+.+|+.+++.++||||+++++++... ...+
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~  100 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI  100 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence            4588899999999999999973     368899999987543 33457789999999999999999999977653 2568


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++||||+++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++....
T Consensus       101 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  177 (302)
T 4e5w_A          101 KLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIE  177 (302)
T ss_dssp             EEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECccccccccc
Confidence            9999999999999999543   2458999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcc--ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          214 NHVT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       214 ~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ....  .......+|..|+|||.+.+..++.++||||||+++|+|++|..|+........    ..............+.
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~----~~~~~~~~~~~~~~~~  253 (302)
T 4e5w_A          178 TDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFL----KMIGPTHGQMTVTRLV  253 (302)
T ss_dssp             TTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH----HHHCSCCGGGHHHHHH
T ss_pred             CCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHh----hccCCcccccCHHHHH
Confidence            4332  223345688889999999988899999999999999999999998753321000    0000000001111111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      ..............++..+.+++.+||+.+|.+|||+.++++.|+.+.
T Consensus       254 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          254 NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            111111111111234567999999999999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=333.89  Aligned_cols=256  Identities=24%  Similarity=0.426  Sum_probs=199.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ++|++.+.||+|+||.||+|... ++.||+|.+....  ..+.+.+|+.+++.++||||+++++++..   ..++||||+
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~hp~iv~~~~~~~~---~~~lv~e~~   81 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIESES--ERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVMEYA   81 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSSTT--HHHHHHHHHHHHHHCCCTTBCCEEEBCTT---TTEEEEECC
T ss_pred             hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecChh--HHHHHHHHHHHHhcCCCCCcCeEEEEEcC---CcEEEEEcC
Confidence            46888999999999999999875 7889999986443  34678899999999999999999997653   378999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh---CCceeccCCCCCEEecCCCc-EEEeeeccccccCCCc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA---SDIIHRDVKTNNILLDNNFC-VKVADFGLSRLFPNHV  216 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~---~~ivH~dlkp~Nill~~~~~-~kl~Dfg~~~~~~~~~  216 (375)
                      ++++|.+++.... ....+++..++.++.|++.||.|||+   +|++||||||+||+++.++. +||+|||++.......
T Consensus        82 ~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~  160 (307)
T 2eva_A           82 EGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHM  160 (307)
T ss_dssp             TTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC--------
T ss_pred             CCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEccccccccccccc
Confidence            9999999996542 22347888999999999999999999   89999999999999998886 7999999997554321


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                          ....||+.|+|||++.+..++.++||||||+++|+|++|+.||.......    .....          ....   
T Consensus       161 ----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~----~~~~~----------~~~~---  219 (307)
T 2eva_A          161 ----TNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPA----FRIMW----------AVHN---  219 (307)
T ss_dssp             --------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSH----HHHHH----------HHHT---
T ss_pred             ----ccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccH----HHHHH----------HHhc---
Confidence                23358999999999999899999999999999999999999997543211    00000          0000   


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYD  344 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~  344 (375)
                      .........++..+.+++.+||+.+|++|||+.++++.|+.+......
T Consensus       220 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~  267 (307)
T 2eva_A          220 GTRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPG  267 (307)
T ss_dssp             TCCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCC
T ss_pred             CCCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccC
Confidence            011111123456789999999999999999999999999998775543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=4.5e-46  Score=330.21  Aligned_cols=250  Identities=28%  Similarity=0.442  Sum_probs=193.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccch----hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNY----KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~----~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||+|... ++.||+|++.....    ...+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   84 (271)
T 3dtc_A            7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLK-EPNLCLV   84 (271)
T ss_dssp             TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECC-C--CEEE
T ss_pred             hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec-CCceEEE
Confidence            56888999999999999999875 88999999865432    234678899999999999999999997766 5678999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC---ceeccCCCCCEEecC--------CCcEEEee
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD---IIHRDVKTNNILLDN--------NFCVKVAD  205 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~---ivH~dlkp~Nill~~--------~~~~kl~D  205 (375)
                      |||+++++|.+++.     ...+++..++.++.|++.||.|||++|   ++||||||+||+++.        ++.+||+|
T Consensus        85 ~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~D  159 (271)
T 3dtc_A           85 MEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITD  159 (271)
T ss_dssp             EECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECC
T ss_pred             EEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEcc
Confidence            99999999999983     346899999999999999999999999   899999999999986        77899999


Q ss_pred             eccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh
Q 017232          206 FGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK  285 (375)
Q Consensus       206 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (375)
                      ||++........   ....+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......      .        
T Consensus       160 fg~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~--------  222 (271)
T 3dtc_A          160 FGLAREWHRTTK---MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA------V--------  222 (271)
T ss_dssp             CCC----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH------H--------
T ss_pred             CCcccccccccc---cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H--------
Confidence            999976543322   23468999999999998899999999999999999999999997543111      0        


Q ss_pred             HHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          286 ALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       286 ~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                       .............   ...++..+.+++.+||+.+|++|||+.|+++.|+++
T Consensus       223 -~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          223 -AYGVAMNKLALPI---PSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             -HHHHHTSCCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             -HHhhhcCCCCCCC---CcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence             0011111111111   123456799999999999999999999999999864

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.4e-46  Score=342.65  Aligned_cols=257  Identities=22%  Similarity=0.368  Sum_probs=201.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCC----EEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGR----AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ++|++.+.||+|+||.||+|... +++    +||+|.+... .....+.+.+|+.+++.++||||+++++++...  ..+
T Consensus        15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~   92 (327)
T 3poz_A           15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQ   92 (327)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--SEE
T ss_pred             HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeE
Confidence            56889999999999999999754 444    3588877543 234457789999999999999999999987753  378


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +|+||+.+|+|.+++...   ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        93 ~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~  169 (327)
T 3poz_A           93 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  169 (327)
T ss_dssp             EEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTT
T ss_pred             EEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccC
Confidence            999999999999999654   34589999999999999999999999999999999999999999999999999987644


Q ss_pred             Cccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          215 HVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       215 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .... ......+|+.|+|||.+.+..++.++|||||||++|+|++ |..||.......                ....+.
T Consensus       170 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~----------------~~~~~~  233 (327)
T 3poz_A          170 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILE  233 (327)
T ss_dssp             TCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHHHH
T ss_pred             CcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHH----------------HHHHHH
Confidence            3222 2223456889999999999999999999999999999999 999997543211                111111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .......   ...++..+.+++.+||+.+|++|||+.++++.|+.+..+
T Consensus       234 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          234 KGERLPQ---PPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             TTCCCCC---CTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             cCCCCCC---CccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            1111111   122456789999999999999999999999999998764

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=5.1e-46  Score=333.07  Aligned_cols=261  Identities=28%  Similarity=0.476  Sum_probs=196.8

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..++|++.+.||+|+||.||+|...  ..||+|++...  .....+.+.+|+.+++.++||||++++++..  ....++|
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~--~~~~~lv   97 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQLAIV   97 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC--SSSCEEE
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeecc--CCccEEE
Confidence            3467999999999999999999765  35999998644  3445677899999999999999999999543  4568999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC-
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH-  215 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-  215 (375)
                      |||+++++|.+++...   ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++...... 
T Consensus        98 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  174 (289)
T 3og7_A           98 TQWCEGSSLYHHLHAS---ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWS  174 (289)
T ss_dssp             EECCCEEEHHHHHTTC------CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC---------
T ss_pred             EEecCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceecccccccc
Confidence            9999999999999533   356899999999999999999999999999999999999999999999999998755421 


Q ss_pred             ccccccCCCCCccccCccccc---ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .........||+.|+|||.+.   +..++.++||||||+++|+|++|..||.......      .....+.        .
T Consensus       175 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~~~~~~--------~  240 (289)
T 3og7_A          175 GSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIEMVG--------R  240 (289)
T ss_dssp             ---------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH------HHHHHHH--------H
T ss_pred             ccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH------HHHHHhc--------c
Confidence            122223446899999999886   5678889999999999999999999997543211      1111111        1


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      .............++..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus       241 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          241 GSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             TSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             cccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            111111111112345679999999999999999999999999998865

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.6e-45  Score=330.78  Aligned_cols=265  Identities=20%  Similarity=0.264  Sum_probs=206.6

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ..++|++.+.||+|+||.||+|.. .+++.||+|++......  ..+.+|+.+++.++|++++..+..+.......++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~   84 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   84 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---C--CCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccc--hHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence            457899999999999999999975 57899999986544322  357789999999999988888776666678899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe---cCCCcEEEeeeccccccCC
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~  214 (375)
                      ||+ +++|.+++...   ...+++..++.++.|++.||.|||++|++||||||+|||+   +.++.+||+|||++.....
T Consensus        85 e~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~  160 (296)
T 4hgt_A           85 ELL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  160 (296)
T ss_dssp             ECC-CCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBC
T ss_pred             Ecc-CCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccC
Confidence            999 99999998643   3458999999999999999999999999999999999999   7899999999999987654


Q ss_pred             Ccc------ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          215 HVT------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       215 ~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      ...      .......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||.........................
T Consensus       161 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  240 (296)
T 4hgt_A          161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  240 (296)
T ss_dssp             TTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH
T ss_pred             cccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhh
Confidence            322      12234568999999999999999999999999999999999999997654333222111111110000000


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                           ..       ...++..+.+++.+||+.+|++|||+.++++.|+++...
T Consensus       241 -----~~-------~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~  281 (296)
T 4hgt_A          241 -----VL-------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR  281 (296)
T ss_dssp             -----HH-------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             -----hh-------hccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHH
Confidence                 00       011346799999999999999999999999999997764

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=9.5e-46  Score=332.72  Aligned_cols=263  Identities=27%  Similarity=0.412  Sum_probs=207.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD----GRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ..+|++.+.||+|+||.||+|...+    ...+|+|.+... .....+.+.+|+.++++++||||+++++++.......+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL  103 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCE
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceE
Confidence            3568889999999999999997542    235899988654 44556788999999999999999999998766677889


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++++|.+++..   ....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus       104 ~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~  180 (298)
T 3f66_A          104 VVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD  180 (298)
T ss_dssp             EEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSC
T ss_pred             EEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccc
Confidence            99999999999999954   234589999999999999999999999999999999999999999999999999986643


Q ss_pred             Ccc---ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          215 HVT---HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       215 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ...   .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||.......      ...         .+
T Consensus       181 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~------~~~---------~~  245 (298)
T 3f66_A          181 KEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD------ITV---------YL  245 (298)
T ss_dssp             GGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT------HHH---------HH
T ss_pred             cchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH------HHH---------HH
Confidence            321   11233457789999999999899999999999999999999 666775443211      000         00


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYD  344 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~  344 (375)
                      ... .   .......++..+.+++.+||..+|++|||+.++++.|+.+......
T Consensus       246 ~~~-~---~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~~  295 (298)
T 3f66_A          246 LQG-R---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  295 (298)
T ss_dssp             HTT-C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSCC
T ss_pred             hcC-C---CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhcc
Confidence            000 0   0000112345789999999999999999999999999998876543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=1.4e-45  Score=333.91  Aligned_cols=265  Identities=25%  Similarity=0.359  Sum_probs=212.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCc
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL------QDGRAVAVKRLYENN-YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  131 (375)
                      .++|++.+.||+|+||.||+|..      .+++.||+|++.... ....+.+.+|+.+++.+ +||||+++++++.. ..
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-~~  100 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-GG  100 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEec-CC
Confidence            46789999999999999999974      346789999987553 34457789999999999 89999999997766 56


Q ss_pred             eeEEEEecccCCChhHhhccCCCC--------------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          132 ELLLVYEFISNGTVADHLHGERAK--------------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~--------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      ..++||||+++++|.+++......              ...+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH  180 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence            789999999999999999765321              235899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccccccCCCccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchh
Q 017232          198 NFCVKVADFGLSRLFPNHVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLS  275 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~  275 (375)
                      ++.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......     
T Consensus       181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----  255 (313)
T 1t46_A          181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-----  255 (313)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-----
T ss_pred             CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchh-----
Confidence            999999999999876543322 2223456789999999988899999999999999999998 999997543211     


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                       .         ....+.........   ..++..+.+++.+||..+|.+|||+.++++.|+++.....
T Consensus       256 -~---------~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  310 (313)
T 1t46_A          256 -K---------FYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISEST  310 (313)
T ss_dssp             -H---------HHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTC
T ss_pred             -H---------HHHHhccCCCCCCc---ccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHhh
Confidence             0         11111111111111   1245678999999999999999999999999999876543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=331.93  Aligned_cols=250  Identities=24%  Similarity=0.358  Sum_probs=195.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--------------------------hhHHHHHHHHHHHH
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--------------------------KRVEQFMNEVDILA  112 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--------------------------~~~~~~~~e~~~l~  112 (375)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....                          ...+.+.+|+.+++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   91 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILK   91 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHH
T ss_pred             ecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHH
Confidence            357999999999999999999654 688999999865431                          11356889999999


Q ss_pred             hcCCCCeEEEeeeeec-CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCC
Q 017232          113 RLRHKNLVSLYGCTSR-HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTN  191 (375)
Q Consensus       113 ~l~h~niv~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~  191 (375)
                      .++||||+++++++.. .....++||||+++++|.+++     ....+++..++.++.|++.||.|||++|++||||||+
T Consensus        92 ~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~  166 (298)
T 2zv2_A           92 KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPS  166 (298)
T ss_dssp             TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHH
Confidence            9999999999997765 356789999999999998865     3346999999999999999999999999999999999


Q ss_pred             CEEecCCCcEEEeeeccccccCCCccccccCCCCCccccCcccccccC---CCCchhHHHHHHHHHHHHhCCCCcccccc
Q 017232          192 NILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ---LTDKSDVFSFGVVLIELISSMPAVDITRH  268 (375)
Q Consensus       192 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~p~~~~~~  268 (375)
                      |||++.++.+||+|||++........ ......||+.|+|||.+.+..   ++.++|||||||++|+|++|..||.....
T Consensus       167 Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~  245 (298)
T 2zv2_A          167 NLLVGEDGHIKIADFGVSNEFKGSDA-LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERI  245 (298)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSSC-EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HEEECCCCCEEEecCCCccccccccc-cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccH
Confidence            99999999999999999987654322 223456999999999987655   37789999999999999999999964321


Q ss_pred             ccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          269 RHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       269 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .      .. .        ..+.........   ...++..+.+++.+||+.||++|||+.|+++
T Consensus       246 ~------~~-~--------~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          246 M------CL-H--------SKIKSQALEFPD---QPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             H------HH-H--------HHHHHCCCCCCS---SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             H------HH-H--------HHHhcccCCCCC---ccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            0      00 0        011111111110   1124467899999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=2.7e-45  Score=329.28  Aligned_cols=266  Identities=21%  Similarity=0.264  Sum_probs=210.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++......  ..+.+|+.+++.++|++++..+..+.......++|||
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~--~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC--CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch--hHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            46799999999999999999976 57899999998654322  3578999999999999888777766666788999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe---cCCCcEEEeeeccccccCCC
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      |+ +++|.+++...   ...+++..++.++.|++.||.|||++|++||||||+||++   +.++.+||+|||++......
T Consensus        86 ~~-~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  161 (296)
T 3uzp_A           86 LL-GPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDA  161 (296)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             ec-CCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccc
Confidence            99 89999999643   2459999999999999999999999999999999999999   48889999999999876543


Q ss_pred             ccc------cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          216 VTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       216 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                      ...      ......||+.|+|||.+.+..++.++|||||||++|+|++|+.||......................... 
T Consensus       162 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-  240 (296)
T 3uzp_A          162 RTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE-  240 (296)
T ss_dssp             TTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHH-
T ss_pred             ccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchH-
Confidence            221      1234569999999999999899999999999999999999999998654332221111111110000000 


Q ss_pred             HHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          290 LVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       290 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                          .+       ...++..+.+++.+||+.+|++|||+.+|++.|+++.....
T Consensus       241 ----~~-------~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~  283 (296)
T 3uzp_A          241 ----VL-------CKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQG  283 (296)
T ss_dssp             ----HH-------TTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             ----HH-------HhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcC
Confidence                00       01234679999999999999999999999999999876543

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=2.3e-46  Score=347.96  Aligned_cols=252  Identities=22%  Similarity=0.353  Sum_probs=197.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  134 (375)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++....   ......+.+|..++.++ +||||+++++++.. ...++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~-~~~~~  129 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLF  129 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEE-CCEEE
Confidence            356999999999999999999765 57899999987542   22334577899999887 89999999998776 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++|+|..++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       130 lV~E~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~  205 (396)
T 4dc2_A          130 FVIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR  205 (396)
T ss_dssp             EEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEEcCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence            999999999999998643    4589999999999999999999999999999999999999999999999999975322


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|++||............      ........+....
T Consensus       206 ~~-~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~------~~~~~~~~i~~~~  278 (396)
T 4dc2_A          206 PG-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------TEDYLFQVILEKQ  278 (396)
T ss_dssp             TT-CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------C------CHHHHHHHHHHCC
T ss_pred             CC-CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchh------hHHHHHHHHhccc
Confidence            21 2234557999999999999999999999999999999999999999754322111000      0000111111111


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYM  328 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  328 (375)
                      ...  +   ..++..+.+|+.+||+.||.+||++
T Consensus       279 ~~~--p---~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          279 IRI--P---RSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             CCC--C---TTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             cCC--C---CcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            111  1   1245678999999999999999996

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.3e-46  Score=346.97  Aligned_cols=263  Identities=21%  Similarity=0.230  Sum_probs=207.0

Q ss_pred             chHHHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeee
Q 017232           52 SYGELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTS  127 (375)
Q Consensus        52 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~  127 (375)
                      .+.+.....++|++.+.||+|+||.||+|..+ +|+.||+|++.....   .....+.+|..++..++||||+++++++.
T Consensus        52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~  131 (412)
T 2vd5_A           52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ  131 (412)
T ss_dssp             HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred             hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence            34444555788999999999999999999775 789999999865322   22345788999999999999999999777


Q ss_pred             cCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeec
Q 017232          128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFG  207 (375)
Q Consensus       128 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg  207 (375)
                      . ...+|+||||+++|+|.+++...   +..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||
T Consensus       132 ~-~~~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFG  207 (412)
T 2vd5_A          132 D-ENYLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFG  207 (412)
T ss_dssp             C-SSEEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCT
T ss_pred             e-CCEEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeech
Confidence            6 67899999999999999999643   2358999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccCCCCCccccCccccc-------ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHH
Q 017232          208 LSRLFPNHVTHVSTAPQGTPGYVDPEYHQ-------CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-------~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      ++..............+||+.|+|||++.       +..++.++|||||||++|||++|++||.......      .   
T Consensus       208 la~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~---  278 (412)
T 2vd5_A          208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAE------T---  278 (412)
T ss_dssp             TCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H---
T ss_pred             hheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHH------H---
Confidence            99876554433334567999999999887       3568999999999999999999999997543211      0   


Q ss_pred             HhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCC---CCHHHHHHH
Q 017232          281 KIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLR---PYMVDVLDA  334 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~R---pt~~evl~~  334 (375)
                            ...++........+.....++..+.+++.+||. +|.+|   |+++|+++.
T Consensus       279 ------~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          279 ------YGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             ------HHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             ------HHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                  111111110001111112345689999999999 99998   588888764

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6e-46  Score=331.22  Aligned_cols=258  Identities=24%  Similarity=0.370  Sum_probs=204.4

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD----GRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      .++|++.+.||+|+||.||+|...+    +..||+|.+... .....+.+.+|+.+++.++||||+++++++..  ...+
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--~~~~   88 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE--EPTW   88 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS--SSCE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC--CCCE
Confidence            4568899999999999999996542    235999998765 34456788999999999999999999997654  3468


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++.....
T Consensus        89 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  165 (281)
T 3cc6_A           89 IIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED  165 (281)
T ss_dssp             EEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC--
T ss_pred             EEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccc
Confidence            999999999999999643   34589999999999999999999999999999999999999999999999999987654


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ..........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||........       .         ..+..
T Consensus       166 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~-------~---------~~~~~  229 (281)
T 3cc6_A          166 EDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDV-------I---------GVLEK  229 (281)
T ss_dssp             -------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGH-------H---------HHHHH
T ss_pred             ccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHH-------H---------HHHhc
Confidence            43333344457889999999998899999999999999999998 9999964432110       0         01111


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ......   ...++..+.+++.+||..+|++|||+.++++.|+.+...
T Consensus       230 ~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          230 GDRLPK---PDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             TCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCC---CCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            111111   112446789999999999999999999999999988653

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.9e-46  Score=338.19  Aligned_cols=267  Identities=24%  Similarity=0.304  Sum_probs=210.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeec---CCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR---HSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~l  135 (375)
                      .++|++.+.||+|+||.||++.. .+++.||+|++........+.+.+|+.+++.++||||+++++++..   .....++
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  107 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL  107 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence            46799999999999999999976 5789999999877766777889999999999999999999997652   3457899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+.+++|.+++.........+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++......
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~  187 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIH  187 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEE
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccc
Confidence            99999999999999775555677999999999999999999999999999999999999999999999999988754321


Q ss_pred             ccc--------cccCCCCCccccCcccccccC---CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh
Q 017232          216 VTH--------VSTAPQGTPGYVDPEYHQCYQ---LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       216 ~~~--------~~~~~~~~~~y~aPE~~~~~~---~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      ...        ......+|+.|+|||++.+..   ++.++||||||+++|+|++|..||.........            
T Consensus       188 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~------------  255 (317)
T 2buj_A          188 VEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDS------------  255 (317)
T ss_dssp             EESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSC------------
T ss_pred             cccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccch------------
Confidence            110        011224689999999887543   688999999999999999999999643211100            


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                        .............   ...++..+.+++.+||+.+|++|||+.++++.|+.+.....
T Consensus       256 --~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  309 (317)
T 2buj_A          256 --VALAVQNQLSIPQ---SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPPAP  309 (317)
T ss_dssp             --HHHHHHCC--CCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCCCC
T ss_pred             --hhHHhhccCCCCc---cccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCCCC
Confidence              0000111111011   11234679999999999999999999999999999875443

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=5.1e-46  Score=336.37  Aligned_cols=266  Identities=25%  Similarity=0.394  Sum_probs=202.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++...   .......+.+|+.+++.++||||+++++++.. ....++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~l  109 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-DNELNI  109 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-CCcEEE
Confidence            45799999999999999999976 47899999998642   34456778999999999999999999997776 568999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++.........+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus       110 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~  189 (310)
T 2wqm_A          110 VLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  189 (310)
T ss_dssp             EEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC---------
T ss_pred             EEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCC
Confidence            99999999999999764444567899999999999999999999999999999999999999999999999998765432


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .. ......+++.|+|||.+.+..++.++||||||+++|+|++|..||......    ..... ..        +.....
T Consensus       190 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~----~~~~~-~~--------~~~~~~  255 (310)
T 2wqm_A          190 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN----LYSLC-KK--------IEQCDY  255 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CC----HHHHH-HH--------HHTTCS
T ss_pred             Cc-cccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchh----HHHHH-HH--------hhcccC
Confidence            22 122346899999999999889999999999999999999999999643211    00110 00        000000


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                      ....   ...++..+.+++.+||..||++|||+.+|++.|+++.+...
T Consensus       256 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~~  300 (310)
T 2wqm_A          256 PPLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACTA  300 (310)
T ss_dssp             CCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhhh
Confidence            0000   11245679999999999999999999999999999987654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-45  Score=333.91  Aligned_cols=245  Identities=27%  Similarity=0.437  Sum_probs=202.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.....   ...+.+.+|..+++.++||||+++++++.. ...+++|
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~-~~~~~lv   84 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMI   84 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEe-CCEEEEE
Confidence            56889999999999999999765 689999999865422   335677889999999999999999997776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... 
T Consensus        85 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-  159 (318)
T 1fot_A           85 MDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-  159 (318)
T ss_dssp             ECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-
T ss_pred             EeCCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCCc-
Confidence            9999999999999643    45899999999999999999999999999999999999999999999999999865432 


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                         ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||.......               ....+......
T Consensus       160 ---~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---------------~~~~i~~~~~~  221 (318)
T 1fot_A          160 ---TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---------------TYEKILNAELR  221 (318)
T ss_dssp             ---BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---------------HHHHHHHCCCC
T ss_pred             ---cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---------------HHHHHHhCCCC
Confidence               234569999999999999999999999999999999999999996543110               11112222111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLDA  334 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~~  334 (375)
                      .  +   ...+..+.+++.+||..+|.+||     +++++++.
T Consensus       222 ~--p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          222 F--P---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             C--C---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             C--C---CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence            1  1   12346789999999999999999     88888753

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.3e-45  Score=337.19  Aligned_cols=264  Identities=24%  Similarity=0.397  Sum_probs=210.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC--------CCCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecC
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ--------DGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRH  129 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  129 (375)
                      .++|++.+.||+|+||.||+|...        ++..||+|++... .......+.+|+.+++.+ +||||+++++++.. 
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-  112 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ-  112 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc-
Confidence            467899999999999999999763        4678999998755 344567789999999999 89999999997766 


Q ss_pred             CceeEEEEecccCCChhHhhccCCCC------------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAK------------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      ....++||||+++++|.+++......            ...+++..++.++.|++.||.|||+.|++|+||||+||+++.
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  192 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE  192 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence            66789999999999999999765321            235899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchh
Q 017232          198 NFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLS  275 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~  275 (375)
                      ++.+||+|||++........ .......+++.|+|||++.+..++.++||||||+++|+|++ |..||.......     
T Consensus       193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~-----  267 (334)
T 2pvf_A          193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEE-----  267 (334)
T ss_dssp             TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH-----
T ss_pred             CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHH-----
Confidence            99999999999986654322 12233457789999999988889999999999999999999 999997543111     


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                       .          ...+........   ...++..+.+++.+||+.+|++|||+.++++.|+.+.....
T Consensus       268 -~----------~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          268 -L----------FKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             -H----------HHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             -H----------HHHHhcCCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence             0          011111111111   12345679999999999999999999999999999876543

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=4.2e-45  Score=337.73  Aligned_cols=269  Identities=15%  Similarity=0.235  Sum_probs=206.1

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeCC------CCEEEEEEecccchhhH-----------HHHHHHHHHHHhcCCCCeEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQD------GRAVAVKRLYENNYKRV-----------EQFMNEVDILARLRHKNLVS  121 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~~------~~~vaiK~~~~~~~~~~-----------~~~~~e~~~l~~l~h~niv~  121 (375)
                      ..++|++.+.||+|+||.||+|....      ++.||+|++........           ..+..|+..+..++||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            34579999999999999999997764      47899999865542211           12334556677788999999


Q ss_pred             EeeeeecC---CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec--
Q 017232          122 LYGCTSRH---SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD--  196 (375)
Q Consensus       122 ~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~--  196 (375)
                      +++++...   ....++||||+ +++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||++  
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~  188 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYK  188 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESS
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecC
Confidence            99976543   24589999999 99999999653   35699999999999999999999999999999999999999  


Q ss_pred             CCCcEEEeeeccccccCCCccc------cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCcccccccc
Q 017232          197 NNFCVKVADFGLSRLFPNHVTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRH  270 (375)
Q Consensus       197 ~~~~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~  270 (375)
                      .++.+||+|||++..+......      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......
T Consensus       189 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~  268 (364)
T 3op5_A          189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDP  268 (364)
T ss_dssp             CTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCH
T ss_pred             CCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCH
Confidence            8899999999999765432211      1123459999999999999999999999999999999999999998543221


Q ss_pred             ccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      .  ..... .........++++..+...      .++..+.+++..|+..+|++||++.+|++.|+++..
T Consensus       269 ~--~~~~~-~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~  329 (364)
T 3op5_A          269 K--YVRDS-KIRYRENIASLMDKCFPAA------NAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLK  329 (364)
T ss_dssp             H--HHHHH-HHHHHHCHHHHHHHHSCTT------CCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             H--HHHHH-HHHhhhhHHHHHHHhcccc------cCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHH
Confidence            1  11111 1111123344444443211      124678999999999999999999999999998765

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=6.3e-46  Score=343.82  Aligned_cols=249  Identities=25%  Similarity=0.373  Sum_probs=200.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||+|... +++.||+|++....   ......+.+|+.+++.++||||+++++++.. ...+++|
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~lv   93 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQD-EEDMFMV   93 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEEEE
Confidence            56889999999999999999665 68899999986542   2335678899999999999999999998776 6679999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+.+|+|.+++..    ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus        94 ~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~  169 (384)
T 4fr4_A           94 VDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET  169 (384)
T ss_dssp             ECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCC
Confidence            999999999999953    3469999999999999999999999999999999999999999999999999998764332


Q ss_pred             cccccCCCCCccccCcccccc---cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          217 THVSTAPQGTPGYVDPEYHQC---YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                        .....+||+.|+|||++.+   ..++.++|||||||++|+|++|.+||.........   ..         ...+...
T Consensus       170 --~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~---~~---------~~~~~~~  235 (384)
T 4fr4_A          170 --QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK---EI---------VHTFETT  235 (384)
T ss_dssp             --CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH---HH---------HHHHHHC
T ss_pred             --ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH---HH---------HHHHhhc
Confidence              2345579999999998863   45899999999999999999999999754322211   00         0001111


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY-MVDVLD  333 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-~~evl~  333 (375)
                      ...  .+   ..++..+.+++.+||+.+|.+||+ ++++++
T Consensus       236 ~~~--~p---~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          236 VVT--YP---SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             CCC--CC---TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             ccC--CC---CcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            111  11   124567899999999999999999 666654

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.1e-46  Score=340.75  Aligned_cols=272  Identities=25%  Similarity=0.416  Sum_probs=214.5

Q ss_pred             cchHHHHHHhcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEe
Q 017232           51 FSYGELEEATNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLY  123 (375)
Q Consensus        51 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~  123 (375)
                      +...+++...++|++.+.||+|+||.||+|...      +++.||+|.+... .......+.+|+.+++.++||||++++
T Consensus        15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   94 (322)
T 1p4o_A           15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL   94 (322)
T ss_dssp             CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred             cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence            334445556778999999999999999999654      3678999998654 334456788999999999999999999


Q ss_pred             eeeecCCceeEEEEecccCCChhHhhccCC------CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          124 GCTSRHSRELLLVYEFISNGTVADHLHGER------AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       124 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      +++.. ....++||||+++++|.+++....      .....+++..++.++.|++.||.|||++||+||||||+||+++.
T Consensus        95 ~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~  173 (322)
T 1p4o_A           95 GVVSQ-GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAE  173 (322)
T ss_dssp             EEECS-SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECT
T ss_pred             EEEcc-CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcC
Confidence            97765 567899999999999999986532      11245789999999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchh
Q 017232          198 NFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLS  275 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~  275 (375)
                      ++.+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......     
T Consensus       174 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~-----  248 (322)
T 1p4o_A          174 DFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ-----  248 (322)
T ss_dssp             TCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH-----
T ss_pred             CCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH-----
Confidence            99999999999976543221 12223356889999999998899999999999999999999 899987543111     


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                       . .        ..+.....    ......++..+.+++.+||+.+|++|||+.++++.|+++....
T Consensus       249 -~-~--------~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~  301 (322)
T 1p4o_A          249 -V-L--------RFVMEGGL----LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPG  301 (322)
T ss_dssp             -H-H--------HHHHTTCC----CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTT
T ss_pred             -H-H--------HHHHcCCc----CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccC
Confidence             0 0        11111111    1111234567899999999999999999999999999876543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.4e-45  Score=341.40  Aligned_cols=276  Identities=20%  Similarity=0.245  Sum_probs=205.1

Q ss_pred             hcCCCCCCccCCC--CcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           60 TNYFDSARELGDG--GFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G--~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      .++|++.+.||+|  +||.||+|... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.. ...++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~  102 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-DNELW  102 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE-CCEEE
Confidence            3568999999999  99999999766 79999999986542  3445678899999999999999999998776 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++++|.+++....  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||.+.....
T Consensus       103 lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~  180 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHF--MDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMIS  180 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTC--TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEE
T ss_pred             EEEEccCCCCHHHHHhhhc--ccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecc
Confidence            9999999999999996542  34589999999999999999999999999999999999999999999999998864421


Q ss_pred             Cc------cccccCCCCCccccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh---
Q 017232          215 HV------THVSTAPQGTPGYVDPEYHQC--YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ---  283 (375)
Q Consensus       215 ~~------~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---  283 (375)
                      ..      ........||+.|+|||++.+  ..++.++|||||||++|+|++|++||..........  ........   
T Consensus       181 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~  258 (389)
T 3gni_B          181 HGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLL--EKLNGTVPCLL  258 (389)
T ss_dssp             TTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHH--HC---------
T ss_pred             ccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHH--HHhcCCCCccc
Confidence            11      111223468999999999887  678999999999999999999999997543322110  00000000   


Q ss_pred             h-------------------hHHHHHHhhh------cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HH
Q 017232          284 N-------------------KALHELVDQT------LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LR  336 (375)
Q Consensus       284 ~-------------------~~~~~~~~~~------l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~  336 (375)
                      +                   ....+.....      ......+....++..+.+|+.+||+.||++|||+.|+++.  ++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~  338 (389)
T 3gni_B          259 DTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFK  338 (389)
T ss_dssp             -----------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGG
T ss_pred             cccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHH
Confidence            0                   0000000000      0000001122345679999999999999999999999865  65


Q ss_pred             hhhc
Q 017232          337 DIES  340 (375)
Q Consensus       337 ~i~~  340 (375)
                      ++..
T Consensus       339 ~~~~  342 (389)
T 3gni_B          339 QIKR  342 (389)
T ss_dssp             GC--
T ss_pred             HHhh
Confidence            5544

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-46  Score=341.33  Aligned_cols=247  Identities=23%  Similarity=0.324  Sum_probs=200.2

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.....   .....+.+|+.+++.++||||+++++++.. ....++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~-~~~~~l   86 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITT-PTDIVM   86 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEE
Confidence            36799999999999999999976 5789999999865422   223568899999999999999999998776 667999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+ +|+|.+++...    ..+++.+++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++......
T Consensus        87 v~E~~-~g~l~~~l~~~----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~  161 (336)
T 3h4j_B           87 VIEYA-GGELFDYIVEK----KRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG  161 (336)
T ss_dssp             EECCC-CEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred             EEECC-CCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence            99999 68898888543    45899999999999999999999999999999999999999999999999999865443


Q ss_pred             ccccccCCCCCccccCcccccccCC-CCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ..  ....+||+.|+|||++.+..+ ++++|||||||++|+|++|..||.............                  
T Consensus       162 ~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~------------------  221 (336)
T 3h4j_B          162 NF--LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVN------------------  221 (336)
T ss_dssp             BT--TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCC------------------
T ss_pred             cc--cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHH------------------
Confidence            22  234569999999999988776 689999999999999999999997543221110000                  


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       . .....+..++..+.+++.+||..||.+|||+.|+++.
T Consensus       222 -~-~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          222 -S-CVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             -S-SCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             -c-CCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence             0 0000011234578899999999999999999999864

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.2e-45  Score=349.23  Aligned_cols=263  Identities=21%  Similarity=0.293  Sum_probs=197.4

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-----c
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-----R  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~  131 (375)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++....     .
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            578999999999999999999654 6899999999654  4445677889999999999999999999775432     4


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      .+++||||+++ +|.+.+.      ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++..
T Consensus       141 ~~~lv~E~~~~-~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~  213 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  213 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC--
T ss_pred             eEEEEEeCCCC-CHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeee
Confidence            67999999975 4666662      2389999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh-------
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN-------  284 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-------  284 (375)
                      .....  ......||+.|+|||++.+..++.++|||||||++|+|++|++||......+...   .....+..       
T Consensus       214 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~---~i~~~lg~p~~~~~~  288 (464)
T 3ttj_A          214 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN---KVIEQLGTPCPEFMK  288 (464)
T ss_dssp             ---CC--CC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH---HHHHHHCSCCHHHHT
T ss_pred             cCCCc--ccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHHhcCCCCHHHHH
Confidence            54322  2334579999999999999999999999999999999999999997654222110   00000000       


Q ss_pred             ---hHHHHHHhh---------------hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          285 ---KALHELVDQ---------------TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       285 ---~~~~~~~~~---------------~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                         ......+..               .+..............+.+|+.+||..||++|||++|+++.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          289 KLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             TSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence               001111111               01111111222336679999999999999999999999874

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.2e-45  Score=334.83  Aligned_cols=273  Identities=24%  Similarity=0.354  Sum_probs=215.9

Q ss_pred             chHHHHHHhcCCCCCCccCCCCcEEEEEEEe------CCCCEEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCeEEEe
Q 017232           52 SYGELEEATNYFDSARELGDGGFGTVYYGEL------QDGRAVAVKRLYENN-YKRVEQFMNEVDILARL-RHKNLVSLY  123 (375)
Q Consensus        52 ~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~  123 (375)
                      ....+....++|++.+.||+|+||.||+|..      .+++.||+|++.... ......+.+|+.++..+ +||||++++
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   97 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL   97 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEE
Confidence            3344445567899999999999999999964      346889999987653 34456789999999999 699999999


Q ss_pred             eeeecCCceeEEEEecccCCChhHhhccCCCC------------CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCC
Q 017232          124 GCTSRHSRELLLVYEFISNGTVADHLHGERAK------------PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTN  191 (375)
Q Consensus       124 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~------------~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~  191 (375)
                      +++...+...++||||+++++|.+++......            ...+++..++.++.|++.||.|||+.|++||||||+
T Consensus        98 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~  177 (316)
T 2xir_A           98 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  177 (316)
T ss_dssp             EEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             EEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccc
Confidence            98877667799999999999999999754321            223889999999999999999999999999999999


Q ss_pred             CEEecCCCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccc
Q 017232          192 NILLDNNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHR  269 (375)
Q Consensus       192 Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~  269 (375)
                      ||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       178 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  257 (316)
T 2xir_A          178 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID  257 (316)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS
T ss_pred             eEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchh
Confidence            99999999999999999986543322 22233457889999999998899999999999999999998 99999754321


Q ss_pred             cccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          270 HEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      .      ....         .+.........   ..++..+.+++.+||+.+|.+|||+.++++.|+.+.+..
T Consensus       258 ~------~~~~---------~~~~~~~~~~~---~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  312 (316)
T 2xir_A          258 E------EFCR---------RLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  312 (316)
T ss_dssp             H------HHHH---------HHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             H------HHHH---------HhccCccCCCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhh
Confidence            1      1111         11111111111   123457899999999999999999999999999987543

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-45  Score=335.83  Aligned_cols=259  Identities=25%  Similarity=0.449  Sum_probs=201.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCC-----CCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQD-----GRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ++|++.+.||+|+||.||+|....     +..||+|.+... .......+.+|+.+++.++||||+++++++.. ....+
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~  122 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMM  122 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEE
T ss_pred             HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEec-CCCcE
Confidence            467778999999999999996542     235999998754 33445678899999999999999999997765 67799


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++++|.+++...   ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus       123 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~  199 (333)
T 1mqb_A          123 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  199 (333)
T ss_dssp             EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEeCCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcc
Confidence            999999999999999643   34689999999999999999999999999999999999999999999999999987643


Q ss_pred             Cccc--cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          215 HVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       215 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ....  ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......                ....+
T Consensus       200 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~----------------~~~~~  263 (333)
T 1mqb_A          200 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE----------------VMKAI  263 (333)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------HHHHH
T ss_pred             ccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHH----------------HHHHH
Confidence            3211  1122346788999999998899999999999999999998 999996443110                00111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      .....   .+....++..+.+++.+||+.+|++||++.++++.|+++....
T Consensus       264 ~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  311 (333)
T 1mqb_A          264 NDGFR---LPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAP  311 (333)
T ss_dssp             HTTCC---CCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSG
T ss_pred             HCCCc---CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence            11111   1111234567999999999999999999999999999987643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.1e-46  Score=342.51  Aligned_cols=277  Identities=24%  Similarity=0.293  Sum_probs=208.7

Q ss_pred             ccccchHHHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcC-----CCCeEE
Q 017232           48 VQVFSYGELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLR-----HKNLVS  121 (375)
Q Consensus        48 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~  121 (375)
                      ...+++.+.....++|++.++||+|+||.||+|... +++.||+|++... ......+..|+.+++.+.     ||||++
T Consensus        22 ~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~  100 (360)
T 3llt_A           22 IVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVK  100 (360)
T ss_dssp             GGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCC
T ss_pred             ceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeec
Confidence            345566666677889999999999999999999764 6899999998643 334456778999999996     999999


Q ss_pred             EeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC----
Q 017232          122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN----  197 (375)
Q Consensus       122 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~----  197 (375)
                      +++++.. ....++||||+ +++|.+++....  ...+++..++.++.||+.||.|||++||+||||||+|||++.    
T Consensus       101 ~~~~~~~-~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~  176 (360)
T 3llt_A          101 YHGKFMY-YDHMCLIFEPL-GPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFE  176 (360)
T ss_dssp             EEEEEEE-TTEEEEEECCC-CCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCC
T ss_pred             ccceeeE-CCeeEEEEcCC-CCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEcccccc
Confidence            9997776 56899999999 899999997542  345899999999999999999999999999999999999975    


Q ss_pred             ---------------------CCcEEEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHH
Q 017232          198 ---------------------NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIEL  256 (375)
Q Consensus       198 ---------------------~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el  256 (375)
                                           ++.+||+|||++......    .....||+.|+|||++.+..++.++|||||||++|+|
T Consensus       177 ~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el  252 (360)
T 3llt_A          177 KSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAEL  252 (360)
T ss_dssp             EEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHH
T ss_pred             ccccchhcccccccccccccCCCCEEEEeccCceecCCC----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHH
Confidence                                 789999999999864432    2344689999999999999999999999999999999


Q ss_pred             HhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh--------------------------hcCCCCChHHHHHHHHH
Q 017232          257 ISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ--------------------------TLGYESDNKVRRTINAV  310 (375)
Q Consensus       257 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~l~~~~~~~~~~~~~~l  310 (375)
                      ++|+.||..............................                          ................+
T Consensus       253 l~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l  332 (360)
T 3llt_A          253 YTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELF  332 (360)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHH
T ss_pred             HHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHH
Confidence            9999999755422211100000000000000000000                          00000001111112568


Q ss_pred             HHHHHHhcCCCCCCCCCHHHHHH
Q 017232          311 AELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       311 ~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .+|+.+||+.||++|||+.|+++
T Consensus       333 ~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          333 CDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHhcCChhhCCCHHHHhc
Confidence            89999999999999999999975

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.6e-45  Score=335.63  Aligned_cols=261  Identities=20%  Similarity=0.330  Sum_probs=204.4

Q ss_pred             hHHHHHHhcCCCCC-CccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcC-CCCeEEEeeeee
Q 017232           53 YGELEEATNYFDSA-RELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLR-HKNLVSLYGCTS  127 (375)
Q Consensus        53 ~~~~~~~~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~  127 (375)
                      +...+...++|.+. +.||+|+||.||+|... +++.||+|++....  ......+.+|+.++..+. ||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~   99 (327)
T 3lm5_A           20 FQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYE   99 (327)
T ss_dssp             SBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEE
T ss_pred             HHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEE
Confidence            33455667788887 88999999999999665 68999999986542  233567889999999995 699999999877


Q ss_pred             cCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC---CCcEEEe
Q 017232          128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVA  204 (375)
Q Consensus       128 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~---~~~~kl~  204 (375)
                      . ....++||||+.+++|.+++...  ....+++..++.++.|++.||.|||++|++||||||+||+++.   ++.+||+
T Consensus       100 ~-~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~  176 (327)
T 3lm5_A          100 N-TSEIILILEYAAGGEIFSLCLPE--LAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIV  176 (327)
T ss_dssp             C-SSEEEEEEECCTTEEGGGGGSSC--C-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEEC
T ss_pred             e-CCeEEEEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEe
Confidence            6 67799999999999999998543  3456999999999999999999999999999999999999987   7899999


Q ss_pred             eeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh
Q 017232          205 DFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       205 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      |||++........  .....+|+.|+|||++.+..++.++||||||+++|+|++|..||.......              
T Consensus       177 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~--------------  240 (327)
T 3lm5_A          177 DFGMSRKIGHACE--LREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE--------------  240 (327)
T ss_dssp             CGGGCEEC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--------------
T ss_pred             eCccccccCCccc--cccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH--------------
Confidence            9999987643322  233469999999999999999999999999999999999999997543211              


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       ....+...... ........++..+.+++.+||+.+|++|||++++++.
T Consensus       241 -~~~~i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          241 -TYLNISQVNVD-YSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -HHHHHHHTCCC-CCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -HHHHHHhcccc-cCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence             00011111111 1111112345678999999999999999999999864

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-45  Score=339.47  Aligned_cols=268  Identities=25%  Similarity=0.318  Sum_probs=205.0

Q ss_pred             HHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-----chhhHHHHHHHHHHHHhcCCCCeEEEeeeeec
Q 017232           55 ELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-----NYKRVEQFMNEVDILARLRHKNLVSLYGCTSR  128 (375)
Q Consensus        55 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-----~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  128 (375)
                      ++....++|++.+.||+|+||.||+|... ++..||+|++...     .....+.+.+|+.+++.++||||+++++++..
T Consensus        20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~   99 (345)
T 3hko_A           20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED   99 (345)
T ss_dssp             CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred             hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence            35567788999999999999999999664 6889999998654     23445788999999999999999999998766


Q ss_pred             CCceeEEEEecccCCChhHhhccCCCC------------------------------------CCCCChHHHHHHHHHHH
Q 017232          129 HSRELLLVYEFISNGTVADHLHGERAK------------------------------------PGALPWPTRLKIAIETA  172 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~~~------------------------------------~~~l~~~~~~~i~~~i~  172 (375)
                       ....++||||+++++|.+++......                                    ...+++..++.++.|++
T Consensus       100 -~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~  178 (345)
T 3hko_A          100 -EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF  178 (345)
T ss_dssp             -SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHH
T ss_pred             -CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHH
Confidence             67899999999999999998532111                                    11235677889999999


Q ss_pred             HHHHHHhhCCceeccCCCCCEEecCCC--cEEEeeeccccccCCC---ccccccCCCCCccccCcccccc--cCCCCchh
Q 017232          173 SALTYLHASDIIHRDVKTNNILLDNNF--CVKVADFGLSRLFPNH---VTHVSTAPQGTPGYVDPEYHQC--YQLTDKSD  245 (375)
Q Consensus       173 ~~l~~Lh~~~ivH~dlkp~Nill~~~~--~~kl~Dfg~~~~~~~~---~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~D  245 (375)
                      .||.|||+.||+||||||+||+++.++  .+||+|||++..+...   .........+|+.|+|||++.+  ..++.++|
T Consensus       179 ~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            999999999999999999999998776  8999999999865321   1112334569999999998865  67899999


Q ss_pred             HHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCC
Q 017232          246 VFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLR  325 (375)
Q Consensus       246 iwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~R  325 (375)
                      ||||||++|+|++|+.||.......               ....+....... ..+....++..+.+++.+||+.+|.+|
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~---------------~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~R  322 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDAD---------------TISQVLNKKLCF-ENPNYNVLSPLARDLLSNLLNRNVDER  322 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHH---------------HHHHHHHCCCCT-TSGGGGGSCHHHHHHHHHHSCSCTTTS
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHH---------------HHHHHHhccccc-CCcccccCCHHHHHHHHHHcCCChhHC
Confidence            9999999999999999997543211               111111111111 111222345679999999999999999


Q ss_pred             CCHHHHHHH--HHhhh
Q 017232          326 PYMVDVLDA--LRDIE  339 (375)
Q Consensus       326 pt~~evl~~--L~~i~  339 (375)
                      ||+.++++.  ++++.
T Consensus       323 ps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          323 FDAMRALQHPWISQFS  338 (345)
T ss_dssp             CCHHHHHHSHHHHTTS
T ss_pred             CCHHHHhcChhhccCh
Confidence            999999873  55443

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.4e-45  Score=326.70  Aligned_cols=253  Identities=18%  Similarity=0.296  Sum_probs=204.8

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-CceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-SRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~~lv~  137 (375)
                      ++|++.+.||+|+||.||+|... ++.||+|++...  .....+.+.+|+.+++.++||||+++++++... ....++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            56888999999999999999886 889999998654  344556789999999999999999999977653 36789999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC--ceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||+++++|.+++...  ....+++..++.++.|++.||.|||+.|  ++|+||||+||+++.++.++|+|||++..... 
T Consensus        89 e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~-  165 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-  165 (271)
T ss_dssp             ECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSC-
T ss_pred             cccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeeecc-
Confidence            999999999999653  2336899999999999999999999999  99999999999999999999999988754322 


Q ss_pred             ccccccCCCCCccccCcccccccCCCC---chhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTD---KSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~---~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                           ....+|+.|+|||.+.+..++.   ++||||||+++|+|++|..||.......      .         ......
T Consensus       166 -----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~---------~~~~~~  225 (271)
T 3kmu_A          166 -----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNME------I---------GMKVAL  225 (271)
T ss_dssp             -----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHH------H---------HHHHHH
T ss_pred             -----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHH------H---------HHHHHh
Confidence                 2335899999999988765544   7999999999999999999997543211      0         011111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      .......   ...++..+.+++.+||+.+|++|||+.++++.|+++..
T Consensus       226 ~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          226 EGLRPTI---PPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             SCCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             cCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            1111111   12245679999999999999999999999999999864

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.8e-46  Score=338.91  Aligned_cols=251  Identities=23%  Similarity=0.362  Sum_probs=198.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|++.+.||+|+||.||+|..+ +++.||+|++...   .......+.+|..++..+ +||||+++++++.. ...+++
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~l   87 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQT-ESRLFF   87 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEe-CCEEEE
Confidence            46888999999999999999765 6889999999654   334456788999999988 89999999998766 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++|+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        88 v~e~~~gg~L~~~l~~~----~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~  163 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQ----RKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP  163 (345)
T ss_dssp             EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT
T ss_pred             EEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCC
Confidence            99999999999998643    45899999999999999999999999999999999999999999999999999753322


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      . ......+||+.|+|||++.+..++.++|||||||++|||++|++||............      ........+.....
T Consensus       164 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~------~~~~~~~~i~~~~~  236 (345)
T 3a8x_A          164 G-DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN------TEDYLFQVILEKQI  236 (345)
T ss_dssp             T-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------------CHHHHHHHHHHCCC
T ss_pred             C-CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccc------cHHHHHHHHHcCCC
Confidence            2 1234457999999999999999999999999999999999999999753322110000      00000111111111


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYM  328 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  328 (375)
                      .  .+   ...+..+.+++.+||+.||++||++
T Consensus       237 ~--~p---~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          237 R--IP---RSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             C--CC---TTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             C--CC---CCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            1  11   1245678999999999999999996

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-46  Score=343.58  Aligned_cols=262  Identities=27%  Similarity=0.409  Sum_probs=199.6

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC--CC--CEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ--DG--RAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~--~~--~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .|++.+.||+|+||.||+|...  ++  ..||+|.+... .....+.+.+|+.+++.++||||+++++++.......++|
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv  169 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV  169 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence            4667789999999999999654  22  36899988653 3455678999999999999999999999776656778999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++...   ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       170 ~e~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~  246 (373)
T 3c1x_A          170 LPYMKHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  246 (373)
T ss_dssp             EECCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EECCCCCCHHHHHhhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeeccccccccccc
Confidence            9999999999999543   3458899999999999999999999999999999999999999999999999997654322


Q ss_pred             cc---cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          217 TH---VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       217 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ..   ......+++.|+|||.+.+..++.++|||||||++|||++ |.+||........   ..    .        +..
T Consensus       247 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~---~~----~--------~~~  311 (373)
T 3c1x_A          247 FDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI---TV----Y--------LLQ  311 (373)
T ss_dssp             -----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCH---HH----H--------HHT
T ss_pred             cccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHH---HH----H--------HHc
Confidence            11   1223457789999999999899999999999999999999 7788865432210   00    0        000


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDD  345 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~~  345 (375)
                      . .   ....+..++..+.+++.+||+.+|++|||+.++++.|+.+.....++
T Consensus       312 ~-~---~~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~  360 (373)
T 3c1x_A          312 G-R---RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  360 (373)
T ss_dssp             T-C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             C-C---CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcccc
Confidence            0 0   00111224567999999999999999999999999999988766543

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-45  Score=328.67  Aligned_cols=257  Identities=25%  Similarity=0.385  Sum_probs=207.4

Q ss_pred             cCCCCCC-ccCCCCcEEEEEEEeC---CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSAR-ELGDGGFGTVYYGELQ---DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|.+.+ .||+|+||.||+|...   ++..||+|++... .....+.+.+|+.+++.++||||+++++++.  ....++
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~--~~~~~l   86 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ--AEALML   86 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEE--SSSEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEec--CCCcEE
Confidence            4566666 8999999999999653   5788999999764 3445678899999999999999999999874  456899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++..   ....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        87 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~  163 (287)
T 1u59_A           87 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  163 (287)
T ss_dssp             EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccC
Confidence            9999999999999853   3356899999999999999999999999999999999999999999999999999876433


Q ss_pred             ccc--cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          216 VTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       216 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ...  ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......      .          ...+.
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~------~----------~~~i~  227 (287)
T 1u59_A          164 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE------V----------MAFIE  227 (287)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH------H----------HHHHH
T ss_pred             cceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHH------H----------HHHHh
Confidence            222  1223346889999999988889999999999999999998 999997543211      0          01111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .......   ...++..+.+++.+||..+|++||++.++++.|+.+...
T Consensus       228 ~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          228 QGKRMEC---PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             TTCCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cCCcCCC---CCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence            1111111   123456899999999999999999999999999987653

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.9e-45  Score=337.81  Aligned_cols=252  Identities=23%  Similarity=0.360  Sum_probs=189.0

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ...++|++.+.||+|+||.||+|... +++.||+|++....  ..+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~-~~~~~lv  126 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFET-PTEISLV  126 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEec-CCeEEEE
Confidence            45678999999999999999999776 58899999987543  23567889999999999999999998776 6779999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC---CCcEEEeeeccccccC
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSRLFP  213 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~~~~  213 (375)
                      |||+++++|.+++..    ...+++.+++.++.|++.||.|||+.||+||||||+|||++.   ++.+||+|||++....
T Consensus       127 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~  202 (349)
T 2w4o_A          127 LELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE  202 (349)
T ss_dssp             ECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred             EEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence            999999999999853    345899999999999999999999999999999999999975   8899999999998654


Q ss_pred             CCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          214 NHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       214 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ...  ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......      ...        ..+...
T Consensus       203 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~------~~~--------~~i~~~  266 (349)
T 2w4o_A          203 HQV--LMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ------FMF--------RRILNC  266 (349)
T ss_dssp             ------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH------HHH--------HHHHTT
T ss_pred             ccc--ccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH------HHH--------HHHHhC
Confidence            322  1234468999999999999899999999999999999999999996443211      011        111111


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ... ...+.....+..+.+++.+||..||++|||+.++++
T Consensus       267 ~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          267 EYY-FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             CCC-CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             CCc-cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111 011111234567899999999999999999999986

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.8e-46  Score=360.11  Aligned_cols=261  Identities=29%  Similarity=0.461  Sum_probs=211.9

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ...++|++.+.||+|+||.||+|.+.++..||||++..... ..+.+.+|+.+|+.++||||+++++++..  ...++||
T Consensus       264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~  340 (535)
T 2h8h_A          264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVT  340 (535)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEE
T ss_pred             cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEee
Confidence            34567888999999999999999998888899999976542 34678999999999999999999997754  5689999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+.+|+|.+++...  ....+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus       341 e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  418 (535)
T 2h8h_A          341 EYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  418 (535)
T ss_dssp             CCCTTEEHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH
T ss_pred             ehhcCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce
Confidence            999999999999542  224589999999999999999999999999999999999999999999999999987654322


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .......++..|+|||++.+..++.++|||||||++|||++ |+.||.......                ....+.....
T Consensus       419 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~----------------~~~~i~~~~~  482 (535)
T 2h8h_A          419 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE----------------VLDQVERGYR  482 (535)
T ss_dssp             HTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH----------------HHHHHHTTCC
T ss_pred             ecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCC
Confidence            22334457789999999988899999999999999999999 999997543110                0111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      ...   ...++..+.+|+.+||+.+|++|||+.+|++.|+.+....
T Consensus       483 ~~~---~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~  525 (535)
T 2h8h_A          483 MPC---PPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  525 (535)
T ss_dssp             CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCC
T ss_pred             CCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhcc
Confidence            111   1235567999999999999999999999999999886543

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.3e-46  Score=337.08  Aligned_cols=276  Identities=25%  Similarity=0.390  Sum_probs=212.0

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-----CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-Ccee
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-----QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-SREL  133 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-~~~~  133 (375)
                      .++|++.+.||+|+||.||+|..     .+++.||+|++........+.+.+|+.+++.++||||+++++++... ....
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  119 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNL  119 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CC
T ss_pred             HHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCce
Confidence            35688999999999999999973     36889999999877666778899999999999999999999976543 3468


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++||||+++++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++....
T Consensus       120 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~  196 (326)
T 2w1i_A          120 KLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLP  196 (326)
T ss_dssp             EEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhcc
Confidence            9999999999999999654   2458999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccc--cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          214 NHVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       214 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      .....  ......++..|+|||.+.+..++.++||||||+++|+|++|..|+.........................+.+
T Consensus       197 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (326)
T 2w1i_A          197 QDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELL  276 (326)
T ss_dssp             SSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHH
T ss_pred             ccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHh
Confidence            43321  1223457778999999988889999999999999999999999886432100000000000000001111222


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ......   +....++..+.+++.+||+.+|++|||+.+|++.|+++...
T Consensus       277 ~~~~~~---~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~  323 (326)
T 2w1i_A          277 KNNGRL---PRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQ  323 (326)
T ss_dssp             HTTCCC---CCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hcCCCC---CCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHH
Confidence            211111   11123557899999999999999999999999999998753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=2.6e-45  Score=328.02  Aligned_cols=252  Identities=26%  Similarity=0.445  Sum_probs=200.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhh-------HHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKR-------VEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      ++|++.+.||+|+||.||+|... +++.||+|++.......       .+.+.+|+.+++.++||||+++++++...   
T Consensus        19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---   95 (287)
T 4f0f_A           19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP---   95 (287)
T ss_dssp             TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT---
T ss_pred             ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC---
Confidence            57888999999999999999764 78999999986442211       16788999999999999999999977553   


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC--ceeccCCCCCEEecCCCc-----EEEee
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--IIHRDVKTNNILLDNNFC-----VKVAD  205 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--ivH~dlkp~Nill~~~~~-----~kl~D  205 (375)
                      .++||||+++++|.+.+...   ...+++..++.++.|++.||.|||++|  ++|+||||+||+++.++.     +||+|
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~D  172 (287)
T 4f0f_A           96 PRMVMEFVPCGDLYHRLLDK---AHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD  172 (287)
T ss_dssp             TEEEEECCTTCBHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECC
T ss_pred             CeEEEEecCCCCHHHHHhcc---cCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCC
Confidence            26999999999999888543   346999999999999999999999999  999999999999988776     99999


Q ss_pred             eccccccCCCccccccCCCCCccccCcccc--cccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh
Q 017232          206 FGLSRLFPNHVTHVSTAPQGTPGYVDPEYH--QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ  283 (375)
Q Consensus       206 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~--~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  283 (375)
                      ||++......    .....+|+.|+|||.+  ....++.++|||||||++|+|++|+.||.........    . .    
T Consensus       173 fg~~~~~~~~----~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~----~-~----  239 (287)
T 4f0f_A          173 FGLSQQSVHS----VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK----F-I----  239 (287)
T ss_dssp             CTTCBCCSSC----EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHH----H-H----
T ss_pred             CCcccccccc----ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHH----H-H----
Confidence            9999754332    2345689999999988  4556788999999999999999999999754322100    0 0    


Q ss_pred             hhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       284 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                          ............   ...++..+.+++.+||+.||++|||+.++++.|+++
T Consensus       240 ----~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          240 ----NMIREEGLRPTI---PEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             ----HHHHHSCCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             ----HHHhccCCCCCC---CcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence                001111111111   123456799999999999999999999999999875

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1.6e-45  Score=329.24  Aligned_cols=253  Identities=26%  Similarity=0.396  Sum_probs=197.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|.+.+.||+|+||.||+|... ++..+|+|++.... ....+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~   99 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFED-YHNMYIVM   99 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheec-CCeEEEEE
Confidence            356899999999999999999764 68899999986543 3345778999999999999999999998766 67799999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe---cCCCcEEEeeeccccccCC
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~  214 (375)
                      ||+++++|.+.+.........+++..++.++.|++.||.|||+.|++||||||+||++   +.++.+||+|||++.....
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~  179 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS  179 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCC
Confidence            9999999999986554445679999999999999999999999999999999999999   5567899999999976544


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ...  .....+++.|+|||++.+ .++.++||||||+++|+|++|+.||.......      ...         ..... 
T Consensus       180 ~~~--~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~------~~~---------~~~~~-  240 (285)
T 3is5_A          180 DEH--STNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEE------VQQ---------KATYK-  240 (285)
T ss_dssp             ---------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------HHH---------HHHHC-
T ss_pred             ccc--CcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHH------HHh---------hhccC-
Confidence            322  234468999999998864 68999999999999999999999997543111      000         00000 


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       ...........+..+.+++.+||+.||++|||+.|+++
T Consensus       241 -~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          241 -EPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             -CCCCCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             -CcccccccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence             00111111113457889999999999999999999985

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=5e-46  Score=338.68  Aligned_cols=257  Identities=23%  Similarity=0.397  Sum_probs=202.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCE----EEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRA----VAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ++|++.+.||+|+||.||+|... ++..    |++|.+.... ......+.+|+.+++.++||||+++++++.  +...+
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~--~~~~~   90 (325)
T 3kex_A           13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP--GSSLQ   90 (325)
T ss_dssp             TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC--BSSEE
T ss_pred             hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCccE
Confidence            56888999999999999999754 4544    7788774432 223345678999999999999999999775  35689


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+.+++|.+++...   ...+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus        91 ~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~  167 (325)
T 3kex_A           91 LVTQYLPLGSLLDHVRQH---RGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPP  167 (325)
T ss_dssp             EEEECCTTCBSHHHHHSS---GGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCC
T ss_pred             EEEEeCCCCCHHHHHHHc---cccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCc
Confidence            999999999999999643   34689999999999999999999999999999999999999999999999999987654


Q ss_pred             Cccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          215 HVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       215 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......                ....+.
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~----------------~~~~~~  231 (325)
T 3kex_A          168 DDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAE----------------VPDLLE  231 (325)
T ss_dssp             CTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTH----------------HHHHHH
T ss_pred             ccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHH----------------HHHHHH
Confidence            3322 2234457789999999998899999999999999999999 999997543211                111111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .......   ...++..+.+++.+||..+|.+|||+.++++.|+.+...
T Consensus       232 ~~~~~~~---~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          232 KGERLAQ---PQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             TTCBCCC---CTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             cCCCCCC---CCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            1111111   111345688999999999999999999999999998654

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.9e-45  Score=326.04  Aligned_cols=251  Identities=21%  Similarity=0.345  Sum_probs=203.9

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ..++|++.+.||+|+||.||+|... ++..||+|++........+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   85 (277)
T 3f3z_A            7 INQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFED-NTDIYLVM   85 (277)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             hhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCeEEEEE
Confidence            3567999999999999999999765 577999999977655566789999999999999999999997776 67799999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe---cCCCcEEEeeeccccccCC
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~  214 (375)
                      ||+++++|.+++...    ..+++..++.++.|++.||.|||++|++|+||||+||++   +.++.++|+|||++.....
T Consensus        86 e~~~~~~L~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~  161 (277)
T 3f3z_A           86 ELCTGGELFERVVHK----RVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP  161 (277)
T ss_dssp             ECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred             eccCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence            999999999988543    458999999999999999999999999999999999999   7889999999999986654


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ...  .....+|+.|+|||.+.+. ++.++||||||+++|+|++|..||.......       ..        ..+... 
T Consensus       162 ~~~--~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~--------~~~~~~-  222 (277)
T 3f3z_A          162 GKM--MRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSE-------VM--------LKIREG-  222 (277)
T ss_dssp             TSC--BCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HH--------HHHHHC-
T ss_pred             ccc--hhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHH-------HH--------HHHHhC-
Confidence            322  2344699999999988764 8999999999999999999999997543211       00        001110 


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ...........++..+.+++.+||+.+|++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          223 TFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000111111234568999999999999999999999986

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.1e-46  Score=340.96  Aligned_cols=249  Identities=24%  Similarity=0.338  Sum_probs=200.7

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCce
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  132 (375)
                      ...++|++.+.||+|+||.||+|..+ +|+.||+|++....   ......+..|..++..+ +||||+++++++.. ...
T Consensus        14 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~-~~~   92 (345)
T 1xjd_A           14 LKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KEN   92 (345)
T ss_dssp             --CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSE
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEe-CCE
Confidence            34567999999999999999999775 68999999996542   23345677899999887 89999999997776 678


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      +++||||+++|+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~  168 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKEN  168 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred             EEEEEeCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhc
Confidence            99999999999999999643    45899999999999999999999999999999999999999999999999999754


Q ss_pred             CCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .... ......+||+.|+|||++.+..++.++|||||||++|||++|.+||.......       ..        ..+..
T Consensus       169 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~-------~~--------~~i~~  232 (345)
T 1xjd_A          169 MLGD-AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LF--------HSIRM  232 (345)
T ss_dssp             CCTT-CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HH--------HHHHH
T ss_pred             ccCC-CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHH-------HH--------HHHHh
Confidence            3221 12345579999999999999999999999999999999999999997543211       00        11111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHH-HHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMV-DVL  332 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-evl  332 (375)
                      ....  .+   ..++..+.+++.+||..+|++||++. +++
T Consensus       233 ~~~~--~p---~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          233 DNPF--YP---RWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             CCCC--CC---TTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             CCCC--CC---cccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            1111  11   12446789999999999999999997 554

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=338.94  Aligned_cols=251  Identities=25%  Similarity=0.365  Sum_probs=199.1

Q ss_pred             CCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCCC
Q 017232           66 ARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~~  144 (375)
                      .+.||+|+||.||+|... +|+.||+|++........+.+.+|+.+++.++||||+++++++.. ....++||||+++++
T Consensus        94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~E~~~~~~  172 (373)
T 2x4f_A           94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFES-KNDIVLVMEYVDGGE  172 (373)
T ss_dssp             EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEEECCTTCE
T ss_pred             ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEeCCCCCc
Confidence            567999999999999664 689999999987766667789999999999999999999998776 677999999999999


Q ss_pred             hhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe--cCCCcEEEeeeccccccCCCccccccC
Q 017232          145 VADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL--DNNFCVKVADFGLSRLFPNHVTHVSTA  222 (375)
Q Consensus       145 L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill--~~~~~~kl~Dfg~~~~~~~~~~~~~~~  222 (375)
                      |.+++...   ...+++..++.++.||+.||.|||+.||+||||||+|||+  +.++.+||+|||++........  ...
T Consensus       173 L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~--~~~  247 (373)
T 2x4f_A          173 LFDRIIDE---SYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK--LKV  247 (373)
T ss_dssp             EHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB--CCC
T ss_pred             HHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc--ccc
Confidence            99988543   2358999999999999999999999999999999999999  5678999999999987654332  233


Q ss_pred             CCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChH
Q 017232          223 PQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNK  302 (375)
Q Consensus       223 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  302 (375)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|..||.......               ....+...... .....
T Consensus       248 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---------------~~~~i~~~~~~-~~~~~  311 (373)
T 2x4f_A          248 NFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE---------------TLNNILACRWD-LEDEE  311 (373)
T ss_dssp             CCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------------HHHHHHHTCCC-SCSGG
T ss_pred             ccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHH---------------HHHHHHhccCC-CChhh
Confidence            469999999999998889999999999999999999999997543211               11111111111 11111


Q ss_pred             HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHHhh
Q 017232          303 VRRTINAVAELAFQCLQSEKDLRPYMVDVLD--ALRDI  338 (375)
Q Consensus       303 ~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~--~L~~i  338 (375)
                      ...++..+.+++.+||+.+|.+|||+.|+++  .+.+.
T Consensus       312 ~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          312 FQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             GTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             hccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            2234567999999999999999999999997  45543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.1e-45  Score=335.66  Aligned_cols=264  Identities=25%  Similarity=0.366  Sum_probs=209.2

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeCC-C-----CEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecC
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQD-G-----RAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRH  129 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  129 (375)
                      ...++|++.+.||+|+||.||+|.... +     ..||+|.+... .....+.+.+|+.+++.+ +||||+++++++.. 
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-  121 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTH-  121 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEec-
Confidence            345789999999999999999997642 2     47999998655 334567789999999999 89999999997766 


Q ss_pred             CceeEEEEecccCCChhHhhccCCC----------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC
Q 017232          130 SRELLLVYEFISNGTVADHLHGERA----------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF  199 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~----------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~  199 (375)
                      ....++||||+++++|.+++.....          ....+++..++.++.|++.||.|||++||+||||||+||+++.++
T Consensus       122 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~  201 (333)
T 2i1m_A          122 GGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGH  201 (333)
T ss_dssp             SSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGG
T ss_pred             CCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCC
Confidence            5679999999999999999864321          134689999999999999999999999999999999999999999


Q ss_pred             cEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHH
Q 017232          200 CVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNL  277 (375)
Q Consensus       200 ~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~  277 (375)
                      .+||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.......      .
T Consensus       202 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~------~  275 (333)
T 2i1m_A          202 VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNS------K  275 (333)
T ss_dssp             EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSH------H
T ss_pred             eEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhH------H
Confidence            999999999986543222 12233456789999999988899999999999999999998 999997543211      0


Q ss_pred             HHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          278 AINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       278 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                               ..............   ..++..+.+++.+||+.+|.+|||+.+|++.|+++..
T Consensus       276 ---------~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~  326 (333)
T 2i1m_A          276 ---------FYKLVKDGYQMAQP---AFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQ  326 (333)
T ss_dssp             ---------HHHHHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------HHHHHhcCCCCCCC---CCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHH
Confidence                     11111111111111   1134578999999999999999999999999998764

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.6e-46  Score=334.36  Aligned_cols=255  Identities=25%  Similarity=0.455  Sum_probs=200.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .++|++.+.||+|+||.||+|... |+.||+|++....  ..+.+.+|+.+++.++||||+++++++.......++||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence            456899999999999999999875 8899999986553  3467889999999999999999999776656678999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++++|.+++....  ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......   
T Consensus        97 ~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~---  171 (278)
T 1byg_A           97 MAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ---  171 (278)
T ss_dssp             CTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred             CCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc---
Confidence            99999999996431  1237889999999999999999999999999999999999999999999999987544322   


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                       ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......      .. .         .+.......
T Consensus       172 -~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~------~~-~---------~~~~~~~~~  234 (278)
T 1byg_A          172 -DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------VV-P---------RVEKGYKMD  234 (278)
T ss_dssp             -----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------HH-H---------HHTTTCCCC
T ss_pred             -cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH------HH-H---------HHhcCCCCC
Confidence             22347889999999998899999999999999999998 999997543211      00 0         111111111


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      .   ...++..+.+++.+||+.+|++|||+.++++.|+.++...
T Consensus       235 ~---~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~~  275 (278)
T 1byg_A          235 A---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTHE  275 (278)
T ss_dssp             C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             C---cccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhhh
Confidence            1   1234567999999999999999999999999999987654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=4.9e-45  Score=325.72  Aligned_cols=253  Identities=21%  Similarity=0.321  Sum_probs=203.8

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...  .....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~~   82 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQE-ESFHYL   82 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEc-CCEEEE
Confidence            3578999999999999999999665 6899999998654  34455778899999999999999999997765 677899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc---EEEeeecccccc
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC---VKVADFGLSRLF  212 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~  212 (375)
                      ||||+++++|.+.+...    ..+++..++.++.|++.||.|||+.|++||||||+||+++.++.   +||+|||++...
T Consensus        83 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~  158 (284)
T 3kk8_A           83 VFDLVTGGELFEDIVAR----EFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV  158 (284)
T ss_dssp             EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence            99999999998888543    45899999999999999999999999999999999999976655   999999999765


Q ss_pred             CCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .....  .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......      .         ...+..
T Consensus       159 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~------~---------~~~~~~  221 (284)
T 3kk8_A          159 NDSEA--WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHR------L---------YAQIKA  221 (284)
T ss_dssp             CSSCB--CCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H---------HHHHHH
T ss_pred             ccCcc--ccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhH------H---------HHHHHh
Confidence            54322  234568999999999999999999999999999999999999996543111      0         001111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .... ...+....++..+.+++.+||+.+|++|||+.++++.
T Consensus       222 ~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          222 GAYD-YPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             TCCC-CCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             cccc-CCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            1111 1111112345678999999999999999999999873

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=2e-45  Score=332.91  Aligned_cols=265  Identities=24%  Similarity=0.381  Sum_probs=201.1

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC----CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc-
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ----DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR-  131 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-  131 (375)
                      ..++|.+.+.||+|+||.||+|...    ++..||+|.+...  .....+.+.+|+.+++.++||||+++++++..... 
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            4567899999999999999999654    3457999998654  34455778999999999999999999997765332 


Q ss_pred             ---eeEEEEecccCCChhHhhccCC--CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeee
Q 017232          132 ---ELLLVYEFISNGTVADHLHGER--AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADF  206 (375)
Q Consensus       132 ---~~~lv~e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Df  206 (375)
                         ..++||||+++++|.+++....  .....+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+||
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Df  191 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADF  191 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSC
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEEeec
Confidence               4599999999999999985433  23466999999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhh
Q 017232          207 GLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       207 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      |++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||.......      ..      
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~------~~------  259 (313)
T 3brb_A          192 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHE------MY------  259 (313)
T ss_dssp             SCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGG------HH------
T ss_pred             CcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HH------
Confidence            99976543321 11223457889999999999899999999999999999999 889997543211      00      


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                         ..+... .   .......++..+.+++.+||..+|++|||+.++++.|+++....
T Consensus       260 ---~~~~~~-~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~l  310 (313)
T 3brb_A          260 ---DYLLHG-H---RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESL  310 (313)
T ss_dssp             ---HHHHTT-C---CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             ---HHHHcC-C---CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhc
Confidence               001111 0   11111234567999999999999999999999999999987643

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=6.6e-45  Score=330.75  Aligned_cols=250  Identities=25%  Similarity=0.367  Sum_probs=203.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchh------hHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK------RVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      .++|++.+.||+|+||.||+|... +|+.||+|++......      ..+.+.+|+.+++.++||||+++++++.. ...
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~   89 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYEN-RTD   89 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEec-CCE
Confidence            456999999999999999999765 6899999998654321      35678999999999999999999997766 678


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC----cEEEeeecc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF----CVKVADFGL  208 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~  208 (375)
                      .++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++    .+||+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~  165 (321)
T 2a2a_A           90 VVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGL  165 (321)
T ss_dssp             EEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCcc
Confidence            9999999999999999953    34689999999999999999999999999999999999999888    799999999


Q ss_pred             ccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      +........  .....||+.|+|||.+.+..++.++||||||+++|+|++|..||.......      .         ..
T Consensus       166 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~---------~~  228 (321)
T 2a2a_A          166 AHEIEDGVE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------T---------LA  228 (321)
T ss_dssp             CEECCTTCC--CCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH------H---------HH
T ss_pred             ceecCcccc--ccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH------H---------HH
Confidence            987654322  234468999999999999899999999999999999999999996543111      0         00


Q ss_pred             HHHhhhcCCCCC-hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          289 ELVDQTLGYESD-NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       289 ~~~~~~l~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .+...  ..... ......+..+.+++.+||..||++|||+.++++
T Consensus       229 ~i~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          229 NITSV--SYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             HHHTT--CCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             HHHhc--ccccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11110  01111 111234567899999999999999999999986

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.7e-45  Score=335.03  Aligned_cols=250  Identities=21%  Similarity=0.270  Sum_probs=178.8

Q ss_pred             CCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEEEEecccCC
Q 017232           66 ARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNG  143 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~~  143 (375)
                      .+.||+|+||.||+|... +++.||+|++...   ....+.+|+.+++.+. ||||+++++++.. ....++||||++++
T Consensus        16 ~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~-~~~~~lv~e~~~~~   91 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHD-QLHTFLVMELLNGG   91 (325)
T ss_dssp             SCCSEEETTEEEEEEEETTTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEEECCCCSC
T ss_pred             CCccccCCCeEEEEEEECCCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEc-CCEEEEEEEccCCC
Confidence            378999999999999765 6899999998654   2356778999999997 9999999998776 67899999999999


Q ss_pred             ChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC---cEEEeeeccccccCCCccccc
Q 017232          144 TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       144 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~---~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      +|.+++...    ..+++.+++.++.|++.||.|||++||+||||||+|||++.++   .+||+|||++........ ..
T Consensus        92 ~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~-~~  166 (325)
T 3kn6_A           92 ELFERIKKK----KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ-PL  166 (325)
T ss_dssp             BHHHHHHHC----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             cHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC-cc
Confidence            999999643    4699999999999999999999999999999999999998766   899999999986543322 22


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD  300 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  300 (375)
                      ....+|+.|+|||++.+..++.++|||||||++|+|++|.+||..................+.        .. ......
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~--------~~-~~~~~~  237 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIK--------KG-DFSFEG  237 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHT--------TT-CCCCCS
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHH--------cC-CCCCCc
Confidence            344689999999999999999999999999999999999999976543211111111111111        11 111112


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          301 NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .....++..+.+++.+||..||.+|||+.++++
T Consensus       238 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          238 EAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             HHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence            222345678999999999999999999998874

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=2.7e-45  Score=328.14  Aligned_cols=264  Identities=22%  Similarity=0.347  Sum_probs=196.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|++.+.||+|+||.||+|...+|+.||+|++.....  .....+.+|+.+++.++||||+++++++.. ....++|||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   80 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFE   80 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-CCeEEEEEE
Confidence            47889999999999999999888899999999865432  224678899999999999999999998776 567999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |+++ +|.+++...   ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~~-~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-  155 (288)
T 1ob3_A           81 HLDQ-DLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (288)
T ss_dssp             CCSE-EHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             ecCC-CHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc-
Confidence            9974 898888543   34689999999999999999999999999999999999999999999999999976543222 


Q ss_pred             cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH------HHH--
Q 017232          219 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA------LHE--  289 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~------~~~--  289 (375)
                      ......+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||.........   ...........      ..+  
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~  232 (288)
T 1ob3_A          156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL---MRIFRILGTPNSKNWPNVTELP  232 (288)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGST
T ss_pred             ccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHHCCCChhhchhhhccc
Confidence            1233468999999998865 45899999999999999999999999754321110   00000000000      000  


Q ss_pred             HHhhhcCCC----CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          290 LVDQTLGYE----SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       290 ~~~~~l~~~----~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..++.....    .......++..+.+++.+||+.||++|||+.|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            000000000    00000123467889999999999999999999985

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.2e-45  Score=338.96  Aligned_cols=253  Identities=22%  Similarity=0.320  Sum_probs=192.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .++|++.+.||+|+||+||++... +++.||+|++...... .+.+.+|+.+++.++||||+++++++.. ....++|||
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~lv~e   96 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAI-DENVQREIINHRSLRHPNIVRFKEVILT-PTHLAIIME   96 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTS-CHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccc-cHHHHHHHHHHHhCCCCCCCcEEEEEee-CCEEEEEEE
Confidence            467999999999999999999766 7899999998654332 2567899999999999999999998776 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc--EEEeeeccccccCCCc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHV  216 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~~~~~~  216 (375)
                      |+++++|.+++...    +.+++..++.++.|++.||.|||++||+||||||+|||++.++.  +||+|||++.......
T Consensus        97 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~  172 (361)
T 3uc3_A           97 YASGGELYERICNA----GRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS  172 (361)
T ss_dssp             CCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-------
T ss_pred             eCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC
Confidence            99999999998543    35899999999999999999999999999999999999987765  9999999987432221


Q ss_pred             cccccCCCCCccccCcccccccCCCCc-hhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDK-SDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~-~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                        ......||+.|+|||++.+..++.+ +|||||||++|+|++|++||.........  ...         ...+.....
T Consensus       173 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~--~~~---------~~~~~~~~~  239 (361)
T 3uc3_A          173 --QPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY--RKT---------IQRILSVKY  239 (361)
T ss_dssp             ----------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH--HHH---------HHHHHTTCC
T ss_pred             --CCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH--HHH---------HHHHhcCCC
Confidence              1234469999999999988777665 89999999999999999999754322111  111         111111111


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ....   ...++..+.+|+.+||..+|++|||+.|+++.
T Consensus       240 ~~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          240 SIPD---DIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             CCCT---TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             CCCC---cCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            1111   01234678899999999999999999999875

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=2.7e-45  Score=336.49  Aligned_cols=245  Identities=25%  Similarity=0.369  Sum_probs=202.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||+|... +|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++.. ...+++|
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv  119 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc-CCEEEEE
Confidence            57899999999999999999765 689999999865422   335678899999999999999999997776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       120 ~e~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~  195 (350)
T 1rdq_E          120 MEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             EcCCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCCc
Confidence            9999999999999643    358999999999999999999999999999999999999999999999999998654322


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                          ...+||+.|+|||++.+..++.++|||||||++|+|++|.+||.......               ....+......
T Consensus       196 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---------------~~~~i~~~~~~  256 (350)
T 1rdq_E          196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---------------IYEKIVSGKVR  256 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------HHHHHHHCCCC
T ss_pred             ----ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---------------HHHHHHcCCCC
Confidence                33469999999999999999999999999999999999999997543110               01111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPY-----MVDVLDA  334 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~evl~~  334 (375)
                        .+   ..++..+.+++.+||+.||.+||+     ++++++.
T Consensus       257 --~p---~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          257 --FP---SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             --CC---TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CC---CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence              11   124567899999999999999998     7777653

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=8.9e-46  Score=337.19  Aligned_cols=258  Identities=22%  Similarity=0.358  Sum_probs=200.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCE----EEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRA----VAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~----vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      .++|++.+.||+|+||.||+|... +++.    |++|.+... .......+.+|+.+++.++||||+++++++...  ..
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~   91 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TV   91 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--SE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--Cc
Confidence            357899999999999999999754 4544    577776443 334567789999999999999999999987753  37


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++|++++.+++|.+++...   ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        92 ~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~  168 (327)
T 3lzb_A           92 QLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG  168 (327)
T ss_dssp             EEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred             eEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence            8999999999999999654   3458999999999999999999999999999999999999999999999999998764


Q ss_pred             CCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          214 NHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       214 ~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      .... .......+|+.|+|||.+.+..++.++|||||||++|+|++ |.+||.......                ....+
T Consensus       169 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~----------------~~~~~  232 (327)
T 3lzb_A          169 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSIL  232 (327)
T ss_dssp             -----------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG----------------HHHHH
T ss_pred             CccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHH
Confidence            3322 12223446789999999999999999999999999999999 999997543221                11111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ........   ...++..+.+++.+||..+|.+|||+.|+++.|+++...
T Consensus       233 ~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          233 EKGERLPQ---PPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             HTTCCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             HcCCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            11111111   122456789999999999999999999999999998754

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-45  Score=328.15  Aligned_cols=262  Identities=26%  Similarity=0.398  Sum_probs=206.7

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CC---CEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DG---RAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .|++.+.||+|+||.||+|... ++   ..||+|.+... .....+.+.+|+.+++.++||||+++++++.......++|
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v  101 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL  101 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence            3556789999999999999653 22   37999998654 3445678899999999999999999999887766666999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+.+++|.+++...   ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus       102 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  178 (298)
T 3pls_A          102 LPYMCHGDLLQFIRSP---QRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDRE  178 (298)
T ss_dssp             ECCCTTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGG
T ss_pred             EecccCCCHHHHHhcc---ccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCc
Confidence            9999999999999642   3568999999999999999999999999999999999999999999999999997654322


Q ss_pred             c---ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhC-CCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          217 T---HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS-MPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       217 ~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .   .......+++.|+|||.+.+..++.++||||||+++|+|++| .+||.......                ....+.
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~----------------~~~~~~  242 (298)
T 3pls_A          179 YYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFD----------------LTHFLA  242 (298)
T ss_dssp             GGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGG----------------HHHHHH
T ss_pred             ccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHH----------------HHHHhh
Confidence            1   122334578899999999999999999999999999999995 45554332111                011111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDD  345 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~~  345 (375)
                      ......   ....++..+.+++.+||+.+|.+|||+.++++.|+++.......
T Consensus       243 ~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          243 QGRRLP---QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             cCCCCC---CCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence            111111   11123467899999999999999999999999999988765543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=4.2e-45  Score=331.25  Aligned_cols=267  Identities=23%  Similarity=0.280  Sum_probs=198.3

Q ss_pred             hcCCCCC-CccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEE
Q 017232           60 TNYFDSA-RELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        60 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .+.|++. +.||+|+||.||+|... +++.||+|++..........+.+|+.++.++ +||||+++++++.. ....++|
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-~~~~~lv   89 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-EDRFYLV   89 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-CCEEEEE
Confidence            3567774 78999999999999754 7899999999766555567889999999985 79999999998776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc---EEEeeeccccccC
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC---VKVADFGLSRLFP  213 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~~~~~  213 (375)
                      |||+++++|.+++...    ..+++..++.++.|++.||.|||++||+||||||+||+++.++.   +||+|||++....
T Consensus        90 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~  165 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKR----RHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK  165 (316)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred             EEcCCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence            9999999999999643    45899999999999999999999999999999999999988776   9999999987653


Q ss_pred             CCc------cccccCCCCCccccCcccccc-----cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHh
Q 017232          214 NHV------THVSTAPQGTPGYVDPEYHQC-----YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKI  282 (375)
Q Consensus       214 ~~~------~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  282 (375)
                      ...      ........||+.|+|||++.+     ..++.++|||||||++|+|++|++||...................
T Consensus       166 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  245 (316)
T 2ac3_A          166 LNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPAC  245 (316)
T ss_dssp             ----------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHH
T ss_pred             cCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhH
Confidence            211      111223458999999998875     568899999999999999999999997654322110000000000


Q ss_pred             hhhHHHHHHhhhcCCCCC-hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          283 QNKALHELVDQTLGYESD-NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       283 ~~~~~~~~~~~~l~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .......+.....  ... .....++..+.+++.+||..||++|||+.|+++
T Consensus       246 ~~~~~~~i~~~~~--~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          246 QNMLFESIQEGKY--EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             HHHHHHHHHHCCC--CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHhccCc--ccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0000111111111  111 111234567999999999999999999999986

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.5e-45  Score=340.44  Aligned_cols=268  Identities=25%  Similarity=0.392  Sum_probs=192.9

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcC-CCCeEEEeeeeec-CCce
Q 017232           58 EATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLR-HKNLVSLYGCTSR-HSRE  132 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~-~~~~  132 (375)
                      ...++|++.+.||+|+||.||+|.. .+|+.||+|++...  .......+.+|+.+++.+. ||||+++++++.. +...
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            4567899999999999999999965 47899999998543  3445667889999999997 9999999997764 3447


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      +|+||||++ ++|..++..     ..+++..+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||++...
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~  159 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSF  159 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEES
T ss_pred             EEEEecccC-cCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccc
Confidence            899999997 689988854     35899999999999999999999999999999999999999999999999999765


Q ss_pred             CCC--------------------ccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccc
Q 017232          213 PNH--------------------VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHE  271 (375)
Q Consensus       213 ~~~--------------------~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~  271 (375)
                      ...                    ........+||+.|+|||++.+ ..++.++|||||||++|||++|++||........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~  239 (388)
T 3oz6_A          160 VNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQ  239 (388)
T ss_dssp             SSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            321                    1112234579999999998876 6789999999999999999999999976543221


Q ss_pred             cchhHHHHHHhhhhHH-----------HHHHh---hhc---CCCCChHH-------------HHHHHHHHHHHHHhcCCC
Q 017232          272 INLSNLAINKIQNKAL-----------HELVD---QTL---GYESDNKV-------------RRTINAVAELAFQCLQSE  321 (375)
Q Consensus       272 ~~~~~~~~~~~~~~~~-----------~~~~~---~~l---~~~~~~~~-------------~~~~~~l~~li~~cl~~~  321 (375)
                      ...   ....+.....           ...+.   ...   ........             ..++..+.+|+.+||..|
T Consensus       240 ~~~---i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~d  316 (388)
T 3oz6_A          240 LER---IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFN  316 (388)
T ss_dssp             HHH---HHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSS
T ss_pred             HHH---HHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccC
Confidence            110   0000000000           00000   000   00000000             023457899999999999


Q ss_pred             CCCCCCHHHHHHH
Q 017232          322 KDLRPYMVDVLDA  334 (375)
Q Consensus       322 P~~Rpt~~evl~~  334 (375)
                      |++|||++|+++.
T Consensus       317 P~~R~t~~e~l~H  329 (388)
T 3oz6_A          317 PNKRISANDALKH  329 (388)
T ss_dssp             GGGSCCHHHHTTS
T ss_pred             cccCCCHHHHhCC
Confidence            9999999999865

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=5.2e-45  Score=332.13  Aligned_cols=249  Identities=25%  Similarity=0.339  Sum_probs=192.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL----QDGRAVAVKRLYENN----YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  131 (375)
                      .++|++.+.||+|+||.||+|..    .+++.||+|++....    ......+.+|+.+++.++||||+++++++.. ..
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~   94 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT-GG   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC-SS
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc-CC
Confidence            35689999999999999999976    478999999987542    2334567889999999999999999997776 67


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ..++||||+++++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        95 ~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~  170 (327)
T 3a62_A           95 KLYLILEYLSGGELFMQLERE----GIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKE  170 (327)
T ss_dssp             CEEEEEECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred             EEEEEEeCCCCCcHHHHHHhC----CCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence            899999999999999999643    4588999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ...... ......||+.|+|||++.+..++.++|||||||++|+|++|.+||.......               ....+.
T Consensus       171 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---------------~~~~i~  234 (327)
T 3a62_A          171 SIHDGT-VTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---------------TIDKIL  234 (327)
T ss_dssp             ---------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---------------HHHHHH
T ss_pred             cccCCc-cccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---------------HHHHHH
Confidence            432221 2234569999999999998899999999999999999999999997543211               011111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLDA  334 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~~  334 (375)
                      .....  .+   ..++..+.+++.+||..+|++||     ++.++++.
T Consensus       235 ~~~~~--~p---~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          235 KCKLN--LP---PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             HTCCC--CC---TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             hCCCC--CC---CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            11111  11   12346789999999999999999     67777753

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.8e-45  Score=331.42  Aligned_cols=263  Identities=22%  Similarity=0.251  Sum_probs=198.9

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~  110 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-DGQLY  110 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEE
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-CCeEE
Confidence            3478999999999999999999765 68899999986542   2334678899999999999999999997776 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++++|.+++...    ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++.....
T Consensus       111 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  186 (309)
T 2h34_A          111 VDMRLINGVDLAAMLRRQ----GPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTD  186 (309)
T ss_dssp             EEEECCCCEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred             EEEEecCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence            999999999999999643    4589999999999999999999999999999999999999999999999999876654


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ..........+++.|+|||.+.+..++.++||||||+++|+|++|..||......       ..         ...+...
T Consensus       187 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-------~~---------~~~~~~~  250 (309)
T 2h34_A          187 EKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS-------VM---------GAHINQA  250 (309)
T ss_dssp             ----------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-------HH---------HHHHHSC
T ss_pred             cccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH-------HH---------HHHhccC
Confidence            3333334456899999999999889999999999999999999999999754311       00         0011100


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhhhcCCC
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRP-YMVDVLDALRDIESDGY  343 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-t~~evl~~L~~i~~~~~  343 (375)
                      .. ........++..+.+++.+||+.+|++|| +++++++.|+.+.....
T Consensus       251 ~~-~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~~  299 (309)
T 2h34_A          251 IP-RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATAD  299 (309)
T ss_dssp             CC-CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC---
T ss_pred             CC-CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhhc
Confidence            00 00011122445789999999999999999 99999999998765543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=7.2e-45  Score=328.98  Aligned_cols=246  Identities=24%  Similarity=0.303  Sum_probs=193.0

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  134 (375)
                      ..++|++.++||+|+||+||+|... +|+.||||++...  ..........|+..+..+ +||||+++++++.. +...+
T Consensus        55 ~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-~~~~~  133 (311)
T 3p1a_A           55 FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-GGILY  133 (311)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEE
T ss_pred             hhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-CCEEE
Confidence            3467999999999999999999776 7999999988653  233334455666666555 89999999998776 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+ +++|.+++...   +..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++.....
T Consensus       134 lv~e~~-~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~  209 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGT  209 (311)
T ss_dssp             EEEECC-CCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-
T ss_pred             EEEecc-CCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeeccc
Confidence            999999 67898888654   34599999999999999999999999999999999999999999999999999876644


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ...  .....||+.|+|||++.+ .++.++|||||||++|||++|..++.....          ...+....        
T Consensus       210 ~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~~----------~~~~~~~~--------  268 (311)
T 3p1a_A          210 AGA--GEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGEG----------WQQLRQGY--------  268 (311)
T ss_dssp             -------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH----------HHHHTTTC--------
T ss_pred             CCC--CcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCccH----------HHHHhccC--------
Confidence            322  234458999999999886 789999999999999999999766643211          01111100        


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                         ........++..+.+++.+||+.+|++|||+.|+++
T Consensus       269 ---~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          269 ---LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence               011111234567999999999999999999999985

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=5.4e-45  Score=330.69  Aligned_cols=261  Identities=23%  Similarity=0.386  Sum_probs=187.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..... .....+.+|+.+++.++||||+++++++.. ....++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHT-ENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECC-TTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEE-CCeEEEEE
Confidence            457999999999999999999765 689999999865432 234678899999999999999999997766 67899999


Q ss_pred             ecccCCChhHhhccCC--CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          138 EFISNGTVADHLHGER--AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~--~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||++ ++|.+++....  .....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            9997 69998886532  22345899999999999999999999999999999999999999999999999999866432


Q ss_pred             ccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh----------
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN----------  284 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~----------  284 (375)
                      .. ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.........   .........          
T Consensus       162 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          162 VN-TFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL---KLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             CC-CCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCSCCTTTCGGGG
T ss_pred             cc-cCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH---HHHHHHhCCCChhHhhhhh
Confidence            22 2234468999999998876 46899999999999999999999999755422111   000000000          


Q ss_pred             --------------hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          285 --------------KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       285 --------------~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                                    ......+.+....       ..+..+.+++.+||+.||++|||+.|+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKE-------PLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSS-------CCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccccchhHHHhhcccccc-------cCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence                          0000011111100       13457899999999999999999999886

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.8e-45  Score=340.41  Aligned_cols=276  Identities=20%  Similarity=0.291  Sum_probs=211.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-ceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-RELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~lv  136 (375)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.... ....+.+.+|+.+++.++||||+++++++.... ...++|
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv   87 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLI   87 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEE
Confidence            357899999999999999999766 58999999987543 334567789999999999999999999776533 468999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe----cCCCcEEEeeecccccc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL----DNNFCVKVADFGLSRLF  212 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill----~~~~~~kl~Dfg~~~~~  212 (375)
                      |||+++++|.+++.... ....+++..++.++.|++.||.|||++||+||||||+|||+    +.++.+||+|||++...
T Consensus        88 ~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~  166 (396)
T 4eut_A           88 MEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAREL  166 (396)
T ss_dssp             ECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEEC
T ss_pred             EecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEc
Confidence            99999999999996542 22348999999999999999999999999999999999999    78888999999999876


Q ss_pred             CCCccccccCCCCCccccCcccccc--------cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQC--------YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~--------~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      .....  .....||+.|+|||++.+        ..++.++|||||||++|+|++|+.||.........  ..........
T Consensus       167 ~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~--~~~~~~~~~~  242 (396)
T 4eut_A          167 EDDEQ--FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRN--KEVMYKIITG  242 (396)
T ss_dssp             CCGGG--SSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTC--HHHHHHHHHS
T ss_pred             cCCCc--cccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccch--HHHHHHHhcC
Confidence            54332  234569999999998765        56788999999999999999999999754322211  1111111110


Q ss_pred             hHHHHH------Hh------hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          285 KALHEL------VD------QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       285 ~~~~~~------~~------~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .....+      ..      ..+. ........+...+.+++.+||+.||++||++.++++.++++...
T Consensus       243 ~p~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          243 KPSGAISGVQKAENGPIDWSGDMP-VSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             CCTTCCEEEECSTTCCEEEESSCC-TTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             CCcccchhheeccCCCcccCccCC-cccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            000000      00      0000 00111245677899999999999999999999999999987664

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.3e-45  Score=334.38  Aligned_cols=251  Identities=20%  Similarity=0.329  Sum_probs=196.0

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCC--CCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRH--KNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~l  135 (375)
                      .++|++.+.||+|+||.||++...+++.||+|++...  .......+.+|+.++..++|  |||+++++++.. ....++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~~l   86 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYM   86 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEee-CCEEEE
Confidence            4568999999999999999998888999999998644  34455778999999999986  999999997776 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      |||+ .+++|.+++...    ..+++.+++.++.|++.||.|||+.||+||||||+|||++ ++.+||+|||++......
T Consensus        87 v~e~-~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~  160 (343)
T 3dbq_A           87 VMEC-GNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD  160 (343)
T ss_dssp             EECC-CSEEHHHHHHHS----CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC---
T ss_pred             EEeC-CCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcc
Confidence            9994 578999999643    4689999999999999999999999999999999999997 678999999999876443


Q ss_pred             ccc-cccCCCCCccccCcccccc-----------cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh
Q 017232          216 VTH-VSTAPQGTPGYVDPEYHQC-----------YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ  283 (375)
Q Consensus       216 ~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  283 (375)
                      ... ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||.......             
T Consensus       161 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~-------------  227 (343)
T 3dbq_A          161 TTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-------------  227 (343)
T ss_dssp             ---------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-------------
T ss_pred             cccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHH-------------
Confidence            222 2234569999999998865           678889999999999999999999996432110             


Q ss_pred             hhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       284 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       .......+.......+.   ..+..+.+++.+||+.||.+|||+.++++.
T Consensus       228 -~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          228 -SKLHAIIDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             -HHHHHHHCTTSCCCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -HHHHHHhcCCcccCCcc---cCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence             11122222222222111   123468899999999999999999999875

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=3.7e-45  Score=347.51  Aligned_cols=246  Identities=27%  Similarity=0.414  Sum_probs=202.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|.+.+.||+|+||.||+|... +|+.||+|++.....   .....+.+|+.+++.++||||+++++++.. ....++|
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~-~~~~~lv   94 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIST-PSDIFMV   94 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEE
Confidence            56889999999999999999765 799999999865432   234678899999999999999999998776 5779999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++..    .+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        95 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~  170 (476)
T 2y94_A           95 MEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE  170 (476)
T ss_dssp             EECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC
T ss_pred             EeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc
Confidence            999999999999943    3569999999999999999999999999999999999999999999999999998764432


Q ss_pred             cccccCCCCCccccCcccccccCC-CCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQL-TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .  ....+||+.|+|||++.+..+ +.++|||||||++|+|++|..||......      .. .        ..+.....
T Consensus       171 ~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~------~~-~--------~~i~~~~~  233 (476)
T 2y94_A          171 F--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVP------TL-F--------KKICDGIF  233 (476)
T ss_dssp             C--BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSH------HH-H--------HHHHTTCC
T ss_pred             c--ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHH------HH-H--------HHHhcCCc
Confidence            2  234569999999999988765 67999999999999999999999754321      11 1        11111111


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .  .+   ..++..+.+++.+||..||++|||+.++++
T Consensus       234 ~--~p---~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          234 Y--TP---QYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             C--CC---TTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             C--CC---ccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            1  01   123457899999999999999999999997

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.5e-45  Score=331.00  Aligned_cols=269  Identities=23%  Similarity=0.357  Sum_probs=198.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-KRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-CCeEEEE
Confidence            367999999999999999999765 58999999885543  2335678899999999999999999998776 6779999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++.......
T Consensus        81 ~e~~~~~~l~~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  156 (311)
T 4agu_A           81 FEYCDHTVLHELDRY----QRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS  156 (311)
T ss_dssp             EECCSEEHHHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEeCCCchHHHHHhh----hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc
Confidence            999999999988753    3458999999999999999999999999999999999999999999999999998654332


Q ss_pred             cccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh-
Q 017232          217 THVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT-  294 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  294 (375)
                      . ......+|+.|+|||++.+ ..++.++||||||+++|+|++|.+||............................... 
T Consensus       157 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (311)
T 4agu_A          157 D-YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQY  235 (311)
T ss_dssp             ----------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGG
T ss_pred             c-ccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccc
Confidence            2 2234468999999998876 668999999999999999999999997654322111111000000000000000000 


Q ss_pred             cCC-------CCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          295 LGY-------ESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       295 l~~-------~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ...       ...   .....++..+.+++.+||+.||++|||++++++.
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          236 FSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             GTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             cccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            000       000   0001345678999999999999999999999864

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=4.7e-45  Score=334.98  Aligned_cols=248  Identities=25%  Similarity=0.360  Sum_probs=200.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  134 (375)
                      .++|++.+.||+|+||.||+|..+ +++.||+|++....   ....+.+..|..++..+ +||||+++++++.. ...+|
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~-~~~~~   97 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLY   97 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEEC-SSEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEc-CCEEE
Confidence            467999999999999999999776 47899999986542   23346678899999888 79999999997776 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||++||+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus        98 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~  173 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  173 (353)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred             EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCccccccc
Confidence            999999999999999643    3589999999999999999999999999999999999999999999999999975432


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|++||.......               ....+....
T Consensus       174 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---------------~~~~i~~~~  237 (353)
T 2i0e_A          174 DG-VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---------------LFQSIMEHN  237 (353)
T ss_dssp             TT-CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------HHHHHHHCC
T ss_pred             CC-cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHH---------------HHHHHHhCC
Confidence            22 12344579999999999999999999999999999999999999997543110               111122211


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPY-----MVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~evl~  333 (375)
                      ...  +   ...+..+.+++.+||..+|.+||+     ++++++
T Consensus       238 ~~~--p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          238 VAY--P---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             CCC--C---TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             CCC--C---CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            111  1   124567899999999999999996     466654

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.6e-45  Score=333.38  Aligned_cols=259  Identities=25%  Similarity=0.377  Sum_probs=196.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC---ce
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS---RE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~  132 (375)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++...   .......+.+|+.+++.++||||+++++++....   ..
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            46799999999999999999975 57899999999654   3344567889999999999999999999765432   23


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      .++||||+++++|.+++...    ..+++.+++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++...
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~  166 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  166 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC---
T ss_pred             cEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCcccc
Confidence            59999999999999999643    45899999999999999999999999999999999999999999999999999865


Q ss_pred             CCCcc--ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          213 PNHVT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       213 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      .....  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.......      ........      
T Consensus       167 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~------~~~~~~~~------  234 (311)
T 3ork_A          167 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVRE------  234 (311)
T ss_dssp             ---------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHC------
T ss_pred             cccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH------HHHHHhcC------
Confidence            43222  12233468999999999999899999999999999999999999997543211      11111100      


Q ss_pred             HhhhcCCCCChH--HHHHHHHHHHHHHHhcCCCCCCCCCHHHHH-HHHHhhhc
Q 017232          291 VDQTLGYESDNK--VRRTINAVAELAFQCLQSEKDLRPYMVDVL-DALRDIES  340 (375)
Q Consensus       291 ~~~~l~~~~~~~--~~~~~~~l~~li~~cl~~~P~~Rpt~~evl-~~L~~i~~  340 (375)
                            ......  ...++..+.+++.+||+.||++||++.+++ ..|..+..
T Consensus       235 ------~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  281 (311)
T 3ork_A          235 ------DPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN  281 (311)
T ss_dssp             ------CCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred             ------CCCCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence                  000110  112456799999999999999999666554 55665544

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.2e-45  Score=334.81  Aligned_cols=261  Identities=28%  Similarity=0.410  Sum_probs=205.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEE--EEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAV--AVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~v--aiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|++.+.||+|+||.||+|... ++..+  ++|.+... .......+.+|+.+++.+ +||||+++++++.. ....++
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-~~~~~l  103 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYL  103 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-CCceEE
Confidence            46889999999999999999654 56544  99988653 233456788999999999 89999999998766 678999


Q ss_pred             EEecccCCChhHhhccCC------------CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEE
Q 017232          136 VYEFISNGTVADHLHGER------------AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKV  203 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl  203 (375)
                      ||||+++++|.+++....            .....+++.+++.++.|++.||.|||++|++||||||+||+++.++.+||
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL  183 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI  183 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEE
Confidence            999999999999997543            23357899999999999999999999999999999999999999999999


Q ss_pred             eeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHh
Q 017232          204 ADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKI  282 (375)
Q Consensus       204 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  282 (375)
                      +|||++......  .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......      . .   
T Consensus       184 ~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~------~-~---  251 (327)
T 1fvr_A          184 ADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE------L-Y---  251 (327)
T ss_dssp             CCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H-H---
T ss_pred             cccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHH------H-H---
Confidence            999998743221  11223347889999999988889999999999999999998 999997543111      0 0   


Q ss_pred             hhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          283 QNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       283 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                            ..+........   ...++..+.+++.+||..+|++|||+.++++.|+.+.....
T Consensus       252 ------~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          252 ------EKLPQGYRLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             ------HHGGGTCCCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             ------HHhhcCCCCCC---CCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence                  11111111111   12345679999999999999999999999999999877644

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=7.2e-45  Score=324.53  Aligned_cols=254  Identities=27%  Similarity=0.415  Sum_probs=206.2

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeec--------
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR--------  128 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~--------  128 (375)
                      ...++|++.+.||+|+||.||+|... +++.||+|.+....    ..+.+|+.+++.++||||+++++++..        
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   83 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS   83 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC----
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccc
Confidence            34567999999999999999999776 78999999987654    245689999999999999999997643        


Q ss_pred             -------CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcE
Q 017232          129 -------HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCV  201 (375)
Q Consensus       129 -------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~  201 (375)
                             .....++||||+++++|.+++....  ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+
T Consensus        84 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           84 SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             -----CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEE
T ss_pred             cccccccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCE
Confidence                   2455899999999999999996542  3468999999999999999999999999999999999999999999


Q ss_pred             EEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHH
Q 017232          202 KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK  281 (375)
Q Consensus       202 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  281 (375)
                      ||+|||++........  .....+++.|+|||.+.+..++.++||||||+++|+|++|..|+....              
T Consensus       162 kl~Dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--------------  225 (284)
T 2a19_B          162 KIGDFGLVTSLKNDGK--RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--------------  225 (284)
T ss_dssp             EECCCTTCEESSCCSC--CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--------------
T ss_pred             EECcchhheecccccc--ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--------------
Confidence            9999999987654322  233468999999999999899999999999999999999998874211              


Q ss_pred             hhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          282 IQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                         .....+....+..       .++..+.+++.+||+.+|.+|||+.++++.|+.+.....
T Consensus       226 ---~~~~~~~~~~~~~-------~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~~  277 (284)
T 2a19_B          226 ---KFFTDLRDGIISD-------IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPE  277 (284)
T ss_dssp             ---HHHHHHHTTCCCT-------TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC---
T ss_pred             ---HHHHHhhcccccc-------cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCCC
Confidence               0001111111111       133568899999999999999999999999999876544

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.8e-45  Score=332.77  Aligned_cols=268  Identities=24%  Similarity=0.393  Sum_probs=202.4

Q ss_pred             HHHHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhc--CCCCeEEEeeeeecCC--
Q 017232           55 ELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL--RHKNLVSLYGCTSRHS--  130 (375)
Q Consensus        55 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l--~h~niv~~~~~~~~~~--  130 (375)
                      ......++|++.+.||+|+||.||+|... ++.||+|++.....   ..+..|.+++..+  +||||+++++++....  
T Consensus        31 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~---~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~  106 (337)
T 3mdy_A           31 VQRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAADIKGTGS  106 (337)
T ss_dssp             HHTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG
T ss_pred             cccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecccc---chhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC
Confidence            34455678999999999999999999876 89999999864432   3344555555554  8999999999776532  


Q ss_pred             -ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC--------CceeccCCCCCEEecCCCcE
Q 017232          131 -RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS--------DIIHRDVKTNNILLDNNFCV  201 (375)
Q Consensus       131 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--------~ivH~dlkp~Nill~~~~~~  201 (375)
                       ...++||||+++++|.+++..     ..+++..++.++.|++.||.|||+.        |++||||||+|||++.++.+
T Consensus       107 ~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~  181 (337)
T 3mdy_A          107 WTQLYLITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTC  181 (337)
T ss_dssp             GCEEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCE
T ss_pred             CCceEEEEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCE
Confidence             578999999999999999953     3589999999999999999999999        99999999999999999999


Q ss_pred             EEeeeccccccCCCcccc---ccCCCCCccccCcccccccCCCCc------hhHHHHHHHHHHHHhCC----------CC
Q 017232          202 KVADFGLSRLFPNHVTHV---STAPQGTPGYVDPEYHQCYQLTDK------SDVFSFGVVLIELISSM----------PA  262 (375)
Q Consensus       202 kl~Dfg~~~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~------~DiwslG~il~elltg~----------~p  262 (375)
                      ||+|||++..........   .....||+.|+|||++.+...+..      +|||||||++|||++|.          .|
T Consensus       182 kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p  261 (337)
T 3mdy_A          182 CIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLP  261 (337)
T ss_dssp             EECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCT
T ss_pred             EEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccccccccccc
Confidence            999999997654332221   124469999999999887666655      99999999999999994          44


Q ss_pred             ccccccccccchhHHHHHHhhhhHHHHHH-hhhcCCCCCh--HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          263 VDITRHRHEINLSNLAINKIQNKALHELV-DQTLGYESDN--KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      |.........  ..         ...... ..........  ....++..+.+++.+||+.||++|||+.+|++.|+.+.
T Consensus       262 ~~~~~~~~~~--~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~  330 (337)
T 3mdy_A          262 YHDLVPSDPS--YE---------DMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMS  330 (337)
T ss_dssp             TTTTSCSSCC--HH---------HHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhhhcCCCCc--hh---------hhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHH
Confidence            4332211110  00         011111 1111111111  12357788999999999999999999999999999987


Q ss_pred             cCC
Q 017232          340 SDG  342 (375)
Q Consensus       340 ~~~  342 (375)
                      ...
T Consensus       331 ~~~  333 (337)
T 3mdy_A          331 ESQ  333 (337)
T ss_dssp             HTT
T ss_pred             hhc
Confidence            654

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.2e-45  Score=327.76  Aligned_cols=255  Identities=24%  Similarity=0.338  Sum_probs=201.4

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CC-------CEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DG-------RAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~-------~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  131 (375)
                      .++|++.+.||+|+||.||+|... ++       ..||+|.+........+.+.+|+.+++.++||||+++++++.. ..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~   85 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC-GD   85 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC-TT
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe-CC
Confidence            356889999999999999999654 33       4799999977766667889999999999999999999997776 56


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc--------EEE
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC--------VKV  203 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~--------~kl  203 (375)
                      ..++||||+++++|.+++...   ...+++..++.++.|++.||.|||++|++||||||+|||++.++.        +||
T Consensus        86 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl  162 (289)
T 4fvq_A           86 ENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKL  162 (289)
T ss_dssp             CCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred             CCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeee
Confidence            789999999999999999653   234899999999999999999999999999999999999998887        999


Q ss_pred             eeeccccccCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhC-CCCccccccccccchhHHHHHH
Q 017232          204 ADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISS-MPAVDITRHRHEINLSNLAINK  281 (375)
Q Consensus       204 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg-~~p~~~~~~~~~~~~~~~~~~~  281 (375)
                      +|||++.......     ...+++.|+|||++.+ ..++.++||||||+++|+|++| .+|+.......           
T Consensus       163 ~Dfg~~~~~~~~~-----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~-----------  226 (289)
T 4fvq_A          163 SDPGISITVLPKD-----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR-----------  226 (289)
T ss_dssp             CCCCSCTTTSCHH-----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH-----------
T ss_pred             ccCcccccccCcc-----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHH-----------
Confidence            9999987543321     1237888999999887 6789999999999999999995 45554322110           


Q ss_pred             hhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCC
Q 017232          282 IQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYD  344 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~  344 (375)
                           .............     ..+..+.+++.+||+.+|++|||+.++++.|+++......
T Consensus       227 -----~~~~~~~~~~~~~-----~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~~~  279 (289)
T 4fvq_A          227 -----KLQFYEDRHQLPA-----PKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLV  279 (289)
T ss_dssp             -----HHHHHHTTCCCCC-----CSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC-----
T ss_pred             -----HHHHhhccCCCCC-----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCC
Confidence                 0001111110000     1134688999999999999999999999999998875553

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.6e-45  Score=334.47  Aligned_cols=267  Identities=19%  Similarity=0.232  Sum_probs=198.4

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC----CCCEEEEEEecccchhh-----------HHHHHHHHHHHHhcCCCCeEEEee
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ----DGRAVAVKRLYENNYKR-----------VEQFMNEVDILARLRHKNLVSLYG  124 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~~~~~-----------~~~~~~e~~~l~~l~h~niv~~~~  124 (375)
                      .++|++.+.||+|+||.||+|...    ++..+|+|++.......           ...+.+|+..++.++||||+++++
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~  115 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYG  115 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEE
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeec
Confidence            357999999999999999999775    57889999986543211           123567888999999999999999


Q ss_pred             eeecC---CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC--
Q 017232          125 CTSRH---SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF--  199 (375)
Q Consensus       125 ~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~--  199 (375)
                      ++...   ....++||||+ +++|.+++...    ..+++.+++.++.||+.||.|||++||+||||||+|||++.++  
T Consensus       116 ~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          116 SGLTEFKGRSYRFMVMERL-GIDLQKISGQN----GTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEESSSCEEEEEEEECE-EEEHHHHCBGG----GBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTT
T ss_pred             ccccccCCCcEEEEEEecc-CCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCC
Confidence            76552   56789999999 99999999643    2689999999999999999999999999999999999998877  


Q ss_pred             cEEEeeeccccccCCCcc------ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccc
Q 017232          200 CVKVADFGLSRLFPNHVT------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEIN  273 (375)
Q Consensus       200 ~~kl~Dfg~~~~~~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~  273 (375)
                      .+||+|||++..+.....      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......... 
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~-  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA-  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH-
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHH-
Confidence            999999999976543211      1113456999999999999989999999999999999999999999643211100 


Q ss_pred             hhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          274 LSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       274 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                       ........... ...........      ..++..+.+++.+||..+|++|||+.+|++.|+++..
T Consensus       270 -~~~~~~~~~~~-~~~~~~~~~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          270 -VQTAKTNLLDE-LPQSVLKWAPS------GSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             -HHHHHHHHHHT-TTHHHHHHSCT------TSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             -HHHHHHhhccc-ccHHHHhhccc------cccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence             00000000000 00011110000      0234579999999999999999999999999998654

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=334.87  Aligned_cols=278  Identities=22%  Similarity=0.338  Sum_probs=198.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHH--HHHHhcCCCCeEEEeeee----ecCCcee
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEV--DILARLRHKNLVSLYGCT----SRHSREL  133 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~--~~l~~l~h~niv~~~~~~----~~~~~~~  133 (375)
                      .++|++.+.||+|+||.||+|.. +++.||+|++......   .+..|.  ..+..++||||+++++.+    ......+
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~---~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGGGHH---HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEE-CCeEEEEEEeeccchh---hHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            35788999999999999999976 5899999998654432   333344  445558999999998743    2234467


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC---------CceeccCCCCCEEecCCCcEEEe
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS---------DIIHRDVKTNNILLDNNFCVKVA  204 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~---------~ivH~dlkp~Nill~~~~~~kl~  204 (375)
                      ++||||+++|+|.+++...     ..++..++.++.|++.||.|||+.         ||+||||||+|||++.++.+||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~~-----~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~  162 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSLH-----TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVIS  162 (336)
T ss_dssp             EEEECCCTTCBHHHHHHHC-----CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEEC
T ss_pred             EEEEecCCCCcHHHHHhhc-----ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEe
Confidence            8999999999999999543     358889999999999999999999         99999999999999999999999


Q ss_pred             eeccccccCCCc-------cccccCCCCCccccCcccccc-------cCCCCchhHHHHHHHHHHHHhCCCCcccccccc
Q 017232          205 DFGLSRLFPNHV-------THVSTAPQGTPGYVDPEYHQC-------YQLTDKSDVFSFGVVLIELISSMPAVDITRHRH  270 (375)
Q Consensus       205 Dfg~~~~~~~~~-------~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~elltg~~p~~~~~~~~  270 (375)
                      |||++.......       ........||+.|+|||++.+       ..++.++|||||||++|||++|..||.......
T Consensus       163 DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~  242 (336)
T 3g2f_A          163 DFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP  242 (336)
T ss_dssp             CCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCC
T ss_pred             eccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchh
Confidence            999998654321       112224469999999999876       456779999999999999999976653322211


Q ss_pred             ccchhHHHHHHhhh---hHHHHHHhhh-cCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          271 EINLSNLAINKIQN---KALHELVDQT-LGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       271 ~~~~~~~~~~~~~~---~~~~~~~~~~-l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                      ..... +.......   .......... .....+   .....++..+.+++.+||+.||++|||+.|+++.|+++...-.
T Consensus       243 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          243 EYQMA-FQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCCT-THHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             HHHHh-hhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            11100 00000000   0111111110 111111   0112356679999999999999999999999999999986655


Q ss_pred             CCCc
Q 017232          344 DDKK  347 (375)
Q Consensus       344 ~~~~  347 (375)
                      ....
T Consensus       322 ~~~~  325 (336)
T 3g2f_A          322 RNKS  325 (336)
T ss_dssp             C---
T ss_pred             hccc
Confidence            4443

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2.1e-44  Score=343.09  Aligned_cols=194  Identities=26%  Similarity=0.402  Sum_probs=153.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC----Cce
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH----SRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~  132 (375)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++...    ...
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            467999999999999999999655 7899999998653  344567789999999999999999999977432    356


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      +|+||||+ +++|.+++..    ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus       132 ~~lv~e~~-~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~  206 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV  206 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCT
T ss_pred             EEEEEecc-ccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhc
Confidence            89999998 5789988853    346999999999999999999999999999999999999999999999999999875


Q ss_pred             CCCcc--------------------------ccccCCCCCccccCcccc-cccCCCCchhHHHHHHHHHHHHh
Q 017232          213 PNHVT--------------------------HVSTAPQGTPGYVDPEYH-QCYQLTDKSDVFSFGVVLIELIS  258 (375)
Q Consensus       213 ~~~~~--------------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~ellt  258 (375)
                      .....                          ......+||+.|+|||++ .+..++.++|||||||++|||++
T Consensus       207 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          207 DYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             TSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred             cCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence            42211                          122345689999999975 56679999999999999999999

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=326.11  Aligned_cols=267  Identities=25%  Similarity=0.338  Sum_probs=196.0

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccch-----hhHHHHHHHHHHHHhc---CCCCeEEEeeeeecC
Q 017232           59 ATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNY-----KRVEQFMNEVDILARL---RHKNLVSLYGCTSRH  129 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~-----~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~~  129 (375)
                      ..++|++.+.||+|+||+||+|.. .+++.||+|++.....     .....+.+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            467899999999999999999975 4789999999864321     1123456677776666   599999999977653


Q ss_pred             Cc----eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEee
Q 017232          130 SR----ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD  205 (375)
Q Consensus       130 ~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~D  205 (375)
                      ..    ..++||||+. ++|.+++...  ....+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKA--PPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTC--CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEee
Confidence            32    5899999996 6999998654  234489999999999999999999999999999999999999999999999


Q ss_pred             eccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh
Q 017232          206 FGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK  285 (375)
Q Consensus       206 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (375)
                      ||++........  .....+|+.|+|||++.+..++.++|||||||++|+|++|.+||.........   ..........
T Consensus       164 fg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~  238 (308)
T 3g33_A          164 FGLARIYSYQMA--LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL---GKIFDLIGLP  238 (308)
T ss_dssp             CSCTTTSTTCCC--SGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH---HHHHHHHCCC
T ss_pred             CccccccCCCcc--cCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCC
Confidence            999986543322  23346899999999999889999999999999999999999999754422110   0000000000


Q ss_pred             HHHHH------HhhhcCCCC----ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          286 ALHEL------VDQTLGYES----DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       286 ~~~~~------~~~~l~~~~----~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ....+      .........    ......++..+.+++.+||+.||++|||+.|+++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          239 PEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             CTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             ChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            00000      000000000    0001123467899999999999999999999985

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=7.4e-45  Score=326.01  Aligned_cols=265  Identities=21%  Similarity=0.290  Sum_probs=196.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|++.+.||+|+||+||+|... +++.||+|++....  ......+.+|+.+++.++||||+++++++.. ....++||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-CCEEEEEE
Confidence            57899999999999999999765 68999999986542  3334678899999999999999999998776 67899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+++ +|.+.+...   ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++........
T Consensus        81 e~~~~-~l~~~~~~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  156 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             ECCSE-EHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS
T ss_pred             ecCCC-CHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc
Confidence            99975 566555432   35699999999999999999999999999999999999999999999999999986643322


Q ss_pred             ccccCCCCCccccCcccccccC-CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH--Hhhh
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQ-LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL--VDQT  294 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  294 (375)
                       ......+|+.|+|||++.+.. ++.++|||||||++|+|++|..||-.......  ................+  ....
T Consensus       157 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~--~~~~i~~~~~~~~~~~~~~~~~~  233 (292)
T 3o0g_A          157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             -cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHH--HHHHHHHHhCCCChhhhhhhccc
Confidence             223456899999999987765 79999999999999999988777532221110  00000000000000000  0000


Q ss_pred             --c--------CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 --L--------GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 --l--------~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        .        ..........++..+.+++.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence              0        00000011124567889999999999999999999985

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.5e-44  Score=342.37  Aligned_cols=263  Identities=22%  Similarity=0.293  Sum_probs=205.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .++|++.++||+|+||.||+|.. .+++.||||++......  ..+.+|+.+++.++|++.+..+..+.......+||||
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH--PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS--CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc--HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            46799999999999999999975 57899999987644322  3577899999999876555544544455778899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe---cCCCcEEEeeeccccccCCC
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      |+ +++|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..+...
T Consensus        84 ~~-g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~  159 (483)
T 3sv0_A           84 LL-GPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDT  159 (483)
T ss_dssp             CC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCT
T ss_pred             CC-CCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCC
Confidence            99 89999999643   3459999999999999999999999999999999999999   68899999999999876543


Q ss_pred             ccc------cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          216 VTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       216 ~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                      ...      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||............    ..+.......
T Consensus       160 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~----~~i~~~~~~~  235 (483)
T 3sv0_A          160 STHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKY----EKISEKKVAT  235 (483)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHH----HHHHHHHHHS
T ss_pred             ccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHH----HHHhhccccc
Confidence            221      122456999999999999999999999999999999999999999765432211111    1111111110


Q ss_pred             HHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          290 LVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       290 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      .+        ......++.++.+++..||+.+|++||++.+|++.|+++..
T Consensus       236 ~~--------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~  278 (483)
T 3sv0_A          236 SI--------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFI  278 (483)
T ss_dssp             CH--------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHH
T ss_pred             cH--------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence            00        01111234679999999999999999999999999999755

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.2e-44  Score=337.36  Aligned_cols=250  Identities=20%  Similarity=0.328  Sum_probs=196.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcC--CCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLR--HKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .+|++.+.||+|+||.||+|...+++.||||++...  .......+.+|+.+++.++  ||||+++++++.. ...+++|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~-~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEec-CCEEEEE
Confidence            459999999999999999998888999999998644  3445678899999999996  5999999997766 5679999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      || +.+++|.+++...    ..+++.+++.++.||+.||.|||+.||+||||||+|||++ ++.+||+|||++.......
T Consensus       135 ~E-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~  208 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDT  208 (390)
T ss_dssp             EE-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC----
T ss_pred             Ee-cCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCC
Confidence            99 5688999999643    3588999999999999999999999999999999999995 5889999999998764332


Q ss_pred             cc-cccCCCCCccccCcccccc-----------cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh
Q 017232          217 TH-VSTAPQGTPGYVDPEYHQC-----------YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       217 ~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      .. ......||+.|+|||++.+           ..++.++|||||||++|+|++|++||.......              
T Consensus       209 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--------------  274 (390)
T 2zmd_A          209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI--------------  274 (390)
T ss_dssp             -----CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH--------------
T ss_pred             ccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHH--------------
Confidence            22 2334579999999998865           368889999999999999999999996432110              


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ..+..+++.......+..   .+..+.+++.+||..||++|||+.|+++.
T Consensus       275 ~~~~~~~~~~~~~~~~~~---~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          275 SKLHAIIDPNHEIEFPDI---PEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             HHHHHHHCTTSCCCCCCC---SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHhCccccCCCCcc---chHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            111222322222211111   13568899999999999999999999864

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=1.2e-44  Score=338.24  Aligned_cols=254  Identities=22%  Similarity=0.281  Sum_probs=191.4

Q ss_pred             hcCCCCC-CccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHH-hcCCCCeEEEeeeeec---CCcee
Q 017232           60 TNYFDSA-RELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILA-RLRHKNLVSLYGCTSR---HSREL  133 (375)
Q Consensus        60 ~~~y~~~-~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~---~~~~~  133 (375)
                      .++|.+. +.||+|+||+||+|... +++.||||++...     ..+.+|+.++. ..+||||+++++++..   +...+
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~  134 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL  134 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEE
Confidence            3567665 68999999999999665 6899999998533     34567888874 4589999999997653   35678


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC---CCcEEEeeecccc
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSR  210 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~  210 (375)
                      ++||||+++|+|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++.
T Consensus       135 ~lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~  212 (400)
T 1nxk_A          135 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  212 (400)
T ss_dssp             EEEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEeccccc
Confidence            9999999999999999653  2346999999999999999999999999999999999999997   7899999999998


Q ss_pred             ccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      .......  ....+||+.|+|||++.+..++.++|||||||++|+|++|.+||..........   .....        +
T Consensus       213 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~~~~~--------i  279 (400)
T 1nxk_A          213 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTR--------I  279 (400)
T ss_dssp             ECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCC---SHHHH--------H
T ss_pred             ccCCCCc--cccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccH---HHHHH--------H
Confidence            6543222  234568999999999999999999999999999999999999997544221110   00011        1


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ....... .......++..+.+|+.+||..||++|||+.++++.
T Consensus       280 ~~~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          280 RMGQYEF-PNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HHTCCCC-CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HcCcccC-CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            1111110 001112345678999999999999999999999975

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=8.2e-45  Score=341.59  Aligned_cols=254  Identities=22%  Similarity=0.327  Sum_probs=192.9

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--------hhHHHHHHHHHHHHhcCCCCeEEEeeeee
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--------KRVEQFMNEVDILARLRHKNLVSLYGCTS  127 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~  127 (375)
                      ....++|.+.+.||+|+||.||+|... +++.||+|++.....        .....+.+|+.++++++||||+++++++.
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~  210 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD  210 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            345788999999999999999999654 689999999865321        12234789999999999999999999765


Q ss_pred             cCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC---cEEEe
Q 017232          128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF---CVKVA  204 (375)
Q Consensus       128 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~---~~kl~  204 (375)
                      .  ...++||||+++++|.+++.    ....+++..++.++.|++.||.|||++||+||||||+|||++.++   .+||+
T Consensus       211 ~--~~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~  284 (419)
T 3i6u_A          211 A--EDYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKIT  284 (419)
T ss_dssp             S--SEEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred             c--CceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEe
Confidence            3  45799999999999999884    335699999999999999999999999999999999999997544   59999


Q ss_pred             eeccccccCCCccccccCCCCCccccCcccccc---cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHH
Q 017232          205 DFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC---YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK  281 (375)
Q Consensus       205 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  281 (375)
                      |||++.......  ......||+.|+|||++.+   ..++.++|||||||++|+|++|.+||........  +.    ..
T Consensus       285 DFG~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~--~~----~~  356 (419)
T 3i6u_A          285 DFGHSKILGETS--LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LK----DQ  356 (419)
T ss_dssp             CSSTTTSCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCC--HH----HH
T ss_pred             ecccceecCCCc--cccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHH--HH----HH
Confidence            999998765322  2234569999999998753   5678899999999999999999999975432211  00    00


Q ss_pred             hhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          282 IQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      +..         ............++..+.+++.+||+.+|++|||+.++++
T Consensus       357 i~~---------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          357 ITS---------GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             HHT---------TCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             Hhc---------CCCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            100         0000011111234567999999999999999999999986

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=6e-45  Score=326.42  Aligned_cols=258  Identities=24%  Similarity=0.348  Sum_probs=204.4

Q ss_pred             hcCCCCCC-ccCCCCcEEEEEEEeC---CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           60 TNYFDSAR-ELGDGGFGTVYYGELQ---DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        60 ~~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      .++|.+.+ .||+|+||.||+|...   +++.||+|++....  ....+.+.+|+.+++.++||||+++++++.  ....
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~--~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE--AESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE--SSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEC--CCCc
Confidence            35677777 8999999999999442   46789999986543  233567899999999999999999999773  4568


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++||||+++++|.+++...    ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++....
T Consensus        93 ~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~  168 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR  168 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECC
T ss_pred             EEEEEeCCCCCHHHHHHhC----cCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeec
Confidence            9999999999999999643    458999999999999999999999999999999999999999999999999998765


Q ss_pred             CCcccc--ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          214 NHVTHV--STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       214 ~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ......  .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......                ....
T Consensus       169 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~----------------~~~~  232 (291)
T 1xbb_A          169 ADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAM  232 (291)
T ss_dssp             TTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHH
T ss_pred             cCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH----------------HHHH
Confidence            433221  222346788999999988889999999999999999999 999997543211                1111


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      +.......   ....++..+.+++.+||+.+|++|||+.++++.|+++-...
T Consensus       233 ~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  281 (291)
T 1xbb_A          233 LEKGERMG---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  281 (291)
T ss_dssp             HHTTCCCC---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHcCCCCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHH
Confidence            11111111   11234567999999999999999999999999999886543

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=8.6e-45  Score=330.84  Aligned_cols=262  Identities=26%  Similarity=0.391  Sum_probs=204.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe------CCCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL------QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~------~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      .++|++.+.||+|+||.||+|..      .++..||+|.+... .......+.+|+.+++.++||||+++++++.. ...
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~  107 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQ-SLP  107 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcC-CCC
Confidence            35789999999999999999973      35778999998654 34455678899999999999999999997766 567


Q ss_pred             eEEEEecccCCChhHhhccCCCC---CCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC---CCcEEEeee
Q 017232          133 LLLVYEFISNGTVADHLHGERAK---PGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADF  206 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~---~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~---~~~~kl~Df  206 (375)
                      .++||||+++++|.+++......   ...+++..++.++.|++.||.|||+.|++||||||+||+++.   +..+||+||
T Consensus       108 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Df  187 (327)
T 2yfx_A          108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDF  187 (327)
T ss_dssp             CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCC
T ss_pred             cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECcc
Confidence            89999999999999999765432   245889999999999999999999999999999999999984   446999999


Q ss_pred             ccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhh
Q 017232          207 GLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       207 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      |++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.......              
T Consensus       188 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~--------------  253 (327)
T 2yfx_A          188 GMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQE--------------  253 (327)
T ss_dssp             HHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH--------------
T ss_pred             ccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHH--------------
Confidence            99875432221 12223457889999999988899999999999999999998 999997543110              


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                        ....+.......   ....++..+.+++.+||+.+|.+|||+.++++.|+.+...
T Consensus       254 --~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          254 --VLEFVTSGGRMD---PPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             --HHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             --HHHHHhcCCCCC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence              001111111111   1123456789999999999999999999999999988764

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-44  Score=326.17  Aligned_cols=252  Identities=23%  Similarity=0.385  Sum_probs=200.9

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ..++|.+.+.||+|+||.||+|... +|+.||+|++..........+.+|+.+++.++||||+++++++.. ....++||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   85 (304)
T 2jam_A            7 IRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYES-TTHYYLVM   85 (304)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             hhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhccc-CCEEEEEE
Confidence            3467999999999999999999765 789999999976654455678899999999999999999997766 67899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe---cCCCcEEEeeeccccccCC
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~  214 (375)
                      ||+++++|.+++...    ..+++..++.++.|++.||.|||+.|++|+||||+||++   +.++.++|+|||++.....
T Consensus        86 e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~  161 (304)
T 2jam_A           86 QLVSGGELFDRILER----GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN  161 (304)
T ss_dssp             CCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC
T ss_pred             EcCCCccHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC
Confidence            999999999998543    358999999999999999999999999999999999999   7889999999999875433


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ..   .....+++.|+|||.+.+..++.++||||||+++|+|++|.+||.......       ..        ..+....
T Consensus       162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-------~~--------~~i~~~~  223 (304)
T 2jam_A          162 GI---MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK-------LF--------EKIKEGY  223 (304)
T ss_dssp             BT---THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHH-------HH--------HHHHHCC
T ss_pred             Cc---cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHH-------HH--------HHHHcCC
Confidence            21   122358999999999999899999999999999999999999997543110       00        1111111


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ... ..+....++..+.+++.+||..+|++|||+.++++.
T Consensus       224 ~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          224 YEF-ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             CCC-CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCC-CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            110 011112345679999999999999999999999873

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.7e-45  Score=336.71  Aligned_cols=248  Identities=27%  Similarity=0.385  Sum_probs=192.0

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHH-HHhcCCCCeEEEeeeeecCCceeE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDI-LARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      .++|++.+.||+|+||.||+|+.+ +++.||+|++.....   .....+..|..+ ++.++||||+++++++.. ...+|
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~-~~~~~  115 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQT-ADKLY  115 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEEC-SSEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEe-CCEEE
Confidence            356999999999999999999766 588999999965432   233455667666 467899999999997776 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++|+|.+++...    ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus       116 lv~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~  191 (373)
T 2r5t_A          116 FVLDYINGGELFYHLQRE----RCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIE  191 (373)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBC
T ss_pred             EEEeCCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCcccccccc
Confidence            999999999999998643    3589999999999999999999999999999999999999999999999999975432


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .. ......+||+.|+|||++.+..++.++|||||||++|||++|.+||.......               ....+....
T Consensus       192 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---------------~~~~i~~~~  255 (373)
T 2r5t_A          192 HN-STTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---------------MYDNILNKP  255 (373)
T ss_dssp             CC-CCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHH---------------HHHHHHHSC
T ss_pred             CC-CccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH---------------HHHHHHhcc
Confidence            22 12344579999999999999999999999999999999999999997543111               111122221


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      +...     ..++..+.+++.+||+.||.+||++.+.++
T Consensus       256 ~~~~-----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~  289 (373)
T 2r5t_A          256 LQLK-----PNITNSARHLLEGLLQKDRTKRLGAKDDFM  289 (373)
T ss_dssp             CCCC-----SSSCHHHHHHHHHHTCSSGGGSTTTTTTHH
T ss_pred             cCCC-----CCCCHHHHHHHHHHcccCHHhCCCCCCCHH
Confidence            2111     123467899999999999999999864433

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=5.1e-45  Score=333.77  Aligned_cols=253  Identities=19%  Similarity=0.313  Sum_probs=198.3

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..++|++.+.||+|+||.||++..+ +|+.||+|++......    ..+|++++.++ +||||+++++++.. ....++|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~-~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDD-GKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEc-CCEEEEE
Confidence            4567999999999999999999765 6889999998655322    34688888888 79999999998766 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC----CcEEEeeecccccc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN----FCVKVADFGLSRLF  212 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~~  212 (375)
                      |||+++|+|.+++..    ...+++..+..++.||+.||.|||++||+||||||+|||+..+    +.+||+|||++...
T Consensus        95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~  170 (342)
T 2qr7_A           95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL  170 (342)
T ss_dssp             ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence            999999999999853    3468999999999999999999999999999999999998433    35999999999866


Q ss_pred             CCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ..... .....++|+.|+|||++.+..++.++|||||||++|+|++|.+||........   ... .        ..+..
T Consensus       171 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~---~~~-~--------~~i~~  237 (342)
T 2qr7_A          171 RAENG-LLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTP---EEI-L--------ARIGS  237 (342)
T ss_dssp             BCTTC-CBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCH---HHH-H--------HHHHH
T ss_pred             cCCCC-ceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCH---HHH-H--------HHHcc
Confidence            44322 22345789999999999888899999999999999999999999975321110   000 1        11111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ..... .......++..+.+++.+||..||++|||+.++++.
T Consensus       238 ~~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          238 GKFSL-SGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             CCCCC-CSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             CCccc-CccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11110 011112345678999999999999999999999874

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.3e-45  Score=332.94  Aligned_cols=248  Identities=28%  Similarity=0.409  Sum_probs=198.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .+.|+..+.||+|+||.||+|.. .+++.||+|++...   .....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l  131 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWL  131 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-CCeEEE
Confidence            34588999999999999999975 57899999998643   23345678899999999999999999998776 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+. |+|.+++...   ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       132 v~e~~~-g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~  207 (348)
T 1u5q_A          132 VMEYCL-GSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA  207 (348)
T ss_dssp             EEECCS-EEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred             EEecCC-CCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC
Confidence            999997 6788877533   346899999999999999999999999999999999999999999999999999765432


Q ss_pred             ccccccCCCCCccccCccccc---ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                           ....||+.|+|||++.   +..++.++|||||||++|||++|.+||.......      ..         ..+..
T Consensus       208 -----~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~------~~---------~~~~~  267 (348)
T 1u5q_A          208 -----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------AL---------YHIAQ  267 (348)
T ss_dssp             -----CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH---------HHHHH
T ss_pred             -----CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH------HH---------HHHHh
Confidence                 2346999999999874   5678999999999999999999999996443111      00         01111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL  335 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L  335 (375)
                      ......   ....++..+.+++.+||+.+|++|||+.++++..
T Consensus       268 ~~~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~  307 (348)
T 1u5q_A          268 NESPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHR  307 (348)
T ss_dssp             SCCCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCH
T ss_pred             cCCCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            100000   0112345788999999999999999999998653

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=3.8e-44  Score=331.21  Aligned_cols=256  Identities=25%  Similarity=0.370  Sum_probs=204.0

Q ss_pred             HHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--------hhhHHHHHHHHHHHHhc-CCCCeEEEee
Q 017232           55 ELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--------YKRVEQFMNEVDILARL-RHKNLVSLYG  124 (375)
Q Consensus        55 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l-~h~niv~~~~  124 (375)
                      ......++|++.+.||+|+||.||+|... +|+.||||++....        ....+.+.+|+.+++.+ +||||+++++
T Consensus        88 ~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~  167 (365)
T 2y7j_A           88 AAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLID  167 (365)
T ss_dssp             HHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             hhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEE
Confidence            34556678999999999999999999775 79999999986542        12245678999999999 7999999999


Q ss_pred             eeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEe
Q 017232          125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVA  204 (375)
Q Consensus       125 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~  204 (375)
                      ++.. ....++||||+++++|.+++...    ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+
T Consensus       168 ~~~~-~~~~~lv~e~~~g~~L~~~l~~~----~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~  242 (365)
T 2y7j_A          168 SYES-SSFMFLVFDLMRKGELFDYLTEK----VALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLS  242 (365)
T ss_dssp             EEEB-SSEEEEEECCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEEC
T ss_pred             EEee-CCEEEEEEEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEE
Confidence            7766 67899999999999999999642    458999999999999999999999999999999999999999999999


Q ss_pred             eeccccccCCCccccccCCCCCccccCcccccc------cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHH
Q 017232          205 DFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC------YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA  278 (375)
Q Consensus       205 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~  278 (375)
                      |||++........  .....||+.|+|||++.+      ..++.++|||||||++|+|++|..||.......       .
T Consensus       243 DfG~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~-------~  313 (365)
T 2y7j_A          243 DFGFSCHLEPGEK--LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL-------M  313 (365)
T ss_dssp             CCTTCEECCTTCC--BCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-------H
T ss_pred             ecCcccccCCCcc--cccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH-------H
Confidence            9999887654322  234569999999998764      357889999999999999999999996543110       0


Q ss_pred             HHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          279 INKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       279 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..        .+...... ...+.....+..+.+++.+||..+|++|||+.++++
T Consensus       314 ~~--------~i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          314 LR--------MIMEGQYQ-FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             HH--------HHHHTCCC-CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HH--------HHHhCCCC-CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            00        01111110 001111234567899999999999999999999986

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.2e-44  Score=347.82  Aligned_cols=250  Identities=26%  Similarity=0.395  Sum_probs=203.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|.+.+.||+|+||.||+|..+ +|+.||+|++.....   .....+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus       185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~lV  263 (543)
T 3c4z_A          185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFET-KTDLCLV  263 (543)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEee-CCEEEEE
Confidence            67888999999999999999775 699999999965432   234678899999999999999999997776 6779999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||++||+|.+++.........+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~  343 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ  343 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC
Confidence            99999999999997665455679999999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .. ....+||+.|+|||++.+..++.++|||||||++|||++|.+||........  ....         ...+......
T Consensus       344 ~~-~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~--~~~~---------~~~i~~~~~~  411 (543)
T 3c4z_A          344 TK-TKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE--NKEL---------KQRVLEQAVT  411 (543)
T ss_dssp             CC-BCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCC--HHHH---------HHHHHHCCCC
T ss_pred             cc-cccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchh--HHHH---------HHHHhhcccC
Confidence            22 2334799999999999999999999999999999999999999976532111  0111         0111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYM  328 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  328 (375)
                        .+   ..++..+.+++.+||..+|++||++
T Consensus       412 --~p---~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          412 --YP---DKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             --CC---TTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             --CC---cccCHHHHHHHHHhccCCHhHCCCC
Confidence              11   2245678999999999999999976

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.6e-46  Score=337.94  Aligned_cols=244  Identities=23%  Similarity=0.312  Sum_probs=199.9

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccch--------hhHHHHHHHHHHHHhcCCCCeEEEeeeeec
Q 017232           58 EATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNY--------KRVEQFMNEVDILARLRHKNLVSLYGCTSR  128 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~  128 (375)
                      ...++|++.+.||+|+||.||+|.. .+++.||+|++.....        .....+.+|+.+++.++||||+++++++..
T Consensus        21 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~  100 (335)
T 3dls_A           21 EYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFEN  100 (335)
T ss_dssp             HHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEEC
T ss_pred             ccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEee
Confidence            3457899999999999999999965 4789999999865421        123356789999999999999999998766


Q ss_pred             CCceeEEEEecccCC-ChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeec
Q 017232          129 HSRELLLVYEFISNG-TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFG  207 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg  207 (375)
                       ....++||||+.+| +|.+++..    ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||
T Consensus       101 -~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg  175 (335)
T 3dls_A          101 -QGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFG  175 (335)
T ss_dssp             -SSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCT
T ss_pred             -CCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecc
Confidence             67899999999766 99999853    3458999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccCCCCCccccCcccccccCC-CCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH
Q 017232          208 LSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA  286 (375)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (375)
                      ++........  .....||+.|+|||++.+..+ +.++|||||||++|+|++|..||........               
T Consensus       176 ~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~---------------  238 (335)
T 3dls_A          176 SAAYLERGKL--FYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETVE---------------  238 (335)
T ss_dssp             TCEECCTTCC--BCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGTT---------------
T ss_pred             cceECCCCCc--eeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHHh---------------
Confidence            9987654332  223458999999999988776 7899999999999999999999964321110               


Q ss_pred             HHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          287 LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       287 ~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                            ....  .+   ..++..+.+++.+||+.+|++|||+.++++.
T Consensus       239 ------~~~~--~~---~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 ------AAIH--PP---YLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ------TCCC--CS---SCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ------hccC--CC---cccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  0000  00   0134578999999999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=2e-44  Score=320.44  Aligned_cols=253  Identities=25%  Similarity=0.364  Sum_probs=202.5

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   83 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLF   83 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-CCEEEEE
Confidence            3467999999999999999999765 78999999986443 3345678899999999999999999997766 6778999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        84 ~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  159 (276)
T 2yex_A           84 LEYCSGGELFDRIEP----DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN  159 (276)
T ss_dssp             EECCTTEEGGGGSBT----TTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred             EEecCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCc
Confidence            999999999999843    3468999999999999999999999999999999999999999999999999997653222


Q ss_pred             -cccccCCCCCccccCcccccccCC-CCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          217 -THVSTAPQGTPGYVDPEYHQCYQL-TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       217 -~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                       ........+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.........      .        ..+....
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~--------~~~~~~~  225 (276)
T 2yex_A          160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------Y--------SDWKEKK  225 (276)
T ss_dssp             EECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHH------H--------HHHHTTC
T ss_pred             chhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHH------H--------HHhhhcc
Confidence             122334568999999999887665 67899999999999999999999754422110      0        0011100


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .   ........+..+.+++.+||..+|++|||+.++++
T Consensus       226 ~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          226 T---YLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             T---TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             c---ccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence            0   00111234567889999999999999999999875

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=2e-45  Score=327.48  Aligned_cols=258  Identities=24%  Similarity=0.396  Sum_probs=204.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeee-cCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTS-RHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~~l  135 (375)
                      .++|++.+.||+|+||.||+|... +++.||+|.+...  .....+.+.+|+.+++.++||||+++++++. ......++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   84 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   84 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence            357889999999999999999765 6899999998654  3445567899999999999999999999654 34567899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC-----ceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD-----IIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      ||||+++++|.+++.........+++..++.++.|++.||.|||+.|     ++|+||||+||+++.++.+||+|||++.
T Consensus        85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~  164 (279)
T 2w5a_A           85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  164 (279)
T ss_dssp             EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred             EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence            99999999999999765444566999999999999999999999999     9999999999999999999999999987


Q ss_pred             ccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ........ .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......       ....        +
T Consensus       165 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-------~~~~--------i  228 (279)
T 2w5a_A          165 ILNHDTSF-AKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGK--------I  228 (279)
T ss_dssp             HC---CHH-HHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHH--------H
T ss_pred             eecccccc-ccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHH-------HHHH--------H
Confidence            65433211 122358999999999998889999999999999999999999997543110       0111        1


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRD  337 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~  337 (375)
                      ...... ..   ...++..+.+++.+||+.+|++|||+.++++.+..
T Consensus       229 ~~~~~~-~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          229 REGKFR-RI---PYRYSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             HHTCCC-CC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             hhcccc-cC---CcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            111110 01   11245679999999999999999999999976543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=3.6e-45  Score=336.73  Aligned_cols=265  Identities=15%  Similarity=0.198  Sum_probs=204.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC---------CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEE---------
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD---------GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS---------  121 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~---------  121 (375)
                      .++|++.+.||+|+||.||+|....         ++.||+|++...     ..+.+|+.+++.++||||++         
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~  115 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTP  115 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCC
Confidence            3579999999999999999997663         789999998654     35778999999999999887         


Q ss_pred             ------EeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe
Q 017232          122 ------LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL  195 (375)
Q Consensus       122 ------~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill  195 (375)
                            +++++...+...++||||+ +++|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus       116 ~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~  192 (352)
T 2jii_A          116 LLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS--PKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV  192 (352)
T ss_dssp             TCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEE
T ss_pred             ccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC--CcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEE
Confidence                  5665555567899999999 99999999754  23569999999999999999999999999999999999999


Q ss_pred             cCCC--cEEEeeeccccccCCCccc------cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccc
Q 017232          196 DNNF--CVKVADFGLSRLFPNHVTH------VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITR  267 (375)
Q Consensus       196 ~~~~--~~kl~Dfg~~~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~  267 (375)
                      +.++  .+||+|||++.........      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||....
T Consensus       193 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          193 DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            9998  8999999999765432211      1133469999999999999899999999999999999999999997653


Q ss_pred             cccccchhHHHHHHhhhhHHHHHHhhh--cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          268 HRHEINLSNLAINKIQNKALHELVDQT--LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                      ....     .....     ...+....  +.... .....++..+.+++.+||..+|++|||+.+|++.|+++.....
T Consensus       273 ~~~~-----~~~~~-----~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  339 (352)
T 2jii_A          273 PNTE-----DIMKQ-----KQKFVDKPGPFVGPC-GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLR  339 (352)
T ss_dssp             TCHH-----HHHHH-----HHHHHHSCCCEECTT-SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             cCHH-----HHHHH-----HHhccCChhhhhhhc-cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcC
Confidence            2110     00000     00000000  00000 0000124679999999999999999999999999999876543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=2.7e-44  Score=320.77  Aligned_cols=259  Identities=23%  Similarity=0.354  Sum_probs=205.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch------hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY------KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      .++|++.+.||+|+||.||+|... +++.||+|++.....      ...+.+.+|+.+++.++||||+++++++.. ...
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~   82 (283)
T 3bhy_A            4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFEN-KTD   82 (283)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred             hhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecC-CCe
Confidence            356899999999999999999776 689999999865422      135678999999999999999999997776 677


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC----cEEEeeecc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF----CVKVADFGL  208 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~  208 (375)
                      .++||||+++++|.+++...    ..+++..++.++.|++.||.|||++|++|+||||+||+++.++    .++|+|||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~  158 (283)
T 3bhy_A           83 VVLILELVSGGELFDFLAEK----ESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI  158 (283)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEeecCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence            99999999999999999542    4589999999999999999999999999999999999998877    899999999


Q ss_pred             ccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      +........  .....+++.|+|||++.+..++.++||||||+++|+|++|..||.......      .         ..
T Consensus       159 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~---------~~  221 (283)
T 3bhy_A          159 AHKIEAGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQE------T---------LT  221 (283)
T ss_dssp             CEECC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H---------HH
T ss_pred             ceeccCCCc--ccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH------H---------HH
Confidence            986543322  233458999999999998899999999999999999999999997543211      0         00


Q ss_pred             HHHhhhcCCCCC-hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHHhhhcCC
Q 017232          289 ELVDQTLGYESD-NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD--ALRDIESDG  342 (375)
Q Consensus       289 ~~~~~~l~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~--~L~~i~~~~  342 (375)
                      .+...  ..... ......+..+.+++.+||..+|++|||+.++++  .++.+....
T Consensus       222 ~~~~~--~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~  276 (283)
T 3bhy_A          222 NISAV--NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRN  276 (283)
T ss_dssp             HHHTT--CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHHHCC
T ss_pred             HhHhc--ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHHHHh
Confidence            01000  01111 111234567899999999999999999999998  466665543

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=4.4e-44  Score=328.12  Aligned_cols=273  Identities=22%  Similarity=0.350  Sum_probs=210.6

Q ss_pred             cchHHHHHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHh--cCCCCeEEEeeeeec
Q 017232           51 FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILAR--LRHKNLVSLYGCTSR  128 (375)
Q Consensus        51 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~--l~h~niv~~~~~~~~  128 (375)
                      .+........++|++.+.||+|+||.||+|... ++.||+|++....   ...+.+|.+++..  ++||||+++++++..
T Consensus        32 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~~---~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~  107 (342)
T 1b6c_B           32 LPLLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAADNK  107 (342)
T ss_dssp             SCHHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECGGG---HHHHHHHHHHHHHSCCCCTTBCCEEEEEEC
T ss_pred             CceeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCchh---HHHHHHHHHHHHHhhcCCCcEEEEEeeecc
Confidence            334444566788999999999999999999874 8999999986443   3567788888888  789999999997766


Q ss_pred             CC---ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHh--------hCCceeccCCCCCEEecC
Q 017232          129 HS---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--------ASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       129 ~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--------~~~ivH~dlkp~Nill~~  197 (375)
                      ..   ...++||||+++++|.+++..     ..+++..++.++.|++.||.|||        +.|++||||||+||+++.
T Consensus       108 ~~~~~~~~~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~  182 (342)
T 1b6c_B          108 DNGTWTQLWLVSDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK  182 (342)
T ss_dssp             CCSSCCCEEEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECT
T ss_pred             cCCccceeEEEEeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECC
Confidence            44   278999999999999999954     35899999999999999999999        899999999999999999


Q ss_pred             CCcEEEeeeccccccCCCccc---cccCCCCCccccCccccccc------CCCCchhHHHHHHHHHHHHhC---------
Q 017232          198 NFCVKVADFGLSRLFPNHVTH---VSTAPQGTPGYVDPEYHQCY------QLTDKSDVFSFGVVLIELISS---------  259 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg---------  259 (375)
                      ++.+||+|||++.........   ......+|+.|+|||++.+.      .++.++||||||+++|+|++|         
T Consensus       183 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~  262 (342)
T 1b6c_B          183 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  262 (342)
T ss_dssp             TSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCC
T ss_pred             CCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccc
Confidence            999999999999766443322   22345699999999988765      334689999999999999999         


Q ss_pred             -CCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCCh--HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          260 -MPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN--KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       260 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                       ..||......... ...+         ...+....+......  ....+...+.+++.+||+.+|++|||+.+|++.|+
T Consensus       263 ~~~p~~~~~~~~~~-~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~  332 (342)
T 1b6c_B          263 YQLPYYDLVPSDPS-VEEM---------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS  332 (342)
T ss_dssp             CCCTTTTTSCSSCC-HHHH---------HHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHH
T ss_pred             cccCccccCcCccc-HHHH---------HHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHH
Confidence             5566433221100 0000         011111112222221  12356678999999999999999999999999999


Q ss_pred             hhhcCC
Q 017232          337 DIESDG  342 (375)
Q Consensus       337 ~i~~~~  342 (375)
                      ++....
T Consensus       333 ~i~~~~  338 (342)
T 1b6c_B          333 QLSQQE  338 (342)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            987654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.1e-44  Score=344.35  Aligned_cols=252  Identities=26%  Similarity=0.404  Sum_probs=201.9

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ..++|++.+.||+|+||+||+|... +++.||+|++....  ......+.+|+.+++.++||||+++++++.. ...+++
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l   98 (486)
T 3mwu_A           20 FAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFYI   98 (486)
T ss_dssp             HHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             hhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEc-CCEEEE
Confidence            4467999999999999999999765 78999999985432  2335678899999999999999999998776 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec---CCCcEEEeeecccccc
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD---NNFCVKVADFGLSRLF  212 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~  212 (375)
                      ||||+.+++|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++   .++.+||+|||++...
T Consensus        99 v~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~  174 (486)
T 3mwu_A           99 VGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCF  174 (486)
T ss_dssp             EECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred             EEEcCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence            99999999999988543    4589999999999999999999999999999999999995   5567999999999866


Q ss_pred             CCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .....  .....||+.|+|||++.+ .++.++||||+||++|+|++|.+||.......      .         ...+..
T Consensus       175 ~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~------~---------~~~i~~  236 (486)
T 3mwu_A          175 QQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------I---------LKRVET  236 (486)
T ss_dssp             CCC------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H---------HHHHHH
T ss_pred             CCCCc--cCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H---------HHHHHh
Confidence            44322  234569999999999876 58999999999999999999999997543211      0         011111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ..... ..+....++..+.+++.+||..+|.+|||+.++++.
T Consensus       237 ~~~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          237 GKYAF-DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             TCCCS-CSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             CCCCC-CCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11111 112223345679999999999999999999999975

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.2e-45  Score=335.80  Aligned_cols=265  Identities=20%  Similarity=0.314  Sum_probs=196.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-----c
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-----R  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~  131 (375)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            46799999999999999999976 47999999998543  3344567889999999999999999999776532     3


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      .+++||||+ +++|.+++..     ..+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++..
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecC-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence            569999999 8899999854     3589999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhH--------HHHHHh
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN--------LAINKI  282 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~  282 (375)
                      ....    .....+|+.|+|||++.+ ..++.++||||+||++|+|++|++||.............        .....+
T Consensus       178 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~  253 (367)
T 1cm8_A          178 ADSE----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  253 (367)
T ss_dssp             CCSS----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             cccc----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHh
Confidence            5432    234568999999998876 679999999999999999999999997654322110000        000001


Q ss_pred             hhhHHHHHHhhhcC---CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          283 QNKALHELVDQTLG---YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       283 ~~~~~~~~~~~~l~---~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ........+.....   ..........+..+.+|+.+||..||++|||+.++++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          254 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            11111111111000   00001111234678999999999999999999999873

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6.2e-45  Score=324.30  Aligned_cols=247  Identities=28%  Similarity=0.433  Sum_probs=198.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .++|++.+.||+|+||.||+|... ++..||+|++.....   .....+.+|+.+++.++||||+++++++.. ....++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   86 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYL   86 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEec-CCEEEE
Confidence            356889999999999999999665 577999999865422   224568899999999999999999998776 677999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++......
T Consensus        87 v~e~~~~~~l~~~l~~~----~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~  162 (279)
T 3fdn_A           87 ILEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS  162 (279)
T ss_dssp             EECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC---
T ss_pred             EEecCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc
Confidence            99999999999998543    35899999999999999999999999999999999999999999999999988654332


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .   .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......      .         ...+...  
T Consensus       163 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~---------~~~~~~~--  222 (279)
T 3fdn_A          163 R---RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------T---------YKRISRV--  222 (279)
T ss_dssp             --------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------H---------HHHHHHT--
T ss_pred             c---ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHH------H---------HHHHHhC--
Confidence            2   233468999999999999899999999999999999999999997543111      0         0011111  


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ....+   ...+..+.+++.+||+.+|++|||+.|+++.
T Consensus       223 ~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          223 EFTFP---DFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             CCCCC---TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             CCCCC---CcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            11111   1134578899999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.8e-44  Score=338.48  Aligned_cols=199  Identities=26%  Similarity=0.394  Sum_probs=166.0

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----ce
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----RE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~  132 (375)
                      .++|++.+.||+|+||.||+|... +++.||||++...  .....+.+.+|+.+++.++||||+++++++....    ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            467999999999999999999655 6889999999653  3445678899999999999999999999776543    57


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      +|+||||+. ++|.+++..    ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus       105 ~~lv~e~~~-~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          105 LYIVLEIAD-SDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             EEEEEECCS-EEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEecCC-cCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            899999996 699999853    346899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCcc---------------------ccccCCCCCccccCcccc-cccCCCCchhHHHHHHHHHHHHhCCCCc
Q 017232          213 PNHVT---------------------HVSTAPQGTPGYVDPEYH-QCYQLTDKSDVFSFGVVLIELISSMPAV  263 (375)
Q Consensus       213 ~~~~~---------------------~~~~~~~~~~~y~aPE~~-~~~~~~~~~DiwslG~il~elltg~~p~  263 (375)
                      .....                     ......+||+.|+|||++ .+..++.++|||||||++|||++|..||
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccc
Confidence            43221                     122456789999999975 5667999999999999999999855544

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=7.5e-45  Score=324.93  Aligned_cols=247  Identities=19%  Similarity=0.320  Sum_probs=198.2

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  134 (375)
                      ..++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+..+..+ +||||+++++++.. ....+
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-~~~~~   87 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-DDHML   87 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-TTEEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-CCeEE
Confidence            4567999999999999999999765 7999999998754  233456788999999999 89999999998766 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC----------------
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN----------------  198 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~----------------  198 (375)
                      +||||+++++|.+++.........+++..++.++.||+.||.|||++||+||||||+||+++.+                
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~  167 (289)
T 1x8b_A           88 IQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWA  167 (289)
T ss_dssp             EEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC------------------
T ss_pred             EEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccccc
Confidence            9999999999999997654334668999999999999999999999999999999999999844                


Q ss_pred             ---CcEEEeeeccccccCCCccccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccch
Q 017232          199 ---FCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL  274 (375)
Q Consensus       199 ---~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~  274 (375)
                         ..++|+|||.+.......     ...+|+.|+|||.+.+. .++.++|||||||++|+|++|.+++.....      
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~-----~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~------  236 (289)
T 1x8b_A          168 SNKVMFKIGDLGHVTRISSPQ-----VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ------  236 (289)
T ss_dssp             --CCCEEECCCTTCEETTCSC-----CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH------
T ss_pred             CCceEEEEcccccccccCCcc-----ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH------
Confidence               479999999998764432     23489999999988765 566899999999999999999987643210      


Q ss_pred             hHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          275 SNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                                  ...+......    .....++..+.+++.+||..||++|||+.++++
T Consensus       237 ------------~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          237 ------------WHEIRQGRLP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             ------------HHHHHTTCCC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------------HHHHHcCCCC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence                        0111111111    011123467899999999999999999999985

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-44  Score=355.03  Aligned_cols=251  Identities=24%  Similarity=0.379  Sum_probs=199.6

Q ss_pred             ccCCCCcEEEEEEEeC---CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecccCC
Q 017232           68 ELGDGGFGTVYYGELQ---DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNG  143 (375)
Q Consensus        68 ~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~~~  143 (375)
                      .||+|+||.||+|...   ++..||||++.... ....+.+.+|+.+++.++||||+++++++..  ..+++||||+.+|
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~E~~~~g  420 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGG  420 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEEECCTTC
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEEEeCCCC
Confidence            7999999999999654   46679999997653 3356789999999999999999999998765  4589999999999


Q ss_pred             ChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc--cc
Q 017232          144 TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV--ST  221 (375)
Q Consensus       144 ~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~--~~  221 (375)
                      +|.+++...   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........  ..
T Consensus       421 ~L~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~  497 (613)
T 2ozo_A          421 PLHKFLVGK---REEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS  497 (613)
T ss_dssp             BHHHHHTTC---TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----------
T ss_pred             cHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeecc
Confidence            999999532   4569999999999999999999999999999999999999999999999999998764332211  12


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCC
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD  300 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  300 (375)
                      ...+++.|+|||++.+..++.++|||||||++|||++ |+.||.......                ....+........ 
T Consensus       498 ~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~~~~i~~~~~~~~-  560 (613)
T 2ozo_A          498 AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE----------------VMAFIEQGKRMEC-  560 (613)
T ss_dssp             ----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH----------------HHHHHHTTCCCCC-
T ss_pred             CCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHHcCCCCCC-
Confidence            2335689999999998899999999999999999998 999997543211                1111111111111 


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          301 NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                        +..++..+.+++.+||..+|++||++.+|++.|+.+....
T Consensus       561 --p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~  600 (613)
T 2ozo_A          561 --PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  600 (613)
T ss_dssp             --CTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             --CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHh
Confidence              1235678999999999999999999999999999876543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=7e-45  Score=345.11  Aligned_cols=248  Identities=25%  Similarity=0.332  Sum_probs=193.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .++|++.+.||+|+||.||+|... +|+.||+|++...   .......+.+|+.+++.++||||+++++++.. ...+++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-~~~~~l  225 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-HDRLCF  225 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-TTEEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-CCEEEE
Confidence            467999999999999999999654 6899999998654   22334567789999999999999999998776 567999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      ||||+++++|.+++...    ..+++..+..++.||+.||+|||+ .||+||||||+|||++.++.+||+|||++.....
T Consensus       226 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  301 (446)
T 4ejn_A          226 VMEYANGGELFFHLSRE----RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK  301 (446)
T ss_dssp             EECCCSSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC
T ss_pred             EEeeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccC
Confidence            99999999999998543    458999999999999999999998 9999999999999999999999999999975433


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .         ...+....
T Consensus       302 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~------~---------~~~i~~~~  365 (446)
T 4ejn_A          302 DGA-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------L---------FELILMEE  365 (446)
T ss_dssp             ------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H---------HHHHHHCC
T ss_pred             CCc-ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH------H---------HHHHHhCC
Confidence            222 2344579999999999999999999999999999999999999996543211      0         01111111


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~  333 (375)
                      ..  .+   ..++..+.+++.+||+.||.+||     +++|+++
T Consensus       366 ~~--~p---~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          366 IR--FP---RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             CC--CC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             CC--CC---ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            11  11   12346789999999999999999     9999886

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=331.14  Aligned_cols=260  Identities=26%  Similarity=0.394  Sum_probs=193.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CCCeEEEeeeee-------cCC
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCTS-------RHS  130 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~-------~~~  130 (375)
                      ..+|++.+.||+|+||.||+|... +++.||+|++..........+.+|+.++..+. ||||+++++++.       ...
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            457999999999999999999764 78999999997777777778899999999996 999999999763       345


Q ss_pred             ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC--ceeccCCCCCEEecCCCcEEEeeecc
Q 017232          131 RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--IIHRDVKTNNILLDNNFCVKVADFGL  208 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--ivH~dlkp~Nill~~~~~~kl~Dfg~  208 (375)
                      ..+++||||+. |+|.+++.... ....+++..++.++.||+.||.|||+.|  ++|+||||+|||++.++.+||+|||+
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~  184 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKME-SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGS  184 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHH-TTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTT
T ss_pred             ceEEEEEEecC-CCHHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCcc
Confidence            56899999995 78988886532 2346999999999999999999999999  99999999999999999999999999


Q ss_pred             ccccCCCcccc-----------ccCCCCCccccCcccc---cccCCCCchhHHHHHHHHHHHHhCCCCccccccccccch
Q 017232          209 SRLFPNHVTHV-----------STAPQGTPGYVDPEYH---QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL  274 (375)
Q Consensus       209 ~~~~~~~~~~~-----------~~~~~~~~~y~aPE~~---~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~  274 (375)
                      +..........           .....+|+.|+|||++   .+..++.++||||||+++|+|++|..||.......    
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~----  260 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLR----  260 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHH----
Confidence            98765322211           1134589999999988   56678899999999999999999999996432110    


Q ss_pred             hHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          275 SNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                                     +..........   ......+.+++.+||+.+|.+|||+.|+++.|+.+.....
T Consensus       261 ---------------~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          261 ---------------IVNGKYSIPPH---DTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             --------------------CCCCTT---CCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             ---------------hhcCcccCCcc---cccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence                           11111110000   1122457899999999999999999999999999876544

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=9.6e-45  Score=349.40  Aligned_cols=254  Identities=27%  Similarity=0.363  Sum_probs=204.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....   ......+.+|+.+++.++||||+++++++.. ...+++
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~-~~~l~l  261 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYET-KDALCL  261 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEee-CCEEEE
Confidence            467999999999999999999765 79999999986542   2234567899999999999999999997776 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||++||+|.+++...  ....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus       262 VmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          262 VLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            99999999999998654  2345899999999999999999999999999999999999999999999999999876543


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      ..  ....+||+.|+|||++.+..++.++|||||||++|||++|.+||.........   ...         ...+.. .
T Consensus       340 ~~--~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~---~~i---------~~~i~~-~  404 (576)
T 2acx_A          340 QT--IKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR---EEV---------ERLVKE-V  404 (576)
T ss_dssp             CC--EECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH---HHH---------HHHHHH-C
T ss_pred             cc--ccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhH---HHH---------HHHhhc-c
Confidence            22  23447999999999999989999999999999999999999999765322110   000         011110 0


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLDA  334 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~~  334 (375)
                      .....   ..++..+.+|+.+||..||.+||     ++.|+++.
T Consensus       405 ~~~~p---~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 PEEYS---ERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             CCCCC---TTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             cccCC---ccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            11111   12456799999999999999999     67887753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-44  Score=321.37  Aligned_cols=249  Identities=28%  Similarity=0.404  Sum_probs=181.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++.....   ...+.+.+|+.+++.++||||+++++++.. ....++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   88 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFED-SNYVYL   88 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEEC-SSEEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEcc-CCeEEE
Confidence            35689999999999999999976 4789999999865432   224678899999999999999999997766 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~  165 (278)
T 3cok_A           89 VLEMCHNGEMNRYLKNR---VKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMP  165 (278)
T ss_dssp             EEECCTTEEHHHHHHTC---SSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC--
T ss_pred             EEecCCCCcHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCC
Confidence            99999999999998643   356899999999999999999999999999999999999999999999999999865432


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      ... .....+++.|+|||.+.+..++.++||||||+++|+|++|++||.........      . ..        .....
T Consensus       166 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~------~-~~--------~~~~~  229 (278)
T 3cok_A          166 HEK-HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL------N-KV--------VLADY  229 (278)
T ss_dssp             ---------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC------------C--------CSSCC
T ss_pred             CCc-ceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH------H-HH--------hhccc
Confidence            221 22346899999999999888999999999999999999999999754422110      0 00        00000


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        ..+   ..++..+.+++.+||+.||++|||+.++++
T Consensus       230 --~~~---~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          230 --EMP---SFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             --CCC---TTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             --CCc---cccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence              001   123457889999999999999999999885

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.7e-44  Score=325.60  Aligned_cols=250  Identities=22%  Similarity=0.330  Sum_probs=204.0

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ..++|.+.+.||+|+||.||++... +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.. ....+
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~  117 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVF  117 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEE
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec-CCeEE
Confidence            3467999999999999999999765 5789999998654   33455678899999999999999999998776 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++++|.+++...    ..+++.+++.++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.....
T Consensus       118 lv~e~~~~~~L~~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~  193 (335)
T 2owb_A          118 VVLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY  193 (335)
T ss_dssp             EEECCCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred             EEEecCCCCCHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence            999999999999988543    4589999999999999999999999999999999999999999999999999986543


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ... ......+++.|+|||++.+..++.++||||||+++|+|++|+.||.......      .         ...+....
T Consensus       194 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~---------~~~~~~~~  257 (335)
T 2owb_A          194 DGE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------T---------YLRIKKNE  257 (335)
T ss_dssp             TTC-CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H---------HHHHHHTC
T ss_pred             Ccc-cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHH------H---------HHHHhcCC
Confidence            222 1234568999999999998889999999999999999999999997543111      0         00111111


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ..  ..   ..+...+.+++.+||+.||++|||+.++++.
T Consensus       258 ~~--~~---~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          258 YS--IP---KHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CC--CC---TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CC--CC---ccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            11  11   1234568899999999999999999999873

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.8e-44  Score=346.00  Aligned_cols=252  Identities=26%  Similarity=0.412  Sum_probs=204.1

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ..++|++.+.||+|+||.||+|... +|+.||+|++....   ......+.+|+.+++.++||||+++++++.. ....+
T Consensus        24 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~  102 (484)
T 3nyv_A           24 FSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFED-KGYFY  102 (484)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEE
T ss_pred             ccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEe-CCEEE
Confidence            3457999999999999999999765 78999999985432   3345778999999999999999999998776 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe---cCCCcEEEeeeccccc
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRL  211 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~  211 (375)
                      +||||+.+++|.+.+..    ...+++..++.++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++..
T Consensus       103 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~  178 (484)
T 3nyv_A          103 LVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTH  178 (484)
T ss_dssp             EEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred             EEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence            99999999999998853    3468999999999999999999999999999999999999   5678999999999986


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ......  .....||+.|+|||++.+ .++.++||||+||++|+|++|.+||.......       .        ...+.
T Consensus       179 ~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~--------~~~i~  240 (484)
T 3nyv_A          179 FEASKK--MKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD-------I--------LKKVE  240 (484)
T ss_dssp             BCCCCS--HHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------H--------HHHHH
T ss_pred             cccccc--cccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH-------H--------HHHHH
Confidence            654332  223459999999999876 68999999999999999999999997543211       0        01111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ...... ..+....++..+.+++.+||..+|.+|||+.++++.
T Consensus       241 ~~~~~~-~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          241 KGKYTF-ELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             HCCCCC-CSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             cCCCCC-CCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence            111111 112223355779999999999999999999999974

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=5.6e-45  Score=339.16  Aligned_cols=274  Identities=22%  Similarity=0.290  Sum_probs=200.7

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC------
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH------  129 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~------  129 (375)
                      +...++|++.+.||+|+||.||+|.. .+|+.||+|++......    ..+|+.+++.++||||+++++++...      
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~   78 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK   78 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence            34567899999999999999999965 57999999998654322    24799999999999999999976432      


Q ss_pred             -------------------------------CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHH
Q 017232          130 -------------------------------SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL  178 (375)
Q Consensus       130 -------------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~L  178 (375)
                                                     ...+++||||++ ++|.+.+.........+++..++.++.||+.||.||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  157 (383)
T 3eb0_A           79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI  157 (383)
T ss_dssp             -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence                                           334889999997 588887765444556799999999999999999999


Q ss_pred             hhCCceeccCCCCCEEec-CCCcEEEeeeccccccCCCccccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHH
Q 017232          179 HASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIEL  256 (375)
Q Consensus       179 h~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el  256 (375)
                      |++||+||||||+|||++ .++.+||+|||++........  .....+|+.|+|||++.+. .++.++||||+||++|+|
T Consensus       158 H~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el  235 (383)
T 3eb0_A          158 HSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP--SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGEL  235 (383)
T ss_dssp             HTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSC--CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHH
T ss_pred             HHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCC--CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHH
Confidence            999999999999999997 689999999999986544332  2344689999999988764 489999999999999999


Q ss_pred             HhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh--hcC---C----CCCh---HHHHHHHHHHHHHHHhcCCCCCC
Q 017232          257 ISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ--TLG---Y----ESDN---KVRRTINAVAELAFQCLQSEKDL  324 (375)
Q Consensus       257 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~l~---~----~~~~---~~~~~~~~l~~li~~cl~~~P~~  324 (375)
                      ++|++||......+..   ..............+...  ...   .    ....   .....+..+.+|+.+||..+|++
T Consensus       236 l~g~~pf~~~~~~~~~---~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  312 (383)
T 3eb0_A          236 ILGKPLFSGETSIDQL---VRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDL  312 (383)
T ss_dssp             HHSSCSSCCSSHHHHH---HHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGG
T ss_pred             HhCCCCCCCCChHHHH---HHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhh
Confidence            9999999765432211   000111110001111100  000   0    0000   00123457899999999999999


Q ss_pred             CCCHHHHHHH--HHhhhc
Q 017232          325 RPYMVDVLDA--LRDIES  340 (375)
Q Consensus       325 Rpt~~evl~~--L~~i~~  340 (375)
                      |||+.|+++.  ++.+..
T Consensus       313 R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          313 RINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             SCCHHHHHTSGGGHHHHH
T ss_pred             CCCHHHHhcCHHHHHHHh
Confidence            9999999853  555543

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.3e-44  Score=323.81  Aligned_cols=262  Identities=24%  Similarity=0.347  Sum_probs=191.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccc-hhh-HHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN-YKR-VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~-~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++.... ... ...+..+...++.++||||+++++++.. ....++|
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-~~~~~lv   84 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-EGDVWIC   84 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSSEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-cCCEEEE
Confidence            46789999999999999999976 478999999986542 222 2334445555788899999999998776 6678999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      |||++ ++|.+++.........+++..++.++.|++.||.|||++ |++||||||+||+++.++.+||+|||++......
T Consensus        85 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  163 (290)
T 3fme_A           85 MELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDD  163 (290)
T ss_dssp             EECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC---------
T ss_pred             Eehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCccccccc
Confidence            99997 588888765444556799999999999999999999998 9999999999999999999999999999765443


Q ss_pred             ccccccCCCCCccccCcccc----cccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          216 VTHVSTAPQGTPGYVDPEYH----QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ..  .....+|+.|+|||++    .+..++.++||||||+++|+|++|..||.......              .......
T Consensus       164 ~~--~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--------------~~~~~~~  227 (290)
T 3fme_A          164 VA--KDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF--------------QQLKQVV  227 (290)
T ss_dssp             --------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH--------------HHHHHHH
T ss_pred             cc--ccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH--------------HHHHHHh
Confidence            22  2233589999999985    56678999999999999999999999997432111              0011111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHHhhhcCC
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD--ALRDIESDG  342 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~--~L~~i~~~~  342 (375)
                      .......   ....++..+.+++.+||+.+|++|||+.++++  .+....+..
T Consensus       228 ~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~~~  277 (290)
T 3fme_A          228 EEPSPQL---PADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG  277 (290)
T ss_dssp             HSCCCCC---CTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSC
T ss_pred             ccCCCCc---ccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcccc
Confidence            1111111   11224567899999999999999999999988  455554443

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4e-44  Score=344.10  Aligned_cols=252  Identities=25%  Similarity=0.398  Sum_probs=198.3

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ..++|++.+.||+|+||+||+|... ++..||+|++....  ......+.+|+.+++.++||||+++++++.. ....++
T Consensus        35 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~~l  113 (494)
T 3lij_A           35 LSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFED-KRNYYL  113 (494)
T ss_dssp             HHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             hhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEe-CCEEEE
Confidence            3456999999999999999999765 68899999986543  2234678899999999999999999998776 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC---CcEEEeeecccccc
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN---FCVKVADFGLSRLF  212 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~~  212 (375)
                      ||||+.+|+|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||++...
T Consensus       114 v~e~~~~g~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          114 VMECYKGGELFDEIIHR----MKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            99999999999988543    458999999999999999999999999999999999999764   45999999999876


Q ss_pred             CCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .....  .....||+.|+|||++.+ .++.++||||+||++|+|++|.+||.......       ..        ..+..
T Consensus       190 ~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~--------~~i~~  251 (494)
T 3lij_A          190 ENQKK--MKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQE-------IL--------RKVEK  251 (494)
T ss_dssp             BTTBC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HH--------HHHHH
T ss_pred             CCCcc--ccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH-------HH--------HHHHh
Confidence            54322  334569999999998864 68999999999999999999999997543211       00        11111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .... ...+....++..+.+++.+||+.+|.+|||+.++++.
T Consensus       252 ~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          252 GKYT-FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             TCCC-CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             CCCC-CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence            1111 1112222345678999999999999999999999864

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.2e-44  Score=343.20  Aligned_cols=252  Identities=26%  Similarity=0.406  Sum_probs=200.4

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-------------hhHHHHHHHHHHHHhcCCCCeEEEee
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-------------KRVEQFMNEVDILARLRHKNLVSLYG  124 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~niv~~~~  124 (375)
                      ..++|++.++||+|+||+||+|... +++.||+|++.....             ...+.+.+|+.+++.++||||+++++
T Consensus        34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  113 (504)
T 3q5i_A           34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD  113 (504)
T ss_dssp             GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            4578999999999999999999765 688999999865421             23467889999999999999999999


Q ss_pred             eeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC---cE
Q 017232          125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF---CV  201 (375)
Q Consensus       125 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~---~~  201 (375)
                      ++.. ...+++|||||++|+|.+.+...    ..+++..++.++.||+.||.|||++||+||||||+|||++.++   .+
T Consensus       114 ~~~~-~~~~~lv~e~~~gg~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~  188 (504)
T 3q5i_A          114 VFED-KKYFYLVTEFYEGGELFEQIINR----HKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNI  188 (504)
T ss_dssp             EEEC-SSEEEEEEECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSE
T ss_pred             EEEc-CCEEEEEEecCCCCcHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccE
Confidence            8776 67899999999999999988543    4589999999999999999999999999999999999998776   69


Q ss_pred             EEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHH
Q 017232          202 KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK  281 (375)
Q Consensus       202 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  281 (375)
                      ||+|||++........  .....||+.|+|||++.+ .++.++||||+||++|+|++|.+||.......       ....
T Consensus       189 kl~Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-------~~~~  258 (504)
T 3q5i_A          189 KIVDFGLSSFFSKDYK--LRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD-------IIKK  258 (504)
T ss_dssp             EECCCTTCEECCTTSC--BCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHH
T ss_pred             EEEECCCCEEcCCCCc--cccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-------HHHH
Confidence            9999999987654322  234569999999998875 68999999999999999999999997543211       0111


Q ss_pred             hhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          282 IQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                              +...... ...+....++..+.+++.+||..+|.+|||+.|+++.
T Consensus       259 --------i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          259 --------VEKGKYY-FDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             --------HHHCCCC-CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --------HHcCCCC-CCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                    1111010 0111112345679999999999999999999999864

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=334.43  Aligned_cols=258  Identities=17%  Similarity=0.190  Sum_probs=205.1

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEE------EeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC---CCCeEEEeeeeec
Q 017232           58 EATNYFDSARELGDGGFGTVYYG------ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR---HKNLVSLYGCTSR  128 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~  128 (375)
                      ...++|.+.+.||+|+||.||+|      ...+++.||+|++.....   ..+..|+.++..++   |+|++++++++..
T Consensus        62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~  138 (365)
T 3e7e_A           62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANP---WEFYIGTQLMERLKPSMQHMFMKFYSAHLF  138 (365)
T ss_dssp             CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCH---HHHHHHHHHHHHSCGGGGGGBCCEEEEEEC
T ss_pred             ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCCh---hHHHHHHHHHHHhhhhhhhhhhhhheeeec
Confidence            34567999999999999999999      345689999999976543   35667788888886   9999999997776


Q ss_pred             CCceeEEEEecccCCChhHhhccCCC-CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC----------
Q 017232          129 HSRELLLVYEFISNGTVADHLHGERA-KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN----------  197 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~----------  197 (375)
                       ....++||||+++|+|.+++..... ....+++..++.++.||+.||+|||++||+||||||+|||++.          
T Consensus       139 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          139 -QNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             -SSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC-----
T ss_pred             -CCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCcccccc
Confidence             5678999999999999999975332 3456999999999999999999999999999999999999998          


Q ss_pred             -CCcEEEeeeccccccCC-CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchh
Q 017232          198 -NFCVKVADFGLSRLFPN-HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLS  275 (375)
Q Consensus       198 -~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~  275 (375)
                       ++.+||+|||++..... .........+||+.|+|||++.+..++.++|||||||++|||++|+.||......... ..
T Consensus       218 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~  296 (365)
T 3e7e_A          218 LSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECK-PE  296 (365)
T ss_dssp             -CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTEEE-EC
T ss_pred             ccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCcee-ec
Confidence             89999999999975431 1222334567999999999999999999999999999999999999999644321100 00


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCC-CCHHHHHHHHHhhhcCCC
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLR-PYMVDVLDALRDIESDGY  343 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~R-pt~~evl~~L~~i~~~~~  343 (375)
                                       ..+...      ...+.+.+++..||+.+|.+| |++.++.+.|+++.....
T Consensus       297 -----------------~~~~~~------~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~~  342 (365)
T 3e7e_A          297 -----------------GLFRRL------PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHY  342 (365)
T ss_dssp             -----------------SCCTTC------SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHHT
T ss_pred             -----------------hhcccc------CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHhh
Confidence                             000000      013457789999999999998 788899999988766543

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=4.4e-44  Score=322.64  Aligned_cols=250  Identities=26%  Similarity=0.418  Sum_probs=203.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .+.|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   99 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-DTKLWIIM   99 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-CCeEEEEE
Confidence            356888999999999999999654 68999999986543 3446788999999999999999999997776 56799999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+++++|.+++.     ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........
T Consensus       100 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~  174 (303)
T 3a7i_A          100 EYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI  174 (303)
T ss_dssp             ECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC
T ss_pred             EeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCcccc
Confidence            9999999999984     34689999999999999999999999999999999999999999999999999976544322


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                       ......+++.|+|||.+.+..++.++||||||+++|+|++|.+||.......      .. .         .+......
T Consensus       175 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~-~---------~~~~~~~~  237 (303)
T 3a7i_A          175 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMK------VL-F---------LIPKNNPP  237 (303)
T ss_dssp             -CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH-H---------HHHHSCCC
T ss_pred             -ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHH------HH-H---------HhhcCCCC
Confidence             2234468999999999999899999999999999999999999997543111      00 0         00000000


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL  335 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L  335 (375)
                      ..   ...++..+.+++.+||..+|++|||+.++++..
T Consensus       238 ~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~  272 (303)
T 3a7i_A          238 TL---EGNYSKPLKEFVEACLNKEPSFRPTAKELLKHK  272 (303)
T ss_dssp             CC---CSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCH
T ss_pred             CC---ccccCHHHHHHHHHHcCCChhhCcCHHHHhhCh
Confidence            00   112345789999999999999999999998753

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=5.8e-44  Score=330.88  Aligned_cols=265  Identities=20%  Similarity=0.283  Sum_probs=194.2

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-----c
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-----R  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~  131 (375)
                      .++|++.+.||+|+||.||+|... +++.||+|++...  .......+.+|+.+++.++||||+++++++....     .
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            467999999999999999999654 6889999998653  3445567889999999999999999999776533     3


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ..++||||++ ++|.+.+.      ..+++..+..++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       104 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  176 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  176 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC---
T ss_pred             ceEEEEEcCC-CCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeecccc
Confidence            7899999997 57888774      2388999999999999999999999999999999999999999999999999986


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhH--------HHHHHhh
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN--------LAINKIQ  283 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~--------~~~~~~~  283 (375)
                      .....  ......+|+.|+|||++.+..++.++|||||||++|+|++|..||.............        .....+ 
T Consensus       177 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-  253 (371)
T 2xrw_A          177 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL-  253 (371)
T ss_dssp             ---------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTS-
T ss_pred             ccccc--ccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh-
Confidence            54322  2234568999999999999899999999999999999999999997654221100000        000000 


Q ss_pred             hhHHHHHH---------------hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          284 NKALHELV---------------DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       284 ~~~~~~~~---------------~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ........               ...............+..+.+|+.+||..||++|||++|+++.
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             CHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            00000111               0111111112223446789999999999999999999999874

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=7.3e-44  Score=327.88  Aligned_cols=271  Identities=21%  Similarity=0.303  Sum_probs=198.4

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-------
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRH-------  129 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  129 (375)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++.....  .....+.+|+.+++.++||||+++++++...       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   95 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   95 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC-------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccC
Confidence            35799999999999999999976 4789999999855432  2235678899999999999999999977653       


Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      ...+++||||++ ++|.+.+...   ...+++.+++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        96 ~~~~~lv~e~~~-~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a  171 (351)
T 3mi9_A           96 KGSIYLVFDFCE-HDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  171 (351)
T ss_dssp             -CEEEEEEECCS-EEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccC-CCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhc
Confidence            346899999997 4777777433   245899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCC---ccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh
Q 017232          210 RLFPNH---VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK  285 (375)
Q Consensus       210 ~~~~~~---~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  285 (375)
                      ......   .........+|+.|+|||++.+ ..++.++|||||||++|+|++|.+||......................
T Consensus       172 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~  251 (351)
T 3mi9_A          172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  251 (351)
T ss_dssp             EECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             ccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            865422   1222334568999999998876 458999999999999999999999997654222110000000000000


Q ss_pred             HHHHH-----Hhhh--cCCCCChHHH-----HHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          286 ALHEL-----VDQT--LGYESDNKVR-----RTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       286 ~~~~~-----~~~~--l~~~~~~~~~-----~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .....     ....  ..........     .....+.+|+.+||..||++|||+.|+++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          252 VWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            00000     0000  0000000000     113568899999999999999999999874

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.6e-44  Score=327.07  Aligned_cols=268  Identities=22%  Similarity=0.307  Sum_probs=194.3

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhh-----HHHHHHHHHHHHhcCCCCeEEEeeeeecCCc
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKR-----VEQFMNEVDILARLRHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  131 (375)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++.......     ...+.+|+.+++.++||||+++++++.. ..
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~   85 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KS   85 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TT
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEee-CC
Confidence            34578999999999999999999765 68999999986532211     2357889999999999999999997765 66


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ..++||||+++ +|.+++..   ....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~~lv~e~~~~-~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~  161 (346)
T 1ua2_A           86 NISLVFDFMET-DLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKS  161 (346)
T ss_dssp             CCEEEEECCSE-EHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGST
T ss_pred             ceEEEEEcCCC-CHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEeccccee
Confidence            78999999975 88888843   334689999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ...... ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.........  .. ............+
T Consensus       162 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~--~~-i~~~~~~~~~~~~  237 (346)
T 1ua2_A          162 FGSPNR-AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL--TR-IFETLGTPTEEQW  237 (346)
T ss_dssp             TTSCCC-CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHHHCCCCTTTS
T ss_pred             ccCCcc-cCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH--HH-HHHHcCCCChhhh
Confidence            643322 22345689999999988654 5889999999999999999999999755321100  00 0000000000000


Q ss_pred             Hh-----hhcCC-CCC-----hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          291 VD-----QTLGY-ESD-----NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       291 ~~-----~~l~~-~~~-----~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .+     ..... ...     ......+..+.+++.+||..||++|||+.|+++.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          238 PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             SSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            00     00000 000     0001234679999999999999999999999874

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.3e-44  Score=330.26  Aligned_cols=268  Identities=24%  Similarity=0.417  Sum_probs=197.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .++|++.+.||+|+||.||+|... +|+.||+|++....  ....+.+.+|+.+++.++||||+++++++.. ....++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv  102 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-KKRWYLV  102 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-CCEEEEE
Confidence            356899999999999999999765 58999999985543  3334567899999999999999999998776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus       103 ~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  178 (331)
T 4aaa_A          103 FEFVDHTILDDLELF----PNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG  178 (331)
T ss_dssp             EECCSEEHHHHHHHS----TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC-------
T ss_pred             EecCCcchHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc
Confidence            999999988887642    3458999999999999999999999999999999999999999999999999997654322


Q ss_pred             cccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh-
Q 017232          217 THVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT-  294 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  294 (375)
                      . ......+++.|+|||++.+. .++.++|||||||++|+|++|.+||..................... ......... 
T Consensus       179 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  256 (331)
T 4aaa_A          179 E-VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIP-RHQELFNKNP  256 (331)
T ss_dssp             ------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCH-HHHHHHHHCG
T ss_pred             c-ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCh-hhhhHhhhcc
Confidence            2 22344689999999988765 7899999999999999999999999765432211000000000000 000000000 


Q ss_pred             ---------cCCCCC--hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          295 ---------LGYESD--NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       295 ---------l~~~~~--~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                               ......  .....++..+.+++.+||+.||++|||+.|+++.
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          257 VFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             GGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                     000000  0011345679999999999999999999998863

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=9.7e-44  Score=319.02  Aligned_cols=251  Identities=22%  Similarity=0.344  Sum_probs=196.4

Q ss_pred             CCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           63 FDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      |.....||+|+||.||+|.. .+++.||+|.+........+.+.+|+.+++.++||||+++++++.. ....++||||++
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e~~~  102 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-NGFIKIFMEQVP  102 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEEECCS
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-CCcEEEEEEeCC
Confidence            55566899999999999975 4688999999977666666788999999999999999999998776 567899999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC-CCcEEEeeeccccccCCCccccc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-NFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      +++|.+++.... ....+++..++.++.|++.||.|||++|++|+||||+||+++. ++.+||+|||++........ ..
T Consensus       103 ~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~  180 (295)
T 2clq_A          103 GGSLSALLRSKW-GPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP-CT  180 (295)
T ss_dssp             EEEHHHHHHHTT-CCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC------
T ss_pred             CCCHHHHHHhhc-cCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC-cc
Confidence            999999996542 2345678889999999999999999999999999999999987 89999999999986543222 12


Q ss_pred             cCCCCCccccCcccccccC--CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQ--LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ....+++.|+|||++.+..  ++.++||||||+++|+|++|..||........     ..         ...........
T Consensus       181 ~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~-----~~---------~~~~~~~~~~~  246 (295)
T 2clq_A          181 ETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA-----AM---------FKVGMFKVHPE  246 (295)
T ss_dssp             CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH-----HH---------HHHHHHCCCCC
T ss_pred             cccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH-----HH---------Hhhcccccccc
Confidence            3446899999999987643  78999999999999999999999964432110     00         00000001111


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..   ..++..+.+++.+||..+|++|||+.++++
T Consensus       247 ~~---~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          247 IP---ESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             CC---TTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             cc---ccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            11   124567899999999999999999999985

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.6e-44  Score=353.79  Aligned_cols=250  Identities=24%  Similarity=0.368  Sum_probs=199.1

Q ss_pred             CccCCCCcEEEEEEEeC---CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ---DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      +.||+|+||.||+|.+.   .++.||||++....  ....+.+.+|+.+++.++||||+++++++..  ...++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~--~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCEEEEEEccC
Confidence            36999999999999543   46789999987542  3345789999999999999999999998754  45889999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc--cc
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT--HV  219 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~  219 (375)
                      +|+|.+++..    ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.....  ..
T Consensus       453 ~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  528 (635)
T 4fl3_A          453 LGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  528 (635)
T ss_dssp             TEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------
T ss_pred             CCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcccccc
Confidence            9999999954    34589999999999999999999999999999999999999999999999999987644322  11


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      .....+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......                ....+.......
T Consensus       529 ~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~----------------~~~~i~~~~~~~  592 (635)
T 4fl3_A          529 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGERMG  592 (635)
T ss_dssp             ------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTCCCC
T ss_pred             ccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH----------------HHHHHHcCCCCC
Confidence            223346788999999999899999999999999999998 999997543211                111111111111


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                         .+..++..+.+++.+||+.+|++|||+.+|++.|+++..+
T Consensus       593 ---~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~  632 (635)
T 4fl3_A          593 ---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  632 (635)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             ---CCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence               1123567899999999999999999999999999987654

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=3.5e-43  Score=320.53  Aligned_cols=259  Identities=20%  Similarity=0.273  Sum_probs=199.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecC-CceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCTSRH-SRELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~-~~~~~lv  136 (375)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++....   .+.+.+|+.+++.++ ||||+++++++... ....++|
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv  111 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALV  111 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc---hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEE
Confidence            36799999999999999999965 578999999986543   356889999999997 99999999977653 4568999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC-cEEEeeeccccccCCC
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF-CVKVADFGLSRLFPNH  215 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  215 (375)
                      |||+.+++|.+++.       .+++..++.++.|++.||.|||++||+||||||+|||++.++ .+||+|||++......
T Consensus       112 ~e~~~~~~l~~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          112 FEHVNNTDFKQLYQ-------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             EECCCCCCHHHHGG-------GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             EeccCchhHHHHHH-------hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            99999999999883       278999999999999999999999999999999999999776 8999999999865443


Q ss_pred             ccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ..  .....+++.|+|||++.+ ..++.++|||||||++|+|++|..||........  ...............+.+...
T Consensus       185 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~--~l~~~~~~~~~~~~~~~~~~~  260 (330)
T 3nsz_A          185 QE--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD--QLVRIAKVLGTEDLYDYIDKY  260 (330)
T ss_dssp             CC--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHH--HHHHHHHHHCHHHHHHHHHHT
T ss_pred             Cc--cccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHH--HHHHHHHhcCCchhhhHHHHh
Confidence            32  234468999999998876 6789999999999999999999999953322110  011111111111222222111


Q ss_pred             cCCCCChH---------------------HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 LGYESDNK---------------------VRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~---------------------~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      . ....+.                     ...++..+.+|+.+||+.||++|||++|+++
T Consensus       261 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          261 N-IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             T-CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             c-cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0 000000                     0114567999999999999999999999987

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.6e-44  Score=325.33  Aligned_cols=252  Identities=23%  Similarity=0.332  Sum_probs=195.5

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--------hhHHHHHHHHHHHHhcCCCCeEEEeeeeecC
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--------KRVEQFMNEVDILARLRHKNLVSLYGCTSRH  129 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  129 (375)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.....        .....+.+|+.+++.++||||+++++++...
T Consensus         8 l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   87 (322)
T 2ycf_A            8 LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE   87 (322)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS
T ss_pred             hhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC
Confidence            4567999999999999999999665 688999999865421        2234578999999999999999999977653


Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc---EEEeee
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC---VKVADF  206 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~---~kl~Df  206 (375)
                        ..++||||+++++|.+++..    ...+++..++.++.|++.||.|||++|++||||||+||+++.++.   +||+||
T Consensus        88 --~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Df  161 (322)
T 2ycf_A           88 --DYYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF  161 (322)
T ss_dssp             --SEEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred             --ceEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccC
Confidence              38999999999999998843    356899999999999999999999999999999999999987665   999999


Q ss_pred             ccccccCCCccccccCCCCCccccCccccc---ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh
Q 017232          207 GLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ  283 (375)
Q Consensus       207 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  283 (375)
                      |++........  .....+|+.|+|||++.   +..++.++|||||||++|+|++|..||........  +..    .+.
T Consensus       162 g~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~----~~~  233 (322)
T 2ycf_A          162 GHSKILGETSL--MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS--LKD----QIT  233 (322)
T ss_dssp             TTCEECCCCHH--HHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSC--HHH----HHH
T ss_pred             ccceecccccc--cccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHH--HHH----HHH
Confidence            99987644321  12235899999999863   46788999999999999999999999975432211  111    011


Q ss_pred             hhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       284 ~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..         ...........++..+.+++.+||..||++|||+.++++
T Consensus       234 ~~---------~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          234 SG---------KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             HT---------CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             hC---------ccccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            00         000001111234567899999999999999999999985

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-43  Score=318.14  Aligned_cols=247  Identities=26%  Similarity=0.419  Sum_probs=196.6

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeec---CCceeEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSR---HSRELLL  135 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~l  135 (375)
                      .|++.+.||+|+||.||+|... ++..||+|.+...  .....+.+.+|+.+++.++||||+++++++..   ....+++
T Consensus        27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l  106 (290)
T 1t4h_A           27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence            4777889999999999999664 6889999998654  34456778999999999999999999997654   2466899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC--ceeccCCCCCEEec-CCCcEEEeeecccccc
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--IIHRDVKTNNILLD-NNFCVKVADFGLSRLF  212 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~  212 (375)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||+.|  ++|+||||+||+++ .++.+||+|||++...
T Consensus       107 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~  182 (290)
T 1t4h_A          107 VTELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK  182 (290)
T ss_dssp             EEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred             EEEecCCCCHHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence            99999999999999643    45899999999999999999999999  99999999999997 7899999999999755


Q ss_pred             CCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .....   ....+++.|+|||++.+ .++.++||||||+++|+|++|..||.......     .. ...+..        
T Consensus       183 ~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-----~~-~~~~~~--------  244 (290)
T 1t4h_A          183 RASFA---KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-----QI-YRRVTS--------  244 (290)
T ss_dssp             CTTSB---EESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-----HH-HHHHTT--------
T ss_pred             ccccc---ccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH-----HH-HHHHhc--------
Confidence            43322   23458999999998875 58999999999999999999999996543211     00 000000        


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       ..  .........+..+.+++.+||+.+|++|||+.++++
T Consensus       245 -~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          245 -GV--KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             -TC--CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             -cC--CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence             00  011111122356899999999999999999999985

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1e-44  Score=335.15  Aligned_cols=267  Identities=19%  Similarity=0.291  Sum_probs=202.0

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----ce
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----RE  132 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~  132 (375)
                      ..++|++.+.||+|+||.||+|... ++..||+|++... .......+.+|+.+++.++||||+++++++....    ..
T Consensus        25 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  104 (364)
T 3qyz_A           25 VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD  104 (364)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred             ccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccce
Confidence            3467999999999999999999655 6889999998654 3344577889999999999999999999775432    46


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      .++||||+. ++|.+++..     ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       105 ~~iv~e~~~-~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          105 VYIVQDLME-TDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             EEEEEECCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEEcccC-cCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            899999996 689998853     35899999999999999999999999999999999999999999999999999866


Q ss_pred             CCCccc--cccCCCCCccccCccccc-ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh----
Q 017232          213 PNHVTH--VSTAPQGTPGYVDPEYHQ-CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK----  285 (375)
Q Consensus       213 ~~~~~~--~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~----  285 (375)
                      ......  ......||+.|+|||++. +..++.++|||||||++|+|++|++||..........   .........    
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~~  255 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLN---HILGILGSPSQED  255 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHH---HHHHHHCSCCHHH
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHH---HHHHHhCCCCHHH
Confidence            433221  123457999999999765 4458999999999999999999999997654332111   111100000    


Q ss_pred             -------HHHHHHhhhcCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          286 -------ALHELVDQTLGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       286 -------~~~~~~~~~l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                             ...............   ......+..+.+|+.+||..||++|||+.|+++.
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          256 LNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             HHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                   001111000000000   0001234678999999999999999999999863

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2e-45  Score=334.59  Aligned_cols=264  Identities=21%  Similarity=0.307  Sum_probs=192.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhh-HHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|++.+.||+|+||.||+|... +++.||+|++....... ...+.+|+.+++.++||||+++++++.. ....++|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-EKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-SSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-CCEEEEEec
Confidence            57889999999999999999765 78999999986543221 1234579999999999999999998766 677999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      |++ ++|.+++...   ...+++..++.++.|++.||.|||+.||+||||||+||+++.++.+||+|||++........ 
T Consensus        81 ~~~-~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-  155 (324)
T 3mtl_A           81 YLD-KDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK-  155 (324)
T ss_dssp             CCS-EEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             ccc-cCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc-
Confidence            997 6898888643   34589999999999999999999999999999999999999999999999999876543222 


Q ss_pred             cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh---hhHH------H
Q 017232          219 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ---NKAL------H  288 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~---~~~~------~  288 (375)
                      ......+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.........   ........   ....      .
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~~~~~~~~~~~  232 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL---HFIFRILGTPTEETWPGILSNE  232 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCTTTSTTGGGCH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCChHhchhhhcch
Confidence            2233468999999998876 56899999999999999999999999765422211   00000000   0000      0


Q ss_pred             HHHhhhcCC-CCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          289 ELVDQTLGY-ESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       289 ~~~~~~l~~-~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ......... ...   .....++..+.+|+.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          233 EFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             HHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             hhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            000000000 000   011123467889999999999999999999987

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-45  Score=336.19  Aligned_cols=255  Identities=24%  Similarity=0.321  Sum_probs=200.2

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe----CCCCEEEEEEecccc----hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCC
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL----QDGRAVAVKRLYENN----YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHS  130 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~----~~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  130 (375)
                      .++|++.+.||+|+||.||+|..    .+++.||+|++....    ......+.+|+.+++.+ +||||+++++++.. .
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-~  131 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-E  131 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-T
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee-C
Confidence            36799999999999999999976    368999999986432    12234567899999999 69999999997766 5


Q ss_pred             ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          131 RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      ...++||||+++++|.+++...    ..+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus       132 ~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~  207 (355)
T 1vzo_A          132 TKLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK  207 (355)
T ss_dssp             TEEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred             ceEEEEeecCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence            6799999999999999999643    358999999999999999999999999999999999999999999999999998


Q ss_pred             ccCCCccccccCCCCCccccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQC--YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      ..............||+.|+|||++.+  ..++.++|||||||++|+|++|+.||........  ......         
T Consensus       208 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~~~~---------  276 (355)
T 1vzo_A          208 EFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS--QAEISR---------  276 (355)
T ss_dssp             ECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC--HHHHHH---------
T ss_pred             ecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccch--HHHHHH---------
Confidence            664433333344569999999999875  3578899999999999999999999975432211  111110         


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHHH
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLDAL  335 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~~L  335 (375)
                      .+.....  ..   ...++..+.+++.+||..||++||     ++.++++..
T Consensus       277 ~~~~~~~--~~---~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          277 RILKSEP--PY---PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             HHHHCCC--CC---CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             HHhccCC--CC---CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            0111100  11   112446788999999999999999     888888653

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1e-43  Score=328.37  Aligned_cols=275  Identities=20%  Similarity=0.267  Sum_probs=201.9

Q ss_pred             cchHHHHHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccc-----------hhhHHHHHHHHHHHHhcCCCCe
Q 017232           51 FSYGELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENN-----------YKRVEQFMNEVDILARLRHKNL  119 (375)
Q Consensus        51 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-----------~~~~~~~~~e~~~l~~l~h~ni  119 (375)
                      ....++....++|++.+.||+|+||.||+|...+|..||+|++....           ....+.+.+|+.+++.++||||
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   91 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNI   91 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTB
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCc
Confidence            34567788899999999999999999999988889999999985432           2224678999999999999999


Q ss_pred             EEEeeeeec----CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe
Q 017232          120 VSLYGCTSR----HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL  195 (375)
Q Consensus       120 v~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill  195 (375)
                      +++++++..    ....+++||||+. ++|.+.+..   ....+++..++.++.||+.||.|||++|++||||||+||++
T Consensus        92 v~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~  167 (362)
T 3pg1_A           92 LGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILL  167 (362)
T ss_dssp             CCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             cceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEE
Confidence            999997643    2346899999997 688888753   33468999999999999999999999999999999999999


Q ss_pred             cCCCcEEEeeeccccccCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccch
Q 017232          196 DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL  274 (375)
Q Consensus       196 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~  274 (375)
                      +.++.+||+|||++........  .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||.........  
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~--  243 (362)
T 3pg1_A          168 ADNNDITICDFNLAREDTADAN--KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQL--  243 (362)
T ss_dssp             CTTCCEEECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--
T ss_pred             cCCCCEEEEecCcccccccccc--cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHH--
Confidence            9999999999999975433222  233468999999998876 67899999999999999999999999764422111  


Q ss_pred             hHHHHHHhh-----------hhHHHHHHhhhcCCCCC----hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          275 SNLAINKIQ-----------NKALHELVDQTLGYESD----NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       275 ~~~~~~~~~-----------~~~~~~~~~~~l~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       ........           .....+...........    ......+..+.+++.+||+.||++|||+.|+++.
T Consensus       244 -~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          244 -NKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             -HHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -HHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence             00000000           01111111111111110    0111234578999999999999999999999863

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=3.5e-44  Score=320.29  Aligned_cols=245  Identities=27%  Similarity=0.426  Sum_probs=201.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||.||+|... ++..||+|++.....   .....+.+|+.+++.++||||+++++++.. ....++|
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   92 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHD-RKRIYLM   92 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEc-CCEEEEE
Confidence            56889999999999999999765 578899999865422   224678899999999999999999998776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++...    ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        93 ~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (284)
T 2vgo_A           93 LEFAPRGELYKELQKH----GRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR  168 (284)
T ss_dssp             ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC
T ss_pred             EEeCCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCcccc
Confidence            9999999999998643    358999999999999999999999999999999999999999999999999987654322


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                         .....+++.|+|||.+.+..++.++||||||+++|+|++|..||.......      .         ...+......
T Consensus       169 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~------~---------~~~~~~~~~~  230 (284)
T 2vgo_A          169 ---RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE------T---------HRRIVNVDLK  230 (284)
T ss_dssp             ---BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------H---------HHHHHTTCCC
T ss_pred             ---cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhH------H---------HHHHhccccC
Confidence               234468999999999999899999999999999999999999997543211      0         0111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        .+   ...+..+.+++.+||..+|.+|||+.++++
T Consensus       231 --~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          231 --FP---PFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             --CC---TTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             --CC---CcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence              11   123467889999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=3.6e-44  Score=321.22  Aligned_cols=260  Identities=27%  Similarity=0.437  Sum_probs=197.0

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC--CCC--EEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ--DGR--AVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~--~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      .++|++.+.||+|+||.||+|.+.  ++.  .||+|++...   .....+.+.+|+.+++.++||||+++++++...  .
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~   94 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--P   94 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--S
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC--C
Confidence            356899999999999999999753  333  6899988654   234467889999999999999999999977653  3


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      .++||||+.+++|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++...
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccc
Confidence            78999999999999999643   245899999999999999999999999999999999999999999999999999876


Q ss_pred             CCCccc--cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          213 PNHVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       213 ~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                      ......  ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.......      .         ...
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~------~---------~~~  236 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------I---------LHK  236 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H---------HHH
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHH------H---------HHH
Confidence            543221  1223457788999999988889999999999999999999 999997543211      0         011


Q ss_pred             HHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          290 LVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       290 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                      +......   .+....++..+.+++.+||..+|++|||+.++++.|+++....
T Consensus       237 ~~~~~~~---~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~  286 (291)
T 1u46_A          237 IDKEGER---LPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPTD  286 (291)
T ss_dssp             HHTSCCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             HHccCCC---CCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCccc
Confidence            1111111   1111234567999999999999999999999999999987654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9e-44  Score=319.22  Aligned_cols=249  Identities=22%  Similarity=0.330  Sum_probs=203.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .++|.+.+.||+|+||.||+|... +++.||+|++...   .....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~l   92 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFED-NDFVFV   92 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeecc-CCEEEE
Confidence            356889999999999999999766 5889999998654   33445678899999999999999999998766 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++...    ..+++.+++.++.|++.||.|||++|++|+||||+||+++.++.+||+|||++......
T Consensus        93 v~e~~~~~~L~~~~~~~----~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~  168 (294)
T 2rku_A           93 VLELCRRRSLLELHKRR----KALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYD  168 (294)
T ss_dssp             EEECCTTCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCST
T ss_pred             EEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccC
Confidence            99999999999988542    45899999999999999999999999999999999999999999999999999865432


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .. ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.......      .         ...+.....
T Consensus       169 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~---------~~~~~~~~~  232 (294)
T 2rku_A          169 GE-RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE------T---------YLRIKKNEY  232 (294)
T ss_dssp             TC-CBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH------H---------HHHHHTTCC
T ss_pred             cc-ccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------H---------HHHHhhccC
Confidence            22 1234468999999999998889999999999999999999999997543211      0         011111111


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .  ..   ..++..+.+++.+||+.+|++|||+.++++.
T Consensus       233 ~--~~---~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          233 S--IP---KHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             C--CC---TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             C--Cc---cccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1  11   1234578899999999999999999999874

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=1e-43  Score=332.18  Aligned_cols=267  Identities=22%  Similarity=0.259  Sum_probs=200.2

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcC--------CCCeEEEeeeeec-
Q 017232           59 ATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLR--------HKNLVSLYGCTSR-  128 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~--------h~niv~~~~~~~~-  128 (375)
                      ..++|++.++||+|+||.||+|.. .+++.||+|++... ....+.+.+|+.+++.++        |+||+++++++.. 
T Consensus        35 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           35 FNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             cCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            357899999999999999999965 46889999998644 334567889999999985        7889999997652 


Q ss_pred             --CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCC------
Q 017232          129 --HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNF------  199 (375)
Q Consensus       129 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~------  199 (375)
                        .....++||||+ +++|.+.+...  ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++      
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~  190 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRL  190 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhh
Confidence              356789999999 56676666543  234699999999999999999999998 999999999999999775      


Q ss_pred             -------------------------------------------cEEEeeeccccccCCCccccccCCCCCccccCccccc
Q 017232          200 -------------------------------------------CVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ  236 (375)
Q Consensus       200 -------------------------------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  236 (375)
                                                                 .+||+|||++......    .....||+.|+|||++.
T Consensus       191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~~~  266 (397)
T 1wak_A          191 AAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEVLI  266 (397)
T ss_dssp             HHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHHHH
T ss_pred             hhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChhhc
Confidence                                                       7999999999865432    23446899999999999


Q ss_pred             ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhH---HHHHHhhhhHHHHHHhhhcC--------------C--
Q 017232          237 CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN---LAINKIQNKALHELVDQTLG--------------Y--  297 (375)
Q Consensus       237 ~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~--------------~--  297 (375)
                      +..++.++|||||||++|+|++|+.||.............   .............+......              .  
T Consensus       267 ~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  346 (397)
T 1wak_A          267 GSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLK  346 (397)
T ss_dssp             TSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCC
T ss_pred             CCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccC
Confidence            9899999999999999999999999997554322111000   00000000000000000000              0  


Q ss_pred             ---------CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          298 ---------ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       298 ---------~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                               .........+..+.+|+.+||+.||++|||+.|+++
T Consensus       347 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          347 PWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             CCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             CcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence                     000011345678999999999999999999999985

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=6.7e-44  Score=329.47  Aligned_cols=265  Identities=21%  Similarity=0.319  Sum_probs=185.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-----Cc
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-----SR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~  131 (375)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++...  .....+.+.+|+.+++.++||||+++++++...     ..
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            46799999999999999999965 47899999998653  334556788999999999999999999977542     25


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ..++|+|++ +++|.+++..     ..+++..++.++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~  181 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH  181 (367)
T ss_dssp             CCEEEEECC-CEECC----------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC------
T ss_pred             eEEEEeccc-CCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeecccccc
Confidence            679999999 6899888842     4699999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHH--------HHHh
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA--------INKI  282 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~  282 (375)
                      ....    .....+|+.|+|||++.+ ..++.++|||||||++|+|++|++||...............        ...+
T Consensus       182 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~  257 (367)
T 2fst_X          182 TADE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKI  257 (367)
T ss_dssp             -------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             cccc----CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHh
Confidence            5432    233468999999998876 67899999999999999999999999765432211000000        0000


Q ss_pred             hhhHHHHHHhhhcCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          283 QNKALHELVDQTLGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       283 ~~~~~~~~~~~~l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ........+.........   ......+..+.+|+.+||..||++|||+.++++.
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          258 SSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            111111111111000000   0001234678999999999999999999999864

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=4e-44  Score=318.52  Aligned_cols=248  Identities=27%  Similarity=0.403  Sum_probs=193.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.....   .....+.+|+.+++.++||||+++++++.. ....++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~l   88 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIST-PTDFFM   88 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCeEEE
Confidence            367899999999999999999776 789999999865422   234678899999999999999999997766 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++...    ..+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        89 v~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~  164 (276)
T 2h6d_A           89 VMEYVSGGELFDYICKH----GRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG  164 (276)
T ss_dssp             EEECCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-
T ss_pred             EEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCC
Confidence            99999999999999543    35899999999999999999999999999999999999999999999999999865443


Q ss_pred             ccccccCCCCCccccCcccccccCC-CCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ..  .....+++.|+|||.+.+..+ +.++||||||+++|+|++|..||.......       ....        + ...
T Consensus       165 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~~~~--------~-~~~  226 (276)
T 2h6d_A          165 EF--LRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPT-------LFKK--------I-RGG  226 (276)
T ss_dssp             --------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHH--------H-HHC
T ss_pred             cc--eecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH-------HHHH--------h-hcC
Confidence            22  233468999999999887665 579999999999999999999997543110       0001        1 110


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .. ..+   ..++..+.+++.+||+.+|++|||+.++++.
T Consensus       227 ~~-~~~---~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          227 VF-YIP---EYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             CC-CCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             cc-cCc---hhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            00 001   1234578899999999999999999999974

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.7e-44  Score=333.29  Aligned_cols=277  Identities=22%  Similarity=0.345  Sum_probs=207.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|++.+.||+|+||.||+|... ++..||+|++... .....+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~lv~  110 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM  110 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-CCEEEEEE
Confidence            467999999999999999999765 6899999998765 34455778999999999999999999997776 67799999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||+++++|.+++...    ..+++..+..++.|++.||.|||+. ||+|+||||+||+++.++.++|+|||++...... 
T Consensus       111 e~~~~~~L~~~l~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          111 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             CCCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             ECCCCCCHHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            999999999999643    3589999999999999999999996 9999999999999999999999999998654221 


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhH--------------------
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSN--------------------  276 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~--------------------  276 (375)
                        ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.............                    
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence              1233468999999999999999999999999999999999999997543221000000                    


Q ss_pred             ---HHHHHhhhhHHHHHHhhhcCCCC-ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhhhcCCCC
Q 017232          277 ---LAINKIQNKALHELVDQTLGYES-DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDIESDGYD  344 (375)
Q Consensus       277 ---~~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i~~~~~~  344 (375)
                         +...........+..+....... ......++..+.+|+.+||+.||++|||+.++++.  +........+
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~  337 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVD  337 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCCC
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhhh
Confidence               00000000000111111110000 00001234579999999999999999999999974  5555544443

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=3.1e-44  Score=327.37  Aligned_cols=266  Identities=18%  Similarity=0.274  Sum_probs=190.3

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ...++|++.+.||+|+||.||+|... +++.||+|++.....  .....+.+|+.+++.++||||+++++++.. ....+
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-~~~~~  109 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-NHRLH  109 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-TTEEE
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-CCEEE
Confidence            44568999999999999999999654 789999999865432  224567789999999999999999998776 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe-----cCCCcEEEeeeccc
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL-----DNNFCVKVADFGLS  209 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill-----~~~~~~kl~Dfg~~  209 (375)
                      +||||++ ++|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||+     +.++.+||+|||++
T Consensus       110 lv~e~~~-~~L~~~~~~~----~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a  184 (329)
T 3gbz_A          110 LIFEYAE-NDLKKYMDKN----PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA  184 (329)
T ss_dssp             EEEECCS-EEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHH
T ss_pred             EEEecCC-CCHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCc
Confidence            9999997 5999998543    358999999999999999999999999999999999999     45556999999999


Q ss_pred             cccCCCccccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh---h
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN---K  285 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~  285 (375)
                      ........ ......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.........  .. .......   .
T Consensus       185 ~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~--~~-~~~~~~~~~~~  260 (329)
T 3gbz_A          185 RAFGIPIR-QFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQL--FK-IFEVLGLPDDT  260 (329)
T ss_dssp             HHHC------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH--HH-HHHHHCCCCTT
T ss_pred             cccCCccc-ccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHH--HH-HHHHhCCCchh
Confidence            86643322 22334689999999988764 4899999999999999999999999754321110  00 0000000   0


Q ss_pred             HHHHHH-----hhhcCCCCChH-----HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          286 ALHELV-----DQTLGYESDNK-----VRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       286 ~~~~~~-----~~~l~~~~~~~-----~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ......     ...........     ...++..+.+|+.+||+.||++|||+.|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            000000     00000000000     0013467889999999999999999999986

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.3e-44  Score=324.33  Aligned_cols=265  Identities=20%  Similarity=0.343  Sum_probs=195.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeec----------
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR----------  128 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~----------  128 (375)
                      .++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++..          
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~   89 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG   89 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC---
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccc
Confidence            467999999999999999999766 589999999987777777889999999999999999999987642          


Q ss_pred             ---CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec-CCCcEEEe
Q 017232          129 ---HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVA  204 (375)
Q Consensus       129 ---~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~-~~~~~kl~  204 (375)
                         .....++||||++ ++|.+++.     ...+++..++.++.|++.||+|||++|++||||||+||+++ .++.+||+
T Consensus        90 ~~~~~~~~~lv~e~~~-~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~  163 (320)
T 2i6l_A           90 SLTELNSVYIVQEYME-TDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIG  163 (320)
T ss_dssp             -CCSCSEEEEEEECCS-EEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEEC
T ss_pred             cccccCceeEEeeccC-CCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEc
Confidence               2467899999997 69999983     34689999999999999999999999999999999999997 56799999


Q ss_pred             eeccccccCCCcc--ccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHH
Q 017232          205 DFGLSRLFPNHVT--HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK  281 (375)
Q Consensus       205 Dfg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  281 (375)
                      |||++........  .......++..|+|||.+.+ ..++.++||||||+++|+|++|+.||.........   ......
T Consensus       164 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~---~~~~~~  240 (320)
T 2i6l_A          164 DFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQM---QLILES  240 (320)
T ss_dssp             CCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHH
T ss_pred             cCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHh
Confidence            9999986543211  11223357889999998765 67899999999999999999999999755421110   000000


Q ss_pred             h---hhhHHHHH-------HhhhcCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          282 I---QNKALHEL-------VDQTLGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       282 ~---~~~~~~~~-------~~~~l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .   ......++       ..........   .....++..+.+++.+||+.||++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          241 IPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             SCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            0   00000000       0011100000   001124567999999999999999999999986

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.6e-43  Score=319.13  Aligned_cols=252  Identities=25%  Similarity=0.399  Sum_probs=197.6

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ...++|++.+.||+|+||.||+|... +|+.||+|.+....  ....+.+|+.+++.++||||+++++++.. ....++|
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv  102 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFK-NTDLWIV  102 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEe-CCEEEEE
Confidence            34567999999999999999999765 58999999986543  23568899999999999999999997776 5678999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+++++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus       103 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          103 MEYCGAGSVSDIIRLR---NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             EECCTTEEHHHHHHHH---TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             eecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            9999999999998532   3468999999999999999999999999999999999999999999999999997654432


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      . ......+++.|+|||.+.+..++.++||||||+++|+|++|..||.......      ..         . .......
T Consensus       180 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~---------~-~~~~~~~  242 (314)
T 3com_A          180 A-KRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMR------AI---------F-MIPTNPP  242 (314)
T ss_dssp             S-CBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH---------H-HHHHSCC
T ss_pred             c-ccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHH------HH---------H-HHhcCCC
Confidence            2 2234468999999999998899999999999999999999999997543111      00         0 0000000


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ... .....++..+.+++.+||..+|.+|||+.++++
T Consensus       243 ~~~-~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          243 PTF-RKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             CCC-SSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ccc-CCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000 011123467899999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.4e-44  Score=321.83  Aligned_cols=253  Identities=25%  Similarity=0.375  Sum_probs=197.4

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ..++|++.+.||+|+||.||+|... +++.||+|++........+.+.+|+.+++.++||||+++++++.. ....++||
T Consensus        17 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv~   95 (302)
T 2j7t_A           17 PNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-DGKLWIMI   95 (302)
T ss_dssp             GGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-C-CEEEEE
T ss_pred             CccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-CCeEEEEE
Confidence            3467999999999999999999776 589999999877666667889999999999999999999997776 56789999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+++++|.+++...   ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++....... 
T Consensus        96 e~~~~~~l~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-  171 (302)
T 2j7t_A           96 EFCPGGAVDAIMLEL---DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL-  171 (302)
T ss_dssp             ECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH-
T ss_pred             EeCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc-
Confidence            999999999988543   2458999999999999999999999999999999999999999999999999875322111 


Q ss_pred             ccccCCCCCccccCcccc-----cccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          218 HVSTAPQGTPGYVDPEYH-----QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~-----~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .......+++.|+|||++     .+..++.++||||||+++|+|++|.+||.......      ..         ..+..
T Consensus       172 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~---------~~~~~  236 (302)
T 2j7t_A          172 QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR------VL---------LKIAK  236 (302)
T ss_dssp             HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH---------HHHHH
T ss_pred             cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHH------HH---------HHHhc
Confidence            111234589999999987     45678899999999999999999999997543211      00         00110


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ...  ........++..+.+++.+||..+|++|||+.++++
T Consensus       237 ~~~--~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          237 SDP--PTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             SCC--CCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             cCC--cccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            000  000111234567899999999999999999999875

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=9e-44  Score=351.17  Aligned_cols=260  Identities=23%  Similarity=0.374  Sum_probs=205.4

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGELQD----GRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  131 (375)
                      +...++|++.+.||+|+||.||+|....    +..||+|.+... .....+.+.+|+.+++.++||||+++++++.  ..
T Consensus       386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~  463 (656)
T 2j0j_A          386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--EN  463 (656)
T ss_dssp             BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC--SS
T ss_pred             ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe--cC
Confidence            3345678999999999999999997642    457999988654 3344577899999999999999999999774  34


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ..++||||+++|+|.+++...   ...+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       464 ~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~  540 (656)
T 2j0j_A          464 PVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY  540 (656)
T ss_dssp             SCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCS
T ss_pred             ceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCee
Confidence            689999999999999999643   34589999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      .............+++.|+|||.+.+..++.++|||||||++|||++ |.+||.......      . ...        +
T Consensus       541 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~------~-~~~--------i  605 (656)
T 2j0j_A          541 MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND------V-IGR--------I  605 (656)
T ss_dssp             CCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H-HHH--------H
T ss_pred             cCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH------H-HHH--------H
Confidence            65443333334457789999999998899999999999999999997 999997543211      0 000        1


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                       .....   .+.+..++..+.+++.+||..+|++|||+.++++.|+++..
T Consensus       606 -~~~~~---~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~  651 (656)
T 2j0j_A          606 -ENGER---LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  651 (656)
T ss_dssp             -HHTCC---CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -HcCCC---CCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence             11111   11112345679999999999999999999999999998754

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2.6e-44  Score=335.64  Aligned_cols=275  Identities=20%  Similarity=0.268  Sum_probs=198.0

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-----ceeE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-----RELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~~~~  134 (375)
                      ..+|++.+.||+|+||.||+|....+..||+|++......    ..+|+.+++.++||||+++++++....     ..++
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEE
Confidence            3568999999999999999998877777999988654321    236999999999999999999764422     2478


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec-CCCcEEEeeeccccccC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFP  213 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~  213 (375)
                      +||||++++ +...+.........+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++....
T Consensus       115 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~  193 (394)
T 4e7w_A          115 LVLEYVPET-VYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILI  193 (394)
T ss_dssp             EEEECCSEE-HHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             EEeeccCcc-HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCccccc
Confidence            999999764 4444332222345799999999999999999999999999999999999999 79999999999998764


Q ss_pred             CCccccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          214 NHVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       214 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .....  ....+|+.|+|||++.+. .++.++|||||||++|+|++|++||................+............
T Consensus       194 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  271 (394)
T 4e7w_A          194 AGEPN--VSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP  271 (394)
T ss_dssp             TTCCC--CSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG
T ss_pred             CCCCC--cccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh
Confidence            43322  344689999999988664 589999999999999999999999976543221100000000000001111100


Q ss_pred             hhcCCCC-----ChHH----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhhhcC
Q 017232          293 QTLGYES-----DNKV----RRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDIESD  341 (375)
Q Consensus       293 ~~l~~~~-----~~~~----~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i~~~  341 (375)
                      .......     .+..    ...+.++.+|+.+||..||.+|||+.|+++.  ++++...
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  331 (394)
T 4e7w_A          272 NYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDELRTG  331 (394)
T ss_dssp             GGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTTTSS
T ss_pred             hhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhhccc
Confidence            0000000     0000    1134679999999999999999999999975  5555443

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.6e-43  Score=316.76  Aligned_cols=253  Identities=23%  Similarity=0.323  Sum_probs=201.8

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---------hhhHHHHHHHHHHHHhcC-CCCeEEEeeee
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---------YKRVEQFMNEVDILARLR-HKNLVSLYGCT  126 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~niv~~~~~~  126 (375)
                      ...++|++.+.||+|+||.||+|... +|+.||+|++....         ....+.+.+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34578999999999999999999765 68999999986442         122456789999999995 99999999977


Q ss_pred             ecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeee
Q 017232          127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADF  206 (375)
Q Consensus       127 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Df  206 (375)
                      .. ....++||||+++++|.+++...    ..+++..++.++.|++.||.|||++|++|+||+|+||+++.++.+||+||
T Consensus        94 ~~-~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~df  168 (298)
T 1phk_A           94 ET-NTFFFLVFDLMKKGELFDYLTEK----VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDF  168 (298)
T ss_dssp             EC-SSEEEEEEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCC
T ss_pred             cc-CCeEEEEEeccCCCcHHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecc
Confidence            65 67899999999999999999642    45899999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCccccccCCCCCccccCccccc------ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHH
Q 017232          207 GLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ------CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       207 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~------~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      |++........  .....+++.|+|||++.      ...++.++||||||+++|+|++|..||.......       .  
T Consensus       169 g~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-------~--  237 (298)
T 1phk_A          169 GFSCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------M--  237 (298)
T ss_dssp             TTCEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------H--
T ss_pred             cchhhcCCCcc--cccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH-------H--
Confidence            99986543322  23446899999999875      4467889999999999999999999996543110       0  


Q ss_pred             HhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          281 KIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                            ...+....... ..+....++..+.+++.+||+.+|++|||+.++++
T Consensus       238 ------~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          238 ------LRMIMSGNYQF-GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             ------HHHHHHTCCCC-CTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ------HHHHhcCCccc-CcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence                  01111111111 11111234567999999999999999999999985

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=317.47  Aligned_cols=253  Identities=21%  Similarity=0.289  Sum_probs=197.7

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc----hhhHHHHHHHHHHHHhcCCCCeEEEeeeee-cCCce
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN----YKRVEQFMNEVDILARLRHKNLVSLYGCTS-RHSRE  132 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~----~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~  132 (375)
                      ..++|++.+.||+|+||.||+|... +++.||+|++....    ......+.+|+.+++.++||||+++++++. .....
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~   82 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQK   82 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---C
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCe
Confidence            3578999999999999999999764 68899999986543    234567899999999999999999999764 33567


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      .++||||+.++ |.+++...  ....+++..++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++...
T Consensus        83 ~~lv~e~~~~~-l~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~  159 (305)
T 2wtk_C           83 MYMVMEYCVCG-MQEMLDSV--PEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEAL  159 (305)
T ss_dssp             EEEEEECCSEE-HHHHHHHS--TTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             EEEEehhccCC-HHHHHHhC--cccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeecccccccc
Confidence            89999999866 77777554  3456899999999999999999999999999999999999999999999999999865


Q ss_pred             CCC-ccccccCCCCCccccCcccccccC--CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          213 PNH-VTHVSTAPQGTPGYVDPEYHQCYQ--LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       213 ~~~-~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                      ... .........+++.|+|||++.+..  ++.++||||||+++|+|++|..||.......      . .        ..
T Consensus       160 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~-~--------~~  224 (305)
T 2wtk_C          160 HPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK------L-F--------EN  224 (305)
T ss_dssp             CTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------H-H--------HH
T ss_pred             CccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH------H-H--------HH
Confidence            432 122223456899999999887643  3779999999999999999999997543110      0 0        01


Q ss_pred             HHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          290 LVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       290 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      +......  ..   ..++..+.+++.+||..||++|||+.++++.
T Consensus       225 i~~~~~~--~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          225 IGKGSYA--IP---GDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHCCCC--CC---SSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HhcCCCC--CC---CccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1111111  11   1234678899999999999999999999974

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-44  Score=326.20  Aligned_cols=259  Identities=25%  Similarity=0.396  Sum_probs=197.8

Q ss_pred             hHHHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecC-
Q 017232           53 YGELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRH-  129 (375)
Q Consensus        53 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~-  129 (375)
                      +.++....++|++.+.||+|+||.||+|... +++.||+|++..... ....+.+|+.+++.+ +||||+++++++... 
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~   94 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD-EEEEIKQEINMLKKYSHHRNIATYYGAFIKKN   94 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc-cHHHHHHHHHHHHhccCCCCeeeeeeEEeecc
Confidence            3344456778999999999999999999764 789999999865432 336788999999999 799999999977653 


Q ss_pred             ----CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEee
Q 017232          130 ----SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD  205 (375)
Q Consensus       130 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~D  205 (375)
                          ....++||||+++++|.+++....  ...+++..++.++.||+.||.|||+.|++|+||||+||+++.++.+||+|
T Consensus        95 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~D  172 (326)
T 2x7f_A           95 PPGMDDQLWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVD  172 (326)
T ss_dssp             --CCCCEEEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECC
T ss_pred             CccccceEEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEee
Confidence                457899999999999999997542  34689999999999999999999999999999999999999999999999


Q ss_pred             eccccccCCCccccccCCCCCccccCccccc-----ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHH
Q 017232          206 FGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       206 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      ||++........ ......+++.|+|||++.     +..++.++|||||||++|+|++|..||.......      ..  
T Consensus       173 fg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~------~~--  243 (326)
T 2x7f_A          173 FGVSAQLDRTVG-RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMR------AL--  243 (326)
T ss_dssp             CTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHH------HH--
T ss_pred             CcCceecCcCcc-ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHH------HH--
Confidence            999876543221 123346899999999886     5678899999999999999999999996443111      00  


Q ss_pred             HhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          281 KIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                             ..+........   ....++..+.+++.+||..+|.+|||+.++++
T Consensus       244 -------~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          244 -------FLIPRNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             -------HHHHHSCCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             -------HHhhcCccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                   00111000000   00123457899999999999999999999987

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.4e-44  Score=338.55  Aligned_cols=270  Identities=22%  Similarity=0.288  Sum_probs=197.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-----CceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-----SRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-----~~~~~  134 (375)
                      .+|++.+.||+|+||.||+|... +|+.||||++.....    ...+|+.+++.++||||+++++++...     ...++
T Consensus        54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            46888999999999999999775 689999999865432    234699999999999999999866431     23467


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC-CcEEEeeeccccccC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN-FCVKVADFGLSRLFP  213 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~-~~~kl~Dfg~~~~~~  213 (375)
                      +||||+++ +|.+.+.........+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||++....
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            99999974 6666665433345679999999999999999999999999999999999999955 678999999998654


Q ss_pred             CCccccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH-
Q 017232          214 NHVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV-  291 (375)
Q Consensus       214 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  291 (375)
                      ....  .....+|+.|+|||++.+. .++.++|||||||++|||++|++||......+..   ......+.......+. 
T Consensus       209 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l---~~i~~~lg~p~~~~~~~  283 (420)
T 1j1b_A          209 RGEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL---VEIIKVLGTPTREQIRE  283 (420)
T ss_dssp             TTCC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCSCCHHHHHH
T ss_pred             cCCC--ceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH---HHHHHHhCCCCHHHHHh
Confidence            3322  2334689999999988764 7899999999999999999999999765422111   0011111000001110 


Q ss_pred             -hhhc-CCCCC-----hH----HHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhhhc
Q 017232          292 -DQTL-GYESD-----NK----VRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDIES  340 (375)
Q Consensus       292 -~~~l-~~~~~-----~~----~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i~~  340 (375)
                       .+.. .....     +.    ....+..+.+|+.+||..||.+|||+.|+++.  ++++..
T Consensus       284 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  345 (420)
T 1j1b_A          284 MNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  345 (420)
T ss_dssp             HCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccccc
Confidence             0000 00000     00    01234679999999999999999999999863  555543

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.5e-45  Score=339.85  Aligned_cols=250  Identities=14%  Similarity=0.147  Sum_probs=190.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHH---HHHhcCCCCeEEEe-------ee
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN---NYKRVEQFMNEVD---ILARLRHKNLVSLY-------GC  125 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~---~l~~l~h~niv~~~-------~~  125 (375)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...   .....+.+.+|+.   +++.++||||++++       ++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            46788899999999999999975 46899999998643   3345678889994   55555799999988       44


Q ss_pred             eecCCc----------------eeEEEEecccCCChhHhhccCCC---CCCCCChHHHHHHHHHHHHHHHHHhhCCceec
Q 017232          126 TSRHSR----------------ELLLVYEFISNGTVADHLHGERA---KPGALPWPTRLKIAIETASALTYLHASDIIHR  186 (375)
Q Consensus       126 ~~~~~~----------------~~~lv~e~~~~~~L~~~l~~~~~---~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~  186 (375)
                      +...+.                ..++||||+ +|+|.+++.....   ....+++..++.++.||+.||+|||++||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence            433211                378999999 6899999965321   11233458888999999999999999999999


Q ss_pred             cCCCCCEEecCCCcEEEeeeccccccCCCccccccCCCCCccccCccccccc-----------CCCCchhHHHHHHHHHH
Q 017232          187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY-----------QLTDKSDVFSFGVVLIE  255 (375)
Q Consensus       187 dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-----------~~~~~~DiwslG~il~e  255 (375)
                      ||||+|||++.++.+||+|||++.....    ......| +.|+|||++.+.           .++.++|||||||++|+
T Consensus       231 Dikp~NIll~~~~~~kL~DFG~a~~~~~----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~e  305 (377)
T 3byv_A          231 YLRPVDIVLDQRGGVFLTGFEHLVRDGA----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYW  305 (377)
T ss_dssp             CCCGGGEEECTTCCEEECCGGGCEETTC----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCCCEEEEechhheecCC----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHH
Confidence            9999999999999999999999986433    1233457 999999999887           89999999999999999


Q ss_pred             HHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--
Q 017232          256 LISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD--  333 (375)
Q Consensus       256 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~--  333 (375)
                      |++|+.||............                   ... .    ..++..+.+++.+||+.||++|||+.++++  
T Consensus       306 lltg~~Pf~~~~~~~~~~~~-------------------~~~-~----~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp  361 (377)
T 3byv_A          306 IWCADLPITKDAALGGSEWI-------------------FRS-C----KNIPQPVRALLEGFLRYPKEDRLLPLQAMETP  361 (377)
T ss_dssp             HHHSSCCC------CCSGGG-------------------GSS-C----CCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSH
T ss_pred             HHHCCCCCcccccccchhhh-------------------hhh-c----cCCCHHHHHHHHHHcCCCchhCCCHHHHhhCh
Confidence            99999999754322211000                   000 0    113457889999999999999999999986  


Q ss_pred             HHHhhh
Q 017232          334 ALRDIE  339 (375)
Q Consensus       334 ~L~~i~  339 (375)
                      .++.+.
T Consensus       362 ~f~~~~  367 (377)
T 3byv_A          362 EYEQLR  367 (377)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            344443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=6.3e-43  Score=329.58  Aligned_cols=200  Identities=24%  Similarity=0.306  Sum_probs=171.2

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhc------CCCCeEEEeeeeecCCc
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARL------RHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~  131 (375)
                      ...+|++.+.||+|+||.||+|... +++.||||++.... .....+.+|+.+++.+      +|+||+++++++.. ..
T Consensus        95 ~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-~~  172 (429)
T 3kvw_A           95 VAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK-RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-RN  172 (429)
T ss_dssp             ETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-TT
T ss_pred             ccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc-chHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-CC
Confidence            3467999999999999999999655 68999999986543 3345677888888887      57799999997776 67


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc--EEEeeeccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC--VKVADFGLS  209 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~  209 (375)
                      .+++||||+. ++|.+++....  ...+++..++.++.||+.||.|||+.||+||||||+|||++.++.  +||+|||++
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a  249 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS  249 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred             eEEEEEeccC-CCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccc
Confidence            8999999995 68999986543  345899999999999999999999999999999999999999887  999999999


Q ss_pred             cccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccc
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITR  267 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~  267 (375)
                      ......    .....+|+.|+|||++.+..++.++|||||||++|+|++|.+||....
T Consensus       250 ~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          250 CYEHQR----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             EETTCC----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eecCCc----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            764332    234468999999999999999999999999999999999999997654

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=1.2e-43  Score=325.91  Aligned_cols=261  Identities=22%  Similarity=0.348  Sum_probs=201.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhh-----------------HHHHHHHHHHHHhcCCCCeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKR-----------------VEQFMNEVDILARLRHKNLVSL  122 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~  122 (375)
                      .++|++.+.||+|+||.||+|.. +++.||+|++.......                 .+.+.+|+.+++.++||||+++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~  108 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC  108 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence            46799999999999999999988 89999999986542221                 1678999999999999999999


Q ss_pred             eeeeecCCceeEEEEecccCCChhHh------hccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEe
Q 017232          123 YGCTSRHSRELLLVYEFISNGTVADH------LHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILL  195 (375)
Q Consensus       123 ~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill  195 (375)
                      ++++.. ....++||||+++++|.++      +..  .....+++..++.++.|++.||.|||+ .|++|+||+|+||++
T Consensus       109 ~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~l~~--~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~Nil~  185 (348)
T 2pml_X          109 EGIITN-YDEVYIIYEYMENDSILKFDEYFFVLDK--NYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILM  185 (348)
T ss_dssp             SEEEES-SSEEEEEEECCTTCBSSEESSSEESSCS--SSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGGEEE
T ss_pred             EEEEee-CCeEEEEEeccCCCcHHHHHHHhhhhhh--ccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHhEEE
Confidence            998776 5789999999999999998      432  124679999999999999999999999 999999999999999


Q ss_pred             cCCCcEEEeeeccccccCCCccccccCCCCCccccCccccccc-CCCC-chhHHHHHHHHHHHHhCCCCccccccccccc
Q 017232          196 DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY-QLTD-KSDVFSFGVVLIELISSMPAVDITRHRHEIN  273 (375)
Q Consensus       196 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~-~~DiwslG~il~elltg~~p~~~~~~~~~~~  273 (375)
                      +.++.++|+|||++......   ......+++.|+|||.+.+. .++. ++||||||+++|+|++|..||.......   
T Consensus       186 ~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---  259 (348)
T 2pml_X          186 DKNGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV---  259 (348)
T ss_dssp             CTTSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH---
T ss_pred             cCCCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH---
Confidence            99999999999999865443   23445689999999998876 5666 9999999999999999999997554211   


Q ss_pred             hhHHHHHHhhhhHHH------HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          274 LSNLAINKIQNKALH------ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       274 ~~~~~~~~~~~~~~~------~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                         .....+......      .................++..+.+++.+||+.+|.+|||+.++++
T Consensus       260 ---~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          260 ---ELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             ---HHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ---HHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence               001111100000      000000000000001234567899999999999999999999986

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.9e-43  Score=348.52  Aligned_cols=248  Identities=25%  Similarity=0.365  Sum_probs=201.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  134 (375)
                      .++|++.+.||+|+||.||+|... +++.||||++....   ....+.+..|..++..+ +||+|+++++++.. ...+|
T Consensus       340 ~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~-~~~~~  418 (674)
T 3pfq_A          340 LTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQT-MDRLY  418 (674)
T ss_dssp             CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBC-SSEEE
T ss_pred             ccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEe-CCEEE
Confidence            467999999999999999999765 68899999986542   23345677899999887 69999999997765 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++|+|.+++...    ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       419 lV~E~~~gg~L~~~l~~~----~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~  494 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQV----GRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIW  494 (674)
T ss_dssp             EEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCC
T ss_pred             EEEeCcCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeecccc
Confidence            999999999999999643    4589999999999999999999999999999999999999999999999999985432


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ... .....+||+.|+|||++.+..++.++|||||||++|||++|.+||.......               ....+....
T Consensus       495 ~~~-~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~---------------~~~~i~~~~  558 (674)
T 3pfq_A          495 DGV-TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE---------------LFQSIMEHN  558 (674)
T ss_dssp             TTC-CBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---------------HHHHHHSSC
T ss_pred             CCc-ccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHH---------------HHHHHHhCC
Confidence            222 2345579999999999999999999999999999999999999997543211               111122221


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCH-----HHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYM-----VDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~-----~evl~  333 (375)
                      ...  +   ..++.++.+|+.+||..||++||++     +||++
T Consensus       559 ~~~--p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~  597 (674)
T 3pfq_A          559 VAY--P---KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  597 (674)
T ss_dssp             CCC--C---TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHS
T ss_pred             CCC--C---ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhc
Confidence            111  1   1345679999999999999999998     55554

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.7e-42  Score=319.77  Aligned_cols=273  Identities=19%  Similarity=0.241  Sum_probs=189.9

Q ss_pred             HHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC---
Q 017232           55 ELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS---  130 (375)
Q Consensus        55 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---  130 (375)
                      ......++|++.+.||+|+||.||+|... +|+.||+|++..... ....+.+++..+..++||||+++++++....   
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~   95 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPR-FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERD   95 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECCTT-CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSC
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcc-ccHHHHHHHHHHHhcCCCCcccHHHhhhcccccc
Confidence            34566789999999999999999999765 689999998855432 2235567888889999999999999765422   


Q ss_pred             ---ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHh--hCCceeccCCCCCEEecC-CCcEEEe
Q 017232          131 ---RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--ASDIIHRDVKTNNILLDN-NFCVKVA  204 (375)
Q Consensus       131 ---~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--~~~ivH~dlkp~Nill~~-~~~~kl~  204 (375)
                         ...++||||+++ +|...+.........+++..++.++.|++.||.|||  +.||+||||||+|||++. ++.+||+
T Consensus        96 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           96 RRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             TTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEEC
T ss_pred             ccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEe
Confidence               237899999975 555555433345567899999999999999999999  999999999999999996 8999999


Q ss_pred             eeccccccCCCccccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhh
Q 017232          205 DFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ  283 (375)
Q Consensus       205 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~  283 (375)
                      |||++........  .....+|+.|+|||++.+. .++.++|||||||++|+|++|++||.........   ........
T Consensus       175 Dfg~a~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~---~~~~~~~~  249 (360)
T 3e3p_A          175 DFGSAKKLSPSEP--NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQL---HEIVRVLG  249 (360)
T ss_dssp             CCTTCBCCCTTSC--CCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHC
T ss_pred             eCCCceecCCCCC--cccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHH---HHHHHHcC
Confidence            9999987654332  2344689999999988654 4899999999999999999999999765422111   00000000


Q ss_pred             hh--HHHHHHhhhc------CCCCCh-------HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          284 NK--ALHELVDQTL------GYESDN-------KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       284 ~~--~~~~~~~~~l------~~~~~~-------~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ..  .....+.+..      .....+       .....+..+.+|+.+||+.||.+|||+.|+++.
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          250 CPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             CCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            00  0000000000      000000       001135679999999999999999999999864

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=331.95  Aligned_cols=205  Identities=26%  Similarity=0.419  Sum_probs=155.7

Q ss_pred             hcCCCC-CCccCCCCcEEEEEEEeC---CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeee-cCCceeE
Q 017232           60 TNYFDS-ARELGDGGFGTVYYGELQ---DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTS-RHSRELL  134 (375)
Q Consensus        60 ~~~y~~-~~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~-~~~~~~~  134 (375)
                      .+.|.+ .++||+|+||.||+|..+   +++.||+|++......  ..+.+|+.+++.++||||+++++++. .....++
T Consensus        19 ~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           19 EDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS--MSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             HHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC--HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC--HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            345666 457999999999999865   5789999998654322  46788999999999999999999764 3467899


Q ss_pred             EEEecccCCChhHhhccCC-----CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe----cCCCcEEEee
Q 017232          135 LVYEFISNGTVADHLHGER-----AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL----DNNFCVKVAD  205 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~-----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill----~~~~~~kl~D  205 (375)
                      +||||+. ++|.+++....     .....+++..++.++.||+.||.|||++||+||||||+|||+    +.++.+||+|
T Consensus        97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~D  175 (405)
T 3rgf_A           97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIAD  175 (405)
T ss_dssp             EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred             EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence            9999996 57877775321     122358999999999999999999999999999999999999    7788999999


Q ss_pred             eccccccCCCcc--ccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccc
Q 017232          206 FGLSRLFPNHVT--HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITR  267 (375)
Q Consensus       206 fg~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~  267 (375)
                      ||++........  .......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||....
T Consensus       176 fg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          176 MGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             TTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             CCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            999987653221  22234568999999998877 458999999999999999999999997544

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6e-43  Score=314.83  Aligned_cols=253  Identities=25%  Similarity=0.405  Sum_probs=190.8

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC--------
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH--------  129 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~--------  129 (375)
                      ..++|++.+.||+|+||.||+|... +++.||+|++... ......+.+|+.+++.++||||+++++++...        
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            3567999999999999999999764 7899999998543 34457788999999999999999999976432        


Q ss_pred             ----CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEee
Q 017232          130 ----SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD  205 (375)
Q Consensus       130 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~D  205 (375)
                          ....++||||+++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++.++.+||+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEee
Confidence                45789999999999999999653   23578889999999999999999999999999999999999999999999


Q ss_pred             eccccccCCCc-------------cccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccc
Q 017232          206 FGLSRLFPNHV-------------THVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHE  271 (375)
Q Consensus       206 fg~~~~~~~~~-------------~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~  271 (375)
                      ||++.......             ........+++.|+|||++.+. .++.++|||||||++|+|++   ||......  
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~--  234 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMER--  234 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHH--
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhH--
Confidence            99997654221             1112334689999999998764 68999999999999999998   33211100  


Q ss_pred             cchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          272 INLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                         .         .....+...... .........+..+.+++.+||+.||++|||+.++++
T Consensus       235 ---~---------~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          235 ---V---------NILKKLRSVSIE-FPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             ---H---------HHHHHHHSTTCC-CCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---H---------HHHHhccccccc-cCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence               0         000111111110 011111223456889999999999999999999986

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=5.7e-43  Score=312.92  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=200.8

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      ...++|++.+.||+|+||.||+|... +++.||+|++....  ......+.+|+.+++.++||||+++++++.. ....+
T Consensus        19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~   97 (287)
T 2wei_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILED-SSSFY   97 (287)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEE
T ss_pred             HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeC-CCeEE
Confidence            44578999999999999999999765 78999999986542  2345678899999999999999999997766 67899


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC---CcEEEeeeccccc
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN---FCVKVADFGLSRL  211 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~---~~~kl~Dfg~~~~  211 (375)
                      +||||+.+++|.+.+...    ..+++..++.++.|++.||.|||++|++|+||||+||+++.+   +.+||+|||++..
T Consensus        98 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~  173 (287)
T 2wei_A           98 IVGELYTGGELFDEIIKR----KRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTC  173 (287)
T ss_dssp             EEECCCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGT
T ss_pred             EEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCccee
Confidence            999999999999988543    358999999999999999999999999999999999999754   4699999999876


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ......  .....+++.|+|||.+.+ .++.++||||||+++|+|++|..||.......      . .        ..+.
T Consensus       174 ~~~~~~--~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~------~-~--------~~~~  235 (287)
T 2wei_A          174 FQQNTK--MKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD------I-L--------KRVE  235 (287)
T ss_dssp             BCCCSS--CSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-H--------HHHH
T ss_pred             ecCCCc--cccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH------H-H--------HHHH
Confidence            543322  122347889999998876 48999999999999999999999997543211      0 0        1111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ...... ..+....++..+.+++.+||..+|++|||+.++++
T Consensus       236 ~~~~~~-~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          236 TGKYAF-DLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HCCCCC-CSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cCCCCC-CchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            111110 11111234567899999999999999999999997

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.7e-44  Score=331.55  Aligned_cols=254  Identities=11%  Similarity=0.064  Sum_probs=180.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHHHHHHHHHhc--CCCCeEEEe-------eeee
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFMNEVDILARL--RHKNLVSLY-------GCTS  127 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l--~h~niv~~~-------~~~~  127 (375)
                      .+|++.+.||+|+||.||+|... +|+.||+|++.....   ...+.+.+|+.+++.+  +||||++++       +++.
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45888999999999999999765 789999999976532   3455677886555555  699988855       3222


Q ss_pred             cCC----------------ceeEEEEecccCCChhHhhccCCCCCCCCChHHH------HHHHHHHHHHHHHHhhCCcee
Q 017232          128 RHS----------------RELLLVYEFISNGTVADHLHGERAKPGALPWPTR------LKIAIETASALTYLHASDIIH  185 (375)
Q Consensus       128 ~~~----------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~------~~i~~~i~~~l~~Lh~~~ivH  185 (375)
                      ..+                ..+++||||++ ++|.+++....   ..+++..+      +.++.||+.||+|||++||+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSKGLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCcc
Confidence            111                34899999998 89999996542   23455555      678899999999999999999


Q ss_pred             ccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCCCCccccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCc
Q 017232          186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC--YQLTDKSDVFSFGVVLIELISSMPAV  263 (375)
Q Consensus       186 ~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~p~  263 (375)
                      |||||+|||++.++.+||+|||++........    ...+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||
T Consensus       218 rDikp~NIll~~~~~~kL~DFG~a~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf  293 (371)
T 3q60_A          218 GHFTPDNLFIMPDGRLMLGDVSALWKVGTRGP----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPF  293 (371)
T ss_dssp             TTCSGGGEEECTTSCEEECCGGGEEETTCEEE----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCST
T ss_pred             CcCCHHHEEECCCCCEEEEecceeeecCCCcc----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999986543221    2346799999999987  78999999999999999999999999


Q ss_pred             cccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          264 DITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ...................        ......   .+....++..+.+++.+||+.||++|||+.++++
T Consensus       294 ~~~~~~~~~~~~~~~~~~~--------~~~~~~---~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  352 (371)
T 3q60_A          294 GLVTPGIKGSWKRPSLRVP--------GTDSLA---FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME  352 (371)
T ss_dssp             TBCCTTCTTCCCBCCTTSC--------CCCSCC---CTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTT
T ss_pred             CCcCcccccchhhhhhhhc--------cccccc---hhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            7664321110000000000        000000   0001124567999999999999999999999975

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=4.5e-43  Score=322.79  Aligned_cols=268  Identities=23%  Similarity=0.320  Sum_probs=199.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC----Ccee
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH----SREL  133 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~~  133 (375)
                      .++|++.+.||+|+||.||+|... +|+.||+|++... .......+.+|+.+++.++||||+++++++...    ....
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            467999999999999999999765 6899999998654 334456788999999999999999999976543    2678


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++||||+. ++|.+++..     ..+++..++.++.|++.||.|||++|++||||||+||+++.++.+||+|||++....
T Consensus        90 ~lv~e~~~-~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~  163 (353)
T 2b9h_A           90 YIIQELMQ-TDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIID  163 (353)
T ss_dssp             EEEECCCS-EEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEeccC-ccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEecccccccc
Confidence            99999996 689998854     358999999999999999999999999999999999999999999999999998664


Q ss_pred             CCccc---------cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHH----
Q 017232          214 NHVTH---------VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAI----  279 (375)
Q Consensus       214 ~~~~~---------~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~----  279 (375)
                      .....         ......||+.|+|||++.+ ..++.++|||||||++|+|++|.+||................    
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (353)
T 2b9h_A          164 ESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPH  243 (353)
T ss_dssp             ----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             cccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCc
Confidence            32211         1123468999999997654 678999999999999999999999997654211100000000    


Q ss_pred             -----HHhhhhHHHHHHhhhcCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          280 -----NKIQNKALHELVDQTLGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       280 -----~~~~~~~~~~~~~~~l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                           .........+...........   .....++..+.+++.+||..||++|||+.++++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          244 SDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             STTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                 000001111111110000000   001134567899999999999999999999987

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=6.4e-44  Score=323.86  Aligned_cols=261  Identities=21%  Similarity=0.314  Sum_probs=197.1

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ...++|++.+.||+|+||.||+|...+  .+|+|++....  ....+.+.+|+.+++.++||||+++++++.. ....++
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~i  106 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-PPHLAI  106 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-SSCEEE
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-CCceEE
Confidence            345779999999999999999998764  49999886432  2233457789999999999999999997776 567999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++...   ...+++..++.++.|++.||.|||++|++|+||||+||+++ ++.++|+|||++......
T Consensus       107 v~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~  182 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDA---KIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVL  182 (319)
T ss_dssp             ECBCCCSEEHHHHTTSS---CCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC-----
T ss_pred             EeecccCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccc
Confidence            99999999999999542   34689999999999999999999999999999999999998 679999999998754321


Q ss_pred             c----cccccCCCCCccccCcccccc---------cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHh
Q 017232          216 V----THVSTAPQGTPGYVDPEYHQC---------YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKI  282 (375)
Q Consensus       216 ~----~~~~~~~~~~~~y~aPE~~~~---------~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  282 (375)
                      .    ........|++.|+|||++.+         ..++.++||||||+++|+|++|..||.......      ..    
T Consensus       183 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~------~~----  252 (319)
T 2y4i_B          183 QAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEA------II----  252 (319)
T ss_dssp             -----CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHH------HH----
T ss_pred             cccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH------HH----
Confidence            1    112233458899999998764         357889999999999999999999997543211      00    


Q ss_pred             hhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          283 QNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       283 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                           ..+... ......  ...++..+.+++.+||..+|++|||+.++++.|+.+.....
T Consensus       253 -----~~~~~~-~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~~  305 (319)
T 2y4i_B          253 -----WQMGTG-MKPNLS--QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNR  305 (319)
T ss_dssp             -----HHHHTT-CCCCCC--CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC-----
T ss_pred             -----HHhccC-CCCCCC--cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhhc
Confidence                 000000 000000  01234568899999999999999999999999999887643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.9e-42  Score=314.46  Aligned_cols=266  Identities=20%  Similarity=0.290  Sum_probs=199.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe--CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCC------CeEEEeeeeecCCc
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL--QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHK------NLVSLYGCTSRHSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~  131 (375)
                      .++|++.+.||+|+||.||+|..  .+++.||+|++.... ...+.+.+|+.+++.++|+      +++++++++.. ..
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~-~~   90 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVD-RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH-HG   90 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE-TT
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCC-chhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc-CC
Confidence            46799999999999999999975  368899999986543 3456788899999998765      49999997766 56


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC--------------
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN--------------  197 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~--------------  197 (375)
                      ..++||||+ +++|.+++...  ....+++..++.++.|++.||.|||++||+||||||+|||++.              
T Consensus        91 ~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~  167 (339)
T 1z57_A           91 HICIVFELL-GLSTYDFIKEN--GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRD  167 (339)
T ss_dssp             EEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CE
T ss_pred             cEEEEEcCC-CCCHHHHHHhc--CCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccc
Confidence            899999999 89999998654  2246889999999999999999999999999999999999987              


Q ss_pred             -----CCcEEEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCcccccccccc
Q 017232          198 -----NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEI  272 (375)
Q Consensus       198 -----~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~  272 (375)
                           ++.+||+|||++......    .....+|+.|+|||++.+..++.++|||||||++|+|++|.+||.........
T Consensus       168 ~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  243 (339)
T 1z57_A          168 ERTLINPDIKVVDFGSATYDDEH----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHL  243 (339)
T ss_dssp             EEEESCCCEEECCCSSCEETTSC----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHH
T ss_pred             cccccCCCceEeeCcccccCccc----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence                 668999999999764332    23346899999999999989999999999999999999999999755432211


Q ss_pred             chhHHHHHHhhhhHH----------------------HHHHhhhcCC--CCChHHHHHHHHHHHHHHHhcCCCCCCCCCH
Q 017232          273 NLSNLAINKIQNKAL----------------------HELVDQTLGY--ESDNKVRRTINAVAELAFQCLQSEKDLRPYM  328 (375)
Q Consensus       273 ~~~~~~~~~~~~~~~----------------------~~~~~~~l~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~  328 (375)
                      ...............                      ..........  .........+..+.+++.+||+.||.+|||+
T Consensus       244 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~  323 (339)
T 1z57_A          244 AMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL  323 (339)
T ss_dssp             HHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCH
Confidence            100000000000000                      0000000000  0000012345779999999999999999999


Q ss_pred             HHHHHH
Q 017232          329 VDVLDA  334 (375)
Q Consensus       329 ~evl~~  334 (375)
                      .|+++.
T Consensus       324 ~ell~h  329 (339)
T 1z57_A          324 REALKH  329 (339)
T ss_dssp             HHHTTS
T ss_pred             HHHhcC
Confidence            999854

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-42  Score=320.77  Aligned_cols=264  Identities=20%  Similarity=0.300  Sum_probs=196.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc-----
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR-----  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  131 (375)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++...  .......+.+|+.+++.++||||+++++++.....     
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            467999999999999999999655 6899999998654  33345678899999999999999999997765332     


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ..++||||+. ++|.+.+.      ..+++..++.++.|++.||.|||+.||+||||||+|||++.++.+||+|||++..
T Consensus       121 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~  193 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG------MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  193 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC--
T ss_pred             eEEEEEcccc-ccHHHHhh------cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCcccc
Confidence            2499999996 68888772      2389999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHH--------HHHHh
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL--------AINKI  282 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~--------~~~~~  282 (375)
                      ....    .....+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||..............        ....+
T Consensus       194 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  269 (371)
T 4exu_A          194 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  269 (371)
T ss_dssp             ----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTC
T ss_pred             cccC----cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHh
Confidence            5432    233468999999998876 6789999999999999999999999975542211100000        00000


Q ss_pred             hhhHHHHHHhhhcCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          283 QNKALHELVDQTLGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       283 ~~~~~~~~~~~~l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ..................   .....++..+.+|+.+||+.||++|||+.|+++.
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          270 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             SCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            001111111111111110   0111235689999999999999999999999864

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=9.7e-43  Score=317.02  Aligned_cols=267  Identities=23%  Similarity=0.356  Sum_probs=198.4

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEe--CCCCEEEEEEecccchh--hHHHHHHHHHHHHhc---CCCCeEEEeeeee----
Q 017232           59 ATNYFDSARELGDGGFGTVYYGEL--QDGRAVAVKRLYENNYK--RVEQFMNEVDILARL---RHKNLVSLYGCTS----  127 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~vaiK~~~~~~~~--~~~~~~~e~~~l~~l---~h~niv~~~~~~~----  127 (375)
                      ..++|++.+.||+|+||.||+|..  .+++.||+|++......  ....+.+|+.+++.+   +||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            457899999999999999999977  36789999998643221  123456677777666   8999999999765    


Q ss_pred             cCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeec
Q 017232          128 RHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFG  207 (375)
Q Consensus       128 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg  207 (375)
                      ......++||||+. ++|.+++....  ...+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg  165 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFG  165 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCc
Confidence            23567899999997 69999986542  3458999999999999999999999999999999999999999999999999


Q ss_pred             cccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH
Q 017232          208 LSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL  287 (375)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (375)
                      ++.......  ......+++.|+|||++.+..++.++||||||+++|+|++|.+||.........   ............
T Consensus       166 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~i~~~~~~~~~  240 (326)
T 1blx_A          166 LARIYSFQM--ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQL---GKILDVIGLPGE  240 (326)
T ss_dssp             SCCCCCGGG--GGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH---HHHHHHHCCCCG
T ss_pred             ccccccCCC--CccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHH---HHHHHHcCCCCc
Confidence            997654322  233456899999999999889999999999999999999999999755421100   000000000000


Q ss_pred             HHHH------hhhcC----CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          288 HELV------DQTLG----YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       288 ~~~~------~~~l~----~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ..+.      .....    .........++..+.+++.+||..+|++|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          241 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000      00000    0000001123467889999999999999999999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=2.2e-43  Score=317.80  Aligned_cols=261  Identities=27%  Similarity=0.408  Sum_probs=184.2

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.+++.++||||+++++++.. ....++|
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~lv   91 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVV-KDELWLV   91 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEES-SSCEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEee-cCCcEEE
Confidence            3578999999999999999999654 68999999886543 3345678899999999999999999997776 5678999


Q ss_pred             EecccCCChhHhhccCC----CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          137 YEFISNGTVADHLHGER----AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~----~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      |||+++++|.+++....    .....+++..++.++.|++.||.|||+.|++|+||||+||+++.++.+||+|||++...
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  171 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL  171 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence            99999999999986421    12456899999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcc----ccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH-
Q 017232          213 PNHVT----HVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA-  286 (375)
Q Consensus       213 ~~~~~----~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~-  286 (375)
                      .....    .......+|+.|+|||.+.+ ..++.++||||||+++|+|++|..||........      ......... 
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~------~~~~~~~~~~  245 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV------LMLTLQNDPP  245 (303)
T ss_dssp             C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH------HHHHHTSSCC
T ss_pred             ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH------HHHHhccCCC
Confidence            43211    11223468999999998875 5689999999999999999999999975442210      000000000 


Q ss_pred             -H-HHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          287 -L-HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       287 -~-~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       . .........       ..++..+.+++.+||+.||.+|||+.++++
T Consensus       246 ~~~~~~~~~~~~-------~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          246 SLETGVQDKEML-------KKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             CTTC-----CCC-------CCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             ccccccccchhh-------hhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence             0 000000000       113357889999999999999999999986

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.2e-42  Score=314.68  Aligned_cols=253  Identities=20%  Similarity=0.321  Sum_probs=195.9

Q ss_pred             HHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcC--CCCeEEEeeeeecCCcee
Q 017232           58 EATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLR--HKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        58 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~  133 (375)
                      ...++|++.+.||+|+||.||++...+++.||+|++...  .......+.+|+.++..++  ||||+++++++.. ....
T Consensus        25 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~-~~~~  103 (313)
T 3cek_A           25 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEIT-DQYI  103 (313)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEEC-SSEE
T ss_pred             eccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeec-CCEE
Confidence            345679999999999999999998888999999998643  3445678899999999997  5999999997766 6679


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++||| +.+++|.+++...    ..+++..++.++.|++.||.|||+.|++||||||+||++++ +.+||+|||++....
T Consensus       104 ~lv~e-~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~  177 (313)
T 3cek_A          104 YMVME-CGNIDLNSWLKKK----KSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ  177 (313)
T ss_dssp             EEEEC-CCSEEHHHHHHHC----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEET-TEEEECCCSSSCC--
T ss_pred             EEEEe-cCCCcHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEEC-CeEEEeecccccccc
Confidence            99999 5588999999643    46899999999999999999999999999999999999965 899999999998664


Q ss_pred             CCccc-cccCCCCCccccCcccccc-----------cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHH
Q 017232          214 NHVTH-VSTAPQGTPGYVDPEYHQC-----------YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINK  281 (375)
Q Consensus       214 ~~~~~-~~~~~~~~~~y~aPE~~~~-----------~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~  281 (375)
                      ..... ......+++.|+|||.+.+           ..++.++||||||+++|+|++|..||.......           
T Consensus       178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~-----------  246 (313)
T 3cek_A          178 PDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQI-----------  246 (313)
T ss_dssp             ------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----------
T ss_pred             CccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHH-----------
Confidence            33221 1233468999999998865           467889999999999999999999996432110           


Q ss_pred             hhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          282 IQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       282 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                         .......+.........   ..+..+.+++.+||..+|++|||+.++++.
T Consensus       247 ---~~~~~~~~~~~~~~~~~---~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          247 ---SKLHAIIDPNHEIEFPD---IPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             ---HHHHHHHCTTSCCCCCC---CSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---HHHHHHHhcccccCCcc---cchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence               01112222222111111   123578899999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=9.3e-43  Score=320.77  Aligned_cols=264  Identities=20%  Similarity=0.301  Sum_probs=195.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCc-----
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSR-----  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  131 (375)
                      .++|.+.+.||+|+||.||+|... +|+.||+|++...  .......+.+|+.+++.++||||+++++++.....     
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            357889999999999999999764 6899999998654  33345678899999999999999999997765432     


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ..++||||+. ++|.+++.      ..+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++..
T Consensus       103 ~~~lv~e~~~-~~l~~~~~------~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~  175 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMG------LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARH  175 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC
T ss_pred             eEEEEecccc-CCHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccC
Confidence            3599999997 68887762      2489999999999999999999999999999999999999999999999999976


Q ss_pred             cCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHH--------HHHh
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA--------INKI  282 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~  282 (375)
                      ....    .....+|+.|+|||++.+ ..++.++|||||||++|+|++|..||...............        ...+
T Consensus       176 ~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  251 (353)
T 3coi_A          176 ADAE----MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKL  251 (353)
T ss_dssp             ------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTC
T ss_pred             CCCC----ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHH
Confidence            5432    223468999999998876 67899999999999999999999999765422110000000        0000


Q ss_pred             hhhHHHHHHhhhc---CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          283 QNKALHELVDQTL---GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       283 ~~~~~~~~~~~~l---~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .+......+....   ...........+..+.+++.+||..||++|||+.++++.
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          252 NDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             SCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            0011111111000   000111112345679999999999999999999999863

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=8.1e-42  Score=316.74  Aligned_cols=262  Identities=19%  Similarity=0.281  Sum_probs=197.0

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-----------CCCeEEEeeeee
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-----------HKNLVSLYGCTS  127 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~  127 (375)
                      .++|++.+.||+|+||.||+|.. .+++.||+|++.... .....+.+|+.+++.++           ||||+++++++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             CCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc-cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            35799999999999999999976 478999999986443 33466788999998886           899999999765


Q ss_pred             cC---CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEec------C
Q 017232          128 RH---SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLD------N  197 (375)
Q Consensus       128 ~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~------~  197 (375)
                      ..   ...+++|||++ +++|.+++....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++      .
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~  173 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPEN  173 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTT
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcC
Confidence            42   23789999999 899999997542  34589999999999999999999998 999999999999994      4


Q ss_pred             CCcEEEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHH
Q 017232          198 NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL  277 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~  277 (375)
                      .+.+||+|||++......    .....+|+.|+|||++.+..++.++|||||||++|+|++|..||..............
T Consensus       174 ~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~  249 (373)
T 1q8y_A          174 LIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDH  249 (373)
T ss_dssp             EEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHH
T ss_pred             cceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHH
Confidence            458999999999865432    2334689999999999998999999999999999999999999975542211100000


Q ss_pred             HHHH---hhhhH------------------------------HHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCC
Q 017232          278 AINK---IQNKA------------------------------LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDL  324 (375)
Q Consensus       278 ~~~~---~~~~~------------------------------~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~  324 (375)
                      ....   +....                              .........     ......+..+.+|+.+||+.||++
T Consensus       250 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          250 IAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKY-----KFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             HHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTT-----CCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             HHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcc-----cCCcchHHHHHHHHHHHhccCccc
Confidence            0000   00000                              000011000     011356778999999999999999


Q ss_pred             CCCHHHHHHH
Q 017232          325 RPYMVDVLDA  334 (375)
Q Consensus       325 Rpt~~evl~~  334 (375)
                      |||+.|+++.
T Consensus       325 Rpt~~ell~h  334 (373)
T 1q8y_A          325 RADAGGLVNH  334 (373)
T ss_dssp             CBCHHHHHTC
T ss_pred             cCCHHHHhhC
Confidence            9999999873

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.1e-42  Score=317.89  Aligned_cols=255  Identities=20%  Similarity=0.279  Sum_probs=173.2

Q ss_pred             HhcCCCCCC-ccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeec---CCcee
Q 017232           59 ATNYFDSAR-ELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR---HSREL  133 (375)
Q Consensus        59 ~~~~y~~~~-~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~  133 (375)
                      ..++|.+.+ .||+|+||.||+|... +|+.||+|++.....    ........++.++||||+++++++..   .....
T Consensus        26 ~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~----~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  101 (336)
T 3fhr_A           26 VTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK----ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL  101 (336)
T ss_dssp             GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH----HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH----HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceE
Confidence            346788855 5999999999999766 689999999865421    11222334667799999999997654   24558


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC---CCcEEEeeecccc
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSR  210 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~  210 (375)
                      ++||||+++++|.+++...  ....+++..++.++.|++.||.|||++|++||||||+||+++.   ++.+||+|||++.
T Consensus       102 ~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~  179 (336)
T 3fhr_A          102 LIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK  179 (336)
T ss_dssp             EEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccce
Confidence            9999999999999999653  2346999999999999999999999999999999999999976   4559999999997


Q ss_pred             ccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ......   .....+|+.|+|||++.+..++.++||||||+++|+|++|..||.........   ....        ..+
T Consensus       180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---~~~~--------~~~  245 (336)
T 3fhr_A          180 ETTQNA---LQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAIS---PGMK--------RRI  245 (336)
T ss_dssp             EC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------------
T ss_pred             eccccc---cccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhh---hhHH--------Hhh
Confidence            654322   23346899999999998888999999999999999999999999654322110   0000        000


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ...... ...+....++..+.+++.+||+.+|++|||+.++++.
T Consensus       246 ~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          246 RLGQYG-FPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             -----C-CCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hccccc-cCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            000000 0111112345678999999999999999999999983

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.2e-42  Score=325.40  Aligned_cols=251  Identities=25%  Similarity=0.378  Sum_probs=185.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      +.|.+.+.||+|+||+||.+...+|+.||||++....   .+.+.+|+.+++.+ +||||+++++++.. ....++||||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~---~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~lv~E~   90 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETT-DRFLYIALEL   90 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG---HHHHHHHHHHHHHHTTSTTBCCEEEEEEC-SSEEEEEECC
T ss_pred             heeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH---HHHHHHHHHHHHhccCCCCcCeEEEEEec-CCeEEEEEec
Confidence            3455568899999999988877789999999986543   34567899999887 89999999997665 6789999999


Q ss_pred             ccCCChhHhhccCCCCCCC---CChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC-------------CcEEE
Q 017232          140 ISNGTVADHLHGERAKPGA---LPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN-------------FCVKV  203 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~---l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~-------------~~~kl  203 (375)
                      +. |+|.+++.........   .++..++.++.||+.||.|||++||+||||||+|||++.+             +.+||
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            95 6999999654322211   2344567899999999999999999999999999999754             48999


Q ss_pred             eeeccccccCCCccc---cccCCCCCccccCcccccc-------cCCCCchhHHHHHHHHHHHHh-CCCCcccccccccc
Q 017232          204 ADFGLSRLFPNHVTH---VSTAPQGTPGYVDPEYHQC-------YQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEI  272 (375)
Q Consensus       204 ~Dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-------~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~  272 (375)
                      +|||++.........   ......||+.|+|||++.+       ..++.++|||||||++|||++ |.+||.......  
T Consensus       170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--  247 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--  247 (434)
T ss_dssp             CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred             cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence            999999876543221   1224469999999998865       568999999999999999998 999996432110  


Q ss_pred             chhHHHHHHhhhhHHHHHHhhhcCCC--CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          273 NLSNLAINKIQNKALHELVDQTLGYE--SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~l~~~--~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                                     ..+........  .......++..+.+++.+||+.||.+|||+.++++
T Consensus       248 ---------------~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          248 ---------------SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             ---------------HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---------------HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence                           01111111100  01111345678999999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=6.6e-43  Score=318.37  Aligned_cols=265  Identities=24%  Similarity=0.350  Sum_probs=180.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc-hhhHHHHHHHHH-HHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN-YKRVEQFMNEVD-ILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~-~~~~~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .++|++.+.||+|+||.||+|... +|+.||+|++.... ......+..|+. +++.++||||+++++++.. ....++|
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-~~~~~lv   99 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-EGDCWIC   99 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-CCceEEE
Confidence            367889999999999999999775 78999999986653 333445566666 6777899999999998776 5678999


Q ss_pred             EecccCCChhHhhccCC-CCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          137 YEFISNGTVADHLHGER-AKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~-~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      |||+.+ +|.+++.... .....+++..++.++.|++.||.|||+. |++||||||+||+++.++.+||+|||++.....
T Consensus       100 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~  178 (327)
T 3aln_A          100 MELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD  178 (327)
T ss_dssp             ECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC---
T ss_pred             EeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccc
Confidence            999974 7877765321 1245689999999999999999999999 999999999999999999999999999976543


Q ss_pred             CccccccCCCCCccccCcccc----cccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          215 HVTHVSTAPQGTPGYVDPEYH----QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~----~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ...  .....|++.|+|||++    .+..++.++||||||+++|+|++|..||.........         +     ...
T Consensus       179 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~---------~-----~~~  242 (327)
T 3aln_A          179 SIA--KTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQ---------L-----TQV  242 (327)
T ss_dssp             -----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------------------CCC
T ss_pred             ccc--cccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHH---------H-----HHH
Confidence            322  2233589999999998    4567899999999999999999999999753211000         0     000


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhhhcCC
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDIESDG  342 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i~~~~  342 (375)
                      ...............++..+.+++.+||..||++|||+.++++.  +.......
T Consensus       243 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~  296 (327)
T 3aln_A          243 VKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA  296 (327)
T ss_dssp             CCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSC
T ss_pred             hcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhH
Confidence            00000000000001234578999999999999999999999873  44444333

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-42  Score=322.67  Aligned_cols=248  Identities=24%  Similarity=0.322  Sum_probs=185.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .+|.+.+.||+|+||+||.....+++.||||++......   .+.+|+.+++.+ +||||+++++++.. ....++||||
T Consensus        24 ~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~~---~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~~~~lv~E~   99 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFS---FADREVQLLRESDEHPNVIRYFCTEKD-RQFQYIAIEL   99 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTEE---ECHHHHHHHHHSCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             EEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHHH---HHHHHHHHHHhccCCCCcCeEEEEEec-CCEEEEEEEC
Confidence            458888999999999977666678999999998654322   246799999999 79999999997765 6788999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC-----CCcEEEeeeccccccCC
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-----NFCVKVADFGLSRLFPN  214 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~~~~~~~  214 (375)
                      +. ++|.+++....   ....+..++.++.||+.||.|||++||+||||||+|||++.     ...+||+|||++.....
T Consensus       100 ~~-g~L~~~l~~~~---~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~  175 (432)
T 3p23_A          100 CA-ATLQEYVEQKD---FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV  175 (432)
T ss_dssp             CS-EEHHHHHHSSS---CCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--
T ss_pred             CC-CCHHHHHHhcC---CCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccC
Confidence            96 69999996542   23556677899999999999999999999999999999953     33588999999987643


Q ss_pred             Ccc--ccccCCCCCccccCccccc---ccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          215 HVT--HVSTAPQGTPGYVDPEYHQ---CYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       215 ~~~--~~~~~~~~~~~y~aPE~~~---~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      ...  .......||+.|+|||++.   +..++.++|||||||++|+|++ |.+||.......       .          
T Consensus       176 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~-------~----------  238 (432)
T 3p23_A          176 GRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ-------A----------  238 (432)
T ss_dssp             ----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH-------H----------
T ss_pred             CCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH-------H----------
Confidence            221  2223456999999999987   4567889999999999999999 999996432110       0          


Q ss_pred             HHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       289 ~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .....................+.+++.+||+.||++|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          239 NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            000000111111111234456889999999999999999999984

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.5e-41  Score=311.21  Aligned_cols=266  Identities=21%  Similarity=0.291  Sum_probs=196.6

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CC-CEEEEEEecccchhhHHHHHHHHHHHHhcCCCC------eEEEeeeeecCC
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DG-RAVAVKRLYENNYKRVEQFMNEVDILARLRHKN------LVSLYGCTSRHS  130 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~-~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~  130 (375)
                      ..++|++.+.||+|+||.||+|... ++ ..||+|++... ....+.+.+|+.+++.++|++      ++.+++++.. .
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~-~   94 (355)
T 2eu9_A           17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF-H   94 (355)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE-T
T ss_pred             ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee-C
Confidence            3468999999999999999999764 44 68999998644 334467788999999997655      8888887665 6


Q ss_pred             ceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe---------------
Q 017232          131 RELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL---------------  195 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill---------------  195 (375)
                      ...++||||+ +++|.+.+...  ....+++.+++.++.||+.||.|||++||+||||||+|||+               
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~  171 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSC  171 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred             CeEEEEEecc-CCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccc
Confidence            6899999999 67777777543  23468999999999999999999999999999999999999               


Q ss_pred             ----cCCCcEEEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccc
Q 017232          196 ----DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHE  271 (375)
Q Consensus       196 ----~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~  271 (375)
                          +.++.+||+|||++.......    ....||+.|+|||++.+..++.++|||||||++|+|++|.+||........
T Consensus       172 ~~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  247 (355)
T 2eu9_A          172 EEKSVKNTSIRVADFGSATFDHEHH----TTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREH  247 (355)
T ss_dssp             CEEEESCCCEEECCCTTCEETTSCC----CSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             cccccCCCcEEEeecCccccccccc----cCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence                567899999999997643322    334689999999999998999999999999999999999999975543221


Q ss_pred             cchhHHHHHHhhhhHH----------------------HHHHhhhcCC--CCChHHHHHHHHHHHHHHHhcCCCCCCCCC
Q 017232          272 INLSNLAINKIQNKAL----------------------HELVDQTLGY--ESDNKVRRTINAVAELAFQCLQSEKDLRPY  327 (375)
Q Consensus       272 ~~~~~~~~~~~~~~~~----------------------~~~~~~~l~~--~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt  327 (375)
                      ................                      ..........  ............+.+|+.+||..||++|||
T Consensus       248 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt  327 (355)
T 2eu9_A          248 LVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRIT  327 (355)
T ss_dssp             HHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcC
Confidence            1000000000000000                      0000000000  000000123457899999999999999999


Q ss_pred             HHHHHH
Q 017232          328 MVDVLD  333 (375)
Q Consensus       328 ~~evl~  333 (375)
                      +.|+++
T Consensus       328 ~~e~l~  333 (355)
T 2eu9_A          328 LAEALL  333 (355)
T ss_dssp             HHHHTT
T ss_pred             HHHHhc
Confidence            999984

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1.6e-41  Score=315.73  Aligned_cols=203  Identities=25%  Similarity=0.298  Sum_probs=170.8

Q ss_pred             HHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CC-----CeEEEeeeeec
Q 017232           56 LEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HK-----NLVSLYGCTSR  128 (375)
Q Consensus        56 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----niv~~~~~~~~  128 (375)
                      .....++|++.+.||+|+||.||+|... +++.||||++.... .....+..|+.+++.++ |+     +++++++++..
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~  127 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKK-AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF  127 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSH-HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccH-HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc
Confidence            3445678999999999999999999665 68899999986442 33466778899988885 55     48999997766


Q ss_pred             CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHh--hCCceeccCCCCCEEec--CCCcEEEe
Q 017232          129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH--ASDIIHRDVKTNNILLD--NNFCVKVA  204 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh--~~~ivH~dlkp~Nill~--~~~~~kl~  204 (375)
                       ....++||||+. ++|.+++....  ...+++..+..++.|++.||.|||  ..||+||||||+|||++  .++.+||+
T Consensus       128 -~~~~~lv~e~~~-~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~  203 (382)
T 2vx3_A          128 -RNHLCLVFEMLS-YNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIV  203 (382)
T ss_dssp             -TTEEEEEEECCC-CBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEEC
T ss_pred             -CCceEEEEecCC-CCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEE
Confidence             578999999996 59999996542  245899999999999999999999  46999999999999994  57889999


Q ss_pred             eeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccc
Q 017232          205 DFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITR  267 (375)
Q Consensus       205 Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~  267 (375)
                      |||++......    .....+|+.|+|||++.+..++.++|||||||++|+|++|++||....
T Consensus       204 DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          204 DFGSSCQLGQR----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CCTTCEETTCC----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eccCceecccc----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999876432    234568999999999999999999999999999999999999998654

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.1e-42  Score=315.99  Aligned_cols=250  Identities=24%  Similarity=0.364  Sum_probs=196.9

Q ss_pred             ccchHHHHHHhcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchh------hHHHHHHHHHHHHhcC--CCCeE
Q 017232           50 VFSYGELEEATNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYK------RVEQFMNEVDILARLR--HKNLV  120 (375)
Q Consensus        50 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l~--h~niv  120 (375)
                      ..+..+.....++|++.+.||+|+||.||+|.. .+++.||+|++......      ....+.+|+.+++.++  |+||+
T Consensus        32 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~  111 (320)
T 3a99_A           32 LAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVI  111 (320)
T ss_dssp             --------CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBC
T ss_pred             cCcccccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCce
Confidence            344445556678899999999999999999965 47899999998654221      1234667999999996  59999


Q ss_pred             EEeeeeecCCceeEEEEecccC-CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec-CC
Q 017232          121 SLYGCTSRHSRELLLVYEFISN-GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NN  198 (375)
Q Consensus       121 ~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~-~~  198 (375)
                      ++++++.. ....++|||++.+ ++|.+++..    ...+++..++.++.|++.||.|||+.||+||||||+|||++ ++
T Consensus       112 ~~~~~~~~-~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~  186 (320)
T 3a99_A          112 RLLDWFER-PDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNR  186 (320)
T ss_dssp             CEEEEEEC-SSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTT
T ss_pred             EEEEEEec-CCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCC
Confidence            99997776 6778999999976 899999864    24589999999999999999999999999999999999999 78


Q ss_pred             CcEEEeeeccccccCCCccccccCCCCCccccCcccccccCC-CCchhHHHHHHHHHHHHhCCCCccccccccccchhHH
Q 017232          199 FCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNL  277 (375)
Q Consensus       199 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~  277 (375)
                      +.+||+|||++.......   .....+|+.|+|||++.+..+ +.++||||||+++|+|++|+.||.....         
T Consensus       187 ~~~kL~Dfg~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~---------  254 (320)
T 3a99_A          187 GELKLIDFGSGALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE---------  254 (320)
T ss_dssp             TEEEECCCTTCEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH---------
T ss_pred             CCEEEeeCcccccccccc---ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh---------
Confidence            999999999998765332   233468999999998887665 6789999999999999999999964321         


Q ss_pred             HHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          278 AINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       278 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                                  .........     ..++..+.+++.+||..+|++|||+.++++
T Consensus       255 ------------~~~~~~~~~-----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          255 ------------IIRGQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ------------HHHCCCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ------------hhccccccc-----ccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                        000001000     113457889999999999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=4e-42  Score=311.13  Aligned_cols=246  Identities=24%  Similarity=0.371  Sum_probs=190.4

Q ss_pred             HHHHHhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchh------hHHHHHHHHHHHHhc----CCCCeEEEe
Q 017232           55 ELEEATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYK------RVEQFMNEVDILARL----RHKNLVSLY  123 (375)
Q Consensus        55 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~------~~~~~~~e~~~l~~l----~h~niv~~~  123 (375)
                      +.+...++|++.+.||+|+||.||+|... +++.||+|++......      ....+.+|+.++..+    +||||++++
T Consensus        25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~  104 (312)
T 2iwi_A           25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL  104 (312)
T ss_dssp             --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred             chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence            34556788999999999999999999664 6889999998654321      223456799999999    899999999


Q ss_pred             eeeecCCceeEEEEec-ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec-CCCcE
Q 017232          124 GCTSRHSRELLLVYEF-ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD-NNFCV  201 (375)
Q Consensus       124 ~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~-~~~~~  201 (375)
                      +++.. ....++|||+ +.+++|.+++...    ..+++..++.++.|++.||.|||+.|++||||||+||+++ .++.+
T Consensus       105 ~~~~~-~~~~~~v~e~~~~~~~L~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~  179 (312)
T 2iwi_A          105 DWFET-QEGFMLVLERPLPAQDLFDYITEK----GPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCA  179 (312)
T ss_dssp             EEC------CEEEEECCSSEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEE
T ss_pred             EEEec-CCeEEEEEEecCCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeE
Confidence            97765 5678999999 7899999999643    3589999999999999999999999999999999999999 89999


Q ss_pred             EEeeeccccccCCCccccccCCCCCccccCcccccccCCC-CchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHH
Q 017232          202 KVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT-DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       202 kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~-~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      ||+|||++.......   .....+++.|+|||++.+..+. .++||||||+++|+|++|+.||.....            
T Consensus       180 kl~dfg~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~------------  244 (312)
T 2iwi_A          180 KLIDFGSGALLHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE------------  244 (312)
T ss_dssp             EECCCSSCEECCSSC---BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH------------
T ss_pred             EEEEcchhhhcccCc---ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH------------
Confidence            999999998765432   2344589999999988776664 489999999999999999999964310            


Q ss_pred             HhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          281 KIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                               ........  .   ..++..+.+++.+||..+|++|||+.++++.
T Consensus       245 ---------~~~~~~~~--~---~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          245 ---------ILEAELHF--P---AHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ---------HHHTCCCC--C---TTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---------HhhhccCC--c---ccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     11111111  1   1234578899999999999999999999863

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.3e-41  Score=305.01  Aligned_cols=259  Identities=22%  Similarity=0.346  Sum_probs=180.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-hh-HHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-KR-VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~-~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      .++|++.+.||+|+||.||+|... +|+.||+|++..... .. ...+..+..+++.++||||+++++++.. ....++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-NTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-CCcEEEE
Confidence            456888999999999999999775 789999999865532 22 2334445557888899999999998776 5689999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      |||+ ++.+..+....   ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++.+||+|||++......
T Consensus       103 ~e~~-~~~~~~l~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRM---QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             ECCC-SEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             Eecc-CCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999 55555555322   34689999999999999999999995 9999999999999999999999999998765432


Q ss_pred             ccccccCCCCCccccCccccc-----ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQ-----CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ..  .....+++.|+|||++.     +..++.++||||||+++|+|++|+.||.......     ..         ...+
T Consensus       179 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~-----~~---------~~~~  242 (318)
T 2dyl_A          179 KA--KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF-----EV---------LTKV  242 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH-----HH---------HHHH
T ss_pred             cc--ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH-----HH---------HHHH
Confidence            22  22345899999999884     4568899999999999999999999997532110     00         0111


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhhhcC
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDIESD  341 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i~~~  341 (375)
                      ......  ..+....++..+.+++.+||..+|.+|||+.++++.  +++....
T Consensus       243 ~~~~~~--~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (318)
T 2dyl_A          243 LQEEPP--LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETL  293 (318)
T ss_dssp             HHSCCC--CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHS
T ss_pred             hccCCC--CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcccc
Confidence            111000  000001234578999999999999999999999873  4444433

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.7e-42  Score=332.14  Aligned_cols=274  Identities=24%  Similarity=0.279  Sum_probs=203.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeec-----CCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSR-----HSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~  132 (375)
                      .++|++.+.||+|+||.||+|.. .+|+.||+|++... .....+.+.+|+.+++.++||||+++++++..     ....
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36899999999999999999966 46899999998654 44456778999999999999999999996543     2566


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCc---EEEeeeccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC---VKVADFGLS  209 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~---~kl~Dfg~~  209 (375)
                      .++||||+++++|.+++.... ....+++..++.++.|++.||.|||+.||+||||||+||+++.++.   +||+|||++
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a  171 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYA  171 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccc
Confidence            799999999999999997543 3346899999999999999999999999999999999999997665   999999999


Q ss_pred             cccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          210 RLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                      ........  .....+|+.|+|||.+.+..++.++||||||+++|+|++|..||.........     .. .+.......
T Consensus       172 ~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~-----~~-~i~~~~~~~  243 (676)
T 3qa8_A          172 KELDQGEL--CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW-----HG-KVREKSNEH  243 (676)
T ss_dssp             CBTTSCCC--CCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHS-----ST-TCC------
T ss_pred             cccccccc--cccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhh-----hh-hhhcccchh
Confidence            87654322  23456999999999999999999999999999999999999999643211100     00 000000000


Q ss_pred             -HHh----hhcCC-----CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHH-----HHHHHHhhhcCC
Q 017232          290 -LVD----QTLGY-----ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVD-----VLDALRDIESDG  342 (375)
Q Consensus       290 -~~~----~~l~~-----~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~e-----vl~~L~~i~~~~  342 (375)
                       ...    .....     .........+..+.+++.+||..||++|||+.+     +.+.++.+....
T Consensus       244 ~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~k  311 (676)
T 3qa8_A          244 IVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK  311 (676)
T ss_dssp             CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCCC
T ss_pred             hhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhcc
Confidence             000    00000     001111235678999999999999999999988     566677666544

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2e-40  Score=295.89  Aligned_cols=234  Identities=11%  Similarity=0.054  Sum_probs=183.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      .++|++.+.||+|+||.||+|... +++.||+|++....   ....+.+.+|+.++..++||||+++++++.. .+..|+
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-~~~~~l  108 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-RAGGLV  108 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-CCcEEE
Confidence            367999999999999999999765 58999999996542   3445778999999999999999999998776 577999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||++|++|.+++..     + ....++..++.|++.||.|||++||+||||||+|||++.++.+||++++        
T Consensus       109 v~e~~~g~~L~~~l~~-----~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~--------  174 (286)
T 3uqc_A          109 VAEWIRGGSLQEVADT-----S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA--------  174 (286)
T ss_dssp             EEECCCEEEHHHHHTT-----C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC--------
T ss_pred             EEEecCCCCHHHHHhc-----C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc--------
Confidence            9999999999999832     2 3556788999999999999999999999999999999999999998443        


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchh-HHHHHHhhhhHHHHHHhhh
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLS-NLAINKIQNKALHELVDQT  294 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  294 (375)
                                   |++       .++.++|||||||++|+|++|+.||............ ........  ...      
T Consensus       175 -------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~--~~~------  226 (286)
T 3uqc_A          175 -------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPI--EPA------  226 (286)
T ss_dssp             -------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBC--CHH------
T ss_pred             -------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCC--Chh------
Confidence                         223       3588999999999999999999999865432211000 00000000  000      


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCC
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGY  343 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~  343 (375)
                            .....++..+.+++.+||+.||++| |+.|+++.|+++.....
T Consensus       227 ------~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~~~  268 (286)
T 3uqc_A          227 ------DIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAVAD  268 (286)
T ss_dssp             ------HHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC---
T ss_pred             ------hcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhccCC
Confidence                  0001234678999999999999999 99999999999887654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=8.1e-41  Score=332.79  Aligned_cols=242  Identities=21%  Similarity=0.349  Sum_probs=194.5

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC--CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce---
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ--DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE---  132 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~---  132 (375)
                      ..++|++.+.||+|+||.||+|...  +|+.||||++... .......+.+|+.++..++||||+++++++...+..   
T Consensus        78 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           78 VAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             ETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             eCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            3478999999999999999999765  5899999998654 344556788999999999999999999977654332   


Q ss_pred             -eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          133 -LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       133 -~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                       .|+||||+++++|.+++..      .+++.+++.++.||+.||.|||++||+||||||+|||++.+ .+||+|||++..
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~------~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ------KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             EEEEEEECCCCEECC----C------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             eeEEEEEeCCCCcHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence             6999999999999887632      58999999999999999999999999999999999999885 899999999986


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ....     ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.........                   
T Consensus       231 ~~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~~-------------------  285 (681)
T 2pzi_A          231 INSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGLP-------------------  285 (681)
T ss_dssp             TTCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSCC-------------------
T ss_pred             cccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCccccccccc-------------------
Confidence            5433     334699999999988765 488999999999999999999988643211100                   


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC-HHHHHHHHHhhh
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY-MVDVLDALRDIE  339 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-~~evl~~L~~i~  339 (375)
                             ...........+.+++.+||+.||++||+ ++++...|..+.
T Consensus       286 -------~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  327 (681)
T 2pzi_A          286 -------EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVL  327 (681)
T ss_dssp             -------TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             -------ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHH
Confidence                   00111223457889999999999999995 666777777654

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.8e-40  Score=294.69  Aligned_cols=233  Identities=20%  Similarity=0.254  Sum_probs=177.4

Q ss_pred             hcCCCCC-CccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHH-HhcCCCCeEEEeeeeec---CCcee
Q 017232           60 TNYFDSA-RELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDIL-ARLRHKNLVSLYGCTSR---HSREL  133 (375)
Q Consensus        60 ~~~y~~~-~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~---~~~~~  133 (375)
                      .++|.+. +.||+|+||.||+|.. .+++.||+|++...     ..+.+|+.++ +.++||||+++++++..   .....
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~   90 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   90 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceE
Confidence            3557776 7799999999999966 47899999998543     3456788887 55689999999997653   35678


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC---CCcEEEeeecccc
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSR  210 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~  210 (375)
                      ++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.|++||||||+||+++.   ++.+||+|||++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~  168 (299)
T 3m2w_A           91 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  168 (299)
T ss_dssp             EEEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCE
T ss_pred             EEEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccc
Confidence            9999999999999999754  2346999999999999999999999999999999999999998   7889999999986


Q ss_pred             ccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ...                       +..++.++|||||||++|+|++|.+||.............   ..+.       
T Consensus       169 ~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~---~~~~-------  215 (299)
T 3m2w_A          169 ETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMK---TRIR-------  215 (299)
T ss_dssp             ECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSC---CSSC-------
T ss_pred             ccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHH---HHHh-------
Confidence            432                       1346789999999999999999999996543211000000   0000       


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                        .............++..+.+++.+||+.+|++|||+.|+++.
T Consensus       216 --~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          216 --MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             --TTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             --hccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence              000000001112345679999999999999999999999973

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.4e-40  Score=309.55  Aligned_cols=243  Identities=16%  Similarity=0.136  Sum_probs=180.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCC-CCe---------------E
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRH-KNL---------------V  120 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h-~ni---------------v  120 (375)
                      ..|+..+.||+|+||.||+|.. .+|+.||||++....   ....+.+.+|+.+++.++| .|.               +
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4577788999999999999974 479999999987332   2235678899999999977 221               1


Q ss_pred             EE------eeeeec----CCceeEEEEecccCCChhHhhccC---CCCCCCCChHHHHHHHHHHHHHHHHHhhCCceecc
Q 017232          121 SL------YGCTSR----HSRELLLVYEFISNGTVADHLHGE---RAKPGALPWPTRLKIAIETASALTYLHASDIIHRD  187 (375)
Q Consensus       121 ~~------~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~d  187 (375)
                      .+      ..+...    ....++++|+++ +++|.+++...   ......+++..++.++.|++.||.|||++||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            11      110111    022467788876 68898888422   22345578889999999999999999999999999


Q ss_pred             CCCCCEEecCCCcEEEeeeccccccCCCccccccCCCCCccccCcccc----------cccCCCCchhHHHHHHHHHHHH
Q 017232          188 VKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH----------QCYQLTDKSDVFSFGVVLIELI  257 (375)
Q Consensus       188 lkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----------~~~~~~~~~DiwslG~il~ell  257 (375)
                      |||+|||++.++.+||+|||++......    .....| +.|+|||++          .+..++.++|||||||++|+|+
T Consensus       237 iKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          237 LRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             CCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            9999999999999999999998765432    234457 999999998          5566888999999999999999


Q ss_pred             hCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          258 SSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       258 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      +|+.||..........                   ..+....     .++..+.+|+.+||+.+|++|||+.++++
T Consensus       312 tg~~Pf~~~~~~~~~~-------------------~~~~~~~-----~~~~~~~~li~~~l~~dP~~Rpt~~~~l~  363 (413)
T 3dzo_A          312 CADLPNTDDAALGGSE-------------------WIFRSCK-----NIPQPVRALLEGFLRYPKEDRLLPLQAME  363 (413)
T ss_dssp             HSSCCCCTTGGGSCSG-------------------GGGSSCC-----CCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HCCCCCCCcchhhhHH-------------------HHHhhcc-----cCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            9999997554222110                   0011000     12357899999999999999999877754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.6e-40  Score=299.70  Aligned_cols=241  Identities=18%  Similarity=0.205  Sum_probs=186.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccc--------hhhHHHHHHHHHHHHhcC---------CCCeEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENN--------YKRVEQFMNEVDILARLR---------HKNLVSL  122 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~niv~~  122 (375)
                      .++|++.+.||+|+||.||+|.. +|+.||||++....        ....+.+.+|+.+++.++         ||||+++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l   97 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL   97 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred             cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence            35688999999999999999987 68999999996542        223467889999999886         7777777


Q ss_pred             eeeee-----------------c------------CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHH
Q 017232          123 YGCTS-----------------R------------HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS  173 (375)
Q Consensus       123 ~~~~~-----------------~------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~  173 (375)
                      .+++.                 .            ....+++||||+++|++.+.+..     ..+++..++.++.||+.
T Consensus        98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-----~~~~~~~~~~i~~qi~~  172 (336)
T 2vuw_A           98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-----KLSSLATAKSILHQLTA  172 (336)
T ss_dssp             EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-----TCCCHHHHHHHHHHHHH
T ss_pred             cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-----cCCCHHHHHHHHHHHHH
Confidence            66432                 1            25679999999999987776632     45899999999999999


Q ss_pred             HHHHHh-hCCceeccCCCCCEEecCCC--------------------cEEEeeeccccccCCCccccccCCCCCccccCc
Q 017232          174 ALTYLH-ASDIIHRDVKTNNILLDNNF--------------------CVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP  232 (375)
Q Consensus       174 ~l~~Lh-~~~ivH~dlkp~Nill~~~~--------------------~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aP  232 (375)
                      ||.||| ++||+||||||+|||++.++                    .+||+|||+++.....      ...||+.|+||
T Consensus       173 aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aP  246 (336)
T 2vuw_A          173 SLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCS
T ss_pred             HHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccCh
Confidence            999999 99999999999999999887                    8999999999865432      23589999999


Q ss_pred             ccccccCCCCchhHHHHHHH-HHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh-c-CCCCChHHHHHHHH
Q 017232          233 EYHQCYQLTDKSDVFSFGVV-LIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT-L-GYESDNKVRRTINA  309 (375)
Q Consensus       233 E~~~~~~~~~~~DiwslG~i-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-l-~~~~~~~~~~~~~~  309 (375)
                      |++.+.. +.++||||+|++ .+++++|..||....         |.     ......+.... . ..........++.+
T Consensus       247 E~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~---------~~-----~~~~~~~~~~~~~~~~~~~~~~~~~s~~  311 (336)
T 2vuw_A          247 DLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVL---------WL-----HYLTDKMLKQMTFKTKCNTPAMKQIKRK  311 (336)
T ss_dssp             GGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHH---------HH-----HHHHHHHHHTCCCSSCCCSHHHHHHHHH
T ss_pred             hhhcCCC-ccceehhhhhCCCCcccccccCCCcchh---------hh-----hHHHHhhhhhhccCcccchhhhhhcCHH
Confidence            9998766 889999998777 777888999885210         00     00111111111 1 11223345567889


Q ss_pred             HHHHHHHhcCCCCCCCCCHHHHH
Q 017232          310 VAELAFQCLQSEKDLRPYMVDVL  332 (375)
Q Consensus       310 l~~li~~cl~~~P~~Rpt~~evl  332 (375)
                      +.+|+.+||+.+     |+.|++
T Consensus       312 ~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          312 IQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHGGGSS-----SHHHHH
T ss_pred             HHHHHHHHhccC-----CHHHHH
Confidence            999999999976     898887

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3.9e-33  Score=270.52  Aligned_cols=185  Identities=16%  Similarity=0.087  Sum_probs=127.3

Q ss_pred             ccCCCCcEEEEEE-EeCCCCEEEEEEeccc----------chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEE
Q 017232           68 ELGDGGFGTVYYG-ELQDGRAVAVKRLYEN----------NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        68 ~lg~G~~g~V~~~-~~~~~~~vaiK~~~~~----------~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ..+.|++|.+..+ +.-.|+.|++|++...          .....+.+.+|+++|+++ .|+||+++++++++ +...||
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed-~~~~yL  319 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGEN-AQSGWL  319 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEEC-SSEEEE
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEE-CCEEEE
Confidence            3566777766665 3335888999998543          123346799999999999 69999999997776 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||++|++|.+.+..    .++++..   .|+.||+.||+|+|++||+||||||+|||++.+|.+||+|||+++.....
T Consensus       320 VMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~  392 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQD  392 (569)
T ss_dssp             EEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC--
T ss_pred             EEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCC
Confidence            9999999999999953    3456553   58899999999999999999999999999999999999999999866543


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPA  262 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p  262 (375)
                      ... ....+||+.|+|||++.+ .+..++|+||+|++++++.++..+
T Consensus       393 ~~~-~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~  437 (569)
T 4azs_A          393 CSW-PTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSN  437 (569)
T ss_dssp             -CC-SHHHHHHHHHHHHHHC------------------CCCCTTHHH
T ss_pred             Ccc-ccCceechhhccHHHhCC-CCCCcccccccccchhhhccccch
Confidence            222 234569999999999986 467789999999998887665444

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=4.7e-29  Score=240.63  Aligned_cols=184  Identities=18%  Similarity=0.206  Sum_probs=140.1

Q ss_pred             CCCCccCCCCcEEEEEEEeCCCCEEEEEEecccch--------hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           64 DSARELGDGGFGTVYYGELQDGRAVAVKRLYENNY--------KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ...+.||+|+||.||++.. .+..+++|+......        ...+.+.+|+.++++++||||+++..++.. ....++
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~~~l  416 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVD-LDNKRI  416 (540)
T ss_dssp             ---------CCEEEEEEEC-SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEE-TTTTEE
T ss_pred             CCCCEEeeCCCEEEEEEEE-CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEe-CCccEE
Confidence            4467899999999999954 478899998643321        123458899999999999999944433333 445699


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++++|.+++..            +..++.|++.||.|||++||+||||||+|||++.  .+||+|||+++.....
T Consensus       417 VmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~  482 (540)
T 3en9_A          417 MMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD  482 (540)
T ss_dssp             EEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred             EEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence            9999999999999943            4589999999999999999999999999999998  9999999999877543


Q ss_pred             cccc------ccCCCCCccccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCc
Q 017232          216 VTHV------STAPQGTPGYVDPEYHQC--YQLTDKSDVFSFGVVLIELISSMPAV  263 (375)
Q Consensus       216 ~~~~------~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~p~  263 (375)
                      ....      .....||+.|+|||++.+  ..|+..+|+|+..+-.++-+.++.++
T Consensus       483 ~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          483 EDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             cccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            2211      123468999999999887  56788899999988888877766554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.3e-26  Score=204.01  Aligned_cols=153  Identities=14%  Similarity=0.073  Sum_probs=121.1

Q ss_pred             HHHHHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccch------------------hhHHHHHHHHHHHHhcC
Q 017232           54 GELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNY------------------KRVEQFMNEVDILARLR  115 (375)
Q Consensus        54 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~  115 (375)
                      ..+......|.+.+.||+|+||.||+|...+|+.||+|.+.....                  .....+.+|+.+++.++
T Consensus        83 ~~~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~  162 (282)
T 1zar_A           83 HRLVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ  162 (282)
T ss_dssp             HHHHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc
Confidence            334444556777899999999999999887799999999864321                  13456889999999999


Q ss_pred             CCCeEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEe
Q 017232          116 HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILL  195 (375)
Q Consensus       116 h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill  195 (375)
                        | +++.+++..  +..++||||++|++|.+ +..          .....++.|++.||.|||+.||+||||||+|||+
T Consensus       163 --~-~~v~~~~~~--~~~~lvmE~~~g~~L~~-l~~----------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl  226 (282)
T 1zar_A          163 --G-LAVPKVYAW--EGNAVLMELIDAKELYR-VRV----------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLV  226 (282)
T ss_dssp             --T-SSSCCEEEE--ETTEEEEECCCCEEGGG-CCC----------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred             --C-CCcCeEEec--cceEEEEEecCCCcHHH-cch----------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEE
Confidence              4 555554433  45699999999999988 411          2345799999999999999999999999999999


Q ss_pred             cCCCcEEEeeeccccccCCCccccccCCCCCccccCcccccc
Q 017232          196 DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC  237 (375)
Q Consensus       196 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  237 (375)
                      + ++.+||+|||++..              +..+.|||++..
T Consensus       227 ~-~~~vkl~DFG~a~~--------------~~~~~a~e~l~r  253 (282)
T 1zar_A          227 S-EEGIWIIDFPQSVE--------------VGEEGWREILER  253 (282)
T ss_dssp             E-TTEEEECCCTTCEE--------------TTSTTHHHHHHH
T ss_pred             E-CCcEEEEECCCCeE--------------CCCCCHHHHHHH
Confidence            9 99999999999863              344678887653

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=1.4e-21  Score=171.15  Aligned_cols=137  Identities=20%  Similarity=0.213  Sum_probs=106.5

Q ss_pred             CCCCCCccCCCCcEEEEEEEe-CCCCE--EEEEEecccchh------------------------hHHHHHHHHHHHHhc
Q 017232           62 YFDSARELGDGGFGTVYYGEL-QDGRA--VAVKRLYENNYK------------------------RVEQFMNEVDILARL  114 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~-~~~~~--vaiK~~~~~~~~------------------------~~~~~~~e~~~l~~l  114 (375)
                      -|.+.+.||+|+||.||+|.. .+|+.  ||||++......                        ....+.+|+.++..+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            367789999999999999977 67888  999986443111                        123578899999999


Q ss_pred             CCCCe--EEEeeeeecCCceeEEEEecccC-C----ChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHh-hCCceec
Q 017232          115 RHKNL--VSLYGCTSRHSRELLLVYEFISN-G----TVADHLHGERAKPGALPWPTRLKIAIETASALTYLH-ASDIIHR  186 (375)
Q Consensus       115 ~h~ni--v~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh-~~~ivH~  186 (375)
                      .|+++  ...++.     ...+|||||+.+ |    +|.+....       .++..+..++.|++.||.||| +.||+||
T Consensus       128 ~~~~i~~p~~~~~-----~~~~lVmE~~g~~g~~~~~L~~~~~~-------~~~~~~~~i~~qi~~~l~~lH~~~givHr  195 (258)
T 1zth_A          128 KEAGVSVPQPYTY-----MKNVLLMEFIGEDELPAPTLVELGRE-------LKELDVEGIFNDVVENVKRLYQEAELVHA  195 (258)
T ss_dssp             HHTTCCCCCEEEE-----ETTEEEEECCEETTEECCBHHHHGGG-------GGGSCHHHHHHHHHHHHHHHHHTSCEECS
T ss_pred             HhCCCCCCeEEEc-----CCCEEEEEecCCCCCccccHHHHhhc-------cChHHHHHHHHHHHHHHHHHHHHCCEEeC
Confidence            88754  333331     246899999942 3    66666522       235577899999999999999 9999999


Q ss_pred             cCCCCCEEecCCCcEEEeeecccccc
Q 017232          187 DVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       187 dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      ||||+|||++.  .++|+|||++...
T Consensus       196 Dlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          196 DLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             SCSTTSEEESS--SEEECCCTTCEET
T ss_pred             CCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999998  8999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.79  E-value=3.3e-20  Score=168.85  Aligned_cols=137  Identities=12%  Similarity=0.129  Sum_probs=101.7

Q ss_pred             CCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccch---------------hh-------HHHHHHHHHHHHhcCCCCe
Q 017232           62 YFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNY---------------KR-------VEQFMNEVDILARLRHKNL  119 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~---------------~~-------~~~~~~e~~~l~~l~h~ni  119 (375)
                      -|.+.++||.|++|.||+|...+|+.||||+++....               ..       .....+|...|.++.+.++
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv  175 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF  175 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            4999999999999999999988999999998743210               00       0112356777777754433


Q ss_pred             E--EEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          120 V--SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       120 v--~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      .  ..++ +.    ..+|||||++|++|..+..          ......++.|++.+|.+||+.|||||||||.|||+++
T Consensus       176 ~vp~p~~-~~----~~~LVME~i~G~~L~~l~~----------~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~  240 (397)
T 4gyi_A          176 PVPEPIA-QS----RHTIVMSLVDALPMRQVSS----------VPDPASLYADLIALILRLAKHGLIHGDFNEFNILIRE  240 (397)
T ss_dssp             SCCCEEE-EE----TTEEEEECCSCEEGGGCCC----------CSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEE
T ss_pred             CCCeeee-cc----CceEEEEecCCccHhhhcc----------cHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeC
Confidence            2  2222 11    2379999999988876541          1234678899999999999999999999999999987


Q ss_pred             CC----------cEEEeeeccccccC
Q 017232          198 NF----------CVKVADFGLSRLFP  213 (375)
Q Consensus       198 ~~----------~~kl~Dfg~~~~~~  213 (375)
                      ++          .+.|+||+.+....
T Consensus       241 dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          241 EKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             CCCcccccccccceEEEEeCCcccCC
Confidence            76          38999999887543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.48  E-value=1.7e-13  Score=119.93  Aligned_cols=143  Identities=13%  Similarity=0.070  Sum_probs=110.9

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEE
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~l  135 (375)
                      ......|++...++.|+.+.||++... +..+++|............+.+|+.+++.+. +..+.+++++... .+..++
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-~~~~~l   87 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWSNL   87 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-CCceEE
Confidence            344567888888999999999999765 6889999986532222345788999999985 5667778876554 567899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-----------------------------------
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-----------------------------------  180 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-----------------------------------  180 (375)
                      ||||++|.+|.+.+.         +......++.+++.+|..||+                                   
T Consensus        88 v~e~i~G~~l~~~~~---------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEYE---------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHCC---------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhccC---------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            999999999987641         122345788899999999998                                   


Q ss_pred             ------------------------CCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          181 ------------------------SDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       181 ------------------------~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                                              ..++|+|++|.||+++++..+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                    348999999999999876666799999764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.31  E-value=2.4e-12  Score=112.38  Aligned_cols=132  Identities=17%  Similarity=0.167  Sum_probs=95.4

Q ss_pred             CCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCe--EEEeeeeecCCceeEEEEecc
Q 017232           63 FDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL--VSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        63 y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~lv~e~~  140 (375)
                      |.+....+.|..+.||++...+|..+++|.....   ....+.+|+.+++.+.+.++  .+++++... ++..++||||+
T Consensus        22 ~~~~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~-~~~~~~v~e~i   97 (264)
T 1nd4_A           22 YDWAQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEV   97 (264)
T ss_dssp             CEEEECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECC
T ss_pred             CceEecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccC-CCCCEEEEEec
Confidence            4433333466679999998777888999987544   22456789999998865444  447765544 45689999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC--------------------------------------
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--------------------------------------  182 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--------------------------------------  182 (375)
                      +|.+|.  ...       ..   ...++.+++..|..||+..                                      
T Consensus        98 ~G~~l~--~~~-------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (264)
T 1nd4_A           98 PGQDLL--SSH-------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGL  165 (264)
T ss_dssp             SSEETT--TSC-------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTC
T ss_pred             CCcccC--cCc-------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCc
Confidence            998874  210       11   2356677778888888643                                      


Q ss_pred             --------------------ceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          183 --------------------IIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       183 --------------------ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                                          ++|+|++|.||++++++.+.|+||+.+.
T Consensus       166 ~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          166 APAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             CHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcc
Confidence                                9999999999999887667799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.16  E-value=7.7e-11  Score=107.91  Aligned_cols=140  Identities=16%  Similarity=0.244  Sum_probs=103.0

Q ss_pred             CCCccCCCCcEEEEEEEeCCCCEEEEEEec--ccc-hhhHHHHHHHHHHHHhcCC--CCeEEEeeeeecCC--ceeEEEE
Q 017232           65 SARELGDGGFGTVYYGELQDGRAVAVKRLY--ENN-YKRVEQFMNEVDILARLRH--KNLVSLYGCTSRHS--RELLLVY  137 (375)
Q Consensus        65 ~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~--~~~-~~~~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~--~~~~lv~  137 (375)
                      ..+.|+.|.++.||+....+ ..+++|+..  ... ......+.+|+.+++.+..  ..+.+++.++....  +..++||
T Consensus        42 ~~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vm  120 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIM  120 (359)
T ss_dssp             EEEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEE
T ss_pred             eEEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEE
Confidence            45679999999999998764 678888765  322 1233567889999999973  44667777554421  3478999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-------------------------------------
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-------------------------------------  180 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-------------------------------------  180 (375)
                      ||++|..+.+..      ...++..+...++.+++.+|..||+                                     
T Consensus       121 e~v~G~~l~~~~------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (359)
T 3dxp_A          121 EFVSGRVLWDQS------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESI  194 (359)
T ss_dssp             ECCCCBCCCCTT------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCC
T ss_pred             EecCCeecCCCc------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCC
Confidence            999988775422      1236778888999999999999997                                     


Q ss_pred             ---------------------CCceeccCCCCCEEecCCCc--EEEeeeccccc
Q 017232          181 ---------------------SDIIHRDVKTNNILLDNNFC--VKVADFGLSRL  211 (375)
Q Consensus       181 ---------------------~~ivH~dlkp~Nill~~~~~--~kl~Dfg~~~~  211 (375)
                                           ..++|+|+++.||+++.++.  +.|+||+.+..
T Consensus       195 ~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          195 PAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             hHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                 35899999999999987753  68999998864

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.08  E-value=6.1e-11  Score=105.98  Aligned_cols=185  Identities=19%  Similarity=0.198  Sum_probs=118.4

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CCC--eEEEeeeeecCC--ceeEEEEecc
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKN--LVSLYGCTSRHS--RELLLVYEFI  140 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~n--iv~~~~~~~~~~--~~~~lv~e~~  140 (375)
                      .+.++.|....||+..    ..+++|+....  .....+.+|+.+++.+. +..  +..++.......  ...|+||+++
T Consensus        25 i~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i   98 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKI   98 (304)
T ss_dssp             CCEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECC
T ss_pred             eEecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEccc
Confidence            4568999999999864    45899976433  34567889999998884 322  223333222211  2347899999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh----------------------------------------
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA----------------------------------------  180 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~----------------------------------------  180 (375)
                      +|.+|.+...      ..++..+...++.+++..+..||+                                        
T Consensus        99 ~G~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  172 (304)
T 3sg8_A           99 KGVPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKK  172 (304)
T ss_dssp             CCEECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHH
T ss_pred             CCeECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHH
Confidence            9988875432      125667777788888888888885                                        


Q ss_pred             ------------------CCceeccCCCCCEEecC--CCcEEEeeeccccccCCCccccccCCCCCccccCcccc----c
Q 017232          181 ------------------SDIIHRDVKTNNILLDN--NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYH----Q  236 (375)
Q Consensus       181 ------------------~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~----~  236 (375)
                                        ..++|+|++|.||+++.  +..+.|+||+.+......... ....... .-..|+..    .
T Consensus       173 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl-~~~~~~~-~~~~~~~~~~~l~  250 (304)
T 3sg8_A          173 VDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDF-ISLMEDD-EEYGMEFVSKILN  250 (304)
T ss_dssp             HHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHH-HTTCCTT-TSCCHHHHHHHHH
T ss_pred             HHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHH-HHHHhhc-cccCHHHHHHHHH
Confidence                              13799999999999998  556889999988653221110 0000000 00122211    1


Q ss_pred             ccC----------CCCchhHHHHHHHHHHHHhCCCCcc
Q 017232          237 CYQ----------LTDKSDVFSFGVVLIELISSMPAVD  264 (375)
Q Consensus       237 ~~~----------~~~~~DiwslG~il~elltg~~p~~  264 (375)
                      ...          .....+.|+++.++|.+.+|.++|-
T Consensus       251 ~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          251 HYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             HHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             HcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            111          0112689999999999999987663

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.74  E-value=1.1e-07  Score=84.91  Aligned_cols=134  Identities=16%  Similarity=0.203  Sum_probs=90.6

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCC---CeEEEeeeeecCCceeEEEEecccC
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHK---NLVSLYGCTSRHSRELLLVYEFISN  142 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~lv~e~~~~  142 (375)
                      .+.++.|....||+.    |..+++|+..  .......+.+|..+|+.+.+.   .+.+.+.+.....+..++|||+++|
T Consensus        24 v~~l~~G~~n~v~~v----g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G   97 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQG   97 (306)
T ss_dssp             EEEEEECSSEEEEEE----TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCS
T ss_pred             eeecCCCcceeEEEE----CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCC
Confidence            456888999999988    5678889743  233456788999999999742   2344444443334557899999999


Q ss_pred             CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-----------------------------------------
Q 017232          143 GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-----------------------------------------  181 (375)
Q Consensus       143 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-----------------------------------------  181 (375)
                      .++......      .++..+...++.++...|..||+.                                         
T Consensus        98 ~~l~~~~~~------~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~  171 (306)
T 3tdw_A           98 QILGEDGMA------VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDY  171 (306)
T ss_dssp             EECHHHHHT------TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHH
T ss_pred             eECchhhhh------hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHH
Confidence            888763211      134444444555555555555432                                         


Q ss_pred             -------------------CceeccCCCCCEEecC---CCc-EEEeeeccccc
Q 017232          182 -------------------DIIHRDVKTNNILLDN---NFC-VKVADFGLSRL  211 (375)
Q Consensus       182 -------------------~ivH~dlkp~Nill~~---~~~-~kl~Dfg~~~~  211 (375)
                                         .++|+|++|.||+++.   ++. +.|+||+.+..
T Consensus       172 l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          172 LTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                               3599999999999987   455 58999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.49  E-value=1.2e-06  Score=76.43  Aligned_cols=130  Identities=18%  Similarity=0.132  Sum_probs=91.3

Q ss_pred             cCCCCcE-EEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCceeEEEEecccCCCh
Q 017232           69 LGDGGFG-TVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTV  145 (375)
Q Consensus        69 lg~G~~g-~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~lv~e~~~~~~L  145 (375)
                      +..|..| .||+.... ++..+++|+-...   ....+.+|...|+.+. +--+.++++++.. .+..++|||+++|.++
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-~~~~~lvme~l~G~~~  107 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRT-PDDAWLLTTAIPGKTA  107 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEEEEEEECCCSEEH
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEE-CCeEEEEEEeeCCccc
Confidence            4445444 68988655 4677999975433   3456788999998885 2224455655544 5678999999999888


Q ss_pred             hHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC--------------------------------------------
Q 017232          146 ADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS--------------------------------------------  181 (375)
Q Consensus       146 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~--------------------------------------------  181 (375)
                      .+....        .......++.++...|..||+.                                            
T Consensus       108 ~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (272)
T 4gkh_A          108 FQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV  179 (272)
T ss_dssp             HHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred             cccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence            776532        1223345667777777777741                                            


Q ss_pred             --------------CceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          182 --------------DIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       182 --------------~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                                    .++|+|+.+.||++++++.+-|+||+.+.
T Consensus       180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccc
Confidence                          27999999999999988777899999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.42  E-value=3.3e-07  Score=83.51  Aligned_cols=82  Identities=2%  Similarity=-0.007  Sum_probs=52.5

Q ss_pred             CCcc-CCCCcEEEEEEEeC-------CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcC-C--CCeEEEeeeeecCC-
Q 017232           66 AREL-GDGGFGTVYYGELQ-------DGRAVAVKRLYENN---YKRVEQFMNEVDILARLR-H--KNLVSLYGCTSRHS-  130 (375)
Q Consensus        66 ~~~l-g~G~~g~V~~~~~~-------~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~-  130 (375)
                      .+.| +.|....+|+....       ++..+++|......   ......+.+|+.+++.+. +  -.+.+++.+..... 
T Consensus        25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~  104 (357)
T 3ats_A           25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV  104 (357)
T ss_dssp             EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred             EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence            3557 88999999998654       26688999764332   101234667888888774 2  23555666443321 


Q ss_pred             -ceeEEEEecccCCChhH
Q 017232          131 -RELLLVYEFISNGTVAD  147 (375)
Q Consensus       131 -~~~~lv~e~~~~~~L~~  147 (375)
                       +..++|||+++|.++.+
T Consensus       105 ~g~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          105 LGTPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             TSSCEEEEECCCCBCCCB
T ss_pred             cCCceEEEEecCCCChhh
Confidence             34689999999876653

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.23  E-value=9.6e-06  Score=73.13  Aligned_cols=139  Identities=20%  Similarity=0.265  Sum_probs=76.6

Q ss_pred             CccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-----CCCeEEEe-e-eeecCCceeEEEEec
Q 017232           67 RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-----HKNLVSLY-G-CTSRHSRELLLVYEF  139 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv~~~-~-~~~~~~~~~~lv~e~  139 (375)
                      +.|+.|..+.||+....+| .+++|+.... .   ..+..|..+++.+.     .|.++... + .+....+..+++|+|
T Consensus        38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~-~---~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~  112 (346)
T 2q83_A           38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP-E---KKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW  112 (346)
T ss_dssp             EECC----CEEEEEEETTE-EEEEEEECSC-H---HHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred             eeccccccCcEEEEEeCCC-CEEEEecCCC-H---HHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence            3466677899999987655 4899988652 2   22334555555442     34444311 1 111124567899999


Q ss_pred             ccCCChh--------------HhhccCCC-C--C-------CCCChHHH-------------------------------
Q 017232          140 ISNGTVA--------------DHLHGERA-K--P-------GALPWPTR-------------------------------  164 (375)
Q Consensus       140 ~~~~~L~--------------~~l~~~~~-~--~-------~~l~~~~~-------------------------------  164 (375)
                      ++|.++.              ..++.... .  .       ..-.|...                               
T Consensus       113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  192 (346)
T 2q83_A          113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI  192 (346)
T ss_dssp             CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred             ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence            9986542              11111100 0  0       00112110                               


Q ss_pred             HHHHHHHHHHHHHHh-------------hCCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          165 LKIAIETASALTYLH-------------ASDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       165 ~~i~~~i~~~l~~Lh-------------~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      ..+...+..++.+|+             ..+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            011112334555665             3579999999999999888889999999774

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.20  E-value=2.7e-06  Score=78.63  Aligned_cols=75  Identities=21%  Similarity=0.226  Sum_probs=47.6

Q ss_pred             CCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-------hhHHHHHHHHHHHHhcCC--CCe-EEEeeeeecCCceeE
Q 017232           66 ARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-------KRVEQFMNEVDILARLRH--KNL-VSLYGCTSRHSRELL  134 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-------~~~~~~~~e~~~l~~l~h--~ni-v~~~~~~~~~~~~~~  134 (375)
                      .+.||.|..+.||++... +++.+++|.......       .....+..|.++++.+..  +.. .+++.+ .  ....+
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~-d--~~~~~  111 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D--TEMAV  111 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E--TTTTE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE-c--CCccE
Confidence            457999999999999654 468899997643211       112345678888887742  333 344442 2  23457


Q ss_pred             EEEecccCC
Q 017232          135 LVYEFISNG  143 (375)
Q Consensus       135 lv~e~~~~~  143 (375)
                      +|||++++.
T Consensus       112 lvmE~l~g~  120 (397)
T 2olc_A          112 TVMEDLSHL  120 (397)
T ss_dssp             EEECCCTTS
T ss_pred             EEEEeCCCc
Confidence            999999764

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.12  E-value=5.8e-06  Score=72.81  Aligned_cols=79  Identities=22%  Similarity=0.178  Sum_probs=56.3

Q ss_pred             CCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCC---CeEEEeeeeecCCceeEEEEe
Q 017232           62 YFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHK---NLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .....+.+|.|..+.||+.+..+|+.|++|+...........+..|+..|+.+...   -+.++++. .  .  -++|||
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~-~--~--~~lv~e   90 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW-D--D--RTLAME   90 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE-E--T--TEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec-c--C--ceEEEE
Confidence            34456779999999999999999999999987554443345678899999988422   23344432 1  1  378999


Q ss_pred             cccCCCh
Q 017232          139 FISNGTV  145 (375)
Q Consensus       139 ~~~~~~L  145 (375)
                      |+.++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9987643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.94  E-value=2.4e-05  Score=69.91  Aligned_cols=158  Identities=14%  Similarity=0.174  Sum_probs=85.1

Q ss_pred             ccchHHHHHHhcCCCC-----CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCC--eEEE
Q 017232           50 VFSYGELEEATNYFDS-----ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN--LVSL  122 (375)
Q Consensus        50 ~~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~  122 (375)
                      .++..++......|.+     .+.|+.|....+|+....+| .+++|......  ....+..|+.++..+...+  +.++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~~--~~~~l~~e~~~l~~L~~~g~~vP~~   82 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLP   82 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCB
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCCC--CHHHHHHHHHHHHHHHHCCCCCCcc
Confidence            3455566666666765     23467788899999987765 68899876521  1124456777776664212  2222


Q ss_pred             eee-----eecCCceeEEEEecccCCChhH--------------hhccCC-C-C-C--CCCC---hHHHHH---------
Q 017232          123 YGC-----TSRHSRELLLVYEFISNGTVAD--------------HLHGER-A-K-P--GALP---WPTRLK---------  166 (375)
Q Consensus       123 ~~~-----~~~~~~~~~lv~e~~~~~~L~~--------------~l~~~~-~-~-~--~~l~---~~~~~~---------  166 (375)
                      +..     +....+..+++|+|++|..+..              .++... . . .  ....   |...+.         
T Consensus        83 ~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~  162 (322)
T 2ppq_A           83 LPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEV  162 (322)
T ss_dssp             CCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGT
T ss_pred             cCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhh
Confidence            211     1111345689999998865321              111110 0 0 0  0011   111000         


Q ss_pred             ---HHHHHHHHHHHHhh-------CCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          167 ---IAIETASALTYLHA-------SDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       167 ---i~~~i~~~l~~Lh~-------~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                         +...+...++.+..       .+++|+|+.+.||++++++.+.|+||+.+.
T Consensus       163 ~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          163 EKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             STTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence               00113334455542       369999999999999987666899999775

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.88  E-value=9e-05  Score=61.10  Aligned_cols=98  Identities=13%  Similarity=0.107  Sum_probs=65.2

Q ss_pred             CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccccc
Q 017232          143 GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST  221 (375)
Q Consensus       143 ~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  221 (375)
                      .+|.+.|..   .+.++++.++|.++.|.+.+|.-+-. +.-..+=+.|..|++..+|.+-+.+ +.+.           
T Consensus        33 vSL~eIL~~---~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRL---YNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHH---cCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------
Confidence            478888854   35689999999999999999887722 1112333457899999999988764 1110           


Q ss_pred             CCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh
Q 017232          222 APQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS  258 (375)
Q Consensus       222 ~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt  258 (375)
                        .....+.|||... ...+.+.=|||||+++|.-+-
T Consensus        98 --~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 --AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             -----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred             --ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence              1223456788654 345678899999999999885

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.80  E-value=5.7e-05  Score=70.28  Aligned_cols=80  Identities=15%  Similarity=0.096  Sum_probs=46.8

Q ss_pred             hhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccccCCCCCccccCccccccc---CCCCchhHHHHHHHHHH
Q 017232          179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY---QLTDKSDVFSFGVVLIE  255 (375)
Q Consensus       179 h~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~DiwslG~il~e  255 (375)
                      +...++|+|++|.|||++.++ +.++||+.+..-............-...|++|+.....   ......++......+|+
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWN  308 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHH
Confidence            456799999999999998877 99999998864321100000000011235555544311   11123455677778887


Q ss_pred             HHhC
Q 017232          256 LISS  259 (375)
Q Consensus       256 lltg  259 (375)
                      .+++
T Consensus       309 ~y~~  312 (420)
T 2pyw_A          309 LFNK  312 (420)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7764

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.68  E-value=0.00051  Score=60.93  Aligned_cols=75  Identities=21%  Similarity=0.217  Sum_probs=55.5

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC---CCCeEEEeeeeecCCceeEEEEecccC
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR---HKNLVSLYGCTSRHSRELLLVYEFISN  142 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~lv~e~~~~  142 (375)
                      .+.|+.|....+|+.... +..+++|+....   ....+..|...|+.+.   ...+.+++..... .+..++||||+++
T Consensus        41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~-~g~~~lvme~l~G  115 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLINDE-VQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNS-QGHSFLLLEALNK  115 (312)
T ss_dssp             EEEECCSSSSEEEEEESS-SCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEEC-SSEEEEEEECCCC
T ss_pred             eEEeCCccceeeeEEEEC-CCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeec-CCceEEEEEeccC
Confidence            467899999999999764 678899976533   2456788988888884   2456666664443 4668999999998


Q ss_pred             CCh
Q 017232          143 GTV  145 (375)
Q Consensus       143 ~~L  145 (375)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            764

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.63  E-value=0.00072  Score=60.36  Aligned_cols=160  Identities=17%  Similarity=0.140  Sum_probs=87.6

Q ss_pred             ccccchHHHHHHhcCCCC-----CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCC--eE
Q 017232           48 VQVFSYGELEEATNYFDS-----ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN--LV  120 (375)
Q Consensus        48 ~~~~~~~~~~~~~~~y~~-----~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv  120 (375)
                      +...+...+......|.+     ...++ |....||+....+|+.+++|....... ....+..|..++..+....  +.
T Consensus         8 ~~~l~~~~i~~~l~~~g~~~~~~~~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~~~-~~~~~~~E~~~~~~L~~~g~~vp   85 (328)
T 1zyl_A            8 FQTLHPDTIMDALFEHGIRVDSGLTPLN-SYENRVYQFQDEDRRRFVVKFYRPERW-TADQILEEHQFALQLVNDEVPVA   85 (328)
T ss_dssp             CCCCCHHHHHHHHHHTTCCCCSCCEEEC-CSSSEEEEECCTTCCCEEEEEECTTTS-CHHHHHHHHHHHHHHHHTTCSBC
T ss_pred             CCCCCHHHHHHHHHHcCCCCCceEEeec-CcccceEEEEcCCCCEEEEEEcCCCCC-CHHHHHHHHHHHHHHHHcCCeec
Confidence            444555555544444432     23466 888899998877787899998863321 2345666777777774222  33


Q ss_pred             EEeee----eecCCceeEEEEecccCCChhH--------------hhcc----CCC-CCCCCChHHH-------------
Q 017232          121 SLYGC----TSRHSRELLLVYEFISNGTVAD--------------HLHG----ERA-KPGALPWPTR-------------  164 (375)
Q Consensus       121 ~~~~~----~~~~~~~~~lv~e~~~~~~L~~--------------~l~~----~~~-~~~~l~~~~~-------------  164 (375)
                      +++..    .....+..+++|++++|.++..              .++.    ... .....++...             
T Consensus        86 ~~~~~~g~~~~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  165 (328)
T 1zyl_A           86 APVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATL  165 (328)
T ss_dssp             CCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSS
T ss_pred             ceeecCCcEEEEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCc
Confidence            33332    0111345678999998754320              0111    000 0011111110             


Q ss_pred             ---------HHHHHHHHHHHHHH----hhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          165 ---------LKIAIETASALTYL----HASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       165 ---------~~i~~~i~~~l~~L----h~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                               ...+..++..+..+    ....++|+|+++.||+++ + .+.|+||+.+..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          166 IPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             SCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence                     11122222222222    234589999999999998 4 899999987753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.61  E-value=0.00016  Score=64.00  Aligned_cols=71  Identities=11%  Similarity=0.039  Sum_probs=42.7

Q ss_pred             CCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCe-EEEeeeeecCCceeEEEEecc-cCC
Q 017232           66 ARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL-VSLYGCTSRHSRELLLVYEFI-SNG  143 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~-~~~  143 (375)
                      .+.|+.|....+|+.     ..+++|+....... .....+|+.+++.+...++ .++++..   ...-++++||+ +|.
T Consensus        23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~~---~~~~~~v~e~i~~g~   93 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHVD---PATGVMVTRYIAGAQ   93 (301)
T ss_dssp             CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEEC---TTTCCEEEECCTTCE
T ss_pred             eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEEE---CCCCEEEEeecCCCc
Confidence            677999999999998     55888977543211 1123457777777642222 3444432   22236899999 665


Q ss_pred             Ch
Q 017232          144 TV  145 (375)
Q Consensus       144 ~L  145 (375)
                      ++
T Consensus        94 ~l   95 (301)
T 3dxq_A           94 TM   95 (301)
T ss_dssp             EC
T ss_pred             cC
Confidence            44

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.50  E-value=0.0004  Score=62.23  Aligned_cols=31  Identities=32%  Similarity=0.410  Sum_probs=27.1

Q ss_pred             CCceeccCCCCCEEecCC----CcEEEeeeccccc
Q 017232          181 SDIIHRDVKTNNILLDNN----FCVKVADFGLSRL  211 (375)
Q Consensus       181 ~~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~  211 (375)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            469999999999999874    6799999998864

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.48  E-value=0.00037  Score=64.89  Aligned_cols=73  Identities=18%  Similarity=0.289  Sum_probs=48.2

Q ss_pred             CCccCCCCcEEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCe-EEEeeeeecCCceeEEE
Q 017232           66 ARELGDGGFGTVYYGELQD--------GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL-VSLYGCTSRHSRELLLV  136 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv  136 (375)
                      .+.|+.|....+|++...+        +..+++|+......  ...+..|..+++.+...++ .++++.+.  +   .+|
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~--~~~li~E~~~l~~L~~~g~~P~l~~~~~--~---g~v  150 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPET--ESHLVAESVIFTLLSERHLGPKLYGIFS--G---GRL  150 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCC--HHHHHHHHHHHHHHHHTTSSSCEEEEET--T---EEE
T ss_pred             EEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCc--HHHHHHHHHHHHHHHhCCCCCcEEEEeC--C---CEE
Confidence            4568889999999997653        57899998743221  1345578888888853333 45555432  2   289


Q ss_pred             EecccCCCh
Q 017232          137 YEFISNGTV  145 (375)
Q Consensus       137 ~e~~~~~~L  145 (375)
                      +||++|.+|
T Consensus       151 ~e~l~G~~l  159 (429)
T 1nw1_A          151 EEYIPSRPL  159 (429)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeCCccc
Confidence            999986444

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.37  E-value=0.00041  Score=63.26  Aligned_cols=140  Identities=19%  Similarity=0.251  Sum_probs=80.3

Q ss_pred             CCccCCCCcEEEEEEEeC--------CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCe-EEEeeeeecCCceeEEE
Q 017232           66 ARELGDGGFGTVYYGELQ--------DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL-VSLYGCTSRHSRELLLV  136 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~--------~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv  136 (375)
                      .+.|..|....+|+....        ++..+++|+... .........+|..+++.+...++ .++++++..     .+|
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-----g~v  128 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE-----GRL  128 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-----EEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-----ccE
Confidence            456777888889998764        247899998533 22234556689999888852222 445554332     289


Q ss_pred             EecccCCChhHh-----------------hccCCCC-CCCC--ChHHHHHHHHHHHH-------------------HHHH
Q 017232          137 YEFISNGTVADH-----------------LHGERAK-PGAL--PWPTRLKIAIETAS-------------------ALTY  177 (375)
Q Consensus       137 ~e~~~~~~L~~~-----------------l~~~~~~-~~~l--~~~~~~~i~~~i~~-------------------~l~~  177 (375)
                      |||++|.+|..-                 ++..... ....  .+.++..+..++..                   .+..
T Consensus       129 ~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  208 (379)
T 3feg_A          129 EQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGN  208 (379)
T ss_dssp             EECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHH
T ss_pred             EEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHH
Confidence            999998655311                 1111110 1111  23445555444322                   1223


Q ss_pred             H----hhC----CceeccCCCCCEEecCC----CcEEEeeeccccc
Q 017232          178 L----HAS----DIIHRDVKTNNILLDNN----FCVKVADFGLSRL  211 (375)
Q Consensus       178 L----h~~----~ivH~dlkp~Nill~~~----~~~kl~Dfg~~~~  211 (375)
                      |    ...    .++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       209 L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          209 LRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            3    222    58999999999999876    7899999998753

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.22  E-value=0.00055  Score=62.33  Aligned_cols=74  Identities=8%  Similarity=0.114  Sum_probs=42.8

Q ss_pred             CCccCCCCcEEEEEEEeCC---------CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCe-EEEeeeeecCCceeEE
Q 017232           66 ARELGDGGFGTVYYGELQD---------GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL-VSLYGCTSRHSRELLL  135 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~---------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~l  135 (375)
                      ...|+.|....+|+....+         +..+++|+..... ........|..+++.+...++ .++++.. .    -++
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-~----~~~  111 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF-N----GGR  111 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE-T----TEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec-C----CcE
Confidence            3467888889999997654         2688888764432 211123567778777753333 3455432 2    268


Q ss_pred             EEecccCCCh
Q 017232          136 VYEFISNGTV  145 (375)
Q Consensus       136 v~e~~~~~~L  145 (375)
                      ||||++|.++
T Consensus       112 v~e~i~G~~l  121 (369)
T 3c5i_A          112 IEEWLYGDPL  121 (369)
T ss_dssp             EEECCCSEEC
T ss_pred             EEEEecCCcC
Confidence            9999987543

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.21  E-value=0.0019  Score=58.03  Aligned_cols=30  Identities=23%  Similarity=0.438  Sum_probs=27.0

Q ss_pred             CceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          182 DIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       182 ~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      .++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            699999999999999888899999987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=96.92  E-value=0.0044  Score=57.97  Aligned_cols=74  Identities=12%  Similarity=0.049  Sum_probs=46.2

Q ss_pred             CCccCCCCcEEEEEEEeCC-CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCe-EEEeeeeecCCceeEEEEecccCC
Q 017232           66 ARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL-VSLYGCTSRHSRELLLVYEFISNG  143 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~-~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv~e~~~~~  143 (375)
                      .+.|+.|....+|+....+ +..+++|+..... ...-.-.+|..+++.|...++ .++++.+ . +   .+||||++|.
T Consensus       113 i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~-~~~idR~~E~~vl~~L~~~gl~P~ll~~~-~-~---G~v~e~I~G~  186 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDMSKQAKYLIRLYGPKT-DEIINREREKKISCILYNKNIAKKIYVFF-T-N---GRIEEFMDGY  186 (458)
T ss_dssp             EEEECC--CEEEEEEEETTTTEEEEEEEECC-C-CSCSCHHHHHHHHHHHTTSSSBCCEEEEE-T-T---EEEEECCCSE
T ss_pred             EEEcCCCeEeEEEEEEECCCCceEEEEECCCCh-hhhcCHHHHHHHHHHHHhcCCCCCEEEEe-C-C---eEEEEeeCCc
Confidence            3467888889999998764 4788898764322 111112478889998875555 3556544 2 2   2599999875


Q ss_pred             Ch
Q 017232          144 TV  145 (375)
Q Consensus       144 ~L  145 (375)
                      +|
T Consensus       187 ~l  188 (458)
T 2qg7_A          187 AL  188 (458)
T ss_dssp             EC
T ss_pred             cC
Confidence            54

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.45  E-value=0.0048  Score=57.01  Aligned_cols=74  Identities=11%  Similarity=0.108  Sum_probs=46.6

Q ss_pred             CCccCCCCcEEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCe-EEEeeeeecCCceeEEE
Q 017232           66 ARELGDGGFGTVYYGELQD--------GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL-VSLYGCTSRHSRELLLV  136 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv  136 (375)
                      .+.+..|-...+|+....+        +..+++++..... ...-+..+|..+++.+...++ .++++.+ .    -++|
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~-~----~~~I  148 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF-P----EGRI  148 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE-T----TEEE
T ss_pred             EEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc-C----CCEE
Confidence            4567788889999997753        5789999864332 111223568888877752223 3444422 2    2689


Q ss_pred             EecccCCCh
Q 017232          137 YEFISNGTV  145 (375)
Q Consensus       137 ~e~~~~~~L  145 (375)
                      |||++|.+|
T Consensus       149 ~efI~G~~l  157 (424)
T 3mes_A          149 EEFIDGEPL  157 (424)
T ss_dssp             EECCCSEEC
T ss_pred             EEEeCCccC
Confidence            999998654

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.32  E-value=0.073  Score=48.81  Aligned_cols=29  Identities=31%  Similarity=0.456  Sum_probs=24.8

Q ss_pred             ceeccCCCCCEEe------cCCCcEEEeeeccccc
Q 017232          183 IIHRDVKTNNILL------DNNFCVKVADFGLSRL  211 (375)
Q Consensus       183 ivH~dlkp~Nill------~~~~~~kl~Dfg~~~~  211 (375)
                      ++|+|+.+.|||+      +++..+.++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      4567799999988753

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=90.65  E-value=0.91  Score=37.26  Aligned_cols=116  Identities=9%  Similarity=0.134  Sum_probs=76.2

Q ss_pred             CCCCeEEEeeeeecCCceeEEEEecccCC-ChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCE
Q 017232          115 RHKNLVSLYGCTSRHSRELLLVYEFISNG-TVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNI  193 (375)
Q Consensus       115 ~h~niv~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Ni  193 (375)
                      .||++++. .+... .+.+.+.++.-+.+ ++.. +       ..++....+.++.+|+....+++  .-+|--++|+|+
T Consensus        43 ~~~~Fl~~-~I~e~-eD~v~~~y~~~~~~~~f~~-i-------k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P~NL  110 (215)
T 4ann_A           43 HSPYFIDA-ELTEL-RDSFQIHYDINDNHTPFDN-I-------KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAPDEL  110 (215)
T ss_dssp             CCTTBCCE-EEEEC-SSEEEEEECCCTTSEEGGG-G-------GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSGGGE
T ss_pred             cCCcccce-EEEEc-ccEEEEEEEcCcccCCHHH-H-------HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEecceE
Confidence            58888865 22333 45566666654322 2222 3       23677888999999888774444  347888999999


Q ss_pred             EecCCCcEEEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccc
Q 017232          194 LLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDI  265 (375)
Q Consensus       194 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~  265 (375)
                      +++.++.+++.-.|+-..+                  +|.     ..+...=.-.+=|++..+++++..|+.
T Consensus       111 ~f~~~~~p~i~~RGik~~l------------------~P~-----~~~ee~fL~qyKAliiall~~K~~Fe~  159 (215)
T 4ann_A          111 FFTRDGLPIAKTRGLQNVV------------------DPL-----PVSEAEFLTRYKALVICAFNEKQSFDA  159 (215)
T ss_dssp             EECTTSCEEESCCEETTTB------------------SCC-----CCCHHHHHHHHHHHHHHHHCTTCCHHH
T ss_pred             EEcCCCCEEEEEccCccCC------------------CCC-----CCCHHHHHHHHHHHHHHHHcCCCCHHH
Confidence            9999999999887764322                  121     112222334688899999999988864

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.57  E-value=1.7  Score=35.80  Aligned_cols=115  Identities=11%  Similarity=0.082  Sum_probs=74.9

Q ss_pred             CCCCeEEEeeeeecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHH-HHhhCCceeccCCCCCE
Q 017232          115 RHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT-YLHASDIIHRDVKTNNI  193 (375)
Q Consensus       115 ~h~niv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~-~Lh~~~ivH~dlkp~Ni  193 (375)
                      .||++ +.-  .....+.+.+.++.-+++.-...+       ..++....+.++.+|+.... ++  ..-+|--++|+|+
T Consensus        48 ~~~~f-~~~--I~~~eD~~~i~y~~~~~~~~f~~i-------~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI-VRD--IDVSEDEVKVVIKPPSSFLTFAAI-------RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS-EEE--EEECSSEEEEEEECCTTCEEHHHH-------HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGE
T ss_pred             cCCCC-CeE--EEEeCCEEEEEEEcCcccCcHHHH-------HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceE
Confidence            57888 322  223355666666665443323333       13677888988888877555 34  3457888999999


Q ss_pred             EecCCCcEEEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHH-HHHHHHHHHHhCCCCccc
Q 017232          194 LLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVF-SFGVVLIELISSMPAVDI  265 (375)
Q Consensus       194 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw-slG~il~elltg~~p~~~  265 (375)
                      +++.++.+++.-.|+-..                  ++|.     ..+ ..|.| ++=|++..++.++..|+.
T Consensus       116 ~f~~~~~p~i~hRGi~~~------------------lpP~-----e~~-ee~fl~qyKali~all~~K~~Fe~  164 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKES------------------LPPD-----EWD-DERLLREVKATVLALTEGEYRFDE  164 (219)
T ss_dssp             EECTTCCEEESCCEETTT------------------BSSC-----SCC-HHHHHHHHHHHHHHHTTCSSCHHH
T ss_pred             EEeCCCcEEEEEcCCccc------------------CCCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHHH
Confidence            999999999998886432                  2222     112 23443 578889999999888864

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=89.51  E-value=0.16  Score=29.79  Aligned_cols=16  Identities=38%  Similarity=0.646  Sum_probs=8.4

Q ss_pred             HHHHHHHHHHhcCccc
Q 017232            5 AAIFLIYLRRKKNKHS   20 (375)
Q Consensus         5 ~~~~~~~~~~~~~~~~   20 (375)
                      ++++++++||++++++
T Consensus        27 ~~~~~~~~RRRr~~~k   42 (44)
T 2l2t_A           27 GLTFAVYVRRKSIKKK   42 (44)
T ss_dssp             HHHHHHHHHTTCSSCC
T ss_pred             HHHHHHHhhhhhhhhc
Confidence            3444556666655543

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=89.49  E-value=0.16  Score=29.95  Aligned_cols=15  Identities=20%  Similarity=0.286  Sum_probs=8.2

Q ss_pred             HHHHHHHHHHhcCcc
Q 017232            5 AAIFLIYLRRKKNKH   19 (375)
Q Consensus         5 ~~~~~~~~~~~~~~~   19 (375)
                      ++++++++||+++++
T Consensus        28 ~~~~~~~~RRr~~~~   42 (44)
T 2ks1_B           28 ALGIGLFMRRRHIVR   42 (44)
T ss_dssp             HHHHHHHHHTTTCCS
T ss_pred             HHHHHHHhhhhHhhc
Confidence            344455666666554

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=88.85  E-value=0.24  Score=29.02  Aligned_cols=17  Identities=24%  Similarity=0.569  Sum_probs=10.3

Q ss_pred             HHHHHHHHHHHhcCccc
Q 017232            4 MAAIFLIYLRRKKNKHS   20 (375)
Q Consensus         4 ~~~~~~~~~~~~~~~~~   20 (375)
                      +++++++++||++++++
T Consensus        27 ~~l~~~~~~RRR~~~~k   43 (44)
T 2jwa_A           27 LGVVFGILIKRRQQKIR   43 (44)
T ss_dssp             HHHHHHHHHHHHCSCCC
T ss_pred             HHHHHHhheehhhhhcc
Confidence            34555667777766643

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=84.12  E-value=0.11  Score=48.70  Aligned_cols=59  Identities=8%  Similarity=0.062  Sum_probs=16.8

Q ss_pred             CCCCccCCCCcEEEEEEEeCC-CCEEEE------EEecccc--hhhHHHHHHHHHHHHhcCCCCeEEEeee
Q 017232           64 DSARELGDGGFGTVYYGELQD-GRAVAV------KRLYENN--YKRVEQFMNEVDILARLRHKNLVSLYGC  125 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~-~~~vai------K~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~~~  125 (375)
                      .+.+.||   ||.||+|.+.. ..+||+      |......  .+....+.+|..+++.++|||+++.+++
T Consensus       145 ~l~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f  212 (463)
T 3cxl_A          145 PIYEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNF  212 (463)
T ss_dssp             CSTTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCE
T ss_pred             cccccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcce
Confidence            3456777   99999997764 357888      6654432  2334567888999999999999998874

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	375
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-70
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-65
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	8e-65
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-63
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	3e-63
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-60
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	6e-60
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-60
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	4e-59
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-59
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	1e-58
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-58
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	3e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-57
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-56
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	7e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	9e-56
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	9e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	1e-54
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-53
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-52
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-52
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	6e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-49
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	5e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-47
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-47
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	7e-47
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-46
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-45
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	2e-44
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-43
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	1e-42
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-42
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-41
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-41
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	3e-41
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	6e-41
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	9e-41
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-40
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-40
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-39
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-37
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-36
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	6e-34
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	9e-33
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-31
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-20

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (561), Expect = 1e-70
 Identities = 74/276 (26%), Positives = 129/276 (46%), Gaps = 23/276 (8%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           + +G G FGTVY G+     AV +  +     ++++ F NEV +L + RH N++   G +
Sbjct: 14  QRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           +    +L +V ++    ++  HLH    K         + IA +TA  + YLHA  IIHR
Sbjct: 74  TAP--QLAIVTQWCEGSSLYHHLHIIETK---FEMIKLIDIARQTAQGMDYLHAKSIIHR 128

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNH-VTHVSTAPQGTPGYVDPEYHQCYQ---LTD 242
           D+K+NNI L  +  VK+ DFGL+ +      +H      G+  ++ PE  +       + 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188

Query: 243 KSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNK 302
           +SDV++FG+VL EL++             IN  +  I  +    L   + +         
Sbjct: 189 QSDVYAFGIVLYELMTGQLPYS------NINNRDQIIFMVGRGYLSPDLSKVRSNCPK-- 240

Query: 303 VRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
                 A+  L  +CL+ ++D RP    +L ++  +
Sbjct: 241 ------AMKRLMAECLKKKRDERPLFPQILASIELL 270

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  207 bits (528), Expect = 1e-65
 Identities = 65/272 (23%), Positives = 115/272 (42%), Gaps = 23/272 (8%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
             LG G FG V+ G       VAVK L + +    + F+ E +++ +L+H+ LV LY   
Sbjct: 19  ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSP-DAFLAEANLMKQLQHQRLVRLYAVV 77

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           ++    + ++ E++ NG++ D L         L     L +A + A  + ++   + IHR
Sbjct: 78  TQE--PIYIITEYMENGSLVDFLKTPSGIK--LTINKLLDMAAQIAEGMAFIEERNYIHR 133

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D++  NIL+ +    K+ADFGL+RL  ++        +    +  PE       T KSDV
Sbjct: 134 DLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDV 193

Query: 247 FSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRT 306
           +SFG++L E+++            E+      I  ++        D              
Sbjct: 194 WSFGILLTEIVTHGRIPYPGMTNPEV------IQNLERGYRMVRPDNCP----------- 236

Query: 307 INAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
              + +L   C +   + RP    +   L D 
Sbjct: 237 -EELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (521), Expect = 8e-65
 Identities = 70/284 (24%), Positives = 123/284 (43%), Gaps = 35/284 (12%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           + +G G FG V  G+   G  VAVK +   N    + F+ E  ++ +LRH NLV L G  
Sbjct: 13  QTIGKGEFGDVMLGDY-RGNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLVQLLGVI 69

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
                 L +V E+++ G++ D+L         L     LK +++   A+ YL  ++ +HR
Sbjct: 70  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV--LGGDCLLKFSLDVCEAMEYLEGNNFVHR 127

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D+   N+L+  +   KV+DFGL++   +         +    +  PE  +  + + KSDV
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG----KLPVKWTAPEALREKKFSTKSDV 183

Query: 247 FSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRT 306
           +SFG++L E+ S            ++      + +++     +  D              
Sbjct: 184 WSFGILLWEIYSFGRVPYPRIPLKDV------VPRVEKGYKMDAPDGCP----------- 226

Query: 307 INAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTHE 350
             AV E+   C   +  +RP  + + + L  I        KTHE
Sbjct: 227 -PAVYEVMKNCWHLDAAMRPSFLQLREQLEHI--------KTHE 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (512), Expect = 2e-63
 Identities = 69/272 (25%), Positives = 122/272 (44%), Gaps = 23/272 (8%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +ELG G FG V YG+ +    VA+K + E +    ++F+ E  ++  L H+ LV LYG  
Sbjct: 10  KELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSE-DEFIEEAKVMMNLSHEKLVQLYGV- 67

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
               R + ++ E+++NG + ++L   R           L++  +   A+ YL +   +HR
Sbjct: 68  CTKQRPIFIITEYMANGCLLNYLREMR---HRFQTQQLLEMCKDVCEAMEYLESKQFLHR 124

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D+   N L+++   VKV+DFGLSR   +     S   +    +  PE     + + KSD+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184

Query: 247 FSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRT 306
           ++FGV++ E+ S               L  +   +  N    E + Q L     +     
Sbjct: 185 WAFGVLMWEIYS---------------LGKMPYERFTNSETAEHIAQGLRLYRPHLASE- 228

Query: 307 INAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
              V  + + C   + D RP    +L  + D+
Sbjct: 229 --KVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (513), Expect = 3e-63
 Identities = 74/272 (27%), Positives = 121/272 (44%), Gaps = 23/272 (8%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
            +LG G FG V+ G       VA+K L        E F+ E  ++ +LRH+ LV LY   
Sbjct: 23  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSP-EAFLQEAQVMKKLRHEKLVQLYAVV 81

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
           S     + +V E++S G++ D L GE  K      P  + +A + AS + Y+   + +HR
Sbjct: 82  SEE--PIYIVTEYMSKGSLLDFLKGETGKYL--RLPQLVDMAAQIASGMAYVERMNYVHR 137

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D++  NIL+  N   KVADFGL+RL  ++        +    +  PE     + T KSDV
Sbjct: 138 DLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 197

Query: 247 FSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRT 306
           +SFG++L EL +            E+      +++++         +             
Sbjct: 198 WSFGILLTELTTKGRVPYPGMVNREV------LDQVERGYRMPCPPECP----------- 240

Query: 307 INAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
             ++ +L  QC + E + RP    +   L D 
Sbjct: 241 -ESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 271

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (505), Expect = 2e-62
 Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 23/276 (8%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
           +E+G G FG V+ G   +   VA+K + E      E F+ E +++ +L H  LV LYG  
Sbjct: 11  QEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSE-EDFIEEAEVMMKLSHPKLVQLYGV- 68

Query: 127 SRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHR 186
                 + LV+EF+ +G ++D+L  +R         T L + ++    + YL  + +IHR
Sbjct: 69  CLEQAPICLVFEFMEHGCLSDYLRTQRGLF---AAETLLGMCLDVCEGMAYLEEACVIHR 125

Query: 187 DVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDV 246
           D+   N L+  N  +KV+DFG++R   +     ST  +    +  PE     + + KSDV
Sbjct: 126 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 185

Query: 247 FSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRT 306
           +SFGV++ E+ S        R   E+      +  I       L    L           
Sbjct: 186 WSFGVLMWEVFSEGKIPYENRSNSEV------VEDISTG--FRLYKPRLASTH------- 230

Query: 307 INAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG 342
              V ++   C +   + RP    +L  L +I   G
Sbjct: 231 ---VYQIMNHCWKERPEDRPAFSRLLRQLAEIAESG 263

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  194 bits (494), Expect = 2e-60
 Identities = 77/291 (26%), Positives = 122/291 (41%), Gaps = 23/291 (7%)

Query: 52  SYGELEEATNYFDSARELGDGGFGTVYYGELQD-GRAVAVKRLYENNYKRVEQFMNEVDI 110
           +Y + E          +LG G +G VY G  +     VAVK L E+    VE+F+ E  +
Sbjct: 8   NYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAV 66

Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           +  ++H NLV L G          ++ EF++ G + D+L         +     L +A +
Sbjct: 67  MKEIKHPNLVQLLGV-CTREPPFYIITEFMTYGNLLDYLR--ECNRQEVSAVVLLYMATQ 123

Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
            +SA+ YL   + IHRD+   N L+  N  VKVADFGLSRL            +    + 
Sbjct: 124 ISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWT 183

Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL 290
            PE     + + KSDV++FGV+L E+ +   +                   I    ++EL
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPY---------------PGIDLSQVYEL 228

Query: 291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
           +++    E           V EL   C Q     RP   ++  A   +  +
Sbjct: 229 LEKDYRMERPEGC---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  194 bits (493), Expect = 3e-60
 Identities = 67/309 (21%), Positives = 127/309 (41%), Gaps = 40/309 (12%)

Query: 48  VQVFSYGELEEATNYFDSA---------RELGDGGFGTVYYGEL----QDGRAVAVKRLY 94
           +  F++ +  EA   F            + +G G FG V  G L    +    VA+K L 
Sbjct: 4   IDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLK 63

Query: 95  ENNYKR-VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER 153
               ++    F++E  I+ +  H N++ L       S  ++++ EF+ NG++   L    
Sbjct: 64  SGYTEKQRRDFLSEASIMGQFDHPNVIHLE-GVVTKSTPVMIITEFMENGSLDSFLRQ-- 120

Query: 154 AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP 213
              G       + +    A+ + YL   + +HRD+   NIL+++N   KV+DFGLSR   
Sbjct: 121 -NDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 179

Query: 214 N----HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHR 269
           +         +   +    +  PE  Q  + T  SDV+S+G+V+ E++S           
Sbjct: 180 DDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS----------- 228

Query: 270 HEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMV 329
                       + N+ +   ++Q              +A+ +L   C Q +++ RP   
Sbjct: 229 ----YGERPYWDMTNQDVINAIEQDYRLPPPMDC---PSALHQLMLDCWQKDRNHRPKFG 281

Query: 330 DVLDALRDI 338
            +++ L  +
Sbjct: 282 QIVNTLDKM 290

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 6e-60
 Identities = 65/283 (22%), Positives = 111/283 (39%), Gaps = 11/283 (3%)

Query: 56  LEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLY-ENNYKRVEQFMNEVDILAR 113
           +E   + F+   ELG G  G V+       G  +A K ++ E       Q + E+ +L  
Sbjct: 1   MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60

Query: 114 LRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
                +V  YG       E+ +  E +  G++   L     K G +P     K++I    
Sbjct: 61  CNSPYIVGFYGA-FYSDGEISICMEHMDGGSLDQVLK----KAGRIPEQILGKVSIAVIK 115

Query: 174 ALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
            LTYL     I+HRDVK +NIL+++   +K+ DFG+S    + +     +  GT  Y+ P
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA---NSFVGTRSYMSP 172

Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E  Q    + +SD++S G+ L+E+      +     +    +    +     +       
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 232

Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
                 S     R   A+ EL    +       P  V  L+  
Sbjct: 233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQ 275

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 8e-60
 Identities = 61/296 (20%), Positives = 125/296 (42%), Gaps = 33/296 (11%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCT 126
             +G G FG V+ G+   G  VAVK    +  +R      E+     LRH+N++      
Sbjct: 9   ESIGKGRFGEVWRGKW-RGEEVAVKIF-SSREERSWFREAEIYQTVMLRHENILGFIAAD 66

Query: 127 SR---HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-- 181
           ++      +L LV ++  +G++ D+L+        +     +K+A+ TAS L +LH    
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-----VTVEGMIKLALSTASGLAHLHMEIV 121

Query: 182 ------DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ---GTPGYVDP 232
                  I HRD+K+ NIL+  N    +AD GL+    +    +  AP    GT  Y+ P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181

Query: 233 EY------HQCYQLTDKSDVFSFGVVLIELISSMP----AVDITRHRHEINLSNLAINKI 282
           E        + ++   ++D+++ G+V  E+           D     +++  S+ ++ ++
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEM 241

Query: 283 QNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
           +     + +   +     +     +  +A++  +C  +    R   + +   L  +
Sbjct: 242 RKVVCEQKLRPNIPNRWQSC--EALRVMAKIMRECWYANGAARLTALRIKKTLSQL 295

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (484), Expect = 4e-59
 Identities = 68/280 (24%), Positives = 117/280 (41%), Gaps = 29/280 (10%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKR--VEQFMNEVDILARLRHKNL 119
           ++    +G G +G         DG+ +  K L   +      +  ++EV++L  L+H N+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 120 VSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           V  Y     R +  L +V E+   G +A  +     +   L     L++  +   AL   
Sbjct: 66  VRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKEC 125

Query: 179 H-----ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
           H        ++HRD+K  N+ LD    VK+ DFGL+R+  NH T  + A  GTP Y+ PE
Sbjct: 126 HRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-NHDTSFAKAFVGTPYYMSPE 184

Query: 234 YHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ 293
                   +KSD++S G +L EL + MP       +           KI+      +   
Sbjct: 185 QMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGKIREGKFRRIPY- 236

Query: 294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD 333
                      R  + + E+  + L  +   RP + ++L+
Sbjct: 237 -----------RYSDELNEIITRMLNLKDYHRPSVEEILE 265

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (486), Expect = 4e-59
 Identities = 69/312 (22%), Positives = 118/312 (37%), Gaps = 47/312 (15%)

Query: 55  ELEEATNYFDSARELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKRVE-QFMNE 107
            LE   N  +  R++G+G FG V+          +    VAVK L E     ++  F  E
Sbjct: 7   SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQRE 66

Query: 108 VDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER-------------- 153
             ++A   + N+V L G      + + L++E+++ G + + L                  
Sbjct: 67  AALMAEFDNPNIVKLLGVC-AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLST 125

Query: 154 ------AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFG 207
                   P  L    +L IA + A+ + YL     +HRD+ T N L+  N  VK+ADFG
Sbjct: 126 RARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFG 185

Query: 208 LSR-LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDIT 266
           LSR ++                ++ PE     + T +SDV+++GVVL E+ S        
Sbjct: 186 LSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYG 245

Query: 267 RHRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRP 326
               E+      I  +++  +    +                 +  L   C       RP
Sbjct: 246 MAHEEV------IYYVRDGNILACPEN------------CPLELYNLMRLCWSKLPADRP 287

Query: 327 YMVDVLDALRDI 338
               +   L+ +
Sbjct: 288 SFCSIHRILQRM 299

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 1e-58
 Identities = 66/284 (23%), Positives = 113/284 (39%), Gaps = 29/284 (10%)

Query: 61  NYFDSARELGDGGFGTVYYGELQ---DGRAVAVKRLYENNYKR-VEQFMNEVDILARLRH 116
           N   +  ELG G FG+V  G  +       VA+K L +   K   E+ M E  I+ +L +
Sbjct: 9   NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 68

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
             +V L G     +  L+LV E    G +   L G+R     +P     ++  + +  + 
Sbjct: 69  PYIVRLIGVC--QAEALMLVMEMAGGGPLHKFLVGKR---EEIPVSNVAELLHQVSMGMK 123

Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP--NHVTHVSTAPQGTPGYVDPEY 234
           YL   + +HRD+   N+LL N    K++DFGLS+     +      +A +    +  PE 
Sbjct: 124 YLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPEC 183

Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT 294
               + + +SDV+S+GV + E +S            E+      +  I+     E   + 
Sbjct: 184 INFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV------MAFIEQGKRMECPPEC 237

Query: 295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
                          +  L   C   + + RP  + V   +R  
Sbjct: 238 P------------PELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 3e-58
 Identities = 62/279 (22%), Positives = 112/279 (40%), Gaps = 31/279 (11%)

Query: 67  RELGDGGFGTVYYGELQD---GRAVAVKRLYE--NNYKRVEQFMNEVDILARLRHKNLVS 121
           +ELG G FGTV  G  Q     + VAVK L    N+    ++ + E +++ +L +  +V 
Sbjct: 13  KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVR 72

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           + G     S   +LV E    G +  +L     +   +     +++  + +  + YL  S
Sbjct: 73  MIGICEAES--WMLVMEMAELGPLNKYLQ----QNRHVKDKNIIELVHQVSMGMKYLEES 126

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GTPGYVDPEYHQCYQ 239
           + +HRD+   N+LL      K++DFGLS+       +            +  PE    Y+
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK 186

Query: 240 LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
            + KSDV+SFGV++ E  S                       ++   +  ++++      
Sbjct: 187 FSSKSDVWSFGVLMWEAFS---------------YGQKPYRGMKGSEVTAMLEKGERMGC 231

Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
                R    + +L   C   + + RP    V   LR+ 
Sbjct: 232 PAGCPR---EMYDLMNLCWTYDVENRPGFAAVELRLRNY 267

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (477), Expect = 1e-57
 Identities = 73/291 (25%), Positives = 126/291 (43%), Gaps = 29/291 (9%)

Query: 67  RELGDGGFGTVYYGELQD----GRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLVS 121
             +G G FG VY+G L D        AVK L    +   V QF+ E  I+    H N++S
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G   R     L+V  ++ +G + + +  E   P        +   ++ A  + +L + 
Sbjct: 93  LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP---TVKDLIGFGLQVAKGMKFLASK 149

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN---HVTHVSTAPQGTPGYVDPEYHQCY 238
             +HRD+   N +LD  F VKVADFGL+R   +      H  T  +    ++  E  Q  
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQ 209

Query: 239 QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
           + T KSDV+SFGV+L EL++            ++N  ++ +  +Q + L           
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRG-----APPYPDVNTFDITVYLLQGRRLL---------- 254

Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDDKKTH 349
              +     + + E+  +C   + ++RP   +++  +  I S    +   H
Sbjct: 255 ---QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 302

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (472), Expect = 3e-57
 Identities = 66/281 (23%), Positives = 121/281 (43%), Gaps = 34/281 (12%)

Query: 62  YFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKR--VEQFMNEVDILARLRHKN 118
           +     E+G G F TVY G   +    VA   L +    +   ++F  E ++L  L+H N
Sbjct: 10  FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPN 69

Query: 119 LVSLYGC---TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           +V  Y     T +  + ++LV E +++GT+  +L     +   +          +    L
Sbjct: 70  IVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK----RFKVMKIKVLRSWCRQILKGL 125

Query: 176 TYLHA--SDIIHRDVKTNNILL-DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
            +LH     IIHRD+K +NI +      VK+ D GL+ L          A  GTP ++ P
Sbjct: 126 QFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFA---KAVIGTPEFMAP 182

Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E ++  +  +  DV++FG+ ++E+ +S       ++  +I        ++ +       D
Sbjct: 183 EMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------YRRVTSGVKPASFD 235

Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD 333
           +             I  V E+   C++  KD R  + D+L+
Sbjct: 236 KVA-----------IPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 6e-57
 Identities = 74/273 (27%), Positives = 117/273 (42%), Gaps = 28/273 (10%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            ELGDG FG VY  +  +     A K +   + + +E +M E+DILA   H N+V L   
Sbjct: 18  GELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDA 77

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
              +   L ++ EF + G V   +         L       +  +T  AL YLH + IIH
Sbjct: 78  -FYYENNLWILIEFCAGGAVDAVML---ELERPLTESQIQVVCKQTLDALNYLHDNKIIH 133

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD--- 242
           RD+K  NIL   +  +K+ADFG+S      +    +   GTP ++ PE   C    D   
Sbjct: 134 RDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS-FIGTPYWMAPEVVMCETSKDRPY 192

Query: 243 --KSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD 300
             K+DV+S G+ LIE+    P        HE+N   + +   +++             + 
Sbjct: 193 DYKADVWSLGITLIEMAEIEPP------HHELNPMRVLLKIAKSE-----------PPTL 235

Query: 301 NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD 333
            +  R  +   +   +CL+   D R     +L 
Sbjct: 236 AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-56
 Identities = 71/282 (25%), Positives = 119/282 (42%), Gaps = 31/282 (10%)

Query: 67  RELGDGGFGTVYYGEL----QDGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNL 119
            +LGDG FG V  GE         +VAVK L     +  + ++ F+ EV+ +  L H+NL
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           + LYG     +  + +V E    G++ D L   +   G     T  + A++ A  + YL 
Sbjct: 74  IRLYGVV--LTPPMKMVTELAPLGSLLDRLRKHQ---GHFLLGTLSRYAVQVAEGMGYLE 128

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH--VSTAPQGTPGYVDPEYHQC 237
           +   IHRD+   N+LL     VK+ DFGL R  P +  H  +    +    +  PE  + 
Sbjct: 129 SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT 188

Query: 238 YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY 297
              +  SD + FGV L E+ +      I  +  +I      ++KI  +       +    
Sbjct: 189 RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI------LHKIDKEGERLPRPEDCPQ 242

Query: 298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE 339
           +           +  +  QC   + + RP  V + D L + +
Sbjct: 243 D-----------IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 7e-56
 Identities = 68/284 (23%), Positives = 123/284 (43%), Gaps = 30/284 (10%)

Query: 63  FDSARELGDGGFGTVYYGELQDG-----RAVAVKRLY-ENNYKRVEQFMNEVDILARLRH 116
               + +G G FG VY G L+         VA+K L      K+   F+ E  I+ +  H
Sbjct: 9   VTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSH 68

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            N++ L G      + ++++ E++ NG +   L     K G       + +    A+ + 
Sbjct: 69  HNIIRLEGVI-SKYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMK 124

Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH--VTHVSTAPQGTPGYVDPEY 234
           YL   + +HRD+   NIL+++N   KV+DFGLSR+  +    T+ ++  +    +  PE 
Sbjct: 125 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 184

Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT 294
               + T  SDV+SFG+V+ E+++           HE+                + ++  
Sbjct: 185 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV---------------MKAINDG 229

Query: 295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
               +        +A+ +L  QC Q E+  RP   D++  L  +
Sbjct: 230 FRLPTPMDC---PSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  183 bits (465), Expect = 9e-56
 Identities = 69/284 (24%), Positives = 104/284 (36%), Gaps = 37/284 (13%)

Query: 57  EEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRL---YENNYKRVEQFMNEVDILA 112
           ++    F   RE+G G FG VY+   +++   VA+K++    + + ++ +  + EV  L 
Sbjct: 11  DDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 113 RLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
           +LRH N +   GC         LV E+                   L       +     
Sbjct: 71  KLRHPNTIQYRGC-YLREHTAWLVMEYCLGSASDLLEV----HKKPLQEVEIAAVTHGAL 125

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
             L YLH+ ++IHRDVK  NILL     VK+ DFG + +     + V     GTP ++ P
Sbjct: 126 QGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFV-----GTPYWMAP 180

Query: 233 EYHQCY---QLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALH 288
           E        Q   K DV+S G+  IEL     P  ++            A+  I      
Sbjct: 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--------ALYHIAQNESP 232

Query: 289 ELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
            L                          CLQ     RP    +L
Sbjct: 233 ALQSGHWSEY-----------FRNFVDSCLQKIPQDRPTSEVLL 265

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 9e-56
 Identities = 71/274 (25%), Positives = 111/274 (40%), Gaps = 38/274 (13%)

Query: 67  RELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKR---VEQFMNEVDILARLRHKNLVSL 122
           R LG G FG VY     Q    +A+K L++   ++     Q   EV+I + LRH N++ L
Sbjct: 12  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 71

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           YG     +  + L+ E+   GTV   L     K              E A+AL+Y H+  
Sbjct: 72  YGY-FHDATRVYLILEYAPLGTVYRELQ----KLSKFDEQRTATYITELANALSYCHSKR 126

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           +IHRD+K  N+LL +   +K+ADFG S   P+          GT  Y+ PE  +     +
Sbjct: 127 VIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT---LCGTLDYLPPEMIEGRMHDE 183

Query: 243 KSDVFSFGVVLIELISSMP---AVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
           K D++S GV+  E +   P   A         I+           +   +L+        
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGARDLIS------- 236

Query: 300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD 333
                           + L+     RP + +VL+
Sbjct: 237 ----------------RLLKHNPSQRPMLREVLE 254

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 1e-55
 Identities = 68/274 (24%), Positives = 110/274 (40%), Gaps = 26/274 (9%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRL-YENNYKRVEQFMNEVDILARLRHKNLV 120
           +D  + LG+G +G V          AVAVK +  +      E    E+ I   L H+N+V
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 121 SLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA 180
             YG   R      L  E+ S G + D +         +P P   +   +  + + YLH 
Sbjct: 67  KFYGH-RREGNIQYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHG 121

Query: 181 SDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
             I HRD+K  N+LLD    +K++DFGL+ +F  N+   +     GT  YV PE  +  +
Sbjct: 122 IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE 181

Query: 240 L-TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE 298
              +  DV+S G+VL  +++     D                   + +  E  D      
Sbjct: 182 FHAEPVDVWSCGIVLTAMLAGELPWDQP-----------------SDSCQEYSDWKEKKT 224

Query: 299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
             N  ++  +A   L  + L      R  + D+ 
Sbjct: 225 YLNPWKKIDSAPLALLHKILVENPSARITIPDIK 258

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 1e-54
 Identities = 62/277 (22%), Positives = 116/277 (41%), Gaps = 28/277 (10%)

Query: 67  RELGDGGFGTVYYGEL----QDGRAVAVKRLYENNYKRV-EQFMNEVDILARLRHKNLVS 121
           R +G+G FG V+ G          AVA+K         V E+F+ E   + +  H ++V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           L G  + +   + ++ E  + G +   L     +  +L   + +  A + ++AL YL + 
Sbjct: 73  LIGVITEN--PVWIIMELCTLGELRSFLQ---VRKYSLDLASLILYAYQLSTALAYLESK 127

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
             +HRD+   N+L+ +N CVK+ DFGLSR   +   + ++  +    ++ PE     + T
Sbjct: 128 RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFT 187

Query: 242 DKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESDN 301
             SDV+ FGV + E++            +++      I +I+N     +           
Sbjct: 188 SASDVWMFGVCMWEILMHGVKPFQGVKNNDV------IGRIENGERLPMPPNCP------ 235

Query: 302 KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
                   +  L  +C   +   RP   ++   L  I
Sbjct: 236 ------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 1e-53
 Identities = 64/298 (21%), Positives = 111/298 (37%), Gaps = 41/298 (13%)

Query: 67  RELGDGGFGTVYYGEL------QDGRAVAVKRLY-ENNYKRVEQFMNEVDILARL-RHKN 118
           + LG G FG V                VAVK L    +    E  M+E+ +L+ L  H N
Sbjct: 29  KTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMN 88

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP--------------GALPWPTR 164
           +V+L G         L++ E+   G + + L  +R                  AL     
Sbjct: 89  IVNLLGA-CTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147

Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH-VSTAP 223
           L  + + A  + +L + + IHRD+   NILL +    K+ DFGL+R   N   + V    
Sbjct: 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA 207

Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ 283
           +    ++ PE       T +SDV+S+G+ L EL S   +                     
Sbjct: 208 RLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK----------- 256

Query: 284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD 341
               ++++ +     S          + ++   C  ++   RP    ++  +    S+
Sbjct: 257 ---FYKMIKEGFRMLSPEHA---PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE 308

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (451), Expect = 1e-53
 Identities = 65/299 (21%), Positives = 114/299 (38%), Gaps = 50/299 (16%)

Query: 67  RELGDGGFGTVYYGELQD------GRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKN 118
           + LG G FG V                VAVK L E  +    E  M+E+ ++ +L  H+N
Sbjct: 43  KVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHEN 102

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAK-------------------PGAL 159
           +V+L G     S  + L++E+   G + ++L  +R K                      L
Sbjct: 103 IVNLLGA-CTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 161

Query: 160 PWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV 219
            +   L  A + A  + +L     +HRD+   N+L+ +   VK+ DFGL+R   +   +V
Sbjct: 162 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYV 221

Query: 220 S-TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS--SMPAVDITRHRHEINLSN 276
                +    ++ PE       T KSDV+S+G++L E+ S    P   I           
Sbjct: 222 VRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP---------- 271

Query: 277 LAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDAL 335
                  +   ++L+      +           +  +   C   +   RP   ++   L
Sbjct: 272 ------VDANFYKLIQNGFKMDQPFYA---TEEIYIIMQSCWAFDSRKRPSFPNLTSFL 321

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (449), Expect = 1e-53
 Identities = 74/317 (23%), Positives = 117/317 (36%), Gaps = 40/317 (12%)

Query: 63  FDSARELGDGGFGTVYYGELQDG---RAVAVKRLYENNYKR-VEQFMNEVDILARL-RHK 117
                 +G+G FG V    ++        A+KR+ E   K     F  E+++L +L  H 
Sbjct: 12  IKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHP 71

Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGE------------RAKPGALPWPTRL 165
           N+++L G    H   L L  E+  +G + D L                +    L     L
Sbjct: 72  NIINLLGAC-EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 130

Query: 166 KIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQG 225
             A + A  + YL     IHRD+   NIL+  N+  K+ADFGLSR    +V         
Sbjct: 131 HFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR--L 188

Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK 285
              ++  E       T  SDV+S+GV+L E++S            E+        K+   
Sbjct: 189 PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL------YEKLPQG 242

Query: 286 ALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI--ESDGY 343
              E                  + V +L  QC + +   RP    +L +L  +  E   Y
Sbjct: 243 YRLEKPLNCD------------DEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERKTY 290

Query: 344 DDKKTHEEMMTQSPDSV 360
            +   +E+      D  
Sbjct: 291 VNTTLYEKFTYAGIDCS 307

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (442), Expect = 2e-52
 Identities = 54/196 (27%), Positives = 97/196 (49%), Gaps = 8/196 (4%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            ++G G  GTVY   ++  G+ VA++++      + E  +NE+ ++   ++ N+V+    
Sbjct: 26  EKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDS 85

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
                 EL +V E+++ G++ D +                 +  E   AL +LH++ +IH
Sbjct: 86  -YLVGDELWVVMEYLAGGSLTDVVTETCM-----DEGQIAAVCRECLQALEFLHSNQVIH 139

Query: 186 RDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSD 245
           RD+K++NILL  +  VK+ DFG         +  ST   GTP ++ PE         K D
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST-MVGTPYWMAPEVVTRKAYGPKVD 198

Query: 246 VFSFGVVLIELISSMP 261
           ++S G++ IE+I   P
Sbjct: 199 IWSLGIMAIEMIEGEP 214

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 2e-52
 Identities = 61/306 (19%), Positives = 120/306 (39%), Gaps = 32/306 (10%)

Query: 63  FDSARELGDGGFGTVYYGELQD-----GRAVAVKRLYE-NNYKRVEQFMNEVDILARLRH 116
           F   + LG G FGTVY G            VA+K L E  + K  ++ ++E  ++A + +
Sbjct: 11  FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
            ++  L G     +  + L+ + +  G + D++   +           L   ++ A  + 
Sbjct: 71  PHVCRLLGIC--LTSTVQLITQLMPFGCLLDYVREHKDNI---GSQYLLNWCVQIAKGMN 125

Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPEYH 235
           YL    ++HRD+   N+L+     VK+ DFGL++L       + +   +    ++  E  
Sbjct: 126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESI 185

Query: 236 QCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
                T +SDV+S+GV + EL++                 +   + I    +  ++++  
Sbjct: 186 LHRIYTHQSDVWSYGVTVWELMT---------------FGSKPYDGIPASEISSILEKGE 230

Query: 296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD--GYDDKKTHEEMM 353
                         V  +  +C   + D RP   +++     +  D   Y   +  E M 
Sbjct: 231 RLPQPPICTI---DVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLVIQGDERMH 287

Query: 354 TQSPDS 359
             SP  
Sbjct: 288 LPSPTD 293

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  170 bits (432), Expect = 6e-51
 Identities = 66/293 (22%), Positives = 120/293 (40%), Gaps = 33/293 (11%)

Query: 67  RELGDGGFGTVYYGEL------QDGRAVAVKRLYENNYKR-VEQFMNEVDILARLRHKNL 119
           RELG G FG VY G        +    VA+K + E    R   +F+NE  ++      ++
Sbjct: 26  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 85

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGER------AKPGALPWPTRLKIAIETAS 173
           V L G  S   +  L++ E ++ G +  +L   R                 +++A E A 
Sbjct: 86  VRLLGVVS-QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 144

Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH-VTHVSTAPQGTPGYVDP 232
            + YL+A+  +HRD+   N ++  +F VK+ DFG++R                   ++ P
Sbjct: 145 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSP 204

Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E  +    T  SDV+SFGVVL E+ +            ++      +  +    L +  D
Sbjct: 205 ESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV------LRFVMEGGLLDKPD 258

Query: 293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDD 345
                          + + EL   C Q    +RP  ++++ ++++    G+ +
Sbjct: 259 NCP------------DMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE 299

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  170 bits (431), Expect = 2e-50
 Identities = 49/198 (24%), Positives = 90/198 (45%), Gaps = 9/198 (4%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            ELG G FG V+   E   G   A K +   +    E    E+  ++ LRH  LV+L+  
Sbjct: 32  EELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDA 91

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
                 E++++YEF+S G + + +  E      +     ++   +    L ++H ++ +H
Sbjct: 92  -FEDDNEMVMIYEFMSGGELFEKVADEH---NKMSEDEAVEYMRQVCKGLCHMHENNYVH 147

Query: 186 RDVKTNNILL--DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
            D+K  NI+     +  +K+ DFGL+       +   T   GT  +  PE  +   +   
Sbjct: 148 LDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVT--TGTAEFAAPEVAEGKPVGYY 205

Query: 244 SDVFSFGVVLIELISSMP 261
           +D++S GV+   L+S + 
Sbjct: 206 TDMWSVGVLSYILLSGLS 223

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 1e-49
 Identities = 58/200 (29%), Positives = 93/200 (46%), Gaps = 10/200 (5%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVSL 122
           + LG+G F TV    EL   R  A+K L   +     +V     E D+++RL H   V L
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 73

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           Y    +   +L     +  NG +  ++     K G+           E  SAL YLH   
Sbjct: 74  YFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYTAEIVSALEYLHGKG 128

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLF-PNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
           IIHRD+K  NILL+ +  +++ DFG +++  P      + +  GT  YV PE        
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSAC 188

Query: 242 DKSDVFSFGVVLIELISSMP 261
             SD+++ G ++ +L++ +P
Sbjct: 189 KSSDLWALGCIIYQLVAGLP 208

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 5e-49
 Identities = 67/293 (22%), Positives = 113/293 (38%), Gaps = 38/293 (12%)

Query: 67  RELGDGGFGTVYYG------ELQDGRAVAVKRLYEN-NYKRVEQFMNEVDILAR-LRHKN 118
           + LG G FG V         +    R VAVK L E   +      M+E+ IL     H N
Sbjct: 19  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 78

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGER------------AKPGALPWPTRLK 166
           +V+L G  ++    L+++ EF   G ++ +L  +R                 L     + 
Sbjct: 79  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLIC 138

Query: 167 IAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV-STAPQG 225
            + + A  + +L +   IHRD+   NILL     VK+ DFGL+R       +V     + 
Sbjct: 139 YSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 198

Query: 226 TPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK 285
              ++ PE       T +SDV+SFGV+L E+ S             + +      +++  
Sbjct: 199 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKIDEEFCRRLKEG 253

Query: 286 ALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
                 D             T   + +    C   E   RP   ++++ L ++
Sbjct: 254 TRMRAPDY------------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 68/291 (23%), Positives = 118/291 (40%), Gaps = 30/291 (10%)

Query: 60  TNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRL---YENNYKRVEQFMNEVDILARLR 115
           ++ ++    LG GG   V+    L+  R VAVK L      +     +F  E    A L 
Sbjct: 6   SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65

Query: 116 HKNLVSLYGC---TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETA 172
           H  +V++Y      +       +V E++   T+ D +H      G +     +++  +  
Sbjct: 66  HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH----TEGPMTPKRAIEVIADAC 121

Query: 173 SALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV--STAPQGTPGYV 230
            AL + H + IIHRDVK  NI++     VKV DFG++R   +    V  + A  GT  Y+
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL 290
            PE  +   +  +SDV+S G VL E+++  P          +   ++  + I   A HE 
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFT-GDSPVSVAYQHVREDPIPPSARHEG 240

Query: 291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY-MVDVLDALRDIES 340
           +   L                 +  + L    + R     ++   L  + +
Sbjct: 241 LSADL---------------DAVVLKALAKNPENRYQTAAEMRADLVRVHN 276

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  162 bits (411), Expect = 2e-47
 Identities = 51/204 (25%), Positives = 88/204 (43%), Gaps = 9/204 (4%)

Query: 61  NYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL 119
           +Y+D   ELG G FG V+   E   GR    K +            NE+ I+ +L H  L
Sbjct: 29  DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           ++L+        E++L+ EF+S G + D +    A+   +     +    +    L ++H
Sbjct: 89  INLHDA-FEDKYEMVLILEFLSGGELFDRI---AAEDYKMSEAEVINYMRQACEGLKHMH 144

Query: 180 ASDIIHRDVKTNNILLDNNFC--VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC 237
              I+H D+K  NI+ +      VK+ DFGL+           T    T  +  PE    
Sbjct: 145 EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVT--TATAEFAAPEIVDR 202

Query: 238 YQLTDKSDVFSFGVVLIELISSMP 261
             +   +D+++ GV+   L+S + 
Sbjct: 203 EPVGFYTDMWAIGVLGYVLLSGLS 226

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (405), Expect = 7e-47
 Identities = 46/198 (23%), Positives = 85/198 (42%), Gaps = 10/198 (5%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
            +LG G FG V+   E    +    K + +           E+ IL   RH+N++ L+  
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNILHLHES 69

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
                 EL++++EFIS   + + +         L     +    +   AL +LH+ +I H
Sbjct: 70  -FESMEELVMIFEFISGLDIFERI---NTSAFELNEREIVSYVHQVCEALQFLHSHNIGH 125

Query: 186 RDVKTNNILLDN--NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
            D++  NI+     +  +K+ +FG +R                P Y  PE HQ   ++  
Sbjct: 126 FDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLL--FTAPEYYAPEVHQHDVVSTA 183

Query: 244 SDVFSFGVVLIELISSMP 261
           +D++S G ++  L+S + 
Sbjct: 184 TDMWSLGTLVYVLLSGIN 201

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 5e-46
 Identities = 64/297 (21%), Positives = 121/297 (40%), Gaps = 42/297 (14%)

Query: 67  RELGDGGFGTVYYGEL--------QDGRAVAVKRLYENNYKR-VEQFMNEVDILARL-RH 116
           + LG+G FG V   E              VAVK L  +  ++ +   ++E++++  + +H
Sbjct: 19  KPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKH 78

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKP------------GALPWPTR 164
           KN+++L G  +     L ++ E+ S G + ++L   R                 L     
Sbjct: 79  KNIINLLGACT-QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 137

Query: 165 LKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVST-AP 223
           +  A + A  + YL +   IHRD+   N+L+  +  +K+ADFGL+R   +   +  T   
Sbjct: 138 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197

Query: 224 QGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQ 283
           +    ++ PE       T +SDV+SFGV+L E+         T                 
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI--------FTLGGSPYPGVP------- 242

Query: 284 NKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES 340
            + L +L+ +    +  +      N +  +   C  +    RP    +++ L  I +
Sbjct: 243 VEELFKLLKEGHRMDKPSNC---TNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA 296

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  156 bits (395), Expect = 2e-45
 Identities = 56/214 (26%), Positives = 98/214 (45%), Gaps = 12/214 (5%)

Query: 53  YGELEEATNYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRL-YENNYKRVEQFMNEVDI 110
           + + E+  + +D    LG G F  V   E  +  + VA+K +  +    +     NE+ +
Sbjct: 1   WKQAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAV 60

Query: 111 LARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
           L +++H N+V+L          L L+ + +S G + D +     + G        ++  +
Sbjct: 61  LHKIKHPNIVALDDI-YESGGHLYLIMQLVSGGELFDRIV----EKGFYTERDASRLIFQ 115

Query: 171 TASALTYLHASDIIHRDVKTNNILL---DNNFCVKVADFGLSRLFPNHVTHVSTAPQGTP 227
              A+ YLH   I+HRD+K  N+L    D +  + ++DFGLS++       V +   GTP
Sbjct: 116 VLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTP 173

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
           GYV PE       +   D +S GV+   L+   P
Sbjct: 174 GYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  155 bits (392), Expect = 2e-45
 Identities = 64/287 (22%), Positives = 108/287 (37%), Gaps = 40/287 (13%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRL---------YENNYKRVEQFMNEVDILA 112
           ++    LG G    V         +  AVK +          E   +  E  + EVDIL 
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 113 RLR-HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIET 171
           ++  H N++ L       +    LV++ +  G + D+L     +   L      KI    
Sbjct: 65  KVSGHPNIIQLKDT-YETNTFFFLVFDLMKKGELFDYLT----EKVTLSEKETRKIMRAL 119

Query: 172 ASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVD 231
              +  LH  +I+HRD+K  NILLD++  +K+ DFG S               GTP Y+ 
Sbjct: 120 LEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP--GEKLREVCGTPSYLA 177

Query: 232 PEYHQCYQL------TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK 285
           PE  +C           + D++S GV++  L++  P      HR ++ +    +  I + 
Sbjct: 178 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFW---HRKQMLM----LRMIMSG 230

Query: 286 ALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL 332
                  +   Y            V +L  + L  +   R    + L
Sbjct: 231 NYQFGSPEWDDYSDT---------VKDLVSRFLVVQPQKRYTAEEAL 268

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-44
 Identities = 64/298 (21%), Positives = 117/298 (39%), Gaps = 19/298 (6%)

Query: 59  ATNYFDSARELGDGGFGTVYYGE--LQDGRAVAVKRLYENNYKR--VEQFMNEVDILARL 114
           A   ++   E+G+G +G V+        GR VA+KR+     +       + EV +L  L
Sbjct: 5   ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 115 ---RHKNLVSLYG-CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIE 170
               H N+V L+  CT   +     +     +       + ++     +P  T   +  +
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 171 TASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYV 230
               L +LH+  ++HRD+K  NIL+ ++  +K+ADFGL+R++   +   S     T  Y 
Sbjct: 125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVV--VTLWYR 182

Query: 231 DPEYHQCYQLTDKSDVFSFGVVLIELISSMPA------VDITRHRHEINLSNLAINKIQN 284
            PE           D++S G +  E+    P       VD      ++       +  ++
Sbjct: 183 APEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD 242

Query: 285 KALHELVDQTLGYESDNKVRRTINAVA-ELAFQCLQSEKDLRPYMVDVLDA--LRDIE 339
            AL      +   +   K    I+ +  +L  +CL      R      L     +D+E
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE 300

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  151 bits (383), Expect = 6e-44
 Identities = 54/282 (19%), Positives = 93/282 (32%), Gaps = 28/282 (9%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           R++G G FG +Y G  +  G  VA+K        +  Q   E  I   ++    +     
Sbjct: 13  RKIGSGSFGDIYLGTDIAAGEEVAIKLECVK--TKHPQLHIESKIYKMMQGGVGIPTIRW 70

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
                   ++V E +            R         T L +A +  S + Y+H+ + IH
Sbjct: 71  CGAEGDYNVMVMELLGPSLEDLFNFCSRK----FSLKTVLLLADQMISRIEYIHSKNFIH 126

Query: 186 RDVKTNNIL---LDNNFCVKVADFGLSRLFPNHVTHV------STAPQGTPGYVDPEYHQ 236
           RDVK +N L         V + DFGL++ + +  TH       +    GT  Y     H 
Sbjct: 127 RDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHL 186

Query: 237 CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG 296
             + + + D+ S G VL+            +   +         K  +  +  L      
Sbjct: 187 GIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG--- 243

Query: 297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI 338
                      +  A     C     D +P    +    R++
Sbjct: 244 ---------YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  150 bits (380), Expect = 3e-43
 Identities = 74/309 (23%), Positives = 134/309 (43%), Gaps = 28/309 (9%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKNLVSL 122
           R LG G FG V+      +GR  A+K L        K+VE   +E  +L+ + H  ++ +
Sbjct: 10  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 69

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
           +G   + ++++ ++ ++I  G +   L   +  P     P     A E   AL YLH+ D
Sbjct: 70  WGT-FQDAQQIFMIMDYIEGGELFSLLRKSQRFP----NPVAKFYAAEVCLALEYLHSKD 124

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           II+RD+K  NILLD N  +K+ DFG ++  P+    +     GTP Y+ PE         
Sbjct: 125 IIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC----GTPDYIAPEVVSTKPYNK 180

Query: 243 KSDVFSFGVVLIELISSMP---AVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES 299
             D +SFG+++ E+++        +  +   +I  + L      N+ + +L+ + +  + 
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDL 240

Query: 300 DNKVRRTINAVAELA----FQCLQSEKDLR-----PYMVDVLDALRDIESDGYDDKKTHE 350
             ++    N   ++     F+ +  EK L      PY   +     D       DK   E
Sbjct: 241 SQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQQGQGDTS---QFDKYPEE 297

Query: 351 EMMTQSPDS 359
           ++       
Sbjct: 298 DINYGVQGE 306

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 6e-43
 Identities = 61/280 (21%), Positives = 104/280 (37%), Gaps = 21/280 (7%)

Query: 69  LGDGGFGTVYYGE-LQDGRAVAVKRL-----YENNYKRVEQFMNEVDILARLRHKNLVSL 122
           LG+G F TVY        + VA+K++      E         + E+ +L  L H N++ L
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 123 YGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD 182
                 H   + LV++F+      D     +     L         + T   L YLH   
Sbjct: 66  LDAF-GHKSNISLVFDFMET----DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 183 IIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           I+HRD+K NN+LLD N  +K+ADFGL++ F +      T    T  Y  PE     ++  
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP-NRAYTHQVVTRWYRAPELLFGARMYG 179

Query: 243 -KSDVFSFGVVLIELISSMPAVDITRHRHEINL--------SNLAINKIQNKALHELVDQ 293
              D+++ G +L EL+  +P +       ++          +      + +   +     
Sbjct: 180 VGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKS 239

Query: 294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD 333
             G    +      + + +L           R      L 
Sbjct: 240 FPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  149 bits (376), Expect = 7e-43
 Identities = 45/297 (15%), Positives = 89/297 (29%), Gaps = 37/297 (12%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           R +G+G FG ++ G  L + + VA+K           Q  +E      L     +     
Sbjct: 11  RRIGEGSFGVIFEGTNLLNNQQVAIKFE--PRRSDAPQLRDEYRTYKLLAGCTGIPNVYY 68

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIH 185
             +     +LV + +                      T    A +  + +  +H   +++
Sbjct: 69  FGQEGLHNVLVIDLLGP----SLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVY 124

Query: 186 RDVKTNNILLDNNF-----CVKVADFGLSRLFPNHVTHVSTAPQ------GTPGYVDPEY 234
           RD+K +N L+          + V DFG+ + + + VT      +      GT  Y+    
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT 294
           H   + + + D+ + G V +  +         +             K Q+  L EL    
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAG- 243

Query: 295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI-------ESDGYD 344
                            +          D  P    +      +       E + +D
Sbjct: 244 -----------FPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTEDENFD 289

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-42
 Identities = 59/282 (20%), Positives = 109/282 (38%), Gaps = 31/282 (10%)

Query: 61  NYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKN 118
           +Y  +++ LG G  G V      +     A+K L     +   +   EV++  R  +  +
Sbjct: 12  DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML-----QDCPKARREVELHWRASQCPH 66

Query: 119 LVSLYGC---TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASAL 175
           +V +           + LL+V E +  G +   +     +          +I      A+
Sbjct: 67  IVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQA--FTEREASEIMKSIGEAI 124

Query: 176 TYLHASDIIHRDVKTNNILLD---NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP 232
            YLH+ +I HRDVK  N+L      N  +K+ DFG ++   +H +  +     TP YV P
Sbjct: 125 QYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTP--CYTPYYVAP 182

Query: 233 EYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD 292
           E     +     D++S GV++  L+   P        H + +S     +I+         
Sbjct: 183 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFY---SNHGLAISPGMKTRIRMGQ------ 233

Query: 293 QTLGYESDNKVRRTINAVA-ELAFQCLQSEKDLRPYMVDVLD 333
               YE  N     ++     L    L++E   R  + + ++
Sbjct: 234 ----YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 1e-42
 Identities = 55/298 (18%), Positives = 123/298 (41%), Gaps = 24/298 (8%)

Query: 54  GELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL-YENNYKRVEQFMNEVDIL 111
           G++ +    + +   +G+G +G V    +  +   VA+K++    +    ++ + E+ IL
Sbjct: 1   GQVFDVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKIL 60

Query: 112 ARLRHKNLVSLYGC---TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIA 168
            R RH+N++ +       +    + + +   +    +   L  +      L         
Sbjct: 61  LRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-----LSNDHICYFL 115

Query: 169 IETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQ--GT 226
            +    L Y+H+++++HRD+K +N+LL+    +K+ DFGL+R+      H     +   T
Sbjct: 116 YQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVAT 175

Query: 227 PGYVDPEYHQCYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK 285
             Y  PE     +   KS D++S G +L E++S+ P      +  ++N     +     +
Sbjct: 176 RWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQE 235

Query: 286 ALHELVDQTLGY----------ESDNKVRRTINAVA-ELAFQCLQSEKDLRPYMVDVL 332
            L+ +++                  N++    ++ A +L  + L      R  +   L
Sbjct: 236 DLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  148 bits (375), Expect = 2e-42
 Identities = 61/237 (25%), Positives = 99/237 (41%), Gaps = 14/237 (5%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRL---YENNYKRVEQFMNEVDILAR-LRHKNLVS 121
           + LG G FG V+  E  +  +  A+K L          VE  M E  +L+    H  L  
Sbjct: 8   KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 67

Query: 122 LYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS 181
           ++    +    L  V E+++ G +  H+                  A E    L +LH+ 
Sbjct: 68  MFCT-FQTKENLFFVMEYLNGGDLMYHIQ----SCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 182 DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLT 241
            I++RD+K +NILLD +  +K+ADFG+ +         +T   GTP Y+ PE     +  
Sbjct: 123 GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT-FCGTPDYIAPEILLGQKYN 181

Query: 242 DKSDVFSFGVVLIELISSMP---AVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
              D +SFGV+L E++         D     H I + N    +   K   +L+ +  
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLF 238

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (370), Expect = 2e-41
 Identities = 57/207 (27%), Positives = 88/207 (42%), Gaps = 15/207 (7%)

Query: 63  FDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVS 121
           +   + +G+G FG VY  +L   G  VA+K++     +       E+ I+ +L H N+V 
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL----QDKRFKNRELQIMRKLDHCNIVR 77

Query: 122 LYGC-----TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           L          +    L LV +++         H  RAK   LP         +   +L 
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAK-QTLPVIYVKLYMYQLFRSLA 136

Query: 177 YLHASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDP-EY 234
           Y+H+  I HRD+K  N+LLD +   +K+ DFG ++       +VS        Y  P   
Sbjct: 137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICS--RYYRAPELI 194

Query: 235 HQCYQLTDKSDVFSFGVVLIELISSMP 261
                 T   DV+S G VL EL+   P
Sbjct: 195 FGATDYTSSIDVWSAGCVLAELLLGQP 221

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  145 bits (365), Expect = 2e-41
 Identities = 53/278 (19%), Positives = 107/278 (38%), Gaps = 16/278 (5%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVK--RLYENNYKRVEQFMNEVDILARLRHKNLVSLYG 124
            ++G+G +G VY  +   G   A+K  RL + +       + E+ IL  L+H N+V LY 
Sbjct: 8   EKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYD 67

Query: 125 CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDII 184
                 + L+LV+E +           E    G L   T     ++  + + Y H   ++
Sbjct: 68  VI-HTKKRLVLVFEHLDQDLKKLLDVCE----GGLESVTAKSFLLQLLNGIAYCHDRRVL 122

Query: 185 HRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKS 244
           HRD+K  N+L++    +K+ADFGL+R F   V   +                  + +   
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182

Query: 245 DVFSFGVVLIELISSMPAVDITRHRHEINL--------SNLAINKIQNKALHELVDQTLG 296
           D++S G +  E+++  P         ++          ++     +     ++       
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242

Query: 297 YESDNKVRRTINAVA-ELAFQCLQSEKDLRPYMVDVLD 333
                   + ++    +L  + L+ + + R      L+
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (366), Expect = 3e-41
 Identities = 64/293 (21%), Positives = 118/293 (40%), Gaps = 30/293 (10%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKR--VEQFMNEVDILARLRHKNLVSLY 123
            ++G G FG V+     + G+ VA+K++   N K       + E+ IL  L+H+N+V+L 
Sbjct: 16  AKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLI 75

Query: 124 GC-------TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
                     +R    + LV++F  +       +               ++     + L 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSN----VLVKFTLSEIKRVMQMLLNGLY 131

Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF---PNHVTHVSTAPQGTPGYVDPE 233
           Y+H + I+HRD+K  N+L+  +  +K+ADFGL+R F    N   +  T    T  Y  PE
Sbjct: 132 YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPE 191

Query: 234 YHQCYQL-TDKSDVFSFGVVLIELISSMPAVDITRHRHEINL--------SNLAINKIQN 284
                +      D++  G ++ E+ +  P +     +H++ L        +      + N
Sbjct: 192 LLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDN 251

Query: 285 KALHELVDQTLGYESDNKVRRTINAVAELAF----QCLQSEKDLRPYMVDVLD 333
             L+E ++   G +   K R         A     + L  +   R    D L+
Sbjct: 252 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (365), Expect = 6e-41
 Identities = 74/312 (23%), Positives = 119/312 (38%), Gaps = 23/312 (7%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRL---YENNYKRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V        GR  A+K L          V   + E  +L   RH  
Sbjct: 7   FDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPF 66

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           L +L      H R L  V E+ + G +  HL     +              E  SAL YL
Sbjct: 67  LTALKYAFQTHDR-LCFVMEYANGGELFFHLS----RERVFTEERARFYGAEIVSALEYL 121

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+ D+++RD+K  N++LD +  +K+ DFGL +   +          GTP Y+ PE  +  
Sbjct: 122 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT-MKTFCGTPEYLAPEVLEDN 180

Query: 239 QLTDKSDVFSFGVVLIELISSMP---AVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
                 D +  GVV+ E++         D  R    I +  +   +  +     L+   L
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTLSPEAKSLLAGLL 240

Query: 296 GYESDNKVRRTINAVAELA----FQCLQ----SEKDLRPYMVDVLDALRDIESDGYDDKK 347
             +   ++    +   E+     F  +      +K L P     + +  D     +DD+ 
Sbjct: 241 KKDPKQRLGGGPSDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTSEVDTRY--FDDEF 298

Query: 348 THEEMMTQSPDS 359
           T + +    PD 
Sbjct: 299 TAQSITITPPDR 310

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 9e-41
 Identities = 57/240 (23%), Positives = 95/240 (39%), Gaps = 21/240 (8%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLY------ENNYKRVEQFMNEVDILARLR--HK 117
             LG GGFG+VY G  + D   VA+K +               +   EV +L ++     
Sbjct: 10  PLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS 69

Query: 118 NLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTY 177
            ++ L           +L+ E             ER   GAL          +   A+ +
Sbjct: 70  GVIRLLDW-FERPDSFVLILERPEPVQDLFDFITER---GALQEELARSFFWQVLEAVRH 125

Query: 178 LHASDIIHRDVKTNNILLD-NNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQ 236
            H   ++HRD+K  NIL+D N   +K+ DFG   L  + V    T   GT  Y  PE+ +
Sbjct: 126 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVY---TDFDGTRVYSPPEWIR 182

Query: 237 CYQLTDKS-DVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
            ++   +S  V+S G++L +++      +   H  EI    +   +  +     L+   L
Sbjct: 183 YHRYHGRSAAVWSLGILLYDMVCGDIPFE---HDEEIIRGQVFFRQRVSSECQHLIRWCL 239

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 1e-40
 Identities = 56/282 (19%), Positives = 107/282 (37%), Gaps = 16/282 (5%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKR--VEQFMNEVDILARLRHKNL 119
           F    ++G+G +G VY       G  VA+K++  +          + E+ +L  L H N+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 120 VSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLH 179
           V L         +L LV+EF+           + +    +P P       +    L + H
Sbjct: 64  VKLLDVI-HTENKLYLVFEFLHQD---LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH 119

Query: 180 ASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQ 239
           +  ++HRD+K  N+L++    +K+ADFGL+R F   V   +                C  
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179

Query: 240 LTDKSDVFSFGVVLIELISS---MPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG 296
            +   D++S G +  E+++     P          I  +    +++    +  + D    
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239

Query: 297 Y-----ESDNKVRRTINAVA-ELAFQCLQSEKDLRPYMVDVL 332
           +     +  +KV   ++     L  Q L  + + R      L
Sbjct: 240 FPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAAL 281

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  144 bits (363), Expect = 2e-40
 Identities = 67/310 (21%), Positives = 116/310 (37%), Gaps = 21/310 (6%)

Query: 63  FDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNY---KRVEQFMNEVDILARLRHKN 118
           FD  + LG G FG V   +  + G   A+K L +      K++E  +NE  IL  +    
Sbjct: 43  FDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPF 102

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
           LV L      +   L +V E+++ G +  HL     + G    P     A +      YL
Sbjct: 103 LVKLEFSFKDN-SNLYMVMEYVAGGEMFSHLR----RIGRFSEPHARFYAAQIVLTFEYL 157

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H+ D+I+RD+K  N+L+D    ++V DFG ++        +     GTP  + PE     
Sbjct: 158 HSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL----CGTPEALAPEIILSK 213

Query: 239 QLTDKSDVFSFGVVLIELISSMP---AVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
                 D ++ GV++ E+ +  P   A    +   +I    +      +  L +L+   L
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLL 273

Query: 296 GYESDNKVRRTINAVAELA----FQCLQSEKDL-RPYMVDVLDALRDIESDGYDDKKTHE 350
             +   +     N V ++     F          R      +   +        D    E
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFKGPGDTSNFDDYEEE 333

Query: 351 EMMTQSPDSV 360
           E+     +  
Sbjct: 334 EIRVSINEKC 343

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  144 bits (364), Expect = 2e-40
 Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 16/206 (7%)

Query: 61  NYFDSARELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKR---VEQFMNEVDILARLR- 115
           N F   R +G GGFG VY       G+  A+K L +   K        +NE  +L+ +  
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 116 --HKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETAS 173
                +V +         +L  + + ++ G +  HL     + G          A E   
Sbjct: 64  GDCPFIVCMSYA-FHTPDKLSFILDLMNGGDLHYHLS----QHGVFSEADMRFYAAEIIL 118

Query: 174 ALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPE 233
            L ++H   +++RD+K  NILLD +  V+++D GL+  F     H S    GT GY+ PE
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS---VGTHGYMAPE 175

Query: 234 YHQCYQLTD-KSDVFSFGVVLIELIS 258
             Q     D  +D FS G +L +L+ 
Sbjct: 176 VLQKGVAYDSSADWFSLGCMLFKLLR 201

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 6e-39
 Identities = 62/295 (21%), Positives = 112/295 (37%), Gaps = 37/295 (12%)

Query: 50  VFSYGELEEATNYFDSARELGDGGFGTVYYG-ELQDGRAVAVKRL------YENNYKRVE 102
           VF    ++   +Y+D+  ELG G F  V    E   G   A K +              E
Sbjct: 2   VFRQENVD---DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSRE 58

Query: 103 QFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWP 162
               EV IL  ++H N+++L+     +  +++L+ E ++ G     L    A+  +L   
Sbjct: 59  DIEREVSILKEIQHPNVITLHEV-YENKTDVILILELVAGG----ELFDFLAEKESLTEE 113

Query: 163 TRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFC----VKVADFGLSRLFPNHVTH 218
              +   +  + + YLH+  I H D+K  NI+L +       +K+ DFGL+        +
Sbjct: 114 EATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF--GN 171

Query: 219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA 278
                 GTP +V PE      L  ++D++S GV+   L        ++     +  +   
Sbjct: 172 EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL--------LSGASPFLGDTKQE 223

Query: 279 INKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD 333
                +   +E  D+     S            +   + L  +   R  + D L 
Sbjct: 224 TLANVSAVNYEFEDEYFSNTSA--------LAKDFIRRLLVKDPKKRMTIQDSLQ 270

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (339), Expect = 1e-37
 Identities = 62/280 (22%), Positives = 113/280 (40%), Gaps = 18/280 (6%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLY--ENNYKRVEQFMNEVDILARLRHKNLVSLY 123
            ++G+G +GTV+  +  +    VA+KR+   +++       + E+ +L  L+HKN+V L+
Sbjct: 8   EKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLH 67

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
                  ++L LV+EF       D      +  G L          +    L + H+ ++
Sbjct: 68  DVL-HSDKKLTLVFEFCDQ----DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNV 122

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           +HRD+K  N+L++ N  +K+A+FGL+R F   V   S                    +  
Sbjct: 123 LHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182

Query: 244 SDVFSFGVVLIELISS----MPAVDITRHRHEINLSNLAINKIQNKALHELVD-----QT 294
            D++S G +  EL ++     P  D+      I        + Q  ++ +L D       
Sbjct: 183 IDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMY 242

Query: 295 LGYESDNKVRRTINAVA-ELAFQCLQSEKDLRPYMVDVLD 333
               S   V   +NA   +L    L+     R    + L 
Sbjct: 243 PATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 5e-36
 Identities = 53/281 (18%), Positives = 103/281 (36%), Gaps = 18/281 (6%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLY--ENNYKRVEQFMNEVDILARLRHKNLVSLY 123
           + +G G +G V    + + G  VA+K+LY    +    ++   E+ +L  +RH+N++ L 
Sbjct: 24  QPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLL 83

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
                    L    +F           G+  K   L       +  +    L Y+HA+ I
Sbjct: 84  DV-FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGI 142

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           IHRD+K  N+ ++ +  +K+ DFGL+R   + +T                     + T  
Sbjct: 143 IHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRA---PEVILNWMRYTQT 199

Query: 244 SDVFSFGVVLIELISSMP--------AVDITRHRHEINLSNLAINKIQNKALHELVDQTL 295
            D++S G ++ E+I+                  +         + ++Q+      +    
Sbjct: 200 VDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLP 259

Query: 296 GYESDNKVRRTINAVAE---LAFQCLQSEKDLRPYMVDVLD 333
             E  +      NA      L  + L  + + R    + L 
Sbjct: 260 ELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA 300

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  127 bits (319), Expect = 2e-34
 Identities = 49/200 (24%), Positives = 86/200 (43%), Gaps = 17/200 (8%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYG 124
           R+LG G +  V+    + +   V VK L      + ++   E+ IL  LR   N+++L  
Sbjct: 41  RKLGRGKYSEVFEAINITNNEKVVVKIL---KPVKKKKIKREIKILENLRGGPNIITLAD 97

Query: 125 -CTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
                 SR   LV+E ++N                L          E   AL Y H+  I
Sbjct: 98  IVKDPVSRTPALVFEHVNNTDFKQLYQT-------LTDYDIRFYMYEILKALDYCHSMGI 150

Query: 184 IHRDVKTNNILLDN-NFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTD 242
           +HRDVK +N+++D+ +  +++ D+GL+  +     +       +  +  PE    YQ+ D
Sbjct: 151 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY--NVRVASRYFKGPELLVDYQMYD 208

Query: 243 -KSDVFSFGVVLIELISSMP 261
              D++S G +L  +I    
Sbjct: 209 YSLDMWSLGCMLASMIFRKE 228

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (316), Expect = 6e-34
 Identities = 54/205 (26%), Positives = 85/205 (41%), Gaps = 14/205 (6%)

Query: 67  RELGDGGFGTVYYGEL----QDGRAVAVKRL----YENNYKRVEQFMNEVDILARLRHKN 118
           + LG G +G V+          G+  A+K L         K  E    E  +L  +R   
Sbjct: 30  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 89

Query: 119 LVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
            +       +   +L L+ ++I+ G +  HL     +              E   AL +L
Sbjct: 90  FLVTLHYAFQTETKLHLILDYINGGELFTHLS----QRERFTEHEVQIYVGEIVLALEHL 145

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQC- 237
           H   II+RD+K  NILLD+N  V + DFGLS+ F    T  +    GT  Y+ P+  +  
Sbjct: 146 HKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGG 205

Query: 238 -YQLTDKSDVFSFGVVLIELISSMP 261
                   D +S GV++ EL++   
Sbjct: 206 DSGHDKAVDWWSLGVLMYELLTGAS 230

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 9e-33
 Identities = 45/203 (22%), Positives = 85/203 (41%), Gaps = 17/203 (8%)

Query: 67  RELGDGGFGTVYYG-ELQDGRAVAVKRLY--ENNYKRVEQFMNEVDILARLRHKNLVSLY 123
           + +G G  G V    +    R VA+K+L     N    ++   E+ ++  + HKN++SL 
Sbjct: 23  KPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLL 82

Query: 124 GC-----TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYL 178
                  T    +++ LV E +                          +  +    + +L
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL-------DHERMSYLLYQMLCGIKHL 135

Query: 179 HASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCY 238
           H++ IIHRD+K +NI++ ++  +K+ DFGL+R        + T    T  Y  PE     
Sbjct: 136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS--FMMTPYVVTRYYRAPEVILGM 193

Query: 239 QLTDKSDVFSFGVVLIELISSMP 261
              +  D++S G ++ E++    
Sbjct: 194 GYKENVDIWSVGCIMGEMVRHKI 216

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (298), Expect = 3e-31
 Identities = 42/198 (21%), Positives = 82/198 (41%), Gaps = 7/198 (3%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRL--YENNYKRVEQFMNEVDILARLRHKNLVSLY 123
             +G G +G+V      + G  VAVK+L     +    ++   E+ +L  ++H+N++ L 
Sbjct: 24  SPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLL 83

Query: 124 GCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDI 183
                 +R L    +      +         K   L       +  +    L Y+H++DI
Sbjct: 84  DV-FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI 142

Query: 184 IHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDK 243
           IHRD+K +N+ ++ +  +K+ DFGL+R   + +T                          
Sbjct: 143 IHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT---GYVATRWYRAPEIMLNWMHYNQT 199

Query: 244 SDVFSFGVVLIELISSMP 261
            D++S G ++ EL++   
Sbjct: 200 VDIWSVGCIMAELLTGRT 217

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  113 bits (284), Expect = 3e-29
 Identities = 46/214 (21%), Positives = 85/214 (39%), Gaps = 24/214 (11%)

Query: 67  RELGDGGFGTVYYGE-LQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGC 125
           R+LG G F TV+  + + +   VA+K +   +    E   +E+ +L R+   +       
Sbjct: 19  RKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 77

Query: 126 TSRHSRELLLVYEFISNGTVADHLHGE-----------RAKPGALPWPTRLKIAIETASA 174
            + H  +LL  +       V   +  E           + +   +P     +I+ +    
Sbjct: 78  GANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLG 137

Query: 175 LTYLHASD-IIHRDVKTNNILLDNNFC------VKVADFGLSRLFPNHVTHVSTAPQGTP 227
           L Y+H    IIH D+K  N+L++          +K+AD G +  +  H T+       T 
Sbjct: 138 LDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS----IQTR 193

Query: 228 GYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMP 261
            Y  PE          +D++S   ++ ELI+   
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 85.2 bits (210), Expect = 3e-20
 Identities = 23/154 (14%), Positives = 46/154 (29%), Gaps = 19/154 (12%)

Query: 67  RELGDGGFGTVYYGELQDGRAVAVKRLYENN----------YKRVEQFMNEVDILARLRH 116
           + +G+G    V+    +      VK     +                F       AR   
Sbjct: 6   KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65

Query: 117 KNLVSLYGCTSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALT 176
           + L  L G           VY +  N  + + +  +      +  P   ++       + 
Sbjct: 66  RALQKLQGLAVPK------VYAWEGNAVLMELIDAKELYRVRVENP--DEVLDMILEEVA 117

Query: 177 YLHASDIIHRDVKTNNILLDNNFCVKVADFGLSR 210
             +   I+H D+   N+L+     + + DF  S 
Sbjct: 118 KFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	375
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.8
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.2
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.74
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.73
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	97.67
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.07

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-57  Score=396.93  Aligned_cols=257  Identities=26%  Similarity=0.464  Sum_probs=200.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ++|++.+.||+|+||+||+|.+.+++.||||++..... ..+.+.+|+.++++++||||+++++++.. ....++||||+
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLE-QAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcC-cHHHHHHHHHHHHhcCCCCcccccceecc-CCceEEEEEec
Confidence            46888999999999999999998888999999875443 34678999999999999999999998776 56789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      ++|+|.+++...   ...+++..++.++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++..........
T Consensus        83 ~~g~L~~~l~~~---~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~  159 (263)
T d1sm2a_          83 EHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS  159 (263)
T ss_dssp             TTCBHHHHHHTT---TTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC-------------
T ss_pred             CCCcHHHHhhcc---ccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceee
Confidence            999999998643   35689999999999999999999999999999999999999999999999999987655444444


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....||+.|+|||++.+..++.++|||||||++|||+| |.+||......      .. ..         .+........
T Consensus       160 ~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~------~~-~~---------~i~~~~~~~~  223 (263)
T d1sm2a_         160 TGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNS------EV-VE---------DISTGFRLYK  223 (263)
T ss_dssp             -----CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHH------HH-HH---------HHHHTCCCCC
T ss_pred             cceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHH------HH-HH---------HHHhcCCCCC
Confidence            45568999999999999999999999999999999999 56666543211      00 11         1111111111


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                         +..++..+.+++.+||+.||++|||++||++.|++|...
T Consensus       224 ---p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         224 ---PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             ---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---ccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence               123456789999999999999999999999999998653

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-56  Score=394.85  Aligned_cols=249  Identities=23%  Similarity=0.368  Sum_probs=206.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      ++|++.++||+|+||+||+|.. .+|+.||||++........+.+.+|+.+++.++||||+++++++.. .+.+|+||||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmEy   98 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-GDELWVVMEY   98 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-CCEEEEEEEe
Confidence            4799999999999999999965 4799999999876655556789999999999999999999998776 6789999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      |++|+|.+++..     ..+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+..... .
T Consensus        99 ~~gg~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~-~  172 (293)
T d1yhwa1          99 LAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-K  172 (293)
T ss_dssp             CTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC-C
T ss_pred             cCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc-c
Confidence            999999998743     3589999999999999999999999999999999999999999999999999987644322 2


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|++||.......      ...         .+..... .. 
T Consensus       173 ~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~~~---------~~~~~~~-~~-  235 (293)
T d1yhwa1         173 RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR------ALY---------LIATNGT-PE-  235 (293)
T ss_dssp             BCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------HHH---------HHHHHCS-CC-
T ss_pred             ccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHH------HHH---------HHHhCCC-CC-
Confidence            345579999999999999999999999999999999999999996443211      000         0111100 00 


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ......++..+.+|+.+||+.||++|||+.|+++
T Consensus       236 ~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         236 LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0111235577999999999999999999999874

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-57  Score=394.90  Aligned_cols=252  Identities=25%  Similarity=0.372  Sum_probs=201.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|++.+.||+|+||+||+|..+ +|+.||+|++..... ...+.+.+|+.+++.++||||+++++++.. .+.+|+||
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-~~~~~ivm   82 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-GNIQYLFL   82 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CceeEEEE
Confidence            356999999999999999999765 789999999865532 334568899999999999999999998876 67899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc-
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  216 (375)
                      |||++|+|.+++.    ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        83 Ey~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~  158 (271)
T d1nvra_          83 EYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR  158 (271)
T ss_dssp             ECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred             eccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence            9999999999984    33569999999999999999999999999999999999999999999999999998764332 


Q ss_pred             cccccCCCCCccccCcccccccCC-CCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQL-TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .......+||+.|+|||++.+..+ +.++||||+||++|||++|++||.........      ..        ...... 
T Consensus       159 ~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~------~~--------~~~~~~-  223 (271)
T d1nvra_         159 ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE------YS--------DWKEKK-  223 (271)
T ss_dssp             ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH------HH--------HHHTTC-
T ss_pred             cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH------HH--------HHhcCC-
Confidence            223345679999999999988776 56899999999999999999999754422110      00        000000 


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        .........+..+.+|+.+||+.||++|||++|+++
T Consensus       224 --~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         224 --TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             --TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --CCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence              111111234567889999999999999999999864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-57  Score=397.15  Aligned_cols=261  Identities=29%  Similarity=0.468  Sum_probs=204.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|++.+.||+|+||+||+|+++  ..||||++...  .....+.|.+|+.++++++|||||++++++..  ..+++||
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~--~~~~lv~   82 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA--PQLAIVT   82 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS--SSCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec--cEEEEEE
Confidence            467999999999999999999865  35999998643  44556789999999999999999999997643  4589999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc-
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV-  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-  216 (375)
                      |||++|+|.+++...   ...+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        83 Ey~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~  159 (276)
T d1uwha_          83 QWCEGSSLYHHLHII---ETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG  159 (276)
T ss_dssp             ECCCEEEHHHHHHTS---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC------
T ss_pred             ecCCCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC
Confidence            999999999999643   3459999999999999999999999999999999999999999999999999998764322 


Q ss_pred             cccccCCCCCccccCcccccc---cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          217 THVSTAPQGTPGYVDPEYHQC---YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ........||+.|+|||++.+   ..++.++|||||||++|||+||+.||.......      .....+..        .
T Consensus       160 ~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~------~~~~~~~~--------~  225 (276)
T d1uwha_         160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD------QIIFMVGR--------G  225 (276)
T ss_dssp             ------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH------HHHHHHHH--------T
T ss_pred             cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHH------HHHHHHhc--------C
Confidence            223345579999999998864   357889999999999999999999997543211      01111110        0


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ............+++.+.+|+.+||+.+|++|||+.+|++.|+.+...
T Consensus       226 ~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         226 YLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             SCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            000011111123456899999999999999999999999999998764

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-57  Score=396.00  Aligned_cols=257  Identities=25%  Similarity=0.418  Sum_probs=209.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      .++|++.+.||+|+||.||+|..+++..||||++..... ..+.+.+|+.++++++|||||++++++..  +..++||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~~~~~~~E~~~l~~l~HpnIv~~~g~~~~--~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-SPDAFLAEANLMKQLQHQRLVRLYAVVTQ--EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-CHHHHHHHHHHHHhCCCCCEeEEEeeecc--CCeEEEEEe
Confidence            456888999999999999999998889999999965433 34679999999999999999999997654  457999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +++|+|.+++...  ....+++.++..++.||+.||.|||++||+||||||+|||+++++.+||+|||+++.........
T Consensus        89 ~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~  166 (272)
T d1qpca_          89 MENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTA  166 (272)
T ss_dssp             CTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEEC
T ss_pred             CCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccc
Confidence            9999999987433  23458999999999999999999999999999999999999999999999999998876554444


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCC-CCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSM-PAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      .....+|+.|+|||++.+..++.++|||||||++|||+||. +|+.......       ...         .+.....  
T Consensus       167 ~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~-------~~~---------~i~~~~~--  228 (272)
T d1qpca_         167 REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE-------VIQ---------NLERGYR--  228 (272)
T ss_dssp             CTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-------HHH---------HHHTTCC--
T ss_pred             ccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHH-------HHH---------HHHhcCC--
Confidence            45567899999999999889999999999999999999954 5554332110       001         1111111  


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                       ...+..++..+.+|+.+||+.+|++|||+++|++.|+++-.
T Consensus       229 -~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         229 -MVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             -CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -CCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence             11112355679999999999999999999999999998643

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-55  Score=385.35  Aligned_cols=254  Identities=26%  Similarity=0.458  Sum_probs=212.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ++|++.++||+|+||+||+|+.++++.||||+++.... ..+.+.+|+.++++++||||++++|++.. ...+++||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~-~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~-~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM-SEDEFIEEAKVMMNLSHEKLVQLYGVCTK-QRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSS-CHHHHHHHHHHHHTCCCTTBCCEEEEECC-SSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcC-CHHHHHHHHHHHHhcCCCceeeEEEEEee-CCceEEEEEcc
Confidence            57999999999999999999998888999999876543 34678999999999999999999998776 56799999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      ++|+|..++...   ...+++..++.++.|++.||.|||++||+||||||+||+++.++.+||+|||++...........
T Consensus        82 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  158 (258)
T d1k2pa_          82 ANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSS  158 (258)
T ss_dssp             TTEEHHHHHHSG---GGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCC
T ss_pred             CCCcHHHhhhcc---ccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceee
Confidence            999999997543   34589999999999999999999999999999999999999999999999999987655444444


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||+......       ....         +.....   
T Consensus       159 ~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~-------~~~~---------i~~~~~---  219 (258)
T d1k2pa_         159 VGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE-------TAEH---------IAQGLR---  219 (258)
T ss_dssp             CCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH-------HHHH---------HHTTCC---
T ss_pred             cccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH-------HHHH---------HHhCCC---
Confidence            45678999999999999999999999999999999998 899997554211       0111         111111   


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhh
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDI  338 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i  338 (375)
                      ...+..++..+.+|+.+||+.+|++|||++++++.|.+|
T Consensus       220 ~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         220 LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             CCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence            111123456899999999999999999999999999764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9e-57  Score=398.61  Aligned_cols=260  Identities=29%  Similarity=0.428  Sum_probs=212.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .++|++.+.||+|+||+||+|..+ +|+.||||++.... ...+++.+|+.+|++++|||||++++++.. ...+++|||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv~E   93 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCTR-EPPFYIITE   93 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSSCEEEEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEee-CCeeEEEee
Confidence            456888999999999999999775 58899999986543 345679999999999999999999998776 677899999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      ||++|+|.+++...  ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........
T Consensus        94 ~~~~g~l~~~l~~~--~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~  171 (287)
T d1opja_          94 FMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT  171 (287)
T ss_dssp             CCTTCBHHHHHHHS--CTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE
T ss_pred             cccCcchHHHhhhc--cccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCce
Confidence            99999999998654  3456899999999999999999999999999999999999999999999999999877655444


Q ss_pred             cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          219 VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      ......|++.|+|||++.+..++.++|||||||++|||++|..|+......               ....+.+.......
T Consensus       172 ~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~---------------~~~~~~i~~~~~~~  236 (287)
T d1opja_         172 AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL---------------SQVYELLEKDYRME  236 (287)
T ss_dssp             EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCH---------------HHHHHHHHTTCCCC
T ss_pred             eeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchH---------------HHHHHHHhcCCCCC
Confidence            444456889999999999999999999999999999999966555322111               01111222222211


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .+   ..++..+.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       237 ~~---~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~~  276 (287)
T d1opja_         237 RP---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE  276 (287)
T ss_dssp             CC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTSS
T ss_pred             CC---ccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence            11   23557899999999999999999999999999987654

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-57  Score=395.70  Aligned_cols=253  Identities=25%  Similarity=0.410  Sum_probs=196.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeec-CCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSR-HSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-~~~~~~lv  136 (375)
                      ++|++.+.||+|+||+||+|..+ +|+.||+|++...  .....+.+.+|+.++++++||||+++++++.. ....+|+|
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv   83 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV   83 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence            46899999999999999999664 7899999998654  33445678999999999999999999997653 34568999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC-----ceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD-----IIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~-----ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      ||||++|+|.+++.........+++..++.++.||+.||.|||++|     |+||||||+|||++.++.+||+|||++..
T Consensus        84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~  163 (269)
T d2java1          84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI  163 (269)
T ss_dssp             EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred             EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence            9999999999998765445567999999999999999999999976     99999999999999999999999999987


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ...... ......||+.|+|||++.+..++.++|||||||++|||+||++||.......       ....        +.
T Consensus       164 ~~~~~~-~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~-------~~~~--------i~  227 (269)
T d2java1         164 LNHDTS-FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKE-------LAGK--------IR  227 (269)
T ss_dssp             C------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH-------HHHH--------HH
T ss_pred             cccCCC-ccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHH-------HHHH--------HH
Confidence            654322 2334579999999999999999999999999999999999999997543211       1111        11


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .....    ..+..+++++.+|+.+||+.||++|||+.|+++
T Consensus       228 ~~~~~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         228 EGKFR----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HTCCC----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             cCCCC----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            11111    111234567999999999999999999999975

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-56  Score=388.84  Aligned_cols=245  Identities=28%  Similarity=0.434  Sum_probs=203.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||+||+|..+ +++.||+|++....   ....+.+.+|+.+++.++||||+++++++.. ...+++|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHD-ATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEE-CCEEEEE
Confidence            46889999999999999999765 68999999986442   2335678899999999999999999998776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||||++|+|.+++...    ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        85 mEy~~~g~L~~~l~~~----~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~  160 (263)
T d2j4za1          85 LEYAPLGTVYRELQKL----SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR  160 (263)
T ss_dssp             EECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred             EeecCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCCc
Confidence            9999999999999543    459999999999999999999999999999999999999999999999999998654432


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                         .....||+.|+|||++.+..++.++|||||||++|+|++|++||.......      . .        ..+..... 
T Consensus       161 ---~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~-~--------~~i~~~~~-  221 (263)
T d2j4za1         161 ---RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE------T-Y--------KRISRVEF-  221 (263)
T ss_dssp             ---CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------H-H--------HHHHTTCC-
T ss_pred             ---ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH------H-H--------HHHHcCCC-
Confidence               234569999999999999999999999999999999999999997543111      0 1        11111111 


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       ..+   ..+++++.+|+.+||+.||++|||++|+++
T Consensus       222 -~~p---~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         222 -TFP---DFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             -CCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             -CCC---ccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence             111   124567899999999999999999999986

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2e-55  Score=392.24  Aligned_cols=258  Identities=25%  Similarity=0.451  Sum_probs=198.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CC---CEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DG---RAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~---~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|++.+.||+|+||+||+|..+ ++   ..||||.+... .....+.|.+|+.+|++++|||||++++++.. ...+++
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-~~~~~i  104 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-STPVMI  104 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSSCEE
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-CCEEEE
Confidence            45677889999999999999765 23   35889988654 44456789999999999999999999998766 567999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      |||||++|+|.+++...   ...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus       105 v~Ey~~~g~L~~~~~~~---~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EEECCTTEEHHHHHHTT---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEecCCCcceeeeccc---cCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999999988543   346999999999999999999999999999999999999999999999999999876533


Q ss_pred             ccc----cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          216 VTH----VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       216 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ...    ......+|+.|+|||.+.+..++.++|||||||++|||+| |++||.......                +...
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~----------------~~~~  245 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQD----------------VINA  245 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH----------------HHHH
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHH----------------HHHH
Confidence            221    1122357899999999999999999999999999999998 899997543211                0111


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      +.....   .+.+..++..+.+|+.+||+.+|++|||+.||++.|+++.++
T Consensus       246 i~~~~~---~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         246 IEQDYR---LPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             HHTTCC---CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             HHcCCC---CCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            111111   112234567899999999999999999999999999988653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-55  Score=387.37  Aligned_cols=251  Identities=27%  Similarity=0.394  Sum_probs=204.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      +.|++.+.||+|+||.||+|... +|+.||+|++........+.+.+|+.++++++|||||++++++.. .+.+++||||
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~lvmEy   90 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-ENNLWILIEF   90 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-TTEEEEEEEC
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-CCeEEEEEec
Confidence            45888999999999999999765 789999999977666667788999999999999999999998776 6789999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      |++|+|.+++...   ...+++.++..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ..
T Consensus        91 ~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~~  166 (288)
T d2jfla1          91 CAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR  166 (288)
T ss_dssp             CTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-HH
T ss_pred             CCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc-cc
Confidence            9999999987542   3469999999999999999999999999999999999999999999999999997543221 12


Q ss_pred             ccCCCCCccccCccccc-----ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          220 STAPQGTPGYVDPEYHQ-----CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~-----~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      .....||+.|+|||++.     +..++.++|||||||++|+|++|++||.......      ..         ..+....
T Consensus       167 ~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~------~~---------~~i~~~~  231 (288)
T d2jfla1         167 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMR------VL---------LKIAKSE  231 (288)
T ss_dssp             HTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGG------HH---------HHHHHSC
T ss_pred             ccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHH------HH---------HHHHcCC
Confidence            23457999999999873     4568899999999999999999999997543221      11         1111110


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .  ........++.++.+|+.+||+.||++|||+.|+++
T Consensus       232 ~--~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         232 P--PTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             C--CCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             C--CCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0  011112235678999999999999999999999875

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-55  Score=389.80  Aligned_cols=249  Identities=23%  Similarity=0.371  Sum_probs=202.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||+||+|... +|+.||||++....   ....+.+.+|+.++++++||||+++++++.. .+.+|+|
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-~~~~~iv   86 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQD-DEKLYFG   86 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEEC-SSEEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEE-CCEEEEE
Confidence            45899999999999999999764 78999999986542   2345678999999999999999999998776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||||++|+|.+++...    +.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++..+....
T Consensus        87 mEy~~gg~L~~~~~~~----~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  162 (288)
T d1uu3a_          87 LSYAKNGELLKYIRKI----GSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES  162 (288)
T ss_dssp             ECCCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred             EEccCCCCHHHhhhcc----CCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCC
Confidence            9999999999988543    469999999999999999999999999999999999999999999999999998765332


Q ss_pred             -cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          217 -THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       217 -~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|++||.......       ..        ..+.....
T Consensus       163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~-------~~--------~~i~~~~~  227 (288)
T d1uu3a_         163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL-------IF--------QKIIKLEY  227 (288)
T ss_dssp             -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HH--------HHHHTTCC
T ss_pred             cccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH-------HH--------HHHHcCCC
Confidence             222344579999999999999999999999999999999999999997543111       00        11111111


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                        ..+   ..+++.+.+|+.+||+.||++|||++|+++.
T Consensus       228 --~~p---~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         228 --DFP---EKFFPKARDLVEKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             --CCC---TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCH
T ss_pred             --CCC---ccCCHHHHHHHHHHccCCHhHCcCHHHHcCC
Confidence              111   1245678999999999999999999997653

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-54  Score=383.29  Aligned_cols=256  Identities=25%  Similarity=0.369  Sum_probs=206.6

Q ss_pred             cCCCCCC-ccCCCCcEEEEEEEeC---CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSAR-ELGDGGFGTVYYGELQ---DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~-~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|.+.+ +||+|+||.||+|..+   ++..||||++... .....+.+.+|+.+|++++|||||++++++..  +.+++
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CeEEE
Confidence            3455566 4999999999999654   3557999998754 34456789999999999999999999998764  45899


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++|+|.+++..   ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        86 vmE~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhccccc
Confidence            9999999999998843   3356999999999999999999999999999999999999999999999999999876543


Q ss_pred             ccc--cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          216 VTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       216 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ...  ......||+.|+|||++.+..++.++|||||||++|||+| |++||.......       ....         +.
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~-------~~~~---------i~  226 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE-------VMAF---------IE  226 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH-------HHHH---------HH
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH-------HHHH---------HH
Confidence            322  2234468899999999998899999999999999999998 999997543211       0111         11


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      ...   ..+.+..++.++.+|+.+||+.+|++|||+.+|++.|+.+..
T Consensus       227 ~~~---~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         227 QGK---RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             TTC---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cCC---CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            111   111123456789999999999999999999999999987643

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3.7e-54  Score=391.38  Aligned_cols=253  Identities=21%  Similarity=0.330  Sum_probs=208.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .++|++.+.||+|+||.||+|... +|+.||||++........+.+.+|+.+|++++|||||++++++.. .+.+++|||
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~ivmE  103 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-DNEMVMIYE  103 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEE
Confidence            457999999999999999999764 789999999987776667889999999999999999999998776 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec--CCCcEEEeeeccccccCCCc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD--NNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||+||+|.+++..   ..+.+++.++..++.||+.||.|||++||+||||||+|||++  .++.+||+|||++.......
T Consensus       104 ~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~  180 (350)
T d1koaa2         104 FMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  180 (350)
T ss_dssp             CCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred             cCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence            9999999999853   234699999999999999999999999999999999999995  46789999999998765433


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      ..  ....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .         +..+......
T Consensus       181 ~~--~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~------~---------~~~i~~~~~~  243 (350)
T d1koaa2         181 SV--KVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE------T---------LRNVKSCDWN  243 (350)
T ss_dssp             CE--EEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H---------HHHHHHTCCC
T ss_pred             cc--ceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH------H---------HHHHHhCCCC
Confidence            32  33469999999999999999999999999999999999999997543211      0         1111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       ........++..+.+|+.+||..||++|||++|+++.
T Consensus       244 -~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         244 -MDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             -SCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             -CCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             1112222345678999999999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.7e-55  Score=390.76  Aligned_cols=253  Identities=22%  Similarity=0.380  Sum_probs=190.7

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch-hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY-KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~-~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..+.|++.+.||+|+||+||+|..+ +|+.||||++..... .....+.+|+.+|+.++||||+++++++.. +..+|+|
T Consensus         7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~lv   85 (307)
T d1a06a_           7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYES-GGHLYLI   85 (307)
T ss_dssp             GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             CccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEE
Confidence            4467999999999999999999765 689999999865432 234567899999999999999999998776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec---CCCcEEEeeeccccccC
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD---NNFCVKVADFGLSRLFP  213 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~  213 (375)
                      ||||+||+|.+++..    .+.+++.++..++.||+.||+|||++||+||||||+|||+.   +++.+||+|||++....
T Consensus        86 mE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~  161 (307)
T d1a06a_          86 MQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED  161 (307)
T ss_dssp             ECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred             EeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence            999999999999953    35699999999999999999999999999999999999994   57899999999998654


Q ss_pred             CCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          214 NHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       214 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ....  ....+||+.|+|||++.+..++.++|||||||++|+|++|++||.......      .         ...+...
T Consensus       162 ~~~~--~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~---------~~~i~~~  224 (307)
T d1a06a_         162 PGSV--LSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK------L---------FEQILKA  224 (307)
T ss_dssp             -------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH------H---------HHHHHTT
T ss_pred             CCCe--eeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH------H---------HHHHhcc
Confidence            3322  234569999999999999999999999999999999999999997543111      0         0111111


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      .... ..+....+++.+.+|+.+||+.||++|||++|+++.
T Consensus       225 ~~~~-~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         225 EYEF-DSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             CCCC-CTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             CCCC-CCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            1111 111122356789999999999999999999999873

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.6e-54  Score=390.03  Aligned_cols=252  Identities=22%  Similarity=0.331  Sum_probs=207.6

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++..........+.+|+.+|++++|||||++++++.. ...+|+||||
T Consensus        29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~ivmE~  107 (352)
T d1koba_          29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFED-KYEMVLILEF  107 (352)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEEC-SSEEEEEEEC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEEEc
Confidence            4699999999999999999976 4799999999987766666788999999999999999999998776 6789999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec--CCCcEEEeeeccccccCCCcc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD--NNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~--~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      |+||+|.+.+..   ....+++.+++.++.||+.||.|||++||+||||||+|||++  .++.+||+|||++..+.....
T Consensus       108 ~~gg~L~~~~~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         108 LSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             CCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             CCCChHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            999999988743   344699999999999999999999999999999999999997  678999999999987754332


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                        .....||+.|+|||++.+..++.++|||||||++|+|++|++||.......      .         +..+.......
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~---------~~~i~~~~~~~  247 (352)
T d1koba_         185 --VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE------T---------LQNVKRCDWEF  247 (352)
T ss_dssp             --EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH------H---------HHHHHHCCCCC
T ss_pred             --eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------H---------HHHHHhCCCCC
Confidence              233469999999999999999999999999999999999999997543211      0         01111111110


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       .......++.++.+|+.+||+.||++|||+.|+++.
T Consensus       248 -~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         248 -DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             -CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             -CcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence             111112345678999999999999999999999873

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-54  Score=380.08  Aligned_cols=258  Identities=26%  Similarity=0.457  Sum_probs=199.7

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCC-----CEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDG-----RAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      +.|+..+.||+|+||.||+|.++++     ..||||++... .......|.+|+.++++++|||||+++|++.. ....+
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~-~~~~~   85 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISK-YKPMM   85 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-SSSEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEec-CCceE
Confidence            3577788999999999999976532     36999998654 34445678999999999999999999998776 56789


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+.++++.+.+...   ...+++.++..++.|++.||+|||+++|+||||||+|||++.++.+||+|||+++....
T Consensus        86 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~  162 (283)
T d1mqba_          86 IITEYMENGALDKFLREK---DGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLED  162 (283)
T ss_dssp             EEEECCTTEEHHHHHHHT---TTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC------
T ss_pred             EEEEecccCcchhhhhcc---cccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccC
Confidence            999999999999887543   34699999999999999999999999999999999999999999999999999987643


Q ss_pred             Ccc--ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCc-cccccccccchhHHHHHHhhhhHHHHHH
Q 017232          215 HVT--HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAV-DITRHRHEINLSNLAINKIQNKALHELV  291 (375)
Q Consensus       215 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (375)
                      ...  .......||+.|+|||++.+..++.++|||||||++|||++|..|+ ..... .               .....+
T Consensus       163 ~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~---------------~~~~~i  226 (283)
T d1mqba_         163 DPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-H---------------EVMKAI  226 (283)
T ss_dssp             -----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-H---------------HHHHHH
T ss_pred             CCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH-H---------------HHHHHH
Confidence            322  2223346899999999999999999999999999999999965554 32221 0               011111


Q ss_pred             hhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          292 DQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       292 ~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ......   +.+..++..+.+|+.+||+.+|++|||+.||++.|+++.+.
T Consensus       227 ~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         227 NDGFRL---PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             HTTCCC---CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             hccCCC---CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence            111111   11223567799999999999999999999999999988764

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-55  Score=392.18  Aligned_cols=276  Identities=22%  Similarity=0.332  Sum_probs=208.4

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|++.++||+|+||+||+|... +|+.||+|++... .......+.+|+.+|+.++|||||++++++.. ...+++||
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~-~~~~~iVm   83 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-DGEISICM   83 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCEEEEEE
Confidence            567999999999999999999764 7899999998654 33445678999999999999999999998876 67799999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhC-CceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHAS-DIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~-~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||+++|+|.+++...    +.+++..++.++.|++.||.|||++ ||+||||||+|||++.++.+||+|||+|...... 
T Consensus        84 Ey~~gg~L~~~l~~~----~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-  158 (322)
T d1s9ja_          84 EHMDGGSLDQVLKKA----GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  158 (322)
T ss_dssp             ECCTTEEHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EcCCCCcHHHHHhhc----CCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-
Confidence            999999999999643    4589999999999999999999975 9999999999999999999999999999865322 


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccch-hHHHHHHhh------------
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINL-SNLAINKIQ------------  283 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~-~~~~~~~~~------------  283 (375)
                        .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||........... .........            
T Consensus       159 --~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (322)
T d1s9ja_         159 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  236 (322)
T ss_dssp             --TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC---------------------
T ss_pred             --ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccccccc
Confidence              22345799999999999999999999999999999999999999975432211000 000000000            


Q ss_pred             ----------hhHHHHHHhhhcCCCCCh-HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHHhhhcCCC
Q 017232          284 ----------NKALHELVDQTLGYESDN-KVRRTINAVAELAFQCLQSEKDLRPYMVDVLD--ALRDIESDGY  343 (375)
Q Consensus       284 ----------~~~~~~~~~~~l~~~~~~-~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~--~L~~i~~~~~  343 (375)
                                .....+............ .....+.++.+++.+||..||++|||++|+++  .+.+......
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~~~~  309 (322)
T d1s9ja_         237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV  309 (322)
T ss_dssp             ---------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred             ccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCcccc
Confidence                      000011111111000000 00012457899999999999999999999998  4666555443

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.1e-54  Score=378.91  Aligned_cols=248  Identities=24%  Similarity=0.368  Sum_probs=198.6

Q ss_pred             CccCCCCcEEEEEEEeC---CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEeccc
Q 017232           67 RELGDGGFGTVYYGELQ---DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFIS  141 (375)
Q Consensus        67 ~~lg~G~~g~V~~~~~~---~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~~  141 (375)
                      ++||+|+||+||+|.++   .++.||||++...  +....+.+.+|+.+|++++|||||++++++..  +..+|||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~--~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc--CCEEEEEEcCC
Confidence            46999999999999654   3468999998653  23345679999999999999999999998764  35789999999


Q ss_pred             CCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc--c
Q 017232          142 NGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH--V  219 (375)
Q Consensus       142 ~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~--~  219 (375)
                      +|+|.+++...    ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++........  .
T Consensus        91 ~g~L~~~l~~~----~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~  166 (277)
T d1xbba_          91 LGPLNKYLQQN----RHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKA  166 (277)
T ss_dssp             TEEHHHHHHHC----TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC
T ss_pred             CCcHHHHHhhc----cCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccc
Confidence            99999998643    45999999999999999999999999999999999999999999999999999876543222  2


Q ss_pred             ccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCC
Q 017232          220 STAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYE  298 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  298 (375)
                      .....||+.|+|||.+.+..++.++|||||||++|||+| |++||.......                +...+....   
T Consensus       167 ~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~----------------~~~~i~~~~---  227 (277)
T d1xbba_         167 QTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE----------------VTAMLEKGE---  227 (277)
T ss_dssp             ----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH----------------HHHHHHTTC---
T ss_pred             ccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHH----------------HHHHHHcCC---
Confidence            234468999999999999899999999999999999998 899997543111                111111111   


Q ss_pred             CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          299 SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       299 ~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      ..+.+..++.++.+|+.+||+.||++|||+++|++.|+..-
T Consensus       228 ~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         228 RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            11112235678999999999999999999999999988753

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=381.72  Aligned_cols=258  Identities=29%  Similarity=0.455  Sum_probs=203.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ++|++.+.||+|+||.||+|..+++..||||++..... ..+.|.+|+.++++++|||||++++++..  +..++||||+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~~~~~~~E~~~l~~l~h~nIv~~~g~~~~--~~~~lv~Ey~   93 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYM   93 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-CHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCC
T ss_pred             HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-CHHHHHHHHHHHHhcccCCEeEEEEEEec--CCeEEEEEec
Confidence            56899999999999999999998888999999865543 34679999999999999999999998754  4578999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      ++|+|..++...  ....+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++...........
T Consensus        94 ~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  171 (285)
T d1fmka3          94 SKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  171 (285)
T ss_dssp             TTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             CCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceee
Confidence            999999988653  234599999999999999999999999999999999999999999999999999987654443334


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYESD  300 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  300 (375)
                      ....+|+.|+|||++.+..++.++|||||||++|||++|..|+.......     .          ....+.......  
T Consensus       172 ~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~-----~----------~~~~i~~~~~~~--  234 (285)
T d1fmka3         172 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR-----E----------VLDQVERGYRMP--  234 (285)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH-----H----------HHHHHHTTCCCC--
T ss_pred             ccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH-----H----------HHHHHHhcCCCC--
Confidence            44568999999999999999999999999999999999655543222110     0          011111111111  


Q ss_pred             hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          301 NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       301 ~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                       ....+++.+.+++.+||+.||++|||+++|+++|+.....
T Consensus       235 -~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         235 -CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             -CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             -CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence             1234567899999999999999999999999999986654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=374.80  Aligned_cols=245  Identities=26%  Similarity=0.405  Sum_probs=195.9

Q ss_pred             CCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeec---CCceeEEEE
Q 017232           64 DSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSR---HSRELLLVY  137 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~~lv~  137 (375)
                      ++.++||+|+||+||+|... ++..||+|++...  .....+.+.+|+++|++++|||||++++++..   ....+++||
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm   91 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT   91 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence            55678999999999999765 6889999998654  34456778999999999999999999997653   245689999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCC--ceeccCCCCCEEec-CCCcEEEeeeccccccCC
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASD--IIHRDVKTNNILLD-NNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~--ivH~dlkp~Nill~-~~~~~kl~Dfg~~~~~~~  214 (375)
                      ||+++|+|.+++...    ..+++..+..++.||+.||+|||+++  |+||||||+|||++ .++.+||+|||++.....
T Consensus        92 E~~~~g~L~~~l~~~----~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~  167 (270)
T d1t4ha_          92 ELMTSGTLKTYLKRF----KVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  167 (270)
T ss_dssp             ECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             eCCCCCcHHHHHhcc----ccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence            999999999999543    45899999999999999999999998  99999999999996 578999999999986443


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT  294 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (375)
                      ..   ....+||+.|+|||++.+ .++.++|||||||++|||++|+.||.......      .....+...         
T Consensus       168 ~~---~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~------~~~~~i~~~---------  228 (270)
T d1t4ha_         168 SF---AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA------QIYRRVTSG---------  228 (270)
T ss_dssp             TS---BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH------HHHHHHTTT---------
T ss_pred             Cc---cCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH------HHHHHHHcC---------
Confidence            22   234579999999999876 69999999999999999999999996433211      011111110         


Q ss_pred             cCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 LGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .  .........++++.+|+.+||+.||++|||++|+++
T Consensus       229 ~--~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         229 V--KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             C--CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             C--CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence            0  001111123456889999999999999999999975

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-54  Score=385.76  Aligned_cols=245  Identities=27%  Similarity=0.397  Sum_probs=199.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ..|+.++.||+|+||+||+|.. .+|+.||||++....   ....+.+.+|+.++++++|||||++++++.. ...+++|
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~iv   93 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-EHTAWLV   93 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-CCEEEEE
Confidence            3488899999999999999965 478899999986543   3345678999999999999999999998776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||||.+|+|..++..    ...+++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        94 ~E~~~~g~l~~~~~~----~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~-  168 (309)
T d1u5ra_          94 MEYCLGSASDLLEVH----KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-  168 (309)
T ss_dssp             EECCSEEHHHHHHHH----TSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB-
T ss_pred             EEecCCCchHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCCC-
Confidence            999999998766643    346999999999999999999999999999999999999999999999999999865432 


Q ss_pred             cccccCCCCCccccCcccccc---cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          217 THVSTAPQGTPGYVDPEYHQC---YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~---~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                          ....||+.|+|||++.+   ..|+.++|||||||++|||++|.+||.......      .         ...+...
T Consensus       169 ----~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~------~---------~~~i~~~  229 (309)
T d1u5ra_         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS------A---------LYHIAQN  229 (309)
T ss_dssp             ----CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH------H---------HHHHHHS
T ss_pred             ----CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHH------H---------HHHHHhC
Confidence                33469999999998864   458999999999999999999999996443111      0         0111111


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      ...   ......+++.+.+|+.+||+.||++|||++|+++
T Consensus       230 ~~~---~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         230 ESP---ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             CCC---CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             CCC---CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            111   0111224567999999999999999999999976

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-54  Score=386.61  Aligned_cols=258  Identities=24%  Similarity=0.371  Sum_probs=204.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC-C-----CEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCc
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD-G-----RAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~-~-----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  131 (375)
                      .++|++.+.||+|+||+||+|.... +     ..||+|.+... .......+.+|+.++.++ +|||||++++++.. .+
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~-~~  114 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTL-SG  114 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEee-CC
Confidence            3578899999999999999997643 2     36899988654 333456788999999998 89999999998776 56


Q ss_pred             eeEEEEecccCCChhHhhccCCC-------------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCC
Q 017232          132 ELLLVYEFISNGTVADHLHGERA-------------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNN  192 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~-------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~N  192 (375)
                      .+++|||||++|+|.+++...+.                   ....+++..++.++.|++.||+|||++||+||||||+|
T Consensus       115 ~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~N  194 (325)
T d1rjba_         115 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  194 (325)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             eEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhc
Confidence            79999999999999999975432                   12458999999999999999999999999999999999


Q ss_pred             EEecCCCcEEEeeeccccccCCCccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCcccccccc
Q 017232          193 ILLDNNFCVKVADFGLSRLFPNHVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRH  270 (375)
Q Consensus       193 ill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~  270 (375)
                      ||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+| |.+||.......
T Consensus       195 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~  274 (325)
T d1rjba_         195 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  274 (325)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             cccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHH
Confidence            99999999999999999865433322 2234457999999999999999999999999999999997 899997543211


Q ss_pred             ccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Q 017232          271 EINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALR  336 (375)
Q Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~  336 (375)
                            .         +..++........   +..++..+.+|+.+||+.+|++|||++||++.|.
T Consensus       275 ------~---------~~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         275 ------N---------FYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             ------H---------HHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ------H---------HHHHHhcCCCCCC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence                  1         1112222221111   1235578999999999999999999999999985

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-53  Score=377.92  Aligned_cols=250  Identities=24%  Similarity=0.350  Sum_probs=204.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccch------hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNY------KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      .++|++.+.||+|+||+||+|.. .+|+.||||++.....      ...+.+.+|+.+|++++|||||++++++.. ...
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~   87 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYEN-KTD   87 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-SSE
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-CCE
Confidence            46799999999999999999976 4789999999864321      235778999999999999999999998776 678


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC----cEEEeeecc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF----CVKVADFGL  208 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~----~~kl~Dfg~  208 (375)
                      +++|||||++|+|.+++...    +.+++..++.++.|++.||+|||++||+||||||+|||++.++    .+|++|||+
T Consensus        88 ~~iv~E~~~gg~L~~~i~~~----~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          88 VILILELVAGGELFDFLAEK----ESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             EEEEEECCCSCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             EEEEEEcCCCccccchhccc----cccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence            99999999999999999543    4699999999999999999999999999999999999998776    499999999


Q ss_pred             ccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      +........  .....+|+.|+|||++.+..++.++||||+||++|+|++|+.||.......      .         ..
T Consensus       164 a~~~~~~~~--~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~------~---------~~  226 (293)
T d1jksa_         164 AHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE------T---------LA  226 (293)
T ss_dssp             CEECTTSCB--CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH------H---------HH
T ss_pred             hhhcCCCcc--ccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH------H---------HH
Confidence            987654332  234568999999999999999999999999999999999999997543211      0         01


Q ss_pred             HHHhhhcCCCCC-hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          289 ELVDQTLGYESD-NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       289 ~~~~~~l~~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .+...  ..... .....++..+.+|+.+||+.||++|||++|+++
T Consensus       227 ~i~~~--~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         227 NVSAV--NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             HHHTT--CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             HHHhc--CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            11111  11111 122345667899999999999999999999976

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-54  Score=377.68  Aligned_cols=257  Identities=24%  Similarity=0.382  Sum_probs=198.4

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC----CCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD----GRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      .++|++.+.||+|+||.||+|....    +..||+|.+... .....+.+.+|+.++++++||||+++++++.  ...++
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~--~~~~~   83 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT--ENPVW   83 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC--SSSCE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe--cCeEE
Confidence            3578899999999999999997642    356889988654 3444567999999999999999999999775  35689


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +||||+++|+|.+++...   ...+++..++.++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        84 iv~E~~~~g~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~  160 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMED  160 (273)
T ss_dssp             EEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC---------
T ss_pred             EEEEeccCCcHHhhhhcc---CCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccC
Confidence            999999999999987543   34689999999999999999999999999999999999999999999999999987654


Q ss_pred             CccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ..........+|+.|+|||.+.+..++.++|||||||++|||++ |.+||.......       ....+.          
T Consensus       161 ~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~-------~~~~i~----------  223 (273)
T d1mp8a_         161 STYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND-------VIGRIE----------  223 (273)
T ss_dssp             ----------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG-------HHHHHH----------
T ss_pred             CcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH-------HHHHHH----------
Confidence            44444445568999999999999999999999999999999998 899997654321       011111          


Q ss_pred             hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          294 TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       294 ~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                        .....+.+..++..+.+|+.+||+.||++|||+.||++.|+.+..
T Consensus       224 --~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  268 (273)
T d1mp8a_         224 --NGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE  268 (273)
T ss_dssp             --TTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --cCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence              111111223456789999999999999999999999999998754

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-54  Score=374.98  Aligned_cols=253  Identities=26%  Similarity=0.464  Sum_probs=200.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      ++|++.+.||+|+||.||+|..+ |+.||||+++...  ..+.+.+|++++++++||||+++++++......+++||||+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~~--~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~   83 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM   83 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcHH--HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence            45788899999999999999885 7889999996543  34678999999999999999999998766566789999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccccc
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHVS  220 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  220 (375)
                      ++|+|.+++...  ....+++..++.++.||+.||.|||+.+|+||||||+|||++.++.+||+|||++.......    
T Consensus        84 ~~g~L~~~l~~~--~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~----  157 (262)
T d1byga_          84 AKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----  157 (262)
T ss_dssp             TTEEHHHHHHHH--HHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC------------
T ss_pred             CCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCCC----
Confidence            999999999643  22358999999999999999999999999999999999999999999999999998654322    


Q ss_pred             cCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCCCC
Q 017232          221 TAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGYES  299 (375)
Q Consensus       221 ~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  299 (375)
                      ....++..|+|||.+.+..+++++|||||||++|||+| |++||.......      . ..         .+........
T Consensus       158 ~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~------~-~~---------~i~~~~~~~~  221 (262)
T d1byga_         158 DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------V-VP---------RVEKGYKMDA  221 (262)
T ss_dssp             ----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG------H-HH---------HHTTTCCCCC
T ss_pred             ccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHH------H-HH---------HHHcCCCCCC
Confidence            23357889999999998899999999999999999998 788876543211      1 11         1111111111


Q ss_pred             ChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          300 DNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       300 ~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                         +..++..+.+|+.+||+.||++|||+.+|+++|+.++..
T Consensus       222 ---~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         222 ---PDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence               223456799999999999999999999999999998753

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-53  Score=379.68  Aligned_cols=263  Identities=26%  Similarity=0.376  Sum_probs=210.0

Q ss_pred             HHHhcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEecccc-hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC
Q 017232           57 EEATNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYENN-YKRVEQFMNEVDILARLRHKNLVSLYGCTSRH  129 (375)
Q Consensus        57 ~~~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~  129 (375)
                      +...++|++.+.||+|+||+||+|+.+      +++.||||++.... ....+.+.+|+.+++.++||||+++++++.. 
T Consensus         9 e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-   87 (301)
T d1lufa_           9 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV-   87 (301)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS-
T ss_pred             cCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc-
Confidence            334578999999999999999999764      35789999987553 3345679999999999999999999998776 


Q ss_pred             CceeEEEEecccCCChhHhhccCCC--------------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCC
Q 017232          130 SRELLLVYEFISNGTVADHLHGERA--------------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVK  189 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlk  189 (375)
                      ....+++|||+++|+|.+++.....                    ....+++..++.++.|++.||+|||+++++|||||
T Consensus        88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK  167 (301)
T d1lufa_          88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA  167 (301)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence            6779999999999999999865321                    12358899999999999999999999999999999


Q ss_pred             CCCEEecCCCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCC-CCccccc
Q 017232          190 TNNILLDNNFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSM-PAVDITR  267 (375)
Q Consensus       190 p~Nill~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~p~~~~~  267 (375)
                      |+|||++.++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++|. +||....
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            9999999999999999999976543322 2223456889999999999999999999999999999999985 6776543


Q ss_pred             cccccchhHHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          268 HRHEINLSNLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      ...      . ...+        .+.    ...+.+..++.++.+|+.+||+.+|++||||.||+++|++|.
T Consensus       248 ~~e------~-~~~v--------~~~----~~~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 HEE------V-IYYV--------RDG----NILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHH------H-HHHH--------HTT----CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHH------H-HHHH--------HcC----CCCCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            211      0 1111        111    111112235567999999999999999999999999999875

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-53  Score=381.15  Aligned_cols=247  Identities=26%  Similarity=0.341  Sum_probs=204.6

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++++.||+|+||.||+|.. .+|+.||+|++....   ....+.+.+|+.+|+.++||||+++++++.. ...+|+|
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~-~~~~~iv   83 (337)
T d1o6la_           5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQT-HDRLCFV   83 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecc-ccccccc
Confidence            5699999999999999999976 479999999996542   2345678899999999999999999998876 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||||+||+|.+++...    ..+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus        84 ~ey~~gg~L~~~~~~~----~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~  159 (337)
T d1o6la_          84 MEYANGGELFFHLSRE----RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG  159 (337)
T ss_dssp             EECCTTCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred             eeccCCCchhhhhhcc----cCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC
Confidence            9999999999998643    458999999999999999999999999999999999999999999999999998654332


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      . .....+||+.|+|||++.+..|+.++||||+||++|||++|++||.......      . .        ..+......
T Consensus       160 ~-~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~------~-~--------~~i~~~~~~  223 (337)
T d1o6la_         160 A-TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER------L-F--------ELILMEEIR  223 (337)
T ss_dssp             C-CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH------H-H--------HHHHHCCCC
T ss_pred             c-ccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH------H-H--------HHHhcCCCC
Confidence            2 2344579999999999999999999999999999999999999997654211      0 0        111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRPY-----MVDVLD  333 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~evl~  333 (375)
                        .+   ..++.++.+||.+||+.||.+||+     +.|+++
T Consensus       224 --~p---~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         224 --FP---RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             --CC---TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             --CC---ccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence              11   224567899999999999999995     788876

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=375.03  Aligned_cols=264  Identities=25%  Similarity=0.358  Sum_probs=201.9

Q ss_pred             HhcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCC
Q 017232           59 ATNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHS  130 (375)
Q Consensus        59 ~~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  130 (375)
                      ..++|++.++||+|+||.||+|...      +++.||||++... .....+.+.+|..++.++ +|+||+.+++++...+
T Consensus        11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   90 (299)
T d1ywna1          11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG   90 (299)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTT
T ss_pred             cHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCC
Confidence            3467999999999999999999653      2468999998654 334456778888888877 6899999999877767


Q ss_pred             ceeEEEEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCC
Q 017232          131 RELLLVYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNN  198 (375)
Q Consensus       131 ~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~  198 (375)
                      ..+++|||||++|+|.+++...+.            ....+++.++..++.||+.||.|||++||+||||||+|||++.+
T Consensus        91 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~  170 (299)
T d1ywna1          91 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  170 (299)
T ss_dssp             SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGG
T ss_pred             CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCC
Confidence            789999999999999999965432            23458999999999999999999999999999999999999999


Q ss_pred             CcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhC-CCCccccccccccchhH
Q 017232          199 FCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISS-MPAVDITRHRHEINLSN  276 (375)
Q Consensus       199 ~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg-~~p~~~~~~~~~~~~~~  276 (375)
                      +.+||+|||+++....... .......||+.|+|||++.+..++.++|||||||++|||+|| .+||.......      
T Consensus       171 ~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~------  244 (299)
T d1ywna1         171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE------  244 (299)
T ss_dssp             GCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH------
T ss_pred             CcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHH------
Confidence            9999999999986543332 223345799999999999999999999999999999999986 56776443211      


Q ss_pred             HHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          277 LAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      ....         .+........+   ..+++.+.+++.+||+.||++|||+.||++.|+++.+
T Consensus       245 ~~~~---------~~~~~~~~~~~---~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         245 EFCR---------RLKEGTRMRAP---DYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             HHHH---------HHHHTCCCCCC---TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHH---------HHhcCCCCCCC---ccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            1111         11111111111   2245678999999999999999999999999998754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-52  Score=371.36  Aligned_cols=260  Identities=24%  Similarity=0.376  Sum_probs=202.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC---ce
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS---RE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~  132 (375)
                      .++|++.+.||+|+||.||+|.. .+|+.||||++...   +......+.+|+.+++.++||||+++++++....   ..
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~   85 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   85 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence            46799999999999999999965 47999999999654   3344567899999999999999999999765432   35


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      +|+||||++|++|.+++...    +.+++.+++.++.||+.||+|||++||+||||||+|||++.++..+++|||.+...
T Consensus        86 ~~lvmE~~~g~~L~~~~~~~----~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~  161 (277)
T d1o6ya_          86 PYIVMEYVDGVTLRDIVHTE----GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAI  161 (277)
T ss_dssp             EEEEEECCCEEEHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEEC
T ss_pred             EEEEEECCCCCEehhhhccc----CCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhh
Confidence            89999999999999988543    46999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCc--cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          213 PNHV--THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       213 ~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      ....  ........||+.|+|||++.+..+++++|||||||++|+|+||++||.......      .....+....    
T Consensus       162 ~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~------~~~~~~~~~~----  231 (277)
T d1o6ya_         162 ADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS------VAYQHVREDP----  231 (277)
T ss_dssp             C----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH------HHHHHHHCCC----
T ss_pred             ccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHH------HHHHHHhcCC----
Confidence            3222  222344579999999999999999999999999999999999999997543211      1111111100    


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCC-CHHHHHHHHHhhh
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRP-YMVDVLDALRDIE  339 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-t~~evl~~L~~i~  339 (375)
                            .........++..+.+++.+||+.||++|| |++++++.|.++.
T Consensus       232 ------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         232 ------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             ------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             ------CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence                  000011123456799999999999999999 8999999998775

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.3e-52  Score=372.39  Aligned_cols=245  Identities=27%  Similarity=0.423  Sum_probs=203.3

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++.+.||+|+||+||+|..+ +|+.||||++....   ....+.+.+|+.+++.++||||+++++++.. ...+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQD-AQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEEC-SSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEee-CCeeeeE
Confidence            46899999999999999999764 69999999986542   2345678899999999999999999998776 6789999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||||+||+|..++...    ..+++..+..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus        83 mE~~~gg~l~~~~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~  158 (316)
T d1fota_          83 MDYIEGGELFSLLRKS----QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT  158 (316)
T ss_dssp             ECCCCSCBHHHHHHHT----SSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred             eeecCCcccccccccc----ccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEecccc
Confidence            9999999999988543    457889999999999999999999999999999999999999999999999998765432


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                          ...+||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      .         ...+......
T Consensus       159 ----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~------~---------~~~i~~~~~~  219 (316)
T d1fota_         159 ----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK------T---------YEKILNAELR  219 (316)
T ss_dssp             ----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH------H---------HHHHHHCCCC
T ss_pred             ----ccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH------H---------HHHHHcCCCC
Confidence                34579999999999999999999999999999999999999997543211      0         1111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLDA  334 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~~  334 (375)
                        .+   ..++.++.+++.+||..||.+|+     |++++++.
T Consensus       220 --~p---~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         220 --FP---PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             --CC---TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             --CC---CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence              11   12456789999999999999996     89999863

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=376.12  Aligned_cols=257  Identities=22%  Similarity=0.369  Sum_probs=203.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCC----EEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGR----AVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELL  134 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~----~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  134 (375)
                      .+|++++.||+|+||+||+|... +|+    +||+|.+... .....+.+.+|+.++++++|||||++++++..  ...+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~--~~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT--STVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec--CCee
Confidence            35889999999999999999764 443    6889988654 33456789999999999999999999998875  3467


Q ss_pred             EEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCC
Q 017232          135 LVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPN  214 (375)
Q Consensus       135 lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~  214 (375)
                      +++|++.+++|.+.+...   ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        87 ~v~e~~~~~~l~~~~~~~---~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~  163 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGA  163 (317)
T ss_dssp             EEEECCTTCBHHHHHHHT---SSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTT
T ss_pred             EEEEeccCCccccccccc---ccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceeccc
Confidence            889999999999988653   45689999999999999999999999999999999999999999999999999987654


Q ss_pred             Cccc-cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          215 HVTH-VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       215 ~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      .... ......||+.|+|||++.+..++.++|||||||++|||+| |.+||+......                +...+.
T Consensus       164 ~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~----------------~~~~i~  227 (317)
T d1xkka_         164 EEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE----------------ISSILE  227 (317)
T ss_dssp             TCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG----------------HHHHHH
T ss_pred             ccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH----------------HHHHHH
Confidence            3322 2233468999999999999999999999999999999998 789987543211                111111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      .....   +.+..++..+.+|+.+||+.+|++|||+.||++.|+.+..+
T Consensus       228 ~~~~~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         228 KGERL---PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             HTCCC---CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             cCCCC---CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence            11111   11123567799999999999999999999999999988654

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-52  Score=372.69  Aligned_cols=250  Identities=20%  Similarity=0.307  Sum_probs=204.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      .++|++.+.||+|+||+||+|..+ +|+.||+|++...... ...+.+|+.+|+.++||||+++++++.. ...+|+|||
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~-~~~~~~Ei~il~~l~HpnIv~~~~~~~~-~~~~~lvmE   81 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTD-QVLVKKEISILNIARHRNILHLHESFES-MEELVMIFE   81 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHH-HHHHHHHHHHHHHSCCTTBCCEEEEEEE-TTEEEEEEC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCccc-HHHHHHHHHHHHhCCCCCCCeEEEEEEE-CCEEEEEEe
Confidence            467999999999999999999765 6889999999765433 3567899999999999999999998876 678999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC--CCcEEEeeeccccccCCCc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN--NFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~--~~~~kl~Dfg~~~~~~~~~  216 (375)
                      ||+||+|.+++..   .+..+++.+++.++.||+.||+|||++||+||||||+|||++.  .+.+||+|||++.......
T Consensus        82 ~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~  158 (321)
T d1tkia_          82 FISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD  158 (321)
T ss_dssp             CCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC
T ss_pred             cCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC
Confidence            9999999999953   2346999999999999999999999999999999999999985  4579999999998764432


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                      .  .....+|+.|+|||...+..++.++||||+||++|+|++|.+||.......               ....+..... 
T Consensus       159 ~--~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---------------~~~~i~~~~~-  220 (321)
T d1tkia_         159 N--FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---------------IIENIMNAEY-  220 (321)
T ss_dssp             E--EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---------------HHHHHHHTCC-
T ss_pred             c--ccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---------------HHHHHHhCCC-
Confidence            2  233458999999999999999999999999999999999999997553211               0111111111 


Q ss_pred             CCCC-hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          297 YESD-NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       297 ~~~~-~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                       ..+ .....++.++.+|+.+||..||++|||++|+++
T Consensus       221 -~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         221 -TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             -CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             111 111234567899999999999999999999987

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=369.37  Aligned_cols=259  Identities=27%  Similarity=0.419  Sum_probs=205.7

Q ss_pred             CCccCCCCcEEEEEEEeCCC----CEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEecc
Q 017232           66 ARELGDGGFGTVYYGELQDG----RAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEFI  140 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~~----~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~~  140 (375)
                      .++||+|+||+||+|...++    ..||||++... +....+.+.+|++++++++||||++++|++...+...++|||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~  111 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM  111 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence            46799999999999976532    35899998643 55566889999999999999999999998776667899999999


Q ss_pred             cCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc---
Q 017232          141 SNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT---  217 (375)
Q Consensus       141 ~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---  217 (375)
                      ++++|.+++...   ...+++..+..++.|++.||.|||+.+|+||||||+|||+++++.+||+|||+++.......   
T Consensus       112 ~~g~l~~~~~~~---~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~  188 (311)
T d1r0pa_         112 KHGDLRNFIRNE---THNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV  188 (311)
T ss_dssp             TTCBHHHHHHCT---TCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCT
T ss_pred             ecCchhhhhccc---cccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccc
Confidence            999999998643   34578889999999999999999999999999999999999999999999999987643322   


Q ss_pred             ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcCC
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLGY  297 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  297 (375)
                      .......||+.|+|||.+.+..++.++||||||+++|||+||..||........  ....            +...    
T Consensus       189 ~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~--~~~~------------i~~g----  250 (311)
T d1r0pa_         189 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD--ITVY------------LLQG----  250 (311)
T ss_dssp             TCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHH------------HHTT----
T ss_pred             eecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHH--HHHH------------HHcC----
Confidence            122334689999999999999999999999999999999998777653321110  0010            1100    


Q ss_pred             CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCCCCC
Q 017232          298 ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDGYDD  345 (375)
Q Consensus       298 ~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~~~~  345 (375)
                      .....+..++..+.+|+.+||+.||++|||+.||++.|+.+.+....+
T Consensus       251 ~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~  298 (311)
T d1r0pa_         251 RRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  298 (311)
T ss_dssp             CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             CCCCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence            011111234567999999999999999999999999999998764443

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=9.6e-52  Score=363.83  Aligned_cols=251  Identities=24%  Similarity=0.327  Sum_probs=203.5

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccch---------hhHHHHHHHHHHHHhcC-CCCeEEEeeeeec
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNY---------KRVEQFMNEVDILARLR-HKNLVSLYGCTSR  128 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  128 (375)
                      .++|++.+.||+|+||+||+|+. .+|+.||||++.....         ...+.+.+|+.++++++ ||||+++++++..
T Consensus         2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~   81 (277)
T d1phka_           2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   81 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence            36799999999999999999976 4789999999865421         12346889999999997 9999999998776


Q ss_pred             CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecc
Q 017232          129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL  208 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  208 (375)
                       ++.+||||||+++|+|.+++..    .+.+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        82 -~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~  156 (277)
T d1phka_          82 -NTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGF  156 (277)
T ss_dssp             -SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTT
T ss_pred             -CcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchh
Confidence             6789999999999999999964    34699999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccCCCCCccccCcccccc------cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHh
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQC------YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKI  282 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~------~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~  282 (375)
                      +........  .....||+.|+|||.+.+      ..++.++||||+||++|+|++|++||.......       .    
T Consensus       157 a~~~~~~~~--~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~-------~----  223 (277)
T d1phka_         157 SCQLDPGEK--LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML-------M----  223 (277)
T ss_dssp             CEECCTTCC--BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------H----
T ss_pred             eeEccCCCc--eeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH-------H----
Confidence            987654322  244579999999998764      346789999999999999999999997543111       0    


Q ss_pred             hhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          283 QNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       283 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                          ...+...... ...+....+++++.+|+.+||+.+|++|||++|+++
T Consensus       224 ----~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         224 ----LRMIMSGNYQ-FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             ----HHHHHHTCCC-CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ----HHHHHhCCCC-CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence                1111111111 111222346678999999999999999999999875

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=367.13  Aligned_cols=256  Identities=27%  Similarity=0.442  Sum_probs=197.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCC--C--CEEEEEEeccc---chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           61 NYFDSARELGDGGFGTVYYGELQD--G--RAVAVKRLYEN---NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~--~--~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      ++|++.+.||+|+||.||+|+...  +  ..||||++...   .....+.|.+|+.++++++||||+++++++..  ...
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--~~~   85 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PPM   85 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSC
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--cch
Confidence            468899999999999999996542  2  36899988654   33445789999999999999999999998864  357


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      ++||||++++++.+.+...   ...+++..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||++....
T Consensus        86 ~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          86 KMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             EEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             heeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            8999999999999887643   3459999999999999999999999999999999999999999999999999998765


Q ss_pred             CCccc--cccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          214 NHVTH--VSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       214 ~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      .....  ......++..|+|||.+.+..++.++|||||||++|||+| |.+||.......      .         ...+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~------~---------~~~i  227 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQ------I---------LHKI  227 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH------H---------HHHH
T ss_pred             cCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHH------H---------HHHH
Confidence            43322  2233457889999999999999999999999999999998 899997543211      1         1111


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                      .......   +....++..+.+|+.+||+.||++|||+.+|++.|++.+
T Consensus       228 ~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~  273 (273)
T d1u46a_         228 DKEGERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ  273 (273)
T ss_dssp             HTSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HhCCCCC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhcC
Confidence            1111111   111234567999999999999999999999999998764

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-51  Score=373.62  Aligned_cols=253  Identities=23%  Similarity=0.284  Sum_probs=199.3

Q ss_pred             hcCCCCCC-ccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhc-CCCCeEEEeeeeec---CCcee
Q 017232           60 TNYFDSAR-ELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARL-RHKNLVSLYGCTSR---HSREL  133 (375)
Q Consensus        60 ~~~y~~~~-~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~---~~~~~  133 (375)
                      .++|.+.. .||+|+||+||+|.. .+++.||||++...     ..+.+|+.++.++ +||||+++++++..   ....+
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~   84 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL   84 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEE
Confidence            35788875 599999999999965 57899999998543     3567899887655 89999999997653   34678


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC---CCcEEEeeecccc
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN---NFCVKVADFGLSR  210 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~---~~~~kl~Dfg~~~  210 (375)
                      |+|||||+||+|.+++...  ....+++.+++.++.||+.||+|||++||+||||||+|||++.   .+.+||+|||++.
T Consensus        85 ~ivmEy~~gg~L~~~i~~~--~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~  162 (335)
T d2ozaa1          85 LIVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK  162 (335)
T ss_dssp             EEEEECCCSEEHHHHHHSC--SCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCE
T ss_pred             EEEEECCCCCcHHHHHHhc--CCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceee
Confidence            9999999999999999643  2346999999999999999999999999999999999999975   5679999999998


Q ss_pred             ccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          211 LFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      .......  .....||+.|+|||++.+..++.++|||||||++|+|+||++||..........   .....+..      
T Consensus       163 ~~~~~~~--~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~---~~~~~i~~------  231 (335)
T d2ozaa1         163 ETTSHNS--LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISP---GMKTRIRM------  231 (335)
T ss_dssp             ECCCCCC--CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------CCCS------
T ss_pred             eccCCCc--cccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHH---HHHHHHhc------
Confidence            7654332  244579999999999999999999999999999999999999997554221100   00000000      


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        .... ...+....++.++.+|+.+||+.||++|||+.|+++
T Consensus       232 --~~~~-~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         232 --GQYE-FPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             --CSSS-CCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             --CCCC-CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence              0000 111233456678999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-51  Score=367.64  Aligned_cols=262  Identities=24%  Similarity=0.381  Sum_probs=206.4

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeCC--------CCEEEEEEecccc-hhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecC
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQD--------GRAVAVKRLYENN-YKRVEQFMNEVDILARL-RHKNLVSLYGCTSRH  129 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~-~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~  129 (375)
                      .++|++.+.||+|+||.||+|+..+        +..||||++.... ......+.+|...+.++ +|||||++++++.. 
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~-   90 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ-   90 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc-
Confidence            3568889999999999999996532        2479999987653 34457788899999888 79999999998876 


Q ss_pred             CceeEEEEecccCCChhHhhccCCC------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          130 SRELLLVYEFISNGTVADHLHGERA------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      +...++||||+++|+|.+++.....            ....+++.+++.++.||+.||+|||+.+|+||||||+|||++.
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  170 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence            5679999999999999999975532            2356899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchh
Q 017232          198 NFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLS  275 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~  275 (375)
                      ++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++ |.+||......      
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~------  244 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE------  244 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH------
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHH------
Confidence            99999999999987654322 22344568999999999999999999999999999999998 78888644311      


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                       .         ....+........   +..++..+.+|+.+||+.+|++|||+.||++.|++|.+.
T Consensus       245 -~---------~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         245 -E---------LFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             -H---------HHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -H---------HHHHHHcCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence             0         1111212111111   123456799999999999999999999999999998653

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-52  Score=372.04  Aligned_cols=260  Identities=28%  Similarity=0.398  Sum_probs=204.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCC--EEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGR--AVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~--~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|++.++||+|+||.||+|.++ +|.  .||||++... .....+.+.+|+.+|+++ +||||+++++++.. ...+++
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~-~~~~~i   88 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-RGYLYL   88 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-TTEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEec-CCeeEE
Confidence            46888999999999999999765 444  4778887543 333456789999999999 79999999998876 678999


Q ss_pred             EEecccCCChhHhhccCC------------CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEE
Q 017232          136 VYEFISNGTVADHLHGER------------AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKV  203 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~------------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl  203 (375)
                      ||||+++|+|.+++....            .....+++.++..++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl  168 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI  168 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEE
Confidence            999999999999996541            23467999999999999999999999999999999999999999999999


Q ss_pred             eeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCC-CCccccccccccchhHHHHHHh
Q 017232          204 ADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSM-PAVDITRHRHEINLSNLAINKI  282 (375)
Q Consensus       204 ~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~  282 (375)
                      +|||++........  .....+|..|+|||.+.+..++.++|||||||++|||++|. +||.......       ...  
T Consensus       169 ~DfG~a~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~-------~~~--  237 (309)
T d1fvra_         169 ADFGLSRGQEVYVK--KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAE-------LYE--  237 (309)
T ss_dssp             CCTTCEESSCEECC--C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH-------HHH--
T ss_pred             cccccccccccccc--ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHH-------HHH--
Confidence            99999976443222  22345899999999999999999999999999999999975 5675432111       011  


Q ss_pred             hhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcCC
Q 017232          283 QNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESDG  342 (375)
Q Consensus       283 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~~  342 (375)
                             .+..   +...+.+..+++.+.+|+.+||+.||++|||++||++.|+++....
T Consensus       238 -------~i~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         238 -------KLPQ---GYRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             -------HGGG---TCCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             -------HHHh---cCCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence                   1111   1111112235678999999999999999999999999999987643

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.4e-51  Score=376.52  Aligned_cols=248  Identities=24%  Similarity=0.310  Sum_probs=196.5

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch---hhHHHHH---HHHHHHHhcCCCCeEEEeeeeecCCcee
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY---KRVEQFM---NEVDILARLRHKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~---~~~~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~  133 (375)
                      ++|++.+.||+|+||.||+|... +|+.||||++.....   .....+.   .++.+++.++|||||++++++.. .+.+
T Consensus         4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~-~~~~   82 (364)
T d1omwa3           4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHT-PDKL   82 (364)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEEC-SSEE
T ss_pred             HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEE-CCEE
Confidence            57999999999999999999765 699999999854321   1122333   34666777789999999998776 6779


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      |+|||||++|+|.+++...    ..+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+.
T Consensus        83 ~ivmE~~~gg~L~~~l~~~----~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~  158 (364)
T d1omwa3          83 SFILDLMNGGDLHYHLSQH----GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  158 (364)
T ss_dssp             EEEECCCCSCBHHHHHHHH----CSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred             EEEEEecCCCcHHHHHHhc----ccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecC
Confidence            9999999999999999543    458899999999999999999999999999999999999999999999999998765


Q ss_pred             CCccccccCCCCCccccCccccc-ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHh
Q 017232          214 NHVTHVSTAPQGTPGYVDPEYHQ-CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVD  292 (375)
Q Consensus       214 ~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  292 (375)
                      ...   .....||+.|+|||++. +..++.++|||||||++|||+||++||.........                .+..
T Consensus       159 ~~~---~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~----------------~~~~  219 (364)
T d1omwa3         159 KKK---PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH----------------EIDR  219 (364)
T ss_dssp             SSC---CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHH----------------HHHH
T ss_pred             CCc---ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHH----------------HHHH
Confidence            432   23456999999999886 456899999999999999999999999765432210                0111


Q ss_pred             hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 017232          293 QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY-----MVDVLD  333 (375)
Q Consensus       293 ~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~evl~  333 (375)
                      ...... ...+..++..+.+||.+||+.||++|||     ++|+++
T Consensus       220 ~~~~~~-~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         220 MTLTMA-VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HSSSCC-CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             hcccCC-CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            111100 1111124567899999999999999999     688875

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.6e-52  Score=377.24  Aligned_cols=244  Identities=25%  Similarity=0.370  Sum_probs=203.0

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLV  136 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv  136 (375)
                      ++|++++.||+|+||.||+|..+ +|+.||||++....   ....+.+.+|+.+|+.++||||+++++++.. ...+++|
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~~v  119 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKD-NSNLYMV  119 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccc-ccccccc
Confidence            56999999999999999999764 79999999986432   2345678899999999999999999997776 6778999


Q ss_pred             EecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCc
Q 017232          137 YEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       137 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      |||+.+|+|..++...    +.+++.+++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++......
T Consensus       120 ~e~~~~g~l~~~l~~~----~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~  195 (350)
T d1rdqe_         120 MEYVAGGEMFSHLRRI----GRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT  195 (350)
T ss_dssp             EECCTTCBHHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCB
T ss_pred             cccccccchhhhHhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccc
Confidence            9999999999998543    459999999999999999999999999999999999999999999999999998765332


Q ss_pred             cccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhcC
Q 017232          217 THVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTLG  296 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  296 (375)
                          ....||+.|+|||++.+..++.++|||||||++|+|+||++||.......       ..        ..+......
T Consensus       196 ----~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-------~~--------~~i~~~~~~  256 (350)
T d1rdqe_         196 ----WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ-------IY--------EKIVSGKVR  256 (350)
T ss_dssp             ----CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HH--------HHHHHCCCC
T ss_pred             ----ccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH-------HH--------HHHhcCCCC
Confidence                34569999999999999999999999999999999999999997543111       01        111111111


Q ss_pred             CCCChHHHHHHHHHHHHHHHhcCCCCCCCC-----CHHHHHH
Q 017232          297 YESDNKVRRTINAVAELAFQCLQSEKDLRP-----YMVDVLD  333 (375)
Q Consensus       297 ~~~~~~~~~~~~~l~~li~~cl~~~P~~Rp-----t~~evl~  333 (375)
                        .   +..++.++.+++.+||..||.+|+     |++++++
T Consensus       257 --~---p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         257 --F---PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             --C---CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             --C---CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence              1   123456799999999999999994     8999886

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-51  Score=366.86  Aligned_cols=263  Identities=25%  Similarity=0.365  Sum_probs=212.2

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHHhc-CCCCeEEEeeeeecCCc
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYEN-NYKRVEQFMNEVDILARL-RHKNLVSLYGCTSRHSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  131 (375)
                      .++|++.++||+|+||.||+|+..      +++.||||++... .......+.+|+.+++.+ +|||||++++++.. ..
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~-~~  100 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTI-GG  100 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEee-CC
Confidence            467888999999999999999752      4568999999754 344556789999999999 69999999998776 56


Q ss_pred             eeEEEEecccCCChhHhhccCCC--------------CCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC
Q 017232          132 ELLLVYEFISNGTVADHLHGERA--------------KPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN  197 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~  197 (375)
                      ..++|||||++|+|.+++.....              ....+++..+..++.||+.||+|||++|++||||||+||+++.
T Consensus       101 ~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~  180 (311)
T d1t46a_         101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH  180 (311)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred             EEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccc
Confidence            78999999999999999876432              2346899999999999999999999999999999999999999


Q ss_pred             CCcEEEeeeccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCccccccccccchh
Q 017232          198 NFCVKVADFGLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELIS-SMPAVDITRHRHEINLS  275 (375)
Q Consensus       198 ~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ellt-g~~p~~~~~~~~~~~~~  275 (375)
                      ++.+|++|||.+........ .......+|+.|+|||.+.+..++.++|||||||++|||+| |.+||.......     
T Consensus       181 ~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~-----  255 (311)
T d1t46a_         181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDS-----  255 (311)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSH-----
T ss_pred             cCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHH-----
Confidence            99999999999987654332 23344578999999999999999999999999999999998 666665443211     


Q ss_pred             HHHHHHhhhhHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          276 NLAINKIQNKALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                                .+..++........+   ..++..+.+|+.+||+.||++|||+.+|+++|+++.++
T Consensus       256 ----------~~~~~i~~~~~~~~~---~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         256 ----------KFYKMIKEGFRMLSP---EHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             ----------HHHHHHHHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----------HHHHHHhcCCCCCCc---ccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence                      112222222222221   22456799999999999999999999999999986554

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-52  Score=369.50  Aligned_cols=274  Identities=22%  Similarity=0.321  Sum_probs=201.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC---ceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS---RELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~lv~  137 (375)
                      ..|.+.+.||+|+||.||+|+. +|+.||||++...... ......|+..+..++||||+++++++....   ..+++||
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~-~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~   80 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVS   80 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE-CCEEEEEEEECccchh-HHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEE
Confidence            4577788999999999999986 5889999998654322 122334555566789999999999776533   3689999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh--------CCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA--------SDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~--------~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      ||+++|+|.+++..     ..+++..++.++.|++.||.|||+        +||+||||||+||||+.++.+||+|||++
T Consensus        81 Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~  155 (303)
T d1vjya_          81 DYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             ECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcc
Confidence            99999999999964     258999999999999999999997        59999999999999999999999999999


Q ss_pred             cccCCCccc---cccCCCCCccccCccccccc------CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHH
Q 017232          210 RLFPNHVTH---VSTAPQGTPGYVDPEYHQCY------QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAIN  280 (375)
Q Consensus       210 ~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~------~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~  280 (375)
                      .........   ......||+.|+|||++.+.      .++.++|||||||++|||+||.+||.................
T Consensus       156 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~  235 (303)
T d1vjya_         156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhccccc
Confidence            876433221   22345799999999988754      256789999999999999999998865432221110000000


Q ss_pred             HhhhhHHHHHHhhhcCCCCCh--HHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          281 KIQNKALHELVDQTLGYESDN--KVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       281 ~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                      ..............++...+.  ...+....+.+|+.+||+.||++|||+.||++.|+++...
T Consensus       236 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            000001111222222222222  1234567799999999999999999999999999998753

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=370.79  Aligned_cols=247  Identities=25%  Similarity=0.353  Sum_probs=200.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccc---hhhHHHHHHHHHHHH-hcCCCCeEEEeeeeecCCceeEE
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENN---YKRVEQFMNEVDILA-RLRHKNLVSLYGCTSRHSRELLL  135 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~l  135 (375)
                      ++|++.+.||+|+||+||+|... +|+.||||++....   ....+.+..|..++. .++||||+++++++.. ++.+|+
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~-~~~~yi   80 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQT-KENLFF   80 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEEC-SSEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEcc-CCceeE
Confidence            57899999999999999999665 78999999996542   223455667777665 6899999999998776 678999


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNH  215 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  215 (375)
                      ||||+++|+|.+++...    ..+++.+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++......
T Consensus        81 vmEy~~~g~L~~~i~~~----~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~  156 (320)
T d1xjda_          81 VMEYLNGGDLMYHIQSC----HKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG  156 (320)
T ss_dssp             EEECCTTCBHHHHHHHH----SSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred             EEeecCCCcHHHHhhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhcccc
Confidence            99999999999999643    45899999999999999999999999999999999999999999999999999865433


Q ss_pred             ccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhhc
Q 017232          216 VTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQTL  295 (375)
Q Consensus       216 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  295 (375)
                      .. ......||+.|+|||++.+..++.++||||+||++|+|++|+.||.......       ....+.        ....
T Consensus       157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~-------~~~~i~--------~~~~  220 (320)
T d1xjda_         157 DA-KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE-------LFHSIR--------MDNP  220 (320)
T ss_dssp             TC-CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH-------HHHHHH--------HCCC
T ss_pred             cc-cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH-------HHHHHH--------cCCC
Confidence            22 2344579999999999999999999999999999999999999997543211       111111        1111


Q ss_pred             CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHH-HHHH
Q 017232          296 GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMV-DVLD  333 (375)
Q Consensus       296 ~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~-evl~  333 (375)
                        ..+   ..++..+.+|+.+||..||++|||+. ++++
T Consensus       221 --~~p---~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         221 --FYP---RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             --CCC---TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             --CCC---ccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence              111   12456799999999999999999996 6754

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-51  Score=365.98  Aligned_cols=259  Identities=23%  Similarity=0.285  Sum_probs=191.7

Q ss_pred             CCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhh-----HHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           66 ARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKR-----VEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      +++||+|+||+||+|..+ +|+.||||++.......     .+.+.+|+.+++.++|||||++++++.. ...+++||||
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~-~~~~~ivmE~   81 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH-KSNISLVFDF   81 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECC-TTCCEEEEEC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCceeehhhh
Confidence            568999999999999764 68999999986543221     2468899999999999999999998776 6679999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcccc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTHV  219 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  219 (375)
                      +.++++..+..    ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++......... 
T Consensus        82 ~~~~~~~~~~~----~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~-  156 (299)
T d1ua2a_          82 METDLEVIIKD----NSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA-  156 (299)
T ss_dssp             CSEEHHHHHTT----CCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred             hcchHHhhhhh----cccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCccc-
Confidence            98887776652    3456899999999999999999999999999999999999999999999999999866543322 


Q ss_pred             ccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh-----
Q 017232          220 STAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ-----  293 (375)
Q Consensus       220 ~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----  293 (375)
                      ....+||+.|+|||++.+ ..++.++||||+||++|||++|.+||......+..   ....+.........+.+.     
T Consensus       157 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l---~~i~~~~~~~~~~~~~~~~~~~~  233 (299)
T d1ua2a_         157 YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL---TRIFETLGTPTEEQWPDMCSLPD  233 (299)
T ss_dssp             CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH---HHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             ccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHH---HHHHHhcCCCChhhccchhccch
Confidence            234579999999998764 46799999999999999999999999755422211   000000000000000000     


Q ss_pred             --hcCCCCC----hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          294 --TLGYESD----NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       294 --~l~~~~~----~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        .......    ......++.+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         234 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             hhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence              0000000    000123467899999999999999999999985

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=366.16  Aligned_cols=262  Identities=24%  Similarity=0.402  Sum_probs=209.7

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC------CCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCce
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ------DGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~------~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  132 (375)
                      .++|++.+.||+|+||+||+|.+.      +++.||||++... .......+.+|+.++++++||||+++++++.. ...
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~-~~~   97 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ-GQP   97 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS-SSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEec-CCc
Confidence            467888999999999999999653      3578999999654 34445678999999999999999999997765 567


Q ss_pred             eEEEEecccCCChhHhhccCC------CCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeee
Q 017232          133 LLLVYEFISNGTVADHLHGER------AKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADF  206 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~------~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Df  206 (375)
                      .++||||+.+|+|.+++...+      .....+++..+..++.|++.||.|||+++|+||||||+|||++.++.+||+||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DF  177 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF  177 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeec
Confidence            899999999999999886432      12245788999999999999999999999999999999999999999999999


Q ss_pred             ccccccCCCcc-ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCC-CCccccccccccchhHHHHHHhhh
Q 017232          207 GLSRLFPNHVT-HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSM-PAVDITRHRHEINLSNLAINKIQN  284 (375)
Q Consensus       207 g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~  284 (375)
                      |++........ .......+|+.|+|||.+.+..++.++||||||+++|||+||. +||.......      .       
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~------~-------  244 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ------V-------  244 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH------H-------
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHH------H-------
Confidence            99986643322 2233446899999999999999999999999999999999984 7775433111      0       


Q ss_pred             hHHHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhcC
Q 017232          285 KALHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIESD  341 (375)
Q Consensus       285 ~~~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~~  341 (375)
                        ...+.+    ....+.+..++..+.+++.+||+.+|++|||+.+|+++|++....
T Consensus       245 --~~~i~~----~~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~  295 (308)
T d1p4oa_         245 --LRFVME----GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  295 (308)
T ss_dssp             --HHHHHT----TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             --HHHHHh----CCCCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence              111111    111112223556899999999999999999999999999887553

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-51  Score=363.82  Aligned_cols=269  Identities=21%  Similarity=0.339  Sum_probs=197.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|+++++||+|+||+||+|.. .+|+.||||++.....  ...+.+.+|+.++++++||||+++++++.. ...+|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-ENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-TTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-ccceeEEE
Confidence            5799999999999999999976 5799999999965432  234678899999999999999999998876 67899999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      ||+.++ +.+++...  ....+++.+++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus        81 e~~~~~-~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~  157 (298)
T d1gz8a_          81 EFLHQD-LKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR  157 (298)
T ss_dssp             ECCSEE-HHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB
T ss_pred             eecCCc-hhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcc
Confidence            999754 44444322  345699999999999999999999999999999999999999999999999999987644332


Q ss_pred             ccccCCCCCccccCcccccccC-CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHH---h-
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQ-LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELV---D-  292 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~-  292 (375)
                       ......||+.|+|||.+.... ++.++||||+||++|+|++|+.||....................+.......   + 
T Consensus       158 -~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         158 -TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             -CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             -cceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence             233457999999999876655 5789999999999999999999997543211100000000000000000000   0 


Q ss_pred             -hhc-CCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          293 -QTL-GYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       293 -~~l-~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                       ... .....   ......+..+.+|+.+||..||++|||+.|+++.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence             000 00000   0111234678999999999999999999999874

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.8e-50  Score=359.03  Aligned_cols=264  Identities=22%  Similarity=0.353  Sum_probs=197.9

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccch--hhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEe
Q 017232           61 NYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNY--KRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYE  138 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e  138 (375)
                      ++|+++++||+|+||+||+|..++|+.||||++.....  ...+.+.+|+.+|++++||||+++++++.. .+..+++||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-~~~~~i~~e   80 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-KKRLVLVFE   80 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-SSCEEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-CCceeEEEE
Confidence            57999999999999999999989999999999965432  235678999999999999999999998776 677999999


Q ss_pred             cccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCccc
Q 017232          139 FISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVTH  218 (375)
Q Consensus       139 ~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  218 (375)
                      ++.++.+..+..    ..+.+++..++.++.||+.||+|||+.||+||||||+|||++.++.+|++|||.+........ 
T Consensus        81 ~~~~~~~~~~~~----~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~-  155 (286)
T d1ob3a_          81 HLDQDLKKLLDV----CEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR-  155 (286)
T ss_dssp             CCSEEHHHHHHT----STTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC----
T ss_pred             eehhhhHHHHHh----hcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCcc-
Confidence            998776666653    345699999999999999999999999999999999999999999999999999987644322 


Q ss_pred             cccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh---hHHHHHH---
Q 017232          219 VSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN---KALHELV---  291 (375)
Q Consensus       219 ~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~---  291 (375)
                      ......+++.|+|||.+.+ ..++.++||||+||++|||++|++||......+..  ... ......   .......   
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~--~~i-~~~~~~~~~~~~~~~~~~~  232 (286)
T d1ob3a_         156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL--MRI-FRILGTPNSKNWPNVTELP  232 (286)
T ss_dssp             ------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH--HHH-HHHHCCCCTTTSTTGGGST
T ss_pred             ccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHH--HHH-HHhhCCCChhhccchhhhh
Confidence            2233458999999998765 45689999999999999999999999754322111  000 000000   0000000   


Q ss_pred             --hhhcC-C---CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          292 --DQTLG-Y---ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       292 --~~~l~-~---~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        ..... .   .........+..+.+|+.+||+.||++|||++|+++
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence              00000 0   000111223457889999999999999999999974

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-50  Score=361.55  Aligned_cols=271  Identities=23%  Similarity=0.344  Sum_probs=198.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CC-CCEEEEEEecccch--hhHHHHHHHHHHHHhc---CCCCeEEEeeeeec----
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QD-GRAVAVKRLYENNY--KRVEQFMNEVDILARL---RHKNLVSLYGCTSR----  128 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~-~~~vaiK~~~~~~~--~~~~~~~~e~~~l~~l---~h~niv~~~~~~~~----  128 (375)
                      .++|+++++||+|+||+||+|.. ++ ++.||||++.....  .....+.+|+.+++.+   +||||+++++++..    
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999976 34 56799999865422  1223456777777666   79999999997642    


Q ss_pred             CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecc
Q 017232          129 HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGL  208 (375)
Q Consensus       129 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~  208 (375)
                      ....++++|||+.++.+......   ....+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||+
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~~---~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~  162 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDKV---PEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL  162 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHHS---CTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCS
T ss_pred             cCceEEEEEEeccCCchhhhhhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhh
Confidence            34578999999988776554432   345689999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHH
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALH  288 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (375)
                      +......  .......||+.|+|||++.+..++.++||||+||++|||++|++||..........   ............
T Consensus       163 ~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~---~i~~~~~~~~~~  237 (305)
T d1blxa_         163 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG---KILDVIGLPGEE  237 (305)
T ss_dssp             CCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH---HHHHHHCCCCGG
T ss_pred             hhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH---HHHHhhCCCchh
Confidence            8765432  23345679999999999999999999999999999999999999997554221110   000000000000


Q ss_pred             HH------Hhhhc----CCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhh
Q 017232          289 EL------VDQTL----GYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDI  338 (375)
Q Consensus       289 ~~------~~~~l----~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i  338 (375)
                      .+      .....    ...........++.+.+|+.+||+.||++|||+.|+++.  |+++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         238 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             cccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            00      00000    000000111234578899999999999999999999874  5544

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-50  Score=356.20  Aligned_cols=240  Identities=23%  Similarity=0.368  Sum_probs=193.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccch------hhHHHHHHHHHHHHhcC--CCCeEEEeeeeecCC
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNY------KRVEQFMNEVDILARLR--HKNLVSLYGCTSRHS  130 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~------~~~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~  130 (375)
                      .++|++.+.||+|+||+||+|... +|+.||||++.....      .....+.+|+.++++++  ||||+++++++.. .
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~-~   81 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER-P   81 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC-S
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEee-C
Confidence            467999999999999999999664 789999999864321      11234668999999997  8999999998776 6


Q ss_pred             ceeEEEEecccC-CChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC-CCcEEEeeecc
Q 017232          131 RELLLVYEFISN-GTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-NFCVKVADFGL  208 (375)
Q Consensus       131 ~~~~lv~e~~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~-~~~~kl~Dfg~  208 (375)
                      +..++||||+.+ +++.+++..    ...+++.+++.++.||+.||+|||++||+||||||+|||++. ++.+||+|||+
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~  157 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGS  157 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECcccc
Confidence            789999999976 577777743    346999999999999999999999999999999999999985 57999999999


Q ss_pred             ccccCCCccccccCCCCCccccCcccccccCC-CCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHH
Q 017232          209 SRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQL-TDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKAL  287 (375)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  287 (375)
                      +.......   .....||+.|+|||++.+..+ +.++||||+||++|+|++|+.||.....                   
T Consensus       158 a~~~~~~~---~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-------------------  215 (273)
T d1xwsa_         158 GALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-------------------  215 (273)
T ss_dssp             CEECCSSC---BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-------------------
T ss_pred             ceeccccc---ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-------------------
Confidence            98654322   234579999999999887665 5678999999999999999999964320                   


Q ss_pred             HHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          288 HELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       288 ~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                        +........     ..++.++.+|+.+||+.||++|||++|+++
T Consensus       216 --i~~~~~~~~-----~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         216 --IIRGQVFFR-----QRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             --HHHCCCCCS-----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             --HhhcccCCC-----CCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence              111111111     123467899999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.9e-48  Score=348.09  Aligned_cols=261  Identities=20%  Similarity=0.259  Sum_probs=199.1

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEEec
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVYEF  139 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~e~  139 (375)
                      ++|++.+.||+|+||.||+|.. .+|+.||||++......  ..+..|+++++.++|+|++..+..+.......++||||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~--~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS--CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC--HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            5799999999999999999966 46899999987654322  35778999999999887776666555557889999999


Q ss_pred             ccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEec---CCCcEEEeeeccccccCCCc
Q 017232          140 ISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLD---NNFCVKVADFGLSRLFPNHV  216 (375)
Q Consensus       140 ~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~---~~~~~kl~Dfg~~~~~~~~~  216 (375)
                      + +++|...+..   ....+++..+..++.|++.||+|||++||+||||||+|||++   .+..++|+|||++..+....
T Consensus        85 ~-~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~  160 (299)
T d1ckia_          85 L-GPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDAR  160 (299)
T ss_dssp             C-CCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTT
T ss_pred             c-CCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccc
Confidence            9 5666666543   234699999999999999999999999999999999999975   45579999999998765432


Q ss_pred             c------ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHH
Q 017232          217 T------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHEL  290 (375)
Q Consensus       217 ~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  290 (375)
                      .      .......||+.|+|||.+.+..++.++|||||||++|||++|..||.........................  
T Consensus       161 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~--  238 (299)
T d1ckia_         161 THQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE--  238 (299)
T ss_dssp             TCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH--
T ss_pred             cccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh--
Confidence            2      12234579999999999999999999999999999999999999997654332221111110000000000  


Q ss_pred             HhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhh
Q 017232          291 VDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIE  339 (375)
Q Consensus       291 ~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~  339 (375)
                                .....++.++.+++..|++.+|++||++.++.+.|+.+.
T Consensus       239 ----------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~  277 (299)
T d1ckia_         239 ----------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF  277 (299)
T ss_dssp             ----------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred             ----------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHH
Confidence                      001124467899999999999999999999999998764

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.8e-49  Score=357.54  Aligned_cols=269  Identities=19%  Similarity=0.263  Sum_probs=195.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc-chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC----cee
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN-NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS----REL  133 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~----~~~  133 (375)
                      ..+|+++++||+|+||+||+|.. .+|+.||||++... .....+.+.+|+.+|+.++||||+++++++....    ..+
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            45799999999999999999965 58999999999654 3445667899999999999999999999775432    234


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccC
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFP  213 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~  213 (375)
                      +++ +++.+|+|.+++..     ..+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++....
T Consensus        87 ~l~-~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~  160 (345)
T d1pmea_          87 YLV-THLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVAD  160 (345)
T ss_dssp             EEE-EECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEE-EeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence            555 55668999999953     358999999999999999999999999999999999999999999999999998654


Q ss_pred             CCcc--ccccCCCCCccccCccccc-ccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhh-----
Q 017232          214 NHVT--HVSTAPQGTPGYVDPEYHQ-CYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNK-----  285 (375)
Q Consensus       214 ~~~~--~~~~~~~~~~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-----  285 (375)
                      ....  .......||+.|+|||++. +..++.++||||+||++|+|++|++||......+...............     
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            3222  2234456999999999874 4567889999999999999999999997654322111110000000000     


Q ss_pred             ---HHHHHHhhhcCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          286 ---ALHELVDQTLGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       286 ---~~~~~~~~~l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                         ...............   ......+..+.+|+.+||..||++|||+.|+++.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence               000000000000000   0011233568899999999999999999999864

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.1e-49  Score=357.59  Aligned_cols=269  Identities=20%  Similarity=0.321  Sum_probs=196.9

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCC-----c
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHS-----R  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-----~  131 (375)
                      .++|+++++||+|+||+||+|... +|+.||||++...  .....+.+.+|+.+|+.++|||||++++++...+     .
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            467999999999999999999754 6999999999654  3344567899999999999999999999876533     3


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      .+|+||||+ +.+|..++..     ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+|++|||++..
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~  170 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  170 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             eEEEEEecc-cccHHHHHHh-----ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceec
Confidence            579999999 6778777642     4599999999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHH--------HHHh
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLA--------INKI  282 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~--------~~~~  282 (375)
                      .....    ....+|+.|+|||.+.+ ..++.++||||+||++|+|++|++||...............        ....
T Consensus       171 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (346)
T d1cm8a_         171 ADSEM----TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRL  246 (346)
T ss_dssp             CCSSC----CSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTC
T ss_pred             cCCcc----ccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhh
Confidence            64432    34569999999998876 45689999999999999999999999765432211100000        0000


Q ss_pred             hhhHHHHHHhhhcC---CCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhh
Q 017232          283 QNKALHELVDQTLG---YESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDI  338 (375)
Q Consensus       283 ~~~~~~~~~~~~l~---~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i  338 (375)
                      ..............   ..........+..+.+|+.+||..||++|||+.|+++.  |+.+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~  307 (346)
T d1cm8a_         247 QSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  307 (346)
T ss_dssp             SCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             cchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcC
Confidence            00000000100000   00011111234578899999999999999999999974  5554

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-49  Score=358.59  Aligned_cols=272  Identities=21%  Similarity=0.271  Sum_probs=196.5

Q ss_pred             CCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCeEEEeeeeec-----CCceeEE
Q 017232           62 YFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNLVSLYGCTSR-----HSRELLL  135 (375)
Q Consensus        62 ~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~~~~l  135 (375)
                      +|+..++||+|+||+||+|... +|+.||||++.....    ...+|+.+|++++||||+++++++..     +..++++
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l   96 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL   96 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred             CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence            4777889999999999999765 699999999965532    23479999999999999999997643     2345799


Q ss_pred             EEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC-cEEEeeeccccccCC
Q 017232          136 VYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF-CVKVADFGLSRLFPN  214 (375)
Q Consensus       136 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~  214 (375)
                      |||||+++.+. .+.........+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.....
T Consensus        97 v~Ey~~~~~~~-~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~  175 (350)
T d1q5ka_          97 VLDYVPETVYR-VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR  175 (350)
T ss_dssp             EEECCSEEHHH-HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCT
T ss_pred             EEeccCCccHH-HHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccC
Confidence            99999765433 3332223456799999999999999999999999999999999999999775 899999999987644


Q ss_pred             CccccccCCCCCccccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhh
Q 017232          215 HVTHVSTAPQGTPGYVDPEYHQC-YQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQ  293 (375)
Q Consensus       215 ~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  293 (375)
                      ...  .....|++.|+|||.+.+ ..++.++||||+||++|||++|++||......+.........+.............
T Consensus       176 ~~~--~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~  253 (350)
T d1q5ka_         176 GEP--NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN  253 (350)
T ss_dssp             TSC--CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-
T ss_pred             Ccc--cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc
Confidence            332  234569999999997764 57899999999999999999999999755432211100000000000111111100


Q ss_pred             hcCCCCC---------hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH--HHhhhc
Q 017232          294 TLGYESD---------NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA--LRDIES  340 (375)
Q Consensus       294 ~l~~~~~---------~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~--L~~i~~  340 (375)
                      .......         ......++.+.+|+.+||..||++|||+.|+++.  |+++..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  311 (350)
T d1q5ka_         254 YTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDELRD  311 (350)
T ss_dssp             --CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGGC
T ss_pred             hhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccccC
Confidence            0000000         0001234578999999999999999999999963  666544

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-48  Score=352.12  Aligned_cols=269  Identities=21%  Similarity=0.285  Sum_probs=194.1

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC-------
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH-------  129 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~-------  129 (375)
                      .++|+++++||+|+||+||+|.. .+|+.||||++...  ......++.+|+.+|+.++|||++++++++...       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            36799999999999999999976 47999999998544  223346788999999999999999999966432       


Q ss_pred             CceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccc
Q 017232          130 SRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLS  209 (375)
Q Consensus       130 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~  209 (375)
                      ...+++||||+.++.+....    .....+++..++.++.|++.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~----~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~  164 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS----NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLA  164 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT----CTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTC
T ss_pred             CceEEEEEeccCCCccchhh----hcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeeccee
Confidence            34689999999877666544    23456899999999999999999999999999999999999999999999999999


Q ss_pred             cccCCCcc---ccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh-
Q 017232          210 RLFPNHVT---HVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN-  284 (375)
Q Consensus       210 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-  284 (375)
                      ..+.....   .......||+.|+|||++.+. .++.++||||+||++|||++|++||..................... 
T Consensus       165 ~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  244 (318)
T d3blha1         165 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPE  244 (318)
T ss_dssp             EECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             eecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChh
Confidence            76653221   222335699999999988754 6899999999999999999999999754321111000000000000 


Q ss_pred             -------hHHHHHHhhhcCCCCChHH-----HHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          285 -------KALHELVDQTLGYESDNKV-----RRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       285 -------~~~~~~~~~~l~~~~~~~~-----~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                             ......... .........     ......+.+|+.+||+.||++|||++|+++
T Consensus       245 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         245 VWPNVDNYELYEKLEL-VKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             TSTTCCCC-------C-CSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hccccchhhhhhhhcc-cccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence                   000000000 000000000     112346789999999999999999999985

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-47  Score=350.38  Aligned_cols=266  Identities=20%  Similarity=0.264  Sum_probs=194.3

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeec-----CCc
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSR-----HSR  131 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~-----~~~  131 (375)
                      .++|+++++||+|+||+||+|... +|+.||||++...  +......+.+|+.+++.++||||+++++++..     ...
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~   95 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ   95 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCc
Confidence            367999999999999999999765 6999999999654  34455678899999999999999999997753     246


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      .+|+|||||.++.+ +.+.      ..+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||++..
T Consensus        96 ~~~iv~Ey~~~~l~-~~~~------~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~  168 (355)
T d2b1pa1          96 DVYLVMELMDANLC-QVIQ------MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART  168 (355)
T ss_dssp             EEEEEEECCSEEHH-HHHT------SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             eeEEEEeccchHHH-Hhhh------cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhc
Confidence            88999999976544 4442      2489999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHH-----HHh--hh
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAI-----NKI--QN  284 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-----~~~--~~  284 (375)
                      .....  ......+|+.|+|||++.+..+++++||||+||++|+|++|++||................     ..+  ..
T Consensus       169 ~~~~~--~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (355)
T d2b1pa1         169 AGTSF--MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_dssp             --------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSC
T ss_pred             ccccc--ccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhh
Confidence            54332  2334468999999999999999999999999999999999999997554221110000000     000  00


Q ss_pred             hHHHHHHh---------------hhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Q 017232          285 KALHELVD---------------QTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDA  334 (375)
Q Consensus       285 ~~~~~~~~---------------~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~  334 (375)
                      ....+...               ..............+..+.+|+.+||..||++|||++|+++.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            11111111               111122223344567889999999999999999999999854

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=3.6e-47  Score=338.16  Aligned_cols=262  Identities=17%  Similarity=0.219  Sum_probs=203.6

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEeC-CCCEEEEEEecccchhhHHHHHHHHHHHHhcCC-CCeEEEeeeeecCCceeEEEE
Q 017232           60 TNYFDSARELGDGGFGTVYYGELQ-DGRAVAVKRLYENNYKRVEQFMNEVDILARLRH-KNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~lv~  137 (375)
                      .++|++.+.||+|+||+||+|... +|+.||||++.....  ...+.+|++.++.++| +|++.+++++.. +...++||
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~-~~~~~~vm   80 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQE-GLHNVLVI   80 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEE-TTEEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeec-CCccEEEE
Confidence            367999999999999999999765 689999998755432  2356789999999975 899999987665 67889999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecC-----CCcEEEeeecccccc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDN-----NFCVKVADFGLSRLF  212 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~-----~~~~kl~Dfg~~~~~  212 (375)
                      ||+ +++|.+++...   ...+++..+..++.|++.||+|||++||+||||||+|||++.     ++.+||+|||+++..
T Consensus        81 e~~-~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~  156 (293)
T d1csna_          81 DLL-GPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY  156 (293)
T ss_dssp             ECC-CCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred             Eec-CCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence            999 68999988543   345899999999999999999999999999999999999964     678999999999876


Q ss_pred             CCCcc------ccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhH
Q 017232          213 PNHVT------HVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKA  286 (375)
Q Consensus       213 ~~~~~------~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  286 (375)
                      .....      .......||+.|+|||++.+..++.++|||||||++|||++|..||.......................
T Consensus       157 ~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~  236 (293)
T d1csna_         157 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTP  236 (293)
T ss_dssp             BCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSC
T ss_pred             ccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCC
Confidence            43221      122345699999999999999999999999999999999999999975443321111111000000000


Q ss_pred             HHHHHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhhhc
Q 017232          287 LHELVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLDALRDIES  340 (375)
Q Consensus       287 ~~~~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~~L~~i~~  340 (375)
                      ..+     +.       ..+++++.+++..|+..+|++||+++.+.+.|+++..
T Consensus       237 ~~~-----l~-------~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~  278 (293)
T d1csna_         237 LRE-----LC-------AGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  278 (293)
T ss_dssp             HHH-----HT-------TTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             hHH-----hc-------CCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHH
Confidence            111     10       1234678999999999999999999999999888643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=4.5e-47  Score=343.56  Aligned_cols=259  Identities=20%  Similarity=0.287  Sum_probs=197.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CCCeEEEeeeeec-CCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCTSR-HSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~-~~~~~~lv~  137 (375)
                      ++|+++++||+|+||+||+|+. .+|+.||||++....   .+.+.+|+.+|+.++ ||||+++++++.. ....+++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC---HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH---HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence            5799999999999999999976 478999999986543   356789999999995 9999999997764 346789999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCC-cEEEeeeccccccCCCc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNF-CVKVADFGLSRLFPNHV  216 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~~  216 (375)
                      |||.+++|....       +.+++.+++.++.||+.||+|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus       112 e~~~~~~L~~~~-------~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGGGTT-------TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHHHHh-------cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999999987764       2489999999999999999999999999999999999998655 69999999998765433


Q ss_pred             cccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHHHHhhh-
Q 017232          217 THVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHELVDQT-  294 (375)
Q Consensus       217 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  294 (375)
                      .  .....+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||.........  .......+......+..... 
T Consensus       185 ~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~--~~~i~~~~g~~~~~~~~~~~~  260 (328)
T d3bqca1         185 E--YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ--LVRIAKVLGTEDLYDYIDKYN  260 (328)
T ss_dssp             C--CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHH--HHHHHHHHCHHHHHHHHHHTT
T ss_pred             c--ccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHH--HHHHHHHHCCchhhhhhhhcc
Confidence            2  2345689999999987764 5799999999999999999999999654322111  11111111111111111100 


Q ss_pred             ----------cCC---------CCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          295 ----------LGY---------ESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       295 ----------l~~---------~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                                +..         ........++.++.+|+.+||..||++|||++|+++
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      000         000011224467899999999999999999999986

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-48  Score=348.58  Aligned_cols=252  Identities=24%  Similarity=0.318  Sum_probs=199.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEeC----CCCEEEEEEeccc----chhhHHHHHHHHHHHHhcCC-CCeEEEeeeeecCCc
Q 017232           61 NYFDSARELGDGGFGTVYYGELQ----DGRAVAVKRLYEN----NYKRVEQFMNEVDILARLRH-KNLVSLYGCTSRHSR  131 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~vaiK~~~~~----~~~~~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  131 (375)
                      ++|++.+.||+|+||+||+|...    +|+.||||++...    +....+.+.+|+.++++++| |||+++++++.. ..
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~-~~  102 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT-ET  102 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE-TT
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc-CC
Confidence            55999999999999999999642    4789999998643    22234567889999999976 899999997776 56


Q ss_pred             eeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccc
Q 017232          132 ELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRL  211 (375)
Q Consensus       132 ~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~  211 (375)
                      .++++|||+.+|+|.+++...    ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++..
T Consensus       103 ~~~~v~e~~~~~~L~~~i~~~----~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~  178 (322)
T d1vzoa_         103 KLHLILDYINGGELFTHLSQR----ERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE  178 (322)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred             ceeeeeecccccHHHHHHHhc----ccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhh
Confidence            899999999999999998644    3478899999999999999999999999999999999999999999999999987


Q ss_pred             cCCCccccccCCCCCccccCccccccc--CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhhhHHHH
Q 017232          212 FPNHVTHVSTAPQGTPGYVDPEYHQCY--QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQNKALHE  289 (375)
Q Consensus       212 ~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (375)
                      +............|++.|+|||.+.+.  .++.++|||||||+||+|++|..||.........  .....         .
T Consensus       179 ~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~--~~i~~---------~  247 (322)
T d1vzoa_         179 FVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ--AEISR---------R  247 (322)
T ss_dssp             CCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH--HHHHH---------H
T ss_pred             hcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHH--HHHHH---------h
Confidence            655444444556799999999988654  4788999999999999999999999765433211  11100         0


Q ss_pred             HHhhhcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCC-----HHHHHH
Q 017232          290 LVDQTLGYESDNKVRRTINAVAELAFQCLQSEKDLRPY-----MVDVLD  333 (375)
Q Consensus       290 ~~~~~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt-----~~evl~  333 (375)
                      .......     .+..++..+.+|+.+||+.||++|||     ++|+++
T Consensus       248 ~~~~~~~-----~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         248 ILKSEPP-----YPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHCCCC-----CCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             cccCCCC-----CcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            1111111     11135578999999999999999994     788875

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-47  Score=336.63  Aligned_cols=265  Identities=22%  Similarity=0.279  Sum_probs=199.4

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecCCceeEEEE
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRHSRELLLVY  137 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~lv~  137 (375)
                      ++|+++++||+|+||+||+|+. .+|+.||||+++..  .......+.+|+.+++.++||||+++++++.. ....++|+
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~-~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-DKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-SSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccccc-ccceeEEe
Confidence            5799999999999999999976 47899999998644  33446788999999999999999999997776 67789999


Q ss_pred             ecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeeccccccCCCcc
Q 017232          138 EFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLFPNHVT  217 (375)
Q Consensus       138 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  217 (375)
                      +++.+++|..++.    ..+.+++..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||.+........
T Consensus        81 ~~~~~~~l~~~~~----~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~  156 (292)
T d1unla_          81 EFCDQDLKKYFDS----CNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR  156 (292)
T ss_dssp             ECCSEEHHHHHHH----TTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCS
T ss_pred             eeccccccccccc----cccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCc
Confidence            9999988888774    335689999999999999999999999999999999999999999999999999987654322


Q ss_pred             ccccCCCCCccccCcccccccC-CCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHHHhhh---hHHH---HH
Q 017232          218 HVSTAPQGTPGYVDPEYHQCYQ-LTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAINKIQN---KALH---EL  290 (375)
Q Consensus       218 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~---~~  290 (375)
                       ......+++.|+|||.+.+.. ++.++||||+||++|||++|+.||........  ...........   ....   ..
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~  233 (292)
T d1unla_         157 -CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDD--QLKRIFRLLGTPTEEQWPSMTKL  233 (292)
T ss_dssp             -CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHH--HHHHHHHHHCCCCTTTCTTGGGS
T ss_pred             -cceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHH--HHHHHHhhcCCCChhhhhhhhhc
Confidence             223345788899999877654 68999999999999999999988643221110  00000000000   0000   00


Q ss_pred             Hhh------hcCCCCChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH
Q 017232          291 VDQ------TLGYESDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD  333 (375)
Q Consensus       291 ~~~------~l~~~~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~  333 (375)
                      .+.      .............+..+.+|+.+||+.||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            000      0000011111233457889999999999999999999976

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-47  Score=347.23  Aligned_cols=270  Identities=20%  Similarity=0.295  Sum_probs=195.8

Q ss_pred             hcCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEeccc--chhhHHHHHHHHHHHHhcCCCCeEEEeeeeecC----Cce
Q 017232           60 TNYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYEN--NYKRVEQFMNEVDILARLRHKNLVSLYGCTSRH----SRE  132 (375)
Q Consensus        60 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~--~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~----~~~  132 (375)
                      .++|++.++||+|+||+||+|.. .+|+.||||++...  .....+.+.+|+.+|+.++|||++++++++...    ...
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            46799999999999999999965 57999999998654  334456788999999999999999999976432    223


Q ss_pred             eEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEeeecccccc
Q 017232          133 LLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVADFGLSRLF  212 (375)
Q Consensus       133 ~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~  212 (375)
                      .+++++++.+|+|.+++.     ...+++..++.++.||+.||+|||++||+||||||+|||++.++.+|++|||++...
T Consensus        97 ~~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~  171 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  171 (348)
T ss_dssp             CCEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CC
T ss_pred             eEEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhccc
Confidence            455666777999999983     245999999999999999999999999999999999999999999999999998754


Q ss_pred             CCCccccccCCCCCccccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHHH--------Hhh
Q 017232          213 PNHVTHVSTAPQGTPGYVDPEYHQCY-QLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAIN--------KIQ  283 (375)
Q Consensus       213 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~~--------~~~  283 (375)
                      ..    ......|++.|+|||...+. .++.++||||+||++|+|++|++||.................        ...
T Consensus       172 ~~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (348)
T d2gfsa1         172 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  247 (348)
T ss_dssp             TG----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCC
T ss_pred             Cc----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhcc
Confidence            32    22345689999999986664 468899999999999999999999975542211100000000        000


Q ss_pred             hhHHHHHHhhhcCCCCC---hHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHH--HHHhh
Q 017232          284 NKALHELVDQTLGYESD---NKVRRTINAVAELAFQCLQSEKDLRPYMVDVLD--ALRDI  338 (375)
Q Consensus       284 ~~~~~~~~~~~l~~~~~---~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl~--~L~~i  338 (375)
                      .................   ......+..+.+|+.+||..||++|||+.|+++  .|.++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         248 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             CHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             chhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence            00001111100000000   001123467889999999999999999999987  35443

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.7e-41  Score=306.45  Aligned_cols=268  Identities=19%  Similarity=0.231  Sum_probs=187.2

Q ss_pred             cCCCCCCccCCCCcEEEEEEEe-CCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-----------CCCeEEEeeeeec
Q 017232           61 NYFDSARELGDGGFGTVYYGEL-QDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-----------HKNLVSLYGCTSR  128 (375)
Q Consensus        61 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  128 (375)
                      ++|+++++||+|+||+||+|+. .+|+.||||++..... ..+.+.+|+.+++.++           |+||+++++++..
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~-~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV-YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH-HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc-chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            4599999999999999999976 4799999999976543 2356778998888875           5789999886543


Q ss_pred             -CCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh-CCceeccCCCCCEEecCCCc------
Q 017232          129 -HSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA-SDIIHRDVKTNNILLDNNFC------  200 (375)
Q Consensus       129 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~-~~ivH~dlkp~Nill~~~~~------  200 (375)
                       .....+++++++..+......... .....+++..++.++.||+.||.|||+ .||+||||||+|||++.++.      
T Consensus        92 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~  170 (362)
T d1q8ya_          92 KGPNGVHVVMVFEVLGENLLALIKK-YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQ  170 (362)
T ss_dssp             EETTEEEEEEEECCCCEEHHHHHHH-TTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEE
T ss_pred             ccccceeeeeeeccccccccccccc-ccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccce
Confidence             234556666666544332222211 244568999999999999999999998 89999999999999986653      


Q ss_pred             EEEeeeccccccCCCccccccCCCCCccccCcccccccCCCCchhHHHHHHHHHHHHhCCCCccccccccccchhHHHH-
Q 017232          201 VKVADFGLSRLFPNHVTHVSTAPQGTPGYVDPEYHQCYQLTDKSDVFSFGVVLIELISSMPAVDITRHRHEINLSNLAI-  279 (375)
Q Consensus       201 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p~~~~~~~~~~~~~~~~~-  279 (375)
                      ++++|||.+......    .....||+.|+|||++.+..++.++||||+||++++|++|+.||................ 
T Consensus       171 ~kl~dfg~s~~~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~  246 (362)
T d1q8ya_         171 IKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQ  246 (362)
T ss_dssp             EEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHH
T ss_pred             eeEeecccccccccc----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHH
Confidence            999999998754322    234569999999999999999999999999999999999999997544322111111000 


Q ss_pred             --HHhhh---hHH------HHHHhh-----hcCCC-----------CChHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Q 017232          280 --NKIQN---KAL------HELVDQ-----TLGYE-----------SDNKVRRTINAVAELAFQCLQSEKDLRPYMVDVL  332 (375)
Q Consensus       280 --~~~~~---~~~------~~~~~~-----~l~~~-----------~~~~~~~~~~~l~~li~~cl~~~P~~Rpt~~evl  332 (375)
                        ..+..   ...      ....+.     .....           ........+..+.+|+.+||..||.+|||++|++
T Consensus       247 ~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L  326 (362)
T d1q8ya_         247 IIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLV  326 (362)
T ss_dssp             HHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHH
T ss_pred             HHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHh
Confidence              00000   000      000000     00000           0001134567899999999999999999999998


Q ss_pred             HH
Q 017232          333 DA  334 (375)
Q Consensus       333 ~~  334 (375)
                      +.
T Consensus       327 ~H  328 (362)
T d1q8ya_         327 NH  328 (362)
T ss_dssp             TC
T ss_pred             cC
Confidence            63

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=9.1e-26  Score=186.74  Aligned_cols=164  Identities=13%  Similarity=0.095  Sum_probs=120.3

Q ss_pred             CCCCccCCCCcEEEEEEEeCCCCEEEEEEecccch------------------hhHHHHHHHHHHHHhcCCCCeEEEeee
Q 017232           64 DSARELGDGGFGTVYYGELQDGRAVAVKRLYENNY------------------KRVEQFMNEVDILARLRHKNLVSLYGC  125 (375)
Q Consensus        64 ~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~niv~~~~~  125 (375)
                      .+.++||+|+||+||+|...+|+.||||++.....                  ........|...+.++.|.+++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            35678999999999999888899999998643211                  112334568889999999999988764


Q ss_pred             eecCCceeEEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhhCCceeccCCCCCEEecCCCcEEEee
Q 017232          126 TSRHSRELLLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHASDIIHRDVKTNNILLDNNFCVKVAD  205 (375)
Q Consensus       126 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~~~ivH~dlkp~Nill~~~~~~kl~D  205 (375)
                      . .    .+++|||+++..+..           ++...+..++.|++.++.|||++||+||||||+|||+++++ ++|+|
T Consensus        83 ~-~----~~lvme~~~~~~~~~-----------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~~-~~liD  145 (191)
T d1zara2          83 E-G----NAVLMELIDAKELYR-----------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEG-IWIID  145 (191)
T ss_dssp             E-T----TEEEEECCCCEEGGG-----------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETTE-EEECC
T ss_pred             c-C----CEEEEEeeccccccc-----------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCCC-EEEEE
Confidence            2 1    279999998765433           34455678999999999999999999999999999999654 89999


Q ss_pred             eccccccCCCccccccCCCCCccccCcc-----cccccCCCCchhHHHHHHHH
Q 017232          206 FGLSRLFPNHVTHVSTAPQGTPGYVDPE-----YHQCYQLTDKSDVFSFGVVL  253 (375)
Q Consensus       206 fg~~~~~~~~~~~~~~~~~~~~~y~aPE-----~~~~~~~~~~~DiwslG~il  253 (375)
                      ||++.....+...         .|....     .+....|+.++|+||+.--+
T Consensus       146 FG~a~~~~~~~~~---------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         146 FPQSVEVGEEGWR---------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             CTTCEETTSTTHH---------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CCCcccCCCCCcH---------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            9999765432211         111110     01135678899999975443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.80  E-value=1.2e-08  Score=86.71  Aligned_cols=145  Identities=14%  Similarity=0.089  Sum_probs=98.2

Q ss_pred             HHHHHhcCCCCCCccCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-CCCeEEEeeeeecCCcee
Q 017232           55 ELEEATNYFDSARELGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-HKNLVSLYGCTSRHSREL  133 (375)
Q Consensus        55 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~  133 (375)
                      ++......|++.+..+.++.+.||+.... +..+++|+...........+.+|...+..+. +--+.+++..... ++..
T Consensus         8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~-~~~~   85 (263)
T d1j7la_           8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-DGWS   85 (263)
T ss_dssp             HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-TTEE
T ss_pred             HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEec-CCce
Confidence            45566677877776665666789998754 5678888876554444445677888887774 2223445554433 5678


Q ss_pred             EEEEecccCCChhHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh---------------------------------
Q 017232          134 LLVYEFISNGTVADHLHGERAKPGALPWPTRLKIAIETASALTYLHA---------------------------------  180 (375)
Q Consensus       134 ~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~---------------------------------  180 (375)
                      ++||++++|.++.+....         ......++.++...+..||+                                 
T Consensus        86 ~lv~~~l~G~~~~~~~~~---------~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (263)
T d1j7la_          86 NLLMSEADGVLCSEEYED---------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCE  156 (263)
T ss_dssp             EEEEECCSSEEHHHHTTT---------CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGG
T ss_pred             EEEEEecccccccccccc---------cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhh
Confidence            999999998888665421         11223345556666666663                                 


Q ss_pred             --------------------------CCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          181 --------------------------SDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       181 --------------------------~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                                                ..++|+|+.|.||++++++.+-|+||+.+.
T Consensus       157 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         157 NWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             GGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             cccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhcc
Confidence                                      027999999999999987767799999875

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.20  E-value=3.9e-06  Score=70.31  Aligned_cols=126  Identities=17%  Similarity=0.124  Sum_probs=81.7

Q ss_pred             cCCCC-cEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCC--eEEEeeeeecCCceeEEEEecccCCCh
Q 017232           69 LGDGG-FGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKN--LVSLYGCTSRHSRELLLVYEFISNGTV  145 (375)
Q Consensus        69 lg~G~-~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~lv~e~~~~~~L  145 (375)
                      +..|. .+.||+....++..+++|.......   ..+..|...++.+....  +.+++.+... .+..++||++++|.++
T Consensus        18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~-~~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTE-AGRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CSCTTSSCEEEEEECTTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEEC-SSCEEEEEECCSSEET
T ss_pred             cCCcccCCeEEEEEeCCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeeccc-ccceEEEEEeeecccc
Confidence            44444 4679999988888899997654432   24566777777774322  4445554444 5668899999988665


Q ss_pred             hHhhccCCCCCCCCChHHHHHHHHHHHHHHHHHhh---------------------------------------------
Q 017232          146 ADHLHGERAKPGALPWPTRLKIAIETASALTYLHA---------------------------------------------  180 (375)
Q Consensus       146 ~~~l~~~~~~~~~l~~~~~~~i~~~i~~~l~~Lh~---------------------------------------------  180 (375)
                      .+..         ...   ...+.++...|..||+                                             
T Consensus        94 ~~~~---------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (255)
T d1nd4a_          94 LSSH---------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  161 (255)
T ss_dssp             TTSC---------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             cccc---------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHH
Confidence            3321         111   1122333444444442                                             


Q ss_pred             ------C-------CceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          181 ------S-------DIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       181 ------~-------~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                            .       .++|+|+.|.|||++++..+-|+||+.+.
T Consensus       162 ~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         162 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence                  1       27999999999999987777899999775

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.74  E-value=2.5e-05  Score=69.75  Aligned_cols=76  Identities=20%  Similarity=0.186  Sum_probs=46.3

Q ss_pred             CCccCCCCcEEEEEEEeC-CCCEEEEEEeccc------c-hhhHHHHHHHHHHHHhcC--CC-CeEEEeeeeecCCceeE
Q 017232           66 ARELGDGGFGTVYYGELQ-DGRAVAVKRLYEN------N-YKRVEQFMNEVDILARLR--HK-NLVSLYGCTSRHSRELL  134 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~------~-~~~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~~  134 (375)
                      .+.||.|....||++... +++.+++|.-...      . .-.......|++.|+.+.  .| .+.+++.+ .  ....+
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~-d--~~~~~  107 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS-D--TEMAV  107 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE-E--TTTTE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE-c--CCCCE
Confidence            446899999999999765 4678999964321      1 112234456888877663  23 34455543 2  23457


Q ss_pred             EEEecccCCC
Q 017232          135 LVYEFISNGT  144 (375)
Q Consensus       135 lv~e~~~~~~  144 (375)
                      +|||++.+..
T Consensus       108 lvmE~L~~~~  117 (392)
T d2pula1         108 TVMEDLSHLK  117 (392)
T ss_dssp             EEECCCTTSE
T ss_pred             EEEeccCCcc
Confidence            8999997654

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.73  E-value=2.8e-05  Score=67.60  Aligned_cols=71  Identities=18%  Similarity=0.180  Sum_probs=45.2

Q ss_pred             CcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCe-----EEEee-eeecCCceeEEEEecccCCC
Q 017232           73 GFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL-----VSLYG-CTSRHSRELLLVYEFISNGT  144 (375)
Q Consensus        73 ~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-----v~~~~-~~~~~~~~~~lv~e~~~~~~  144 (375)
                      .--.||++...+|..|++|+.... ....+++..|...+..|...++     +..-+ .........+.+++++.|..
T Consensus        34 ~EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          34 YENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             ccceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            346899999999999999987544 2234667778888877742221     11111 11122456788999987643

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=97.67  E-value=0.00022  Score=61.37  Aligned_cols=157  Identities=12%  Similarity=0.069  Sum_probs=81.6

Q ss_pred             cchHHHHHHhcCCCCCCc-----cCCCCcEEEEEEEeCCCCEEEEEEecccchhhHHHHHHHHHHHHhcC-----CCCeE
Q 017232           51 FSYGELEEATNYFDSARE-----LGDGGFGTVYYGELQDGRAVAVKRLYENNYKRVEQFMNEVDILARLR-----HKNLV  120 (375)
Q Consensus        51 ~~~~~~~~~~~~y~~~~~-----lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-----h~niv  120 (375)
                      ++..+++....+|.+.+.     |..|.--+.|+.+..+|+ +++|+......  ...+..|+.++..|.     .|..+
T Consensus         3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~~--~~~l~~~~~~l~~L~~~g~pvp~pi   79 (316)
T d2ppqa1           3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRVE--KNDLPFFLGLMQHLAAKGLSCPLPL   79 (316)
T ss_dssp             CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred             CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCCC--HHHHHHHHHHHHhhhhccccccccc
Confidence            456778888888877544     446777889999887665 89998754321  233445666666663     22222


Q ss_pred             EEee--eeecCCceeEEEEecccCCChhH--------------hhcc----CCCC-CCCC------------------Ch
Q 017232          121 SLYG--CTSRHSRELLLVYEFISNGTVAD--------------HLHG----ERAK-PGAL------------------PW  161 (375)
Q Consensus       121 ~~~~--~~~~~~~~~~lv~e~~~~~~L~~--------------~l~~----~~~~-~~~l------------------~~  161 (375)
                      ...+  ...........++.+..+.....              .++.    .... ....                  ..
T Consensus        80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (316)
T d2ppqa1          80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE  159 (316)
T ss_dssp             CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred             eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence            2111  11111234455666665532211              0000    0000 0000                  00


Q ss_pred             HHHHHHHHHHHHHHHHHhh----CCceeccCCCCCEEecCCCcEEEeeecccc
Q 017232          162 PTRLKIAIETASALTYLHA----SDIIHRDVKTNNILLDNNFCVKVADFGLSR  210 (375)
Q Consensus       162 ~~~~~i~~~i~~~l~~Lh~----~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~  210 (375)
                      ......+..+...+...+.    .|++|+|+.++||+++++...-|+||+.+.
T Consensus       160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEecccccc
Confidence            1111222222222333222    279999999999999998878899999875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.07  E-value=0.00097  Score=59.14  Aligned_cols=73  Identities=18%  Similarity=0.292  Sum_probs=47.8

Q ss_pred             CCccCCCCcEEEEEEEeCC--------CCEEEEEEecccchhhHHHHHHHHHHHHhcCCCCe-EEEeeeeecCCceeEEE
Q 017232           66 ARELGDGGFGTVYYGELQD--------GRAVAVKRLYENNYKRVEQFMNEVDILARLRHKNL-VSLYGCTSRHSRELLLV  136 (375)
Q Consensus        66 ~~~lg~G~~g~V~~~~~~~--------~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~lv  136 (375)
                      ++.|+.|-.-.+|++...+        .+.|++++....  .......+|..+++.+.-.++ .++++++..     .+|
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~--~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~-----g~I  119 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFSG-----GRL  119 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEETT-----EEE
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc--chhhHHHHHHHHHHHHHhCCCCCeEEEEcCC-----ceE
Confidence            4578889999999997654        345677665422  223345678888888853344 356664432     579


Q ss_pred             EecccCCCh
Q 017232          137 YEFISNGTV  145 (375)
Q Consensus       137 ~e~~~~~~L  145 (375)
                      +||++|.++
T Consensus       120 ~efi~g~~l  128 (395)
T d1nw1a_         120 EEYIPSRPL  128 (395)
T ss_dssp             ECCCCEEEC
T ss_pred             EEEeccccC
Confidence            999987544